Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 1:

SGAPTYNWGENDTDV 6.05% (n=617)
FGVPTYSWGENETDV 4.06% (n=414)
AGAPTYNWGANETDV 4.05% (n=413)
AGAPTYRWGANDTDV 3.74% (n=382)
SGVPTYSWGGNETDV 3.53% (n=360)
SGAPTFNWGENDTDV 3.05% (n=311)
SGAPTYNWGDNDTDV 3.04% (n=310)
SGAPTYSWGANDTDV 2.99% (n=305)
SGAPTYSWGENDTDV 2.91% (n=297)
SGAPTYNWGENETDV 2.76% (n=282)
AGAPAYNWGENDTDV 2.70% (n=275)
FGAPTYSWGENETDV 2.63% (n=268)
SGVPTYRWGENETDV 2.54% (n=259)
LGVPTYNWGSNDTDV 2.42% (n=247)
AGAPTYNWGENDTDV 2.27% (n=232)
SGAPTYSWGENETDV 1.91% (n=195)
LGAPTYNWGSNETDV 1.72% (n=175)
LGAPTYNWGSNDTDV 1.64% (n=167)
SGEPTYNWGENDTDV 1.49% (n=152)
SGVPTYNWGENETDV 1.40% (n=143)
SGVPTYSWGENETDV 1.37% (n=140)
AGVPTYRWGENETDV 1.24% (n=126)
FGVPTYTWGENETDV 1.24% (n=126)
SGAPTYNWGANDTDV 1.16% (n=118)
AGIPTYSWGENDTDV 1.13% (n=115)
SGAPTYNWGENATDV 1.10% (n=112)
LGVPTYSWGENETDV 1.07% (n=109)
FGVPTYRWGENETDV 0.94% (n=96)
SGAPTYGWGANDTDV 0.90% (n=92)
FGAPTYTWGENETDV 0.80% (n=82)
LGVPTYTWGGNVTDV 0.78% (n=80)
SGAPTYTWGENETDV 0.76% (n=78)
SGAPTYNWGDNETDV 0.72% (n=73)
LGAPTYNWGCNDTDV 0.57% (n=58)
FGAPTYNWGENETDV 0.57% (n=58)
LGVPTYNWGDNDTDV 0.56% (n=57)
LGAPTYNWGENDTDV 0.54% (n=55)
SGVPTYTWGENETDV 0.54% (n=55)
SGVPTYNWGSNETDV 0.52% (n=53)
SGVPTYNWGENDTDV 0.50% (n=51)
FGVPTYNWGENETDV 0.49% (n=50)
FGVPTYSWGGNETDV 0.48% (n=49)
TGVPTYNWGENDTDV 0.43% (n=44)
LGAPTYNWGDNDTDV 0.42% (n=43)
LGAPTYSWGENDTDV 0.40% (n=41)
LGAPTYNWGSNDTDI 0.37% (n=38)
MGAPTYNWGENDTDV 0.35% (n=36)
LGQPTYNWGENETDV 0.35% (n=36)
SGVPTYNWGANDTDV 0.34% (n=35)
AGAPAYNWGENNTDV 0.34% (n=35)
YGVPTYSWGENETDV 0.34% (n=35)
AGVPTYNWGENETDV 0.33% (n=34)
SGAPTYNWGSNDTDV 0.32% (n=33)
LGVPTYNWGENDTDV 0.30% (n=31)
LGAPTYNWGGNDTDV 0.29% (n=30)
SGAPTYNWGANDTDI 0.27% (n=28)
SGAPTYNWGANETDV 0.26% (n=27)
LGAPTYNWGGKDTDV 0.26% (n=27)
RGAPTYNWGAREEDV 0.25% (n=26)
SGAPTYSWGANETDV 0.25% (n=25)
AGVPTYNWGENDTDV 0.24% (n=24)
RGVPTYSWGENDTDV 0.24% (n=24)
RGVPTYNWGANDTDV 0.24% (n=24)
RGVPTYSWGGNDTDV 0.23% (n=23)
LGVPTYTWGENETDV 0.23% (n=23)
AGVPTYSWGENETDV 0.22% (n=22)
LGAPTYNWGANDTDV 0.21% (n=21)
AGAPTYNWGSNDTDV 0.20% (n=20)
RGAPTYNWGSNDTDV 0.20% (n=20)
HGAPTYRWGENETDV 0.20% (n=20)
LGVPTYGWGSNDTDV 0.19% (n=19)
SGAPTYRWGENETDV 0.19% (n=19)
LGHPTYNWGENETDV 0.19% (n=19)
LGVPTYNWGANDTDV 0.18% (n=18)
SGVPTYNWGAKETDV 0.18% (n=18)
LGAPTYKWGANETDV 0.18% (n=18)
AGAPAYNWGENVTDV 0.18% (n=18)
FGAPTYNWGENQTDV 0.18% (n=18)
LGAPTYTWGSNDTDV 0.17% (n=17)
AGAPTYNWGANDTDV 0.17% (n=17)
AGAPTYNWGENETDV 0.16% (n=16)
LGVPTYSWGANDTDF 0.16% (n=16)
SGVPTYNWGADETDV 0.16% (n=16)
SGAPTYSWGEKETDV 0.16% (n=16)
AGVPTYSWGENDTDV 0.15% (n=15)
LGAPTYSWGSNETDV 0.15% (n=15)
SGAPTYRWGANETDV 0.15% (n=15)
RGAPTYNWGGNDTDV 0.15% (n=15)
RGVPTYNWGSNDTDV 0.15% (n=15)
LGAPTHTWGANDTDV 0.15% (n=15)
AGTPTYSWGANETDV 0.15% (n=15)
AGAPTYSWGENDTDV 0.14% (n=14)
LGVPTYNWGENETDV 0.14% (n=14)
SGVPTYNWGGNETDV 0.13% (n=13)
SGVPTYSWGKNETDV 0.13% (n=13)
-------------DV 0.12% (n=12)
SGVPTYNWGANVTDV 0.12% (n=12)
LGAPTYNWGENETDV 0.12% (n=12)
LGVPTYNWGANVTDV 0.12% (n=12)
FGAPTYNWGANETDV 0.12% (n=12)
MGAPTYNWGENETDV 0.11% (n=11)
FGVPTYNWGDNETDV 0.11% (n=11)
LGVPTYTWGENDTDV 0.11% (n=11)
LGDPTYGWGDNDTDV 0.10% (n=10)
SGVPTYNWGANETDV 0.10% (n=10)
LGVPTYNWGTNETDV 0.10% (n=10)
SGVPTYNWGANEMDV 0.10% (n=10)
SGAPTYNWGEGGTDV 0.10% (n=10)
SGAPTYNWGGNKTDV 0.10% (n=10)
FGAPTYRWGENETDV 0.10% (n=10)
FGVPTYTWGENKTDV 0.10% (n=10)
FGVPTYSWGGNVTDV 0.10% (n=10)
LGVPTYDWGSNDTDV 0.09% (n=9)
FGVPTYNWGGNETDV 0.09% (n=9)
HGVPTYSWGENETDV 0.09% (n=9)
--------GENETDV 0.09% (n=9)
LGAPTYDWGSNDTDV 0.08% (n=8)
LGVPTYTWGGNDTDF 0.08% (n=8)
LGAPTYSWGSNDTDV 0.08% (n=8)
LGVPTYRWGENETDV 0.08% (n=8)
SGVPTYNWGANKTDV 0.08% (n=8)
SGAPTYNWGENKTDV 0.08% (n=8)
FGAPTYNWGDNETDV 0.08% (n=8)
TGAPTYNWGANDTDV 0.07% (n=7)
LGVPTYSWGANNTDV 0.07% (n=7)
RGVPTYNWGENDTDV 0.07% (n=7)
LGAPTYNWGGNETDV 0.07% (n=7)
SGAPTYTWGENDTDV 0.07% (n=7)
FGVPTYSWGENKTDV 0.07% (n=7)
FGAPTYNWGGNETDV 0.07% (n=7)
SGAPTYTWGANDTDV 0.06% (n=6)
LGVPTYNWGANDTDF 0.06% (n=6)
RGMPTYSWGENDTDV 0.06% (n=6)
SGAPTYNWGSNETDV 0.06% (n=6)
RGAPTYNWGTREEDV 0.06% (n=6)
SGAPTYNWGGNETDV 0.06% (n=6)
LGVPTYNWGGNRTDV 0.06% (n=6)
FGAPTYNWGNNETDV 0.06% (n=6)
SGAPTYSWGENKTDV 0.06% (n=6)
SGVPTYSWGENDTDV 0.05% (n=5)
SGTPTYNWGANDTDF 0.05% (n=5)
SGAPTHSWGENDTDV 0.05% (n=5)
SGAPTYSWGEKDTDV 0.05% (n=5)
SGAPTHNWGANDTDV 0.05% (n=5)
KGAPTYTWGANDTDV 0.05% (n=5)
LGVPTYNWGDNETDV 0.05% (n=5)
SGVPTYNWGAHETDV 0.05% (n=5)
SGAPTYNWGAKETDV 0.05% (n=5)
AGAPTYGWGENDTDV 0.05% (n=5)
LGAPTYSWGENETDV 0.05% (n=5)
AGVPTYTWGENETDV 0.05% (n=5)
LGVPTFTWGSNNTDV 0.05% (n=5)
VGAPTYNWGENETDV 0.05% (n=5)
FGVPTYSWGANETDV 0.05% (n=5)
FGVPTYAWGGNETDV 0.05% (n=5)
FGAPTYSWGENETGV 0.05% (n=5)
SGMPTYNWGQNDTDV 0.04% (n=4)
SGAPTYNWGVNETDI 0.04% (n=4)
LGTPTFTWGGSVKDV 0.04% (n=4)
SGAPTYNWGCNETDV 0.04% (n=4)
LGLPTYNWGENDTDV 0.04% (n=4)
SGAPTYNWGGNDTDV 0.04% (n=4)
SGAPTFSWGENDTDV 0.04% (n=4)
LGVPTYNWGGNDTDV 0.04% (n=4)
-----YSWGENDTDV 0.04% (n=4)
LGVPTYNWGSDDKDV 0.04% (n=4)
SGVPTYNWGVNKTDV 0.04% (n=4)
SGMPTYNWGAKETDV 0.04% (n=4)
SGAPTYGWGENDTDV 0.04% (n=4)
TGAPTYNWGENDTDV 0.04% (n=4)
SGASTYNWGDNDTDV 0.04% (n=4)
RGAPTYNWGTQEEDV 0.04% (n=4)
RGAPTYNWGTREGDV 0.04% (n=4)
FGVPTYKWGENETDV 0.04% (n=4)
SGVPT---------- 0.04% (n=4)
FGVPT---------- 0.04% (n=4)
FGVPTYSWGE----- 0.04% (n=4)
SGVPTYSWGENKTDV 0.04% (n=4)
FGVPTYSWGENVTDV 0.04% (n=4)
RGVPTYSWGENETDV 0.04% (n=4)
SGVPTYKWGENETDV 0.04% (n=4)
YGVPTYKWGENETDV 0.04% (n=4)
YGVPTYTWGENETDV 0.04% (n=4)
LGVATYSWGATDADV 0.03% (n=3)
SGAPTYSWGTNDTDV 0.03% (n=3)
SEAPTYNWGENDTDV 0.03% (n=3)
SGAPTYNWGQNETDV 0.03% (n=3)
AGVPTYTWGENDTDV 0.03% (n=3)
QGAPTYNWGANETDV 0.03% (n=3)
AGVPTYTWGEKDTDV 0.03% (n=3)
SGLPTYNWGENDTDV 0.03% (n=3)
LGAPTYNWGSNSTDV 0.03% (n=3)
SGAPTYSWGENVTDV 0.03% (n=3)
AGAPTYNWGENDMDV 0.03% (n=3)
AGVPTYNWGSNDTDV 0.03% (n=3)
HGVPTYNWGENETDV 0.03% (n=3)
AGAPTYSWGENETDV 0.03% (n=3)
SGAPTYNWGENESDV 0.03% (n=3)
LGVPTYSWGENDTDV 0.03% (n=3)
LGTPTYNWGENDTDV 0.03% (n=3)
LGAPTYNWGANETDV 0.03% (n=3)
LGAPTYSWGANDTDV 0.03% (n=3)
AGVPTYNWGGNDTDV 0.03% (n=3)
LGAPTFSWGENDTDV 0.03% (n=3)
AGVPTYNWGGNETDV 0.03% (n=3)
SGMPTYNWGGNETDV 0.03% (n=3)
SGVPTYDWGSNDVDV 0.03% (n=3)
AGVPTYSWGVNDTDV 0.03% (n=3)
FGAPTYSWGANETDV 0.03% (n=3)
LGALTYNWGSNDTDI 0.03% (n=3)
AGAPTYNWGNNDTDV 0.03% (n=3)
SGAPTYDWGENETDA 0.03% (n=3)
AGAPAYNWGGNDTDV 0.03% (n=3)
SGVPTYTWGENKTDV 0.03% (n=3)
FGAPTYTWGANETDV 0.03% (n=3)
FGVPTYTWGANETDV 0.03% (n=3)
SGAPTYTWGANETDV 0.03% (n=3)
SGAPTFSWGENETDV 0.03% (n=3)
FGAPTYNWGVNETDV 0.03% (n=3)
SGAPTYSWGGNETDV 0.03% (n=3)
SGVPTYGWGENETDV 0.03% (n=3)
FGAPTYRWGANETDV 0.03% (n=3)
SGAPTYRWGENDTDV 0.02% (n=2)
LGVPTYNWGSNRTDV 0.02% (n=2)
LGAPTYNWGGDDTDV 0.02% (n=2)
SGVPTYSWGANDTDV 0.02% (n=2)
AGAPTYSWGGNDTDV 0.02% (n=2)
AGAPTYSWGANDTDV 0.02% (n=2)
SGVPTYNWGENETDI 0.02% (n=2)
LGAPTFNWGSNDTDV 0.02% (n=2)
SGTPTYNWGANDTYF 0.02% (n=2)
SGAPTYNWGENDADV 0.02% (n=2)
LGDPTFGWGGNDTDV 0.02% (n=2)
LGAPTYNWGENDKDV 0.02% (n=2)
RGAPTFTFGENETDV 0.02% (n=2)
AGAPTYNWGEDDSDV 0.02% (n=2)
VGVPTYTWGENETDV 0.02% (n=2)
LGAPTYSWGSNDSDV 0.02% (n=2)
LGVPTYSWGSNETDV 0.02% (n=2)
AGAPTYNWGDNDTDV 0.02% (n=2)
AGVPTYNWGDNDTDV 0.02% (n=2)
RGAPTYNWGENDTDV 0.02% (n=2)
SGAPTYDWGENDTDV 0.02% (n=2)
VGAPTYNWGANDTDV 0.02% (n=2)
LGVPTYNWGDSDTDV 0.02% (n=2)
SGVPTYNWGDNETDV 0.02% (n=2)
AGAPAYNWGANDTDV 0.02% (n=2)
SGMPTYNWGENDTDV 0.02% (n=2)
VGLAYFQLGYQYHGR 0.02% (n=2)
SGEPTYRWGESEADV 0.02% (n=2)
SGAPTYSWGVNDTDV 0.02% (n=2)
SGAPTYSWGANDADV 0.02% (n=2)
AGVPTYSWGGNDTDV 0.02% (n=2)
RGVPTYSWGGTDTDV 0.02% (n=2)
AGVPTYNWGGNDTDF 0.02% (n=2)
SGVPTYNWGAGETDV 0.02% (n=2)
SGAPTNNWGENATDV 0.02% (n=2)
SGAPTYNWGENHTDV 0.02% (n=2)
SGAPTYNWGENVTDV 0.02% (n=2)
TGVPTYTWGENDTDV 0.02% (n=2)
SGAPTYNWGENTTDV 0.02% (n=2)
SGAPTYNWGGNETDI 0.02% (n=2)
SGAPTYNWSENETDV 0.02% (n=2)
SGAPTYNWGEEDTDV 0.02% (n=2)
AGAPTYKWGANDTDV 0.02% (n=2)
AGVPTYRWGENDTDV 0.02% (n=2)
RGAPTYDWGAREEDV 0.02% (n=2)
RGAPTYNWGIREEDV 0.02% (n=2)
RGAPTYNWGANDTDV 0.02% (n=2)
LGVPTYTWGNSSTDV 0.02% (n=2)
SGAATYSWGSDTKDV 0.02% (n=2)
LGVPTYNWGCNVTDV 0.02% (n=2)
VGVPTYNWGENETDV 0.02% (n=2)
SGVPTYNWGENVTDV 0.02% (n=2)
LGAPTYTWGENDTDV 0.02% (n=2)
SGVPTYNWGDNDTDV 0.02% (n=2)
SGTPTHNWGENETDV 0.02% (n=2)
LGVPTYNWGENATDV 0.02% (n=2)
FGVPTYSWGVNETDV 0.02% (n=2)
SGVPTYSWGENETDM 0.02% (n=2)
FGVPTYNWGENETDI 0.02% (n=2)
FGAPTYKWGENETDV 0.02% (n=2)
SGVPTYTWGENETDM 0.02% (n=2)
FGVPTYSWGENGTDV 0.02% (n=2)
LGVPTYSWGGNETDV 0.02% (n=2)
VGVPTYSWGENETDV 0.02% (n=2)
FGVPTYDWGENETDV 0.02% (n=2)
FGAPTYQWGENETDV 0.02% (n=2)
FGVPTYNWGENEADV 0.02% (n=2)
FGTPTYTWGENETDV 0.02% (n=2)
YGAPTYTWGENETDV 0.02% (n=2)
SGTPTYNWGENKTDV 0.02% (n=2)
FGVPTYNWGENQTDV 0.02% (n=2)
FGVPTYRWGANETDV 0.02% (n=2)
SGVPTYSWGANETDV 0.02% (n=2)
FGVPTYNWGANETDV 0.02% (n=2)
HGVPTYRWGENETDV 0.02% (n=2)
LGVPTYTWGENEADV 0.02% (n=2)
YGAPTYNWGENETDV 0.02% (n=2)
FGIPTYTWGENETDV 0.02% (n=2)
SGVPTYTWGGNETDV 0.02% (n=2)
LGVPTYTWGENKTDV 0.02% (n=2)
LDVPTYSWGENETDV 0.02% (n=2)
HGVPTYTWGENKTDV 0.02% (n=2)
YGAPTYNWGGNETDV 0.02% (n=2)
FGAPTYSWGGNETDV 0.02% (n=2)
FGVPTYSWGENATDV 0.02% (n=2)
SGAPTYTWGESETDV 0.02% (n=2)
FGAPTFSWGENETDV 0.02% (n=2)
FGVPTFSWGENETDV 0.02% (n=2)
SGAPTFNWGENETDV 0.02% (n=2)
RGVPTYTWGGNKSDV 0.02% (n=2)
--------GENEIDV 0.02% (n=2)
--------GESETDV 0.02% (n=2)
FGTPTYNWGENETDV 0.02% (n=2)
TGLPTYTWGENETDV 0.02% (n=2)
LGVPTYSWGTNDTDV 0.01% (n=1)
ADVPTYSWGENETDV 0.01% (n=1)
AGVPTYSWGENGTDV 0.01% (n=1)
AGVPTYSWGENETNV 0.01% (n=1)
LGVPTYTWGSNDTDF 0.01% (n=1)
LGAPTYTWGSNDTDA 0.01% (n=1)
SGVSTYSWGENDTDV 0.01% (n=1)
FGVPTYNWGANDTDV 0.01% (n=1)
LGAPTYSWGSNKTDV 0.01% (n=1)
SGVPTYNWGENDVDV 0.01% (n=1)
SGAPTCNWGENDTDV 0.01% (n=1)
SGAPTYNWGSNDTVV 0.01% (n=1)
FGVPTYNWCANETGV 0.01% (n=1)
AGAPTYSWGGNNADV 0.01% (n=1)
SGAPTYNWGNNDTDV 0.01% (n=1)
LGVATYSWGANEADV 0.01% (n=1)
SGAPTYNWGANDMDV 0.01% (n=1)
SGAPT-NWGENDTDV 0.01% (n=1)
SGAPTYNWGANNTDV 0.01% (n=1)
SGAPTYNWGANETDI 0.01% (n=1)
LGAPTHDWGSNDTDV 0.01% (n=1)
LGAPTFTWGSNDTDV 0.01% (n=1)
SGAPTYNWGTNDTNV 0.01% (n=1)
SGQPTYNWGENETDV 0.01% (n=1)
SCAPTYNWGENDTDF 0.01% (n=1)
SEAPTYNWGENDTGV 0.01% (n=1)
SGAPTYSWGADDTDV 0.01% (n=1)
SGVPTYNWGINETDV 0.01% (n=1)
LGDPTYSWGVTDTDV 0.01% (n=1)
LGVPTYNWGDNGADV 0.01% (n=1)
LDVPTYNWGDNDTDV 0.01% (n=1)
LGVPTYN*GDNDTDV 0.01% (n=1)
SGAPTYSWVENDTDV 0.01% (n=1)
WGAPTYNWGANDTDV 0.01% (n=1)
AGAPTYNWGSDTTDV 0.01% (n=1)
WGVPTYTCGENDTDV 0.01% (n=1)
LGAPTFNWGGNETDV 0.01% (n=1)
MGAPTYNWGANDTDI 0.01% (n=1)
RGAPTYNWGCNDTDV 0.01% (n=1)
SGAPTFNWGDNDTDV 0.01% (n=1)
SGAPTYSWGEHDTDV 0.01% (n=1)
LGAPTYTWGSNVSDV 0.01% (n=1)
LGAPTYTWGSNHSDV 0.01% (n=1)
KGSPTYRWGENETDV 0.01% (n=1)
FGAPTYSWGDNETDV 0.01% (n=1)
RGVPTFNWGANDTDV 0.01% (n=1)
LGVPTFNWGSNDTDV 0.01% (n=1)
QGAPTYNWGENDTDV 0.01% (n=1)
LGVPTYNWGNTSEDV 0.01% (n=1)
TGAPTYTWGENETDV 0.01% (n=1)
LGQPTYNWGENDTDV 0.01% (n=1)
SGVPTHSWGENETDV 0.01% (n=1)
KGEPTYNWGDNDTDV 0.01% (n=1)
SGAPTFNWGQNDTDV 0.01% (n=1)
SGAPTYSWGVNETDV 0.01% (n=1)
SGAPTYNWGQNDTDV 0.01% (n=1)
LGAPTYSWGANVTDV 0.01% (n=1)
LGAPTYSWGENDKDV 0.01% (n=1)
AGAPTYSWGSNVTDV 0.01% (n=1)
WGAPTYNWGENDTDV 0.01% (n=1)
AGAPTFSWGANDTDV 0.01% (n=1)
LGAPTYRWGSNDTDV 0.01% (n=1)
SGAPTYDWGGNVTDV 0.01% (n=1)
AGAPTYNWGINDTDV 0.01% (n=1)
AGVPTYNWGENATDV 0.01% (n=1)
AGVPTYNWGCNDTDV 0.01% (n=1)
AGAPTYNWGCNDTDV 0.01% (n=1)
EGAPTYNWGDNDTDV 0.01% (n=1)
KGSPTYSWGENVTDV 0.01% (n=1)
SGAPSYNWGENETDV 0.01% (n=1)
LGAPTFNWGENDTDV 0.01% (n=1)
AGVPTYNWGINDTDV 0.01% (n=1)
KGAPTYNWGENDTDV 0.01% (n=1)
LGAPTYNWGSNDSDV 0.01% (n=1)
SGAPTYSWGERDRDV 0.01% (n=1)
HGAPTYNWGENDTDV 0.01% (n=1)
QGVPTYNWGANDTDV 0.01% (n=1)
LGAPTYDWGANDTDV 0.01% (n=1)
LGAPTYDWGRNDTDV 0.01% (n=1)
VGVPTYNWGANDTDV 0.01% (n=1)
SGAPTYNWGANESDV 0.01% (n=1)
SGVPTYSWGADEADV 0.01% (n=1)
SGVPTYNFGANQTDV 0.01% (n=1)
SGTPTYTWGENETDV 0.01% (n=1)
AGAPTYNWGESDMDV 0.01% (n=1)
LGAPTYNWGSSDKDV 0.01% (n=1)
LGAPTYSWGVNDTDV 0.01% (n=1)
LGVPTYNWGRNDTDF 0.01% (n=1)
VGVPTYNWGENDSDV 0.01% (n=1)
LGVPTYNWGQNDTDV 0.01% (n=1)
SGAPTYDWGANDTDV 0.01% (n=1)
LGAPTYRWGENDTDV 0.01% (n=1)
SGAPTYNWGRNDTDV 0.01% (n=1)
SGAPTFNWGANDTDV 0.01% (n=1)
LNTPTFTWGESDKDV 0.01% (n=1)
PGAPTYNWGANEADV 0.01% (n=1)
LGAPTYNWGSNNTDV 0.01% (n=1)
LGAPTYSWGSDDTDV 0.01% (n=1)
LGVPTYNWGNNDTDV 0.01% (n=1)
LGVPTYNWGGNETDV 0.01% (n=1)
WGVPTYNWGDNDTDV 0.01% (n=1)
MGVPTYNWGENDTDV 0.01% (n=1)
SGVPTYNWGTNATDV 0.01% (n=1)
VGAPTYNWGSNDTDV 0.01% (n=1)
SGAPTYNWGSNYTDV 0.01% (n=1)
AGAPSYNWGSNDTDV 0.01% (n=1)
SGQATYSWGEKETDV 0.01% (n=1)
RGVPTYTWGEKETDV 0.01% (n=1)
LGSPTYRWGENETDV 0.01% (n=1)
SGAPTYNWGENDSDV 0.01% (n=1)
AGVPTYDWGSNVTDV 0.01% (n=1)
LGAPTYDWGSNETDV 0.01% (n=1)
LGAPTYSWGGKVTDV 0.01% (n=1)
LGVPTYGWGENDTDV 0.01% (n=1)
AGAPTYDWGSNDTDV 0.01% (n=1)
AGVPTYNWGTNDTDV 0.01% (n=1)
VGVPTYNWGENDTDV 0.01% (n=1)
LGAPTYTWGENETDV 0.01% (n=1)
SGLPTYNWGANDTDV 0.01% (n=1)
LGMPTYNWGENETDV 0.01% (n=1)
RGVPTYNWGENVTDV 0.01% (n=1)
LGVPTHSWGENEADV 0.01% (n=1)
GRKPTYSWGADEADV 0.01% (n=1)
LGVPTYTWGSNDTDV 0.01% (n=1)
AGAPTYSWGANETDV 0.01% (n=1)
WGVPTYNFGTNETDV 0.01% (n=1)
AGAPTYTWGANDTDV 0.01% (n=1)
LGAPTFNWGDSDEDV 0.01% (n=1)
SGAPSYTWGENETDV 0.01% (n=1)
SGAPTYNWGENDTDG 0.01% (n=1)
LGTPTYDWGSNDTDV 0.01% (n=1)
AGAPTYNWGVNDTDF 0.01% (n=1)
SGAPIYSWGEKDTDV 0.01% (n=1)
SGAPTYNWGCNDTDV 0.01% (n=1)
LGAPTFNWGENESDV 0.01% (n=1)
SGAPTYDWGENESDV 0.01% (n=1)
SGAPTYNWGTNDTDV 0.01% (n=1)
SGAPTYNWGSNNTDV 0.01% (n=1)
FGVPTYSWGENDTDV 0.01% (n=1)
SGVPTYTWGERDTDV 0.01% (n=1)
LGAPTYNWGANDSDV 0.01% (n=1)
AGVPTLNWGSNETDV 0.01% (n=1)
SGVPTYNWGGNETGV 0.01% (n=1)
LGALTYNWGSNDTDV 0.01% (n=1)
LGAPTYNWGSNVTDV 0.01% (n=1)
LGAPTYNWGSNDTGI 0.01% (n=1)
SGAPTYNWGENDTDA 0.01% (n=1)
SGAPTHNWGASDTDV 0.01% (n=1)
LGVPIYGWGSNDTDV 0.01% (n=1)
SGAATYSWGENDTDV 0.01% (n=1)
SGAPTYSWGEYDTDV 0.01% (n=1)
SGAPTYS*GENDTDV 0.01% (n=1)
SGGPTYSWGENDTDV 0.01% (n=1)
SGAPTYSWGENDTGI 0.01% (n=1)
SGAPTCSWGENDTDV 0.01% (n=1)
PGAPTYSWGENDTDV 0.01% (n=1)
SGAPTYGRGENDTDV 0.01% (n=1)
SGAPTYSRGENDTDV 0.01% (n=1)
SGAPTYSWGGNDTDV 0.01% (n=1)
AGAPTYNWGTNDTDV 0.01% (n=1)
SGAPTHNWGENDTDV 0.01% (n=1)
AGAPTYNWGENGTDV 0.01% (n=1)
AGVPTYNWGEDDTDV 0.01% (n=1)
LGAPTYNWGDNQTDV 0.01% (n=1)
LGAPTYKWGANDTDV 0.01% (n=1)
LGAPTYNWGANETEV 0.01% (n=1)
TGALTYNRGANDTDV 0.01% (n=1)
AGVPTHNWGENETDV 0.01% (n=1)
LGAPTYRWGENETDV 0.01% (n=1)
SGAPTYNWGENETDI 0.01% (n=1)
AGAPTYNWGGNDTDV 0.01% (n=1)
SGVPTYDWGSSDVDV 0.01% (n=1)
SGAPTYSWGANDTAV 0.01% (n=1)
SGAPTYSWGANGTDV 0.01% (n=1)
SGAPTCSWGATDTDV 0.01% (n=1)
SGAPTYSWGVNDTGV 0.01% (n=1)
SGAPTYSRGANDTDV 0.01% (n=1)
SGAPTYSWGANDTGV 0.01% (n=1)
SGAPTYSWGANDTDA 0.01% (n=1)
SGAPAYSWGANDTDV 0.01% (n=1)
SGTPTYSWGANDTDV 0.01% (n=1)
RGVPTYNWGENDTDF 0.01% (n=1)
AGVPTYSWGVNDKDV 0.01% (n=1)
RGVPTYNWGGNDTDV 0.01% (n=1)
SGVPTYNWGAKKTDV 0.01% (n=1)
SGAPTYNWGAHETDV 0.01% (n=1)
SGVPTYNWGTNVTDV 0.01% (n=1)
SGVPTYNWGADKTDV 0.01% (n=1)
LGVPTYNWGADETDV 0.01% (n=1)
SGVPTYNWGANEKDV 0.01% (n=1)
SGVPTYNWGAKQTDV 0.01% (n=1)
SGVPTYNWGARETDV 0.01% (n=1)
SGAPTYNWGASETDV 0.01% (n=1)
SGAPTYNWGATETDV 0.01% (n=1)
LGVPTYNWGTNETDI 0.01% (n=1)
SGVPTYNWGTNKTDV 0.01% (n=1)
SGAPTCSWGANDTDV 0.01% (n=1)
SGAPTYNWGDNEADV 0.01% (n=1)
SGAPTYSWGANDTDI 0.01% (n=1)
SGAPTYNWGVNDTDI 0.01% (n=1)
SGAPTYNWGGNATDV 0.01% (n=1)
SGAPTHNWGENETDV 0.01% (n=1)
SGAPTYNWGEDDTDV 0.01% (n=1)
WGAPAYNWGENDTDV 0.01% (n=1)
SGAPTYSWGENDSDV 0.01% (n=1)
MGAPTYSWGENDTDV 0.01% (n=1)
LGAPTYNWGGNVTDV 0.01% (n=1)
LGAPTYNWGCND--- 0.01% (n=1)
AGVPTYRWGKNETDV 0.01% (n=1)
SGEPTYYWGENDTDV 0.01% (n=1)
SGAPTYDWGVNDTDV 0.01% (n=1)
SGVPTYSWGSNATDV 0.01% (n=1)
RGVPTYTWGENETDV 0.01% (n=1)
LGSPTYSWGENDTDV 0.01% (n=1)
SGVPTYDWGENDTDV 0.01% (n=1)
SGTPTYSWGENDTDV 0.01% (n=1)
SGAPTYSWGSNDTDV 0.01% (n=1)
RGVPTYSWGESEADV 0.01% (n=1)
LGAPTYNWGRNDTDV 0.01% (n=1)
LGAPTYRWGTNDTDV 0.01% (n=1)
RGVPTYTWGANETDV 0.01% (n=1)
LGSPTYNWGENDTDV 0.01% (n=1)
SGAPTYSWGDNDTDV 0.01% (n=1)
RGVPTYNWGANITDV 0.01% (n=1)
LGAPTYTWGDNDTDV 0.01% (n=1)
LGAPTYSWGSDNTDV 0.01% (n=1)
KGIPTYTWGENETDV 0.01% (n=1)
LGAPTYSWGDNDTDV 0.01% (n=1)
SGHPTYNWGANDTDV 0.01% (n=1)
LGAPTYNWGSNITDV 0.01% (n=1)
AGAPTYNWGQNETDV 0.01% (n=1)
LSAPTYNWGSNDTDV 0.01% (n=1)
SGVPTYAWGANETDV 0.01% (n=1)
QGAPTYSWGANDTDV 0.01% (n=1)
RGVPTYNWGDNDTDV 0.01% (n=1)
AGAPTYTWGSNDTDV 0.01% (n=1)
AGAPTYNWGETDKDV 0.01% (n=1)
LGVPTYSWGSNDTDV 0.01% (n=1)
SGVPTYRWGVNETDV 0.01% (n=1)
LGAPTYNWGANMTDV 0.01% (n=1)
FGAPTYNWGGNDTDV 0.01% (n=1)
SGAPTYTWGGNDTDV 0.01% (n=1)
-GAPTYNWGDNDTDV 0.01% (n=1)
WGAPTYNWGVNETDV 0.01% (n=1)
SGAPAYNWGENDTDV 0.01% (n=1)
LGIPTYSWGGNDTDV 0.01% (n=1)
SSAPTYSWGANDTDV 0.01% (n=1)
SGAPTYSWGANNTDV 0.01% (n=1)
SGAPTYSWGENEKDV 0.01% (n=1)
LGVPTYNWGSNNTDV 0.01% (n=1)
SGVPTYNWGSNDTDV 0.01% (n=1)
AGTPTYNWGENDTDV 0.01% (n=1)
SGVPTYNWVSNDTDV 0.01% (n=1)
LGAPTYNWGNNDTDV 0.01% (n=1)
LGAPTYNWGEQDTDV 0.01% (n=1)
TGVPTYNWGENESDV 0.01% (n=1)
QGVPTYNWGENDTDV 0.01% (n=1)
WGVPTYTWGENETDV 0.01% (n=1)
SGAPTYDWGENETDV 0.01% (n=1)
SGAPTYNWGENETDA 0.01% (n=1)
LGAPTYRWGENEKDV 0.01% (n=1)
LGVPTYNWGANETDV 0.01% (n=1)
SGVPTYTWGENESDV 0.01% (n=1)
LGAPTYNWGASDTDV 0.01% (n=1)
LGAPTYNWGANVTDV 0.01% (n=1)
WGVPTYTWGSSDADV 0.01% (n=1)
AGAPTYTWGENETDV 0.01% (n=1)
FGAPTYNWGANDTDV 0.01% (n=1)
LGAPTYNWGGNDADV 0.01% (n=1)
YGAPTYNWGTNDTDV 0.01% (n=1)
LGAPTHTWGANETDV 0.01% (n=1)
LGVPTYSWGANDTDV 0.01% (n=1)
SGAPTYNWGGGDTDV 0.01% (n=1)
SGTPTFSWGENDTDV 0.01% (n=1)
SGGPTYNWGRKDTDV 0.01% (n=1)
SGAPTYNWGMNDTDV 0.01% (n=1)
TGAPTYDWGANETDV 0.01% (n=1)
SGAPTYNWGVNDTDV 0.01% (n=1)
LGAPTFNWGANDTDV 0.01% (n=1)
VGAPAYNWGENDTDV 0.01% (n=1)
AGAPSYNWGENDTDV 0.01% (n=1)
AGAPAYNWGKNDTDV 0.01% (n=1)
AGAPAYNWGENATDV 0.01% (n=1)
AGVPAYNWGENDTDV 0.01% (n=1)
LGAPTSVRGENGTDV 0.01% (n=1)
LGVRTYNWGENETDV 0.01% (n=1)
LGNPTYSWGENDTDV 0.01% (n=1)
LGVPTYSWGENVTDV 0.01% (n=1)
SGVPTYNWGVNESDV 0.01% (n=1)
TGAPTYRWGENETDV 0.01% (n=1)
FGVRT---------- 0.01% (n=1)
SSVPT---------- 0.01% (n=1)
FSVPT---------- 0.01% (n=1)
FGTPTYSWGENETDV 0.01% (n=1)
FGARKYSWGENETDV 0.01% (n=1)
FGASTYSWGENETDV 0.01% (n=1)
FGAPTYSWGENETNV 0.01% (n=1)
HGVPTYSWGENGTDV 0.01% (n=1)
SGVPTYRWGDNETDV 0.01% (n=1)
FGAPTYNWGENKTDV 0.01% (n=1)
SGTPTYRWGENETDV 0.01% (n=1)
FGAPTYSWRENETDV 0.01% (n=1)
FGPPTYSWGENETDV 0.01% (n=1)
YGAPTYTWGVNETDV 0.01% (n=1)
LGVPTYTWGENETNV 0.01% (n=1)
FGVPTYRWGEKETDV 0.01% (n=1)
FGVSTYTWGENETDV 0.01% (n=1)
FGVPTYRWGEIETDV 0.01% (n=1)
PGVPTYSWGGNETDV 0.01% (n=1)
SGVPTYSGRGIETDV 0.01% (n=1)
PGVPTYMWGEYETDV 0.01% (n=1)
SGVPTYSWGGNETDM 0.01% (n=1)
SGVPTYSWGGIKPDV 0.01% (n=1)
SGVPTYSWGGNRTDV 0.01% (n=1)
F-------------- 0.01% (n=1)
YGVPTYSWGENDTDV 0.01% (n=1)
SSVPTYRWGENETDV 0.01% (n=1)
FGVPTYSWGENETCV 0.01% (n=1)
FGAPTYTWGENVTDV 0.01% (n=1)
SGVPTYTWGGNKTDV 0.01% (n=1)
HGVPTFTWGEKETDV 0.01% (n=1)
TGVPTYSWGGNKTDV 0.01% (n=1)
YGAPTYSWGENETDV 0.01% (n=1)
LGNPTYTWGGNETDV 0.01% (n=1)
LGDPTYNWGENETDV 0.01% (n=1)
LGVPTYNWGENGSDV 0.01% (n=1)
FGVPTHNWGGNASDV 0.01% (n=1)
FGVPTYNWGGNVTDV 0.01% (n=1)
FGAPTYSWGVNETDV 0.01% (n=1)
LGAPTYNWGENVTDV 0.01% (n=1)
LGVPTYGWGANETDV 0.01% (n=1)
LGVPTYSWGANETDV 0.01% (n=1)
FGAPTFTWGENVTDV 0.01% (n=1)
SGVPTYDWGGNETDV 0.01% (n=1)
FGVPTYRWGGNETDV 0.01% (n=1)
HGVPTYTWGANETDV 0.01% (n=1)
FGNPTYNWGENKTDV 0.01% (n=1)
SGDPTYNWGGNETDV 0.01% (n=1)
CGVPTYSWGENKTDV 0.01% (n=1)
SGAPTYRWGANESDV 0.01% (n=1)
YGVPTYSWGGNKTDV 0.01% (n=1)
SGVPTYDWGENETDV 0.01% (n=1)
FGVPTYNWGENATDV 0.01% (n=1)
LGAPTYAWGGNETDV 0.01% (n=1)
SGVPTYGWGANETDV 0.01% (n=1)
SGNPTYTWGENATDV 0.01% (n=1)
FGVPTCTWGENETDV 0.01% (n=1)
FGVPTYTWEENETDV 0.01% (n=1)
FGAPTYSWGENGTDV 0.01% (n=1)
SGTPTYNWGGNETDV 0.01% (n=1)
SGAPTYNWGVNETDV 0.01% (n=1)
HGAPTYSWGENETDV 0.01% (n=1)
LGVPTYSWGGNTSDV 0.01% (n=1)
SGAPTYTWGENKTDV 0.01% (n=1)
RGAPTYNWGENATDV 0.01% (n=1)
LGVPTYSWGGNKSDV 0.01% (n=1)
TGAPTYNWGENETDV 0.01% (n=1)
--------------V 0.01% (n=1)
RGVPTYNWGGNVTDV 0.01% (n=1)
FGTATFNWGGNETDV 0.01% (n=1)
FGVPTYSWGDNETDV 0.01% (n=1)
LGVPTYNWGENKSDV 0.01% (n=1)
HGVPTYNWGDNETDV 0.01% (n=1)
FGVPTYAWGANETDV 0.01% (n=1)
SGAPTYTWGTNESDV 0.01% (n=1)
LGVPTYSWGDNETDV 0.01% (n=1)
LGVPTYSWGENEADV 0.01% (n=1)
FGVPSYRWGENETDV 0.01% (n=1)
HGVPTYTWGENETDV 0.01% (n=1)
LGVPTYTWGGNETDV 0.01% (n=1)
SGVPTYNWGVNETDV 0.01% (n=1)
FGVPTYTWGDNETDV 0.01% (n=1)
SGVPTYRWGENGTDV 0.01% (n=1)
YGVPTYNWGGNETDV 0.01% (n=1)
SSRRSYILGENETDV 0.01% (n=1)
FGVPTYSWGENETNV 0.01% (n=1)
FGVPTYRWGDNETDV 0.01% (n=1)
FGVPTYTWGGNASDV 0.01% (n=1)
LGVPTYSWGGNATDV 0.01% (n=1)
LGVPTYSWGENKSDV 0.01% (n=1)
SGAPTYTWGGNETDV 0.01% (n=1)
LGLPTYNWGENETDV 0.01% (n=1)
RGVPTYSWGANETDV 0.01% (n=1)
FGAPTYRWGENESDV 0.01% (n=1)
FGVPTYNWGANQTDV 0.01% (n=1)
FGIPTYSWGENETDV 0.01% (n=1)
SGAPTYHWGENKTDV 0.01% (n=1)
FGAPTYNWGENATDV 0.01% (n=1)
LGVPTYSWGENKTDV 0.01% (n=1)
RGVPTYRWGENSSDV 0.01% (n=1)
HGVPTFSWGENETDV 0.01% (n=1)
FGVPTYSWGANKTDV 0.01% (n=1)
LGVPTYTWGANETDV 0.01% (n=1)
FGTPTYTWGENKTDV 0.01% (n=1)
LGAPTYTWGENATDV 0.01% (n=1)
RGVPTYSWGGNKTDV 0.01% (n=1)
SGVPTYTWGDNETDV 0.01% (n=1)
FGNPTYRWGENKTDV 0.01% (n=1)
SGVPTYSWGESETDV 0.01% (n=1)
FGAPTYTWGGNETDV 0.01% (n=1)
SGVPTYRWGENKTDV 0.01% (n=1)
HGDPTYTWGGNETDV 0.01% (n=1)
SGVPTYTWGENQTDV 0.01% (n=1)
FGTPTYTWGENGTDV 0.01% (n=1)
RGVPTYNWGGNETDV 0.01% (n=1)
SGTPTYTWGENKTDV 0.01% (n=1)
SGVPTYTWGTNETDV 0.01% (n=1)
FGVPTYNWGENVTDV 0.01% (n=1)
RGVPTYTWGVNETDV 0.01% (n=1)
HGVPTYDWGENETDV 0.01% (n=1)
SGAPTYGWGENETDV 0.01% (n=1)
FGVPTYSWGEDETDV 0.01% (n=1)
FGAPTYSRGENEADV 0.01% (n=1)
FGAPTYSWGENETDA 0.01% (n=1)
SGVPTYQWGENKTDV 0.01% (n=1)
DGVPTYGWGGNETDV 0.01% (n=1)
FGVPTYSWGENQTDV 0.01% (n=1)
FGVPTYTWGENETGV 0.01% (n=1)
SGVPTYSWGRNETDV 0.01% (n=1)
SGVPTYSWGKNETDM 0.01% (n=1)
FGVPTHTWGENETDV 0.01% (n=1)
PGVPTYSWGKNETDV 0.01% (n=1)
SGVPTYSWGENETDA 0.01% (n=1)
SGAPTHTWGENETDV 0.01% (n=1)
FGVPTYSWGENESDV 0.01% (n=1)
FGAPTYTWGENGTDV 0.01% (n=1)
FGAPTYTWGRNETDV 0.01% (n=1)
FGAPTYTWGESETDV 0.01% (n=1)
FGAPTYRRGGNETDV 0.01% (n=1)
FGAPTFTWGENETDV 0.01% (n=1)
FGVPTYNWGGNATDV 0.01% (n=1)
SGTPTFSWGENETDV 0.01% (n=1)
SGVPTFSWGENDTDV 0.01% (n=1)
SGTPTYSWGENVTDV 0.01% (n=1)
FGTPTFSWGENQTDV 0.01% (n=1)
SGAPTFSWGEKETDV 0.01% (n=1)
SGVPTFSWGENETDV 0.01% (n=1)
FGAPTYAWGENETDV 0.01% (n=1)
FGVPTYQWGENESDV 0.01% (n=1)
YGAPTFSWGENETDV 0.01% (n=1)
--------GENESDV 0.01% (n=1)
AGVPTYTWGGNETDV 0.01% (n=1)
FGVPTYRWGENETDA 0.01% (n=1)
AGVPTYRWGANETDV 0.01% (n=1)
AGVPTYTWGENETDI 0.01% (n=1)
TGVPTYSWGENETDV 0.01% (n=1)
TGVPTYNWGENETDV 0.01% (n=1)
AGVPTYTWGANDSDV 0.01% (n=1)
QGLPTYNWGANVSDV 0.01% (n=1)
RGAPTYTWGENETDV 0.01% (n=1)
SGNPTFTSGANDTDF 0.01% (n=1)
RGNPTFNSGANDTDF 0.01% (n=1)
SGNPTFNSGANDTDF 0.01% (n=1)
LGVPTYTWGEHESDV 0.01% (n=1)
EGVPTYTWGENETDV 0.01% (n=1)
KGVPTYEWGEGASDV 0.01% (n=1)
KGNPTYRWGENETDV 0.01% (n=1)
RGVPTYNWGENETDV 0.01% (n=1)
TGMPTYTSGANETDF 0.01% (n=1)
TGAPTFTSGANDTDF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 1a:

SGAPTYNWGENDTDV 8.49% (n=617)
AGAPTYNWGANETDV 5.68% (n=413)
AGAPTYRWGANDTDV 5.26% (n=382)
SGAPTFNWGENDTDV 4.28% (n=311)
SGAPTYNWGDNDTDV 4.27% (n=310)
SGAPTYSWGANDTDV 4.20% (n=305)
SGAPTYSWGENDTDV 4.09% (n=297)
AGAPAYNWGENDTDV 3.78% (n=275)
SGAPTYNWGENETDV 3.45% (n=251)
LGVPTYNWGSNDTDV 3.40% (n=247)
AGAPTYNWGENDTDV 3.19% (n=232)
LGAPTYNWGSNETDV 2.41% (n=175)
LGAPTYNWGSNDTDV 2.30% (n=167)
SGAPTYSWGENETDV 2.09% (n=152)
SGEPTYNWGENDTDV 2.09% (n=152)
AGVPTYRWGENETDV 1.71% (n=124)
SGAPTYNWGANDTDV 1.62% (n=118)
AGIPTYSWGENDTDV 1.58% (n=115)
SGAPTYNWGENATDV 1.54% (n=112)
SGAPTYGWGANDTDV 1.27% (n=92)
SGAPTYNWGDNETDV 0.92% (n=67)
SGVPTYRWGENETDV 0.88% (n=64)
SGVPTYNWGENETDV 0.81% (n=59)
LGAPTYNWGCNDTDV 0.80% (n=58)
LGVPTYNWGDNDTDV 0.78% (n=57)
LGAPTYNWGENDTDV 0.76% (n=55)
SGVPTYNWGSNETDV 0.73% (n=53)
SGVPTYNWGENDTDV 0.70% (n=51)
TGVPTYNWGENDTDV 0.61% (n=44)
LGAPTYSWGENDTDV 0.56% (n=41)
LGAPTYNWGDNDTDV 0.55% (n=40)
LGAPTYNWGSNDTDI 0.52% (n=38)
MGAPTYNWGENDTDV 0.50% (n=36)
LGQPTYNWGENETDV 0.50% (n=36)
SGVPTYNWGANDTDV 0.48% (n=35)
AGAPAYNWGENNTDV 0.48% (n=35)
AGVPTYNWGENETDV 0.45% (n=33)
SGAPTYNWGSNDTDV 0.45% (n=33)
LGVPTYNWGENDTDV 0.43% (n=31)
LGAPTYNWGGNDTDV 0.41% (n=30)
SGAPTYNWGANDTDI 0.39% (n=28)
LGAPTYNWGGKDTDV 0.37% (n=27)
RGAPTYNWGAREEDV 0.36% (n=26)
AGVPTYNWGENDTDV 0.33% (n=24)
RGVPTYNWGANDTDV 0.33% (n=24)
RGVPTYSWGENDTDV 0.32% (n=23)
RGVPTYSWGGNDTDV 0.32% (n=23)
SGAPTYNWGANETDV 0.30% (n=22)
LGAPTYNWGANDTDV 0.29% (n=21)
SGAPTYSWGANETDV 0.29% (n=21)
AGAPTYNWGSNDTDV 0.28% (n=20)
RGAPTYNWGSNDTDV 0.28% (n=20)
AGVPTYSWGENETDV 0.26% (n=19)
LGVPTYGWGSNDTDV 0.26% (n=19)
LGVPTYNWGANDTDV 0.25% (n=18)
SGVPTYNWGAKETDV 0.25% (n=18)
LGAPTYKWGANETDV 0.25% (n=18)
AGAPAYNWGENVTDV 0.25% (n=18)
LGAPTYTWGSNDTDV 0.23% (n=17)
AGAPTYNWGANDTDV 0.23% (n=17)
AGAPTYNWGENETDV 0.22% (n=16)
LGVPTYSWGANDTDF 0.22% (n=16)
SGVPTYNWGADETDV 0.22% (n=16)
SGAPTYSWGEKETDV 0.22% (n=16)
AGVPTYSWGENDTDV 0.21% (n=15)
LGAPTYSWGSNETDV 0.21% (n=15)
SGAPTYRWGANETDV 0.21% (n=15)
SGVPTYSWGENETDV 0.21% (n=15)
RGAPTYNWGGNDTDV 0.21% (n=15)
RGVPTYNWGSNDTDV 0.21% (n=15)
LGAPTHTWGANDTDV 0.21% (n=15)
AGTPTYSWGANETDV 0.21% (n=15)
AGAPTYSWGENDTDV 0.19% (n=14)
-------------DV 0.17% (n=12)
SGVPTYNWGANVTDV 0.17% (n=12)
FGVPTYNWGENETDV 0.17% (n=12)
LGVPTYNWGANVTDV 0.17% (n=12)
MGAPTYNWGENETDV 0.15% (n=11)
SGAPTYTWGENETDV 0.15% (n=11)
LGVPTYTWGENDTDV 0.15% (n=11)
LGDPTYGWGDNDTDV 0.14% (n=10)
SGVPTYNWGGNETDV 0.14% (n=10)
LGVPTYNWGTNETDV 0.14% (n=10)
SGVPTYNWGANEMDV 0.14% (n=10)
SGAPTYNWGEGGTDV 0.14% (n=10)
SGAPTYNWGGNKTDV 0.14% (n=10)
LGAPTYNWGENETDV 0.12% (n=9)
LGVPTYDWGSNDTDV 0.12% (n=9)
LGAPTYDWGSNDTDV 0.11% (n=8)
LGVPTYTWGGNDTDF 0.11% (n=8)
LGAPTYSWGSNDTDV 0.11% (n=8)
SGAPTYRWGENETDV 0.11% (n=8)
SGVPTYNWGANKTDV 0.11% (n=8)
SGAPTYNWGENKTDV 0.11% (n=8)
TGAPTYNWGANDTDV 0.10% (n=7)
LGVPTYSWGANNTDV 0.10% (n=7)
RGVPTYNWGENDTDV 0.10% (n=7)
SGVPTYNWGANETDV 0.10% (n=7)
SGAPTYTWGANDTDV 0.08% (n=6)
LGAPTYNWGGNETDV 0.08% (n=6)
SGAPTYTWGENDTDV 0.08% (n=6)
LGVPTYNWGANDTDF 0.08% (n=6)
RGMPTYSWGENDTDV 0.08% (n=6)
SGAPTYNWGSNETDV 0.08% (n=6)
RGAPTYNWGTREEDV 0.08% (n=6)
SGVPTYSWGENDTDV 0.07% (n=5)
SGTPTYNWGANDTDF 0.07% (n=5)
SGAPTHSWGENDTDV 0.07% (n=5)
LGVPTYNWGENETDV 0.07% (n=5)
SGAPTYSWGEKDTDV 0.07% (n=5)
SGAPTHNWGANDTDV 0.07% (n=5)
KGAPTYTWGANDTDV 0.07% (n=5)
LGVPTYNWGDNETDV 0.07% (n=5)
SGVPTYNWGAHETDV 0.07% (n=5)
SGAPTYNWGAKETDV 0.07% (n=5)
AGAPTYGWGENDTDV 0.07% (n=5)
LGVPTFTWGSNNTDV 0.07% (n=5)
VGAPTYNWGENETDV 0.07% (n=5)
SGMPTYNWGQNDTDV 0.06% (n=4)
SGAPTYNWGVNETDI 0.06% (n=4)
LGTPTFTWGGSVKDV 0.06% (n=4)
SGAPTYNWGCNETDV 0.06% (n=4)
LGLPTYNWGENDTDV 0.06% (n=4)
SGAPTYNWGGNDTDV 0.06% (n=4)
SGAPTFSWGENDTDV 0.06% (n=4)
LGVPTYNWGGNDTDV 0.06% (n=4)
LGVPTYRWGENETDV 0.06% (n=4)
-----YSWGENDTDV 0.06% (n=4)
LGVPTYNWGSDDKDV 0.06% (n=4)
SGVPTYNWGVNKTDV 0.06% (n=4)
SGMPTYNWGAKETDV 0.06% (n=4)
SGAPTYGWGENDTDV 0.06% (n=4)
TGAPTYNWGENDTDV 0.06% (n=4)
SGASTYNWGDNDTDV 0.06% (n=4)
RGAPTYNWGTQEEDV 0.06% (n=4)
RGAPTYNWGTREGDV 0.06% (n=4)
LGVATYSWGATDADV 0.04% (n=3)
SGAPTYSWGTNDTDV 0.04% (n=3)
SEAPTYNWGENDTDV 0.04% (n=3)
SGAPTYNWGQNETDV 0.04% (n=3)
AGVPTYTWGENDTDV 0.04% (n=3)
QGAPTYNWGANETDV 0.04% (n=3)
AGVPTYTWGEKDTDV 0.04% (n=3)
SGLPTYNWGENDTDV 0.04% (n=3)
LGAPTYNWGSNSTDV 0.04% (n=3)
SGAPTYSWGENVTDV 0.04% (n=3)
SGVPTYTWGENETDV 0.04% (n=3)
AGAPTYNWGENDMDV 0.04% (n=3)
AGVPTYNWGSNDTDV 0.04% (n=3)
AGAPTYSWGENETDV 0.04% (n=3)
SGAPTYNWGENESDV 0.04% (n=3)
LGVPTYSWGENDTDV 0.04% (n=3)
LGTPTYNWGENDTDV 0.04% (n=3)
LGAPTYSWGANDTDV 0.04% (n=3)
AGVPTYNWGGNDTDV 0.04% (n=3)
LGAPTFSWGENDTDV 0.04% (n=3)
AGVPTYNWGGNETDV 0.04% (n=3)
SGMPTYNWGGNETDV 0.04% (n=3)
SGVPTYDWGSNDVDV 0.04% (n=3)
AGVPTYSWGVNDTDV 0.04% (n=3)
SGAPTYNWGGNETDV 0.04% (n=3)
LGALTYNWGSNDTDI 0.04% (n=3)
AGAPTYNWGNNDTDV 0.04% (n=3)
SGAPTYDWGENETDA 0.04% (n=3)
AGAPAYNWGGNDTDV 0.04% (n=3)
SGAPTYRWGENDTDV 0.03% (n=2)
LGVPTYNWGSNRTDV 0.03% (n=2)
LGAPTYNWGGDDTDV 0.03% (n=2)
SGVPTYSWGANDTDV 0.03% (n=2)
AGAPTYSWGGNDTDV 0.03% (n=2)
AGAPTYSWGANDTDV 0.03% (n=2)
SGVPTYNWGENETDI 0.03% (n=2)
LGAPTFNWGSNDTDV 0.03% (n=2)
SGTPTYNWGANDTYF 0.03% (n=2)
SGAPTYNWGENDADV 0.03% (n=2)
LGDPTFGWGGNDTDV 0.03% (n=2)
LGAPTYNWGENDKDV 0.03% (n=2)
RGAPTFTFGENETDV 0.03% (n=2)
FGAPTYNWGENETDV 0.03% (n=2)
AGAPTYNWGEDDSDV 0.03% (n=2)
LGAPTYSWGSNDSDV 0.03% (n=2)
LGVPTYSWGSNETDV 0.03% (n=2)
AGAPTYNWGDNDTDV 0.03% (n=2)
AGVPTYNWGDNDTDV 0.03% (n=2)
RGAPTYNWGENDTDV 0.03% (n=2)
SGAPTYDWGENDTDV 0.03% (n=2)
VGAPTYNWGANDTDV 0.03% (n=2)
LGAPTYNWGANETDV 0.03% (n=2)
LGVPTYNWGDSDTDV 0.03% (n=2)
AGAPAYNWGANDTDV 0.03% (n=2)
SGMPTYNWGENDTDV 0.03% (n=2)
VGLAYFQLGYQYHGR 0.03% (n=2)
SGEPTYRWGESEADV 0.03% (n=2)
SGAPTYSWGVNDTDV 0.03% (n=2)
SGAPTYSWGANDADV 0.03% (n=2)
AGVPTYSWGGNDTDV 0.03% (n=2)
RGVPTYSWGGTDTDV 0.03% (n=2)
AGVPTYNWGGNDTDF 0.03% (n=2)
SGVPTYNWGAGETDV 0.03% (n=2)
SGAPTNNWGENATDV 0.03% (n=2)
SGAPTYNWGENHTDV 0.03% (n=2)
SGAPTYNWGENVTDV 0.03% (n=2)
LGHPTYNWGENETDV 0.03% (n=2)
TGVPTYTWGENDTDV 0.03% (n=2)
SGAPTYNWGENTTDV 0.03% (n=2)
SGAPTYNWGGNETDI 0.03% (n=2)
SGAPTYNWSENETDV 0.03% (n=2)
SGAPTYNWGEEDTDV 0.03% (n=2)
AGAPTYKWGANDTDV 0.03% (n=2)
AGVPTYRWGENDTDV 0.03% (n=2)
RGAPTYDWGAREEDV 0.03% (n=2)
RGAPTYNWGIREEDV 0.03% (n=2)
RGAPTYNWGANDTDV 0.03% (n=2)
LGVPTYTWGNSSTDV 0.03% (n=2)
SGAATYSWGSDTKDV 0.03% (n=2)
LGVPTYNWGCNVTDV 0.03% (n=2)
LGAPTYSWGENETDV 0.03% (n=2)
SGVPTYNWGDNDTDV 0.03% (n=2)
SGTPTHNWGENETDV 0.03% (n=2)
LGVPTYSWGTNDTDV 0.01% (n=1)
ADVPTYSWGENETDV 0.01% (n=1)
AGVPTYSWGENGTDV 0.01% (n=1)
AGVPTYSWGENETNV 0.01% (n=1)
LGVPTYTWGSNDTDF 0.01% (n=1)
LGAPTYTWGSNDTDA 0.01% (n=1)
SGVSTYSWGENDTDV 0.01% (n=1)
FGVPTYNWGANDTDV 0.01% (n=1)
LGAPTYSWGSNKTDV 0.01% (n=1)
SGVPTYNWGENDVDV 0.01% (n=1)
SGAPTCNWGENDTDV 0.01% (n=1)
SGAPTYNWGSNDTVV 0.01% (n=1)
FGVPTYNWCANETGV 0.01% (n=1)
AGAPTYSWGGNNADV 0.01% (n=1)
SGAPTYNWGNNDTDV 0.01% (n=1)
LGVATYSWGANEADV 0.01% (n=1)
SGAPTYNWGANDMDV 0.01% (n=1)
SGAPT-NWGENDTDV 0.01% (n=1)
SGAPTYNWGANNTDV 0.01% (n=1)
SGAPTYNWGANETDI 0.01% (n=1)
LGAPTHDWGSNDTDV 0.01% (n=1)
LGAPTFTWGSNDTDV 0.01% (n=1)
SGAPTYNWGTNDTNV 0.01% (n=1)
SGQPTYNWGENETDV 0.01% (n=1)
SCAPTYNWGENDTDF 0.01% (n=1)
SEAPTYNWGENDTGV 0.01% (n=1)
SGAPTYSWGADDTDV 0.01% (n=1)
SGVPTYNWGINETDV 0.01% (n=1)
LGDPTYSWGVTDTDV 0.01% (n=1)
LGVPTYNWGDNGADV 0.01% (n=1)
LDVPTYNWGDNDTDV 0.01% (n=1)
LGVPTYN*GDNDTDV 0.01% (n=1)
SGAPTYSWVENDTDV 0.01% (n=1)
WGAPTYNWGANDTDV 0.01% (n=1)
AGAPTYNWGSDTTDV 0.01% (n=1)
WGVPTYTCGENDTDV 0.01% (n=1)
LGAPTFNWGGNETDV 0.01% (n=1)
MGAPTYNWGANDTDI 0.01% (n=1)
RGAPTYNWGCNDTDV 0.01% (n=1)
SGAPTFNWGDNDTDV 0.01% (n=1)
SGAPTYSWGEHDTDV 0.01% (n=1)
VGVPTYTWGENETDV 0.01% (n=1)
LGAPTYTWGSNVSDV 0.01% (n=1)
LGAPTYTWGSNHSDV 0.01% (n=1)
KGSPTYRWGENETDV 0.01% (n=1)
FGAPTYSWGDNETDV 0.01% (n=1)
RGVPTFNWGANDTDV 0.01% (n=1)
LGVPTFNWGSNDTDV 0.01% (n=1)
QGAPTYNWGENDTDV 0.01% (n=1)
FGVPTYNWGDNETDV 0.01% (n=1)
LGVPTYNWGNTSEDV 0.01% (n=1)
TGAPTYTWGENETDV 0.01% (n=1)
LGQPTYNWGENDTDV 0.01% (n=1)
SGVPTHSWGENETDV 0.01% (n=1)
KGEPTYNWGDNDTDV 0.01% (n=1)
SGAPTFNWGQNDTDV 0.01% (n=1)
SGAPTYSWGVNETDV 0.01% (n=1)
SGAPTYNWGQNDTDV 0.01% (n=1)
LGAPTYSWGANVTDV 0.01% (n=1)
LGAPTYSWGENDKDV 0.01% (n=1)
AGAPTYSWGSNVTDV 0.01% (n=1)
WGAPTYNWGENDTDV 0.01% (n=1)
AGAPTFSWGANDTDV 0.01% (n=1)
LGAPTYRWGSNDTDV 0.01% (n=1)
SGAPTYDWGGNVTDV 0.01% (n=1)
AGAPTYNWGINDTDV 0.01% (n=1)
AGVPTYNWGENATDV 0.01% (n=1)
AGVPTYNWGCNDTDV 0.01% (n=1)
AGAPTYNWGCNDTDV 0.01% (n=1)
EGAPTYNWGDNDTDV 0.01% (n=1)
KGSPTYSWGENVTDV 0.01% (n=1)
SGAPSYNWGENETDV 0.01% (n=1)
LGAPTFNWGENDTDV 0.01% (n=1)
AGVPTYNWGINDTDV 0.01% (n=1)
KGAPTYNWGENDTDV 0.01% (n=1)
LGAPTYNWGSNDSDV 0.01% (n=1)
SGAPTYSWGERDRDV 0.01% (n=1)
HGAPTYNWGENDTDV 0.01% (n=1)
HGVPTYNWGENETDV 0.01% (n=1)
QGVPTYNWGANDTDV 0.01% (n=1)
LGAPTYDWGANDTDV 0.01% (n=1)
LGAPTYDWGRNDTDV 0.01% (n=1)
VGVPTYNWGANDTDV 0.01% (n=1)
SGAPTYNWGANESDV 0.01% (n=1)
SGVPTYSWGADEADV 0.01% (n=1)
SGVPTYNFGANQTDV 0.01% (n=1)
SGTPTYTWGENETDV 0.01% (n=1)
AGAPTYNWGESDMDV 0.01% (n=1)
LGAPTYNWGSSDKDV 0.01% (n=1)
LGAPTYSWGVNDTDV 0.01% (n=1)
LGVPTYNWGRNDTDF 0.01% (n=1)
VGVPTYNWGENDSDV 0.01% (n=1)
LGVPTYNWGQNDTDV 0.01% (n=1)
SGAPTYDWGANDTDV 0.01% (n=1)
LGAPTYRWGENDTDV 0.01% (n=1)
SGAPTYNWGRNDTDV 0.01% (n=1)
SGAPTFNWGANDTDV 0.01% (n=1)
LNTPTFTWGESDKDV 0.01% (n=1)
PGAPTYNWGANEADV 0.01% (n=1)
LGAPTYNWGSNNTDV 0.01% (n=1)
LGAPTYSWGSDDTDV 0.01% (n=1)
LGVPTYNWGNNDTDV 0.01% (n=1)
LGVPTYNWGGNETDV 0.01% (n=1)
WGVPTYNWGDNDTDV 0.01% (n=1)
MGVPTYNWGENDTDV 0.01% (n=1)
SGVPTYNWGTNATDV 0.01% (n=1)
VGAPTYNWGSNDTDV 0.01% (n=1)
SGAPTYNWGSNYTDV 0.01% (n=1)
AGAPSYNWGSNDTDV 0.01% (n=1)
SGQATYSWGEKETDV 0.01% (n=1)
RGVPTYTWGEKETDV 0.01% (n=1)
LGSPTYRWGENETDV 0.01% (n=1)
SGAPTYNWGENDSDV 0.01% (n=1)
AGVPTYDWGSNVTDV 0.01% (n=1)
LGAPTYDWGSNETDV 0.01% (n=1)
LGAPTYSWGGKVTDV 0.01% (n=1)
LGVPTYGWGENDTDV 0.01% (n=1)
AGAPTYDWGSNDTDV 0.01% (n=1)
AGVPTYNWGTNDTDV 0.01% (n=1)
VGVPTYNWGENDTDV 0.01% (n=1)
LGAPTYTWGENETDV 0.01% (n=1)
SGLPTYNWGANDTDV 0.01% (n=1)
LGMPTYNWGENETDV 0.01% (n=1)
RGVPTYNWGENVTDV 0.01% (n=1)
LGVPTHSWGENEADV 0.01% (n=1)
GRKPTYSWGADEADV 0.01% (n=1)
LGVPTYTWGSNDTDV 0.01% (n=1)
AGAPTYSWGANETDV 0.01% (n=1)
SGVPTYSWGGNETDV 0.01% (n=1)
WGVPTYNFGTNETDV 0.01% (n=1)
AGAPTYTWGANDTDV 0.01% (n=1)
LGAPTFNWGDSDEDV 0.01% (n=1)
SGAPSYTWGENETDV 0.01% (n=1)
SGAPTYNWGENDTDG 0.01% (n=1)
LGTPTYDWGSNDTDV 0.01% (n=1)
AGAPTYNWGVNDTDF 0.01% (n=1)
SGAPIYSWGEKDTDV 0.01% (n=1)
SGAPTYNWGCNDTDV 0.01% (n=1)
LGAPTFNWGENESDV 0.01% (n=1)
SGAPTYDWGENESDV 0.01% (n=1)
SGAPTYNWGTNDTDV 0.01% (n=1)
SGAPTYNWGSNNTDV 0.01% (n=1)
LGVPTYSWGENETDV 0.01% (n=1)
FGVPTYSWGENDTDV 0.01% (n=1)
SGVPTYTWGERDTDV 0.01% (n=1)
LGAPTYNWGANDSDV 0.01% (n=1)
AGVPTLNWGSNETDV 0.01% (n=1)
SGVPTYNWGDNETDV 0.01% (n=1)
SGVPTYNWGGNETGV 0.01% (n=1)
LGALTYNWGSNDTDV 0.01% (n=1)
LGAPTYNWGSNVTDV 0.01% (n=1)
LGAPTYNWGSNDTGI 0.01% (n=1)
SGAPTYNWGENDTDA 0.01% (n=1)
SGAPTHNWGASDTDV 0.01% (n=1)
LGVPIYGWGSNDTDV 0.01% (n=1)
SGAATYSWGENDTDV 0.01% (n=1)
SGAPTYSWGEYDTDV 0.01% (n=1)
SGAPTYS*GENDTDV 0.01% (n=1)
SGGPTYSWGENDTDV 0.01% (n=1)
SGAPTYSWGENDTGI 0.01% (n=1)
SGAPTCSWGENDTDV 0.01% (n=1)
PGAPTYSWGENDTDV 0.01% (n=1)
SGAPTYGRGENDTDV 0.01% (n=1)
SGAPTYSRGENDTDV 0.01% (n=1)
SGAPTYSWGGNDTDV 0.01% (n=1)
AGAPTYNWGTNDTDV 0.01% (n=1)
SGAPTHNWGENDTDV 0.01% (n=1)
AGAPTYNWGENGTDV 0.01% (n=1)
AGVPTYNWGEDDTDV 0.01% (n=1)
LGAPTYNWGDNQTDV 0.01% (n=1)
LGAPTYKWGANDTDV 0.01% (n=1)
LGAPTYNWGANETEV 0.01% (n=1)
TGALTYNRGANDTDV 0.01% (n=1)
AGVPTHNWGENETDV 0.01% (n=1)
LGAPTYRWGENETDV 0.01% (n=1)
SGAPTYNWGENETDI 0.01% (n=1)
AGAPTYNWGGNDTDV 0.01% (n=1)
SGVPTYDWGSSDVDV 0.01% (n=1)
SGAPTYSWGANDTAV 0.01% (n=1)
SGAPTYSWGANGTDV 0.01% (n=1)
SGAPTCSWGATDTDV 0.01% (n=1)
SGAPTYSWGVNDTGV 0.01% (n=1)
SGAPTYSRGANDTDV 0.01% (n=1)
SGAPTYSWGANDTGV 0.01% (n=1)
SGAPTYSWGANDTDA 0.01% (n=1)
SGAPAYSWGANDTDV 0.01% (n=1)
SGTPTYSWGANDTDV 0.01% (n=1)
RGVPTYNWGENDTDF 0.01% (n=1)
AGVPTYSWGVNDKDV 0.01% (n=1)
RGVPTYNWGGNDTDV 0.01% (n=1)
SGVPTYNWGAKKTDV 0.01% (n=1)
SGAPTYNWGAHETDV 0.01% (n=1)
SGVPTYNWGTNVTDV 0.01% (n=1)
SGVPTYNWGADKTDV 0.01% (n=1)
LGVPTYNWGADETDV 0.01% (n=1)
SGVPTYNWGANEKDV 0.01% (n=1)
SGVPTYNWGAKQTDV 0.01% (n=1)
SGVPTYNWGARETDV 0.01% (n=1)
SGAPTYNWGASETDV 0.01% (n=1)
SGAPTYNWGATETDV 0.01% (n=1)
LGVPTYNWGTNETDI 0.01% (n=1)
SGVPTYNWGTNKTDV 0.01% (n=1)
SGAPTCSWGANDTDV 0.01% (n=1)
SGAPTYNWGDNEADV 0.01% (n=1)
SGAPTYSWGANDTDI 0.01% (n=1)
SGAPTYNWGVNDTDI 0.01% (n=1)
SGAPTYNWGGNATDV 0.01% (n=1)
SGAPTHNWGENETDV 0.01% (n=1)
SGAPTYNWGEDDTDV 0.01% (n=1)
WGAPAYNWGENDTDV 0.01% (n=1)
SGAPTYSWGENDSDV 0.01% (n=1)
MGAPTYSWGENDTDV 0.01% (n=1)
LGAPTYNWGGNVTDV 0.01% (n=1)
AGVPTYRWGKNETDV 0.01% (n=1)
SGEPTYYWGENDTDV 0.01% (n=1)
SGAPTYDWGVNDTDV 0.01% (n=1)
SGVPTYSWGSNATDV 0.01% (n=1)
RGVPTYTWGENETDV 0.01% (n=1)
LGSPTYSWGENDTDV 0.01% (n=1)
SGVPTYDWGENDTDV 0.01% (n=1)
SGTPTYSWGENDTDV 0.01% (n=1)
SGAPTYSWGSNDTDV 0.01% (n=1)
RGVPTYSWGESEADV 0.01% (n=1)
LGAPTYNWGRNDTDV 0.01% (n=1)
LGAPTYRWGTNDTDV 0.01% (n=1)
RGVPTYTWGANETDV 0.01% (n=1)
LGSPTYNWGENDTDV 0.01% (n=1)
SGAPTYSWGDNDTDV 0.01% (n=1)
RGVPTYNWGANITDV 0.01% (n=1)
LGAPTYTWGDNDTDV 0.01% (n=1)
LGAPTYSWGSDNTDV 0.01% (n=1)
KGIPTYTWGENETDV 0.01% (n=1)
VGVPTYNWGENETDV 0.01% (n=1)
LGAPTYSWGDNDTDV 0.01% (n=1)
SGHPTYNWGANDTDV 0.01% (n=1)
LGAPTYNWGSNITDV 0.01% (n=1)
AGAPTYNWGQNETDV 0.01% (n=1)
LSAPTYNWGSNDTDV 0.01% (n=1)
SGVPTYAWGANETDV 0.01% (n=1)
QGAPTYSWGANDTDV 0.01% (n=1)
RGVPTYNWGDNDTDV 0.01% (n=1)
AGAPTYTWGSNDTDV 0.01% (n=1)
AGAPTYNWGETDKDV 0.01% (n=1)
LGVPTYSWGSNDTDV 0.01% (n=1)
AGVPTYTWGENETDV 0.01% (n=1)
SGVPTYRWGVNETDV 0.01% (n=1)
LGAPTYNWGANMTDV 0.01% (n=1)
FGAPTYSWGANETDV 0.01% (n=1)
FGAPTYNWGGNDTDV 0.01% (n=1)
SGAPTYTWGGNDTDV 0.01% (n=1)
-GAPTYNWGDNDTDV 0.01% (n=1)
WGAPTYNWGVNETDV 0.01% (n=1)
SGAPAYNWGENDTDV 0.01% (n=1)
LGIPTYSWGGNDTDV 0.01% (n=1)
SSAPTYSWGANDTDV 0.01% (n=1)
SGAPTYSWGANNTDV 0.01% (n=1)
SGAPTYSWGENEKDV 0.01% (n=1)
LGVPTYNWGSNNTDV 0.01% (n=1)
SGVPTYNWGSNDTDV 0.01% (n=1)
AGTPTYNWGENDTDV 0.01% (n=1)
SGVPTYNWVSNDTDV 0.01% (n=1)
SGVPTYNWGENVTDV 0.01% (n=1)
LGAPTYNWGNNDTDV 0.01% (n=1)
LGAPTYNWGEQDTDV 0.01% (n=1)
TGVPTYNWGENESDV 0.01% (n=1)
QGVPTYNWGENDTDV 0.01% (n=1)
WGVPTYTWGENETDV 0.01% (n=1)
LGAPTYTWGENDTDV 0.01% (n=1)
SGAPTYDWGENETDV 0.01% (n=1)
SGAPTYNWGENETDA 0.01% (n=1)
LGAPTYRWGENEKDV 0.01% (n=1)
LGVPTYNWGANETDV 0.01% (n=1)
SGVPTYTWGENESDV 0.01% (n=1)
LGAPTYNWGASDTDV 0.01% (n=1)
LGAPTYNWGANVTDV 0.01% (n=1)
WGVPTYTWGSSDADV 0.01% (n=1)
AGAPTYTWGENETDV 0.01% (n=1)
FGAPTYNWGANDTDV 0.01% (n=1)
LGAPTYNWGGNDADV 0.01% (n=1)
YGAPTYNWGTNDTDV 0.01% (n=1)
LGAPTHTWGANETDV 0.01% (n=1)
LGVPTYSWGANDTDV 0.01% (n=1)
SGAPTYNWGGGDTDV 0.01% (n=1)
SGTPTFSWGENDTDV 0.01% (n=1)
SGGPTYNWGRKDTDV 0.01% (n=1)
SGAPTYNWGMNDTDV 0.01% (n=1)
TGAPTYDWGANETDV 0.01% (n=1)
LGVPTYNWGENATDV 0.01% (n=1)
SGAPTYNWGVNDTDV 0.01% (n=1)
LGAPTFNWGANDTDV 0.01% (n=1)
VGAPAYNWGENDTDV 0.01% (n=1)
AGAPSYNWGENDTDV 0.01% (n=1)
AGAPAYNWGKNDTDV 0.01% (n=1)
AGAPAYNWGENATDV 0.01% (n=1)
AGVPAYNWGENDTDV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 1b:

FGVPTYSWGENETDV 14.28% (n=414)
SGVPTYSWGGNETDV 12.38% (n=359)
FGAPTYSWGENETDV 9.24% (n=268)
SGVPTYRWGENETDV 6.72% (n=195)
FGVPTYTWGENETDV 4.34% (n=126)
SGVPTYSWGENETDV 4.31% (n=125)
LGVPTYSWGENETDV 3.69% (n=107)
FGVPTYRWGENETDV 3.31% (n=96)
SGVPTYNWGENETDV 2.90% (n=84)
FGAPTYTWGENETDV 2.83% (n=82)
LGVPTYTWGGNVTDV 2.76% (n=80)
SGAPTYTWGENETDV 2.28% (n=66)
FGAPTYNWGENETDV 1.93% (n=56)
SGVPTYTWGENETDV 1.79% (n=52)
FGVPTYSWGGNETDV 1.69% (n=49)
SGAPTYSWGENETDV 1.48% (n=43)
FGVPTYNWGENETDV 1.31% (n=38)
YGVPTYSWGENETDV 1.21% (n=35)
SGAPTYNWGENETDV 1.03% (n=30)
LGVPTYTWGENETDV 0.79% (n=23)
HGAPTYRWGENETDV 0.69% (n=20)
FGAPTYNWGENQTDV 0.62% (n=18)
LGHPTYNWGENETDV 0.59% (n=17)
SGVPTYSWGKNETDV 0.45% (n=13)
FGAPTYNWGANETDV 0.41% (n=12)
SGAPTYRWGENETDV 0.38% (n=11)
FGVPTYNWGDNETDV 0.34% (n=10)
FGAPTYRWGENETDV 0.34% (n=10)
FGVPTYTWGENKTDV 0.34% (n=10)
FGVPTYSWGGNVTDV 0.34% (n=10)
FGVPTYNWGGNETDV 0.31% (n=9)
HGVPTYSWGENETDV 0.31% (n=9)
LGVPTYNWGENETDV 0.31% (n=9)
--------GENETDV 0.31% (n=9)
FGAPTYNWGDNETDV 0.28% (n=8)
FGVPTYSWGENKTDV 0.24% (n=7)
FGAPTYNWGGNETDV 0.24% (n=7)
LGVPTYNWGGNRTDV 0.21% (n=6)
FGAPTYNWGNNETDV 0.21% (n=6)
SGAPTYSWGENKTDV 0.21% (n=6)
FGVPTYSWGANETDV 0.17% (n=5)
SGAPTYNWGANETDV 0.17% (n=5)
FGVPTYAWGGNETDV 0.17% (n=5)
FGAPTYSWGENETGV 0.17% (n=5)
FGVPTYKWGENETDV 0.14% (n=4)
SGVPT---------- 0.14% (n=4)
FGVPT---------- 0.14% (n=4)
FGVPTYSWGE----- 0.14% (n=4)
LGVPTYRWGENETDV 0.14% (n=4)
SGVPTYSWGENKTDV 0.14% (n=4)
FGVPTYSWGENVTDV 0.14% (n=4)
SGVPTYKWGENETDV 0.14% (n=4)
YGVPTYKWGENETDV 0.14% (n=4)
SGAPTYSWGANETDV 0.14% (n=4)
LGAPTYNWGDNDTDV 0.10% (n=3)
SGVPTYTWGENKTDV 0.10% (n=3)
FGAPTYTWGANETDV 0.10% (n=3)
FGVPTYTWGANETDV 0.10% (n=3)
SGAPTYNWGGNETDV 0.10% (n=3)
SGVPTYNWGGNETDV 0.10% (n=3)
SGAPTYTWGANETDV 0.10% (n=3)
SGAPTFSWGENETDV 0.10% (n=3)
RGVPTYSWGENETDV 0.10% (n=3)
LGAPTYSWGENETDV 0.10% (n=3)
SGAPTYNWGDNETDV 0.10% (n=3)
FGAPTYNWGVNETDV 0.10% (n=3)
SGAPTYSWGGNETDV 0.10% (n=3)
SGVPTYNWGANETDV 0.10% (n=3)
SGVPTYGWGENETDV 0.10% (n=3)
FGAPTYRWGANETDV 0.10% (n=3)
YGVPTYTWGENETDV 0.10% (n=3)
FGVPTYSWGVNETDV 0.07% (n=2)
SGVPTYSWGENETDM 0.07% (n=2)
FGVPTYNWGENETDI 0.07% (n=2)
FGAPTYKWGENETDV 0.07% (n=2)
SGVPTYTWGENETDM 0.07% (n=2)
FGAPTYSWGANETDV 0.07% (n=2)
FGVPTYSWGENGTDV 0.07% (n=2)
LGVPTYSWGGNETDV 0.07% (n=2)
VGVPTYSWGENETDV 0.07% (n=2)
FGVPTYDWGENETDV 0.07% (n=2)
AGVPTYRWGENETDV 0.07% (n=2)
FGAPTYQWGENETDV 0.07% (n=2)
FGVPTYNWGENEADV 0.07% (n=2)
FGTPTYTWGENETDV 0.07% (n=2)
YGAPTYTWGENETDV 0.07% (n=2)
SGTPTYNWGENKTDV 0.07% (n=2)
FGVPTYNWGENQTDV 0.07% (n=2)
FGVPTYRWGANETDV 0.07% (n=2)
SGVPTYSWGANETDV 0.07% (n=2)
FGVPTYNWGANETDV 0.07% (n=2)
AGVPTYSWGENETDV 0.07% (n=2)
HGVPTYNWGENETDV 0.07% (n=2)
HGVPTYRWGENETDV 0.07% (n=2)
LGVPTYTWGENEADV 0.07% (n=2)
YGAPTYNWGENETDV 0.07% (n=2)
LGAPTYNWGENETDV 0.07% (n=2)
FGIPTYTWGENETDV 0.07% (n=2)
SGVPTYTWGGNETDV 0.07% (n=2)
LGVPTYTWGENKTDV 0.07% (n=2)
LDVPTYSWGENETDV 0.07% (n=2)
HGVPTYTWGENKTDV 0.07% (n=2)
YGAPTYNWGGNETDV 0.07% (n=2)
FGAPTYSWGGNETDV 0.07% (n=2)
FGVPTYSWGENATDV 0.07% (n=2)
SGAPTYTWGESETDV 0.07% (n=2)
FGAPTFSWGENETDV 0.07% (n=2)
FGVPTFSWGENETDV 0.07% (n=2)
SGAPTFNWGENETDV 0.07% (n=2)
RGVPTYTWGGNKSDV 0.07% (n=2)
--------GENEIDV 0.07% (n=2)
--------GESETDV 0.07% (n=2)
FGTPTYNWGENETDV 0.07% (n=2)
LGAPTSVRGENGTDV 0.03% (n=1)
LGVRTYNWGENETDV 0.03% (n=1)
LGNPTYSWGENDTDV 0.03% (n=1)
LGVPTYSWGENVTDV 0.03% (n=1)
SGVPTYNWGVNESDV 0.03% (n=1)
TGAPTYRWGENETDV 0.03% (n=1)
FGVRT---------- 0.03% (n=1)
SSVPT---------- 0.03% (n=1)
FSVPT---------- 0.03% (n=1)
FGTPTYSWGENETDV 0.03% (n=1)
FGARKYSWGENETDV 0.03% (n=1)
FGASTYSWGENETDV 0.03% (n=1)
FGAPTYSWGENETNV 0.03% (n=1)
HGVPTYSWGENGTDV 0.03% (n=1)
SGVPTYRWGDNETDV 0.03% (n=1)
FGAPTYNWGENKTDV 0.03% (n=1)
SGTPTYRWGENETDV 0.03% (n=1)
FGAPTYSWRENETDV 0.03% (n=1)
FGPPTYSWGENETDV 0.03% (n=1)
YGAPTYTWGVNETDV 0.03% (n=1)
LGVPTYTWGENETNV 0.03% (n=1)
FGVPTYRWGEKETDV 0.03% (n=1)
FGVSTYTWGENETDV 0.03% (n=1)
FGVPTYRWGEIETDV 0.03% (n=1)
PGVPTYSWGGNETDV 0.03% (n=1)
SGVPTYSGRGIETDV 0.03% (n=1)
PGVPTYMWGEYETDV 0.03% (n=1)
SGVPTYSWGGNETDM 0.03% (n=1)
SGVPTYSWGGIKPDV 0.03% (n=1)
SGVPTYSWGGNRTDV 0.03% (n=1)
F-------------- 0.03% (n=1)
YGVPTYSWGENDTDV 0.03% (n=1)
SSVPTYRWGENETDV 0.03% (n=1)
FGVPTYSWGENETCV 0.03% (n=1)
FGAPTYTWGENVTDV 0.03% (n=1)
SGVPTYTWGGNKTDV 0.03% (n=1)
HGVPTFTWGEKETDV 0.03% (n=1)
TGVPTYSWGGNKTDV 0.03% (n=1)
YGAPTYSWGENETDV 0.03% (n=1)
LGAPTYNWGGNETDV 0.03% (n=1)
LGNPTYTWGGNETDV 0.03% (n=1)
LGDPTYNWGENETDV 0.03% (n=1)
LGVPTYNWGENGSDV 0.03% (n=1)
FGVPTHNWGGNASDV 0.03% (n=1)
FGVPTYNWGGNVTDV 0.03% (n=1)
FGAPTYSWGVNETDV 0.03% (n=1)
LGAPTYNWGENVTDV 0.03% (n=1)
LGVPTYGWGANETDV 0.03% (n=1)
LGVPTYSWGANETDV 0.03% (n=1)
FGAPTFTWGENVTDV 0.03% (n=1)
SGVPTYDWGGNETDV 0.03% (n=1)
FGVPTYRWGGNETDV 0.03% (n=1)
HGVPTYTWGANETDV 0.03% (n=1)
FGNPTYNWGENKTDV 0.03% (n=1)
SGDPTYNWGGNETDV 0.03% (n=1)
CGVPTYSWGENKTDV 0.03% (n=1)
SGAPTYRWGANESDV 0.03% (n=1)
YGVPTYSWGGNKTDV 0.03% (n=1)
SGVPTYDWGENETDV 0.03% (n=1)
FGVPTYNWGENATDV 0.03% (n=1)
LGAPTYAWGGNETDV 0.03% (n=1)
SGVPTYGWGANETDV 0.03% (n=1)
SGNPTYTWGENATDV 0.03% (n=1)
VGVPTYTWGENETDV 0.03% (n=1)
FGVPTCTWGENETDV 0.03% (n=1)
FGVPTYTWEENETDV 0.03% (n=1)
FGAPTYSWGENGTDV 0.03% (n=1)
SGTPTYNWGGNETDV 0.03% (n=1)
SGAPTYNWGVNETDV 0.03% (n=1)
HGAPTYSWGENETDV 0.03% (n=1)
LGVPTYSWGGNTSDV 0.03% (n=1)
SGAPTYTWGENKTDV 0.03% (n=1)
RGAPTYNWGENATDV 0.03% (n=1)
LGVPTYSWGGNKSDV 0.03% (n=1)
LGVPTYNWGENATDV 0.03% (n=1)
TGAPTYNWGENETDV 0.03% (n=1)
--------------V 0.03% (n=1)
RGVPTYNWGGNVTDV 0.03% (n=1)
FGTATFNWGGNETDV 0.03% (n=1)
FGVPTYSWGDNETDV 0.03% (n=1)
LGVPTYNWGENKSDV 0.03% (n=1)
HGVPTYNWGDNETDV 0.03% (n=1)
FGVPTYAWGANETDV 0.03% (n=1)
SGAPTYTWGTNESDV 0.03% (n=1)
LGVPTYSWGDNETDV 0.03% (n=1)
LGVPTYSWGENEADV 0.03% (n=1)
FGVPSYRWGENETDV 0.03% (n=1)
HGVPTYTWGENETDV 0.03% (n=1)
LGVPTYTWGGNETDV 0.03% (n=1)
SGVPTYNWGVNETDV 0.03% (n=1)
FGVPTYTWGDNETDV 0.03% (n=1)
SGVPTYRWGENGTDV 0.03% (n=1)
YGVPTYNWGGNETDV 0.03% (n=1)
SSRRSYILGENETDV 0.03% (n=1)
FGVPTYSWGENETNV 0.03% (n=1)
FGVPTYRWGDNETDV 0.03% (n=1)
AGVPTYNWGENETDV 0.03% (n=1)
FGVPTYTWGGNASDV 0.03% (n=1)
LGVPTYSWGGNATDV 0.03% (n=1)
LGVPTYSWGENKSDV 0.03% (n=1)
SGAPTYTWGGNETDV 0.03% (n=1)
RGVPTYSWGENDTDV 0.03% (n=1)
SGVPTYNWGDNETDV 0.03% (n=1)
LGLPTYNWGENETDV 0.03% (n=1)
RGVPTYSWGANETDV 0.03% (n=1)
FGAPTYRWGENESDV 0.03% (n=1)
FGVPTYNWGANQTDV 0.03% (n=1)
FGIPTYSWGENETDV 0.03% (n=1)
SGAPTYHWGENKTDV 0.03% (n=1)
FGAPTYNWGENATDV 0.03% (n=1)
SGAPTYTWGENDTDV 0.03% (n=1)
LGVPTYSWGENKTDV 0.03% (n=1)
RGVPTYRWGENSSDV 0.03% (n=1)
HGVPTFSWGENETDV 0.03% (n=1)
FGVPTYSWGANKTDV 0.03% (n=1)
LGVPTYTWGANETDV 0.03% (n=1)
FGTPTYTWGENKTDV 0.03% (n=1)
LGAPTYTWGENATDV 0.03% (n=1)
RGVPTYSWGGNKTDV 0.03% (n=1)
SGVPTYTWGDNETDV 0.03% (n=1)
FGNPTYRWGENKTDV 0.03% (n=1)
SGVPTYSWGESETDV 0.03% (n=1)
FGAPTYTWGGNETDV 0.03% (n=1)
SGVPTYRWGENKTDV 0.03% (n=1)
HGDPTYTWGGNETDV 0.03% (n=1)
SGVPTYTWGENQTDV 0.03% (n=1)
FGTPTYTWGENGTDV 0.03% (n=1)
RGVPTYNWGGNETDV 0.03% (n=1)
SGTPTYTWGENKTDV 0.03% (n=1)
SGVPTYTWGTNETDV 0.03% (n=1)
FGVPTYNWGENVTDV 0.03% (n=1)
LGAPTYNWGANETDV 0.03% (n=1)
VGVPTYNWGENETDV 0.03% (n=1)
RGVPTYTWGVNETDV 0.03% (n=1)
HGVPTYDWGENETDV 0.03% (n=1)
SGAPTYGWGENETDV 0.03% (n=1)
FGVPTYSWGEDETDV 0.03% (n=1)
FGAPTYSRGENEADV 0.03% (n=1)
FGAPTYSWGENETDA 0.03% (n=1)
SGVPTYQWGENKTDV 0.03% (n=1)
DGVPTYGWGGNETDV 0.03% (n=1)
FGVPTYSWGENQTDV 0.03% (n=1)
FGVPTYTWGENETGV 0.03% (n=1)
SGVPTYSWGRNETDV 0.03% (n=1)
SGVPTYSWGKNETDM 0.03% (n=1)
FGVPTHTWGENETDV 0.03% (n=1)
PGVPTYSWGKNETDV 0.03% (n=1)
SGVPTYSWGENETDA 0.03% (n=1)
SGAPTHTWGENETDV 0.03% (n=1)
FGVPTYSWGENESDV 0.03% (n=1)
FGAPTYTWGENGTDV 0.03% (n=1)
FGAPTYTWGRNETDV 0.03% (n=1)
FGAPTYTWGESETDV 0.03% (n=1)
FGAPTYRRGGNETDV 0.03% (n=1)
FGAPTFTWGENETDV 0.03% (n=1)
FGVPTYNWGGNATDV 0.03% (n=1)
SGTPTFSWGENETDV 0.03% (n=1)
SGVPTFSWGENDTDV 0.03% (n=1)
SGTPTYSWGENVTDV 0.03% (n=1)
FGTPTFSWGENQTDV 0.03% (n=1)
SGAPTFSWGEKETDV 0.03% (n=1)
SGVPTFSWGENETDV 0.03% (n=1)
AGVPTYTWGENETDV 0.03% (n=1)
FGAPTYAWGENETDV 0.03% (n=1)
SGVPTYNWGENVTDV 0.03% (n=1)
FGVPTYQWGENESDV 0.03% (n=1)
YGAPTFSWGENETDV 0.03% (n=1)
--------GENESDV 0.03% (n=1)
AGVPTYTWGGNETDV 0.03% (n=1)
FGVPTYRWGENETDA 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 2:

QGVPTYSWGENETDV 16.89% (n=89)
QGAPTYSWGENETDV 14.23% (n=75)
RGVPTYNWGDNETDV 12.71% (n=67)
RGVPTYTWGENETDV 6.64% (n=35)
LGVPTYTWGENETDV 6.45% (n=34)
QGVPTYTWGENETDV 4.93% (n=26)
QGVPTYNWGENETDV 2.85% (n=15)
AGVPTYTWGENETDV 2.28% (n=12)
LGAPTYTWGENETDV 1.71% (n=9)
RGVPTYSWGENETDV 1.33% (n=7)
QGAPTYGWGENETDV 1.14% (n=6)
AGVPTYSWGENETDV 0.95% (n=5)
AGAPTYTWGENETDV 0.95% (n=5)
TGVPTYGWGENETDV 0.95% (n=5)
LGVPTYSWGENETDV 0.76% (n=4)
QGVPTYNWGDNETDV 0.76% (n=4)
QGAPTYNWGENETDV 0.76% (n=4)
QGAPTYRWGENETDV 0.76% (n=4)
TGVPTYTWGENETDV 0.76% (n=4)
FGVPTYTWGENETDV 0.57% (n=3)
QGVPTYSWGANETDV 0.57% (n=3)
QGVPTYTWGENDTDV 0.57% (n=3)
RGVPTYNWGENETDV 0.57% (n=3)
LGVPTYNWGENETDV 0.57% (n=3)
YGVPTYTWGENETDV 0.57% (n=3)
AGAPTYNWGENETDV 0.57% (n=3)
TGVPTYNWGENETDV 0.57% (n=3)
LGVPT---------- 0.38% (n=2)
PGAPPRTGEGNETDV 0.38% (n=2)
RGAPTYTWGENETDV 0.38% (n=2)
RGVPTYTWGENESDV 0.38% (n=2)
LGVPTYTWGENDTDV 0.38% (n=2)
QGVPTYSWGENQTDV 0.38% (n=2)
QGLPTYTWGENETDV 0.38% (n=2)
SGVPTYSWGENETDV 0.38% (n=2)
FGAPTYNWGENETDV 0.38% (n=2)
AGVPTYNWGENETDV 0.38% (n=2)
TGAPTYTWGENETDV 0.38% (n=2)
SGAPTYTWGENETDV 0.38% (n=2)
RGVPTYTWGENDTDV 0.38% (n=2)
LEAPTYTWGENETDV 0.19% (n=1)
SGVPTYTWGENETDV 0.19% (n=1)
RGAPTYTWGENDTNV 0.19% (n=1)
RGVPTYRWGENETDV 0.19% (n=1)
LGVPTYTWGGNETDV 0.19% (n=1)
PGAPTRMWEGNETDV 0.19% (n=1)
PGAPTRMGEGNETDV 0.19% (n=1)
PGAPPHTGEGNETDV 0.19% (n=1)
YGAPTYTWGENETDF 0.19% (n=1)
RGVPTYTWGANETDF 0.19% (n=1)
RGVPTYTWGENETDF 0.19% (n=1)
LGVPTYTWGENESDV 0.19% (n=1)
QGVPTYTWGVNETDV 0.19% (n=1)
EGVPTYSWGANETDV 0.19% (n=1)
QGVPTYRWGERETDV 0.19% (n=1)
RGAPTYRWGENETDV 0.19% (n=1)
QGAPTCPWRRNDTDV 0.19% (n=1)
QGAPTYSWGANETDV 0.19% (n=1)
EGVPTYSWGENETDV 0.19% (n=1)
QGVPTHTWGENETDV 0.19% (n=1)
QGIPTYSWGENETDV 0.19% (n=1)
QGVPTYTWGDNETDV 0.19% (n=1)
QGVPTYAWGENETDV 0.19% (n=1)
QGIPTYTWGDNETDV 0.19% (n=1)
QGTPTYTWGENETDV 0.19% (n=1)
HGVPTYTWGANETDV 0.19% (n=1)
EGVPTYTWGENETDV 0.19% (n=1)
QGAPTYMWGENETDV 0.19% (n=1)
QGVPTYNWGGNDTDV 0.19% (n=1)
RGVPTYNWGDNGTDV 0.19% (n=1)
QGVPTYRWGENETDV 0.19% (n=1)
QGVPTYSWGENESDV 0.19% (n=1)
LGVPTYSWGENDTDV 0.19% (n=1)
LGVPTYNWGENDTDV 0.19% (n=1)
QGLPTYSWGENETDV 0.19% (n=1)
QGVPTYDWGQNETDV 0.19% (n=1)
LGAPTYSWGENETDV 0.19% (n=1)
QGVATYTWGANDTDV 0.19% (n=1)
QGVPTYSWGVNETDV 0.19% (n=1)
LGTPTYTWGENKTDV 0.19% (n=1)
FGVPTYSWGENETDL 0.19% (n=1)
QGMPTYTWGENDTDF 0.19% (n=1)
QGAPTYTWGENETDV 0.19% (n=1)
HGVPTYSWGDNETDV 0.19% (n=1)
TGMPTYNWGESEKDV 0.19% (n=1)
AGVPTYTWGANETDV 0.19% (n=1)
FGVPTYNWGENETDV 0.19% (n=1)
AGVPTYTWGGNDTDV 0.19% (n=1)
AGVPTYTWEENETDV 0.19% (n=1)
TGQPTYTWGGNVKDV 0.19% (n=1)
SGVPTYNWGENETDV 0.19% (n=1)
AGAPTYTWGANETDV 0.19% (n=1)
AGVPTYGWGENETDV 0.19% (n=1)
VGVPTYNWGENETDV 0.19% (n=1)
NGAPTYNWGENETDV 0.19% (n=1)
FGVPTYSWGENETDV 0.19% (n=1)
FGAPTYTWGENETDV 0.19% (n=1)
LGVPTYSWGGGDKDV 0.19% (n=1)
FGVPTYTWGENETDF 0.19% (n=1)
YGAPTYTWGENETDV 0.19% (n=1)
QGVPTYKWGENETDV 0.19% (n=1)
FGVPTYKWGENETDV 0.19% (n=1)
RGVPTYTWGDNETDV 0.19% (n=1)
LGVPTYSWGVNETDV 0.19% (n=1)
QGVPAYTWGENETDV 0.19% (n=1)
LGVPTYNWGANETDV 0.19% (n=1)
ARVPTYSWGENETDV 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 2a:

RGVPTYTWGENETDV 32.47% (n=25)
LGVPTYTWGENETDV 29.87% (n=23)
LGAPTYTWGENETDV 10.39% (n=8)
LGVPT---------- 2.60% (n=2)
PGAPPRTGEGNETDV 2.60% (n=2)
LEAPTYTWGENETDV 1.30% (n=1)
SGVPTYTWGENETDV 1.30% (n=1)
RGAPTYTWGENDTNV 1.30% (n=1)
RGVPTYRWGENETDV 1.30% (n=1)
LGVPTYTWGGNETDV 1.30% (n=1)
LGVPTYSWGENETDV 1.30% (n=1)
PGAPTRMWEGNETDV 1.30% (n=1)
PGAPTRMGEGNETDV 1.30% (n=1)
PGAPPHTGEGNETDV 1.30% (n=1)
YGAPTYTWGENETDF 1.30% (n=1)
FGVPTYTWGENETDV 1.30% (n=1)
RGVPTYTWGANETDF 1.30% (n=1)
RGAPTYTWGENETDV 1.30% (n=1)
RGVPTYTWGENESDV 1.30% (n=1)
RGVPTYTWGENETDF 1.30% (n=1)
LGVPTYTWGENDTDV 1.30% (n=1)
LGVPTYTWGENESDV 1.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 2b:

QGVPTYSWGENETDV 25.43% (n=89)
QGAPTYSWGENETDV 21.43% (n=75)
RGVPTYNWGDNETDV 19.14% (n=67)
QGVPTYTWGENETDV 7.14% (n=25)
QGVPTYNWGENETDV 4.00% (n=14)
QGAPTYGWGENETDV 1.71% (n=6)
RGVPTYTWGENETDV 1.43% (n=5)
QGVPTYNWGDNETDV 1.14% (n=4)
QGAPTYNWGENETDV 1.14% (n=4)
QGAPTYRWGENETDV 1.14% (n=4)
RGVPTYSWGENETDV 1.14% (n=4)
QGVPTYSWGANETDV 0.86% (n=3)
QGVPTYTWGENDTDV 0.86% (n=3)
QGVPTYSWGENQTDV 0.57% (n=2)
QGLPTYTWGENETDV 0.57% (n=2)
RGVPTYNWGENETDV 0.57% (n=2)
LGVPTYTWGENETDV 0.57% (n=2)
YGVPTYTWGENETDV 0.57% (n=2)
QGVPTYTWGVNETDV 0.29% (n=1)
EGVPTYSWGANETDV 0.29% (n=1)
RGAPTYTWGENETDV 0.29% (n=1)
QGVPTYRWGERETDV 0.29% (n=1)
RGAPTYRWGENETDV 0.29% (n=1)
QGAPTCPWRRNDTDV 0.29% (n=1)
QGAPTYSWGANETDV 0.29% (n=1)
EGVPTYSWGENETDV 0.29% (n=1)
QGVPTHTWGENETDV 0.29% (n=1)
LGVPTYSWGENETDV 0.29% (n=1)
QGIPTYSWGENETDV 0.29% (n=1)
QGVPTYTWGDNETDV 0.29% (n=1)
QGVPTYAWGENETDV 0.29% (n=1)
QGIPTYTWGDNETDV 0.29% (n=1)
QGTPTYTWGENETDV 0.29% (n=1)
HGVPTYTWGANETDV 0.29% (n=1)
SGVPTYSWGENETDV 0.29% (n=1)
EGVPTYTWGENETDV 0.29% (n=1)
QGAPTYMWGENETDV 0.29% (n=1)
QGVPTYNWGGNDTDV 0.29% (n=1)
RGVPTYNWGDNGTDV 0.29% (n=1)
QGVPTYRWGENETDV 0.29% (n=1)
QGVPTYSWGENESDV 0.29% (n=1)
LGVPTYSWGENDTDV 0.29% (n=1)
LGVPTYNWGENDTDV 0.29% (n=1)
QGLPTYSWGENETDV 0.29% (n=1)
QGVPTYDWGQNETDV 0.29% (n=1)
LGAPTYSWGENETDV 0.29% (n=1)
LGVPTYNWGENETDV 0.29% (n=1)
QGVATYTWGANDTDV 0.29% (n=1)
QGVPTYSWGVNETDV 0.29% (n=1)
LGTPTYTWGENKTDV 0.29% (n=1)
FGVPTYSWGENETDL 0.29% (n=1)
QGMPTYTWGENDTDF 0.29% (n=1)
QGAPTYTWGENETDV 0.29% (n=1)
HGVPTYSWGDNETDV 0.29% (n=1)
LGVPTYTWGENDTDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 2c:

AGVPTYTWGENETDV 20.00% (n=12)
AGVPTYSWGENETDV 8.33% (n=5)
TGVPTYGWGENETDV 8.33% (n=5)
TGVPTYTWGENETDV 6.67% (n=4)
AGAPTYNWGENETDV 5.00% (n=3)
LGVPTYTWGENETDV 5.00% (n=3)
AGAPTYTWGENETDV 5.00% (n=3)
TGVPTYNWGENETDV 5.00% (n=3)
FGVPTYTWGENETDV 3.33% (n=2)
AGVPTYNWGENETDV 3.33% (n=2)
LGVPTYNWGENETDV 3.33% (n=2)
TGAPTYTWGENETDV 3.33% (n=2)
TGMPTYNWGESEKDV 1.67% (n=1)
FGAPTYNWGENETDV 1.67% (n=1)
AGVPTYTWGANETDV 1.67% (n=1)
LGVPTYSWGENETDV 1.67% (n=1)
FGVPTYNWGENETDV 1.67% (n=1)
AGVPTYTWGGNDTDV 1.67% (n=1)
AGVPTYTWEENETDV 1.67% (n=1)
TGQPTYTWGGNVKDV 1.67% (n=1)
SGVPTYNWGENETDV 1.67% (n=1)
AGAPTYTWGANETDV 1.67% (n=1)
RGVPTYSWGENETDV 1.67% (n=1)
RGVPTYTWGENETDV 1.67% (n=1)
AGVPTYGWGENETDV 1.67% (n=1)
NGAPTYNWGENETDV 1.67% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 3:

RGAPTYTWGANETDV 12.15% (n=334)
KGVPTYNWGENETDV 6.59% (n=181)
KGVPTYTWGENKTDV 6.11% (n=168)
KGAPTYTWGENETDV 5.75% (n=158)
KGVPTYNWGANETDV 4.22% (n=116)
KGVPTYTWGENETDV 3.89% (n=107)
KGLPTYNFGENETDV 2.98% (n=82)
KGVPTYNWGENESDV 2.95% (n=81)
KGLPTYNFGANETDV 2.91% (n=80)
KGAPTYNWGENETDV 2.58% (n=71)
KGVPTYTWGENESDV 2.44% (n=67)
KGVPTYTWGANETDV 2.33% (n=64)
KGAPTYTWGANETDV 2.04% (n=56)
RGVPTYNWGANETDV 1.78% (n=49)
KGAPTYNWGANESDV 1.60% (n=44)
KGVPTYNWGENKSDV 1.42% (n=39)
KGVPTYTWGENDTDV 1.16% (n=32)
KGSPTYNFGENETDV 1.16% (n=32)
RGAPTYTWGENETDV 1.09% (n=30)
KGAPTYTWGANKTDV 0.98% (n=27)
KGLPTYNFGANESDV 0.95% (n=26)
KGAPTYNWGANVTDV 0.87% (n=24)
EGTPTYDWGENETDV 0.84% (n=23)
KGEPTYTWGENETDV 0.76% (n=21)
RGIPTYNWGANETDA 0.73% (n=20)
RGVPTYNWGENETDV 0.73% (n=20)
KGVPTYAWGENETDV 0.55% (n=15)
KGLPTYSFGENETDV 0.55% (n=15)
KGVPTYSWGENETDV 0.47% (n=13)
RGVPTYTWGENETDV 0.47% (n=13)
----TYTWGANETDV 0.47% (n=13)
KGLPTYTFGENETDV 0.47% (n=13)
KGAPTFNWGENKTDV 0.44% (n=12)
KGAPTFTWGENETDV 0.40% (n=11)
KGAPTYSWGANESDV 0.40% (n=11)
RGAPTYNWGENETDV 0.40% (n=11)
KGVPTYNWGANESDV 0.40% (n=11)
KGAPTYTWGENESDV 0.36% (n=10)
KGAPTYNWGANETDV 0.33% (n=9)
KGAPTYSWGENETDV 0.33% (n=9)
KGAPTFTWGENKTDV 0.33% (n=9)
KGLPTYNFGENKTDV 0.33% (n=9)
KGAPTYTWGENATDV 0.29% (n=8)
KGAPTYSWGANETDV 0.29% (n=8)
RGAPTYNWGANETDV 0.25% (n=7)
KGAPTFNWGGNKTDV 0.25% (n=7)
KGAPTYTWGANESDV 0.25% (n=7)
RGVPTYTWGANETDV 0.22% (n=6)
KGVPTYYWGENKTDV 0.22% (n=6)
KGVPTYTWGANKTDV 0.22% (n=6)
KGAPTYNWGENESDV 0.22% (n=6)
KGVPTYTWGGNETDV 0.22% (n=6)
KGAPTYTWGGNETDV 0.18% (n=5)
KGIPTYNWGANETDA 0.18% (n=5)
TGVPTYTWGENESDV 0.18% (n=5)
QGVPTYTWGENETDV 0.18% (n=5)
RGAPTYNWGANESDV 0.18% (n=5)
KGAPTYGWGANESDV 0.15% (n=4)
KGVPTYTWGTNETDV 0.15% (n=4)
RGAPTYTWGTNETDV 0.15% (n=4)
KGVPTFTWGENETDV 0.15% (n=4)
KGVPTYSWGANETDV 0.15% (n=4)
EGTPTYTWGENETDV 0.15% (n=4)
AGAPTYTWGENESDV 0.15% (n=4)
KGTPTYTWGANETDV 0.15% (n=4)
KGVPTYNWGGNETDV 0.15% (n=4)
KGAPTYTWGTNETDV 0.15% (n=4)
KGTPTYTWGENETDV 0.15% (n=4)
RGVPTYDWGENETDV 0.15% (n=4)
RGSPTYNFGENETDV 0.15% (n=4)
KGAPTYNFGENETDV 0.15% (n=4)
RGLPTYNFGENETDV 0.15% (n=4)
KGLPTYSFGENESDV 0.15% (n=4)
EGVPTYTWGGNKTDV 0.11% (n=3)
KGVPTYTWGANDTDV 0.11% (n=3)
KGVPTYTWGGNATDV 0.11% (n=3)
KGTPTYNWGENETDV 0.11% (n=3)
QGVPTYTWGGNETDV 0.11% (n=3)
KGMPTYTWGENESDV 0.11% (n=3)
RGAPTYSWGENETDV 0.11% (n=3)
SGAPTYSWGENETDV 0.11% (n=3)
KGAPTYSWGAKESDV 0.11% (n=3)
KGVPTYTWGGNKTDV 0.11% (n=3)
RGAPTYTWGENESDV 0.11% (n=3)
KGAPTYNWGGNETDV 0.11% (n=3)
RGVPTYSWGENETDV 0.11% (n=3)
KGVPTYTWGANESDV 0.11% (n=3)
KGLPTYNFGGNESDV 0.11% (n=3)
KGLPTYNFGENESDV 0.11% (n=3)
KGSPTYNFGDNETDV 0.11% (n=3)
KGVPTYTFGENETDV 0.11% (n=3)
KGAPTYNWGANKTDV 0.07% (n=2)
KGTPTYTWGANDTDV 0.07% (n=2)
RGVPTYTWGENEKDV 0.07% (n=2)
KGVPTYTWGGNESDV 0.07% (n=2)
KGAPTYFWGANESDV 0.07% (n=2)
KGAPTYSWGANKSDV 0.07% (n=2)
KGAPTFTWGENVTDV 0.07% (n=2)
KGVPTYTWGENVTDV 0.07% (n=2)
KGVPTYTWGGNVTDV 0.07% (n=2)
QGVPTYTWGENEADV 0.07% (n=2)
GGAPTYSWGENETDV 0.07% (n=2)
VGAPTYSWGENETDV 0.07% (n=2)
KGVPTYTRGENETDV 0.07% (n=2)
KGVPTYNWGANEADV 0.07% (n=2)
KGTPTYTWGANESDV 0.07% (n=2)
KGAPTYTWGVNETDV 0.07% (n=2)
SGAPTYTWGENETDV 0.07% (n=2)
KGVPIYTWGENDTDV 0.07% (n=2)
RGSPTYTWGANETDV 0.07% (n=2)
KGLPTYNWGENETDV 0.07% (n=2)
RGAPTYAWGENETDV 0.07% (n=2)
KGAPTYKWGENETDV 0.07% (n=2)
KGVPTYNWGANVTDV 0.07% (n=2)
KGMPTYNWGENETDV 0.07% (n=2)
KGVPTYNWGTNETDV 0.07% (n=2)
KGAPTYRWGENQSDV 0.07% (n=2)
KGVPTYRWGENETDV 0.07% (n=2)
KGTPTYTWGENATDV 0.07% (n=2)
KGAPTYDWGENETDV 0.07% (n=2)
----TYNWGENESDV 0.07% (n=2)
KGNPTYTWGENKTDV 0.07% (n=2)
KGTPTYTWGANKTDV 0.07% (n=2)
RGVPTYNWGENKTDV 0.07% (n=2)
KGVPTYGWGENETDV 0.07% (n=2)
KGAPTFTWGANKTDV 0.07% (n=2)
KGDPTYNWGENETDV 0.07% (n=2)
RGTPTYTWGANKTDV 0.07% (n=2)
QGAPTYTWGENETDV 0.07% (n=2)
KGAPTYRWGENETDV 0.07% (n=2)
KGAPTYAWGANETDV 0.07% (n=2)
KGAPTYTWGANKSDV 0.07% (n=2)
KGVPTYNWGANVSDV 0.07% (n=2)
KGLPTYNFGENDTDV 0.07% (n=2)
KGVPTYNFGENETDV 0.07% (n=2)
RGAPTYTWGENASDV 0.04% (n=1)
KGVPTYSFGTNETDV 0.04% (n=1)
EGAPTYTWGENVRDV 0.04% (n=1)
KGVPTYTWDANETDV 0.04% (n=1)
KGAPTYNWGANETDM 0.04% (n=1)
KGGPTYNWGGDETDV 0.04% (n=1)
MGAPTYTWGENETDV 0.04% (n=1)
KGASTYNWGADETDV 0.04% (n=1)
KGASTYNWGGDETDV 0.04% (n=1)
KGGSTYNWGGNETDV 0.04% (n=1)
EGVPTFGWGGNKSDV 0.04% (n=1)
EGVPRYNWGENATDV 0.04% (n=1)
KGNPTYTWGENETDV 0.04% (n=1)
KGIPTYSFGENETDC 0.04% (n=1)
KGAPTYTWGANTSDV 0.04% (n=1)
RGLPTYNWGENETDV 0.04% (n=1)
KGAPTYNWGADVTDV 0.04% (n=1)
KGAPTYNWSANVTDV 0.04% (n=1)
KGAPTYTWGEDGTDV 0.04% (n=1)
EGTPTYDWGENEADV 0.04% (n=1)
EGTPTYDWSENETDV 0.04% (n=1)
EG-PTYDWGENETDV 0.04% (n=1)
EGTSTYDWGENETDV 0.04% (n=1)
RGIPTHNWGANETDA 0.04% (n=1)
KGAPTCTWGANETDV 0.04% (n=1)
KGVPTYYWGENETDV 0.04% (n=1)
KGVPTYYWGENKTDM 0.04% (n=1)
KGVPTYCWGENKSDV 0.04% (n=1)
KGVPTYNFGENKTDV 0.04% (n=1)
KGAPTYSWGASESDV 0.04% (n=1)
KGAPTYTWGENEADV 0.04% (n=1)
KGAPTYTWGENETDA 0.04% (n=1)
KGAPTYTWGENETDM 0.04% (n=1)
KGAPTFTWGENETGV 0.04% (n=1)
KGVPTYNWGESESDV 0.04% (n=1)
QGTPTYTWGENETDV 0.04% (n=1)
QGTPTYTWGENETDM 0.04% (n=1)
KGVPTYPWGANKTEG 0.04% (n=1)
RGVPTYSWGENEKDV 0.04% (n=1)
KGRPTYNWGENETDV 0.04% (n=1)
KGVPTYTWGENETDG 0.04% (n=1)
KGAPTYTWGANETDM 0.04% (n=1)
RGAPTYTWSENETDV 0.04% (n=1)
SGAPTYSWSENETDV 0.04% (n=1)
KGVPTYTLSENETDV 0.04% (n=1)
RGVPTYTLGENETDV 0.04% (n=1)
RGAPTYRLGENETNV 0.04% (n=1)
RGVPTYRLGENETDV 0.04% (n=1)
RGAPTYRLGENETDV 0.04% (n=1)
MGTPTYTWGANKTDV 0.04% (n=1)
EGTPTYTKSSNETEV 0.04% (n=1)
KGAPTYTWGANETEV 0.04% (n=1)
RGAPTYCSNDNESDV 0.04% (n=1)
EGTPTYTWGANKTDV 0.04% (n=1)
KGEPTYNWGGNETDV 0.04% (n=1)
RGQPTYNWGENATDV 0.04% (n=1)
KGTPTYSWGENETDV 0.04% (n=1)
RGVPTYNRGANETDV 0.04% (n=1)
GGVPTYNWGANETDV 0.04% (n=1)
KGVPTYNWGANGTDV 0.04% (n=1)
KGRPTYNWGANETDV 0.04% (n=1)
RGAPTYTWGEKETDV 0.04% (n=1)
KGVPTYTWGDNESDV 0.04% (n=1)
RGVPTYNWGENVTDV 0.04% (n=1)
RGAPTYDWGENESDV 0.04% (n=1)
KGVPTYNWGSNDTDV 0.04% (n=1)
RGEPTYNWGENETDV 0.04% (n=1)
KGVPTYDWGANKSDV 0.04% (n=1)
RGVPTYSWGENESDV 0.04% (n=1)
KGVPTYTFGANESDV 0.04% (n=1)
RGTPTYTWGGNKTDV 0.04% (n=1)
KGEPTYNWGANETDV 0.04% (n=1)
KGAPTFNWGENETDV 0.04% (n=1)
KGNPTFNWGENETDV 0.04% (n=1)
AGMPTYNWGENETDV 0.04% (n=1)
KGVPTYNWGANKTDV 0.04% (n=1)
QGVPTYNWGMNETDV 0.04% (n=1)
KGVPTYNWGGNDTDV 0.04% (n=1)
QGAPTFNWGENETDV 0.04% (n=1)
KGEPTYTWGEKETDV 0.04% (n=1)
RGVPTFTWGENETDV 0.04% (n=1)
KGVPTYSWGEKETDV 0.04% (n=1)
TGKPTYTWGENETDV 0.04% (n=1)
GGSPTYNWGENEADV 0.04% (n=1)
KGEPTYTWGETEKDV 0.04% (n=1)
RGVPTYNWGENDTDV 0.04% (n=1)
QGAPTYNWGANESDV 0.04% (n=1)
KGVPTFNWGGNKTDV 0.04% (n=1)
KGAPTFNWGANKTDV 0.04% (n=1)
KGAPTFNWGDNKTDV 0.04% (n=1)
KGAPTYSWGAEESDV 0.04% (n=1)
KGAPTYNWGGNATDV 0.04% (n=1)
KGVPTFNWGRNESDV 0.04% (n=1)
KGVPTYNWGENATDV 0.04% (n=1)
EGTPTFTWGTNETDV 0.04% (n=1)
EGNPTYTWGENKTDV 0.04% (n=1)
KGVATYNWGENETDV 0.04% (n=1)
KGVPTYTWGGNDTDL 0.04% (n=1)
KGTPTYTWGGNKTDV 0.04% (n=1)
KGNPTYTWGENQTDV 0.04% (n=1)
EGAPTYNWGENETDV 0.04% (n=1)
KGAPTYTWGENQTDV 0.04% (n=1)
KGAPTYGWGENESDV 0.04% (n=1)
AGAPTYTWGENKTDV 0.04% (n=1)
RGASTYNWGQWL*AL 0.04% (n=1)
KGAPTYYWGENETDV 0.04% (n=1)
RGASTYQW-E-L*AL 0.04% (n=1)
KGAPTYNWGANESDG 0.04% (n=1)
KGAPTYTGGANESDV 0.04% (n=1)
KGAPTYTWGANKADV 0.04% (n=1)
KGAPTYAWGANKTDV 0.04% (n=1)
KGVPTYTWGANVTDV 0.04% (n=1)
EGAPTYTWGTNATDV 0.04% (n=1)
GGTPTYTWGENESDV 0.04% (n=1)
RGVPTYDWGANESDV 0.04% (n=1)
GGDPTYTWGGNETDV 0.04% (n=1)
KGAPTYNWGENKTDV 0.04% (n=1)
RGTPTYTWGANETDV 0.04% (n=1)
RGAPTYTWGANVTDV 0.04% (n=1)
KGAPTYTWGDNKTDV 0.04% (n=1)
RGAPTYDWGGKETDV 0.04% (n=1)
RGVPTYTWGENESDV 0.04% (n=1)
EGTPTYNWGGNKTDV 0.04% (n=1)
KGAPTYTWGTNVTDV 0.04% (n=1)
EGVPTYTWGENATDV 0.04% (n=1)
KGAPTYTWGMNETDV 0.04% (n=1)
KGTPTYDWGANASDV 0.04% (n=1)
EGVPTYTWGENKTDM 0.04% (n=1)
KGAPTYEWGENETDV 0.04% (n=1)
KGAPTYTWGEKETDV 0.04% (n=1)
KGVPTYTWGTNVTDV 0.04% (n=1)
EGVQTLNWGANDSDV 0.04% (n=1)
QGVPTYNWGANETDV 0.04% (n=1)
EGTPTFTWGENTTDV 0.04% (n=1)
KGVPTYNWGGNATDV 0.04% (n=1)
KGVPTYNWGANDADV 0.04% (n=1)
KGAPTYKWGEGEKDV 0.04% (n=1)
KGIPTYNWGENETDV 0.04% (n=1)
KGAPTYTWGENKTDV 0.04% (n=1)
EGTPTYNWGENVTDV 0.04% (n=1)
AGVPTYTWGANKTDV 0.04% (n=1)
KGVPRYTWGANETDV 0.04% (n=1)
KGAPTYNWGENATDM 0.04% (n=1)
KGVPTYSWGENQTDV 0.04% (n=1)
RGVPTYSWGANESDV 0.04% (n=1)
KGEATFNWGENETDV 0.04% (n=1)
KGVPTYNFGANKTDV 0.04% (n=1)
KGVPTYKWGENETDV 0.04% (n=1)
KGTPTYSWGANQTDV 0.04% (n=1)
KGTPTYTWGEDKSDV 0.04% (n=1)
RGAPTYNWGENESDV 0.04% (n=1)
RGMPTYTWGENESDV 0.04% (n=1)
KGTPTYSWGANETDV 0.04% (n=1)
MGAPTYTWGENESDV 0.04% (n=1)
KGAPTYNWGENQTDV 0.04% (n=1)
KGVPTYTWGANQTDV 0.04% (n=1)
TGVPTYKWGENKTDV 0.04% (n=1)
KGIPTYNWGANETDV 0.04% (n=1)
KGVPTYEWGENQTDV 0.04% (n=1)
KGVPTYTWGEQERDV 0.04% (n=1)
KGVPTFNWGVNETDV 0.04% (n=1)
RGVPTYSWGANETDV 0.04% (n=1)
KGVPTFTWGGNKTDV 0.04% (n=1)
KGVPTYTWGENKSDV 0.04% (n=1)
AGKPTYGWGENETDV 0.04% (n=1)
KGNPTFNWGANATDV 0.04% (n=1)
KGTPTYTWGENKTDV 0.04% (n=1)
SGSPTYTWGENKTDV 0.04% (n=1)
RGVPTYTWGANKSDV 0.04% (n=1)
RGTPTYTWGENETDV 0.04% (n=1)
RGALTYNWGQNDSDV 0.04% (n=1)
RGMPTYTWGENETDV 0.04% (n=1)
GGAPTFTWGENETDV 0.04% (n=1)
KGAPTYQWGENETDV 0.04% (n=1)
TGTPTYNWGENQTDV 0.04% (n=1)
KGDPTYTYGTNKTDV 0.04% (n=1)
KGAPTYNWGVNETDV 0.04% (n=1)
KGSPTYQWGENETDV 0.04% (n=1)
RGVPTYNWGANESDV 0.04% (n=1)
QGVPTYNWGENKTDV 0.04% (n=1)
EGVPTYNWGANESDV 0.04% (n=1)
KGAPTYSWGENKTDV 0.04% (n=1)
KGVPTYNWGVNETDV 0.04% (n=1)
KGVPTYTWGANNTDV 0.04% (n=1)
KGSPTYTWGANETDV 0.04% (n=1)
KGLPTYTWGENKTDM 0.04% (n=1)
KGVPTYNWGDNETDV 0.04% (n=1)
KGAPTYTWGGNQTDV 0.04% (n=1)
EGTPTYTWGGNETDV 0.04% (n=1)
KGRPTYTWGENETDV 0.04% (n=1)
KGAPTYNWGDNETDV 0.04% (n=1)
KGDPTYTWGANETDV 0.04% (n=1)
KGAPTYNWGENATDV 0.04% (n=1)
QGAPTYNWGENETDV 0.04% (n=1)
KGVPTYTFGGNKTDV 0.04% (n=1)
RGAPTYTWGANKTDM 0.04% (n=1)
KGAPTYNFGENQTDV 0.04% (n=1)
KGAPTYKWGANETDV 0.04% (n=1)
KGAPTYTWGANATDV 0.04% (n=1)
RGAPTYDWGENETDV 0.04% (n=1)
EGAPTYTWGENKTDV 0.04% (n=1)
KGNPTYTWGENVTDV 0.04% (n=1)
KGTPTFNWGQNQTDV 0.04% (n=1)
RGNPTFTWGETEKDV 0.04% (n=1)
MGAPTYDWGENETDV 0.04% (n=1)
QGVATYTWGENDADV 0.04% (n=1)
RGNPTYNWGANETDT 0.04% (n=1)
EGIPTYTWGENETDM 0.04% (n=1)
KGAPTYRWGANETDV 0.04% (n=1)
EGTPTYTWGENKTDV 0.04% (n=1)
SGAPTYNWGVNETDV 0.04% (n=1)
QGAPTYSWGENETDV 0.04% (n=1)
KGAPTYNWGENETDL 0.04% (n=1)
KGNPTFDWGANETDV 0.04% (n=1)
KGAPTYNWGENDTDV 0.04% (n=1)
RGAPTYTWGANQTDV 0.04% (n=1)
RGAPTYSWGVNETDV 0.04% (n=1)
KGVPTYNWGENKTDV 0.04% (n=1)
KGAPTYNWGENDTDM 0.04% (n=1)
KGVPTYTFGENQTDV 0.04% (n=1)
KGDPTYNWGENATDW 0.04% (n=1)
RGNPTYEWGENETDV 0.04% (n=1)
KGAPTYTWGGNKTDV 0.04% (n=1)
TGAPTYTWGENKTDV 0.04% (n=1)
KGVPTYTWGENQTDV 0.04% (n=1)
KGSPTYTWGDNESDV 0.04% (n=1)
KGSPTYNWGENETDV 0.04% (n=1)
RGAPTYTWGGNETDV 0.04% (n=1)
EGAPTYNWGGNDTDV 0.04% (n=1)
EGVPTFQWGANKTDV 0.04% (n=1)
KGAPTYNWGANETDA 0.04% (n=1)
EGTPTFNWGENKTDK 0.04% (n=1)
RGVPTYTWGANESDV 0.04% (n=1)
EGVPTYTWGGNKTDM 0.04% (n=1)
KGAPTYQWGANETDV 0.04% (n=1)
KGAPTYTWGANTTDV 0.04% (n=1)
EGSPTYTWGANESDV 0.04% (n=1)
EGTPTYSWGENKTDV 0.04% (n=1)
EGAPTYTWGDNKTDV 0.04% (n=1)
KGNPTYSWGENETDV 0.04% (n=1)
KGLPTYRFGANESDV 0.04% (n=1)
KGLPTYSWGANESDV 0.04% (n=1)
KGNPTYTWGMNETDV 0.04% (n=1)
KGNPTYTWGESATDV 0.04% (n=1)
AGAPTYNWGENETDV 0.04% (n=1)
DGTPTYNWGASPADV 0.04% (n=1)
KGAPTYTWGANDTDV 0.04% (n=1)
QGAPTYSWGGNKTDV 0.04% (n=1)
KGHPTYNWGENETDV 0.04% (n=1)
RGVPTYTWGENKTDF 0.04% (n=1)
TGTPTYTWGANKTDV 0.04% (n=1)
KGVPTYSWGENESDV 0.04% (n=1)
RGTPTYTWGANETDR 0.04% (n=1)
KGIPTHNWGANESDV 0.04% (n=1)
KGLPTYRFGVNESDV 0.04% (n=1)
KGVPTYNFGANETDV 0.04% (n=1)
KGLPTYNFGENEADV 0.04% (n=1)
KGLPTYNFGENETDM 0.04% (n=1)
RGVPTYNFGENETDV 0.04% (n=1)
KGVPTYKFGENESDV 0.04% (n=1)
KGLPTYTFGENESDV 0.04% (n=1)
KGLPTYTFGANESDV 0.04% (n=1)
KGSPTYTFGENETDV 0.04% (n=1)
KGVPTYKFGENETDV 0.04% (n=1)
KGVPTYSFGANETDV 0.04% (n=1)
KGLPTYNFGVNETDV 0.04% (n=1)
RGAPTYNFGENETDV 0.04% (n=1)
RGSPTYTFGANETDV 0.04% (n=1)
KGSPTYSFGANETDV 0.04% (n=1)
KGLPTYNFGEDETDV 0.04% (n=1)
EGSPTYTFGENETDV 0.04% (n=1)
KGLPTYNFGGNQTDV 0.04% (n=1)
KGLPTYNFGENKADK 0.04% (n=1)
KGVPTYSFGENETDV 0.04% (n=1)
KGLPTYNFGGNETDV 0.04% (n=1)
KGLPTYTFGEKETDV 0.04% (n=1)
KGLPTYNFGENEKDV 0.04% (n=1)
RGLPTYTFGENETDV 0.04% (n=1)
TGLPTYTFGENETDV 0.04% (n=1)
RGLPTYNFGVNETDV 0.04% (n=1)
KGVPTYTFGEKETDV 0.04% (n=1)
KGLPTYNFGDNETDV 0.04% (n=1)
EGLPTYSFGANKTDV 0.04% (n=1)
KGSPTYSFGEKETDV 0.04% (n=1)
KGLPTYTFGANETDV 0.04% (n=1)
RGLPTYNFGANETDV 0.04% (n=1)
RGLPTYDFGENETDV 0.04% (n=1)
KGAPTYTFGANETDV 0.04% (n=1)
KGLPTYAFGANETDV 0.04% (n=1)
KGSPTYSFGENETDV 0.04% (n=1)
KGAPTYNFGANETDV 0.04% (n=1)
KGAPTYGFGENETDV 0.04% (n=1)
KGLPTYRFGENETDV 0.04% (n=1)
KGSPTYTFGGNESDV 0.04% (n=1)
KGSPTYNFGANETDV 0.04% (n=1)
KGLPTYNFGENKMDV 0.04% (n=1)
RGVPTYTFGANETDV 0.04% (n=1)
KGIPTYNFGANETDV 0.04% (n=1)
KGLPTCNFGANETDV 0.04% (n=1)
KGSPTYNFGGNETDV 0.04% (n=1)
KGLPTYSFGANESDV 0.04% (n=1)
KGLPTYGFGANESDV 0.04% (n=1)
RGLPTYNFGSNDTDV 0.04% (n=1)
RGVPTYTFGENETDV 0.04% (n=1)
RGTPTYTFGENETDV 0.04% (n=1)
QGVPTYSWGENETDV 0.04% (n=1)
RGAPTYRFGENETDV 0.04% (n=1)
RGAPTYTFGGNDTDV 0.04% (n=1)
RGVPTYTFGGNDSDV 0.04% (n=1)
KGVPTYSFGDNVTDV 0.04% (n=1)
RGAPTYTFGENDTDV 0.04% (n=1)
KGAPTYTFGENVTDV 0.04% (n=1)
LGVPTYNWGENESDV 0.04% (n=1)
LGYPTFTWGANESDV 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 3a:

RGAPTYTWGANETDV 14.19% (n=334)
KGVPTYNWGENETDV 7.69% (n=181)
KGVPTYTWGENKTDV 7.14% (n=168)
KGAPTYTWGENETDV 6.71% (n=158)
KGVPTYNWGANETDV 4.93% (n=116)
KGVPTYTWGENETDV 4.55% (n=107)
KGVPTYNWGENESDV 3.44% (n=81)
KGAPTYNWGENETDV 3.02% (n=71)
KGVPTYTWGENESDV 2.85% (n=67)
KGVPTYTWGANETDV 2.72% (n=64)
KGAPTYTWGANETDV 2.34% (n=55)
RGVPTYNWGANETDV 2.08% (n=49)
KGAPTYNWGANESDV 1.87% (n=44)
KGVPTYNWGENKSDV 1.66% (n=39)
KGVPTYTWGENDTDV 1.36% (n=32)
RGAPTYTWGENETDV 1.27% (n=30)
KGAPTYNWGANVTDV 1.02% (n=24)
EGTPTYDWGENETDV 0.98% (n=23)
KGEPTYTWGENETDV 0.89% (n=21)
RGIPTYNWGANETDA 0.85% (n=20)
RGVPTYNWGENETDV 0.85% (n=20)
KGVPTYAWGENETDV 0.64% (n=15)
KGVPTYSWGENETDV 0.55% (n=13)
RGVPTYTWGENETDV 0.51% (n=12)
KGAPTFNWGENKTDV 0.51% (n=12)
KGAPTFTWGENETDV 0.47% (n=11)
KGAPTYSWGANESDV 0.47% (n=11)
RGAPTYNWGENETDV 0.47% (n=11)
KGVPTYNWGANESDV 0.47% (n=11)
KGAPTYTWGENESDV 0.42% (n=10)
KGAPTYNWGANETDV 0.38% (n=9)
KGAPTYSWGENETDV 0.38% (n=9)
KGAPTFTWGENKTDV 0.38% (n=9)
KGAPTYTWGENATDV 0.34% (n=8)
KGAPTYSWGANETDV 0.34% (n=8)
RGAPTYNWGANETDV 0.30% (n=7)
KGAPTFNWGGNKTDV 0.30% (n=7)
KGAPTYTWGANESDV 0.30% (n=7)
RGVPTYTWGANETDV 0.25% (n=6)
KGVPTYYWGENKTDV 0.25% (n=6)
KGVPTYTWGANKTDV 0.25% (n=6)
KGAPTYNWGENESDV 0.25% (n=6)
KGVPTYTWGGNETDV 0.25% (n=6)
KGAPTYTWGGNETDV 0.21% (n=5)
KGIPTYNWGANETDA 0.21% (n=5)
TGVPTYTWGENESDV 0.21% (n=5)
QGVPTYTWGENETDV 0.21% (n=5)
RGAPTYNWGANESDV 0.21% (n=5)
KGAPTYGWGANESDV 0.17% (n=4)
KGVPTYTWGTNETDV 0.17% (n=4)
RGAPTYTWGTNETDV 0.17% (n=4)
KGVPTFTWGENETDV 0.17% (n=4)
KGVPTYSWGANETDV 0.17% (n=4)
EGTPTYTWGENETDV 0.17% (n=4)
AGAPTYTWGENESDV 0.17% (n=4)
KGTPTYTWGANETDV 0.17% (n=4)
KGVPTYNWGGNETDV 0.17% (n=4)
KGAPTYTWGTNETDV 0.17% (n=4)
KGTPTYTWGENETDV 0.17% (n=4)
RGVPTYDWGENETDV 0.17% (n=4)
EGVPTYTWGGNKTDV 0.13% (n=3)
KGVPTYTWGANDTDV 0.13% (n=3)
KGVPTYTWGGNATDV 0.13% (n=3)
KGTPTYNWGENETDV 0.13% (n=3)
QGVPTYTWGGNETDV 0.13% (n=3)
KGMPTYTWGENESDV 0.13% (n=3)
RGAPTYSWGENETDV 0.13% (n=3)
SGAPTYSWGENETDV 0.13% (n=3)
KGAPTYSWGAKESDV 0.13% (n=3)
KGVPTYTWGGNKTDV 0.13% (n=3)
KGAPTYNWGGNETDV 0.13% (n=3)
RGVPTYSWGENETDV 0.13% (n=3)
KGVPTYTWGANESDV 0.13% (n=3)
KGAPTYNWGANKTDV 0.08% (n=2)
KGTPTYTWGANDTDV 0.08% (n=2)
RGVPTYTWGENEKDV 0.08% (n=2)
KGVPTYTWGGNESDV 0.08% (n=2)
KGAPTYFWGANESDV 0.08% (n=2)
KGAPTYSWGANKSDV 0.08% (n=2)
KGAPTFTWGENVTDV 0.08% (n=2)
KGVPTYTWGENVTDV 0.08% (n=2)
KGVPTYTWGGNVTDV 0.08% (n=2)
QGVPTYTWGENEADV 0.08% (n=2)
GGAPTYSWGENETDV 0.08% (n=2)
VGAPTYSWGENETDV 0.08% (n=2)
KGVPTYTRGENETDV 0.08% (n=2)
KGVPTYNWGANEADV 0.08% (n=2)
KGTPTYTWGANESDV 0.08% (n=2)
KGAPTYTWGVNETDV 0.08% (n=2)
SGAPTYTWGENETDV 0.08% (n=2)
KGVPIYTWGENDTDV 0.08% (n=2)
RGSPTYTWGANETDV 0.08% (n=2)
KGLPTYNWGENETDV 0.08% (n=2)
RGAPTYAWGENETDV 0.08% (n=2)
KGAPTYKWGENETDV 0.08% (n=2)
KGVPTYNWGANVTDV 0.08% (n=2)
KGMPTYNWGENETDV 0.08% (n=2)
KGVPTYNWGTNETDV 0.08% (n=2)
KGAPTYRWGENQSDV 0.08% (n=2)
KGVPTYRWGENETDV 0.08% (n=2)
KGTPTYTWGENATDV 0.08% (n=2)
KGAPTYDWGENETDV 0.08% (n=2)
----TYNWGENESDV 0.08% (n=2)
RGAPTYTWGENESDV 0.08% (n=2)
KGNPTYTWGENKTDV 0.08% (n=2)
KGTPTYTWGANKTDV 0.08% (n=2)
RGVPTYNWGENKTDV 0.08% (n=2)
KGVPTYGWGENETDV 0.08% (n=2)
KGAPTFTWGANKTDV 0.08% (n=2)
KGDPTYNWGENETDV 0.08% (n=2)
RGTPTYTWGANKTDV 0.08% (n=2)
QGAPTYTWGENETDV 0.08% (n=2)
KGAPTYRWGENETDV 0.08% (n=2)
KGAPTYAWGANETDV 0.08% (n=2)
KGAPTYTWGANKSDV 0.08% (n=2)
KGVPTYNWGANVSDV 0.08% (n=2)
RGAPTYTWGENASDV 0.04% (n=1)
KGVPTYSFGTNETDV 0.04% (n=1)
EGAPTYTWGENVRDV 0.04% (n=1)
KGVPTYTWDANETDV 0.04% (n=1)
KGAPTYTWGANKTDV 0.04% (n=1)
KGAPTYNWGANETDM 0.04% (n=1)
KGGPTYNWGGDETDV 0.04% (n=1)
MGAPTYTWGENETDV 0.04% (n=1)
KGASTYNWGADETDV 0.04% (n=1)
KGASTYNWGGDETDV 0.04% (n=1)
KGGSTYNWGGNETDV 0.04% (n=1)
EGVPTFGWGGNKSDV 0.04% (n=1)
EGVPRYNWGENATDV 0.04% (n=1)
KGNPTYTWGENETDV 0.04% (n=1)
KGIPTYSFGENETDC 0.04% (n=1)
KGAPTYTWGANTSDV 0.04% (n=1)
RGLPTYNWGENETDV 0.04% (n=1)
KGAPTYNWGADVTDV 0.04% (n=1)
KGAPTYNWSANVTDV 0.04% (n=1)
KGAPTYTWGEDGTDV 0.04% (n=1)
EGTPTYDWGENEADV 0.04% (n=1)
EGTPTYDWSENETDV 0.04% (n=1)
EG-PTYDWGENETDV 0.04% (n=1)
EGTSTYDWGENETDV 0.04% (n=1)
RGIPTHNWGANETDA 0.04% (n=1)
KGAPTCTWGANETDV 0.04% (n=1)
KGVPTYYWGENETDV 0.04% (n=1)
KGVPTYYWGENKTDM 0.04% (n=1)
KGVPTYCWGENKSDV 0.04% (n=1)
KGVPTYNFGENKTDV 0.04% (n=1)
KGAPTYSWGASESDV 0.04% (n=1)
KGAPTYTWGENEADV 0.04% (n=1)
KGAPTYTWGENETDA 0.04% (n=1)
KGAPTYTWGENETDM 0.04% (n=1)
KGAPTFTWGENETGV 0.04% (n=1)
KGVPTYNWGESESDV 0.04% (n=1)
QGTPTYTWGENETDV 0.04% (n=1)
QGTPTYTWGENETDM 0.04% (n=1)
KGVPTYPWGANKTEG 0.04% (n=1)
RGVPTYSWGENEKDV 0.04% (n=1)
KGRPTYNWGENETDV 0.04% (n=1)
KGVPTYTWGENETDG 0.04% (n=1)
KGAPTYTWGANETDM 0.04% (n=1)
RGAPTYTWSENETDV 0.04% (n=1)
SGAPTYSWSENETDV 0.04% (n=1)
KGVPTYTLSENETDV 0.04% (n=1)
RGVPTYTLGENETDV 0.04% (n=1)
RGAPTYRLGENETNV 0.04% (n=1)
RGVPTYRLGENETDV 0.04% (n=1)
RGAPTYRLGENETDV 0.04% (n=1)
MGTPTYTWGANKTDV 0.04% (n=1)
EGTPTYTKSSNETEV 0.04% (n=1)
KGAPTYTWGANETEV 0.04% (n=1)
RGAPTYCSNDNESDV 0.04% (n=1)
EGTPTYTWGANKTDV 0.04% (n=1)
KGEPTYNWGGNETDV 0.04% (n=1)
RGQPTYNWGENATDV 0.04% (n=1)
KGTPTYSWGENETDV 0.04% (n=1)
RGVPTYNRGANETDV 0.04% (n=1)
GGVPTYNWGANETDV 0.04% (n=1)
KGVPTYNWGANGTDV 0.04% (n=1)
KGRPTYNWGANETDV 0.04% (n=1)
RGAPTYTWGEKETDV 0.04% (n=1)
KGVPTYTWGDNESDV 0.04% (n=1)
RGVPTYNWGENVTDV 0.04% (n=1)
RGAPTYDWGENESDV 0.04% (n=1)
KGVPTYNWGSNDTDV 0.04% (n=1)
RGEPTYNWGENETDV 0.04% (n=1)
KGVPTYDWGANKSDV 0.04% (n=1)
RGVPTYSWGENESDV 0.04% (n=1)
KGVPTYTFGANESDV 0.04% (n=1)
RGTPTYTWGGNKTDV 0.04% (n=1)
KGEPTYNWGANETDV 0.04% (n=1)
KGAPTFNWGENETDV 0.04% (n=1)
KGNPTFNWGENETDV 0.04% (n=1)
AGMPTYNWGENETDV 0.04% (n=1)
KGVPTYNWGANKTDV 0.04% (n=1)
QGVPTYNWGMNETDV 0.04% (n=1)
KGVPTYNWGGNDTDV 0.04% (n=1)
QGAPTFNWGENETDV 0.04% (n=1)
KGEPTYTWGEKETDV 0.04% (n=1)
RGVPTFTWGENETDV 0.04% (n=1)
KGVPTYSWGEKETDV 0.04% (n=1)
TGKPTYTWGENETDV 0.04% (n=1)
GGSPTYNWGENEADV 0.04% (n=1)
KGEPTYTWGETEKDV 0.04% (n=1)
RGVPTYNWGENDTDV 0.04% (n=1)
QGAPTYNWGANESDV 0.04% (n=1)
KGVPTFNWGGNKTDV 0.04% (n=1)
KGAPTFNWGANKTDV 0.04% (n=1)
KGAPTFNWGDNKTDV 0.04% (n=1)
KGAPTYSWGAEESDV 0.04% (n=1)
KGAPTYNWGGNATDV 0.04% (n=1)
KGVPTFNWGRNESDV 0.04% (n=1)
KGVPTYNWGENATDV 0.04% (n=1)
EGTPTFTWGTNETDV 0.04% (n=1)
EGNPTYTWGENKTDV 0.04% (n=1)
KGVATYNWGENETDV 0.04% (n=1)
KGVPTYTWGGNDTDL 0.04% (n=1)
KGTPTYTWGGNKTDV 0.04% (n=1)
KGNPTYTWGENQTDV 0.04% (n=1)
EGAPTYNWGENETDV 0.04% (n=1)
KGAPTYTWGENQTDV 0.04% (n=1)
KGAPTYGWGENESDV 0.04% (n=1)
AGAPTYTWGENKTDV 0.04% (n=1)
RGASTYNWGQWL*AL 0.04% (n=1)
KGAPTYYWGENETDV 0.04% (n=1)
R-----QW-E-L*AL 0.04% (n=1)
KGAPTYNWGANESDG 0.04% (n=1)
KGAPTYTGGANESDV 0.04% (n=1)
KGVPTYTWGANVTDV 0.04% (n=1)
EGAPTYTWGTNATDV 0.04% (n=1)
GGTPTYTWGENESDV 0.04% (n=1)
RGVPTYDWGANESDV 0.04% (n=1)
GGDPTYTWGGNETDV 0.04% (n=1)
KGAPTYNWGENKTDV 0.04% (n=1)
RGTPTYTWGANETDV 0.04% (n=1)
RGAPTYTWGANVTDV 0.04% (n=1)
KGAPTYTWGDNKTDV 0.04% (n=1)
RGAPTYDWGGKETDV 0.04% (n=1)
RGVPTYTWGENESDV 0.04% (n=1)
EGTPTYNWGGNKTDV 0.04% (n=1)
KGAPTYTWGTNVTDV 0.04% (n=1)
EGVPTYTWGENATDV 0.04% (n=1)
KGAPTYTWGMNETDV 0.04% (n=1)
KGTPTYDWGANASDV 0.04% (n=1)
EGVPTYTWGENKTDM 0.04% (n=1)
KGAPTYEWGENETDV 0.04% (n=1)
KGAPTYTWGEKETDV 0.04% (n=1)
KGVPTYTWGTNVTDV 0.04% (n=1)
EGVQTLNWGANDSDV 0.04% (n=1)
QGVPTYNWGANETDV 0.04% (n=1)
EGTPTFTWGENTTDV 0.04% (n=1)
KGVPTYNWGGNATDV 0.04% (n=1)
KGVPTYNWGANDADV 0.04% (n=1)
KGAPTYKWGEGEKDV 0.04% (n=1)
KGIPTYNWGENETDV 0.04% (n=1)
KGAPTYTWGENKTDV 0.04% (n=1)
EGTPTYNWGENVTDV 0.04% (n=1)
AGVPTYTWGANKTDV 0.04% (n=1)
KGVPRYTWGANETDV 0.04% (n=1)
KGAPTYNWGENATDM 0.04% (n=1)
KGVPTYSWGENQTDV 0.04% (n=1)
RGVPTYSWGANESDV 0.04% (n=1)
KGEATFNWGENETDV 0.04% (n=1)
KGVPTYNFGANKTDV 0.04% (n=1)
KGVPTYKWGENETDV 0.04% (n=1)
KGTPTYSWGANQTDV 0.04% (n=1)
KGTPTYTWGEDKSDV 0.04% (n=1)
RGAPTYNWGENESDV 0.04% (n=1)
RGMPTYTWGENESDV 0.04% (n=1)
KGTPTYSWGANETDV 0.04% (n=1)
MGAPTYTWGENESDV 0.04% (n=1)
KGAPTYNWGENQTDV 0.04% (n=1)
KGVPTYTWGANQTDV 0.04% (n=1)
TGVPTYKWGENKTDV 0.04% (n=1)
KGIPTYNWGANETDV 0.04% (n=1)
KGVPTYEWGENQTDV 0.04% (n=1)
KGVPTYTWGEQERDV 0.04% (n=1)
KGVPTFNWGVNETDV 0.04% (n=1)
RGVPTYSWGANETDV 0.04% (n=1)
KGVPTFTWGGNKTDV 0.04% (n=1)
KGVPTYTWGENKSDV 0.04% (n=1)
AGKPTYGWGENETDV 0.04% (n=1)
KGNPTFNWGANATDV 0.04% (n=1)
KGTPTYTWGENKTDV 0.04% (n=1)
SGSPTYTWGENKTDV 0.04% (n=1)
RGVPTYTWGANKSDV 0.04% (n=1)
RGTPTYTWGENETDV 0.04% (n=1)
RGALTYNWGQNDSDV 0.04% (n=1)
RGMPTYTWGENETDV 0.04% (n=1)
GGAPTFTWGENETDV 0.04% (n=1)
KGAPTYQWGENETDV 0.04% (n=1)
TGTPTYNWGENQTDV 0.04% (n=1)
KGDPTYTYGTNKTDV 0.04% (n=1)
KGAPTYNWGVNETDV 0.04% (n=1)
KGSPTYQWGENETDV 0.04% (n=1)
RGVPTYNWGANESDV 0.04% (n=1)
QGVPTYNWGENKTDV 0.04% (n=1)
EGVPTYNWGANESDV 0.04% (n=1)
KGAPTYSWGENKTDV 0.04% (n=1)
KGVPTYNWGVNETDV 0.04% (n=1)
KGVPTYTWGANNTDV 0.04% (n=1)
KGSPTYTWGANETDV 0.04% (n=1)
KGLPTYTWGENKTDM 0.04% (n=1)
KGVPTYNWGDNETDV 0.04% (n=1)
KGAPTYTWGGNQTDV 0.04% (n=1)
EGTPTYTWGGNETDV 0.04% (n=1)
KGRPTYTWGENETDV 0.04% (n=1)
KGAPTYNWGDNETDV 0.04% (n=1)
KGDPTYTWGANETDV 0.04% (n=1)
KGAPTYNWGENATDV 0.04% (n=1)
QGAPTYNWGENETDV 0.04% (n=1)
KGVPTYTFGGNKTDV 0.04% (n=1)
RGAPTYTWGANKTDM 0.04% (n=1)
KGAPTYNFGENQTDV 0.04% (n=1)
KGAPTYKWGANETDV 0.04% (n=1)
KGAPTYTWGANATDV 0.04% (n=1)
RGAPTYDWGENETDV 0.04% (n=1)
EGAPTYTWGENKTDV 0.04% (n=1)
KGNPTYTWGENVTDV 0.04% (n=1)
KGTPTFNWGQNQTDV 0.04% (n=1)
RGNPTFTWGETEKDV 0.04% (n=1)
MGAPTYDWGENETDV 0.04% (n=1)
QGVATYTWGENDADV 0.04% (n=1)
RGNPTYNWGANETDT 0.04% (n=1)
EGIPTYTWGENETDM 0.04% (n=1)
KGAPTYRWGANETDV 0.04% (n=1)
EGTPTYTWGENKTDV 0.04% (n=1)
QGAPTYSWGENETDV 0.04% (n=1)
KGAPTYNWGENETDL 0.04% (n=1)
KGNPTFDWGANETDV 0.04% (n=1)
KGAPTYNWGENDTDV 0.04% (n=1)
RGAPTYTWGANQTDV 0.04% (n=1)
RGAPTYSWGVNETDV 0.04% (n=1)
KGVPTYNWGENKTDV 0.04% (n=1)
KGAPTYNWGENDTDM 0.04% (n=1)
KGVPTYTFGENQTDV 0.04% (n=1)
KGDPTYNWGENATDW 0.04% (n=1)
RGNPTYEWGENETDV 0.04% (n=1)
KGAPTYTWGGNKTDV 0.04% (n=1)
TGAPTYTWGENKTDV 0.04% (n=1)
KGVPTYTWGENQTDV 0.04% (n=1)
KGSPTYTWGDNESDV 0.04% (n=1)
KGSPTYNWGENETDV 0.04% (n=1)
RGAPTYTWGGNETDV 0.04% (n=1)
EGAPTYNWGGNDTDV 0.04% (n=1)
EGVPTFQWGANKTDV 0.04% (n=1)
KGAPTYNWGANETDA 0.04% (n=1)
EGTPTFNWGENKTDK 0.04% (n=1)
RGVPTYTWGANESDV 0.04% (n=1)
EGVPTYTWGGNKTDM 0.04% (n=1)
KGAPTYQWGANETDV 0.04% (n=1)
KGAPTYTWGANTTDV 0.04% (n=1)
EGTPTYSWGENKTDV 0.04% (n=1)
EGAPTYTWGDNKTDV 0.04% (n=1)
KGNPTYSWGENETDV 0.04% (n=1)
KGLPTYRFGANESDV 0.04% (n=1)
KGLPTYSWGANESDV 0.04% (n=1)
KGNPTYTWGMNETDV 0.04% (n=1)
KGNPTYTWGESATDV 0.04% (n=1)
AGAPTYNWGENETDV 0.04% (n=1)
DGTPTYNWGASPADV 0.04% (n=1)
KGAPTYTWGANDTDV 0.04% (n=1)
QGAPTYSWGGNKTDV 0.04% (n=1)
KGHPTYNWGENETDV 0.04% (n=1)
RGVPTYTWGENKTDF 0.04% (n=1)
TGTPTYTWGANKTDV 0.04% (n=1)
KGVPTYSWGENESDV 0.04% (n=1)
RGTPTYTWGANETDR 0.04% (n=1)
KGIPTHNWGANESDV 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 3b:

KGLPTYNFGENETDV 24.48% (n=82)
KGLPTYNFGANETDV 23.88% (n=80)
KGSPTYNFGENETDV 9.55% (n=32)
KGLPTYNFGANESDV 7.76% (n=26)
KGLPTYSFGENETDV 4.48% (n=15)
KGLPTYTFGENETDV 3.88% (n=13)
KGLPTYNFGENKTDV 2.69% (n=9)
RGSPTYNFGENETDV 1.19% (n=4)
KGAPTYNFGENETDV 1.19% (n=4)
RGLPTYNFGENETDV 1.19% (n=4)
KGLPTYSFGENESDV 1.19% (n=4)
KGLPTYNFGGNESDV 0.90% (n=3)
KGLPTYNFGENESDV 0.90% (n=3)
KGSPTYNFGDNETDV 0.90% (n=3)
KGLPTYNFGENDTDV 0.60% (n=2)
KGVPTYNFGENETDV 0.60% (n=2)
KGLPTYRFGVNESDV 0.30% (n=1)
KGVPTYNFGANETDV 0.30% (n=1)
KGLPTYNFGENEADV 0.30% (n=1)
KGLPTYNFGENETDM 0.30% (n=1)
RGVPTYNFGENETDV 0.30% (n=1)
KGVPTYKFGENESDV 0.30% (n=1)
KGLPTYTFGENESDV 0.30% (n=1)
KGLPTYTFGANESDV 0.30% (n=1)
KGSPTYTFGENETDV 0.30% (n=1)
KGVPTYKFGENETDV 0.30% (n=1)
KGVPTYSFGANETDV 0.30% (n=1)
KGLPTYNFGVNETDV 0.30% (n=1)
RGAPTYNFGENETDV 0.30% (n=1)
RGSPTYTFGANETDV 0.30% (n=1)
KGSPTYSFGANETDV 0.30% (n=1)
KGLPTYNFGEDETDV 0.30% (n=1)
EGSPTYTFGENETDV 0.30% (n=1)
KGLPTYNFGGNQTDV 0.30% (n=1)
KGLPTYNFGENKADK 0.30% (n=1)
KGVPTYSFGENETDV 0.30% (n=1)
KGLPTYNFGGNETDV 0.30% (n=1)
KGLPTYTFGEKETDV 0.30% (n=1)
KGLPTYNFGENEKDV 0.30% (n=1)
RGLPTYTFGENETDV 0.30% (n=1)
TGLPTYTFGENETDV 0.30% (n=1)
RGLPTYNFGVNETDV 0.30% (n=1)
KGVPTYTFGEKETDV 0.30% (n=1)
KGLPTYNFGDNETDV 0.30% (n=1)
EGLPTYSFGANKTDV 0.30% (n=1)
KGSPTYSFGEKETDV 0.30% (n=1)
KGLPTYTFGANETDV 0.30% (n=1)
RGLPTYNFGANETDV 0.30% (n=1)
RGLPTYDFGENETDV 0.30% (n=1)
KGAPTYTFGANETDV 0.30% (n=1)
KGLPTYAFGANETDV 0.30% (n=1)
KGSPTYSFGENETDV 0.30% (n=1)
KGAPTYNFGANETDV 0.30% (n=1)
KGAPTYGFGENETDV 0.30% (n=1)
KGLPTYRFGENETDV 0.30% (n=1)
KGSPTYTFGGNESDV 0.30% (n=1)
KGSPTYNFGANETDV 0.30% (n=1)
KGLPTYNFGENKMDV 0.30% (n=1)
RGVPTYTFGANETDV 0.30% (n=1)
KGIPTYNFGANETDV 0.30% (n=1)
KGLPTCNFGANETDV 0.30% (n=1)
KGSPTYNFGGNETDV 0.30% (n=1)
KGLPTYSFGANESDV 0.30% (n=1)
KGLPTYGFGANESDV 0.30% (n=1)
RGLPTYNFGSNDTDV 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 4:

LGVPTYTWGENESDV 43.97% (n=102)
FGVPTYTWGENDTDV 8.19% (n=19)
FGVPTYTWGENETDV 4.31% (n=10)
LGVPTYNWGENETDV 3.88% (n=9)
LGVPTYTWGENETDV 3.45% (n=8)
LGAPTYTWGENETDV 3.02% (n=7)
VGVPTYTWGENETDV 1.72% (n=4)
LGVPTHTWGENESDV 1.72% (n=4)
RGVPTYNWGENETDV 1.72% (n=4)
RGAPTYTWGENETDV 1.72% (n=4)
LGAPTYSWGENETDV 1.29% (n=3)
RGVPTYTWGENETDV 1.29% (n=3)
LGVPTYNWGENESDV 0.86% (n=2)
LGAPTYTWGGNETDV 0.86% (n=2)
SGSPTYNWGENVTDV 0.86% (n=2)
LGDPTYNWGENKTDV 0.86% (n=2)
FGVPTYTWGENESDV 0.43% (n=1)
RGVPTYTWGENVSDV 0.43% (n=1)
RGVPTYTWGENESDV 0.43% (n=1)
LGAPTYNWGENESDV 0.43% (n=1)
LGVPTYTWGANESDA 0.43% (n=1)
SGVPTYNWGGNETDV 0.43% (n=1)
LGVPTYTWGENVSDV 0.43% (n=1)
LGVPTYTWGENASDV 0.43% (n=1)
FGVPTYTLGGNETDV 0.43% (n=1)
FGAPTYTWGENDTDV 0.43% (n=1)
FGVPTYTWGDNESDV 0.43% (n=1)
IGLPTYNWGENESDV 0.43% (n=1)
RGVPTYTWGENKTDV 0.43% (n=1)
LGVPTYSWGANETDV 0.43% (n=1)
LGVPTYNWGDNETDV 0.43% (n=1)
LGAPTYTWGANETDV 0.43% (n=1)
AGLPTYNWGENETDV 0.43% (n=1)
LGAPTYSWGDNETDV 0.43% (n=1)
LGAPTYAWGENETDV 0.43% (n=1)
QGIPTYNWGENETDV 0.43% (n=1)
QGDPTYGWGTGKDDV 0.43% (n=1)
QGAPTYNWGENETDV 0.43% (n=1)
KGNPTYSFGGNDTDV 0.43% (n=1)
SGDPTYNWGENATDV 0.43% (n=1)
RGNPTYYWGGNDTDV 0.43% (n=1)
SGNPTYGWGGNETDV 0.43% (n=1)
RGIPTYTWGENETDV 0.43% (n=1)
LGIPTYTWGANETDV 0.43% (n=1)
AGAPTYNWGENETDV 0.43% (n=1)
RGYPTHNWGANETDV 0.43% (n=1)
AGNPTYTWGANGTDV 0.43% (n=1)
LGVPTYDWGVNETNV 0.43% (n=1)
LGVPTYDWGGNETDV 0.43% (n=1)
LGLPTYGWGGNETDV 0.43% (n=1)
LGVPTYNWGANETDV 0.43% (n=1)
RGVPTYNWGVNETDV 0.43% (n=1)
LGVPTYNWGVNETDV 0.43% (n=1)
LGHPTYSWGENETDV 0.43% (n=1)
QGVPTYTWGENETDV 0.43% (n=1)
RGVPTYTWGGNETDV 0.43% (n=1)
LGDPTYTWGQNKTDV 0.43% (n=1)
RGTPTYNWGENDTDV 0.43% (n=1)
RGHPTYNWGENETDV 0.43% (n=1)
LGLPTYRWGENETDV 0.43% (n=1)
VGVPTYNWGANETDV 0.43% (n=1)
RGAPTYTWGENESDI 0.43% (n=1)
FGLPTYTWGENESDV 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 4a:

LGVPTYTWGENESDV 64.15% (n=102)
FGVPTYTWGENDTDV 11.95% (n=19)
FGVPTYTWGENETDV 6.29% (n=10)
VGVPTYTWGENETDV 2.52% (n=4)
LGVPTHTWGENESDV 2.52% (n=4)
LGVPTYNWGENETDV 1.89% (n=3)
LGVPTYTWGENETDV 1.26% (n=2)
LGVPTYNWGENESDV 1.26% (n=2)
FGVPTYTWGENESDV 0.63% (n=1)
RGVPTYTWGENVSDV 0.63% (n=1)
RGVPTYTWGENESDV 0.63% (n=1)
LGAPTYNWGENESDV 0.63% (n=1)
LGVPTYTWGANESDA 0.63% (n=1)
SGVPTYNWGGNETDV 0.63% (n=1)
LGVPTYTWGENVSDV 0.63% (n=1)
LGVPTYTWGENASDV 0.63% (n=1)
FGVPTYTLGGNETDV 0.63% (n=1)
FGAPTYTWGENDTDV 0.63% (n=1)
FGVPTYTWGDNESDV 0.63% (n=1)
RGVPTYNWGENETDV 0.63% (n=1)
IGLPTYNWGENESDV 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 4d:

LGAPTYTWGENETDV 38.46% (n=5)
LGVPTYTWGENETDV 23.08% (n=3)
RGAPTYTWGENETDV 23.08% (n=3)
LGAPTYTWGGNETDV 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 5:

RGYPTYNWGSNETDI 15.79% (n=6)
RGYPTYNWGSNETDV 10.53% (n=4)
KGNPTYNWGENETDI 5.26% (n=2)
RGYPTYNWGENETDI 5.26% (n=2)
AGVPSYNWGSNETDI 5.26% (n=2)
RGCPTYNWGSNETDI 5.26% (n=2)
KGLPTYTWGENETDV 2.63% (n=1)
KGNPTYSWGENETDI 2.63% (n=1)
RGLPTYNWGENETDV 2.63% (n=1)
LGHPTYTWGENETDI 2.63% (n=1)
RGYPTYTWGENETDV 2.63% (n=1)
RGVPTYTWGENETDV 2.63% (n=1)
KGYPTYNWGSNETDI 2.63% (n=1)
RGYPTYNWGSNDTDI 2.63% (n=1)
RGFPTYNWGENETDV 2.63% (n=1)
RGYPTYNWGENDTDI 2.63% (n=1)
KGYPTYNWGSNETDV 2.63% (n=1)
RGYPTYNWGENETDV 2.63% (n=1)
TGNPTYDWGSNESDV 2.63% (n=1)
LGYPTYSWGDNETDV 2.63% (n=1)
RGYPTYSWGANETDV 2.63% (n=1)
RGCPTYTWGTNETDI 2.63% (n=1)
RGYPTYSWGSNDTDI 2.63% (n=1)
TGYPTYNWGVNETDV 2.63% (n=1)
KGYPTYNWGENDTDV 2.63% (n=1)
KGHPTYNWGSNVTDF 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 6:

RGNPTYTWGENETDV 24.25% (n=81)
KGLPTYTWGENESDV 6.59% (n=22)
KGLPTYNWGENVSDV 3.89% (n=13)
LGNPTYTWGENETDV 2.69% (n=9)
KGLPTYTWGENETDV 2.10% (n=7)
RGAPTYTWGENETDV 1.80% (n=6)
KGLPTYNWGENMSDV 1.80% (n=6)
KGLPTYNWGENASDV 1.50% (n=5)
RGLPTYNWGENESDV 1.50% (n=5)
KGLPTYNWGANVSDV 1.50% (n=5)
RGNPTYTWGDNETDV 1.20% (n=4)
RGNPTYTWGANETDV 1.20% (n=4)
RGVPTYTWGENESDV 1.20% (n=4)
KGLPTYTWGANESDV 1.20% (n=4)
KGLPTYTWGENVSDV 1.20% (n=4)
RGIPTYTWGENETDV 0.90% (n=3)
RGNPTYNWGENETDV 0.90% (n=3)
LGNPTYNWGENETDV 0.90% (n=3)
KGLPTYSWGENESDV 0.90% (n=3)
KGLPTYNWGGNVSDV 0.90% (n=3)
KGFPTYTWGANESDV 0.90% (n=3)
KGFPTYTWGENESDV 0.90% (n=3)
RGLPTYTWGENESDV 0.90% (n=3)
RGHPTYNWGENETDV 0.60% (n=2)
RGNPTYNWGDNETDV 0.60% (n=2)
RGKPTYTWGENETDV 0.60% (n=2)
RGTPTYTWGENETDV 0.60% (n=2)
KGLPTYNWGENESDV 0.60% (n=2)
VGLPTYTWGENETDV 0.60% (n=2)
KGIPTYNWGENATDV 0.60% (n=2)
KGLPTYAWGANETDV 0.60% (n=2)
KGLPTYNWGENETDV 0.60% (n=2)
RGLPTYTWGENETDV 0.60% (n=2)
KGVPTYTWGENETDV 0.60% (n=2)
KGLPTYNWGANESDV 0.60% (n=2)
KGLPTYNWGDNVSDV 0.60% (n=2)
RGNPTYSWGENETDV 0.60% (n=2)
KGNPTYTWGANATDV 0.60% (n=2)
RGAPTYTWGTNETDV 0.60% (n=2)
KGLPTYTWGGNESDV 0.60% (n=2)
RGRPTYNWGDNETDV 0.60% (n=2)
KGLPTYNWGANASDV 0.60% (n=2)
RGFPTYTWGDNESDV 0.60% (n=2)
RGNPTYTWGENESDV 0.30% (n=1)
QGNPTYTWGENVTDV 0.30% (n=1)
PGNPTYTWGENWTDV 0.30% (n=1)
PGNPTYTWGENETDV 0.30% (n=1)
LGNPTYTWGQNETDV 0.30% (n=1)
LGNPTYTWGDNETDV 0.30% (n=1)
RGNPTYSWGDNETDV 0.30% (n=1)
LGSPTYTWGDNETDV 0.30% (n=1)
RGNPTYNWGENVTDV 0.30% (n=1)
LGNPTYSWGENETDV 0.30% (n=1)
RGNPTYHWGENETDV 0.30% (n=1)
RGVPTYTWGENETDV 0.30% (n=1)
LGNPTYNWGDNETDV 0.30% (n=1)
RGNPTYTWGKNETDV 0.30% (n=1)
QGNPTYTWGENETDV 0.30% (n=1)
RGAPTYTFGENETDV 0.30% (n=1)
RGVPTYSFGDNETDV 0.30% (n=1)
KGAPTYSFGDNESDV 0.30% (n=1)
RGLPTYEWGENASDV 0.30% (n=1)
KGLPTYNWGVNESDV 0.30% (n=1)
TGLPTYSWGENESDV 0.30% (n=1)
KGLPTYQWGENQSDV 0.30% (n=1)
KGLPTYSWGENETDV 0.30% (n=1)
AGLPTYTWGENETDV 0.30% (n=1)
RGIPTYTWGENVSDV 0.30% (n=1)
KGNPTYTWGENITDV 0.30% (n=1)
KGFPTYSWGVNESDV 0.30% (n=1)
GGLPTYGWGGNDSDV 0.30% (n=1)
RGLPTFTWGENETDV 0.30% (n=1)
KGHPTYTWGENVTDV 0.30% (n=1)
KGLPTYDWGENVTDV 0.30% (n=1)
KGHPTFNWGENETDV 0.30% (n=1)
RGLPTYNWGENETDV 0.30% (n=1)
KGFPTYTWGENETDV 0.30% (n=1)
KGFPTYSWGGNETDV 0.30% (n=1)
KGFPTYNWGENETDV 0.30% (n=1)
RGLPTYNWGENASDV 0.30% (n=1)
KGLPTYTWGDNVSDV 0.30% (n=1)
KGLPTYAWGENETDV 0.30% (n=1)
KGLPTYNWGNNMSDV 0.30% (n=1)
KGLPTYNWGANETDV 0.30% (n=1)
KGLPTYNWGDNVTDV 0.30% (n=1)
RGLPTYSWGENESDV 0.30% (n=1)
KGLPKYNWGENESDV 0.30% (n=1)
KGLPTYNWGDNESDV 0.30% (n=1)
KGLPTYNWGDNMSDV 0.30% (n=1)
KGLPTYSWGENVSDV 0.30% (n=1)
KGLPTYTWGENASDV 0.30% (n=1)
KGNPTYTWGENVSDV 0.30% (n=1)
KGLPTYNWGVNVSDV 0.30% (n=1)
RGLPTYSWGVNESDV 0.30% (n=1)
RGVPTYPWGGNDSDV 0.30% (n=1)
KGVPTYNWGENETDV 0.30% (n=1)
KGLPTYGWGENETDV 0.30% (n=1)
RGSPTYRWGENETDV 0.30% (n=1)
RGSPTYNWGDNESDV 0.30% (n=1)
KGNPTYTWGDNKTDV 0.30% (n=1)
TGLPTYTWGENMTDV 0.30% (n=1)
KGNPTYTWGENETDV 0.30% (n=1)
KGTPTYTWGENETDV 0.30% (n=1)
TGLPTYTWGENESDV 0.30% (n=1)
KGAPTYTWGTNETDV 0.30% (n=1)
RGLPTYTWGANKTDV 0.30% (n=1)
KGLPTYTLGENESDV 0.30% (n=1)
KGLPTYAWGENKSDV 0.30% (n=1)
RGLPTYTWGGNESDV 0.30% (n=1)
KGLPTYNWGANEGDV 0.30% (n=1)
KGFPTYTWGENDSDV 0.30% (n=1)
KGLPTYSWGANESDV 0.30% (n=1)
RGHPTYTWGENESDV 0.30% (n=1)
KGIPTYNWGGNETDV 0.30% (n=1)
LGNPTYTWGENETDI 0.30% (n=1)
MGNPTYNWGDNETDV 0.30% (n=1)
RGSPTYTWGEHETDV 0.30% (n=1)
DGFATYNWGENATDV 0.30% (n=1)
KGSATYTWGENETDV 0.30% (n=1)
KGLPTYTWGVNETDV 0.30% (n=1)
KGNPTYNWGENETDV 0.30% (n=1)
KGLPTYNWGDNDTDV 0.30% (n=1)
QGAPTFTWGANESDV 0.30% (n=1)
LGAPTYNFGENESDV 0.30% (n=1)
KGVPTYNWGGNESDV 0.30% (n=1)
RGVPTYSWGENQSDV 0.30% (n=1)
GGTPTFTWGANKSDV 0.30% (n=1)
KGFPTYTWGDNESDV 0.30% (n=1)
RGFPTYNWGANASDV 0.30% (n=1)
RGFPTYNWGANESDV 0.30% (n=1)
RGFPTYTWGENETDV 0.30% (n=1)
RGDPTYTWGGNESDV 0.30% (n=1)
RGFPTYTWGENESDV 0.30% (n=1)
RGFPTYTWGANESDV 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Subtype 6a:

RGNPTYTWGENETDV 66.39% (n=79)
LGNPTYTWGENETDV 5.88% (n=7)
RGNPTYTWGDNETDV 3.36% (n=4)
RGIPTYTWGENETDV 2.52% (n=3)
RGNPTYNWGENETDV 2.52% (n=3)
RGNPTYNWGDNETDV 1.68% (n=2)
RGTPTYTWGENETDV 1.68% (n=2)
RGNPTYTWGENESDV 0.84% (n=1)
QGNPTYTWGENVTDV 0.84% (n=1)
PGNPTYTWGENWTDV 0.84% (n=1)
PGNPTYTWGENETDV 0.84% (n=1)
LGNPTYTWGQNETDV 0.84% (n=1)
LGNPTYTWGDNETDV 0.84% (n=1)
RGNPTYSWGDNETDV 0.84% (n=1)
RGHPTYNWGENETDV 0.84% (n=1)
LGSPTYTWGDNETDV 0.84% (n=1)
RGKPTYTWGENETDV 0.84% (n=1)
RGNPTYNWGENVTDV 0.84% (n=1)
LGNPTYSWGENETDV 0.84% (n=1)
RGNPTYHWGENETDV 0.84% (n=1)
RGVPTYTWGENETDV 0.84% (n=1)
LGNPTYNWGDNETDV 0.84% (n=1)
RGAPTYTWGENETDV 0.84% (n=1)
RGNPTYTWGKNETDV 0.84% (n=1)
RGNPTYTWGANETDV 0.84% (n=1)
QGNPTYTWGENETDV 0.84% (n=1)
---------------------------------------------------------------------------------------
Region 522-536 (antibodies: [1:7, A8] ), HCV Genotype 7:

RGVPTYTWGENESDV 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 414-422 (antibodies: [3_11] ), HCV Genotype 1:

INTNGSWHI 59.20% (n=13606)
VNTNGSWHI 23.31% (n=5356)
INSNGSWHI 4.62% (n=1061)
INTNGSWHL 2.33% (n=535)
VNSNGSWHI 1.65% (n=379)
VNANGSWHI 0.86% (n=197)
IKTNGSWHI 0.84% (n=194)
INTNGSWHV 0.83% (n=190)
MNTNGSWHI 0.57% (n=131)
ISTNGSWHI 0.52% (n=119)
TNTNGSWHI 0.51% (n=117)
VNTNGSWHV 0.44% (n=102)
MNSNGSWHI 0.33% (n=75)
INANGSWHI 0.27% (n=61)
VSTNGSWHI 0.25% (n=57)
VNENGSWHI 0.23% (n=52)
INTNNSWHI 0.19% (n=44)
IHTNGSWHI 0.18% (n=41)
IKSNGSWHI 0.12% (n=27)
VNASGSWHI 0.12% (n=27)
INTSGSWHI 0.11% (n=26)
VKTNGSWHI 0.11% (n=25)
ANTNGSWHI 0.10% (n=23)
INTNGSW-- 0.08% (n=19)
VNTSGSWHI 0.08% (n=19)
VNTNGSW-- 0.08% (n=18)
INTNGSRHI 0.07% (n=17)
INTDGSWHI 0.07% (n=16)
IDTNGSWHI 0.06% (n=14)
INTNGSWRI 0.05% (n=12)
VNSNGSWHV 0.05% (n=12)
INTRGSWHI 0.05% (n=12)
INTNGSWHT 0.04% (n=10)
VNTNGSRHI 0.04% (n=10)
INSSGSWHI 0.04% (n=10)
IYSNGSWHI 0.04% (n=10)
VNTNGSWHT 0.04% (n=9)
INTNDSWHI 0.04% (n=9)
INSDGSWHI 0.04% (n=9)
INTNGSCHI 0.04% (n=9)
VNRNGSWHI 0.04% (n=9)
INRNGSWHI 0.04% (n=9)
INTNSSWHI 0.03% (n=8)
VNTDGSWHI 0.03% (n=8)
INPNGSWHI 0.03% (n=7)
INTNGS*HI 0.03% (n=7)
VYTNGSWHI 0.03% (n=7)
VNNNGSWHI 0.03% (n=7)
INTNGSWYI 0.03% (n=7)
VNTNGSWRI 0.03% (n=6)
VNINGSWHI 0.03% (n=6)
VDTNGSWHI 0.02% (n=5)
VNSSGSWHI 0.02% (n=5)
VNTNGNWHI 0.02% (n=5)
INTNGGWHI 0.02% (n=5)
INTNGSWLI 0.02% (n=5)
VNTNSSWHI 0.02% (n=4)
INTNGSGHI 0.02% (n=4)
INTNGTWHI 0.02% (n=4)
VNTNGS*HI 0.02% (n=4)
INSNGSWHV 0.02% (n=4)
VNKNGSWHI 0.02% (n=4)
INNNGSWHI 0.02% (n=4)
VNTNGSWYI 0.02% (n=4)
IRTNGSWHI 0.02% (n=4)
VHTNGSWHI 0.02% (n=4)
INKNGSWHI 0.02% (n=4)
METNGSWHI 0.02% (n=4)
INTEGSWHI 0.01% (n=3)
INTNGNWHI 0.01% (n=3)
IYTNGSWHI 0.01% (n=3)
VTTNGSWHI 0.01% (n=3)
INTNGSWHF 0.01% (n=3)
VHANGSWHI 0.01% (n=3)
TNSNGSWHI 0.01% (n=3)
INTNGSRHL 0.01% (n=3)
INSN----- 0.01% (n=3)
LNTNGSWHI 0.01% (n=3)
LNTNGSWHV 0.01% (n=3)
INTHGSWHI 0.01% (n=2)
INTNGSWDI 0.01% (n=2)
INSNGGWHI 0.01% (n=2)
INTNGRWHI 0.01% (n=2)
VNTNGSWHL 0.01% (n=2)
VNTKGSWHI 0.01% (n=2)
INTTGSSHI 0.01% (n=2)
INSNGSRHI 0.01% (n=2)
INTNGSWHP 0.01% (n=2)
INANGSWHL 0.01% (n=2)
ISTNGSWHL 0.01% (n=2)
INSNGNWHI 0.01% (n=2)
INTNGSWRV 0.01% (n=2)
INTNGCWHI 0.01% (n=2)
IKTNGSWHV 0.01% (n=2)
VNADGSWHI 0.01% (n=2)
IHKNGSWHI 0.01% (n=2)
ININGSWHI 0.01% (n=2)
VATNGSWHI 0.01% (n=2)
INSNGSWHL 0.01% (n=2)
INTNRSWHI 0.01% (n=2)
INT------ 0.01% (n=2)
VNTNDSWHI 0.01% (n=2)
MHTNGSWHI 0.01% (n=2)
I-------- 0.01% (n=2)
VNTNGSWQL 0.00% (n=1)
VNTNGSWLI 0.00% (n=1)
INTNGSWHA 0.00% (n=1)
TKSNGSWHI 0.00% (n=1)
IKSNGSWHS 0.00% (n=1)
IKSNGSRHI 0.00% (n=1)
VNSNGNWHI 0.00% (n=1)
MKTNDSWHI 0.00% (n=1)
IQTNGSWHI 0.00% (n=1)
IKTDGSWHI 0.00% (n=1)
INTNG-WHI 0.00% (n=1)
ISSNGSWHI 0.00% (n=1)
INFNGSWHI 0.00% (n=1)
INTSGSWHT 0.00% (n=1)
INSNGSWYI 0.00% (n=1)
INSNGRWHI 0.00% (n=1)
INTNGSCAI 0.00% (n=1)
INSNGSWHT 0.00% (n=1)
INSNGSWRI 0.00% (n=1)
VSENGSWHI 0.00% (n=1)
VNENGSWHV 0.00% (n=1)
VNENDSWHI 0.00% (n=1)
VNENGSWHT 0.00% (n=1)
INTGGSWHI 0.00% (n=1)
VYSNGSWHI 0.00% (n=1)
VYTNGSWRI 0.00% (n=1)
VDTSGSWHI 0.00% (n=1)
MYTNGSWHI 0.00% (n=1)
VNSHGSWDI 0.00% (n=1)
VNTNGRWHI 0.00% (n=1)
VNKDGSWHI 0.00% (n=1)
INASGSWHI 0.00% (n=1)
VKANDSWHI 0.00% (n=1)
VNVNDSWHI 0.00% (n=1)
INTNGSWQI 0.00% (n=1)
INTNGGWHL 0.00% (n=1)
INTNDSWHL 0.00% (n=1)
INTNGSWRL 0.00% (n=1)
VNTNRSWHI 0.00% (n=1)
VNTNGSWHS 0.00% (n=1)
INTTGSWHI 0.00% (n=1)
INTNGSRHV 0.00% (n=1)
ANTSGSWHI 0.00% (n=1)
TNTNGSWHV 0.00% (n=1)
TSTNGSWHI 0.00% (n=1)
TNTNGSWHT 0.00% (n=1)
IGTNGSWHV 0.00% (n=1)
INPNGGWHI 0.00% (n=1)
INTIGSWHI 0.00% (n=1)
INSIGSWHI 0.00% (n=1)
IKTNGGWHI 0.00% (n=1)
IKTNGRWHI 0.00% (n=1)
MNTNGNWHI 0.00% (n=1)
INTKGSWHI 0.00% (n=1)
VSTNGSWHV 0.00% (n=1)
INSNGSGHI 0.00% (n=1)
INSNDSWHI 0.00% (n=1)
VNTNGSWHN 0.00% (n=1)
MSTNGSWHI 0.00% (n=1)
INTNVSWHI 0.00% (n=1)
VKTEGNWHI 0.00% (n=1)
VNTSGSWHV 0.00% (n=1)
VNTNGGWHV 0.00% (n=1)
CNTNAAWGT 0.00% (n=1)
VNTSGSWYI 0.00% (n=1)
YNTNGSWHI 0.00% (n=1)
VN------- 0.00% (n=1)
VH------- 0.00% (n=1)
IHTNGSWDI 0.00% (n=1)
IHTNGRWHI 0.00% (n=1)
INPNGSWHF 0.00% (n=1)
VHSNGSWHI 0.00% (n=1)
VRANGSWHI 0.00% (n=1)
VHTNGSWHV 0.00% (n=1)
VNTNGGWHI 0.00% (n=1)
MKTNGSWHI 0.00% (n=1)
VNSNGSWRI 0.00% (n=1)
INTNGSWHN 0.00% (n=1)
VNTNGSWNI 0.00% (n=1)
INTNGS--- 0.00% (n=1)
VNTNGS--- 0.00% (n=1)
VNSNGSRHI 0.00% (n=1)
VNNNGIWHI 0.00% (n=1)
V-------- 0.00% (n=1)
MNTSGSWHI 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 1a:

INTNGSWHI 58.29% (n=7960)
VNTNGSWHI 17.55% (n=2396)
INSNGSWHI 7.01% (n=957)
INTNGSWHL 3.90% (n=532)
VNSNGSWHI 1.81% (n=247)
VNANGSWHI 1.43% (n=195)
IKTNGSWHI 1.35% (n=185)
INTNGSWHV 1.10% (n=150)
TNTNGSWHI 0.85% (n=116)
MNTNGSWHI 0.78% (n=106)
ISTNGSWHI 0.62% (n=85)
MNSNGSWHI 0.55% (n=75)
INANGSWHI 0.40% (n=54)
VNENGSWHI 0.38% (n=52)
VSTNGSWHI 0.33% (n=45)
INTNNSWHI 0.32% (n=44)
IKSNGSWHI 0.19% (n=26)
ANTNGSWHI 0.15% (n=20)
INTSGSWHI 0.13% (n=18)
VNTNGSWHV 0.13% (n=18)
VNTNGSW-- 0.12% (n=16)
INTRGSWHI 0.09% (n=12)
INTDGSWHI 0.08% (n=11)
IDTNGSWHI 0.07% (n=10)
INSSGSWHI 0.07% (n=10)
IYSNGSWHI 0.07% (n=10)
INSDGSWHI 0.07% (n=9)
INRNGSWHI 0.07% (n=9)
INTNGSCHI 0.06% (n=8)
VNSNGSWHV 0.06% (n=8)
VNRNGSWHI 0.06% (n=8)
INTNGSWHT 0.05% (n=7)
VNTNGSRHI 0.05% (n=7)
INTNGS*HI 0.05% (n=7)
INTNGSRHI 0.05% (n=7)
VNTSGSWHI 0.05% (n=7)
INPNGSWHI 0.04% (n=6)
INTNDSWHI 0.04% (n=6)
VDTNGSWHI 0.04% (n=5)
VNTNGSWHT 0.04% (n=5)
INTNGSWRI 0.04% (n=5)
VNTDGSWHI 0.04% (n=5)
VYTNGSWHI 0.04% (n=5)
VNNNGSWHI 0.04% (n=5)
VNTNGSWRI 0.03% (n=4)
INTNSSWHI 0.03% (n=4)
INTNGSGHI 0.03% (n=4)
VNSSGSWHI 0.03% (n=4)
VNTNGNWHI 0.03% (n=4)
INSNGSWHV 0.03% (n=4)
VNKNGSWHI 0.03% (n=4)
INNNGSWHI 0.03% (n=4)
IHTNGSWHI 0.03% (n=4)
VNTNGSWYI 0.03% (n=4)
INKNGSWHI 0.03% (n=4)
VNINGSWHI 0.02% (n=3)
INTEGSWHI 0.02% (n=3)
INTNGTWHI 0.02% (n=3)
VNTNGS*HI 0.02% (n=3)
INTNGGWHI 0.02% (n=3)
TNSNGSWHI 0.02% (n=3)
INTNGSRHL 0.02% (n=3)
INSN----- 0.02% (n=3)
INTNGSWYI 0.02% (n=3)
VKTNGSWHI 0.02% (n=3)
IRTNGSWHI 0.02% (n=3)
INTHGSWHI 0.01% (n=2)
INTNGSWDI 0.01% (n=2)
INTNGNWHI 0.01% (n=2)
INTNGSW-- 0.01% (n=2)
VNASGSWHI 0.01% (n=2)
INTTGSSHI 0.01% (n=2)
INSNGSRHI 0.01% (n=2)
INTNGSWHP 0.01% (n=2)
INANGSWHL 0.01% (n=2)
ISTNGSWHL 0.01% (n=2)
INSNGNWHI 0.01% (n=2)
INTNGSWRV 0.01% (n=2)
INTNGCWHI 0.01% (n=2)
IKTNGSWHV 0.01% (n=2)
LNTNGSWHI 0.01% (n=2)
VNADGSWHI 0.01% (n=2)
IHKNGSWHI 0.01% (n=2)
VHTNGSWHI 0.01% (n=2)
VATNGSWHI 0.01% (n=2)
INSNGSWHL 0.01% (n=2)
VNTNGSWQL 0.01% (n=1)
VNTNGSWLI 0.01% (n=1)
INTNGSWHA 0.01% (n=1)
VNTNSSWHI 0.01% (n=1)
TKSNGSWHI 0.01% (n=1)
IKSNGSWHS 0.01% (n=1)
IKSNGSRHI 0.01% (n=1)
VNSNGNWHI 0.01% (n=1)
MKTNDSWHI 0.01% (n=1)
IQTNGSWHI 0.01% (n=1)
IKTDGSWHI 0.01% (n=1)
INTNG-WHI 0.01% (n=1)
ISSNGSWHI 0.01% (n=1)
INFNGSWHI 0.01% (n=1)
INTSGSWHT 0.01% (n=1)
IYTNGSWHI 0.01% (n=1)
INSNGSWYI 0.01% (n=1)
INSNGRWHI 0.01% (n=1)
INTNGSCAI 0.01% (n=1)
INSNGSWHT 0.01% (n=1)
INSNGGWHI 0.01% (n=1)
INSNGSWRI 0.01% (n=1)
VSENGSWHI 0.01% (n=1)
VNENGSWHV 0.01% (n=1)
VNENDSWHI 0.01% (n=1)
VNENGSWHT 0.01% (n=1)
INTNGRWHI 0.01% (n=1)
VNTNGSWHL 0.01% (n=1)
VNTKGSWHI 0.01% (n=1)
VTTNGSWHI 0.01% (n=1)
INTGGSWHI 0.01% (n=1)
VYSNGSWHI 0.01% (n=1)
VYTNGSWRI 0.01% (n=1)
INTNGSWHF 0.01% (n=1)
VDTSGSWHI 0.01% (n=1)
MYTNGSWHI 0.01% (n=1)
VHANGSWHI 0.01% (n=1)
VNSHGSWDI 0.01% (n=1)
VNTNGRWHI 0.01% (n=1)
VNKDGSWHI 0.01% (n=1)
INASGSWHI 0.01% (n=1)
VKANDSWHI 0.01% (n=1)
VNVNDSWHI 0.01% (n=1)
INTNGSWQI 0.01% (n=1)
INTNGGWHL 0.01% (n=1)
INTNDSWHL 0.01% (n=1)
INTNGSWRL 0.01% (n=1)
VNTNRSWHI 0.01% (n=1)
VNTNGSWHS 0.01% (n=1)
INTTGSWHI 0.01% (n=1)
INTNGSRHV 0.01% (n=1)
ANTSGSWHI 0.01% (n=1)
TNTNGSWHV 0.01% (n=1)
TSTNGSWHI 0.01% (n=1)
TNTNGSWHT 0.01% (n=1)
IGTNGSWHV 0.01% (n=1)
INPNGGWHI 0.01% (n=1)
INTIGSWHI 0.01% (n=1)
INSIGSWHI 0.01% (n=1)
IKTNGGWHI 0.01% (n=1)
IKTNGRWHI 0.01% (n=1)
INTNGSWLI 0.01% (n=1)
MNTNGNWHI 0.01% (n=1)
INTKGSWHI 0.01% (n=1)
VSTNGSWHV 0.01% (n=1)
INSNGSGHI 0.01% (n=1)
INSNDSWHI 0.01% (n=1)
VNTNGSWHN 0.01% (n=1)
ININGSWHI 0.01% (n=1)
MSTNGSWHI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 1b:

INTNGSWHI 60.61% (n=5623)
VNTNGSWHI 31.86% (n=2956)
VNSNGSWHI 1.39% (n=129)
INSNGSWHI 1.07% (n=99)
VNTNGSWHV 0.89% (n=83)
INTNGSWHV 0.42% (n=39)
IHTNGSWHI 0.38% (n=35)
ISTNGSWHI 0.32% (n=30)
MNTNGSWHI 0.27% (n=25)
VNASGSWHI 0.27% (n=25)
VKTNGSWHI 0.24% (n=22)
INTNGSW-- 0.18% (n=17)
VNTSGSWHI 0.13% (n=12)
VSTNGSWHI 0.13% (n=12)
INTNGSRHI 0.11% (n=10)
IKTNGSWHI 0.10% (n=9)
INTSGSWHI 0.09% (n=8)
INANGSWHI 0.08% (n=7)
INTNGSWRI 0.08% (n=7)
INTDGSWHI 0.05% (n=5)
INTNGSWLI 0.04% (n=4)
VNTNGSWHT 0.04% (n=4)
VNSNGSWHV 0.04% (n=4)
INTNGSWYI 0.04% (n=4)
INTNSSWHI 0.04% (n=4)
METNGSWHI 0.04% (n=4)
IDTNGSWHI 0.04% (n=4)
VNTNSSWHI 0.03% (n=3)
LNTNGSWHV 0.03% (n=3)
VNINGSWHI 0.03% (n=3)
VNTNGSRHI 0.03% (n=3)
VNTDGSWHI 0.03% (n=3)
ANTNGSWHI 0.03% (n=3)
INTNGSWHT 0.03% (n=3)
INTNDSWHI 0.03% (n=3)
IYTNGSWHI 0.02% (n=2)
VHTNGSWHI 0.02% (n=2)
INTNRSWHI 0.02% (n=2)
INTNGSWHF 0.02% (n=2)
INT------ 0.02% (n=2)
VNNNGSWHI 0.02% (n=2)
INTNGGWHI 0.02% (n=2)
VNTNGSW-- 0.02% (n=2)
VNTNDSWHI 0.02% (n=2)
VYTNGSWHI 0.02% (n=2)
VTTNGSWHI 0.02% (n=2)
VHANGSWHI 0.02% (n=2)
MHTNGSWHI 0.02% (n=2)
VNTNGSWRI 0.02% (n=2)
VNANGSWHI 0.02% (n=2)
INTNVSWHI 0.01% (n=1)
VKTEGNWHI 0.01% (n=1)
VNTSGSWHV 0.01% (n=1)
VNTNGGWHV 0.01% (n=1)
CNTNAAWGT 0.01% (n=1)
VNTSGSWYI 0.01% (n=1)
YNTNGSWHI 0.01% (n=1)
INPNGSWHI 0.01% (n=1)
VN------- 0.01% (n=1)
VH------- 0.01% (n=1)
INTNGNWHI 0.01% (n=1)
IHTNGSWDI 0.01% (n=1)
IHTNGRWHI 0.01% (n=1)
LNTNGSWHI 0.01% (n=1)
INTNGRWHI 0.01% (n=1)
INPNGSWHF 0.01% (n=1)
INTNGSCHI 0.01% (n=1)
VNRNGSWHI 0.01% (n=1)
VHSNGSWHI 0.01% (n=1)
IRTNGSWHI 0.01% (n=1)
VRANGSWHI 0.01% (n=1)
VNSSGSWHI 0.01% (n=1)
VHTNGSWHV 0.01% (n=1)
VNTNGGWHI 0.01% (n=1)
TNTNGSWHI 0.01% (n=1)
MKTNGSWHI 0.01% (n=1)
VNSNGSWRI 0.01% (n=1)
IKSNGSWHI 0.01% (n=1)
VNTNGS*HI 0.01% (n=1)
VNTNGNWHI 0.01% (n=1)
VNTKGSWHI 0.01% (n=1)
ININGSWHI 0.01% (n=1)
INTNGSWHN 0.01% (n=1)
INTNGTWHI 0.01% (n=1)
INSNGGWHI 0.01% (n=1)
INTNGSWHL 0.01% (n=1)
VNTNGSWNI 0.01% (n=1)
INTNGS--- 0.01% (n=1)
VNTNGS--- 0.01% (n=1)
VNSNGSRHI 0.01% (n=1)
VNNNGIWHI 0.01% (n=1)
V-------- 0.01% (n=1)
I-------- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 2:

INTNGSWHI 43.71% (n=591)
INSNGSWHI 20.93% (n=283)
IHTNGSWHI 7.69% (n=104)
IHSNGSWHI 6.36% (n=86)
IHNNGSWHI 5.92% (n=80)
ISTNGSWHI 3.40% (n=46)
VNTNGSWHI 2.44% (n=33)
INTNGSWHV 1.11% (n=15)
IKTNGSWHI 1.11% (n=15)
IHTNGSWHV 0.67% (n=9)
VNSNGSWHI 0.52% (n=7)
IYTNGSWHI 0.44% (n=6)
INSNGSWHV 0.37% (n=5)
INANGSWHI 0.30% (n=4)
IN------- 0.30% (n=4)
INNNGSWHI 0.22% (n=3)
VNANGSWHI 0.22% (n=3)
IRNNGSWHI 0.22% (n=3)
I-------- 0.22% (n=3)
VNTNGSWHV 0.15% (n=2)
INSSGSWHI 0.15% (n=2)
IDTNGSWHI 0.15% (n=2)
VKTNGSWHI 0.15% (n=2)
INTNGSLHI 0.15% (n=2)
VHTNGSWHI 0.07% (n=1)
INSNGSWHT 0.07% (n=1)
TNSNGSWHI 0.07% (n=1)
INTNGSWHL 0.07% (n=1)
IYSNGSWHI 0.07% (n=1)
VNDNGSWHI 0.07% (n=1)
IDTKGSWHI 0.07% (n=1)
VSANGSWHI 0.07% (n=1)
INTSGSWHI 0.07% (n=1)
VNTSGSWHI 0.07% (n=1)
IKSNGSWHI 0.07% (n=1)
VNSNGSWHV 0.07% (n=1)
MNTSGSWHI 0.07% (n=1)
NHSNGSWHI 0.07% (n=1)
INKNGSWHI 0.07% (n=1)
ISSNGSWHI 0.07% (n=1)
INSNGNWHI 0.07% (n=1)
IKNNGSWHI 0.07% (n=1)
VNNNGSWHI 0.07% (n=1)
NHTNGSWHI 0.07% (n=1)
INTNVNWHI 0.07% (n=1)
INTNGS*HI 0.07% (n=1)
INTNSSWHI 0.07% (n=1)
VNTNGSRHI 0.07% (n=1)
VSTNGSWHI 0.07% (n=1)
INTTGSWHV 0.07% (n=1)
VNTNGNLHI 0.07% (n=1)
INTNGSLDI 0.07% (n=1)
INTDGSWHI 0.07% (n=1)
IPMAAGW-I 0.07% (n=1)
IKENGSWHI 0.07% (n=1)
MNTNGSWHI 0.07% (n=1)
IYNNGSWHI 0.07% (n=1)
THTNGSWHI 0.07% (n=1)
IRTNGSWHV 0.07% (n=1)
IYTNGSWHV 0.07% (n=1)
INDNGTWHI 0.07% (n=1)
INSDGSWHI 0.07% (n=1)
IRSNGSWHI 0.07% (n=1)
V-------- 0.07% (n=1)
INPNGSWHI 0.07% (n=1)
MKTNGSWHI 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 2a:

INTNGSWHI 46.32% (n=132)
INSNGSWHI 38.25% (n=109)
INTNGSWHV 3.51% (n=10)
VNTNGSWHI 2.81% (n=8)
INSNGSWHV 1.40% (n=4)
INNNGSWHI 0.70% (n=2)
INSSGSWHI 0.70% (n=2)
VNTNGSWHV 0.35% (n=1)
INSNGSWHT 0.35% (n=1)
TNSNGSWHI 0.35% (n=1)
INTNGSWHL 0.35% (n=1)
IKTNGSWHI 0.35% (n=1)
IYSNGSWHI 0.35% (n=1)
VNSNGSWHI 0.35% (n=1)
VNDNGSWHI 0.35% (n=1)
IDTKGSWHI 0.35% (n=1)
IDTNGSWHI 0.35% (n=1)
VSANGSWHI 0.35% (n=1)
VNANGSWHI 0.35% (n=1)
ISTNGSWHI 0.35% (n=1)
INTSGSWHI 0.35% (n=1)
VNTSGSWHI 0.35% (n=1)
IKSNGSWHI 0.35% (n=1)
VNSNGSWHV 0.35% (n=1)
MNTSGSWHI 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 2b:

INTNGSWHI 71.65% (n=331)
ISTNGSWHI 9.52% (n=44)
VNTNGSWHI 4.11% (n=19)
IKTNGSWHI 2.81% (n=13)
IHTNGSWHI 2.81% (n=13)
INSNGSWHI 1.95% (n=9)
VNSNGSWHI 1.08% (n=5)
INANGSWHI 0.65% (n=3)
INTNGSLHI 0.43% (n=2)
NHSNGSWHI 0.22% (n=1)
INKNGSWHI 0.22% (n=1)
INNNGSWHI 0.22% (n=1)
ISSNGSWHI 0.22% (n=1)
INSNGNWHI 0.22% (n=1)
IKNNGSWHI 0.22% (n=1)
VNNNGSWHI 0.22% (n=1)
VKTNGSWHI 0.22% (n=1)
NHTNGSWHI 0.22% (n=1)
INTNVNWHI 0.22% (n=1)
INTNGS*HI 0.22% (n=1)
INTNSSWHI 0.22% (n=1)
VNTNGSRHI 0.22% (n=1)
VSTNGSWHI 0.22% (n=1)
INTTGSWHV 0.22% (n=1)
VNTNGNLHI 0.22% (n=1)
INTNGSLDI 0.22% (n=1)
INTDGSWHI 0.22% (n=1)
IYTNGSWHI 0.22% (n=1)
------W-I 0.22% (n=1)
IKENGSWHI 0.22% (n=1)
INTNGSWHV 0.22% (n=1)
MNTNGSWHI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 2c:

INSNGSWHI 34.14% (n=155)
IHTNGSWHI 19.60% (n=89)
IHSNGSWHI 18.50% (n=84)
IHNNGSWHI 17.62% (n=80)
INTNGSWHI 3.52% (n=16)
IHTNGSWHV 1.98% (n=9)
IRNNGSWHI 0.66% (n=3)
IYTNGSWHI 0.66% (n=3)
VNTNGSWHI 0.44% (n=2)
INTNGSWHV 0.44% (n=2)
IN------- 0.22% (n=1)
IYNNGSWHI 0.22% (n=1)
THTNGSWHI 0.22% (n=1)
VKTNGSWHI 0.22% (n=1)
VNANGSWHI 0.22% (n=1)
IRTNGSWHV 0.22% (n=1)
INSNGSWHV 0.22% (n=1)
ISTNGSWHI 0.22% (n=1)
IYTNGSWHV 0.22% (n=1)
INDNGTWHI 0.22% (n=1)
INSDGSWHI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 3:

VNTNGSWHI 43.53% (n=1708)
INTNGSWHI 25.64% (n=1006)
VNSNGSWHI 11.90% (n=467)
VRTNGSWHI 8.03% (n=315)
IYTNGSWHV 2.55% (n=100)
INSNGSWHI 2.42% (n=95)
VNTNGSWYI 0.82% (n=32)
IETQGSWHI 0.61% (n=24)
VNANGSWHI 0.48% (n=19)
-NTNGSWHI 0.36% (n=14)
VYTNGSWHI 0.28% (n=11)
IETNGSWHI 0.23% (n=9)
VHTNGSWHI 0.20% (n=8)
VN------- 0.18% (n=7)
VSTNGSWHI 0.13% (n=5)
V-------- 0.13% (n=5)
VKTNGSWHI 0.13% (n=5)
INANGSWHI 0.10% (n=4)
VNTNGSW-- 0.10% (n=4)
IHTNGSWHI 0.10% (n=4)
IN------- 0.10% (n=4)
VNSSGSWHI 0.08% (n=3)
VDTNGSWHI 0.08% (n=3)
VNTNGPWHI 0.08% (n=3)
VKSNGSWHI 0.08% (n=3)
VNTSGSWHI 0.08% (n=3)
IYTNGSWHI 0.08% (n=3)
VETNGSWHI 0.08% (n=3)
VHSNGSWHI 0.08% (n=3)
VSSNGSWHI 0.08% (n=3)
INTNGPWHI 0.05% (n=2)
VNTNDSWHI 0.05% (n=2)
IKTNGSWHI 0.05% (n=2)
VNTNGSWHV 0.05% (n=2)
IDTNGSWHI 0.05% (n=2)
INTNGSWHV 0.05% (n=2)
INTHGSWHI 0.05% (n=2)
VNDSGSWHI 0.05% (n=2)
MNTNGSWHI 0.05% (n=2)
VHNNGSWHI 0.03% (n=1)
ISSNGSWHI 0.03% (n=1)
VNTNGSWHT 0.03% (n=1)
INTNDSWHI 0.03% (n=1)
VNINGSWHI 0.03% (n=1)
INTYGSGHI 0.03% (n=1)
VNTYGSLHI 0.03% (n=1)
ICTNASWHI 0.03% (n=1)
TNTNGSWHI 0.03% (n=1)
INTNGSRHI 0.03% (n=1)
VETKGSWHI 0.03% (n=1)
INTNGSWHT 0.03% (n=1)
MKTGDSWHI 0.03% (n=1)
ISTNGSWHI 0.03% (n=1)
IQTNGSWHI 0.03% (n=1)
IKTNNSWHI 0.03% (n=1)
INSSGSWHI 0.03% (n=1)
INDNGSWHI 0.03% (n=1)
VNKNGSWHI 0.03% (n=1)
INTDGSWHI 0.03% (n=1)
VNNNGSWHI 0.03% (n=1)
VNTDGSWHI 0.03% (n=1)
VNSNGS--- 0.03% (n=1)
VESNGSWHI 0.03% (n=1)
VNSNGSRHI 0.03% (n=1)
MNSNGSWHI 0.03% (n=1)
MESNGSWHI 0.03% (n=1)
TNSNGSWHI 0.03% (n=1)
VNTNGSWHL 0.03% (n=1)
VNSNGSWHV 0.03% (n=1)
VDSNGSWHI 0.03% (n=1)
VYSNGSWHI 0.03% (n=1)
VNSNGFWHI 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 3a:

VNTNGSWHI 49.51% (n=1625)
INTNGSWHI 30.41% (n=998)
VRTNGSWHI 9.60% (n=315)
IYTNGSWHV 3.05% (n=100)
VNSNGSWHI 0.98% (n=32)
VNTNGSWYI 0.98% (n=32)
IETQGSWHI 0.73% (n=24)
VNANGSWHI 0.58% (n=19)
INSNGSWHI 0.58% (n=19)
-NTNGSWHI 0.43% (n=14)
VYTNGSWHI 0.30% (n=10)
VHTNGSWHI 0.24% (n=8)
IETNGSWHI 0.24% (n=8)
VSTNGSWHI 0.15% (n=5)
VKTNGSWHI 0.15% (n=5)
INANGSWHI 0.12% (n=4)
VNTNGSW-- 0.12% (n=4)
IHTNGSWHI 0.12% (n=4)
VDTNGSWHI 0.09% (n=3)
VNTNGPWHI 0.09% (n=3)
VNTSGSWHI 0.09% (n=3)
VETNGSWHI 0.09% (n=3)
INTNGPWHI 0.06% (n=2)
VNTNDSWHI 0.06% (n=2)
IKTNGSWHI 0.06% (n=2)
VKSNGSWHI 0.06% (n=2)
IDTNGSWHI 0.06% (n=2)
INTHGSWHI 0.06% (n=2)
V-------- 0.06% (n=2)
IYTNGSWHI 0.06% (n=2)
VNDSGSWHI 0.06% (n=2)
VHNNGSWHI 0.03% (n=1)
VNSSGSWHI 0.03% (n=1)
ISSNGSWHI 0.03% (n=1)
VNTNGSWHT 0.03% (n=1)
INTNDSWHI 0.03% (n=1)
VNINGSWHI 0.03% (n=1)
INTYGSGHI 0.03% (n=1)
VNTYGSLHI 0.03% (n=1)
ICTNASWHI 0.03% (n=1)
TNTNGSWHI 0.03% (n=1)
VNTNGSWHV 0.03% (n=1)
INTNGSRHI 0.03% (n=1)
VETKGSWHI 0.03% (n=1)
INTNGSWHV 0.03% (n=1)
INTNGSWHT 0.03% (n=1)
MKTGDSWHI 0.03% (n=1)
ISTNGSWHI 0.03% (n=1)
IQTNGSWHI 0.03% (n=1)
IKTNNSWHI 0.03% (n=1)
INSSGSWHI 0.03% (n=1)
INDNGSWHI 0.03% (n=1)
VNKNGSWHI 0.03% (n=1)
INTDGSWHI 0.03% (n=1)
VNNNGSWHI 0.03% (n=1)
VNTDGSWHI 0.03% (n=1)
MNTNGSWHI 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 3b:

VNSNGSWHI 83.54% (n=340)
VNTNGSWHI 11.55% (n=47)
VN------- 0.98% (n=4)
VHSNGSWHI 0.74% (n=3)
VSSNGSWHI 0.49% (n=2)
VNSSGSWHI 0.49% (n=2)
VNSNGS--- 0.25% (n=1)
VESNGSWHI 0.25% (n=1)
IETNGSWHI 0.25% (n=1)
VYTNGSWHI 0.25% (n=1)
VNSNGSRHI 0.25% (n=1)
MNTNGSWHI 0.25% (n=1)
MNSNGSWHI 0.25% (n=1)
MESNGSWHI 0.25% (n=1)
TNSNGSWHI 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 4:

INTNGSWHI 76.79% (n=589)
INSNGSWHI 8.60% (n=66)
VNKNGSWHI 3.78% (n=29)
IHTNGSWHI 2.22% (n=17)
VNTNGSWHI 1.56% (n=12)
VNSNGSWHI 1.43% (n=11)
ISTNGSWHI 1.43% (n=11)
INTNGSWHV 0.78% (n=6)
IDTNGSWHI 0.65% (n=5)
INTNGSWHL 0.52% (n=4)
INTGGSWHI 0.39% (n=3)
TNTNGSWHI 0.39% (n=3)
INSNGSWHV 0.26% (n=2)
IYTNGSWHI 0.26% (n=2)
VKTNGSWHI 0.26% (n=2)
INS------ 0.13% (n=1)
INTNESWHI 0.13% (n=1)
INTNGRWHL 0.13% (n=1)
IYTNGSWHV 0.13% (n=1)
VNTNGSWHV 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 4a:

INTNGSWHI 40.63% (n=65)
INSNGSWHI 36.88% (n=59)
VNKNGSWHI 18.13% (n=29)
VNSNGSWHI 1.88% (n=3)
INSNGSWHV 1.25% (n=2)
INS------ 0.63% (n=1)
VNTNGSWHI 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 4d:

INTNGSWHI 92.25% (n=500)
IHTNGSWHI 2.58% (n=14)
ISTNGSWHI 2.03% (n=11)
IDTNGSWHI 0.74% (n=4)
INTGGSWHI 0.55% (n=3)
TNTNGSWHI 0.55% (n=3)
IYTNGSWHI 0.37% (n=2)
VKTNGSWHI 0.37% (n=2)
INTNESWHI 0.18% (n=1)
VNTNGSWHI 0.18% (n=1)
INSNGSWHI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 5:

INTNGSWHI 66.42% (n=89)
VNTNGSWHI 7.46% (n=10)
INSNGSWHI 4.48% (n=6)
IHSNGSWHI 2.99% (n=4)
ISTNGSWHI 2.24% (n=3)
INNQGSWHI 1.49% (n=2)
IRTNGSWHI 1.49% (n=2)
VNSNGSWHI 1.49% (n=2)
IHTNGSWHI 1.49% (n=2)
INTSGSWHI 0.75% (n=1)
INTNGSWH- 0.75% (n=1)
MKTNGSWHI 0.75% (n=1)
INTNGSCHI 0.75% (n=1)
VHTNGSWHI 0.75% (n=1)
MKTGESWHI 0.75% (n=1)
VKTNGA--- 0.75% (n=1)
HNTNGSWHI 0.75% (n=1)
MNSNGSWHI 0.75% (n=1)
INTNGSWYI 0.75% (n=1)
VRSNGSWHI 0.75% (n=1)
IKTNGSWHI 0.75% (n=1)
METNGSWHI 0.75% (n=1)
IQNGSSWHI 0.75% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 6:

INTNGSWHI 51.34% (n=307)
VNTNGSWHI 15.22% (n=91)
INSNGSWHI 6.69% (n=40)
VNSNGSWHI 5.02% (n=30)
IN------- 3.34% (n=20)
VNSNGSWHV 3.34% (n=20)
INTNGSWHV 2.51% (n=15)
INSNGSWHV 2.01% (n=12)
VN------- 1.51% (n=9)
MNTNGSWHV 1.17% (n=7)
MNTNGSWHI 1.00% (n=6)
VNTNGSWHV 1.00% (n=6)
IHTNGSWHI 0.67% (n=4)
VKTNGSWHI 0.50% (n=3)
VHTNGSWHI 0.33% (n=2)
IKTNGSWHI 0.33% (n=2)
INTNGSWHL 0.33% (n=2)
IYTNGSWHV 0.33% (n=2)
IKNGSSWHI 0.17% (n=1)
IKSNGSWHI 0.17% (n=1)
INTKGSWHI 0.17% (n=1)
VRTNGSWHI 0.17% (n=1)
ICTNGSWHI 0.17% (n=1)
VNNNGSWHI 0.17% (n=1)
VNTSGSWHI 0.17% (n=1)
VHANGSWHI 0.17% (n=1)
IYSNGSWHI 0.17% (n=1)
VNKNGSWHI 0.17% (n=1)
INTNGRWHI 0.17% (n=1)
INTNGSRHI 0.17% (n=1)
IYTNGSWHI 0.17% (n=1)
IK------- 0.17% (n=1)
VHTNGSWHL 0.17% (n=1)
VKINGSWHV 0.17% (n=1)
IKTNGSWHV 0.17% (n=1)
INTDGSWHI 0.17% (n=1)
IETNGSWHI 0.17% (n=1)
ISTNGSWHV 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Subtype 6a:

INTNGSWHI 66.77% (n=219)
VNTNGSWHI 20.73% (n=68)
INSNGSWHI 4.57% (n=15)
IN------- 1.22% (n=4)
VNSNGSWHI 0.91% (n=3)
VHTNGSWHI 0.61% (n=2)
VKTNGSWHI 0.61% (n=2)
IKNGSSWHI 0.30% (n=1)
IKSNGSWHI 0.30% (n=1)
INTKGSWHI 0.30% (n=1)
VRTNGSWHI 0.30% (n=1)
ICTNGSWHI 0.30% (n=1)
IHTNGSWHI 0.30% (n=1)
VNNNGSWHI 0.30% (n=1)
VNTSGSWHI 0.30% (n=1)
VHANGSWHI 0.30% (n=1)
IYSNGSWHI 0.30% (n=1)
IKTNGSWHI 0.30% (n=1)
VNKNGSWHI 0.30% (n=1)
INTNGRWHI 0.30% (n=1)
INTNGSRHI 0.30% (n=1)
IYTNGSWHI 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 414-422 (antibodies: [3_11] ), HCV Genotype 7:

INTNGSWHI 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 1:

QLI 67.40% (n=15514)
QLV 27.46% (n=6322)
HLI 1.56% (n=360)
RLI 0.94% (n=217)
QLM 0.94% (n=216)
KLT 0.37% (n=85)
KLI 0.29% (n=67)
ELI 0.12% (n=28)
QLT 0.10% (n=22)
Q-- 0.09% (n=21)
RLA 0.08% (n=19)
RLT 0.07% (n=17)
RLV 0.07% (n=16)
HLV 0.07% (n=16)
ELV 0.07% (n=15)
QPI 0.06% (n=13)
NLV 0.05% (n=11)
KLV 0.04% (n=10)
QLL 0.03% (n=6)
YLI 0.02% (n=5)
QLA 0.02% (n=5)
*LI 0.02% (n=4)
QPV 0.02% (n=4)
KLM 0.01% (n=3)
QVI 0.01% (n=3)
QMI 0.01% (n=3)
QII 0.01% (n=3)
QFI 0.01% (n=2)
QQV 0.00% (n=1)
QMV 0.00% (n=1)
GLI 0.00% (n=1)
NLI 0.00% (n=1)
PAC 0.00% (n=1)
PAY 0.00% (n=1)
QL- 0.00% (n=1)
LLV 0.00% (n=1)
RII 0.00% (n=1)
PLI 0.00% (n=1)
LLI 0.00% (n=1)
QHI 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 1a:

QLI 70.60% (n=9656)
QLV 22.36% (n=3058)
HLI 2.50% (n=342)
QLM 1.34% (n=183)
RLI 1.07% (n=147)
KLT 0.62% (n=85)
KLI 0.49% (n=67)
QLT 0.15% (n=21)
RLA 0.14% (n=19)
RLT 0.12% (n=17)
Q-- 0.11% (n=15)
RLV 0.10% (n=13)
QPI 0.07% (n=10)
HLV 0.04% (n=6)
YLI 0.04% (n=5)
ELI 0.04% (n=5)
*LI 0.03% (n=4)
KLM 0.02% (n=3)
QVI 0.02% (n=3)
QMI 0.02% (n=3)
QPV 0.02% (n=3)
QLA 0.01% (n=2)
ELV 0.01% (n=2)
QFI 0.01% (n=2)
QLL 0.01% (n=2)
QQV 0.01% (n=1)
QMV 0.01% (n=1)
GLI 0.01% (n=1)
NLI 0.01% (n=1)
NLV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 1b:

QLI 62.63% (n=5820)
QLV 35.04% (n=3256)
RLI 0.75% (n=70)
QLM 0.34% (n=32)
ELI 0.25% (n=23)
HLI 0.19% (n=18)
ELV 0.13% (n=12)
KLV 0.11% (n=10)
NLV 0.11% (n=10)
HLV 0.11% (n=10)
Q-- 0.06% (n=6)
QLL 0.04% (n=4)
QII 0.03% (n=3)
RLV 0.03% (n=3)
QLA 0.03% (n=3)
QPI 0.03% (n=3)
PAC 0.01% (n=1)
PAY 0.01% (n=1)
QL- 0.01% (n=1)
LLV 0.01% (n=1)
QLT 0.01% (n=1)
RII 0.01% (n=1)
QPV 0.01% (n=1)
PLI 0.01% (n=1)
LLI 0.01% (n=1)
QHI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 2:

QLI 66.50% (n=905)
SLI 15.28% (n=208)
NLI 8.23% (n=112)
QLV 2.28% (n=31)
TLI 1.40% (n=19)
HLI 1.10% (n=15)
DLI 1.10% (n=15)
SLV 0.81% (n=11)
YLI 0.51% (n=7)
HLV 0.37% (n=5)
MLI 0.29% (n=4)
TLV 0.29% (n=4)
RLI 0.22% (n=3)
KLI 0.22% (n=3)
NLV 0.22% (n=3)
ALI 0.22% (n=3)
QLT 0.15% (n=2)
RLM 0.07% (n=1)
ILV 0.07% (n=1)
HLN 0.07% (n=1)
TLN 0.07% (n=1)
*LV 0.07% (n=1)
WLI 0.07% (n=1)
SLM 0.07% (n=1)
ELV 0.07% (n=1)
*LI 0.07% (n=1)
RLV 0.07% (n=1)
MLM 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 2a:

QLI 94.20% (n=276)
QLV 5.12% (n=15)
QLT 0.34% (n=1)
RLM 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 2b:

SLI 44.90% (n=207)
NLI 24.30% (n=112)
QLI 9.54% (n=44)
TLI 4.12% (n=19)
DLI 3.25% (n=15)
HLI 2.82% (n=13)
SLV 2.17% (n=10)
YLI 1.52% (n=7)
HLV 1.08% (n=5)
QLV 1.08% (n=5)
MLI 0.87% (n=4)
TLV 0.87% (n=4)
KLI 0.65% (n=3)
NLV 0.65% (n=3)
ALI 0.65% (n=3)
RLI 0.43% (n=2)
ILV 0.22% (n=1)
HLN 0.22% (n=1)
TLN 0.22% (n=1)
*LV 0.22% (n=1)
SLM 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 2c:

QLI 98.24% (n=446)
QLV 0.66% (n=3)
QLT 0.22% (n=1)
ELV 0.22% (n=1)
*LI 0.22% (n=1)
RLI 0.22% (n=1)
HLI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 3:

QLV 57.48% (n=2245)
QLI 22.22% (n=868)
ELI 10.04% (n=392)
HLV 7.94% (n=310)
ELV 1.20% (n=47)
RLV 0.26% (n=10)
NLV 0.18% (n=7)
ALI 0.10% (n=4)
QLM 0.10% (n=4)
ALV 0.05% (n=2)
QLT 0.05% (n=2)
QPV 0.05% (n=2)
KLV 0.05% (n=2)
KLI 0.05% (n=2)
HLI 0.05% (n=2)
RLI 0.03% (n=1)
LLV 0.03% (n=1)
YLI 0.03% (n=1)
NLI 0.03% (n=1)
ELM 0.03% (n=1)
DLV 0.03% (n=1)
SLV 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 3a:

QLV 61.41% (n=2007)
QLI 23.84% (n=779)
ELI 12.00% (n=392)
ELV 1.41% (n=46)
HLV 0.61% (n=20)
RLV 0.18% (n=6)
ALI 0.12% (n=4)
ALV 0.06% (n=2)
QPV 0.06% (n=2)
KLI 0.06% (n=2)
QLT 0.03% (n=1)
RLI 0.03% (n=1)
LLV 0.03% (n=1)
QLM 0.03% (n=1)
YLI 0.03% (n=1)
KLV 0.03% (n=1)
NLI 0.03% (n=1)
ELM 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 3b:

HLV 71.22% (n=287)
QLV 24.07% (n=97)
NLV 1.74% (n=7)
RLV 0.99% (n=4)
QLM 0.74% (n=3)
HLI 0.25% (n=1)
KLV 0.25% (n=1)
DLV 0.25% (n=1)
SLV 0.25% (n=1)
QLT 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 4:

QLI 78.41% (n=603)
GLI 8.06% (n=62)
QLV 6.50% (n=50)
HLI 4.81% (n=37)
RLI 0.65% (n=5)
RLV 0.39% (n=3)
QLT 0.39% (n=3)
MLI 0.26% (n=2)
KLI 0.13% (n=1)
SLI 0.13% (n=1)
HLV 0.13% (n=1)
KLV 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 4a:

GLI 38.51% (n=62)
HLI 22.36% (n=36)
QLV 20.50% (n=33)
QLI 18.63% (n=30)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 4d:

QLI 98.71% (n=535)
QLT 0.55% (n=3)
RLV 0.37% (n=2)
QLV 0.18% (n=1)
HLI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 5:

QLI 77.78% (n=112)
QLV 9.72% (n=14)
Q-- 5.56% (n=8)
QLM 2.08% (n=3)
QFV 1.39% (n=2)
QL- 0.69% (n=1)
QII 0.69% (n=1)
ELI 0.69% (n=1)
RLM 0.69% (n=1)
AAH 0.69% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 6:

QLI 67.94% (n=409)
QLV 27.24% (n=164)
QLM 2.33% (n=14)
HLV 0.83% (n=5)
HLI 0.83% (n=5)
ELI 0.33% (n=2)
MLI 0.33% (n=2)
QFI 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Subtype 6a:

QLI 74.39% (n=244)
QLV 22.87% (n=75)
HLV 1.22% (n=4)
ELI 0.61% (n=2)
QLM 0.30% (n=1)
HLI 0.30% (n=1)
QFI 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 412-414 (antibodies: [95-2, HCV1] ), HCV Genotype 7:

QLI 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 1:

SWH 99.17% (n=22836)
SW- 0.16% (n=37)
SRH 0.15% (n=35)
SWR 0.10% (n=24)
NWH 0.06% (n=13)
SWY 0.06% (n=13)
GWH 0.05% (n=12)
S*H 0.05% (n=11)
SCH 0.04% (n=9)
SWL 0.03% (n=6)
RWH 0.03% (n=6)
SGH 0.02% (n=5)
SWD 0.02% (n=4)
TWH 0.02% (n=4)
SWQ 0.01% (n=2)
SSH 0.01% (n=2)
CWH 0.01% (n=2)
S-- 0.01% (n=2)
-WH 0.00% (n=1)
SCA 0.00% (n=1)
AWG 0.00% (n=1)
SWN 0.00% (n=1)
IWH 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 1a:

SWH 99.12% (n=13570)
SRH 0.15% (n=21)
SW- 0.13% (n=18)
SWR 0.10% (n=14)
NWH 0.07% (n=10)
S*H 0.07% (n=10)
SWY 0.06% (n=8)
SCH 0.06% (n=8)
GWH 0.05% (n=7)
SGH 0.04% (n=5)
RWH 0.03% (n=4)
SWD 0.02% (n=3)
TWH 0.02% (n=3)
SWQ 0.01% (n=2)
SWL 0.01% (n=2)
SSH 0.01% (n=2)
CWH 0.01% (n=2)
-WH 0.01% (n=1)
SCA 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 1b:

SWH 99.24% (n=9219)
SW- 0.20% (n=19)
SRH 0.15% (n=14)
SWR 0.11% (n=10)
GWH 0.05% (n=5)
SWY 0.05% (n=5)
SWL 0.04% (n=4)
NWH 0.03% (n=3)
RWH 0.02% (n=2)
S-- 0.02% (n=2)
AWG 0.01% (n=1)
SWD 0.01% (n=1)
SCH 0.01% (n=1)
S*H 0.01% (n=1)
TWH 0.01% (n=1)
SWN 0.01% (n=1)
IWH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 2:

SWH 99.26% (n=1346)
NWH 0.15% (n=2)
SLH 0.15% (n=2)
S*H 0.07% (n=1)
SRH 0.07% (n=1)
NLH 0.07% (n=1)
SLD 0.07% (n=1)
GW- 0.07% (n=1)
TWH 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 2a:

SWH 100.00% (n=295)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 2b:

SWH 98.05% (n=453)
NWH 0.43% (n=2)
SLH 0.43% (n=2)
S*H 0.22% (n=1)
SRH 0.22% (n=1)
NLH 0.22% (n=1)
SLD 0.22% (n=1)
-W- 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 2c:

SWH 99.78% (n=453)
TWH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 3:

SWH 98.80% (n=3868)
SWY 0.82% (n=32)
PWH 0.13% (n=5)
SW- 0.10% (n=4)
SRH 0.05% (n=2)
SGH 0.03% (n=1)
SLH 0.03% (n=1)
S-- 0.03% (n=1)
FWH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 3a:

SWH 98.66% (n=3240)
SWY 0.97% (n=32)
PWH 0.15% (n=5)
SW- 0.12% (n=4)
SGH 0.03% (n=1)
SLH 0.03% (n=1)
SRH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 3b:

SWH 99.51% (n=404)
S-- 0.25% (n=1)
SRH 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 4:

SWH 99.87% (n=769)
RWH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 4a:

SWH 100.00% (n=162)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 4d:

SWH 100.00% (n=542)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 5:

SWH 97.78% (n=132)
SCH 0.74% (n=1)
A-- 0.74% (n=1)
SWY 0.74% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 6:

SWH 99.66% (n=584)
RWH 0.17% (n=1)
SRH 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Subtype 6a:

SWH 99.40% (n=333)
RWH 0.30% (n=1)
SRH 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 419-421 (antibodies: [95-2, HC33.4, HC84.21, HC84.22, HCV1] ), HCV Genotype 7:

SWH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 1:

QLINTNGSWH 60.28% (n=13866)
QLVNTNGSWH 23.56% (n=5420)
QLINSNGSWH 4.51% (n=1037)
QLVNSNGSWH 1.66% (n=382)
HLINTNGSWH 0.91% (n=209)
QLVNANGSWH 0.86% (n=197)
RLINTNGSWH 0.80% (n=185)
HLIKTNGSWH 0.63% (n=146)
QLMNTNGSWH 0.56% (n=129)
QLISTNGSWH 0.52% (n=120)
KLTNTNGSWH 0.37% (n=84)
QLMNSNGSWH 0.33% (n=75)
QLINANGSWH 0.27% (n=63)
QLVSTNGSWH 0.25% (n=58)
QLVNENGSWH 0.23% (n=53)
QLIKTNGSWH 0.22% (n=50)
QLINTNNSWH 0.19% (n=44)
KLINTNGSWH 0.19% (n=43)
QLINTSGSWH 0.12% (n=27)
QLVNASGSWH 0.12% (n=27)
QLIHTNGSWH 0.12% (n=27)
QLVKTNGSWH 0.10% (n=22)
Q--------- 0.09% (n=21)
QLINTNGSRH 0.09% (n=20)
RLIKSNGSWH 0.08% (n=19)
QLINTNGSW- 0.08% (n=19)
QLTNTNGSWH 0.08% (n=18)
QLVNTNGSW- 0.08% (n=18)
RLANTNGSWH 0.08% (n=18)
RLTNTNGSWH 0.07% (n=17)
QLINTDGSWH 0.07% (n=16)
QLINTNGSWR 0.07% (n=15)
QLIDTNGSWH 0.06% (n=14)
QLVNTSGSWH 0.06% (n=14)
KLINSNGSWH 0.06% (n=13)
ELVNTNGSWH 0.06% (n=13)
QLINTRGSWH 0.05% (n=12)
ELIHTNGSWH 0.05% (n=12)
RLINSNGSWH 0.05% (n=11)
ELINTNGSWH 0.05% (n=11)
NLVNTNGSWH 0.05% (n=11)
QLVNTNGSRH 0.04% (n=10)
QLINTNDSWH 0.04% (n=10)
QLINSSGSWH 0.04% (n=10)
QLIYSNGSWH 0.04% (n=10)
HLVNTNGSWH 0.04% (n=10)
QPINTNGSWH 0.04% (n=9)
QLIKSNGSWH 0.04% (n=9)
QLINSDGSWH 0.04% (n=9)
QLVNRNGSWH 0.04% (n=9)
QLINRNGSWH 0.04% (n=9)
QLINTNSSWH 0.03% (n=8)
RLVNSNGSWH 0.03% (n=8)
KLINTNGSCH 0.03% (n=8)
QLVNTDGSWH 0.03% (n=8)
RLVNTNGSWH 0.03% (n=8)
QLINPNGSWH 0.03% (n=7)
QLINTNGS*H 0.03% (n=7)
QLINTNGSWY 0.03% (n=7)
QLVNINGSWH 0.03% (n=6)
QLVYTNGSWH 0.03% (n=6)
QLINTNGGWH 0.03% (n=6)
QLVNNNGSWH 0.03% (n=6)
QLLNTNGSWH 0.03% (n=6)
KLVNTSGSWH 0.03% (n=6)
QLVNTNGSWR 0.02% (n=5)
QLVDTNGSWH 0.02% (n=5)
YLINTNGSWH 0.02% (n=5)
QLVNSSGSWH 0.02% (n=5)
QLVNTNGNWH 0.02% (n=5)
QLANTNGSWH 0.02% (n=5)
QLINTNGSWL 0.02% (n=5)
QLVHTNGSWH 0.02% (n=5)
QLVNTNSSWH 0.02% (n=4)
QLINTNGTWH 0.02% (n=4)
QLVNTNGS*H 0.02% (n=4)
QLVNKNGSWH 0.02% (n=4)
QPVNTNGSWH 0.02% (n=4)
QLINNNGSWH 0.02% (n=4)
QLVNTNGSWY 0.02% (n=4)
QLIRTNGSWH 0.02% (n=4)
QLINKNGSWH 0.02% (n=4)
QLMETNGSWH 0.02% (n=4)
QLINTEGSWH 0.01% (n=3)
*LINTNGSWH 0.01% (n=3)
QPINSNGSWH 0.01% (n=3)
QLIYTNGSWH 0.01% (n=3)
QVINTNGSWH 0.01% (n=3)
QMINTNGSWH 0.01% (n=3)
QLVTTNGSWH 0.01% (n=3)
QLVHANGSWH 0.01% (n=3)
QLTNSNGSWH 0.01% (n=3)
QLINSN---- 0.01% (n=3)
HLVKTNGSWH 0.01% (n=3)
QLINTNGSWD 0.01% (n=2)
QLINTNGSGH 0.01% (n=2)
QLINTNGNWH 0.01% (n=2)
KLINTNGSGH 0.01% (n=2)
QLINSNGGWH 0.01% (n=2)
QLINTNGRWH 0.01% (n=2)
QLVNTKGSWH 0.01% (n=2)
HLINSNGSWH 0.01% (n=2)
ELINSNGSWH 0.01% (n=2)
KLMNTNGSWH 0.01% (n=2)
QLINTTGSSH 0.01% (n=2)
QLINSNGSRH 0.01% (n=2)
QLINSNGNWH 0.01% (n=2)
QLINTNGCWH 0.01% (n=2)
QLVNADGSWH 0.01% (n=2)
QLIHKNGSWH 0.01% (n=2)
QLININGSWH 0.01% (n=2)
QLVATNGSWH 0.01% (n=2)
QLVNTNGGWH 0.01% (n=2)
QLINTNRSWH 0.01% (n=2)
QIINTNGSWH 0.01% (n=2)
QLVNTNDSWH 0.01% (n=2)
QLMHTNGSWH 0.01% (n=2)
KLVNTNGSWH 0.01% (n=2)
QLI------- 0.01% (n=2)
QLVNTNGSWQ 0.00% (n=1)
QLVNTNGSWL 0.00% (n=1)
QLINTHGSWH 0.00% (n=1)
RLINPNGSWH 0.00% (n=1)
QLTKSNGSWH 0.00% (n=1)
QLIKSNGSRH 0.00% (n=1)
QLVNSNGNWH 0.00% (n=1)
KLMKTNDSWH 0.00% (n=1)
QLIQTNGSWH 0.00% (n=1)
QLIKTDGSWH 0.00% (n=1)
QLINTNG-WH 0.00% (n=1)
QLISSNGSWH 0.00% (n=1)
QLINFNGSWH 0.00% (n=1)
QLINSNGSWY 0.00% (n=1)
QLINSNGRWH 0.00% (n=1)
KLINTNGSCA 0.00% (n=1)
QLINSNGSWR 0.00% (n=1)
QLVSENGSWH 0.00% (n=1)
QQVNENGSWH 0.00% (n=1)
QLVNENDSWH 0.00% (n=1)
QMVNTNGSWH 0.00% (n=1)
GLINTNGSWH 0.00% (n=1)
QLINTGGSWH 0.00% (n=1)
QLVYSNGSWH 0.00% (n=1)
QLVYTNGSWR 0.00% (n=1)
ELVDTSGSWH 0.00% (n=1)
QLMYTNGSWH 0.00% (n=1)
QLVNSHGSWD 0.00% (n=1)
QLVNTNGRWH 0.00% (n=1)
HLVNSNGSWH 0.00% (n=1)
NLINTNGSWH 0.00% (n=1)
QLVNKDGSWH 0.00% (n=1)
RLIHTNGSWH 0.00% (n=1)
QLINASGSWH 0.00% (n=1)
QLVKANDSWH 0.00% (n=1)
ELVNVNDSWH 0.00% (n=1)
QLINTNGSWQ 0.00% (n=1)
QPINTHGSWH 0.00% (n=1)
QLVNTNRSWH 0.00% (n=1)
QFINSNGSWH 0.00% (n=1)
QFINTNGSWH 0.00% (n=1)
QLINTTGSWH 0.00% (n=1)
RLANTSGSWH 0.00% (n=1)
KLTSTNGSWH 0.00% (n=1)
QLIGTNGSWH 0.00% (n=1)
ELINPNGGWH 0.00% (n=1)
QLINTIGSWH 0.00% (n=1)
QLINSIGSWH 0.00% (n=1)
HLIKTNGGWH 0.00% (n=1)
QLIKTNGRWH 0.00% (n=1)
HLISTNGSWH 0.00% (n=1)
QLMNTNGNWH 0.00% (n=1)
QLINTKGSWH 0.00% (n=1)
QLINSNGSGH 0.00% (n=1)
QLINSNDSWH 0.00% (n=1)
*LINTNGSRH 0.00% (n=1)
HLVNNNGSWH 0.00% (n=1)
QLMSTNGSWH 0.00% (n=1)
QLINTNVSWH 0.00% (n=1)
QLVKTEGNWH 0.00% (n=1)
PACNTNAAWG 0.00% (n=1)
KLVNTSGSWY 0.00% (n=1)
PAYNTNGSWH 0.00% (n=1)
QLVN------ 0.00% (n=1)
QIINT----- 0.00% (n=1)
QLVH------ 0.00% (n=1)
QL-------- 0.00% (n=1)
QLINT----- 0.00% (n=1)
ELINTNGNWH 0.00% (n=1)
QLIHTNGSWD 0.00% (n=1)
HLIHTNGSWH 0.00% (n=1)
ELIHTNGRWH 0.00% (n=1)
QLINTNGSCH 0.00% (n=1)
QLVHSNGSWH 0.00% (n=1)
HLVYTNGSWH 0.00% (n=1)
QLVRANGSWH 0.00% (n=1)
LLVNTNGSWH 0.00% (n=1)
RIINTNGSWH 0.00% (n=1)
QLMKTNGSWH 0.00% (n=1)
QLVNSNGSWR 0.00% (n=1)
KLVNTNGSWR 0.00% (n=1)
PLINTNGSWH 0.00% (n=1)
LLINTNGSWH 0.00% (n=1)
QHINTNGSWH 0.00% (n=1)
QLVNTNGSWN 0.00% (n=1)
QLINTNGS-- 0.00% (n=1)
QLVNTNGS-- 0.00% (n=1)
QLVNSNGSRH 0.00% (n=1)
QLVNNNGIWH 0.00% (n=1)
QLV------- 0.00% (n=1)
QLMNTSGSWH 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 1a:

QLINTNGSWH 60.55% (n=8276)
QLVNTNGSWH 17.63% (n=2410)
QLINSNGSWH 6.83% (n=933)
QLVNSNGSWH 1.80% (n=246)
QLVNANGSWH 1.43% (n=195)
HLINTNGSWH 1.40% (n=192)
HLIKTNGSWH 1.07% (n=146)
RLINTNGSWH 0.84% (n=115)
QLMNTNGSWH 0.76% (n=104)
QLISTNGSWH 0.63% (n=86)
KLTNTNGSWH 0.61% (n=84)
QLMNSNGSWH 0.55% (n=75)
QLINANGSWH 0.41% (n=56)
QLVNENGSWH 0.39% (n=53)
QLVSTNGSWH 0.34% (n=46)
QLINTNNSWH 0.32% (n=44)
KLINTNGSWH 0.31% (n=43)
QLIKTNGSWH 0.30% (n=41)
RLIKSNGSWH 0.14% (n=19)
QLINTSGSWH 0.14% (n=19)
RLANTNGSWH 0.13% (n=18)
QLTNTNGSWH 0.12% (n=17)
RLTNTNGSWH 0.12% (n=17)
QLVNTNGSW- 0.12% (n=16)
Q--------- 0.11% (n=15)
KLINSNGSWH 0.10% (n=13)
QLINTRGSWH 0.09% (n=12)
QLINTDGSWH 0.08% (n=11)
RLINSNGSWH 0.08% (n=11)
QLIDTNGSWH 0.07% (n=10)
QLINTNGSRH 0.07% (n=10)
QLINSSGSWH 0.07% (n=10)
QLIYSNGSWH 0.07% (n=10)
QLINSDGSWH 0.07% (n=9)
QLINRNGSWH 0.07% (n=9)
QLIKSNGSWH 0.06% (n=8)
RLVNSNGSWH 0.06% (n=8)
KLINTNGSCH 0.06% (n=8)
QLINTNGSWR 0.06% (n=8)
QLVNRNGSWH 0.06% (n=8)
QLVNTNGSRH 0.05% (n=7)
QLINTNDSWH 0.05% (n=7)
QLINTNGS*H 0.05% (n=7)
QLVNTSGSWH 0.05% (n=7)
QPINTNGSWH 0.04% (n=6)
QLVDTNGSWH 0.04% (n=5)
YLINTNGSWH 0.04% (n=5)
QLINPNGSWH 0.04% (n=5)
QLVNTDGSWH 0.04% (n=5)
QLVYTNGSWH 0.04% (n=5)
RLVNTNGSWH 0.04% (n=5)
QLVNTNGSWR 0.03% (n=4)
QLINTNSSWH 0.03% (n=4)
QLVNSSGSWH 0.03% (n=4)
QLVNTNGNWH 0.03% (n=4)
QLVNKNGSWH 0.03% (n=4)
QLINNNGSWH 0.03% (n=4)
QLINTNGGWH 0.03% (n=4)
QLVNNNGSWH 0.03% (n=4)
QLVNTNGSWY 0.03% (n=4)
QLINKNGSWH 0.03% (n=4)
QLVNINGSWH 0.02% (n=3)
QLINTEGSWH 0.02% (n=3)
QLINTNGTWH 0.02% (n=3)
*LINTNGSWH 0.02% (n=3)
QPINSNGSWH 0.02% (n=3)
QLVNTNGS*H 0.02% (n=3)
QVINTNGSWH 0.02% (n=3)
QMINTNGSWH 0.02% (n=3)
QPVNTNGSWH 0.02% (n=3)
QLIHTNGSWH 0.02% (n=3)
QLTNSNGSWH 0.02% (n=3)
QLINSN---- 0.02% (n=3)
QLINTNGSWY 0.02% (n=3)
HLVKTNGSWH 0.02% (n=3)
QLIRTNGSWH 0.02% (n=3)
QLINTNGSWD 0.01% (n=2)
QLINTNGSGH 0.01% (n=2)
QLINTNGNWH 0.01% (n=2)
KLINTNGSGH 0.01% (n=2)
QLINTNGSW- 0.01% (n=2)
QLANTNGSWH 0.01% (n=2)
QLVNASGSWH 0.01% (n=2)
HLINSNGSWH 0.01% (n=2)
ELINTNGSWH 0.01% (n=2)
ELINSNGSWH 0.01% (n=2)
KLMNTNGSWH 0.01% (n=2)
QLINTTGSSH 0.01% (n=2)
QLINSNGSRH 0.01% (n=2)
QLINSNGNWH 0.01% (n=2)
QLINTNGCWH 0.01% (n=2)
QLLNTNGSWH 0.01% (n=2)
QLVNADGSWH 0.01% (n=2)
QLIHKNGSWH 0.01% (n=2)
QLVHTNGSWH 0.01% (n=2)
QLVATNGSWH 0.01% (n=2)
QLVNTNGSWQ 0.01% (n=1)
QLVNTNGSWL 0.01% (n=1)
QLINTHGSWH 0.01% (n=1)
QLVNTNSSWH 0.01% (n=1)
RLINPNGSWH 0.01% (n=1)
QLTKSNGSWH 0.01% (n=1)
QLIKSNGSRH 0.01% (n=1)
QLVNSNGNWH 0.01% (n=1)
KLMKTNDSWH 0.01% (n=1)
QLIQTNGSWH 0.01% (n=1)
QLIKTDGSWH 0.01% (n=1)
QLINTNG-WH 0.01% (n=1)
QLISSNGSWH 0.01% (n=1)
QLINFNGSWH 0.01% (n=1)
QLIYTNGSWH 0.01% (n=1)
QLINSNGSWY 0.01% (n=1)
QLINSNGRWH 0.01% (n=1)
KLINTNGSCA 0.01% (n=1)
QLINSNGGWH 0.01% (n=1)
QLINSNGSWR 0.01% (n=1)
QLVSENGSWH 0.01% (n=1)
QQVNENGSWH 0.01% (n=1)
QLVNENDSWH 0.01% (n=1)
QLINTNGRWH 0.01% (n=1)
QMVNTNGSWH 0.01% (n=1)
QLVNTKGSWH 0.01% (n=1)
QLVTTNGSWH 0.01% (n=1)
GLINTNGSWH 0.01% (n=1)
QLINTGGSWH 0.01% (n=1)
QLVYSNGSWH 0.01% (n=1)
QLVYTNGSWR 0.01% (n=1)
ELVDTSGSWH 0.01% (n=1)
QLMYTNGSWH 0.01% (n=1)
QLVHANGSWH 0.01% (n=1)
QLVNSHGSWD 0.01% (n=1)
QLVNTNGRWH 0.01% (n=1)
HLVNSNGSWH 0.01% (n=1)
NLINTNGSWH 0.01% (n=1)
QLVNKDGSWH 0.01% (n=1)
NLVNTNGSWH 0.01% (n=1)
RLIHTNGSWH 0.01% (n=1)
QLINASGSWH 0.01% (n=1)
QLVKANDSWH 0.01% (n=1)
ELVNVNDSWH 0.01% (n=1)
QLINTNGSWQ 0.01% (n=1)
QPINTHGSWH 0.01% (n=1)
QLVNTNRSWH 0.01% (n=1)
QFINSNGSWH 0.01% (n=1)
QFINTNGSWH 0.01% (n=1)
QLINTTGSWH 0.01% (n=1)
RLANTSGSWH 0.01% (n=1)
KLTSTNGSWH 0.01% (n=1)
QLIGTNGSWH 0.01% (n=1)
ELINPNGGWH 0.01% (n=1)
QLINTIGSWH 0.01% (n=1)
QLINSIGSWH 0.01% (n=1)
HLIKTNGGWH 0.01% (n=1)
QLIKTNGRWH 0.01% (n=1)
QLINTNGSWL 0.01% (n=1)
HLISTNGSWH 0.01% (n=1)
HLVNTNGSWH 0.01% (n=1)
QLMNTNGNWH 0.01% (n=1)
QLINTKGSWH 0.01% (n=1)
QLINSNGSGH 0.01% (n=1)
QLINSNDSWH 0.01% (n=1)
QLININGSWH 0.01% (n=1)
*LINTNGSRH 0.01% (n=1)
HLVNNNGSWH 0.01% (n=1)
QLMSTNGSWH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 1b:

QLINTNGSWH 59.92% (n=5564)
QLVNTNGSWH 32.36% (n=3005)
QLVNSNGSWH 1.43% (n=133)
QLINSNGSWH 1.07% (n=99)
RLINTNGSWH 0.75% (n=70)
QLISTNGSWH 0.32% (n=30)
QLMNTNGSWH 0.27% (n=25)
QLVNASGSWH 0.27% (n=25)
QLVKTNGSWH 0.24% (n=22)
QLIHTNGSWH 0.24% (n=22)
HLINTNGSWH 0.18% (n=17)
QLINTNGSW- 0.18% (n=17)
ELVNTNGSWH 0.13% (n=12)
ELIHTNGSWH 0.13% (n=12)
QLVSTNGSWH 0.13% (n=12)
QLINTNGSRH 0.11% (n=10)
NLVNTNGSWH 0.11% (n=10)
QLIKTNGSWH 0.10% (n=9)
ELINTNGSWH 0.10% (n=9)
HLVNTNGSWH 0.10% (n=9)
QLINTSGSWH 0.09% (n=8)
QLVNTSGSWH 0.08% (n=7)
QLINANGSWH 0.08% (n=7)
QLINTNGSWR 0.08% (n=7)
KLVNTSGSWH 0.06% (n=6)
Q--------- 0.06% (n=6)
QLINTDGSWH 0.05% (n=5)
QLLNTNGSWH 0.04% (n=4)
QLINTNGSWL 0.04% (n=4)
QLINTNGSWY 0.04% (n=4)
QLINTNSSWH 0.04% (n=4)
QLMETNGSWH 0.04% (n=4)
QLIDTNGSWH 0.04% (n=4)
QLVNTNSSWH 0.03% (n=3)
QLVHTNGSWH 0.03% (n=3)
QLVNINGSWH 0.03% (n=3)
QLVNTNGSRH 0.03% (n=3)
QLVNTDGSWH 0.03% (n=3)
RLVNTNGSWH 0.03% (n=3)
QLANTNGSWH 0.03% (n=3)
QPINTNGSWH 0.03% (n=3)
QLINTNDSWH 0.03% (n=3)
QLIYTNGSWH 0.02% (n=2)
QLVNTNGGWH 0.02% (n=2)
QLINTNRSWH 0.02% (n=2)
QLINPNGSWH 0.02% (n=2)
QLVNNNGSWH 0.02% (n=2)
QLINTNGGWH 0.02% (n=2)
QLVNTNGSW- 0.02% (n=2)
QIINTNGSWH 0.02% (n=2)
QLVNTNDSWH 0.02% (n=2)
QLVTTNGSWH 0.02% (n=2)
QLVHANGSWH 0.02% (n=2)
QLMHTNGSWH 0.02% (n=2)
KLVNTNGSWH 0.02% (n=2)
QLVNANGSWH 0.02% (n=2)
QLINTNVSWH 0.01% (n=1)
QLVKTEGNWH 0.01% (n=1)
PACNTNAAWG 0.01% (n=1)
KLVNTSGSWY 0.01% (n=1)
PAYNTNGSWH 0.01% (n=1)
QLVN------ 0.01% (n=1)
QIINT----- 0.01% (n=1)
QLVH------ 0.01% (n=1)
QL-------- 0.01% (n=1)
QLINT----- 0.01% (n=1)
ELINTNGNWH 0.01% (n=1)
QLIHTNGSWD 0.01% (n=1)
HLIHTNGSWH 0.01% (n=1)
ELIHTNGRWH 0.01% (n=1)
QLINTNGRWH 0.01% (n=1)
QLINTNGSCH 0.01% (n=1)
QLVNRNGSWH 0.01% (n=1)
QLVHSNGSWH 0.01% (n=1)
QLIRTNGSWH 0.01% (n=1)
HLVYTNGSWH 0.01% (n=1)
QLVRANGSWH 0.01% (n=1)
QLVYTNGSWH 0.01% (n=1)
QLVNSSGSWH 0.01% (n=1)
LLVNTNGSWH 0.01% (n=1)
QLTNTNGSWH 0.01% (n=1)
RIINTNGSWH 0.01% (n=1)
QLMKTNGSWH 0.01% (n=1)
QLVNSNGSWR 0.01% (n=1)
QLIKSNGSWH 0.01% (n=1)
QLVNTNGS*H 0.01% (n=1)
QLVNTNGNWH 0.01% (n=1)
KLVNTNGSWR 0.01% (n=1)
QPVNTNGSWH 0.01% (n=1)
QLVNTKGSWH 0.01% (n=1)
QLVNTNGSWR 0.01% (n=1)
QLININGSWH 0.01% (n=1)
PLINTNGSWH 0.01% (n=1)
QLINTNGTWH 0.01% (n=1)
LLINTNGSWH 0.01% (n=1)
QLINSNGGWH 0.01% (n=1)
QHINTNGSWH 0.01% (n=1)
QLVNTNGSWN 0.01% (n=1)
QLINTNGS-- 0.01% (n=1)
QLVNTNGS-- 0.01% (n=1)
QLVNSNGSRH 0.01% (n=1)
QLVNNNGIWH 0.01% (n=1)
QLV------- 0.01% (n=1)
QLI------- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 2:

QLINTNGSWH 22.88% (n=310)
QLINSNGSWH 20.89% (n=283)
SLINTNGSWH 12.47% (n=169)
QLIHTNGSWH 7.38% (n=100)
QLIHSNGSWH 6.35% (n=86)
QLIHNNGSWH 5.90% (n=80)
NLINTNGSWH 5.24% (n=71)
SLISTNGSWH 2.29% (n=31)
QLVNTNGSWH 1.33% (n=18)
TLINTNGSWH 1.25% (n=17)
DLINTNGSWH 1.03% (n=14)
NLIKTNGSWH 0.96% (n=13)
NLISTNGSWH 0.96% (n=13)
HLINTNGSWH 0.89% (n=12)
NLIHTNGSWH 0.81% (n=11)
SLVNTNGSWH 0.59% (n=8)
YLINTNGSWH 0.44% (n=6)
QLIYTNGSWH 0.44% (n=6)
QLIN------ 0.30% (n=4)
QLINNNGSWH 0.22% (n=3)
QLVNSNGSWH 0.22% (n=3)
QLVNANGSWH 0.22% (n=3)
QLINANGSWH 0.22% (n=3)
MLINTNGSWH 0.22% (n=3)
HLVNSNGSWH 0.22% (n=3)
KLINTNGSWH 0.22% (n=3)
NLVNTNGSWH 0.22% (n=3)
TLVNTNGSWH 0.22% (n=3)
ALINTNGSWH 0.22% (n=3)
QLIRNNGSWH 0.22% (n=3)
QLI------- 0.22% (n=3)
QLIKTNGSWH 0.15% (n=2)
QLINSSGSWH 0.15% (n=2)
QLIDTNGSWH 0.15% (n=2)
QLISTNGSWH 0.15% (n=2)
RLINTNGSWH 0.15% (n=2)
HLINSNGSWH 0.15% (n=2)
SLIHTNGSWH 0.15% (n=2)
QLVHTNGSWH 0.07% (n=1)
QLTNSNGSWH 0.07% (n=1)
QLIYSNGSWH 0.07% (n=1)
QLVNDNGSWH 0.07% (n=1)
QLIDTKGSWH 0.07% (n=1)
QLVSANGSWH 0.07% (n=1)
QLINTSGSWH 0.07% (n=1)
QLVNTSGSWH 0.07% (n=1)
QLIKSNGSWH 0.07% (n=1)
RLMNTSGSWH 0.07% (n=1)
ILVNSNGSWH 0.07% (n=1)
HLVNTNGSWH 0.07% (n=1)
HLNHSNGSWH 0.07% (n=1)
YLINKNGSWH 0.07% (n=1)
SLINSNGSWH 0.07% (n=1)
QLISSNGSWH 0.07% (n=1)
NLINSNGNWH 0.07% (n=1)
HLIKNNGSWH 0.07% (n=1)
QLVNNNGSWH 0.07% (n=1)
HLVKTNGSWH 0.07% (n=1)
TLNHTNGSWH 0.07% (n=1)
DLINANGSWH 0.07% (n=1)
NLINTNGSLH 0.07% (n=1)
NLINTNVNWH 0.07% (n=1)
TLINTNGS*H 0.07% (n=1)
TLINTNSSWH 0.07% (n=1)
SLVNTNGSRH 0.07% (n=1)
SLVSTNGSWH 0.07% (n=1)
SLINTTGSWH 0.07% (n=1)
SLINTNGSLH 0.07% (n=1)
*LVNTNGSWH 0.07% (n=1)
TLVNTNGNLH 0.07% (n=1)
SLINTNGSLD 0.07% (n=1)
SLINTDGSWH 0.07% (n=1)
NLIYTNGSWH 0.07% (n=1)
MLINSNGSWH 0.07% (n=1)
WLIPMAAGW- 0.07% (n=1)
SLIKENGSWH 0.07% (n=1)
SLMNTNGSWH 0.07% (n=1)
QLIYNNGSWH 0.07% (n=1)
QLTHTNGSWH 0.07% (n=1)
QLVKTNGSWH 0.07% (n=1)
QLIRTNGSWH 0.07% (n=1)
ELVNTNGSWH 0.07% (n=1)
QLINDNGTWH 0.07% (n=1)
*LINSNGSWH 0.07% (n=1)
RLINSNGSWH 0.07% (n=1)
QLINSDGSWH 0.07% (n=1)
QLIRSNGSWH 0.07% (n=1)
RLV------- 0.07% (n=1)
QLINPNGSWH 0.07% (n=1)
MLMKTNGSWH 0.07% (n=1)
SLVNSNGSWH 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 2a:

QLINTNGSWH 50.69% (n=146)
QLINSNGSWH 39.58% (n=114)
QLVNTNGSWH 3.13% (n=9)
QLINNNGSWH 0.69% (n=2)
QLINSSGSWH 0.69% (n=2)
QLVNSNGSWH 0.69% (n=2)
QLTNSNGSWH 0.35% (n=1)
QLIKTNGSWH 0.35% (n=1)
QLIYSNGSWH 0.35% (n=1)
QLVNDNGSWH 0.35% (n=1)
QLIDTKGSWH 0.35% (n=1)
QLIDTNGSWH 0.35% (n=1)
QLVSANGSWH 0.35% (n=1)
QLVNANGSWH 0.35% (n=1)
QLISTNGSWH 0.35% (n=1)
QLINTSGSWH 0.35% (n=1)
QLVNTSGSWH 0.35% (n=1)
QLIKSNGSWH 0.35% (n=1)
RLMNTSGSWH 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 2b:

SLINTNGSWH 36.58% (n=169)
NLINTNGSWH 15.37% (n=71)
QLINTNGSWH 7.14% (n=33)
SLISTNGSWH 6.71% (n=31)
TLINTNGSWH 3.68% (n=17)
DLINTNGSWH 3.03% (n=14)
NLIKTNGSWH 2.81% (n=13)
NLISTNGSWH 2.81% (n=13)
HLINTNGSWH 2.38% (n=11)
NLIHTNGSWH 2.38% (n=11)
SLVNTNGSWH 1.73% (n=8)
QLINSNGSWH 1.52% (n=7)
YLINTNGSWH 1.30% (n=6)
QLVNTNGSWH 0.65% (n=3)
MLINTNGSWH 0.65% (n=3)
HLVNSNGSWH 0.65% (n=3)
KLINTNGSWH 0.65% (n=3)
NLVNTNGSWH 0.65% (n=3)
TLVNTNGSWH 0.65% (n=3)
ALINTNGSWH 0.65% (n=3)
RLINTNGSWH 0.43% (n=2)
QLINANGSWH 0.43% (n=2)
SLIHTNGSWH 0.43% (n=2)
ILVNSNGSWH 0.22% (n=1)
HLINSNGSWH 0.22% (n=1)
HLVNTNGSWH 0.22% (n=1)
HLNHSNGSWH 0.22% (n=1)
YLINKNGSWH 0.22% (n=1)
QLINNNGSWH 0.22% (n=1)
QLISSNGSWH 0.22% (n=1)
NLINSNGNWH 0.22% (n=1)
HLIKNNGSWH 0.22% (n=1)
QLVNNNGSWH 0.22% (n=1)
HLVKTNGSWH 0.22% (n=1)
TLNHTNGSWH 0.22% (n=1)
DLINANGSWH 0.22% (n=1)
NLINTNGSLH 0.22% (n=1)
NLINTNVNWH 0.22% (n=1)
TLINTNGS*H 0.22% (n=1)
TLINTNSSWH 0.22% (n=1)
SLVNTNGSRH 0.22% (n=1)
SLVSTNGSWH 0.22% (n=1)
SLINTTGSWH 0.22% (n=1)
SLINTNGSLH 0.22% (n=1)
*LVNTNGSWH 0.22% (n=1)
TLVNTNGNLH 0.22% (n=1)
SLINTNGSLD 0.22% (n=1)
SLINTDGSWH 0.22% (n=1)
NLIYTNGSWH 0.22% (n=1)
MLINSNGSWH 0.22% (n=1)
--------W- 0.22% (n=1)
SLIKENGSWH 0.22% (n=1)
SLMNTNGSWH 0.22% (n=1)
QLVNSNGSWH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 2c:

QLINSNGSWH 33.70% (n=153)
QLIHTNGSWH 21.59% (n=98)
QLIHSNGSWH 18.50% (n=84)
QLIHNNGSWH 17.62% (n=80)
QLINTNGSWH 3.96% (n=18)
QLIYTNGSWH 0.88% (n=4)
QLIRNNGSWH 0.66% (n=3)
QLIN------ 0.22% (n=1)
QLIYNNGSWH 0.22% (n=1)
QLTHTNGSWH 0.22% (n=1)
QLVNTNGSWH 0.22% (n=1)
QLVKTNGSWH 0.22% (n=1)
QLVNANGSWH 0.22% (n=1)
QLIRTNGSWH 0.22% (n=1)
QLISTNGSWH 0.22% (n=1)
ELVNTNGSWH 0.22% (n=1)
QLINDNGTWH 0.22% (n=1)
*LINSNGSWH 0.22% (n=1)
RLINSNGSWH 0.22% (n=1)
HLINSNGSWH 0.22% (n=1)
QLINSDGSWH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 3:

QLVNTNGSWH 40.69% (n=1595)
QLINTNGSWH 15.79% (n=619)
ELINTNGSWH 9.72% (n=381)
QLVRTNGSWH 8.04% (n=315)
HLVNSNGSWH 6.33% (n=248)
QLVNSNGSWH 5.31% (n=208)
QLIYTNGSWH 2.60% (n=102)
QLINSNGSWH 2.42% (n=95)
HLVNTNGSWH 1.43% (n=56)
ELVNTNGSWH 1.12% (n=44)
QLVNTNGSWY 0.82% (n=32)
QLIETQGSWH 0.61% (n=24)
QLVNANGSWH 0.46% (n=18)
---NTNGSWH 0.36% (n=14)
QLVYTNGSWH 0.23% (n=9)
QLVHTNGSWH 0.20% (n=8)
QLIETNGSWH 0.18% (n=7)
RLVNTNGSWH 0.18% (n=7)
QLVN------ 0.15% (n=6)
NLVNSNGSWH 0.15% (n=6)
QLVSTNGSWH 0.13% (n=5)
QLV------- 0.13% (n=5)
QLVKTNGSWH 0.13% (n=5)
QLINANGSWH 0.10% (n=4)
QLVNTNGSW- 0.10% (n=4)
ALINTNGSWH 0.10% (n=4)
QLIN------ 0.10% (n=4)
QLVDTNGSWH 0.08% (n=3)
QLVNTNGPWH 0.08% (n=3)
QLVNTSGSWH 0.08% (n=3)
QLIHTNGSWH 0.08% (n=3)
QLVETNGSWH 0.08% (n=3)
QLVHSNGSWH 0.08% (n=3)
RLVNSNGSWH 0.08% (n=3)
ALVNTNGSWH 0.05% (n=2)
QLVNSSGSWH 0.05% (n=2)
ELINTNGPWH 0.05% (n=2)
QLVNTNDSWH 0.05% (n=2)
ELIKTNGSWH 0.05% (n=2)
QLVKSNGSWH 0.05% (n=2)
QPVNTNGSWH 0.05% (n=2)
QLIDTNGSWH 0.05% (n=2)
ELINTHGSWH 0.05% (n=2)
KLVNTNGSWH 0.05% (n=2)
KLINTNGSWH 0.05% (n=2)
QLVNDSGSWH 0.05% (n=2)
HLVSSNGSWH 0.05% (n=2)
QLVHNNGSWH 0.03% (n=1)
QLISSNGSWH 0.03% (n=1)
ELINTNDSWH 0.03% (n=1)
QLVNINGSWH 0.03% (n=1)
QLINTYGSGH 0.03% (n=1)
QLVNTYGSLH 0.03% (n=1)
ELICTNASWH 0.03% (n=1)
QLTNTNGSWH 0.03% (n=1)
QLINTNGSRH 0.03% (n=1)
QLVETKGSWH 0.03% (n=1)
RLIYTNGSWH 0.03% (n=1)
LLVNTNGSWH 0.03% (n=1)
QLMKTGDSWH 0.03% (n=1)
YLINTNGSWH 0.03% (n=1)
ELVYTNGSWH 0.03% (n=1)
QLISTNGSWH 0.03% (n=1)
QLIQTNGSWH 0.03% (n=1)
QLIKTNNSWH 0.03% (n=1)
QLINSSGSWH 0.03% (n=1)
ELIHTNGSWH 0.03% (n=1)
QLINDNGSWH 0.03% (n=1)
NLINTNGSWH 0.03% (n=1)
QLVNKNGSWH 0.03% (n=1)
ELINTDGSWH 0.03% (n=1)
QLVNNNGSWH 0.03% (n=1)
ELIETNGSWH 0.03% (n=1)
ELVNANGSWH 0.03% (n=1)
QLVNTDGSWH 0.03% (n=1)
ELMNTNGSWH 0.03% (n=1)
QLVNSNGS-- 0.03% (n=1)
HLVESNGSWH 0.03% (n=1)
HLIETNGSWH 0.03% (n=1)
DLVYTNGSWH 0.03% (n=1)
NLVNTNGSWH 0.03% (n=1)
HLVNSNGSRH 0.03% (n=1)
SLVNTNGSWH 0.03% (n=1)
QLMNTNGSWH 0.03% (n=1)
HLVNSSGSWH 0.03% (n=1)
QLMNSNGSWH 0.03% (n=1)
QLMESNGSWH 0.03% (n=1)
QLTNSNGSWH 0.03% (n=1)
QLVDSNGSWH 0.03% (n=1)
QLVSSNGSWH 0.03% (n=1)
QLVYSNGSWH 0.03% (n=1)
QLVNSNGFWH 0.03% (n=1)
HLVN------ 0.03% (n=1)
HLINTNGSWH 0.03% (n=1)
ELVKSNGSWH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 3a:

QLVNTNGSWH 47.26% (n=1551)
QLINTNGSWH 18.62% (n=611)
ELINTNGSWH 11.61% (n=381)
QLVRTNGSWH 9.60% (n=315)
QLIYTNGSWH 3.08% (n=101)
ELVNTNGSWH 1.34% (n=44)
QLVNSNGSWH 0.98% (n=32)
QLVNTNGSWY 0.98% (n=32)
QLIETQGSWH 0.73% (n=24)
HLVNTNGSWH 0.61% (n=20)
QLINSNGSWH 0.58% (n=19)
QLVNANGSWH 0.55% (n=18)
---NTNGSWH 0.43% (n=14)
QLVYTNGSWH 0.27% (n=9)
QLVHTNGSWH 0.24% (n=8)
QLIETNGSWH 0.21% (n=7)
RLVNTNGSWH 0.18% (n=6)
QLVSTNGSWH 0.15% (n=5)
QLVKTNGSWH 0.15% (n=5)
QLINANGSWH 0.12% (n=4)
QLVNTNGSW- 0.12% (n=4)
ALINTNGSWH 0.12% (n=4)
QLVDTNGSWH 0.09% (n=3)
QLVNTNGPWH 0.09% (n=3)
QLVNTSGSWH 0.09% (n=3)
QLIHTNGSWH 0.09% (n=3)
QLVETNGSWH 0.09% (n=3)
ALVNTNGSWH 0.06% (n=2)
ELINTNGPWH 0.06% (n=2)
QLVNTNDSWH 0.06% (n=2)
ELIKTNGSWH 0.06% (n=2)
QLVKSNGSWH 0.06% (n=2)
QPVNTNGSWH 0.06% (n=2)
QLIDTNGSWH 0.06% (n=2)
ELINTHGSWH 0.06% (n=2)
QLV------- 0.06% (n=2)
KLINTNGSWH 0.06% (n=2)
QLVNDSGSWH 0.06% (n=2)
QLVHNNGSWH 0.03% (n=1)
QLVNSSGSWH 0.03% (n=1)
QLISSNGSWH 0.03% (n=1)
ELINTNDSWH 0.03% (n=1)
QLVNINGSWH 0.03% (n=1)
QLINTYGSGH 0.03% (n=1)
QLVNTYGSLH 0.03% (n=1)
ELICTNASWH 0.03% (n=1)
QLTNTNGSWH 0.03% (n=1)
QLINTNGSRH 0.03% (n=1)
QLVETKGSWH 0.03% (n=1)
RLIYTNGSWH 0.03% (n=1)
LLVNTNGSWH 0.03% (n=1)
QLMKTGDSWH 0.03% (n=1)
YLINTNGSWH 0.03% (n=1)
KLVNTNGSWH 0.03% (n=1)
ELVYTNGSWH 0.03% (n=1)
QLISTNGSWH 0.03% (n=1)
QLIQTNGSWH 0.03% (n=1)
QLIKTNNSWH 0.03% (n=1)
QLINSSGSWH 0.03% (n=1)
ELIHTNGSWH 0.03% (n=1)
QLINDNGSWH 0.03% (n=1)
NLINTNGSWH 0.03% (n=1)
QLVNKNGSWH 0.03% (n=1)
ELINTDGSWH 0.03% (n=1)
QLVNNNGSWH 0.03% (n=1)
ELIETNGSWH 0.03% (n=1)
ELVNANGSWH 0.03% (n=1)
QLVNTDGSWH 0.03% (n=1)
ELMNTNGSWH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 3b:

HLVNSNGSWH 61.54% (n=248)
QLVNSNGSWH 19.85% (n=80)
HLVNTNGSWH 8.44% (n=34)
QLVNTNGSWH 1.99% (n=8)
NLVNSNGSWH 1.49% (n=6)
QLVN------ 0.99% (n=4)
QLVHSNGSWH 0.74% (n=3)
RLVNSNGSWH 0.74% (n=3)
HLVSSNGSWH 0.50% (n=2)
QLVNSNGS-- 0.25% (n=1)
HLVESNGSWH 0.25% (n=1)
HLIETNGSWH 0.25% (n=1)
KLVNTNGSWH 0.25% (n=1)
DLVYTNGSWH 0.25% (n=1)
NLVNTNGSWH 0.25% (n=1)
QLVNSSGSWH 0.25% (n=1)
RLVNTNGSWH 0.25% (n=1)
HLVNSNGSRH 0.25% (n=1)
SLVNTNGSWH 0.25% (n=1)
QLMNTNGSWH 0.25% (n=1)
HLVNSSGSWH 0.25% (n=1)
QLMNSNGSWH 0.25% (n=1)
QLMESNGSWH 0.25% (n=1)
QLTNSNGSWH 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 4:

QLINTNGSWH 68.97% (n=529)
GLINTNGSWH 8.08% (n=62)
HLINSNGSWH 4.69% (n=36)
QLINSNGSWH 4.04% (n=31)
QLVNKNGSWH 3.78% (n=29)
QLIHTNGSWH 2.22% (n=17)
QLVNTNGSWH 1.56% (n=12)
QLISTNGSWH 1.43% (n=11)
QLVNSNGSWH 1.17% (n=9)
QLIDTNGSWH 0.65% (n=5)
RLINTNGSWH 0.52% (n=4)
QLIYTNGSWH 0.39% (n=3)
QLINTGGSWH 0.39% (n=3)
QLTNTNGSWH 0.39% (n=3)
RLVKTNGSWH 0.26% (n=2)
MLINTNGSWH 0.26% (n=2)
QLINS----- 0.13% (n=1)
QLINTNESWH 0.13% (n=1)
HLINTNGSWH 0.13% (n=1)
KLINTNGSWH 0.13% (n=1)
QLINTNGRWH 0.13% (n=1)
SLINSNGSWH 0.13% (n=1)
HLVNSNGSWH 0.13% (n=1)
KLVNSNGSWH 0.13% (n=1)
RLVNTNGSWH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 4a:

GLINTNGSWH 38.75% (n=62)
HLINSNGSWH 22.50% (n=36)
QLVNKNGSWH 18.13% (n=29)
QLINSNGSWH 15.63% (n=25)
QLVNSNGSWH 1.88% (n=3)
QLINTNGSWH 1.88% (n=3)
QLINS----- 0.63% (n=1)
QLVNTNGSWH 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 4d:

QLINTNGSWH 92.07% (n=499)
QLIHTNGSWH 2.58% (n=14)
QLISTNGSWH 2.03% (n=11)
QLIDTNGSWH 0.74% (n=4)
QLINTGGSWH 0.55% (n=3)
QLTNTNGSWH 0.55% (n=3)
QLIYTNGSWH 0.37% (n=2)
RLVKTNGSWH 0.37% (n=2)
QLINTNESWH 0.18% (n=1)
QLVNTNGSWH 0.18% (n=1)
QLINSNGSWH 0.18% (n=1)
HLINTNGSWH 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 5:

QLINTNGSWH 61.54% (n=88)
Q--------- 5.59% (n=8)
QLVNTNGSWH 5.59% (n=8)
QLINSNGSWH 4.20% (n=6)
QLIHSNGSWH 2.80% (n=4)
QLISTNGSWH 2.10% (n=3)
QLINNQGSWH 1.40% (n=2)
QLIRTNGSWH 1.40% (n=2)
QLVNSNGSWH 1.40% (n=2)
QLIHTNGSWH 1.40% (n=2)
QFVNTNGSWH 1.40% (n=2)
QL-------- 0.70% (n=1)
QLINTSGSWH 0.70% (n=1)
QLMKTNGSWH 0.70% (n=1)
QIINTNGSWH 0.70% (n=1)
QLINTNGSCH 0.70% (n=1)
ELINTNGSWH 0.70% (n=1)
QLVHTNGSWH 0.70% (n=1)
RLMKTGESWH 0.70% (n=1)
QLVKTNGA-- 0.70% (n=1)
AAHNTNGSWH 0.70% (n=1)
QLMNSNGSWH 0.70% (n=1)
QLINTNGSWY 0.70% (n=1)
QLVRSNGSWH 0.70% (n=1)
QLIKTNGSWH 0.70% (n=1)
QLMETNGSWH 0.70% (n=1)
QLIQNGSSWH 0.70% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 6:

QLINTNGSWH 52.76% (n=315)
QLVNTNGSWH 15.58% (n=93)
QLINSNGSWH 8.54% (n=51)
QLVNSNGSWH 8.38% (n=50)
QLIN------ 3.18% (n=19)
QLMNTNGSWH 2.18% (n=13)
QLVN------ 1.51% (n=9)
HLVNTNGSWH 0.67% (n=4)
HLINTNGSWH 0.67% (n=4)
QLIHTNGSWH 0.67% (n=4)
QLVHTNGSWH 0.50% (n=3)
QLVKTNGSWH 0.50% (n=3)
QLIKTNGSWH 0.50% (n=3)
QLIYTNGSWH 0.50% (n=3)
ELINTNGSWH 0.34% (n=2)
MLINTNGSWH 0.34% (n=2)
QLIKNGSSWH 0.17% (n=1)
QLIKSNGSWH 0.17% (n=1)
QLINTKGSWH 0.17% (n=1)
QLVRTNGSWH 0.17% (n=1)
QLICTNGSWH 0.17% (n=1)
QLVNNNGSWH 0.17% (n=1)
HLVNTSGSWH 0.17% (n=1)
QLVHANGSWH 0.17% (n=1)
QLIYSNGSWH 0.17% (n=1)
QLVNKNGSWH 0.17% (n=1)
QLINTNGRWH 0.17% (n=1)
QLINTNGSRH 0.17% (n=1)
QFINTNGSWH 0.17% (n=1)
HLIN------ 0.17% (n=1)
QLIK------ 0.17% (n=1)
QLVKINGSWH 0.17% (n=1)
QLINTDGSWH 0.17% (n=1)
QLIETNGSWH 0.17% (n=1)
QLISTNGSWH 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Subtype 6a:

QLINTNGSWH 65.64% (n=214)
QLVNTNGSWH 19.63% (n=64)
QLINSNGSWH 4.60% (n=15)
QLIN------ 1.23% (n=4)
HLVNTNGSWH 0.92% (n=3)
QLVNSNGSWH 0.92% (n=3)
QLVHTNGSWH 0.61% (n=2)
ELINTNGSWH 0.61% (n=2)
QLVKTNGSWH 0.61% (n=2)
QLIKNGSSWH 0.31% (n=1)
QLIKSNGSWH 0.31% (n=1)
QLINTKGSWH 0.31% (n=1)
QLVRTNGSWH 0.31% (n=1)
QLICTNGSWH 0.31% (n=1)
HLINTNGSWH 0.31% (n=1)
QLIHTNGSWH 0.31% (n=1)
QLVNNNGSWH 0.31% (n=1)
HLVNTSGSWH 0.31% (n=1)
QLVHANGSWH 0.31% (n=1)
QLIYSNGSWH 0.31% (n=1)
QLIKTNGSWH 0.31% (n=1)
QLVNKNGSWH 0.31% (n=1)
QLINTNGRWH 0.31% (n=1)
QLINTNGSRH 0.31% (n=1)
QFINTNGSWH 0.31% (n=1)
QLIYTNGSWH 0.31% (n=1)
---------------------------------------------------------------------------------------
Region 412-421 (antibodies: [AP33, HC33.1, HC33.32] ), HCV Genotype 7:

QLINTNGSWH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 1:

NRT 77.88% (n=17903)
NST 21.53% (n=4950)
NRA 0.15% (n=34)
SRT 0.06% (n=13)
DRT 0.06% (n=13)
NGT 0.05% (n=11)
NHT 0.03% (n=8)
NRM 0.03% (n=6)
NRS 0.02% (n=5)
NCT 0.02% (n=5)
NTT 0.02% (n=5)
NSA 0.02% (n=4)
NKT 0.02% (n=4)
SST 0.01% (n=2)
NPT 0.01% (n=2)
NSM 0.01% (n=2)
HRT 0.01% (n=2)
NQT 0.01% (n=2)
NNT 0.01% (n=2)
NLT 0.01% (n=2)
NRI 0.01% (n=2)
NSS 0.00% (n=1)
NRR 0.00% (n=1)
NRK 0.00% (n=1)
--T 0.00% (n=1)
NSI 0.00% (n=1)
DST 0.00% (n=1)
STG 0.00% (n=1)
NRN 0.00% (n=1)
TRT 0.00% (n=1)
NET 0.00% (n=1)
NRP 0.00% (n=1)
NWT 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 1a:

NRT 65.03% (n=8890)
NST 34.31% (n=4691)
NRA 0.16% (n=22)
NHT 0.06% (n=8)
DRT 0.05% (n=7)
NRM 0.04% (n=6)
NCT 0.04% (n=5)
NTT 0.04% (n=5)
NSA 0.03% (n=4)
NRS 0.03% (n=4)
SRT 0.03% (n=4)
NGT 0.02% (n=3)
SST 0.01% (n=2)
NPT 0.01% (n=2)
NSM 0.01% (n=2)
NKT 0.01% (n=2)
NQT 0.01% (n=2)
NNT 0.01% (n=2)
NLT 0.01% (n=2)
NSS 0.01% (n=1)
NRR 0.01% (n=1)
HRT 0.01% (n=1)
NRK 0.01% (n=1)
--T 0.01% (n=1)
NSI 0.01% (n=1)
DST 0.01% (n=1)
NRI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 1b:

NRT 96.74% (n=8969)
NST 2.76% (n=256)
NRA 0.13% (n=12)
SRT 0.10% (n=9)
NGT 0.09% (n=8)
DRT 0.06% (n=6)
NKT 0.02% (n=2)
NRS 0.01% (n=1)
STG 0.01% (n=1)
NRN 0.01% (n=1)
NRI 0.01% (n=1)
TRT 0.01% (n=1)
NET 0.01% (n=1)
NRP 0.01% (n=1)
NWT 0.01% (n=1)
HRT 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 2:

NRT 99.26% (n=1346)
NST 0.22% (n=3)
NRI 0.15% (n=2)
DRT 0.15% (n=2)
NRH 0.07% (n=1)
NRA 0.07% (n=1)
NWT 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 2a:

NRT 98.31% (n=290)
NST 1.02% (n=3)
NRI 0.34% (n=1)
NRH 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 2b:

NRT 99.35% (n=459)
DRT 0.43% (n=2)
NRA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 2c:

NRT 99.56% (n=452)
NWT 0.22% (n=1)
NRI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 3:

NST 58.73% (n=2297)
NRT 40.71% (n=1592)
NRA 0.13% (n=5)
NTT 0.10% (n=4)
SRT 0.08% (n=3)
NGT 0.05% (n=2)
-RT 0.05% (n=2)
NGA 0.03% (n=1)
NCT 0.03% (n=1)
SST 0.03% (n=1)
NWT 0.03% (n=1)
NSA 0.03% (n=1)
NQT 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 3a:

NST 57.94% (n=1901)
NRT 41.51% (n=1362)
NRA 0.15% (n=5)
SRT 0.09% (n=3)
NGT 0.06% (n=2)
-RT 0.06% (n=2)
NGA 0.03% (n=1)
NCT 0.03% (n=1)
SST 0.03% (n=1)
NWT 0.03% (n=1)
NSA 0.03% (n=1)
NQT 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 3b:

NST 97.28% (n=394)
NRT 1.73% (n=7)
NTT 0.99% (n=4)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 4:

NRT 99.35% (n=760)
NST 0.39% (n=3)
NGT 0.13% (n=1)
NRI 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 4a:

NRT 99.38% (n=161)
NGT 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 4d:

NRT 99.45% (n=539)
NST 0.37% (n=2)
NRI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 5:

N-- 64.34% (n=83)
NRT 28.68% (n=37)
NS- 4.65% (n=6)
NST 2.33% (n=3)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 6:

NRT 99.32% (n=583)
NST 0.68% (n=4)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Subtype 6a:

NRT 99.70% (n=334)
NST 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 423-425 (antibodies: [AR3A, AR3B, AR3C, AR3D] ), HCV Genotype 7:

NRT 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 522-541 (antibodies: [AR3A] ), HCV Genotype 1:

SGAPTYNWGENDTDVFVLNN 5.07% (n=517)
FGVPTYSWGENETDVLLLNN 3.94% (n=402)
AGAPTYNWGANETDVFVLNN 3.93% (n=401)
AGAPTYRWGANDTDVFVLNN 3.75% (n=382)
SGVPTYSWGGNETDVLLLNN 3.50% (n=357)
SGAPTFNWGENDTDVFVLNN 3.04% (n=310)
SGAPTYNWGDNDTDVFVLNN 2.81% (n=286)
SGAPTYSWGANDTDVFVLNN 2.68% (n=273)
AGAPAYNWGENDTDVFVLNN 2.68% (n=273)
SGAPTYSWGENDTDVFVLNN 2.64% (n=269)
FGAPTYSWGENETDVLLLNN 2.50% (n=255)
SGAPTYNWGENETDVFVLNN 2.37% (n=242)
LGVPTYNWGSNDTDVFVLNN 2.36% (n=240)
AGAPTYNWGENDTDVFVLNN 2.20% (n=224)
SGVPTYRWGENETDVLLLNN 1.89% (n=193)
LGAPTYNWGSNETDVFVLNN 1.70% (n=173)
SGEPTYNWGENDTDVFVLNN 1.49% (n=152)
SGAPTYSWGENETDVFVLNN 1.44% (n=147)
AGVPTYRWGENETDVFVLNN 1.22% (n=124)
FGVPTYTWGENETDVLLLNN 1.22% (n=124)
AGIPTYSWGENDTDVFVLNN 1.13% (n=115)
SGAPTYNWGENATDVFVLNN 1.10% (n=112)
SGAPTYNWGANDTDVFVLNN 1.06% (n=108)
LGVPTYSWGENETDVLLLNN 1.06% (n=108)
FGVPTYRWGENETDVLLLNN 0.92% (n=94)
SGAPTYGWGANDTDVFVLNN 0.90% (n=92)
SGVPTYSWGENETDVLLLNN 0.79% (n=81)
SGVPTYNWGENETDVLLLNN 0.79% (n=81)
LGVPTYTWGGNVTDVLLLNN 0.79% (n=80)
FGAPTYTWGENETDVLLLNN 0.72% (n=73)
SGAPTYNWGDNETDVFLLNN 0.67% (n=68)
SGVPTYRWGENETDVFVLNN 0.63% (n=64)
SGVPTYNWGENETDVFVLNN 0.56% (n=57)
LGAPTYNWGCNDTDVFVLNN 0.56% (n=57)
LGAPTYNWGSNDTDVLVLNN 0.54% (n=55)
SGVPTYNWGSNETDVFVLNN 0.52% (n=53)
SGVPTYNWGENDTDVFVLNN 0.49% (n=50)
LGVPTYNWGDNDTDVFVLNN 0.48% (n=49)
FGVPTYSWGGNETDVLLLNN 0.48% (n=49)
SGVPTYTWGENETDVLLLNN 0.45% (n=46)
LGAPTYNWGSNDTDVFILNN 0.44% (n=45)
TGVPTYNWGENDTDVFVLTN 0.42% (n=43)
LGAPTYNWGENDTDVFVLNN 0.40% (n=41)
SGAPTYTWGENETDVL---- 0.40% (n=41)
LGAPTYNWGSNDTDVFVLNN 0.39% (n=40)
SGAPTYSWGENETDVLLLNN 0.39% (n=40)
LGAPTYSWGENDTDVFVLNN 0.36% (n=37)
SGAPTYNWGENDTDVLVLNN 0.36% (n=37)
LGAPTYNWGSNDTDIFILNN 0.36% (n=37)
LGQPTYNWGENETDVFILNN 0.35% (n=36)
AGAPAYNWGENNTDVFVLNN 0.34% (n=35)
YGVPTYSWGENETDVLLLNN 0.34% (n=35)
SGVPTYNWGANDTDVFVLNN 0.33% (n=34)
AGVPTYNWGENETDVFVLNN 0.32% (n=33)
SGAPTYNWGENDTDVFILNN 0.31% (n=32)
SGAPTYNWGSNDTDVFVLNN 0.31% (n=32)
FGVPTYNWGENETDVLLLNN 0.31% (n=32)
SGVPTYSWGENETDVLVLNN 0.30% (n=31)
MGAPTYNWGENDTDVFVLTN 0.29% (n=30)
FGAPTYNWGENETDVLLLNN 0.29% (n=30)
SGAPTYNWGANDTDIFVLNN 0.27% (n=28)
LGAPTYNWGGKDTDVFVLNN 0.26% (n=27)
LGAPTYNWGGNDTDVLVLNN 0.26% (n=26)
RGAPTYNWGAREEDVFVLNN 0.26% (n=26)
LGAPTYNWGDNDTDVLVLNN 0.25% (n=25)
AGVPTYNWGENDTDVFVLNN 0.24% (n=24)
SGAPTYNWGDNDTDVLVLNN 0.23% (n=23)
RGVPTYSWGENDTDVFILNN 0.23% (n=23)
RGVPTYSWGGNDTDVFILNN 0.23% (n=23)
RGVPTYNWGANDTDVFVLNN 0.23% (n=23)
LGAPTYNWGSNDTDVLILNN 0.23% (n=23)
LGVPTYNWGENDTDVFVLNN 0.22% (n=22)
LGVPTYTWGENETDVLLLNN 0.22% (n=22)
SGAPTYSWGANETDVFVLNN 0.21% (n=21)
SGAPTYSWGENDTDVLVLNN 0.20% (n=20)
SGAPTYSWGANDTDVLVLNN 0.20% (n=20)
SGAPTYNWGENETDVLLLNN 0.20% (n=20)
HGAPTYRWGENETDVLLLNN 0.20% (n=20)
AGVPTYSWGENETDVFVLNN 0.19% (n=19)
SGAPTYNWGANETDVFVLNN 0.19% (n=19)
RGAPTYNWGSNDTDVLVLNN 0.19% (n=19)
LGVPTYGWGSNDTDVFVLNN 0.18% (n=18)
SGVPTYNWGAKETDVFVLNN 0.18% (n=18)
LGAPTYKWGANETDVFILNN 0.18% (n=18)
AGAPAYNWGENVTDVFVLNN 0.18% (n=18)
FGAPTYNWGENETDVLILNN 0.18% (n=18)
FGAPTYNWGENQTDVLLLNN 0.18% (n=18)
LGAPTYTWGSNDTDVFVLNN 0.17% (n=17)
LGHPTYNWGENETDVLLLNN 0.17% (n=17)
LGAPTYNWGANDTDVLVLNN 0.16% (n=16)
AGAPTYNWGANDTDVFVLNN 0.16% (n=16)
SGVPTYNWGADETDVFVLNN 0.16% (n=16)
SGAPTYSWGEKETDVFVLNN 0.16% (n=16)
SGAPTYTWGENETDVLLLNN 0.16% (n=16)
LGAPTYSWGSNETDVFILNN 0.15% (n=15)
LGVPTYNWGANDTDVFVLNN 0.15% (n=15)
SGAPTYRWGANETDVFVLNN 0.15% (n=15)
RGVPTYNWGSNDTDVFVLNN 0.15% (n=15)
LGAPTHTWGANDTDVFILNN 0.15% (n=15)
SGAPTYNWGENDTDVLILNN 0.15% (n=15)
AGTPTYSWGANETDVFVLNN 0.15% (n=15)
AGVPTYSWGENDTDVFVLNN 0.14% (n=14)
AGAPTYNWGSNDTDVFVLNN 0.14% (n=14)
RGAPTYNWGGNDTDVLVLNN 0.14% (n=14)
LGAPTYNWGDNDTDVFVLNN 0.13% (n=13)
AGAPTYNWGENETDVFVLNN 0.13% (n=13)
LGVPTYSWGANDTDFLVLNN 0.13% (n=13)
SGVPTYNWGANVTDVFVLNN 0.12% (n=12)
FGVPTYNWGENETDVLVLNN 0.12% (n=12)
LGVPTYNWGANVTDVFVLNN 0.12% (n=12)
SGVPTYSWGENETDVMLLNN 0.12% (n=12)
SGVPTYSWGKNETDVLVLNN 0.12% (n=12)
MGAPTYNWGENETDVFILNN 0.11% (n=11)
AGAPTYSWGENDTDVFVLNN 0.10% (n=10)
LGDPTYGWGDNDTDVLILNN 0.10% (n=10)
SGVPTYNWGGNETDVFILNN 0.10% (n=10)
LGVPTYNWGTNETDVFVLNN 0.10% (n=10)
SGVPTYNWGANEMDVFVLNN 0.10% (n=10)
LGVPTYTWGENDTDVFVLNN 0.10% (n=10)
SGAPTYNWGEGGTDVFVLNN 0.10% (n=10)
SGAPTYNWGGNKTDVFVLNN 0.10% (n=10)
FGVPTYNWGDNETDVLLLNN 0.10% (n=10)
FGVPTYTWGENKTDVLLLNN 0.10% (n=10)
FGVPTYSWGGNVTDVLLLNN 0.10% (n=10)
SGAPTYTWGENETDVFVLNN 0.09% (n=9)
LGVPTYNWGENDTDVLVLNN 0.09% (n=9)
LGVPTYDWGSNDTDVFVLNN 0.09% (n=9)
SGAPTYSWGANDTDVFVLDN 0.09% (n=9)
SGAPTYNWGENETDVLILNN 0.09% (n=9)
FGVPTYNWGGNETDVLLLNN 0.09% (n=9)
FGAPTYRWGENETDVLLLNN 0.09% (n=9)
HGVPTYSWGENETDVLLLNN 0.09% (n=9)
FGAPTYTWGENETDVLILNN 0.09% (n=9)
SGAPTYNWGENETDVFILNN 0.08% (n=8)
-------------DVFVLNN 0.08% (n=8)
LGVPTYNWGDNDTDVLVLNN 0.08% (n=8)
SGAPTYNWGENDTDVIVLNN 0.08% (n=8)
LGAPTYNWGENDTDVLVLNN 0.08% (n=8)
SGVPTYNWGANKTDVFVLNN 0.08% (n=8)
SGAPTYNWGENKTDVFVLNN 0.08% (n=8)
--------GENETDVLLLNN 0.08% (n=8)
LGVPTYNWGSNDTDVLVLNN 0.07% (n=7)
LGVPTYSWGANNTDVFVLNN 0.07% (n=7)
LGAPTYDWGSNDTDVFILNN 0.07% (n=7)
RGVPTYNWGENDTDVFVLNN 0.07% (n=7)
SGVPTYSWGENETDVFVLNN 0.07% (n=7)
SGAPTYRWGENETDVLLLNN 0.07% (n=7)
FGAPTYSWGENETDVLILNN 0.07% (n=7)
SGAPTYTWGANDTDVFVLNN 0.06% (n=6)
SGAPTYRWGENETDVFVLNN 0.06% (n=6)
AGAPTYNWGENDTDVLVLNN 0.06% (n=6)
LGVPTYNWGANDTDFFVLNN 0.06% (n=6)
RGMPTYSWGENDTDVFILNN 0.06% (n=6)
SGAPTYNWGSNETDVFVLNN 0.06% (n=6)
RGAPTYNWGTREEDVFVLNN 0.06% (n=6)
LGVPTYNWGGNRTDVLLLNN 0.06% (n=6)
FGAPTYNWGNNETDVLLLNN 0.06% (n=6)
FGAPTYNWGANETDVLILNN 0.06% (n=6)
FGVPTYSWGENKTDVLLLNN 0.06% (n=6)
FGVPTYSWGENETDVPLLNN 0.06% (n=6)
SGVPTYSWGENDTDVFVLNN 0.05% (n=5)
TGAPTYNWGANDTDVFVLNS 0.05% (n=5)
AGAPTYNWGANETDVLILTN 0.05% (n=5)
SGTPTYNWGANDTDFFVLNN 0.05% (n=5)
LGAPTYNWGENDTDVLILNN 0.05% (n=5)
SGAPTHSWGENDTDVFVLNN 0.05% (n=5)
SGAPTYNWGANDTDVLVLNN 0.05% (n=5)
SGAPTYSWGEKDTDVFVLNN 0.05% (n=5)
SGVPTYNWGANETDVFVLNN 0.05% (n=5)
SGVPTYSWGENETDVFILNN 0.05% (n=5)
SGAPTHNWGANDTDVFVLNN 0.05% (n=5)
KGAPTYTWGANDTDVFVLNN 0.05% (n=5)
LGVPTYNWGDNETDVFVLNN 0.05% (n=5)
SGVPTYNWGAHETDVFVLNN 0.05% (n=5)
SGAPTYNWGAKETDVFVLNN 0.05% (n=5)
AGAPTYGWGENDTDVFVLNN 0.05% (n=5)
LGVPTFTWGSNNTDVFVLNN 0.05% (n=5)
VGAPTYNWGENETDVFVLNN 0.05% (n=5)
FGVPTYSWGANETDVLLLNN 0.05% (n=5)
SGAPTYTWGENETDVLILNN 0.05% (n=5)
LGVPTYNWGENETDVLLLNN 0.05% (n=5)
FGAPTYNWGGNETDVLLLNN 0.05% (n=5)
SGAPTYSWGENKTDVLLLNN 0.05% (n=5)
FGVPTYAWGGNETDVLLLNN 0.05% (n=5)
SGVPTYTWGENETDVL---- 0.05% (n=5)
FGAPTYSWGENETGVLLLNN 0.05% (n=5)
SGMPTYNWGQNDTDVFVLNN 0.04% (n=4)
SGAPTYNWGVNETDIFILNN 0.04% (n=4)
LGTPTFTWGGSVKDVLVLNN 0.04% (n=4)
LGVPTYTWGGNDTDFLVLNN 0.04% (n=4)
SGAPTYNWGCNETDVFVLNN 0.04% (n=4)
LGAPTYNWGENETDVFVLNN 0.04% (n=4)
LGLPTYNWGENDTDVFVLNN 0.04% (n=4)
SGAPTFSWGENDTDVFVLNN 0.04% (n=4)
LGVPTYNWGGNDTDVLVLNN 0.04% (n=4)
SGAPTYSWGENETDVFILNN 0.04% (n=4)
LGAPTYNWGGNDTDVFVLNN 0.04% (n=4)
LGVPTYRWGENETDVFVLNN 0.04% (n=4)
LGAPTYNWGGNETDVFVLNN 0.04% (n=4)
LGVPTYNWGSDDKDVLVLNN 0.04% (n=4)
MGAPTYNWGENDTDVLVLNN 0.04% (n=4)
LGAPTYNWGENETDVLILNN 0.04% (n=4)
SGVPTYNWGVNKTDVFVLNN 0.04% (n=4)
SGMPTYNWGAKETDVFVLNN 0.04% (n=4)
SGAPTYGWGENDTDVFVLNN 0.04% (n=4)
TGAPTYNWGENDTDVFVLTN 0.04% (n=4)
SGASTYNWGDNDTDVFVLNN 0.04% (n=4)
RGAPTYNWGTQEEDVFVLNN 0.04% (n=4)
RGAPTYNWGTREGDVFVLNN 0.04% (n=4)
FGVPTYKWGENETDVLLLNN 0.04% (n=4)
SGVPT--------------- 0.04% (n=4)
FGVPT--------------- 0.04% (n=4)
FGAPTYNWGDNETDVLILNN 0.04% (n=4)
FGVPTYSWGE---------- 0.04% (n=4)
FGAPTYNWGDNETDVLLLNN 0.04% (n=4)
SGAPTYRWGENETDVLILNN 0.04% (n=4)
SGVPTYSWGENKTDVLLLNN 0.04% (n=4)
FGVPTYSWGENVTDVLLLNN 0.04% (n=4)
SGVPTYKWGENETDVLLLNN 0.04% (n=4)
LGVPTYNWGENETDVLLLNS 0.04% (n=4)
YGVPTYKWGENETDVLLLNN 0.04% (n=4)
YGVPTYTWGENETDVLLLNN 0.04% (n=4)
AGVPTYTWGENETDVLLLNN 0.04% (n=4)
FGAPTYNWGENETDVLILNS 0.04% (n=4)
SGAPTYSWGANETDVLLLNN 0.04% (n=4)
AGVPTYSWGENETDVLLLNN 0.03% (n=3)
LGVATYSWGATDADVFVLNN 0.03% (n=3)
SGAPTYNWGENETDVLVLNN 0.03% (n=3)
AGAPTYNWGANETDVLVLTN 0.03% (n=3)
SGAPTYSWGTNDTDVFVLNN 0.03% (n=3)
LGVPTYTWGGNDTDFFVLNN 0.03% (n=3)
SGAPTYNWGQNETDVFVLNN 0.03% (n=3)
QGAPTYNWGANETDVFVLNN 0.03% (n=3)
AGVPTYTWGEKDTDVFVLNN 0.03% (n=3)
SGLPTYNWGENDTDVFVLNN 0.03% (n=3)
LGAPTYNWGSNSTDVFVLNN 0.03% (n=3)
SGAPTYSWGENVTDVFVLNN 0.03% (n=3)
SGAPTYNWGGNDTDVFVLNN 0.03% (n=3)
SGVPTYTWGENETDVFVLNN 0.03% (n=3)
AGAPTYNWGENDMDVFVLNN 0.03% (n=3)
AGAPTYNWGSNDTDVLVLNN 0.03% (n=3)
AGVPTYNWGSNDTDVFVLNN 0.03% (n=3)
SGAPTYTWGENDTDVFVLNN 0.03% (n=3)
SGAPTYNWGENESDVFVLNN 0.03% (n=3)
LGVPTYSWGENDTDVFVLNN 0.03% (n=3)
LGTPTYNWGENDTDVFVLNN 0.03% (n=3)
SGAPTYTWGENETDVFILNN 0.03% (n=3)
LGAPTYSWGANDTDVFVLNN 0.03% (n=3)
AGVPTYNWGGNDTDVFVLNN 0.03% (n=3)
LGAPTFSWGENDTDVFVLNN 0.03% (n=3)
LGAPTYSWGSNDTDVFILNN 0.03% (n=3)
-----YSWGENDTDVLVLNN 0.03% (n=3)
LGAPTYSWGSNDTDVLVLNN 0.03% (n=3)
AGVPTYNWGGNETDVFVLNN 0.03% (n=3)
SGMPTYNWGGNETDVFVLNN 0.03% (n=3)
SGVPTYDWGSNDVDVFVLNN 0.03% (n=3)
AGVPTYSWGVNDTDVFVLNN 0.03% (n=3)
LGALTYNWGSNDTDIFILNN 0.03% (n=3)
AGAPTYNWGNNDTDVFVLNN 0.03% (n=3)
SGAPTYDWGENETDAFVLNN 0.03% (n=3)
AGAPAYNWGGNDTDVFVLNN 0.03% (n=3)
LGAPTYNWGDNDTDVLLLNN 0.03% (n=3)
SGVPTYTWGENKTDVLLLNN 0.03% (n=3)
FGVPTYTWGANETDVLLLNN 0.03% (n=3)
FGAPTYNWGANETDVLLLNN 0.03% (n=3)
SGVPTYNWGGNETDVLLLNN 0.03% (n=3)
LGVPTYRWGENETDVLLLNN 0.03% (n=3)
SGAPTYTWGANETDVLLLNN 0.03% (n=3)
SGAPTFSWGENETDVLLLNN 0.03% (n=3)
SGAPTYSWGGNETDVLLLNN 0.03% (n=3)
SGVPTYGWGENETDVLLLNN 0.03% (n=3)
FGAPTYNWGANETDVLVLNN 0.03% (n=3)
LGVPTYNWGSNRTDVFVLNN 0.02% (n=2)
LGAPTYNWGGDDTDVLVLNN 0.02% (n=2)
SGVPTYSWGANDTDVFVLNN 0.02% (n=2)
LGVPTYNWGANDTDVLILNN 0.02% (n=2)
AGAPTYSWGGNDTDVFVLNN 0.02% (n=2)
AGAPTYSWGANDTDVFVLNN 0.02% (n=2)
LGAPTFNWGSNDTDVFVLNN 0.02% (n=2)
AGAPTYNWGENETDVLILTN 0.02% (n=2)
SGTPTYNWGANDTYFFVLNN 0.02% (n=2)
SEAPTYNWGENDTDVFVLNN 0.02% (n=2)
LGDPTFGWGGNDTDVLILNN 0.02% (n=2)
LGAPTYNWGENDKDVLILNN 0.02% (n=2)
RGAPTFTFGENETDVFILNN 0.02% (n=2)
AGAPTYSWGENDTDVLVLNN 0.02% (n=2)
FGAPTYNWGENETDVFVLNN 0.02% (n=2)
AGAPTYNWGEDDSDVFVLNN 0.02% (n=2)
LGAPTYSWGSNDSDVFVLNN 0.02% (n=2)
LGVPTYNWGENETDVLVLNN 0.02% (n=2)
LGAPTYNWGGNETDVLVLNN 0.02% (n=2)
AGAPTYNWGDNDTDVFVLNN 0.02% (n=2)
AGVPTYNWGDNDTDVFVLNN 0.02% (n=2)
AGAPTYNWGENDTDVLILNN 0.02% (n=2)
AGVPTYTWGENDTDVFVLNN 0.02% (n=2)
LGAPTYSWGSNDTDVFVLNN 0.02% (n=2)
SGAPTYNWGDNETDVFVLNN 0.02% (n=2)
SGVPTYNWGANETDVLVLNN 0.02% (n=2)
SGAPTYDWGENDTDVFVLNN 0.02% (n=2)
LGAPTYNWGANETDVFVLNN 0.02% (n=2)
AGAPTYSWGENETDVFVLNN 0.02% (n=2)
LGVPTYNWGDSDTDVFVLNN 0.02% (n=2)
SGVPTYNWGENETDVFILNN 0.02% (n=2)
SGAPTYSWGENDTDVFALNN 0.02% (n=2)
AGAPAYNWGANDTDVFVLNN 0.02% (n=2)
TGAPTYNWGANDTDVFVLNN 0.02% (n=2)
SGMPTYNWGENDTDVFVLNN 0.02% (n=2)
VGLAYFQLGYQYHGRFFSNQ 0.02% (n=2)
SGEPTYRWGESEADVFVLNN 0.02% (n=2)
SGAPTYSWGVNDTDVFVLNN 0.02% (n=2)
SGAPTYSWGANDADVFVLNN 0.02% (n=2)
AGVPTYSWGGNDTDVFVLNN 0.02% (n=2)
RGVPTYSWGGTDTDVFILNN 0.02% (n=2)
LGVPTYSWGANDTDFFVLNN 0.02% (n=2)
AGVPTYNWGGNDTDFFVLNN 0.02% (n=2)
SGVPTYNWGAGETDVFVLNN 0.02% (n=2)
SGAPTNNWGENATDVFVLNN 0.02% (n=2)
SGAPTYNWGENHTDVFVLNN 0.02% (n=2)
SGAPTYNWGENVTDVFVLNN 0.02% (n=2)
LGHPTYNWGENETDVFILNN 0.02% (n=2)
MGAPTYNWGENDTDVFVLTD 0.02% (n=2)
TGVPTYTWGENDTDVFVLTN 0.02% (n=2)
SGAPTYNWGENTTDVFVLNN 0.02% (n=2)
SGAPTYNWGGNETDIFVLNN 0.02% (n=2)
SGAPTYNWSENETDVFVLNN 0.02% (n=2)
SGAPTYNWGEEDTDVFVLNN 0.02% (n=2)
AGAPTYKWGANDTDVFVLNN 0.02% (n=2)
AGVPTYRWGENDTDVFVLNN 0.02% (n=2)
RGAPTYDWGAREEDVFVLNN 0.02% (n=2)
RGAPTYNWGIREEDVFVLNN 0.02% (n=2)
RGAPTYNWGANDTDVFVLNN 0.02% (n=2)
LGVPTYTWGNSSTDVFVLNN 0.02% (n=2)
SGAATYSWGSDTKDVFVLNN 0.02% (n=2)
SGAPTYNWGGNETDVLVLNN 0.02% (n=2)
AGAPTYNWGANETDVFLLNN 0.02% (n=2)
LGAPTYNWGANDTDVFVLNN 0.02% (n=2)
LGVPTYNWGCNVTDVFVLNN 0.02% (n=2)
LGAPTYSWGENETDVLILNN 0.02% (n=2)
SGAPTYTWGENDTDVLVLNN 0.02% (n=2)
SGTPTHNWGENETDVFVLNN 0.02% (n=2)
FGVPTYTWGENETDVLFLNN 0.02% (n=2)
FGVPTYSWGVNETDVLLLNN 0.02% (n=2)
SGVPTYSWGENETDMMLLNN 0.02% (n=2)
SGAPTYSWGENETDVMLLNN 0.02% (n=2)
FGVPTYNWGENETDILLLNN 0.02% (n=2)
FGAPTYTWGANETDVLLLNN 0.02% (n=2)
FGAPTYSWGENETDVLLLSN 0.02% (n=2)
FGAPTYSWGENETDVLLFNN 0.02% (n=2)
SGVPTYTWGENETDMLLLNS 0.02% (n=2)
SGAPTYNWGANETDVLLLNN 0.02% (n=2)
SGAPTYNWGGNETDVLLLNN 0.02% (n=2)
FGVPTYSWGENGTDVLLLNN 0.02% (n=2)
LGVPTYSWGGNETDVLLLNN 0.02% (n=2)
VGVPTYSWGENETDVLLLNN 0.02% (n=2)
FGVPTYDWGENETDVLLLNN 0.02% (n=2)
AGVPTYRWGENETDVLLLNN 0.02% (n=2)
FGAPTYQWGENETDVLILNN 0.02% (n=2)
FGVPTYNWGENEADVLLLNN 0.02% (n=2)
FGTPTYTWGENETDVLLLNN 0.02% (n=2)
RGVPTYSWGENETDVLLLNN 0.02% (n=2)
LGAPTYSWGENETDVLLLNN 0.02% (n=2)
SGTPTYNWGENKTDVLILNN 0.02% (n=2)
FGVPTYNWGENQTDVLLLNN 0.02% (n=2)
FGVPTYRWGANETDVLLLNN 0.02% (n=2)
SGVPTYSWGANETDVLLLNN 0.02% (n=2)
FGAPTYNWGVNETDVLILNN 0.02% (n=2)
HGVPTYNWGENETDVLLLNN 0.02% (n=2)
HGVPTYRWGENETDVLLLNN 0.02% (n=2)
LGVPTYTWGENEADVLLLNN 0.02% (n=2)
SGVPTYNWGANETDVLLLNN 0.02% (n=2)
LGAPTYNWGENETDVLLLNN 0.02% (n=2)
FGIPTYTWGENETDVLLLNN 0.02% (n=2)
FGVPTYNWGENETDVLLLNS 0.02% (n=2)
SGVPTYTWGGNETDVLLLNN 0.02% (n=2)
LGVPTYTWGENKTDVLLLNN 0.02% (n=2)
LDVPTYSWGENETDVLLLNN 0.02% (n=2)
HGVPTYTWGENKTDVLLLNN 0.02% (n=2)
YGAPTYNWGGNETDVLLLNN 0.02% (n=2)
FGAPTYNWGGNETDVLILNN 0.02% (n=2)
SGAPTYNWGDNETDVLLLNN 0.02% (n=2)
FGVPTYSWGENATDVLLLNN 0.02% (n=2)
SGVPTYNWGENETDVLILNN 0.02% (n=2)
SGAPTYTWGESETDVL---- 0.02% (n=2)
FGAPTFSWGENETDVLLLNN 0.02% (n=2)
FGVPTFSWGENETDVLLLNN 0.02% (n=2)
SGAPTFNWGENETDVLILNN 0.02% (n=2)
RGVPTYTWGGNKSDVLLLNN 0.02% (n=2)
FGAPTYRWGANETDVLLLNN 0.02% (n=2)
--------GESETDVLPLNN 0.02% (n=2)
FGTPTYNWGENETDVLFLTN 0.02% (n=2)
TGLPTYTWGENETDVFILNS 0.02% (n=2)
LGVPTYSWGTNDTDVFVLNN 0.01% (n=1)
ADVPTYSWGENETDVFVLNN 0.01% (n=1)
AGVPTYSWGENGTDVFVLNN 0.01% (n=1)
AGVPTYSWGENETNVFVLNN 0.01% (n=1)
LGVPTYTWGSNDTDFFVLNN 0.01% (n=1)
LGAPTYTWGSNDTDAFVLNN 0.01% (n=1)
LGAPTYSWGENDTDVFVLND 0.01% (n=1)
LGAPTYSWGENDTDVFVLNT 0.01% (n=1)
LGAPTYSWGENDTDVFILNN 0.01% (n=1)
LGAPTYSWGENDTDVLVLNN 0.01% (n=1)
SGAPTYRWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVFNN 0.01% (n=1)
SGVSTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVPNN 0.01% (n=1)
FGVPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYSWGSNKTDVFILNN 0.01% (n=1)
SGVPTYNWGENDVDVFVLNN 0.01% (n=1)
SGAPTCNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNDTVVFVLNN 0.01% (n=1)
FGVPTYNWCANETGVFVLNN 0.01% (n=1)
LGVPTYNWGANDTDVLVLNN 0.01% (n=1)
LGAPTYNWGANDTDVLVLNY 0.01% (n=1)
AGAPTYSWGENDTDVFVLNS 0.01% (n=1)
AGAPTYSWGGNNADVFVLNN 0.01% (n=1)
SGAPTYNWGNNDTDVFVLNN 0.01% (n=1)
LGVATYSWGANEADVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFALNN 0.01% (n=1)
SGAPTYNWGANDMDVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFVINN 0.01% (n=1)
SGAPT-NWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLDI 0.01% (n=1)
SGAPTYNWGENDTDVLVLNS 0.01% (n=1)
SGAPTYNWGANNTDVFVLNN 0.01% (n=1)
SGVPTYNWGENETDIFILNN 0.01% (n=1)
SGAPTYNWGANETDIFILNN 0.01% (n=1)
LGAPTHDWGSNDTDVFILNN 0.01% (n=1)
LGAPTFTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGANETDVFVLTN 0.01% (n=1)
SGAPTYNWGANETDVLVLTN 0.01% (n=1)
SGAPTYNWGTNDTNVFVLNN 0.01% (n=1)
SGQPTYNWGENETDVFVLNN 0.01% (n=1)
SCAPTYNWGENDTDFFVFKN 0.01% (n=1)
SGAPTYNWGENDADVFVLTN 0.01% (n=1)
SGAPTYNWGENDTDVFALNN 0.01% (n=1)
SEAPTYNWGENDTGVFVLNN 0.01% (n=1)
SEAPTYNWGENDTDVFASNN 0.01% (n=1)
SGAPTYSWGADDTDVFVLNN 0.01% (n=1)
SGVPTYNWGINETDVFVLNN 0.01% (n=1)
LGAPTYNWGCNDTDVIILNN 0.01% (n=1)
LGVPTYTWGGNDTDFSVLNN 0.01% (n=1)
LGDPTYSWGVTDTDVFVLNN 0.01% (n=1)
LGVPTYNWGDNGADVLVLNN 0.01% (n=1)
LDVPTYNWGDNDTDVFVLNN 0.01% (n=1)
LGVPTYN*GDNDTDVFVLNN 0.01% (n=1)
SGAPTYSWVENDTDVFVLNN 0.01% (n=1)
-------------DVFILTN 0.01% (n=1)
-------------DVLVLNN 0.01% (n=1)
WGAPTYNWGANDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFVLTN 0.01% (n=1)
AGAPTYNWGSDTTDVFVLNN 0.01% (n=1)
WGVPTYTCGENDTDVFILNN 0.01% (n=1)
LGAPTFNWGGNETDVFILNN 0.01% (n=1)
MGAPTYNWGANDTDILVLNN 0.01% (n=1)
SGAPTYNWGSNDTDVLVLNN 0.01% (n=1)
RGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
SGAPTFNWGDNDTDVLVLNN 0.01% (n=1)
SGAPTYSWGEHDTDVFVLNN 0.01% (n=1)
VGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGAPTYTWGSNVSDVFVLNN 0.01% (n=1)
LGAPTYTWGSNHSDVFVLNN 0.01% (n=1)
KGSPTYRWGENETDVFILNN 0.01% (n=1)
FGAPTYSWGDNETDVFVLNN 0.01% (n=1)
RGVPTFNWGANDTDVFVLNN 0.01% (n=1)
LGVPTFNWGSNDTDVFVLNN 0.01% (n=1)
QGAPTYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFLLNN 0.01% (n=1)
FGVPTYNWGDNETDVFVLNN 0.01% (n=1)
LGVPTYNWGNTSEDVLVLNN 0.01% (n=1)
LGVPTYSWGSNETDVLVLNN 0.01% (n=1)
SGAPTYNWGGNDTDVFVLTN 0.01% (n=1)
TGAPTYTWGENETDVFVLNN 0.01% (n=1)
LGQPTYNWGENDTDVLVLNN 0.01% (n=1)
SGAPTFNWGENDTDVLVLNN 0.01% (n=1)
SGVPTHSWGENETDVFVLNN 0.01% (n=1)
KGEPTYNWGDNDTDVLVLNN 0.01% (n=1)
SGAPTFNWGQNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGANETDVFVLNS 0.01% (n=1)
SGAPTYSWGVNETDVFVLNN 0.01% (n=1)
AGAPTYNWGENETDVFVLNS 0.01% (n=1)
SGAPTYNWGQNDTDVFVLNN 0.01% (n=1)
LGAPTYSWGANVTDVFVLNN 0.01% (n=1)
LGAPTYSWGENDKDVFVLNN 0.01% (n=1)
AGAPTYSWGSNVTDVFVLNN 0.01% (n=1)
WGAPTYNWGENDTDVFVLNN 0.01% (n=1)
AGAPTFSWGANDTDVFVLNN 0.01% (n=1)
LGAPTYRWGSNDTDVFILNN 0.01% (n=1)
SGAPTYDWGGNVTDVFVLNN 0.01% (n=1)
AGAPTYNWGINDTDVLVLNN 0.01% (n=1)
AGVPTYNWGENATDVFVLNN 0.01% (n=1)
AGVPTYNWGCNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
EGAPTYNWGDNDTDVFVLNN 0.01% (n=1)
KGSPTYSWGENVTDVFVLNN 0.01% (n=1)
SGAPSYNWGENETDVFVLNN 0.01% (n=1)
LGAPTFNWGENDTDVFILNN 0.01% (n=1)
AGVPTYNWGINDTDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVFILNN 0.01% (n=1)
LGVPTYGWGSNDTDVFILNN 0.01% (n=1)
KGAPTYNWGENDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNDSDVFVLNN 0.01% (n=1)
SGAPTYSWGERDRDVFVLNN 0.01% (n=1)
HGAPTYNWGENDTDVFVLNN 0.01% (n=1)
HGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGVPTYSWGSNETDVFVLNN 0.01% (n=1)
QGVPTYNWGANDTDVLVLNN 0.01% (n=1)
LGAPTYDWGANDTDVLVLNN 0.01% (n=1)
LGAPTYDWGRNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVLILNN 0.01% (n=1)
VGVPTYNWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANESDVFVLNN 0.01% (n=1)
SGVPTYSWGADEADVFVLNN 0.01% (n=1)
LGAPTYDWGSNDTDVFVLNN 0.01% (n=1)
RGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGVPTYNFGANQTDVFVLNN 0.01% (n=1)
SGTPTYTWGENETDVFILNN 0.01% (n=1)
AGAPTYNWGESDMDVLVLNN 0.01% (n=1)
LGAPTYNWGSSDKDVLILNN 0.01% (n=1)
SGAPTYTWGENDTDVFILNN 0.01% (n=1)
TGVPTYNWGENDTDVLVLNN 0.01% (n=1)
LGAPTYSWGVNDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNETDVFILNN 0.01% (n=1)
LGVPTYNWGRNDTDFLVLNN 0.01% (n=1)
VGVPTYNWGENDSDVFVLNN 0.01% (n=1)
RGAPTYNWGENDTDVFILNN 0.01% (n=1)
LGVPTYNWGQNDTDVFVLNN 0.01% (n=1)
SGAPTYDWGANDTDVFVLNN 0.01% (n=1)
LGAPTYRWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGRNDTDVFVLNN 0.01% (n=1)
SGAPTFNWGANDTDVFVLNN 0.01% (n=1)
AGAPTYSWGENDTDVFLLNN 0.01% (n=1)
LNTPTFTWGESDKDVFILNN 0.01% (n=1)
RGAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENETDVLVLNN 0.01% (n=1)
PGAPTYNWGANEADVFVLNN 0.01% (n=1)
AGAPTYNWGANETDVFVPNN 0.01% (n=1)
LGAPTYNWGSNNTDVFVLNN 0.01% (n=1)
LGAPTYSWGSDDTDVLVLNN 0.01% (n=1)
AGAPTYSWGENETDVFILNS 0.01% (n=1)
LGVPTYNWGNNDTDVLVLNN 0.01% (n=1)
AGVPTYSWGENDTDVLVLNN 0.01% (n=1)
LGVPTYNWGGNETDVLVLNN 0.01% (n=1)
WGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
MGVPTYNWGENDTDVFVLNN 0.01% (n=1)
SGVPTYNWGTNATDVFVLNN 0.01% (n=1)
VGAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNYTDVFVLNN 0.01% (n=1)
AGAPSYNWGSNDTDVFILNN 0.01% (n=1)
SGQATYSWGEKETDVFVLNN 0.01% (n=1)
RGVPTYTWGEKETDVFVLNN 0.01% (n=1)
LGSPTYRWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENDSDVFVLNN 0.01% (n=1)
LGAPTYNWGENDTDVFILNN 0.01% (n=1)
AGVPTYDWGSNVTDVFVLNN 0.01% (n=1)
LGAPTYDWGSNETDVFILNN 0.01% (n=1)
LGAPTYSWGGKVTDVLVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLND 0.01% (n=1)
LGVPTYGWGENDTDVFVLNN 0.01% (n=1)
AGAPTYDWGSNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGENDTDVFLLNN 0.01% (n=1)
AGVPTYNWGTNDTDVFVLNN 0.01% (n=1)
VGVPTYNWGENDTDVFVLNN 0.01% (n=1)
LGVPTYTWGENDTDVFILNN 0.01% (n=1)
LGAPTYTWGENETDVFVLNN 0.01% (n=1)
SGLPTYNWGANDTDVFVLNN 0.01% (n=1)
LGMPTYNWGENETDVFILNN 0.01% (n=1)
RGVPTYNWGENVTDVFVLNN 0.01% (n=1)
LGVPTHSWGENEADVFVLNN 0.01% (n=1)
GRKPTYSWGADEADVFVLNN 0.01% (n=1)
LGVPTYTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYSWGANETDVFVLNN 0.01% (n=1)
AGAPTYNWGANDTDVLVLNN 0.01% (n=1)
SGVPTYSWGGNETDVFVLNN 0.01% (n=1)
WGVPTYNFGTNETDVFVLNN 0.01% (n=1)
AGAPTYTWGANDTDVFVLNN 0.01% (n=1)
LGAPTFNWGDSDEDVLVLNN 0.01% (n=1)
SGAPSYTWGENETDVLVLNN 0.01% (n=1)
SGAPTYNWGENDTDGFVLNN 0.01% (n=1)
LGTPTYDWGSNDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFILNN 0.01% (n=1)
AGAPTYNWGVNDTDFFVLNN 0.01% (n=1)
SGAPTYRWGENDTDVFLLNN 0.01% (n=1)
SGAPIYSWGEKDTDVFVLNN 0.01% (n=1)
VGAPTYNWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
LGAPTFNWGENESDVFVLNN 0.01% (n=1)
SGAPTYDWGENESDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLNS 0.01% (n=1)
SGAPTYNWGANETDVIILNN 0.01% (n=1)
SGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNNTDVFVLNN 0.01% (n=1)
LGVPTYSWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVIILNN 0.01% (n=1)
SGAPTYNWGANDTDVFVLKN 0.01% (n=1)
FGVPTYSWGENDTDVFLLNN 0.01% (n=1)
SGVPTYTWGERDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGAPTYNWGENETDVLVLNN 0.01% (n=1)
LGAPTYNWGANDSDVFVLNN 0.01% (n=1)
AGVPTLNWGSNETDVFVLNN 0.01% (n=1)
FGVPTYNWGENETDVPVLNN 0.01% (n=1)
FGVPTYNWGENETDVLVPNN 0.01% (n=1)
SGVPTYNWGDNETDVFILNN 0.01% (n=1)
SGVPTYSWGENETDVSILNN 0.01% (n=1)
SGVPTYNWGGNETGVFILNN 0.01% (n=1)
LGALTYNWGSNDTDVFILNN 0.01% (n=1)
LGAPTYNWGSNVTDVFILNN 0.01% (n=1)
LGAPTYNWGSNDTGIFILNN 0.01% (n=1)
SGAPTYNWGENDTDALILNN 0.01% (n=1)
SGAPTHNWGASDTDVFVLNN 0.01% (n=1)
LGVPIYGWGSNDTDVFVLNN 0.01% (n=1)
SGAATYSWGENDTDVFVLNN 0.01% (n=1)
-----YSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGEYDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVLNS 0.01% (n=1)
SGAPTYS*GENDTDVFVLNN 0.01% (n=1)
SGGPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVSVLNN 0.01% (n=1)
SGAPTYSWGENDTGIFVLNN 0.01% (n=1)
SGAPTCSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVYVLNN 0.01% (n=1)
PGAPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYGRGENDTDVFVLNN 0.01% (n=1)
SGAPTYSRGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGGNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
SGAPTHNWGENDTDVFVLNN 0.01% (n=1)
AGAPTYNWGENGTDVLVLNN 0.01% (n=1)
AGVPTYNWGEDDTDVLVLNN 0.01% (n=1)
LGAPTYNWGANDTDVLLLNN 0.01% (n=1)
LGAPTYNWGDNQTDVFILNN 0.01% (n=1)
LGAPTYKWGANDTDVLLLNN 0.01% (n=1)
LGAPTYNWGANDTDVFLLNN 0.01% (n=1)
LGAPTYNWGANETEVFLLNN 0.01% (n=1)
TGALTYNRGANDTDVFVLNN 0.01% (n=1)
AGVPTHNWGENETDVFVLNN 0.01% (n=1)
LGAPTYRWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENETDIFVLNN 0.01% (n=1)
AGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGVPTYDWGSSDVDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTAVFVLNN 0.01% (n=1)
SGAPTYSWGANGTDVFVLND 0.01% (n=1)
SGAPTCSWGATDTDVFVLNN 0.01% (n=1)
SGAPTYSWGVNDTGVFVLNN 0.01% (n=1)
SGAPTYSRGANDTDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTGVFVLNN 0.01% (n=1)
SGAPTYSWGANDTDVFVLNS 0.01% (n=1)
SGAPTYSWGANDTDAFVLNN 0.01% (n=1)
SGAPAYSWGANDTDVFVLNN 0.01% (n=1)
SGTPTYSWGANDTDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTDVFVLND 0.01% (n=1)
LGVPTYSWGANDTDFFLLSN 0.01% (n=1)
RGVPTYNWGENDTDFFLLNN 0.01% (n=1)
AGVPTYSWGVNDKDVFVLNN 0.01% (n=1)
RGVPTYNWGGNDTDVFILNN 0.01% (n=1)
SGVPTYNWGAKKTDVFVLNN 0.01% (n=1)
SGAPTYNWGAHETDVFVLNN 0.01% (n=1)
SGVPTYNWGTNVTDVFVLNN 0.01% (n=1)
SGVPTYNWGADKTDVFVLNN 0.01% (n=1)
LGVPTYNWGADETDVFVLNN 0.01% (n=1)
SGVPTYNWGANEKDVFVLNN 0.01% (n=1)
SGVPTYNWGAKQTDVFVLNN 0.01% (n=1)
SGVPTYNWGARETDVFVLNN 0.01% (n=1)
SGAPTYNWGASETDVFVLNN 0.01% (n=1)
SGAPTYNWGATETDVFVLNN 0.01% (n=1)
LGVPTYNWGTNETDIFVLNN 0.01% (n=1)
SGVPTYNWGTNKTDVFVLNN 0.01% (n=1)
SGAPTCSWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGDNEADVFLLNN 0.01% (n=1)
SGAPTYSWGANDTDIFVLNN 0.01% (n=1)
SGAPTYNWGVNDTDIFVLNN 0.01% (n=1)
SGAPTYNWGGNATDVFVLNN 0.01% (n=1)
SGAPTHNWGENETDVFVLNN 0.01% (n=1)
SGVPTYSWGENETDVFVLIN 0.01% (n=1)
SGAPTYNWGEDDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANETDVIVLN- 0.01% (n=1)
WGAPAYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDSDVFVLNN 0.01% (n=1)
MGAPTYSWGENDTDVFVLTN 0.01% (n=1)
LGAPTYNWGGNVTDVLVLNN 0.01% (n=1)
LGAPTYNWGCND-------N 0.01% (n=1)
AGVPTYRWGKNETDVFVLNN 0.01% (n=1)
SGEPTYYWGENDTDVFVLNN 0.01% (n=1)
SGAPTYDWGVNDTDVFVLNN 0.01% (n=1)
SGVPTYSWGSNATDVFVLNN 0.01% (n=1)
RGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGSPTYSWGENDTDVFVLNN 0.01% (n=1)
SGVPTYDWGENDTDVFVLNN 0.01% (n=1)
SGTPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGSNDTDVFVLNN 0.01% (n=1)
RGVPTYSWGESEADVFVLNN 0.01% (n=1)
LGAPTYNWGRNDTDVLVLNN 0.01% (n=1)
LGAPTYRWGTNDTDVFVLNN 0.01% (n=1)
RGVPTYTWGANETDVFVLNN 0.01% (n=1)
LGSPTYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGDNDTDVLVLNN 0.01% (n=1)
RGVPTYNWGANITDVFVLNN 0.01% (n=1)
LGAPTYTWGDNDTDVFILNN 0.01% (n=1)
SGAPTYSWGANDTDVFVPNN 0.01% (n=1)
LGAPTYSWGSDNTDVFVLNN 0.01% (n=1)
KGIPTYTWGENETDVFILNN 0.01% (n=1)
VGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGAPTYSWGDNDTDVLILNN 0.01% (n=1)
SGHPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNITDVLVLNN 0.01% (n=1)
AGAPTYNWGQNETDVFVLNN 0.01% (n=1)
LSAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGVPTYAWGANETDVFVLNN 0.01% (n=1)
QGAPTYSWGANDTDVFVLNN 0.01% (n=1)
RGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
AGAPTYTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGETDKDVFVLNN 0.01% (n=1)
LGVPTYSWGSNDTDVFVLNN 0.01% (n=1)
AGVPTYTWGENETDVFVLNN 0.01% (n=1)
SGVPTYRWGVNETDVFVLNN 0.01% (n=1)
LGAPTYNWGANMTDVLVLNN 0.01% (n=1)
FGAPTYSWGANETDVFVLNN 0.01% (n=1)
FGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVPNN 0.01% (n=1)
SGAPTYTWGGNDTDVFVLNN 0.01% (n=1)
-GAPTYNWGDNDTDVFVFNN 0.01% (n=1)
SGAPTYNWGENDADVFVLNN 0.01% (n=1)
WGAPTYNWGVNETDVFVLNN 0.01% (n=1)
SGAPAYNWGENDTDVFVLNN 0.01% (n=1)
LGIPTYSWGGNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFLLNN 0.01% (n=1)
VGAPTYNWGANDTDVIILNN 0.01% (n=1)
SSAPTYSWGANDTDVLVLNN 0.01% (n=1)
SGAPTYSWGANNTDVFVLDN 0.01% (n=1)
LGAPTYNWGSNDTDIFVLNN 0.01% (n=1)
LGAPTYNWGDNDTDVLILNN 0.01% (n=1)
SGAPTYSWGENEKDVFVLNN 0.01% (n=1)
SGVPTYNWGENETDIFVLNN 0.01% (n=1)
LGAPTYNWGSNDTDVFLLNN 0.01% (n=1)
LGVPTYNWGSNNTDVFVLNN 0.01% (n=1)
SGVPTYNWGSNDTDVFVLNN 0.01% (n=1)
AGTPTYNWGENDTDVFVLNN 0.01% (n=1)
RGVPTYNWGANDTDVSVLNN 0.01% (n=1)
LGAPTYSWGENETDVFVLNN 0.01% (n=1)
SGVPTYNWVSNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGENVTDVFVLNN 0.01% (n=1)
LGAPTYNWGNNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGDNDTDVFILNN 0.01% (n=1)
LGAPTYNWGEQDTDVFVLNN 0.01% (n=1)
TGVPTYNWGENESDVFVLNN 0.01% (n=1)
QGVPTYNWGENDTDVFVLNN 0.01% (n=1)
WGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGAPTYTWGENDTDVFVLNN 0.01% (n=1)
SGAPTYDWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENETDAFVLNN 0.01% (n=1)
LGAPTYRWGENEKDVFVLNN 0.01% (n=1)
LGVPTYNWGANETDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVFVLNG 0.01% (n=1)
SGVPTYTWGENESDVFVLNN 0.01% (n=1)
RGAPTYNWGENDTDVLILNN 0.01% (n=1)
LGAPTYNWGASDTDVFVLNN 0.01% (n=1)
LGAPTYNWGANVTDVLILNN 0.01% (n=1)
LGAPTYNWGSNDTDVFVLYN 0.01% (n=1)
WGVPTYTWGSSDADVFILNN 0.01% (n=1)
LGAPTYNWGSNETDVLVLNN 0.01% (n=1)
AGAPTYTWGENETDVFVLNN 0.01% (n=1)
FGAPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYNWGGNDADVLVLNN 0.01% (n=1)
YGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
LGAPTHTWGANETDVFILNN 0.01% (n=1)
LGVPTYSWGANDTDVFVLNN 0.01% (n=1)
SGVPTYSWGENETDVFLLNN 0.01% (n=1)
SGAPTYNWGGGDTDVFVLNN 0.01% (n=1)
SGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
SGAPTYRWGENETDVLVLNN 0.01% (n=1)
SGTPTFSWGENDTDVFVLNN 0.01% (n=1)
SGGPTYNWGRKDTDVLVLNN 0.01% (n=1)
SGAPTYNWGMNDTDVLVLNN 0.01% (n=1)
TGAPTYDWGANETDVFVLNS 0.01% (n=1)
SGAPTYNWGGNETDVFVLNN 0.01% (n=1)
LGVPTYNWGENATDVFVLNN 0.01% (n=1)
LGAPTYNWGDNDTDVFILNN 0.01% (n=1)
SGAPTYRWGENETDVFLLNN 0.01% (n=1)
SGAPTYNWGVNDTDVFVLNN 0.01% (n=1)
LGAPTFNWGANDTDVLVLNN 0.01% (n=1)
SGVPTYNWGDNDTDVLVLNN 0.01% (n=1)
AGAPAYNWGENDTDVFVPNN 0.01% (n=1)
VGAPAYNWGENDTDVFVLNN 0.01% (n=1)
AGAPAYNWGENDTDVIVLNN 0.01% (n=1)
AGAPSYNWGENDTDVFVLNN 0.01% (n=1)
AGAPAYNWGKNDTDVFVLNN 0.01% (n=1)
AGAPAYNWGENATDVFVLNN 0.01% (n=1)
AGVPAYNWGENDTDVFVLNN 0.01% (n=1)
LGAPTSVRGENGTDVLLLNN 0.01% (n=1)
FGAPTYNWGENETDVLLLNS 0.01% (n=1)
FGAPTYSWGENETDVLLLNS 0.01% (n=1)
LGVRTYNWGENETDVLLLNN 0.01% (n=1)
SGAPTYNWGANETDVLYLNN 0.01% (n=1)
SGAPTYSWGENETDVLLLNS 0.01% (n=1)
LGNPTYSWGENDTDVLLLNN 0.01% (n=1)
LGVPTYSWGENVTDVLLLNN 0.01% (n=1)
FGAPTYKWGENETDVLILNN 0.01% (n=1)
SGVPTYNWGVNESDVLLLNN 0.01% (n=1)
FGVPTYNWGENETDVLYLNN 0.01% (n=1)
TGAPTYRWGENETDVLILNN 0.01% (n=1)
FGVRT--------------- 0.01% (n=1)
SSVPT--------------- 0.01% (n=1)
FSVPT--------------- 0.01% (n=1)
FGTPTYSWGENETDVLLLNN 0.01% (n=1)
FGARKYSWGENETDVLLLNN 0.01% (n=1)
FGASTYSWGENETDVLLLNN 0.01% (n=1)
FGAPTYSWGENETNVLLLNN 0.01% (n=1)
HGVPTYSWGENGTDVLLLNN 0.01% (n=1)
SGVPTYRWGDNETDVLLLNN 0.01% (n=1)
FGAPTYNWGENKTDVLLLNN 0.01% (n=1)
SGAPTYTWGENETDVMILNN 0.01% (n=1)
SGTPTYRWGENETDVLILNS 0.01% (n=1)
FGAPTYSWRENETDVLLLNN 0.01% (n=1)
FGPPTYSWGENETDVLLLNN 0.01% (n=1)
YGAPTYTWGVNETDVLILNN 0.01% (n=1)
FGAPTYSWGANETDVLILNN 0.01% (n=1)
LGVPTYTWGENETNVLLLNN 0.01% (n=1)
FGVPTYRWGENETDVLLLKN 0.01% (n=1)
FGVPTYRWGENETDVLLPKK 0.01% (n=1)
FGVPTYRWGEKETDVLLLNN 0.01% (n=1)
FGVSTYTWGENETDVLLLNN 0.01% (n=1)
FGVPTYSWGENKTDVLLLKK 0.01% (n=1)
FGVPTYRWGEIETDVLLLNN 0.01% (n=1)
SGVPTYSWGGNETDVLLLKN 0.01% (n=1)
PGVPTYSWGGNETDVLLLNN 0.01% (n=1)
SGVPTYSGRGIETDVRFLKN 0.01% (n=1)
PGVPTYMWGEYETDVLSLKN 0.01% (n=1)
SGVPTYSWGGNETDMLFLKN 0.01% (n=1)
SGVPTYSWGGIKPDVLLLKK 0.01% (n=1)
SGVPTYSWGGNETDVLRLKK 0.01% (n=1)
SGVPTYSWGGNRTDVLLLNN 0.01% (n=1)
F------------------- 0.01% (n=1)
FGVPTYSWGENETDVLVLNN 0.01% (n=1)
YGVPTYSWGENDTDVLLLNN 0.01% (n=1)
SSVPTYRWGENETDVLLLNN 0.01% (n=1)
FGVPTYSWGENETCVLLLNN 0.01% (n=1)
FGAPTYRWGENETDVLILNN 0.01% (n=1)
FGAPTYTWGENVTDVLILNN 0.01% (n=1)
SGVPTYTWGGNKTDVLLLNN 0.01% (n=1)
HGVPTFTWGEKETDVLLLNN 0.01% (n=1)
TGVPTYSWGGNKTDVLLLNN 0.01% (n=1)
YGAPTYSWGENETDVLLLNN 0.01% (n=1)
LGAPTYNWGGNETDVLILNN 0.01% (n=1)
LGNPTYTWGGNETDVLLLNN 0.01% (n=1)
LGDPTYNWGENETDVLLLNN 0.01% (n=1)
LGVPTYNWGENGSDVLLLNN 0.01% (n=1)
FGVPTHNWGGNASDVLLLNN 0.01% (n=1)
FGVPTYNWGGNVTDVLLLNN 0.01% (n=1)
FGVPTYNWGENETDVLFLNN 0.01% (n=1)
FGAPTYSWGVNETDVLLLNN 0.01% (n=1)
YGAPTYTWGENETDVLILNN 0.01% (n=1)
LGAPTYNWGENVTDVLILNN 0.01% (n=1)
LGVPTYGWGANETDVLLLNN 0.01% (n=1)
LGVPTYSWGANETDVLLLNN 0.01% (n=1)
FGAPTFTWGENVTDVLLLNN 0.01% (n=1)
SGVPTYDWGGNETDVLLLNN 0.01% (n=1)
FGVPTYRWGGNETDVLLLNN 0.01% (n=1)
HGVPTYTWGANETDVLLLNN 0.01% (n=1)
SGAPTYTWGENETDVLILNS 0.01% (n=1)
FGNPTYNWGENKTDVLLLNN 0.01% (n=1)
SGDPTYNWGGNETDVLLLNN 0.01% (n=1)
CGVPTYSWGENKTDVLLLNN 0.01% (n=1)
SGAPTYRWGANESDVLILNN 0.01% (n=1)
YGVPTYSWGGNKTDVLLLNN 0.01% (n=1)
FGAPTYNWGENETDVLLLDN 0.01% (n=1)
SGAPTYNWGDNETDVLILNN 0.01% (n=1)
SGVPTYDWGENETDVLLLNN 0.01% (n=1)
FGVPTYNWGENATDVLLLNN 0.01% (n=1)
LGVPTYRWGENETDVLLLNS 0.01% (n=1)
FGVPTYNWGANETDVLLLNN 0.01% (n=1)
LGAPTYAWGGNETDVLLLNN 0.01% (n=1)
SGVPTYGWGANETDVLLLNN 0.01% (n=1)
SGNPTYTWGENATDVLLLNN 0.01% (n=1)
FGAPTYNWGENETDVLVLNN 0.01% (n=1)
SGAPTYNWGGNETDVLILNN 0.01% (n=1)
VGVPTYTWGENETDVLLLNN 0.01% (n=1)
FGVPTCTWGENETDVLLLNN 0.01% (n=1)
FGVPTYTWEENETDVLLLNN 0.01% (n=1)
FGAPTYSWGENGTDVLLLNN 0.01% (n=1)
FGAPTYSWGANETDVLILNS 0.01% (n=1)
YGAPTYTWGENETDVLLLNN 0.01% (n=1)
SGVPTYNWGENETDVLFLNN 0.01% (n=1)
SGTPTYNWGGNETDVLLLNN 0.01% (n=1)
SGAPTYNWGVNETDVLILNN 0.01% (n=1)
HGAPTYSWGENETDVLILNN 0.01% (n=1)
LGVPTYSWGGNTSDVLLLNN 0.01% (n=1)
SGAPTYTWGENKTDVLLLNN 0.01% (n=1)
RGAPTYNWGENATDVLVLNN 0.01% (n=1)
LGVPTYSWGGNKSDVLLLNN 0.01% (n=1)
YGAPTYNWGENETDVLLLNN 0.01% (n=1)
LGVPTYNWGENATDVLLLNN 0.01% (n=1)
TGAPTYNWGENETDVLLLNN 0.01% (n=1)
SGAPTYNWGANETDVLVLNN 0.01% (n=1)
--------------VLFLNN 0.01% (n=1)
RGVPTYNWGGNVTDVLLLNN 0.01% (n=1)
FGTATFNWGGNETDVLLLNN 0.01% (n=1)
FGVPTYSWGDNETDVLLLNN 0.01% (n=1)
LGVPTYNWGENKSDVLLLNN 0.01% (n=1)
HGVPTYNWGDNETDVLLLNN 0.01% (n=1)
FGVPTYAWGANETDVLLLNN 0.01% (n=1)
SGAPTYTWGTNESDVLLLNN 0.01% (n=1)
LGVPTYSWGDNETDVLLLNN 0.01% (n=1)
LGVPTYSWGENEADVLLLNN 0.01% (n=1)
FGVPSYRWGENETDVLLLNN 0.01% (n=1)
HGVPTYTWGENETDVLLLNN 0.01% (n=1)
LGVPTYTWGGNETDVLLLNN 0.01% (n=1)
FGAPTYTWGANETDVLYLNN 0.01% (n=1)
SGVPTYSWGENETDVLILNN 0.01% (n=1)
FGAPTYKWGENETDVLLLNN 0.01% (n=1)
SGVPTYNWGVNETDVLLLNN 0.01% (n=1)
FGVPTYTWGDNETDVLLLNN 0.01% (n=1)
SGVPTYRWGENETDVLLPNN 0.01% (n=1)
SGVPTYRWGENGTDVLLLNN 0.01% (n=1)
YGVPTYNWGGNETDVLLLNN 0.01% (n=1)
LGAPTYNWGENETDVLLLNS 0.01% (n=1)
SSRRSYILGENETDVLLLNN 0.01% (n=1)
FGVPTYSWGENETNVLLLNN 0.01% (n=1)
SGVPTYRWGENETDVLLFNN 0.01% (n=1)
FGVPTYSWGENETDVLLPNN 0.01% (n=1)
FGVPTYRWGDNETDVLLLNN 0.01% (n=1)
FGAPTYNWGVNETDVLLLNN 0.01% (n=1)
AGVPTYNWGENETDVLLLNN 0.01% (n=1)
FGVPTYTWGGNASDVLLLNN 0.01% (n=1)
LGVPTYSWGGNATDVLLLNN 0.01% (n=1)
LGVPTYSWGENKSDVLLLNN 0.01% (n=1)
SGAPTYTWGGNETDVLLLNN 0.01% (n=1)
RGVPTYSWGENDTDVLLLNN 0.01% (n=1)
SGVPTYNWGDNETDVLLLNN 0.01% (n=1)
LGLPTYNWGENETDVLLLNN 0.01% (n=1)
RGVPTYSWGANETDVLLLNN 0.01% (n=1)
FGAPTYRWGENESDVLILNN 0.01% (n=1)
FGVPTYNWGANQTDVLLLNN 0.01% (n=1)
FGIPTYSWGENETDVLLLNN 0.01% (n=1)
SGAPTYHWGENKTDVLLLNN 0.01% (n=1)
FGAPTYNWGENATDVLVLNN 0.01% (n=1)
LGVPTYSWGENKTDVLLLNN 0.01% (n=1)
RGVPTYRWGENSSDVLLLNN 0.01% (n=1)
RGVPTYSWGENETDVLVLNN 0.01% (n=1)
HGVPTFSWGENETDVLLLNN 0.01% (n=1)
FGVPTYSWGANKTDVLLLNN 0.01% (n=1)
FGVPTYSWGENETDVLFLNN 0.01% (n=1)
FGAPTYSWGGNETDVLLLNN 0.01% (n=1)
LGVPTYTWGANETDVLLLNN 0.01% (n=1)
FGTPTYTWGENKTDVLLLNN 0.01% (n=1)
LGAPTYTWGENATDVLLLNN 0.01% (n=1)
RGVPTYSWGGNKTDVLLLTN 0.01% (n=1)
SGVPTYTWGDNETDVLLLNN 0.01% (n=1)
YGAPTYNWGENETDVLILNN 0.01% (n=1)
FGNPTYRWGENKTDVLLLNN 0.01% (n=1)
SGAPTYTWGENETDVMILNS 0.01% (n=1)
SGVPTYSWGESETDVLLLNN 0.01% (n=1)
FGAPTYTWGGNETDVLLLNN 0.01% (n=1)
SGVPTYRWGENKTDVLLLNN 0.01% (n=1)
HGDPTYTWGGNETDVLLLNN 0.01% (n=1)
LGVPTYTWGENETDVLVLNN 0.01% (n=1)
SGVPTYTWGENQTDVLLLNN 0.01% (n=1)
FGTPTYTWGENGTDVLLLNN 0.01% (n=1)
RGVPTYNWGGNETDVLLLNN 0.01% (n=1)
SGTPTYTWGENKTDVLLLNN 0.01% (n=1)
SGVPTYTWGENETDVLFLNN 0.01% (n=1)
FGVPTYNWGANETDVLYLNN 0.01% (n=1)
SGAPTYNWGANETDVLILNN 0.01% (n=1)
SGVPTYTWGTNETDVLFLNN 0.01% (n=1)
FGVPTYNWGENVTDVLLLNN 0.01% (n=1)
SGAPTYSWGENKTDVLILNN 0.01% (n=1)
LGAPTYNWGANETDVLVLNN 0.01% (n=1)
VGVPTYNWGENETDVLLLNN 0.01% (n=1)
FGAPTYRWGANETDVLILNN 0.01% (n=1)
RGVPTYTWGVNETDVLLLNN 0.01% (n=1)
HGVPTYDWGENETDVLLLNN 0.01% (n=1)
FGAPTYSWGGNETDVLILNN 0.01% (n=1)
SGAPTYGWGENETDVLLLNN 0.01% (n=1)
FGVPTYSWGENETDVLHLNN 0.01% (n=1)
FGVPTYSWGEDETDVLLLNN 0.01% (n=1)
FGAPTYSRGENEADVLLLNN 0.01% (n=1)
FGAPTYSWGENETDALLLNN 0.01% (n=1)
SGVPTYQWGENKTDVLLLNN 0.01% (n=1)
DGVPTYGWGGNETDVLLLNN 0.01% (n=1)
FGVPTYSWGENQTDVLLLNN 0.01% (n=1)
FGVPTYTWGENETGVLLLNN 0.01% (n=1)
SGVPTYSWGRNETDVLVLNN 0.01% (n=1)
SGVPTYSWGKNETDVLVLDN 0.01% (n=1)
SGVPTYSWGKNETDMLVLNN 0.01% (n=1)
FGVPTHTWGENETDVLLLNN 0.01% (n=1)
FGAPTYNWGENETDVL-LNN 0.01% (n=1)
PGVPTYSWGKNETDVLVLNN 0.01% (n=1)
SGVPTYSWGENETDALVLNN 0.01% (n=1)
SGAPTHTWGENETDVL---- 0.01% (n=1)
FGVPTYSWGENESDVLLLNN 0.01% (n=1)
FGVPTYSWGENETDVLPLNN 0.01% (n=1)
FGAPTYTWGENGTDVLLLNN 0.01% (n=1)
FGAPTYTWGRNETDVLLLNN 0.01% (n=1)
FGAPTYTWGESETDVLLLNN 0.01% (n=1)
FGAPTYRRGGNETDVLLLNN 0.01% (n=1)
FGAPTFTWGENETDVLLLNN 0.01% (n=1)
FGVPTYNWGGNATDVLLLNN 0.01% (n=1)
SGTPTFSWGENETDVLLLNN 0.01% (n=1)
SGVPTFSWGENDTDVLLLNN 0.01% (n=1)
SGTPTYSWGENVTDVLLLNN 0.01% (n=1)
FGTPTFSWGENQTDVLLLNN 0.01% (n=1)
SGAPTFSWGEKETDVLLLNN 0.01% (n=1)
SGVPTFSWGENETDVLLLNN 0.01% (n=1)
FGAPTYAWGENETDVLLLNN 0.01% (n=1)
SGVPTYNWGENVTDVLLLNN 0.01% (n=1)
FGVPTYQWGENESDVLLLNN 0.01% (n=1)
FGAPTYSWGENETDVLLQNN 0.01% (n=1)
YGAPTFSWGENETDVLLLNN 0.01% (n=1)
--------GENEIDVLLLNN 0.01% (n=1)
--------GENESDVLLLNN 0.01% (n=1)
AGVPTYTWGGNETDVLLLNN 0.01% (n=1)
--------GENEIDVLILNN 0.01% (n=1)
--------GENETDVLILNN 0.01% (n=1)
FGVPTYRWGENETDALLLNN 0.01% (n=1)
AGVPTYRWGANETDVLLLNN 0.01% (n=1)
AGVPTYTWGENETDILLLNN 0.01% (n=1)
TGVPTYSWGENETDVLLLNN 0.01% (n=1)
TGVPTYNWGENETDVLLLNN 0.01% (n=1)
AGVPTYTWGANDSDVVVLNS 0.01% (n=1)
QGLPTYNWGANVSDVVILNS 0.01% (n=1)
RGAPTYTWGENETDVFILNN 0.01% (n=1)
SGNPTFTSGANDTDFFLLNN 0.01% (n=1)
RGNPTFNSGANDTDFFLLNN 0.01% (n=1)
SGNPTFNSGANDTDFFLLNN 0.01% (n=1)
LGVPTYTWGEHESDVFLLNN 0.01% (n=1)
EGVPTYTWGENETDVFVLNN 0.01% (n=1)
KGVPTYEWGEGASDVIILNN 0.01% (n=1)
KGNPTYRWGENETDVIILNN 0.01% (n=1)
RGVPTYNWGENETDVFLLNN 0.01% (n=1)
TGMPTYTSGANETDFLLLNN 0.01% (n=1)
TGAPTFTSGANDTDFLLLNN 0.01% (n=1)
LGAPTYTWGENDTDVLLLNN 0.01% (n=1)
RGVPTYSWGENETDVFILNT 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 1a:

SGAPTYNWGENDTDVFVLNN 7.12% (n=517)
AGAPTYNWGANETDVFVLNN 5.52% (n=401)
AGAPTYRWGANDTDVFVLNN 5.26% (n=382)
SGAPTFNWGENDTDVFVLNN 4.27% (n=310)
SGAPTYNWGDNDTDVFVLNN 3.94% (n=286)
SGAPTYSWGANDTDVFVLNN 3.76% (n=273)
AGAPAYNWGENDTDVFVLNN 3.76% (n=273)
SGAPTYSWGENDTDVFVLNN 3.71% (n=269)
SGAPTYNWGENETDVFVLNN 3.32% (n=241)
LGVPTYNWGSNDTDVFVLNN 3.31% (n=240)
AGAPTYNWGENDTDVFVLNN 3.09% (n=224)
LGAPTYNWGSNETDVFVLNN 2.38% (n=173)
SGEPTYNWGENDTDVFVLNN 2.09% (n=152)
SGAPTYSWGENETDVFVLNN 2.02% (n=147)
AGVPTYRWGENETDVFVLNN 1.71% (n=124)
AGIPTYSWGENDTDVFVLNN 1.58% (n=115)
SGAPTYNWGENATDVFVLNN 1.54% (n=112)
SGAPTYNWGANDTDVFVLNN 1.49% (n=108)
SGAPTYGWGANDTDVFVLNN 1.27% (n=92)
SGAPTYNWGDNETDVFLLNN 0.90% (n=65)
SGVPTYRWGENETDVFVLNN 0.88% (n=64)
SGVPTYNWGENETDVFVLNN 0.79% (n=57)
LGAPTYNWGCNDTDVFVLNN 0.79% (n=57)
LGAPTYNWGSNDTDVLVLNN 0.76% (n=55)
SGVPTYNWGSNETDVFVLNN 0.73% (n=53)
SGVPTYNWGENDTDVFVLNN 0.69% (n=50)
LGVPTYNWGDNDTDVFVLNN 0.67% (n=49)
LGAPTYNWGSNDTDVFILNN 0.62% (n=45)
TGVPTYNWGENDTDVFVLTN 0.59% (n=43)
LGAPTYNWGENDTDVFVLNN 0.56% (n=41)
LGAPTYNWGSNDTDVFVLNN 0.55% (n=40)
LGAPTYSWGENDTDVFVLNN 0.51% (n=37)
SGAPTYNWGENDTDVLVLNN 0.51% (n=37)
LGAPTYNWGSNDTDIFILNN 0.51% (n=37)
LGQPTYNWGENETDVFILNN 0.50% (n=36)
AGAPAYNWGENNTDVFVLNN 0.48% (n=35)
SGVPTYNWGANDTDVFVLNN 0.47% (n=34)
AGVPTYNWGENETDVFVLNN 0.45% (n=33)
SGAPTYNWGENDTDVFILNN 0.44% (n=32)
SGAPTYNWGSNDTDVFVLNN 0.44% (n=32)
MGAPTYNWGENDTDVFVLTN 0.41% (n=30)
SGAPTYNWGANDTDIFVLNN 0.39% (n=28)
LGAPTYNWGGKDTDVFVLNN 0.37% (n=27)
LGAPTYNWGGNDTDVLVLNN 0.36% (n=26)
RGAPTYNWGAREEDVFVLNN 0.36% (n=26)
LGAPTYNWGDNDTDVLVLNN 0.34% (n=25)
AGVPTYNWGENDTDVFVLNN 0.33% (n=24)
SGAPTYNWGDNDTDVLVLNN 0.32% (n=23)
RGVPTYSWGENDTDVFILNN 0.32% (n=23)
RGVPTYSWGGNDTDVFILNN 0.32% (n=23)
RGVPTYNWGANDTDVFVLNN 0.32% (n=23)
LGAPTYNWGSNDTDVLILNN 0.32% (n=23)
LGVPTYNWGENDTDVFVLNN 0.30% (n=22)
SGAPTYSWGANETDVFVLNN 0.29% (n=21)
SGAPTYSWGENDTDVLVLNN 0.28% (n=20)
SGAPTYSWGANDTDVLVLNN 0.28% (n=20)
AGVPTYSWGENETDVFVLNN 0.26% (n=19)
SGAPTYNWGANETDVFVLNN 0.26% (n=19)
RGAPTYNWGSNDTDVLVLNN 0.26% (n=19)
LGVPTYGWGSNDTDVFVLNN 0.25% (n=18)
SGVPTYNWGAKETDVFVLNN 0.25% (n=18)
LGAPTYKWGANETDVFILNN 0.25% (n=18)
AGAPAYNWGENVTDVFVLNN 0.25% (n=18)
LGAPTYTWGSNDTDVFVLNN 0.23% (n=17)
LGAPTYNWGANDTDVLVLNN 0.22% (n=16)
AGAPTYNWGANDTDVFVLNN 0.22% (n=16)
SGVPTYNWGADETDVFVLNN 0.22% (n=16)
SGAPTYSWGEKETDVFVLNN 0.22% (n=16)
LGAPTYSWGSNETDVFILNN 0.21% (n=15)
LGVPTYNWGANDTDVFVLNN 0.21% (n=15)
SGAPTYRWGANETDVFVLNN 0.21% (n=15)
RGVPTYNWGSNDTDVFVLNN 0.21% (n=15)
LGAPTHTWGANDTDVFILNN 0.21% (n=15)
SGAPTYNWGENDTDVLILNN 0.21% (n=15)
AGTPTYSWGANETDVFVLNN 0.21% (n=15)
AGVPTYSWGENDTDVFVLNN 0.19% (n=14)
AGAPTYNWGSNDTDVFVLNN 0.19% (n=14)
RGAPTYNWGGNDTDVLVLNN 0.19% (n=14)
LGAPTYNWGDNDTDVFVLNN 0.18% (n=13)
AGAPTYNWGENETDVFVLNN 0.18% (n=13)
LGVPTYSWGANDTDFLVLNN 0.18% (n=13)
SGVPTYNWGANVTDVFVLNN 0.17% (n=12)
LGVPTYNWGANVTDVFVLNN 0.17% (n=12)
MGAPTYNWGENETDVFILNN 0.15% (n=11)
AGAPTYSWGENDTDVFVLNN 0.14% (n=10)
LGDPTYGWGDNDTDVLILNN 0.14% (n=10)
FGVPTYNWGENETDVLVLNN 0.14% (n=10)
SGVPTYNWGGNETDVFILNN 0.14% (n=10)
LGVPTYNWGTNETDVFVLNN 0.14% (n=10)
SGVPTYNWGANEMDVFVLNN 0.14% (n=10)
LGVPTYTWGENDTDVFVLNN 0.14% (n=10)
SGAPTYNWGEGGTDVFVLNN 0.14% (n=10)
SGAPTYNWGGNKTDVFVLNN 0.14% (n=10)
SGAPTYTWGENETDVFVLNN 0.12% (n=9)
LGVPTYNWGENDTDVLVLNN 0.12% (n=9)
LGVPTYDWGSNDTDVFVLNN 0.12% (n=9)
SGAPTYSWGANDTDVFVLDN 0.12% (n=9)
SGAPTYNWGENETDVFILNN 0.11% (n=8)
-------------DVFVLNN 0.11% (n=8)
LGVPTYNWGDNDTDVLVLNN 0.11% (n=8)
SGAPTYNWGENDTDVIVLNN 0.11% (n=8)
LGAPTYNWGENDTDVLVLNN 0.11% (n=8)
SGVPTYNWGANKTDVFVLNN 0.11% (n=8)
SGAPTYNWGENKTDVFVLNN 0.11% (n=8)
LGVPTYNWGSNDTDVLVLNN 0.10% (n=7)
LGVPTYSWGANNTDVFVLNN 0.10% (n=7)
LGAPTYDWGSNDTDVFILNN 0.10% (n=7)
RGVPTYNWGENDTDVFVLNN 0.10% (n=7)
SGVPTYSWGENETDVFVLNN 0.10% (n=7)
SGAPTYTWGANDTDVFVLNN 0.08% (n=6)
SGAPTYRWGENETDVFVLNN 0.08% (n=6)
AGAPTYNWGENDTDVLVLNN 0.08% (n=6)
LGVPTYNWGANDTDFFVLNN 0.08% (n=6)
RGMPTYSWGENDTDVFILNN 0.08% (n=6)
SGAPTYNWGSNETDVFVLNN 0.08% (n=6)
RGAPTYNWGTREEDVFVLNN 0.08% (n=6)
SGVPTYSWGENDTDVFVLNN 0.07% (n=5)
TGAPTYNWGANDTDVFVLNS 0.07% (n=5)
AGAPTYNWGANETDVLILTN 0.07% (n=5)
SGTPTYNWGANDTDFFVLNN 0.07% (n=5)
LGAPTYNWGENDTDVLILNN 0.07% (n=5)
SGAPTHSWGENDTDVFVLNN 0.07% (n=5)
SGAPTYNWGANDTDVLVLNN 0.07% (n=5)
SGAPTYSWGEKDTDVFVLNN 0.07% (n=5)
SGVPTYNWGANETDVFVLNN 0.07% (n=5)
SGVPTYSWGENETDVFILNN 0.07% (n=5)
SGAPTHNWGANDTDVFVLNN 0.07% (n=5)
KGAPTYTWGANDTDVFVLNN 0.07% (n=5)
LGVPTYNWGDNETDVFVLNN 0.07% (n=5)
SGVPTYNWGAHETDVFVLNN 0.07% (n=5)
SGAPTYNWGAKETDVFVLNN 0.07% (n=5)
AGAPTYGWGENDTDVFVLNN 0.07% (n=5)
LGVPTFTWGSNNTDVFVLNN 0.07% (n=5)
VGAPTYNWGENETDVFVLNN 0.07% (n=5)
SGMPTYNWGQNDTDVFVLNN 0.06% (n=4)
SGAPTYNWGVNETDIFILNN 0.06% (n=4)
LGTPTFTWGGSVKDVLVLNN 0.06% (n=4)
LGVPTYTWGGNDTDFLVLNN 0.06% (n=4)
SGAPTYNWGCNETDVFVLNN 0.06% (n=4)
LGAPTYNWGENETDVFVLNN 0.06% (n=4)
LGLPTYNWGENDTDVFVLNN 0.06% (n=4)
SGAPTFSWGENDTDVFVLNN 0.06% (n=4)
LGVPTYNWGGNDTDVLVLNN 0.06% (n=4)
SGAPTYSWGENETDVFILNN 0.06% (n=4)
LGAPTYNWGGNDTDVFVLNN 0.06% (n=4)
LGVPTYRWGENETDVFVLNN 0.06% (n=4)
LGAPTYNWGGNETDVFVLNN 0.06% (n=4)
LGVPTYNWGSDDKDVLVLNN 0.06% (n=4)
MGAPTYNWGENDTDVLVLNN 0.06% (n=4)
LGAPTYNWGENETDVLILNN 0.06% (n=4)
SGVPTYNWGVNKTDVFVLNN 0.06% (n=4)
SGMPTYNWGAKETDVFVLNN 0.06% (n=4)
SGAPTYGWGENDTDVFVLNN 0.06% (n=4)
TGAPTYNWGENDTDVFVLTN 0.06% (n=4)
SGASTYNWGDNDTDVFVLNN 0.06% (n=4)
RGAPTYNWGTQEEDVFVLNN 0.06% (n=4)
RGAPTYNWGTREGDVFVLNN 0.06% (n=4)
LGVATYSWGATDADVFVLNN 0.04% (n=3)
AGAPTYNWGANETDVLVLTN 0.04% (n=3)
SGAPTYSWGTNDTDVFVLNN 0.04% (n=3)
LGVPTYTWGGNDTDFFVLNN 0.04% (n=3)
SGAPTYNWGQNETDVFVLNN 0.04% (n=3)
QGAPTYNWGANETDVFVLNN 0.04% (n=3)
AGVPTYTWGEKDTDVFVLNN 0.04% (n=3)
SGLPTYNWGENDTDVFVLNN 0.04% (n=3)
LGAPTYNWGSNSTDVFVLNN 0.04% (n=3)
SGAPTYSWGENVTDVFVLNN 0.04% (n=3)
SGAPTYNWGGNDTDVFVLNN 0.04% (n=3)
SGVPTYTWGENETDVFVLNN 0.04% (n=3)
AGAPTYNWGENDMDVFVLNN 0.04% (n=3)
AGAPTYNWGSNDTDVLVLNN 0.04% (n=3)
AGVPTYNWGSNDTDVFVLNN 0.04% (n=3)
SGAPTYTWGENDTDVFVLNN 0.04% (n=3)
SGAPTYNWGENESDVFVLNN 0.04% (n=3)
LGVPTYSWGENDTDVFVLNN 0.04% (n=3)
LGTPTYNWGENDTDVFVLNN 0.04% (n=3)
LGAPTYSWGANDTDVFVLNN 0.04% (n=3)
AGVPTYNWGGNDTDVFVLNN 0.04% (n=3)
LGAPTFSWGENDTDVFVLNN 0.04% (n=3)
LGAPTYSWGSNDTDVFILNN 0.04% (n=3)
-----YSWGENDTDVLVLNN 0.04% (n=3)
LGAPTYSWGSNDTDVLVLNN 0.04% (n=3)
AGVPTYNWGGNETDVFVLNN 0.04% (n=3)
SGMPTYNWGGNETDVFVLNN 0.04% (n=3)
SGVPTYDWGSNDVDVFVLNN 0.04% (n=3)
AGVPTYSWGVNDTDVFVLNN 0.04% (n=3)
LGALTYNWGSNDTDIFILNN 0.04% (n=3)
AGAPTYNWGNNDTDVFVLNN 0.04% (n=3)
SGAPTYDWGENETDAFVLNN 0.04% (n=3)
AGAPAYNWGGNDTDVFVLNN 0.04% (n=3)
LGVPTYNWGSNRTDVFVLNN 0.03% (n=2)
LGAPTYNWGGDDTDVLVLNN 0.03% (n=2)
SGVPTYSWGANDTDVFVLNN 0.03% (n=2)
LGVPTYNWGANDTDVLILNN 0.03% (n=2)
AGAPTYSWGGNDTDVFVLNN 0.03% (n=2)
AGAPTYSWGANDTDVFVLNN 0.03% (n=2)
SGAPTYNWGENETDVLVLNN 0.03% (n=2)
LGAPTFNWGSNDTDVFVLNN 0.03% (n=2)
AGAPTYNWGENETDVLILTN 0.03% (n=2)
SGTPTYNWGANDTYFFVLNN 0.03% (n=2)
SEAPTYNWGENDTDVFVLNN 0.03% (n=2)
LGDPTFGWGGNDTDVLILNN 0.03% (n=2)
LGAPTYNWGENDKDVLILNN 0.03% (n=2)
RGAPTFTFGENETDVFILNN 0.03% (n=2)
AGAPTYSWGENDTDVLVLNN 0.03% (n=2)
FGAPTYNWGENETDVFVLNN 0.03% (n=2)
AGAPTYNWGEDDSDVFVLNN 0.03% (n=2)
LGAPTYSWGSNDSDVFVLNN 0.03% (n=2)
LGVPTYNWGENETDVLVLNN 0.03% (n=2)
LGAPTYNWGGNETDVLVLNN 0.03% (n=2)
AGAPTYNWGDNDTDVFVLNN 0.03% (n=2)
AGVPTYNWGDNDTDVFVLNN 0.03% (n=2)
AGAPTYNWGENDTDVLILNN 0.03% (n=2)
AGVPTYTWGENDTDVFVLNN 0.03% (n=2)
LGAPTYSWGSNDTDVFVLNN 0.03% (n=2)
SGAPTYNWGDNETDVFVLNN 0.03% (n=2)
SGAPTYDWGENDTDVFVLNN 0.03% (n=2)
SGAPTYTWGENETDVFILNN 0.03% (n=2)
LGAPTYNWGANETDVFVLNN 0.03% (n=2)
AGAPTYSWGENETDVFVLNN 0.03% (n=2)
LGVPTYNWGDSDTDVFVLNN 0.03% (n=2)
SGVPTYNWGENETDVFILNN 0.03% (n=2)
SGAPTYSWGENDTDVFALNN 0.03% (n=2)
AGAPAYNWGANDTDVFVLNN 0.03% (n=2)
TGAPTYNWGANDTDVFVLNN 0.03% (n=2)
SGMPTYNWGENDTDVFVLNN 0.03% (n=2)
VGLAYFQLGYQYHGRFFSNQ 0.03% (n=2)
SGEPTYRWGESEADVFVLNN 0.03% (n=2)
SGAPTYSWGVNDTDVFVLNN 0.03% (n=2)
SGAPTYSWGANDADVFVLNN 0.03% (n=2)
AGVPTYSWGGNDTDVFVLNN 0.03% (n=2)
RGVPTYSWGGTDTDVFILNN 0.03% (n=2)
LGVPTYSWGANDTDFFVLNN 0.03% (n=2)
AGVPTYNWGGNDTDFFVLNN 0.03% (n=2)
SGVPTYNWGAGETDVFVLNN 0.03% (n=2)
SGAPTNNWGENATDVFVLNN 0.03% (n=2)
SGAPTYNWGENHTDVFVLNN 0.03% (n=2)
SGAPTYNWGENVTDVFVLNN 0.03% (n=2)
LGHPTYNWGENETDVFILNN 0.03% (n=2)
MGAPTYNWGENDTDVFVLTD 0.03% (n=2)
TGVPTYTWGENDTDVFVLTN 0.03% (n=2)
SGAPTYNWGENTTDVFVLNN 0.03% (n=2)
SGAPTYNWGGNETDIFVLNN 0.03% (n=2)
SGAPTYNWSENETDVFVLNN 0.03% (n=2)
SGAPTYNWGEEDTDVFVLNN 0.03% (n=2)
AGAPTYKWGANDTDVFVLNN 0.03% (n=2)
AGVPTYRWGENDTDVFVLNN 0.03% (n=2)
RGAPTYDWGAREEDVFVLNN 0.03% (n=2)
RGAPTYNWGIREEDVFVLNN 0.03% (n=2)
RGAPTYNWGANDTDVFVLNN 0.03% (n=2)
LGVPTYTWGNSSTDVFVLNN 0.03% (n=2)
SGAATYSWGSDTKDVFVLNN 0.03% (n=2)
SGAPTYNWGGNETDVLVLNN 0.03% (n=2)
AGAPTYNWGANETDVFLLNN 0.03% (n=2)
LGAPTYNWGANDTDVFVLNN 0.03% (n=2)
LGVPTYNWGCNVTDVFVLNN 0.03% (n=2)
SGTPTHNWGENETDVFVLNN 0.03% (n=2)
LGVPTYSWGTNDTDVFVLNN 0.01% (n=1)
ADVPTYSWGENETDVFVLNN 0.01% (n=1)
AGVPTYSWGENGTDVFVLNN 0.01% (n=1)
AGVPTYSWGENETNVFVLNN 0.01% (n=1)
LGVPTYTWGSNDTDFFVLNN 0.01% (n=1)
LGAPTYTWGSNDTDAFVLNN 0.01% (n=1)
LGAPTYSWGENDTDVFVLND 0.01% (n=1)
LGAPTYSWGENDTDVFVLNT 0.01% (n=1)
LGAPTYSWGENDTDVFILNN 0.01% (n=1)
LGAPTYSWGENDTDVLVLNN 0.01% (n=1)
SGAPTYRWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVFNN 0.01% (n=1)
SGVSTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVPNN 0.01% (n=1)
FGVPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYSWGSNKTDVFILNN 0.01% (n=1)
SGVPTYNWGENDVDVFVLNN 0.01% (n=1)
SGAPTCNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNDTVVFVLNN 0.01% (n=1)
FGVPTYNWCANETGVFVLNN 0.01% (n=1)
LGVPTYNWGANDTDVLVLNN 0.01% (n=1)
LGAPTYNWGANDTDVLVLNY 0.01% (n=1)
AGAPTYSWGENDTDVFVLNS 0.01% (n=1)
AGAPTYSWGGNNADVFVLNN 0.01% (n=1)
SGAPTYNWGNNDTDVFVLNN 0.01% (n=1)
LGVATYSWGANEADVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFALNN 0.01% (n=1)
SGAPTYNWGANDMDVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFVINN 0.01% (n=1)
SGAPT-NWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLDI 0.01% (n=1)
SGAPTYNWGENDTDVLVLNS 0.01% (n=1)
SGAPTYNWGANNTDVFVLNN 0.01% (n=1)
SGVPTYNWGENETDIFILNN 0.01% (n=1)
SGAPTYNWGANETDIFILNN 0.01% (n=1)
LGAPTHDWGSNDTDVFILNN 0.01% (n=1)
LGAPTFTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGANETDVFVLTN 0.01% (n=1)
SGAPTYNWGANETDVLVLTN 0.01% (n=1)
SGAPTYNWGTNDTNVFVLNN 0.01% (n=1)
SGQPTYNWGENETDVFVLNN 0.01% (n=1)
SCAPTYNWGENDTDFFVFKN 0.01% (n=1)
SGAPTYNWGENDADVFVLTN 0.01% (n=1)
SGAPTYNWGENDTDVFALNN 0.01% (n=1)
SEAPTYNWGENDTGVFVLNN 0.01% (n=1)
SEAPTYNWGENDTDVFASNN 0.01% (n=1)
SGAPTYSWGADDTDVFVLNN 0.01% (n=1)
SGVPTYNWGINETDVFVLNN 0.01% (n=1)
LGAPTYNWGCNDTDVIILNN 0.01% (n=1)
LGVPTYTWGGNDTDFSVLNN 0.01% (n=1)
LGDPTYSWGVTDTDVFVLNN 0.01% (n=1)
LGVPTYNWGDNGADVLVLNN 0.01% (n=1)
LDVPTYNWGDNDTDVFVLNN 0.01% (n=1)
LGVPTYN*GDNDTDVFVLNN 0.01% (n=1)
SGAPTYSWVENDTDVFVLNN 0.01% (n=1)
-------------DVFILTN 0.01% (n=1)
-------------DVLVLNN 0.01% (n=1)
WGAPTYNWGANDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFVLTN 0.01% (n=1)
AGAPTYNWGSDTTDVFVLNN 0.01% (n=1)
WGVPTYTCGENDTDVFILNN 0.01% (n=1)
LGAPTFNWGGNETDVFILNN 0.01% (n=1)
MGAPTYNWGANDTDILVLNN 0.01% (n=1)
SGAPTYNWGSNDTDVLVLNN 0.01% (n=1)
RGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
SGAPTFNWGDNDTDVLVLNN 0.01% (n=1)
SGAPTYSWGEHDTDVFVLNN 0.01% (n=1)
VGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGAPTYTWGSNVSDVFVLNN 0.01% (n=1)
LGAPTYTWGSNHSDVFVLNN 0.01% (n=1)
KGSPTYRWGENETDVFILNN 0.01% (n=1)
FGAPTYSWGDNETDVFVLNN 0.01% (n=1)
RGVPTFNWGANDTDVFVLNN 0.01% (n=1)
LGVPTFNWGSNDTDVFVLNN 0.01% (n=1)
QGAPTYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANDTDVFLLNN 0.01% (n=1)
FGVPTYNWGDNETDVFVLNN 0.01% (n=1)
LGVPTYNWGNTSEDVLVLNN 0.01% (n=1)
LGVPTYSWGSNETDVLVLNN 0.01% (n=1)
SGAPTYNWGGNDTDVFVLTN 0.01% (n=1)
TGAPTYTWGENETDVFVLNN 0.01% (n=1)
LGQPTYNWGENDTDVLVLNN 0.01% (n=1)
SGAPTFNWGENDTDVLVLNN 0.01% (n=1)
SGVPTHSWGENETDVFVLNN 0.01% (n=1)
KGEPTYNWGDNDTDVLVLNN 0.01% (n=1)
SGAPTFNWGQNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGANETDVFVLNS 0.01% (n=1)
SGAPTYSWGVNETDVFVLNN 0.01% (n=1)
AGAPTYNWGENETDVFVLNS 0.01% (n=1)
SGAPTYNWGQNDTDVFVLNN 0.01% (n=1)
LGAPTYSWGANVTDVFVLNN 0.01% (n=1)
LGAPTYSWGENDKDVFVLNN 0.01% (n=1)
AGAPTYSWGSNVTDVFVLNN 0.01% (n=1)
WGAPTYNWGENDTDVFVLNN 0.01% (n=1)
AGAPTFSWGANDTDVFVLNN 0.01% (n=1)
LGAPTYRWGSNDTDVFILNN 0.01% (n=1)
SGAPTYDWGGNVTDVFVLNN 0.01% (n=1)
AGAPTYNWGINDTDVLVLNN 0.01% (n=1)
AGVPTYNWGENATDVFVLNN 0.01% (n=1)
AGVPTYNWGCNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
EGAPTYNWGDNDTDVFVLNN 0.01% (n=1)
KGSPTYSWGENVTDVFVLNN 0.01% (n=1)
SGAPSYNWGENETDVFVLNN 0.01% (n=1)
LGAPTFNWGENDTDVFILNN 0.01% (n=1)
AGVPTYNWGINDTDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVFILNN 0.01% (n=1)
LGVPTYGWGSNDTDVFILNN 0.01% (n=1)
KGAPTYNWGENDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNDSDVFVLNN 0.01% (n=1)
SGAPTYSWGERDRDVFVLNN 0.01% (n=1)
HGAPTYNWGENDTDVFVLNN 0.01% (n=1)
HGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGVPTYSWGSNETDVFVLNN 0.01% (n=1)
QGVPTYNWGANDTDVLVLNN 0.01% (n=1)
LGAPTYDWGANDTDVLVLNN 0.01% (n=1)
LGAPTYDWGRNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVLILNN 0.01% (n=1)
VGVPTYNWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANESDVFVLNN 0.01% (n=1)
SGVPTYSWGADEADVFVLNN 0.01% (n=1)
LGAPTYDWGSNDTDVFVLNN 0.01% (n=1)
RGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGVPTYNFGANQTDVFVLNN 0.01% (n=1)
SGTPTYTWGENETDVFILNN 0.01% (n=1)
AGAPTYNWGESDMDVLVLNN 0.01% (n=1)
LGAPTYNWGSSDKDVLILNN 0.01% (n=1)
SGAPTYTWGENDTDVFILNN 0.01% (n=1)
TGVPTYNWGENDTDVLVLNN 0.01% (n=1)
LGAPTYSWGVNDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNETDVFILNN 0.01% (n=1)
LGVPTYNWGRNDTDFLVLNN 0.01% (n=1)
VGVPTYNWGENDSDVFVLNN 0.01% (n=1)
RGAPTYNWGENDTDVFILNN 0.01% (n=1)
LGVPTYNWGQNDTDVFVLNN 0.01% (n=1)
SGAPTYDWGANDTDVFVLNN 0.01% (n=1)
LGAPTYRWGENDTDVFVLNN 0.01% (n=1)
SGAPTYNWGRNDTDVFVLNN 0.01% (n=1)
SGAPTFNWGANDTDVFVLNN 0.01% (n=1)
AGAPTYSWGENDTDVFLLNN 0.01% (n=1)
LNTPTFTWGESDKDVFILNN 0.01% (n=1)
RGAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENETDVLVLNN 0.01% (n=1)
PGAPTYNWGANEADVFVLNN 0.01% (n=1)
AGAPTYNWGANETDVFVPNN 0.01% (n=1)
LGAPTYNWGSNNTDVFVLNN 0.01% (n=1)
LGAPTYSWGSDDTDVLVLNN 0.01% (n=1)
AGAPTYSWGENETDVFILNS 0.01% (n=1)
LGVPTYNWGNNDTDVLVLNN 0.01% (n=1)
AGVPTYSWGENDTDVLVLNN 0.01% (n=1)
LGVPTYNWGGNETDVLVLNN 0.01% (n=1)
WGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
MGVPTYNWGENDTDVFVLNN 0.01% (n=1)
SGVPTYNWGTNATDVFVLNN 0.01% (n=1)
VGAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNYTDVFVLNN 0.01% (n=1)
AGAPSYNWGSNDTDVFILNN 0.01% (n=1)
SGQATYSWGEKETDVFVLNN 0.01% (n=1)
RGVPTYTWGEKETDVFVLNN 0.01% (n=1)
LGSPTYRWGENETDVFVLNN 0.01% (n=1)
SGVPTYNWGANETDVLVLNN 0.01% (n=1)
SGAPTYNWGENDSDVFVLNN 0.01% (n=1)
LGAPTYNWGENDTDVFILNN 0.01% (n=1)
AGVPTYDWGSNVTDVFVLNN 0.01% (n=1)
LGAPTYDWGSNETDVFILNN 0.01% (n=1)
LGAPTYSWGGKVTDVLVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLND 0.01% (n=1)
LGVPTYGWGENDTDVFVLNN 0.01% (n=1)
AGAPTYDWGSNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGENDTDVFLLNN 0.01% (n=1)
AGVPTYNWGTNDTDVFVLNN 0.01% (n=1)
VGVPTYNWGENDTDVFVLNN 0.01% (n=1)
LGVPTYTWGENDTDVFILNN 0.01% (n=1)
LGAPTYTWGENETDVFVLNN 0.01% (n=1)
SGLPTYNWGANDTDVFVLNN 0.01% (n=1)
LGMPTYNWGENETDVFILNN 0.01% (n=1)
RGVPTYNWGENVTDVFVLNN 0.01% (n=1)
LGVPTHSWGENEADVFVLNN 0.01% (n=1)
GRKPTYSWGADEADVFVLNN 0.01% (n=1)
LGVPTYTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYSWGANETDVFVLNN 0.01% (n=1)
AGAPTYNWGANDTDVLVLNN 0.01% (n=1)
SGVPTYSWGGNETDVFVLNN 0.01% (n=1)
WGVPTYNFGTNETDVFVLNN 0.01% (n=1)
AGAPTYTWGANDTDVFVLNN 0.01% (n=1)
LGAPTFNWGDSDEDVLVLNN 0.01% (n=1)
SGAPSYTWGENETDVLVLNN 0.01% (n=1)
SGAPTYNWGENDTDGFVLNN 0.01% (n=1)
LGTPTYDWGSNDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFILNN 0.01% (n=1)
AGAPTYNWGVNDTDFFVLNN 0.01% (n=1)
SGAPTYRWGENDTDVFLLNN 0.01% (n=1)
SGAPIYSWGEKDTDVFVLNN 0.01% (n=1)
VGAPTYNWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGCNDTDVFVLNN 0.01% (n=1)
LGAPTFNWGENESDVFVLNN 0.01% (n=1)
SGAPTYDWGENESDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVLNS 0.01% (n=1)
SGAPTYNWGANETDVIILNN 0.01% (n=1)
SGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGSNNTDVFVLNN 0.01% (n=1)
LGVPTYSWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVIILNN 0.01% (n=1)
SGAPTYNWGANDTDVFVLKN 0.01% (n=1)
FGVPTYSWGENDTDVFLLNN 0.01% (n=1)
SGVPTYTWGERDTDVFVLNN 0.01% (n=1)
LGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGAPTYNWGENETDVLVLNN 0.01% (n=1)
LGAPTYNWGANDSDVFVLNN 0.01% (n=1)
AGVPTLNWGSNETDVFVLNN 0.01% (n=1)
FGVPTYNWGENETDVPVLNN 0.01% (n=1)
FGVPTYNWGENETDVLVPNN 0.01% (n=1)
SGVPTYNWGDNETDVFILNN 0.01% (n=1)
SGVPTYSWGENETDVSILNN 0.01% (n=1)
SGVPTYNWGGNETGVFILNN 0.01% (n=1)
LGALTYNWGSNDTDVFILNN 0.01% (n=1)
LGAPTYNWGSNVTDVFILNN 0.01% (n=1)
LGAPTYNWGSNDTGIFILNN 0.01% (n=1)
SGAPTYNWGENDTDALILNN 0.01% (n=1)
SGAPTHNWGASDTDVFVLNN 0.01% (n=1)
LGVPIYGWGSNDTDVFVLNN 0.01% (n=1)
SGAATYSWGENDTDVFVLNN 0.01% (n=1)
-----YSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGEYDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVFVLNS 0.01% (n=1)
SGAPTYS*GENDTDVFVLNN 0.01% (n=1)
SGGPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVSVLNN 0.01% (n=1)
SGAPTYSWGENDTGIFVLNN 0.01% (n=1)
SGAPTCSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDTDVYVLNN 0.01% (n=1)
PGAPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYGRGENDTDVFVLNN 0.01% (n=1)
SGAPTYSRGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGGNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
SGAPTHNWGENDTDVFVLNN 0.01% (n=1)
AGAPTYNWGENGTDVLVLNN 0.01% (n=1)
AGVPTYNWGEDDTDVLVLNN 0.01% (n=1)
LGAPTYNWGANDTDVLLLNN 0.01% (n=1)
LGAPTYNWGDNQTDVFILNN 0.01% (n=1)
LGAPTYKWGANDTDVLLLNN 0.01% (n=1)
LGAPTYNWGANDTDVFLLNN 0.01% (n=1)
LGAPTYNWGANETEVFLLNN 0.01% (n=1)
TGALTYNRGANDTDVFVLNN 0.01% (n=1)
AGVPTHNWGENETDVFVLNN 0.01% (n=1)
LGAPTYRWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENETDIFVLNN 0.01% (n=1)
AGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGVPTYDWGSSDVDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTAVFVLNN 0.01% (n=1)
SGAPTYSWGANGTDVFVLND 0.01% (n=1)
SGAPTCSWGATDTDVFVLNN 0.01% (n=1)
SGAPTYSWGVNDTGVFVLNN 0.01% (n=1)
SGAPTYSRGANDTDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTGVFVLNN 0.01% (n=1)
SGAPTYSWGANDTDVFVLNS 0.01% (n=1)
SGAPTYSWGANDTDAFVLNN 0.01% (n=1)
SGAPAYSWGANDTDVFVLNN 0.01% (n=1)
SGTPTYSWGANDTDVFVLNN 0.01% (n=1)
SGAPTYSWGANDTDVFVLND 0.01% (n=1)
LGVPTYSWGANDTDFFLLSN 0.01% (n=1)
RGVPTYNWGENDTDFFLLNN 0.01% (n=1)
AGVPTYSWGVNDKDVFVLNN 0.01% (n=1)
RGVPTYNWGGNDTDVFILNN 0.01% (n=1)
SGVPTYNWGAKKTDVFVLNN 0.01% (n=1)
SGAPTYNWGAHETDVFVLNN 0.01% (n=1)
SGVPTYNWGTNVTDVFVLNN 0.01% (n=1)
SGVPTYNWGADKTDVFVLNN 0.01% (n=1)
LGVPTYNWGADETDVFVLNN 0.01% (n=1)
SGVPTYNWGANEKDVFVLNN 0.01% (n=1)
SGVPTYNWGAKQTDVFVLNN 0.01% (n=1)
SGVPTYNWGARETDVFVLNN 0.01% (n=1)
SGAPTYNWGASETDVFVLNN 0.01% (n=1)
SGAPTYNWGATETDVFVLNN 0.01% (n=1)
LGVPTYNWGTNETDIFVLNN 0.01% (n=1)
SGVPTYNWGTNKTDVFVLNN 0.01% (n=1)
SGAPTCSWGANDTDVFVLNN 0.01% (n=1)
SGAPTYNWGDNEADVFLLNN 0.01% (n=1)
SGAPTYSWGANDTDIFVLNN 0.01% (n=1)
SGAPTYNWGVNDTDIFVLNN 0.01% (n=1)
SGAPTYNWGGNATDVFVLNN 0.01% (n=1)
SGAPTHNWGENETDVFVLNN 0.01% (n=1)
SGVPTYSWGENETDVFVLIN 0.01% (n=1)
SGAPTYNWGEDDTDVFVLNN 0.01% (n=1)
SGAPTYNWGANETDVIVLN- 0.01% (n=1)
WGAPAYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGENDSDVFVLNN 0.01% (n=1)
MGAPTYSWGENDTDVFVLTN 0.01% (n=1)
LGAPTYNWGGNVTDVLVLNN 0.01% (n=1)
-------------------N 0.01% (n=1)
AGVPTYRWGKNETDVFVLNN 0.01% (n=1)
SGEPTYYWGENDTDVFVLNN 0.01% (n=1)
SGAPTYDWGVNDTDVFVLNN 0.01% (n=1)
SGVPTYSWGSNATDVFVLNN 0.01% (n=1)
RGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGSPTYSWGENDTDVFVLNN 0.01% (n=1)
SGVPTYDWGENDTDVFVLNN 0.01% (n=1)
SGTPTYSWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGSNDTDVFVLNN 0.01% (n=1)
RGVPTYSWGESEADVFVLNN 0.01% (n=1)
LGAPTYSWGENETDVLILNN 0.01% (n=1)
LGAPTYNWGRNDTDVLVLNN 0.01% (n=1)
LGAPTYRWGTNDTDVFVLNN 0.01% (n=1)
RGVPTYTWGANETDVFVLNN 0.01% (n=1)
LGSPTYNWGENDTDVFVLNN 0.01% (n=1)
SGAPTYSWGDNDTDVLVLNN 0.01% (n=1)
RGVPTYNWGANITDVFVLNN 0.01% (n=1)
LGAPTYTWGDNDTDVFILNN 0.01% (n=1)
SGAPTYSWGANDTDVFVPNN 0.01% (n=1)
LGAPTYSWGSDNTDVFVLNN 0.01% (n=1)
KGIPTYTWGENETDVFILNN 0.01% (n=1)
VGVPTYNWGENETDVFVLNN 0.01% (n=1)
LGAPTYSWGDNDTDVLILNN 0.01% (n=1)
SGHPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYNWGSNITDVLVLNN 0.01% (n=1)
AGAPTYNWGQNETDVFVLNN 0.01% (n=1)
LSAPTYNWGSNDTDVFVLNN 0.01% (n=1)
SGVPTYAWGANETDVFVLNN 0.01% (n=1)
QGAPTYSWGANDTDVFVLNN 0.01% (n=1)
RGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
AGAPTYTWGSNDTDVFVLNN 0.01% (n=1)
AGAPTYNWGETDKDVFVLNN 0.01% (n=1)
LGVPTYSWGSNDTDVFVLNN 0.01% (n=1)
AGVPTYTWGENETDVFVLNN 0.01% (n=1)
SGVPTYRWGVNETDVFVLNN 0.01% (n=1)
LGAPTYNWGANMTDVLVLNN 0.01% (n=1)
FGAPTYSWGANETDVFVLNN 0.01% (n=1)
FGAPTYNWGGNDTDVFVLNN 0.01% (n=1)
SGAPTYTWGENDTDVLVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFVPNN 0.01% (n=1)
SGAPTYTWGGNDTDVFVLNN 0.01% (n=1)
-GAPTYNWGDNDTDVFVFNN 0.01% (n=1)
SGAPTYNWGENDADVFVLNN 0.01% (n=1)
WGAPTYNWGVNETDVFVLNN 0.01% (n=1)
SGAPAYNWGENDTDVFVLNN 0.01% (n=1)
LGIPTYSWGGNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGENDTDVFLLNN 0.01% (n=1)
VGAPTYNWGANDTDVIILNN 0.01% (n=1)
SSAPTYSWGANDTDVLVLNN 0.01% (n=1)
SGAPTYSWGANNTDVFVLDN 0.01% (n=1)
LGAPTYNWGSNDTDIFVLNN 0.01% (n=1)
LGAPTYNWGDNDTDVLILNN 0.01% (n=1)
SGAPTYSWGENEKDVFVLNN 0.01% (n=1)
SGVPTYNWGENETDIFVLNN 0.01% (n=1)
LGAPTYNWGSNDTDVFLLNN 0.01% (n=1)
LGVPTYNWGSNNTDVFVLNN 0.01% (n=1)
SGVPTYNWGSNDTDVFVLNN 0.01% (n=1)
AGTPTYNWGENDTDVFVLNN 0.01% (n=1)
RGVPTYNWGANDTDVSVLNN 0.01% (n=1)
LGAPTYSWGENETDVFVLNN 0.01% (n=1)
SGVPTYNWVSNDTDVFVLNN 0.01% (n=1)
SGVPTYNWGENVTDVFVLNN 0.01% (n=1)
LGAPTYNWGNNDTDVFVLNN 0.01% (n=1)
SGAPTYNWGDNDTDVFILNN 0.01% (n=1)
LGAPTYNWGEQDTDVFVLNN 0.01% (n=1)
TGVPTYNWGENESDVFVLNN 0.01% (n=1)
QGVPTYNWGENDTDVFVLNN 0.01% (n=1)
WGVPTYTWGENETDVFVLNN 0.01% (n=1)
LGAPTYTWGENDTDVFVLNN 0.01% (n=1)
SGAPTYDWGENETDVFVLNN 0.01% (n=1)
SGAPTYNWGENETDAFVLNN 0.01% (n=1)
LGAPTYRWGENEKDVFVLNN 0.01% (n=1)
LGVPTYNWGANETDVFVLNN 0.01% (n=1)
AGAPTYNWGSNDTDVFVLNG 0.01% (n=1)
SGVPTYTWGENESDVFVLNN 0.01% (n=1)
RGAPTYNWGENDTDVLILNN 0.01% (n=1)
LGAPTYNWGASDTDVFVLNN 0.01% (n=1)
LGAPTYNWGANVTDVLILNN 0.01% (n=1)
LGAPTYNWGSNDTDVFVLYN 0.01% (n=1)
WGVPTYTWGSSDADVFILNN 0.01% (n=1)
LGAPTYNWGSNETDVLVLNN 0.01% (n=1)
AGAPTYTWGENETDVFVLNN 0.01% (n=1)
FGAPTYNWGANDTDVFVLNN 0.01% (n=1)
LGAPTYNWGGNDADVLVLNN 0.01% (n=1)
YGAPTYNWGTNDTDVFVLNN 0.01% (n=1)
LGAPTHTWGANETDVFILNN 0.01% (n=1)
LGVPTYSWGANDTDVFVLNN 0.01% (n=1)
SGVPTYSWGENETDVFLLNN 0.01% (n=1)
SGAPTYNWGGGDTDVFVLNN 0.01% (n=1)
SGVPTYNWGDNDTDVFVLNN 0.01% (n=1)
SGAPTYRWGENETDVLVLNN 0.01% (n=1)
SGTPTFSWGENDTDVFVLNN 0.01% (n=1)
SGGPTYNWGRKDTDVLVLNN 0.01% (n=1)
SGAPTYNWGMNDTDVLVLNN 0.01% (n=1)
TGAPTYDWGANETDVFVLNS 0.01% (n=1)
SGAPTYNWGGNETDVFVLNN 0.01% (n=1)
LGVPTYNWGENATDVFVLNN 0.01% (n=1)
LGAPTYNWGDNDTDVFILNN 0.01% (n=1)
SGAPTYRWGENETDVFLLNN 0.01% (n=1)
SGAPTYNWGVNDTDVFVLNN 0.01% (n=1)
LGAPTFNWGANDTDVLVLNN 0.01% (n=1)
SGVPTYNWGDNDTDVLVLNN 0.01% (n=1)
AGAPAYNWGENDTDVFVPNN 0.01% (n=1)
VGAPAYNWGENDTDVFVLNN 0.01% (n=1)
AGAPAYNWGENDTDVIVLNN 0.01% (n=1)
AGAPSYNWGENDTDVFVLNN 0.01% (n=1)
AGAPAYNWGKNDTDVFVLNN 0.01% (n=1)
AGAPAYNWGENATDVFVLNN 0.01% (n=1)
AGVPAYNWGENDTDVFVLNN 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 1b:

FGVPTYSWGENETDVLLLNN 13.87% (n=402)
SGVPTYSWGGNETDVLLLNN 12.32% (n=357)
FGAPTYSWGENETDVLLLNN 8.80% (n=255)
SGVPTYRWGENETDVLLLNN 6.66% (n=193)
FGVPTYTWGENETDVLLLNN 4.28% (n=124)
LGVPTYSWGENETDVLLLNN 3.69% (n=107)
FGVPTYRWGENETDVLLLNN 3.24% (n=94)
SGVPTYSWGENETDVLLLNN 2.80% (n=81)
SGVPTYNWGENETDVLLLNN 2.80% (n=81)
LGVPTYTWGGNVTDVLLLNN 2.76% (n=80)
FGAPTYTWGENETDVLLLNN 2.52% (n=73)
FGVPTYSWGGNETDVLLLNN 1.69% (n=49)
SGVPTYTWGENETDVLLLNN 1.59% (n=46)
SGAPTYTWGENETDVL---- 1.41% (n=41)
SGAPTYSWGENETDVLLLNN 1.38% (n=40)
YGVPTYSWGENETDVLLLNN 1.21% (n=35)
FGVPTYNWGENETDVLLLNN 1.10% (n=32)
SGVPTYSWGENETDVLVLNN 1.07% (n=31)
FGAPTYNWGENETDVLLLNN 1.04% (n=30)
LGVPTYTWGENETDVLLLNN 0.76% (n=22)
SGAPTYNWGENETDVLLLNN 0.69% (n=20)
HGAPTYRWGENETDVLLLNN 0.69% (n=20)
FGAPTYNWGENETDVLILNN 0.62% (n=18)
FGAPTYNWGENQTDVLLLNN 0.62% (n=18)
LGHPTYNWGENETDVLLLNN 0.59% (n=17)
SGAPTYTWGENETDVLLLNN 0.55% (n=16)
SGVPTYSWGENETDVMLLNN 0.41% (n=12)
SGVPTYSWGKNETDVLVLNN 0.41% (n=12)
FGVPTYNWGDNETDVLLLNN 0.35% (n=10)
FGVPTYTWGENKTDVLLLNN 0.35% (n=10)
FGVPTYSWGGNVTDVLLLNN 0.35% (n=10)
SGAPTYNWGENETDVLILNN 0.31% (n=9)
FGVPTYNWGGNETDVLLLNN 0.31% (n=9)
FGAPTYRWGENETDVLLLNN 0.31% (n=9)
HGVPTYSWGENETDVLLLNN 0.31% (n=9)
FGAPTYTWGENETDVLILNN 0.31% (n=9)
--------GENETDVLLLNN 0.28% (n=8)
SGAPTYRWGENETDVLLLNN 0.24% (n=7)
FGAPTYSWGENETDVLILNN 0.24% (n=7)
LGVPTYNWGGNRTDVLLLNN 0.21% (n=6)
FGAPTYNWGNNETDVLLLNN 0.21% (n=6)
FGAPTYNWGANETDVLILNN 0.21% (n=6)
FGVPTYSWGENKTDVLLLNN 0.21% (n=6)
FGVPTYSWGENETDVPLLNN 0.21% (n=6)
FGVPTYSWGANETDVLLLNN 0.17% (n=5)
SGAPTYTWGENETDVLILNN 0.17% (n=5)
LGVPTYNWGENETDVLLLNN 0.17% (n=5)
FGAPTYNWGGNETDVLLLNN 0.17% (n=5)
SGAPTYSWGENKTDVLLLNN 0.17% (n=5)
FGVPTYAWGGNETDVLLLNN 0.17% (n=5)
SGVPTYTWGENETDVL---- 0.17% (n=5)
FGAPTYSWGENETGVLLLNN 0.17% (n=5)
FGVPTYKWGENETDVLLLNN 0.14% (n=4)
SGVPT--------------- 0.14% (n=4)
FGVPT--------------- 0.14% (n=4)
FGAPTYNWGDNETDVLILNN 0.14% (n=4)
FGVPTYSWGE---------- 0.14% (n=4)
FGAPTYNWGDNETDVLLLNN 0.14% (n=4)
SGAPTYRWGENETDVLILNN 0.14% (n=4)
SGVPTYSWGENKTDVLLLNN 0.14% (n=4)
FGVPTYSWGENVTDVLLLNN 0.14% (n=4)
SGVPTYKWGENETDVLLLNN 0.14% (n=4)
LGVPTYNWGENETDVLLLNS 0.14% (n=4)
YGVPTYKWGENETDVLLLNN 0.14% (n=4)
FGAPTYNWGENETDVLILNS 0.14% (n=4)
SGAPTYSWGANETDVLLLNN 0.14% (n=4)
LGAPTYNWGDNDTDVLLLNN 0.10% (n=3)
SGVPTYTWGENKTDVLLLNN 0.10% (n=3)
FGVPTYTWGANETDVLLLNN 0.10% (n=3)
FGAPTYNWGANETDVLLLNN 0.10% (n=3)
SGVPTYNWGGNETDVLLLNN 0.10% (n=3)
LGVPTYRWGENETDVLLLNN 0.10% (n=3)
SGAPTYTWGANETDVLLLNN 0.10% (n=3)
SGAPTFSWGENETDVLLLNN 0.10% (n=3)
SGAPTYSWGGNETDVLLLNN 0.10% (n=3)
SGVPTYGWGENETDVLLLNN 0.10% (n=3)
YGVPTYTWGENETDVLLLNN 0.10% (n=3)
FGAPTYNWGANETDVLVLNN 0.10% (n=3)
FGVPTYTWGENETDVLFLNN 0.07% (n=2)
FGVPTYSWGVNETDVLLLNN 0.07% (n=2)
FGVPTYNWGENETDVLVLNN 0.07% (n=2)
SGVPTYSWGENETDMMLLNN 0.07% (n=2)
SGAPTYSWGENETDVMLLNN 0.07% (n=2)
FGVPTYNWGENETDILLLNN 0.07% (n=2)
FGAPTYTWGANETDVLLLNN 0.07% (n=2)
FGAPTYSWGENETDVLLLSN 0.07% (n=2)
FGAPTYSWGENETDVLLFNN 0.07% (n=2)
SGVPTYTWGENETDMLLLNS 0.07% (n=2)
SGAPTYNWGANETDVLLLNN 0.07% (n=2)
SGAPTYNWGGNETDVLLLNN 0.07% (n=2)
FGVPTYSWGENGTDVLLLNN 0.07% (n=2)
LGVPTYSWGGNETDVLLLNN 0.07% (n=2)
VGVPTYSWGENETDVLLLNN 0.07% (n=2)
FGVPTYDWGENETDVLLLNN 0.07% (n=2)
AGVPTYRWGENETDVLLLNN 0.07% (n=2)
FGAPTYQWGENETDVLILNN 0.07% (n=2)
FGVPTYNWGENEADVLLLNN 0.07% (n=2)
FGTPTYTWGENETDVLLLNN 0.07% (n=2)
RGVPTYSWGENETDVLLLNN 0.07% (n=2)
LGAPTYSWGENETDVLLLNN 0.07% (n=2)
SGTPTYNWGENKTDVLILNN 0.07% (n=2)
FGVPTYNWGENQTDVLLLNN 0.07% (n=2)
FGVPTYRWGANETDVLLLNN 0.07% (n=2)
SGVPTYSWGANETDVLLLNN 0.07% (n=2)
FGAPTYNWGVNETDVLILNN 0.07% (n=2)
AGVPTYSWGENETDVLLLNN 0.07% (n=2)
HGVPTYNWGENETDVLLLNN 0.07% (n=2)
HGVPTYRWGENETDVLLLNN 0.07% (n=2)
LGVPTYTWGENEADVLLLNN 0.07% (n=2)
SGVPTYNWGANETDVLLLNN 0.07% (n=2)
FGIPTYTWGENETDVLLLNN 0.07% (n=2)
FGVPTYNWGENETDVLLLNS 0.07% (n=2)
SGVPTYTWGGNETDVLLLNN 0.07% (n=2)
LGVPTYTWGENKTDVLLLNN 0.07% (n=2)
LDVPTYSWGENETDVLLLNN 0.07% (n=2)
HGVPTYTWGENKTDVLLLNN 0.07% (n=2)
YGAPTYNWGGNETDVLLLNN 0.07% (n=2)
FGAPTYNWGGNETDVLILNN 0.07% (n=2)
SGAPTYNWGDNETDVLLLNN 0.07% (n=2)
FGVPTYSWGENATDVLLLNN 0.07% (n=2)
SGVPTYNWGENETDVLILNN 0.07% (n=2)
SGAPTYTWGESETDVL---- 0.07% (n=2)
FGAPTFSWGENETDVLLLNN 0.07% (n=2)
FGVPTFSWGENETDVLLLNN 0.07% (n=2)
SGAPTFNWGENETDVLILNN 0.07% (n=2)
RGVPTYTWGGNKSDVLLLNN 0.07% (n=2)
FGAPTYRWGANETDVLLLNN 0.07% (n=2)
--------GESETDVLPLNN 0.07% (n=2)
FGTPTYNWGENETDVLFLTN 0.07% (n=2)
LGAPTSVRGENGTDVLLLNN 0.03% (n=1)
FGAPTYNWGENETDVLLLNS 0.03% (n=1)
FGAPTYSWGENETDVLLLNS 0.03% (n=1)
LGVRTYNWGENETDVLLLNN 0.03% (n=1)
SGAPTYNWGANETDVLYLNN 0.03% (n=1)
SGAPTYSWGENETDVLLLNS 0.03% (n=1)
LGNPTYSWGENDTDVLLLNN 0.03% (n=1)
LGVPTYSWGENVTDVLLLNN 0.03% (n=1)
FGAPTYKWGENETDVLILNN 0.03% (n=1)
SGVPTYNWGVNESDVLLLNN 0.03% (n=1)
SGAPTYNWGENETDVLVLNN 0.03% (n=1)
FGVPTYNWGENETDVLYLNN 0.03% (n=1)
TGAPTYRWGENETDVLILNN 0.03% (n=1)
FGVRT--------------- 0.03% (n=1)
SSVPT--------------- 0.03% (n=1)
FSVPT--------------- 0.03% (n=1)
FGTPTYSWGENETDVLLLNN 0.03% (n=1)
FGARKYSWGENETDVLLLNN 0.03% (n=1)
FGASTYSWGENETDVLLLNN 0.03% (n=1)
FGAPTYSWGENETNVLLLNN 0.03% (n=1)
HGVPTYSWGENGTDVLLLNN 0.03% (n=1)
SGVPTYRWGDNETDVLLLNN 0.03% (n=1)
FGAPTYNWGENKTDVLLLNN 0.03% (n=1)
SGAPTYTWGENETDVMILNN 0.03% (n=1)
SGTPTYRWGENETDVLILNS 0.03% (n=1)
FGAPTYSWRENETDVLLLNN 0.03% (n=1)
FGPPTYSWGENETDVLLLNN 0.03% (n=1)
YGAPTYTWGVNETDVLILNN 0.03% (n=1)
FGAPTYSWGANETDVLILNN 0.03% (n=1)
LGVPTYTWGENETNVLLLNN 0.03% (n=1)
FGVPTYRWGENETDVLLLKN 0.03% (n=1)
FGVPTYRWGENETDVLLPKK 0.03% (n=1)
FGVPTYRWGEKETDVLLLNN 0.03% (n=1)
FGVSTYTWGENETDVLLLNN 0.03% (n=1)
FGVPTYSWGENKTDVLLLKK 0.03% (n=1)
FGVPTYRWGEIETDVLLLNN 0.03% (n=1)
SGVPTYSWGGNETDVLLLKN 0.03% (n=1)
PGVPTYSWGGNETDVLLLNN 0.03% (n=1)
SGVPTYSGRGIETDVRFLKN 0.03% (n=1)
PGVPTYMWGEYETDVLSLKN 0.03% (n=1)
SGVPTYSWGGNETDMLFLKN 0.03% (n=1)
SGVPTYSWGGIKPDVLLLKK 0.03% (n=1)
SGVPTYSWGGNETDVLRLKK 0.03% (n=1)
SGVPTYSWGGNRTDVLLLNN 0.03% (n=1)
F------------------- 0.03% (n=1)
FGVPTYSWGENETDVLVLNN 0.03% (n=1)
YGVPTYSWGENDTDVLLLNN 0.03% (n=1)
SSVPTYRWGENETDVLLLNN 0.03% (n=1)
FGVPTYSWGENETCVLLLNN 0.03% (n=1)
FGAPTYRWGENETDVLILNN 0.03% (n=1)
FGAPTYTWGENVTDVLILNN 0.03% (n=1)
SGVPTYTWGGNKTDVLLLNN 0.03% (n=1)
HGVPTFTWGEKETDVLLLNN 0.03% (n=1)
TGVPTYSWGGNKTDVLLLNN 0.03% (n=1)
YGAPTYSWGENETDVLLLNN 0.03% (n=1)
LGAPTYNWGGNETDVLILNN 0.03% (n=1)
LGNPTYTWGGNETDVLLLNN 0.03% (n=1)
LGDPTYNWGENETDVLLLNN 0.03% (n=1)
LGVPTYNWGENGSDVLLLNN 0.03% (n=1)
FGVPTHNWGGNASDVLLLNN 0.03% (n=1)
FGVPTYNWGGNVTDVLLLNN 0.03% (n=1)
FGVPTYNWGENETDVLFLNN 0.03% (n=1)
FGAPTYSWGVNETDVLLLNN 0.03% (n=1)
YGAPTYTWGENETDVLILNN 0.03% (n=1)
LGAPTYNWGENVTDVLILNN 0.03% (n=1)
LGVPTYGWGANETDVLLLNN 0.03% (n=1)
LGVPTYSWGANETDVLLLNN 0.03% (n=1)
FGAPTFTWGENVTDVLLLNN 0.03% (n=1)
SGVPTYDWGGNETDVLLLNN 0.03% (n=1)
FGVPTYRWGGNETDVLLLNN 0.03% (n=1)
HGVPTYTWGANETDVLLLNN 0.03% (n=1)
SGAPTYTWGENETDVLILNS 0.03% (n=1)
FGNPTYNWGENKTDVLLLNN 0.03% (n=1)
SGDPTYNWGGNETDVLLLNN 0.03% (n=1)
CGVPTYSWGENKTDVLLLNN 0.03% (n=1)
SGAPTYRWGANESDVLILNN 0.03% (n=1)
YGVPTYSWGGNKTDVLLLNN 0.03% (n=1)
FGAPTYNWGENETDVLLLDN 0.03% (n=1)
SGAPTYNWGDNETDVLILNN 0.03% (n=1)
SGVPTYDWGENETDVLLLNN 0.03% (n=1)
FGVPTYNWGENATDVLLLNN 0.03% (n=1)
LGVPTYRWGENETDVLLLNS 0.03% (n=1)
FGVPTYNWGANETDVLLLNN 0.03% (n=1)
LGAPTYAWGGNETDVLLLNN 0.03% (n=1)
SGVPTYGWGANETDVLLLNN 0.03% (n=1)
SGNPTYTWGENATDVLLLNN 0.03% (n=1)
FGAPTYNWGENETDVLVLNN 0.03% (n=1)
SGAPTYNWGGNETDVLILNN 0.03% (n=1)
VGVPTYTWGENETDVLLLNN 0.03% (n=1)
FGVPTCTWGENETDVLLLNN 0.03% (n=1)
FGVPTYTWEENETDVLLLNN 0.03% (n=1)
FGAPTYSWGENGTDVLLLNN 0.03% (n=1)
FGAPTYSWGANETDVLILNS 0.03% (n=1)
YGAPTYTWGENETDVLLLNN 0.03% (n=1)
SGVPTYNWGENETDVLFLNN 0.03% (n=1)
SGTPTYNWGGNETDVLLLNN 0.03% (n=1)
SGAPTYNWGVNETDVLILNN 0.03% (n=1)
HGAPTYSWGENETDVLILNN 0.03% (n=1)
LGVPTYSWGGNTSDVLLLNN 0.03% (n=1)
SGAPTYTWGENKTDVLLLNN 0.03% (n=1)
RGAPTYNWGENATDVLVLNN 0.03% (n=1)
LGVPTYSWGGNKSDVLLLNN 0.03% (n=1)
YGAPTYNWGENETDVLLLNN 0.03% (n=1)
LGVPTYNWGENATDVLLLNN 0.03% (n=1)
TGAPTYNWGENETDVLLLNN 0.03% (n=1)
LGAPTYNWGENETDVLLLNN 0.03% (n=1)
SGAPTYNWGANETDVLVLNN 0.03% (n=1)
SGVPTYNWGANETDVLVLNN 0.03% (n=1)
--------------VLFLNN 0.03% (n=1)
RGVPTYNWGGNVTDVLLLNN 0.03% (n=1)
FGTATFNWGGNETDVLLLNN 0.03% (n=1)
FGVPTYSWGDNETDVLLLNN 0.03% (n=1)
LGVPTYNWGENKSDVLLLNN 0.03% (n=1)
HGVPTYNWGDNETDVLLLNN 0.03% (n=1)
FGVPTYAWGANETDVLLLNN 0.03% (n=1)
SGAPTYTWGTNESDVLLLNN 0.03% (n=1)
LGVPTYSWGDNETDVLLLNN 0.03% (n=1)
LGVPTYSWGENEADVLLLNN 0.03% (n=1)
FGVPSYRWGENETDVLLLNN 0.03% (n=1)
HGVPTYTWGENETDVLLLNN 0.03% (n=1)
LGVPTYTWGGNETDVLLLNN 0.03% (n=1)
FGAPTYTWGANETDVLYLNN 0.03% (n=1)
SGVPTYSWGENETDVLILNN 0.03% (n=1)
FGAPTYKWGENETDVLLLNN 0.03% (n=1)
SGVPTYNWGVNETDVLLLNN 0.03% (n=1)
FGVPTYTWGDNETDVLLLNN 0.03% (n=1)
SGVPTYRWGENETDVLLPNN 0.03% (n=1)
SGVPTYRWGENGTDVLLLNN 0.03% (n=1)
YGVPTYNWGGNETDVLLLNN 0.03% (n=1)
LGAPTYNWGENETDVLLLNS 0.03% (n=1)
SSRRSYILGENETDVLLLNN 0.03% (n=1)
FGVPTYSWGENETNVLLLNN 0.03% (n=1)
SGVPTYRWGENETDVLLFNN 0.03% (n=1)
FGVPTYSWGENETDVLLPNN 0.03% (n=1)
FGVPTYRWGDNETDVLLLNN 0.03% (n=1)
FGAPTYNWGVNETDVLLLNN 0.03% (n=1)
AGVPTYNWGENETDVLLLNN 0.03% (n=1)
FGVPTYTWGGNASDVLLLNN 0.03% (n=1)
LGVPTYSWGGNATDVLLLNN 0.03% (n=1)
LGVPTYSWGENKSDVLLLNN 0.03% (n=1)
SGAPTYTWGGNETDVLLLNN 0.03% (n=1)
RGVPTYSWGENDTDVLLLNN 0.03% (n=1)
SGVPTYNWGDNETDVLLLNN 0.03% (n=1)
LGLPTYNWGENETDVLLLNN 0.03% (n=1)
RGVPTYSWGANETDVLLLNN 0.03% (n=1)
FGAPTYRWGENESDVLILNN 0.03% (n=1)
FGVPTYNWGANQTDVLLLNN 0.03% (n=1)
FGIPTYSWGENETDVLLLNN 0.03% (n=1)
SGAPTYHWGENKTDVLLLNN 0.03% (n=1)
FGAPTYNWGENATDVLVLNN 0.03% (n=1)
SGAPTYTWGENDTDVLVLNN 0.03% (n=1)
LGVPTYSWGENKTDVLLLNN 0.03% (n=1)
RGVPTYRWGENSSDVLLLNN 0.03% (n=1)
RGVPTYSWGENETDVLVLNN 0.03% (n=1)
HGVPTFSWGENETDVLLLNN 0.03% (n=1)
FGVPTYSWGANKTDVLLLNN 0.03% (n=1)
FGVPTYSWGENETDVLFLNN 0.03% (n=1)
FGAPTYSWGGNETDVLLLNN 0.03% (n=1)
LGVPTYTWGANETDVLLLNN 0.03% (n=1)
FGTPTYTWGENKTDVLLLNN 0.03% (n=1)
LGAPTYTWGENATDVLLLNN 0.03% (n=1)
RGVPTYSWGGNKTDVLLLTN 0.03% (n=1)
SGVPTYTWGDNETDVLLLNN 0.03% (n=1)
YGAPTYNWGENETDVLILNN 0.03% (n=1)
FGNPTYRWGENKTDVLLLNN 0.03% (n=1)
SGAPTYTWGENETDVMILNS 0.03% (n=1)
SGVPTYSWGESETDVLLLNN 0.03% (n=1)
FGAPTYTWGGNETDVLLLNN 0.03% (n=1)
SGVPTYRWGENKTDVLLLNN 0.03% (n=1)
HGDPTYTWGGNETDVLLLNN 0.03% (n=1)
LGVPTYTWGENETDVLVLNN 0.03% (n=1)
SGVPTYTWGENQTDVLLLNN 0.03% (n=1)
FGTPTYTWGENGTDVLLLNN 0.03% (n=1)
RGVPTYNWGGNETDVLLLNN 0.03% (n=1)
SGTPTYTWGENKTDVLLLNN 0.03% (n=1)
SGVPTYTWGENETDVLFLNN 0.03% (n=1)
FGVPTYNWGANETDVLYLNN 0.03% (n=1)
SGAPTYNWGANETDVLILNN 0.03% (n=1)
SGVPTYTWGTNETDVLFLNN 0.03% (n=1)
FGVPTYNWGENVTDVLLLNN 0.03% (n=1)
SGAPTYSWGENKTDVLILNN 0.03% (n=1)
LGAPTYNWGANETDVLVLNN 0.03% (n=1)
VGVPTYNWGENETDVLLLNN 0.03% (n=1)
FGAPTYRWGANETDVLILNN 0.03% (n=1)
RGVPTYTWGVNETDVLLLNN 0.03% (n=1)
HGVPTYDWGENETDVLLLNN 0.03% (n=1)
FGAPTYSWGGNETDVLILNN 0.03% (n=1)
SGAPTYGWGENETDVLLLNN 0.03% (n=1)
FGVPTYSWGENETDVLHLNN 0.03% (n=1)
FGVPTYSWGEDETDVLLLNN 0.03% (n=1)
FGAPTYSRGENEADVLLLNN 0.03% (n=1)
FGAPTYSWGENETDALLLNN 0.03% (n=1)
SGVPTYQWGENKTDVLLLNN 0.03% (n=1)
DGVPTYGWGGNETDVLLLNN 0.03% (n=1)
FGVPTYSWGENQTDVLLLNN 0.03% (n=1)
FGVPTYTWGENETGVLLLNN 0.03% (n=1)
SGVPTYSWGRNETDVLVLNN 0.03% (n=1)
SGVPTYSWGKNETDVLVLDN 0.03% (n=1)
SGVPTYSWGKNETDMLVLNN 0.03% (n=1)
FGVPTHTWGENETDVLLLNN 0.03% (n=1)
FGAPTYNWGENETDVL-LNN 0.03% (n=1)
PGVPTYSWGKNETDVLVLNN 0.03% (n=1)
SGVPTYSWGENETDALVLNN 0.03% (n=1)
SGAPTHTWGENETDVL---- 0.03% (n=1)
FGVPTYSWGENESDVLLLNN 0.03% (n=1)
FGVPTYSWGENETDVLPLNN 0.03% (n=1)
FGAPTYTWGENGTDVLLLNN 0.03% (n=1)
FGAPTYTWGRNETDVLLLNN 0.03% (n=1)
FGAPTYTWGESETDVLLLNN 0.03% (n=1)
FGAPTYRRGGNETDVLLLNN 0.03% (n=1)
FGAPTFTWGENETDVLLLNN 0.03% (n=1)
FGVPTYNWGGNATDVLLLNN 0.03% (n=1)
SGTPTFSWGENETDVLLLNN 0.03% (n=1)
SGVPTFSWGENDTDVLLLNN 0.03% (n=1)
SGTPTYSWGENVTDVLLLNN 0.03% (n=1)
FGTPTFSWGENQTDVLLLNN 0.03% (n=1)
SGAPTFSWGEKETDVLLLNN 0.03% (n=1)
SGVPTFSWGENETDVLLLNN 0.03% (n=1)
AGVPTYTWGENETDVLLLNN 0.03% (n=1)
LGAPTYSWGENETDVLILNN 0.03% (n=1)
FGAPTYAWGENETDVLLLNN 0.03% (n=1)
SGVPTYNWGENVTDVLLLNN 0.03% (n=1)
FGVPTYQWGENESDVLLLNN 0.03% (n=1)
FGAPTYSWGENETDVLLQNN 0.03% (n=1)
YGAPTFSWGENETDVLLLNN 0.03% (n=1)
--------GENEIDVLLLNN 0.03% (n=1)
--------GENESDVLLLNN 0.03% (n=1)
AGVPTYTWGGNETDVLLLNN 0.03% (n=1)
--------GENEIDVLILNN 0.03% (n=1)
--------GENETDVLILNN 0.03% (n=1)
FGVPTYRWGENETDALLLNN 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 2:

QGVPTYSWGENETDVFLLNS 15.18% (n=80)
QGAPTYSWGENETDVFLLNS 13.85% (n=73)
RGVPTYNWGDNETDVFLLNS 12.71% (n=67)
RGVPTYTWGENETDVFLLNS 6.64% (n=35)
LGVPTYTWGENETDVFLLNS 5.31% (n=28)
QGVPTYTWGENETDVFLLNS 4.36% (n=23)
QGVPTYNWGENETDVFLLNS 2.47% (n=13)
AGVPTYTWGENETDVFLLNS 2.28% (n=12)
LGAPTYTWGENETDVFLLNS 1.71% (n=9)
QGVPTYSWGENETDVFVLNS 1.33% (n=7)
RGVPTYSWGENETDVFLLNS 1.33% (n=7)
QGAPTYGWGENETDVFLLNS 1.14% (n=6)
AGVPTYSWGENETDVFLLNS 0.95% (n=5)
AGAPTYTWGENETDVFLLNS 0.95% (n=5)
TGVPTYGWGENETDVFLLNS 0.95% (n=5)
LGVPTYSWGENETDVFLLNS 0.76% (n=4)
QGVPTYNWGDNETDVFLLNS 0.76% (n=4)
QGAPTYNWGENETDVFLLNS 0.76% (n=4)
TGVPTYTWGENETDVFLLNS 0.76% (n=4)
LGVPTYTWGENETDVFILNS 0.57% (n=3)
FGVPTYTWGENETDVFLLNS 0.57% (n=3)
QGVPTYSWGANETDVFLLNS 0.57% (n=3)
QGVPTYTWGENDTDVFLLNS 0.57% (n=3)
QGAPTYRWGENETDVFLLNS 0.57% (n=3)
LGVPTYNWGENETDVFLLNS 0.57% (n=3)
YGVPTYTWGENETDVFLLNS 0.57% (n=3)
AGAPTYNWGENETDVFLLNS 0.57% (n=3)
TGVPTYNWGENETDVFLLNS 0.57% (n=3)
LGVPT--------------- 0.38% (n=2)
PGAPPRTGEGNETDVFLLNS 0.38% (n=2)
LGVPTYTWGENETDVFLLNT 0.38% (n=2)
RGAPTYTWGENETDVFLLNS 0.38% (n=2)
LGVPTYTWGENDTDVFLLNS 0.38% (n=2)
QGVPTYSWGENQTDVFLLNS 0.38% (n=2)
QGVPTYTWGENETDVFILNS 0.38% (n=2)
QGLPTYTWGENETDVFLLNS 0.38% (n=2)
SGVPTYSWGENETDVFLLNS 0.38% (n=2)
QGAPTYSWGENETDVFVLNS 0.38% (n=2)
TGAPTYTWGENETDVFLLNS 0.38% (n=2)
SGAPTYTWGENETDVFLLNS 0.38% (n=2)
RGVPTYTWGENDTDVFLLNS 0.38% (n=2)
LEAPTYTWGENETDVFLLNS 0.19% (n=1)
SGVPTYTWGENETDVFLLNS 0.19% (n=1)
RGAPTYTWGENDTNVFLLNS 0.19% (n=1)
RGVPTYRWGENETDVFLLNS 0.19% (n=1)
LGVPTYTWGGNETDVFLLNS 0.19% (n=1)
PGAPTRMWEGNETDVFLLNS 0.19% (n=1)
PGAPTRMGEGNETDVFLLNS 0.19% (n=1)
PGAPPHTGEGNETDVFLLNS 0.19% (n=1)
YGAPTYTWGENETDFFLLKS 0.19% (n=1)
RGVPTYTWGANETDFLILGS 0.19% (n=1)
LGVPTYTWGENETDVFVLNS 0.19% (n=1)
RGVPTYTWGENESDVFILNS 0.19% (n=1)
RGVPTYTWGENETDFFLLNS 0.19% (n=1)
LGVPTYTWGENESDVFLLNS 0.19% (n=1)
QGVPTYTWGVNETDVFLLNS 0.19% (n=1)
QGVPTYNWGENETDVFMLNS 0.19% (n=1)
EGVPTYSWGANETDVFLLNS 0.19% (n=1)
QGVPTYRWGERETDVFLLNS 0.19% (n=1)
RGAPTYRWGENETDVFLLNS 0.19% (n=1)
QGAPTYRWGENETDVFILNS 0.19% (n=1)
QGVPTYSWGENETDVFLLNG 0.19% (n=1)
QGAPTCPWRRNDTDVFVLNS 0.19% (n=1)
QGAPTYSWGANETDVFLLNS 0.19% (n=1)
EGVPTYSWGENETDVFLLNS 0.19% (n=1)
QGVPTHTWGENETDVFLLNS 0.19% (n=1)
QGIPTYSWGENETDVFILNS 0.19% (n=1)
QGVPTYTWGDNETDVFLLNS 0.19% (n=1)
QGVPTYAWGENETDVFLLNS 0.19% (n=1)
QGIPTYTWGDNETDVFLLNS 0.19% (n=1)
QGTPTYTWGENETDVFLLNS 0.19% (n=1)
HGVPTYTWGANETDVFLLNS 0.19% (n=1)
EGVPTYTWGENETDVFLLNS 0.19% (n=1)
QGVPTYSWGENETDVFLINS 0.19% (n=1)
QGVPTYTWGENETDVFVLNS 0.19% (n=1)
QGAPTYMWGENETDVFLLNS 0.19% (n=1)
QGVPTYNWGGNDTDVFLLNS 0.19% (n=1)
RGVPTYNWGDNGTDVFLLNS 0.19% (n=1)
RGVPTYNWGENETDVSLLNS 0.19% (n=1)
RGVPTYNWGENETDVFLLSS 0.19% (n=1)
QGVPTYNWGENETDVLLLNS 0.19% (n=1)
QGVPTYRWGENETDVFLLNS 0.19% (n=1)
QGVPTYSWGENESDVFLLNS 0.19% (n=1)
LGVPTYSWGENDTDVFLLNS 0.19% (n=1)
LGVPTYNWGENDTDVFLLNS 0.19% (n=1)
QGLPTYSWGENETDVFLLNS 0.19% (n=1)
QGVPTYDWGQNETDVFLLNS 0.19% (n=1)
LGAPTYSWGENETDVFLLNS 0.19% (n=1)
QGVATYTWGANDTDVFLLNS 0.19% (n=1)
QGVPTYSWGVNETDVFLLNS 0.19% (n=1)
LGTPTYTWGENKTDVFLLNS 0.19% (n=1)
FGVPTYSWGENETDLFLLNS 0.19% (n=1)
QGMPTYTWGENDTDFFLLNS 0.19% (n=1)
QGAPTYTWGENETDVFLLNS 0.19% (n=1)
HGVPTYSWGDNETDVFLLNS 0.19% (n=1)
TGMPTYNWGESEKDVFVLNS 0.19% (n=1)
FGAPTYNWGENETDVLLLNS 0.19% (n=1)
AGVPTYTWGANETDVFLLNS 0.19% (n=1)
AGVPTYNWGENETDVFVLNS 0.19% (n=1)
FGVPTYNWGENETDVFLLNS 0.19% (n=1)
AGVPTYTWGGNDTDVFLLNS 0.19% (n=1)
AGVPTYTWEENETDVFLLNS 0.19% (n=1)
AGVPTYNWGENETDVFLLNS 0.19% (n=1)
TGQPTYTWGGNVKDVFLLNS 0.19% (n=1)
SGVPTYNWGENETDVFLLNS 0.19% (n=1)
AGAPTYTWGANETDVFLLNS 0.19% (n=1)
AGVPTYGWGENETDVFLLNS 0.19% (n=1)
VGVPTYNWGENETDVFLLNS 0.19% (n=1)
NGAPTYNWGENETDVFLLNS 0.19% (n=1)
FGVPTYSWGENETDVFLLNS 0.19% (n=1)
FGAPTYTWGENETDVFVLNS 0.19% (n=1)
LGVPTYSWGGGDKDVFLLNS 0.19% (n=1)
FGVPTYTWGENETDFFLLNS 0.19% (n=1)
YGAPTYTWGENETDVFILNS 0.19% (n=1)
QGVPTYKWGENETDVFLLNS 0.19% (n=1)
FGVPTYKWGENETDVFLLNS 0.19% (n=1)
RGVPTYNWGENETDVFLLNS 0.19% (n=1)
RGVPTYTWGDNETDVFLLNS 0.19% (n=1)
LGVPTYSWGVNETDVFLLNS 0.19% (n=1)
QGVPAYTWGENETDVFLLNS 0.19% (n=1)
LGVPTYNWGANETDVFLLNS 0.19% (n=1)
RGVPTYTWGENESDVFLLNS 0.19% (n=1)
FGAPTYNWGENETDVFLLNS 0.19% (n=1)
ARVPTYSWGENETDVFLLNN 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 2a:

RGVPTYTWGENETDVFLLNS 32.47% (n=25)
LGVPTYTWGENETDVFLLNS 22.08% (n=17)
LGAPTYTWGENETDVFLLNS 10.39% (n=8)
LGVPTYTWGENETDVFILNS 3.90% (n=3)
LGVPT--------------- 2.60% (n=2)
PGAPPRTGEGNETDVFLLNS 2.60% (n=2)
LGVPTYTWGENETDVFLLNT 2.60% (n=2)
LEAPTYTWGENETDVFLLNS 1.30% (n=1)
SGVPTYTWGENETDVFLLNS 1.30% (n=1)
RGAPTYTWGENDTNVFLLNS 1.30% (n=1)
RGVPTYRWGENETDVFLLNS 1.30% (n=1)
LGVPTYTWGGNETDVFLLNS 1.30% (n=1)
LGVPTYSWGENETDVFLLNS 1.30% (n=1)
PGAPTRMWEGNETDVFLLNS 1.30% (n=1)
PGAPTRMGEGNETDVFLLNS 1.30% (n=1)
PGAPPHTGEGNETDVFLLNS 1.30% (n=1)
YGAPTYTWGENETDFFLLKS 1.30% (n=1)
FGVPTYTWGENETDVFLLNS 1.30% (n=1)
RGVPTYTWGANETDFLILGS 1.30% (n=1)
RGAPTYTWGENETDVFLLNS 1.30% (n=1)
LGVPTYTWGENETDVFVLNS 1.30% (n=1)
RGVPTYTWGENESDVFILNS 1.30% (n=1)
RGVPTYTWGENETDFFLLNS 1.30% (n=1)
LGVPTYTWGENDTDVFLLNS 1.30% (n=1)
LGVPTYTWGENESDVFLLNS 1.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 2b:

QGVPTYSWGENETDVFLLNS 22.86% (n=80)
QGAPTYSWGENETDVFLLNS 20.86% (n=73)
RGVPTYNWGDNETDVFLLNS 19.14% (n=67)
QGVPTYTWGENETDVFLLNS 6.29% (n=22)
QGVPTYNWGENETDVFLLNS 3.43% (n=12)
QGVPTYSWGENETDVFVLNS 2.00% (n=7)
QGAPTYGWGENETDVFLLNS 1.71% (n=6)
RGVPTYTWGENETDVFLLNS 1.43% (n=5)
QGVPTYNWGDNETDVFLLNS 1.14% (n=4)
QGAPTYNWGENETDVFLLNS 1.14% (n=4)
RGVPTYSWGENETDVFLLNS 1.14% (n=4)
QGVPTYSWGANETDVFLLNS 0.86% (n=3)
QGVPTYTWGENDTDVFLLNS 0.86% (n=3)
QGAPTYRWGENETDVFLLNS 0.86% (n=3)
QGVPTYSWGENQTDVFLLNS 0.57% (n=2)
QGVPTYTWGENETDVFILNS 0.57% (n=2)
QGLPTYTWGENETDVFLLNS 0.57% (n=2)
QGAPTYSWGENETDVFVLNS 0.57% (n=2)
LGVPTYTWGENETDVFLLNS 0.57% (n=2)
YGVPTYTWGENETDVFLLNS 0.57% (n=2)
QGVPTYTWGVNETDVFLLNS 0.29% (n=1)
QGVPTYNWGENETDVFMLNS 0.29% (n=1)
EGVPTYSWGANETDVFLLNS 0.29% (n=1)
RGAPTYTWGENETDVFLLNS 0.29% (n=1)
QGVPTYRWGERETDVFLLNS 0.29% (n=1)
RGAPTYRWGENETDVFLLNS 0.29% (n=1)
QGAPTYRWGENETDVFILNS 0.29% (n=1)
QGVPTYSWGENETDVFLLNG 0.29% (n=1)
QGAPTCPWRRNDTDVFVLNS 0.29% (n=1)
QGAPTYSWGANETDVFLLNS 0.29% (n=1)
EGVPTYSWGENETDVFLLNS 0.29% (n=1)
QGVPTHTWGENETDVFLLNS 0.29% (n=1)
LGVPTYSWGENETDVFLLNS 0.29% (n=1)
QGIPTYSWGENETDVFILNS 0.29% (n=1)
QGVPTYTWGDNETDVFLLNS 0.29% (n=1)
QGVPTYAWGENETDVFLLNS 0.29% (n=1)
QGIPTYTWGDNETDVFLLNS 0.29% (n=1)
QGTPTYTWGENETDVFLLNS 0.29% (n=1)
HGVPTYTWGANETDVFLLNS 0.29% (n=1)
SGVPTYSWGENETDVFLLNS 0.29% (n=1)
EGVPTYTWGENETDVFLLNS 0.29% (n=1)
QGVPTYSWGENETDVFLINS 0.29% (n=1)
QGVPTYTWGENETDVFVLNS 0.29% (n=1)
QGAPTYMWGENETDVFLLNS 0.29% (n=1)
QGVPTYNWGGNDTDVFLLNS 0.29% (n=1)
RGVPTYNWGDNGTDVFLLNS 0.29% (n=1)
RGVPTYNWGENETDVSLLNS 0.29% (n=1)
RGVPTYNWGENETDVFLLSS 0.29% (n=1)
QGVPTYNWGENETDVLLLNS 0.29% (n=1)
QGVPTYRWGENETDVFLLNS 0.29% (n=1)
QGVPTYSWGENESDVFLLNS 0.29% (n=1)
LGVPTYSWGENDTDVFLLNS 0.29% (n=1)
LGVPTYNWGENDTDVFLLNS 0.29% (n=1)
QGLPTYSWGENETDVFLLNS 0.29% (n=1)
QGVPTYDWGQNETDVFLLNS 0.29% (n=1)
LGAPTYSWGENETDVFLLNS 0.29% (n=1)
LGVPTYNWGENETDVFLLNS 0.29% (n=1)
QGVATYTWGANDTDVFLLNS 0.29% (n=1)
QGVPTYSWGVNETDVFLLNS 0.29% (n=1)
LGTPTYTWGENKTDVFLLNS 0.29% (n=1)
FGVPTYSWGENETDLFLLNS 0.29% (n=1)
QGMPTYTWGENDTDFFLLNS 0.29% (n=1)
QGAPTYTWGENETDVFLLNS 0.29% (n=1)
HGVPTYSWGDNETDVFLLNS 0.29% (n=1)
LGVPTYTWGENDTDVFLLNS 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 2c:

AGVPTYTWGENETDVFLLNS 20.00% (n=12)
AGVPTYSWGENETDVFLLNS 8.33% (n=5)
TGVPTYGWGENETDVFLLNS 8.33% (n=5)
TGVPTYTWGENETDVFLLNS 6.67% (n=4)
AGAPTYNWGENETDVFLLNS 5.00% (n=3)
LGVPTYTWGENETDVFLLNS 5.00% (n=3)
AGAPTYTWGENETDVFLLNS 5.00% (n=3)
TGVPTYNWGENETDVFLLNS 5.00% (n=3)
FGVPTYTWGENETDVFLLNS 3.33% (n=2)
LGVPTYNWGENETDVFLLNS 3.33% (n=2)
TGAPTYTWGENETDVFLLNS 3.33% (n=2)
TGMPTYNWGESEKDVFVLNS 1.67% (n=1)
FGAPTYNWGENETDVLLLNS 1.67% (n=1)
AGVPTYTWGANETDVFLLNS 1.67% (n=1)
AGVPTYNWGENETDVFVLNS 1.67% (n=1)
LGVPTYSWGENETDVFLLNS 1.67% (n=1)
FGVPTYNWGENETDVFLLNS 1.67% (n=1)
AGVPTYTWGGNDTDVFLLNS 1.67% (n=1)
AGVPTYTWEENETDVFLLNS 1.67% (n=1)
AGVPTYNWGENETDVFLLNS 1.67% (n=1)
TGQPTYTWGGNVKDVFLLNS 1.67% (n=1)
SGVPTYNWGENETDVFLLNS 1.67% (n=1)
AGAPTYTWGANETDVFLLNS 1.67% (n=1)
RGVPTYSWGENETDVFLLNS 1.67% (n=1)
RGVPTYTWGENETDVFLLNS 1.67% (n=1)
AGVPTYGWGENETDVFLLNS 1.67% (n=1)
NGAPTYNWGENETDVFLLNS 1.67% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 3:

RGAPTYTWGANETDVFLLRS 11.35% (n=311)
KGVPTYTWGENKTDVFLLES 6.13% (n=168)
KGVPTYNWGENETDVFLLES 3.68% (n=101)
KGAPTYTWGENETDVFLLES 2.96% (n=81)
KGLPTYNFGANETDVFLLTS 2.85% (n=78)
KGVPTYNWGANETDVFLLES 2.81% (n=77)
KGAPTYTWGENETDVFLLKS 2.33% (n=64)
KGVPTYTWGENESDVFLLES 2.33% (n=64)
KGVPTYNWGENESDVFLLKS 2.23% (n=61)
KGVPTYTWGENETDVFLLES 2.04% (n=56)
KGVPTYNWGENETDVFLLKS 1.97% (n=54)
RGVPTYNWGANETDVFLLKS 1.75% (n=48)
KGAPTYNWGENETDVFLLKS 1.71% (n=47)
KGVPTYNWGANETDVFLLKS 1.35% (n=37)
KGAPTYTWGANETDVFLLES 1.24% (n=34)
KGAPTYNWGANESDVFLLES 1.20% (n=33)
KGLPTYNFGENETDVFLLTS 1.20% (n=33)
KGVPTYTWGENETDVFLLKS 1.13% (n=31)
KGVPTYTWGENDTDVFLLKS 1.09% (n=30)
KGVPTYNWGENKSDVFLLKS 1.02% (n=28)
KGSPTYNFGENETDVFLLTS 1.02% (n=28)
KGAPTYTWGANKTDVFLLDS 0.95% (n=26)
KGLPTYNFGANESDVFLLTS 0.95% (n=26)
KGAPTYNWGANVTDVFLLKS 0.88% (n=24)
KGLPTYNFGENETDVFLLNS 0.84% (n=23)
EGTPTYDWGENETDVFLLGS 0.77% (n=21)
KGVPTYNWGENETDVFLLGS 0.77% (n=21)
KGVPTYTWGANETDVFLLES 0.73% (n=20)
RGIPTYNWGANETDAFLLES 0.73% (n=20)
KGEPTYTWGENETDVFLLKS 0.73% (n=20)
KGVPTYTWGANETDVFLLNS 0.69% (n=19)
RGAPTYTWGANETDVFLLES 0.66% (n=18)
KGVPTYTWGANETDVFLLQS 0.62% (n=17)
RGAPTYTWGENETDVFLLES 0.58% (n=16)
KGVPTYNWGENESDVFLLES 0.55% (n=15)
KGVPTYAWGENETDVFLLES 0.55% (n=15)
KGLPTYNFGENETDVFLLKS 0.55% (n=15)
KGAPTYNWGENETDVFLLES 0.51% (n=14)
RGVPTYNWGENETDVFLLKS 0.51% (n=14)
----TYTWGANETDVFLLKS 0.47% (n=13)
KGVPTYSWGENETDVFLLKS 0.44% (n=12)
KGAPTFNWGENKTDVFLLKS 0.44% (n=12)
KGAPTFTWGENETDVFLLES 0.40% (n=11)
KGAPTYSWGANESDVFLLES 0.40% (n=11)
RGAPTYTWGENETDVFLLKS 0.40% (n=11)
KGVPTYNWGANESDVFLLKS 0.40% (n=11)
KGVPTYNWGENKSDVFLLES 0.36% (n=10)
KGAPTYNWGANESDVFLLKS 0.36% (n=10)
KGAPTFTWGENKTDVFLLES 0.33% (n=9)
KGLPTYNFGENKTDVFLLTS 0.33% (n=9)
KGAPTYTWGENESDVFLLES 0.29% (n=8)
KGLPTYSFGENETDVFLLTS 0.29% (n=8)
KGAPTYTWGANETDVFLLKS 0.26% (n=7)
KGAPTFNWGGNKTDVFLLKS 0.26% (n=7)
KGVPTYYWGENKTDVFLLES 0.22% (n=6)
KGAPTYTWGENATDVFLLKS 0.22% (n=6)
KGVPTYTWGENETDVFLLTS 0.22% (n=6)
RGAPTYNWGENETDVFLLES 0.22% (n=6)
KGVPTYTWGANETDVFLLKS 0.22% (n=6)
KGAPTYTWGANESDVFLLES 0.22% (n=6)
KGIPTYNWGANETDAFLLES 0.18% (n=5)
TGVPTYTWGENESDVFLLES 0.18% (n=5)
RGVPTYNWGENETDVFLLES 0.18% (n=5)
RGVPTYTWGENETDVFLLES 0.18% (n=5)
KGLPTYTFGENETDVFLLKS 0.18% (n=5)
KGAPTYGWGANESDVFLLKS 0.15% (n=4)
KGVPTYNWGENESDVFLLTS 0.15% (n=4)
KGAPTYNWGANETDVFLLES 0.15% (n=4)
KGVPTYSWGANETDVFLLKS 0.15% (n=4)
EGTPTYTWGENETDVFLLES 0.15% (n=4)
KGAPTYTWGANETDVFLLGS 0.15% (n=4)
AGAPTYTWGENESDVFLLQS 0.15% (n=4)
KGAPTYSWGANETDVFLLES 0.15% (n=4)
KGAPTYNWGENESDVFLLES 0.15% (n=4)
RGAPTYNWGENETDVFLLKS 0.15% (n=4)
KGVPTYTWGENETDVFLLRS 0.15% (n=4)
KGAPTYTWGANETDVFLLTS 0.15% (n=4)
KGAPTYSWGENETDVFLLES 0.15% (n=4)
RGVPTYTWGENETDVFLLKS 0.15% (n=4)
RGVPTYDWGENETDVFLLAS 0.15% (n=4)
KGSPTYNFGENETDVFLLNS 0.15% (n=4)
KGLPTYSFGENETDVFLLDS 0.15% (n=4)
EGVPTYTWGGNKTDVFLLKS 0.11% (n=3)
QGVPTYTWGGNETDVFLLKS 0.11% (n=3)
KGVPTYTWGTNETDVFLLKS 0.11% (n=3)
KGAPTYTWGGNETDVFLLES 0.11% (n=3)
KGAPTYNWGANETDVFLLKS 0.11% (n=3)
KGVPTFTWGENETDVFLLES 0.11% (n=3)
KGMPTYTWGENESDVFLLES 0.11% (n=3)
KGVPTYTWGANKTDVFLLNS 0.11% (n=3)
SGAPTYSWGENETDVFLLES 0.11% (n=3)
KGAPTYTWGANETDVFLLRS 0.11% (n=3)
RGAPTYNWGANESDVFLLTS 0.11% (n=3)
KGAPTYSWGENETDVFLLKS 0.11% (n=3)
QGVPTYTWGENETDVFLLKS 0.11% (n=3)
KGVPTYNWGGNETDVFLLKS 0.11% (n=3)
KGAPTYSWGAKESDVFLLES 0.11% (n=3)
RGAPTYTWGENESDVFLLES 0.11% (n=3)
KGAPTYTWGENETDVFLLQS 0.11% (n=3)
KGAPTYNWGENETDVFLLTS 0.11% (n=3)
KGVPTYTWGANESDVFLLKS 0.11% (n=3)
KGVPTYTWGENETDVFLLNS 0.11% (n=3)
KGVPTYTWGENETDVFLLDS 0.11% (n=3)
KGLPTYNFGGNESDVFLLTS 0.11% (n=3)
KGAPTYNFGENETDVFLLTS 0.11% (n=3)
KGSPTYNFGDNETDVFLLNS 0.11% (n=3)
KGLPTYNFGENETDVFLLDS 0.11% (n=3)
KGLPTYSFGENETDVFLLNS 0.11% (n=3)
RGLPTYNFGENETDVFLLTS 0.11% (n=3)
KGLPTYNFGENETDVFLLSS 0.11% (n=3)
KGLPTYTFGENETDVFLLNS 0.11% (n=3)
KGLPTYTFGENETDVFLLTS 0.11% (n=3)
KGLPTYSFGENESDVFLLTS 0.11% (n=3)
KGAPTYNWGANKTDVFLLES 0.07% (n=2)
KGTPTYTWGANDTDVFLLQS 0.07% (n=2)
KGVPTYTWGENETDVFLLQS 0.07% (n=2)
KGVPTYTWGANETDVFLLDS 0.07% (n=2)
RGVPTYTWGENEKDVFLLKS 0.07% (n=2)
KGAPTYTWGENESDVFLLNS 0.07% (n=2)
KGAPTYFWGANESDVFLLES 0.07% (n=2)
KGAPTYSWGANKSDVFLLES 0.07% (n=2)
KGAPTFTWGENVTDVFLLKS 0.07% (n=2)
RGAPTYTWGENETDVFLLTS 0.07% (n=2)
KGAPTYNWGENETDVFLLNP 0.07% (n=2)
KGVPTYTWGGNVTDVFLLES 0.07% (n=2)
QGVPTYTWGENETDVFLLNS 0.07% (n=2)
QGVPTYTWGENEADVFLLNS 0.07% (n=2)
GGAPTYSWGENETDVFLLTS 0.07% (n=2)
VGAPTYSWGENETDVFLLTS 0.07% (n=2)
RGAPTYSWGENETDVFLLTS 0.07% (n=2)
KGVPTYTRGENETDVFLLTS 0.07% (n=2)
KGTPTYTWGANETDVFLLKS 0.07% (n=2)
KGVPTYNWGANEADVFLLKS 0.07% (n=2)
KGAPTYTWGVNETDVFLLES 0.07% (n=2)
SGAPTYTWGENETDVFLLQS 0.07% (n=2)
RGAPTYNWGANETDVFMLES 0.07% (n=2)
KGVPIYTWGENDTDVFLLKS 0.07% (n=2)
RGSPTYTWGANETDVFLLRS 0.07% (n=2)
KGAPTYKWGENETDVFLLKS 0.07% (n=2)
KGVPTYTWGGNETDVFLLES 0.07% (n=2)
KGAPTYNWGENETDVFLLQS 0.07% (n=2)
KGAPTYSWGANETDVFLLKS 0.07% (n=2)
KGVPTYTWGANKTDVFLLES 0.07% (n=2)
KGVPTYRWGENETDVFLLKS 0.07% (n=2)
KGAPTYTWGGNETDVFLLKS 0.07% (n=2)
KGAPTYTWGANETDVFLLDS 0.07% (n=2)
KGAPTYTWGENETDVFLLNS 0.07% (n=2)
KGVPTYTWGENDTDVFLLES 0.07% (n=2)
KGAPTYDWGENETDVFLLES 0.07% (n=2)
KGVPTYTWGGNETDVFLLKS 0.07% (n=2)
----TYNWGENESDVFLLES 0.07% (n=2)
KGAPTYNWGENESDVFLLKS 0.07% (n=2)
KGNPTYTWGENKTDVFLLES 0.07% (n=2)
KGAPTYTWGTNETDVFLLRS 0.07% (n=2)
KGTPTYTWGANKTDVFLLES 0.07% (n=2)
KGAPTYTWGENETDVFLLDS 0.07% (n=2)
KGAPTYNWGENETDVFLLNS 0.07% (n=2)
KGAPTYNWGGNETDVFLLRS 0.07% (n=2)
KGAPTYTWGTNETDVFLLKS 0.07% (n=2)
KGAPTYTWGENETDVFLLGS 0.07% (n=2)
KGTPTYTWGENETDVFLLKS 0.07% (n=2)
KGAPTFTWGANKTDVFLLES 0.07% (n=2)
KGDPTYNWGENETDVFLLKS 0.07% (n=2)
RGTPTYTWGANKTDVFLLES 0.07% (n=2)
KGVPTYTWGENESDVFLLKS 0.07% (n=2)
KGVPTYTWGANDTDVFLLTS 0.07% (n=2)
KGAPTYTWGENATDVFLLES 0.07% (n=2)
KGTPTYTWGENETDVFLLES 0.07% (n=2)
RGAPTYTWGTNETDVFLLDS 0.07% (n=2)
RGVPTYTWGANETDVFLLKS 0.07% (n=2)
RGAPTYNWGANETDVFLLES 0.07% (n=2)
KGVPTYNWGANVSDVFLLKS 0.07% (n=2)
RGSPTYNFGENETDVFLLNS 0.07% (n=2)
KGLPTYNFGENETDVFLLES 0.07% (n=2)
KGLPTYNFGENDTDVFLLNS 0.07% (n=2)
KGLPTYNFGENETDVFLLPS 0.07% (n=2)
KGVPTYTFGENETDVVLLTS 0.07% (n=2)
KGVPTYTWGANDTDVFLLES 0.04% (n=1)
KGVPTYTWGENESDVFLLDS 0.04% (n=1)
KGVPTYTWGGNATDVFLLES 0.04% (n=1)
RGAPTYTWGENASDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYTWGENETDVFLLE- 0.04% (n=1)
KGVPTYSFGTNETDVFLLES 0.04% (n=1)
RGAPTYTWGTNETDVFLLES 0.04% (n=1)
EGAPTYTWGENVRDVFLLES 0.04% (n=1)
RGVPTYTWGANETDVFLLQS 0.04% (n=1)
KGVPTYTWDANETDVFLLNS 0.04% (n=1)
KGAPTYTWGANKTDVFLLES 0.04% (n=1)
KGAPTYNWGANETDMFLLQS 0.04% (n=1)
KGGPTYNWGGDETDVFLLKS 0.04% (n=1)
MGAPTYTWGENETDVFLLKS 0.04% (n=1)
KGASTYNWGADETDVFLLKS 0.04% (n=1)
KGASTYNWGGDETDVFLLKS 0.04% (n=1)
KGGSTYNWGGNETDVFLLKS 0.04% (n=1)
EGVPTFGWGGNKSDVFLLKS 0.04% (n=1)
EGVPRYNWGENATDVFLLQS 0.04% (n=1)
KGNPTYTWGENETDVFLLQS 0.04% (n=1)
KGIPTYSFGENETDCFLLES 0.04% (n=1)
KGAPTYTWGANTSDVFLLES 0.04% (n=1)
KGVPTYTWGGNESDVFLLES 0.04% (n=1)
RGLPTYNWGENETDVFLLKS 0.04% (n=1)
KGAPTYNWGADVTDVFLLKS 0.04% (n=1)
KGAPTYNWSANVTDVFLLKS 0.04% (n=1)
KGAPTYTWGEDGTDVFLLES 0.04% (n=1)
EGTPTYDWGENETDVFPLGS 0.04% (n=1)
EGTPTYDWGENEADVFLLGS 0.04% (n=1)
EGTPTYDWSENETDVFLLGS 0.04% (n=1)
EGTPTYDWGENETDVFLLES 0.04% (n=1)
EG-PTYDWGENETDVFLLGS 0.04% (n=1)
EGTSTYDWGENETDVFLLGS 0.04% (n=1)
RGIPTHNWGANETDAFLLES 0.04% (n=1)
KGAPTCTWGANETDVFLLES 0.04% (n=1)
KGVPTYYWGENETDVFLLES 0.04% (n=1)
KGVPTYNWGENKSDVLLLES 0.04% (n=1)
KGVPTYYWGENKTDMFLLES 0.04% (n=1)
KGVPTYCWGENKSDVFLLES 0.04% (n=1)
KGVPTYNFGENKTDVFLLES 0.04% (n=1)
KGAPTYSWGASESDVFLLES 0.04% (n=1)
KGAPTYSWGENETDVFLLRS 0.04% (n=1)
KGAPTYTWGENEADVFLLKS 0.04% (n=1)
KGAPTYTWGENETDAFLLKS 0.04% (n=1)
KGAPTYTWGENETDMFLLKS 0.04% (n=1)
KGAPTFTWGENETGVFLLES 0.04% (n=1)
KGVPTYNWGESESDVFLLKS 0.04% (n=1)
QGTPTYTWGENETDVFLLES 0.04% (n=1)
QGTPTYTWGENETDMFLLES 0.04% (n=1)
KGVPTYTWGENVTDVFLLES 0.04% (n=1)
KGVPTYPWGANKTEGFLLNS 0.04% (n=1)
RGVPTYSWGENEKDVFLLKS 0.04% (n=1)
KGRPTYNWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGENETDGFLLES 0.04% (n=1)
KGAPTYTWGANETDMFLLGS 0.04% (n=1)
RGAPTYTWSENETDVFLLES 0.04% (n=1)
SGAPTYSWSENETDVFLLES 0.04% (n=1)
KGVPTYTLSENETDVFLLTS 0.04% (n=1)
RGVPTYTLGENETDVFLLTS 0.04% (n=1)
RGAPTYRLGENETNVFLLTS 0.04% (n=1)
RGVPTYRLGENETDVFLLTS 0.04% (n=1)
RGAPTYRLGENETDVFLLTS 0.04% (n=1)
MGTPTYTWGANKTDVFLLKS 0.04% (n=1)
KGAPTYTWGANETDVFLLQS 0.04% (n=1)
EGTPTYTKSSNETEVVVVLS 0.04% (n=1)
KGAPTYTWGANETEVFLLQS 0.04% (n=1)
RGAPTYCSNDNESDVFDVNS 0.04% (n=1)
EGTPTYTWGANKTDVFLVQS 0.04% (n=1)
KGEPTYTWGENETDVFLLHS 0.04% (n=1)
KGEPTYNWGGNETDVFLLQS 0.04% (n=1)
RGQPTYNWGENATDVFLLES 0.04% (n=1)
RGVPTYTWGENETDVFLLRS 0.04% (n=1)
KGTPTYSWGENETDVFLLES 0.04% (n=1)
RGVPTYNRGANETDVFLLKS 0.04% (n=1)
GGVPTYNWGANETDVFLLKS 0.04% (n=1)
KGVPTYNWGANGTDVFLLKS 0.04% (n=1)
KGTPTYTWGANESDVFLLQS 0.04% (n=1)
KGLPTYNWGENETDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLQS 0.04% (n=1)
KGRPTYNWGANETDVFLLES 0.04% (n=1)
RGAPTYTWGEKETDVFLLES 0.04% (n=1)
KGVPTYTWGDNESDVFLLKS 0.04% (n=1)
RGVPTYNWGENVTDVFLLES 0.04% (n=1)
RGAPTYAWGENETDVFLLKS 0.04% (n=1)
RGAPTYDWGENESDVFLLTS 0.04% (n=1)
KGVPTYNWGSNDTDVFLLES 0.04% (n=1)
RGEPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYDWGANKSDVFLLKS 0.04% (n=1)
KGAPTYNWGANESDVFLLAS 0.04% (n=1)
RGVPTYSWGENESDVFLLKS 0.04% (n=1)
KGVPTYNWGENESDVFLLAS 0.04% (n=1)
KGVPTYTWGGNATDVFLLQS 0.04% (n=1)
KGVPTYTFGANESDVFLLES 0.04% (n=1)
RGTPTYTWGGNKTDVFLLES 0.04% (n=1)
RGVPTYTWGANETDVFLLES 0.04% (n=1)
KGVPTYNWGANVTDVFLLTS 0.04% (n=1)
KGEPTYNWGANETDVFLLKS 0.04% (n=1)
KGAPTFNWGENETDVFLLES 0.04% (n=1)
KGNPTFNWGENETDVFLLAS 0.04% (n=1)
AGMPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYNWGENETDVFLLQS 0.04% (n=1)
KGVPTYNWGANKTDVFLLKS 0.04% (n=1)
QGVPTYNWGMNETDVFLLES 0.04% (n=1)
KGVPTYNWGGNDTDVFLLKS 0.04% (n=1)
QGAPTFNWGENETDVFLLTS 0.04% (n=1)
KGEPTYTWGEKETDVFLLKS 0.04% (n=1)
RGVPTFTWGENETDVFLLKS 0.04% (n=1)
KGVPTYSWGEKETDVFLLES 0.04% (n=1)
TGKPTYTWGENETDVFLLKS 0.04% (n=1)
GGSPTYNWGENEADVFLLKS 0.04% (n=1)
KGEPTYTWGETEKDVFLLKS 0.04% (n=1)
KGVPTYNWGENETDVFLLSS 0.04% (n=1)
RGVPTYNWGENDTDVFLLKS 0.04% (n=1)
KGVPTYNWGTNETDVFLLQS 0.04% (n=1)
KGAPTYRWGENQSDVFLLES 0.04% (n=1)
QGAPTYNWGANESDVFLLES 0.04% (n=1)
KGVPTFNWGGNKTDVFLLKS 0.04% (n=1)
KGAPTFNWGANKTDVFLLKS 0.04% (n=1)
KGAPTFNWGDNKTDVFLLKS 0.04% (n=1)
KGAPTYSWGAEESDVFLLES 0.04% (n=1)
KGVPTYNWGANETDVFLLTS 0.04% (n=1)
RGAPTYTWGANETDVFLLGS 0.04% (n=1)
KGAPTYNWGGNATDVFLLTS 0.04% (n=1)
KGVPTFNWGRNESDVFLLES 0.04% (n=1)
KGVPTYNWGENATDVFLLES 0.04% (n=1)
EGTPTFTWGTNETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLDS 0.04% (n=1)
KGTPTYTWGENATDVFLLAS 0.04% (n=1)
EGNPTYTWGENKTDVFLLNS 0.04% (n=1)
KGVATYNWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNDTDLFLLTS 0.04% (n=1)
KGTPTYTWGGNKTDVFLLES 0.04% (n=1)
KGNPTYTWGENQTDVFLLES 0.04% (n=1)
KGVPTYTWGGNESDVFLLKS 0.04% (n=1)
EGAPTYNWGENETDVFLLES 0.04% (n=1)
KGAPTYTWGENQTDVFLLKS 0.04% (n=1)
KGAPTYGWGENESDVFLLGS 0.04% (n=1)
AGAPTYTWGENKTDVFLLKS 0.04% (n=1)
KGAPTYSWGANETDVFLLNS 0.04% (n=1)
KGVPTYTWGENVTDVFLLKS 0.04% (n=1)
RGASTYNWGQWL*ALLILRA 0.04% (n=1)
KGAPTYYWGENETDVFLLKS 0.04% (n=1)
RGASTYQW-E-L*ALLILRA 0.04% (n=1)
KGAPTYNWGANESDGFLLES 0.04% (n=1)
KGAPTYTGGANESDVFLLES 0.04% (n=1)
KGAPTYTWGANKADVFLLDS 0.04% (n=1)
KGAPTYAWGANKTDVFLLDS 0.04% (n=1)
KGVPTYTWGANVTDVFLLES 0.04% (n=1)
EGAPTYTWGTNATDVFLLKS 0.04% (n=1)
GGTPTYTWGENESDVFLLES 0.04% (n=1)
RGAPTYTWGANETDVFLLKS 0.04% (n=1)
RGVPTYDWGANESDVFLLES 0.04% (n=1)
GGDPTYTWGGNETDVFLLES 0.04% (n=1)
KGAPTYNWGENKTDVFLLES 0.04% (n=1)
RGTPTYTWGANETDVFLLES 0.04% (n=1)
RGAPTYTWGANVTDVFLLKS 0.04% (n=1)
KGAPTYTWGDNKTDVFLLES 0.04% (n=1)
RGAPTYDWGGKETDVFLLKS 0.04% (n=1)
RGVPTYTWGENESDVFLLGS 0.04% (n=1)
EGTPTYNWGGNKTDVFLLES 0.04% (n=1)
KGAPTYTWGTNVTDVFLLES 0.04% (n=1)
KGVPTYTWGGNATDVFLLTS 0.04% (n=1)
KGVPTYNWGENETDVFLLTS 0.04% (n=1)
EGVPTYTWGENATDVFLLNS 0.04% (n=1)
RGVPTYTWGANETDVFLLPS 0.04% (n=1)
RGVPTYTWGANETDVFLLRS 0.04% (n=1)
KGAPTYTWGMNETDVFLLES 0.04% (n=1)
KGTPTYDWGANASDVFLLNS 0.04% (n=1)
RGAPTYNWGANETDVFLLKS 0.04% (n=1)
RGVPTYNWGENKTDVFLLKS 0.04% (n=1)
EGVPTYTWGENKTDMFLLES 0.04% (n=1)
KGAPTYEWGENETDVFLLRS 0.04% (n=1)
KGAPTYTWGEKETDVFLLKS 0.04% (n=1)
RGAPTYNWGANETDVFLLDS 0.04% (n=1)
KGVPTYTWGTNVTDVFLLES 0.04% (n=1)
EGVQTLNWGANDSDVFLLQS 0.04% (n=1)
QGVPTYNWGANETDVFLLGS 0.04% (n=1)
EGTPTFTWGENTTDVFLLTS 0.04% (n=1)
RGAPTYNWGENETDVFLLGS 0.04% (n=1)
KGVPTYNWGGNATDVFLLES 0.04% (n=1)
RGVPTYSWGENETDVFLLGS 0.04% (n=1)
KGVPTYNWGANDADVFLLTS 0.04% (n=1)
KGTPTYTWGANESDVFLLES 0.04% (n=1)
KGAPTYKWGEGEKDVFLLES 0.04% (n=1)
KGVPTYGWGENETDVFLLKS 0.04% (n=1)
KGAPTYSWGENETDVFLLQS 0.04% (n=1)
KGIPTYNWGENETDVFLLDS 0.04% (n=1)
KGAPTYTWGENKTDVFLLES 0.04% (n=1)
RGVPTYNWGENKTDVFLLES 0.04% (n=1)
KGVPTYGWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLTS 0.04% (n=1)
KGMPTYNWGENETDVFLLES 0.04% (n=1)
EGTPTYNWGENVTDVFLLKS 0.04% (n=1)
RGVPTYTWGENETDVFLLTS 0.04% (n=1)
AGVPTYTWGANKTDVFLLKS 0.04% (n=1)
KGVPRYTWGANETDVFLLES 0.04% (n=1)
RGVPTYNWGANETDVFLLES 0.04% (n=1)
KGAPTYNWGENATDMFLLQS 0.04% (n=1)
KGTPTYTWGANETDVFLLES 0.04% (n=1)
KGVPTYSWGENQTDVFLLKS 0.04% (n=1)
RGVPTYSWGANESDVFLLKS 0.04% (n=1)
KGEATFNWGENETDVFLLKS 0.04% (n=1)
KGVPTYNFGANKTDVFLLES 0.04% (n=1)
KGVPTYNWGGNETDVFLLNS 0.04% (n=1)
KGVPTYKWGENETDVFLLKS 0.04% (n=1)
KGTPTYSWGANQTDVFLLDS 0.04% (n=1)
KGTPTYTWGEDKSDVFLLES 0.04% (n=1)
RGAPTYNWGANESDVFLLQS 0.04% (n=1)
RGAPTYNWGENESDVFLLES 0.04% (n=1)
RGMPTYTWGENESDVFLLES 0.04% (n=1)
KGTPTYSWGANETDVFLLKS 0.04% (n=1)
MGAPTYTWGENESDVFLLES 0.04% (n=1)
KGAPTYNWGENQTDVFLLKS 0.04% (n=1)
KGVPTYTWGANQTDVFLLNS 0.04% (n=1)
TGVPTYKWGENKTDVFLLKS 0.04% (n=1)
KGVPTYEWGENQTDVFLLKS 0.04% (n=1)
KGVPTYTWGEQERDVFLLES 0.04% (n=1)
KGAPTYNWGGNETDVFLLKS 0.04% (n=1)
KGVPTFNWGVNETDVFLLKS 0.04% (n=1)
RGAPTYTWGANETDVFLLDS 0.04% (n=1)
RGVPTYSWGANETDVFLLKS 0.04% (n=1)
KGVPTYTWGTNETDVFLLDS 0.04% (n=1)
KGVPTFTWGGNKTDVFLLES 0.04% (n=1)
KGVPTYTWGENKSDVFLLKS 0.04% (n=1)
KGVPTYTWGENETDVFLLAS 0.04% (n=1)
AGKPTYGWGENETDVFLLES 0.04% (n=1)
KGNPTFNWGANATDVFLLES 0.04% (n=1)
KGTPTYTWGENKTDVFLLES 0.04% (n=1)
SGSPTYTWGENKTDVFLLAS 0.04% (n=1)
RGVPTYTWGANKSDVFLLKS 0.04% (n=1)
RGTPTYTWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLKS 0.04% (n=1)
KGVPTYNWGTNETDVFLLES 0.04% (n=1)
RGALTYNWGQNDSDVFLLQS 0.04% (n=1)
RGMPTYTWGENETDVFLLDS 0.04% (n=1)
GGAPTFTWGENETDVFLLQS 0.04% (n=1)
QGAPTYTWGENETDVFLLKS 0.04% (n=1)
KGAPTYQWGENETDVFLLKS 0.04% (n=1)
TGTPTYNWGENQTDVFLLES 0.04% (n=1)
KGAPTYRWGENETDVFLLES 0.04% (n=1)
KGDPTYTYGTNKTDVFLLRS 0.04% (n=1)
KGAPTYNWGVNETDVFLLES 0.04% (n=1)
KGSPTYQWGENETDVFLLKS 0.04% (n=1)
RGVPTYNWGANESDVFLLKS 0.04% (n=1)
QGVPTYNWGENKTDVFLLRS 0.04% (n=1)
EGVPTYNWGANESDVFLLQS 0.04% (n=1)
KGAPTYSWGENKTDVFLLES 0.04% (n=1)
KGVPTYNWGVNETDVFLLES 0.04% (n=1)
KGVPTYTWGANNTDVFLLTS 0.04% (n=1)
KGVPTFTWGENETDVFLLDS 0.04% (n=1)
KGSPTYTWGANETDVFLLQS 0.04% (n=1)
KGLPTYNWGENETDVFLLKS 0.04% (n=1)
KGLPTYTWGENKTDMFLLES 0.04% (n=1)
KGVPTYNWGDNETDVFLLRS 0.04% (n=1)
KGAPTYTWGGNQTDVFLLKS 0.04% (n=1)
EGTPTYTWGGNETDVFLLKS 0.04% (n=1)
KGVPTYTWGANKTDVFLLKS 0.04% (n=1)
KGRPTYTWGENETDVFLLES 0.04% (n=1)
QGAPTYTWGENETDVFLLES 0.04% (n=1)
KGAPTYNWGENETDVFQLES 0.04% (n=1)
KGAPTYTWGANETDVFLLAS 0.04% (n=1)
KGAPTYNWGDNETDVFLLAS 0.04% (n=1)
KGDPTYTWGANETDVFLLKS 0.04% (n=1)
KGAPTYNWGENATDVFLLGS 0.04% (n=1)
QGAPTYNWGENETDVFLLES 0.04% (n=1)
KGAPTYAWGANETDVFLLES 0.04% (n=1)
KGVPTYTFGGNKTDVFLLQS 0.04% (n=1)
KGVPTYTWGGNETDVFLLNS 0.04% (n=1)
KGAPTYTWGANKSDVFLLKS 0.04% (n=1)
RGAPTYTWGANETDVFLLNS 0.04% (n=1)
RGAPTYTWGANKTDMFLLHS 0.04% (n=1)
KGAPTYTWGANKSDVFLLTS 0.04% (n=1)
KGAPTYNFGENQTDVFLLES 0.04% (n=1)
RGAPTYTWGANETDVFLLQS 0.04% (n=1)
KGVPTYNWGANETDVFLLNS 0.04% (n=1)
KGAPTYKWGANETDVFLLKS 0.04% (n=1)
KGAPTYTWGANATDVFLLES 0.04% (n=1)
RGAPTYDWGENETDVFLLAS 0.04% (n=1)
EGAPTYTWGENKTDVFLLKS 0.04% (n=1)
KGNPTYTWGENVTDVFLLES 0.04% (n=1)
KGTPTFNWGQNQTDVFLLES 0.04% (n=1)
RGNPTFTWGETEKDVFLLDS 0.04% (n=1)
RGAPTYTWGENETDVFLLNS 0.04% (n=1)
RGVPTYSWGENETDVFLLKS 0.04% (n=1)
MGAPTYDWGENETDVFLLQS 0.04% (n=1)
QGVATYTWGENDADVFLLGS 0.04% (n=1)
RGNPTYNWGANETDTFLLES 0.04% (n=1)
EGIPTYTWGENETDMFLLKS 0.04% (n=1)
KGAPTYRWGANETDVFLLES 0.04% (n=1)
KGAPTYTWGENETDVFLLSS 0.04% (n=1)
EGTPTYTWGENKTDVFLLES 0.04% (n=1)
SGAPTYNWGVNETDVFLLKS 0.04% (n=1)
QGAPTYSWGENETDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLDS 0.04% (n=1)
RGAPTYTWGTNETDVFLLNS 0.04% (n=1)
KGVPTYNWGANVTDVFLLRS 0.04% (n=1)
KGAPTYNWGENETDLFLLES 0.04% (n=1)
KGAPTYSWGANETDVFLLQS 0.04% (n=1)
KGNPTFDWGANETDVFLLES 0.04% (n=1)
KGAPTYNWGANETDVFLLDS 0.04% (n=1)
KGAPTYNWGENDTDVFLLES 0.04% (n=1)
RGAPTYTWGANQTDVFLLQS 0.04% (n=1)
RGAPTYSWGVNETDVFLLES 0.04% (n=1)
RGAPTYSWGENETDVFLLDS 0.04% (n=1)
KGVPTYTWGGNETDVFLLQS 0.04% (n=1)
KGVPTYNWGENKTDVFLLES 0.04% (n=1)
KGAPTYNWGENDTDMFLLQS 0.04% (n=1)
KGVPTYTFGENQTDVFLLES 0.04% (n=1)
KGDPTYNWGENATDWFLLES 0.04% (n=1)
RGNPTYEWGENETDVFLLES 0.04% (n=1)
KGTPTYTWGENATDVFLLES 0.04% (n=1)
KGAPTYRWGENETDVFLLKS 0.04% (n=1)
KGAPTYTWGENETDVFQLTS 0.04% (n=1)
KGAPTYNWGANETDVFLLHS 0.04% (n=1)
KGAPTYTWGGNKTDVFLLES 0.04% (n=1)
TGAPTYTWGENKTDVFLLDS 0.04% (n=1)
KGAPTYTWGENETDVFLLTS 0.04% (n=1)
KGVPTYTWGENQTDVFLLKS 0.04% (n=1)
KGSPTYTWGDNESDVFLLGS 0.04% (n=1)
KGAPTYAWGANETDVFLLGS 0.04% (n=1)
KGSPTYNWGENETDVFLLDS 0.04% (n=1)
RGAPTYTWGGNETDVFLLKS 0.04% (n=1)
EGAPTYNWGGNDTDVFLLES 0.04% (n=1)
EGVPTFQWGANKTDVFLLES 0.04% (n=1)
RGVPTYTWGENETDVFLLDS 0.04% (n=1)
KGAPTYRWGENQSDVFLLGS 0.04% (n=1)
KGAPTYNWGANETDAFLLKS 0.04% (n=1)
EGTPTFNWGENKTDKFLLKS 0.04% (n=1)
RGVPTYTWGANESDVFLLES 0.04% (n=1)
KGAPTYTWGENETDVFLVES 0.04% (n=1)
EGVPTYTWGGNKTDMFLLGS 0.04% (n=1)
KGAPTYQWGANETDVFLLES 0.04% (n=1)
KGAPTYTWGANTTDVFLLES 0.04% (n=1)
EGSPTYTWGANESDVFLLKS 0.04% (n=1)
EGTPTYSWGENKTDVFLLKS 0.04% (n=1)
EGAPTYTWGDNKTDVFLLKS 0.04% (n=1)
KGNPTYSWGENETDVFLLDS 0.04% (n=1)
KGLPTYRFGANESDVFLLES 0.04% (n=1)
KGLPTYSWGANESDVFLLDS 0.04% (n=1)
RGVPTYTWGENETDVFLLSS 0.04% (n=1)
KGNPTYTWGMNETDVFLLNS 0.04% (n=1)
KGNPTYTWGESATDVFLLDS 0.04% (n=1)
AGAPTYNWGENETDVFLLAS 0.04% (n=1)
DGTPTYNWGASPADVFLLAS 0.04% (n=1)
RGAPTYAWGENETDVFLLES 0.04% (n=1)
KGAPTYTWGANDTDVFLLES 0.04% (n=1)
QGAPTYSWGGNKTDVFLLES 0.04% (n=1)
KGVPTYSWGENETDVFLLTS 0.04% (n=1)
RGVPTYNWGENETDVFLLTS 0.04% (n=1)
KGAPTYTWGANESDVFLLTS 0.04% (n=1)
RGVPTYSWGENETDVFLLES 0.04% (n=1)
KGTPTYTWGANETDVFLLTS 0.04% (n=1)
KGHPTYNWGENETDVFLLES 0.04% (n=1)
RGVPTYTWGENKTDFFLLDS 0.04% (n=1)
TGTPTYTWGANKTDVFLLES 0.04% (n=1)
KGVPTYSWGENESDVFLLQS 0.04% (n=1)
RGTPTYTWGANETDRFLLES 0.04% (n=1)
RGAPTYNWGANETDVLLLES 0.04% (n=1)
KGIPTHNWGANESDVFLLKS 0.04% (n=1)
RGAPTYNWGANESDVFLLES 0.04% (n=1)
KGLPTYRFGVNESDVFLLTS 0.04% (n=1)
KGVPTYNFGANETDVFLLTS 0.04% (n=1)
KGLPTYNFGENEADVFLLNS 0.04% (n=1)
KGLPTYNFGENETDMFLLTS 0.04% (n=1)
RGVPTYNFGENETDVFLLTS 0.04% (n=1)
KGVPTYKFGENESDVFLLTS 0.04% (n=1)
KGLPTYNFGENESDVFLLAS 0.04% (n=1)
KGLPTYTFGENESDVFLLNS 0.04% (n=1)
KGLPTYTFGANESDVFLLTS 0.04% (n=1)
KGSPTYTFGENETDVFLLNS 0.04% (n=1)
KGVPTYKFGENETDVFLLTS 0.04% (n=1)
KGVPTYSFGANETDVFLLDS 0.04% (n=1)
KGLPTYNFGVNETDVFLLTS 0.04% (n=1)
RGSPTYNFGENETDVFLLSS 0.04% (n=1)
KGLPTYNFGENETDVFLLAS 0.04% (n=1)
RGAPTYNFGENETDVFLLTS 0.04% (n=1)
RGSPTYTFGANETDVFLLDS 0.04% (n=1)
KGSPTYSFGANETDVFLLDS 0.04% (n=1)
KGLPTYNFGEDETDVFLLKS 0.04% (n=1)
KGLPTYNFGANETDVFLLNS 0.04% (n=1)
EGSPTYTFGENETDVFLLNS 0.04% (n=1)
KGLPTYNFGGNQTDVFLLNS 0.04% (n=1)
KGLPTYNFGENKADKFLLDS 0.04% (n=1)
KGVPTYSFGENETDVFLLSS 0.04% (n=1)
KGVPTYNFGENETDVFLLGS 0.04% (n=1)
KGLPTYNFGGNETDVFLLNS 0.04% (n=1)
KGAPTYNFGENETDVFLLNS 0.04% (n=1)
KGLPTYNFGENESDVFLLTS 0.04% (n=1)
KGLPTYTFGEKETDVFLLSS 0.04% (n=1)
RGLPTYNFGENETDVFLLNS 0.04% (n=1)
KGLPTYNFGENEKDVFLLDS 0.04% (n=1)
RGLPTYTFGENETDVFLLTS 0.04% (n=1)
KGLPTYNFGANETDVFLLRS 0.04% (n=1)
TGLPTYTFGENETDVFLLDS 0.04% (n=1)
RGLPTYNFGVNETDVFLLRS 0.04% (n=1)
KGVPTYTFGEKETDVFLLNS 0.04% (n=1)
KGLPTYNFGDNETDVFLLNS 0.04% (n=1)
EGLPTYSFGANKTDVFLLPS 0.04% (n=1)
KGSPTYSFGEKETDVFLLNS 0.04% (n=1)
RGSPTYNFGENETDVFLLTS 0.04% (n=1)
KGLPTYTFGANETDVFLLTS 0.04% (n=1)
RGLPTYDFGENETDVFLLTS 0.04% (n=1)
KGAPTYTFGANETDVFLLTS 0.04% (n=1)
KGLPTYAFGANETDVFLLTS 0.04% (n=1)
KGSPTYSFGENETDVFLLTS 0.04% (n=1)
KGLPTYNFGENESDVFLLDS 0.04% (n=1)
KGAPTYNFGANETDVFLLTS 0.04% (n=1)
KGAPTYGFGENETDVFLLNS 0.04% (n=1)
KGLPTYRFGENETDVFLLTS 0.04% (n=1)
KGSPTYTFGGNESDVFLLNS 0.04% (n=1)
KGSPTYNFGANETDVFLLTS 0.04% (n=1)
RGVPTYTFGANETDVFLLTS 0.04% (n=1)
KGLPTYSFGENESDVFLLSS 0.04% (n=1)
KGLPTYTFGENETDVFLLAS 0.04% (n=1)
KGIPTYNFGANETDVFLLTS 0.04% (n=1)
KGLPTCNFGANETDVFLLTS 0.04% (n=1)
KGSPTYNFGGNETDVFLLTS 0.04% (n=1)
KGLPTYSFGANESDVFLLTS 0.04% (n=1)
KGLPTYGFGANESDVFLLTS 0.04% (n=1)
KGLPTYTFGENETDVFLLSS 0.04% (n=1)
RGLPTYNFGSNDTDVFLLTS 0.04% (n=1)
RGVPTYTFGENETDVLLLES 0.04% (n=1)
RGTPTYTFGENETDVVLLTS 0.04% (n=1)
KGVPTYTFGENETDVVLLAS 0.04% (n=1)
QGVPTYSWGENETDVFLLKS 0.04% (n=1)
RGAPTYRFGENETDVFLLSS 0.04% (n=1)
RGAPTYTFGGNDTDVFLLSS 0.04% (n=1)
RGVPTYTFGGNDSDVFLLSS 0.04% (n=1)
KGVPTYSFGDNVTDVFLLES 0.04% (n=1)
RGAPTYTFGENDTDVFLLSS 0.04% (n=1)
KGAPTYTFGENVTDVFLLSS 0.04% (n=1)
LGVPTYNWGENESDVFLLES 0.04% (n=1)
LGYPTFTWGANESDVFLLES 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 3a:

RGAPTYTWGANETDVFLLRS 13.24% (n=311)
KGVPTYTWGENKTDVFLLES 7.15% (n=168)
KGVPTYNWGENETDVFLLES 4.30% (n=101)
KGAPTYTWGENETDVFLLES 3.45% (n=81)
KGVPTYNWGANETDVFLLES 3.28% (n=77)
KGAPTYTWGENETDVFLLKS 2.72% (n=64)
KGVPTYTWGENESDVFLLES 2.72% (n=64)
KGVPTYNWGENESDVFLLKS 2.60% (n=61)
KGVPTYTWGENETDVFLLES 2.38% (n=56)
KGVPTYNWGENETDVFLLKS 2.30% (n=54)
RGVPTYNWGANETDVFLLKS 2.04% (n=48)
KGAPTYNWGENETDVFLLKS 2.00% (n=47)
KGVPTYNWGANETDVFLLKS 1.58% (n=37)
KGAPTYTWGANETDVFLLES 1.40% (n=33)
KGAPTYNWGANESDVFLLES 1.40% (n=33)
KGVPTYTWGENETDVFLLKS 1.32% (n=31)
KGVPTYTWGENDTDVFLLKS 1.28% (n=30)
KGVPTYNWGENKSDVFLLKS 1.19% (n=28)
KGAPTYNWGANVTDVFLLKS 1.02% (n=24)
EGTPTYDWGENETDVFLLGS 0.89% (n=21)
KGVPTYNWGENETDVFLLGS 0.89% (n=21)
KGVPTYTWGANETDVFLLES 0.85% (n=20)
RGIPTYNWGANETDAFLLES 0.85% (n=20)
KGEPTYTWGENETDVFLLKS 0.85% (n=20)
KGVPTYTWGANETDVFLLNS 0.81% (n=19)
RGAPTYTWGANETDVFLLES 0.77% (n=18)
KGVPTYTWGANETDVFLLQS 0.72% (n=17)
RGAPTYTWGENETDVFLLES 0.68% (n=16)
KGVPTYNWGENESDVFLLES 0.64% (n=15)
KGVPTYAWGENETDVFLLES 0.64% (n=15)
KGAPTYNWGENETDVFLLES 0.60% (n=14)
RGVPTYNWGENETDVFLLKS 0.60% (n=14)
KGVPTYSWGENETDVFLLKS 0.51% (n=12)
KGAPTFNWGENKTDVFLLKS 0.51% (n=12)
KGAPTFTWGENETDVFLLES 0.47% (n=11)
KGAPTYSWGANESDVFLLES 0.47% (n=11)
RGAPTYTWGENETDVFLLKS 0.47% (n=11)
KGVPTYNWGANESDVFLLKS 0.47% (n=11)
KGVPTYNWGENKSDVFLLES 0.43% (n=10)
KGAPTYNWGANESDVFLLKS 0.43% (n=10)
KGAPTFTWGENKTDVFLLES 0.38% (n=9)
KGAPTYTWGENESDVFLLES 0.34% (n=8)
KGAPTYTWGANETDVFLLKS 0.30% (n=7)
KGAPTFNWGGNKTDVFLLKS 0.30% (n=7)
KGVPTYYWGENKTDVFLLES 0.26% (n=6)
KGAPTYTWGENATDVFLLKS 0.26% (n=6)
KGVPTYTWGENETDVFLLTS 0.26% (n=6)
RGAPTYNWGENETDVFLLES 0.26% (n=6)
KGVPTYTWGANETDVFLLKS 0.26% (n=6)
KGAPTYTWGANESDVFLLES 0.26% (n=6)
KGIPTYNWGANETDAFLLES 0.21% (n=5)
TGVPTYTWGENESDVFLLES 0.21% (n=5)
RGVPTYNWGENETDVFLLES 0.21% (n=5)
RGVPTYTWGENETDVFLLES 0.21% (n=5)
KGAPTYGWGANESDVFLLKS 0.17% (n=4)
KGVPTYNWGENESDVFLLTS 0.17% (n=4)
KGAPTYNWGANETDVFLLES 0.17% (n=4)
KGVPTYSWGANETDVFLLKS 0.17% (n=4)
EGTPTYTWGENETDVFLLES 0.17% (n=4)
KGAPTYTWGANETDVFLLGS 0.17% (n=4)
AGAPTYTWGENESDVFLLQS 0.17% (n=4)
KGAPTYSWGANETDVFLLES 0.17% (n=4)
KGAPTYNWGENESDVFLLES 0.17% (n=4)
RGAPTYNWGENETDVFLLKS 0.17% (n=4)
KGVPTYTWGENETDVFLLRS 0.17% (n=4)
KGAPTYTWGANETDVFLLTS 0.17% (n=4)
KGAPTYSWGENETDVFLLES 0.17% (n=4)
RGVPTYDWGENETDVFLLAS 0.17% (n=4)
EGVPTYTWGGNKTDVFLLKS 0.13% (n=3)
QGVPTYTWGGNETDVFLLKS 0.13% (n=3)
KGVPTYTWGTNETDVFLLKS 0.13% (n=3)
KGAPTYTWGGNETDVFLLES 0.13% (n=3)
KGAPTYNWGANETDVFLLKS 0.13% (n=3)
KGVPTFTWGENETDVFLLES 0.13% (n=3)
KGMPTYTWGENESDVFLLES 0.13% (n=3)
KGVPTYTWGANKTDVFLLNS 0.13% (n=3)
SGAPTYSWGENETDVFLLES 0.13% (n=3)
KGAPTYTWGANETDVFLLRS 0.13% (n=3)
RGAPTYNWGANESDVFLLTS 0.13% (n=3)
KGAPTYSWGENETDVFLLKS 0.13% (n=3)
QGVPTYTWGENETDVFLLKS 0.13% (n=3)
KGVPTYNWGGNETDVFLLKS 0.13% (n=3)
KGAPTYSWGAKESDVFLLES 0.13% (n=3)
KGAPTYTWGENETDVFLLQS 0.13% (n=3)
KGAPTYNWGENETDVFLLTS 0.13% (n=3)
KGVPTYTWGANESDVFLLKS 0.13% (n=3)
KGVPTYTWGENETDVFLLNS 0.13% (n=3)
RGVPTYTWGENETDVFLLKS 0.13% (n=3)
KGVPTYTWGENETDVFLLDS 0.13% (n=3)
KGAPTYNWGANKTDVFLLES 0.09% (n=2)
KGTPTYTWGANDTDVFLLQS 0.09% (n=2)
KGVPTYTWGENETDVFLLQS 0.09% (n=2)
KGVPTYTWGANETDVFLLDS 0.09% (n=2)
RGVPTYTWGENEKDVFLLKS 0.09% (n=2)
KGAPTYTWGENESDVFLLNS 0.09% (n=2)
KGAPTYFWGANESDVFLLES 0.09% (n=2)
KGAPTYSWGANKSDVFLLES 0.09% (n=2)
KGAPTFTWGENVTDVFLLKS 0.09% (n=2)
RGAPTYTWGENETDVFLLTS 0.09% (n=2)
KGAPTYNWGENETDVFLLNP 0.09% (n=2)
KGVPTYTWGGNVTDVFLLES 0.09% (n=2)
QGVPTYTWGENETDVFLLNS 0.09% (n=2)
QGVPTYTWGENEADVFLLNS 0.09% (n=2)
GGAPTYSWGENETDVFLLTS 0.09% (n=2)
VGAPTYSWGENETDVFLLTS 0.09% (n=2)
RGAPTYSWGENETDVFLLTS 0.09% (n=2)
KGVPTYTRGENETDVFLLTS 0.09% (n=2)
KGTPTYTWGANETDVFLLKS 0.09% (n=2)
KGVPTYNWGANEADVFLLKS 0.09% (n=2)
KGAPTYTWGVNETDVFLLES 0.09% (n=2)
SGAPTYTWGENETDVFLLQS 0.09% (n=2)
RGAPTYNWGANETDVFMLES 0.09% (n=2)
KGVPIYTWGENDTDVFLLKS 0.09% (n=2)
RGSPTYTWGANETDVFLLRS 0.09% (n=2)
KGAPTYKWGENETDVFLLKS 0.09% (n=2)
KGVPTYTWGGNETDVFLLES 0.09% (n=2)
KGAPTYNWGENETDVFLLQS 0.09% (n=2)
KGAPTYSWGANETDVFLLKS 0.09% (n=2)
KGVPTYTWGANKTDVFLLES 0.09% (n=2)
KGVPTYRWGENETDVFLLKS 0.09% (n=2)
KGAPTYTWGGNETDVFLLKS 0.09% (n=2)
KGAPTYTWGANETDVFLLDS 0.09% (n=2)
KGAPTYTWGENETDVFLLNS 0.09% (n=2)
KGVPTYTWGENDTDVFLLES 0.09% (n=2)
KGAPTYDWGENETDVFLLES 0.09% (n=2)
KGVPTYTWGGNETDVFLLKS 0.09% (n=2)
----TYNWGENESDVFLLES 0.09% (n=2)
KGAPTYNWGENESDVFLLKS 0.09% (n=2)
RGAPTYTWGENESDVFLLES 0.09% (n=2)
KGNPTYTWGENKTDVFLLES 0.09% (n=2)
KGAPTYTWGTNETDVFLLRS 0.09% (n=2)
KGTPTYTWGANKTDVFLLES 0.09% (n=2)
KGAPTYTWGENETDVFLLDS 0.09% (n=2)
KGAPTYNWGENETDVFLLNS 0.09% (n=2)
KGAPTYNWGGNETDVFLLRS 0.09% (n=2)
KGAPTYTWGTNETDVFLLKS 0.09% (n=2)
KGAPTYTWGENETDVFLLGS 0.09% (n=2)
KGTPTYTWGENETDVFLLKS 0.09% (n=2)
KGAPTFTWGANKTDVFLLES 0.09% (n=2)
KGDPTYNWGENETDVFLLKS 0.09% (n=2)
RGTPTYTWGANKTDVFLLES 0.09% (n=2)
KGVPTYTWGENESDVFLLKS 0.09% (n=2)
KGVPTYTWGANDTDVFLLTS 0.09% (n=2)
KGAPTYTWGENATDVFLLES 0.09% (n=2)
KGTPTYTWGENETDVFLLES 0.09% (n=2)
RGAPTYTWGTNETDVFLLDS 0.09% (n=2)
RGVPTYTWGANETDVFLLKS 0.09% (n=2)
RGAPTYNWGANETDVFLLES 0.09% (n=2)
KGVPTYNWGANVSDVFLLKS 0.09% (n=2)
KGVPTYTWGANDTDVFLLES 0.04% (n=1)
KGVPTYTWGENESDVFLLDS 0.04% (n=1)
KGVPTYTWGGNATDVFLLES 0.04% (n=1)
RGAPTYTWGENASDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYTWGENETDVFLLE- 0.04% (n=1)
KGVPTYSFGTNETDVFLLES 0.04% (n=1)
RGAPTYTWGTNETDVFLLES 0.04% (n=1)
EGAPTYTWGENVRDVFLLES 0.04% (n=1)
RGVPTYTWGANETDVFLLQS 0.04% (n=1)
KGVPTYTWDANETDVFLLNS 0.04% (n=1)
KGAPTYTWGANKTDVFLLES 0.04% (n=1)
KGAPTYNWGANETDMFLLQS 0.04% (n=1)
KGGPTYNWGGDETDVFLLKS 0.04% (n=1)
MGAPTYTWGENETDVFLLKS 0.04% (n=1)
KGASTYNWGADETDVFLLKS 0.04% (n=1)
KGASTYNWGGDETDVFLLKS 0.04% (n=1)
KGGSTYNWGGNETDVFLLKS 0.04% (n=1)
EGVPTFGWGGNKSDVFLLKS 0.04% (n=1)
EGVPRYNWGENATDVFLLQS 0.04% (n=1)
KGNPTYTWGENETDVFLLQS 0.04% (n=1)
KGIPTYSFGENETDCFLLES 0.04% (n=1)
KGAPTYTWGANTSDVFLLES 0.04% (n=1)
KGVPTYTWGGNESDVFLLES 0.04% (n=1)
RGLPTYNWGENETDVFLLKS 0.04% (n=1)
KGAPTYNWGADVTDVFLLKS 0.04% (n=1)
KGAPTYNWSANVTDVFLLKS 0.04% (n=1)
KGAPTYTWGEDGTDVFLLES 0.04% (n=1)
EGTPTYDWGENETDVFPLGS 0.04% (n=1)
EGTPTYDWGENEADVFLLGS 0.04% (n=1)
EGTPTYDWSENETDVFLLGS 0.04% (n=1)
EGTPTYDWGENETDVFLLES 0.04% (n=1)
EG-PTYDWGENETDVFLLGS 0.04% (n=1)
EGTSTYDWGENETDVFLLGS 0.04% (n=1)
RGIPTHNWGANETDAFLLES 0.04% (n=1)
KGAPTCTWGANETDVFLLES 0.04% (n=1)
KGVPTYYWGENETDVFLLES 0.04% (n=1)
KGVPTYNWGENKSDVLLLES 0.04% (n=1)
KGVPTYYWGENKTDMFLLES 0.04% (n=1)
KGVPTYCWGENKSDVFLLES 0.04% (n=1)
KGVPTYNFGENKTDVFLLES 0.04% (n=1)
KGAPTYSWGASESDVFLLES 0.04% (n=1)
KGAPTYSWGENETDVFLLRS 0.04% (n=1)
KGAPTYTWGENEADVFLLKS 0.04% (n=1)
KGAPTYTWGENETDAFLLKS 0.04% (n=1)
KGAPTYTWGENETDMFLLKS 0.04% (n=1)
KGAPTFTWGENETGVFLLES 0.04% (n=1)
KGVPTYNWGESESDVFLLKS 0.04% (n=1)
QGTPTYTWGENETDVFLLES 0.04% (n=1)
QGTPTYTWGENETDMFLLES 0.04% (n=1)
KGVPTYTWGENVTDVFLLES 0.04% (n=1)
KGVPTYPWGANKTEGFLLNS 0.04% (n=1)
RGVPTYSWGENEKDVFLLKS 0.04% (n=1)
KGRPTYNWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGENETDGFLLES 0.04% (n=1)
KGAPTYTWGANETDMFLLGS 0.04% (n=1)
RGAPTYTWSENETDVFLLES 0.04% (n=1)
SGAPTYSWSENETDVFLLES 0.04% (n=1)
KGVPTYTLSENETDVFLLTS 0.04% (n=1)
RGVPTYTLGENETDVFLLTS 0.04% (n=1)
RGAPTYRLGENETNVFLLTS 0.04% (n=1)
RGVPTYRLGENETDVFLLTS 0.04% (n=1)
RGAPTYRLGENETDVFLLTS 0.04% (n=1)
MGTPTYTWGANKTDVFLLKS 0.04% (n=1)
KGAPTYTWGANETDVFLLQS 0.04% (n=1)
EGTPTYTKSSNETEVVVVLS 0.04% (n=1)
KGAPTYTWGANETEVFLLQS 0.04% (n=1)
RGAPTYCSNDNESDVFDVNS 0.04% (n=1)
EGTPTYTWGANKTDVFLVQS 0.04% (n=1)
KGEPTYTWGENETDVFLLHS 0.04% (n=1)
KGEPTYNWGGNETDVFLLQS 0.04% (n=1)
RGQPTYNWGENATDVFLLES 0.04% (n=1)
RGVPTYTWGENETDVFLLRS 0.04% (n=1)
KGTPTYSWGENETDVFLLES 0.04% (n=1)
RGVPTYNRGANETDVFLLKS 0.04% (n=1)
GGVPTYNWGANETDVFLLKS 0.04% (n=1)
KGVPTYNWGANGTDVFLLKS 0.04% (n=1)
KGTPTYTWGANESDVFLLQS 0.04% (n=1)
KGLPTYNWGENETDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLQS 0.04% (n=1)
KGRPTYNWGANETDVFLLES 0.04% (n=1)
RGAPTYTWGEKETDVFLLES 0.04% (n=1)
KGVPTYTWGDNESDVFLLKS 0.04% (n=1)
RGVPTYNWGENVTDVFLLES 0.04% (n=1)
RGAPTYAWGENETDVFLLKS 0.04% (n=1)
RGAPTYDWGENESDVFLLTS 0.04% (n=1)
KGVPTYNWGSNDTDVFLLES 0.04% (n=1)
RGEPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYDWGANKSDVFLLKS 0.04% (n=1)
KGAPTYNWGANESDVFLLAS 0.04% (n=1)
RGVPTYSWGENESDVFLLKS 0.04% (n=1)
KGVPTYNWGENESDVFLLAS 0.04% (n=1)
KGVPTYTWGGNATDVFLLQS 0.04% (n=1)
KGVPTYTFGANESDVFLLES 0.04% (n=1)
RGTPTYTWGGNKTDVFLLES 0.04% (n=1)
RGVPTYTWGANETDVFLLES 0.04% (n=1)
KGVPTYNWGANVTDVFLLTS 0.04% (n=1)
KGEPTYNWGANETDVFLLKS 0.04% (n=1)
KGAPTFNWGENETDVFLLES 0.04% (n=1)
KGNPTFNWGENETDVFLLAS 0.04% (n=1)
AGMPTYNWGENETDVFLLKS 0.04% (n=1)
KGVPTYNWGENETDVFLLQS 0.04% (n=1)
KGVPTYNWGANKTDVFLLKS 0.04% (n=1)
QGVPTYNWGMNETDVFLLES 0.04% (n=1)
KGVPTYNWGGNDTDVFLLKS 0.04% (n=1)
QGAPTFNWGENETDVFLLTS 0.04% (n=1)
KGEPTYTWGEKETDVFLLKS 0.04% (n=1)
RGVPTFTWGENETDVFLLKS 0.04% (n=1)
KGVPTYSWGEKETDVFLLES 0.04% (n=1)
TGKPTYTWGENETDVFLLKS 0.04% (n=1)
GGSPTYNWGENEADVFLLKS 0.04% (n=1)
KGEPTYTWGETEKDVFLLKS 0.04% (n=1)
KGVPTYNWGENETDVFLLSS 0.04% (n=1)
RGVPTYNWGENDTDVFLLKS 0.04% (n=1)
KGVPTYNWGTNETDVFLLQS 0.04% (n=1)
KGAPTYRWGENQSDVFLLES 0.04% (n=1)
QGAPTYNWGANESDVFLLES 0.04% (n=1)
KGVPTFNWGGNKTDVFLLKS 0.04% (n=1)
KGAPTFNWGANKTDVFLLKS 0.04% (n=1)
KGAPTFNWGDNKTDVFLLKS 0.04% (n=1)
KGAPTYSWGAEESDVFLLES 0.04% (n=1)
KGVPTYNWGANETDVFLLTS 0.04% (n=1)
RGAPTYTWGANETDVFLLGS 0.04% (n=1)
KGAPTYNWGGNATDVFLLTS 0.04% (n=1)
KGVPTFNWGRNESDVFLLES 0.04% (n=1)
KGVPTYNWGENATDVFLLES 0.04% (n=1)
EGTPTFTWGTNETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLDS 0.04% (n=1)
KGTPTYTWGENATDVFLLAS 0.04% (n=1)
EGNPTYTWGENKTDVFLLNS 0.04% (n=1)
KGVATYNWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNDTDLFLLTS 0.04% (n=1)
KGTPTYTWGGNKTDVFLLES 0.04% (n=1)
KGNPTYTWGENQTDVFLLES 0.04% (n=1)
KGVPTYTWGGNESDVFLLKS 0.04% (n=1)
EGAPTYNWGENETDVFLLES 0.04% (n=1)
KGAPTYTWGENQTDVFLLKS 0.04% (n=1)
KGAPTYGWGENESDVFLLGS 0.04% (n=1)
AGAPTYTWGENKTDVFLLKS 0.04% (n=1)
KGAPTYSWGANETDVFLLNS 0.04% (n=1)
KGVPTYTWGENVTDVFLLKS 0.04% (n=1)
RGASTYNWGQWL*ALLILRA 0.04% (n=1)
KGAPTYYWGENETDVFLLKS 0.04% (n=1)
R-----QW-E-L*ALLILRA 0.04% (n=1)
KGAPTYNWGANESDGFLLES 0.04% (n=1)
KGAPTYTGGANESDVFLLES 0.04% (n=1)
KGVPTYTWGANVTDVFLLES 0.04% (n=1)
EGAPTYTWGTNATDVFLLKS 0.04% (n=1)
GGTPTYTWGENESDVFLLES 0.04% (n=1)
RGAPTYTWGANETDVFLLKS 0.04% (n=1)
RGVPTYDWGANESDVFLLES 0.04% (n=1)
GGDPTYTWGGNETDVFLLES 0.04% (n=1)
KGAPTYNWGENKTDVFLLES 0.04% (n=1)
RGTPTYTWGANETDVFLLES 0.04% (n=1)
RGAPTYTWGANVTDVFLLKS 0.04% (n=1)
KGAPTYTWGDNKTDVFLLES 0.04% (n=1)
RGAPTYDWGGKETDVFLLKS 0.04% (n=1)
RGVPTYTWGENESDVFLLGS 0.04% (n=1)
EGTPTYNWGGNKTDVFLLES 0.04% (n=1)
KGAPTYTWGTNVTDVFLLES 0.04% (n=1)
KGVPTYTWGGNATDVFLLTS 0.04% (n=1)
KGVPTYNWGENETDVFLLTS 0.04% (n=1)
EGVPTYTWGENATDVFLLNS 0.04% (n=1)
RGVPTYTWGANETDVFLLPS 0.04% (n=1)
RGVPTYTWGANETDVFLLRS 0.04% (n=1)
KGAPTYTWGMNETDVFLLES 0.04% (n=1)
KGTPTYDWGANASDVFLLNS 0.04% (n=1)
RGAPTYNWGANETDVFLLKS 0.04% (n=1)
RGVPTYNWGENKTDVFLLKS 0.04% (n=1)
EGVPTYTWGENKTDMFLLES 0.04% (n=1)
KGAPTYEWGENETDVFLLRS 0.04% (n=1)
KGAPTYTWGEKETDVFLLKS 0.04% (n=1)
RGAPTYNWGANETDVFLLDS 0.04% (n=1)
KGVPTYTWGTNVTDVFLLES 0.04% (n=1)
EGVQTLNWGANDSDVFLLQS 0.04% (n=1)
QGVPTYNWGANETDVFLLGS 0.04% (n=1)
EGTPTFTWGENTTDVFLLTS 0.04% (n=1)
RGAPTYNWGENETDVFLLGS 0.04% (n=1)
KGVPTYNWGGNATDVFLLES 0.04% (n=1)
RGVPTYSWGENETDVFLLGS 0.04% (n=1)
KGVPTYNWGANDADVFLLTS 0.04% (n=1)
KGTPTYTWGANESDVFLLES 0.04% (n=1)
KGAPTYKWGEGEKDVFLLES 0.04% (n=1)
KGVPTYGWGENETDVFLLKS 0.04% (n=1)
KGAPTYSWGENETDVFLLQS 0.04% (n=1)
KGIPTYNWGENETDVFLLDS 0.04% (n=1)
KGAPTYTWGENKTDVFLLES 0.04% (n=1)
RGVPTYNWGENKTDVFLLES 0.04% (n=1)
KGVPTYGWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLTS 0.04% (n=1)
KGMPTYNWGENETDVFLLES 0.04% (n=1)
EGTPTYNWGENVTDVFLLKS 0.04% (n=1)
RGVPTYTWGENETDVFLLTS 0.04% (n=1)
AGVPTYTWGANKTDVFLLKS 0.04% (n=1)
KGVPRYTWGANETDVFLLES 0.04% (n=1)
RGVPTYNWGANETDVFLLES 0.04% (n=1)
KGAPTYNWGENATDMFLLQS 0.04% (n=1)
KGTPTYTWGANETDVFLLES 0.04% (n=1)
KGVPTYSWGENQTDVFLLKS 0.04% (n=1)
RGVPTYSWGANESDVFLLKS 0.04% (n=1)
KGEATFNWGENETDVFLLKS 0.04% (n=1)
KGVPTYNFGANKTDVFLLES 0.04% (n=1)
KGVPTYNWGGNETDVFLLNS 0.04% (n=1)
KGVPTYKWGENETDVFLLKS 0.04% (n=1)
KGTPTYSWGANQTDVFLLDS 0.04% (n=1)
KGTPTYTWGEDKSDVFLLES 0.04% (n=1)
RGAPTYNWGANESDVFLLQS 0.04% (n=1)
RGAPTYNWGENESDVFLLES 0.04% (n=1)
RGMPTYTWGENESDVFLLES 0.04% (n=1)
KGTPTYSWGANETDVFLLKS 0.04% (n=1)
MGAPTYTWGENESDVFLLES 0.04% (n=1)
KGAPTYNWGENQTDVFLLKS 0.04% (n=1)
KGVPTYTWGANQTDVFLLNS 0.04% (n=1)
TGVPTYKWGENKTDVFLLKS 0.04% (n=1)
KGVPTYEWGENQTDVFLLKS 0.04% (n=1)
KGVPTYTWGEQERDVFLLES 0.04% (n=1)
KGAPTYNWGGNETDVFLLKS 0.04% (n=1)
KGVPTFNWGVNETDVFLLKS 0.04% (n=1)
RGAPTYTWGANETDVFLLDS 0.04% (n=1)
RGVPTYSWGANETDVFLLKS 0.04% (n=1)
KGVPTYTWGTNETDVFLLDS 0.04% (n=1)
KGVPTFTWGGNKTDVFLLES 0.04% (n=1)
KGVPTYTWGENKSDVFLLKS 0.04% (n=1)
KGVPTYTWGENETDVFLLAS 0.04% (n=1)
AGKPTYGWGENETDVFLLES 0.04% (n=1)
KGNPTFNWGANATDVFLLES 0.04% (n=1)
KGTPTYTWGENKTDVFLLES 0.04% (n=1)
SGSPTYTWGENKTDVFLLAS 0.04% (n=1)
RGVPTYTWGANKSDVFLLKS 0.04% (n=1)
RGTPTYTWGENETDVFLLES 0.04% (n=1)
KGVPTYTWGGNKTDVFLLKS 0.04% (n=1)
KGVPTYNWGTNETDVFLLES 0.04% (n=1)
RGALTYNWGQNDSDVFLLQS 0.04% (n=1)
RGMPTYTWGENETDVFLLDS 0.04% (n=1)
GGAPTFTWGENETDVFLLQS 0.04% (n=1)
QGAPTYTWGENETDVFLLKS 0.04% (n=1)
KGAPTYQWGENETDVFLLKS 0.04% (n=1)
TGTPTYNWGENQTDVFLLES 0.04% (n=1)
KGAPTYRWGENETDVFLLES 0.04% (n=1)
KGDPTYTYGTNKTDVFLLRS 0.04% (n=1)
KGAPTYNWGVNETDVFLLES 0.04% (n=1)
KGSPTYQWGENETDVFLLKS 0.04% (n=1)
RGVPTYNWGANESDVFLLKS 0.04% (n=1)
QGVPTYNWGENKTDVFLLRS 0.04% (n=1)
EGVPTYNWGANESDVFLLQS 0.04% (n=1)
KGAPTYSWGENKTDVFLLES 0.04% (n=1)
KGVPTYNWGVNETDVFLLES 0.04% (n=1)
KGVPTYTWGANNTDVFLLTS 0.04% (n=1)
KGVPTFTWGENETDVFLLDS 0.04% (n=1)
KGSPTYTWGANETDVFLLQS 0.04% (n=1)
KGLPTYNWGENETDVFLLKS 0.04% (n=1)
KGLPTYTWGENKTDMFLLES 0.04% (n=1)
KGVPTYNWGDNETDVFLLRS 0.04% (n=1)
KGAPTYTWGGNQTDVFLLKS 0.04% (n=1)
EGTPTYTWGGNETDVFLLKS 0.04% (n=1)
KGVPTYTWGANKTDVFLLKS 0.04% (n=1)
KGRPTYTWGENETDVFLLES 0.04% (n=1)
QGAPTYTWGENETDVFLLES 0.04% (n=1)
KGAPTYNWGENETDVFQLES 0.04% (n=1)
KGAPTYTWGANETDVFLLAS 0.04% (n=1)
KGAPTYNWGDNETDVFLLAS 0.04% (n=1)
KGDPTYTWGANETDVFLLKS 0.04% (n=1)
KGAPTYNWGENATDVFLLGS 0.04% (n=1)
QGAPTYNWGENETDVFLLES 0.04% (n=1)
KGAPTYAWGANETDVFLLES 0.04% (n=1)
KGVPTYTFGGNKTDVFLLQS 0.04% (n=1)
KGVPTYTWGGNETDVFLLNS 0.04% (n=1)
KGAPTYTWGANKSDVFLLKS 0.04% (n=1)
RGAPTYTWGANETDVFLLNS 0.04% (n=1)
RGAPTYTWGANKTDMFLLHS 0.04% (n=1)
KGAPTYTWGANKSDVFLLTS 0.04% (n=1)
KGAPTYNFGENQTDVFLLES 0.04% (n=1)
RGAPTYTWGANETDVFLLQS 0.04% (n=1)
KGVPTYNWGANETDVFLLNS 0.04% (n=1)
KGAPTYKWGANETDVFLLKS 0.04% (n=1)
KGAPTYTWGANATDVFLLES 0.04% (n=1)
RGAPTYDWGENETDVFLLAS 0.04% (n=1)
EGAPTYTWGENKTDVFLLKS 0.04% (n=1)
KGNPTYTWGENVTDVFLLES 0.04% (n=1)
KGTPTFNWGQNQTDVFLLES 0.04% (n=1)
RGNPTFTWGETEKDVFLLDS 0.04% (n=1)
RGAPTYTWGENETDVFLLNS 0.04% (n=1)
RGVPTYSWGENETDVFLLKS 0.04% (n=1)
MGAPTYDWGENETDVFLLQS 0.04% (n=1)
QGVATYTWGENDADVFLLGS 0.04% (n=1)
RGNPTYNWGANETDTFLLES 0.04% (n=1)
EGIPTYTWGENETDMFLLKS 0.04% (n=1)
KGAPTYRWGANETDVFLLES 0.04% (n=1)
KGAPTYTWGENETDVFLLSS 0.04% (n=1)
EGTPTYTWGENKTDVFLLES 0.04% (n=1)
QGAPTYSWGENETDVFLLES 0.04% (n=1)
KGTPTYNWGENETDVFLLDS 0.04% (n=1)
RGAPTYTWGTNETDVFLLNS 0.04% (n=1)
KGVPTYNWGANVTDVFLLRS 0.04% (n=1)
KGAPTYNWGENETDLFLLES 0.04% (n=1)
KGAPTYSWGANETDVFLLQS 0.04% (n=1)
KGNPTFDWGANETDVFLLES 0.04% (n=1)
KGAPTYNWGANETDVFLLDS 0.04% (n=1)
KGAPTYNWGENDTDVFLLES 0.04% (n=1)
RGAPTYTWGANQTDVFLLQS 0.04% (n=1)
RGAPTYSWGVNETDVFLLES 0.04% (n=1)
RGAPTYSWGENETDVFLLDS 0.04% (n=1)
KGVPTYTWGGNETDVFLLQS 0.04% (n=1)
KGVPTYNWGENKTDVFLLES 0.04% (n=1)
KGAPTYNWGENDTDMFLLQS 0.04% (n=1)
KGVPTYTFGENQTDVFLLES 0.04% (n=1)
KGDPTYNWGENATDWFLLES 0.04% (n=1)
RGNPTYEWGENETDVFLLES 0.04% (n=1)
KGTPTYTWGENATDVFLLES 0.04% (n=1)
KGAPTYRWGENETDVFLLKS 0.04% (n=1)
KGAPTYTWGENETDVFQLTS 0.04% (n=1)
KGAPTYNWGANETDVFLLHS 0.04% (n=1)
KGAPTYTWGGNKTDVFLLES 0.04% (n=1)
TGAPTYTWGENKTDVFLLDS 0.04% (n=1)
KGAPTYTWGENETDVFLLTS 0.04% (n=1)
KGVPTYTWGENQTDVFLLKS 0.04% (n=1)
KGSPTYTWGDNESDVFLLGS 0.04% (n=1)
KGAPTYAWGANETDVFLLGS 0.04% (n=1)
KGSPTYNWGENETDVFLLDS 0.04% (n=1)
RGAPTYTWGGNETDVFLLKS 0.04% (n=1)
EGAPTYNWGGNDTDVFLLES 0.04% (n=1)
EGVPTFQWGANKTDVFLLES 0.04% (n=1)
RGVPTYTWGENETDVFLLDS 0.04% (n=1)
KGAPTYRWGENQSDVFLLGS 0.04% (n=1)
KGAPTYNWGANETDAFLLKS 0.04% (n=1)
EGTPTFNWGENKTDKFLLKS 0.04% (n=1)
RGVPTYTWGANESDVFLLES 0.04% (n=1)
KGAPTYTWGENETDVFLVES 0.04% (n=1)
EGVPTYTWGGNKTDMFLLGS 0.04% (n=1)
KGAPTYQWGANETDVFLLES 0.04% (n=1)
KGAPTYTWGANTTDVFLLES 0.04% (n=1)
EGTPTYSWGENKTDVFLLKS 0.04% (n=1)
EGAPTYTWGDNKTDVFLLKS 0.04% (n=1)
KGNPTYSWGENETDVFLLDS 0.04% (n=1)
KGLPTYRFGANESDVFLLES 0.04% (n=1)
KGLPTYSWGANESDVFLLDS 0.04% (n=1)
RGVPTYTWGENETDVFLLSS 0.04% (n=1)
KGNPTYTWGMNETDVFLLNS 0.04% (n=1)
KGNPTYTWGESATDVFLLDS 0.04% (n=1)
AGAPTYNWGENETDVFLLAS 0.04% (n=1)
DGTPTYNWGASPADVFLLAS 0.04% (n=1)
RGAPTYAWGENETDVFLLES 0.04% (n=1)
KGAPTYTWGANDTDVFLLES 0.04% (n=1)
QGAPTYSWGGNKTDVFLLES 0.04% (n=1)
KGVPTYSWGENETDVFLLTS 0.04% (n=1)
RGVPTYNWGENETDVFLLTS 0.04% (n=1)
KGAPTYTWGANESDVFLLTS 0.04% (n=1)
RGVPTYSWGENETDVFLLES 0.04% (n=1)
KGTPTYTWGANETDVFLLTS 0.04% (n=1)
KGHPTYNWGENETDVFLLES 0.04% (n=1)
RGVPTYTWGENKTDFFLLDS 0.04% (n=1)
TGTPTYTWGANKTDVFLLES 0.04% (n=1)
KGVPTYSWGENESDVFLLQS 0.04% (n=1)
RGTPTYTWGANETDRFLLES 0.04% (n=1)
RGAPTYNWGANETDVLLLES 0.04% (n=1)
KGIPTHNWGANESDVFLLKS 0.04% (n=1)
RGAPTYNWGANESDVFLLES 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 3b:

KGLPTYNFGANETDVFLLTS 23.49% (n=78)
KGLPTYNFGENETDVFLLTS 9.94% (n=33)
KGSPTYNFGENETDVFLLTS 8.43% (n=28)
KGLPTYNFGANESDVFLLTS 7.83% (n=26)
KGLPTYNFGENETDVFLLNS 6.93% (n=23)
KGLPTYNFGENETDVFLLKS 4.52% (n=15)
KGLPTYNFGENKTDVFLLTS 2.71% (n=9)
KGLPTYSFGENETDVFLLTS 2.41% (n=8)
KGLPTYTFGENETDVFLLKS 1.51% (n=5)
KGSPTYNFGENETDVFLLNS 1.20% (n=4)
KGLPTYSFGENETDVFLLDS 1.20% (n=4)
KGLPTYNFGGNESDVFLLTS 0.90% (n=3)
KGAPTYNFGENETDVFLLTS 0.90% (n=3)
KGSPTYNFGDNETDVFLLNS 0.90% (n=3)
KGLPTYNFGENETDVFLLDS 0.90% (n=3)
KGLPTYSFGENETDVFLLNS 0.90% (n=3)
RGLPTYNFGENETDVFLLTS 0.90% (n=3)
KGLPTYNFGENETDVFLLSS 0.90% (n=3)
KGLPTYTFGENETDVFLLNS 0.90% (n=3)
KGLPTYTFGENETDVFLLTS 0.90% (n=3)
KGLPTYSFGENESDVFLLTS 0.90% (n=3)
RGSPTYNFGENETDVFLLNS 0.60% (n=2)
KGLPTYNFGENETDVFLLES 0.60% (n=2)
KGLPTYNFGENDTDVFLLNS 0.60% (n=2)
KGLPTYNFGENETDVFLLPS 0.60% (n=2)
KGLPTYRFGVNESDVFLLTS 0.30% (n=1)
KGVPTYNFGANETDVFLLTS 0.30% (n=1)
KGLPTYNFGENEADVFLLNS 0.30% (n=1)
KGLPTYNFGENETDMFLLTS 0.30% (n=1)
RGVPTYNFGENETDVFLLTS 0.30% (n=1)
KGVPTYKFGENESDVFLLTS 0.30% (n=1)
KGLPTYNFGENESDVFLLAS 0.30% (n=1)
KGLPTYTFGENESDVFLLNS 0.30% (n=1)
KGLPTYTFGANESDVFLLTS 0.30% (n=1)
KGSPTYTFGENETDVFLLNS 0.30% (n=1)
KGVPTYKFGENETDVFLLTS 0.30% (n=1)
KGVPTYSFGANETDVFLLDS 0.30% (n=1)
KGLPTYNFGVNETDVFLLTS 0.30% (n=1)
RGSPTYNFGENETDVFLLSS 0.30% (n=1)
KGLPTYNFGENETDVFLLAS 0.30% (n=1)
RGAPTYNFGENETDVFLLTS 0.30% (n=1)
RGSPTYTFGANETDVFLLDS 0.30% (n=1)
KGSPTYSFGANETDVFLLDS 0.30% (n=1)
KGLPTYNFGEDETDVFLLKS 0.30% (n=1)
KGLPTYNFGANETDVFLLNS 0.30% (n=1)
EGSPTYTFGENETDVFLLNS 0.30% (n=1)
KGLPTYNFGGNQTDVFLLNS 0.30% (n=1)
KGLPTYNFGENKADKFLLDS 0.30% (n=1)
KGVPTYSFGENETDVFLLSS 0.30% (n=1)
KGVPTYNFGENETDVFLLGS 0.30% (n=1)
KGLPTYNFGGNETDVFLLNS 0.30% (n=1)
KGAPTYNFGENETDVFLLNS 0.30% (n=1)
KGLPTYNFGENESDVFLLTS 0.30% (n=1)
KGLPTYTFGEKETDVFLLSS 0.30% (n=1)
RGLPTYNFGENETDVFLLNS 0.30% (n=1)
KGLPTYNFGENEKDVFLLDS 0.30% (n=1)
RGLPTYTFGENETDVFLLTS 0.30% (n=1)
KGLPTYNFGANETDVFLLRS 0.30% (n=1)
TGLPTYTFGENETDVFLLDS 0.30% (n=1)
RGLPTYNFGVNETDVFLLRS 0.30% (n=1)
KGVPTYTFGEKETDVFLLNS 0.30% (n=1)
KGLPTYNFGDNETDVFLLNS 0.30% (n=1)
EGLPTYSFGANKTDVFLLPS 0.30% (n=1)
KGSPTYSFGEKETDVFLLNS 0.30% (n=1)
RGSPTYNFGENETDVFLLTS 0.30% (n=1)
KGLPTYTFGANETDVFLLTS 0.30% (n=1)
RGLPTYDFGENETDVFLLTS 0.30% (n=1)
KGAPTYTFGANETDVFLLTS 0.30% (n=1)
KGLPTYAFGANETDVFLLTS 0.30% (n=1)
KGSPTYSFGENETDVFLLTS 0.30% (n=1)
KGLPTYNFGENESDVFLLDS 0.30% (n=1)
KGAPTYNFGANETDVFLLTS 0.30% (n=1)
KGAPTYGFGENETDVFLLNS 0.30% (n=1)
KGLPTYRFGENETDVFLLTS 0.30% (n=1)
KGSPTYTFGGNESDVFLLNS 0.30% (n=1)
KGSPTYNFGANETDVFLLTS 0.30% (n=1)
RGVPTYTFGANETDVFLLTS 0.30% (n=1)
KGLPTYSFGENESDVFLLSS 0.30% (n=1)
KGLPTYTFGENETDVFLLAS 0.30% (n=1)
KGIPTYNFGANETDVFLLTS 0.30% (n=1)
KGLPTCNFGANETDVFLLTS 0.30% (n=1)
KGSPTYNFGGNETDVFLLTS 0.30% (n=1)
KGLPTYSFGANESDVFLLTS 0.30% (n=1)
KGLPTYGFGANESDVFLLTS 0.30% (n=1)
KGLPTYTFGENETDVFLLSS 0.30% (n=1)
RGLPTYNFGSNDTDVFLLTS 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 4:

LGVPTYTWGENESDVFILNS 26.72% (n=62)
LGVPTYTWGENESDVFLLNS 17.24% (n=40)
FGVPTYTWGENDTDVF---- 8.19% (n=19)
FGVPTYTWGENETDVF---- 3.02% (n=7)
LGAPTYTWGENETDVFLLNT 2.16% (n=5)
VGVPTYTWGENETDVFLLNS 1.72% (n=4)
LGVPTYTWGENETDVFLLNS 1.72% (n=4)
LGVPTHTWGENESDVFLLNS 1.72% (n=4)
FGVPTYTWGENETDVFLLNS 1.29% (n=3)
LGVPTYNWGENETDVFLLNS 1.29% (n=3)
RGAPTYTWGENETDVFLLNT 1.29% (n=3)
LGVPTYTWGENETDVFILNS 1.29% (n=3)
LGVPTYNWGENESDVFLLNS 0.86% (n=2)
RGVPTYNWGENETDVIILNS 0.86% (n=2)
LGAPTYTWGGNETDVFLLNT 0.86% (n=2)
LGAPTYSWGENETDVIILNS 0.86% (n=2)
LGAPTYTWGENETDVFILNS 0.86% (n=2)
RGVPTYTWGENETDVFILNS 0.86% (n=2)
LGVPTYNWGENETDVFVLNS 0.86% (n=2)
LGDPTYNWGENKTDVFILNS 0.86% (n=2)
FGVPTYTWGENESDVFLLNS 0.43% (n=1)
RGVPTYTWGENVSDVFLLNS 0.43% (n=1)
RGVPTYTWGENESDVFLLNS 0.43% (n=1)
LGAPTYNWGENESDVFLLNS 0.43% (n=1)
LGVPTYTWGANESDAFLLNS 0.43% (n=1)
SGVPTYNWGGNETDVFLLNS 0.43% (n=1)
LGVPTYTWGENVSDVFLLNS 0.43% (n=1)
LGVPTYTWGENASDVFLLNS 0.43% (n=1)
FGVPTYTLGGNETDVF---- 0.43% (n=1)
FGAPTYTWGENDTDVF---- 0.43% (n=1)
FGVPTYTWGDNESDVFLLNA 0.43% (n=1)
RGVPTYNWGENETDVFLLNS 0.43% (n=1)
IGLPTYNWGENESDVFLLNS 0.43% (n=1)
RGVPTYTWGENKTDVFLLGS 0.43% (n=1)
LGVPTYTWGENETDVFLLNT 0.43% (n=1)
LGVPTYSWGANETDVFILNS 0.43% (n=1)
LGVPTYNWGDNETDVLILNS 0.43% (n=1)
LGVPTYNWGENETDVIILNS 0.43% (n=1)
LGAPTYTWGANETDVIILNS 0.43% (n=1)
AGLPTYNWGENETDVFILNS 0.43% (n=1)
LGVPTYNWGENETDVFTLNS 0.43% (n=1)
SGSPTYNWGENVTDVLILNS 0.43% (n=1)
SGSPTYNWGENVTDVIIMNS 0.43% (n=1)
LGAPTYSWGDNETDVLILNS 0.43% (n=1)
LGAPTYAWGENETDVIILNS 0.43% (n=1)
QGIPTYNWGENETDVIILNS 0.43% (n=1)
QGDPTYGWGTGKDDVFILNS 0.43% (n=1)
QGAPTYNWGENETDVIILNS 0.43% (n=1)
KGNPTYSFGGNDTDVIILNS 0.43% (n=1)
SGDPTYNWGENATDVLILNS 0.43% (n=1)
RGNPTYYWGGNDTDVVILNS 0.43% (n=1)
SGNPTYGWGGNETDVIILNS 0.43% (n=1)
RGIPTYTWGENETDVFILNS 0.43% (n=1)
RGVPTYTWGENETDVFVLNS 0.43% (n=1)
LGVPTYNWGENETDVFILNS 0.43% (n=1)
LGIPTYTWGANETDVFILNS 0.43% (n=1)
AGAPTYNWGENETDVLILNS 0.43% (n=1)
RGYPTHNWGANETDVFILNS 0.43% (n=1)
AGNPTYTWGANGTDVFILNS 0.43% (n=1)
RGAPTYTWGENETDVFILNS 0.43% (n=1)
LGVPTYDWGVNETNVFILNS 0.43% (n=1)
LGVPTYDWGGNETDVFILNS 0.43% (n=1)
LGAPTYSWGENETDVFILNS 0.43% (n=1)
LGLPTYGWGGNETDVFILNS 0.43% (n=1)
LGVPTYNWGANETDVFVLNS 0.43% (n=1)
RGVPTYNWGVNETDVFVLNS 0.43% (n=1)
RGVPTYNWGENETDVFVLNS 0.43% (n=1)
LGVPTYNWGVNETDVFVLNS 0.43% (n=1)
LGHPTYSWGENETDVIILNS 0.43% (n=1)
QGVPTYTWGENETDVFILNS 0.43% (n=1)
RGVPTYTWGGNETDVFFLNS 0.43% (n=1)
LGDPTYTWGQNKTDVFILNS 0.43% (n=1)
RGTPTYNWGENDTDVIIMNA 0.43% (n=1)
RGHPTYNWGENETDVLILNS 0.43% (n=1)
LGLPTYRWGENETDVFILNS 0.43% (n=1)
VGVPTYNWGANETDVFLLNS 0.43% (n=1)
RGAPTYTWGENESDIFLLNS 0.43% (n=1)
LGVPTYNWGENETDVLILNS 0.43% (n=1)
FGLPTYTWGENESDVFVLNA 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 4a:

LGVPTYTWGENESDVFILNS 38.99% (n=62)
LGVPTYTWGENESDVFLLNS 25.16% (n=40)
FGVPTYTWGENDTDVF---- 11.95% (n=19)
FGVPTYTWGENETDVF---- 4.40% (n=7)
VGVPTYTWGENETDVFLLNS 2.52% (n=4)
LGVPTHTWGENESDVFLLNS 2.52% (n=4)
FGVPTYTWGENETDVFLLNS 1.89% (n=3)
LGVPTYNWGENETDVFLLNS 1.89% (n=3)
LGVPTYTWGENETDVFLLNS 1.26% (n=2)
LGVPTYNWGENESDVFLLNS 1.26% (n=2)
FGVPTYTWGENESDVFLLNS 0.63% (n=1)
RGVPTYTWGENVSDVFLLNS 0.63% (n=1)
RGVPTYTWGENESDVFLLNS 0.63% (n=1)
LGAPTYNWGENESDVFLLNS 0.63% (n=1)
LGVPTYTWGANESDAFLLNS 0.63% (n=1)
SGVPTYNWGGNETDVFLLNS 0.63% (n=1)
LGVPTYTWGENVSDVFLLNS 0.63% (n=1)
LGVPTYTWGENASDVFLLNS 0.63% (n=1)
FGVPTYTLGGNETDVF---- 0.63% (n=1)
FGAPTYTWGENDTDVF---- 0.63% (n=1)
FGVPTYTWGDNESDVFLLNA 0.63% (n=1)
RGVPTYNWGENETDVFLLNS 0.63% (n=1)
IGLPTYNWGENESDVFLLNS 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 4d:

LGAPTYTWGENETDVFLLNT 38.46% (n=5)
RGAPTYTWGENETDVFLLNT 23.08% (n=3)
LGVPTYTWGENETDVFLLNS 15.38% (n=2)
LGAPTYTWGGNETDVFLLNT 15.38% (n=2)
LGVPTYTWGENETDVFLLNT 7.69% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 5:

RGYPTYNWGSNETDIFLLNN 10.81% (n=4)
RGYPTYNWGSNETDVFLLNN 8.11% (n=3)
KGNPTYNWGENETDIFLLNN 5.41% (n=2)
AGVPSYNWGSNETDIFLLNS 5.41% (n=2)
RGCPTYNWGSNETDILLLNN 5.41% (n=2)
KGLPTYTWGENETDVFILNN 2.70% (n=1)
KGNPTYSWGENETDIFLLNN 2.70% (n=1)
RGLPTYNWGENETDVFLLNN 2.70% (n=1)
LGHPTYTWGENETDIFLLNN 2.70% (n=1)
RGYPTYTWGENETDVFLLNN 2.70% (n=1)
RGVPTYTWGENETDVLLLNN 2.70% (n=1)
RGYPTYNWGSNETDILLLNN 2.70% (n=1)
KGYPTYNWGSNETDILLLNN 2.70% (n=1)
RGYPTYNWGSNDTDILLLNN 2.70% (n=1)
RGYPTYNWGSNETDIFILNN 2.70% (n=1)
RGFPTYNWGENETDVFLLNN 2.70% (n=1)
RGYPTYNWGENDTDILILNN 2.70% (n=1)
KGYPTYNWGSNETDVFVLNN 2.70% (n=1)
RGYPTYNWGENETDVLLLNN 2.70% (n=1)
TGNPTYDWGSNESDVFLLNN 2.70% (n=1)
LGYPTYSWGDNETDVFLLNN 2.70% (n=1)
RGYPTYNWGENETDILLLNN 2.70% (n=1)
RGYPTYSWGANETDVFLLNN 2.70% (n=1)
RGCPTYTWGTNETDIFLLNN 2.70% (n=1)
RGYPTYNWGENETDIFLLNN 2.70% (n=1)
RGYPTYSWGSNDTDILLLNN 2.70% (n=1)
KGYPTYNWGENDTDVLLLNN 2.70% (n=1)
RGYPTYNWGSNETDVILLNS 2.70% (n=1)
KGHPTYNWGSNVTDFFLMNN 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 6:

RGNPTYTWGENETDVFMLES 19.28% (n=64)
KGLPTYTWGENESDVFLLES 5.12% (n=17)
KGLPTYNWGENVSDVFLLQS 3.92% (n=13)
LGNPTYTWGENETDVFMLES 2.11% (n=7)
RGNPTYTWGENETDVFILES 1.81% (n=6)
KGLPTYNWGENMSDVFLLQS 1.81% (n=6)
RGNPTYTWGENETDVFMLGS 1.51% (n=5)
KGLPTYTWGENETDVFLLQS 1.51% (n=5)
KGLPTYTWGENESDVFLLQS 1.51% (n=5)
KGLPTYNWGANVSDVFLLQS 1.51% (n=5)
RGNPTYTWGDNETDVFMLES 1.20% (n=4)
KGLPTYNWGENASDVFLLQS 1.20% (n=4)
RGAPTYTWGENETDVFILQS 1.20% (n=4)
KGLPTYTWGENVSDVFLLQS 0.90% (n=3)
KGLPTYTWGANESDVFLLES 0.90% (n=3)
KGFPTYTWGENESDVFLLES 0.90% (n=3)
RGNPTYNWGDNETDVFMLES 0.60% (n=2)
RGNPTYNWGENETDVFMLES 0.60% (n=2)
RGTPTYTWGENETDVFILES 0.60% (n=2)
LGNPTYNWGENETDVFMLES 0.60% (n=2)
RGVPTYTWGENESDVFLLES 0.60% (n=2)
KGLPTYSWGENESDVFLLES 0.60% (n=2)
KGLPTYNWGENESDVFLLES 0.60% (n=2)
RGNPTYTWGANETDVFMMSS 0.60% (n=2)
KGLPTYAWGANETDVFLLQS 0.60% (n=2)
KGLPTYNWGGNVSDVFLLQS 0.60% (n=2)
RGLPTYNWGENESDVFLLQS 0.60% (n=2)
KGLPTYNWGDNVSDVFLLQS 0.60% (n=2)
KGNPTYTWGANATDVFLLES 0.60% (n=2)
RGLPTYNWGENESDVFLLES 0.60% (n=2)
KGLPTYTWGGNESDVFLLES 0.60% (n=2)
RGRPTYNWGDNETDVFLLES 0.60% (n=2)
KGLPTYNWGANASDVFLLQG 0.60% (n=2)
RGLPTYTWGENESDVFLLQG 0.60% (n=2)
RGFPTYTWGDNESDVFLLQS 0.60% (n=2)
KGFPTYTWGANESDVFLLQS 0.60% (n=2)
RGNPTYTWGENESDVFMLES 0.30% (n=1)
QGNPTYTWGENVTDVFMLES 0.30% (n=1)
PGNPTYTWGENWTDVFMLDS 0.30% (n=1)
PGNPTYTWGENETDVFMLDS 0.30% (n=1)
LGNPTYTWGQNETDVFMYDS 0.30% (n=1)
RGIPTYTWGENETDVFILES 0.30% (n=1)
RGNPTYTWGENETDVFMLQS 0.30% (n=1)
RGNPTYTWGENETDVFMLDS 0.30% (n=1)
LGNPTYTWGDNETDVFMLES 0.30% (n=1)
RGNPTYTWGENETDVFMLAS 0.30% (n=1)
RGNPTYSWGDNETDVFMLES 0.30% (n=1)
RGHPTYNWGENETDVLMLES 0.30% (n=1)
LGSPTYTWGDNETDVFMLES 0.30% (n=1)
RGKPTYTWGENETDVFILES 0.30% (n=1)
RGNPTYNWGENVTDVFILES 0.30% (n=1)
LGNPTYSWGENETDVFMLGS 0.30% (n=1)
RGNPTYHWGENETDVFMLES 0.30% (n=1)
RGNPTYNWGENETDVFMLDS 0.30% (n=1)
RGIPTYTWGENETDVFMLES 0.30% (n=1)
RGVPTYTWGENETDVFLLES 0.30% (n=1)
LGNPTYNWGDNETDVFMLES 0.30% (n=1)
RGAPTYTWGENETDVFILES 0.30% (n=1)
RGIPTYTWGENETDVFILKS 0.30% (n=1)
RGNPTYTWGKNETDVFMLES 0.30% (n=1)
RGNPTYTWGANETDVFMLES 0.30% (n=1)
QGNPTYTWGENETDVFMLES 0.30% (n=1)
RGAPTYTFGENETDVLLLES 0.30% (n=1)
RGVPTYSFGDNETDVFLLES 0.30% (n=1)
KGAPTYSFGDNESDVFLLES 0.30% (n=1)
RGLPTYEWGENASDVFLLES 0.30% (n=1)
KGLPTYNWGVNESDVFLLES 0.30% (n=1)
TGLPTYSWGENESDVFLLES 0.30% (n=1)
KGLPTYQWGENQSDVFLLES 0.30% (n=1)
KGLPTYSWGENETDVFLLES 0.30% (n=1)
VGLPTYTWGENETDVFILKS 0.30% (n=1)
VGLPTYTWGENETDVFILES 0.30% (n=1)
AGLPTYTWGENETDVFILTS 0.30% (n=1)
RGIPTYTWGENVSDVFLLHS 0.30% (n=1)
KGNPTYTWGENITDVFQLHS 0.30% (n=1)
KGFPTYSWGVNESDVFILRS 0.30% (n=1)
KGIPTYNWGENATDVFLLYS 0.30% (n=1)
GGLPTYGWGGNDSDVFLLSS 0.30% (n=1)
RGLPTFTWGENETDVFLLGS 0.30% (n=1)
KGHPTYTWGENVTDVFLLES 0.30% (n=1)
KGLPTYDWGENVTDVFLLES 0.30% (n=1)
KGHPTFNWGENETDVFLLSS 0.30% (n=1)
RGHPTYNWGENETDVFLLSS 0.30% (n=1)
KGLPTYTWGANESDVFLLRS 0.30% (n=1)
RGLPTYNWGENETDVFLLRN 0.30% (n=1)
KGFPTYTWGENETDVFLLQS 0.30% (n=1)
KGFPTYSWGGNETDVFLLQS 0.30% (n=1)
KGLPTYNWGENETDVFLLQS 0.30% (n=1)
KGFPTYNWGENETDVFLLQS 0.30% (n=1)
KGLPTYNWGGNVSDVILLQN 0.30% (n=1)
KGLPTYNWGENASDVFLLRS 0.30% (n=1)
RGLPTYNWGENASDVFLLQS 0.30% (n=1)
KGLPTYTWGDNVSDVFLLQS 0.30% (n=1)
RGLPTYTWGENETDVFLLQS 0.30% (n=1)
KGLPTYAWGENETDVFLLQS 0.30% (n=1)
KGVPTYTWGENETDVFLLQS 0.30% (n=1)
KGLPTYNWGNNMSDVFLLQS 0.30% (n=1)
KGLPTYNWGANESDVFLLQS 0.30% (n=1)
KGLPTYNWGANETDVFLLQS 0.30% (n=1)
KGLPTYNWGDNVTDVFLLQS 0.30% (n=1)
RGLPTYSWGENESDVFLLQS 0.30% (n=1)
KGLPKYNWGENESDVFLLQS 0.30% (n=1)
KGLPTYNWGDNESDVFLLQG 0.30% (n=1)
KGLPTYNWGDNMSDVFLLQS 0.30% (n=1)
KGLPTYSWGENVSDVFLLQS 0.30% (n=1)
KGLPTYTWGENASDVFLLQS 0.30% (n=1)
KGNPTYTWGENVSDVFLLRS 0.30% (n=1)
KGLPTYNWGENETDVFLLRS 0.30% (n=1)
KGLPTYNWGVNVSDVFLLQS 0.30% (n=1)
RGLPTYSWGVNESDVFLLES 0.30% (n=1)
RGVPTYTWGENESDVFLLAS 0.30% (n=1)
RGVPTYPWGGNDSDVFLLAS 0.30% (n=1)
KGVPTYTWGENETDVFLLES 0.30% (n=1)
KGVPTYNWGENETDVFLLES 0.30% (n=1)
KGLPTYGWGENETDVFLLAS 0.30% (n=1)
RGSPTYRWGENETDVFLLES 0.30% (n=1)
RGSPTYNWGDNESDVFLLAS 0.30% (n=1)
KGNPTYTWGDNKTDVFLLAS 0.30% (n=1)
RGLPTYNWGENESDVFLLAS 0.30% (n=1)
RGNPTYSWGENETDVFLLGS 0.30% (n=1)
TGLPTYTWGENMTDVFLLAS 0.30% (n=1)
RGLPTYTWGENETDVFLLAS 0.30% (n=1)
KGLPTYTWGENVSDVFLLTS 0.30% (n=1)
KGLPTYSWGENESDVFLLMS 0.30% (n=1)
KGNPTYTWGENETDVFILNS 0.30% (n=1)
RGNPTYTWGENETDVFILGS 0.30% (n=1)
KGTPTYTWGENETDVFILNS 0.30% (n=1)
RGNPTYSWGENETDVFILDS 0.30% (n=1)
TGLPTYTWGENESDVFLLES 0.30% (n=1)
KGAPTYTWGTNETDVFLLES 0.30% (n=1)
RGAPTYTWGTNETDVFLLES 0.30% (n=1)
RGLPTYTWGANKTDVFLLSS 0.30% (n=1)
KGLPTYTLGENESDVFLLES 0.30% (n=1)
KGLPTYAWGENKSDVFLLES 0.30% (n=1)
RGLPTYTWGGNESDVFLLES 0.30% (n=1)
KGLPTYNWGANEGDVFLLES 0.30% (n=1)
KGLPTYNWGANESDVFLLES 0.30% (n=1)
KGFPTYTWGANESDVFLLES 0.30% (n=1)
KGFPTYTWGENDSDVFLLES 0.30% (n=1)
KGLPTYSWGANESDVFLLES 0.30% (n=1)
RGHPTYTWGENESDVFLLQT 0.30% (n=1)
KGLPTYTWGENETDVFLLES 0.30% (n=1)
KGIPTYNWGGNETDVFLLES 0.30% (n=1)
LGNPTYTWGENETDIFMLAS 0.30% (n=1)
MGNPTYNWGDNETDVFMLTS 0.30% (n=1)
LGNPTYTWGENETDVFMLGS 0.30% (n=1)
RGAPTYTWGENETDVLILQS 0.30% (n=1)
RGSPTYTWGEHETDVFILQS 0.30% (n=1)
RGAPTYTWGTNETDVFLLQS 0.30% (n=1)
DGFATYNWGENATDVFLLQG 0.30% (n=1)
KGSATYTWGENETDVFLLES 0.30% (n=1)
KGIPTYNWGENATDVFLLQS 0.30% (n=1)
KGLPTYTWGENETDVFLLQG 0.30% (n=1)
KGLPTYTWGVNETDVFLLTS 0.30% (n=1)
KGNPTYNWGENETDVFILSS 0.30% (n=1)
RGVPTYTWGENESDVFLMTS 0.30% (n=1)
LGNPTYTWGENETDVFMMSS 0.30% (n=1)
LGNPTYNWGENETDVFMMSS 0.30% (n=1)
QGAPTFTWGANESDVFLMSS 0.30% (n=1)
RGKPTYTWGENETDVFIMES 0.30% (n=1)
LGAPTYNFGENESDVFLMQS 0.30% (n=1)
KGVPTYNWGGNESDVFLLES 0.30% (n=1)
RGVPTYSWGENQSDVFLLTG 0.30% (n=1)
GGTPTFTWGANKSDVFLLTS 0.30% (n=1)
RGNPTYTWGANETDVFMLYS 0.30% (n=1)
RGLPTYTWGENESDVFLLQS 0.30% (n=1)
KGFPTYTWGDNESDVFLLQS 0.30% (n=1)
RGFPTYNWGANASDVFLLQS 0.30% (n=1)
RGFPTYNWGANESDVFLLQS 0.30% (n=1)
RGFPTYTWGENETDVFLLQS 0.30% (n=1)
RGDPTYTWGGNESDVLILQS 0.30% (n=1)
RGNPTYTWGENETDVFLLAS 0.30% (n=1)
RGFPTYTWGENESDVFLLQS 0.30% (n=1)
RGFPTYTWGANESDVFLLQS 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Subtype 6a:

RGNPTYTWGENETDVFMLES 54.24% (n=64)
LGNPTYTWGENETDVFMLES 5.93% (n=7)
RGNPTYTWGENETDVFILES 5.08% (n=6)
RGNPTYTWGENETDVFMLGS 4.24% (n=5)
RGNPTYTWGDNETDVFMLES 3.39% (n=4)
RGNPTYNWGDNETDVFMLES 1.69% (n=2)
RGNPTYNWGENETDVFMLES 1.69% (n=2)
RGTPTYTWGENETDVFILES 1.69% (n=2)
RGNPTYTWGENESDVFMLES 0.85% (n=1)
QGNPTYTWGENVTDVFMLES 0.85% (n=1)
PGNPTYTWGENWTDVFMLDS 0.85% (n=1)
PGNPTYTWGENETDVFMLDS 0.85% (n=1)
LGNPTYTWGQNETDVFMYDS 0.85% (n=1)
RGIPTYTWGENETDVFILES 0.85% (n=1)
RGNPTYTWGENETDVFMLQS 0.85% (n=1)
RGNPTYTWGENETDVFMLDS 0.85% (n=1)
LGNPTYTWGDNETDVFMLES 0.85% (n=1)
RGNPTYTWGENETDVFMLAS 0.85% (n=1)
RGNPTYSWGDNETDVFMLES 0.85% (n=1)
RGHPTYNWGENETDVLMLES 0.85% (n=1)
LGSPTYTWGDNETDVFMLES 0.85% (n=1)
RGKPTYTWGENETDVFILES 0.85% (n=1)
RGNPTYNWGENVTDVFILES 0.85% (n=1)
LGNPTYSWGENETDVFMLGS 0.85% (n=1)
RGNPTYHWGENETDVFMLES 0.85% (n=1)
RGNPTYNWGENETDVFMLDS 0.85% (n=1)
RGIPTYTWGENETDVFMLES 0.85% (n=1)
RGVPTYTWGENETDVFLLES 0.85% (n=1)
LGNPTYNWGDNETDVFMLES 0.85% (n=1)
RGAPTYTWGENETDVFILES 0.85% (n=1)
RGIPTYTWGENETDVFILKS 0.85% (n=1)
RGNPTYTWGKNETDVFMLES 0.85% (n=1)
RGNPTYTWGANETDVFMLES 0.85% (n=1)
QGNPTYTWGENETDVFMLES 0.85% (n=1)
---------------------------------------------------------------------------------------
Region 522-541 (antibodies: [AR3A] ), HCV Genotype 7:

RGVPTYTWGENESDVFLLNS 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 1:

WGENETDV 28.66% (n=2932)
WGENDTDV 24.13% (n=2468)
WGANDTDV 10.63% (n=1087)
WGSNDTDV 5.71% (n=584)
WGANETDV 5.71% (n=584)
WGGNETDV 4.81% (n=492)
WGDNDTDV 4.30% (n=440)
WGSNETDV 2.47% (n=253)
WGENATDV 1.22% (n=125)
WGDNETDV 1.05% (n=107)
WGGNDTDV 0.92% (n=94)
WGGNVTDV 0.92% (n=94)
WGCNDTDV 0.61% (n=62)
WGENKTDV 0.54% (n=55)
WGSNDTDI 0.40% (n=41)
WGENVTDV 0.37% (n=38)
WGENNTDV 0.34% (n=35)
WGANDTDI 0.29% (n=30)
WGAREEDV 0.27% (n=28)
WGANDTDF 0.26% (n=27)
WGAKETDV 0.26% (n=27)
WGGKDTDV 0.26% (n=27)
WGANVTDV 0.25% (n=26)
WGENQTDV 0.22% (n=23)
WGEKETDV 0.21% (n=21)
WGADETDV 0.17% (n=17)
WGVNETDV 0.16% (n=16)
WGKNETDV 0.15% (n=15)
WGGNKTDV 0.14% (n=14)
------DV 0.12% (n=12)
WGTNETDV 0.11% (n=11)
WGGNDTDF 0.10% (n=10)
WGENESDV 0.10% (n=10)
WGANEMDV 0.10% (n=10)
WGEGGTDV 0.10% (n=10)
WGTNDTDV 0.09% (n=9)
WGENGTDV 0.09% (n=9)
WGANNTDV 0.09% (n=9)
WGEKDTDV 0.09% (n=9)
WGSNNTDV 0.09% (n=9)
WGANKTDV 0.09% (n=9)
-GENETDV 0.09% (n=9)
WGVNDTDV 0.08% (n=8)
WGQNDTDV 0.07% (n=7)
WGENETDA 0.07% (n=7)
WGGNRTDV 0.07% (n=7)
WGNNDTDV 0.06% (n=6)
WGENETDI 0.06% (n=6)
WGENEADV 0.06% (n=6)
WGAHETDV 0.06% (n=6)
WGTREEDV 0.06% (n=6)
WGNNETDV 0.06% (n=6)
WGENETGV 0.06% (n=6)
WGENETNV 0.04% (n=4)
WGVNETDI 0.04% (n=4)
WGGSVKDV 0.04% (n=4)
WGQNETDV 0.04% (n=4)
WGCNETDV 0.04% (n=4)
WGSDDKDV 0.04% (n=4)
WGVNKTDV 0.04% (n=4)
WGTQEEDV 0.04% (n=4)
WGTREGDV 0.04% (n=4)
WGENETDM 0.04% (n=4)
WGE----- 0.04% (n=4)
WGESETDV 0.04% (n=4)
SGANDTDF 0.04% (n=4)
WGGDDTDV 0.03% (n=3)
WGATDADV 0.03% (n=3)
WGENDKDV 0.03% (n=3)
WGSNSTDV 0.03% (n=3)
WGSNDSDV 0.03% (n=3)
WGSNVTDV 0.03% (n=3)
WGENDMDV 0.03% (n=3)
WGRNDTDV 0.03% (n=3)
WGENDSDV 0.03% (n=3)
WGESEADV 0.03% (n=3)
WGSNDVDV 0.03% (n=3)
WGGNATDV 0.03% (n=3)
WGGNKSDV 0.03% (n=3)
WGENVSDV 0.03% (n=3)
WGSNRTDV 0.02% (n=2)
WGANEADV 0.02% (n=2)
WGANDTYF 0.02% (n=2)
WGENDTDF 0.02% (n=2)
WGENDADV 0.02% (n=2)
FGENETDV 0.02% (n=2)
WGEDDSDV 0.02% (n=2)
WGINDTDV 0.02% (n=2)
WGANESDV 0.02% (n=2)
WGADEADV 0.02% (n=2)
WGANDSDV 0.02% (n=2)
WGDSDTDV 0.02% (n=2)
WGASDTDV 0.02% (n=2)
RGENDTDV 0.02% (n=2)
WGEDDTDV 0.02% (n=2)
RGANDTDV 0.02% (n=2)
LGYQYHGR 0.02% (n=2)
WGANDADV 0.02% (n=2)
WGGTDTDV 0.02% (n=2)
WGAGETDV 0.02% (n=2)
WGENHTDV 0.02% (n=2)
WGENTTDV 0.02% (n=2)
WGGNETDI 0.02% (n=2)
WSENETDV 0.02% (n=2)
WGEEDTDV 0.02% (n=2)
WGIREEDV 0.02% (n=2)
WGNSSTDV 0.02% (n=2)
WGSDTKDV 0.02% (n=2)
WGCNVTDV 0.02% (n=2)
WGENEKDV 0.02% (n=2)
WGGNASDV 0.02% (n=2)
WGENKSDV 0.02% (n=2)
WGRNETDV 0.02% (n=2)
-GENEIDV 0.02% (n=2)
-GESETDV 0.02% (n=2)
WGSNDTDF 0.01% (n=1)
WGSNDTDA 0.01% (n=1)
WGSNKTDV 0.01% (n=1)
WGENDVDV 0.01% (n=1)
WGSNDTVV 0.01% (n=1)
WCANETGV 0.01% (n=1)
WGGNNADV 0.01% (n=1)
WGANDMDV 0.01% (n=1)
WGANETDI 0.01% (n=1)
WGTNDTNV 0.01% (n=1)
WGENDTGV 0.01% (n=1)
WGADDTDV 0.01% (n=1)
WGINETDV 0.01% (n=1)
WGVTDTDV 0.01% (n=1)
WGDNGADV 0.01% (n=1)
*GDNDTDV 0.01% (n=1)
WVENDTDV 0.01% (n=1)
WGSDTTDV 0.01% (n=1)
CGENDTDV 0.01% (n=1)
WGEHDTDV 0.01% (n=1)
WGSNVSDV 0.01% (n=1)
WGSNHSDV 0.01% (n=1)
WGNTSEDV 0.01% (n=1)
WGERDRDV 0.01% (n=1)
FGANQTDV 0.01% (n=1)
WGESDMDV 0.01% (n=1)
WGSSDKDV 0.01% (n=1)
WGRNDTDF 0.01% (n=1)
WGESDKDV 0.01% (n=1)
WGSDDTDV 0.01% (n=1)
WGTNATDV 0.01% (n=1)
WGSNYTDV 0.01% (n=1)
WGGKVTDV 0.01% (n=1)
FGTNETDV 0.01% (n=1)
WGDSDEDV 0.01% (n=1)
WGENDTDG 0.01% (n=1)
WGVNDTDF 0.01% (n=1)
WGERDTDV 0.01% (n=1)
WGGNETGV 0.01% (n=1)
WGSNDTGI 0.01% (n=1)
WGENDTDA 0.01% (n=1)
WGEYDTDV 0.01% (n=1)
*GENDTDV 0.01% (n=1)
WGENDTGI 0.01% (n=1)
WGDNQTDV 0.01% (n=1)
WGANETEV 0.01% (n=1)
WGSSDVDV 0.01% (n=1)
WGANDTAV 0.01% (n=1)
WGANGTDV 0.01% (n=1)
WGATDTDV 0.01% (n=1)
WGVNDTGV 0.01% (n=1)
WGANDTGV 0.01% (n=1)
WGANDTDA 0.01% (n=1)
WGVNDKDV 0.01% (n=1)
WGAKKTDV 0.01% (n=1)
WGTNVTDV 0.01% (n=1)
WGADKTDV 0.01% (n=1)
WGANEKDV 0.01% (n=1)
WGAKQTDV 0.01% (n=1)
WGARETDV 0.01% (n=1)
WGASETDV 0.01% (n=1)
WGATETDV 0.01% (n=1)
WGTNETDI 0.01% (n=1)
WGTNKTDV 0.01% (n=1)
WGDNEADV 0.01% (n=1)
WGVNDTDI 0.01% (n=1)
WGCND--- 0.01% (n=1)
WGSNATDV 0.01% (n=1)
WGANITDV 0.01% (n=1)
WGSDNTDV 0.01% (n=1)
WGSNITDV 0.01% (n=1)
WGETDKDV 0.01% (n=1)
WGANMTDV 0.01% (n=1)
WVSNDTDV 0.01% (n=1)
WGEQDTDV 0.01% (n=1)
WGSSDADV 0.01% (n=1)
WGGNDADV 0.01% (n=1)
WGGGDTDV 0.01% (n=1)
WGRKDTDV 0.01% (n=1)
WGMNDTDV 0.01% (n=1)
WGKNDTDV 0.01% (n=1)
RGENGTDV 0.01% (n=1)
WGVNESDV 0.01% (n=1)
WRENETDV 0.01% (n=1)
WGEIETDV 0.01% (n=1)
GRGIETDV 0.01% (n=1)
WGEYETDV 0.01% (n=1)
WGGNETDM 0.01% (n=1)
WGGIKPDV 0.01% (n=1)
WGENETCV 0.01% (n=1)
WGENGSDV 0.01% (n=1)
WEENETDV 0.01% (n=1)
WGGNTSDV 0.01% (n=1)
-------V 0.01% (n=1)
WGTNESDV 0.01% (n=1)
LGENETDV 0.01% (n=1)
WGANQTDV 0.01% (n=1)
WGENSSDV 0.01% (n=1)
WGEDETDV 0.01% (n=1)
RGENEADV 0.01% (n=1)
WGKNETDM 0.01% (n=1)
RGGNETDV 0.01% (n=1)
-GENESDV 0.01% (n=1)
WGANVSDV 0.01% (n=1)
WGEHESDV 0.01% (n=1)
WGEGASDV 0.01% (n=1)
SGANETDF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 1a:

WGENDTDV 33.86% (n=2462)
WGANDTDV 14.95% (n=1087)
WGENETDV 11.99% (n=872)
WGSNDTDV 8.03% (n=584)
WGANETDV 7.19% (n=523)
WGDNDTDV 6.01% (n=437)
WGSNETDV 3.48% (n=253)
WGENATDV 1.61% (n=117)
WGGNDTDV 1.29% (n=94)
WGDNETDV 1.03% (n=75)
WGCNDTDV 0.85% (n=62)
WGSNDTDI 0.56% (n=41)
WGENNTDV 0.48% (n=35)
WGANDTDI 0.41% (n=30)
WGGNETDV 0.39% (n=28)
WGAREEDV 0.39% (n=28)
WGANDTDF 0.37% (n=27)
WGAKETDV 0.37% (n=27)
WGGKDTDV 0.37% (n=27)
WGANVTDV 0.36% (n=26)
WGENVTDV 0.36% (n=26)
WGEKETDV 0.25% (n=18)
WGADETDV 0.23% (n=17)
------DV 0.17% (n=12)
WGGNDTDF 0.14% (n=10)
WGTNETDV 0.14% (n=10)
WGANEMDV 0.14% (n=10)
WGEGGTDV 0.14% (n=10)
WGGNKTDV 0.14% (n=10)
WGTNDTDV 0.12% (n=9)
WGANNTDV 0.12% (n=9)
WGEKDTDV 0.12% (n=9)
WGSNNTDV 0.12% (n=9)
WGVNDTDV 0.11% (n=8)
WGANKTDV 0.11% (n=8)
WGENKTDV 0.11% (n=8)
WGQNDTDV 0.10% (n=7)
WGENESDV 0.10% (n=7)
WGNNDTDV 0.08% (n=6)
WGAHETDV 0.08% (n=6)
WGTREEDV 0.08% (n=6)
WGVNETDI 0.06% (n=4)
WGGSVKDV 0.06% (n=4)
WGQNETDV 0.06% (n=4)
WGCNETDV 0.06% (n=4)
WGSDDKDV 0.06% (n=4)
WGVNKTDV 0.06% (n=4)
WGTQEEDV 0.06% (n=4)
WGTREGDV 0.06% (n=4)
WGENETDA 0.06% (n=4)
WGGDDTDV 0.04% (n=3)
WGATDADV 0.04% (n=3)
WGENETDI 0.04% (n=3)
WGENDKDV 0.04% (n=3)
WGSNSTDV 0.04% (n=3)
WGSNDSDV 0.04% (n=3)
WGVNETDV 0.04% (n=3)
WGSNVTDV 0.04% (n=3)
WGENDMDV 0.04% (n=3)
WGRNDTDV 0.04% (n=3)
WGENDSDV 0.04% (n=3)
WGESEADV 0.04% (n=3)
WGSNDVDV 0.04% (n=3)
WGENGTDV 0.03% (n=2)
WGSNRTDV 0.03% (n=2)
WGANEADV 0.03% (n=2)
WGANDTYF 0.03% (n=2)
WGENDTDF 0.03% (n=2)
WGENDADV 0.03% (n=2)
FGENETDV 0.03% (n=2)
WGEDDSDV 0.03% (n=2)
WGGNVTDV 0.03% (n=2)
WGINDTDV 0.03% (n=2)
WGADEADV 0.03% (n=2)
WGDSDTDV 0.03% (n=2)
WGASDTDV 0.03% (n=2)
RGENDTDV 0.03% (n=2)
WGEDDTDV 0.03% (n=2)
RGANDTDV 0.03% (n=2)
LGYQYHGR 0.03% (n=2)
WGANDADV 0.03% (n=2)
WGGTDTDV 0.03% (n=2)
WGAGETDV 0.03% (n=2)
WGENHTDV 0.03% (n=2)
WGENTTDV 0.03% (n=2)
WGGNETDI 0.03% (n=2)
WSENETDV 0.03% (n=2)
WGEEDTDV 0.03% (n=2)
WGIREEDV 0.03% (n=2)
WGNSSTDV 0.03% (n=2)
WGSDTKDV 0.03% (n=2)
WGCNVTDV 0.03% (n=2)
WGENEKDV 0.03% (n=2)
WGENETNV 0.01% (n=1)
WGSNDTDF 0.01% (n=1)
WGSNDTDA 0.01% (n=1)
WGSNKTDV 0.01% (n=1)
WGENDVDV 0.01% (n=1)
WGSNDTVV 0.01% (n=1)
WCANETGV 0.01% (n=1)
WGGNNADV 0.01% (n=1)
WGANDMDV 0.01% (n=1)
WGANETDI 0.01% (n=1)
WGTNDTNV 0.01% (n=1)
WGENDTGV 0.01% (n=1)
WGADDTDV 0.01% (n=1)
WGINETDV 0.01% (n=1)
WGVTDTDV 0.01% (n=1)
WGDNGADV 0.01% (n=1)
*GDNDTDV 0.01% (n=1)
WVENDTDV 0.01% (n=1)
WGSDTTDV 0.01% (n=1)
CGENDTDV 0.01% (n=1)
WGEHDTDV 0.01% (n=1)
WGSNVSDV 0.01% (n=1)
WGSNHSDV 0.01% (n=1)
WGNTSEDV 0.01% (n=1)
WGERDRDV 0.01% (n=1)
WGANESDV 0.01% (n=1)
FGANQTDV 0.01% (n=1)
WGESDMDV 0.01% (n=1)
WGSSDKDV 0.01% (n=1)
WGRNDTDF 0.01% (n=1)
WGESDKDV 0.01% (n=1)
WGSDDTDV 0.01% (n=1)
WGTNATDV 0.01% (n=1)
WGSNYTDV 0.01% (n=1)
WGGKVTDV 0.01% (n=1)
WGENEADV 0.01% (n=1)
FGTNETDV 0.01% (n=1)
WGDSDEDV 0.01% (n=1)
WGENDTDG 0.01% (n=1)
WGVNDTDF 0.01% (n=1)
WGERDTDV 0.01% (n=1)
WGANDSDV 0.01% (n=1)
WGGNETGV 0.01% (n=1)
WGSNDTGI 0.01% (n=1)
WGENDTDA 0.01% (n=1)
WGEYDTDV 0.01% (n=1)
*GENDTDV 0.01% (n=1)
WGENDTGI 0.01% (n=1)
WGDNQTDV 0.01% (n=1)
WGANETEV 0.01% (n=1)
WGSSDVDV 0.01% (n=1)
WGANDTAV 0.01% (n=1)
WGANGTDV 0.01% (n=1)
WGATDTDV 0.01% (n=1)
WGVNDTGV 0.01% (n=1)
WGANDTGV 0.01% (n=1)
WGANDTDA 0.01% (n=1)
WGVNDKDV 0.01% (n=1)
WGAKKTDV 0.01% (n=1)
WGTNVTDV 0.01% (n=1)
WGADKTDV 0.01% (n=1)
WGANEKDV 0.01% (n=1)
WGAKQTDV 0.01% (n=1)
WGARETDV 0.01% (n=1)
WGASETDV 0.01% (n=1)
WGATETDV 0.01% (n=1)
WGTNETDI 0.01% (n=1)
WGTNKTDV 0.01% (n=1)
WGDNEADV 0.01% (n=1)
WGVNDTDI 0.01% (n=1)
WGGNATDV 0.01% (n=1)
WGKNETDV 0.01% (n=1)
WGSNATDV 0.01% (n=1)
WGANITDV 0.01% (n=1)
WGSDNTDV 0.01% (n=1)
WGSNITDV 0.01% (n=1)
WGETDKDV 0.01% (n=1)
WGANMTDV 0.01% (n=1)
WVSNDTDV 0.01% (n=1)
WGEQDTDV 0.01% (n=1)
WGSSDADV 0.01% (n=1)
WGGNDADV 0.01% (n=1)
WGGGDTDV 0.01% (n=1)
WGRKDTDV 0.01% (n=1)
WGMNDTDV 0.01% (n=1)
WGKNDTDV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 1b:

WGENETDV 69.81% (n=2042)
WGGNETDV 15.86% (n=464)
WGGNVTDV 3.15% (n=92)
WGANETDV 2.05% (n=60)
WGENKTDV 1.61% (n=47)
WGDNETDV 0.99% (n=29)
WGENQTDV 0.79% (n=23)
WGKNETDV 0.48% (n=14)
WGVNETDV 0.44% (n=13)
WGENVTDV 0.41% (n=12)
-GENETDV 0.31% (n=9)
WGENATDV 0.27% (n=8)
WGGNRTDV 0.24% (n=7)
WGENGTDV 0.24% (n=7)
WGNNETDV 0.21% (n=6)
WGENETGV 0.21% (n=6)
WGENDTDV 0.17% (n=5)
WGENEADV 0.17% (n=5)
WGENETDM 0.14% (n=4)
WGE----- 0.14% (n=4)
WGGNKTDV 0.14% (n=4)
WGESETDV 0.14% (n=4)
WGDNDTDV 0.10% (n=3)
WGENETNV 0.10% (n=3)
WGEKETDV 0.10% (n=3)
WGGNKSDV 0.10% (n=3)
WGENESDV 0.10% (n=3)
WGENETDA 0.10% (n=3)
WGENVSDV 0.10% (n=3)
WGENETDI 0.07% (n=2)
WGGNASDV 0.07% (n=2)
WGENKSDV 0.07% (n=2)
WGGNATDV 0.07% (n=2)
WGRNETDV 0.07% (n=2)
-GENEIDV 0.07% (n=2)
-GESETDV 0.07% (n=2)
RGENGTDV 0.03% (n=1)
WGVNESDV 0.03% (n=1)
WRENETDV 0.03% (n=1)
WGEIETDV 0.03% (n=1)
GRGIETDV 0.03% (n=1)
WGEYETDV 0.03% (n=1)
WGGNETDM 0.03% (n=1)
WGGIKPDV 0.03% (n=1)
WGENETCV 0.03% (n=1)
WGENGSDV 0.03% (n=1)
WGANESDV 0.03% (n=1)
WEENETDV 0.03% (n=1)
WGGNTSDV 0.03% (n=1)
-------V 0.03% (n=1)
WGTNESDV 0.03% (n=1)
LGENETDV 0.03% (n=1)
WGANQTDV 0.03% (n=1)
WGENSSDV 0.03% (n=1)
WGANKTDV 0.03% (n=1)
WGTNETDV 0.03% (n=1)
WGEDETDV 0.03% (n=1)
RGENEADV 0.03% (n=1)
WGKNETDM 0.03% (n=1)
RGGNETDV 0.03% (n=1)
-GENESDV 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 2:

WGENETDV 75.95% (n=401)
WGDNETDV 14.20% (n=75)
WGENDTDV 1.70% (n=9)
WGANETDV 1.70% (n=9)
GEGNETDV 0.76% (n=4)
WGENESDV 0.76% (n=4)
WGENETDF 0.57% (n=3)
WGVNETDV 0.57% (n=3)
WGENQTDV 0.38% (n=2)
WGGNDTDV 0.38% (n=2)
WGENDTNV 0.19% (n=1)
WGGNETDV 0.19% (n=1)
WEGNETDV 0.19% (n=1)
WGANETDF 0.19% (n=1)
WGERETDV 0.19% (n=1)
WRRNDTDV 0.19% (n=1)
WGDNGTDV 0.19% (n=1)
WGQNETDV 0.19% (n=1)
WGANDTDV 0.19% (n=1)
WGENKTDV 0.19% (n=1)
WGENETDL 0.19% (n=1)
WGENDTDF 0.19% (n=1)
WGESEKDV 0.19% (n=1)
WEENETDV 0.19% (n=1)
WGGNVKDV 0.19% (n=1)
WGGGDKDV 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 2a:

WGENETDV 82.89% (n=63)
GEGNETDV 5.26% (n=4)
WGENETDF 2.63% (n=2)
WGENESDV 2.63% (n=2)
WGENDTNV 1.32% (n=1)
WGGNETDV 1.32% (n=1)
WEGNETDV 1.32% (n=1)
WGANETDF 1.32% (n=1)
WGENDTDV 1.32% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 2b:

WGENETDV 71.43% (n=250)
WGDNETDV 21.14% (n=74)
WGANETDV 1.71% (n=6)
WGENDTDV 1.71% (n=6)
WGVNETDV 0.57% (n=2)
WGENQTDV 0.57% (n=2)
WGERETDV 0.29% (n=1)
WRRNDTDV 0.29% (n=1)
WGGNDTDV 0.29% (n=1)
WGDNGTDV 0.29% (n=1)
WGENESDV 0.29% (n=1)
WGQNETDV 0.29% (n=1)
WGANDTDV 0.29% (n=1)
WGENKTDV 0.29% (n=1)
WGENETDL 0.29% (n=1)
WGENDTDF 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 2c:

WGENETDV 90.32% (n=56)
WGANETDV 3.23% (n=2)
WGESEKDV 1.61% (n=1)
WGGNDTDV 1.61% (n=1)
WEENETDV 1.61% (n=1)
WGGNVKDV 1.61% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 3:

WGENETDV 28.37% (n=783)
WGANETDV 25.04% (n=691)
WGENKTDV 7.72% (n=213)
WGENESDV 6.92% (n=191)
FGENETDV 6.38% (n=176)
WGANESDV 3.59% (n=99)
FGANETDV 3.48% (n=96)
WGANKTDV 1.78% (n=49)
WGENKSDV 1.49% (n=41)
WGENDTDV 1.30% (n=36)
FGANESDV 1.12% (n=31)
WGANVTDV 1.01% (n=28)
WGANETDA 0.98% (n=27)
WGGNETDV 0.94% (n=26)
WGGNKTDV 0.72% (n=20)
WGTNETDV 0.54% (n=15)
WGENATDV 0.54% (n=15)
FGENKTDV 0.40% (n=11)
FGENESDV 0.33% (n=9)
WGANDTDV 0.25% (n=7)
WGENVTDV 0.25% (n=7)
WGVNETDV 0.25% (n=7)
WGENQTDV 0.25% (n=7)
WGANKSDV 0.22% (n=6)
WGGNATDV 0.18% (n=5)
WGENEADV 0.18% (n=5)
WGEKETDV 0.14% (n=4)
FGGNESDV 0.14% (n=4)
FGDNETDV 0.14% (n=4)
FGENDTDV 0.14% (n=4)
WGENEKDV 0.11% (n=3)
WSENETDV 0.11% (n=3)
WGENKTDM 0.11% (n=3)
WGENETDM 0.11% (n=3)
LGENETDV 0.11% (n=3)
WGMNETDV 0.11% (n=3)
WGDNKTDV 0.11% (n=3)
WGAKESDV 0.11% (n=3)
WGANQTDV 0.11% (n=3)
FGEKETDV 0.11% (n=3)
WGANETDM 0.07% (n=2)
WGGDETDV 0.07% (n=2)
WGGNESDV 0.07% (n=2)
WGGNVTDV 0.07% (n=2)
RGENETDV 0.07% (n=2)
WGANEADV 0.07% (n=2)
WGDNESDV 0.07% (n=2)
WGGNDTDV 0.07% (n=2)
WGETEKDV 0.07% (n=2)
WGENQSDV 0.07% (n=2)
WGTNVTDV 0.07% (n=2)
FGANKTDV 0.07% (n=2)
WGANATDV 0.07% (n=2)
WGDNETDV 0.07% (n=2)
FGENQTDV 0.07% (n=2)
WGANVSDV 0.07% (n=2)
FGVNETDV 0.07% (n=2)
FGGNETDV 0.07% (n=2)
WGENASDV 0.04% (n=1)
FGTNETDV 0.04% (n=1)
WGENVRDV 0.04% (n=1)
WDANETDV 0.04% (n=1)
WGADETDV 0.04% (n=1)
WGGNKSDV 0.04% (n=1)
FGENETDC 0.04% (n=1)
WGANTSDV 0.04% (n=1)
WGADVTDV 0.04% (n=1)
WSANVTDV 0.04% (n=1)
WGEDGTDV 0.04% (n=1)
WGASESDV 0.04% (n=1)
WGENETDA 0.04% (n=1)
WGENETGV 0.04% (n=1)
WGESESDV 0.04% (n=1)
WGANKTEG 0.04% (n=1)
GGGDETDV 0.04% (n=1)
WGENETDG 0.04% (n=1)
LSENETDV 0.04% (n=1)
LGENETNV 0.04% (n=1)
KSSNETEV 0.04% (n=1)
WGANETEV 0.04% (n=1)
SNDNESDV 0.04% (n=1)
RGANETDV 0.04% (n=1)
WGANGTDV 0.04% (n=1)
WGSNDTDV 0.04% (n=1)
WGAEESDV 0.04% (n=1)
WGRNESDV 0.04% (n=1)
WGGNDTDL 0.04% (n=1)
WGQWL*AL 0.04% (n=1)
W-E-L*AL 0.04% (n=1)
WGANESDG 0.04% (n=1)
GGANESDV 0.04% (n=1)
WGANKADV 0.04% (n=1)
WGTNATDV 0.04% (n=1)
WGGKETDV 0.04% (n=1)
WGANASDV 0.04% (n=1)
WGANDSDV 0.04% (n=1)
WGENTTDV 0.04% (n=1)
WGANDADV 0.04% (n=1)
WGEGEKDV 0.04% (n=1)
WGENATDM 0.04% (n=1)
WGEDKSDV 0.04% (n=1)
WGEQERDV 0.04% (n=1)
WGQNDSDV 0.04% (n=1)
YGTNKTDV 0.04% (n=1)
WGANNTDV 0.04% (n=1)
WGGNQTDV 0.04% (n=1)
FGGNKTDV 0.04% (n=1)
WGANKTDM 0.04% (n=1)
WGQNQTDV 0.04% (n=1)
WGENDADV 0.04% (n=1)
WGANETDT 0.04% (n=1)
WGENETDL 0.04% (n=1)
WGENDTDM 0.04% (n=1)
WGENATDW 0.04% (n=1)
WGENKTDK 0.04% (n=1)
WGGNKTDM 0.04% (n=1)
WGANTTDV 0.04% (n=1)
WGESATDV 0.04% (n=1)
WGASPADV 0.04% (n=1)
WGENKTDF 0.04% (n=1)
WGANETDR 0.04% (n=1)
FGVNESDV 0.04% (n=1)
FGENEADV 0.04% (n=1)
FGENETDM 0.04% (n=1)
FGEDETDV 0.04% (n=1)
FGGNQTDV 0.04% (n=1)
FGENKADK 0.04% (n=1)
FGENEKDV 0.04% (n=1)
FGENTTDV 0.04% (n=1)
FGENKMDV 0.04% (n=1)
FGSNDTDV 0.04% (n=1)
FGGNDTDV 0.04% (n=1)
FGGNDSDV 0.04% (n=1)
FGDNVTDV 0.04% (n=1)
FGENVTDV 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 3a:

WGENETDV 33.14% (n=781)
WGANETDV 28.72% (n=677)
WGENKTDV 9.04% (n=213)
WGENESDV 8.02% (n=189)
WGANESDV 4.12% (n=97)
WGENKSDV 1.74% (n=41)
WGENDTDV 1.53% (n=36)
WGANVTDV 1.19% (n=28)
WGANETDA 1.15% (n=27)
WGGNETDV 1.10% (n=26)
WGANKTDV 0.93% (n=22)
WGGNKTDV 0.85% (n=20)
WGTNETDV 0.64% (n=15)
WGENATDV 0.64% (n=15)
WGANDTDV 0.30% (n=7)
WGENVTDV 0.30% (n=7)
WGENQTDV 0.30% (n=7)
WGANKSDV 0.25% (n=6)
WGVNETDV 0.25% (n=6)
WGGNATDV 0.21% (n=5)
WGENEADV 0.21% (n=5)
WGEKETDV 0.17% (n=4)
WGENEKDV 0.13% (n=3)
WSENETDV 0.13% (n=3)
WGENKTDM 0.13% (n=3)
WGENETDM 0.13% (n=3)
LGENETDV 0.13% (n=3)
WGMNETDV 0.13% (n=3)
WGDNKTDV 0.13% (n=3)
WGAKESDV 0.13% (n=3)
WGANQTDV 0.13% (n=3)
WGANETDM 0.08% (n=2)
WGGDETDV 0.08% (n=2)
WGGNESDV 0.08% (n=2)
WGGNVTDV 0.08% (n=2)
RGENETDV 0.08% (n=2)
WGANEADV 0.08% (n=2)
WGDNESDV 0.08% (n=2)
FGANESDV 0.08% (n=2)
WGGNDTDV 0.08% (n=2)
WGETEKDV 0.08% (n=2)
WGENQSDV 0.08% (n=2)
WGTNVTDV 0.08% (n=2)
WGANATDV 0.08% (n=2)
WGDNETDV 0.08% (n=2)
FGENQTDV 0.08% (n=2)
WGANVSDV 0.08% (n=2)
WGENASDV 0.04% (n=1)
FGTNETDV 0.04% (n=1)
WGENVRDV 0.04% (n=1)
WDANETDV 0.04% (n=1)
WGADETDV 0.04% (n=1)
WGGNKSDV 0.04% (n=1)
FGENETDC 0.04% (n=1)
WGANTSDV 0.04% (n=1)
WGADVTDV 0.04% (n=1)
WSANVTDV 0.04% (n=1)
WGEDGTDV 0.04% (n=1)
FGENKTDV 0.04% (n=1)
WGASESDV 0.04% (n=1)
WGENETDA 0.04% (n=1)
WGENETGV 0.04% (n=1)
WGESESDV 0.04% (n=1)
WGANKTEG 0.04% (n=1)
GGGDETDV 0.04% (n=1)
WGENETDG 0.04% (n=1)
LSENETDV 0.04% (n=1)
LGENETNV 0.04% (n=1)
KSSNETEV 0.04% (n=1)
WGANETEV 0.04% (n=1)
SNDNESDV 0.04% (n=1)
RGANETDV 0.04% (n=1)
WGANGTDV 0.04% (n=1)
WGSNDTDV 0.04% (n=1)
WGAEESDV 0.04% (n=1)
WGRNESDV 0.04% (n=1)
WGGNDTDL 0.04% (n=1)
WGQWL*AL 0.04% (n=1)
W-E-L*AL 0.04% (n=1)
WGANESDG 0.04% (n=1)
GGANESDV 0.04% (n=1)
WGTNATDV 0.04% (n=1)
WGGKETDV 0.04% (n=1)
WGANASDV 0.04% (n=1)
WGANDSDV 0.04% (n=1)
WGENTTDV 0.04% (n=1)
WGANDADV 0.04% (n=1)
WGEGEKDV 0.04% (n=1)
WGENATDM 0.04% (n=1)
FGANKTDV 0.04% (n=1)
WGEDKSDV 0.04% (n=1)
WGEQERDV 0.04% (n=1)
WGQNDSDV 0.04% (n=1)
YGTNKTDV 0.04% (n=1)
WGANNTDV 0.04% (n=1)
WGGNQTDV 0.04% (n=1)
FGGNKTDV 0.04% (n=1)
WGANKTDM 0.04% (n=1)
WGQNQTDV 0.04% (n=1)
WGENDADV 0.04% (n=1)
WGANETDT 0.04% (n=1)
WGENETDL 0.04% (n=1)
WGENDTDM 0.04% (n=1)
WGENATDW 0.04% (n=1)
WGENKTDK 0.04% (n=1)
WGGNKTDM 0.04% (n=1)
WGANTTDV 0.04% (n=1)
WGESATDV 0.04% (n=1)
WGASPADV 0.04% (n=1)
WGENKTDF 0.04% (n=1)
WGANETDR 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 3b:

FGENETDV 49.42% (n=169)
FGANETDV 28.07% (n=96)
FGANESDV 8.48% (n=29)
FGENKTDV 2.92% (n=10)
FGENESDV 2.63% (n=9)
FGGNESDV 1.17% (n=4)
FGDNETDV 1.17% (n=4)
FGENDTDV 0.88% (n=3)
FGEKETDV 0.88% (n=3)
FGVNETDV 0.58% (n=2)
FGGNETDV 0.58% (n=2)
FGVNESDV 0.29% (n=1)
FGENEADV 0.29% (n=1)
FGENETDM 0.29% (n=1)
FGEDETDV 0.29% (n=1)
FGGNQTDV 0.29% (n=1)
FGENKADK 0.29% (n=1)
FGENEKDV 0.29% (n=1)
FGENTTDV 0.29% (n=1)
FGANKTDV 0.29% (n=1)
FGENKMDV 0.29% (n=1)
FGSNDTDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 4:

WGENESDV 48.93% (n=114)
WGENETDV 26.61% (n=62)
WGENDTDV 9.01% (n=21)
WGGNETDV 3.00% (n=7)
WGANETDV 2.58% (n=6)
WGENKTDV 1.29% (n=3)
WGENVSDV 0.86% (n=2)
WGDNETDV 0.86% (n=2)
WGENVTDV 0.86% (n=2)
WGVNETDV 0.86% (n=2)
WGANESDA 0.43% (n=1)
WGENASDV 0.43% (n=1)
LGGNETDV 0.43% (n=1)
WGDNESDV 0.43% (n=1)
WGTGKDDV 0.43% (n=1)
FGGNDTDV 0.43% (n=1)
WGENATDV 0.43% (n=1)
WGGNDTDV 0.43% (n=1)
WGANGTDV 0.43% (n=1)
WGVNETNV 0.43% (n=1)
WGQNKTDV 0.43% (n=1)
WGENESDI 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 4a:

WGENESDV 70.63% (n=113)
WGENETDV 12.50% (n=20)
WGENDTDV 12.50% (n=20)
WGENVSDV 1.25% (n=2)
WGANESDA 0.63% (n=1)
WGGNETDV 0.63% (n=1)
WGENASDV 0.63% (n=1)
LGGNETDV 0.63% (n=1)
WGDNESDV 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 4d:

WGENETDV 84.62% (n=11)
WGGNETDV 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 5:

WGSNETDI 28.95% (n=11)
WGENETDV 15.79% (n=6)
WGENETDI 15.79% (n=6)
WGSNETDV 13.16% (n=5)
WGSNDTDI 5.26% (n=2)
WGENDTDI 2.63% (n=1)
WGSNESDV 2.63% (n=1)
WGDNETDV 2.63% (n=1)
WGANETDV 2.63% (n=1)
WGTNETDI 2.63% (n=1)
WGVNETDV 2.63% (n=1)
WGENDTDV 2.63% (n=1)
WGSNVTDF 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 6:

WGENETDV 44.44% (n=152)
WGENESDV 15.20% (n=52)
WGENVSDV 5.85% (n=20)
WGDNETDV 3.80% (n=13)
WGANESDV 3.80% (n=13)
WGENASDV 2.34% (n=8)
WGANETDV 2.05% (n=7)
WGENMSDV 1.75% (n=6)
WGANVSDV 1.46% (n=5)
WGDNESDV 1.46% (n=5)
WGGNESDV 1.46% (n=5)
WGENVTDV 1.17% (n=4)
WGVNESDV 0.88% (n=3)
WGENATDV 0.88% (n=3)
WGGNVSDV 0.88% (n=3)
WGDNVSDV 0.88% (n=3)
WGTNETDV 0.88% (n=3)
WGANASDV 0.88% (n=3)
WGENQSDV 0.58% (n=2)
WGGNDSDV 0.58% (n=2)
WGGNETDV 0.58% (n=2)
WGANATDV 0.58% (n=2)
WGENWTDV 0.29% (n=1)
WGQNETDV 0.29% (n=1)
WGENDTDV 0.29% (n=1)
WGKNETDV 0.29% (n=1)
FGENETDV 0.29% (n=1)
FGDNETDV 0.29% (n=1)
FGDNESDV 0.29% (n=1)
WGENITDV 0.29% (n=1)
WGNNMSDV 0.29% (n=1)
WGDNVTDV 0.29% (n=1)
WGDNMSDV 0.29% (n=1)
WGVNVSDV 0.29% (n=1)
WGDNKTDV 0.29% (n=1)
WGENMTDV 0.29% (n=1)
WGANKTDV 0.29% (n=1)
LGENESDV 0.29% (n=1)
WGENKSDV 0.29% (n=1)
WGENKGDV 0.29% (n=1)
WGANEGDV 0.29% (n=1)
WGENDSDV 0.29% (n=1)
WGENETDI 0.29% (n=1)
WGEHETDV 0.29% (n=1)
WGVNETDV 0.29% (n=1)
WGDNDTDV 0.29% (n=1)
FGENESDV 0.29% (n=1)
WGANKSDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Subtype 6a:

WGENETDV 85.25% (n=104)
WGDNETDV 8.20% (n=10)
WGENVTDV 1.64% (n=2)
WGENESDV 0.82% (n=1)
WGENWTDV 0.82% (n=1)
WGQNETDV 0.82% (n=1)
WGENDTDV 0.82% (n=1)
WGKNETDV 0.82% (n=1)
WGANETDV 0.82% (n=1)
---------------------------------------------------------------------------------------
Region 529-536 (antibodies: [AR3B, CBH-2, HC-11] ), HCV Genotype 7:

WGENESDV 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 524-541 (antibodies: [AR3C] ), HCV Genotype 1:

APTYNWGENDTDVFVLNN 7.72% (n=788)
VPTYSWGENETDVLLLNN 6.33% (n=646)
APTYNWGANETDVFVLNN 4.16% (n=425)
VPTYSWGGNETDVLLLNN 4.02% (n=410)
APTYRWGANDTDVFVLNN 3.74% (n=382)
APTYSWGENDTDVFVLNN 3.11% (n=317)
APTFNWGENDTDVFVLNN 3.04% (n=310)
APTYNWGDNDTDVFVLNN 2.96% (n=302)
APTYSWGENETDVLLLNN 2.92% (n=298)
VPTYRWGENETDVLLLNN 2.91% (n=297)
APTYSWGANDTDVFVLNN 2.73% (n=279)
APAYNWGENDTDVFVLNN 2.70% (n=276)
APTYNWGENETDVFVLNN 2.61% (n=266)
VPTYNWGSNDTDVFVLNN 2.54% (n=259)
VPTYTWGENETDVLLLNN 1.98% (n=202)
VPTYRWGENETDVFVLNN 1.88% (n=192)
APTYNWGSNETDVFVLNN 1.75% (n=179)
EPTYNWGENDTDVFVLNN 1.49% (n=152)
APTYSWGENETDVFVLNN 1.47% (n=150)
APTYNWGANDTDVFVLNN 1.30% (n=133)
VPTYNWGENETDVLLLNN 1.21% (n=123)
IPTYSWGENDTDVFVLNN 1.13% (n=115)
APTYNWGENATDVFVLNN 1.10% (n=112)
VPTYNWGENDTDVFVLNN 1.04% (n=106)
VPTYNWGENETDVFVLNN 0.91% (n=93)
APTYGWGANDTDVFVLNN 0.90% (n=92)
APTYTWGENETDVLLLNN 0.88% (n=90)
APTYNWGSNDTDVFVLNN 0.87% (n=89)
VPTYTWGGNVTDVLLLNN 0.78% (n=80)
APTYNWGSNDTDVLVLNN 0.76% (n=78)
VPTYNWGANDTDVFVLNN 0.73% (n=74)
APTYNWGDNETDVFLLNN 0.67% (n=68)
APTYNWGCNDTDVFVLNN 0.59% (n=60)
APTYNWGENDTDVLVLNN 0.54% (n=55)
VPTYNWGDNDTDVFVLNN 0.54% (n=55)
APTYNWGENETDVLLLNN 0.53% (n=54)
VPTYNWGSNETDVFVLNN 0.52% (n=53)
APTYNWGDNDTDVLVLNN 0.47% (n=48)
APTYNWGSNDTDVFILNN 0.45% (n=46)
VPTYNWGENDTDVFVLTN 0.42% (n=43)
APTYTWGENETDVL---- 0.40% (n=41)
APTYNWGGNDTDVLVLNN 0.39% (n=40)
APTYNWGSNDTDIFILNN 0.36% (n=37)
QPTYNWGENETDVFILNN 0.35% (n=36)
APTYRWGENETDVLLLNN 0.35% (n=36)
APAYNWGENNTDVFVLNN 0.34% (n=35)
APTYNWGENDTDVFILNN 0.33% (n=34)
APTYNWGENDTDVFVLTN 0.33% (n=34)
VPTYSWGENETDVLVLNN 0.32% (n=33)
APTYNWGENETDVLILNN 0.31% (n=32)
VPTYSWGENETDVFVLNN 0.27% (n=28)
APTYNWGANDTDIFVLNN 0.27% (n=28)
APTYNWGGKDTDVFVLNN 0.26% (n=27)
APTYNWGAREEDVFVLNN 0.25% (n=26)
VPTYNWGANVTDVFVLNN 0.24% (n=24)
APTYNWGSNDTDVLILNN 0.24% (n=24)
APTYSWGENDTDVLVLNN 0.23% (n=23)
APTYNWGENDTDVLILNN 0.23% (n=23)
APTYSWGANETDVFVLNN 0.23% (n=23)
VPTYSWGENDTDVFILNN 0.23% (n=23)
VPTYSWGGNDTDVFILNN 0.23% (n=23)
VPTYSWGENDTDVFVLNN 0.22% (n=22)
APTYNWGANDTDVLVLNN 0.22% (n=22)
APTYSWGANDTDVLVLNN 0.21% (n=21)
APTYNWGENETDVFILNN 0.19% (n=19)
APTYTWGSNDTDVFVLNN 0.18% (n=18)
VPTYGWGSNDTDVFVLNN 0.18% (n=18)
VPTYNWGAKETDVFVLNN 0.18% (n=18)
APTYKWGANETDVFILNN 0.18% (n=18)
APAYNWGENVTDVFVLNN 0.18% (n=18)
APTYNWGENQTDVLLLNN 0.18% (n=18)
VPTYNWGADETDVFVLNN 0.17% (n=17)
HPTYNWGENETDVLLLNN 0.17% (n=17)
VPTYTWGENKTDVLLLNN 0.17% (n=17)
APTYSWGEKETDVFVLNN 0.16% (n=16)
APTYSWGSNETDVFILNN 0.15% (n=15)
APTYRWGANETDVFVLNN 0.15% (n=15)
APTHTWGANDTDVFILNN 0.15% (n=15)
TPTYSWGANETDVFVLNN 0.15% (n=15)
APTYTWGENETDVLILNN 0.15% (n=15)
VPTYNWGENETDVLVLNN 0.14% (n=14)
VPTYNWGGNETDVLLLNN 0.14% (n=14)
VPTYSWGANDTDFLVLNN 0.13% (n=13)
VPTYSWGKNETDVLVLNN 0.13% (n=13)
APTYTWGENETDVFVLNN 0.12% (n=12)
APTYTWGANDTDVFVLNN 0.12% (n=12)
VPTYTWGENDTDVFVLNN 0.12% (n=12)
VPTYNWGDNETDVLLLNN 0.12% (n=12)
VPTYSWGENETDVMLLNN 0.12% (n=12)
VPTYKWGENETDVLLLNN 0.12% (n=12)
VPTYSWGENKTDVLLLNN 0.12% (n=12)
DPTYGWGDNDTDVLILNN 0.10% (n=10)
APTYNWGGNDTDVFVLNN 0.10% (n=10)
VPTYNWGENDTDVLVLNN 0.10% (n=10)
VPTYNWGGNETDVFILNN 0.10% (n=10)
VPTYNWGTNETDVFVLNN 0.10% (n=10)
VPTYNWGANEMDVFVLNN 0.10% (n=10)
APTYNWGEGGTDVFVLNN 0.10% (n=10)
APTYNWGGNKTDVFVLNN 0.10% (n=10)
APTYSWGENETDVLILNN 0.10% (n=10)
VPTYSWGANETDVLLLNN 0.10% (n=10)
VPT--------------- 0.10% (n=10)
VPTYSWGGNVTDVLLLNN 0.10% (n=10)
VPTYNWGDNDTDVLVLNN 0.09% (n=9)
VPTYDWGSNDTDVFVLNN 0.09% (n=9)
APTYSWGANDTDVFVLDN 0.09% (n=9)
APTYGWGENDTDVFVLNN 0.09% (n=9)
APTYNWGGNETDVLLLNN 0.09% (n=9)
-----------DVFVLNN 0.08% (n=8)
VPTYTWGENETDVFVLNN 0.08% (n=8)
APTYNWGENDTDVIVLNN 0.08% (n=8)
VPTYNWGANKTDVFVLNN 0.08% (n=8)
APTYNWGENKTDVFVLNN 0.08% (n=8)
------GENETDVLLLNN 0.08% (n=8)
VPTYNWGSNDTDVLVLNN 0.07% (n=7)
VPTYSWGANNTDVFVLNN 0.07% (n=7)
APTYDWGSNDTDVFILNN 0.07% (n=7)
LPTYNWGENDTDVFVLNN 0.07% (n=7)
APTFSWGENDTDVFVLNN 0.07% (n=7)
APTYRWGENETDVFVLNN 0.07% (n=7)
APTYNWGANETDVLILNN 0.07% (n=7)
APTFSWGENETDVLLLNN 0.07% (n=7)
VPTYNWGDNETDVFVLNN 0.06% (n=6)
VPTYNWGANETDVFVLNN 0.06% (n=6)
VPTYNWGANDTDFFVLNN 0.06% (n=6)
MPTYSWGENDTDVFILNN 0.06% (n=6)
APTYNWGTREEDVFVLNN 0.06% (n=6)
APTYRWGENETDVLILNN 0.06% (n=6)
VPTYNWGGNRTDVLLLNN 0.06% (n=6)
APTYNWGNNETDVLLLNN 0.06% (n=6)
APTYNWGDNETDVLLLNN 0.06% (n=6)
VPTYNWGENETDVLLLNS 0.06% (n=6)
VPTYSWGENETDVPLLNN 0.06% (n=6)
APTYNWGANDTDVFVLNS 0.05% (n=5)
APTYNWGNNDTDVFVLNN 0.05% (n=5)
APTYNWGENETDVLVLNN 0.05% (n=5)
APTYNWGANETDVLILTN 0.05% (n=5)
TPTYNWGANDTDFFVLNN 0.05% (n=5)
APTHSWGENDTDVFVLNN 0.05% (n=5)
APTYSWGEKDTDVFVLNN 0.05% (n=5)
VPTYSWGENETDVFILNN 0.05% (n=5)
APTHNWGANDTDVFVLNN 0.05% (n=5)
APTYNWGGNETDVFVLNN 0.05% (n=5)
VPTYNWGAHETDVFVLNN 0.05% (n=5)
APTYNWGAKETDVFVLNN 0.05% (n=5)
VPTFTWGSNNTDVFVLNN 0.05% (n=5)
VPTYSWGENVTDVLLLNN 0.05% (n=5)
APTYTWGANETDVLLLNN 0.05% (n=5)
VPTYTWGANETDVLLLNN 0.05% (n=5)
APTYNWGDNETDVLILNN 0.05% (n=5)
APTYNWGANETDVLLLNN 0.05% (n=5)
APTYSWGENKTDVLLLNN 0.05% (n=5)
VPTYAWGGNETDVLLLNN 0.05% (n=5)
APTYNWGANETDVLVLNN 0.05% (n=5)
VPTYTWGENETDVL---- 0.05% (n=5)
APTYSWGENETGVLLLNN 0.05% (n=5)
MPTYNWGQNDTDVFVLNN 0.04% (n=4)
APTYNWGVNETDIFILNN 0.04% (n=4)
APTYNWGANETDVLVLTN 0.04% (n=4)
TPTFTWGGSVKDVLVLNN 0.04% (n=4)
VPTYTWGGNDTDFLVLNN 0.04% (n=4)
APTYNWGQNETDVFVLNN 0.04% (n=4)
APTYNWGCNETDVFVLNN 0.04% (n=4)
APTYNWGGNETDVLVLNN 0.04% (n=4)
VPTYNWGGNDTDVLVLNN 0.04% (n=4)
APTYSWGENETDVFILNN 0.04% (n=4)
APTYTWGENDTDVFVLNN 0.04% (n=4)
TPTYNWGENDTDVFVLNN 0.04% (n=4)
APTYTWGENETDVFILNN 0.04% (n=4)
VPTYNWGSDDKDVLVLNN 0.04% (n=4)
VPTYNWGVNKTDVFVLNN 0.04% (n=4)
MPTYNWGAKETDVFVLNN 0.04% (n=4)
ASTYNWGDNDTDVFVLNN 0.04% (n=4)
APTYNWGTQEEDVFVLNN 0.04% (n=4)
APTYNWGTREGDVFVLNN 0.04% (n=4)
VPTYSWGE---------- 0.04% (n=4)
VPTYDWGENETDVLLLNN 0.04% (n=4)
APTYNWGGNETDVLILNN 0.04% (n=4)
APTYSWGGNETDVLLLNN 0.04% (n=4)
VPTYTWGGNETDVLLLNN 0.04% (n=4)
VPTFSWGENETDVLLLNN 0.04% (n=4)
VPTYNWGENETDVLILNN 0.04% (n=4)
APTYNWGENETDVLILNS 0.04% (n=4)
APTYSWGANETDVLLLNN 0.04% (n=4)
APTYNWGGDDTDVLVLNN 0.03% (n=3)
VPTYSWGANDTDVFVLNN 0.03% (n=3)
APTYSWGGNDTDVFVLNN 0.03% (n=3)
VATYSWGATDADVFVLNN 0.03% (n=3)
APTYSWGTNDTDVFVLNN 0.03% (n=3)
VPTYTWGGNDTDFFVLNN 0.03% (n=3)
VPTYTWGEKDTDVFVLNN 0.03% (n=3)
APTYNWGSNSTDVFVLNN 0.03% (n=3)
APTYSWGENVTDVFVLNN 0.03% (n=3)
APTYNWGENDMDVFVLNN 0.03% (n=3)
APTYSWGSNDTDVFVLNN 0.03% (n=3)
APTYSWGVNDTDVFVLNN 0.03% (n=3)
APTYNWGENESDVFVLNN 0.03% (n=3)
VPTYNWGENETDVFILNN 0.03% (n=3)
APTYNWGTNDTDVFVLNN 0.03% (n=3)
VPTYNWGGNDTDVFVLNN 0.03% (n=3)
APTYSWGSNDTDVFILNN 0.03% (n=3)
---YSWGENDTDVLVLNN 0.03% (n=3)
APTYSWGSNDTDVLVLNN 0.03% (n=3)
VPTYNWGGNETDVFVLNN 0.03% (n=3)
MPTYNWGGNETDVFVLNN 0.03% (n=3)
VPTYDWGSNDVDVFVLNN 0.03% (n=3)
VPTYSWGVNDTDVFVLNN 0.03% (n=3)
ALTYNWGSNDTDIFILNN 0.03% (n=3)
APTYDWGENETDAFVLNN 0.03% (n=3)
APAYNWGGNDTDVFVLNN 0.03% (n=3)
VPTYTWGENETDVLFLNN 0.03% (n=3)
APTYNWGDNDTDVLLLNN 0.03% (n=3)
VPTYSWGENGTDVLLLNN 0.03% (n=3)
VPTYRWGANETDVLLLNN 0.03% (n=3)
APTYNWGVNETDVLILNN 0.03% (n=3)
VPTYNWGANETDVLLLNN 0.03% (n=3)
VPTYGWGENETDVLLLNN 0.03% (n=3)
VPTYTWGENVSDVLLLNN 0.03% (n=3)
APTYRWGENDTDVFVLNN 0.02% (n=2)
VPTYNWGSNRTDVFVLNN 0.02% (n=2)
VPTYNWGANDTDVLVLNN 0.02% (n=2)
VPTYNWGANDTDVLILNN 0.02% (n=2)
APTYSWGENDTDVFVLNS 0.02% (n=2)
APTFNWGSNDTDVFVLNN 0.02% (n=2)
APTYNWGENETDVLILTN 0.02% (n=2)
TPTYNWGANDTYFFVLNN 0.02% (n=2)
DPTFGWGGNDTDVLILNN 0.02% (n=2)
APTYNWGENDKDVLILNN 0.02% (n=2)
APTFTFGENETDVFILNN 0.02% (n=2)
APTYNWGEDDSDVFVLNN 0.02% (n=2)
APTYSWGSNDSDVFVLNN 0.02% (n=2)
APTYNWGANDTDVFLLNN 0.02% (n=2)
VPTYNWGENATDVFVLNN 0.02% (n=2)
APTYDWGSNDTDVFVLNN 0.02% (n=2)
APTYNWGSNNTDVFVLNN 0.02% (n=2)
APTYNWGDNETDVFVLNN 0.02% (n=2)
VPTYNWGANETDVLVLNN 0.02% (n=2)
APTYDWGENDTDVFVLNN 0.02% (n=2)
VPTYNWGENVTDVFVLNN 0.02% (n=2)
VPTYNWGDSDTDVFVLNN 0.02% (n=2)
APTYSWGENDTDVFALNN 0.02% (n=2)
APAYNWGANDTDVFVLNN 0.02% (n=2)
MPTYNWGENDTDVFVLNN 0.02% (n=2)
LAYFQLGYQYHGRFFSNQ 0.02% (n=2)
EPTYRWGESEADVFVLNN 0.02% (n=2)
APTYSWGANDADVFVLNN 0.02% (n=2)
VPTYSWGGNDTDVFVLNN 0.02% (n=2)
VPTYSWGGTDTDVFILNN 0.02% (n=2)
VPTYSWGANDTDFFVLNN 0.02% (n=2)
VPTYNWGGNDTDFFVLNN 0.02% (n=2)
VPTYNWGAGETDVFVLNN 0.02% (n=2)
APTNNWGENATDVFVLNN 0.02% (n=2)
APTYNWGENHTDVFVLNN 0.02% (n=2)
APTYNWGENVTDVFVLNN 0.02% (n=2)
HPTYNWGENETDVFILNN 0.02% (n=2)
APTYNWGENDTDVFVLTD 0.02% (n=2)
VPTYTWGENDTDVFVLTN 0.02% (n=2)
APTYNWGENTTDVFVLNN 0.02% (n=2)
APTYNWGGNETDIFVLNN 0.02% (n=2)
APTYNWSENETDVFVLNN 0.02% (n=2)
APTYNWGEEDTDVFVLNN 0.02% (n=2)
APTYKWGANDTDVFVLNN 0.02% (n=2)
VPTYRWGENDTDVFVLNN 0.02% (n=2)
APTYDWGAREEDVFVLNN 0.02% (n=2)
APTYNWGIREEDVFVLNN 0.02% (n=2)
VPTYTWGNSSTDVFVLNN 0.02% (n=2)
AATYSWGSDTKDVFVLNN 0.02% (n=2)
APTYNWGANETDVFLLNN 0.02% (n=2)
VPTYNWGCNVTDVFVLNN 0.02% (n=2)
APTYTWGENDTDVLVLNN 0.02% (n=2)
APTYNWGDNDTDVFILNN 0.02% (n=2)
TPTHNWGENETDVFVLNN 0.02% (n=2)
APTYNWGENETDVLLLNS 0.02% (n=2)
APTYSWGENETDVLLLNS 0.02% (n=2)
VPTYSWGVNETDVLLLNN 0.02% (n=2)
VPTYSWGENETDMMLLNN 0.02% (n=2)
APTYSWGENETDVMLLNN 0.02% (n=2)
VPTYNWGENETDILLLNN 0.02% (n=2)
APTYSWGENETDVLLLSN 0.02% (n=2)
APTYSWGENETDVLLFNN 0.02% (n=2)
VPTYRWGDNETDVLLLNN 0.02% (n=2)
VPTYTWGENETDMLLLNS 0.02% (n=2)
VPTYSWGENDTDVLLLNN 0.02% (n=2)
VPTYSWGGNKTDVLLLNN 0.02% (n=2)
APTYQWGENETDVLILNN 0.02% (n=2)
VPTYNWGGNVTDVLLLNN 0.02% (n=2)
VPTYNWGENETDVLFLNN 0.02% (n=2)
VPTYNWGENEADVLLLNN 0.02% (n=2)
TPTYTWGENETDVLLLNN 0.02% (n=2)
VPTYGWGANETDVLLLNN 0.02% (n=2)
TPTYNWGENKTDVLILNN 0.02% (n=2)
VPTYNWGENQTDVLLLNN 0.02% (n=2)
VPTYNWGENATDVLLLNN 0.02% (n=2)
VPTYTWGENEADVLLLNN 0.02% (n=2)
APTYNWGENATDVLVLNN 0.02% (n=2)
IPTYTWGENETDVLLLNN 0.02% (n=2)
VPTYSWGENETDVLLLNS 0.02% (n=2)
VPTYSWGDNETDVLLLNN 0.02% (n=2)
VPTYTWGDNETDVLLLNN 0.02% (n=2)
APTYTWGGNETDVLLLNN 0.02% (n=2)
TPTYTWGENKTDVLLLNN 0.02% (n=2)
VPTYNWGENVTDVLLLNN 0.02% (n=2)
VPTYSWGENATDVLLLNN 0.02% (n=2)
APTYTWGESETDVL---- 0.02% (n=2)
APTFNWGENETDVLILNN 0.02% (n=2)
VPTYTWGGNKSDVLLLNN 0.02% (n=2)
APTYRWGANETDVLLLNN 0.02% (n=2)
------GESETDVLPLNN 0.02% (n=2)
TPTYNWGENETDVLFLTN 0.02% (n=2)
LPTYTWGENETDVFILNS 0.02% (n=2)
NPTFNSGANDTDFFLLNN 0.02% (n=2)
VPTYSWGTNDTDVFVLNN 0.01% (n=1)
VPTYSWGENGTDVFVLNN 0.01% (n=1)
VPTYSWGENETNVFVLNN 0.01% (n=1)
VPTYTWGSNDTDFFVLNN 0.01% (n=1)
APTYTWGSNDTDAFVLNN 0.01% (n=1)
APTYSWGENDTDVFVLND 0.01% (n=1)
APTYSWGENDTDVFVLNT 0.01% (n=1)
APTYSWGENDTDVFILNN 0.01% (n=1)
APTYSWGENDTDVFVFNN 0.01% (n=1)
VSTYSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFVPNN 0.01% (n=1)
APTYSWGSNKTDVFILNN 0.01% (n=1)
VPTYNWGENDVDVFVLNN 0.01% (n=1)
APTCNWGENDTDVFVLNN 0.01% (n=1)
APTYNWGSNDTVVFVLNN 0.01% (n=1)
VPTYNWCANETGVFVLNN 0.01% (n=1)
APTYNWGANDTDVLVLNY 0.01% (n=1)
APTYSWGGNNADVFVLNN 0.01% (n=1)
VATYSWGANEADVFVLNN 0.01% (n=1)
APTYNWGANDTDVFALNN 0.01% (n=1)
APTYNWGANDMDVFVLNN 0.01% (n=1)
APTYNWGANDTDVFVINN 0.01% (n=1)
APT-NWGENDTDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFVLDI 0.01% (n=1)
APTYNWGENDTDVLVLNS 0.01% (n=1)
APTYNWGANNTDVFVLNN 0.01% (n=1)
VPTYNWGENETDIFILNN 0.01% (n=1)
APTYNWGANETDIFILNN 0.01% (n=1)
APTHDWGSNDTDVFILNN 0.01% (n=1)
APTFTWGSNDTDVFVLNN 0.01% (n=1)
APTYNWGANETDVFVLTN 0.01% (n=1)
APTYNWGTNDTNVFVLNN 0.01% (n=1)
QPTYNWGENETDVFVLNN 0.01% (n=1)
APTYNWGENDTDFFVFKN 0.01% (n=1)
APTYNWGENDADVFVLTN 0.01% (n=1)
APTYNWGENDTDVFALNN 0.01% (n=1)
APTYNWGENDTGVFVLNN 0.01% (n=1)
APTYNWGENDTDVFASNN 0.01% (n=1)
APTYSWGADDTDVFVLNN 0.01% (n=1)
VPTYNWGINETDVFVLNN 0.01% (n=1)
APTYNWGCNDTDVIILNN 0.01% (n=1)
VPTYTWGGNDTDFSVLNN 0.01% (n=1)
DPTYSWGVTDTDVFVLNN 0.01% (n=1)
VPTYNWGDNGADVLVLNN 0.01% (n=1)
VPTYN*GDNDTDVFVLNN 0.01% (n=1)
APTYSWVENDTDVFVLNN 0.01% (n=1)
-----------DVFILTN 0.01% (n=1)
-----------DVLVLNN 0.01% (n=1)
VPTYNWGENETDVFVLTN 0.01% (n=1)
APTYNWGSDTTDVFVLNN 0.01% (n=1)
VPTYTCGENDTDVFILNN 0.01% (n=1)
APTFNWGGNETDVFILNN 0.01% (n=1)
APTYNWGANDTDILVLNN 0.01% (n=1)
APTFNWGDNDTDVLVLNN 0.01% (n=1)
APTYSWGEHDTDVFVLNN 0.01% (n=1)
APTYTWGSNVSDVFVLNN 0.01% (n=1)
APTYTWGSNHSDVFVLNN 0.01% (n=1)
SPTYRWGENETDVFILNN 0.01% (n=1)
APTYSWGDNETDVFVLNN 0.01% (n=1)
VPTFNWGANDTDVFVLNN 0.01% (n=1)
VPTFNWGSNDTDVFVLNN 0.01% (n=1)
VPTYNWGNTSEDVLVLNN 0.01% (n=1)
VPTYSWGSNETDVLVLNN 0.01% (n=1)
APTYNWGGNDTDVFVLTN 0.01% (n=1)
QPTYNWGENDTDVLVLNN 0.01% (n=1)
APTFNWGENDTDVLVLNN 0.01% (n=1)
VPTHSWGENETDVFVLNN 0.01% (n=1)
EPTYNWGDNDTDVLVLNN 0.01% (n=1)
APTFNWGQNDTDVFVLNN 0.01% (n=1)
VPTYNWGANETDVFVLNS 0.01% (n=1)
APTYSWGVNETDVFVLNN 0.01% (n=1)
APTYNWGENETDVFVLNS 0.01% (n=1)
APTYNWGQNDTDVFVLNN 0.01% (n=1)
APTYSWGANVTDVFVLNN 0.01% (n=1)
APTYSWGENDKDVFVLNN 0.01% (n=1)
APTYSWGSNVTDVFVLNN 0.01% (n=1)
APTFSWGANDTDVFVLNN 0.01% (n=1)
APTYRWGSNDTDVFILNN 0.01% (n=1)
APTYDWGGNVTDVFVLNN 0.01% (n=1)
APTYNWGINDTDVLVLNN 0.01% (n=1)
VPTYNWGCNDTDVFVLNN 0.01% (n=1)
SPTYSWGENVTDVFVLNN 0.01% (n=1)
APSYNWGENETDVFVLNN 0.01% (n=1)
APTFNWGENDTDVFILNN 0.01% (n=1)
VPTYNWGINDTDVFVLNN 0.01% (n=1)
VPTYGWGSNDTDVFILNN 0.01% (n=1)
APTYNWGSNDSDVFVLNN 0.01% (n=1)
APTYSWGERDRDVFVLNN 0.01% (n=1)
VPTYSWGSNETDVFVLNN 0.01% (n=1)
APTYDWGANDTDVLVLNN 0.01% (n=1)
APTYDWGRNDTDVFVLNN 0.01% (n=1)
APTYNWGANESDVFVLNN 0.01% (n=1)
VPTYSWGADEADVFVLNN 0.01% (n=1)
VPTYNFGANQTDVFVLNN 0.01% (n=1)
TPTYTWGENETDVFILNN 0.01% (n=1)
APTYNWGESDMDVLVLNN 0.01% (n=1)
APTYNWGSSDKDVLILNN 0.01% (n=1)
APTYTWGENDTDVFILNN 0.01% (n=1)
APTYNWGSNETDVFILNN 0.01% (n=1)
VPTYNWGRNDTDFLVLNN 0.01% (n=1)
VPTYNWGENDSDVFVLNN 0.01% (n=1)
VPTYNWGQNDTDVFVLNN 0.01% (n=1)
APTYDWGANDTDVFVLNN 0.01% (n=1)
APTYNWGRNDTDVFVLNN 0.01% (n=1)
APTFNWGANDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFLLNN 0.01% (n=1)
TPTFTWGESDKDVFILNN 0.01% (n=1)
APTYSWGENETDVLVLNN 0.01% (n=1)
APTYNWGANEADVFVLNN 0.01% (n=1)
APTYNWGANETDVFVPNN 0.01% (n=1)
APTYSWGSDDTDVLVLNN 0.01% (n=1)
APTYSWGENETDVFILNS 0.01% (n=1)
VPTYNWGNNDTDVLVLNN 0.01% (n=1)
VPTYSWGENDTDVLVLNN 0.01% (n=1)
VPTYNWGGNETDVLVLNN 0.01% (n=1)
VPTYNWGTNATDVFVLNN 0.01% (n=1)
APTYNWGSNYTDVFVLNN 0.01% (n=1)
APSYNWGSNDTDVFILNN 0.01% (n=1)
QATYSWGEKETDVFVLNN 0.01% (n=1)
VPTYTWGEKETDVFVLNN 0.01% (n=1)
SPTYRWGENETDVFVLNN 0.01% (n=1)
APTYNWGENDSDVFVLNN 0.01% (n=1)
VPTYDWGSNVTDVFVLNN 0.01% (n=1)
APTYDWGSNETDVFILNN 0.01% (n=1)
APTYSWGGKVTDVLVLNN 0.01% (n=1)
APTYNWGENDTDVFVLND 0.01% (n=1)
VPTYGWGENDTDVFVLNN 0.01% (n=1)
VPTYNWGENDTDVFLLNN 0.01% (n=1)
VPTYNWGTNDTDVFVLNN 0.01% (n=1)
VPTYTWGENDTDVFILNN 0.01% (n=1)
LPTYNWGANDTDVFVLNN 0.01% (n=1)
MPTYNWGENETDVFILNN 0.01% (n=1)
VPTHSWGENEADVFVLNN 0.01% (n=1)
KPTYSWGADEADVFVLNN 0.01% (n=1)
VPTYTWGSNDTDVFVLNN 0.01% (n=1)
VPTYSWGGNETDVFVLNN 0.01% (n=1)
VPTYNFGTNETDVFVLNN 0.01% (n=1)
APTFNWGDSDEDVLVLNN 0.01% (n=1)
APSYTWGENETDVLVLNN 0.01% (n=1)
APTYNWGENDTDGFVLNN 0.01% (n=1)
TPTYDWGSNDTDVFVLNN 0.01% (n=1)
APTYNWGVNDTDFFVLNN 0.01% (n=1)
APTYRWGENDTDVFLLNN 0.01% (n=1)
APIYSWGEKDTDVFVLNN 0.01% (n=1)
APTFNWGENESDVFVLNN 0.01% (n=1)
APTYDWGENESDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFVLNS 0.01% (n=1)
APTYNWGANETDVIILNN 0.01% (n=1)
APTYNWGENDTDVIILNN 0.01% (n=1)
APTYNWGANDTDVFVLKN 0.01% (n=1)
VPTYSWGENDTDVFLLNN 0.01% (n=1)
VPTYTWGERDTDVFVLNN 0.01% (n=1)
APTYNWGANDSDVFVLNN 0.01% (n=1)
VPTLNWGSNETDVFVLNN 0.01% (n=1)
VPTYNWGENETDVPVLNN 0.01% (n=1)
VPTYNWGENETDVLVPNN 0.01% (n=1)
VPTYNWGDNETDVFILNN 0.01% (n=1)
VPTYSWGENETDVSILNN 0.01% (n=1)
VPTYNWGGNETGVFILNN 0.01% (n=1)
ALTYNWGSNDTDVFILNN 0.01% (n=1)
APTYNWGSNVTDVFILNN 0.01% (n=1)
APTYNWGSNDTGIFILNN 0.01% (n=1)
APTYNWGENDTDALILNN 0.01% (n=1)
APTHNWGASDTDVFVLNN 0.01% (n=1)
VPIYGWGSNDTDVFVLNN 0.01% (n=1)
AATYSWGENDTDVFVLNN 0.01% (n=1)
---YSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGEYDTDVFVLNN 0.01% (n=1)
APTYS*GENDTDVFVLNN 0.01% (n=1)
GPTYSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVSVLNN 0.01% (n=1)
APTYSWGENDTGIFVLNN 0.01% (n=1)
APTCSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVYVLNN 0.01% (n=1)
APTYGRGENDTDVFVLNN 0.01% (n=1)
APTYSRGENDTDVFVLNN 0.01% (n=1)
APTHNWGENDTDVFVLNN 0.01% (n=1)
APTYNWGENGTDVLVLNN 0.01% (n=1)
VPTYNWGEDDTDVLVLNN 0.01% (n=1)
APTYNWGANDTDVLLLNN 0.01% (n=1)
APTYNWGDNQTDVFILNN 0.01% (n=1)
APTYKWGANDTDVLLLNN 0.01% (n=1)
APTYNWGANETEVFLLNN 0.01% (n=1)
ALTYNRGANDTDVFVLNN 0.01% (n=1)
VPTHNWGENETDVFVLNN 0.01% (n=1)
APTYNWGENETDIFVLNN 0.01% (n=1)
VPTYDWGSSDVDVFVLNN 0.01% (n=1)
APTYSWGANDTAVFVLNN 0.01% (n=1)
APTYSWGANGTDVFVLND 0.01% (n=1)
APTCSWGATDTDVFVLNN 0.01% (n=1)
APTYSWGVNDTGVFVLNN 0.01% (n=1)
APTYSRGANDTDVFVLNN 0.01% (n=1)
APTYSWGANDTGVFVLNN 0.01% (n=1)
APTYSWGANDTDVFVLNS 0.01% (n=1)
APTYSWGANDTDAFVLNN 0.01% (n=1)
APAYSWGANDTDVFVLNN 0.01% (n=1)
TPTYSWGANDTDVFVLNN 0.01% (n=1)
APTYSWGANDTDVFVLND 0.01% (n=1)
VPTYSWGANDTDFFLLSN 0.01% (n=1)
VPTYNWGENDTDFFLLNN 0.01% (n=1)
VPTYSWGVNDKDVFVLNN 0.01% (n=1)
VPTYNWGGNDTDVFILNN 0.01% (n=1)
VPTYNWGAKKTDVFVLNN 0.01% (n=1)
APTYNWGAHETDVFVLNN 0.01% (n=1)
VPTYNWGTNVTDVFVLNN 0.01% (n=1)
VPTYNWGADKTDVFVLNN 0.01% (n=1)
VPTYNWGANEKDVFVLNN 0.01% (n=1)
VPTYNWGAKQTDVFVLNN 0.01% (n=1)
VPTYNWGARETDVFVLNN 0.01% (n=1)
APTYNWGASETDVFVLNN 0.01% (n=1)
APTYNWGATETDVFVLNN 0.01% (n=1)
VPTYNWGTNETDIFVLNN 0.01% (n=1)
VPTYNWGTNKTDVFVLNN 0.01% (n=1)
APTCSWGANDTDVFVLNN 0.01% (n=1)
APTYNWGDNEADVFLLNN 0.01% (n=1)
APTYSWGANDTDIFVLNN 0.01% (n=1)
APTYNWGVNDTDIFVLNN 0.01% (n=1)
APTYNWGGNATDVFVLNN 0.01% (n=1)
APTHNWGENETDVFVLNN 0.01% (n=1)
VPTYSWGENETDVFVLIN 0.01% (n=1)
APTYNWGEDDTDVFVLNN 0.01% (n=1)
APTYNWGANETDVIVLN- 0.01% (n=1)
APTYSWGENDSDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFVLTN 0.01% (n=1)
APTYNWGGNVTDVLVLNN 0.01% (n=1)
APTYNWGCND-------N 0.01% (n=1)
VPTYRWGKNETDVFVLNN 0.01% (n=1)
EPTYYWGENDTDVFVLNN 0.01% (n=1)
APTYDWGVNDTDVFVLNN 0.01% (n=1)
VPTYSWGSNATDVFVLNN 0.01% (n=1)
SPTYSWGENDTDVFVLNN 0.01% (n=1)
VPTYDWGENDTDVFVLNN 0.01% (n=1)
TPTYSWGENDTDVFVLNN 0.01% (n=1)
VPTYSWGESEADVFVLNN 0.01% (n=1)
APTYNWGRNDTDVLVLNN 0.01% (n=1)
APTYRWGTNDTDVFVLNN 0.01% (n=1)
VPTYTWGANETDVFVLNN 0.01% (n=1)
SPTYNWGENDTDVFVLNN 0.01% (n=1)
APTYSWGDNDTDVLVLNN 0.01% (n=1)
VPTYNWGANITDVFVLNN 0.01% (n=1)
APTYTWGDNDTDVFILNN 0.01% (n=1)
APTYSWGANDTDVFVPNN 0.01% (n=1)
APTYSWGSDNTDVFVLNN 0.01% (n=1)
IPTYTWGENETDVFILNN 0.01% (n=1)
APTYSWGDNDTDVLILNN 0.01% (n=1)
HPTYNWGANDTDVFVLNN 0.01% (n=1)
APTYNWGSNITDVLVLNN 0.01% (n=1)
VPTYAWGANETDVFVLNN 0.01% (n=1)
APTYNWGETDKDVFVLNN 0.01% (n=1)
VPTYSWGSNDTDVFVLNN 0.01% (n=1)
VPTYRWGVNETDVFVLNN 0.01% (n=1)
APTYNWGANMTDVLVLNN 0.01% (n=1)
APTYNWGENDTDVFVPNN 0.01% (n=1)
APTYTWGGNDTDVFVLNN 0.01% (n=1)
APTYNWGDNDTDVFVFNN 0.01% (n=1)
APTYNWGENDADVFVLNN 0.01% (n=1)
APTYNWGVNETDVFVLNN 0.01% (n=1)
IPTYSWGGNDTDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFLLNN 0.01% (n=1)
APTYNWGANDTDVIILNN 0.01% (n=1)
APTYSWGANNTDVFVLDN 0.01% (n=1)
APTYNWGSNDTDIFVLNN 0.01% (n=1)
APTYNWGDNDTDVLILNN 0.01% (n=1)
APTYSWGENEKDVFVLNN 0.01% (n=1)
VPTYNWGENETDIFVLNN 0.01% (n=1)
APTYNWGSNDTDVFLLNN 0.01% (n=1)
VPTYNWGSNNTDVFVLNN 0.01% (n=1)
VPTYNWGANDTDVSVLNN 0.01% (n=1)
VPTYNWVSNDTDVFVLNN 0.01% (n=1)
APTYSWGSNNTDVFVLNN 0.01% (n=1)
APTYNWGEQDTDVFVLNN 0.01% (n=1)
VPTYNWGENESDVFVLNN 0.01% (n=1)
APTYDWGENETDVFVLNN 0.01% (n=1)
APTYNWGENETDAFVLNN 0.01% (n=1)
APTYRWGENEKDVFVLNN 0.01% (n=1)
APTYNWGSNDTDVFVLNG 0.01% (n=1)
VPTYTWGENESDVFVLNN 0.01% (n=1)
APTYNWGASDTDVFVLNN 0.01% (n=1)
APTYNWGANVTDVLILNN 0.01% (n=1)
APTYNWGSNDTDVFVLYN 0.01% (n=1)
VPTYTWGSSDADVFILNN 0.01% (n=1)
APTYNWGSNETDVLVLNN 0.01% (n=1)
APTYNWGGNDADVLVLNN 0.01% (n=1)
APTHTWGANETDVFILNN 0.01% (n=1)
VPTYSWGENETDVFLLNN 0.01% (n=1)
APTYNWGGGDTDVFVLNN 0.01% (n=1)
APTYRWGENETDVLVLNN 0.01% (n=1)
TPTFSWGENDTDVFVLNN 0.01% (n=1)
GPTYNWGRKDTDVLVLNN 0.01% (n=1)
APTYNWGMNDTDVLVLNN 0.01% (n=1)
APTYDWGANETDVFVLNS 0.01% (n=1)
APTYRWGENETDVFLLNN 0.01% (n=1)
APTYNWGVNDTDVFVLNN 0.01% (n=1)
APTFNWGANDTDVLVLNN 0.01% (n=1)
APAYNWGENDTDVFVPNN 0.01% (n=1)
APAYNWGENDTDVIVLNN 0.01% (n=1)
APSYNWGENDTDVFVLNN 0.01% (n=1)
APAYNWGKNDTDVFVLNN 0.01% (n=1)
APAYNWGENATDVFVLNN 0.01% (n=1)
VPAYNWGENDTDVFVLNN 0.01% (n=1)
APTSVRGENGTDVLLLNN 0.01% (n=1)
VRTYNWGENETDVLLLNN 0.01% (n=1)
APTYNWGANETDVLYLNN 0.01% (n=1)
NPTYSWGENDTDVLLLNN 0.01% (n=1)
APTYKWGENETDVLILNN 0.01% (n=1)
VPTYNWGVNESDVLLLNN 0.01% (n=1)
VPTYNWGENETDVLYLNN 0.01% (n=1)
VRT--------------- 0.01% (n=1)
TPTYSWGENETDVLLLNN 0.01% (n=1)
ARKYSWGENETDVLLLNN 0.01% (n=1)
ASTYSWGENETDVLLLNN 0.01% (n=1)
APTYSWGENETNVLLLNN 0.01% (n=1)
APTYNWGENKTDVLLLNN 0.01% (n=1)
APTYTWGENETDVMILNN 0.01% (n=1)
TPTYRWGENETDVLILNS 0.01% (n=1)
APTYSWRENETDVLLLNN 0.01% (n=1)
PPTYSWGENETDVLLLNN 0.01% (n=1)
APTYTWGVNETDVLILNN 0.01% (n=1)
APTYSWGANETDVLILNN 0.01% (n=1)
VPTYTWGENETNVLLLNN 0.01% (n=1)
VPTYRWGENETDVLLLKN 0.01% (n=1)
VPTYRWGENETDVLLPKK 0.01% (n=1)
VPTYRWGEKETDVLLLNN 0.01% (n=1)
VSTYTWGENETDVLLLNN 0.01% (n=1)
VPTYSWGENKTDVLLLKK 0.01% (n=1)
VPTYRWGEIETDVLLLNN 0.01% (n=1)
VPTYSWGGNETDVLLLKN 0.01% (n=1)
VPTYSGRGIETDVRFLKN 0.01% (n=1)
VPTYMWGEYETDVLSLKN 0.01% (n=1)
VPTYSWGGNETDMLFLKN 0.01% (n=1)
VPTYSWGGIKPDVLLLKK 0.01% (n=1)
VPTYSWGGNETDVLRLKK 0.01% (n=1)
VPTYSWGGNRTDVLLLNN 0.01% (n=1)
VPTYSWGENETCVLLLNN 0.01% (n=1)
APTYTWGENVTDVLILNN 0.01% (n=1)
VPTYTWGGNKTDVLLLNN 0.01% (n=1)
VPTFTWGEKETDVLLLNN 0.01% (n=1)
NPTYTWGGNETDVLLLNN 0.01% (n=1)
DPTYNWGENETDVLLLNN 0.01% (n=1)
VPTYNWGENGSDVLLLNN 0.01% (n=1)
VPTHNWGGNASDVLLLNN 0.01% (n=1)
APTYSWGVNETDVLLLNN 0.01% (n=1)
APTYNWGENVTDVLILNN 0.01% (n=1)
APTFTWGENVTDVLLLNN 0.01% (n=1)
VPTYDWGGNETDVLLLNN 0.01% (n=1)
VPTYRWGGNETDVLLLNN 0.01% (n=1)
APTYTWGENETDVLILNS 0.01% (n=1)
NPTYNWGENKTDVLLLNN 0.01% (n=1)
DPTYNWGGNETDVLLLNN 0.01% (n=1)
APTYRWGANESDVLILNN 0.01% (n=1)
APTYNWGENETDVLLLDN 0.01% (n=1)
VPTYRWGENETDVLLLNS 0.01% (n=1)
APTYAWGGNETDVLLLNN 0.01% (n=1)
NPTYTWGENATDVLLLNN 0.01% (n=1)
VPTCTWGENETDVLLLNN 0.01% (n=1)
VPTYTWEENETDVLLLNN 0.01% (n=1)
APTYSWGENGTDVLLLNN 0.01% (n=1)
APTYSWGANETDVLILNS 0.01% (n=1)
TPTYNWGGNETDVLLLNN 0.01% (n=1)
VPTYSWGGNTSDVLLLNN 0.01% (n=1)
APTYTWGENKTDVLLLNN 0.01% (n=1)
VPTYSWGGNKSDVLLLNN 0.01% (n=1)
------------VLFLNN 0.01% (n=1)
TATFNWGGNETDVLLLNN 0.01% (n=1)
VPTYNWGENKSDVLLLNN 0.01% (n=1)
VPTYAWGANETDVLLLNN 0.01% (n=1)
APTYTWGTNESDVLLLNN 0.01% (n=1)
VPTYSWGENEADVLLLNN 0.01% (n=1)
VPSYRWGENETDVLLLNN 0.01% (n=1)
APTYTWGANETDVLYLNN 0.01% (n=1)
VPTYSWGENETDVLILNN 0.01% (n=1)
APTYKWGENETDVLLLNN 0.01% (n=1)
VPTYNWGVNETDVLLLNN 0.01% (n=1)
VPTYRWGENETDVLLPNN 0.01% (n=1)
VPTYRWGENGTDVLLLNN 0.01% (n=1)
RRSYILGENETDVLLLNN 0.01% (n=1)
VPTYSWGENETNVLLLNN 0.01% (n=1)
VPTYRWGENETDVLLFNN 0.01% (n=1)
VPTYSWGENETDVLLPNN 0.01% (n=1)
APTYNWGVNETDVLLLNN 0.01% (n=1)
VPTYTWGGNASDVLLLNN 0.01% (n=1)
VPTYSWGGNATDVLLLNN 0.01% (n=1)
VPTYSWGENKSDVLLLNN 0.01% (n=1)
LPTYNWGENETDVLLLNN 0.01% (n=1)
APTYRWGENESDVLILNN 0.01% (n=1)
VPTYNWGANQTDVLLLNN 0.01% (n=1)
IPTYSWGENETDVLLLNN 0.01% (n=1)
APTYHWGENKTDVLLLNN 0.01% (n=1)
VPTYRWGENSSDVLLLNN 0.01% (n=1)
VPTYSWGANKTDVLLLNN 0.01% (n=1)
VPTYSWGENETDVLFLNN 0.01% (n=1)
APTYTWGENATDVLLLNN 0.01% (n=1)
VPTYSWGGNKTDVLLLTN 0.01% (n=1)
NPTYRWGENKTDVLLLNN 0.01% (n=1)
APTYTWGENETDVMILNS 0.01% (n=1)
VPTYSWGESETDVLLLNN 0.01% (n=1)
VPTYRWGENKTDVLLLNN 0.01% (n=1)
DPTYTWGGNETDVLLLNN 0.01% (n=1)
VPTYTWGENETDVLVLNN 0.01% (n=1)
VPTYTWGENQTDVLLLNN 0.01% (n=1)
TPTYTWGENGTDVLLLNN 0.01% (n=1)
VPTYNWGANETDVLYLNN 0.01% (n=1)
VPTYTWGTNETDVLFLNN 0.01% (n=1)
APTYSWGENKTDVLILNN 0.01% (n=1)
APTYRWGANETDVLILNN 0.01% (n=1)
VPTYTWGVNETDVLLLNN 0.01% (n=1)
APTYSWGGNETDVLILNN 0.01% (n=1)
APTYGWGENETDVLLLNN 0.01% (n=1)
VPTYSWGENETDVLHLNN 0.01% (n=1)
VPTYSWGEDETDVLLLNN 0.01% (n=1)
APTYSRGENEADVLLLNN 0.01% (n=1)
APTYSWGENETDALLLNN 0.01% (n=1)
VPTYQWGENKTDVLLLNN 0.01% (n=1)
VPTYQWGENETDVLLLNN 0.01% (n=1)
VPTYGWGGNETDVLLLNN 0.01% (n=1)
VPTYSWGENQTDVLLLNN 0.01% (n=1)
VPTYTWGENETGVLLLNN 0.01% (n=1)
VPTYSWGRNETDVLVLNN 0.01% (n=1)
VPTYSWGKNETDVLVLDN 0.01% (n=1)
VPTYSWGKNETDMLVLNN 0.01% (n=1)
VPTHTWGENETDVLLLNN 0.01% (n=1)
APTYNWGENETDVL-LNN 0.01% (n=1)
VPTYSWGENETDALVLNN 0.01% (n=1)
APTHTWGENETDVL---- 0.01% (n=1)
VPTYSWGENESDVLLLNN 0.01% (n=1)
VPTYSWGENETDVLPLNN 0.01% (n=1)
APTYTWGENGTDVLLLNN 0.01% (n=1)
APTYTWGRNETDVLLLNN 0.01% (n=1)
APTYTWGESETDVLLLNN 0.01% (n=1)
APTYRRGGNETDVLLLNN 0.01% (n=1)
APTFTWGENETDVLLLNN 0.01% (n=1)
VPTYNWGGNATDVLLLNN 0.01% (n=1)
TPTFSWGENETDVLLLNN 0.01% (n=1)
VPTFSWGENDTDVLLLNN 0.01% (n=1)
TPTYSWGENVTDVLLLNN 0.01% (n=1)
TPTFSWGENQTDVLLLNN 0.01% (n=1)
APTFSWGEKETDVLLLNN 0.01% (n=1)
APTYAWGENETDVLLLNN 0.01% (n=1)
VPTYQWGENESDVLLLNN 0.01% (n=1)
APTYSWGENETDVLLQNN 0.01% (n=1)
------GENEIDVLLLNN 0.01% (n=1)
------GENESDVLLLNN 0.01% (n=1)
------GENEIDVLILNN 0.01% (n=1)
------GENETDVLILNN 0.01% (n=1)
VPTYRWGENETDALLLNN 0.01% (n=1)
VPTYTWGENETDILLLNN 0.01% (n=1)
VPTYTWGANDSDVVVLNS 0.01% (n=1)
LPTYNWGANVSDVVILNS 0.01% (n=1)
NPTFTSGANDTDFFLLNN 0.01% (n=1)
VPTYTWGEHESDVFLLNN 0.01% (n=1)
VPTYEWGEGASDVIILNN 0.01% (n=1)
NPTYRWGENETDVIILNN 0.01% (n=1)
VPTYNWGENETDVFLLNN 0.01% (n=1)
MPTYTSGANETDFLLLNN 0.01% (n=1)
APTFTSGANDTDFLLLNN 0.01% (n=1)
APTYTWGENDTDVLLLNN 0.01% (n=1)
VPTYSWGENETDVFILNT 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 1a:

APTYNWGENDTDVFVLNN 10.85% (n=788)
APTYNWGANETDVFVLNN 5.85% (n=425)
APTYRWGANDTDVFVLNN 5.26% (n=382)
APTYSWGENDTDVFVLNN 4.37% (n=317)
APTFNWGENDTDVFVLNN 4.27% (n=310)
APTYNWGDNDTDVFVLNN 4.16% (n=302)
APTYSWGANDTDVFVLNN 3.84% (n=279)
APAYNWGENDTDVFVLNN 3.80% (n=276)
APTYNWGENETDVFVLNN 3.65% (n=265)
VPTYNWGSNDTDVFVLNN 3.57% (n=259)
VPTYRWGENETDVFVLNN 2.64% (n=192)
APTYNWGSNETDVFVLNN 2.46% (n=179)
EPTYNWGENDTDVFVLNN 2.09% (n=152)
APTYSWGENETDVFVLNN 2.07% (n=150)
APTYNWGANDTDVFVLNN 1.83% (n=133)
IPTYSWGENDTDVFVLNN 1.58% (n=115)
APTYNWGENATDVFVLNN 1.54% (n=112)
VPTYNWGENDTDVFVLNN 1.46% (n=106)
VPTYNWGENETDVFVLNN 1.28% (n=93)
APTYGWGANDTDVFVLNN 1.27% (n=92)
APTYNWGSNDTDVFVLNN 1.23% (n=89)
APTYNWGSNDTDVLVLNN 1.07% (n=78)
VPTYNWGANDTDVFVLNN 1.02% (n=74)
APTYNWGDNETDVFLLNN 0.90% (n=65)
APTYNWGCNDTDVFVLNN 0.83% (n=60)
APTYNWGENDTDVLVLNN 0.76% (n=55)
VPTYNWGDNDTDVFVLNN 0.76% (n=55)
VPTYNWGSNETDVFVLNN 0.73% (n=53)
APTYNWGDNDTDVLVLNN 0.66% (n=48)
APTYNWGSNDTDVFILNN 0.63% (n=46)
VPTYNWGENDTDVFVLTN 0.59% (n=43)
APTYNWGGNDTDVLVLNN 0.55% (n=40)
APTYNWGSNDTDIFILNN 0.51% (n=37)
QPTYNWGENETDVFILNN 0.50% (n=36)
APAYNWGENNTDVFVLNN 0.48% (n=35)
APTYNWGENDTDVFILNN 0.47% (n=34)
APTYNWGENDTDVFVLTN 0.47% (n=34)
VPTYSWGENETDVFVLNN 0.39% (n=28)
APTYNWGANDTDIFVLNN 0.39% (n=28)
APTYNWGGKDTDVFVLNN 0.37% (n=27)
APTYNWGAREEDVFVLNN 0.36% (n=26)
VPTYNWGANVTDVFVLNN 0.33% (n=24)
APTYNWGSNDTDVLILNN 0.33% (n=24)
APTYSWGENDTDVLVLNN 0.32% (n=23)
APTYNWGENDTDVLILNN 0.32% (n=23)
APTYSWGANETDVFVLNN 0.32% (n=23)
VPTYSWGENDTDVFILNN 0.32% (n=23)
VPTYSWGGNDTDVFILNN 0.32% (n=23)
VPTYSWGENDTDVFVLNN 0.30% (n=22)
APTYNWGANDTDVLVLNN 0.30% (n=22)
APTYSWGANDTDVLVLNN 0.29% (n=21)
APTYNWGENETDVFILNN 0.26% (n=19)
APTYTWGSNDTDVFVLNN 0.25% (n=18)
VPTYGWGSNDTDVFVLNN 0.25% (n=18)
VPTYNWGAKETDVFVLNN 0.25% (n=18)
APTYKWGANETDVFILNN 0.25% (n=18)
APAYNWGENVTDVFVLNN 0.25% (n=18)
VPTYNWGADETDVFVLNN 0.23% (n=17)
APTYSWGEKETDVFVLNN 0.22% (n=16)
APTYSWGSNETDVFILNN 0.21% (n=15)
APTYRWGANETDVFVLNN 0.21% (n=15)
APTHTWGANDTDVFILNN 0.21% (n=15)
TPTYSWGANETDVFVLNN 0.21% (n=15)
VPTYSWGANDTDFLVLNN 0.18% (n=13)
APTYTWGENETDVFVLNN 0.17% (n=12)
APTYTWGANDTDVFVLNN 0.17% (n=12)
VPTYNWGENETDVLVLNN 0.17% (n=12)
VPTYTWGENDTDVFVLNN 0.17% (n=12)
DPTYGWGDNDTDVLILNN 0.14% (n=10)
APTYNWGGNDTDVFVLNN 0.14% (n=10)
VPTYNWGENDTDVLVLNN 0.14% (n=10)
VPTYNWGGNETDVFILNN 0.14% (n=10)
VPTYNWGTNETDVFVLNN 0.14% (n=10)
VPTYNWGANEMDVFVLNN 0.14% (n=10)
APTYNWGEGGTDVFVLNN 0.14% (n=10)
APTYNWGGNKTDVFVLNN 0.14% (n=10)
VPTYNWGDNDTDVLVLNN 0.12% (n=9)
VPTYDWGSNDTDVFVLNN 0.12% (n=9)
APTYSWGANDTDVFVLDN 0.12% (n=9)
APTYGWGENDTDVFVLNN 0.12% (n=9)
-----------DVFVLNN 0.11% (n=8)
APTYNWGENDTDVIVLNN 0.11% (n=8)
VPTYNWGANKTDVFVLNN 0.11% (n=8)
APTYNWGENKTDVFVLNN 0.11% (n=8)
VPTYNWGSNDTDVLVLNN 0.10% (n=7)
VPTYSWGANNTDVFVLNN 0.10% (n=7)
APTYDWGSNDTDVFILNN 0.10% (n=7)
VPTYTWGENETDVFVLNN 0.10% (n=7)
LPTYNWGENDTDVFVLNN 0.10% (n=7)
APTFSWGENDTDVFVLNN 0.10% (n=7)
APTYRWGENETDVFVLNN 0.10% (n=7)
VPTYNWGDNETDVFVLNN 0.08% (n=6)
VPTYNWGANETDVFVLNN 0.08% (n=6)
VPTYNWGANDTDFFVLNN 0.08% (n=6)
MPTYSWGENDTDVFILNN 0.08% (n=6)
APTYNWGTREEDVFVLNN 0.08% (n=6)
APTYNWGANDTDVFVLNS 0.07% (n=5)
APTYNWGNNDTDVFVLNN 0.07% (n=5)
APTYNWGANETDVLILTN 0.07% (n=5)
TPTYNWGANDTDFFVLNN 0.07% (n=5)
APTHSWGENDTDVFVLNN 0.07% (n=5)
APTYSWGEKDTDVFVLNN 0.07% (n=5)
VPTYSWGENETDVFILNN 0.07% (n=5)
APTHNWGANDTDVFVLNN 0.07% (n=5)
APTYNWGGNETDVFVLNN 0.07% (n=5)
VPTYNWGAHETDVFVLNN 0.07% (n=5)
APTYNWGAKETDVFVLNN 0.07% (n=5)
VPTFTWGSNNTDVFVLNN 0.07% (n=5)
MPTYNWGQNDTDVFVLNN 0.06% (n=4)
APTYNWGVNETDIFILNN 0.06% (n=4)
APTYNWGANETDVLVLTN 0.06% (n=4)
TPTFTWGGSVKDVLVLNN 0.06% (n=4)
VPTYTWGGNDTDFLVLNN 0.06% (n=4)
APTYNWGQNETDVFVLNN 0.06% (n=4)
APTYNWGCNETDVFVLNN 0.06% (n=4)
APTYNWGGNETDVLVLNN 0.06% (n=4)
VPTYNWGGNDTDVLVLNN 0.06% (n=4)
APTYSWGENETDVFILNN 0.06% (n=4)
APTYTWGENDTDVFVLNN 0.06% (n=4)
TPTYNWGENDTDVFVLNN 0.06% (n=4)
VPTYNWGSDDKDVLVLNN 0.06% (n=4)
APTYNWGENETDVLILNN 0.06% (n=4)
VPTYNWGVNKTDVFVLNN 0.06% (n=4)
MPTYNWGAKETDVFVLNN 0.06% (n=4)
ASTYNWGDNDTDVFVLNN 0.06% (n=4)
APTYNWGTQEEDVFVLNN 0.06% (n=4)
APTYNWGTREGDVFVLNN 0.06% (n=4)
APTYNWGGDDTDVLVLNN 0.04% (n=3)
VPTYSWGANDTDVFVLNN 0.04% (n=3)
APTYSWGGNDTDVFVLNN 0.04% (n=3)
VATYSWGATDADVFVLNN 0.04% (n=3)
APTYNWGENETDVLVLNN 0.04% (n=3)
APTYSWGTNDTDVFVLNN 0.04% (n=3)
VPTYTWGGNDTDFFVLNN 0.04% (n=3)
VPTYTWGEKDTDVFVLNN 0.04% (n=3)
APTYNWGSNSTDVFVLNN 0.04% (n=3)
APTYSWGENVTDVFVLNN 0.04% (n=3)
APTYNWGENDMDVFVLNN 0.04% (n=3)
APTYSWGSNDTDVFVLNN 0.04% (n=3)
APTYSWGVNDTDVFVLNN 0.04% (n=3)
APTYNWGENESDVFVLNN 0.04% (n=3)
VPTYNWGENETDVFILNN 0.04% (n=3)
APTYNWGTNDTDVFVLNN 0.04% (n=3)
VPTYNWGGNDTDVFVLNN 0.04% (n=3)
APTYSWGSNDTDVFILNN 0.04% (n=3)
---YSWGENDTDVLVLNN 0.04% (n=3)
APTYSWGSNDTDVLVLNN 0.04% (n=3)
VPTYNWGGNETDVFVLNN 0.04% (n=3)
MPTYNWGGNETDVFVLNN 0.04% (n=3)
VPTYDWGSNDVDVFVLNN 0.04% (n=3)
VPTYSWGVNDTDVFVLNN 0.04% (n=3)
ALTYNWGSNDTDIFILNN 0.04% (n=3)
APTYDWGENETDAFVLNN 0.04% (n=3)
APAYNWGGNDTDVFVLNN 0.04% (n=3)
APTYRWGENDTDVFVLNN 0.03% (n=2)
VPTYNWGSNRTDVFVLNN 0.03% (n=2)
VPTYNWGANDTDVLVLNN 0.03% (n=2)
VPTYNWGANDTDVLILNN 0.03% (n=2)
APTYSWGENDTDVFVLNS 0.03% (n=2)
APTFNWGSNDTDVFVLNN 0.03% (n=2)
APTYNWGENETDVLILTN 0.03% (n=2)
TPTYNWGANDTYFFVLNN 0.03% (n=2)
DPTFGWGGNDTDVLILNN 0.03% (n=2)
APTYNWGENDKDVLILNN 0.03% (n=2)
APTFTFGENETDVFILNN 0.03% (n=2)
APTYNWGEDDSDVFVLNN 0.03% (n=2)
APTYSWGSNDSDVFVLNN 0.03% (n=2)
APTYNWGANDTDVFLLNN 0.03% (n=2)
VPTYNWGENATDVFVLNN 0.03% (n=2)
APTYDWGSNDTDVFVLNN 0.03% (n=2)
APTYNWGSNNTDVFVLNN 0.03% (n=2)
APTYNWGDNETDVFVLNN 0.03% (n=2)
APTYDWGENDTDVFVLNN 0.03% (n=2)
VPTYNWGENVTDVFVLNN 0.03% (n=2)
APTYTWGENETDVFILNN 0.03% (n=2)
VPTYNWGDSDTDVFVLNN 0.03% (n=2)
APTYSWGENDTDVFALNN 0.03% (n=2)
APAYNWGANDTDVFVLNN 0.03% (n=2)
MPTYNWGENDTDVFVLNN 0.03% (n=2)
LAYFQLGYQYHGRFFSNQ 0.03% (n=2)
EPTYRWGESEADVFVLNN 0.03% (n=2)
APTYSWGANDADVFVLNN 0.03% (n=2)
VPTYSWGGNDTDVFVLNN 0.03% (n=2)
VPTYSWGGTDTDVFILNN 0.03% (n=2)
VPTYSWGANDTDFFVLNN 0.03% (n=2)
VPTYNWGGNDTDFFVLNN 0.03% (n=2)
VPTYNWGAGETDVFVLNN 0.03% (n=2)
APTNNWGENATDVFVLNN 0.03% (n=2)
APTYNWGENHTDVFVLNN 0.03% (n=2)
APTYNWGENVTDVFVLNN 0.03% (n=2)
HPTYNWGENETDVFILNN 0.03% (n=2)
APTYNWGENDTDVFVLTD 0.03% (n=2)
VPTYTWGENDTDVFVLTN 0.03% (n=2)
APTYNWGENTTDVFVLNN 0.03% (n=2)
APTYNWGGNETDIFVLNN 0.03% (n=2)
APTYNWSENETDVFVLNN 0.03% (n=2)
APTYNWGEEDTDVFVLNN 0.03% (n=2)
APTYKWGANDTDVFVLNN 0.03% (n=2)
VPTYRWGENDTDVFVLNN 0.03% (n=2)
APTYDWGAREEDVFVLNN 0.03% (n=2)
APTYNWGIREEDVFVLNN 0.03% (n=2)
VPTYTWGNSSTDVFVLNN 0.03% (n=2)
AATYSWGSDTKDVFVLNN 0.03% (n=2)
APTYNWGANETDVFLLNN 0.03% (n=2)
VPTYNWGCNVTDVFVLNN 0.03% (n=2)
APTYNWGDNDTDVFILNN 0.03% (n=2)
TPTHNWGENETDVFVLNN 0.03% (n=2)
VPTYSWGTNDTDVFVLNN 0.01% (n=1)
VPTYSWGENGTDVFVLNN 0.01% (n=1)
VPTYSWGENETNVFVLNN 0.01% (n=1)
VPTYTWGSNDTDFFVLNN 0.01% (n=1)
APTYTWGSNDTDAFVLNN 0.01% (n=1)
APTYSWGENDTDVFVLND 0.01% (n=1)
APTYSWGENDTDVFVLNT 0.01% (n=1)
APTYSWGENDTDVFILNN 0.01% (n=1)
APTYSWGENDTDVFVFNN 0.01% (n=1)
VSTYSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFVPNN 0.01% (n=1)
APTYSWGSNKTDVFILNN 0.01% (n=1)
VPTYNWGENDVDVFVLNN 0.01% (n=1)
APTCNWGENDTDVFVLNN 0.01% (n=1)
APTYNWGSNDTVVFVLNN 0.01% (n=1)
VPTYNWCANETGVFVLNN 0.01% (n=1)
APTYNWGANDTDVLVLNY 0.01% (n=1)
APTYSWGGNNADVFVLNN 0.01% (n=1)
VATYSWGANEADVFVLNN 0.01% (n=1)
APTYNWGANDTDVFALNN 0.01% (n=1)
APTYNWGANDMDVFVLNN 0.01% (n=1)
APTYNWGANDTDVFVINN 0.01% (n=1)
APT-NWGENDTDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFVLDI 0.01% (n=1)
APTYNWGENDTDVLVLNS 0.01% (n=1)
APTYNWGANNTDVFVLNN 0.01% (n=1)
VPTYNWGENETDIFILNN 0.01% (n=1)
APTYNWGANETDIFILNN 0.01% (n=1)
APTHDWGSNDTDVFILNN 0.01% (n=1)
APTFTWGSNDTDVFVLNN 0.01% (n=1)
APTYNWGANETDVFVLTN 0.01% (n=1)
APTYNWGTNDTNVFVLNN 0.01% (n=1)
QPTYNWGENETDVFVLNN 0.01% (n=1)
APTYNWGENDTDFFVFKN 0.01% (n=1)
APTYNWGENDADVFVLTN 0.01% (n=1)
APTYNWGENDTDVFALNN 0.01% (n=1)
APTYNWGENDTGVFVLNN 0.01% (n=1)
APTYNWGENDTDVFASNN 0.01% (n=1)
APTYSWGADDTDVFVLNN 0.01% (n=1)
VPTYNWGINETDVFVLNN 0.01% (n=1)
APTYNWGCNDTDVIILNN 0.01% (n=1)
VPTYTWGGNDTDFSVLNN 0.01% (n=1)
DPTYSWGVTDTDVFVLNN 0.01% (n=1)
VPTYNWGDNGADVLVLNN 0.01% (n=1)
VPTYN*GDNDTDVFVLNN 0.01% (n=1)
APTYSWVENDTDVFVLNN 0.01% (n=1)
-----------DVFILTN 0.01% (n=1)
-----------DVLVLNN 0.01% (n=1)
VPTYNWGENETDVFVLTN 0.01% (n=1)
APTYNWGSDTTDVFVLNN 0.01% (n=1)
VPTYTCGENDTDVFILNN 0.01% (n=1)
APTFNWGGNETDVFILNN 0.01% (n=1)
APTYNWGANDTDILVLNN 0.01% (n=1)
APTFNWGDNDTDVLVLNN 0.01% (n=1)
APTYSWGEHDTDVFVLNN 0.01% (n=1)
APTYTWGSNVSDVFVLNN 0.01% (n=1)
APTYTWGSNHSDVFVLNN 0.01% (n=1)
SPTYRWGENETDVFILNN 0.01% (n=1)
APTYSWGDNETDVFVLNN 0.01% (n=1)
VPTFNWGANDTDVFVLNN 0.01% (n=1)
VPTFNWGSNDTDVFVLNN 0.01% (n=1)
VPTYNWGNTSEDVLVLNN 0.01% (n=1)
VPTYSWGSNETDVLVLNN 0.01% (n=1)
APTYNWGGNDTDVFVLTN 0.01% (n=1)
QPTYNWGENDTDVLVLNN 0.01% (n=1)
APTFNWGENDTDVLVLNN 0.01% (n=1)
VPTHSWGENETDVFVLNN 0.01% (n=1)
EPTYNWGDNDTDVLVLNN 0.01% (n=1)
APTFNWGQNDTDVFVLNN 0.01% (n=1)
VPTYNWGANETDVFVLNS 0.01% (n=1)
APTYSWGVNETDVFVLNN 0.01% (n=1)
APTYNWGENETDVFVLNS 0.01% (n=1)
APTYNWGQNDTDVFVLNN 0.01% (n=1)
APTYSWGANVTDVFVLNN 0.01% (n=1)
APTYSWGENDKDVFVLNN 0.01% (n=1)
APTYSWGSNVTDVFVLNN 0.01% (n=1)
APTFSWGANDTDVFVLNN 0.01% (n=1)
APTYRWGSNDTDVFILNN 0.01% (n=1)
APTYDWGGNVTDVFVLNN 0.01% (n=1)
APTYNWGINDTDVLVLNN 0.01% (n=1)
VPTYNWGCNDTDVFVLNN 0.01% (n=1)
SPTYSWGENVTDVFVLNN 0.01% (n=1)
APSYNWGENETDVFVLNN 0.01% (n=1)
APTFNWGENDTDVFILNN 0.01% (n=1)
VPTYNWGINDTDVFVLNN 0.01% (n=1)
VPTYGWGSNDTDVFILNN 0.01% (n=1)
APTYNWGSNDSDVFVLNN 0.01% (n=1)
APTYSWGERDRDVFVLNN 0.01% (n=1)
VPTYSWGSNETDVFVLNN 0.01% (n=1)
APTYDWGANDTDVLVLNN 0.01% (n=1)
APTYDWGRNDTDVFVLNN 0.01% (n=1)
APTYNWGANESDVFVLNN 0.01% (n=1)
VPTYSWGADEADVFVLNN 0.01% (n=1)
VPTYNFGANQTDVFVLNN 0.01% (n=1)
TPTYTWGENETDVFILNN 0.01% (n=1)
APTYNWGESDMDVLVLNN 0.01% (n=1)
APTYNWGSSDKDVLILNN 0.01% (n=1)
APTYTWGENDTDVFILNN 0.01% (n=1)
APTYNWGSNETDVFILNN 0.01% (n=1)
VPTYNWGRNDTDFLVLNN 0.01% (n=1)
VPTYNWGENDSDVFVLNN 0.01% (n=1)
VPTYNWGQNDTDVFVLNN 0.01% (n=1)
APTYDWGANDTDVFVLNN 0.01% (n=1)
APTYNWGRNDTDVFVLNN 0.01% (n=1)
APTFNWGANDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFLLNN 0.01% (n=1)
TPTFTWGESDKDVFILNN 0.01% (n=1)
APTYSWGENETDVLVLNN 0.01% (n=1)
APTYNWGANEADVFVLNN 0.01% (n=1)
APTYNWGANETDVFVPNN 0.01% (n=1)
APTYSWGSDDTDVLVLNN 0.01% (n=1)
APTYSWGENETDVFILNS 0.01% (n=1)
VPTYNWGNNDTDVLVLNN 0.01% (n=1)
VPTYSWGENDTDVLVLNN 0.01% (n=1)
VPTYNWGGNETDVLVLNN 0.01% (n=1)
VPTYNWGTNATDVFVLNN 0.01% (n=1)
APTYNWGSNYTDVFVLNN 0.01% (n=1)
APSYNWGSNDTDVFILNN 0.01% (n=1)
QATYSWGEKETDVFVLNN 0.01% (n=1)
VPTYTWGEKETDVFVLNN 0.01% (n=1)
SPTYRWGENETDVFVLNN 0.01% (n=1)
VPTYNWGANETDVLVLNN 0.01% (n=1)
APTYNWGENDSDVFVLNN 0.01% (n=1)
VPTYDWGSNVTDVFVLNN 0.01% (n=1)
APTYDWGSNETDVFILNN 0.01% (n=1)
APTYSWGGKVTDVLVLNN 0.01% (n=1)
APTYNWGENDTDVFVLND 0.01% (n=1)
VPTYGWGENDTDVFVLNN 0.01% (n=1)
VPTYNWGENDTDVFLLNN 0.01% (n=1)
VPTYNWGTNDTDVFVLNN 0.01% (n=1)
VPTYTWGENDTDVFILNN 0.01% (n=1)
LPTYNWGANDTDVFVLNN 0.01% (n=1)
MPTYNWGENETDVFILNN 0.01% (n=1)
VPTHSWGENEADVFVLNN 0.01% (n=1)
KPTYSWGADEADVFVLNN 0.01% (n=1)
VPTYTWGSNDTDVFVLNN 0.01% (n=1)
VPTYSWGGNETDVFVLNN 0.01% (n=1)
VPTYNFGTNETDVFVLNN 0.01% (n=1)
APTFNWGDSDEDVLVLNN 0.01% (n=1)
APSYTWGENETDVLVLNN 0.01% (n=1)
APTYNWGENDTDGFVLNN 0.01% (n=1)
TPTYDWGSNDTDVFVLNN 0.01% (n=1)
APTYNWGVNDTDFFVLNN 0.01% (n=1)
APTYRWGENDTDVFLLNN 0.01% (n=1)
APIYSWGEKDTDVFVLNN 0.01% (n=1)
APTFNWGENESDVFVLNN 0.01% (n=1)
APTYDWGENESDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFVLNS 0.01% (n=1)
APTYNWGANETDVIILNN 0.01% (n=1)
APTYNWGENDTDVIILNN 0.01% (n=1)
APTYNWGANDTDVFVLKN 0.01% (n=1)
VPTYSWGENDTDVFLLNN 0.01% (n=1)
VPTYTWGERDTDVFVLNN 0.01% (n=1)
APTYNWGANDSDVFVLNN 0.01% (n=1)
VPTLNWGSNETDVFVLNN 0.01% (n=1)
VPTYNWGENETDVPVLNN 0.01% (n=1)
VPTYNWGENETDVLVPNN 0.01% (n=1)
VPTYNWGDNETDVFILNN 0.01% (n=1)
VPTYSWGENETDVSILNN 0.01% (n=1)
VPTYNWGGNETGVFILNN 0.01% (n=1)
ALTYNWGSNDTDVFILNN 0.01% (n=1)
APTYNWGSNVTDVFILNN 0.01% (n=1)
APTYNWGSNDTGIFILNN 0.01% (n=1)
APTYNWGENDTDALILNN 0.01% (n=1)
APTHNWGASDTDVFVLNN 0.01% (n=1)
VPIYGWGSNDTDVFVLNN 0.01% (n=1)
AATYSWGENDTDVFVLNN 0.01% (n=1)
---YSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGEYDTDVFVLNN 0.01% (n=1)
APTYS*GENDTDVFVLNN 0.01% (n=1)
GPTYSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVSVLNN 0.01% (n=1)
APTYSWGENDTGIFVLNN 0.01% (n=1)
APTCSWGENDTDVFVLNN 0.01% (n=1)
APTYSWGENDTDVYVLNN 0.01% (n=1)
APTYGRGENDTDVFVLNN 0.01% (n=1)
APTYSRGENDTDVFVLNN 0.01% (n=1)
APTHNWGENDTDVFVLNN 0.01% (n=1)
APTYNWGENGTDVLVLNN 0.01% (n=1)
VPTYNWGEDDTDVLVLNN 0.01% (n=1)
APTYNWGANDTDVLLLNN 0.01% (n=1)
APTYNWGDNQTDVFILNN 0.01% (n=1)
APTYKWGANDTDVLLLNN 0.01% (n=1)
APTYNWGANETEVFLLNN 0.01% (n=1)
ALTYNRGANDTDVFVLNN 0.01% (n=1)
VPTHNWGENETDVFVLNN 0.01% (n=1)
APTYNWGENETDIFVLNN 0.01% (n=1)
VPTYDWGSSDVDVFVLNN 0.01% (n=1)
APTYSWGANDTAVFVLNN 0.01% (n=1)
APTYSWGANGTDVFVLND 0.01% (n=1)
APTCSWGATDTDVFVLNN 0.01% (n=1)
APTYSWGVNDTGVFVLNN 0.01% (n=1)
APTYSRGANDTDVFVLNN 0.01% (n=1)
APTYSWGANDTGVFVLNN 0.01% (n=1)
APTYSWGANDTDVFVLNS 0.01% (n=1)
APTYSWGANDTDAFVLNN 0.01% (n=1)
APAYSWGANDTDVFVLNN 0.01% (n=1)
TPTYSWGANDTDVFVLNN 0.01% (n=1)
APTYSWGANDTDVFVLND 0.01% (n=1)
VPTYSWGANDTDFFLLSN 0.01% (n=1)
VPTYNWGENDTDFFLLNN 0.01% (n=1)
VPTYSWGVNDKDVFVLNN 0.01% (n=1)
VPTYNWGGNDTDVFILNN 0.01% (n=1)
VPTYNWGAKKTDVFVLNN 0.01% (n=1)
APTYNWGAHETDVFVLNN 0.01% (n=1)
VPTYNWGTNVTDVFVLNN 0.01% (n=1)
VPTYNWGADKTDVFVLNN 0.01% (n=1)
VPTYNWGANEKDVFVLNN 0.01% (n=1)
VPTYNWGAKQTDVFVLNN 0.01% (n=1)
VPTYNWGARETDVFVLNN 0.01% (n=1)
APTYNWGASETDVFVLNN 0.01% (n=1)
APTYNWGATETDVFVLNN 0.01% (n=1)
VPTYNWGTNETDIFVLNN 0.01% (n=1)
VPTYNWGTNKTDVFVLNN 0.01% (n=1)
APTCSWGANDTDVFVLNN 0.01% (n=1)
APTYNWGDNEADVFLLNN 0.01% (n=1)
APTYSWGANDTDIFVLNN 0.01% (n=1)
APTYNWGVNDTDIFVLNN 0.01% (n=1)
APTYNWGGNATDVFVLNN 0.01% (n=1)
APTHNWGENETDVFVLNN 0.01% (n=1)
VPTYSWGENETDVFVLIN 0.01% (n=1)
APTYNWGEDDTDVFVLNN 0.01% (n=1)
APTYNWGANETDVIVLN- 0.01% (n=1)
APTYSWGENDSDVFVLNN 0.01% (n=1)
APTYSWGENDTDVFVLTN 0.01% (n=1)
APTYNWGGNVTDVLVLNN 0.01% (n=1)
-----------------N 0.01% (n=1)
VPTYRWGKNETDVFVLNN 0.01% (n=1)
EPTYYWGENDTDVFVLNN 0.01% (n=1)
APTYDWGVNDTDVFVLNN 0.01% (n=1)
VPTYSWGSNATDVFVLNN 0.01% (n=1)
SPTYSWGENDTDVFVLNN 0.01% (n=1)
VPTYDWGENDTDVFVLNN 0.01% (n=1)
TPTYSWGENDTDVFVLNN 0.01% (n=1)
VPTYSWGESEADVFVLNN 0.01% (n=1)
APTYSWGENETDVLILNN 0.01% (n=1)
APTYNWGRNDTDVLVLNN 0.01% (n=1)
APTYRWGTNDTDVFVLNN 0.01% (n=1)
VPTYTWGANETDVFVLNN 0.01% (n=1)
SPTYNWGENDTDVFVLNN 0.01% (n=1)
APTYSWGDNDTDVLVLNN 0.01% (n=1)
VPTYNWGANITDVFVLNN 0.01% (n=1)
APTYTWGDNDTDVFILNN 0.01% (n=1)
APTYSWGANDTDVFVPNN 0.01% (n=1)
APTYSWGSDNTDVFVLNN 0.01% (n=1)
IPTYTWGENETDVFILNN 0.01% (n=1)
APTYSWGDNDTDVLILNN 0.01% (n=1)
HPTYNWGANDTDVFVLNN 0.01% (n=1)
APTYNWGSNITDVLVLNN 0.01% (n=1)
VPTYAWGANETDVFVLNN 0.01% (n=1)
APTYNWGETDKDVFVLNN 0.01% (n=1)
VPTYSWGSNDTDVFVLNN 0.01% (n=1)
VPTYRWGVNETDVFVLNN 0.01% (n=1)
APTYNWGANMTDVLVLNN 0.01% (n=1)
APTYTWGENDTDVLVLNN 0.01% (n=1)
APTYNWGENDTDVFVPNN 0.01% (n=1)
APTYTWGGNDTDVFVLNN 0.01% (n=1)
APTYNWGDNDTDVFVFNN 0.01% (n=1)
APTYNWGENDADVFVLNN 0.01% (n=1)
APTYNWGVNETDVFVLNN 0.01% (n=1)
IPTYSWGGNDTDVFVLNN 0.01% (n=1)
APTYNWGENDTDVFLLNN 0.01% (n=1)
APTYNWGANDTDVIILNN 0.01% (n=1)
APTYSWGANNTDVFVLDN 0.01% (n=1)
APTYNWGSNDTDIFVLNN 0.01% (n=1)
APTYNWGDNDTDVLILNN 0.01% (n=1)
APTYSWGENEKDVFVLNN 0.01% (n=1)
VPTYNWGENETDIFVLNN 0.01% (n=1)
APTYNWGSNDTDVFLLNN 0.01% (n=1)
VPTYNWGSNNTDVFVLNN 0.01% (n=1)
VPTYNWGANDTDVSVLNN 0.01% (n=1)
VPTYNWVSNDTDVFVLNN 0.01% (n=1)
APTYSWGSNNTDVFVLNN 0.01% (n=1)
APTYNWGEQDTDVFVLNN 0.01% (n=1)
VPTYNWGENESDVFVLNN 0.01% (n=1)
APTYDWGENETDVFVLNN 0.01% (n=1)
APTYNWGENETDAFVLNN 0.01% (n=1)
APTYRWGENEKDVFVLNN 0.01% (n=1)
APTYNWGSNDTDVFVLNG 0.01% (n=1)
VPTYTWGENESDVFVLNN 0.01% (n=1)
APTYNWGASDTDVFVLNN 0.01% (n=1)
APTYNWGANVTDVLILNN 0.01% (n=1)
APTYNWGSNDTDVFVLYN 0.01% (n=1)
VPTYTWGSSDADVFILNN 0.01% (n=1)
APTYNWGSNETDVLVLNN 0.01% (n=1)
APTYNWGGNDADVLVLNN 0.01% (n=1)
APTHTWGANETDVFILNN 0.01% (n=1)
VPTYSWGENETDVFLLNN 0.01% (n=1)
APTYNWGGGDTDVFVLNN 0.01% (n=1)
APTYRWGENETDVLVLNN 0.01% (n=1)
TPTFSWGENDTDVFVLNN 0.01% (n=1)
GPTYNWGRKDTDVLVLNN 0.01% (n=1)
APTYNWGMNDTDVLVLNN 0.01% (n=1)
APTYDWGANETDVFVLNS 0.01% (n=1)
APTYRWGENETDVFLLNN 0.01% (n=1)
APTYNWGVNDTDVFVLNN 0.01% (n=1)
APTFNWGANDTDVLVLNN 0.01% (n=1)
APAYNWGENDTDVFVPNN 0.01% (n=1)
APAYNWGENDTDVIVLNN 0.01% (n=1)
APSYNWGENDTDVFVLNN 0.01% (n=1)
APAYNWGKNDTDVFVLNN 0.01% (n=1)
APAYNWGENATDVFVLNN 0.01% (n=1)
VPAYNWGENDTDVFVLNN 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 1b:

VPTYSWGENETDVLLLNN 22.09% (n=643)
VPTYSWGGNETDVLLLNN 14.08% (n=410)
APTYSWGENETDVLLLNN 10.24% (n=298)
VPTYRWGENETDVLLLNN 10.20% (n=297)
VPTYTWGENETDVLLLNN 6.80% (n=198)
VPTYNWGENETDVLLLNN 4.19% (n=122)
APTYTWGENETDVLLLNN 3.09% (n=90)
VPTYTWGGNVTDVLLLNN 2.75% (n=80)
APTYNWGENETDVLLLNN 1.82% (n=53)
APTYTWGENETDVL---- 1.41% (n=41)
APTYRWGENETDVLLLNN 1.24% (n=36)
VPTYSWGENETDVLVLNN 1.13% (n=33)
APTYNWGENETDVLILNN 0.96% (n=28)
APTYNWGENQTDVLLLNN 0.62% (n=18)
HPTYNWGENETDVLLLNN 0.58% (n=17)
VPTYTWGENKTDVLLLNN 0.58% (n=17)
APTYTWGENETDVLILNN 0.52% (n=15)
VPTYNWGGNETDVLLLNN 0.48% (n=14)
VPTYSWGKNETDVLVLNN 0.45% (n=13)
VPTYNWGDNETDVLLLNN 0.41% (n=12)
VPTYSWGENETDVMLLNN 0.41% (n=12)
VPTYKWGENETDVLLLNN 0.41% (n=12)
VPTYSWGENKTDVLLLNN 0.41% (n=12)
VPTYSWGANETDVLLLNN 0.34% (n=10)
VPT--------------- 0.34% (n=10)
VPTYSWGGNVTDVLLLNN 0.34% (n=10)
APTYNWGGNETDVLLLNN 0.31% (n=9)
APTYSWGENETDVLILNN 0.31% (n=9)
------GENETDVLLLNN 0.27% (n=8)
APTYNWGANETDVLILNN 0.24% (n=7)
APTFSWGENETDVLLLNN 0.24% (n=7)
APTYRWGENETDVLILNN 0.21% (n=6)
VPTYNWGGNRTDVLLLNN 0.21% (n=6)
APTYNWGNNETDVLLLNN 0.21% (n=6)
APTYNWGDNETDVLLLNN 0.21% (n=6)
VPTYNWGENETDVLLLNS 0.21% (n=6)
VPTYSWGENETDVPLLNN 0.21% (n=6)
VPTYSWGENVTDVLLLNN 0.17% (n=5)
APTYTWGANETDVLLLNN 0.17% (n=5)
VPTYTWGANETDVLLLNN 0.17% (n=5)
APTYNWGDNETDVLILNN 0.17% (n=5)
APTYNWGANETDVLLLNN 0.17% (n=5)
APTYSWGENKTDVLLLNN 0.17% (n=5)
VPTYAWGGNETDVLLLNN 0.17% (n=5)
APTYNWGANETDVLVLNN 0.17% (n=5)
VPTYTWGENETDVL---- 0.17% (n=5)
APTYSWGENETGVLLLNN 0.17% (n=5)
VPTYSWGE---------- 0.14% (n=4)
VPTYDWGENETDVLLLNN 0.14% (n=4)
APTYNWGGNETDVLILNN 0.14% (n=4)
APTYSWGGNETDVLLLNN 0.14% (n=4)
VPTYTWGGNETDVLLLNN 0.14% (n=4)
VPTFSWGENETDVLLLNN 0.14% (n=4)
VPTYNWGENETDVLILNN 0.14% (n=4)
APTYNWGENETDVLILNS 0.14% (n=4)
APTYSWGANETDVLLLNN 0.14% (n=4)
VPTYTWGENETDVLFLNN 0.10% (n=3)
APTYNWGDNDTDVLLLNN 0.10% (n=3)
VPTYSWGENGTDVLLLNN 0.10% (n=3)
APTYNWGVNETDVLILNN 0.10% (n=3)
VPTYNWGANETDVLLLNN 0.10% (n=3)
VPTYGWGENETDVLLLNN 0.10% (n=3)
VPTYTWGENVSDVLLLNN 0.10% (n=3)
APTYNWGENETDVLLLNS 0.07% (n=2)
APTYSWGENETDVLLLNS 0.07% (n=2)
VPTYSWGVNETDVLLLNN 0.07% (n=2)
VPTYNWGENETDVLVLNN 0.07% (n=2)
VPTYSWGENETDMMLLNN 0.07% (n=2)
APTYSWGENETDVMLLNN 0.07% (n=2)
VPTYNWGENETDILLLNN 0.07% (n=2)
APTYNWGENETDVLVLNN 0.07% (n=2)
APTYSWGENETDVLLLSN 0.07% (n=2)
APTYSWGENETDVLLFNN 0.07% (n=2)
VPTYRWGDNETDVLLLNN 0.07% (n=2)
VPTYTWGENETDMLLLNS 0.07% (n=2)
VPTYSWGENDTDVLLLNN 0.07% (n=2)
VPTYSWGGNKTDVLLLNN 0.07% (n=2)
APTYQWGENETDVLILNN 0.07% (n=2)
VPTYNWGGNVTDVLLLNN 0.07% (n=2)
VPTYNWGENETDVLFLNN 0.07% (n=2)
VPTYNWGENEADVLLLNN 0.07% (n=2)
TPTYTWGENETDVLLLNN 0.07% (n=2)
VPTYGWGANETDVLLLNN 0.07% (n=2)
TPTYNWGENKTDVLILNN 0.07% (n=2)
VPTYNWGENQTDVLLLNN 0.07% (n=2)
VPTYRWGANETDVLLLNN 0.07% (n=2)
VPTYNWGENATDVLLLNN 0.07% (n=2)
VPTYTWGENEADVLLLNN 0.07% (n=2)
APTYNWGENATDVLVLNN 0.07% (n=2)
IPTYTWGENETDVLLLNN 0.07% (n=2)
VPTYSWGENETDVLLLNS 0.07% (n=2)
VPTYSWGDNETDVLLLNN 0.07% (n=2)
VPTYTWGDNETDVLLLNN 0.07% (n=2)
APTYTWGGNETDVLLLNN 0.07% (n=2)
TPTYTWGENKTDVLLLNN 0.07% (n=2)
VPTYNWGENVTDVLLLNN 0.07% (n=2)
VPTYSWGENATDVLLLNN 0.07% (n=2)
APTYTWGESETDVL---- 0.07% (n=2)
APTFNWGENETDVLILNN 0.07% (n=2)
VPTYTWGGNKSDVLLLNN 0.07% (n=2)
APTYRWGANETDVLLLNN 0.07% (n=2)
------GESETDVLPLNN 0.07% (n=2)
TPTYNWGENETDVLFLTN 0.07% (n=2)
APTSVRGENGTDVLLLNN 0.03% (n=1)
VRTYNWGENETDVLLLNN 0.03% (n=1)
APTYNWGANETDVLYLNN 0.03% (n=1)
NPTYSWGENDTDVLLLNN 0.03% (n=1)
APTYKWGENETDVLILNN 0.03% (n=1)
VPTYNWGVNESDVLLLNN 0.03% (n=1)
VPTYNWGENETDVLYLNN 0.03% (n=1)
VRT--------------- 0.03% (n=1)
TPTYSWGENETDVLLLNN 0.03% (n=1)
ARKYSWGENETDVLLLNN 0.03% (n=1)
ASTYSWGENETDVLLLNN 0.03% (n=1)
APTYSWGENETNVLLLNN 0.03% (n=1)
APTYNWGENKTDVLLLNN 0.03% (n=1)
APTYTWGENETDVMILNN 0.03% (n=1)
TPTYRWGENETDVLILNS 0.03% (n=1)
APTYSWRENETDVLLLNN 0.03% (n=1)
PPTYSWGENETDVLLLNN 0.03% (n=1)
APTYTWGVNETDVLILNN 0.03% (n=1)
APTYSWGANETDVLILNN 0.03% (n=1)
VPTYTWGENETNVLLLNN 0.03% (n=1)
VPTYRWGENETDVLLLKN 0.03% (n=1)
VPTYRWGENETDVLLPKK 0.03% (n=1)
VPTYRWGEKETDVLLLNN 0.03% (n=1)
VSTYTWGENETDVLLLNN 0.03% (n=1)
VPTYSWGENKTDVLLLKK 0.03% (n=1)
VPTYRWGEIETDVLLLNN 0.03% (n=1)
VPTYSWGGNETDVLLLKN 0.03% (n=1)
VPTYSGRGIETDVRFLKN 0.03% (n=1)
VPTYMWGEYETDVLSLKN 0.03% (n=1)
VPTYSWGGNETDMLFLKN 0.03% (n=1)
VPTYSWGGIKPDVLLLKK 0.03% (n=1)
VPTYSWGGNETDVLRLKK 0.03% (n=1)
VPTYSWGGNRTDVLLLNN 0.03% (n=1)
VPTYSWGENETCVLLLNN 0.03% (n=1)
APTYTWGENVTDVLILNN 0.03% (n=1)
VPTYTWGGNKTDVLLLNN 0.03% (n=1)
VPTFTWGEKETDVLLLNN 0.03% (n=1)
NPTYTWGGNETDVLLLNN 0.03% (n=1)
DPTYNWGENETDVLLLNN 0.03% (n=1)
VPTYNWGENGSDVLLLNN 0.03% (n=1)
VPTHNWGGNASDVLLLNN 0.03% (n=1)
APTYSWGVNETDVLLLNN 0.03% (n=1)
APTYNWGENVTDVLILNN 0.03% (n=1)
APTFTWGENVTDVLLLNN 0.03% (n=1)
VPTYDWGGNETDVLLLNN 0.03% (n=1)
VPTYRWGGNETDVLLLNN 0.03% (n=1)
APTYTWGENETDVLILNS 0.03% (n=1)
NPTYNWGENKTDVLLLNN 0.03% (n=1)
DPTYNWGGNETDVLLLNN 0.03% (n=1)
APTYRWGANESDVLILNN 0.03% (n=1)
APTYNWGENETDVLLLDN 0.03% (n=1)
VPTYRWGENETDVLLLNS 0.03% (n=1)
APTYAWGGNETDVLLLNN 0.03% (n=1)
NPTYTWGENATDVLLLNN 0.03% (n=1)
VPTCTWGENETDVLLLNN 0.03% (n=1)
VPTYTWEENETDVLLLNN 0.03% (n=1)
APTYSWGENGTDVLLLNN 0.03% (n=1)
APTYSWGANETDVLILNS 0.03% (n=1)
TPTYNWGGNETDVLLLNN 0.03% (n=1)
VPTYSWGGNTSDVLLLNN 0.03% (n=1)
APTYTWGENKTDVLLLNN 0.03% (n=1)
VPTYSWGGNKSDVLLLNN 0.03% (n=1)
VPTYNWGANETDVLVLNN 0.03% (n=1)
------------VLFLNN 0.03% (n=1)
TATFNWGGNETDVLLLNN 0.03% (n=1)
VPTYNWGENKSDVLLLNN 0.03% (n=1)
VPTYAWGANETDVLLLNN 0.03% (n=1)
APTYTWGTNESDVLLLNN 0.03% (n=1)
VPTYSWGENEADVLLLNN 0.03% (n=1)
VPSYRWGENETDVLLLNN 0.03% (n=1)
APTYTWGANETDVLYLNN 0.03% (n=1)
VPTYSWGENETDVLILNN 0.03% (n=1)
APTYKWGENETDVLLLNN 0.03% (n=1)
VPTYNWGVNETDVLLLNN 0.03% (n=1)
VPTYRWGENETDVLLPNN 0.03% (n=1)
VPTYRWGENGTDVLLLNN 0.03% (n=1)
RRSYILGENETDVLLLNN 0.03% (n=1)
VPTYSWGENETNVLLLNN 0.03% (n=1)
VPTYRWGENETDVLLFNN 0.03% (n=1)
VPTYSWGENETDVLLPNN 0.03% (n=1)
APTYNWGVNETDVLLLNN 0.03% (n=1)
VPTYTWGGNASDVLLLNN 0.03% (n=1)
VPTYSWGGNATDVLLLNN 0.03% (n=1)
VPTYSWGENKSDVLLLNN 0.03% (n=1)
LPTYNWGENETDVLLLNN 0.03% (n=1)
APTYRWGENESDVLILNN 0.03% (n=1)
VPTYNWGANQTDVLLLNN 0.03% (n=1)
IPTYSWGENETDVLLLNN 0.03% (n=1)
APTYHWGENKTDVLLLNN 0.03% (n=1)
APTYTWGENDTDVLVLNN 0.03% (n=1)
VPTYRWGENSSDVLLLNN 0.03% (n=1)
VPTYSWGANKTDVLLLNN 0.03% (n=1)
VPTYSWGENETDVLFLNN 0.03% (n=1)
APTYTWGENATDVLLLNN 0.03% (n=1)
VPTYSWGGNKTDVLLLTN 0.03% (n=1)
NPTYRWGENKTDVLLLNN 0.03% (n=1)
APTYTWGENETDVMILNS 0.03% (n=1)
VPTYSWGESETDVLLLNN 0.03% (n=1)
VPTYRWGENKTDVLLLNN 0.03% (n=1)
DPTYTWGGNETDVLLLNN 0.03% (n=1)
VPTYTWGENETDVLVLNN 0.03% (n=1)
VPTYTWGENQTDVLLLNN 0.03% (n=1)
TPTYTWGENGTDVLLLNN 0.03% (n=1)
VPTYNWGANETDVLYLNN 0.03% (n=1)
VPTYTWGTNETDVLFLNN 0.03% (n=1)
APTYSWGENKTDVLILNN 0.03% (n=1)
APTYRWGANETDVLILNN 0.03% (n=1)
VPTYTWGVNETDVLLLNN 0.03% (n=1)
APTYSWGGNETDVLILNN 0.03% (n=1)
APTYGWGENETDVLLLNN 0.03% (n=1)
VPTYSWGENETDVLHLNN 0.03% (n=1)
VPTYSWGEDETDVLLLNN 0.03% (n=1)
APTYSRGENEADVLLLNN 0.03% (n=1)
APTYSWGENETDALLLNN 0.03% (n=1)
VPTYQWGENKTDVLLLNN 0.03% (n=1)
VPTYQWGENETDVLLLNN 0.03% (n=1)
VPTYGWGGNETDVLLLNN 0.03% (n=1)
VPTYSWGENQTDVLLLNN 0.03% (n=1)
VPTYTWGENETGVLLLNN 0.03% (n=1)
VPTYSWGRNETDVLVLNN 0.03% (n=1)
VPTYSWGKNETDVLVLDN 0.03% (n=1)
VPTYSWGKNETDMLVLNN 0.03% (n=1)
VPTHTWGENETDVLLLNN 0.03% (n=1)
APTYNWGENETDVL-LNN 0.03% (n=1)
VPTYSWGENETDALVLNN 0.03% (n=1)
APTHTWGENETDVL---- 0.03% (n=1)
VPTYSWGENESDVLLLNN 0.03% (n=1)
VPTYSWGENETDVLPLNN 0.03% (n=1)
APTYTWGENGTDVLLLNN 0.03% (n=1)
APTYTWGRNETDVLLLNN 0.03% (n=1)
APTYTWGESETDVLLLNN 0.03% (n=1)
APTYRRGGNETDVLLLNN 0.03% (n=1)
APTFTWGENETDVLLLNN 0.03% (n=1)
VPTYNWGGNATDVLLLNN 0.03% (n=1)
TPTFSWGENETDVLLLNN 0.03% (n=1)
VPTFSWGENDTDVLLLNN 0.03% (n=1)
TPTYSWGENVTDVLLLNN 0.03% (n=1)
TPTFSWGENQTDVLLLNN 0.03% (n=1)
APTFSWGEKETDVLLLNN 0.03% (n=1)
APTYAWGENETDVLLLNN 0.03% (n=1)
VPTYQWGENESDVLLLNN 0.03% (n=1)
APTYSWGENETDVLLQNN 0.03% (n=1)
------GENEIDVLLLNN 0.03% (n=1)
------GENESDVLLLNN 0.03% (n=1)
------GENEIDVLILNN 0.03% (n=1)
------GENETDVLILNN 0.03% (n=1)
VPTYRWGENETDALLLNN 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 2:

VPTYTWGENETDVFLLNS 20.87% (n=110)
VPTYSWGENETDVFLLNS 18.98% (n=100)
APTYSWGENETDVFLLNS 14.04% (n=74)
VPTYNWGDNETDVFLLNS 13.47% (n=71)
VPTYNWGENETDVFLLNS 4.55% (n=24)
APTYTWGENETDVFLLNS 4.17% (n=22)
APTYNWGENETDVFLLNS 1.71% (n=9)
VPTYTWGENDTDVFLLNS 1.33% (n=7)
VPTYSWGENETDVFVLNS 1.33% (n=7)
APTYGWGENETDVFLLNS 1.14% (n=6)
VPTYGWGENETDVFLLNS 1.14% (n=6)
VPTYTWGENETDVFILNS 0.95% (n=5)
VPTYSWGANETDVFLLNS 0.76% (n=4)
APTYRWGENETDVFLLNS 0.76% (n=4)
VPT--------------- 0.38% (n=2)
VPTYRWGENETDVFLLNS 0.38% (n=2)
APPRTGEGNETDVFLLNS 0.38% (n=2)
VPTYTWGENETDVFLLNT 0.38% (n=2)
VPTYTWGENETDVFVLNS 0.38% (n=2)
VPTYTWGENETDFFLLNS 0.38% (n=2)
VPTYTWGENESDVFLLNS 0.38% (n=2)
VPTYSWGENQTDVFLLNS 0.38% (n=2)
VPTYTWGDNETDVFLLNS 0.38% (n=2)
LPTYTWGENETDVFLLNS 0.38% (n=2)
VPTYTWGANETDVFLLNS 0.38% (n=2)
APTYSWGENETDVFVLNS 0.38% (n=2)
VPTYSWGVNETDVFLLNS 0.38% (n=2)
VPTYKWGENETDVFLLNS 0.38% (n=2)
APTYTWGENDTNVFLLNS 0.19% (n=1)
VPTYTWGGNETDVFLLNS 0.19% (n=1)
APTRMWEGNETDVFLLNS 0.19% (n=1)
APTRMGEGNETDVFLLNS 0.19% (n=1)
APPHTGEGNETDVFLLNS 0.19% (n=1)
APTYTWGENETDFFLLKS 0.19% (n=1)
VPTYTWGANETDFLILGS 0.19% (n=1)
VPTYTWGENESDVFILNS 0.19% (n=1)
VPTYTWGVNETDVFLLNS 0.19% (n=1)
VPTYNWGENETDVFMLNS 0.19% (n=1)
VPTYRWGERETDVFLLNS 0.19% (n=1)
APTYRWGENETDVFILNS 0.19% (n=1)
VPTYSWGENETDVFLLNG 0.19% (n=1)
APTCPWRRNDTDVFVLNS 0.19% (n=1)
APTYSWGANETDVFLLNS 0.19% (n=1)
VPTHTWGENETDVFLLNS 0.19% (n=1)
IPTYSWGENETDVFILNS 0.19% (n=1)
VPTYAWGENETDVFLLNS 0.19% (n=1)
IPTYTWGDNETDVFLLNS 0.19% (n=1)
TPTYTWGENETDVFLLNS 0.19% (n=1)
VPTYSWGENETDVFLINS 0.19% (n=1)
APTYMWGENETDVFLLNS 0.19% (n=1)
VPTYNWGGNDTDVFLLNS 0.19% (n=1)
VPTYNWGDNGTDVFLLNS 0.19% (n=1)
VPTYNWGENETDVSLLNS 0.19% (n=1)
VPTYNWGENETDVFLLSS 0.19% (n=1)
VPTYNWGENETDVLLLNS 0.19% (n=1)
VPTYSWGENESDVFLLNS 0.19% (n=1)
VPTYSWGENDTDVFLLNS 0.19% (n=1)
VPTYNWGENDTDVFLLNS 0.19% (n=1)
LPTYSWGENETDVFLLNS 0.19% (n=1)
VPTYDWGQNETDVFLLNS 0.19% (n=1)
VATYTWGANDTDVFLLNS 0.19% (n=1)
TPTYTWGENKTDVFLLNS 0.19% (n=1)
VPTYSWGENETDLFLLNS 0.19% (n=1)
MPTYTWGENDTDFFLLNS 0.19% (n=1)
VPTYSWGDNETDVFLLNS 0.19% (n=1)
MPTYNWGESEKDVFVLNS 0.19% (n=1)
APTYNWGENETDVLLLNS 0.19% (n=1)
VPTYNWGENETDVFVLNS 0.19% (n=1)
VPTYTWGGNDTDVFLLNS 0.19% (n=1)
VPTYTWEENETDVFLLNS 0.19% (n=1)
QPTYTWGGNVKDVFLLNS 0.19% (n=1)
APTYTWGANETDVFLLNS 0.19% (n=1)
APTYTWGENETDVFVLNS 0.19% (n=1)
VPTYSWGGGDKDVFLLNS 0.19% (n=1)
APTYTWGENETDVFILNS 0.19% (n=1)
VPAYTWGENETDVFLLNS 0.19% (n=1)
VPTYNWGANETDVFLLNS 0.19% (n=1)
VPTYSWGENETDVFLLNN 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 2a:

VPTYTWGENETDVFLLNS 57.14% (n=44)
APTYTWGENETDVFLLNS 12.99% (n=10)
VPTYTWGENETDVFILNS 3.90% (n=3)
VPT--------------- 2.60% (n=2)
APPRTGEGNETDVFLLNS 2.60% (n=2)
VPTYTWGENETDVFLLNT 2.60% (n=2)
APTYTWGENDTNVFLLNS 1.30% (n=1)
VPTYRWGENETDVFLLNS 1.30% (n=1)
VPTYTWGGNETDVFLLNS 1.30% (n=1)
VPTYSWGENETDVFLLNS 1.30% (n=1)
APTRMWEGNETDVFLLNS 1.30% (n=1)
APTRMGEGNETDVFLLNS 1.30% (n=1)
APPHTGEGNETDVFLLNS 1.30% (n=1)
APTYTWGENETDFFLLKS 1.30% (n=1)
VPTYTWGANETDFLILGS 1.30% (n=1)
VPTYTWGENETDVFVLNS 1.30% (n=1)
VPTYTWGENESDVFILNS 1.30% (n=1)
VPTYTWGENETDFFLLNS 1.30% (n=1)
VPTYTWGENDTDVFLLNS 1.30% (n=1)
VPTYTWGENESDVFLLNS 1.30% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 2b:

VPTYSWGENETDVFLLNS 24.86% (n=87)
APTYSWGENETDVFLLNS 21.14% (n=74)
VPTYNWGDNETDVFLLNS 20.29% (n=71)
VPTYTWGENETDVFLLNS 9.14% (n=32)
VPTYNWGENETDVFLLNS 3.71% (n=13)
VPTYSWGENETDVFVLNS 2.00% (n=7)
APTYGWGENETDVFLLNS 1.71% (n=6)
APTYNWGENETDVFLLNS 1.14% (n=4)
VPTYSWGANETDVFLLNS 1.14% (n=4)
APTYRWGENETDVFLLNS 1.14% (n=4)
VPTYTWGENDTDVFLLNS 1.14% (n=4)
APTYTWGENETDVFLLNS 0.57% (n=2)
VPTYSWGENQTDVFLLNS 0.57% (n=2)
VPTYTWGENETDVFILNS 0.57% (n=2)
LPTYTWGENETDVFLLNS 0.57% (n=2)
APTYSWGENETDVFVLNS 0.57% (n=2)
VPTYTWGVNETDVFLLNS 0.29% (n=1)
VPTYNWGENETDVFMLNS 0.29% (n=1)
VPTYRWGERETDVFLLNS 0.29% (n=1)
APTYRWGENETDVFILNS 0.29% (n=1)
VPTYSWGENETDVFLLNG 0.29% (n=1)
APTCPWRRNDTDVFVLNS 0.29% (n=1)
APTYSWGANETDVFLLNS 0.29% (n=1)
VPTHTWGENETDVFLLNS 0.29% (n=1)
IPTYSWGENETDVFILNS 0.29% (n=1)
VPTYTWGDNETDVFLLNS 0.29% (n=1)
VPTYAWGENETDVFLLNS 0.29% (n=1)
IPTYTWGDNETDVFLLNS 0.29% (n=1)
TPTYTWGENETDVFLLNS 0.29% (n=1)
VPTYTWGANETDVFLLNS 0.29% (n=1)
VPTYSWGENETDVFLINS 0.29% (n=1)
VPTYTWGENETDVFVLNS 0.29% (n=1)
APTYMWGENETDVFLLNS 0.29% (n=1)
VPTYNWGGNDTDVFLLNS 0.29% (n=1)
VPTYNWGDNGTDVFLLNS 0.29% (n=1)
VPTYNWGENETDVSLLNS 0.29% (n=1)
VPTYNWGENETDVFLLSS 0.29% (n=1)
VPTYNWGENETDVLLLNS 0.29% (n=1)
VPTYRWGENETDVFLLNS 0.29% (n=1)
VPTYSWGENESDVFLLNS 0.29% (n=1)
VPTYSWGENDTDVFLLNS 0.29% (n=1)
VPTYNWGENDTDVFLLNS 0.29% (n=1)
LPTYSWGENETDVFLLNS 0.29% (n=1)
VPTYDWGQNETDVFLLNS 0.29% (n=1)
VATYTWGANDTDVFLLNS 0.29% (n=1)
VPTYSWGVNETDVFLLNS 0.29% (n=1)
TPTYTWGENKTDVFLLNS 0.29% (n=1)
VPTYSWGENETDLFLLNS 0.29% (n=1)
MPTYTWGENDTDFFLLNS 0.29% (n=1)
VPTYSWGDNETDVFLLNS 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 2c:

VPTYTWGENETDVFLLNS 36.67% (n=22)
VPTYNWGENETDVFLLNS 13.33% (n=8)
VPTYSWGENETDVFLLNS 11.67% (n=7)
VPTYGWGENETDVFLLNS 10.00% (n=6)
APTYTWGENETDVFLLNS 8.33% (n=5)
APTYNWGENETDVFLLNS 6.67% (n=4)
MPTYNWGESEKDVFVLNS 1.67% (n=1)
APTYNWGENETDVLLLNS 1.67% (n=1)
VPTYTWGANETDVFLLNS 1.67% (n=1)
VPTYNWGENETDVFVLNS 1.67% (n=1)
VPTYTWGGNDTDVFLLNS 1.67% (n=1)
VPTYTWEENETDVFLLNS 1.67% (n=1)
QPTYTWGGNVKDVFLLNS 1.67% (n=1)
APTYTWGANETDVFLLNS 1.67% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 3:

APTYTWGANETDVFLLRS 11.44% (n=314)
VPTYTWGENKTDVFLLES 6.12% (n=168)
VPTYNWGENETDVFLLES 3.86% (n=106)
APTYTWGENETDVFLLES 3.57% (n=98)
VPTYNWGANETDVFLLKS 3.13% (n=86)
VPTYNWGANETDVFLLES 2.84% (n=78)
LPTYNFGANETDVFLLTS 2.84% (n=78)
APTYTWGENETDVFLLKS 2.81% (n=77)
VPTYTWGENESDVFLLES 2.51% (n=69)
VPTYNWGENETDVFLLKS 2.48% (n=68)
VPTYTWGENETDVFLLES 2.22% (n=61)
VPTYNWGENESDVFLLKS 2.22% (n=61)
APTYTWGANETDVFLLES 1.90% (n=52)
APTYNWGENETDVFLLKS 1.86% (n=51)
VPTYTWGENETDVFLLKS 1.38% (n=38)
LPTYNFGENETDVFLLTS 1.31% (n=36)
APTYNWGANESDVFLLES 1.28% (n=35)
VPTYTWGENDTDVFLLKS 1.09% (n=30)
SPTYNFGENETDVFLLTS 1.06% (n=29)
VPTYNWGENKSDVFLLKS 1.02% (n=28)
APTYTWGANKTDVFLLDS 0.95% (n=26)
LPTYNFGANESDVFLLTS 0.95% (n=26)
IPTYNWGANETDAFLLES 0.91% (n=25)
APTYNWGANVTDVFLLKS 0.87% (n=24)
LPTYNFGENETDVFLLNS 0.87% (n=24)
APTYNWGENETDVFLLES 0.84% (n=23)
VPTYTWGANETDVFLLES 0.77% (n=21)
TPTYDWGENETDVFLLGS 0.77% (n=21)
VPTYNWGENETDVFLLGS 0.77% (n=21)
EPTYTWGENETDVFLLKS 0.73% (n=20)
VPTYTWGANETDVFLLNS 0.69% (n=19)
VPTYTWGANETDVFLLQS 0.66% (n=18)
VPTYNWGENESDVFLLES 0.58% (n=16)
VPTYAWGENETDVFLLES 0.55% (n=15)
LPTYNFGENETDVFLLKS 0.55% (n=15)
VPTYSWGENETDVFLLKS 0.51% (n=14)
--TYTWGANETDVFLLKS 0.47% (n=13)
APTFNWGENKTDVFLLKS 0.44% (n=12)
APTYTWGENESDVFLLES 0.44% (n=12)
VPTYNWGANESDVFLLKS 0.44% (n=12)
APTFTWGENETDVFLLES 0.40% (n=11)
APTYSWGANESDVFLLES 0.40% (n=11)
VPTYNWGENKSDVFLLES 0.36% (n=10)
APTYNWGANESDVFLLKS 0.36% (n=10)
APTFTWGENKTDVFLLES 0.33% (n=9)
LPTYNFGENKTDVFLLTS 0.33% (n=9)
APTYTWGANETDVFLLKS 0.29% (n=8)
TPTYTWGENETDVFLLES 0.29% (n=8)
APTYSWGENETDVFLLES 0.29% (n=8)
VPTYTWGANETDVFLLKS 0.29% (n=8)
LPTYSFGENETDVFLLTS 0.29% (n=8)
VPTYTWGENETDVFLLTS 0.26% (n=7)
APTFNWGGNKTDVFLLKS 0.26% (n=7)
VPTYYWGENKTDVFLLES 0.22% (n=6)
APTYTWGENATDVFLLKS 0.22% (n=6)
APTYNWGANETDVFLLES 0.22% (n=6)
APTYSWGENETDVFLLTS 0.22% (n=6)
APTYTWGANESDVFLLES 0.22% (n=6)
SPTYNFGENETDVFLLNS 0.22% (n=6)
VPTYTWGGNETDVFLLKS 0.18% (n=5)
VPTYSWGANETDVFLLKS 0.18% (n=5)
VPTYTWGENETDVFLLNS 0.18% (n=5)
APTYTWGANETDVFLLGS 0.18% (n=5)
VPTYTWGENETDVFLLRS 0.18% (n=5)
APTYNWGENESDVFLLES 0.18% (n=5)
APTYTWGENETDVFLLQS 0.18% (n=5)
TPTYTWGANKTDVFLLES 0.18% (n=5)
LPTYTFGENETDVFLLKS 0.18% (n=5)
VPTYTWGGNKTDVFLLKS 0.15% (n=4)
APTYGWGANESDVFLLKS 0.15% (n=4)
APTYNWGANETDVFLLKS 0.15% (n=4)
MPTYTWGENESDVFLLES 0.15% (n=4)
VPTYNWGENESDVFLLTS 0.15% (n=4)
APTYTWGENESDVFLLQS 0.15% (n=4)
APTYSWGANETDVFLLES 0.15% (n=4)
APTYTWGANETDVFLLTS 0.15% (n=4)
VPTYTWGENETDVFLLDS 0.15% (n=4)
VPTYDWGENETDVFLLAS 0.15% (n=4)
APTYNFGENETDVFLLTS 0.15% (n=4)
LPTYSFGENETDVFLLDS 0.15% (n=4)
LPTYTFGENETDVFLLTS 0.15% (n=4)
VPTYTWGTNETDVFLLKS 0.11% (n=3)
APTYTWGGNETDVFLLES 0.11% (n=3)
VPTFTWGENETDVFLLES 0.11% (n=3)
APTYTWGENETDVFLLTS 0.11% (n=3)
VPTYTWGANKTDVFLLNS 0.11% (n=3)
APTYNWGANESDVFLLTS 0.11% (n=3)
APTYSWGENETDVFLLKS 0.11% (n=3)
VPTYNWGGNETDVFLLKS 0.11% (n=3)
APTYSWGAKESDVFLLES 0.11% (n=3)
APTYTWGGNETDVFLLKS 0.11% (n=3)
APTYTWGANETDVFLLDS 0.11% (n=3)
APTYTWGENETDVFLLNS 0.11% (n=3)
APTYNWGENETDVFLLTS 0.11% (n=3)
VPTYTWGANESDVFLLKS 0.11% (n=3)
LPTYNFGGNESDVFLLTS 0.11% (n=3)
SPTYNFGDNETDVFLLNS 0.11% (n=3)
LPTYNFGENETDVFLLDS 0.11% (n=3)
LPTYSFGENETDVFLLNS 0.11% (n=3)
LPTYNFGENETDVFLLSS 0.11% (n=3)
LPTYTFGENETDVFLLNS 0.11% (n=3)
LPTYSFGENESDVFLLTS 0.11% (n=3)
APTYNWGANKTDVFLLES 0.07% (n=2)
TPTYTWGANDTDVFLLQS 0.07% (n=2)
VPTYTWGENETDVFLLQS 0.07% (n=2)
VPTYTWGANETDVFLLDS 0.07% (n=2)
VPTYTWGENEKDVFLLKS 0.07% (n=2)
APTYTWGENESDVFLLNS 0.07% (n=2)
LPTYNWGENETDVFLLKS 0.07% (n=2)
APTYFWGANESDVFLLES 0.07% (n=2)
APTYSWGANKSDVFLLES 0.07% (n=2)
APTFTWGENVTDVFLLKS 0.07% (n=2)
APTYNWGENETDVFLLNP 0.07% (n=2)
VPTYTWGGNVTDVFLLES 0.07% (n=2)
VPTYTWGENEADVFLLNS 0.07% (n=2)
VPTYTRGENETDVFLLTS 0.07% (n=2)
APTYTWGANETDVFLLQS 0.07% (n=2)
TPTYTWGANETDVFLLKS 0.07% (n=2)
VPTYNWGANEADVFLLKS 0.07% (n=2)
APTYTWGVNETDVFLLES 0.07% (n=2)
APTYNWGANETDVFMLES 0.07% (n=2)
VPIYTWGENDTDVFLLKS 0.07% (n=2)
SPTYTWGANETDVFLLRS 0.07% (n=2)
APTYKWGENETDVFLLKS 0.07% (n=2)
TPTYTWGGNKTDVFLLES 0.07% (n=2)
VPTYTWGGNETDVFLLES 0.07% (n=2)
APTYNWGENETDVFLLQS 0.07% (n=2)
APTYSWGANETDVFLLKS 0.07% (n=2)
VPTYTWGANKTDVFLLES 0.07% (n=2)
VPTYRWGENETDVFLLKS 0.07% (n=2)
VPTYTWGENDTDVFLLES 0.07% (n=2)
APTYDWGENETDVFLLES 0.07% (n=2)
APTYTWGENKTDVFLLKS 0.07% (n=2)
--TYNWGENESDVFLLES 0.07% (n=2)
APTYNWGENESDVFLLKS 0.07% (n=2)
TPTYTWGANETDVFLLES 0.07% (n=2)
NPTYTWGENKTDVFLLES 0.07% (n=2)
APTYTWGTNETDVFLLRS 0.07% (n=2)
VPTYNWGENETDVFLLTS 0.07% (n=2)
APTYTWGENETDVFLLDS 0.07% (n=2)
APTYNWGENETDVFLLNS 0.07% (n=2)
APTYNWGGNETDVFLLRS 0.07% (n=2)
APTYNWGANETDVFLLDS 0.07% (n=2)
APTYTWGTNETDVFLLKS 0.07% (n=2)
APTYTWGENETDVFLLGS 0.07% (n=2)
VPTYNWGENKTDVFLLES 0.07% (n=2)
VPTYTWGANKTDVFLLKS 0.07% (n=2)
TPTYTWGENETDVFLLKS 0.07% (n=2)
APTFTWGANKTDVFLLES 0.07% (n=2)
DPTYNWGENETDVFLLKS 0.07% (n=2)
TPTYTWGENKTDVFLLES 0.07% (n=2)
VPTYTWGENESDVFLLKS 0.07% (n=2)
VPTYTWGANDTDVFLLTS 0.07% (n=2)
APTYTWGENATDVFLLES 0.07% (n=2)
APTYTWGTNETDVFLLDS 0.07% (n=2)
VPTYNWGANVSDVFLLKS 0.07% (n=2)
SPTYTFGENETDVFLLNS 0.07% (n=2)
LPTYNFGENETDVFLLES 0.07% (n=2)
LPTYNFGENDTDVFLLNS 0.07% (n=2)
LPTYNFGENETDVFLLPS 0.07% (n=2)
VPTYTFGENETDVVLLTS 0.07% (n=2)
VPTYTWGANDTDVFLLES 0.04% (n=1)
VPTYTWGENESDVFLLDS 0.04% (n=1)
VPTYTWGGNATDVFLLES 0.04% (n=1)
APTYTWGENASDVFLLES 0.04% (n=1)
TPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYTWGENETDVFLLE- 0.04% (n=1)
VPTYSFGTNETDVFLLES 0.04% (n=1)
APTYTWGTNETDVFLLES 0.04% (n=1)
APTYTWGENVRDVFLLES 0.04% (n=1)
VPTYTWDANETDVFLLNS 0.04% (n=1)
APTYTWGANKTDVFLLES 0.04% (n=1)
APTYNWGANETDMFLLQS 0.04% (n=1)
GPTYNWGGDETDVFLLKS 0.04% (n=1)
ASTYNWGADETDVFLLKS 0.04% (n=1)
ASTYNWGGDETDVFLLKS 0.04% (n=1)
GSTYNWGGNETDVFLLKS 0.04% (n=1)
VPTFGWGGNKSDVFLLKS 0.04% (n=1)
VPRYNWGENATDVFLLQS 0.04% (n=1)
NPTYTWGENETDVFLLQS 0.04% (n=1)
IPTYSFGENETDCFLLES 0.04% (n=1)
APTYTWGANTSDVFLLES 0.04% (n=1)
VPTYTWGGNESDVFLLES 0.04% (n=1)
APTYNWGADVTDVFLLKS 0.04% (n=1)
APTYNWSANVTDVFLLKS 0.04% (n=1)
APTYTWGEDGTDVFLLES 0.04% (n=1)
TPTYDWGENETDVFPLGS 0.04% (n=1)
TPTYDWGENEADVFLLGS 0.04% (n=1)
TPTYDWSENETDVFLLGS 0.04% (n=1)
TPTYDWGENETDVFLLES 0.04% (n=1)
-PTYDWGENETDVFLLGS 0.04% (n=1)
TSTYDWGENETDVFLLGS 0.04% (n=1)
IPTHNWGANETDAFLLES 0.04% (n=1)
APTCTWGANETDVFLLES 0.04% (n=1)
VPTYYWGENETDVFLLES 0.04% (n=1)
VPTYNWGENKSDVLLLES 0.04% (n=1)
VPTYYWGENKTDMFLLES 0.04% (n=1)
VPTYCWGENKSDVFLLES 0.04% (n=1)
VPTYNFGENKTDVFLLES 0.04% (n=1)
APTYSWGASESDVFLLES 0.04% (n=1)
APTYSWGENETDVFLLRS 0.04% (n=1)
APTYTWGENEADVFLLKS 0.04% (n=1)
APTYTWGENETDAFLLKS 0.04% (n=1)
APTYTWGENETDMFLLKS 0.04% (n=1)
APTFTWGENETGVFLLES 0.04% (n=1)
VPTYNWGESESDVFLLKS 0.04% (n=1)
TPTYTWGENETDMFLLES 0.04% (n=1)
VPTYTWGENVTDVFLLES 0.04% (n=1)
VPTYPWGANKTEGFLLNS 0.04% (n=1)
VPTYSWGENEKDVFLLKS 0.04% (n=1)
RPTYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGENETDGFLLES 0.04% (n=1)
APTYTWGANETDMFLLGS 0.04% (n=1)
APTYTWSENETDVFLLES 0.04% (n=1)
APTYSWSENETDVFLLES 0.04% (n=1)
VPTYTLSENETDVFLLTS 0.04% (n=1)
VPTYTLGENETDVFLLTS 0.04% (n=1)
APTYRLGENETNVFLLTS 0.04% (n=1)
VPTYRLGENETDVFLLTS 0.04% (n=1)
APTYRLGENETDVFLLTS 0.04% (n=1)
TPTYTWGANKTDVFLLKS 0.04% (n=1)
TPTYTKSSNETEVVVVLS 0.04% (n=1)
APTYTWGANETEVFLLQS 0.04% (n=1)
APTYCSNDNESDVFDVNS 0.04% (n=1)
TPTYTWGANKTDVFLVQS 0.04% (n=1)
EPTYTWGENETDVFLLHS 0.04% (n=1)
EPTYNWGGNETDVFLLQS 0.04% (n=1)
QPTYNWGENATDVFLLES 0.04% (n=1)
TPTYSWGENETDVFLLES 0.04% (n=1)
VPTYNRGANETDVFLLKS 0.04% (n=1)
VPTYNWGANGTDVFLLKS 0.04% (n=1)
TPTYTWGANESDVFLLQS 0.04% (n=1)
LPTYNWGENETDVFLLES 0.04% (n=1)
TPTYNWGENETDVFLLQS 0.04% (n=1)
RPTYNWGANETDVFLLES 0.04% (n=1)
APTYTWGEKETDVFLLES 0.04% (n=1)
VPTYTWGDNESDVFLLKS 0.04% (n=1)
VPTYNWGENVTDVFLLES 0.04% (n=1)
APTYAWGENETDVFLLKS 0.04% (n=1)
APTYDWGENESDVFLLTS 0.04% (n=1)
VPTYNWGSNDTDVFLLES 0.04% (n=1)
EPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYDWGANKSDVFLLKS 0.04% (n=1)
APTYNWGANESDVFLLAS 0.04% (n=1)
VPTYSWGENESDVFLLKS 0.04% (n=1)
VPTYNWGENESDVFLLAS 0.04% (n=1)
VPTYTWGGNATDVFLLQS 0.04% (n=1)
VPTYTFGANESDVFLLES 0.04% (n=1)
VPTYNWGANVTDVFLLTS 0.04% (n=1)
EPTYNWGANETDVFLLKS 0.04% (n=1)
APTFNWGENETDVFLLES 0.04% (n=1)
NPTFNWGENETDVFLLAS 0.04% (n=1)
MPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYNWGENETDVFLLQS 0.04% (n=1)
VPTYNWGANKTDVFLLKS 0.04% (n=1)
VPTYNWGMNETDVFLLES 0.04% (n=1)
VPTYNWGGNDTDVFLLKS 0.04% (n=1)
APTFNWGENETDVFLLTS 0.04% (n=1)
EPTYTWGEKETDVFLLKS 0.04% (n=1)
VPTFTWGENETDVFLLKS 0.04% (n=1)
VPTYSWGEKETDVFLLES 0.04% (n=1)
KPTYTWGENETDVFLLKS 0.04% (n=1)
SPTYNWGENEADVFLLKS 0.04% (n=1)
EPTYTWGETEKDVFLLKS 0.04% (n=1)
VPTYNWGENETDVFLLSS 0.04% (n=1)
VPTYNWGENDTDVFLLKS 0.04% (n=1)
VPTYNWGTNETDVFLLQS 0.04% (n=1)
APTYRWGENQSDVFLLES 0.04% (n=1)
VPTFNWGGNKTDVFLLKS 0.04% (n=1)
APTFNWGANKTDVFLLKS 0.04% (n=1)
APTFNWGDNKTDVFLLKS 0.04% (n=1)
APTYSWGAEESDVFLLES 0.04% (n=1)
VPTYNWGANETDVFLLTS 0.04% (n=1)
APTYNWGGNATDVFLLTS 0.04% (n=1)
VPTFNWGRNESDVFLLES 0.04% (n=1)
VPTYNWGENATDVFLLES 0.04% (n=1)
TPTFTWGTNETDVFLLES 0.04% (n=1)
VPTYTWGGNKTDVFLLDS 0.04% (n=1)
TPTYTWGENATDVFLLAS 0.04% (n=1)
NPTYTWGENKTDVFLLNS 0.04% (n=1)
VATYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGGNDTDLFLLTS 0.04% (n=1)
NPTYTWGENQTDVFLLES 0.04% (n=1)
VPTYTWGGNESDVFLLKS 0.04% (n=1)
APTYTWGENQTDVFLLKS 0.04% (n=1)
APTYGWGENESDVFLLGS 0.04% (n=1)
APTYSWGANETDVFLLNS 0.04% (n=1)
VPTYTWGENVTDVFLLKS 0.04% (n=1)
ASTYNWGQWL*ALLILRA 0.04% (n=1)
APTYYWGENETDVFLLKS 0.04% (n=1)
ASTYQW-E-L*ALLILRA 0.04% (n=1)
APTYNWGANESDGFLLES 0.04% (n=1)
APTYTGGANESDVFLLES 0.04% (n=1)
APTYTWGANKADVFLLDS 0.04% (n=1)
APTYAWGANKTDVFLLDS 0.04% (n=1)
VPTYTWGANVTDVFLLES 0.04% (n=1)
APTYTWGTNATDVFLLKS 0.04% (n=1)
TPTYTWGENESDVFLLES 0.04% (n=1)
VPTYDWGANESDVFLLES 0.04% (n=1)
DPTYTWGGNETDVFLLES 0.04% (n=1)
APTYNWGENKTDVFLLES 0.04% (n=1)
APTYTWGANVTDVFLLKS 0.04% (n=1)
APTYTWGDNKTDVFLLES 0.04% (n=1)
APTYDWGGKETDVFLLKS 0.04% (n=1)
VPTYTWGENESDVFLLGS 0.04% (n=1)
TPTYNWGGNKTDVFLLES 0.04% (n=1)
APTYTWGTNVTDVFLLES 0.04% (n=1)
VPTYTWGGNATDVFLLTS 0.04% (n=1)
VPTYTWGENATDVFLLNS 0.04% (n=1)
VPTYTWGANETDVFLLPS 0.04% (n=1)
VPTYTWGANETDVFLLRS 0.04% (n=1)
APTYTWGMNETDVFLLES 0.04% (n=1)
TPTYDWGANASDVFLLNS 0.04% (n=1)
VPTYNWGENKTDVFLLKS 0.04% (n=1)
VPTYTWGENKTDMFLLES 0.04% (n=1)
APTYEWGENETDVFLLRS 0.04% (n=1)
APTYTWGEKETDVFLLKS 0.04% (n=1)
VPTYTWGTNVTDVFLLES 0.04% (n=1)
VQTLNWGANDSDVFLLQS 0.04% (n=1)
VPTYNWGANETDVFLLGS 0.04% (n=1)
TPTFTWGENTTDVFLLTS 0.04% (n=1)
APTYNWGENETDVFLLGS 0.04% (n=1)
VPTYNWGGNATDVFLLES 0.04% (n=1)
VPTYSWGENETDVFLLGS 0.04% (n=1)
VPTYNWGANDADVFLLTS 0.04% (n=1)
TPTYTWGANESDVFLLES 0.04% (n=1)
APTYKWGEGEKDVFLLES 0.04% (n=1)
VPTYGWGENETDVFLLKS 0.04% (n=1)
APTYSWGENETDVFLLQS 0.04% (n=1)
IPTYNWGENETDVFLLDS 0.04% (n=1)
APTYTWGENKTDVFLLES 0.04% (n=1)
VPTYGWGENETDVFLLES 0.04% (n=1)
VPTYTWGGNKTDVFLLTS 0.04% (n=1)
MPTYNWGENETDVFLLES 0.04% (n=1)
TPTYNWGENVTDVFLLKS 0.04% (n=1)
VPRYTWGANETDVFLLES 0.04% (n=1)
APTYNWGENATDMFLLQS 0.04% (n=1)
VPTYSWGENQTDVFLLKS 0.04% (n=1)
VPTYSWGANESDVFLLKS 0.04% (n=1)
EATFNWGENETDVFLLKS 0.04% (n=1)
VPTYNFGANKTDVFLLES 0.04% (n=1)
VPTYNWGGNETDVFLLNS 0.04% (n=1)
VPTYKWGENETDVFLLKS 0.04% (n=1)
TPTYSWGANQTDVFLLDS 0.04% (n=1)
TPTYTWGEDKSDVFLLES 0.04% (n=1)
APTYNWGANESDVFLLQS 0.04% (n=1)
TPTYSWGANETDVFLLKS 0.04% (n=1)
APTYNWGENQTDVFLLKS 0.04% (n=1)
VPTYTWGANQTDVFLLNS 0.04% (n=1)
VPTYKWGENKTDVFLLKS 0.04% (n=1)
VPTYEWGENQTDVFLLKS 0.04% (n=1)
VPTYTWGEQERDVFLLES 0.04% (n=1)
APTYNWGGNETDVFLLKS 0.04% (n=1)
VPTFNWGVNETDVFLLKS 0.04% (n=1)
VPTYTWGTNETDVFLLDS 0.04% (n=1)
VPTFTWGGNKTDVFLLES 0.04% (n=1)
VPTYTWGENKSDVFLLKS 0.04% (n=1)
VPTYTWGENETDVFLLAS 0.04% (n=1)
KPTYGWGENETDVFLLES 0.04% (n=1)
NPTFNWGANATDVFLLES 0.04% (n=1)
SPTYTWGENKTDVFLLAS 0.04% (n=1)
VPTYTWGANKSDVFLLKS 0.04% (n=1)
VPTYNWGTNETDVFLLES 0.04% (n=1)
ALTYNWGQNDSDVFLLQS 0.04% (n=1)
MPTYTWGENETDVFLLDS 0.04% (n=1)
APTFTWGENETDVFLLQS 0.04% (n=1)
APTYQWGENETDVFLLKS 0.04% (n=1)
TPTYNWGENQTDVFLLES 0.04% (n=1)
APTYRWGENETDVFLLES 0.04% (n=1)
DPTYTYGTNKTDVFLLRS 0.04% (n=1)
APTYNWGVNETDVFLLES 0.04% (n=1)
SPTYQWGENETDVFLLKS 0.04% (n=1)
VPTYNWGENKTDVFLLRS 0.04% (n=1)
VPTYNWGANESDVFLLQS 0.04% (n=1)
APTYSWGENKTDVFLLES 0.04% (n=1)
VPTYNWGVNETDVFLLES 0.04% (n=1)
VPTYTWGANNTDVFLLTS 0.04% (n=1)
VPTFTWGENETDVFLLDS 0.04% (n=1)
SPTYTWGANETDVFLLQS 0.04% (n=1)
LPTYTWGENKTDMFLLES 0.04% (n=1)
VPTYNWGDNETDVFLLRS 0.04% (n=1)
APTYTWGGNQTDVFLLKS 0.04% (n=1)
TPTYTWGGNETDVFLLKS 0.04% (n=1)
RPTYTWGENETDVFLLES 0.04% (n=1)
APTYNWGENETDVFQLES 0.04% (n=1)
APTYTWGANETDVFLLAS 0.04% (n=1)
APTYNWGDNETDVFLLAS 0.04% (n=1)
DPTYTWGANETDVFLLKS 0.04% (n=1)
APTYNWGENATDVFLLGS 0.04% (n=1)
APTYAWGANETDVFLLES 0.04% (n=1)
VPTYTFGGNKTDVFLLQS 0.04% (n=1)
VPTYTWGGNETDVFLLNS 0.04% (n=1)
APTYTWGANKSDVFLLKS 0.04% (n=1)
APTYTWGANETDVFLLNS 0.04% (n=1)
APTYTWGANKTDMFLLHS 0.04% (n=1)
APTYTWGANKSDVFLLTS 0.04% (n=1)
APTYNFGENQTDVFLLES 0.04% (n=1)
VPTYNWGANETDVFLLNS 0.04% (n=1)
APTYKWGANETDVFLLKS 0.04% (n=1)
APTYTWGANATDVFLLES 0.04% (n=1)
APTYDWGENETDVFLLAS 0.04% (n=1)
NPTYTWGENVTDVFLLES 0.04% (n=1)
TPTFNWGQNQTDVFLLES 0.04% (n=1)
NPTFTWGETEKDVFLLDS 0.04% (n=1)
APTYDWGENETDVFLLQS 0.04% (n=1)
VATYTWGENDADVFLLGS 0.04% (n=1)
NPTYNWGANETDTFLLES 0.04% (n=1)
IPTYTWGENETDMFLLKS 0.04% (n=1)
APTYRWGANETDVFLLES 0.04% (n=1)
APTYTWGENETDVFLLSS 0.04% (n=1)
APTYNWGVNETDVFLLKS 0.04% (n=1)
TPTYNWGENETDVFLLDS 0.04% (n=1)
APTYTWGTNETDVFLLNS 0.04% (n=1)
VPTYNWGANVTDVFLLRS 0.04% (n=1)
APTYNWGENETDLFLLES 0.04% (n=1)
APTYSWGANETDVFLLQS 0.04% (n=1)
NPTFDWGANETDVFLLES 0.04% (n=1)
APTYNWGENDTDVFLLES 0.04% (n=1)
APTYTWGANQTDVFLLQS 0.04% (n=1)
APTYSWGVNETDVFLLES 0.04% (n=1)
APTYSWGENETDVFLLDS 0.04% (n=1)
VPTYTWGGNETDVFLLQS 0.04% (n=1)
APTYNWGENDTDMFLLQS 0.04% (n=1)
VPTYTFGENQTDVFLLES 0.04% (n=1)
DPTYNWGENATDWFLLES 0.04% (n=1)
NPTYEWGENETDVFLLES 0.04% (n=1)
TPTYTWGENATDVFLLES 0.04% (n=1)
APTYRWGENETDVFLLKS 0.04% (n=1)
APTYTWGENETDVFQLTS 0.04% (n=1)
APTYNWGANETDVFLLHS 0.04% (n=1)
APTYTWGGNKTDVFLLES 0.04% (n=1)
APTYTWGENKTDVFLLDS 0.04% (n=1)
VPTYTWGENQTDVFLLKS 0.04% (n=1)
SPTYTWGDNESDVFLLGS 0.04% (n=1)
APTYAWGANETDVFLLGS 0.04% (n=1)
SPTYNWGENETDVFLLDS 0.04% (n=1)
APTYNWGGNDTDVFLLES 0.04% (n=1)
VPTFQWGANKTDVFLLES 0.04% (n=1)
APTYRWGENQSDVFLLGS 0.04% (n=1)
APTYNWGANETDAFLLKS 0.04% (n=1)
TPTFNWGENKTDKFLLKS 0.04% (n=1)
VPTYTWGANESDVFLLES 0.04% (n=1)
APTYTWGENETDVFLVES 0.04% (n=1)
VPTYTWGGNKTDMFLLGS 0.04% (n=1)
APTYQWGANETDVFLLES 0.04% (n=1)
APTYTWGANTTDVFLLES 0.04% (n=1)
SPTYTWGANESDVFLLKS 0.04% (n=1)
TPTYSWGENKTDVFLLKS 0.04% (n=1)
APTYTWGDNKTDVFLLKS 0.04% (n=1)
NPTYSWGENETDVFLLDS 0.04% (n=1)
LPTYRFGANESDVFLLES 0.04% (n=1)
LPTYSWGANESDVFLLDS 0.04% (n=1)
VPTYTWGENETDVFLLSS 0.04% (n=1)
NPTYTWGMNETDVFLLNS 0.04% (n=1)
NPTYTWGESATDVFLLDS 0.04% (n=1)
APTYNWGENETDVFLLAS 0.04% (n=1)
TPTYNWGASPADVFLLAS 0.04% (n=1)
APTYAWGENETDVFLLES 0.04% (n=1)
APTYTWGANDTDVFLLES 0.04% (n=1)
APTYSWGGNKTDVFLLES 0.04% (n=1)
VPTYSWGENETDVFLLTS 0.04% (n=1)
APTYTWGANESDVFLLTS 0.04% (n=1)
VPTYSWGENETDVFLLES 0.04% (n=1)
TPTYTWGANETDVFLLTS 0.04% (n=1)
HPTYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGENKTDFFLLDS 0.04% (n=1)
VPTYSWGENESDVFLLQS 0.04% (n=1)
TPTYTWGANETDRFLLES 0.04% (n=1)
APTYNWGANETDVLLLES 0.04% (n=1)
IPTHNWGANESDVFLLKS 0.04% (n=1)
LPTYRFGVNESDVFLLTS 0.04% (n=1)
VPTYNFGANETDVFLLTS 0.04% (n=1)
LPTYNFGENEADVFLLNS 0.04% (n=1)
LPTYNFGENETDMFLLTS 0.04% (n=1)
VPTYNFGENETDVFLLTS 0.04% (n=1)
VPTYKFGENESDVFLLTS 0.04% (n=1)
LPTYNFGENESDVFLLAS 0.04% (n=1)
LPTYTFGENESDVFLLNS 0.04% (n=1)
LPTYTFGANESDVFLLTS 0.04% (n=1)
VPTYKFGENETDVFLLTS 0.04% (n=1)
VPTYSFGANETDVFLLDS 0.04% (n=1)
LPTYNFGVNETDVFLLTS 0.04% (n=1)
SPTYNFGENETDVFLLSS 0.04% (n=1)
LPTYNFGENETDVFLLAS 0.04% (n=1)
SPTYTFGANETDVFLLDS 0.04% (n=1)
SPTYSFGANETDVFLLDS 0.04% (n=1)
LPTYNFGEDETDVFLLKS 0.04% (n=1)
LPTYNFGANETDVFLLNS 0.04% (n=1)
LPTYNFGGNQTDVFLLNS 0.04% (n=1)
LPTYNFGENKADKFLLDS 0.04% (n=1)
VPTYSFGENETDVFLLSS 0.04% (n=1)
VPTYNFGENETDVFLLGS 0.04% (n=1)
LPTYNFGGNETDVFLLNS 0.04% (n=1)
APTYNFGENETDVFLLNS 0.04% (n=1)
LPTYNFGENESDVFLLTS 0.04% (n=1)
LPTYTFGEKETDVFLLSS 0.04% (n=1)
LPTYNFGENEKDVFLLDS 0.04% (n=1)
LPTYNFGANETDVFLLRS 0.04% (n=1)
LPTYTFGENETDVFLLDS 0.04% (n=1)
LPTYNFGVNETDVFLLRS 0.04% (n=1)
VPTYTFGEKETDVFLLNS 0.04% (n=1)
LPTYNFGDNETDVFLLNS 0.04% (n=1)
LPTYNFGENTTDVFLLNS 0.04% (n=1)
LPTYSFGANKTDVFLLPS 0.04% (n=1)
SPTYSFGEKETDVFLLNS 0.04% (n=1)
LPTYTFGANETDVFLLTS 0.04% (n=1)
SPTYNFGENKTDVFLLNS 0.04% (n=1)
LPTYDFGENETDVFLLTS 0.04% (n=1)
APTYTFGANETDVFLLTS 0.04% (n=1)
LPTYAFGANETDVFLLTS 0.04% (n=1)
SPTYSFGENETDVFLLTS 0.04% (n=1)
LPTYNFGENESDVFLLDS 0.04% (n=1)
APTYNFGANETDVFLLTS 0.04% (n=1)
APTYGFGENETDVFLLNS 0.04% (n=1)
LPTYRFGENETDVFLLTS 0.04% (n=1)
SPTYTFGGNESDVFLLNS 0.04% (n=1)
SPTYNFGANETDVFLLTS 0.04% (n=1)
VPTYTFGANETDVFLLTS 0.04% (n=1)
LPTYSFGENESDVFLLSS 0.04% (n=1)
LPTYTFGENETDVFLLAS 0.04% (n=1)
IPTYNFGANETDVFLLTS 0.04% (n=1)
LPTCNFGANETDVFLLTS 0.04% (n=1)
SPTYNFGGNETDVFLLTS 0.04% (n=1)
LPTYSFGANESDVFLLTS 0.04% (n=1)
LPTYGFGANESDVFLLTS 0.04% (n=1)
LPTYTFGENETDVFLLSS 0.04% (n=1)
LPTYNFGSNDTDVFLLTS 0.04% (n=1)
VPTYTFGENETDVLLLES 0.04% (n=1)
TPTYTFGENETDVVLLTS 0.04% (n=1)
VPTYTFGENETDVVLLAS 0.04% (n=1)
APTYRFGENETDVFLLSS 0.04% (n=1)
APTYTFGGNDTDVFLLSS 0.04% (n=1)
VPTYTFGGNDSDVFLLSS 0.04% (n=1)
VPTYSFGDNVTDVFLLES 0.04% (n=1)
APTYTFGENDTDVFLLSS 0.04% (n=1)
APTYTFGENVTDVFLLSS 0.04% (n=1)
YPTFTWGANESDVFLLES 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 3a:

APTYTWGANETDVFLLRS 13.36% (n=314)
VPTYTWGENKTDVFLLES 7.15% (n=168)
VPTYNWGENETDVFLLES 4.51% (n=106)
APTYTWGENETDVFLLES 4.17% (n=98)
VPTYNWGANETDVFLLKS 3.66% (n=86)
VPTYNWGANETDVFLLES 3.32% (n=78)
APTYTWGENETDVFLLKS 3.28% (n=77)
VPTYTWGENESDVFLLES 2.94% (n=69)
VPTYNWGENETDVFLLKS 2.89% (n=68)
VPTYTWGENETDVFLLES 2.60% (n=61)
VPTYNWGENESDVFLLKS 2.60% (n=61)
APTYTWGANETDVFLLES 2.17% (n=51)
APTYNWGENETDVFLLKS 2.17% (n=51)
VPTYTWGENETDVFLLKS 1.57% (n=37)
APTYNWGANESDVFLLES 1.49% (n=35)
VPTYTWGENDTDVFLLKS 1.28% (n=30)
VPTYNWGENKSDVFLLKS 1.19% (n=28)
IPTYNWGANETDAFLLES 1.06% (n=25)
APTYNWGANVTDVFLLKS 1.02% (n=24)
APTYNWGENETDVFLLES 0.98% (n=23)
VPTYTWGANETDVFLLES 0.89% (n=21)
TPTYDWGENETDVFLLGS 0.89% (n=21)
VPTYNWGENETDVFLLGS 0.89% (n=21)
EPTYTWGENETDVFLLKS 0.85% (n=20)
VPTYTWGANETDVFLLNS 0.81% (n=19)
VPTYTWGANETDVFLLQS 0.77% (n=18)
VPTYNWGENESDVFLLES 0.64% (n=15)
VPTYAWGENETDVFLLES 0.64% (n=15)
VPTYSWGENETDVFLLKS 0.55% (n=13)
APTFNWGENKTDVFLLKS 0.51% (n=12)
VPTYNWGANESDVFLLKS 0.51% (n=12)
APTFTWGENETDVFLLES 0.47% (n=11)
APTYSWGANESDVFLLES 0.47% (n=11)
APTYTWGENESDVFLLES 0.47% (n=11)
VPTYNWGENKSDVFLLES 0.43% (n=10)
APTYNWGANESDVFLLKS 0.43% (n=10)
APTFTWGENKTDVFLLES 0.38% (n=9)
APTYTWGANETDVFLLKS 0.34% (n=8)
TPTYTWGENETDVFLLES 0.34% (n=8)
APTYSWGENETDVFLLES 0.34% (n=8)
VPTYTWGANETDVFLLKS 0.34% (n=8)
VPTYTWGENETDVFLLTS 0.30% (n=7)
APTFNWGGNKTDVFLLKS 0.30% (n=7)
VPTYYWGENKTDVFLLES 0.26% (n=6)
APTYTWGENATDVFLLKS 0.26% (n=6)
APTYNWGANETDVFLLES 0.26% (n=6)
APTYSWGENETDVFLLTS 0.26% (n=6)
APTYTWGANESDVFLLES 0.26% (n=6)
VPTYTWGGNETDVFLLKS 0.21% (n=5)
VPTYSWGANETDVFLLKS 0.21% (n=5)
VPTYTWGENETDVFLLNS 0.21% (n=5)
APTYTWGANETDVFLLGS 0.21% (n=5)
VPTYTWGENETDVFLLRS 0.21% (n=5)
APTYNWGENESDVFLLES 0.21% (n=5)
APTYTWGENETDVFLLQS 0.21% (n=5)
TPTYTWGANKTDVFLLES 0.21% (n=5)
VPTYTWGGNKTDVFLLKS 0.17% (n=4)
APTYGWGANESDVFLLKS 0.17% (n=4)
APTYNWGANETDVFLLKS 0.17% (n=4)
MPTYTWGENESDVFLLES 0.17% (n=4)
VPTYNWGENESDVFLLTS 0.17% (n=4)
APTYTWGENESDVFLLQS 0.17% (n=4)
APTYSWGANETDVFLLES 0.17% (n=4)
APTYTWGANETDVFLLTS 0.17% (n=4)
VPTYTWGENETDVFLLDS 0.17% (n=4)
VPTYDWGENETDVFLLAS 0.17% (n=4)
VPTYTWGTNETDVFLLKS 0.13% (n=3)
APTYTWGGNETDVFLLES 0.13% (n=3)
VPTFTWGENETDVFLLES 0.13% (n=3)
APTYTWGENETDVFLLTS 0.13% (n=3)
VPTYTWGANKTDVFLLNS 0.13% (n=3)
APTYNWGANESDVFLLTS 0.13% (n=3)
APTYSWGENETDVFLLKS 0.13% (n=3)
VPTYNWGGNETDVFLLKS 0.13% (n=3)
APTYSWGAKESDVFLLES 0.13% (n=3)
APTYTWGGNETDVFLLKS 0.13% (n=3)
APTYTWGANETDVFLLDS 0.13% (n=3)
APTYTWGENETDVFLLNS 0.13% (n=3)
APTYNWGENETDVFLLTS 0.13% (n=3)
VPTYTWGANESDVFLLKS 0.13% (n=3)
APTYNWGANKTDVFLLES 0.09% (n=2)
TPTYTWGANDTDVFLLQS 0.09% (n=2)
VPTYTWGENETDVFLLQS 0.09% (n=2)
VPTYTWGANETDVFLLDS 0.09% (n=2)
VPTYTWGENEKDVFLLKS 0.09% (n=2)
APTYTWGENESDVFLLNS 0.09% (n=2)
LPTYNWGENETDVFLLKS 0.09% (n=2)
APTYFWGANESDVFLLES 0.09% (n=2)
APTYSWGANKSDVFLLES 0.09% (n=2)
APTFTWGENVTDVFLLKS 0.09% (n=2)
APTYNWGENETDVFLLNP 0.09% (n=2)
VPTYTWGGNVTDVFLLES 0.09% (n=2)
VPTYTWGENEADVFLLNS 0.09% (n=2)
VPTYTRGENETDVFLLTS 0.09% (n=2)
APTYTWGANETDVFLLQS 0.09% (n=2)
TPTYTWGANETDVFLLKS 0.09% (n=2)
VPTYNWGANEADVFLLKS 0.09% (n=2)
APTYTWGVNETDVFLLES 0.09% (n=2)
APTYNWGANETDVFMLES 0.09% (n=2)
VPIYTWGENDTDVFLLKS 0.09% (n=2)
SPTYTWGANETDVFLLRS 0.09% (n=2)
APTYKWGENETDVFLLKS 0.09% (n=2)
TPTYTWGGNKTDVFLLES 0.09% (n=2)
VPTYTWGGNETDVFLLES 0.09% (n=2)
APTYNWGENETDVFLLQS 0.09% (n=2)
APTYSWGANETDVFLLKS 0.09% (n=2)
VPTYTWGANKTDVFLLES 0.09% (n=2)
VPTYRWGENETDVFLLKS 0.09% (n=2)
VPTYTWGENDTDVFLLES 0.09% (n=2)
APTYDWGENETDVFLLES 0.09% (n=2)
APTYTWGENKTDVFLLKS 0.09% (n=2)
--TYNWGENESDVFLLES 0.09% (n=2)
APTYNWGENESDVFLLKS 0.09% (n=2)
TPTYTWGANETDVFLLES 0.09% (n=2)
NPTYTWGENKTDVFLLES 0.09% (n=2)
APTYTWGTNETDVFLLRS 0.09% (n=2)
VPTYNWGENETDVFLLTS 0.09% (n=2)
APTYTWGENETDVFLLDS 0.09% (n=2)
APTYNWGENETDVFLLNS 0.09% (n=2)
APTYNWGGNETDVFLLRS 0.09% (n=2)
APTYNWGANETDVFLLDS 0.09% (n=2)
APTYTWGTNETDVFLLKS 0.09% (n=2)
APTYTWGENETDVFLLGS 0.09% (n=2)
VPTYNWGENKTDVFLLES 0.09% (n=2)
VPTYTWGANKTDVFLLKS 0.09% (n=2)
TPTYTWGENETDVFLLKS 0.09% (n=2)
APTFTWGANKTDVFLLES 0.09% (n=2)
DPTYNWGENETDVFLLKS 0.09% (n=2)
TPTYTWGENKTDVFLLES 0.09% (n=2)
VPTYTWGENESDVFLLKS 0.09% (n=2)
VPTYTWGANDTDVFLLTS 0.09% (n=2)
APTYTWGENATDVFLLES 0.09% (n=2)
APTYTWGTNETDVFLLDS 0.09% (n=2)
VPTYNWGANVSDVFLLKS 0.09% (n=2)
VPTYTWGANDTDVFLLES 0.04% (n=1)
VPTYTWGENESDVFLLDS 0.04% (n=1)
VPTYTWGGNATDVFLLES 0.04% (n=1)
APTYTWGENASDVFLLES 0.04% (n=1)
TPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYTWGENETDVFLLE- 0.04% (n=1)
VPTYSFGTNETDVFLLES 0.04% (n=1)
APTYTWGTNETDVFLLES 0.04% (n=1)
APTYTWGENVRDVFLLES 0.04% (n=1)
VPTYTWDANETDVFLLNS 0.04% (n=1)
APTYTWGANKTDVFLLES 0.04% (n=1)
APTYNWGANETDMFLLQS 0.04% (n=1)
GPTYNWGGDETDVFLLKS 0.04% (n=1)
ASTYNWGADETDVFLLKS 0.04% (n=1)
ASTYNWGGDETDVFLLKS 0.04% (n=1)
GSTYNWGGNETDVFLLKS 0.04% (n=1)
VPTFGWGGNKSDVFLLKS 0.04% (n=1)
VPRYNWGENATDVFLLQS 0.04% (n=1)
NPTYTWGENETDVFLLQS 0.04% (n=1)
IPTYSFGENETDCFLLES 0.04% (n=1)
APTYTWGANTSDVFLLES 0.04% (n=1)
VPTYTWGGNESDVFLLES 0.04% (n=1)
APTYNWGADVTDVFLLKS 0.04% (n=1)
APTYNWSANVTDVFLLKS 0.04% (n=1)
APTYTWGEDGTDVFLLES 0.04% (n=1)
TPTYDWGENETDVFPLGS 0.04% (n=1)
TPTYDWGENEADVFLLGS 0.04% (n=1)
TPTYDWSENETDVFLLGS 0.04% (n=1)
TPTYDWGENETDVFLLES 0.04% (n=1)
-PTYDWGENETDVFLLGS 0.04% (n=1)
TSTYDWGENETDVFLLGS 0.04% (n=1)
IPTHNWGANETDAFLLES 0.04% (n=1)
APTCTWGANETDVFLLES 0.04% (n=1)
VPTYYWGENETDVFLLES 0.04% (n=1)
VPTYNWGENKSDVLLLES 0.04% (n=1)
VPTYYWGENKTDMFLLES 0.04% (n=1)
VPTYCWGENKSDVFLLES 0.04% (n=1)
VPTYNFGENKTDVFLLES 0.04% (n=1)
APTYSWGASESDVFLLES 0.04% (n=1)
APTYSWGENETDVFLLRS 0.04% (n=1)
APTYTWGENEADVFLLKS 0.04% (n=1)
APTYTWGENETDAFLLKS 0.04% (n=1)
APTYTWGENETDMFLLKS 0.04% (n=1)
APTFTWGENETGVFLLES 0.04% (n=1)
VPTYNWGESESDVFLLKS 0.04% (n=1)
TPTYTWGENETDMFLLES 0.04% (n=1)
VPTYTWGENVTDVFLLES 0.04% (n=1)
VPTYPWGANKTEGFLLNS 0.04% (n=1)
VPTYSWGENEKDVFLLKS 0.04% (n=1)
RPTYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGENETDGFLLES 0.04% (n=1)
APTYTWGANETDMFLLGS 0.04% (n=1)
APTYTWSENETDVFLLES 0.04% (n=1)
APTYSWSENETDVFLLES 0.04% (n=1)
VPTYTLSENETDVFLLTS 0.04% (n=1)
VPTYTLGENETDVFLLTS 0.04% (n=1)
APTYRLGENETNVFLLTS 0.04% (n=1)
VPTYRLGENETDVFLLTS 0.04% (n=1)
APTYRLGENETDVFLLTS 0.04% (n=1)
TPTYTWGANKTDVFLLKS 0.04% (n=1)
TPTYTKSSNETEVVVVLS 0.04% (n=1)
APTYTWGANETEVFLLQS 0.04% (n=1)
APTYCSNDNESDVFDVNS 0.04% (n=1)
TPTYTWGANKTDVFLVQS 0.04% (n=1)
EPTYTWGENETDVFLLHS 0.04% (n=1)
EPTYNWGGNETDVFLLQS 0.04% (n=1)
QPTYNWGENATDVFLLES 0.04% (n=1)
TPTYSWGENETDVFLLES 0.04% (n=1)
VPTYNRGANETDVFLLKS 0.04% (n=1)
VPTYNWGANGTDVFLLKS 0.04% (n=1)
TPTYTWGANESDVFLLQS 0.04% (n=1)
LPTYNWGENETDVFLLES 0.04% (n=1)
TPTYNWGENETDVFLLQS 0.04% (n=1)
RPTYNWGANETDVFLLES 0.04% (n=1)
APTYTWGEKETDVFLLES 0.04% (n=1)
VPTYTWGDNESDVFLLKS 0.04% (n=1)
VPTYNWGENVTDVFLLES 0.04% (n=1)
APTYAWGENETDVFLLKS 0.04% (n=1)
APTYDWGENESDVFLLTS 0.04% (n=1)
VPTYNWGSNDTDVFLLES 0.04% (n=1)
EPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYDWGANKSDVFLLKS 0.04% (n=1)
APTYNWGANESDVFLLAS 0.04% (n=1)
VPTYSWGENESDVFLLKS 0.04% (n=1)
VPTYNWGENESDVFLLAS 0.04% (n=1)
VPTYTWGGNATDVFLLQS 0.04% (n=1)
VPTYTFGANESDVFLLES 0.04% (n=1)
VPTYNWGANVTDVFLLTS 0.04% (n=1)
EPTYNWGANETDVFLLKS 0.04% (n=1)
APTFNWGENETDVFLLES 0.04% (n=1)
NPTFNWGENETDVFLLAS 0.04% (n=1)
MPTYNWGENETDVFLLKS 0.04% (n=1)
VPTYNWGENETDVFLLQS 0.04% (n=1)
VPTYNWGANKTDVFLLKS 0.04% (n=1)
VPTYNWGMNETDVFLLES 0.04% (n=1)
VPTYNWGGNDTDVFLLKS 0.04% (n=1)
APTFNWGENETDVFLLTS 0.04% (n=1)
EPTYTWGEKETDVFLLKS 0.04% (n=1)
VPTFTWGENETDVFLLKS 0.04% (n=1)
VPTYSWGEKETDVFLLES 0.04% (n=1)
KPTYTWGENETDVFLLKS 0.04% (n=1)
SPTYNWGENEADVFLLKS 0.04% (n=1)
EPTYTWGETEKDVFLLKS 0.04% (n=1)
VPTYNWGENETDVFLLSS 0.04% (n=1)
VPTYNWGENDTDVFLLKS 0.04% (n=1)
VPTYNWGTNETDVFLLQS 0.04% (n=1)
APTYRWGENQSDVFLLES 0.04% (n=1)
VPTFNWGGNKTDVFLLKS 0.04% (n=1)
APTFNWGANKTDVFLLKS 0.04% (n=1)
APTFNWGDNKTDVFLLKS 0.04% (n=1)
APTYSWGAEESDVFLLES 0.04% (n=1)
VPTYNWGANETDVFLLTS 0.04% (n=1)
APTYNWGGNATDVFLLTS 0.04% (n=1)
VPTFNWGRNESDVFLLES 0.04% (n=1)
VPTYNWGENATDVFLLES 0.04% (n=1)
TPTFTWGTNETDVFLLES 0.04% (n=1)
VPTYTWGGNKTDVFLLDS 0.04% (n=1)
TPTYTWGENATDVFLLAS 0.04% (n=1)
NPTYTWGENKTDVFLLNS 0.04% (n=1)
VATYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGGNDTDLFLLTS 0.04% (n=1)
NPTYTWGENQTDVFLLES 0.04% (n=1)
VPTYTWGGNESDVFLLKS 0.04% (n=1)
APTYTWGENQTDVFLLKS 0.04% (n=1)
APTYGWGENESDVFLLGS 0.04% (n=1)
APTYSWGANETDVFLLNS 0.04% (n=1)
VPTYTWGENVTDVFLLKS 0.04% (n=1)
ASTYNWGQWL*ALLILRA 0.04% (n=1)
APTYYWGENETDVFLLKS 0.04% (n=1)
----QW-E-L*ALLILRA 0.04% (n=1)
APTYNWGANESDGFLLES 0.04% (n=1)
APTYTGGANESDVFLLES 0.04% (n=1)
VPTYTWGANVTDVFLLES 0.04% (n=1)
APTYTWGTNATDVFLLKS 0.04% (n=1)
TPTYTWGENESDVFLLES 0.04% (n=1)
VPTYDWGANESDVFLLES 0.04% (n=1)
DPTYTWGGNETDVFLLES 0.04% (n=1)
APTYNWGENKTDVFLLES 0.04% (n=1)
APTYTWGANVTDVFLLKS 0.04% (n=1)
APTYTWGDNKTDVFLLES 0.04% (n=1)
APTYDWGGKETDVFLLKS 0.04% (n=1)
VPTYTWGENESDVFLLGS 0.04% (n=1)
TPTYNWGGNKTDVFLLES 0.04% (n=1)
APTYTWGTNVTDVFLLES 0.04% (n=1)
VPTYTWGGNATDVFLLTS 0.04% (n=1)
VPTYTWGENATDVFLLNS 0.04% (n=1)
VPTYTWGANETDVFLLPS 0.04% (n=1)
VPTYTWGANETDVFLLRS 0.04% (n=1)
APTYTWGMNETDVFLLES 0.04% (n=1)
TPTYDWGANASDVFLLNS 0.04% (n=1)
VPTYNWGENKTDVFLLKS 0.04% (n=1)
VPTYTWGENKTDMFLLES 0.04% (n=1)
APTYEWGENETDVFLLRS 0.04% (n=1)
APTYTWGEKETDVFLLKS 0.04% (n=1)
VPTYTWGTNVTDVFLLES 0.04% (n=1)
VQTLNWGANDSDVFLLQS 0.04% (n=1)
VPTYNWGANETDVFLLGS 0.04% (n=1)
TPTFTWGENTTDVFLLTS 0.04% (n=1)
APTYNWGENETDVFLLGS 0.04% (n=1)
VPTYNWGGNATDVFLLES 0.04% (n=1)
VPTYSWGENETDVFLLGS 0.04% (n=1)
VPTYNWGANDADVFLLTS 0.04% (n=1)
TPTYTWGANESDVFLLES 0.04% (n=1)
APTYKWGEGEKDVFLLES 0.04% (n=1)
VPTYGWGENETDVFLLKS 0.04% (n=1)
APTYSWGENETDVFLLQS 0.04% (n=1)
IPTYNWGENETDVFLLDS 0.04% (n=1)
APTYTWGENKTDVFLLES 0.04% (n=1)
VPTYGWGENETDVFLLES 0.04% (n=1)
VPTYTWGGNKTDVFLLTS 0.04% (n=1)
MPTYNWGENETDVFLLES 0.04% (n=1)
TPTYNWGENVTDVFLLKS 0.04% (n=1)
VPRYTWGANETDVFLLES 0.04% (n=1)
APTYNWGENATDMFLLQS 0.04% (n=1)
VPTYSWGENQTDVFLLKS 0.04% (n=1)
VPTYSWGANESDVFLLKS 0.04% (n=1)
EATFNWGENETDVFLLKS 0.04% (n=1)
VPTYNFGANKTDVFLLES 0.04% (n=1)
VPTYNWGGNETDVFLLNS 0.04% (n=1)
VPTYKWGENETDVFLLKS 0.04% (n=1)
TPTYSWGANQTDVFLLDS 0.04% (n=1)
TPTYTWGEDKSDVFLLES 0.04% (n=1)
APTYNWGANESDVFLLQS 0.04% (n=1)
TPTYSWGANETDVFLLKS 0.04% (n=1)
APTYNWGENQTDVFLLKS 0.04% (n=1)
VPTYTWGANQTDVFLLNS 0.04% (n=1)
VPTYKWGENKTDVFLLKS 0.04% (n=1)
VPTYEWGENQTDVFLLKS 0.04% (n=1)
VPTYTWGEQERDVFLLES 0.04% (n=1)
APTYNWGGNETDVFLLKS 0.04% (n=1)
VPTFNWGVNETDVFLLKS 0.04% (n=1)
VPTYTWGTNETDVFLLDS 0.04% (n=1)
VPTFTWGGNKTDVFLLES 0.04% (n=1)
VPTYTWGENKSDVFLLKS 0.04% (n=1)
VPTYTWGENETDVFLLAS 0.04% (n=1)
KPTYGWGENETDVFLLES 0.04% (n=1)
NPTFNWGANATDVFLLES 0.04% (n=1)
SPTYTWGENKTDVFLLAS 0.04% (n=1)
VPTYTWGANKSDVFLLKS 0.04% (n=1)
VPTYNWGTNETDVFLLES 0.04% (n=1)
ALTYNWGQNDSDVFLLQS 0.04% (n=1)
MPTYTWGENETDVFLLDS 0.04% (n=1)
APTFTWGENETDVFLLQS 0.04% (n=1)
APTYQWGENETDVFLLKS 0.04% (n=1)
TPTYNWGENQTDVFLLES 0.04% (n=1)
APTYRWGENETDVFLLES 0.04% (n=1)
DPTYTYGTNKTDVFLLRS 0.04% (n=1)
APTYNWGVNETDVFLLES 0.04% (n=1)
SPTYQWGENETDVFLLKS 0.04% (n=1)
VPTYNWGENKTDVFLLRS 0.04% (n=1)
VPTYNWGANESDVFLLQS 0.04% (n=1)
APTYSWGENKTDVFLLES 0.04% (n=1)
VPTYNWGVNETDVFLLES 0.04% (n=1)
VPTYTWGANNTDVFLLTS 0.04% (n=1)
VPTFTWGENETDVFLLDS 0.04% (n=1)
SPTYTWGANETDVFLLQS 0.04% (n=1)
LPTYTWGENKTDMFLLES 0.04% (n=1)
VPTYNWGDNETDVFLLRS 0.04% (n=1)
APTYTWGGNQTDVFLLKS 0.04% (n=1)
TPTYTWGGNETDVFLLKS 0.04% (n=1)
RPTYTWGENETDVFLLES 0.04% (n=1)
APTYNWGENETDVFQLES 0.04% (n=1)
APTYTWGANETDVFLLAS 0.04% (n=1)
APTYNWGDNETDVFLLAS 0.04% (n=1)
DPTYTWGANETDVFLLKS 0.04% (n=1)
APTYNWGENATDVFLLGS 0.04% (n=1)
APTYAWGANETDVFLLES 0.04% (n=1)
VPTYTFGGNKTDVFLLQS 0.04% (n=1)
VPTYTWGGNETDVFLLNS 0.04% (n=1)
APTYTWGANKSDVFLLKS 0.04% (n=1)
APTYTWGANETDVFLLNS 0.04% (n=1)
APTYTWGANKTDMFLLHS 0.04% (n=1)
APTYTWGANKSDVFLLTS 0.04% (n=1)
APTYNFGENQTDVFLLES 0.04% (n=1)
VPTYNWGANETDVFLLNS 0.04% (n=1)
APTYKWGANETDVFLLKS 0.04% (n=1)
APTYTWGANATDVFLLES 0.04% (n=1)
APTYDWGENETDVFLLAS 0.04% (n=1)
NPTYTWGENVTDVFLLES 0.04% (n=1)
TPTFNWGQNQTDVFLLES 0.04% (n=1)
NPTFTWGETEKDVFLLDS 0.04% (n=1)
APTYDWGENETDVFLLQS 0.04% (n=1)
VATYTWGENDADVFLLGS 0.04% (n=1)
NPTYNWGANETDTFLLES 0.04% (n=1)
IPTYTWGENETDMFLLKS 0.04% (n=1)
APTYRWGANETDVFLLES 0.04% (n=1)
APTYTWGENETDVFLLSS 0.04% (n=1)
TPTYNWGENETDVFLLDS 0.04% (n=1)
APTYTWGTNETDVFLLNS 0.04% (n=1)
VPTYNWGANVTDVFLLRS 0.04% (n=1)
APTYNWGENETDLFLLES 0.04% (n=1)
APTYSWGANETDVFLLQS 0.04% (n=1)
NPTFDWGANETDVFLLES 0.04% (n=1)
APTYNWGENDTDVFLLES 0.04% (n=1)
APTYTWGANQTDVFLLQS 0.04% (n=1)
APTYSWGVNETDVFLLES 0.04% (n=1)
APTYSWGENETDVFLLDS 0.04% (n=1)
VPTYTWGGNETDVFLLQS 0.04% (n=1)
APTYNWGENDTDMFLLQS 0.04% (n=1)
VPTYTFGENQTDVFLLES 0.04% (n=1)
DPTYNWGENATDWFLLES 0.04% (n=1)
NPTYEWGENETDVFLLES 0.04% (n=1)
TPTYTWGENATDVFLLES 0.04% (n=1)
APTYRWGENETDVFLLKS 0.04% (n=1)
APTYTWGENETDVFQLTS 0.04% (n=1)
APTYNWGANETDVFLLHS 0.04% (n=1)
APTYTWGGNKTDVFLLES 0.04% (n=1)
APTYTWGENKTDVFLLDS 0.04% (n=1)
VPTYTWGENQTDVFLLKS 0.04% (n=1)
SPTYTWGDNESDVFLLGS 0.04% (n=1)
APTYAWGANETDVFLLGS 0.04% (n=1)
SPTYNWGENETDVFLLDS 0.04% (n=1)
APTYNWGGNDTDVFLLES 0.04% (n=1)
VPTFQWGANKTDVFLLES 0.04% (n=1)
APTYRWGENQSDVFLLGS 0.04% (n=1)
APTYNWGANETDAFLLKS 0.04% (n=1)
TPTFNWGENKTDKFLLKS 0.04% (n=1)
VPTYTWGANESDVFLLES 0.04% (n=1)
APTYTWGENETDVFLVES 0.04% (n=1)
VPTYTWGGNKTDMFLLGS 0.04% (n=1)
APTYQWGANETDVFLLES 0.04% (n=1)
APTYTWGANTTDVFLLES 0.04% (n=1)
TPTYSWGENKTDVFLLKS 0.04% (n=1)
APTYTWGDNKTDVFLLKS 0.04% (n=1)
NPTYSWGENETDVFLLDS 0.04% (n=1)
LPTYRFGANESDVFLLES 0.04% (n=1)
LPTYSWGANESDVFLLDS 0.04% (n=1)
VPTYTWGENETDVFLLSS 0.04% (n=1)
NPTYTWGMNETDVFLLNS 0.04% (n=1)
NPTYTWGESATDVFLLDS 0.04% (n=1)
APTYNWGENETDVFLLAS 0.04% (n=1)
TPTYNWGASPADVFLLAS 0.04% (n=1)
APTYAWGENETDVFLLES 0.04% (n=1)
APTYTWGANDTDVFLLES 0.04% (n=1)
APTYSWGGNKTDVFLLES 0.04% (n=1)
VPTYSWGENETDVFLLTS 0.04% (n=1)
APTYTWGANESDVFLLTS 0.04% (n=1)
VPTYSWGENETDVFLLES 0.04% (n=1)
TPTYTWGANETDVFLLTS 0.04% (n=1)
HPTYNWGENETDVFLLES 0.04% (n=1)
VPTYTWGENKTDFFLLDS 0.04% (n=1)
VPTYSWGENESDVFLLQS 0.04% (n=1)
TPTYTWGANETDRFLLES 0.04% (n=1)
APTYNWGANETDVLLLES 0.04% (n=1)
IPTHNWGANESDVFLLKS 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 3b:

LPTYNFGANETDVFLLTS 23.35% (n=78)
LPTYNFGENETDVFLLTS 10.78% (n=36)
SPTYNFGENETDVFLLTS 8.68% (n=29)
LPTYNFGANESDVFLLTS 7.78% (n=26)
LPTYNFGENETDVFLLNS 7.19% (n=24)
LPTYNFGENETDVFLLKS 4.49% (n=15)
LPTYNFGENKTDVFLLTS 2.69% (n=9)
LPTYSFGENETDVFLLTS 2.40% (n=8)
SPTYNFGENETDVFLLNS 1.80% (n=6)
LPTYTFGENETDVFLLKS 1.50% (n=5)
APTYNFGENETDVFLLTS 1.20% (n=4)
LPTYSFGENETDVFLLDS 1.20% (n=4)
LPTYTFGENETDVFLLTS 1.20% (n=4)
LPTYNFGGNESDVFLLTS 0.90% (n=3)
SPTYNFGDNETDVFLLNS 0.90% (n=3)
LPTYNFGENETDVFLLDS 0.90% (n=3)
LPTYSFGENETDVFLLNS 0.90% (n=3)
LPTYNFGENETDVFLLSS 0.90% (n=3)
LPTYTFGENETDVFLLNS 0.90% (n=3)
LPTYSFGENESDVFLLTS 0.90% (n=3)
SPTYTFGENETDVFLLNS 0.60% (n=2)
LPTYNFGENETDVFLLES 0.60% (n=2)
LPTYNFGENDTDVFLLNS 0.60% (n=2)
LPTYNFGENETDVFLLPS 0.60% (n=2)
LPTYRFGVNESDVFLLTS 0.30% (n=1)
VPTYNFGANETDVFLLTS 0.30% (n=1)
LPTYNFGENEADVFLLNS 0.30% (n=1)
LPTYNFGENETDMFLLTS 0.30% (n=1)
VPTYNFGENETDVFLLTS 0.30% (n=1)
VPTYKFGENESDVFLLTS 0.30% (n=1)
LPTYNFGENESDVFLLAS 0.30% (n=1)
LPTYTFGENESDVFLLNS 0.30% (n=1)
LPTYTFGANESDVFLLTS 0.30% (n=1)
VPTYKFGENETDVFLLTS 0.30% (n=1)
VPTYSFGANETDVFLLDS 0.30% (n=1)
LPTYNFGVNETDVFLLTS 0.30% (n=1)
SPTYNFGENETDVFLLSS 0.30% (n=1)
LPTYNFGENETDVFLLAS 0.30% (n=1)
SPTYTFGANETDVFLLDS 0.30% (n=1)
SPTYSFGANETDVFLLDS 0.30% (n=1)
LPTYNFGEDETDVFLLKS 0.30% (n=1)
LPTYNFGANETDVFLLNS 0.30% (n=1)
LPTYNFGGNQTDVFLLNS 0.30% (n=1)
LPTYNFGENKADKFLLDS 0.30% (n=1)
VPTYSFGENETDVFLLSS 0.30% (n=1)
VPTYNFGENETDVFLLGS 0.30% (n=1)
LPTYNFGGNETDVFLLNS 0.30% (n=1)
APTYNFGENETDVFLLNS 0.30% (n=1)
LPTYNFGENESDVFLLTS 0.30% (n=1)
LPTYTFGEKETDVFLLSS 0.30% (n=1)
LPTYNFGENEKDVFLLDS 0.30% (n=1)
LPTYNFGANETDVFLLRS 0.30% (n=1)
LPTYTFGENETDVFLLDS 0.30% (n=1)
LPTYNFGVNETDVFLLRS 0.30% (n=1)
VPTYTFGEKETDVFLLNS 0.30% (n=1)
LPTYNFGDNETDVFLLNS 0.30% (n=1)
LPTYNFGENTTDVFLLNS 0.30% (n=1)
LPTYSFGANKTDVFLLPS 0.30% (n=1)
SPTYSFGEKETDVFLLNS 0.30% (n=1)
LPTYTFGANETDVFLLTS 0.30% (n=1)
SPTYNFGENKTDVFLLNS 0.30% (n=1)
LPTYDFGENETDVFLLTS 0.30% (n=1)
APTYTFGANETDVFLLTS 0.30% (n=1)
LPTYAFGANETDVFLLTS 0.30% (n=1)
SPTYSFGENETDVFLLTS 0.30% (n=1)
LPTYNFGENESDVFLLDS 0.30% (n=1)
APTYNFGANETDVFLLTS 0.30% (n=1)
APTYGFGENETDVFLLNS 0.30% (n=1)
LPTYRFGENETDVFLLTS 0.30% (n=1)
SPTYTFGGNESDVFLLNS 0.30% (n=1)
SPTYNFGANETDVFLLTS 0.30% (n=1)
VPTYTFGANETDVFLLTS 0.30% (n=1)
LPTYSFGENESDVFLLSS 0.30% (n=1)
LPTYTFGENETDVFLLAS 0.30% (n=1)
IPTYNFGANETDVFLLTS 0.30% (n=1)
LPTCNFGANETDVFLLTS 0.30% (n=1)
SPTYNFGGNETDVFLLTS 0.30% (n=1)
LPTYSFGANESDVFLLTS 0.30% (n=1)
LPTYGFGANESDVFLLTS 0.30% (n=1)
LPTYTFGENETDVFLLSS 0.30% (n=1)
LPTYNFGSNDTDVFLLTS 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 4:

VPTYTWGENESDVFILNS 26.72% (n=62)
VPTYTWGENESDVFLLNS 18.10% (n=42)
VPTYTWGENDTDVF---- 8.19% (n=19)
VPTYTWGENETDVFLLNS 4.74% (n=11)
APTYTWGENETDVFLLNT 3.45% (n=8)
VPTYTWGENETDVF---- 3.02% (n=7)
VPTYTWGENETDVFILNS 2.59% (n=6)
VPTHTWGENESDVFLLNS 1.72% (n=4)
VPTYNWGENETDVFLLNS 1.72% (n=4)
VPTYNWGENETDVIILNS 1.29% (n=3)
APTYTWGENETDVFILNS 1.29% (n=3)
VPTYNWGENETDVFVLNS 1.29% (n=3)
VPTYTWGENVSDVFLLNS 0.86% (n=2)
VPTYNWGENESDVFLLNS 0.86% (n=2)
APTYTWGGNETDVFLLNT 0.86% (n=2)
APTYSWGENETDVIILNS 0.86% (n=2)
VPTYNWGVNETDVFVLNS 0.86% (n=2)
DPTYNWGENKTDVFILNS 0.86% (n=2)
APTYNWGENESDVFLLNS 0.43% (n=1)
VPTYTWGANESDAFLLNS 0.43% (n=1)
VPTYNWGGNETDVFLLNS 0.43% (n=1)
VPTYTWGENASDVFLLNS 0.43% (n=1)
VPTYTLGGNETDVF---- 0.43% (n=1)
APTYTWGENDTDVF---- 0.43% (n=1)
VPTYTWGDNESDVFLLNA 0.43% (n=1)
LPTYNWGENESDVFLLNS 0.43% (n=1)
VPTYTWGENKTDVFLLGS 0.43% (n=1)
VPTYTWGENETDVFLLNT 0.43% (n=1)
VPTYSWGANETDVFILNS 0.43% (n=1)
VPTYNWGDNETDVLILNS 0.43% (n=1)
APTYTWGANETDVIILNS 0.43% (n=1)
LPTYNWGENETDVFILNS 0.43% (n=1)
VPTYNWGENETDVFTLNS 0.43% (n=1)
SPTYNWGENVTDVLILNS 0.43% (n=1)
SPTYNWGENVTDVIIMNS 0.43% (n=1)
APTYSWGDNETDVLILNS 0.43% (n=1)
APTYAWGENETDVIILNS 0.43% (n=1)
IPTYNWGENETDVIILNS 0.43% (n=1)
DPTYGWGTGKDDVFILNS 0.43% (n=1)
APTYNWGENETDVIILNS 0.43% (n=1)
NPTYSFGGNDTDVIILNS 0.43% (n=1)
DPTYNWGENATDVLILNS 0.43% (n=1)
NPTYYWGGNDTDVVILNS 0.43% (n=1)
NPTYGWGGNETDVIILNS 0.43% (n=1)
IPTYTWGENETDVFILNS 0.43% (n=1)
VPTYTWGENETDVFVLNS 0.43% (n=1)
VPTYNWGENETDVFILNS 0.43% (n=1)
IPTYTWGANETDVFILNS 0.43% (n=1)
APTYNWGENETDVLILNS 0.43% (n=1)
YPTHNWGANETDVFILNS 0.43% (n=1)
NPTYTWGANGTDVFILNS 0.43% (n=1)
VPTYDWGVNETNVFILNS 0.43% (n=1)
VPTYDWGGNETDVFILNS 0.43% (n=1)
APTYSWGENETDVFILNS 0.43% (n=1)
LPTYGWGGNETDVFILNS 0.43% (n=1)
VPTYNWGANETDVFVLNS 0.43% (n=1)
HPTYSWGENETDVIILNS 0.43% (n=1)
VPTYTWGGNETDVFFLNS 0.43% (n=1)
DPTYTWGQNKTDVFILNS 0.43% (n=1)
TPTYNWGENDTDVIIMNA 0.43% (n=1)
HPTYNWGENETDVLILNS 0.43% (n=1)
LPTYRWGENETDVFILNS 0.43% (n=1)
VPTYNWGANETDVFLLNS 0.43% (n=1)
APTYTWGENESDIFLLNS 0.43% (n=1)
VPTYNWGENETDVLILNS 0.43% (n=1)
LPTYTWGENESDVFVLNA 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 4a:

VPTYTWGENESDVFILNS 38.99% (n=62)
VPTYTWGENESDVFLLNS 26.42% (n=42)
VPTYTWGENDTDVF---- 11.95% (n=19)
VPTYTWGENETDVFLLNS 5.66% (n=9)
VPTYTWGENETDVF---- 4.40% (n=7)
VPTHTWGENESDVFLLNS 2.52% (n=4)
VPTYNWGENETDVFLLNS 2.52% (n=4)
VPTYTWGENVSDVFLLNS 1.26% (n=2)
VPTYNWGENESDVFLLNS 1.26% (n=2)
APTYNWGENESDVFLLNS 0.63% (n=1)
VPTYTWGANESDAFLLNS 0.63% (n=1)
VPTYNWGGNETDVFLLNS 0.63% (n=1)
VPTYTWGENASDVFLLNS 0.63% (n=1)
VPTYTLGGNETDVF---- 0.63% (n=1)
APTYTWGENDTDVF---- 0.63% (n=1)
VPTYTWGDNESDVFLLNA 0.63% (n=1)
LPTYNWGENESDVFLLNS 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 4d:

APTYTWGENETDVFLLNT 61.54% (n=8)
VPTYTWGENETDVFLLNS 15.38% (n=2)
APTYTWGGNETDVFLLNT 15.38% (n=2)
VPTYTWGENETDVFLLNT 7.69% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 5:

YPTYNWGSNETDIFLLNN 10.81% (n=4)
YPTYNWGSNETDVFLLNN 8.11% (n=3)
NPTYNWGENETDIFLLNN 5.41% (n=2)
YPTYNWGSNETDILLLNN 5.41% (n=2)
VPSYNWGSNETDIFLLNS 5.41% (n=2)
CPTYNWGSNETDILLLNN 5.41% (n=2)
LPTYTWGENETDVFILNN 2.70% (n=1)
NPTYSWGENETDIFLLNN 2.70% (n=1)
LPTYNWGENETDVFLLNN 2.70% (n=1)
HPTYTWGENETDIFLLNN 2.70% (n=1)
YPTYTWGENETDVFLLNN 2.70% (n=1)
VPTYTWGENETDVLLLNN 2.70% (n=1)
YPTYNWGSNDTDILLLNN 2.70% (n=1)
YPTYNWGSNETDIFILNN 2.70% (n=1)
FPTYNWGENETDVFLLNN 2.70% (n=1)
YPTYNWGENDTDILILNN 2.70% (n=1)
YPTYNWGSNETDVFVLNN 2.70% (n=1)
YPTYNWGENETDVLLLNN 2.70% (n=1)
NPTYDWGSNESDVFLLNN 2.70% (n=1)
YPTYSWGDNETDVFLLNN 2.70% (n=1)
YPTYNWGENETDILLLNN 2.70% (n=1)
YPTYSWGANETDVFLLNN 2.70% (n=1)
CPTYTWGTNETDIFLLNN 2.70% (n=1)
YPTYNWGENETDIFLLNN 2.70% (n=1)
YPTYSWGSNDTDILLLNN 2.70% (n=1)
YPTYNWGENDTDVLLLNN 2.70% (n=1)
YPTYNWGSNETDVILLNS 2.70% (n=1)
HPTYNWGSNVTDFFLMNN 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 6:

NPTYTWGENETDVFMLES 21.56% (n=72)
LPTYTWGENESDVFLLES 5.69% (n=19)
LPTYNWGENVSDVFLLQS 3.89% (n=13)
NPTYTWGENETDVFILES 1.80% (n=6)
NPTYTWGENETDVFMLGS 1.80% (n=6)
LPTYTWGENETDVFLLQS 1.80% (n=6)
LPTYNWGENMSDVFLLQS 1.80% (n=6)
LPTYTWGENESDVFLLQS 1.80% (n=6)
NPTYTWGDNETDVFMLES 1.50% (n=5)
LPTYNWGENASDVFLLQS 1.50% (n=5)
LPTYNWGANVSDVFLLQS 1.50% (n=5)
NPTYNWGENETDVFMLES 1.20% (n=4)
LPTYNWGENESDVFLLES 1.20% (n=4)
APTYTWGENETDVFILQS 1.20% (n=4)
NPTYNWGDNETDVFMLES 0.90% (n=3)
LPTYSWGENESDVFLLES 0.90% (n=3)
LPTYTWGENVSDVFLLQS 0.90% (n=3)
LPTYTWGGNESDVFLLES 0.90% (n=3)
LPTYTWGANESDVFLLES 0.90% (n=3)
FPTYTWGENESDVFLLES 0.90% (n=3)
FPTYTWGDNESDVFLLQS 0.90% (n=3)
FPTYTWGANESDVFLLQS 0.90% (n=3)
NPTYTWGENETDVFMLDS 0.60% (n=2)
VPTYTWGENETDVFLLES 0.60% (n=2)
TPTYTWGENETDVFILES 0.60% (n=2)
VPTYTWGENESDVFLLES 0.60% (n=2)
NPTYTWGANETDVFMMSS 0.60% (n=2)
LPTYAWGANETDVFLLQS 0.60% (n=2)
FPTYTWGENETDVFLLQS 0.60% (n=2)
LPTYNWGGNVSDVFLLQS 0.60% (n=2)
LPTYNWGENESDVFLLQS 0.60% (n=2)
LPTYNWGDNVSDVFLLQS 0.60% (n=2)
NPTYTWGANATDVFLLES 0.60% (n=2)
APTYTWGTNETDVFLLES 0.60% (n=2)
RPTYNWGDNETDVFLLES 0.60% (n=2)
LPTYNWGANASDVFLLQG 0.60% (n=2)
LPTYTWGENESDVFLLQG 0.60% (n=2)
NPTYTWGENESDVFMLES 0.30% (n=1)
NPTYTWGENVTDVFMLES 0.30% (n=1)
NPTYTWGENWTDVFMLDS 0.30% (n=1)
NPTYTWGQNETDVFMYDS 0.30% (n=1)
IPTYTWGENETDVFILES 0.30% (n=1)
NPTYTWGENETDVFMLQS 0.30% (n=1)
NPTYTWGENETDVFMLAS 0.30% (n=1)
NPTYSWGDNETDVFMLES 0.30% (n=1)
HPTYNWGENETDVLMLES 0.30% (n=1)
SPTYTWGDNETDVFMLES 0.30% (n=1)
KPTYTWGENETDVFILES 0.30% (n=1)
NPTYNWGENVTDVFILES 0.30% (n=1)
NPTYSWGENETDVFMLGS 0.30% (n=1)
NPTYHWGENETDVFMLES 0.30% (n=1)
NPTYNWGENETDVFMLDS 0.30% (n=1)
IPTYTWGENETDVFMLES 0.30% (n=1)
APTYTWGENETDVFILES 0.30% (n=1)
IPTYTWGENETDVFILKS 0.30% (n=1)
NPTYTWGKNETDVFMLES 0.30% (n=1)
NPTYTWGANETDVFMLES 0.30% (n=1)
APTYTFGENETDVLLLES 0.30% (n=1)
VPTYSFGDNETDVFLLES 0.30% (n=1)
APTYSFGDNESDVFLLES 0.30% (n=1)
LPTYEWGENASDVFLLES 0.30% (n=1)
LPTYNWGVNESDVFLLES 0.30% (n=1)
LPTYQWGENQSDVFLLES 0.30% (n=1)
LPTYSWGENETDVFLLES 0.30% (n=1)
LPTYTWGENETDVFILKS 0.30% (n=1)
LPTYTWGENETDVFILES 0.30% (n=1)
LPTYTWGENETDVFILTS 0.30% (n=1)
IPTYTWGENVSDVFLLHS 0.30% (n=1)
NPTYTWGENITDVFQLHS 0.30% (n=1)
FPTYSWGVNESDVFILRS 0.30% (n=1)
IPTYNWGENATDVFLLYS 0.30% (n=1)
LPTYGWGGNDSDVFLLSS 0.30% (n=1)
LPTFTWGENETDVFLLGS 0.30% (n=1)
HPTYTWGENVTDVFLLES 0.30% (n=1)
LPTYDWGENVTDVFLLES 0.30% (n=1)
HPTFNWGENETDVFLLSS 0.30% (n=1)
HPTYNWGENETDVFLLSS 0.30% (n=1)
LPTYTWGANESDVFLLRS 0.30% (n=1)
LPTYNWGENETDVFLLRN 0.30% (n=1)
FPTYSWGGNETDVFLLQS 0.30% (n=1)
LPTYNWGENETDVFLLQS 0.30% (n=1)
FPTYNWGENETDVFLLQS 0.30% (n=1)
LPTYNWGGNVSDVILLQN 0.30% (n=1)
LPTYNWGENASDVFLLRS 0.30% (n=1)
LPTYTWGDNVSDVFLLQS 0.30% (n=1)
LPTYAWGENETDVFLLQS 0.30% (n=1)
VPTYTWGENETDVFLLQS 0.30% (n=1)
LPTYNWGNNMSDVFLLQS 0.30% (n=1)
LPTYNWGANESDVFLLQS 0.30% (n=1)
LPTYNWGANETDVFLLQS 0.30% (n=1)
LPTYNWGDNVTDVFLLQS 0.30% (n=1)
LPTYSWGENESDVFLLQS 0.30% (n=1)
LPKYNWGENESDVFLLQS 0.30% (n=1)
LPTYNWGDNESDVFLLQG 0.30% (n=1)
LPTYNWGDNMSDVFLLQS 0.30% (n=1)
LPTYSWGENVSDVFLLQS 0.30% (n=1)
LPTYTWGENASDVFLLQS 0.30% (n=1)
NPTYTWGENVSDVFLLRS 0.30% (n=1)
LPTYNWGENETDVFLLRS 0.30% (n=1)
LPTYNWGVNVSDVFLLQS 0.30% (n=1)
LPTYSWGVNESDVFLLES 0.30% (n=1)
VPTYTWGENESDVFLLAS 0.30% (n=1)
VPTYPWGGNDSDVFLLAS 0.30% (n=1)
VPTYNWGENETDVFLLES 0.30% (n=1)
LPTYGWGENETDVFLLAS 0.30% (n=1)
SPTYRWGENETDVFLLES 0.30% (n=1)
SPTYNWGDNESDVFLLAS 0.30% (n=1)
NPTYTWGDNKTDVFLLAS 0.30% (n=1)
LPTYNWGENESDVFLLAS 0.30% (n=1)
NPTYSWGENETDVFLLGS 0.30% (n=1)
LPTYTWGENMTDVFLLAS 0.30% (n=1)
LPTYTWGENETDVFLLAS 0.30% (n=1)
LPTYTWGENVSDVFLLTS 0.30% (n=1)
LPTYSWGENESDVFLLMS 0.30% (n=1)
NPTYTWGENETDVFILNS 0.30% (n=1)
NPTYTWGENETDVFILGS 0.30% (n=1)
TPTYTWGENETDVFILNS 0.30% (n=1)
NPTYSWGENETDVFILDS 0.30% (n=1)
LPTYTWGANKTDVFLLSS 0.30% (n=1)
LPTYTLGENESDVFLLES 0.30% (n=1)
LPTYAWGENKSDVFLLES 0.30% (n=1)
LPTYNWGANEGDVFLLES 0.30% (n=1)
LPTYNWGANESDVFLLES 0.30% (n=1)
FPTYTWGANESDVFLLES 0.30% (n=1)
FPTYTWGENDSDVFLLES 0.30% (n=1)
LPTYSWGANESDVFLLES 0.30% (n=1)
HPTYTWGENESDVFLLQT 0.30% (n=1)
LPTYTWGENETDVFLLES 0.30% (n=1)
IPTYNWGGNETDVFLLES 0.30% (n=1)
NPTYTWGENETDIFMLAS 0.30% (n=1)
NPTYNWGDNETDVFMLTS 0.30% (n=1)
APTYTWGENETDVLILQS 0.30% (n=1)
SPTYTWGEHETDVFILQS 0.30% (n=1)
APTYTWGTNETDVFLLQS 0.30% (n=1)
FATYNWGENATDVFLLQG 0.30% (n=1)
SATYTWGENETDVFLLES 0.30% (n=1)
IPTYNWGENATDVFLLQS 0.30% (n=1)
LPTYTWGENETDVFLLQG 0.30% (n=1)
LPTYTWGVNETDVFLLTS 0.30% (n=1)
NPTYNWGENETDVFILSS 0.30% (n=1)
VPTYTWGENESDVFLMTS 0.30% (n=1)
NPTYTWGENETDVFMMSS 0.30% (n=1)
NPTYNWGENETDVFMMSS 0.30% (n=1)
APTFTWGANESDVFLMSS 0.30% (n=1)
KPTYTWGENETDVFIMES 0.30% (n=1)
APTYNFGENESDVFLMQS 0.30% (n=1)
VPTYNWGGNESDVFLLES 0.30% (n=1)
VPTYSWGENQSDVFLLTG 0.30% (n=1)
NPTYAWGENETDVFLLTS 0.30% (n=1)
TPTFTWGANKSDVFLLTS 0.30% (n=1)
NPTYTWGANETDVFMLYS 0.30% (n=1)
FPTYNWGANASDVFLLQS 0.30% (n=1)
FPTYNWGANESDVFLLQS 0.30% (n=1)
DPTYTWGGNESDVLILQS 0.30% (n=1)
NPTYTWGENETDVFLLAS 0.30% (n=1)
FPTYTWGENESDVFLLQS 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Subtype 6a:

NPTYTWGENETDVFMLES 61.02% (n=72)
NPTYTWGENETDVFILES 5.08% (n=6)
NPTYTWGENETDVFMLGS 4.24% (n=5)
NPTYTWGDNETDVFMLES 4.24% (n=5)
NPTYNWGDNETDVFMLES 2.54% (n=3)
NPTYTWGENETDVFMLDS 1.69% (n=2)
NPTYNWGENETDVFMLES 1.69% (n=2)
TPTYTWGENETDVFILES 1.69% (n=2)
NPTYTWGENESDVFMLES 0.85% (n=1)
NPTYTWGENVTDVFMLES 0.85% (n=1)
NPTYTWGENWTDVFMLDS 0.85% (n=1)
NPTYTWGQNETDVFMYDS 0.85% (n=1)
IPTYTWGENETDVFILES 0.85% (n=1)
NPTYTWGENETDVFMLQS 0.85% (n=1)
NPTYTWGENETDVFMLAS 0.85% (n=1)
NPTYSWGDNETDVFMLES 0.85% (n=1)
HPTYNWGENETDVLMLES 0.85% (n=1)
SPTYTWGDNETDVFMLES 0.85% (n=1)
KPTYTWGENETDVFILES 0.85% (n=1)
NPTYNWGENVTDVFILES 0.85% (n=1)
NPTYSWGENETDVFMLGS 0.85% (n=1)
NPTYHWGENETDVFMLES 0.85% (n=1)
NPTYNWGENETDVFMLDS 0.85% (n=1)
IPTYTWGENETDVFMLES 0.85% (n=1)
VPTYTWGENETDVFLLES 0.85% (n=1)
APTYTWGENETDVFILES 0.85% (n=1)
IPTYTWGENETDVFILKS 0.85% (n=1)
NPTYTWGKNETDVFMLES 0.85% (n=1)
NPTYTWGANETDVFMLES 0.85% (n=1)
---------------------------------------------------------------------------------------
Region 524-541 (antibodies: [AR3C] ), HCV Genotype 7:

VPTYTWGENESDVFLLNS 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 529-531 (antibodies: [AR3D] ), HCV Genotype 1:

WGE 57.05% (n=5835)
WGA 18.57% (n=1899)
WGS 9.06% (n=927)
WGG 7.49% (n=766)
WGD 5.42% (n=554)
WGC 0.67% (n=69)
WGT 0.39% (n=40)
WGV 0.37% (n=38)
WGK 0.17% (n=17)
WGN 0.15% (n=15)
-GE 0.14% (n=14)
WGQ 0.11% (n=11)
WGR 0.07% (n=7)
WGI 0.05% (n=5)
SGA 0.05% (n=5)
RGE 0.04% (n=4)
FGE 0.02% (n=2)
RGA 0.02% (n=2)
LGY 0.02% (n=2)
WSE 0.02% (n=2)
WCA 0.01% (n=1)
*GD 0.01% (n=1)
WVE 0.01% (n=1)
CGE 0.01% (n=1)
FGA 0.01% (n=1)
FGT 0.01% (n=1)
*GE 0.01% (n=1)
WVS 0.01% (n=1)
WGM 0.01% (n=1)
WRE 0.01% (n=1)
GRG 0.01% (n=1)
WEE 0.01% (n=1)
LGE 0.01% (n=1)
RGG 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 1a:

WGE 49.79% (n=3617)
WGA 25.23% (n=1833)
WGS 12.76% (n=927)
WGD 7.14% (n=519)
WGG 2.59% (n=188)
WGC 0.94% (n=68)
WGT 0.52% (n=38)
WGV 0.33% (n=24)
WGQ 0.15% (n=11)
WGN 0.12% (n=9)
WGI 0.07% (n=5)
WGR 0.07% (n=5)
FGE 0.03% (n=2)
RGE 0.03% (n=2)
RGA 0.03% (n=2)
LGY 0.03% (n=2)
WSE 0.03% (n=2)
WGK 0.03% (n=2)
WCA 0.01% (n=1)
*GD 0.01% (n=1)
WVE 0.01% (n=1)
CGE 0.01% (n=1)
FGA 0.01% (n=1)
FGT 0.01% (n=1)
*GE 0.01% (n=1)
WVS 0.01% (n=1)
WGM 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 1b:

WGE 74.97% (n=2196)
WGG 19.73% (n=578)
WGA 2.15% (n=63)
WGD 1.09% (n=32)
WGK 0.51% (n=15)
WGV 0.48% (n=14)
-GE 0.48% (n=14)
WGN 0.20% (n=6)
RGE 0.07% (n=2)
WGT 0.07% (n=2)
WGR 0.07% (n=2)
WRE 0.03% (n=1)
GRG 0.03% (n=1)
WEE 0.03% (n=1)
LGE 0.03% (n=1)
RGG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 2:

WGE 80.49% (n=425)
WGD 14.39% (n=76)
WGA 2.08% (n=11)
WGG 0.95% (n=5)
GEG 0.76% (n=4)
WGV 0.57% (n=3)
WEG 0.19% (n=1)
WRR 0.19% (n=1)
WGQ 0.19% (n=1)
WEE 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 2a:

WGE 90.79% (n=69)
GEG 5.26% (n=4)
WGG 1.32% (n=1)
WEG 1.32% (n=1)
WGA 1.32% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 2b:

WGE 75.14% (n=263)
WGD 21.43% (n=75)
WGA 2.00% (n=7)
WGV 0.57% (n=2)
WRR 0.29% (n=1)
WGG 0.29% (n=1)
WGQ 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 2c:

WGE 91.94% (n=57)
WGA 3.23% (n=2)
WGG 3.23% (n=2)
WEE 1.61% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 3:

WGE 48.25% (n=1335)
WGA 34.04% (n=942)
FGE 7.84% (n=217)
FGA 4.66% (n=129)
WGG 2.31% (n=64)
WGT 0.65% (n=18)
FGG 0.40% (n=11)
WGV 0.25% (n=7)
WGD 0.25% (n=7)
FGD 0.18% (n=5)
LGE 0.14% (n=4)
WSE 0.11% (n=3)
WGM 0.11% (n=3)
WGQ 0.11% (n=3)
FGV 0.11% (n=3)
RGE 0.07% (n=2)
FGT 0.04% (n=1)
WDA 0.04% (n=1)
WSA 0.04% (n=1)
GGG 0.04% (n=1)
LSE 0.04% (n=1)
KSS 0.04% (n=1)
SND 0.04% (n=1)
RGA 0.04% (n=1)
WGS 0.04% (n=1)
WGR 0.04% (n=1)
W-E 0.04% (n=1)
GGA 0.04% (n=1)
YGT 0.04% (n=1)
FGS 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 3a:

WGE 56.40% (n=1331)
WGA 38.05% (n=898)
WGG 2.71% (n=64)
WGT 0.76% (n=18)
WGD 0.30% (n=7)
WGV 0.25% (n=6)
FGE 0.17% (n=4)
LGE 0.17% (n=4)
WSE 0.13% (n=3)
FGA 0.13% (n=3)
WGM 0.13% (n=3)
WGQ 0.13% (n=3)
RGE 0.08% (n=2)
FGT 0.04% (n=1)
WDA 0.04% (n=1)
WSA 0.04% (n=1)
GGG 0.04% (n=1)
LSE 0.04% (n=1)
KSS 0.04% (n=1)
SND 0.04% (n=1)
RGA 0.04% (n=1)
WGS 0.04% (n=1)
WGR 0.04% (n=1)
W-E 0.04% (n=1)
GGA 0.04% (n=1)
YGT 0.04% (n=1)
FGG 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 3b:

FGE 58.96% (n=204)
FGA 36.42% (n=126)
FGG 2.31% (n=8)
FGD 1.16% (n=4)
FGV 0.87% (n=3)
FGS 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 4:

WGE 88.84% (n=207)
WGA 3.43% (n=8)
WGG 3.43% (n=8)
WGD 1.29% (n=3)
WGV 1.29% (n=3)
LGG 0.43% (n=1)
WGT 0.43% (n=1)
FGG 0.43% (n=1)
WGQ 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 4a:

WGE 97.50% (n=156)
WGA 0.63% (n=1)
WGG 0.63% (n=1)
LGG 0.63% (n=1)
WGD 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 4d:

WGE 84.62% (n=11)
WGG 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 5:

WGS 52.63% (n=20)
WGE 36.84% (n=14)
WGD 2.63% (n=1)
WGA 2.63% (n=1)
WGT 2.63% (n=1)
WGV 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 6:

WGE 74.64% (n=262)
WGA 9.40% (n=33)
WGD 7.98% (n=28)
WGG 3.42% (n=12)
WGV 1.42% (n=5)
WGT 0.85% (n=3)
FGE 0.57% (n=2)
FGD 0.57% (n=2)
WGQ 0.28% (n=1)
WGK 0.28% (n=1)
WGN 0.28% (n=1)
LGE 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Subtype 6a:

WGE 89.43% (n=110)
WGD 8.13% (n=10)
WGQ 0.81% (n=1)
WGK 0.81% (n=1)
WGA 0.81% (n=1)
---------------------------------------------------------------------------------------
Region 529-531 (antibodies: [AR3D] ), HCV Genotype 7:

WGE 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 1:

LYHVTNDC 58.54% (n=6629)
VYHVTNDC 24.36% (n=2758)
IYHVTNDC 9.08% (n=1028)
AYHVTNDC 2.32% (n=263)
MYHVTNDC 1.32% (n=149)
--HVTNDC 1.02% (n=115)
VYQVTNDC 0.55% (n=62)
-----NDC 0.54% (n=61)
GYHVTNDC 0.24% (n=27)
MYQVTNDC 0.11% (n=12)
VYYVTNDC 0.10% (n=11)
FYHVTNDC 0.09% (n=10)
AYQVTNDC 0.09% (n=10)
LYHATNDC 0.08% (n=9)
VCHVTNDC 0.07% (n=8)
--QVTNDC 0.07% (n=8)
VY------ 0.07% (n=8)
LYYVTNDC 0.06% (n=7)
LYQVTNDC 0.06% (n=7)
VYHVSNDC 0.06% (n=7)
IYQVTNDC 0.05% (n=6)
LYHVTNGC 0.05% (n=6)
PYHVTNDC 0.05% (n=6)
LYRVTNDC 0.04% (n=5)
TYHVTNDC 0.04% (n=4)
VYHATADC 0.04% (n=4)
SYHVTNDC 0.04% (n=4)
LYHVTNNC 0.03% (n=3)
LYHVANDC 0.03% (n=3)
LYHITNDC 0.03% (n=3)
LYHLTNDC 0.03% (n=3)
VYHATNDC 0.03% (n=3)
LYLVTNDC 0.03% (n=3)
VYHVANDC 0.03% (n=3)
LYHVTNHC 0.02% (n=2)
IYHVTNDR 0.02% (n=2)
LYHGNNAL 0.02% (n=2)
--HLTNDC 0.02% (n=2)
VYHVTSDC 0.02% (n=2)
VYLVTNDC 0.02% (n=2)
VYVVTNDC 0.02% (n=2)
VYAVTNDC 0.02% (n=2)
IYHVTDDC 0.02% (n=2)
IFHVTNDC 0.02% (n=2)
IYHVANDC 0.02% (n=2)
VYHVTDDC 0.02% (n=2)
VHHVTNDC 0.02% (n=2)
AYCVTNDC 0.02% (n=2)
IYHITNDC 0.02% (n=2)
----TNDC 0.01% (n=1)
LYHVTNDR 0.01% (n=1)
IYHDTNDC 0.01% (n=1)
LCHVTNDC 0.01% (n=1)
LYHVTNDS 0.01% (n=1)
LYHVTKDG 0.01% (n=1)
LYHVTNDG 0.01% (n=1)
LYHVTNDW 0.01% (n=1)
LHHVTNDC 0.01% (n=1)
LCYVTNDC 0.01% (n=1)
LYHVTQES 0.01% (n=1)
PRGFTMSP 0.01% (n=1)
HYHVTNDC 0.01% (n=1)
LYHVTDDC 0.01% (n=1)
NFTMSKPA 0.01% (n=1)
FYHVTNGC 0.01% (n=1)
LYHVTIDC 0.01% (n=1)
LYHVTSDC 0.01% (n=1)
IYYVTNDC 0.01% (n=1)
SYYATNDC 0.01% (n=1)
IYHVT--- 0.01% (n=1)
IYHVTNGC 0.01% (n=1)
IYHLTNDC 0.01% (n=1)
VYHATSDC 0.01% (n=1)
VYHATDDC 0.01% (n=1)
VYHVMNDC 0.01% (n=1)
----TSDC 0.01% (n=1)
VHHVTSD- 0.01% (n=1)
VYHVTNN- 0.01% (n=1)
MYHLTNDC 0.01% (n=1)
---VTNDC 0.01% (n=1)
VYHVTHDC 0.01% (n=1)
DVHGSYYC 0.01% (n=1)
VYHVTNDR 0.01% (n=1)
VYHVTIDC 0.01% (n=1)
VYHVTNNC 0.01% (n=1)
VNHVTNDC 0.01% (n=1)
VYRVTNDC 0.01% (n=1)
VYHVTNDY 0.01% (n=1)
VYHVTNDF 0.01% (n=1)
VYHLTNDC 0.01% (n=1)
QYHVTNDC 0.01% (n=1)
VYMVTNDC 0.01% (n=1)
-YHVTNDC 0.01% (n=1)
MYLVSNDC 0.01% (n=1)
KYLVSNDC 0.01% (n=1)
ADHVTNDC 0.01% (n=1)
VYIVTNDC 0.01% (n=1)
SYHITNDC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 1a:

LYHVTNDC 89.23% (n=6568)
IYHVTNDC 8.56% (n=630)
-----NDC 0.83% (n=61)
VYHVTNDC 0.23% (n=17)
FYHVTNDC 0.14% (n=10)
LYHATNDC 0.12% (n=9)
LYYVTNDC 0.10% (n=7)
LYHVTNGC 0.08% (n=6)
PYHVTNDC 0.08% (n=6)
LYRVTNDC 0.07% (n=5)
LYHVTNNC 0.04% (n=3)
LYHVANDC 0.04% (n=3)
LYHITNDC 0.04% (n=3)
LYHLTNDC 0.04% (n=3)
LYHVTNHC 0.03% (n=2)
IYHVTNDR 0.03% (n=2)
LYHGNNAL 0.03% (n=2)
----TNDC 0.01% (n=1)
LYHVTNDR 0.01% (n=1)
IYHDTNDC 0.01% (n=1)
LCHVTNDC 0.01% (n=1)
LYHVTNDS 0.01% (n=1)
TYHVTNDC 0.01% (n=1)
LYQVTNDC 0.01% (n=1)
LYHVTKDG 0.01% (n=1)
LYHVTNDG 0.01% (n=1)
LYHVTNDW 0.01% (n=1)
LHHVTNDC 0.01% (n=1)
LCYVTNDC 0.01% (n=1)
LYHVTQES 0.01% (n=1)
PRGFTMSP 0.01% (n=1)
HYHVTNDC 0.01% (n=1)
LYHVTDDC 0.01% (n=1)
NFTMSKPA 0.01% (n=1)
FYHVTNGC 0.01% (n=1)
LYHVTIDC 0.01% (n=1)
LYHVTSDC 0.01% (n=1)
IYYVTNDC 0.01% (n=1)
SYYATNDC 0.01% (n=1)
IYHVT--- 0.01% (n=1)
IYHVTNGC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 1b:

VYHVTNDC 69.60% (n=2717)
IYHVTNDC 9.76% (n=381)
AYHVTNDC 6.74% (n=263)
MYHVTNDC 3.79% (n=148)
--HVTNDC 2.95% (n=115)
VYQVTNDC 1.59% (n=62)
LYHVTNDC 1.36% (n=53)
GYHVTNDC 0.67% (n=26)
MYQVTNDC 0.31% (n=12)
VYYVTNDC 0.28% (n=11)
AYQVTNDC 0.26% (n=10)
VCHVTNDC 0.20% (n=8)
--QVTNDC 0.20% (n=8)
VY------ 0.20% (n=8)
VYHVSNDC 0.18% (n=7)
LYQVTNDC 0.13% (n=5)
VYHATADC 0.10% (n=4)
SYHVTNDC 0.10% (n=4)
VYHATNDC 0.08% (n=3)
TYHVTNDC 0.08% (n=3)
LYLVTNDC 0.08% (n=3)
VYHVANDC 0.08% (n=3)
--HLTNDC 0.05% (n=2)
VYHVTSDC 0.05% (n=2)
VYLVTNDC 0.05% (n=2)
VYVVTNDC 0.05% (n=2)
VYAVTNDC 0.05% (n=2)
IYHVTDDC 0.05% (n=2)
IFHVTNDC 0.05% (n=2)
IYHVANDC 0.05% (n=2)
VYHVTDDC 0.05% (n=2)
VHHVTNDC 0.05% (n=2)
AYCVTNDC 0.05% (n=2)
IYQVTNDC 0.05% (n=2)
IYHLTNDC 0.03% (n=1)
VYHATSDC 0.03% (n=1)
VYHATDDC 0.03% (n=1)
VYHVMNDC 0.03% (n=1)
----TSDC 0.03% (n=1)
VHHVTSD- 0.03% (n=1)
VYHVTNN- 0.03% (n=1)
MYHLTNDC 0.03% (n=1)
---VTNDC 0.03% (n=1)
VYHVTHDC 0.03% (n=1)
DVHGSYYC 0.03% (n=1)
VYHVTNDR 0.03% (n=1)
VYHVTIDC 0.03% (n=1)
VYHVTNNC 0.03% (n=1)
VNHVTNDC 0.03% (n=1)
VYRVTNDC 0.03% (n=1)
VYHVTNDY 0.03% (n=1)
VYHVTNDF 0.03% (n=1)
VYHLTNDC 0.03% (n=1)
QYHVTNDC 0.03% (n=1)
VYMVTNDC 0.03% (n=1)
-YHVTNDC 0.03% (n=1)
MYLVSNDC 0.03% (n=1)
KYLVSNDC 0.03% (n=1)
ADHVTNDC 0.03% (n=1)
VYIVTNDC 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 2:

SYMVTNDC 43.10% (n=409)
SYYATNDC 34.04% (n=323)
GYMVTNDC 8.54% (n=81)
IYMVTNDC 3.16% (n=30)
SYMATNDC 2.85% (n=27)
GYYATNDC 1.48% (n=14)
TYMVTNDC 1.26% (n=12)
TYMATNDC 0.95% (n=9)
IYMATNDC 0.74% (n=7)
--MVTNDC 0.53% (n=5)
AYMVTNDC 0.42% (n=4)
NYMVTNDC 0.32% (n=3)
AYMATNDC 0.21% (n=2)
IYYATNDC 0.21% (n=2)
GYYTTNDC 0.21% (n=2)
LYVATNDC 0.21% (n=2)
LYMVTNDC 0.21% (n=2)
SYMVANDC 0.11% (n=1)
GYMLTNDC 0.11% (n=1)
SYMLTNDC 0.11% (n=1)
GYHATNDC 0.11% (n=1)
--YATNDC 0.11% (n=1)
SYYTTNDC 0.11% (n=1)
LYMATNDC 0.11% (n=1)
SYILTNDC 0.11% (n=1)
SYMPTNDC 0.11% (n=1)
LYIVTNDC 0.11% (n=1)
LYTVTNDC 0.11% (n=1)
LYIATNDC 0.11% (n=1)
FYMATNDC 0.11% (n=1)
IYQVTNDC 0.11% (n=1)
MYQVTNDC 0.11% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 2a:

SYMVTNDC 75.05% (n=367)
GYMVTNDC 14.11% (n=69)
IYMVTNDC 6.13% (n=30)
TYMVTNDC 1.23% (n=6)
--MVTNDC 1.02% (n=5)
NYMVTNDC 0.61% (n=3)
AYMVTNDC 0.61% (n=3)
AYMATNDC 0.20% (n=1)
SYMVANDC 0.20% (n=1)
IYMATNDC 0.20% (n=1)
GYMLTNDC 0.20% (n=1)
SYMATNDC 0.20% (n=1)
SYMLTNDC 0.20% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 2b:

SYYATNDC 93.88% (n=322)
GYYATNDC 4.08% (n=14)
IYYATNDC 0.58% (n=2)
GYYTTNDC 0.58% (n=2)
GYHATNDC 0.29% (n=1)
--YATNDC 0.29% (n=1)
SYYTTNDC 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 2c:

SYMATNDC 52.50% (n=21)
SYMVTNDC 32.50% (n=13)
LYVATNDC 5.00% (n=2)
LYMATNDC 2.50% (n=1)
SYILTNDC 2.50% (n=1)
SYMPTNDC 2.50% (n=1)
LYMVTNDC 2.50% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 3:

LYVLTNDC 50.37% (n=1277)
LYILTNDC 43.23% (n=1096)
LYLLTNDC 2.33% (n=59)
LYMLTNDC 1.66% (n=42)
LYTLTNDC 0.71% (n=18)
LYTVTNDC 0.28% (n=7)
LYVVTNDC 0.12% (n=3)
LYIVTNDC 0.12% (n=3)
LYMVTNDC 0.12% (n=3)
LHVLTNDC 0.08% (n=2)
LYVRTNDC 0.08% (n=2)
L------- 0.08% (n=2)
LYVITNDC 0.08% (n=2)
PYVLTNDC 0.04% (n=1)
LYVLTNYC 0.04% (n=1)
LYVLTHDC 0.04% (n=1)
LYVLTNAR 0.04% (n=1)
LYVLANGC 0.04% (n=1)
LYVPTNDC 0.04% (n=1)
LYALTNDC 0.04% (n=1)
LYVLTNNC 0.04% (n=1)
LYILTNHC 0.04% (n=1)
-YVLTNDC 0.04% (n=1)
LYFLTNDC 0.04% (n=1)
LYIITNDC 0.04% (n=1)
LYILTNDS 0.04% (n=1)
LCVLTNDC 0.04% (n=1)
IYILTNDC 0.04% (n=1)
SYILTNDC 0.04% (n=1)
LYVSTNDC 0.04% (n=1)
QYMLTNDC 0.04% (n=1)
IYMVTNDC 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 3a:

LYVLTNDC 59.70% (n=1212)
LYILTNDC 36.55% (n=742)
LYLLTNDC 2.36% (n=48)
LHVLTNDC 0.10% (n=2)
LYVRTNDC 0.10% (n=2)
L------- 0.10% (n=2)
LYVVTNDC 0.10% (n=2)
LYIVTNDC 0.10% (n=2)
PYVLTNDC 0.05% (n=1)
LYVLTNYC 0.05% (n=1)
LYVLTHDC 0.05% (n=1)
LYVLTNAR 0.05% (n=1)
LYVLANGC 0.05% (n=1)
LYVPTNDC 0.05% (n=1)
LYALTNDC 0.05% (n=1)
LYVLTNNC 0.05% (n=1)
LYVITNDC 0.05% (n=1)
LYILTNHC 0.05% (n=1)
-YVLTNDC 0.05% (n=1)
LYFLTNDC 0.05% (n=1)
LYIITNDC 0.05% (n=1)
LYILTNDS 0.05% (n=1)
LCVLTNDC 0.05% (n=1)
IYILTNDC 0.05% (n=1)
SYILTNDC 0.05% (n=1)
LYVSTNDC 0.05% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 3b:

LYILTNDC 72.83% (n=319)
LYVLTNDC 13.47% (n=59)
LYMLTNDC 9.13% (n=40)
LYLLTNDC 2.51% (n=11)
LYTLTNDC 1.60% (n=7)
QYMLTNDC 0.23% (n=1)
LYVITNDC 0.23% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 4:

IYHVTNDC 25.31% (n=161)
IYHITNDC 22.33% (n=142)
VYHITNDC 21.86% (n=139)
VYHVTNDC 15.72% (n=100)
VY------ 5.82% (n=37)
IY------ 3.14% (n=20)
VYYVTNDC 2.04% (n=13)
IYYVTNDC 0.94% (n=6)
VYYITNDC 0.63% (n=4)
IYHLTNDC 0.47% (n=3)
IYQVTNDC 0.47% (n=3)
IYPLSNDC 0.31% (n=2)
IYPLYKDC 0.16% (n=1)
IYHPSNDC 0.16% (n=1)
IYHVSNDC 0.16% (n=1)
TYYVTNDC 0.16% (n=1)
VCHVTNDC 0.16% (n=1)
GYYITNDC 0.16% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 4a:

IYHVTNDC 41.89% (n=111)
IYHITNDC 30.57% (n=81)
VYHVTNDC 17.74% (n=47)
VYHITNDC 5.66% (n=15)
VYYVTNDC 2.26% (n=6)
IYPLSNDC 0.75% (n=2)
IYPLYKDC 0.38% (n=1)
IYHPSNDC 0.38% (n=1)
IYHVSNDC 0.38% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 4d:

VYHITNDC 53.49% (n=69)
VYHVTNDC 36.43% (n=47)
VYYVTNDC 3.88% (n=5)
IYHVTNDC 1.55% (n=2)
IYHITNDC 1.55% (n=2)
VYYITNDC 1.55% (n=2)
TYYVTNDC 0.78% (n=1)
VCHVTNDC 0.78% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 5:

IYHVTNDC 70.63% (n=202)
VYHVTNDC 20.28% (n=58)
LYHVTNDC 4.20% (n=12)
IYYVTNDC 1.75% (n=5)
IYHITNDC 1.75% (n=5)
VYHLTNDC 0.35% (n=1)
LYYVTNDC 0.35% (n=1)
VSHVTNDC 0.35% (n=1)
IYHFTNDC 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 6:

LYHLTNDC 73.33% (n=1042)
IYHLTNDC 15.34% (n=218)
LYYLTNDC 5.98% (n=85)
VYHLTNDC 1.97% (n=28)
LYHVTNDC 0.84% (n=12)
IYQLTNDC 0.77% (n=11)
MYHLTNDC 0.28% (n=4)
IYHVTNDC 0.28% (n=4)
QYYLTNDC 0.14% (n=2)
VYHITNDC 0.14% (n=2)
LYHLTNDF 0.07% (n=1)
LYHITNDC 0.07% (n=1)
LYQLTNDC 0.07% (n=1)
IYYLTNDC 0.07% (n=1)
IYHLTTDC 0.07% (n=1)
NYHLTNDC 0.07% (n=1)
-YHLTNDC 0.07% (n=1)
-----NDC 0.07% (n=1)
SYHLTNDC 0.07% (n=1)
IYHLTYDC 0.07% (n=1)
IYHLINDC 0.07% (n=1)
VYHVTNDC 0.07% (n=1)
LYYVTNDC 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Subtype 6a:

LYHLTNDC 97.01% (n=941)
LYYLTNDC 1.75% (n=17)
LYHVTNDC 0.41% (n=4)
IYHLTNDC 0.31% (n=3)
QYYLTNDC 0.21% (n=2)
LYHLTNDF 0.10% (n=1)
LYHITNDC 0.10% (n=1)
LYQLTNDC 0.10% (n=1)
---------------------------------------------------------------------------------------
Region 200-207 (antibodies: [AR4A, AR5A] ), HCV Genotype 7:

VYHLTNDC 75.00% (n=3)
LYHLTNDC 25.00% (n=1)
---------------------------------------------------------------------------------------

Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 1:

DRD 99.30% (n=7799)
HRD 0.29% (n=23)
DRG 0.11% (n=9)
DGD 0.08% (n=6)
GRD 0.06% (n=5)
DWD 0.04% (n=3)
AQQ 0.03% (n=2)
DKD 0.03% (n=2)
NRD 0.03% (n=2)
GRG 0.01% (n=1)
DRN 0.01% (n=1)
VRD 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 1a:

DRD 99.59% (n=6006)
DRG 0.13% (n=8)
DGD 0.08% (n=5)
GRD 0.05% (n=3)
DWD 0.05% (n=3)
DKD 0.03% (n=2)
HRD 0.02% (n=1)
GRG 0.02% (n=1)
DRN 0.02% (n=1)
VRD 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 1b:

DRD 98.44% (n=1762)
HRD 1.23% (n=22)
NRD 0.11% (n=2)
GRD 0.11% (n=2)
DGD 0.06% (n=1)
DRG 0.06% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 2:

DRD 98.05% (n=452)
HRD 1.08% (n=5)
NRD 0.43% (n=2)
QRD 0.22% (n=1)
GQG 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 2a:

DRD 89.39% (n=59)
HRD 7.58% (n=5)
QRD 1.52% (n=1)
NRD 1.52% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 2b:

DRD 99.70% (n=334)
GQG 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 2c:

DRD 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 3:

DRD 99.40% (n=2479)
DRG 0.16% (n=4)
DHD 0.08% (n=2)
DCD 0.08% (n=2)
DRY 0.04% (n=1)
GRD 0.04% (n=1)
DRN 0.04% (n=1)
D-- 0.04% (n=1)
D-D 0.04% (n=1)
NRD 0.04% (n=1)
YPD 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 3a:

DRD 99.35% (n=2300)
DRG 0.17% (n=4)
DHD 0.09% (n=2)
DCD 0.09% (n=2)
DRY 0.04% (n=1)
GRD 0.04% (n=1)
DRN 0.04% (n=1)
D-- 0.04% (n=1)
D-D 0.04% (n=1)
NRD 0.04% (n=1)
YPD 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 3b:

DRD 100.00% (n=160)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 4:

HRD 95.63% (n=197)
DRD 4.37% (n=9)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 4a:

HRD 100.00% (n=132)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 4d:

HRD 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 5:

DRD 100.00% (n=37)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 6:

DRD 99.10% (n=221)
DRN 0.45% (n=1)
DRG 0.45% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Subtype 6a:

DRD 99.02% (n=101)
DRN 0.98% (n=1)
---------------------------------------------------------------------------------------
Region 656-658 (antibodies: [AR4A, AR5A] ), HCV Genotype 7:

DRD 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 691-693 (antibodies: [AR4A] ), HCV Genotype 1:

HLH 99.69% (n=7810)
HPH 0.09% (n=7)
HLY 0.04% (n=3)
HIH 0.04% (n=3)
RLH 0.03% (n=2)
HLL 0.03% (n=2)
HLR 0.03% (n=2)
HRH 0.03% (n=2)
RIP 0.01% (n=1)
PLH 0.01% (n=1)
HLQ 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 1a:

HLH 99.72% (n=5998)
HPH 0.10% (n=6)
HLY 0.03% (n=2)
RLH 0.03% (n=2)
HLR 0.03% (n=2)
HRH 0.03% (n=2)
RIP 0.02% (n=1)
HIH 0.02% (n=1)
HLL 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 1b:

HLH 99.61% (n=1782)
HIH 0.11% (n=2)
HLY 0.06% (n=1)
HLL 0.06% (n=1)
HPH 0.06% (n=1)
PLH 0.06% (n=1)
HLQ 0.06% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 2:

HLH 100.00% (n=461)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 2a:

HLH 100.00% (n=66)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 2b:

HLH 100.00% (n=335)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 2c:

HLH 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 3:

HLH 99.48% (n=2486)
HPH 0.12% (n=3)
HHH 0.12% (n=3)
RLH 0.04% (n=1)
HLY 0.04% (n=1)
YLH 0.04% (n=1)
HLP 0.04% (n=1)
PLH 0.04% (n=1)
HLR 0.04% (n=1)
HFH 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 3a:

HLH 99.53% (n=2310)
HPH 0.13% (n=3)
HHH 0.13% (n=3)
RLH 0.04% (n=1)
HLY 0.04% (n=1)
YLH 0.04% (n=1)
HLP 0.04% (n=1)
PLH 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 3b:

HLH 98.75% (n=158)
HLR 0.63% (n=1)
HFH 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 4:

HLH 100.00% (n=205)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 4a:

HLH 100.00% (n=132)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 4d:

HLH 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 5:

HLH 100.00% (n=37)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 6:

HLH 100.00% (n=224)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Subtype 6a:

HLH 100.00% (n=102)
---------------------------------------------------------------------------------------
Region 691-693 (antibodies: [AR4A] ), HCV Genotype 7:

HLH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 697-699 (antibodies: [AR4A] ), HCV Genotype 1:

VDV 98.33% (n=7697)
VDI 1.32% (n=103)
VDA 0.10% (n=8)
VDM 0.06% (n=5)
VAV 0.03% (n=2)
ADV 0.03% (n=2)
VGV 0.03% (n=2)
LDM 0.01% (n=1)
VDT 0.01% (n=1)
VNV 0.01% (n=1)
VDL 0.01% (n=1)
VEV 0.01% (n=1)
VVV 0.01% (n=1)
GDV 0.01% (n=1)
VHA 0.01% (n=1)
MDV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 1a:

VDV 99.58% (n=5989)
VDA 0.12% (n=7)
VDM 0.05% (n=3)
VAV 0.03% (n=2)
VDI 0.03% (n=2)
ADV 0.03% (n=2)
VGV 0.03% (n=2)
LDM 0.02% (n=1)
VDT 0.02% (n=1)
VNV 0.02% (n=1)
VDL 0.02% (n=1)
VEV 0.02% (n=1)
VVV 0.02% (n=1)
GDV 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 1b:

VDV 94.51% (n=1686)
VDI 5.21% (n=93)
VDM 0.11% (n=2)
VHA 0.06% (n=1)
MDV 0.06% (n=1)
VDA 0.06% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 2:

VDV 99.35% (n=458)
ADV 0.22% (n=1)
GNV 0.22% (n=1)
VDT 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 2a:

VDV 98.48% (n=65)
ADV 1.52% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 2b:

VDV 99.40% (n=333)
GNV 0.30% (n=1)
VDT 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 2c:

VDV 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 3:

VDV 98.52% (n=2459)
VDI 1.00% (n=25)
VDA 0.16% (n=4)
VGV 0.16% (n=4)
VDF 0.08% (n=2)
VNV 0.04% (n=1)
VDT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 3a:

VDV 98.53% (n=2284)
VDI 1.08% (n=25)
VDA 0.17% (n=4)
VDF 0.09% (n=2)
VGV 0.04% (n=1)
VNV 0.04% (n=1)
VDT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 3b:

VDV 98.13% (n=157)
VGV 1.88% (n=3)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 4:

VDV 98.54% (n=203)
VDI 1.46% (n=3)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 4a:

VDV 100.00% (n=133)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 4d:

VDV 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 5:

VDT 100.00% (n=37)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 6:

VDV 90.18% (n=202)
VDI 5.36% (n=12)
VDT 4.46% (n=10)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Subtype 6a:

VDV 95.10% (n=97)
VDI 2.94% (n=3)
VDT 1.96% (n=2)
---------------------------------------------------------------------------------------
Region 697-699 (antibodies: [AR4A] ), HCV Genotype 7:

VDA 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 638-640 (antibodies: [AR5A] ), HCV Genotype 1:

HRL 98.66% (n=7750)
HRF 0.76% (n=60)
HRI 0.20% (n=16)
HRP 0.09% (n=7)
HGL 0.08% (n=6)
HRM 0.04% (n=3)
RRL 0.04% (n=3)
HRV 0.04% (n=3)
HQL 0.03% (n=2)
QRL 0.03% (n=2)
HRQ 0.01% (n=1)
NRL 0.01% (n=1)
HKL 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 1a:

HRL 99.72% (n=6018)
HGL 0.10% (n=6)
HRM 0.05% (n=3)
RRL 0.03% (n=2)
H-- 0.03% (n=2)
HRV 0.02% (n=1)
HRQ 0.02% (n=1)
HRP 0.02% (n=1)
NRL 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 1b:

HRL 95.36% (n=1707)
HRF 3.07% (n=55)
HRI 0.89% (n=16)
HRP 0.34% (n=6)
QRL 0.11% (n=2)
HRV 0.11% (n=2)
HKL 0.06% (n=1)
RRL 0.06% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 2:

HRL 86.33% (n=398)
HRF 11.06% (n=51)
HRM 1.30% (n=6)
PRL 0.43% (n=2)
NRL 0.22% (n=1)
HAL 0.22% (n=1)
QRL 0.22% (n=1)
HRV 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 2a:

HRL 98.48% (n=65)
NRL 1.52% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 2b:

HRL 84.18% (n=282)
HRF 13.13% (n=44)
HRM 1.49% (n=5)
PRL 0.60% (n=2)
HAL 0.30% (n=1)
QRL 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 2c:

HRL 95.00% (n=19)
HRF 5.00% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 3:

HRF 93.63% (n=2339)
HRL 5.40% (n=135)
HRV 0.32% (n=8)
HRI 0.24% (n=6)
HWF 0.16% (n=4)
H-- 0.08% (n=2)
HRS 0.08% (n=2)
PRF 0.04% (n=1)
RRF 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 3a:

HRF 93.32% (n=2164)
HRL 5.65% (n=131)
HRV 0.34% (n=8)
HRI 0.26% (n=6)
HWF 0.17% (n=4)
H-- 0.09% (n=2)
HRS 0.09% (n=2)
PRF 0.04% (n=1)
RRF 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 3b:

HRF 100.00% (n=160)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 4:

HRM 61.95% (n=127)
HRL 34.63% (n=71)
HRV 2.93% (n=6)
HHM 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 4a:

HRM 94.66% (n=124)
HRL 2.29% (n=3)
HRV 2.29% (n=3)
HHM 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 4d:

HRL 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 5:

HRL 94.59% (n=35)
HRF 5.41% (n=2)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 6:

HRF 90.09% (n=200)
HRL 7.66% (n=17)
QRF 1.35% (n=3)
HRI 0.45% (n=1)
HQF 0.45% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Subtype 6a:

HRF 99.02% (n=101)
HRL 0.98% (n=1)
---------------------------------------------------------------------------------------
Region 638-640 (antibodies: [AR5A] ), HCV Genotype 7:

HRL 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 1:

GFLAA 22.61% (n=5190)
GWIAG 21.97% (n=5043)
GWVAG 17.55% (n=4028)
GWLAG 15.23% (n=3496)
GFIAA 10.14% (n=2327)
GWLAA 2.67% (n=614)
GFIAG 1.96% (n=449)
GFFAA 1.80% (n=414)
GFISA 1.22% (n=281)
GWVAA 0.56% (n=129)
GFLAS 0.47% (n=107)
GFLAG 0.45% (n=103)
GWMAG 0.43% (n=99)
GFVAA 0.37% (n=85)
GWIAA 0.31% (n=71)
GFITA 0.28% (n=65)
GWLTG 0.19% (n=43)
GWITG 0.19% (n=43)
GFVAG 0.18% (n=41)
GWLAS 0.11% (n=26)
GFLTA 0.10% (n=23)
GFFTA 0.10% (n=23)
GFLSA 0.07% (n=17)
GFIAS 0.06% (n=13)
GFFSA 0.06% (n=13)
GWLVG 0.05% (n=11)
GWVTG 0.04% (n=10)
GLLAA 0.04% (n=9)
GSLAA 0.03% (n=7)
DWLAG 0.03% (n=6)
GWAAG 0.03% (n=6)
GRVAG 0.02% (n=5)
GFITS 0.02% (n=5)
AWIAG 0.02% (n=5)
AGIAG 0.02% (n=5)
G*VAG 0.02% (n=5)
GFIAT 0.02% (n=5)
GFMAG 0.02% (n=4)
GFTAG 0.02% (n=4)
GWIVG 0.02% (n=4)
GW--- 0.02% (n=4)
GFLAV 0.02% (n=4)
G*IAG 0.01% (n=3)
GWLAR 0.01% (n=3)
GGVAG 0.01% (n=3)
DWVAG 0.01% (n=3)
GWTAG 0.01% (n=3)
SWLAG 0.01% (n=3)
GWFVG 0.01% (n=3)
GFLAT 0.01% (n=3)
EFLAA 0.01% (n=3)
GFLVA 0.01% (n=3)
GFMAA 0.01% (n=3)
GSIAA 0.01% (n=3)
G*LAG 0.01% (n=2)
GWGAG 0.01% (n=2)
GRIAG 0.01% (n=2)
AWLAG 0.01% (n=2)
GWKAG 0.01% (n=2)
GWVAR 0.01% (n=2)
GWLAW 0.01% (n=2)
GFIDA 0.01% (n=2)
GVLAA 0.01% (n=2)
GFVAS 0.01% (n=2)
GFIAE 0.01% (n=2)
GFFVA 0.01% (n=2)
RFPAA 0.01% (n=2)
GLIAA 0.01% (n=2)
GFPAA 0.01% (n=2)
GFITR 0.00% (n=1)
SWVAG 0.00% (n=1)
GWDSR 0.00% (n=1)
RWIGR 0.00% (n=1)
GWLGS 0.00% (n=1)
GWEAG 0.00% (n=1)
GCLAG 0.00% (n=1)
GWIGG 0.00% (n=1)
GFITG 0.00% (n=1)
GLVAG 0.00% (n=1)
GYPAD 0.00% (n=1)
GWVAS 0.00% (n=1)
GWIRG 0.00% (n=1)
GCIAG 0.00% (n=1)
GWVAE 0.00% (n=1)
GRLVG 0.00% (n=1)
DFIAG 0.00% (n=1)
GLTAG 0.00% (n=1)
GLIAG 0.00% (n=1)
G*VAA 0.00% (n=1)
GWLAE 0.00% (n=1)
GWVVG 0.00% (n=1)
GWWRG 0.00% (n=1)
GWVPG 0.00% (n=1)
GWLSG 0.00% (n=1)
GFLTG 0.00% (n=1)
GWIA- 0.00% (n=1)
G---- 0.00% (n=1)
GGLAG 0.00% (n=1)
GWISG 0.00% (n=1)
GFLGA 0.00% (n=1)
GFLPA 0.00% (n=1)
GFLAE 0.00% (n=1)
RFLAA 0.00% (n=1)
GFIKA 0.00% (n=1)
GSLAS 0.00% (n=1)
GILAA 0.00% (n=1)
VFFAA 0.00% (n=1)
GFTAA 0.00% (n=1)
GFFTV 0.00% (n=1)
GFFAS 0.00% (n=1)
GFIAV 0.00% (n=1)
GFVSA 0.00% (n=1)
GFTSA 0.00% (n=1)
GWIAS 0.00% (n=1)
GFLVS 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 1a:

GWIAG 36.93% (n=5043)
GWVAG 29.46% (n=4023)
GWLAG 25.59% (n=3494)
GFIAG 2.87% (n=392)
GWVAA 0.85% (n=116)
GWMAG 0.72% (n=99)
GFLAG 0.67% (n=92)
GWLAA 0.51% (n=69)
GWIAA 0.43% (n=59)
GWLTG 0.31% (n=43)
GWITG 0.31% (n=43)
GFVAG 0.30% (n=41)
GWLVG 0.08% (n=11)
GWVTG 0.07% (n=10)
DWLAG 0.04% (n=6)
GWAAG 0.04% (n=6)
GRVAG 0.04% (n=5)
AWIAG 0.04% (n=5)
AGIAG 0.04% (n=5)
G*VAG 0.04% (n=5)
GFMAG 0.03% (n=4)
GFTAG 0.03% (n=4)
GWIVG 0.03% (n=4)
GW--- 0.03% (n=4)
G*IAG 0.02% (n=3)
GWLAR 0.02% (n=3)
GGVAG 0.02% (n=3)
DWVAG 0.02% (n=3)
GWTAG 0.02% (n=3)
SWLAG 0.02% (n=3)
GWLAS 0.02% (n=3)
GWFVG 0.02% (n=3)
G*LAG 0.01% (n=2)
GFITS 0.01% (n=2)
GWGAG 0.01% (n=2)
GRIAG 0.01% (n=2)
AWLAG 0.01% (n=2)
GWKAG 0.01% (n=2)
GWVAR 0.01% (n=2)
GWLAW 0.01% (n=2)
GFITR 0.01% (n=1)
SWVAG 0.01% (n=1)
GWDSR 0.01% (n=1)
RWIGR 0.01% (n=1)
GWLGS 0.01% (n=1)
GWEAG 0.01% (n=1)
GCLAG 0.01% (n=1)
GWIGG 0.01% (n=1)
GFITG 0.01% (n=1)
GLVAG 0.01% (n=1)
GFIAS 0.01% (n=1)
GYPAD 0.01% (n=1)
GWVAS 0.01% (n=1)
GFVAA 0.01% (n=1)
GWIRG 0.01% (n=1)
GCIAG 0.01% (n=1)
GWVAE 0.01% (n=1)
GRLVG 0.01% (n=1)
DFIAG 0.01% (n=1)
GLTAG 0.01% (n=1)
GLIAG 0.01% (n=1)
G*VAA 0.01% (n=1)
GWLAE 0.01% (n=1)
GWVVG 0.01% (n=1)
GWWRG 0.01% (n=1)
GWVPG 0.01% (n=1)
GWLSG 0.01% (n=1)
GFLTG 0.01% (n=1)
GWIA- 0.01% (n=1)
G---- 0.01% (n=1)
GFLAA 0.01% (n=1)
GGLAG 0.01% (n=1)
GWISG 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 1b:

GFLAA 55.99% (n=5180)
GFIAA 25.07% (n=2319)
GWLAA 5.85% (n=541)
GFFAA 4.48% (n=414)
GFISA 3.04% (n=281)
GFLAS 1.14% (n=105)
GFVAA 0.91% (n=84)
GFITA 0.70% (n=65)
GFIAG 0.59% (n=55)
GFLTA 0.25% (n=23)
GFFTA 0.25% (n=23)
GWLAS 0.22% (n=20)
GFLSA 0.18% (n=17)
GFFSA 0.14% (n=13)
GFIAS 0.13% (n=12)
GWIAA 0.13% (n=12)
GWVAA 0.12% (n=11)
GLLAA 0.10% (n=9)
GSLAA 0.08% (n=7)
GFIAT 0.05% (n=5)
GFLAV 0.04% (n=4)
GFLAG 0.03% (n=3)
GFLAT 0.03% (n=3)
GFITS 0.03% (n=3)
EFLAA 0.03% (n=3)
GFLVA 0.03% (n=3)
GFMAA 0.03% (n=3)
GSIAA 0.03% (n=3)
GFIDA 0.02% (n=2)
GVLAA 0.02% (n=2)
GFVAS 0.02% (n=2)
GFIAE 0.02% (n=2)
GFFVA 0.02% (n=2)
RFPAA 0.02% (n=2)
GLIAA 0.02% (n=2)
GFPAA 0.02% (n=2)
GFLGA 0.01% (n=1)
GFLPA 0.01% (n=1)
GFLAE 0.01% (n=1)
RFLAA 0.01% (n=1)
GFIKA 0.01% (n=1)
GSLAS 0.01% (n=1)
GILAA 0.01% (n=1)
VFFAA 0.01% (n=1)
GFTAA 0.01% (n=1)
GFFTV 0.01% (n=1)
GFFAS 0.01% (n=1)
GFIAV 0.01% (n=1)
GFVSA 0.01% (n=1)
GFTSA 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 2:

GFIAA 34.68% (n=464)
GFIAS 27.95% (n=374)
GFLAS 19.73% (n=264)
GFLAA 3.66% (n=49)
GWLAS 3.36% (n=45)
GFVAS 2.69% (n=36)
GFVAA 0.82% (n=11)
GFITS 0.82% (n=11)
GFMAS 0.60% (n=8)
GFFAA 0.52% (n=7)
GFISS 0.45% (n=6)
GFFAS 0.45% (n=6)
GFLVS 0.45% (n=6)
GWIHS 0.37% (n=5)
GFITA 0.30% (n=4)
GWIAS 0.30% (n=4)
GSIAA 0.30% (n=4)
GFMAA 0.22% (n=3)
GFISA 0.15% (n=2)
GFIVS 0.15% (n=2)
GFLTS 0.15% (n=2)
GFIAT 0.15% (n=2)
GCLSS 0.15% (n=2)
GFFTA 0.07% (n=1)
GFLGS 0.07% (n=1)
GFLSS 0.07% (n=1)
GFVCQ 0.07% (n=1)
GFVTQ 0.07% (n=1)
GFIRA 0.07% (n=1)
GFIHS 0.07% (n=1)
GWLAP 0.07% (n=1)
GLIAS 0.07% (n=1)
GFIAP 0.07% (n=1)
GFLSA 0.07% (n=1)
GFFSA 0.07% (n=1)
GFIAG 0.07% (n=1)
GFLTA 0.07% (n=1)
GWVAA 0.07% (n=1)
GFIAV 0.07% (n=1)
GLIAA 0.07% (n=1)
GIIAA 0.07% (n=1)
GFPAS 0.07% (n=1)
GLLAS 0.07% (n=1)
GFLAP 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 2a:

GFLAS 44.44% (n=124)
GFIAS 16.13% (n=45)
GFVAS 12.90% (n=36)
GFLAA 8.24% (n=23)
GFIAA 6.81% (n=19)
GFVAA 2.15% (n=6)
GFFAS 1.43% (n=4)
GFMAS 1.08% (n=3)
GFMAA 0.72% (n=2)
GFITA 0.72% (n=2)
GFIAT 0.72% (n=2)
GFLVS 0.72% (n=2)
GFFTA 0.36% (n=1)
GFISA 0.36% (n=1)
GFIVS 0.36% (n=1)
GFLGS 0.36% (n=1)
GFISS 0.36% (n=1)
GFLTS 0.36% (n=1)
GFLSS 0.36% (n=1)
GFVCQ 0.36% (n=1)
GFVTQ 0.36% (n=1)
GFITS 0.36% (n=1)
GFIRA 0.36% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 2b:

GFIAS 67.97% (n=314)
GWLAS 9.52% (n=44)
GFLAS 9.31% (n=43)
GFIAA 3.03% (n=14)
GFITS 2.16% (n=10)
GFMAS 1.08% (n=5)
GFISS 1.08% (n=5)
GWIHS 1.08% (n=5)
GWIAS 0.87% (n=4)
GFFAA 0.65% (n=3)
GCLSS 0.43% (n=2)
GFITA 0.43% (n=2)
GFVAA 0.43% (n=2)
GFMAA 0.22% (n=1)
GFIHS 0.22% (n=1)
GWLAP 0.22% (n=1)
GLIAS 0.22% (n=1)
GFIAP 0.22% (n=1)
GFLAA 0.22% (n=1)
GFFAS 0.22% (n=1)
GFIVS 0.22% (n=1)
GFLSA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 2c:

GFIAA 92.04% (n=416)
GFLAA 3.32% (n=15)
GFFAA 0.88% (n=4)
GSIAA 0.88% (n=4)
GFIAS 0.44% (n=2)
GFLAS 0.44% (n=2)
GFVAA 0.22% (n=1)
GFFSA 0.22% (n=1)
GFIAG 0.22% (n=1)
GFLTA 0.22% (n=1)
GWLAS 0.22% (n=1)
GWVAA 0.22% (n=1)
GFIAV 0.22% (n=1)
GLIAA 0.22% (n=1)
GIIAA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 3:

GFIAG 83.22% (n=3233)
GFLAG 9.91% (n=385)
GFLAA 4.48% (n=174)
GFVAG 0.80% (n=31)
GFLVG 0.59% (n=23)
GFMAG 0.21% (n=8)
GSIAG 0.13% (n=5)
GFFAG 0.13% (n=5)
RFLAG 0.10% (n=4)
GLIAG 0.08% (n=3)
GFIAR 0.05% (n=2)
GFIAE 0.05% (n=2)
GFITG 0.05% (n=2)
GFIVG 0.03% (n=1)
EFIAG 0.03% (n=1)
EFLAG 0.03% (n=1)
GFTAG 0.03% (n=1)
GS*LG 0.03% (n=1)
GSLAG 0.03% (n=1)
G-IAG 0.03% (n=1)
GFIAA 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 3a:

GFIAG 85.74% (n=2795)
GFLAG 11.72% (n=382)
GFVAG 0.77% (n=25)
GFLVG 0.71% (n=23)
GFMAG 0.25% (n=8)
GSIAG 0.15% (n=5)
GFFAG 0.15% (n=5)
RFLAG 0.12% (n=4)
GLIAG 0.09% (n=3)
GFIAE 0.06% (n=2)
GFIAR 0.03% (n=1)
GFIVG 0.03% (n=1)
EFIAG 0.03% (n=1)
GFITG 0.03% (n=1)
EFLAG 0.03% (n=1)
GFTAG 0.03% (n=1)
GS*LG 0.03% (n=1)
GSLAG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 3b:

GFIAG 97.50% (n=390)
GFVAG 1.25% (n=5)
GFLAG 0.50% (n=2)
GFIAR 0.25% (n=1)
G-IAG 0.25% (n=1)
GFITG 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 4:

GFIAS 40.31% (n=308)
GFLAS 36.91% (n=282)
GFIAG 10.99% (n=84)
GFLAG 6.02% (n=46)
GFLAN 1.57% (n=12)
GFLAA 1.05% (n=8)
GFFAS 0.52% (n=4)
GFIAA 0.52% (n=4)
GWLAS 0.39% (n=3)
GFIVS 0.26% (n=2)
GFLTG 0.13% (n=1)
GLIAS 0.13% (n=1)
GFITG 0.13% (n=1)
GFMVG 0.13% (n=1)
GFFAA 0.13% (n=1)
GFVAS 0.13% (n=1)
GWAAA 0.13% (n=1)
GWVAS 0.13% (n=1)
GWFAA 0.13% (n=1)
GWLAG 0.13% (n=1)
GFVAG 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 4a:

GFLAS 75.31% (n=122)
GFLAG 17.90% (n=29)
GFLAA 3.70% (n=6)
GFIAG 1.23% (n=2)
GFFAS 0.62% (n=1)
GFLAN 0.62% (n=1)
GFLTG 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 4d:

GFIAS 55.72% (n=302)
GFLAS 28.78% (n=156)
GFIAG 10.89% (n=59)
GFLAN 2.03% (n=11)
GFIAA 0.74% (n=4)
GFLAG 0.55% (n=3)
GFFAS 0.55% (n=3)
GFIVS 0.37% (n=2)
GLIAS 0.18% (n=1)
GFITG 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 5:

GFIAG 82.05% (n=32)
GFVAG 7.69% (n=3)
GFLAG 7.69% (n=3)
GFFAG 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 6:

GFIAS 43.03% (n=244)
GFIAG 23.46% (n=133)
GFLAG 7.58% (n=43)
GFIAA 6.17% (n=35)
GFVAS 4.23% (n=24)
GFLAS 2.65% (n=15)
GFVAA 1.94% (n=11)
GFMAA 1.59% (n=9)
GFMAS 1.23% (n=7)
GFITA 0.71% (n=4)
GFLAA 0.71% (n=4)
GFLSA 0.71% (n=4)
GFITS 0.53% (n=3)
GFFAA 0.53% (n=3)
GFVAG 0.53% (n=3)
GFFAS 0.35% (n=2)
GFLTS 0.35% (n=2)
GFISA 0.35% (n=2)
GFLAN 0.35% (n=2)
GFLAP 0.35% (n=2)
GWLAS 0.35% (n=2)
GFLTG 0.35% (n=2)
GFIVS 0.18% (n=1)
GFVSA 0.18% (n=1)
EFIAS 0.18% (n=1)
GFRAS 0.18% (n=1)
GFLVS 0.18% (n=1)
GFFVP 0.18% (n=1)
GFFTA 0.18% (n=1)
GFVTA 0.18% (n=1)
GFITG 0.18% (n=1)
GFFTS 0.18% (n=1)
GWLAG 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Subtype 6a:

GFIAS 72.19% (n=231)
GFVAS 7.50% (n=24)
GFIAA 7.19% (n=23)
GFVAA 3.13% (n=10)
GFLAS 2.81% (n=9)
GFMAS 1.56% (n=5)
GFMAA 1.25% (n=4)
GFITS 0.94% (n=3)
GFIAG 0.94% (n=3)
GFIVS 0.31% (n=1)
GFITA 0.31% (n=1)
GFVSA 0.31% (n=1)
GFLAA 0.31% (n=1)
GFFAS 0.31% (n=1)
EFIAS 0.31% (n=1)
GFLTS 0.31% (n=1)
GFRAS 0.31% (n=1)
---------------------------------------------------------------------------------------
Region 436-440 (antibodies: [CBH-2] ), HCV Genotype 7:

GFIAA 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 405-412 (antibodies: [H77.16] ), HCV Genotype 1:

PGAKQNIQ 11.07% (n=2586)
SGAKQNIQ 4.31% (n=1007)
PGARQNIQ 3.92% (n=915)
PGAKQNVQ 2.44% (n=570)
SGASQNIQ 2.23% (n=522)
PGPSQKIQ 2.00% (n=466)
PGASQKIQ 1.80% (n=420)
PGAQQDIQ 1.64% (n=383)
PGPKQNIQ 1.55% (n=361)
IGPSQKIQ 1.49% (n=349)
RGPKQNIQ 1.41% (n=330)
PGAMQNIQ 1.37% (n=321)
PGASQNIQ 1.36% (n=317)
SGASQKIQ 1.22% (n=284)
SGPSQKIQ 1.19% (n=278)
PGASQRIQ 1.18% (n=275)
PGAQQNVQ 1.16% (n=271)
QGAKQNIQ 1.14% (n=266)
PGPAQKLQ 1.11% (n=260)
SGARQNIQ 1.09% (n=255)
TGAKQNIQ 1.05% (n=246)
PGPSQNIQ 1.00% (n=233)
PGAQQNIQ 0.99% (n=231)
AGSRQNVQ 0.98% (n=229)
LGPSQKIQ 0.86% (n=201)
FGASQNIQ 0.84% (n=197)
PGPQQKIQ 0.84% (n=196)
PGAKQDIQ 0.82% (n=192)
PGAQQKIQ 0.82% (n=191)
FGASQKIQ 0.80% (n=187)
RGAQQNIQ 0.79% (n=184)
QGPKQNVH 0.78% (n=183)
LGPKQNIQ 0.78% (n=182)
PGARQNVQ 0.76% (n=178)
PGPSQKLQ 0.66% (n=155)
QGPQQKIQ 0.64% (n=150)
RGPKQNIH 0.64% (n=149)
PGPQQNIQ 0.62% (n=145)
LGPRQKLQ 0.60% (n=140)
AGSSQRIQ 0.58% (n=135)
QGAQQNIQ 0.57% (n=134)
VGASQKIQ 0.56% (n=130)
PGSRQHIQ 0.55% (n=129)
SGPKQNIQ 0.52% (n=122)
RGAKQNIQ 0.52% (n=122)
VGPSQKIQ 0.52% (n=122)
PGSKQNIQ 0.51% (n=118)
SGAQQNIQ 0.48% (n=111)
RGPSQKIQ 0.47% (n=109)
LGASQKIQ 0.46% (n=108)
QGARQNIQ 0.42% (n=98)
QGPKQNIQ 0.41% (n=95)
AGPSQKIQ 0.40% (n=94)
SGAKQNVQ 0.39% (n=92)
AGSSQNIQ 0.39% (n=91)
LGPQQKIQ 0.37% (n=87)
LGAKQDVQ 0.37% (n=87)
SGPSQNIQ 0.37% (n=86)
TGPKQNIQ 0.36% (n=85)
PGPAQNIQ 0.34% (n=79)
LGPSQKVQ 0.33% (n=78)
PGPAQKIQ 0.33% (n=77)
PGSRQNIQ 0.31% (n=72)
TGPKQDVQ 0.31% (n=72)
QGPSQKIQ 0.30% (n=71)
AGAKQNIQ 0.29% (n=68)
PGSSQKIQ 0.29% (n=68)
PGPS---- 0.29% (n=68)
PGASQNVQ 0.28% (n=66)
AGSSQKIQ 0.28% (n=66)
NGPSQKIQ 0.27% (n=64)
LGAKQNIQ 0.27% (n=64)
VGPSQNIQ 0.27% (n=64)
FGPSQKIQ 0.27% (n=64)
PGSAQKIQ 0.27% (n=64)
LGASQKLQ 0.26% (n=60)
LGSSQKIQ 0.25% (n=58)
PGASQQIQ 0.25% (n=58)
PGPSQNIK 0.24% (n=57)
QGAKQSIQ 0.24% (n=57)
RGSQQHIQ 0.24% (n=57)
RGAKQDIQ 0.24% (n=56)
PGPSQEIQ 0.24% (n=56)
SGPAQKIQ 0.24% (n=55)
VGPHQKIQ 0.24% (n=55)
SGPS---- 0.24% (n=55)
RGPKQDIQ 0.23% (n=54)
VGSKQNLQ 0.23% (n=53)
SGSSQNIQ 0.22% (n=52)
PGPTQKIQ 0.22% (n=52)
TGSYQKVQ 0.22% (n=52)
SGAKQDIQ 0.22% (n=51)
QGAKQDIQ 0.21% (n=50)
LGSRQNIQ 0.21% (n=49)
TGPSQNLQ 0.21% (n=49)
PGAKQRIQ 0.21% (n=48)
PGPRQNIQ 0.20% (n=47)
PGPSQDIQ 0.20% (n=47)
PGPAQTIQ 0.20% (n=47)
PGANQNIQ 0.20% (n=46)
PGPSQRIQ 0.20% (n=46)
AGPKQNIQ 0.19% (n=45)
QGPRQNIQ 0.19% (n=44)
PGPKQNVQ 0.19% (n=44)
PGAKQKIQ 0.19% (n=44)
PGSSQNIQ 0.18% (n=43)
PGPA---- 0.18% (n=43)
SGASQNIR 0.18% (n=43)
RGAQQKIQ 0.18% (n=41)
SGSRQNIQ 0.17% (n=40)
QGPGQKIQ 0.17% (n=40)
VGSSQRIQ 0.17% (n=40)
LGPSQNIQ 0.17% (n=39)
RGARQKLQ 0.16% (n=38)
SGPKQKIQ 0.16% (n=38)
PGASQKLQ 0.16% (n=37)
QGPKQKIQ 0.16% (n=37)
SGPKQDIK 0.15% (n=36)
PGPAQQIQ 0.15% (n=36)
TGPSQKIQ 0.15% (n=35)
RGPKQNVQ 0.14% (n=33)
QGPKQNVQ 0.14% (n=33)
SGAQQNVQ 0.14% (n=32)
RGPSQTIQ 0.14% (n=32)
LGSSQKVQ 0.13% (n=31)
RGASQKLQ 0.13% (n=31)
RGAQQSIQ 0.13% (n=30)
PGAKQDVQ 0.12% (n=29)
PGPKQDIQ 0.12% (n=29)
TGPRQKIQ 0.12% (n=29)
LGPTQKIQ 0.12% (n=29)
LGAQQKIQ 0.12% (n=28)
RGPSQNLQ 0.12% (n=28)
PGAKQNIR 0.12% (n=27)
PGPSQNLQ 0.12% (n=27)
VGPKQNIQ 0.12% (n=27)
AGPSQNIQ 0.12% (n=27)
RGPSQRIQ 0.12% (n=27)
SGPA---- 0.11% (n=25)
QGPKQDIQ 0.10% (n=24)
PGSRQKIQ 0.10% (n=24)
PGANQNVQ 0.10% (n=23)
LGAKQKIQ 0.10% (n=23)
RGPSQNIQ 0.10% (n=23)
IGPSQNIQ 0.10% (n=23)
FGPS---- 0.10% (n=23)
RGARQNIQ 0.09% (n=22)
LGPRQNIQ 0.09% (n=22)
LGSNQKIQ 0.09% (n=22)
RGPA---- 0.09% (n=22)
LGPS---- 0.09% (n=22)
RGPSQDIR 0.09% (n=21)
SGPQQNIQ 0.09% (n=21)
SGPSQRIQ 0.09% (n=21)
PGSYQKVQ 0.09% (n=21)
MGPKQNIQ 0.09% (n=20)
AGPKQDVQ 0.09% (n=20)
QGPSQNIK 0.09% (n=20)
QGSRQNIQ 0.09% (n=20)
PGSSQKVQ 0.09% (n=20)
TGSNQKIQ 0.09% (n=20)
LGPT---- 0.09% (n=20)
QGARQNVQ 0.08% (n=19)
SGPKQDVQ 0.08% (n=19)
SGPTQKIQ 0.08% (n=19)
LGSHQKVQ 0.08% (n=19)
QGSAQKIQ 0.08% (n=19)
VGAKQNIQ 0.08% (n=18)
QGPSQNIR 0.08% (n=18)
PGAKQNLQ 0.08% (n=18)
AGASQRIQ 0.08% (n=18)
RGAKQDVQ 0.07% (n=17)
LGARQKIQ 0.07% (n=17)
RGAQQDIQ 0.07% (n=17)
KGAKQDIQ 0.07% (n=17)
QGSQQKIQ 0.07% (n=17)
SGSSQKIQ 0.07% (n=17)
VGSS---- 0.07% (n=17)
RGPSQTIR 0.07% (n=16)
PGAQQNVR 0.07% (n=16)
PGPAQNLQ 0.07% (n=16)
PGSNQKIQ 0.07% (n=16)
PG------ 0.07% (n=16)
RGPS---- 0.07% (n=16)
AGARQNIQ 0.06% (n=15)
LGASQNIQ 0.06% (n=15)
PGARQAIQ 0.06% (n=15)
TGSKQDVQ 0.06% (n=15)
PGPTQNIQ 0.06% (n=15)
FGANQNIQ 0.06% (n=15)
PGSAQNIQ 0.06% (n=15)
PGASQKIE 0.06% (n=15)
LGPQQNIQ 0.06% (n=14)
PGARQKIQ 0.06% (n=14)
QGAQQNVQ 0.06% (n=14)
QGAKQDIK 0.06% (n=14)
PGARQDIQ 0.06% (n=14)
RGAMQNIQ 0.06% (n=14)
FGPSQNIQ 0.06% (n=14)
AGSA---- 0.06% (n=14)
PGPT---- 0.06% (n=14)
PGSKQDVQ 0.06% (n=13)
PGPKQNLQ 0.06% (n=13)
PGPKQDVR 0.06% (n=13)
PGAKQDIK 0.06% (n=13)
PGPKQDVQ 0.06% (n=13)
KGAQQNIQ 0.06% (n=13)
PGASQRVQ 0.06% (n=13)
SGPAQEIQ 0.06% (n=13)
LGPAQKLQ 0.06% (n=13)
VGP----- 0.06% (n=13)
TGAKQDIQ 0.05% (n=12)
SGPRQNIQ 0.05% (n=12)
PGSKQDIQ 0.05% (n=12)
PGPSQSIQ 0.05% (n=12)
RGAQQNVQ 0.05% (n=12)
QGAKQGVQ 0.05% (n=12)
LGPQQKVQ 0.05% (n=12)
VGPQQKIQ 0.05% (n=12)
PGP----- 0.05% (n=12)
QGSKQNVQ 0.05% (n=11)
KGANQDIQ 0.05% (n=11)
AGPQQKIQ 0.05% (n=11)
SGPQQKIQ 0.05% (n=11)
MGAKQNIQ 0.05% (n=11)
LGPQQKLQ 0.05% (n=11)
LGSSQKLQ 0.05% (n=11)
SGPSQKIR 0.05% (n=11)
RGPAQEVQ 0.05% (n=11)
PGPSQNVQ 0.04% (n=10)
LGPKQNVQ 0.04% (n=10)
QGAKQNVQ 0.04% (n=10)
RGASQNIQ 0.04% (n=10)
IGAKQNIQ 0.04% (n=10)
RGSKQNIQ 0.04% (n=10)
PGSQQNVQ 0.04% (n=10)
PGPKQKVQ 0.04% (n=10)
AGAMQNIQ 0.04% (n=10)
SGSAQKIQ 0.04% (n=10)
SGSAQNIQ 0.04% (n=10)
PGPTQHIQ 0.04% (n=10)
TGSRQNLQ 0.04% (n=10)
SGAS---- 0.04% (n=10)
LGSSQNIQ 0.04% (n=10)
LGARQNIQ 0.04% (n=9)
PGSKQNVQ 0.04% (n=9)
RGPRQNIQ 0.04% (n=9)
RGPNQKIQ 0.04% (n=9)
PGSQQNIQ 0.04% (n=9)
PGSRQNVQ 0.04% (n=9)
QGASQKIQ 0.04% (n=9)
PGAMQDIQ 0.04% (n=9)
PGSSQRIQ 0.04% (n=9)
VGASQKLQ 0.04% (n=9)
SGPRQKIQ 0.04% (n=9)
AGSKQKLQ 0.04% (n=9)
FGSAQRIQ 0.04% (n=9)
VGSRQNVQ 0.04% (n=9)
AGPTQRIQ 0.04% (n=9)
SGAQQKIQ 0.03% (n=8)
PGSQQHIQ 0.03% (n=8)
RGPKQDVQ 0.03% (n=8)
LGAQQNIQ 0.03% (n=8)
AGAKQDIQ 0.03% (n=8)
PGASQKVQ 0.03% (n=8)
LGPKQKIQ 0.03% (n=8)
QGAKQNLQ 0.03% (n=8)
PGSKQNLQ 0.03% (n=8)
LGPSQNLQ 0.03% (n=8)
RGPRQNVQ 0.03% (n=8)
KGARQNIQ 0.03% (n=8)
LGPAQKIQ 0.03% (n=8)
AGASQKIQ 0.03% (n=8)
PGPAQRIQ 0.03% (n=8)
AGPTQNIQ 0.03% (n=8)
PGPLQKIQ 0.03% (n=8)
PGSSQKLQ 0.03% (n=8)
VGPA---- 0.03% (n=8)
LGSA---- 0.03% (n=8)
---SQKIQ 0.03% (n=8)
PGPSQELQ 0.03% (n=8)
RGAKQNVQ 0.03% (n=7)
PGPSQNIR 0.03% (n=7)
PGAKQKVQ 0.03% (n=7)
VGARQNIQ 0.03% (n=7)
PGARQNLQ 0.03% (n=7)
PGPRQDVQ 0.03% (n=7)
SGAKQKIQ 0.03% (n=7)
LGANQNIQ 0.03% (n=7)
SGPSQKLQ 0.03% (n=7)
RGSAQKIQ 0.03% (n=7)
FGAQQNIQ 0.03% (n=7)
SGSKQKIQ 0.03% (n=7)
AGPAQEIH 0.03% (n=7)
RGGQQDIR 0.03% (n=7)
AGSS---- 0.03% (n=7)
PGAS---- 0.03% (n=7)
QGASQNIQ 0.03% (n=6)
TGAQQKIQ 0.03% (n=6)
LGAKQNVQ 0.03% (n=6)
AGAQQNIQ 0.03% (n=6)
SGARQNVQ 0.03% (n=6)
VGAQQNIQ 0.03% (n=6)
LGPSQNIK 0.03% (n=6)
QGPSQSIR 0.03% (n=6)
VGARQKLQ 0.03% (n=6)
LGASQKVQ 0.03% (n=6)
SGPAQRIQ 0.03% (n=6)
RGPSQEIQ 0.03% (n=6)
PGPAQKVQ 0.03% (n=6)
TGPAQKIQ 0.03% (n=6)
SGASQKIE 0.03% (n=6)
HGPSQKIQ 0.03% (n=6)
RGASQKIQ 0.03% (n=6)
FGSAQKIQ 0.03% (n=6)
LGPGQKIQ 0.03% (n=6)
LGPSQKIH 0.03% (n=6)
SGPGQNVQ 0.03% (n=6)
AGPSQTIQ 0.03% (n=6)
PGAKQSIQ 0.02% (n=5)
LGARQNVQ 0.02% (n=5)
AGASQNIQ 0.02% (n=5)
VGAKQDIQ 0.02% (n=5)
TGARQNIQ 0.02% (n=5)
PGPSQHIQ 0.02% (n=5)
TGARQKIQ 0.02% (n=5)
TGPSQNIQ 0.02% (n=5)
PGPMQNVQ 0.02% (n=5)
PGPQQNVQ 0.02% (n=5)
VGSRQNIQ 0.02% (n=5)
MGAQQNIQ 0.02% (n=5)
PGAKQNVR 0.02% (n=5)
QGAKQNIR 0.02% (n=5)
RGPQQKIQ 0.02% (n=5)
RGPTQKIQ 0.02% (n=5)
VGPSQKLQ 0.02% (n=5)
LGPAQNIQ 0.02% (n=5)
AGPAQSIK 0.02% (n=5)
AGPAQSIN 0.02% (n=5)
LGPSQRIQ 0.02% (n=5)
PGSQQKIQ 0.02% (n=5)
TGASQKIQ 0.02% (n=5)
TGARQNLQ 0.02% (n=5)
RGAQQKLQ 0.02% (n=5)
LG------ 0.02% (n=5)
SGPT---- 0.02% (n=5)
RGSA---- 0.02% (n=5)
PGTKQNIQ 0.02% (n=4)
PGAEQNVQ 0.02% (n=4)
PGAQHNVQ 0.02% (n=4)
RGPSQKLY 0.02% (n=4)
FGAKQNIQ 0.02% (n=4)
IGPKQNIQ 0.02% (n=4)
TGPKQNVQ 0.02% (n=4)
PGAQQKVQ 0.02% (n=4)
WGPSQNIR 0.02% (n=4)
PGSNQNIQ 0.02% (n=4)
PGARQSIQ 0.02% (n=4)
SGPKQDIQ 0.02% (n=4)
IGARQNIQ 0.02% (n=4)
TGAKQNVQ 0.02% (n=4)
LGAKQDIQ 0.02% (n=4)
FGPKQNIQ 0.02% (n=4)
VGPQQNIQ 0.02% (n=4)
PGPKQNIR 0.02% (n=4)
RGANQNIQ 0.02% (n=4)
LGPKQDIQ 0.02% (n=4)
VGAKQKIQ 0.02% (n=4)
QGSNQNIQ 0.02% (n=4)
VGPRQNIQ 0.02% (n=4)
PGAMRNIQ 0.02% (n=4)
SGSKQNIQ 0.02% (n=4)
QGANQKIQ 0.02% (n=4)
PGARQNVR 0.02% (n=4)
RGPSQKLQ 0.02% (n=4)
AGPSQKLQ 0.02% (n=4)
RGASQEIQ 0.02% (n=4)
AGSAQKIQ 0.02% (n=4)
LGPSQKLQ 0.02% (n=4)
SGPSQKIE 0.02% (n=4)
RGPQQNVQ 0.02% (n=4)
PGPFQKIQ 0.02% (n=4)
LGAHQKIQ 0.02% (n=4)
SGPSQQIQ 0.02% (n=4)
SGPNQKIQ 0.02% (n=4)
LGPA---- 0.02% (n=4)
RGSS---- 0.02% (n=4)
FGPTQKIQ 0.02% (n=4)
IGPA---- 0.02% (n=4)
PGPSQQLQ 0.02% (n=4)
PGPAQKPQ 0.02% (n=4)
PGSQQKVQ 0.02% (n=4)
NGPSQRIQ 0.01% (n=3)
PGAKQDIR 0.01% (n=3)
PGAKRNVQ 0.01% (n=3)
RGPKQDIR 0.01% (n=3)
PGAQQNLQ 0.01% (n=3)
PGVKQNIQ 0.01% (n=3)
PGAKQHIQ 0.01% (n=3)
SGPNQNIQ 0.01% (n=3)
LGPKQDVQ 0.01% (n=3)
RGSKQDIQ 0.01% (n=3)
SGPKQNVQ 0.01% (n=3)
PGAKQNTQ 0.01% (n=3)
PGAQQRIQ 0.01% (n=3)
MGAKQRIQ 0.01% (n=3)
RGPKQNLQ 0.01% (n=3)
RGSRQNIQ 0.01% (n=3)
PGASHNIQ 0.01% (n=3)
QGPSQKLQ 0.01% (n=3)
VGPKQKIQ 0.01% (n=3)
PGPSQKVQ 0.01% (n=3)
TGSKQNLQ 0.01% (n=3)
QGPSQNIQ 0.01% (n=3)
PGPRQKVQ 0.01% (n=3)
PGARQNIR 0.01% (n=3)
PGPRQDIQ 0.01% (n=3)
KGPKQNIQ 0.01% (n=3)
QGAQQKIQ 0.01% (n=3)
RGPSQQIQ 0.01% (n=3)
PGPKQNIH 0.01% (n=3)
PGSMQNIQ 0.01% (n=3)
LGPNQKIQ 0.01% (n=3)
PGPQQEVQ 0.01% (n=3)
PGPQQKVQ 0.01% (n=3)
PGPSQQIQ 0.01% (n=3)
TGPKQDIQ 0.01% (n=3)
QGPQQRIQ 0.01% (n=3)
RGPAQKIQ 0.01% (n=3)
PGPTQKLQ 0.01% (n=3)
VGPSQKVQ 0.01% (n=3)
TGPTQPIN 0.01% (n=3)
SGPTQRIQ 0.01% (n=3)
RGPAQNIQ 0.01% (n=3)
SGPTQNIQ 0.01% (n=3)
PGPRQKIQ 0.01% (n=3)
PGPAQRLQ 0.01% (n=3)
FGPAQKIQ 0.01% (n=3)
SGASQKVQ 0.01% (n=3)
VGAHQKVQ 0.01% (n=3)
LGPTQRIQ 0.01% (n=3)
YGAKQDIR 0.01% (n=3)
PGPKQKLQ 0.01% (n=3)
SGSA---- 0.01% (n=3)
HGPS---- 0.01% (n=3)
FGPA---- 0.01% (n=3)
SGASQRIQ 0.01% (n=3)
VGSHQKIQ 0.01% (n=3)
RGAHQNIQ 0.01% (n=3)
PGARQNVK 0.01% (n=2)
RGPSQKLH 0.01% (n=2)
RGPNQNVQ 0.01% (n=2)
QGARQSIQ 0.01% (n=2)
PGAEQNIQ 0.01% (n=2)
PGAKQGIQ 0.01% (n=2)
LGPRQKIQ 0.01% (n=2)
EGAQQKIQ 0.01% (n=2)
RGSRQDIQ 0.01% (n=2)
RGPQQNIQ 0.01% (n=2)
RGARQEIR 0.01% (n=2)
LGPKQNLQ 0.01% (n=2)
PGARQDVQ 0.01% (n=2)
PGAKQDLQ 0.01% (n=2)
VGSNQKIQ 0.01% (n=2)
TGSQQNVQ 0.01% (n=2)
NGPKQDVQ 0.01% (n=2)
SGAKQDVQ 0.01% (n=2)
SGSRQNVQ 0.01% (n=2)
QGARQKVQ 0.01% (n=2)
RGPTQNIQ 0.01% (n=2)
LGPSQKIE 0.01% (n=2)
LGAKQDIR 0.01% (n=2)
RGPKQHIQ 0.01% (n=2)
RGSKQNVQ 0.01% (n=2)
PGALQNVQ 0.01% (n=2)
TGAKQNLQ 0.01% (n=2)
QGSKQNIQ 0.01% (n=2)
PGPKQKIQ 0.01% (n=2)
LGSKQNIE 0.01% (n=2)
VGPKQDIR 0.01% (n=2)
PGAKRNIQ 0.01% (n=2)
QGAKQDVQ 0.01% (n=2)
SGARQKIQ 0.01% (n=2)
PGTMQNIQ 0.01% (n=2)
PGSRQSIQ 0.01% (n=2)
SGPQQDIQ 0.01% (n=2)
QDPKQDIQ 0.01% (n=2)
SGPRQNLQ 0.01% (n=2)
PGAKQSVQ 0.01% (n=2)
QGPSQNVQ 0.01% (n=2)
PGPGQKIQ 0.01% (n=2)
SGRKQDIQ 0.01% (n=2)
QGPSQKIE 0.01% (n=2)
RDAQQKIQ 0.01% (n=2)
SGAKQNIR 0.01% (n=2)
QGPKQNIH 0.01% (n=2)
LGAQQNVQ 0.01% (n=2)
MGPKQKIQ 0.01% (n=2)
QGARQKLQ 0.01% (n=2)
AGSRQYVQ 0.01% (n=2)
TGSQQHVQ 0.01% (n=2)
PGARQHVQ 0.01% (n=2)
AGPRQNLQ 0.01% (n=2)
PGHNQKIQ 0.01% (n=2)
PGAKQNIH 0.01% (n=2)
RGAKQN-- 0.01% (n=2)
LGPNQRIQ 0.01% (n=2)
RGPQQDIR 0.01% (n=2)
AGARQDIQ 0.01% (n=2)
RGAQQKVQ 0.01% (n=2)
PGAMQNVQ 0.01% (n=2)
CGPSQKIQ 0.01% (n=2)
TGPAQNIQ 0.01% (n=2)
FGSSQKIQ 0.01% (n=2)
PGPAHKIQ 0.01% (n=2)
PGAAQKIQ 0.01% (n=2)
LGPSHKIQ 0.01% (n=2)
VGPSQRIQ 0.01% (n=2)
FGAPQNIQ 0.01% (n=2)
SGASHNIQ 0.01% (n=2)
SGASQDIQ 0.01% (n=2)
PGASQSIQ 0.01% (n=2)
SGASHNIH 0.01% (n=2)
SGAPQNIQ 0.01% (n=2)
SWASQNIQ 0.01% (n=2)
PGASQNTQ 0.01% (n=2)
PGVSQKIQ 0.01% (n=2)
LGPAQPIK 0.01% (n=2)
PGPAHRIQ 0.01% (n=2)
SGSQQKIQ 0.01% (n=2)
SGPNQRIQ 0.01% (n=2)
RGSNQKIQ 0.01% (n=2)
TGPSQKLQ 0.01% (n=2)
SGPAQNIQ 0.01% (n=2)
SGPAQKIE 0.01% (n=2)
RGAQQRIQ 0.01% (n=2)
SGPSQPLQ 0.01% (n=2)
PGASQGIQ 0.01% (n=2)
FGPQQKIQ 0.01% (n=2)
MGSAQKIQ 0.01% (n=2)
RGSHQKIQ 0.01% (n=2)
HGPAQKIQ 0.01% (n=2)
SGASQKLQ 0.01% (n=2)
SGSAQRIQ 0.01% (n=2)
AGSKQKIQ 0.01% (n=2)
PGPSQTIQ 0.01% (n=2)
PGPVQKIQ 0.01% (n=2)
AGASQNVQ 0.01% (n=2)
KGSRQNIQ 0.01% (n=2)
FGSAQRVQ 0.01% (n=2)
SGPQQKVQ 0.01% (n=2)
AGSSQNVQ 0.01% (n=2)
LGPSQTIQ 0.01% (n=2)
AGSKQNIQ 0.01% (n=2)
YGPKQDIR 0.01% (n=2)
SGASQEIQ 0.01% (n=2)
LGPSQNIH 0.01% (n=2)
FGAQQKVQ 0.01% (n=2)
QGPTQKIQ 0.01% (n=2)
AGPTQKIQ 0.01% (n=2)
PGPTQRIQ 0.01% (n=2)
TGPNQKIQ 0.01% (n=2)
PGATQNIQ 0.01% (n=2)
RGSSQKIQ 0.01% (n=2)
KGPSQKIQ 0.01% (n=2)
LGPAQTIQ 0.01% (n=2)
TGPSQRIQ 0.01% (n=2)
LGSHQKIQ 0.01% (n=2)
PGASRKIQ 0.01% (n=2)
IGPSQEIQ 0.01% (n=2)
RGPNQNIQ 0.01% (n=2)
TGSRQNIQ 0.01% (n=2)
PGSRQKVQ 0.01% (n=2)
AGSSQRVQ 0.01% (n=2)
AGSPQKIQ 0.01% (n=2)
---AQKIQ 0.01% (n=2)
PEPQQKIQ 0.01% (n=2)
SGASQKIR 0.01% (n=2)
VGSKQTIQ 0.01% (n=2)
VGPAQKIE 0.01% (n=2)
PGPVQHLQ 0.01% (n=2)
PGAQQQLQ 0.01% (n=2)
VGAKQDVQ 0.00% (n=1)
AGAKQDVQ 0.00% (n=1)
RGASQNVQ 0.00% (n=1)
SGAKQDIR 0.00% (n=1)
PGAKLNVQ 0.00% (n=1)
SGAKRNIQ 0.00% (n=1)
PGPSQNAQ 0.00% (n=1)
PCPRQNIQ 0.00% (n=1)
PGPKENIQ 0.00% (n=1)
PGPKRNIQ 0.00% (n=1)
LGAGQNVQ 0.00% (n=1)
RGPKQNV* 0.00% (n=1)
RGPSQDTR 0.00% (n=1)
KGPSQNIY 0.00% (n=1)
PGPKQSVQ 0.00% (n=1)
QGARQNTQ 0.00% (n=1)
QGAKRDIQ 0.00% (n=1)
TGAKRNIQ 0.00% (n=1)
PGPSQDVR 0.00% (n=1)
RGPQQHIQ 0.00% (n=1)
QGPKQNIR 0.00% (n=1)
VGPKQDIK 0.00% (n=1)
PGARQEIQ 0.00% (n=1)
LGANQNVQ 0.00% (n=1)
RGSKQDVQ 0.00% (n=1)
RGPEQNVQ 0.00% (n=1)
PGPGQNIQ 0.00% (n=1)
LGPNQNIQ 0.00% (n=1)
PGASQNAQ 0.00% (n=1)
QAPSRVIQ 0.00% (n=1)
QGPKLNVQ 0.00% (n=1)
QGLKQNVQ 0.00% (n=1)
PGAQHNIQ 0.00% (n=1)
RGAKQDIH 0.00% (n=1)
PGPSQKIR 0.00% (n=1)
PGPSQNTQ 0.00% (n=1)
LGPKQDIR 0.00% (n=1)
PSSKQDIQ 0.00% (n=1)
MGPSQKIQ 0.00% (n=1)
PGGKQNIQ 0.00% (n=1)
QDAKQDIK 0.00% (n=1)
LGPKQNIR 0.00% (n=1)
PGPKQQVQ 0.00% (n=1)
SGPKQGIK 0.00% (n=1)
PGSSQNLQ 0.00% (n=1)
PDPSQNLQ 0.00% (n=1)
PGPSQDLQ 0.00% (n=1)
PGPRQNVQ 0.00% (n=1)
AGPRQDIQ 0.00% (n=1)
PGLSQEIQ 0.00% (n=1)
KGAKQNIQ 0.00% (n=1)
SGANQNIQ 0.00% (n=1)
SGASQSIQ 0.00% (n=1)
PGAQQNTQ 0.00% (n=1)
SGPQQNVQ 0.00% (n=1)
AGAQQKIQ 0.00% (n=1)
VGARQPIG 0.00% (n=1)
SGPQQKIH 0.00% (n=1)
PGPRQTIR 0.00% (n=1)
LGSKQNIQ 0.00% (n=1)
LGARQDIQ 0.00% (n=1)
QGLKQDIQ 0.00% (n=1)
PGAQQTVQ 0.00% (n=1)
KGAN*DIQ 0.00% (n=1)
QGARRNVQ 0.00% (n=1)
AGAKQNVQ 0.00% (n=1)
IGAQQNIQ 0.00% (n=1)
PGAKQHVQ 0.00% (n=1)
IGPQQKIQ 0.00% (n=1)
KGARQNVQ 0.00% (n=1)
KGPNQNIQ 0.00% (n=1)
PGAQQNIK 0.00% (n=1)
QGAQQKVQ 0.00% (n=1)
SGPSQHIQ 0.00% (n=1)
RGAKQNLQ 0.00% (n=1)
RGAQQDVQ 0.00% (n=1)
PGPRQSIK 0.00% (n=1)
LGAQQNIR 0.00% (n=1)
SGPKQNIH 0.00% (n=1)
SGPKQKLQ 0.00% (n=1)
RGAKQQIN 0.00% (n=1)
PGAKQDVR 0.00% (n=1)
VGSRQNLQ 0.00% (n=1)
VGAQQKIQ 0.00% (n=1)
MGPKQNLQ 0.00% (n=1)
RGANQDIH 0.00% (n=1)
PGHHQNIQ 0.00% (n=1)
QGPRQSIQ 0.00% (n=1)
QGPQQNIQ 0.00% (n=1)
PGPNQKIQ 0.00% (n=1)
PGAKQNIE 0.00% (n=1)
PGPKQNLR 0.00% (n=1)
TGSKQNVQ 0.00% (n=1)
TGSRQNVQ 0.00% (n=1)
RGARQDIQ 0.00% (n=1)
TGAEQNIQ 0.00% (n=1)
TDAKQNIQ 0.00% (n=1)
QGPKQDVQ 0.00% (n=1)
TGPKQNIH 0.00% (n=1)
VGPKQNVQ 0.00% (n=1)
PGAKQDIN 0.00% (n=1)
FGSNQKIQ 0.00% (n=1)
VGPNQNIQ 0.00% (n=1)
RGPKQDLQ 0.00% (n=1)
PGARQDVR 0.00% (n=1)
MGPKQDIR 0.00% (n=1)
HGPRQNIQ 0.00% (n=1)
PGAQQRVQ 0.00% (n=1)
QGANQKVQ 0.00% (n=1)
LGAKQDVR 0.00% (n=1)
QGPKQDVR 0.00% (n=1)
LGPRQNVQ 0.00% (n=1)
LGPRQEIQ 0.00% (n=1)
PGAMQNIR 0.00% (n=1)
TGSQQNIQ 0.00% (n=1)
VGARQNVQ 0.00% (n=1)
LGPRQKIE 0.00% (n=1)
TGPQQQIQ 0.00% (n=1)
YGPQQNIQ 0.00% (n=1)
TGSSQNIQ 0.00% (n=1)
RGANQNVQ 0.00% (n=1)
VGSKQNIQ 0.00% (n=1)
QGPRQDVR 0.00% (n=1)
QGSQQNIQ 0.00% (n=1)
PGAAQNVQ 0.00% (n=1)
PGSKQNIR 0.00% (n=1)
SGPQQSIQ 0.00% (n=1)
PGAGQNIQ 0.00% (n=1)
PGAEQDIQ 0.00% (n=1)
PGPKQKAQ 0.00% (n=1)
SGAKHNDQ 0.00% (n=1)
QGAMQNVQ 0.00% (n=1)
QGAMQNIQ 0.00% (n=1)
PGAMQSIQ 0.00% (n=1)
PGVMQNIQ 0.00% (n=1)
PGTEQDIQ 0.00% (n=1)
SGAMQNIQ 0.00% (n=1)
RGPRLNIQ 0.00% (n=1)
RGPNQKVQ 0.00% (n=1)
PGANQRVQ 0.00% (n=1)
RGANQKVQ 0.00% (n=1)
LGSKQNLQ 0.00% (n=1)
PGAKQNI* 0.00% (n=1)
QGPSQQIQ 0.00% (n=1)
KGPSQDVQ 0.00% (n=1)
RGSRQDVQ 0.00% (n=1)
QGAKQKIQ 0.00% (n=1)
SGAKQSIQ 0.00% (n=1)
PGVRQNIQ 0.00% (n=1)
SGAGQNIQ 0.00% (n=1)
RGARQKIQ 0.00% (n=1)
PGPGQNIK 0.00% (n=1)
PGPRQNIK 0.00% (n=1)
NGPPQKIQ 0.00% (n=1)
DGPSQKIQ 0.00% (n=1)
EGAKQDIQ 0.00% (n=1)
KGARQDIQ 0.00% (n=1)
RGAQQKI* 0.00% (n=1)
RGAQRKIQ 0.00% (n=1)
PGSK*NIQ 0.00% (n=1)
LGSR*NIQ 0.00% (n=1)
SGAKHNIQ 0.00% (n=1)
PGAKQYIQ 0.00% (n=1)
PGPQQNIH 0.00% (n=1)
AGPRQKIQ 0.00% (n=1)
AGPSQNVQ 0.00% (n=1)
IGAKQKIQ 0.00% (n=1)
AGSQQNIQ 0.00% (n=1)
PGSQQDIQ 0.00% (n=1)
TGPKQDIR 0.00% (n=1)
RGANQGIR 0.00% (n=1)
RGAKQDIR 0.00% (n=1)
QGPNQKVQ 0.00% (n=1)
SGSKQNVQ 0.00% (n=1)
LGPKQDIH 0.00% (n=1)
QGARQQIR 0.00% (n=1)
SGSQQNVQ 0.00% (n=1)
SGPSQNLH 0.00% (n=1)
RGPQQNIR 0.00% (n=1)
TGPRQNVQ 0.00% (n=1)
TSAKQNIQ 0.00% (n=1)
MGPQQNIQ 0.00% (n=1)
MGAQQNIR 0.00% (n=1)
IGPRQN-- 0.00% (n=1)
PGPKQN-- 0.00% (n=1)
PGAQQK-- 0.00% (n=1)
VGPTQN-- 0.00% (n=1)
AGAKQN-- 0.00% (n=1)
RGSQQN-- 0.00% (n=1)
PGARQN-- 0.00% (n=1)
SGAKQN-- 0.00% (n=1)
PGAQQE-- 0.00% (n=1)
FGPKQN-- 0.00% (n=1)
PGSRQN-- 0.00% (n=1)
SGPKQH-- 0.00% (n=1)
SGPKQN-- 0.00% (n=1)
RGAQQEIQ 0.00% (n=1)
TGPKQN-- 0.00% (n=1)
RGPKQN-- 0.00% (n=1)
LGASQNVQ 0.00% (n=1)
SGPRQNIR 0.00% (n=1)
VGSKQNVQ 0.00% (n=1)
RGPRQDIQ 0.00% (n=1)
PGAQQKLQ 0.00% (n=1)
QGAQQEIQ 0.00% (n=1)
PGPKQDIR 0.00% (n=1)
SGSMQNIQ 0.00% (n=1)
HGPKQNIQ 0.00% (n=1)
PGAQQNIR 0.00% (n=1)
LGAQQDIQ 0.00% (n=1)
LGARQNIR 0.00% (n=1)
QGPRQNVQ 0.00% (n=1)
EGPKQNVQ 0.00% (n=1)
PGPNQSVQ 0.00% (n=1)
RGARQNVQ 0.00% (n=1)
MGPKQNVQ 0.00% (n=1)
RGPQQEVQ 0.00% (n=1)
PGPQQRVQ 0.00% (n=1)
VGANQNIQ 0.00% (n=1)
PGAKQNV* 0.00% (n=1)
PSAKQNVQ 0.00% (n=1)
PGTKQNVQ 0.00% (n=1)
PGAKQNVH 0.00% (n=1)
PGPAQNIR 0.00% (n=1)
RGSQQNVQ 0.00% (n=1)
PGPQQNLQ 0.00% (n=1)
PGALQNIQ 0.00% (n=1)
PGAHQNIQ 0.00% (n=1)
AGPKQDIQ 0.00% (n=1)
LGPRQKVQ 0.00% (n=1)
QGARQKIQ 0.00% (n=1)
LSPRQNIQ 0.00% (n=1)
PDAKQNIQ 0.00% (n=1)
KGPKQDIQ 0.00% (n=1)
PGPSQDVQ 0.00% (n=1)
PGAKQN-- 0.00% (n=1)
LGPRQKI- 0.00% (n=1)
PGPKQNVH 0.00% (n=1)
FGPHQKLQ 0.00% (n=1)
AGPAQKIQ 0.00% (n=1)
SGPSQNVQ 0.00% (n=1)
RGSAQKLQ 0.00% (n=1)
AGSAQNIQ 0.00% (n=1)
QGPKQQIQ 0.00% (n=1)
RGSAQEIQ 0.00% (n=1)
RGAKQKVQ 0.00% (n=1)
QGAKQKVQ 0.00% (n=1)
QGPKQKVQ 0.00% (n=1)
PGAKQEVQ 0.00% (n=1)
SEPSQKNQ 0.00% (n=1)
LGASQRVQ 0.00% (n=1)
VGSSQKIQ 0.00% (n=1)
VGASQRIQ 0.00% (n=1)
RGANQKIQ 0.00% (n=1)
PGSSQKDQ 0.00% (n=1)
LGVSEDIP 0.00% (n=1)
SGPAQSIN 0.00% (n=1)
AGPAQSVN 0.00% (n=1)
SGPTSENP 0.00% (n=1)
LGSAQKLE 0.00% (n=1)
FGASQNLQ 0.00% (n=1)
AGASQKIE 0.00% (n=1)
CGASQKIQ 0.00% (n=1)
SGPAQTIQ 0.00% (n=1)
SGPAQKVQ 0.00% (n=1)
SRASQKIE 0.00% (n=1)
RGPSQEIH 0.00% (n=1)
PGGSQKIE 0.00% (n=1)
PGASQNIH 0.00% (n=1)
LGAQQKVQ 0.00% (n=1)
QGPAQRIQ 0.00% (n=1)
AGSQENIQ 0.00% (n=1)
FGAQQRIQ 0.00% (n=1)
AGPAQNIQ 0.00% (n=1)
PGPTQNLQ 0.00% (n=1)
TGRCQTIQ 0.00% (n=1)
PGAPQRIQ 0.00% (n=1)
DGPQQKIQ 0.00% (n=1)
DGPRQKIQ 0.00% (n=1)
SGPTQKLQ 0.00% (n=1)
VGSNQNIQ 0.00% (n=1)
VGPAQKLQ 0.00% (n=1)
PGARQKVQ 0.00% (n=1)
PGAHQKIQ 0.00% (n=1)
PGPQ*KIQ 0.00% (n=1)
PGSRRKIQ 0.00% (n=1)
RGPSRRIQ 0.00% (n=1)
FGSSQNVQ 0.00% (n=1)
PGAAQNIQ 0.00% (n=1)
AGSHQKIQ 0.00% (n=1)
VGPAQNIQ 0.00% (n=1)
SGARQNLQ 0.00% (n=1)
PGACQNIQ 0.00% (n=1)
TGPSQTIQ 0.00% (n=1)
MGSSQKIQ 0.00% (n=1)
TGPTQRIQ 0.00% (n=1)
FGSHQNVQ 0.00% (n=1)
LGPAQNIR 0.00% (n=1)
AGPTQNLQ 0.00% (n=1)
RGPAQSLQ 0.00% (n=1)
AGPAQKIH 0.00% (n=1)
FGPSQRIQ 0.00% (n=1)
TGSSQKIQ 0.00% (n=1)
RGPHQNIQ 0.00% (n=1)
AGPLQQIQ 0.00% (n=1)
LGSAQKVQ 0.00% (n=1)
LGPAQRIQ 0.00% (n=1)
AGPAQKLQ 0.00% (n=1)
HGARQNIQ 0.00% (n=1)
TGSAQRIQ 0.00% (n=1)
PGPSQSIH 0.00% (n=1)
FGPAQNIQ 0.00% (n=1)
RGPAQRIQ 0.00% (n=1)
VGPTQNLQ 0.00% (n=1)
SGSRQKIQ 0.00% (n=1)
SGPKQSIQ 0.00% (n=1)
PGPSQPIQ 0.00% (n=1)
LGPGQKVQ 0.00% (n=1)
LGSQQKIQ 0.00% (n=1)
RGSRQSIQ 0.00% (n=1)
RGSKQTLQ 0.00% (n=1)
FGSNQNVQ 0.00% (n=1)
PGTSQKIQ 0.00% (n=1)
PGASRNIQ 0.00% (n=1)
SGPSQEIQ 0.00% (n=1)
PGPPQKIQ 0.00% (n=1)
FGPSQNTQ 0.00% (n=1)
PGPAQQVQ 0.00% (n=1)
QGSQQKVQ 0.00% (n=1)
QGSQQRIQ 0.00% (n=1)
SGPSQKVQ 0.00% (n=1)
LEPSQKVQ 0.00% (n=1)
FGSRQNIQ 0.00% (n=1)
PGPAQEIH 0.00% (n=1)
AGPAQEIQ 0.00% (n=1)
SGPAQEIH 0.00% (n=1)
LGAHQKLQ 0.00% (n=1)
RGGQQNIQ 0.00% (n=1)
RGGKQDIR 0.00% (n=1)
SGSRQNLQ 0.00% (n=1)
VGPSQQIQ 0.00% (n=1)
PGASQHIQ 0.00% (n=1)
RGPKQKLQ 0.00% (n=1)
SGATQNIQ 0.00% (n=1)
PGPSQMIQ 0.00% (n=1)
SGPAQQIQ 0.00% (n=1)
FGPSRKIQ 0.00% (n=1)
VGPTQNIQ 0.00% (n=1)
LGPTQNVQ 0.00% (n=1)
TGAKQKIQ 0.00% (n=1)
PGANQKIQ 0.00% (n=1)
SGPKQEIR 0.00% (n=1)
PGPNQQIQ 0.00% (n=1)
PGPIQKIQ 0.00% (n=1)
PGPGQEIK 0.00% (n=1)
PGPQQRIQ 0.00% (n=1)
TGPTQKIQ 0.00% (n=1)
PGSAQRIQ 0.00% (n=1)
AGPHQKIQ 0.00% (n=1)
PGPTQTIQ 0.00% (n=1)
PGSAQEIK 0.00% (n=1)
AGSQQKLQ 0.00% (n=1)
QGPTQKLQ 0.00% (n=1)
VGPTQKLQ 0.00% (n=1)
RGPTQELR 0.00% (n=1)
-GPSQNIQ 0.00% (n=1)
RGPSQGIQ 0.00% (n=1)
-GPSQKIQ 0.00% (n=1)
PGAAQTIQ 0.00% (n=1)
TGPSQSIQ 0.00% (n=1)
SGAAQNIQ 0.00% (n=1)
QGPRQNIL 0.00% (n=1)
TGPA---- 0.00% (n=1)
HGP----- 0.00% (n=1)
TGSA---- 0.00% (n=1)
VG------ 0.00% (n=1)
VGAS---- 0.00% (n=1)
PGSS---- 0.00% (n=1)
SGVS---- 0.00% (n=1)
LGSS---- 0.00% (n=1)
PGATQKIQ 0.00% (n=1)
SGPTQKVQ 0.00% (n=1)
PGPHQKIQ 0.00% (n=1)
RGPHQKIQ 0.00% (n=1)
LGPAQKLH 0.00% (n=1)
PGPSQKFQ 0.00% (n=1)
VGASQNIQ 0.00% (n=1)
TGPS---- 0.00% (n=1)
LGPRQNLQ 0.00% (n=1)
AGPPQNIQ 0.00% (n=1)
SGPSQCIQ 0.00% (n=1)
SGPPQNIQ 0.00% (n=1)
PGPSRKIQ 0.00% (n=1)
LGSAQKIQ 0.00% (n=1)
AGASQDIQ 0.00% (n=1)
PGAFQNIH 0.00% (n=1)
PGPSQTLQ 0.00% (n=1)
PGLYQRIQ 0.00% (n=1)
AGPSQKVQ 0.00% (n=1)
TGSAQKIQ 0.00% (n=1)
PGPSQKIE 0.00% (n=1)
LGSAQKLQ 0.00% (n=1)
QGPDQKIQ 0.00% (n=1)
LGSHQSIQ 0.00% (n=1)
YGSSQNIQ 0.00% (n=1)
RWASQKIQ 0.00% (n=1)
AGAKQKIQ 0.00% (n=1)
PGASQRLQ 0.00% (n=1)
FGSQQKIQ 0.00% (n=1)
SGSQQNIQ 0.00% (n=1)
RGSRQNLQ 0.00% (n=1)
CGSKQNIQ 0.00% (n=1)
RGPGQNIQ 0.00% (n=1)
RGSNQNIQ 0.00% (n=1)
AGAAQNVQ 0.00% (n=1)
VGSAQNIQ 0.00% (n=1)
FGSSQNIQ 0.00% (n=1)
VGSAQNIR 0.00% (n=1)
RGSAQNIQ 0.00% (n=1)
LGSAQNIQ 0.00% (n=1)
PGSAQNVQ 0.00% (n=1)
QGSAQNIQ 0.00% (n=1)
SGASQRVQ 0.00% (n=1)
FGASQNVQ 0.00% (n=1)
TGAQQK-- 0.00% (n=1)
SRPQQK-- 0.00% (n=1)
TGPQQ--- 0.00% (n=1)
TGPQQRIQ 0.00% (n=1)
PGAQQR-- 0.00% (n=1)
LGSYQKIQ 0.00% (n=1)
---KQKIQ 0.00% (n=1)
RGPSQEVQ 0.00% (n=1)
RGPSQELQ 0.00% (n=1)
AGPAQNLQ 0.00% (n=1)
QEPQQKIQ 0.00% (n=1)
QGPRQKIQ 0.00% (n=1)
PGSRQHTQ 0.00% (n=1)
PGLRQHIQ 0.00% (n=1)
PGPSRKLQ 0.00% (n=1)
PGSSQELQ 0.00% (n=1)
PEPSQKLQ 0.00% (n=1)
PRPSQKLQ 0.00% (n=1)
PGPSQKPQ 0.00% (n=1)
LGSSQEIQ 0.00% (n=1)
PGPSQELK 0.00% (n=1)
LGSPQNTQ 0.00% (n=1)
PGP*QKIQ 0.00% (n=1)
LGPQQRIQ 0.00% (n=1)
FGASHKIQ 0.00% (n=1)
VGASQKIR 0.00% (n=1)
VGASQKTQ 0.00% (n=1)
PWPAQNLQ 0.00% (n=1)
PGPAQKLP 0.00% (n=1)
PGPAQKLL 0.00% (n=1)
PGLAQKLQ 0.00% (n=1)
PGPALKLQ 0.00% (n=1)
SGTSQKIQ 0.00% (n=1)
LGASQ*LQ 0.00% (n=1)
SGPNQKVQ 0.00% (n=1)
VGSQQKIQ 0.00% (n=1)
RGSHQNIQ 0.00% (n=1)
RGPQQTIQ 0.00% (n=1)
LGSQQKVQ 0.00% (n=1)
IGRSQKI- 0.00% (n=1)
PGQEQKIQ 0.00% (n=1)
HGPSQNIQ 0.00% (n=1)
YGASQKIQ 0.00% (n=1)
AGPAQRIQ 0.00% (n=1)
VGPTQKIQ 0.00% (n=1)
IGPRQNIQ 0.00% (n=1)
PGSRQNLQ 0.00% (n=1)
PGSRQSLQ 0.00% (n=1)
QGSKQSLQ 0.00% (n=1)
PGPQQRLQ 0.00% (n=1)
LGPHQKIQ 0.00% (n=1)
PGASQDVQ 0.00% (n=1)
QGAQQRLQ 0.00% (n=1)
PGAQQSLQ 0.00% (n=1)
MGPKQKLQ 0.00% (n=1)
LGPQQKLE 0.00% (n=1)
LGAQQRLQ 0.00% (n=1)
RGPTQKLQ 0.00% (n=1)
RGSQQNIQ 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 1a:

PGAKQNIQ 18.59% (n=2533)
SGAKQNIQ 7.01% (n=956)
PGARQNIQ 5.94% (n=810)
PGAKQNVQ 4.17% (n=569)
PGAQQDIQ 2.81% (n=383)
PGPKQNIQ 2.44% (n=332)
RGPKQNIQ 2.42% (n=330)
PGAMQNIQ 2.36% (n=321)
PGAQQNVQ 1.99% (n=271)
QGAKQNIQ 1.95% (n=266)
TGAKQNIQ 1.80% (n=245)
AGSRQNVQ 1.66% (n=226)
PGAKQDIQ 1.40% (n=191)
PGAQQKIQ 1.38% (n=188)
RGAQQNIQ 1.35% (n=184)
QGPKQNVH 1.34% (n=183)
LGPKQNIQ 1.34% (n=182)
PGARQNVQ 1.31% (n=178)
RGPKQNIH 1.09% (n=149)
PGPQQNIQ 1.04% (n=142)
PGAQQNIQ 1.03% (n=140)
LGPRQKLQ 1.03% (n=140)
QGAQQNIQ 0.98% (n=134)
RGAKQNIQ 0.90% (n=122)
PGPSQNIQ 0.87% (n=118)
SGPKQNIQ 0.84% (n=115)
PGSKQNIQ 0.72% (n=98)
QGARQNIQ 0.72% (n=98)
SGAKQNVQ 0.68% (n=92)
LGAKQDVQ 0.64% (n=87)
TGPKQNIQ 0.60% (n=82)
TGPKQDVQ 0.53% (n=72)
SGASQNIQ 0.51% (n=70)
QGPKQNIQ 0.50% (n=68)
AGAKQNIQ 0.50% (n=68)
PGASQNVQ 0.48% (n=65)
LGAKQNIQ 0.47% (n=64)
NGPSQKIQ 0.46% (n=63)
SGARQNIQ 0.43% (n=58)
PGPSQNIK 0.42% (n=57)
QGAKQSIQ 0.42% (n=57)
RGAKQDIQ 0.41% (n=56)
PGPSQEIQ 0.41% (n=56)
RGSQQHIQ 0.41% (n=56)
RGPKQDIQ 0.40% (n=54)
SGAKQDIQ 0.37% (n=51)
QGAKQDIQ 0.37% (n=50)
PGPSQKIQ 0.36% (n=49)
LGSRQNIQ 0.35% (n=48)
PGPRQNIQ 0.33% (n=45)
AGPKQNIQ 0.33% (n=45)
PGPSQDIQ 0.32% (n=44)
LGPQQKIQ 0.32% (n=44)
QGPSQKIQ 0.32% (n=43)
QGPRQNIQ 0.31% (n=42)
PGPKQNVQ 0.30% (n=41)
RGAQQKIQ 0.30% (n=41)
LGPSQKIQ 0.29% (n=40)
PGASQNIQ 0.28% (n=38)
RGARQKLQ 0.28% (n=38)
QGPKQKIQ 0.27% (n=37)
SGPKQDIK 0.26% (n=36)
RGPKQNVQ 0.24% (n=33)
QGPKQNVQ 0.24% (n=33)
SGAQQNVQ 0.23% (n=32)
PGANQNIQ 0.23% (n=32)
SGPSQNIQ 0.22% (n=30)
RGAQQSIQ 0.22% (n=30)
PGAKQDVQ 0.21% (n=29)
TGPRQKIQ 0.21% (n=29)
LGAQQKIQ 0.21% (n=28)
PGPKQDIQ 0.21% (n=28)
PGAKQNIR 0.20% (n=27)
PGSRQNIQ 0.20% (n=27)
RGPSQNLQ 0.20% (n=27)
VGPKQNIQ 0.20% (n=27)
QGPKQDIQ 0.18% (n=24)
PGANQNVQ 0.17% (n=23)
RGARQNIQ 0.16% (n=22)
LGPRQNIQ 0.16% (n=22)
RGPSQDIR 0.15% (n=21)
LGPSQNIQ 0.15% (n=21)
PGPSQNLQ 0.15% (n=21)
PGPQQKIQ 0.15% (n=21)
MGPKQNIQ 0.15% (n=20)
AGPKQDVQ 0.15% (n=20)
QGPSQNIK 0.15% (n=20)
QGARQNVQ 0.14% (n=19)
SGPKQDVQ 0.14% (n=19)
VGAKQNIQ 0.13% (n=18)
QGPSQNIR 0.13% (n=18)
RGAKQDVQ 0.12% (n=17)
LGARQKIQ 0.12% (n=17)
RGAQQDIQ 0.12% (n=17)
KGAKQDIQ 0.12% (n=17)
RGPSQNIQ 0.12% (n=16)
SGPQQNIQ 0.12% (n=16)
RGPSQTIR 0.12% (n=16)
PGAQQNVR 0.12% (n=16)
LGAKQKIQ 0.11% (n=15)
PGARQAIQ 0.11% (n=15)
TGSKQDVQ 0.11% (n=15)
FGANQNIQ 0.11% (n=15)
QGAQQNVQ 0.10% (n=14)
PGAKQKIQ 0.10% (n=14)
QGAKQDIK 0.10% (n=14)
PGARQDIQ 0.10% (n=14)
RGAMQNIQ 0.10% (n=14)
RGPSQKIQ 0.10% (n=14)
PGSKQDVQ 0.10% (n=13)
PGPKQNLQ 0.10% (n=13)
PGPKQDVR 0.10% (n=13)
PGAKQDIK 0.10% (n=13)
PGPKQDVQ 0.10% (n=13)
LGPQQNIQ 0.10% (n=13)
KGAQQNIQ 0.10% (n=13)
TGAKQDIQ 0.09% (n=12)
PGSKQDIQ 0.09% (n=12)
RGAQQNVQ 0.09% (n=12)
QGAKQGVQ 0.09% (n=12)
QGSKQNVQ 0.08% (n=11)
KGANQDIQ 0.08% (n=11)
AGPQQKIQ 0.08% (n=11)
MGAKQNIQ 0.08% (n=11)
PGPSQNVQ 0.07% (n=10)
LGPKQNVQ 0.07% (n=10)
QGAKQNVQ 0.07% (n=10)
IGAKQNIQ 0.07% (n=10)
PGPKQKVQ 0.07% (n=10)
AGAMQNIQ 0.07% (n=10)
PGARQKIQ 0.07% (n=9)
LGARQNIQ 0.07% (n=9)
PGSKQNVQ 0.07% (n=9)
RGPNQKIQ 0.07% (n=9)
PGSRQNVQ 0.07% (n=9)
PGSQQNVQ 0.07% (n=9)
PGAMQDIQ 0.07% (n=9)
QGPQQKIQ 0.07% (n=9)
SGPSQKIQ 0.06% (n=8)
RGPRQNIQ 0.06% (n=8)
PGSQQNIQ 0.06% (n=8)
PGSQQHIQ 0.06% (n=8)
RGPKQDVQ 0.06% (n=8)
AGAKQDIQ 0.06% (n=8)
QGAKQNLQ 0.06% (n=8)
PGSKQNLQ 0.06% (n=8)
LGPSQNLQ 0.06% (n=8)
RGPRQNVQ 0.06% (n=8)
KGARQNIQ 0.06% (n=8)
RGAKQNVQ 0.05% (n=7)
PGASQKLQ 0.05% (n=7)
PGPSQNIR 0.05% (n=7)
LGAQQNIQ 0.05% (n=7)
VGARQNIQ 0.05% (n=7)
PGAKQNLQ 0.05% (n=7)
PGPRQDVQ 0.05% (n=7)
LGANQNIQ 0.05% (n=7)
QGASQNIQ 0.04% (n=6)
IGPSQKIQ 0.04% (n=6)
LGAKQNVQ 0.04% (n=6)
PGAKQKVQ 0.04% (n=6)
VGAQQNIQ 0.04% (n=6)
LGPSQNIK 0.04% (n=6)
QGPSQSIR 0.04% (n=6)
TGPSQKIQ 0.04% (n=6)
VGARQKLQ 0.04% (n=6)
PGAKQSIQ 0.04% (n=5)
LGARQNVQ 0.04% (n=5)
RGASQNIQ 0.04% (n=5)
TGAQQKIQ 0.04% (n=5)
VGPSQKIQ 0.04% (n=5)
VGAKQDIQ 0.04% (n=5)
RGSKQNIQ 0.04% (n=5)
TGARQKIQ 0.04% (n=5)
VGPSQNIQ 0.04% (n=5)
PGPMQNVQ 0.04% (n=5)
PGPQQNVQ 0.04% (n=5)
MGAQQNIQ 0.04% (n=5)
SGAKQKIQ 0.04% (n=5)
PGAKQNVR 0.04% (n=5)
QGAKQNIR 0.04% (n=5)
PGTKQNIQ 0.03% (n=4)
PGAEQNVQ 0.03% (n=4)
PGAQHNVQ 0.03% (n=4)
RGPSQKLY 0.03% (n=4)
FGAKQNIQ 0.03% (n=4)
IGPKQNIQ 0.03% (n=4)
TGPKQNVQ 0.03% (n=4)
SGAQQKIQ 0.03% (n=4)
SGPRQNIQ 0.03% (n=4)
PGAQQKVQ 0.03% (n=4)
WGPSQNIR 0.03% (n=4)
SGAQQNIQ 0.03% (n=4)
PGSNQNIQ 0.03% (n=4)
AGAQQNIQ 0.03% (n=4)
SGPKQDIQ 0.03% (n=4)
IGARQNIQ 0.03% (n=4)
TGAKQNVQ 0.03% (n=4)
LGAKQDIQ 0.03% (n=4)
TGARQNIQ 0.03% (n=4)
PGPKQNIR 0.03% (n=4)
RGANQNIQ 0.03% (n=4)
LGPKQDIQ 0.03% (n=4)
VGAKQKIQ 0.03% (n=4)
QGSNQNIQ 0.03% (n=4)
VGPRQNIQ 0.03% (n=4)
PGAMRNIQ 0.03% (n=4)
VGSRQNIQ 0.03% (n=4)
QGANQKIQ 0.03% (n=4)
PGARQNVR 0.03% (n=4)
PGAKQDIR 0.02% (n=3)
PGAKRNVQ 0.02% (n=3)
RGPKQDIR 0.02% (n=3)
PGVKQNIQ 0.02% (n=3)
PGAKQHIQ 0.02% (n=3)
LGPKQDVQ 0.02% (n=3)
RGSKQDIQ 0.02% (n=3)
AGARQNIQ 0.02% (n=3)
SGPKQNVQ 0.02% (n=3)
PGAKQNTQ 0.02% (n=3)
MGAKQRIQ 0.02% (n=3)
RGPKQNLQ 0.02% (n=3)
FGPKQNIQ 0.02% (n=3)
VGPQQNIQ 0.02% (n=3)
VGPKQKIQ 0.02% (n=3)
TGSKQNLQ 0.02% (n=3)
PGPRQKVQ 0.02% (n=3)
PGARQNIR 0.02% (n=3)
PGPRQDIQ 0.02% (n=3)
KGPKQNIQ 0.02% (n=3)
PGSMQNIQ 0.02% (n=3)
PGPQQEVQ 0.02% (n=3)
TGPKQDIQ 0.02% (n=3)
PGAQQNLQ 0.01% (n=2)
PGARQNVK 0.01% (n=2)
RGPNQNVQ 0.01% (n=2)
QGARQSIQ 0.01% (n=2)
SGPNQNIQ 0.01% (n=2)
PGAEQNIQ 0.01% (n=2)
PGAKQGIQ 0.01% (n=2)
EGAQQKIQ 0.01% (n=2)
RGSRQDIQ 0.01% (n=2)
AGPSQKIQ 0.01% (n=2)
RGPQQNIQ 0.01% (n=2)
RGARQEIR 0.01% (n=2)
PGARQSIQ 0.01% (n=2)
LGPKQNLQ 0.01% (n=2)
PGARQDVQ 0.01% (n=2)
PGAKQDLQ 0.01% (n=2)
TGSQQNVQ 0.01% (n=2)
NGPKQDVQ 0.01% (n=2)
SGAKQDVQ 0.01% (n=2)
SGSRQNVQ 0.01% (n=2)
LGAKQDIR 0.01% (n=2)
RGPKQHIQ 0.01% (n=2)
PGALQNVQ 0.01% (n=2)
TGAKQNLQ 0.01% (n=2)
QGSKQNIQ 0.01% (n=2)
LGSKQNIE 0.01% (n=2)
VGPKQDIR 0.01% (n=2)
PGAKRNIQ 0.01% (n=2)
QGAKQDVQ 0.01% (n=2)
PGTMQNIQ 0.01% (n=2)
PGSRQSIQ 0.01% (n=2)
SGPQQDIQ 0.01% (n=2)
QDPKQDIQ 0.01% (n=2)
PGAKQSVQ 0.01% (n=2)
PGPSQKVQ 0.01% (n=2)
QGPSQNVQ 0.01% (n=2)
SGRKQDIQ 0.01% (n=2)
QGPSQKIE 0.01% (n=2)
RDAQQKIQ 0.01% (n=2)
SGAKQNIR 0.01% (n=2)
QGPKQNIH 0.01% (n=2)
LGAQQNVQ 0.01% (n=2)
MGPKQKIQ 0.01% (n=2)
QGARQKLQ 0.01% (n=2)
SGPQQKIQ 0.01% (n=2)
AGSRQYVQ 0.01% (n=2)
QGAQQKIQ 0.01% (n=2)
TGSQQHVQ 0.01% (n=2)
PGARQHVQ 0.01% (n=2)
RGPSQQIQ 0.01% (n=2)
SGSKQNIQ 0.01% (n=2)
AGPRQNLQ 0.01% (n=2)
PGHNQKIQ 0.01% (n=2)
PGAKQNIH 0.01% (n=2)
RGAKQN-- 0.01% (n=2)
LGPNQRIQ 0.01% (n=2)
RGPQQDIR 0.01% (n=2)
PGPQQKVQ 0.01% (n=2)
AGARQDIQ 0.01% (n=2)
RGPQQKIQ 0.01% (n=2)
PGAMQNVQ 0.01% (n=2)
VGAKQDVQ 0.01% (n=1)
AGAKQDVQ 0.01% (n=1)
RGASQNVQ 0.01% (n=1)
SGAKQDIR 0.01% (n=1)
PGAKLNVQ 0.01% (n=1)
SGAKRNIQ 0.01% (n=1)
PGPSQNAQ 0.01% (n=1)
PCPRQNIQ 0.01% (n=1)
PGPKENIQ 0.01% (n=1)
PGPKRNIQ 0.01% (n=1)
LGAGQNVQ 0.01% (n=1)
RGPKQNV* 0.01% (n=1)
RGPSQKLH 0.01% (n=1)
RGPSQDTR 0.01% (n=1)
KGPSQNIY 0.01% (n=1)
PGPKQSVQ 0.01% (n=1)
QGARQNTQ 0.01% (n=1)
QGAKRDIQ 0.01% (n=1)
TGAKRNIQ 0.01% (n=1)
PGPSQDVR 0.01% (n=1)
RGPQQHIQ 0.01% (n=1)
QGPKQNIR 0.01% (n=1)
VGPKQDIK 0.01% (n=1)
PGARQEIQ 0.01% (n=1)
LGANQNVQ 0.01% (n=1)
RGSKQDVQ 0.01% (n=1)
RGPEQNVQ 0.01% (n=1)
PGPGQNIQ 0.01% (n=1)
LGPNQNIQ 0.01% (n=1)
PGASQNAQ 0.01% (n=1)
QAPSRVIQ 0.01% (n=1)
QGPKLNVQ 0.01% (n=1)
QGLKQNVQ 0.01% (n=1)
PGAQHNIQ 0.01% (n=1)
RGAKQDIH 0.01% (n=1)
PGPSQKIR 0.01% (n=1)
PGPSQNTQ 0.01% (n=1)
PGPSQSIQ 0.01% (n=1)
LGPRQKIQ 0.01% (n=1)
LGPKQDIR 0.01% (n=1)
PSSKQDIQ 0.01% (n=1)
MGPSQKIQ 0.01% (n=1)
PGGKQNIQ 0.01% (n=1)
QDAKQDIK 0.01% (n=1)
AGASQNIQ 0.01% (n=1)
LGPKQNIR 0.01% (n=1)
PGPKQQVQ 0.01% (n=1)
SGPKQGIK 0.01% (n=1)
PGSSQNLQ 0.01% (n=1)
PDPSQNLQ 0.01% (n=1)
PGPSQDLQ 0.01% (n=1)
PGPRQNVQ 0.01% (n=1)
AGPRQDIQ 0.01% (n=1)
PGLSQEIQ 0.01% (n=1)
KGAKQNIQ 0.01% (n=1)
SGANQNIQ 0.01% (n=1)
PGAQQRIQ 0.01% (n=1)
SGASQSIQ 0.01% (n=1)
LGASQNIQ 0.01% (n=1)
PGASQKIQ 0.01% (n=1)
PGAQQNTQ 0.01% (n=1)
SGPQQNVQ 0.01% (n=1)
AGAQQKIQ 0.01% (n=1)
VGARQPIG 0.01% (n=1)
SGPQQKIH 0.01% (n=1)
PGPRQTIR 0.01% (n=1)
LGSKQNIQ 0.01% (n=1)
VGSNQKIQ 0.01% (n=1)
LGARQDIQ 0.01% (n=1)
QGLKQDIQ 0.01% (n=1)
PGAQQTVQ 0.01% (n=1)
KGAN*DIQ 0.01% (n=1)
QGARRNVQ 0.01% (n=1)
PGAKQRIQ 0.01% (n=1)
SGARQNVQ 0.01% (n=1)
QGARQKVQ 0.01% (n=1)
AGAKQNVQ 0.01% (n=1)
IGAQQNIQ 0.01% (n=1)
PGAKQHVQ 0.01% (n=1)
IGPQQKIQ 0.01% (n=1)
KGARQNVQ 0.01% (n=1)
KGPNQNIQ 0.01% (n=1)
PGAQQNIK 0.01% (n=1)
QGAQQKVQ 0.01% (n=1)
RGPTQNIQ 0.01% (n=1)
LGPSQKIE 0.01% (n=1)
SGPSQHIQ 0.01% (n=1)
RGAKQNLQ 0.01% (n=1)
QGASQKIQ 0.01% (n=1)
RGAQQDVQ 0.01% (n=1)
PGPRQSIK 0.01% (n=1)
LGAQQNIR 0.01% (n=1)
SGPKQNIH 0.01% (n=1)
SGPKQKLQ 0.01% (n=1)
RGAKQQIN 0.01% (n=1)
PGAKQDVR 0.01% (n=1)
VGSRQNLQ 0.01% (n=1)
VGAQQKIQ 0.01% (n=1)
MGPKQNLQ 0.01% (n=1)
RGSKQNVQ 0.01% (n=1)
RGANQDIH 0.01% (n=1)
PGHHQNIQ 0.01% (n=1)
RGSRQNIQ 0.01% (n=1)
QGPRQSIQ 0.01% (n=1)
QGPQQNIQ 0.01% (n=1)
PGPNQKIQ 0.01% (n=1)
PGPKQKIQ 0.01% (n=1)
PGPSQHIQ 0.01% (n=1)
PGAKQNIE 0.01% (n=1)
PGPKQNLR 0.01% (n=1)
TGSKQNVQ 0.01% (n=1)
TGSRQNVQ 0.01% (n=1)
RGARQDIQ 0.01% (n=1)
TGAEQNIQ 0.01% (n=1)
TDAKQNIQ 0.01% (n=1)
QGPKQDVQ 0.01% (n=1)
TGPKQNIH 0.01% (n=1)
VGPKQNVQ 0.01% (n=1)
PGAKQDIN 0.01% (n=1)
FGSNQKIQ 0.01% (n=1)
VGPNQNIQ 0.01% (n=1)
RGPKQDLQ 0.01% (n=1)
PGARQDVR 0.01% (n=1)
PGASHNIQ 0.01% (n=1)
MGPKQDIR 0.01% (n=1)
HGPRQNIQ 0.01% (n=1)
PGAQQRVQ 0.01% (n=1)
QGPSQKLQ 0.01% (n=1)
QGANQKVQ 0.01% (n=1)
LGAKQDVR 0.01% (n=1)
QGPKQDVR 0.01% (n=1)
PGASQKVQ 0.01% (n=1)
LGPRQNVQ 0.01% (n=1)
LGPRQEIQ 0.01% (n=1)
TGPSQNIQ 0.01% (n=1)
PGAMQNIR 0.01% (n=1)
TGSQQNIQ 0.01% (n=1)
LGPKQKIQ 0.01% (n=1)
VGARQNVQ 0.01% (n=1)
LGPRQKIE 0.01% (n=1)
TGPQQQIQ 0.01% (n=1)
YGPQQNIQ 0.01% (n=1)
TGSSQNIQ 0.01% (n=1)
RGANQNVQ 0.01% (n=1)
SGARQKIQ 0.01% (n=1)
VGSKQNIQ 0.01% (n=1)
QGPRQDVR 0.01% (n=1)
QGSQQNIQ 0.01% (n=1)
PGAAQNVQ 0.01% (n=1)
PGSKQNIR 0.01% (n=1)
SGPQQSIQ 0.01% (n=1)
PGAGQNIQ 0.01% (n=1)
PGAEQDIQ 0.01% (n=1)
SGPRQNLQ 0.01% (n=1)
PGPKQKAQ 0.01% (n=1)
SGAKHNDQ 0.01% (n=1)
PGARQNLQ 0.01% (n=1)
PGPTQNIQ 0.01% (n=1)
QGAMQNVQ 0.01% (n=1)
QGAMQNIQ 0.01% (n=1)
PGAMQSIQ 0.01% (n=1)
PGVMQNIQ 0.01% (n=1)
PGTEQDIQ 0.01% (n=1)
SGAMQNIQ 0.01% (n=1)
RGPRLNIQ 0.01% (n=1)
RGPNQKVQ 0.01% (n=1)
PGANQRVQ 0.01% (n=1)
RGANQKVQ 0.01% (n=1)
LGSKQNLQ 0.01% (n=1)
PGAKQNI* 0.01% (n=1)
QGPSQQIQ 0.01% (n=1)
KGPSQDVQ 0.01% (n=1)
QGPSQNIQ 0.01% (n=1)
PGPGQKIQ 0.01% (n=1)
RGSRQDVQ 0.01% (n=1)
QGAKQKIQ 0.01% (n=1)
SGAKQSIQ 0.01% (n=1)
PGVRQNIQ 0.01% (n=1)
SGAGQNIQ 0.01% (n=1)
RGARQKIQ 0.01% (n=1)
PGPGQNIK 0.01% (n=1)
PGPRQNIK 0.01% (n=1)
NGPSQRIQ 0.01% (n=1)
NGPPQKIQ 0.01% (n=1)
DGPSQKIQ 0.01% (n=1)
EGAKQDIQ 0.01% (n=1)
KGARQDIQ 0.01% (n=1)
RGAQQKI* 0.01% (n=1)
RGAQRKIQ 0.01% (n=1)
PGSK*NIQ 0.01% (n=1)
LGSR*NIQ 0.01% (n=1)
QGSRQNIQ 0.01% (n=1)
SGAKHNIQ 0.01% (n=1)
PGAKQYIQ 0.01% (n=1)
PGPQQNIH 0.01% (n=1)
AGPRQKIQ 0.01% (n=1)
AGPSQNVQ 0.01% (n=1)
IGAKQKIQ 0.01% (n=1)
AGSQQNIQ 0.01% (n=1)
PGSQQDIQ 0.01% (n=1)
TGPKQDIR 0.01% (n=1)
PGPKQNIH 0.01% (n=1)
RGANQGIR 0.01% (n=1)
SGSRQNIQ 0.01% (n=1)
RGAKQDIR 0.01% (n=1)
QGPNQKVQ 0.01% (n=1)
SGSKQNVQ 0.01% (n=1)
LGPKQDIH 0.01% (n=1)
QGARQQIR 0.01% (n=1)
SGSQQNVQ 0.01% (n=1)
SGPSQNLH 0.01% (n=1)
RGPQQNIR 0.01% (n=1)
TGPRQNVQ 0.01% (n=1)
TSAKQNIQ 0.01% (n=1)
MGPQQNIQ 0.01% (n=1)
MGAQQNIR 0.01% (n=1)
IGPRQN-- 0.01% (n=1)
PGPKQN-- 0.01% (n=1)
PGAQQK-- 0.01% (n=1)
VGPTQN-- 0.01% (n=1)
AGAKQN-- 0.01% (n=1)
RGSQQN-- 0.01% (n=1)
PGARQN-- 0.01% (n=1)
SGAKQN-- 0.01% (n=1)
PGAQQE-- 0.01% (n=1)
FGPKQN-- 0.01% (n=1)
PGSRQN-- 0.01% (n=1)
SGPKQH-- 0.01% (n=1)
SGPKQN-- 0.01% (n=1)
RGAQQEIQ 0.01% (n=1)
TGPKQN-- 0.01% (n=1)
RGPKQN-- 0.01% (n=1)
LGASQNVQ 0.01% (n=1)
SGPRQNIR 0.01% (n=1)
VGSKQNVQ 0.01% (n=1)
RGPRQDIQ 0.01% (n=1)
PGAQQKLQ 0.01% (n=1)
QGAQQEIQ 0.01% (n=1)
PGPKQDIR 0.01% (n=1)
SGSMQNIQ 0.01% (n=1)
HGPKQNIQ 0.01% (n=1)
LGPNQKIQ 0.01% (n=1)
PGAQQNIR 0.01% (n=1)
LGAQQDIQ 0.01% (n=1)
LGARQNIR 0.01% (n=1)
QGPRQNVQ 0.01% (n=1)
EGPKQNVQ 0.01% (n=1)
PGPNQSVQ 0.01% (n=1)
RGARQNVQ 0.01% (n=1)
MGPKQNVQ 0.01% (n=1)
RGPQQEVQ 0.01% (n=1)
PGPQQRVQ 0.01% (n=1)
VGANQNIQ 0.01% (n=1)
PGAKQNV* 0.01% (n=1)
PSAKQNVQ 0.01% (n=1)
PGTKQNVQ 0.01% (n=1)
PGAKQNVH 0.01% (n=1)
PGPAQNIR 0.01% (n=1)
PGPSQQIQ 0.01% (n=1)
RGSQQNVQ 0.01% (n=1)
PGPQQNLQ 0.01% (n=1)
PGALQNIQ 0.01% (n=1)
RGAQQKVQ 0.01% (n=1)
PGAHQNIQ 0.01% (n=1)
AGPKQDIQ 0.01% (n=1)
LGPRQKVQ 0.01% (n=1)
QGARQKIQ 0.01% (n=1)
LSPRQNIQ 0.01% (n=1)
PDAKQNIQ 0.01% (n=1)
KGPKQDIQ 0.01% (n=1)
QGSQQKIQ 0.01% (n=1)
QGPQQRIQ 0.01% (n=1)
PGPSQDVQ 0.01% (n=1)
PGAKQN-- 0.01% (n=1)
LGPRQKI- 0.01% (n=1)
PGPKQNVH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 1b:

SGASQNIQ 4.67% (n=452)
PGASQKIQ 4.33% (n=419)
PGPSQKIQ 4.30% (n=416)
IGPSQKIQ 3.54% (n=343)
SGASQKIQ 2.93% (n=284)
PGASQNIQ 2.85% (n=276)
PGASQRIQ 2.84% (n=275)
SGPSQKIQ 2.79% (n=270)
PGPAQKLQ 2.69% (n=260)
FGASQNIQ 2.04% (n=197)
SGARQNIQ 2.04% (n=197)
FGASQKIQ 1.93% (n=187)
PGPQQKIQ 1.81% (n=175)
LGPSQKIQ 1.66% (n=161)
PGPSQKLQ 1.60% (n=155)
QGPQQKIQ 1.46% (n=141)
AGSSQRIQ 1.39% (n=135)
VGASQKIQ 1.34% (n=130)
PGSRQHIQ 1.33% (n=129)
VGPSQKIQ 1.21% (n=117)
PGPSQNIQ 1.19% (n=115)
LGASQKIQ 1.12% (n=108)
SGAQQNIQ 1.11% (n=107)
PGARQNIQ 1.05% (n=102)
RGPSQKIQ 0.98% (n=95)
AGPSQKIQ 0.95% (n=92)
AGSSQNIQ 0.94% (n=91)
PGAQQNIQ 0.93% (n=90)
PGPAQNIQ 0.82% (n=79)
LGPSQKVQ 0.81% (n=78)
PGPAQKIQ 0.80% (n=77)
PGSSQKIQ 0.70% (n=68)
PGPS---- 0.70% (n=68)
AGSSQKIQ 0.68% (n=66)
FGPSQKIQ 0.66% (n=64)
PGSAQKIQ 0.66% (n=64)
LGASQKLQ 0.62% (n=60)
VGPSQNIQ 0.61% (n=59)
LGSSQKIQ 0.60% (n=58)
PGASQQIQ 0.60% (n=58)
SGPSQNIQ 0.58% (n=56)
SGPAQKIQ 0.57% (n=55)
VGPHQKIQ 0.57% (n=55)
SGPS---- 0.57% (n=55)
VGSKQNLQ 0.55% (n=53)
SGSSQNIQ 0.54% (n=52)
PGPTQKIQ 0.54% (n=52)
TGSYQKVQ 0.54% (n=52)
SGAKQNIQ 0.53% (n=51)
PGAKQNIQ 0.51% (n=49)
TGPSQNLQ 0.51% (n=49)
PGPAQTIQ 0.49% (n=47)
PGAKQRIQ 0.49% (n=47)
PGPSQRIQ 0.48% (n=46)
PGSRQNIQ 0.46% (n=45)
LGPQQKIQ 0.44% (n=43)
PGSSQNIQ 0.44% (n=43)
PGPA---- 0.44% (n=43)
SGASQNIR 0.44% (n=43)
QGPGQKIQ 0.41% (n=40)
VGSSQRIQ 0.41% (n=40)
SGSRQNIQ 0.40% (n=39)
SGPKQKIQ 0.39% (n=38)
PGPAQQIQ 0.37% (n=36)
RGPSQTIQ 0.33% (n=32)
LGSSQKVQ 0.32% (n=31)
RGASQKLQ 0.32% (n=31)
PGASQKLQ 0.31% (n=30)
TGPSQKIQ 0.30% (n=29)
PGAKQKIQ 0.30% (n=29)
LGPTQKIQ 0.30% (n=29)
QGPSQKIQ 0.29% (n=28)
PGPKQNIQ 0.28% (n=27)
AGPSQNIQ 0.28% (n=27)
QGPKQNIQ 0.28% (n=27)
RGPSQRIQ 0.27% (n=26)
SGPA---- 0.26% (n=25)
PGSRQKIQ 0.25% (n=24)
IGPSQNIQ 0.24% (n=23)
FGPS---- 0.24% (n=23)
LGSNQKIQ 0.23% (n=22)
RGPA---- 0.23% (n=22)
LGPS---- 0.23% (n=22)
SGPSQRIQ 0.22% (n=21)
PGSYQKVQ 0.22% (n=21)
PGSSQKVQ 0.21% (n=20)
TGSNQKIQ 0.21% (n=20)
LGPT---- 0.21% (n=20)
SGPTQKIQ 0.20% (n=19)
LGSHQKVQ 0.20% (n=19)
QGSRQNIQ 0.20% (n=19)
PGSKQNIQ 0.20% (n=19)
QGSAQKIQ 0.20% (n=19)
LGPSQNIQ 0.19% (n=18)
AGASQRIQ 0.19% (n=18)
SGSSQKIQ 0.18% (n=17)
VGSS---- 0.18% (n=17)
PGPAQNLQ 0.17% (n=16)
PGSNQKIQ 0.17% (n=16)
QGSQQKIQ 0.17% (n=16)
PG------ 0.17% (n=16)
RGPS---- 0.17% (n=16)
PGSAQNIQ 0.15% (n=15)
PGASQKIE 0.15% (n=15)
FGPSQNIQ 0.14% (n=14)
PGPTQNIQ 0.14% (n=14)
PGANQNIQ 0.14% (n=14)
LGASQNIQ 0.14% (n=14)
AGSA---- 0.14% (n=14)
PGPT---- 0.14% (n=14)
PGASQRVQ 0.13% (n=13)
SGPAQEIQ 0.13% (n=13)
LGPAQKLQ 0.13% (n=13)
VGP----- 0.13% (n=13)
AGARQNIQ 0.12% (n=12)
LGPQQKVQ 0.12% (n=12)
VGPQQKIQ 0.12% (n=12)
PGP----- 0.12% (n=12)
PGPSQSIQ 0.11% (n=11)
PGAKQNLQ 0.11% (n=11)
LGPQQKLQ 0.11% (n=11)
LGSSQKLQ 0.11% (n=11)
SGPSQKIR 0.11% (n=11)
RGPAQEVQ 0.11% (n=11)
SGSAQKIQ 0.10% (n=10)
SGSAQNIQ 0.10% (n=10)
PGPTQHIQ 0.10% (n=10)
TGSRQNLQ 0.10% (n=10)
SGAS---- 0.10% (n=10)
LGSSQNIQ 0.10% (n=10)
PGSSQRIQ 0.09% (n=9)
SGPQQKIQ 0.09% (n=9)
VGASQKLQ 0.09% (n=9)
SGPRQKIQ 0.09% (n=9)
AGSKQKLQ 0.09% (n=9)
FGSAQRIQ 0.09% (n=9)
VGSRQNVQ 0.09% (n=9)
AGPTQRIQ 0.09% (n=9)
LGPAQKIQ 0.08% (n=8)
AGASQKIQ 0.08% (n=8)
PGPAQRIQ 0.08% (n=8)
AGPTQNIQ 0.08% (n=8)
QGASQKIQ 0.08% (n=8)
PGPLQKIQ 0.08% (n=8)
SGPRQNIQ 0.08% (n=8)
PGSSQKLQ 0.08% (n=8)
VGPA---- 0.08% (n=8)
LGSA---- 0.08% (n=8)
---SQKIQ 0.08% (n=8)
PGPSQELQ 0.08% (n=8)
SGPSQKLQ 0.07% (n=7)
PGASQKVQ 0.07% (n=7)
RGSAQKIQ 0.07% (n=7)
LGPKQKIQ 0.07% (n=7)
LGAKQKIQ 0.07% (n=7)
RGPSQNIQ 0.07% (n=7)
FGAQQNIQ 0.07% (n=7)
SGPKQNIQ 0.07% (n=7)
SGSKQKIQ 0.07% (n=7)
AGPAQEIH 0.07% (n=7)
RGGQQDIR 0.07% (n=7)
AGSS---- 0.07% (n=7)
PGAS---- 0.07% (n=7)
LGASQKVQ 0.06% (n=6)
SGPAQRIQ 0.06% (n=6)
RGPSQEIQ 0.06% (n=6)
PGPAQKVQ 0.06% (n=6)
TGPAQKIQ 0.06% (n=6)
SGASQKIE 0.06% (n=6)
HGPSQKIQ 0.06% (n=6)
RGASQKIQ 0.06% (n=6)
FGSAQKIQ 0.06% (n=6)
LGPGQKIQ 0.06% (n=6)
PGPSQNLQ 0.06% (n=6)
LGPSQKIH 0.06% (n=6)
SGPGQNVQ 0.06% (n=6)
PGARQNLQ 0.06% (n=6)
AGPSQTIQ 0.06% (n=6)
RGPTQKIQ 0.05% (n=5)
VGPSQKLQ 0.05% (n=5)
LGPAQNIQ 0.05% (n=5)
AGPAQSIK 0.05% (n=5)
AGPAQSIN 0.05% (n=5)
SGPQQNIQ 0.05% (n=5)
LGPSQRIQ 0.05% (n=5)
PGARQKIQ 0.05% (n=5)
PGSQQKIQ 0.05% (n=5)
TGASQKIQ 0.05% (n=5)
RGASQNIQ 0.05% (n=5)
RGSKQNIQ 0.05% (n=5)
TGARQNLQ 0.05% (n=5)
SGARQNVQ 0.05% (n=5)
RGAQQKLQ 0.05% (n=5)
LG------ 0.05% (n=5)
SGPT---- 0.05% (n=5)
RGSA---- 0.05% (n=5)
RGPSQKLQ 0.04% (n=4)
AGPSQKLQ 0.04% (n=4)
RGASQEIQ 0.04% (n=4)
AGSAQKIQ 0.04% (n=4)
AGASQNIQ 0.04% (n=4)
SGAQQKIQ 0.04% (n=4)
PGPSQHIQ 0.04% (n=4)
LGPSQKLQ 0.04% (n=4)
SGPSQKIE 0.04% (n=4)
RGPQQNVQ 0.04% (n=4)
PGPFQKIQ 0.04% (n=4)
LGAHQKIQ 0.04% (n=4)
SGPSQQIQ 0.04% (n=4)
SGPNQKIQ 0.04% (n=4)
LGPA---- 0.04% (n=4)
RGSS---- 0.04% (n=4)
FGPTQKIQ 0.04% (n=4)
IGPA---- 0.04% (n=4)
PGPSQQLQ 0.04% (n=4)
PGPAQKPQ 0.04% (n=4)
PGSQQKVQ 0.04% (n=4)
PGAQQKIQ 0.03% (n=3)
TGPKQNIQ 0.03% (n=3)
RGPAQKIQ 0.03% (n=3)
PGPTQKLQ 0.03% (n=3)
VGPSQKVQ 0.03% (n=3)
TGPTQPIN 0.03% (n=3)
SGPTQRIQ 0.03% (n=3)
RGPAQNIQ 0.03% (n=3)
SGPTQNIQ 0.03% (n=3)
PGPRQKIQ 0.03% (n=3)
PGPAQRLQ 0.03% (n=3)
FGPAQKIQ 0.03% (n=3)
SGASQKVQ 0.03% (n=3)
RGPQQKIQ 0.03% (n=3)
VGAHQKVQ 0.03% (n=3)
PGPKQNVQ 0.03% (n=3)
AGSRQNVQ 0.03% (n=3)
TGPSQNIQ 0.03% (n=3)
LGPTQRIQ 0.03% (n=3)
YGAKQDIR 0.03% (n=3)
PGPKQKLQ 0.03% (n=3)
SGSA---- 0.03% (n=3)
HGPS---- 0.03% (n=3)
FGPA---- 0.03% (n=3)
SGASQRIQ 0.03% (n=3)
VGSHQKIQ 0.03% (n=3)
PGPQQNIQ 0.03% (n=3)
PGPSQDIQ 0.03% (n=3)
RGAHQNIQ 0.03% (n=3)
CGPSQKIQ 0.02% (n=2)
LGPNQKIQ 0.02% (n=2)
TGPAQNIQ 0.02% (n=2)
FGSSQKIQ 0.02% (n=2)
PGPAHKIQ 0.02% (n=2)
PGAAQKIQ 0.02% (n=2)
LGPSHKIQ 0.02% (n=2)
VGPSQRIQ 0.02% (n=2)
FGAPQNIQ 0.02% (n=2)
SGASHNIQ 0.02% (n=2)
SGASQDIQ 0.02% (n=2)
PGASQSIQ 0.02% (n=2)
PGASHNIQ 0.02% (n=2)
SGASHNIH 0.02% (n=2)
SGAPQNIQ 0.02% (n=2)
SWASQNIQ 0.02% (n=2)
PGASQNTQ 0.02% (n=2)
PGVSQKIQ 0.02% (n=2)
LGPAQPIK 0.02% (n=2)
PGPAHRIQ 0.02% (n=2)
SGSQQKIQ 0.02% (n=2)
SGPNQRIQ 0.02% (n=2)
RGSNQKIQ 0.02% (n=2)
TGPSQKLQ 0.02% (n=2)
SGPAQNIQ 0.02% (n=2)
SGPAQKIE 0.02% (n=2)
PGPRQNIQ 0.02% (n=2)
RGAQQRIQ 0.02% (n=2)
SGPSQPLQ 0.02% (n=2)
PGASQGIQ 0.02% (n=2)
FGPQQKIQ 0.02% (n=2)
MGSAQKIQ 0.02% (n=2)
SGSKQNIQ 0.02% (n=2)
RGSHQKIQ 0.02% (n=2)
HGPAQKIQ 0.02% (n=2)
SGASQKLQ 0.02% (n=2)
SGSAQRIQ 0.02% (n=2)
AGSKQKIQ 0.02% (n=2)
QGPSQKLQ 0.02% (n=2)
PGPSQTIQ 0.02% (n=2)
PGPVQKIQ 0.02% (n=2)
AGASQNVQ 0.02% (n=2)
RGSRQNIQ 0.02% (n=2)
KGSRQNIQ 0.02% (n=2)
FGSAQRVQ 0.02% (n=2)
SGPQQKVQ 0.02% (n=2)
AGSSQNVQ 0.02% (n=2)
LGPSQTIQ 0.02% (n=2)
PGARQSIQ 0.02% (n=2)
SGAKQKIQ 0.02% (n=2)
AGSKQNIQ 0.02% (n=2)
YGPKQDIR 0.02% (n=2)
SGASQEIQ 0.02% (n=2)
LGPSQNIH 0.02% (n=2)
PGPSQQIQ 0.02% (n=2)
QGPSQNIQ 0.02% (n=2)
AGAQQNIQ 0.02% (n=2)
FGAQQKVQ 0.02% (n=2)
QGPTQKIQ 0.02% (n=2)
AGPTQKIQ 0.02% (n=2)
PGPTQRIQ 0.02% (n=2)
TGPNQKIQ 0.02% (n=2)
PGATQNIQ 0.02% (n=2)
RGSSQKIQ 0.02% (n=2)
KGPSQKIQ 0.02% (n=2)
LGPAQTIQ 0.02% (n=2)
TGPSQRIQ 0.02% (n=2)
LGSHQKIQ 0.02% (n=2)
PGASRKIQ 0.02% (n=2)
IGPSQEIQ 0.02% (n=2)
PGPKQNIH 0.02% (n=2)
TGSRQNIQ 0.02% (n=2)
PGSRQKVQ 0.02% (n=2)
AGSSQRVQ 0.02% (n=2)
AGSPQKIQ 0.02% (n=2)
---AQKIQ 0.02% (n=2)
QGPQQRIQ 0.02% (n=2)
PEPQQKIQ 0.02% (n=2)
SGASQKIR 0.02% (n=2)
QGPRQNIQ 0.02% (n=2)
VGSKQTIQ 0.02% (n=2)
VGPAQKIE 0.02% (n=2)
PGPVQHLQ 0.02% (n=2)
FGPHQKLQ 0.01% (n=1)
AGPAQKIQ 0.01% (n=1)
SGPSQNVQ 0.01% (n=1)
RGSAQKLQ 0.01% (n=1)
AGSAQNIQ 0.01% (n=1)
QGPKQQIQ 0.01% (n=1)
RGSAQEIQ 0.01% (n=1)
RGAQQKVQ 0.01% (n=1)
RGAKQKVQ 0.01% (n=1)
QGAKQKVQ 0.01% (n=1)
QGPKQKVQ 0.01% (n=1)
QGARQKVQ 0.01% (n=1)
PGAKQEVQ 0.01% (n=1)
SEPSQKNQ 0.01% (n=1)
LGASQRVQ 0.01% (n=1)
VGSSQKIQ 0.01% (n=1)
VGASQRIQ 0.01% (n=1)
RGANQKIQ 0.01% (n=1)
TGARQNIQ 0.01% (n=1)
PGSSQKDQ 0.01% (n=1)
LGVSEDIP 0.01% (n=1)
SGPAQSIN 0.01% (n=1)
AGPAQSVN 0.01% (n=1)
SGPTSENP 0.01% (n=1)
LGSAQKLE 0.01% (n=1)
RGSKQNVQ 0.01% (n=1)
FGASQNLQ 0.01% (n=1)
AGASQKIE 0.01% (n=1)
CGASQKIQ 0.01% (n=1)
SGPAQTIQ 0.01% (n=1)
SGPAQKVQ 0.01% (n=1)
SRASQKIE 0.01% (n=1)
RGPSQEIH 0.01% (n=1)
PGGSQKIE 0.01% (n=1)
PGASQNIH 0.01% (n=1)
LGAQQKVQ 0.01% (n=1)
QGPAQRIQ 0.01% (n=1)
AGSQENIQ 0.01% (n=1)
FGAQQRIQ 0.01% (n=1)
AGPAQNIQ 0.01% (n=1)
PGPTQNLQ 0.01% (n=1)
TGRCQTIQ 0.01% (n=1)
PGAPQRIQ 0.01% (n=1)
DGPQQKIQ 0.01% (n=1)
DGPRQKIQ 0.01% (n=1)
SGPTQKLQ 0.01% (n=1)
VGSNQNIQ 0.01% (n=1)
VGPQQNIQ 0.01% (n=1)
SGARQKIQ 0.01% (n=1)
VGPAQKLQ 0.01% (n=1)
PGARQKVQ 0.01% (n=1)
LGSRQNIQ 0.01% (n=1)
PGAHQKIQ 0.01% (n=1)
PGPQ*KIQ 0.01% (n=1)
PGSRRKIQ 0.01% (n=1)
RGPSRRIQ 0.01% (n=1)
FGSSQNVQ 0.01% (n=1)
RGPTQNIQ 0.01% (n=1)
PGAAQNIQ 0.01% (n=1)
PGAKQKVQ 0.01% (n=1)
AGSHQKIQ 0.01% (n=1)
VGPAQNIQ 0.01% (n=1)
SGARQNLQ 0.01% (n=1)
PGACQNIQ 0.01% (n=1)
TGPSQTIQ 0.01% (n=1)
MGSSQKIQ 0.01% (n=1)
TGPTQRIQ 0.01% (n=1)
FGSHQNVQ 0.01% (n=1)
RGPSQQIQ 0.01% (n=1)
LGPAQNIR 0.01% (n=1)
QGAQQKIQ 0.01% (n=1)
AGPTQNLQ 0.01% (n=1)
RGPAQSLQ 0.01% (n=1)
AGPAQKIH 0.01% (n=1)
FGPSQRIQ 0.01% (n=1)
TGSSQKIQ 0.01% (n=1)
RGPHQNIQ 0.01% (n=1)
AGPLQQIQ 0.01% (n=1)
LGSAQKVQ 0.01% (n=1)
LGPAQRIQ 0.01% (n=1)
AGPAQKLQ 0.01% (n=1)
RGPSQKLH 0.01% (n=1)
HGARQNIQ 0.01% (n=1)
TGSAQRIQ 0.01% (n=1)
PGPSQSIH 0.01% (n=1)
FGPAQNIQ 0.01% (n=1)
RGPAQRIQ 0.01% (n=1)
RGPSQNLQ 0.01% (n=1)
VGPTQNLQ 0.01% (n=1)
SGSRQKIQ 0.01% (n=1)
SGPKQSIQ 0.01% (n=1)
PGPSQPIQ 0.01% (n=1)
LGPGQKVQ 0.01% (n=1)
PGPGQKIQ 0.01% (n=1)
LGSQQKIQ 0.01% (n=1)
PGPKQDIQ 0.01% (n=1)
RGSRQSIQ 0.01% (n=1)
LGPSQKIE 0.01% (n=1)
RGSKQTLQ 0.01% (n=1)
FGSNQNVQ 0.01% (n=1)
PGTSQKIQ 0.01% (n=1)
PGASRNIQ 0.01% (n=1)
SGPSQEIQ 0.01% (n=1)
PGPPQKIQ 0.01% (n=1)
FGPSQNTQ 0.01% (n=1)
PGPAQQVQ 0.01% (n=1)
QGSQQKVQ 0.01% (n=1)
QGSQQRIQ 0.01% (n=1)
SGPSQKVQ 0.01% (n=1)
LEPSQKVQ 0.01% (n=1)
FGSRQNIQ 0.01% (n=1)
PGPAQEIH 0.01% (n=1)
AGPAQEIQ 0.01% (n=1)
SGPAQEIH 0.01% (n=1)
LGAHQKLQ 0.01% (n=1)
RGGQQNIQ 0.01% (n=1)
RGGKQDIR 0.01% (n=1)
SGSRQNLQ 0.01% (n=1)
VGPSQQIQ 0.01% (n=1)
PGASQHIQ 0.01% (n=1)
RGPKQKLQ 0.01% (n=1)
SGATQNIQ 0.01% (n=1)
PGPSQMIQ 0.01% (n=1)
SGPAQQIQ 0.01% (n=1)
FGPSRKIQ 0.01% (n=1)
VGPTQNIQ 0.01% (n=1)
LGPTQNVQ 0.01% (n=1)
TGAKQKIQ 0.01% (n=1)
PGANQKIQ 0.01% (n=1)
SGPKQEIR 0.01% (n=1)
PGPNQQIQ 0.01% (n=1)
PGPIQKIQ 0.01% (n=1)
PGPGQEIK 0.01% (n=1)
PGPQQRIQ 0.01% (n=1)
TGPTQKIQ 0.01% (n=1)
PGSAQRIQ 0.01% (n=1)
AGPHQKIQ 0.01% (n=1)
PGPTQTIQ 0.01% (n=1)
PGSAQEIK 0.01% (n=1)
AGSQQKLQ 0.01% (n=1)
QGPTQKLQ 0.01% (n=1)
VGPTQKLQ 0.01% (n=1)
RGPTQELR 0.01% (n=1)
-GPSQNIQ 0.01% (n=1)
RGPSQGIQ 0.01% (n=1)
-GPSQKIQ 0.01% (n=1)
PGAAQTIQ 0.01% (n=1)
TGPSQSIQ 0.01% (n=1)
SGAAQNIQ 0.01% (n=1)
QGPRQNIL 0.01% (n=1)
TGPA---- 0.01% (n=1)
HGP----- 0.01% (n=1)
TGSA---- 0.01% (n=1)
VG------ 0.01% (n=1)
VGAS---- 0.01% (n=1)
PGSS---- 0.01% (n=1)
SGVS---- 0.01% (n=1)
LGSS---- 0.01% (n=1)
PGATQKIQ 0.01% (n=1)
SGPTQKVQ 0.01% (n=1)
PGPHQKIQ 0.01% (n=1)
RGPHQKIQ 0.01% (n=1)
LGPAQKLH 0.01% (n=1)
PGPSQKFQ 0.01% (n=1)
VGASQNIQ 0.01% (n=1)
TGPS---- 0.01% (n=1)
LGPRQNLQ 0.01% (n=1)
RGPNQNIQ 0.01% (n=1)
AGPPQNIQ 0.01% (n=1)
SGPSQCIQ 0.01% (n=1)
SGPPQNIQ 0.01% (n=1)
PGPSRKIQ 0.01% (n=1)
LGSAQKIQ 0.01% (n=1)
AGASQDIQ 0.01% (n=1)
PGAFQNIH 0.01% (n=1)
PGPSQTLQ 0.01% (n=1)
PGLYQRIQ 0.01% (n=1)
AGPSQKVQ 0.01% (n=1)
TGSAQKIQ 0.01% (n=1)
PGPSQKIE 0.01% (n=1)
LGPRQKIQ 0.01% (n=1)
LGSAQKLQ 0.01% (n=1)
QGPDQKIQ 0.01% (n=1)
LGSHQSIQ 0.01% (n=1)
YGSSQNIQ 0.01% (n=1)
RWASQKIQ 0.01% (n=1)
FGPKQNIQ 0.01% (n=1)
AGAKQKIQ 0.01% (n=1)
PGASQRLQ 0.01% (n=1)
VGSRQNIQ 0.01% (n=1)
PGSQQNVQ 0.01% (n=1)
FGSQQKIQ 0.01% (n=1)
SGSQQNIQ 0.01% (n=1)
RGSRQNLQ 0.01% (n=1)
CGSKQNIQ 0.01% (n=1)
SGPRQNLQ 0.01% (n=1)
RGPGQNIQ 0.01% (n=1)
RGSNQNIQ 0.01% (n=1)
AGAAQNVQ 0.01% (n=1)
VGSAQNIQ 0.01% (n=1)
FGSSQNIQ 0.01% (n=1)
SGPNQNIQ 0.01% (n=1)
LGAQQNIQ 0.01% (n=1)
VGSAQNIR 0.01% (n=1)
RGSAQNIQ 0.01% (n=1)
LGSAQNIQ 0.01% (n=1)
PGSAQNVQ 0.01% (n=1)
QGSAQNIQ 0.01% (n=1)
PGAKQDIQ 0.01% (n=1)
SGASQRVQ 0.01% (n=1)
FGASQNVQ 0.01% (n=1)
TGAQQK-- 0.01% (n=1)
SRPQQK-- 0.01% (n=1)
TGPQQ--- 0.01% (n=1)
TGPQQRIQ 0.01% (n=1)
PGAQQR-- 0.01% (n=1)
LGSYQKIQ 0.01% (n=1)
---KQKIQ 0.01% (n=1)
RGPSQEVQ 0.01% (n=1)
RGPSQELQ 0.01% (n=1)
AGPAQNLQ 0.01% (n=1)
PGPKQKIQ 0.01% (n=1)
QEPQQKIQ 0.01% (n=1)
QGPRQKIQ 0.01% (n=1)
PGSRQHTQ 0.01% (n=1)
PGLRQHIQ 0.01% (n=1)
PGPSRKLQ 0.01% (n=1)
PGSSQELQ 0.01% (n=1)
PEPSQKLQ 0.01% (n=1)
PRPSQKLQ 0.01% (n=1)
PGPSQKPQ 0.01% (n=1)
LGSSQEIQ 0.01% (n=1)
PGPSQELK 0.01% (n=1)
LGSPQNTQ 0.01% (n=1)
PGPQQKVQ 0.01% (n=1)
PGP*QKIQ 0.01% (n=1)
LGPQQRIQ 0.01% (n=1)
FGASHKIQ 0.01% (n=1)
VGASQKIR 0.01% (n=1)
VGASQKTQ 0.01% (n=1)
PWPAQNLQ 0.01% (n=1)
PGPAQKLP 0.01% (n=1)
PGPAQKLL 0.01% (n=1)
PGLAQKLQ 0.01% (n=1)
PGPALKLQ 0.01% (n=1)
SGTSQKIQ 0.01% (n=1)
LGASQ*LQ 0.01% (n=1)
PGAQQRIQ 0.01% (n=1)
SGPNQKVQ 0.01% (n=1)
TGAQQKIQ 0.01% (n=1)
VGSQQKIQ 0.01% (n=1)
VGSNQKIQ 0.01% (n=1)
RGSHQNIQ 0.01% (n=1)
RGPRQNIQ 0.01% (n=1)
RGPQQTIQ 0.01% (n=1)
LGSQQKVQ 0.01% (n=1)
PGASQNVQ 0.01% (n=1)
IGRSQKI- 0.01% (n=1)
PGQEQKIQ 0.01% (n=1)
HGPSQNIQ 0.01% (n=1)
YGASQKIQ 0.01% (n=1)
AGPAQRIQ 0.01% (n=1)
VGPTQKIQ 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 2:

RGSRQNIQ 11.44% (n=149)
QGAKQHIQ 9.75% (n=127)
PGPSQKIQ 6.22% (n=81)
PGAKQNIQ 5.83% (n=76)
PGAKQHIQ 3.30% (n=43)
PGPSQKLN 2.92% (n=38)
SGAQQEIS 2.92% (n=38)
PGARQNIQ 2.69% (n=35)
PGPSQKLS 2.38% (n=31)
RGARQHIQ 2.07% (n=27)
LGPQQKIN 1.69% (n=22)
SGAKQNIQ 1.23% (n=16)
QGPSQKLS 1.23% (n=16)
SGSQQKLS 1.15% (n=15)
PGPQQQIT 1.15% (n=15)
TGAKQNIQ 0.92% (n=12)
SGAQQKIN 0.92% (n=12)
PGAKQRIQ 0.92% (n=12)
RGPQQKLS 0.84% (n=11)
SGAQQRIS 0.84% (n=11)
HGPQQNIQ 0.77% (n=10)
SGPKQNIQ 0.77% (n=10)
KGARQHIQ 0.77% (n=10)
KGAKQHIQ 0.77% (n=10)
PGPKQNIN 0.69% (n=9)
SGAQQQIS 0.69% (n=9)
PGPQQNIQ 0.61% (n=8)
PGSKQNIQ 0.54% (n=7)
PGAQQNIQ 0.54% (n=7)
AGPKQTLS 0.46% (n=6)
SGPQQRLQ 0.46% (n=6)
MGPRQKIQ 0.38% (n=5)
PGASQNIQ 0.38% (n=5)
PGSQQNIQ 0.38% (n=5)
PGPKQRID 0.38% (n=5)
PGPRQTLS 0.38% (n=5)
LGPSQRIN 0.38% (n=5)
PGPSQRIQ 0.38% (n=5)
LGSQQNIQ 0.31% (n=4)
SGPQQNIQ 0.31% (n=4)
PGPRQKID 0.31% (n=4)
SGPKQKID 0.31% (n=4)
LGPQQKLS 0.31% (n=4)
PGSQQRLQ 0.23% (n=3)
PGARQNLQ 0.23% (n=3)
VGAKQNIQ 0.23% (n=3)
AGARQNIQ 0.23% (n=3)
PGAKQNLQ 0.23% (n=3)
SGARQNIQ 0.23% (n=3)
PGARQHIQ 0.23% (n=3)
LGHKQNVQ 0.23% (n=3)
PGHKQNVQ 0.23% (n=3)
PGSRQNIQ 0.23% (n=3)
PGPQQKIQ 0.23% (n=3)
PGPQQRIQ 0.23% (n=3)
PGPKQNIQ 0.23% (n=3)
AGAQQKLS 0.23% (n=3)
LGSQQRLS 0.23% (n=3)
PGARQKIS 0.23% (n=3)
LGPQQKIK 0.23% (n=3)
SGPQQKLT 0.23% (n=3)
SGPQQNLN 0.23% (n=3)
QGSRQNIQ 0.23% (n=3)
RGSRQDIQ 0.23% (n=3)
PGSKQHIQ 0.15% (n=2)
QGAKQNIQ 0.15% (n=2)
PGARQKIQ 0.15% (n=2)
RGPQQKIQ 0.15% (n=2)
AGAKQNIQ 0.15% (n=2)
QGARQNIQ 0.15% (n=2)
RGAQQNIQ 0.15% (n=2)
IGAKQNIQ 0.15% (n=2)
SGARQKLQ 0.15% (n=2)
PGAKQDIQ 0.15% (n=2)
LGARQKIQ 0.15% (n=2)
AGSRQNIQ 0.15% (n=2)
SGAQQKIQ 0.15% (n=2)
VGSKQNIQ 0.15% (n=2)
PGPRQNIQ 0.15% (n=2)
PGPQQTIQ 0.15% (n=2)
LGAKQNIQ 0.15% (n=2)
FGPKQNIQ 0.15% (n=2)
TGPQQKIQ 0.15% (n=2)
HGAKQNIQ 0.15% (n=2)
SGSRQNIQ 0.15% (n=2)
TGAKQNIY 0.15% (n=2)
TGSRQNIQ 0.15% (n=2)
DGARQKIQ 0.15% (n=2)
PGPQQKIS 0.15% (n=2)
VGPQQKIN 0.15% (n=2)
AGSQQRLS 0.15% (n=2)
PGPKQTLS 0.15% (n=2)
PGPRQRIH 0.15% (n=2)
VGPSQKIN 0.15% (n=2)
RGPQQKLH 0.15% (n=2)
PGPKQQIT 0.15% (n=2)
LGPKQKIN 0.15% (n=2)
LGAQQQLS 0.15% (n=2)
SGPQQKLS 0.15% (n=2)
SGPQQKLN 0.15% (n=2)
AGPSQKIS 0.15% (n=2)
SGARQKIS 0.15% (n=2)
FGPSQKIS 0.15% (n=2)
LGPSQTIN 0.15% (n=2)
FGPRQKLS 0.15% (n=2)
HGPQQKLS 0.15% (n=2)
SGAQQKIS 0.15% (n=2)
RGAKQHIQ 0.15% (n=2)
PGARQRIQ 0.15% (n=2)
QGPQQRIQ 0.15% (n=2)
SGPQQKIQ 0.15% (n=2)
RGSRQHIQ 0.15% (n=2)
QGPKQNIQ 0.15% (n=2)
PGPQQKLQ 0.15% (n=2)
PGAKQTLQ 0.08% (n=1)
PGAQQHVQ 0.08% (n=1)
PGPIQHIQ 0.08% (n=1)
PGARQQVQ 0.08% (n=1)
RGAHQNIQ 0.08% (n=1)
PGAKQIIQ 0.08% (n=1)
SGAKQNTQ 0.08% (n=1)
YGAKQNIQ 0.08% (n=1)
RGPQQQIQ 0.08% (n=1)
AGAQQNIQ 0.08% (n=1)
QGPRQNIQ 0.08% (n=1)
SGAQQNIQ 0.08% (n=1)
PGPTQNIQ 0.08% (n=1)
RGPRQNLQ 0.08% (n=1)
SGSKQNLQ 0.08% (n=1)
SGPTQNLQ 0.08% (n=1)
PGAKQKIQ 0.08% (n=1)
FGAKQNIQ 0.08% (n=1)
FGPSQNIQ 0.08% (n=1)
SGARQKIQ 0.08% (n=1)
LGPQQRIQ 0.08% (n=1)
QGSNQNIQ 0.08% (n=1)
FGSRQNIQ 0.08% (n=1)
PGPMQNIQ 0.08% (n=1)
PGSKQNLQ 0.08% (n=1)
PGAKQSIQ 0.08% (n=1)
AGPRQNIQ 0.08% (n=1)
SGSRQNVQ 0.08% (n=1)
VGPQQNIQ 0.08% (n=1)
SGSRQSIQ 0.08% (n=1)
LGSRQNIQ 0.08% (n=1)
QGPSQNLR 0.08% (n=1)
LGAQQNVQ 0.08% (n=1)
SGSKQNIQ 0.08% (n=1)
SGPQQKLI 0.08% (n=1)
SGAQQEIR 0.08% (n=1)
PGPQQNVH 0.08% (n=1)
SGPKQNIH 0.08% (n=1)
PGAKQNIH 0.08% (n=1)
TGPRQNIQ 0.08% (n=1)
LGPQQKNH 0.08% (n=1)
TGAKQSIQ 0.08% (n=1)
LGPSQRLQ 0.08% (n=1)
FGAQQNIQ 0.08% (n=1)
TGPQQNLH 0.08% (n=1)
SGAKQNIY 0.08% (n=1)
TGPRQNLQ 0.08% (n=1)
YGAQQNIQ 0.08% (n=1)
SGPSQSIQ 0.08% (n=1)
PGPQQNIY 0.08% (n=1)
IGPQQKLN 0.08% (n=1)
LGPKQNIQ 0.08% (n=1)
LGAQQRLS 0.08% (n=1)
SGPRQNIQ 0.08% (n=1)
PGAKQNLH 0.08% (n=1)
FGAQQPIS 0.08% (n=1)
RGPKQNLQ 0.08% (n=1)
AGPSQKLS 0.08% (n=1)
NGSKQNIY 0.08% (n=1)
FGPHHSIN 0.08% (n=1)
QGSQQNIH 0.08% (n=1)
AGPQQKLQ 0.08% (n=1)
PGPKQNIH 0.08% (n=1)
PGAKQNIM 0.08% (n=1)
PGPKQNLQ 0.08% (n=1)
RGPQQQLR 0.08% (n=1)
TGAKQKLS 0.08% (n=1)
PGPRQQLQ 0.08% (n=1)
SGAQQKIH 0.08% (n=1)
SGARQKIM 0.08% (n=1)
IGPKQNIQ 0.08% (n=1)
PGASQKIS 0.08% (n=1)
PGAKQNIN 0.08% (n=1)
AGAKQNIN 0.08% (n=1)
PGPQQNIH 0.08% (n=1)
RGPQQQLH 0.08% (n=1)
FGPQQQLH 0.08% (n=1)
PGSRQDIS 0.08% (n=1)
TGAKQNLY 0.08% (n=1)
LGPKQKID 0.08% (n=1)
VGPKQKID 0.08% (n=1)
PGPKKQIT 0.08% (n=1)
SCPQQKIN 0.08% (n=1)
LCPQQKIN 0.08% (n=1)
PGPEQQIT 0.08% (n=1)
PGP*QQIT 0.08% (n=1)
WGAKQQLS 0.08% (n=1)
TGSQQKLS 0.08% (n=1)
SGSKQKLS 0.08% (n=1)
LGSQQKLS 0.08% (n=1)
PGPRQTVS 0.08% (n=1)
PGPRQTL* 0.08% (n=1)
SGPKQKLT 0.08% (n=1)
TGSQQQLS 0.08% (n=1)
TGPKQNLN 0.08% (n=1)
RGPTRQIN 0.08% (n=1)
PGPSQKFN 0.08% (n=1)
SGAKQNLY 0.08% (n=1)
HGPKQKIN 0.08% (n=1)
SGAKQKIQ 0.08% (n=1)
SGPAQKLS 0.08% (n=1)
YGPSQKLN 0.08% (n=1)
SGPQQRLS 0.08% (n=1)
SGPQQRIN 0.08% (n=1)
PGPSQRLS 0.08% (n=1)
FGSRQKLS 0.08% (n=1)
LGPSQTLS 0.08% (n=1)
PGPSQRIN 0.08% (n=1)
SGPSQRLS 0.08% (n=1)
LGPSQRLS 0.08% (n=1)
PGARQQLM 0.08% (n=1)
VGPQQKIS 0.08% (n=1)
PGAQQPLS 0.08% (n=1)
PGSKQKIS 0.08% (n=1)
TGAQQKIS 0.08% (n=1)
PGPKQNLA 0.08% (n=1)
LGSRQRLS 0.08% (n=1)
TGPSQKIN 0.08% (n=1)
VPVRKSVW 0.08% (n=1)
LGAQQKLS 0.08% (n=1)
PGAQQKIS 0.08% (n=1)
SGPQQNLQ 0.08% (n=1)
LGPSQKLA 0.08% (n=1)
PGSKQNVH 0.08% (n=1)
QGPNQRIS 0.08% (n=1)
PGARQQIS 0.08% (n=1)
FGAQQRLS 0.08% (n=1)
PGGKQDIM 0.08% (n=1)
PGPSQHIS 0.08% (n=1)
PGPQQNLN 0.08% (n=1)
PGPSQQLS 0.08% (n=1)
AGPKQTIS 0.08% (n=1)
TGPQQPLS 0.08% (n=1)
PGAQQKLS 0.08% (n=1)
IGPQQKLS 0.08% (n=1)
VGPHQRLS 0.08% (n=1)
SGPQQRIH 0.08% (n=1)
FGPQQNIH 0.08% (n=1)
PGPKQKLS 0.08% (n=1)
RGPQQTIS 0.08% (n=1)
LGARQRIS 0.08% (n=1)
SGPSQRIQ 0.08% (n=1)
LGPQQQIQ 0.08% (n=1)
SGSSQNIQ 0.08% (n=1)
LGSQQRVQ 0.08% (n=1)
QGARQHIQ 0.08% (n=1)
QGARQRIQ 0.08% (n=1)
FGPSQRIQ 0.08% (n=1)
PGPKQRIQ 0.08% (n=1)
SGLQQRIQ 0.08% (n=1)
PGPKQHIQ 0.08% (n=1)
TGAKQHIQ 0.08% (n=1)
QGPQQKIQ 0.08% (n=1)
RGPSQRIQ 0.08% (n=1)
PGPRQHIQ 0.08% (n=1)
PGPNQKLQ 0.08% (n=1)
PGARQSIQ 0.08% (n=1)
QGPKQRIQ 0.08% (n=1)
VGSQQKIQ 0.08% (n=1)
KGPNQNIQ 0.08% (n=1)
LGSQQRIQ 0.08% (n=1)
SGPKQRIQ 0.08% (n=1)
TGPNQRIQ 0.08% (n=1)
LGSNQKIQ 0.08% (n=1)
PGAKQAIQ 0.08% (n=1)
LGAQQRIQ 0.08% (n=1)
VGPNQRLE 0.08% (n=1)
PGPQQRLQ 0.08% (n=1)
QGSQQQIQ 0.08% (n=1)
QGPKQHIQ 0.08% (n=1)
RGPKQRIQ 0.08% (n=1)
PGAQQHIQ 0.08% (n=1)
FGPRQTIQ 0.08% (n=1)
RGSQQNVQ 0.08% (n=1)
RGSRQNI* 0.08% (n=1)
RGSRQNIR 0.08% (n=1)
RGSRQNTQ 0.08% (n=1)
RGSRQNIH 0.08% (n=1)
QGAQQRIQ 0.08% (n=1)
QGSQQHIQ 0.08% (n=1)
TGSQQNIQ 0.08% (n=1)
PGPSQNLQ 0.08% (n=1)
LGPRQNIQ 0.08% (n=1)
PGAKQNVQ 0.08% (n=1)
RGPSQNIQ 0.08% (n=1)
RGASQNIQ 0.08% (n=1)
RGPQQNIQ 0.08% (n=1)
MGAQQKIQ 0.08% (n=1)
AGSQQHLR 0.08% (n=1)
PGPRQNVQ 0.08% (n=1)
RGSSQNVQ 0.08% (n=1)
NGPQQRLQ 0.08% (n=1)
SGPQQHLQ 0.08% (n=1)
FGPQQKLQ 0.08% (n=1)
VGARQKIQ 0.08% (n=1)
FGSQQNIQ 0.08% (n=1)
PGPSQKTQ 0.08% (n=1)
PGPSRKIQ 0.08% (n=1)
RGPSQKIQ 0.08% (n=1)
QGPSQKIQ 0.08% (n=1)
TGPSQNIM 0.08% (n=1)
VGARQNIQ 0.08% (n=1)
PGASQSLQ 0.08% (n=1)
PGSQQNLQ 0.08% (n=1)
PGPQQNLH 0.08% (n=1)
PGPQQRLS 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 2a:

PGAKQNIQ 26.67% (n=64)
PGARQNIQ 12.92% (n=31)
SGAKQNIQ 6.67% (n=16)
HGPQQNIQ 4.17% (n=10)
SGPKQNIQ 3.33% (n=8)
TGAKQNIQ 2.92% (n=7)
MGPRQKIQ 2.08% (n=5)
PGPQQNIQ 2.08% (n=5)
LGSQQNIQ 1.67% (n=4)
PGSKQNIQ 1.67% (n=4)
PGAQQNIQ 1.67% (n=4)
VGAKQNIQ 1.25% (n=3)
SGARQNIQ 1.25% (n=3)
PGASQNIQ 1.25% (n=3)
LGHKQNVQ 1.25% (n=3)
PGHKQNVQ 1.25% (n=3)
AGAKQNIQ 0.83% (n=2)
QGARQNIQ 0.83% (n=2)
RGAQQNIQ 0.83% (n=2)
AGARQNIQ 0.83% (n=2)
SGARQKLQ 0.83% (n=2)
SGPQQNIQ 0.83% (n=2)
PGAKQDIQ 0.83% (n=2)
AGSRQNIQ 0.83% (n=2)
PGSRQNIQ 0.83% (n=2)
PGSQQNIQ 0.83% (n=2)
HGAKQNIQ 0.83% (n=2)
RGPQQKIQ 0.42% (n=1)
RGAHQNIQ 0.42% (n=1)
PGAKQIIQ 0.42% (n=1)
SGAKQNTQ 0.42% (n=1)
YGAKQNIQ 0.42% (n=1)
RGPQQQIQ 0.42% (n=1)
AGAQQNIQ 0.42% (n=1)
QGPRQNIQ 0.42% (n=1)
IGAKQNIQ 0.42% (n=1)
SGAQQNIQ 0.42% (n=1)
PGAKQNLQ 0.42% (n=1)
PGPTQNIQ 0.42% (n=1)
RGPRQNLQ 0.42% (n=1)
LGARQKIQ 0.42% (n=1)
SGSKQNLQ 0.42% (n=1)
SGPTQNLQ 0.42% (n=1)
PGAKQKIQ 0.42% (n=1)
FGAKQNIQ 0.42% (n=1)
SGAQQKIQ 0.42% (n=1)
PGARQHIQ 0.42% (n=1)
FGPSQNIQ 0.42% (n=1)
PGPQQKIQ 0.42% (n=1)
VGSKQNIQ 0.42% (n=1)
SGARQKIQ 0.42% (n=1)
LGPQQRIQ 0.42% (n=1)
PGPQQRIQ 0.42% (n=1)
PGPRQNIQ 0.42% (n=1)
QGSNQNIQ 0.42% (n=1)
PGPQQTIQ 0.42% (n=1)
FGSRQNIQ 0.42% (n=1)
PGPKQNIQ 0.42% (n=1)
PGPMQNIQ 0.42% (n=1)
PGSKQNLQ 0.42% (n=1)
LGAKQNIQ 0.42% (n=1)
PGAKQSIQ 0.42% (n=1)
PGARQNLQ 0.42% (n=1)
FGPKQNIQ 0.42% (n=1)
TGPQQKIQ 0.42% (n=1)
AGPRQNIQ 0.42% (n=1)
QGAKQNIQ 0.42% (n=1)
SGSRQNVQ 0.42% (n=1)
VGPQQNIQ 0.42% (n=1)
SGSRQSIQ 0.42% (n=1)
LGSRQNIQ 0.42% (n=1)
QGPSQNLR 0.42% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 2b:

PGPSQKLN 8.33% (n=38)
SGAQQEIS 8.33% (n=38)
PGPSQKLS 6.80% (n=31)
LGPQQKIN 4.82% (n=22)
QGPSQKLS 3.51% (n=16)
SGSQQKLS 3.29% (n=15)
PGPQQQIT 3.29% (n=15)
SGAQQKIN 2.63% (n=12)
RGPQQKLS 2.41% (n=11)
SGAQQRIS 2.41% (n=11)
PGPKQNIN 1.97% (n=9)
SGAQQQIS 1.97% (n=9)
PGAKQNIQ 1.32% (n=6)
AGPKQTLS 1.32% (n=6)
PGPKQRID 1.10% (n=5)
PGPRQTLS 1.10% (n=5)
LGPSQRIN 1.10% (n=5)
PGPRQKID 0.88% (n=4)
SGPKQKID 0.88% (n=4)
LGPQQKLS 0.88% (n=4)
TGAKQNIQ 0.66% (n=3)
AGAQQKLS 0.66% (n=3)
LGSQQRLS 0.66% (n=3)
PGARQKIS 0.66% (n=3)
LGPQQKIK 0.66% (n=3)
SGPQQKLT 0.66% (n=3)
SGPQQNLN 0.66% (n=3)
SGSRQNIQ 0.44% (n=2)
TGAKQNIY 0.44% (n=2)
TGSRQNIQ 0.44% (n=2)
PGPQQNIQ 0.44% (n=2)
DGARQKIQ 0.44% (n=2)
VGPQQKIN 0.44% (n=2)
AGSQQRLS 0.44% (n=2)
PGPKQTLS 0.44% (n=2)
PGPRQRIH 0.44% (n=2)
VGPSQKIN 0.44% (n=2)
RGPQQKLH 0.44% (n=2)
PGPKQQIT 0.44% (n=2)
LGPKQKIN 0.44% (n=2)
LGAQQQLS 0.44% (n=2)
SGPQQKLS 0.44% (n=2)
SGPQQKLN 0.44% (n=2)
AGPSQKIS 0.44% (n=2)
SGARQKIS 0.44% (n=2)
FGPSQKIS 0.44% (n=2)
LGPSQTIN 0.44% (n=2)
FGPRQKLS 0.44% (n=2)
HGPQQKLS 0.44% (n=2)
SGAQQKIS 0.44% (n=2)
LGAQQNVQ 0.22% (n=1)
SGSKQNIQ 0.22% (n=1)
SGPQQKLI 0.22% (n=1)
SGAQQEIR 0.22% (n=1)
PGPQQNVH 0.22% (n=1)
FGPKQNIQ 0.22% (n=1)
SGPKQNIH 0.22% (n=1)
VGSKQNIQ 0.22% (n=1)
PGAKQNIH 0.22% (n=1)
TGPRQNIQ 0.22% (n=1)
LGPQQKNH 0.22% (n=1)
TGAKQSIQ 0.22% (n=1)
LGPSQRLQ 0.22% (n=1)
FGAQQNIQ 0.22% (n=1)
TGPQQNLH 0.22% (n=1)
SGAKQNIY 0.22% (n=1)
TGPRQNLQ 0.22% (n=1)
YGAQQNIQ 0.22% (n=1)
PGASQNIQ 0.22% (n=1)
SGPSQSIQ 0.22% (n=1)
PGPQQNIY 0.22% (n=1)
PGAKQNLQ 0.22% (n=1)
SGPKQNIQ 0.22% (n=1)
IGPQQKLN 0.22% (n=1)
LGPKQNIQ 0.22% (n=1)
PGARQNIQ 0.22% (n=1)
LGAQQRLS 0.22% (n=1)
PGSQQNIQ 0.22% (n=1)
SGPRQNIQ 0.22% (n=1)
PGAKQNLH 0.22% (n=1)
PGPQQKIQ 0.22% (n=1)
FGAQQPIS 0.22% (n=1)
RGPKQNLQ 0.22% (n=1)
AGPSQKLS 0.22% (n=1)
NGSKQNIY 0.22% (n=1)
FGPHHSIN 0.22% (n=1)
QGSQQNIH 0.22% (n=1)
AGPQQKLQ 0.22% (n=1)
PGPKQNIH 0.22% (n=1)
PGAKQNIM 0.22% (n=1)
PGPKQNLQ 0.22% (n=1)
PGPKQNIQ 0.22% (n=1)
RGPQQQLR 0.22% (n=1)
TGAKQKLS 0.22% (n=1)
PGPRQQLQ 0.22% (n=1)
SGAQQKIH 0.22% (n=1)
SGARQKIM 0.22% (n=1)
IGAKQNIQ 0.22% (n=1)
IGPKQNIQ 0.22% (n=1)
PGASQKIS 0.22% (n=1)
PGAKQNIN 0.22% (n=1)
AGAKQNIN 0.22% (n=1)
PGPQQNIH 0.22% (n=1)
PGAQQNIQ 0.22% (n=1)
RGPQQQLH 0.22% (n=1)
FGPQQQLH 0.22% (n=1)
PGSRQDIS 0.22% (n=1)
TGAKQNLY 0.22% (n=1)
LGPKQKID 0.22% (n=1)
VGPKQKID 0.22% (n=1)
PGPKKQIT 0.22% (n=1)
SCPQQKIN 0.22% (n=1)
LCPQQKIN 0.22% (n=1)
PGPEQQIT 0.22% (n=1)
PGP*QQIT 0.22% (n=1)
WGAKQQLS 0.22% (n=1)
TGSQQKLS 0.22% (n=1)
SGSKQKLS 0.22% (n=1)
LGSQQKLS 0.22% (n=1)
PGPRQTVS 0.22% (n=1)
PGPRQTL* 0.22% (n=1)
SGPKQKLT 0.22% (n=1)
TGSQQQLS 0.22% (n=1)
TGPKQNLN 0.22% (n=1)
RGPTRQIN 0.22% (n=1)
PGPSQKFN 0.22% (n=1)
SGAKQNLY 0.22% (n=1)
HGPKQKIN 0.22% (n=1)
SGAKQKIQ 0.22% (n=1)
PGARQNLQ 0.22% (n=1)
SGPAQKLS 0.22% (n=1)
YGPSQKLN 0.22% (n=1)
SGPQQRLS 0.22% (n=1)
SGPQQRIN 0.22% (n=1)
PGPSQRLS 0.22% (n=1)
FGSRQKLS 0.22% (n=1)
LGPSQTLS 0.22% (n=1)
PGPSQRIN 0.22% (n=1)
SGPSQRLS 0.22% (n=1)
LGPSQRLS 0.22% (n=1)
PGARQQLM 0.22% (n=1)
VGPQQKIS 0.22% (n=1)
PGAQQPLS 0.22% (n=1)
PGSKQKIS 0.22% (n=1)
TGAQQKIS 0.22% (n=1)
PGPKQNLA 0.22% (n=1)
LGSRQRLS 0.22% (n=1)
TGPSQKIN 0.22% (n=1)
LGAQQKLS 0.22% (n=1)
PGAQQKIS 0.22% (n=1)
PGPQQKIS 0.22% (n=1)
SGPQQNLQ 0.22% (n=1)
LGPSQKLA 0.22% (n=1)
PGSKQNVH 0.22% (n=1)
PGSRQNIQ 0.22% (n=1)
QGPNQRIS 0.22% (n=1)
PGARQQIS 0.22% (n=1)
FGAQQRLS 0.22% (n=1)
PGGKQDIM 0.22% (n=1)
PGPSQHIS 0.22% (n=1)
PGPQQNLN 0.22% (n=1)
PGPSQQLS 0.22% (n=1)
AGPKQTIS 0.22% (n=1)
TGPQQPLS 0.22% (n=1)
PGAQQKLS 0.22% (n=1)
IGPQQKLS 0.22% (n=1)
VGPHQRLS 0.22% (n=1)
SGPQQRIH 0.22% (n=1)
PGPQQRIQ 0.22% (n=1)
FGPQQNIH 0.22% (n=1)
PGPKQKLS 0.22% (n=1)
RGPQQTIS 0.22% (n=1)
LGARQRIS 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 2c:

RGSRQNIQ 32.82% (n=149)
QGAKQHIQ 27.97% (n=127)
PGAKQHIQ 9.47% (n=43)
RGARQHIQ 5.95% (n=27)
PGAKQRIQ 2.64% (n=12)
KGARQHIQ 2.20% (n=10)
KGAKQHIQ 2.20% (n=10)
SGPQQRLQ 1.32% (n=6)
RGSRQDIQ 0.66% (n=3)
RGAKQHIQ 0.44% (n=2)
PGARQHIQ 0.44% (n=2)
PGARQRIQ 0.44% (n=2)
QGPQQRIQ 0.44% (n=2)
QGSRQNIQ 0.44% (n=2)
QGPKQNIQ 0.44% (n=2)
PGAKQNIQ 0.22% (n=1)
SGPSQRIQ 0.22% (n=1)
LGPQQQIQ 0.22% (n=1)
SGSSQNIQ 0.22% (n=1)
PGPQQNIQ 0.22% (n=1)
LGSQQRVQ 0.22% (n=1)
QGARQHIQ 0.22% (n=1)
QGARQRIQ 0.22% (n=1)
PGSKQNIQ 0.22% (n=1)
FGPSQRIQ 0.22% (n=1)
PGPKQRIQ 0.22% (n=1)
SGLQQRIQ 0.22% (n=1)
PGPKQHIQ 0.22% (n=1)
RGPQQKIQ 0.22% (n=1)
SGPQQKIQ 0.22% (n=1)
TGAKQHIQ 0.22% (n=1)
PGARQNIQ 0.22% (n=1)
QGPQQKIQ 0.22% (n=1)
PGSKQHIQ 0.22% (n=1)
PGPQQTIQ 0.22% (n=1)
RGPSQRIQ 0.22% (n=1)
PGPRQHIQ 0.22% (n=1)
TGAKQNIQ 0.22% (n=1)
PGPNQKLQ 0.22% (n=1)
PGARQSIQ 0.22% (n=1)
QGPKQRIQ 0.22% (n=1)
VGSQQKIQ 0.22% (n=1)
KGPNQNIQ 0.22% (n=1)
LGSQQRIQ 0.22% (n=1)
PGPQQRIQ 0.22% (n=1)
SGPKQRIQ 0.22% (n=1)
TGPNQRIQ 0.22% (n=1)
LGSNQKIQ 0.22% (n=1)
RGSRQHIQ 0.22% (n=1)
PGAKQAIQ 0.22% (n=1)
LGAQQRIQ 0.22% (n=1)
PGPQQKIQ 0.22% (n=1)
PGPRQNIQ 0.22% (n=1)
VGPNQRLE 0.22% (n=1)
PGPQQRLQ 0.22% (n=1)
QGSQQQIQ 0.22% (n=1)
QGPKQHIQ 0.22% (n=1)
RGPKQRIQ 0.22% (n=1)
PGAQQHIQ 0.22% (n=1)
LGARQKIQ 0.22% (n=1)
FGPRQTIQ 0.22% (n=1)
RGSQQNVQ 0.22% (n=1)
RGSRQNI* 0.22% (n=1)
RGSRQNIR 0.22% (n=1)
RGSRQNTQ 0.22% (n=1)
RGSRQNIH 0.22% (n=1)
SGAQQKIQ 0.22% (n=1)
PGARQKIQ 0.22% (n=1)
PGPSQRIQ 0.22% (n=1)
QGAQQRIQ 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 3:

LGPQQKLQ 8.81% (n=343)
VGPRQNLQ 6.39% (n=249)
VGASQKLE 6.09% (n=237)
VGAQQKLQ 4.11% (n=160)
VGAKQKLQ 4.03% (n=157)
PGAKQNLQ 3.75% (n=146)
PGARQNLQ 3.75% (n=146)
PGAQQKIQ 2.54% (n=99)
AGANQKLQ 2.52% (n=98)
PGSRQNIQ 1.90% (n=74)
LGAQQKLQ 1.69% (n=66)
RGARQNLQ 1.62% (n=63)
PGAKQKLQ 1.62% (n=63)
AGARQNLQ 1.39% (n=54)
TGAQQRLQ 1.16% (n=45)
VGAKQNLQ 1.03% (n=40)
RGPSQNLH 1.03% (n=40)
RGARQKLQ 1.00% (n=39)
TGAQQKLQ 0.92% (n=36)
QGAQQKLQ 0.92% (n=36)
MGANQRLE 0.90% (n=35)
VGASQNLQ 0.90% (n=35)
SGPKQNLQ 0.90% (n=35)
LGPRQNLH 0.87% (n=34)
RGAQQKLQ 0.85% (n=33)
MGASQNLE 0.82% (n=32)
PGPRQNLQ 0.82% (n=32)
LGARQNLQ 0.77% (n=30)
MGANQKLE 0.77% (n=30)
PGSRQNLQ 0.77% (n=30)
AGAQQKLQ 0.77% (n=30)
RGPRQNLH 0.77% (n=30)
QGAKQKLQ 0.72% (n=28)
PGARQNLH 0.72% (n=28)
VGANQKLQ 0.69% (n=27)
QGASQNLQ 0.64% (n=25)
MGAKQNLQ 0.64% (n=25)
MGASQKLE 0.56% (n=22)
PGAQQKLQ 0.51% (n=20)
LGASQKLQ 0.51% (n=20)
MGANQKLQ 0.49% (n=19)
SGAKQNLQ 0.44% (n=17)
VGASQKLQ 0.44% (n=17)
PGPKQNLQ 0.44% (n=17)
VGPKQNLQ 0.44% (n=17)
PGAQQNLQ 0.41% (n=16)
LGPKQNLQ 0.41% (n=16)
RGPSQNLQ 0.39% (n=15)
MGAQQKLQ 0.36% (n=14)
RGASQKLE 0.36% (n=14)
VGAQQKLH 0.36% (n=14)
AGARQSLQ 0.36% (n=14)
PGPSQNLQ 0.36% (n=14)
FGPKQNLQ 0.33% (n=13)
TGPKQNLQ 0.31% (n=12)
AGPKQNLQ 0.31% (n=12)
TGAKQNLQ 0.31% (n=12)
PGARQKLQ 0.31% (n=12)
SGPRQNLQ 0.31% (n=12)
PGSKQNLQ 0.31% (n=12)
QGARQNLQ 0.28% (n=11)
AGAKQKLQ 0.28% (n=11)
VGANQNLQ 0.28% (n=11)
AGAKQNLQ 0.23% (n=9)
SGAKQKLQ 0.23% (n=9)
SGPKQKLQ 0.23% (n=9)
PGPNQNLQ 0.23% (n=9)
PGASQNLQ 0.23% (n=9)
PGPSQNLH 0.23% (n=9)
SGPKQNLH 0.23% (n=9)
VGARQNLQ 0.21% (n=8)
PGAQQRLQ 0.21% (n=8)
VGAQQKLE 0.21% (n=8)
QGPKQNLH 0.21% (n=8)
LGPRQSLH 0.21% (n=8)
QGPSQSLH 0.21% (n=8)
MGAQQNLQ 0.18% (n=7)
PGPQQKLQ 0.18% (n=7)
IGAQQKLQ 0.18% (n=7)
IGPQQKLQ 0.18% (n=7)
FGPRQNLQ 0.18% (n=7)
QGAQQNLQ 0.18% (n=7)
PGPKQNLH 0.18% (n=7)
WGPSQSLH 0.18% (n=7)
VGAQQNLQ 0.15% (n=6)
SGARQNLQ 0.15% (n=6)
VGARQKLQ 0.15% (n=6)
QGPKQNLQ 0.15% (n=6)
PGPQQNLQ 0.15% (n=6)
RGAQQNLQ 0.15% (n=6)
RGPQQNLQ 0.15% (n=6)
QGPSQNLH 0.15% (n=6)
VGPQQKLQ 0.13% (n=5)
SGAQQKLQ 0.13% (n=5)
LGSRQNLQ 0.13% (n=5)
SGPNQKLQ 0.13% (n=5)
TGPNQDLQ 0.13% (n=5)
RGASQNLQ 0.13% (n=5)
LGAKQKLQ 0.13% (n=5)
QGSRQNLQ 0.13% (n=5)
MGPKQNLQ 0.13% (n=5)
RGPSQKLQ 0.13% (n=5)
LGPSQNLH 0.13% (n=5)
VGPKQNLH 0.13% (n=5)
LGPSQKLH 0.13% (n=5)
TGAKQKLQ 0.10% (n=4)
RGPKQNLQ 0.10% (n=4)
PGASQKLQ 0.10% (n=4)
SGPQQKLQ 0.10% (n=4)
AGPNQDLQ 0.10% (n=4)
TGARQNLQ 0.10% (n=4)
LGAKQNLQ 0.10% (n=4)
AGPSQKLQ 0.10% (n=4)
RGAQQKLE 0.10% (n=4)
TGPSQNLQ 0.10% (n=4)
VGSRQNLQ 0.10% (n=4)
LGSKQNLQ 0.10% (n=4)
PGPRQNLH 0.10% (n=4)
LGPKQNLH 0.10% (n=4)
PGPQQNLH 0.10% (n=4)
LGANQKLQ 0.08% (n=3)
SGASQNLQ 0.08% (n=3)
MGARQKLE 0.08% (n=3)
SGAQQNLQ 0.08% (n=3)
SGANQNLQ 0.08% (n=3)
LGAQQNLQ 0.08% (n=3)
SGPQQK-- 0.08% (n=3)
TGPSQKLQ 0.08% (n=3)
PGASQRLE 0.08% (n=3)
LGAQQKLE 0.08% (n=3)
LGPKQKIQ 0.08% (n=3)
LGPKQKLQ 0.08% (n=3)
LGPRQNLQ 0.08% (n=3)
PGPSQKLQ 0.08% (n=3)
QGAKQNLQ 0.08% (n=3)
RGPRQNLQ 0.08% (n=3)
LGPSQNLQ 0.08% (n=3)
AGAQQNLQ 0.08% (n=3)
RGSNQNLQ 0.08% (n=3)
RGPKQNLH 0.08% (n=3)
QGPRQNLH 0.08% (n=3)
PGPSQKLH 0.08% (n=3)
TGPKQNLH 0.08% (n=3)
TGPSQNLH 0.08% (n=3)
KGPSQNLQ 0.08% (n=3)
AGPRQNLH 0.08% (n=3)
AGPKQNLH 0.08% (n=3)
MGAKQKLQ 0.05% (n=2)
MGSNQKLQ 0.05% (n=2)
TGPNQKLA 0.05% (n=2)
LGPRQQLQ 0.05% (n=2)
MGARQNLE 0.05% (n=2)
MGAKQNLE 0.05% (n=2)
VGTKQKLQ 0.05% (n=2)
PGAKQDLQ 0.05% (n=2)
VGPSQNLQ 0.05% (n=2)
PGAGQKLQ 0.05% (n=2)
PGAKQELQ 0.05% (n=2)
TGPNQNLQ 0.05% (n=2)
RGPQQKLA 0.05% (n=2)
RGASQSLQ 0.05% (n=2)
PGAQRRLQ 0.05% (n=2)
MGASQNLQ 0.05% (n=2)
PGANQKLQ 0.05% (n=2)
AGPSQTLQ 0.05% (n=2)
VGAKQN-- 0.05% (n=2)
MGAQQK-- 0.05% (n=2)
VGPKQKLQ 0.05% (n=2)
RGAKQNLQ 0.05% (n=2)
IGARQKLQ 0.05% (n=2)
TGPQQKLQ 0.05% (n=2)
VGPSQKLQ 0.05% (n=2)
QGPNQNLQ 0.05% (n=2)
QGPSQNLQ 0.05% (n=2)
PGAKQQLQ 0.05% (n=2)
RGAKQDLQ 0.05% (n=2)
LGARQKLQ 0.05% (n=2)
TGPRQNLQ 0.05% (n=2)
RGSKQNLQ 0.05% (n=2)
LGSNQKLQ 0.05% (n=2)
PGARQKLE 0.05% (n=2)
MGAQQKLE 0.05% (n=2)
PGAQQKLE 0.05% (n=2)
RGPSQELQ 0.05% (n=2)
RGPQQKLQ 0.05% (n=2)
PGPKQNLE 0.05% (n=2)
IGAKQKLQ 0.05% (n=2)
SGPKQDLQ 0.05% (n=2)
QGASQKLE 0.05% (n=2)
IGPKQNLQ 0.05% (n=2)
RGSQQNLQ 0.05% (n=2)
AGPQQNLQ 0.05% (n=2)
PGPSQRLQ 0.05% (n=2)
SGSQQNLQ 0.05% (n=2)
LGPQQKLH 0.05% (n=2)
RGPQQNLH 0.05% (n=2)
MGPKQNLH 0.05% (n=2)
SGPKQDLR 0.05% (n=2)
MGPRQNLH 0.05% (n=2)
VGPRQNLH 0.05% (n=2)
SGPSQNLH 0.05% (n=2)
TGPRQNLH 0.05% (n=2)
QGPKQKLQ 0.05% (n=2)
SGPQQNLQ 0.05% (n=2)
PGAAQRIQ 0.05% (n=2)
TGAKQPLH 0.05% (n=2)
TGPNQKLQ 0.03% (n=1)
AGPKQDLQ 0.03% (n=1)
VGPSQDLQ 0.03% (n=1)
LGASQNLQ 0.03% (n=1)
MGPSQSLQ 0.03% (n=1)
AGPRQKLQ 0.03% (n=1)
RGARQNLE 0.03% (n=1)
QGARQRLQ 0.03% (n=1)
IGSNQKLQ 0.03% (n=1)
VGAQQELQ 0.03% (n=1)
PGAKQNQQ 0.03% (n=1)
GGASQKLE 0.03% (n=1)
TGARQRLQ 0.03% (n=1)
SGAQQRLQ 0.03% (n=1)
SGAKRNLQ 0.03% (n=1)
SGARQKLQ 0.03% (n=1)
LGAQQKPQ 0.03% (n=1)
IGRHQRLE 0.03% (n=1)
LGRLQRLE 0.03% (n=1)
PESRQGHE 0.03% (n=1)
VGPKHNLQ 0.03% (n=1)
PGPSQSLQ 0.03% (n=1)
RGPSQRLQ 0.03% (n=1)
AGARQKLQ 0.03% (n=1)
VGASQDLQ 0.03% (n=1)
FGAKQNLQ 0.03% (n=1)
PGSRQSLQ 0.03% (n=1)
RGANQNVQ 0.03% (n=1)
RGARQNPQ 0.03% (n=1)
VGARQSLQ 0.03% (n=1)
AGARQNLR 0.03% (n=1)
RGPEQRLE 0.03% (n=1)
IGAKQTLQ 0.03% (n=1)
SGAKQRLQ 0.03% (n=1)
SGAKQWLQ 0.03% (n=1)
QGPHQKLA 0.03% (n=1)
QGPQQKLA 0.03% (n=1)
QGPKQDLQ 0.03% (n=1)
VGARQRLQ 0.03% (n=1)
RGPNQNLQ 0.03% (n=1)
VGAHQKLQ 0.03% (n=1)
IGRQQNLQ 0.03% (n=1)
PGAQRRLR 0.03% (n=1)
AGSKQNVQ 0.03% (n=1)
AGANQRLQ 0.03% (n=1)
LGASQKLL 0.03% (n=1)
------LE 0.03% (n=1)
PGAQPELQ 0.03% (n=1)
VGASQN-- 0.03% (n=1)
IGAKQN-- 0.03% (n=1)
TGANQRLQ 0.03% (n=1)
LGAQQK-- 0.03% (n=1)
MGSKQNLQ 0.03% (n=1)
VGFPTK-- 0.03% (n=1)
IGSKQNLQ 0.03% (n=1)
AGPKQRLE 0.03% (n=1)
IAPR---- 0.03% (n=1)
PGARQN-- 0.03% (n=1)
QGSRQE-- 0.03% (n=1)
RGPQH--- 0.03% (n=1)
PGAHQK-- 0.03% (n=1)
AGPRQ--- 0.03% (n=1)
AGPSQK-- 0.03% (n=1)
TGPKQN-- 0.03% (n=1)
PGPKQN-- 0.03% (n=1)
PGVQQN-- 0.03% (n=1)
RGPKQN-- 0.03% (n=1)
V------- 0.03% (n=1)
AGAQQK-- 0.03% (n=1)
VGPKPK-- 0.03% (n=1)
PGSKQN-- 0.03% (n=1)
TGPQQK-- 0.03% (n=1)
PGPQQR-- 0.03% (n=1)
RGPQQN-- 0.03% (n=1)
SGPQQN-- 0.03% (n=1)
SGPKQN-- 0.03% (n=1)
MGAQQN-- 0.03% (n=1)
VGAQQK-- 0.03% (n=1)
RGPKQKLQ 0.03% (n=1)
AGPRQKLE 0.03% (n=1)
VGVRQKLQ 0.03% (n=1)
AGPSQNLE 0.03% (n=1)
PGAKQNIQ 0.03% (n=1)
MGPQQRLQ 0.03% (n=1)
AGAQQKLE 0.03% (n=1)
KGAQQNLQ 0.03% (n=1)
QGSRQKLE 0.03% (n=1)
PGSKQNVQ 0.03% (n=1)
QGSRQELR 0.03% (n=1)
VGSQQKLQ 0.03% (n=1)
MGPSQKLQ 0.03% (n=1)
RGASQKLQ 0.03% (n=1)
RGAKQSLQ 0.03% (n=1)
PGPIQKLE 0.03% (n=1)
VGAQQHLQ 0.03% (n=1)
VGSKQKLQ 0.03% (n=1)
QGSNQKLQ 0.03% (n=1)
LGPKQSLY 0.03% (n=1)
AGASQNLQ 0.03% (n=1)
MGPQQKLQ 0.03% (n=1)
PGARQHLQ 0.03% (n=1)
TGPQQNLQ 0.03% (n=1)
HGPKQRLQ 0.03% (n=1)
RGANQNLQ 0.03% (n=1)
HGPKQKLQ 0.03% (n=1)
IGPRQNLQ 0.03% (n=1)
LGSQQKLQ 0.03% (n=1)
TGPSQNLR 0.03% (n=1)
IGAQQKLE 0.03% (n=1)
SGPKQKLE 0.03% (n=1)
RGSRQDLR 0.03% (n=1)
IGAKQNLQ 0.03% (n=1)
VGPKQNLK 0.03% (n=1)
AGPMQRLQ 0.03% (n=1)
PGPKQHLQ 0.03% (n=1)
AGARQPLQ 0.03% (n=1)
QGPSQSLK 0.03% (n=1)
LGPRQKLE 0.03% (n=1)
RGSRQNLQ 0.03% (n=1)
MGPRQNLQ 0.03% (n=1)
FGARQNLQ 0.03% (n=1)
PGPRQKLQ 0.03% (n=1)
AGPSQRLQ 0.03% (n=1)
VGASQQLQ 0.03% (n=1)
QGAQQSLQ 0.03% (n=1)
VGAKQQLQ 0.03% (n=1)
PGAKQSLQ 0.03% (n=1)
QGANQKLQ 0.03% (n=1)
AGPNQKLQ 0.03% (n=1)
AGSKQNLQ 0.03% (n=1)
IGARQNLQ 0.03% (n=1)
IGPKQKLQ 0.03% (n=1)
SGAKQKLE 0.03% (n=1)
LGSSQNLQ 0.03% (n=1)
VGSQQKLE 0.03% (n=1)
LGPSQKLE 0.03% (n=1)
PGPKQQLQ 0.03% (n=1)
MGPKQKLQ 0.03% (n=1)
RGARQHLQ 0.03% (n=1)
RGPQQQLQ 0.03% (n=1)
RGPKQQLQ 0.03% (n=1)
RGPHQNLQ 0.03% (n=1)
QGPNQKLQ 0.03% (n=1)
FGAKQKLQ 0.03% (n=1)
RGPQQKLE 0.03% (n=1)
WGPKQNLH 0.03% (n=1)
PGSQQKLQ 0.03% (n=1)
LGANQNLQ 0.03% (n=1)
IGPQQKLE 0.03% (n=1)
TGARQNIQ 0.03% (n=1)
PGAKQNLE 0.03% (n=1)
PGPRQNLE 0.03% (n=1)
SGSRQNLQ 0.03% (n=1)
TGPRQKIQ 0.03% (n=1)
LGPRQHLQ 0.03% (n=1)
SGAKQRLE 0.03% (n=1)
SGAKQSLQ 0.03% (n=1)
RGPNQKLQ 0.03% (n=1)
PGPQQRLQ 0.03% (n=1)
AGSQQRLQ 0.03% (n=1)
RGANQPLQ 0.03% (n=1)
RGANQRLQ 0.03% (n=1)
VGPKQRLQ 0.03% (n=1)
KGPTQNLQ 0.03% (n=1)
WGPSQRLH 0.03% (n=1)
RGPRQNLE 0.03% (n=1)
VGSSQNLQ 0.03% (n=1)
AGANQKLE 0.03% (n=1)
VGAKQKLN 0.03% (n=1)
MGPNQKLH 0.03% (n=1)
QGAHQNLQ 0.03% (n=1)
SGPSQNLQ 0.03% (n=1)
TGAQQKLE 0.03% (n=1)
MGPQQNLR 0.03% (n=1)
LGASQKIE 0.03% (n=1)
AGPRQNLE 0.03% (n=1)
PGAKQVLQ 0.03% (n=1)
QGAKQDLQ 0.03% (n=1)
PGPKQKLQ 0.03% (n=1)
VGSSQKLQ 0.03% (n=1)
KGPKQNIQ 0.03% (n=1)
RGAQQDLQ 0.03% (n=1)
LGARQKLE 0.03% (n=1)
QGSKQDLQ 0.03% (n=1)
AGPRQHLQ 0.03% (n=1)
AGPQQNLE 0.03% (n=1)
SGPSQKLQ 0.03% (n=1)
PGPQQKLE 0.03% (n=1)
SGPRQKLQ 0.03% (n=1)
QGASQKLQ 0.03% (n=1)
QGPGQKLQ 0.03% (n=1)
TGPKQNLE 0.03% (n=1)
QGPKQELR 0.03% (n=1)
RGPKQDLQ 0.03% (n=1)
QGPSQKLQ 0.03% (n=1)
RGANQQLQ 0.03% (n=1)
PGAAQNLK 0.03% (n=1)
AGPSQKLE 0.03% (n=1)
PGPAQNLQ 0.03% (n=1)
LGPSQKLQ 0.03% (n=1)
PGARQPLQ 0.03% (n=1)
VGPSQSLQ 0.03% (n=1)
VGANQKL- 0.03% (n=1)
MGPSQNLH 0.03% (n=1)
RGPKQSLH 0.03% (n=1)
FGPQQNLQ 0.03% (n=1)
IGPSQKLH 0.03% (n=1)
QGPVQKLH 0.03% (n=1)
PGPSQQLH 0.03% (n=1)
LGPQQNLH 0.03% (n=1)
PGPKQSLQ 0.03% (n=1)
QGAKQNLH 0.03% (n=1)
AGPRQNLQ 0.03% (n=1)
RGPNQNLH 0.03% (n=1)
PGPNQNLH 0.03% (n=1)
PGSKQNLH 0.03% (n=1)
KGPQQNLH 0.03% (n=1)
MGPSQKLH 0.03% (n=1)
RGPKQDLH 0.03% (n=1)
PGPKQDLH 0.03% (n=1)
SGPAQNLK 0.03% (n=1)
PGPNQNLD 0.03% (n=1)
SGPTQNLN 0.03% (n=1)
QGPKQHLH 0.03% (n=1)
QGPKQKLN 0.03% (n=1)
PGPSQDLQ 0.03% (n=1)
LGPRQNLR 0.03% (n=1)
LGSRQNLN 0.03% (n=1)
PGPKQNLN 0.03% (n=1)
PGAKQALH 0.03% (n=1)
PGPSQNLR 0.03% (n=1)
VGPSQKLH 0.03% (n=1)
RGPSQDLH 0.03% (n=1)
SGPQQKLN 0.03% (n=1)
RGPKQSLS 0.03% (n=1)
SGPKQQLH 0.03% (n=1)
IGPKQNLH 0.03% (n=1)
FGPAQKLH 0.03% (n=1)
AGPQQNLH 0.03% (n=1)
PGPRQDLH 0.03% (n=1)
RGPSQNLN 0.03% (n=1)
RGPSQGLH 0.03% (n=1)
WGPKQNLQ 0.03% (n=1)
KGPSQKLQ 0.03% (n=1)
PGPTQHLN 0.03% (n=1)
QGPRQKLQ 0.03% (n=1)
LGPKQTIQ 0.03% (n=1)
SGARQQLQ 0.03% (n=1)
SGPSQTLQ 0.03% (n=1)
SGPAQKLQ 0.03% (n=1)
PGPRQTLQ 0.03% (n=1)
PGPAQQIQ 0.03% (n=1)
PGAQQNIQ 0.03% (n=1)
PGARQQLQ 0.03% (n=1)
SGPKQNIQ 0.03% (n=1)
PGSNQNLQ 0.03% (n=1)
TGPKQHIQ 0.03% (n=1)
PGSRQNLH 0.03% (n=1)
TGSKQNLH 0.03% (n=1)
TGPTQNLQ 0.03% (n=1)
QGPQQKLE 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 3a:

LGPQQKLQ 10.44% (n=342)
VGPRQNLQ 7.60% (n=249)
VGASQKLE 7.24% (n=237)
VGAQQKLQ 4.89% (n=160)
VGAKQKLQ 4.79% (n=157)
PGAKQNLQ 4.34% (n=142)
PGARQNLQ 4.34% (n=142)
AGANQKLQ 2.99% (n=98)
LGAQQKLQ 2.02% (n=66)
RGARQNLQ 1.92% (n=63)
PGAKQKLQ 1.92% (n=63)
AGARQNLQ 1.65% (n=54)
TGAQQRLQ 1.37% (n=45)
VGAKQNLQ 1.22% (n=40)
RGARQKLQ 1.19% (n=39)
TGAQQKLQ 1.10% (n=36)
QGAQQKLQ 1.10% (n=36)
MGANQRLE 1.07% (n=35)
VGASQNLQ 1.07% (n=35)
MGASQNLE 0.98% (n=32)
PGPRQNLQ 0.95% (n=31)
LGARQNLQ 0.92% (n=30)
MGANQKLE 0.92% (n=30)
AGAQQKLQ 0.92% (n=30)
SGPKQNLQ 0.92% (n=30)
QGAKQKLQ 0.85% (n=28)
VGANQKLQ 0.82% (n=27)
PGSRQNLQ 0.79% (n=26)
QGASQNLQ 0.76% (n=25)
MGAKQNLQ 0.76% (n=25)
MGASQKLE 0.67% (n=22)
PGAQQKLQ 0.61% (n=20)
LGASQKLQ 0.61% (n=20)
MGANQKLQ 0.58% (n=19)
SGAKQNLQ 0.52% (n=17)
VGASQKLQ 0.52% (n=17)
PGAQQNLQ 0.49% (n=16)
VGPKQNLQ 0.46% (n=15)
MGAQQKLQ 0.43% (n=14)
RGASQKLE 0.43% (n=14)
LGPKQNLQ 0.43% (n=14)
VGAQQKLH 0.43% (n=14)
AGARQSLQ 0.43% (n=14)
PGPKQNLQ 0.43% (n=14)
FGPKQNLQ 0.40% (n=13)
TGAKQNLQ 0.37% (n=12)
PGARQKLQ 0.37% (n=12)
AGPKQNLQ 0.34% (n=11)
AGAKQKLQ 0.34% (n=11)
VGANQNLQ 0.34% (n=11)
QGARQNLQ 0.31% (n=10)
AGAKQNLQ 0.27% (n=9)
SGAKQKLQ 0.27% (n=9)
SGPKQKLQ 0.27% (n=9)
PGASQNLQ 0.27% (n=9)
TGPKQNLQ 0.24% (n=8)
VGARQNLQ 0.24% (n=8)
PGPNQNLQ 0.24% (n=8)
PGAQQRLQ 0.24% (n=8)
VGAQQKLE 0.24% (n=8)
PGPSQNLQ 0.24% (n=8)
MGAQQNLQ 0.21% (n=7)
IGAQQKLQ 0.21% (n=7)
IGPQQKLQ 0.21% (n=7)
SGPRQNLQ 0.21% (n=7)
FGPRQNLQ 0.21% (n=7)
QGAQQNLQ 0.21% (n=7)
VGAQQNLQ 0.18% (n=6)
PGPQQKLQ 0.18% (n=6)
SGARQNLQ 0.18% (n=6)
VGARQKLQ 0.18% (n=6)
RGAQQKLQ 0.18% (n=6)
RGAQQNLQ 0.18% (n=6)
PGSKQNLQ 0.18% (n=6)
SGAQQKLQ 0.15% (n=5)
SGPNQKLQ 0.15% (n=5)
TGPNQDLQ 0.15% (n=5)
RGASQNLQ 0.15% (n=5)
LGAKQKLQ 0.15% (n=5)
QGSRQNLQ 0.15% (n=5)
PGPQQNLQ 0.15% (n=5)
TGAKQKLQ 0.12% (n=4)
VGPQQKLQ 0.12% (n=4)
RGPKQNLQ 0.12% (n=4)
PGASQKLQ 0.12% (n=4)
SGPQQKLQ 0.12% (n=4)
AGPNQDLQ 0.12% (n=4)
LGAKQNLQ 0.12% (n=4)
RGAQQKLE 0.12% (n=4)
VGSRQNLQ 0.12% (n=4)
LGANQKLQ 0.09% (n=3)
SGASQNLQ 0.09% (n=3)
RGPSQNLQ 0.09% (n=3)
MGARQKLE 0.09% (n=3)
LGSRQNLQ 0.09% (n=3)
SGAQQNLQ 0.09% (n=3)
SGANQNLQ 0.09% (n=3)
LGAQQNLQ 0.09% (n=3)
SGPQQK-- 0.09% (n=3)
TGARQNLQ 0.09% (n=3)
PGASQRLE 0.09% (n=3)
LGAQQKLE 0.09% (n=3)
LGPKQKIQ 0.09% (n=3)
LGPKQKLQ 0.09% (n=3)
AGPSQKLQ 0.09% (n=3)
QGPKQNLQ 0.09% (n=3)
PGPSQKLQ 0.09% (n=3)
MGPKQNLQ 0.09% (n=3)
RGPQQNLQ 0.09% (n=3)
QGAKQNLQ 0.09% (n=3)
RGPRQNLQ 0.09% (n=3)
AGAQQNLQ 0.09% (n=3)
RGSNQNLQ 0.09% (n=3)
MGAKQKLQ 0.06% (n=2)
MGSNQKLQ 0.06% (n=2)
TGPNQKLA 0.06% (n=2)
LGPRQQLQ 0.06% (n=2)
MGARQNLE 0.06% (n=2)
MGAKQNLE 0.06% (n=2)
VGTKQKLQ 0.06% (n=2)
PGAKQDLQ 0.06% (n=2)
VGPSQNLQ 0.06% (n=2)
PGAGQKLQ 0.06% (n=2)
PGAKQELQ 0.06% (n=2)
TGPNQNLQ 0.06% (n=2)
RGPQQKLA 0.06% (n=2)
RGASQSLQ 0.06% (n=2)
PGAQRRLQ 0.06% (n=2)
MGASQNLQ 0.06% (n=2)
PGANQKLQ 0.06% (n=2)
AGPSQTLQ 0.06% (n=2)
VGAKQN-- 0.06% (n=2)
MGAQQK-- 0.06% (n=2)
TGPSQKLQ 0.06% (n=2)
VGPKQKLQ 0.06% (n=2)
RGAKQNLQ 0.06% (n=2)
IGARQKLQ 0.06% (n=2)
TGPQQKLQ 0.06% (n=2)
LGPRQNLQ 0.06% (n=2)
QGPNQNLQ 0.06% (n=2)
QGPSQNLQ 0.06% (n=2)
PGAKQQLQ 0.06% (n=2)
RGAKQDLQ 0.06% (n=2)
TGPSQNLQ 0.06% (n=2)
LGARQKLQ 0.06% (n=2)
LGPSQNLQ 0.06% (n=2)
TGPRQNLQ 0.06% (n=2)
RGSKQNLQ 0.06% (n=2)
LGSKQNLQ 0.06% (n=2)
LGSNQKLQ 0.06% (n=2)
PGARQKLE 0.06% (n=2)
MGAQQKLE 0.06% (n=2)
RGPSQKLQ 0.06% (n=2)
PGAQQKLE 0.06% (n=2)
RGPQQKLQ 0.06% (n=2)
PGPKQNLE 0.06% (n=2)
IGAKQKLQ 0.06% (n=2)
PGPSQNLH 0.06% (n=2)
QGASQKLE 0.06% (n=2)
IGPKQNLQ 0.06% (n=2)
RGSQQNLQ 0.06% (n=2)
PGPSQRLQ 0.06% (n=2)
TGPNQKLQ 0.03% (n=1)
AGPKQDLQ 0.03% (n=1)
VGPSQDLQ 0.03% (n=1)
LGASQNLQ 0.03% (n=1)
MGPSQSLQ 0.03% (n=1)
AGPRQKLQ 0.03% (n=1)
RGARQNLE 0.03% (n=1)
QGARQRLQ 0.03% (n=1)
IGSNQKLQ 0.03% (n=1)
VGAQQELQ 0.03% (n=1)
PGAKQNQQ 0.03% (n=1)
GGASQKLE 0.03% (n=1)
TGARQRLQ 0.03% (n=1)
SGAQQRLQ 0.03% (n=1)
SGAKRNLQ 0.03% (n=1)
SGARQKLQ 0.03% (n=1)
LGAQQKPQ 0.03% (n=1)
IGRHQRLE 0.03% (n=1)
LGRLQRLE 0.03% (n=1)
PESRQGHE 0.03% (n=1)
VGPKHNLQ 0.03% (n=1)
PGPSQSLQ 0.03% (n=1)
RGPSQRLQ 0.03% (n=1)
AGARQKLQ 0.03% (n=1)
VGASQDLQ 0.03% (n=1)
FGAKQNLQ 0.03% (n=1)
PGSRQSLQ 0.03% (n=1)
RGANQNVQ 0.03% (n=1)
RGARQNPQ 0.03% (n=1)
VGARQSLQ 0.03% (n=1)
AGARQNLR 0.03% (n=1)
RGPEQRLE 0.03% (n=1)
IGAKQTLQ 0.03% (n=1)
SGAKQRLQ 0.03% (n=1)
SGAKQWLQ 0.03% (n=1)
QGPHQKLA 0.03% (n=1)
QGPQQKLA 0.03% (n=1)
QGPKQDLQ 0.03% (n=1)
VGARQRLQ 0.03% (n=1)
RGPNQNLQ 0.03% (n=1)
VGAHQKLQ 0.03% (n=1)
IGRQQNLQ 0.03% (n=1)
PGAQRRLR 0.03% (n=1)
AGSKQNVQ 0.03% (n=1)
AGANQRLQ 0.03% (n=1)
LGASQKLL 0.03% (n=1)
------LE 0.03% (n=1)
PGAQPELQ 0.03% (n=1)
VGASQN-- 0.03% (n=1)
IGAKQN-- 0.03% (n=1)
TGANQRLQ 0.03% (n=1)
LGAQQK-- 0.03% (n=1)
MGSKQNLQ 0.03% (n=1)
VGFPTK-- 0.03% (n=1)
IGSKQNLQ 0.03% (n=1)
AGPKQRLE 0.03% (n=1)
IAPR---- 0.03% (n=1)
PGARQN-- 0.03% (n=1)
QGSRQE-- 0.03% (n=1)
RGPQH--- 0.03% (n=1)
PGAHQK-- 0.03% (n=1)
AGPRQ--- 0.03% (n=1)
AGPSQK-- 0.03% (n=1)
TGPKQN-- 0.03% (n=1)
PGPKQN-- 0.03% (n=1)
PGVQQN-- 0.03% (n=1)
RGPKQN-- 0.03% (n=1)
V------- 0.03% (n=1)
AGAQQK-- 0.03% (n=1)
VGPKPK-- 0.03% (n=1)
PGSKQN-- 0.03% (n=1)
TGPQQK-- 0.03% (n=1)
PGPQQR-- 0.03% (n=1)
RGPQQN-- 0.03% (n=1)
SGPQQN-- 0.03% (n=1)
SGPKQN-- 0.03% (n=1)
MGAQQN-- 0.03% (n=1)
VGAQQK-- 0.03% (n=1)
RGPKQKLQ 0.03% (n=1)
AGPRQKLE 0.03% (n=1)
VGVRQKLQ 0.03% (n=1)
AGPSQNLE 0.03% (n=1)
PGAKQNIQ 0.03% (n=1)
MGPQQRLQ 0.03% (n=1)
AGAQQKLE 0.03% (n=1)
KGAQQNLQ 0.03% (n=1)
VGPSQKLQ 0.03% (n=1)
QGSRQKLE 0.03% (n=1)
PGSKQNVQ 0.03% (n=1)
QGSRQELR 0.03% (n=1)
VGSQQKLQ 0.03% (n=1)
MGPSQKLQ 0.03% (n=1)
RGASQKLQ 0.03% (n=1)
RGAKQSLQ 0.03% (n=1)
PGPIQKLE 0.03% (n=1)
VGAQQHLQ 0.03% (n=1)
VGSKQKLQ 0.03% (n=1)
QGSNQKLQ 0.03% (n=1)
LGPKQSLY 0.03% (n=1)
AGASQNLQ 0.03% (n=1)
MGPQQKLQ 0.03% (n=1)
PGARQHLQ 0.03% (n=1)
HGPKQRLQ 0.03% (n=1)
RGANQNLQ 0.03% (n=1)
HGPKQKLQ 0.03% (n=1)
IGPRQNLQ 0.03% (n=1)
LGSQQKLQ 0.03% (n=1)
TGPSQNLR 0.03% (n=1)
IGAQQKLE 0.03% (n=1)
SGPKQKLE 0.03% (n=1)
RGSRQDLR 0.03% (n=1)
IGAKQNLQ 0.03% (n=1)
VGPKQNLK 0.03% (n=1)
AGPMQRLQ 0.03% (n=1)
PGPKQHLQ 0.03% (n=1)
AGARQPLQ 0.03% (n=1)
QGPSQSLK 0.03% (n=1)
LGPRQKLE 0.03% (n=1)
RGSRQNLQ 0.03% (n=1)
MGPRQNLQ 0.03% (n=1)
FGARQNLQ 0.03% (n=1)
PGPRQKLQ 0.03% (n=1)
AGPSQRLQ 0.03% (n=1)
VGASQQLQ 0.03% (n=1)
QGAQQSLQ 0.03% (n=1)
VGAKQQLQ 0.03% (n=1)
PGAKQSLQ 0.03% (n=1)
QGANQKLQ 0.03% (n=1)
RGPSQELQ 0.03% (n=1)
AGPNQKLQ 0.03% (n=1)
AGSKQNLQ 0.03% (n=1)
IGARQNLQ 0.03% (n=1)
IGPKQKLQ 0.03% (n=1)
SGAKQKLE 0.03% (n=1)
LGSSQNLQ 0.03% (n=1)
VGSQQKLE 0.03% (n=1)
LGPSQKLE 0.03% (n=1)
PGPKQQLQ 0.03% (n=1)
MGPKQKLQ 0.03% (n=1)
RGARQHLQ 0.03% (n=1)
RGPQQQLQ 0.03% (n=1)
RGPKQQLQ 0.03% (n=1)
RGPHQNLQ 0.03% (n=1)
QGPNQKLQ 0.03% (n=1)
FGAKQKLQ 0.03% (n=1)
RGPQQKLE 0.03% (n=1)
WGPKQNLH 0.03% (n=1)
PGSQQKLQ 0.03% (n=1)
LGANQNLQ 0.03% (n=1)
IGPQQKLE 0.03% (n=1)
TGARQNIQ 0.03% (n=1)
PGAKQNLE 0.03% (n=1)
PGPRQNLE 0.03% (n=1)
SGSRQNLQ 0.03% (n=1)
TGPRQKIQ 0.03% (n=1)
LGPRQHLQ 0.03% (n=1)
SGAKQRLE 0.03% (n=1)
SGAKQSLQ 0.03% (n=1)
RGPNQKLQ 0.03% (n=1)
PGPQQRLQ 0.03% (n=1)
AGSQQRLQ 0.03% (n=1)
RGANQPLQ 0.03% (n=1)
RGANQRLQ 0.03% (n=1)
VGPKQRLQ 0.03% (n=1)
KGPTQNLQ 0.03% (n=1)
WGPSQRLH 0.03% (n=1)
RGPRQNLE 0.03% (n=1)
AGANQKLE 0.03% (n=1)
VGAKQKLN 0.03% (n=1)
MGPNQKLH 0.03% (n=1)
QGAHQNLQ 0.03% (n=1)
SGPSQNLQ 0.03% (n=1)
SGPKQDLQ 0.03% (n=1)
TGAQQKLE 0.03% (n=1)
MGPQQNLR 0.03% (n=1)
LGASQKIE 0.03% (n=1)
AGPRQNLE 0.03% (n=1)
PGAKQVLQ 0.03% (n=1)
PGPRQNLH 0.03% (n=1)
QGAKQDLQ 0.03% (n=1)
PGPKQKLQ 0.03% (n=1)
VGSSQKLQ 0.03% (n=1)
KGPKQNIQ 0.03% (n=1)
RGAQQDLQ 0.03% (n=1)
LGARQKLE 0.03% (n=1)
QGSKQDLQ 0.03% (n=1)
AGPRQHLQ 0.03% (n=1)
AGPQQNLE 0.03% (n=1)
SGPSQKLQ 0.03% (n=1)
AGPQQNLQ 0.03% (n=1)
PGPQQKLE 0.03% (n=1)
SGPRQKLQ 0.03% (n=1)
QGASQKLQ 0.03% (n=1)
QGPGQKLQ 0.03% (n=1)
TGPKQNLE 0.03% (n=1)
QGPKQELR 0.03% (n=1)
RGPKQDLQ 0.03% (n=1)
QGPSQKLQ 0.03% (n=1)
RGANQQLQ 0.03% (n=1)
PGAAQNLK 0.03% (n=1)
AGPSQKLE 0.03% (n=1)
PGPAQNLQ 0.03% (n=1)
LGPSQKLQ 0.03% (n=1)
PGARQPLQ 0.03% (n=1)
VGPSQSLQ 0.03% (n=1)
VGANQKL- 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 3b:

RGPSQNLH 10.36% (n=40)
LGPRQNLH 8.81% (n=34)
RGPRQNLH 7.77% (n=30)
PGARQNLH 7.25% (n=28)
RGPSQNLQ 2.85% (n=11)
SGPKQNLH 2.33% (n=9)
QGPKQNLH 2.07% (n=8)
LGPRQSLH 2.07% (n=8)
QGPSQSLH 2.07% (n=8)
PGPKQNLH 1.81% (n=7)
PGPSQNLH 1.81% (n=7)
WGPSQSLH 1.81% (n=7)
QGPSQNLH 1.55% (n=6)
PGPSQNLQ 1.55% (n=6)
LGPSQNLH 1.30% (n=5)
VGPKQNLH 1.30% (n=5)
LGPSQKLH 1.30% (n=5)
SGPKQNLQ 1.30% (n=5)
LGPKQNLH 1.04% (n=4)
PGSRQNLQ 1.04% (n=4)
PGPQQNLH 1.04% (n=4)
SGPRQNLQ 1.04% (n=4)
TGPKQNLQ 1.04% (n=4)
RGPSQKLQ 0.78% (n=3)
PGPRQNLH 0.78% (n=3)
PGPKQNLQ 0.78% (n=3)
RGPQQNLQ 0.78% (n=3)
RGPKQNLH 0.78% (n=3)
QGPRQNLH 0.78% (n=3)
PGPSQKLH 0.78% (n=3)
PGSKQNLQ 0.78% (n=3)
TGPKQNLH 0.78% (n=3)
PGAKQNLQ 0.78% (n=3)
TGPSQNLH 0.78% (n=3)
KGPSQNLQ 0.78% (n=3)
AGPRQNLH 0.78% (n=3)
AGPKQNLH 0.78% (n=3)
QGPKQNLQ 0.78% (n=3)
SGSQQNLQ 0.52% (n=2)
LGPKQNLQ 0.52% (n=2)
LGPQQKLH 0.52% (n=2)
RGPQQNLH 0.52% (n=2)
LGSKQNLQ 0.52% (n=2)
MGPKQNLH 0.52% (n=2)
MGPKQNLQ 0.52% (n=2)
SGPKQDLR 0.52% (n=2)
MGPRQNLH 0.52% (n=2)
VGPRQNLH 0.52% (n=2)
SGPSQNLH 0.52% (n=2)
TGPRQNLH 0.52% (n=2)
QGPKQKLQ 0.52% (n=2)
TGPSQNLQ 0.52% (n=2)
SGPQQNLQ 0.52% (n=2)
VGPKQNLQ 0.26% (n=1)
MGPSQNLH 0.26% (n=1)
TGPSQKLQ 0.26% (n=1)
AGPKQNLQ 0.26% (n=1)
RGPKQSLH 0.26% (n=1)
LGPRQNLQ 0.26% (n=1)
FGPQQNLQ 0.26% (n=1)
IGPSQKLH 0.26% (n=1)
QGPVQKLH 0.26% (n=1)
PGPSQQLH 0.26% (n=1)
LGPQQNLH 0.26% (n=1)
PGPKQSLQ 0.26% (n=1)
PGPNQNLQ 0.26% (n=1)
AGPSQKLQ 0.26% (n=1)
PGARQNLQ 0.26% (n=1)
RGPSQELQ 0.26% (n=1)
QGAKQNLH 0.26% (n=1)
AGPQQNLQ 0.26% (n=1)
AGPRQNLQ 0.26% (n=1)
RGPNQNLH 0.26% (n=1)
QGARQNLQ 0.26% (n=1)
PGPNQNLH 0.26% (n=1)
PGPQQNLQ 0.26% (n=1)
PGSKQNLH 0.26% (n=1)
KGPQQNLH 0.26% (n=1)
LGPQQKLQ 0.26% (n=1)
MGPSQKLH 0.26% (n=1)
RGPKQDLH 0.26% (n=1)
PGPKQDLH 0.26% (n=1)
SGPAQNLK 0.26% (n=1)
PGPNQNLD 0.26% (n=1)
SGPTQNLN 0.26% (n=1)
QGPKQHLH 0.26% (n=1)
QGPKQKLN 0.26% (n=1)
PGPSQDLQ 0.26% (n=1)
LGPRQNLR 0.26% (n=1)
LGSRQNLN 0.26% (n=1)
SGPKQDLQ 0.26% (n=1)
PGPKQNLN 0.26% (n=1)
PGAKQALH 0.26% (n=1)
VGPSQKLQ 0.26% (n=1)
PGPSQNLR 0.26% (n=1)
VGPSQKLH 0.26% (n=1)
PGPQQKLQ 0.26% (n=1)
RGPSQDLH 0.26% (n=1)
SGPQQKLN 0.26% (n=1)
RGPKQSLS 0.26% (n=1)
SGPKQQLH 0.26% (n=1)
IGPKQNLH 0.26% (n=1)
FGPAQKLH 0.26% (n=1)
AGPQQNLH 0.26% (n=1)
PGPRQDLH 0.26% (n=1)
RGPSQNLN 0.26% (n=1)
LGPSQNLQ 0.26% (n=1)
PGPRQNLQ 0.26% (n=1)
RGPSQGLH 0.26% (n=1)
WGPKQNLQ 0.26% (n=1)
VGPQQKLQ 0.26% (n=1)
KGPSQKLQ 0.26% (n=1)
PGPTQHLN 0.26% (n=1)
LGSRQNLQ 0.26% (n=1)
QGPRQKLQ 0.26% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 4:

RGSQQNVQ 22.85% (n=175)
SGPSQNLG 8.09% (n=62)
QGSQQNVQ 7.70% (n=59)
RGSQQNLQ 7.05% (n=54)
PGSKQNLQ 6.92% (n=53)
PGSRQNVQ 5.87% (n=45)
PGSQQNVQ 3.92% (n=30)
PGAQQRIQ 3.52% (n=27)
QGSRQNVQ 2.61% (n=20)
PGPSQKLH 2.48% (n=19)
PGSQQNIQ 2.48% (n=19)
PGPKQNLH 2.22% (n=17)
QGSQQNIQ 1.44% (n=11)
PGSKQNIQ 1.31% (n=10)
PGSRQNIQ 1.17% (n=9)
PGARQNLQ 0.91% (n=7)
PGAKQNIQ 0.78% (n=6)
SGSQQNIQ 0.78% (n=6)
RGSQQNIQ 0.78% (n=6)
SGSRQNIQ 0.78% (n=6)
LGSQQNVQ 0.65% (n=5)
PGAKQNLQ 0.65% (n=5)
PGAQQNLQ 0.65% (n=5)
SGSKQNIQ 0.65% (n=5)
QGSRQNIQ 0.65% (n=5)
SGPKQNLQ 0.65% (n=5)
SGSKQNLQ 0.52% (n=4)
PGPQQKLQ 0.39% (n=3)
PGAKQNVQ 0.39% (n=3)
LGSQQNIQ 0.39% (n=3)
SGSQQNLQ 0.26% (n=2)
QGSQQNLQ 0.26% (n=2)
QGPKQNIQ 0.26% (n=2)
PGPRQNIQ 0.26% (n=2)
RGSRQNIQ 0.26% (n=2)
SGAKQNLQ 0.26% (n=2)
YGSQQNLQ 0.13% (n=1)
PGASQKLQ 0.13% (n=1)
TGPQQNLQ 0.13% (n=1)
AGARQNLQ 0.13% (n=1)
PGAQQTLQ 0.13% (n=1)
HGSRQNVQ 0.13% (n=1)
AGSAQNLQ 0.13% (n=1)
PGSQQRLQ 0.13% (n=1)
PGAQQRMQ 0.13% (n=1)
RGSRQDVQ 0.13% (n=1)
AGPRQNVQ 0.13% (n=1)
PGPRQNLQ 0.13% (n=1)
KGSKQNIQ 0.13% (n=1)
PGPKQRIQ 0.13% (n=1)
MGGQQHIQ 0.13% (n=1)
PGSHQKIQ 0.13% (n=1)
LGPSQKLQ 0.13% (n=1)
QGSRQNLQ 0.13% (n=1)
PGSKQNVQ 0.13% (n=1)
TGSKQNIQ 0.13% (n=1)
LGPQQNIQ 0.13% (n=1)
RGPRQNIQ 0.13% (n=1)
LGSKQNIQ 0.13% (n=1)
RGPQQEMR 0.13% (n=1)
RGPQQEIR 0.13% (n=1)
QGSRQNIH 0.13% (n=1)
QGSKQNIQ 0.13% (n=1)
TGSRQNIQ 0.13% (n=1)
VGSKQDLQ 0.13% (n=1)
PGSRQNLQ 0.13% (n=1)
AGSRQNLQ 0.13% (n=1)
TGASQNLQ 0.13% (n=1)
PGPQQRIQ 0.13% (n=1)
PGPTQKIQ 0.13% (n=1)
PGSRQNIM 0.13% (n=1)
PGSMQNIM 0.13% (n=1)
LGPQQKIQ 0.13% (n=1)
RGARQDLK 0.13% (n=1)
VGPQQQLR 0.13% (n=1)
PGPKQNLQ 0.13% (n=1)
FGARQNLQ 0.13% (n=1)
YGPKQNLQ 0.13% (n=1)
PGASQNLQ 0.13% (n=1)
PGARQKIQ 0.13% (n=1)
PGSQQKIQ 0.13% (n=1)
SGPQQNLQ 0.13% (n=1)
TGSRQNLQ 0.13% (n=1)
PGAQQRLQ 0.13% (n=1)
SGPEQNLQ 0.13% (n=1)
LGAKQNLQ 0.13% (n=1)
PGAQQNIR 0.13% (n=1)
PGPRQHLS 0.13% (n=1)
PGPRQALQ 0.13% (n=1)
SGPKQNIQ 0.13% (n=1)
PGPQQRLQ 0.13% (n=1)
SGPQQKLQ 0.13% (n=1)
PGPNQQLQ 0.13% (n=1)
PGPQQRVQ 0.13% (n=1)
PGPSQNLH 0.13% (n=1)
RGPRQDLQ 0.13% (n=1)
RGPKQNLR 0.13% (n=1)
PGAKQNLR 0.13% (n=1)
SGAKQPLQ 0.13% (n=1)
PGGRQDIR 0.13% (n=1)
LGPRQKLQ 0.13% (n=1)
TGPKQDIK 0.13% (n=1)
PGAKQSLQ 0.13% (n=1)
LGPRQNLQ 0.13% (n=1)
RGPQQNLR 0.13% (n=1)
PGAKQDVQ 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 4a:

SGPSQNLG 38.51% (n=62)
PGAQQRIQ 16.77% (n=27)
PGPSQKLH 11.80% (n=19)
PGPKQNLH 10.56% (n=17)
SGSKQNLQ 2.48% (n=4)
PGAKQNLQ 2.48% (n=4)
PGAQQNLQ 2.48% (n=4)
PGARQNLQ 1.86% (n=3)
PGPQQKLQ 1.24% (n=2)
PGAKQNVQ 1.24% (n=2)
SGSQQNLQ 1.24% (n=2)
LGSQQNVQ 0.62% (n=1)
YGSQQNLQ 0.62% (n=1)
PGASQKLQ 0.62% (n=1)
TGPQQNLQ 0.62% (n=1)
AGARQNLQ 0.62% (n=1)
PGAQQTLQ 0.62% (n=1)
HGSRQNVQ 0.62% (n=1)
AGSAQNLQ 0.62% (n=1)
PGSQQRLQ 0.62% (n=1)
PGSQQNVQ 0.62% (n=1)
PGAQQRMQ 0.62% (n=1)
RGSRQDVQ 0.62% (n=1)
AGPRQNVQ 0.62% (n=1)
PGPRQNLQ 0.62% (n=1)
KGSKQNIQ 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 4d:

RGSQQNVQ 32.29% (n=175)
QGSQQNVQ 10.89% (n=59)
RGSQQNLQ 9.96% (n=54)
PGSKQNLQ 9.59% (n=52)
PGSRQNVQ 8.30% (n=45)
PGSQQNVQ 5.35% (n=29)
QGSRQNVQ 3.69% (n=20)
PGSQQNIQ 3.51% (n=19)
QGSQQNIQ 2.03% (n=11)
PGSKQNIQ 1.85% (n=10)
PGSRQNIQ 1.48% (n=8)
SGSQQNIQ 1.11% (n=6)
RGSQQNIQ 1.11% (n=6)
SGSKQNIQ 0.92% (n=5)
QGSRQNIQ 0.92% (n=5)
SGSRQNIQ 0.92% (n=5)
LGSQQNVQ 0.74% (n=4)
PGAKQNIQ 0.55% (n=3)
LGSQQNIQ 0.55% (n=3)
QGSQQNLQ 0.37% (n=2)
PGPRQNIQ 0.37% (n=2)
RGSRQNIQ 0.37% (n=2)
MGGQQHIQ 0.18% (n=1)
PGSHQKIQ 0.18% (n=1)
LGPSQKLQ 0.18% (n=1)
QGSRQNLQ 0.18% (n=1)
QGPKQNIQ 0.18% (n=1)
PGSKQNVQ 0.18% (n=1)
TGSKQNIQ 0.18% (n=1)
LGPQQNIQ 0.18% (n=1)
RGPRQNIQ 0.18% (n=1)
LGSKQNIQ 0.18% (n=1)
RGPQQEMR 0.18% (n=1)
RGPQQEIR 0.18% (n=1)
PGAKQNVQ 0.18% (n=1)
QGSRQNIH 0.18% (n=1)
QGSKQNIQ 0.18% (n=1)
TGSRQNIQ 0.18% (n=1)
VGSKQDLQ 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 5:

PGARQNLQ 6.71% (n=10)
PGAKQNLQ 4.70% (n=7)
PGPQQNLQ 4.03% (n=6)
PGPKQNLQ 4.03% (n=6)
PGAKQDLQ 4.03% (n=6)
PGPSQNLQ 3.36% (n=5)
LGPQQKLQ 3.36% (n=5)
PGSQQNLQ 3.36% (n=5)
PGANQPLQ 2.68% (n=4)
AGPSQNLQ 2.01% (n=3)
PGSKQNLQ 2.01% (n=3)
PGPSQRLQ 2.01% (n=3)
PGSRQNLQ 2.01% (n=3)
PGPRQNLQ 2.01% (n=3)
RGPQQNLQ 2.01% (n=3)
PGAKQNIQ 1.34% (n=2)
FGARQPLQ 1.34% (n=2)
SGPSQNLQ 1.34% (n=2)
PGPQQKLQ 1.34% (n=2)
SGAQQNLQ 1.34% (n=2)
SGPQQKLQ 1.34% (n=2)
PGPAQNLQ 1.34% (n=2)
PGPQRQLQ 1.34% (n=2)
SGPKQNLQ 0.67% (n=1)
LGPKQNIQ 0.67% (n=1)
YGPKQNLQ 0.67% (n=1)
PGSAQNVQ 0.67% (n=1)
P------- 0.67% (n=1)
AGPQQNL- 0.67% (n=1)
TGPSQN-- 0.67% (n=1)
PGPQQNL- 0.67% (n=1)
PGPKQHLQ 0.67% (n=1)
PGAKQN-- 0.67% (n=1)
IGAQQKLQ 0.67% (n=1)
LGPRQKLQ 0.67% (n=1)
SGPRQNLQ 0.67% (n=1)
PGARQQLQ 0.67% (n=1)
TGPSQNLQ 0.67% (n=1)
VGPRQQLQ 0.67% (n=1)
SGPQQHLQ 0.67% (n=1)
IGSQQNLQ 0.67% (n=1)
TGPSQSLQ 0.67% (n=1)
PGSQQKLQ 0.67% (n=1)
PGARQKLQ 0.67% (n=1)
LGAQQ--- 0.67% (n=1)
-SSHQHLQ 0.67% (n=1)
RGPQQQLQ 0.67% (n=1)
LGPKQRLQ 0.67% (n=1)
LGAQQKLQ 0.67% (n=1)
TGAKQDLQ 0.67% (n=1)
SGSRQNLQ 0.67% (n=1)
PRAKAELQ 0.67% (n=1)
LGAKQKLQ 0.67% (n=1)
FGAHQKLE 0.67% (n=1)
LGPSQKLQ 0.67% (n=1)
SGAKQNLQ 0.67% (n=1)
TGARQNLQ 0.67% (n=1)
RGAKQDLR 0.67% (n=1)
P-SKQPLQ 0.67% (n=1)
TGAKQNLQ 0.67% (n=1)
PGSQAESA 0.67% (n=1)
SGPNQNLQ 0.67% (n=1)
IGPYQNLQ 0.67% (n=1)
PGPTQELQ 0.67% (n=1)
PRPRQKLQ 0.67% (n=1)
PGPAQQLQ 0.67% (n=1)
IGPSQKLQ 0.67% (n=1)
FGPKQKLQ 0.67% (n=1)
SGPKQDLQ 0.67% (n=1)
TGSKQNLQ 0.67% (n=1)
LGPKQNLQ 0.67% (n=1)
MGPRQNLQ 0.67% (n=1)
PGASQNLQ 0.67% (n=1)
PGPIQNLQ 0.67% (n=1)
PGPAQRLQ 0.67% (n=1)
RGPKQKLQ 0.67% (n=1)
YGPQQKLQ 0.67% (n=1)
RGANQNLQ 0.67% (n=1)
TGPKQNIQ 0.67% (n=1)
AGPQQNLQ 0.67% (n=1)
VGPSQKLQ 0.67% (n=1)
RGSHQKLQ 0.67% (n=1)
RGAHQNLQ 0.67% (n=1)
RGAQQKLQ 0.67% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 6:

PGAKQNLQ 12.04% (n=62)
PGARQNLQ 8.93% (n=46)
SGAKQNLQ 4.08% (n=21)
PGAKQNIQ 3.50% (n=18)
TGAKQNLQ 3.11% (n=16)
PGARQNIQ 2.91% (n=15)
SGARQNLQ 2.52% (n=13)
SGPKQNLQ 2.52% (n=13)
PGPKQNLQ 2.33% (n=12)
PGSKQNIQ 2.33% (n=12)
PGSRQNLQ 1.94% (n=10)
TGPKQNLQ 1.55% (n=8)
PGPKQNIQ 1.55% (n=8)
PGSRQNIQ 1.55% (n=8)
PGPRQNLQ 1.36% (n=7)
PGSKQNLQ 1.36% (n=7)
PGAQQNIQ 1.17% (n=6)
PGSQQNIQ 1.17% (n=6)
FGPKQNLQ 0.97% (n=5)
TGARQNLQ 0.97% (n=5)
PGPQQKLQ 0.97% (n=5)
PGASQNLQ 0.78% (n=4)
PGAQQNLQ 0.78% (n=4)
SGPQQNLQ 0.78% (n=4)
SGSKQNLQ 0.78% (n=4)
SGPNQKIQ 0.78% (n=4)
QGSRQNLQ 0.78% (n=4)
RGSQQNIQ 0.78% (n=4)
PGPQQNLQ 0.58% (n=3)
SGPRQNLQ 0.58% (n=3)
SGPKQSLQ 0.58% (n=3)
LGPQQNLQ 0.58% (n=3)
TGPKQNIQ 0.58% (n=3)
PGSKQNVQ 0.58% (n=3)
AGSRQNIQ 0.58% (n=3)
SGSRQNLQ 0.58% (n=3)
AGPSQKLQ 0.58% (n=3)
PGPSQNLQ 0.39% (n=2)
IGAKQNLQ 0.39% (n=2)
YGSKQNLQ 0.39% (n=2)
SGPQQKLQ 0.39% (n=2)
LGPKQNLQ 0.39% (n=2)
YGAKQNLQ 0.39% (n=2)
PGARQKLQ 0.39% (n=2)
PGPKQNLH 0.39% (n=2)
SGARQNIQ 0.39% (n=2)
LGARQNLQ 0.39% (n=2)
TGAKQNIQ 0.39% (n=2)
SGARQKLQ 0.39% (n=2)
LGASQKLQ 0.39% (n=2)
TGAKQNIH 0.39% (n=2)
SGAKQNIQ 0.39% (n=2)
SGSQQKLQ 0.39% (n=2)
PGSQQNLQ 0.39% (n=2)
LGSRQNLQ 0.39% (n=2)
RGSQQNLQ 0.39% (n=2)
AGARQNLQ 0.39% (n=2)
PGPTQNLQ 0.39% (n=2)
TGGKQNIQ 0.39% (n=2)
HGPKQNIQ 0.39% (n=2)
PGSAQKLQ 0.39% (n=2)
VGSQQNLQ 0.39% (n=2)
LGAKQNLQ 0.19% (n=1)
LGARQKLQ 0.19% (n=1)
AGARQSIQ 0.19% (n=1)
PGPKQKLQ 0.19% (n=1)
TGPKQTLQ 0.19% (n=1)
PGPKQGLQ 0.19% (n=1)
AGPKQNLQ 0.19% (n=1)
SGPKQNLH 0.19% (n=1)
SGPSQKLH 0.19% (n=1)
AGPRQNLQ 0.19% (n=1)
FGPQQNVQ 0.19% (n=1)
FGPQQKLQ 0.19% (n=1)
PGASQKLQ 0.19% (n=1)
FGPKQKLQ 0.19% (n=1)
PGAKQDLQ 0.19% (n=1)
SGARQNLH 0.19% (n=1)
FGAKQKLQ 0.19% (n=1)
FGSKQNLQ 0.19% (n=1)
LGPSQKLQ 0.19% (n=1)
PGAMQNLQ 0.19% (n=1)
SGPKQTLQ 0.19% (n=1)
SGPRQKLQ 0.19% (n=1)
LGPSQTIQ 0.19% (n=1)
LGPKQKLQ 0.19% (n=1)
QGPKQNLQ 0.19% (n=1)
FGPSQNLQ 0.19% (n=1)
PGANQNLQ 0.19% (n=1)
LGSRQNIQ 0.19% (n=1)
TGAQQNIQ 0.19% (n=1)
SGSKQNIQ 0.19% (n=1)
LGSQQNVQ 0.19% (n=1)
FGAKQNLQ 0.19% (n=1)
QGPSQRLQ 0.19% (n=1)
LGPNQNIQ 0.19% (n=1)
TGPRQNLQ 0.19% (n=1)
RGPRQNLQ 0.19% (n=1)
LGAKQNVQ 0.19% (n=1)
PGARQTLQ 0.19% (n=1)
SGAQQKLQ 0.19% (n=1)
AGSQQNLQ 0.19% (n=1)
SGSQQNLQ 0.19% (n=1)
TGPSQRLQ 0.19% (n=1)
SGSKQHLQ 0.19% (n=1)
QGSQQNLQ 0.19% (n=1)
PGPQQSLQ 0.19% (n=1)
QGPQQRLQ 0.19% (n=1)
LGPQQYLQ 0.19% (n=1)
LGPQQRLQ 0.19% (n=1)
QGAKQRLQ 0.19% (n=1)
LGPKQRLQ 0.19% (n=1)
PGAKQHLQ 0.19% (n=1)
PGAHQRLQ 0.19% (n=1)
PGPQQHLQ 0.19% (n=1)
PGPQQRLQ 0.19% (n=1)
HGPQQHIQ 0.19% (n=1)
VGPKQNIQ 0.19% (n=1)
AGSKQNLQ 0.19% (n=1)
PGPSQDLQ 0.19% (n=1)
PGARQDLQ 0.19% (n=1)
RGPQQNLQ 0.19% (n=1)
VGARQNLQ 0.19% (n=1)
IGPQQKLH 0.19% (n=1)
QGAQQNIQ 0.19% (n=1)
LGAQQNIQ 0.19% (n=1)
PGASQNIQ 0.19% (n=1)
TGPKQSIQ 0.19% (n=1)
PGSSQNIQ 0.19% (n=1)
AGPRQKIQ 0.19% (n=1)
PGAAQNIQ 0.19% (n=1)
TGSRQNIQ 0.19% (n=1)
TGSKQNIQ 0.19% (n=1)
LGARQNIQ 0.19% (n=1)
SGPRQDIQ 0.19% (n=1)
FGARQNIQ 0.19% (n=1)
PGPRQSIQ 0.19% (n=1)
SGPKQNIQ 0.19% (n=1)
SGSQQNIQ 0.19% (n=1)
RGAQQSIQ 0.19% (n=1)
QGSRQKIQ 0.19% (n=1)
QGAKQNLQ 0.19% (n=1)
PGPSQNLH 0.19% (n=1)
VGAKQDLQ 0.19% (n=1)
LGAKQRIQ 0.19% (n=1)
PGPQQNIQ 0.19% (n=1)
QGSQQNIQ 0.19% (n=1)
RGSQQHLQ 0.19% (n=1)
LGPQQKLQ 0.19% (n=1)
RGARQNLQ 0.19% (n=1)
IGPKQNIQ 0.19% (n=1)
SGSAQNLQ 0.19% (n=1)
PGSAQNLQ 0.19% (n=1)
PGASQHLQ 0.19% (n=1)
VGSKQNLQ 0.19% (n=1)
TGSQQNLQ 0.19% (n=1)
MGSKQNLQ 0.19% (n=1)
LGSKQNLQ 0.19% (n=1)
LGPKQKIQ 0.19% (n=1)
TGPQQNLQ 0.19% (n=1)
VGSKQNIQ 0.19% (n=1)
LGPSQHIQ 0.19% (n=1)
PGPSQQLQ 0.19% (n=1)
QGPKQNIQ 0.19% (n=1)
QGPRQNIQ 0.19% (n=1)
VGARQNIQ 0.19% (n=1)
TGPQQHLM 0.19% (n=1)
TGPKQRIQ 0.19% (n=1)
PGAQQKLM 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Subtype 6a:

PGAKQNLQ 21.03% (n=57)
PGARQNLQ 15.13% (n=41)
SGAKQNLQ 7.38% (n=20)
TGAKQNLQ 5.54% (n=15)
PGPKQNLQ 4.43% (n=12)
SGARQNLQ 3.69% (n=10)
TGPKQNLQ 2.95% (n=8)
SGPKQNLQ 2.95% (n=8)
FGPKQNLQ 1.85% (n=5)
PGPRQNLQ 1.85% (n=5)
TGARQNLQ 1.85% (n=5)
PGAKQNIQ 1.85% (n=5)
PGASQNLQ 1.11% (n=3)
SGPRQNLQ 1.11% (n=3)
PGAQQNLQ 1.11% (n=3)
SGPKQSLQ 1.11% (n=3)
SGPQQNLQ 1.11% (n=3)
PGPQQNLQ 0.74% (n=2)
PGPSQNLQ 0.74% (n=2)
IGAKQNLQ 0.74% (n=2)
YGSKQNLQ 0.74% (n=2)
PGPQQKLQ 0.74% (n=2)
YGAKQNLQ 0.74% (n=2)
PGARQKLQ 0.74% (n=2)
SGARQKLQ 0.74% (n=2)
LGAKQNLQ 0.37% (n=1)
LGARQKLQ 0.37% (n=1)
AGARQSIQ 0.37% (n=1)
PGPKQKLQ 0.37% (n=1)
TGPKQTLQ 0.37% (n=1)
PGPKQGLQ 0.37% (n=1)
SGPQQKLQ 0.37% (n=1)
AGPKQNLQ 0.37% (n=1)
LGPKQNLQ 0.37% (n=1)
SGPKQNLH 0.37% (n=1)
SGPSQKLH 0.37% (n=1)
AGPRQNLQ 0.37% (n=1)
FGPQQNVQ 0.37% (n=1)
FGPQQKLQ 0.37% (n=1)
LGPQQNLQ 0.37% (n=1)
PGASQKLQ 0.37% (n=1)
FGPKQKLQ 0.37% (n=1)
PGARQNIQ 0.37% (n=1)
PGAKQDLQ 0.37% (n=1)
SGARQNLH 0.37% (n=1)
FGAKQKLQ 0.37% (n=1)
FGSKQNLQ 0.37% (n=1)
LGPSQKLQ 0.37% (n=1)
PGAMQNLQ 0.37% (n=1)
SGSKQNLQ 0.37% (n=1)
SGPKQTLQ 0.37% (n=1)
PGSKQNIQ 0.37% (n=1)
SGPRQKLQ 0.37% (n=1)
LGPSQTIQ 0.37% (n=1)
LGPKQKLQ 0.37% (n=1)
PGPKQNLH 0.37% (n=1)
QGPKQNLQ 0.37% (n=1)
FGPSQNLQ 0.37% (n=1)
PGANQNLQ 0.37% (n=1)
LGSRQNIQ 0.37% (n=1)
TGAQQNIQ 0.37% (n=1)
SGSKQNIQ 0.37% (n=1)
LGSQQNVQ 0.37% (n=1)
FGAKQNLQ 0.37% (n=1)
QGPSQRLQ 0.37% (n=1)
LGPNQNIQ 0.37% (n=1)
SGARQNIQ 0.37% (n=1)
TGPRQNLQ 0.37% (n=1)
LGARQNLQ 0.37% (n=1)
RGPRQNLQ 0.37% (n=1)
LGAKQNVQ 0.37% (n=1)
TGAKQNIQ 0.37% (n=1)
PGARQTLQ 0.37% (n=1)
SGAQQKLQ 0.37% (n=1)
---------------------------------------------------------------------------------------
Region 405-412 (antibodies: [H77.16] ), HCV Genotype 7:

PGPSQRLQ 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 528-534 (antibodies: [H77.31] ), HCV Genotype 1:

NWGENDT 18.43% (n=1880)
SWGENET 12.26% (n=1251)
NWGENET 6.98% (n=712)
NWGSNDT 5.47% (n=558)
RWGENET 5.40% (n=551)
SWGENDT 5.39% (n=550)
NWGANET 4.64% (n=473)
NWGDNDT 4.19% (n=427)
SWGGNET 4.11% (n=419)
TWGENET 3.97% (n=405)
RWGANDT 3.74% (n=382)
SWGANDT 3.32% (n=339)
NWGANDT 2.98% (n=304)
NWGSNET 2.30% (n=235)
NWGENAT 1.19% (n=121)
NWGDNET 0.98% (n=100)
GWGANDT 0.90% (n=92)
TWGGNVT 0.78% (n=80)
NWGGNDT 0.63% (n=64)
NWGCNDT 0.61% (n=62)
NWGGNET 0.59% (n=60)
SWGANET 0.53% (n=54)
NWGENNT 0.34% (n=35)
SWGGNDT 0.28% (n=29)
TWGANDT 0.26% (n=27)
NWGAKET 0.26% (n=27)
NWGGKDT 0.26% (n=27)
NWGAREE 0.25% (n=26)
NWGANVT 0.25% (n=25)
TWGENDT 0.25% (n=25)
NWGENVT 0.25% (n=25)
TWGSNDT 0.22% (n=22)
RWGANET 0.21% (n=21)
DWGSNDT 0.20% (n=20)
GWGSNDT 0.20% (n=20)
TWGENKT 0.20% (n=20)
NWGENQT 0.20% (n=20)
SWGENKT 0.19% (n=19)
SWGEKET 0.18% (n=18)
KWGANET 0.18% (n=18)
SWGSNET 0.17% (n=17)
NWGADET 0.17% (n=17)
SWGKNET 0.15% (n=15)
KWGENET 0.14% (n=14)
TWGANET 0.13% (n=13)
NWGENKT 0.12% (n=12)
NWGTNET 0.11% (n=11)
NWGVNET 0.10% (n=10)
GWGDNDT 0.10% (n=10)
SWGENVT 0.10% (n=10)
SWGSNDT 0.10% (n=10)
GWGENDT 0.10% (n=10)
NWGANEM 0.10% (n=10)
NWGEGGT 0.10% (n=10)
NWGGNKT 0.10% (n=10)
SWGGNVT 0.10% (n=10)
TWGGNDT 0.09% (n=9)
--GENET 0.09% (n=9)
SWGANNT 0.08% (n=8)
NWGANKT 0.08% (n=8)
DWGENET 0.08% (n=8)
TWGGNET 0.08% (n=8)
NWGQNDT 0.07% (n=7)
SWGVNDT 0.07% (n=7)
NWGNNDT 0.06% (n=6)
SWGEKDT 0.06% (n=6)
NWGAHET 0.06% (n=6)
NWGTREE 0.06% (n=6)
NWGGNRT 0.06% (n=6)
NWGNNET 0.06% (n=6)
AWGGNET 0.06% (n=6)
SWGENGT 0.05% (n=5)
RWGENDT 0.05% (n=5)
NWGTNDT 0.05% (n=5)
NWGENES 0.05% (n=5)
TWGSNNT 0.05% (n=5)
SWGTNDT 0.04% (n=4)
TWGGSVK 0.04% (n=4)
NWGQNET 0.04% (n=4)
NWGCNET 0.04% (n=4)
SWGVNET 0.04% (n=4)
NWGSDDK 0.04% (n=4)
NWGVNKT 0.04% (n=4)
NWGTQEE 0.04% (n=4)
NWGTREG 0.04% (n=4)
SWGE--- 0.04% (n=4)
GWGENET 0.04% (n=4)
NWGGDDT 0.03% (n=3)
SWGATDA 0.03% (n=3)
TWGEKDT 0.03% (n=3)
NWGSNST 0.03% (n=3)
SWGDNET 0.03% (n=3)
NWGENDM 0.03% (n=3)
NWGRNDT 0.03% (n=3)
NWGSNNT 0.03% (n=3)
DWGENDT 0.03% (n=3)
NWGVNDT 0.03% (n=3)
KWGANDT 0.03% (n=3)
DWGSNDV 0.03% (n=3)
NWGGNVT 0.03% (n=3)
TWGENVT 0.03% (n=3)
SWGGNKT 0.03% (n=3)
QWGENET 0.03% (n=3)
TWGENVS 0.03% (n=3)
TWGESET 0.03% (n=3)
NWGSNRT 0.02% (n=2)
NWGENDA 0.02% (n=2)
GWGGNDT 0.02% (n=2)
NWGENDK 0.02% (n=2)
TFGENET 0.02% (n=2)
NWGEDDS 0.02% (n=2)
SWGSNDS 0.02% (n=2)
NWGINDT 0.02% (n=2)
DWGANDT 0.02% (n=2)
SWGADEA 0.02% (n=2)
NWGENDS 0.02% (n=2)
TWGEKET 0.02% (n=2)
SWGENEA 0.02% (n=2)
NWGDSDT 0.02% (n=2)
NWGASDT 0.02% (n=2)
NWGEDDT 0.02% (n=2)
QLGYQYH 0.02% (n=2)
RWGESEA 0.02% (n=2)
SWGANDA 0.02% (n=2)
SWGGTDT 0.02% (n=2)
NWGAGET 0.02% (n=2)
NWGGNAT 0.02% (n=2)
NWGENHT 0.02% (n=2)
NWGENTT 0.02% (n=2)
NWSENET 0.02% (n=2)
NWGEEDT 0.02% (n=2)
DWGAREE 0.02% (n=2)
NWGIREE 0.02% (n=2)
TWGNSST 0.02% (n=2)
SWGSDTK 0.02% (n=2)
NWGCNVT 0.02% (n=2)
SWGDNDT 0.02% (n=2)
AWGANET 0.02% (n=2)
RWGDNET 0.02% (n=2)
TWGVNET 0.02% (n=2)
NWGENEA 0.02% (n=2)
GWGANET 0.02% (n=2)
TWGENAT 0.02% (n=2)
TWGENEA 0.02% (n=2)
TWGDNET 0.02% (n=2)
RWGENKT 0.02% (n=2)
TWGENGT 0.02% (n=2)
SWGENAT 0.02% (n=2)
SWGENQT 0.02% (n=2)
TWGGNKS 0.02% (n=2)
--GENEI 0.02% (n=2)
--GESET 0.02% (n=2)
TSGANDT 0.02% (n=2)
NSGANDT 0.02% (n=2)
SWGSNKT 0.01% (n=1)
NWGENDV 0.01% (n=1)
NWCANET 0.01% (n=1)
SWGGNNA 0.01% (n=1)
SWGANEA 0.01% (n=1)
NWGANDM 0.01% (n=1)
NWGANNT 0.01% (n=1)
SWGADDT 0.01% (n=1)
NWGINET 0.01% (n=1)
SWGVTDT 0.01% (n=1)
NWGDNGA 0.01% (n=1)
N*GDNDT 0.01% (n=1)
SWVENDT 0.01% (n=1)
NWGSDTT 0.01% (n=1)
TCGENDT 0.01% (n=1)
SWGEHDT 0.01% (n=1)
TWGSNVS 0.01% (n=1)
TWGSNHS 0.01% (n=1)
NWGNTSE 0.01% (n=1)
SWGANVT 0.01% (n=1)
SWGENDK 0.01% (n=1)
SWGSNVT 0.01% (n=1)
RWGSNDT 0.01% (n=1)
DWGGNVT 0.01% (n=1)
NWGSNDS 0.01% (n=1)
SWGERDR 0.01% (n=1)
DWGRNDT 0.01% (n=1)
NWGANES 0.01% (n=1)
NFGANQT 0.01% (n=1)
NWGESDM 0.01% (n=1)
NWGSSDK 0.01% (n=1)
TWGESDK 0.01% (n=1)
NWGANEA 0.01% (n=1)
SWGSDDT 0.01% (n=1)
NWGTNAT 0.01% (n=1)
NWGSNYT 0.01% (n=1)
DWGSNVT 0.01% (n=1)
DWGSNET 0.01% (n=1)
SWGGKVT 0.01% (n=1)
NFGTNET 0.01% (n=1)
NWGDSDE 0.01% (n=1)
DWGENES 0.01% (n=1)
TWGERDT 0.01% (n=1)
NWGANDS 0.01% (n=1)
NWGSNVT 0.01% (n=1)
SWGEYDT 0.01% (n=1)
S*GENDT 0.01% (n=1)
GRGENDT 0.01% (n=1)
SRGENDT 0.01% (n=1)
NWGENGT 0.01% (n=1)
NWGDNQT 0.01% (n=1)
NRGANDT 0.01% (n=1)
DWGSSDV 0.01% (n=1)
SWGANGT 0.01% (n=1)
SWGATDT 0.01% (n=1)
SRGANDT 0.01% (n=1)
SWGVNDK 0.01% (n=1)
NWGAKKT 0.01% (n=1)
NWGTNVT 0.01% (n=1)
NWGADKT 0.01% (n=1)
NWGANEK 0.01% (n=1)
NWGAKQT 0.01% (n=1)
NWGARET 0.01% (n=1)
NWGASET 0.01% (n=1)
NWGATET 0.01% (n=1)
NWGTNKT 0.01% (n=1)
NWGDNEA 0.01% (n=1)
SWGENDS 0.01% (n=1)
NWGCND- 0.01% (n=1)
RWGKNET 0.01% (n=1)
YWGENDT 0.01% (n=1)
DWGVNDT 0.01% (n=1)
SWGSNAT 0.01% (n=1)
SWGESEA 0.01% (n=1)
RWGTNDT 0.01% (n=1)
NWGANIT 0.01% (n=1)
TWGDNDT 0.01% (n=1)
SWGSDNT 0.01% (n=1)
NWGSNIT 0.01% (n=1)
NWGETDK 0.01% (n=1)
RWGVNET 0.01% (n=1)
NWGANMT 0.01% (n=1)
SWGENEK 0.01% (n=1)
NWVSNDT 0.01% (n=1)
SWGSNNT 0.01% (n=1)
NWGEQDT 0.01% (n=1)
RWGENEK 0.01% (n=1)
TWGENES 0.01% (n=1)
TWGSSDA 0.01% (n=1)
NWGGNDA 0.01% (n=1)
NWGGGDT 0.01% (n=1)
NWGRKDT 0.01% (n=1)
NWGMNDT 0.01% (n=1)
DWGANET 0.01% (n=1)
NWGKNDT 0.01% (n=1)
VRGENGT 0.01% (n=1)
NWGVNES 0.01% (n=1)
SWRENET 0.01% (n=1)
RWGEKET 0.01% (n=1)
RWGEIET 0.01% (n=1)
SGRGIET 0.01% (n=1)
MWGEYET 0.01% (n=1)
SWGGIKP 0.01% (n=1)
SWGGNRT 0.01% (n=1)
TWGGNKT 0.01% (n=1)
NWGENGS 0.01% (n=1)
NWGGNAS 0.01% (n=1)
DWGGNET 0.01% (n=1)
RWGGNET 0.01% (n=1)
RWGANES 0.01% (n=1)
TWEENET 0.01% (n=1)
SWGGNTS 0.01% (n=1)
SWGGNKS 0.01% (n=1)
NWGENKS 0.01% (n=1)
TWGTNES 0.01% (n=1)
RWGENGT 0.01% (n=1)
ILGENET 0.01% (n=1)
TWGGNAS 0.01% (n=1)
SWGGNAT 0.01% (n=1)
SWGENKS 0.01% (n=1)
RWGENES 0.01% (n=1)
NWGANQT 0.01% (n=1)
HWGENKT 0.01% (n=1)
RWGENSS 0.01% (n=1)
SWGANKT 0.01% (n=1)
SWGESET 0.01% (n=1)
TWGENQT 0.01% (n=1)
TWGTNET 0.01% (n=1)
SWGEDET 0.01% (n=1)
SRGENEA 0.01% (n=1)
QWGENKT 0.01% (n=1)
GWGGNET 0.01% (n=1)
SWGRNET 0.01% (n=1)
SWGENES 0.01% (n=1)
TWGRNET 0.01% (n=1)
RRGGNET 0.01% (n=1)
AWGENET 0.01% (n=1)
QWGENES 0.01% (n=1)
--GENES 0.01% (n=1)
TWGANDS 0.01% (n=1)
NWGANVS 0.01% (n=1)
TWGEHES 0.01% (n=1)
EWGEGAS 0.01% (n=1)
TSGANET 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 1a:

NWGENDT 25.89% (n=1880)
NWGSNDT 7.68% (n=558)
SWGENDT 7.52% (n=546)
NWGENET 6.25% (n=454)
NWGANET 6.20% (n=450)
NWGDNDT 5.84% (n=424)
RWGANDT 5.26% (n=382)
SWGANDT 4.67% (n=339)
NWGANDT 4.19% (n=304)
NWGSNET 3.24% (n=235)
RWGENET 2.80% (n=203)
SWGENET 2.69% (n=195)
NWGENAT 1.61% (n=117)
GWGANDT 1.27% (n=92)
NWGDNET 1.02% (n=74)
NWGGNDT 0.88% (n=64)
NWGCNDT 0.85% (n=62)
SWGANET 0.52% (n=38)
NWGENNT 0.48% (n=35)
NWGGNET 0.41% (n=30)
SWGGNDT 0.40% (n=29)
TWGANDT 0.37% (n=27)
NWGAKET 0.37% (n=27)
NWGGKDT 0.37% (n=27)
NWGAREE 0.36% (n=26)
NWGANVT 0.34% (n=25)
TWGENET 0.33% (n=24)
TWGENDT 0.32% (n=23)
TWGSNDT 0.30% (n=22)
NWGENVT 0.30% (n=22)
DWGSNDT 0.28% (n=20)
GWGSNDT 0.28% (n=20)
KWGANET 0.25% (n=18)
SWGSNET 0.23% (n=17)
SWGEKET 0.23% (n=17)
NWGADET 0.23% (n=17)
RWGANET 0.21% (n=15)
NWGTNET 0.15% (n=11)
GWGDNDT 0.14% (n=10)
SWGSNDT 0.14% (n=10)
GWGENDT 0.14% (n=10)
NWGANEM 0.14% (n=10)
NWGEGGT 0.14% (n=10)
NWGGNKT 0.14% (n=10)
TWGGNDT 0.12% (n=9)
SWGANNT 0.11% (n=8)
NWGANKT 0.11% (n=8)
NWGENKT 0.11% (n=8)
NWGQNDT 0.10% (n=7)
SWGVNDT 0.10% (n=7)
NWGNNDT 0.08% (n=6)
SWGEKDT 0.08% (n=6)
NWGAHET 0.08% (n=6)
NWGTREE 0.08% (n=6)
RWGENDT 0.07% (n=5)
NWGVNET 0.07% (n=5)
NWGTNDT 0.07% (n=5)
NWGENES 0.07% (n=5)
TWGSNNT 0.07% (n=5)
SWGTNDT 0.06% (n=4)
TWGGSVK 0.06% (n=4)
NWGQNET 0.06% (n=4)
NWGCNET 0.06% (n=4)
SWGENVT 0.06% (n=4)
NWGSDDK 0.06% (n=4)
NWGVNKT 0.06% (n=4)
NWGTQEE 0.06% (n=4)
NWGTREG 0.06% (n=4)
DWGENET 0.06% (n=4)
NWGGDDT 0.04% (n=3)
SWGATDA 0.04% (n=3)
TWGEKDT 0.04% (n=3)
NWGSNST 0.04% (n=3)
NWGENDM 0.04% (n=3)
NWGRNDT 0.04% (n=3)
NWGSNNT 0.04% (n=3)
DWGENDT 0.04% (n=3)
NWGVNDT 0.04% (n=3)
KWGANDT 0.04% (n=3)
DWGSNDV 0.04% (n=3)
NWGSNRT 0.03% (n=2)
NWGENDA 0.03% (n=2)
GWGGNDT 0.03% (n=2)
NWGENDK 0.03% (n=2)
TFGENET 0.03% (n=2)
NWGEDDS 0.03% (n=2)
SWGSNDS 0.03% (n=2)
NWGINDT 0.03% (n=2)
DWGANDT 0.03% (n=2)
SWGADEA 0.03% (n=2)
NWGENDS 0.03% (n=2)
NWGDSDT 0.03% (n=2)
NWGASDT 0.03% (n=2)
NWGEDDT 0.03% (n=2)
QLGYQYH 0.03% (n=2)
RWGESEA 0.03% (n=2)
SWGANDA 0.03% (n=2)
SWGGTDT 0.03% (n=2)
NWGAGET 0.03% (n=2)
NWGENHT 0.03% (n=2)
NWGENTT 0.03% (n=2)
NWSENET 0.03% (n=2)
NWGEEDT 0.03% (n=2)
DWGAREE 0.03% (n=2)
NWGIREE 0.03% (n=2)
TWGNSST 0.03% (n=2)
SWGSDTK 0.03% (n=2)
NWGCNVT 0.03% (n=2)
TWGANET 0.03% (n=2)
SWGDNDT 0.03% (n=2)
SWGENGT 0.01% (n=1)
SWGSNKT 0.01% (n=1)
NWGENDV 0.01% (n=1)
NWCANET 0.01% (n=1)
SWGGNNA 0.01% (n=1)
SWGANEA 0.01% (n=1)
NWGANDM 0.01% (n=1)
NWGANNT 0.01% (n=1)
SWGADDT 0.01% (n=1)
NWGINET 0.01% (n=1)
SWGVTDT 0.01% (n=1)
NWGDNGA 0.01% (n=1)
N*GDNDT 0.01% (n=1)
SWVENDT 0.01% (n=1)
NWGSDTT 0.01% (n=1)
TCGENDT 0.01% (n=1)
SWGEHDT 0.01% (n=1)
TWGSNVS 0.01% (n=1)
TWGSNHS 0.01% (n=1)
SWGDNET 0.01% (n=1)
NWGNTSE 0.01% (n=1)
SWGVNET 0.01% (n=1)
SWGANVT 0.01% (n=1)
SWGENDK 0.01% (n=1)
SWGSNVT 0.01% (n=1)
RWGSNDT 0.01% (n=1)
DWGGNVT 0.01% (n=1)
NWGSNDS 0.01% (n=1)
SWGERDR 0.01% (n=1)
DWGRNDT 0.01% (n=1)
NWGANES 0.01% (n=1)
NFGANQT 0.01% (n=1)
NWGESDM 0.01% (n=1)
NWGSSDK 0.01% (n=1)
TWGESDK 0.01% (n=1)
NWGANEA 0.01% (n=1)
SWGSDDT 0.01% (n=1)
NWGTNAT 0.01% (n=1)
NWGSNYT 0.01% (n=1)
TWGEKET 0.01% (n=1)
DWGSNVT 0.01% (n=1)
DWGSNET 0.01% (n=1)
SWGGKVT 0.01% (n=1)
SWGENEA 0.01% (n=1)
SWGGNET 0.01% (n=1)
NFGTNET 0.01% (n=1)
NWGDSDE 0.01% (n=1)
DWGENES 0.01% (n=1)
TWGERDT 0.01% (n=1)
NWGANDS 0.01% (n=1)
NWGSNVT 0.01% (n=1)
SWGEYDT 0.01% (n=1)
S*GENDT 0.01% (n=1)
GRGENDT 0.01% (n=1)
SRGENDT 0.01% (n=1)
NWGENGT 0.01% (n=1)
NWGDNQT 0.01% (n=1)
NRGANDT 0.01% (n=1)
DWGSSDV 0.01% (n=1)
SWGANGT 0.01% (n=1)
SWGATDT 0.01% (n=1)
SRGANDT 0.01% (n=1)
SWGVNDK 0.01% (n=1)
NWGAKKT 0.01% (n=1)
NWGTNVT 0.01% (n=1)
NWGADKT 0.01% (n=1)
NWGANEK 0.01% (n=1)
NWGAKQT 0.01% (n=1)
NWGARET 0.01% (n=1)
NWGASET 0.01% (n=1)
NWGATET 0.01% (n=1)
NWGTNKT 0.01% (n=1)
NWGDNEA 0.01% (n=1)
NWGGNAT 0.01% (n=1)
SWGENDS 0.01% (n=1)
NWGGNVT 0.01% (n=1)
RWGKNET 0.01% (n=1)
YWGENDT 0.01% (n=1)
DWGVNDT 0.01% (n=1)
SWGSNAT 0.01% (n=1)
SWGESEA 0.01% (n=1)
RWGTNDT 0.01% (n=1)
NWGANIT 0.01% (n=1)
TWGDNDT 0.01% (n=1)
SWGSDNT 0.01% (n=1)
NWGSNIT 0.01% (n=1)
AWGANET 0.01% (n=1)
NWGETDK 0.01% (n=1)
RWGVNET 0.01% (n=1)
NWGANMT 0.01% (n=1)
SWGENEK 0.01% (n=1)
NWVSNDT 0.01% (n=1)
SWGSNNT 0.01% (n=1)
NWGEQDT 0.01% (n=1)
RWGENEK 0.01% (n=1)
TWGENES 0.01% (n=1)
TWGSSDA 0.01% (n=1)
NWGGNDA 0.01% (n=1)
NWGGGDT 0.01% (n=1)
NWGRKDT 0.01% (n=1)
NWGMNDT 0.01% (n=1)
DWGANET 0.01% (n=1)
NWGKNDT 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 1b:

SWGENET 36.18% (n=1052)
SWGGNET 14.37% (n=418)
TWGENET 12.76% (n=371)
RWGENET 11.93% (n=347)
NWGENET 8.73% (n=254)
TWGGNVT 2.75% (n=80)
NWGGNET 1.03% (n=30)
NWGDNET 0.79% (n=23)
NWGANET 0.79% (n=23)
TWGENKT 0.69% (n=20)
NWGENQT 0.69% (n=20)
SWGENKT 0.65% (n=19)
SWGANET 0.55% (n=16)
SWGKNET 0.52% (n=15)
KWGENET 0.48% (n=14)
TWGANET 0.38% (n=11)
SWGGNVT 0.34% (n=10)
--GENET 0.31% (n=9)
TWGGNET 0.28% (n=8)
SWGENVT 0.21% (n=6)
NWGGNRT 0.21% (n=6)
NWGNNET 0.21% (n=6)
AWGGNET 0.21% (n=6)
RWGANET 0.17% (n=5)
NWGVNET 0.17% (n=5)
SWGENDT 0.14% (n=4)
SWGENGT 0.14% (n=4)
NWGENKT 0.14% (n=4)
SWGE--- 0.14% (n=4)
DWGENET 0.14% (n=4)
NWGENAT 0.14% (n=4)
GWGENET 0.14% (n=4)
SWGVNET 0.10% (n=3)
NWGDNDT 0.10% (n=3)
TWGENVT 0.10% (n=3)
SWGGNKT 0.10% (n=3)
QWGENET 0.10% (n=3)
NWGENVT 0.10% (n=3)
TWGENVS 0.10% (n=3)
TWGESET 0.10% (n=3)
RWGDNET 0.07% (n=2)
TWGVNET 0.07% (n=2)
NWGGNVT 0.07% (n=2)
NWGENEA 0.07% (n=2)
GWGANET 0.07% (n=2)
TWGENAT 0.07% (n=2)
TWGENEA 0.07% (n=2)
SWGDNET 0.07% (n=2)
TWGDNET 0.07% (n=2)
RWGENKT 0.07% (n=2)
TWGENGT 0.07% (n=2)
SWGENAT 0.07% (n=2)
SWGENQT 0.07% (n=2)
TWGGNKS 0.07% (n=2)
--GENEI 0.07% (n=2)
--GESET 0.07% (n=2)
VRGENGT 0.03% (n=1)
NWGVNES 0.03% (n=1)
SWRENET 0.03% (n=1)
RWGEKET 0.03% (n=1)
RWGEIET 0.03% (n=1)
SGRGIET 0.03% (n=1)
MWGEYET 0.03% (n=1)
SWGGIKP 0.03% (n=1)
SWGGNRT 0.03% (n=1)
TWGGNKT 0.03% (n=1)
TWGEKET 0.03% (n=1)
NWGENGS 0.03% (n=1)
NWGGNAS 0.03% (n=1)
DWGGNET 0.03% (n=1)
RWGGNET 0.03% (n=1)
RWGANES 0.03% (n=1)
TWEENET 0.03% (n=1)
SWGGNTS 0.03% (n=1)
SWGGNKS 0.03% (n=1)
NWGENKS 0.03% (n=1)
AWGANET 0.03% (n=1)
TWGTNES 0.03% (n=1)
SWGENEA 0.03% (n=1)
RWGENGT 0.03% (n=1)
ILGENET 0.03% (n=1)
TWGGNAS 0.03% (n=1)
SWGGNAT 0.03% (n=1)
SWGENKS 0.03% (n=1)
RWGENES 0.03% (n=1)
NWGANQT 0.03% (n=1)
HWGENKT 0.03% (n=1)
TWGENDT 0.03% (n=1)
RWGENSS 0.03% (n=1)
SWGANKT 0.03% (n=1)
SWGESET 0.03% (n=1)
TWGENQT 0.03% (n=1)
TWGTNET 0.03% (n=1)
SWGEDET 0.03% (n=1)
SRGENEA 0.03% (n=1)
QWGENKT 0.03% (n=1)
GWGGNET 0.03% (n=1)
SWGRNET 0.03% (n=1)
SWGENES 0.03% (n=1)
TWGRNET 0.03% (n=1)
RRGGNET 0.03% (n=1)
NWGGNAT 0.03% (n=1)
SWGEKET 0.03% (n=1)
AWGENET 0.03% (n=1)
QWGENES 0.03% (n=1)
--GENES 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 2:

SWGENET 35.80% (n=189)
TWGENET 28.98% (n=153)
NWGDNET 13.45% (n=71)
NWGENET 7.58% (n=40)
GWGENET 2.27% (n=12)
TWGENDT 1.70% (n=9)
RWGENET 1.33% (n=7)
SWGANET 0.95% (n=5)
TWGANET 0.76% (n=4)
TGEGNET 0.57% (n=3)
TWGENES 0.57% (n=3)
TWGDNET 0.57% (n=3)
SWGENQT 0.38% (n=2)
SWGVNET 0.38% (n=2)
KWGENET 0.38% (n=2)
TWGGNET 0.19% (n=1)
MWEGNET 0.19% (n=1)
MGEGNET 0.19% (n=1)
TWGVNET 0.19% (n=1)
RWGERET 0.19% (n=1)
PWRRNDT 0.19% (n=1)
AWGENET 0.19% (n=1)
MWGENET 0.19% (n=1)
NWGGNDT 0.19% (n=1)
NWGDNGT 0.19% (n=1)
SWGENES 0.19% (n=1)
SWGENDT 0.19% (n=1)
NWGENDT 0.19% (n=1)
DWGQNET 0.19% (n=1)
TWGANDT 0.19% (n=1)
TWGENKT 0.19% (n=1)
SWGDNET 0.19% (n=1)
NWGESEK 0.19% (n=1)
TWGGNDT 0.19% (n=1)
TWEENET 0.19% (n=1)
TWGGNVK 0.19% (n=1)
SWGGGDK 0.19% (n=1)
NWGANET 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 2a:

TWGENET 82.89% (n=63)
TGEGNET 3.95% (n=3)
TWGENDT 2.63% (n=2)
TWGENES 2.63% (n=2)
RWGENET 1.32% (n=1)
TWGGNET 1.32% (n=1)
SWGENET 1.32% (n=1)
MWEGNET 1.32% (n=1)
MGEGNET 1.32% (n=1)
TWGANET 1.32% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 2b:

SWGENET 50.00% (n=175)
NWGDNET 20.29% (n=71)
TWGENET 11.71% (n=41)
NWGENET 6.00% (n=21)
RWGENET 1.71% (n=6)
GWGENET 1.71% (n=6)
SWGANET 1.43% (n=5)
TWGENDT 1.43% (n=5)
SWGENQT 0.57% (n=2)
TWGDNET 0.57% (n=2)
TWGVNET 0.29% (n=1)
RWGERET 0.29% (n=1)
PWRRNDT 0.29% (n=1)
AWGENET 0.29% (n=1)
TWGANET 0.29% (n=1)
MWGENET 0.29% (n=1)
NWGGNDT 0.29% (n=1)
NWGDNGT 0.29% (n=1)
SWGENES 0.29% (n=1)
SWGENDT 0.29% (n=1)
NWGENDT 0.29% (n=1)
DWGQNET 0.29% (n=1)
TWGANDT 0.29% (n=1)
SWGVNET 0.29% (n=1)
TWGENKT 0.29% (n=1)
SWGDNET 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 2c:

TWGENET 45.16% (n=28)
NWGENET 24.19% (n=15)
SWGENET 11.29% (n=7)
GWGENET 9.68% (n=6)
TWGANET 3.23% (n=2)
NWGESEK 1.61% (n=1)
TWGGNDT 1.61% (n=1)
TWEENET 1.61% (n=1)
TWGGNVK 1.61% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 3:

TWGANET 17.66% (n=487)
TWGENET 13.64% (n=376)
NWGENET 11.21% (n=309)
NWGANET 7.83% (n=216)
TWGENKT 6.89% (n=190)
NFGENET 4.75% (n=131)
TWGENES 3.48% (n=96)
NWGENES 3.30% (n=91)
NFGANET 3.12% (n=86)
NWGANES 2.36% (n=65)
TWGANKT 1.60% (n=44)
NWGENKS 1.41% (n=39)
SWGENET 1.41% (n=39)
TWGENDT 1.23% (n=34)
DWGENET 1.20% (n=33)
NWGANVT 0.94% (n=26)
NFGANES 0.94% (n=26)
TFGENET 0.83% (n=23)
SFGENET 0.65% (n=18)
NWGENKT 0.65% (n=18)
TWGGNET 0.62% (n=17)
AWGENET 0.62% (n=17)
TWGANES 0.54% (n=15)
SWGANET 0.51% (n=14)
TWGTNET 0.47% (n=13)
SWGANES 0.47% (n=13)
TWGGNKT 0.40% (n=11)
NFGENKT 0.40% (n=11)
TWGENAT 0.40% (n=11)
NWGGNET 0.33% (n=9)
NWGGNKT 0.33% (n=9)
TWGANDT 0.25% (n=7)
YWGENKT 0.25% (n=7)
NWGENAT 0.22% (n=6)
TWGENVT 0.18% (n=5)
NWGANKT 0.15% (n=4)
GWGANES 0.15% (n=4)
RWGENET 0.15% (n=4)
NWGVNET 0.15% (n=4)
NFGDNET 0.15% (n=4)
TFGANET 0.15% (n=4)
SFGENES 0.15% (n=4)
TWGGNAT 0.11% (n=3)
TWGENEA 0.11% (n=3)
RLGENET 0.11% (n=3)
TWGEKET 0.11% (n=3)
KWGENET 0.11% (n=3)
NWGENDT 0.11% (n=3)
SWGAKES 0.11% (n=3)
TWGENQT 0.11% (n=3)
GWGENET 0.11% (n=3)
TWGANKS 0.11% (n=3)
NFGGNES 0.11% (n=3)
NFGENES 0.11% (n=3)
NFGENDT 0.11% (n=3)
TWGENEK 0.07% (n=2)
NWGGDET 0.07% (n=2)
TWGGNES 0.07% (n=2)
YWGENET 0.07% (n=2)
FWGANES 0.07% (n=2)
SWGANKS 0.07% (n=2)
TWGGNVT 0.07% (n=2)
TRGENET 0.07% (n=2)
NWGANEA 0.07% (n=2)
TWGVNET 0.07% (n=2)
TWGDNES 0.07% (n=2)
NWGENVT 0.07% (n=2)
SWGENES 0.07% (n=2)
TFGANES 0.07% (n=2)
NWGGNDT 0.07% (n=2)
TWGETEK 0.07% (n=2)
NWGTNET 0.07% (n=2)
RWGENQS 0.07% (n=2)
NWGGNAT 0.07% (n=2)
TWGANVT 0.07% (n=2)
TWGDNKT 0.07% (n=2)
TWGTNVT 0.07% (n=2)
TWGMNET 0.07% (n=2)
EWGENET 0.07% (n=2)
NWGENQT 0.07% (n=2)
TWGANQT 0.07% (n=2)
QWGENET 0.07% (n=2)
SWGENKT 0.07% (n=2)
NWGDNET 0.07% (n=2)
AWGANET 0.07% (n=2)
NWGANVS 0.07% (n=2)
SFGANET 0.07% (n=2)
NFGVNET 0.07% (n=2)
NFGGNET 0.07% (n=2)
TFGEKET 0.07% (n=2)
RFGENET 0.07% (n=2)
TWGENAS 0.04% (n=1)
SFGTNET 0.04% (n=1)
TWGENVR 0.04% (n=1)
TWDANET 0.04% (n=1)
NWGADET 0.04% (n=1)
GWGGNKS 0.04% (n=1)
TWGANTS 0.04% (n=1)
NWGADVT 0.04% (n=1)
NWSANVT 0.04% (n=1)
TWGEDGT 0.04% (n=1)
DWGENEA 0.04% (n=1)
DWSENET 0.04% (n=1)
CWGENKS 0.04% (n=1)
SWGASES 0.04% (n=1)
NWGESES 0.04% (n=1)
PWGANKT 0.04% (n=1)
NGGGDET 0.04% (n=1)
SWGENEK 0.04% (n=1)
TWSENET 0.04% (n=1)
SWSENET 0.04% (n=1)
TLSENET 0.04% (n=1)
TLGENET 0.04% (n=1)
TKSSNET 0.04% (n=1)
CSNDNES 0.04% (n=1)
NRGANET 0.04% (n=1)
NWGANGT 0.04% (n=1)
DWGENES 0.04% (n=1)
NWGSNDT 0.04% (n=1)
DWGANKS 0.04% (n=1)
NWGMNET 0.04% (n=1)
SWGEKET 0.04% (n=1)
NWGENEA 0.04% (n=1)
NWGDNKT 0.04% (n=1)
SWGAEES 0.04% (n=1)
NWGRNES 0.04% (n=1)
TWGGNDT 0.04% (n=1)
GWGENES 0.04% (n=1)
NWGQWL* 0.04% (n=1)
QW-E-L* 0.04% (n=1)
TGGANES 0.04% (n=1)
TWGANKA 0.04% (n=1)
AWGANKT 0.04% (n=1)
TWGTNAT 0.04% (n=1)
DWGANES 0.04% (n=1)
DWGGKET 0.04% (n=1)
DWGANAS 0.04% (n=1)
NWGANDS 0.04% (n=1)
TWGENTT 0.04% (n=1)
NWGANDA 0.04% (n=1)
KWGEGEK 0.04% (n=1)
SWGENQT 0.04% (n=1)
NFGANKT 0.04% (n=1)
SWGANQT 0.04% (n=1)
TWGEDKS 0.04% (n=1)
KWGENKT 0.04% (n=1)
EWGENQT 0.04% (n=1)
TWGEQER 0.04% (n=1)
TWGENKS 0.04% (n=1)
NWGANAT 0.04% (n=1)
NWGQNDS 0.04% (n=1)
TYGTNKT 0.04% (n=1)
TWGANNT 0.04% (n=1)
TWGGNQT 0.04% (n=1)
TFGGNKT 0.04% (n=1)
NFGENQT 0.04% (n=1)
KWGANET 0.04% (n=1)
TWGANAT 0.04% (n=1)
NWGQNQT 0.04% (n=1)
TWGENDA 0.04% (n=1)
RWGANET 0.04% (n=1)
DWGANET 0.04% (n=1)
SWGVNET 0.04% (n=1)
TFGENQT 0.04% (n=1)
QWGANKT 0.04% (n=1)
QWGANET 0.04% (n=1)
TWGANTT 0.04% (n=1)
RFGANES 0.04% (n=1)
TWGESAT 0.04% (n=1)
NWGASPA 0.04% (n=1)
SWGGNKT 0.04% (n=1)
RFGVNES 0.04% (n=1)
NFGENEA 0.04% (n=1)
KFGENES 0.04% (n=1)
TFGENES 0.04% (n=1)
KFGENET 0.04% (n=1)
NFGEDET 0.04% (n=1)
NFGGNQT 0.04% (n=1)
NFGENKA 0.04% (n=1)
NFGENEK 0.04% (n=1)
AFGENET 0.04% (n=1)
NFGENTT 0.04% (n=1)
SFGANKT 0.04% (n=1)
SFGEKET 0.04% (n=1)
DFGENET 0.04% (n=1)
AFGANET 0.04% (n=1)
GFGENET 0.04% (n=1)
TFGGNES 0.04% (n=1)
NFGENKM 0.04% (n=1)
SFGANES 0.04% (n=1)
GFGANES 0.04% (n=1)
NFGSNDT 0.04% (n=1)
TFGGNDT 0.04% (n=1)
TFGGNDS 0.04% (n=1)
SFGDNVT 0.04% (n=1)
TFGENDT 0.04% (n=1)
TFGENVT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 3a:

TWGANET 20.07% (n=473)
TWGENET 15.91% (n=375)
NWGENET 13.11% (n=309)
NWGANET 9.16% (n=216)
TWGENKT 8.06% (n=190)
TWGENES 4.03% (n=95)
NWGENES 3.82% (n=90)
NWGANES 2.76% (n=65)
NWGENKS 1.65% (n=39)
SWGENET 1.61% (n=38)
TWGENDT 1.44% (n=34)
DWGENET 1.40% (n=33)
NWGANVT 1.10% (n=26)
TWGANKT 0.76% (n=18)
NWGENKT 0.76% (n=18)
TWGGNET 0.72% (n=17)
AWGENET 0.72% (n=17)
SWGANET 0.59% (n=14)
TWGTNET 0.55% (n=13)
SWGANES 0.55% (n=13)
TWGANES 0.55% (n=13)
TWGGNKT 0.47% (n=11)
TWGENAT 0.47% (n=11)
NWGGNET 0.38% (n=9)
NWGGNKT 0.38% (n=9)
TWGANDT 0.30% (n=7)
YWGENKT 0.30% (n=7)
NWGENAT 0.25% (n=6)
TWGENVT 0.21% (n=5)
NWGANKT 0.17% (n=4)
GWGANES 0.17% (n=4)
RWGENET 0.17% (n=4)
TWGGNAT 0.13% (n=3)
TWGENEA 0.13% (n=3)
RLGENET 0.13% (n=3)
TWGEKET 0.13% (n=3)
KWGENET 0.13% (n=3)
NWGENDT 0.13% (n=3)
SWGAKES 0.13% (n=3)
TWGENQT 0.13% (n=3)
GWGENET 0.13% (n=3)
NWGVNET 0.13% (n=3)
TWGANKS 0.13% (n=3)
TWGENEK 0.08% (n=2)
NWGGDET 0.08% (n=2)
TWGGNES 0.08% (n=2)
YWGENET 0.08% (n=2)
FWGANES 0.08% (n=2)
SWGANKS 0.08% (n=2)
TWGGNVT 0.08% (n=2)
TRGENET 0.08% (n=2)
NWGANEA 0.08% (n=2)
TWGVNET 0.08% (n=2)
TWGDNES 0.08% (n=2)
NWGENVT 0.08% (n=2)
SWGENES 0.08% (n=2)
NWGGNDT 0.08% (n=2)
TWGETEK 0.08% (n=2)
NWGTNET 0.08% (n=2)
RWGENQS 0.08% (n=2)
NWGGNAT 0.08% (n=2)
TWGANVT 0.08% (n=2)
TWGDNKT 0.08% (n=2)
TWGTNVT 0.08% (n=2)
TWGMNET 0.08% (n=2)
EWGENET 0.08% (n=2)
NWGENQT 0.08% (n=2)
TWGANQT 0.08% (n=2)
QWGENET 0.08% (n=2)
SWGENKT 0.08% (n=2)
NWGDNET 0.08% (n=2)
AWGANET 0.08% (n=2)
NWGANVS 0.08% (n=2)
TWGENAS 0.04% (n=1)
SFGTNET 0.04% (n=1)
TWGENVR 0.04% (n=1)
TWDANET 0.04% (n=1)
NWGADET 0.04% (n=1)
GWGGNKS 0.04% (n=1)
SFGENET 0.04% (n=1)
TWGANTS 0.04% (n=1)
NWGADVT 0.04% (n=1)
NWSANVT 0.04% (n=1)
TWGEDGT 0.04% (n=1)
DWGENEA 0.04% (n=1)
DWSENET 0.04% (n=1)
CWGENKS 0.04% (n=1)
NFGENKT 0.04% (n=1)
SWGASES 0.04% (n=1)
NWGESES 0.04% (n=1)
PWGANKT 0.04% (n=1)
NGGGDET 0.04% (n=1)
SWGENEK 0.04% (n=1)
TWSENET 0.04% (n=1)
SWSENET 0.04% (n=1)
TLSENET 0.04% (n=1)
TLGENET 0.04% (n=1)
TKSSNET 0.04% (n=1)
CSNDNES 0.04% (n=1)
NRGANET 0.04% (n=1)
NWGANGT 0.04% (n=1)
DWGENES 0.04% (n=1)
NWGSNDT 0.04% (n=1)
DWGANKS 0.04% (n=1)
TFGANES 0.04% (n=1)
NWGMNET 0.04% (n=1)
SWGEKET 0.04% (n=1)
NWGENEA 0.04% (n=1)
NWGDNKT 0.04% (n=1)
SWGAEES 0.04% (n=1)
NWGRNES 0.04% (n=1)
TWGGNDT 0.04% (n=1)
GWGENES 0.04% (n=1)
NWGQWL* 0.04% (n=1)
QW-E-L* 0.04% (n=1)
TGGANES 0.04% (n=1)
TWGTNAT 0.04% (n=1)
DWGANES 0.04% (n=1)
DWGGKET 0.04% (n=1)
DWGANAS 0.04% (n=1)
NWGANDS 0.04% (n=1)
TWGENTT 0.04% (n=1)
NWGANDA 0.04% (n=1)
KWGEGEK 0.04% (n=1)
SWGENQT 0.04% (n=1)
NFGANKT 0.04% (n=1)
SWGANQT 0.04% (n=1)
TWGEDKS 0.04% (n=1)
KWGENKT 0.04% (n=1)
EWGENQT 0.04% (n=1)
TWGEQER 0.04% (n=1)
TWGENKS 0.04% (n=1)
NWGANAT 0.04% (n=1)
NWGQNDS 0.04% (n=1)
TYGTNKT 0.04% (n=1)
TWGANNT 0.04% (n=1)
TWGGNQT 0.04% (n=1)
TFGGNKT 0.04% (n=1)
NFGENQT 0.04% (n=1)
KWGANET 0.04% (n=1)
TWGANAT 0.04% (n=1)
NWGQNQT 0.04% (n=1)
TWGENDA 0.04% (n=1)
RWGANET 0.04% (n=1)
DWGANET 0.04% (n=1)
SWGVNET 0.04% (n=1)
TFGENQT 0.04% (n=1)
QWGANKT 0.04% (n=1)
QWGANET 0.04% (n=1)
TWGANTT 0.04% (n=1)
RFGANES 0.04% (n=1)
TWGESAT 0.04% (n=1)
NWGASPA 0.04% (n=1)
SWGGNKT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 3b:

NFGENET 38.53% (n=131)
NFGANET 25.29% (n=86)
NFGANES 7.65% (n=26)
TFGENET 5.29% (n=18)
SFGENET 5.00% (n=17)
NFGENKT 2.94% (n=10)
NFGDNET 1.18% (n=4)
TFGANET 1.18% (n=4)
SFGENES 1.18% (n=4)
NFGGNES 0.88% (n=3)
NFGENES 0.88% (n=3)
NFGENDT 0.88% (n=3)
SFGANET 0.59% (n=2)
NFGVNET 0.59% (n=2)
NFGGNET 0.59% (n=2)
TFGEKET 0.59% (n=2)
RFGVNES 0.29% (n=1)
NFGENEA 0.29% (n=1)
KFGENES 0.29% (n=1)
TFGENES 0.29% (n=1)
TFGANES 0.29% (n=1)
KFGENET 0.29% (n=1)
NFGEDET 0.29% (n=1)
NFGGNQT 0.29% (n=1)
NFGENKA 0.29% (n=1)
NFGENEK 0.29% (n=1)
AFGENET 0.29% (n=1)
NFGENTT 0.29% (n=1)
SFGANKT 0.29% (n=1)
SFGEKET 0.29% (n=1)
DFGENET 0.29% (n=1)
AFGANET 0.29% (n=1)
GFGENET 0.29% (n=1)
RFGENET 0.29% (n=1)
TFGGNES 0.29% (n=1)
NFGENKM 0.29% (n=1)
SFGANES 0.29% (n=1)
GFGANES 0.29% (n=1)
NFGSNDT 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 4:

TWGENES 47.64% (n=111)
TWGENET 16.31% (n=38)
TWGENDT 8.58% (n=20)
NWGENET 7.73% (n=18)
NWGENES 1.72% (n=4)
SWGENET 1.72% (n=4)
TWGGNET 1.29% (n=3)
NWGANET 1.29% (n=3)
TWGENVS 0.86% (n=2)
TWGANET 0.86% (n=2)
NWGENVT 0.86% (n=2)
GWGGNET 0.86% (n=2)
NWGVNET 0.86% (n=2)
NWGENKT 0.86% (n=2)
TWGANES 0.43% (n=1)
NWGGNET 0.43% (n=1)
TWGENAS 0.43% (n=1)
TLGGNET 0.43% (n=1)
TWGDNES 0.43% (n=1)
TWGENKT 0.43% (n=1)
SWGANET 0.43% (n=1)
NWGDNET 0.43% (n=1)
SWGDNET 0.43% (n=1)
AWGENET 0.43% (n=1)
GWGTGKD 0.43% (n=1)
SFGGNDT 0.43% (n=1)
NWGENAT 0.43% (n=1)
YWGGNDT 0.43% (n=1)
TWGANGT 0.43% (n=1)
DWGVNET 0.43% (n=1)
DWGGNET 0.43% (n=1)
TWGQNKT 0.43% (n=1)
NWGENDT 0.43% (n=1)
RWGENET 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 4a:

TWGENES 68.13% (n=109)
TWGENDT 12.50% (n=20)
TWGENET 10.00% (n=16)
NWGENES 2.50% (n=4)
NWGENET 2.50% (n=4)
TWGENVS 1.25% (n=2)
TWGANES 0.63% (n=1)
NWGGNET 0.63% (n=1)
TWGENAS 0.63% (n=1)
TLGGNET 0.63% (n=1)
TWGDNES 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 4d:

TWGENET 84.62% (n=11)
TWGGNET 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 5:

NWGSNET 42.11% (n=16)
NWGENET 18.42% (n=7)
TWGENET 10.53% (n=4)
NWGENDT 5.26% (n=2)
SWGENET 2.63% (n=1)
NWGSNDT 2.63% (n=1)
DWGSNES 2.63% (n=1)
SWGDNET 2.63% (n=1)
SWGANET 2.63% (n=1)
TWGTNET 2.63% (n=1)
SWGSNDT 2.63% (n=1)
NWGVNET 2.63% (n=1)
NWGSNVT 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 6:

TWGENET 37.24% (n=127)
TWGENES 11.14% (n=38)
NWGENET 4.99% (n=17)
NWGENVS 3.81% (n=13)
TWGANES 2.64% (n=9)
NWGENES 2.35% (n=8)
TWGDNET 1.76% (n=6)
NWGDNET 1.76% (n=6)
TWGENVS 1.76% (n=6)
NWGENMS 1.76% (n=6)
NWGENAS 1.76% (n=6)
SWGENES 1.47% (n=5)
NWGANVS 1.47% (n=5)
SWGENET 1.17% (n=4)
TWGANET 1.17% (n=4)
TWGDNES 1.17% (n=4)
TWGGNES 1.17% (n=4)
NWGENAT 0.88% (n=3)
NWGGNVS 0.88% (n=3)
NWGANES 0.88% (n=3)
TWGTNET 0.88% (n=3)
NWGANAS 0.88% (n=3)
TWGENVT 0.59% (n=2)
SWGVNES 0.59% (n=2)
AWGANET 0.59% (n=2)
AWGENET 0.59% (n=2)
NWGDNES 0.59% (n=2)
NWGDNVS 0.59% (n=2)
TWGANAT 0.59% (n=2)
TWGENWT 0.29% (n=1)
TWGQNET 0.29% (n=1)
SWGDNET 0.29% (n=1)
NWGENVT 0.29% (n=1)
HWGENET 0.29% (n=1)
NWGENDT 0.29% (n=1)
TWGKNET 0.29% (n=1)
TFGENET 0.29% (n=1)
SFGDNET 0.29% (n=1)
SFGDNES 0.29% (n=1)
EWGENAS 0.29% (n=1)
NWGVNES 0.29% (n=1)
QWGENQS 0.29% (n=1)
TWGENIT 0.29% (n=1)
GWGGNDS 0.29% (n=1)
DWGENVT 0.29% (n=1)
SWGGNET 0.29% (n=1)
TWGDNVS 0.29% (n=1)
NWGNNMS 0.29% (n=1)
NWGANET 0.29% (n=1)
NWGDNVT 0.29% (n=1)
NWGDNMS 0.29% (n=1)
SWGENVS 0.29% (n=1)
TWGENAS 0.29% (n=1)
NWGVNVS 0.29% (n=1)
PWGGNDS 0.29% (n=1)
GWGENET 0.29% (n=1)
RWGENET 0.29% (n=1)
TWGDNKT 0.29% (n=1)
TWGENMT 0.29% (n=1)
TWGANKT 0.29% (n=1)
TLGENES 0.29% (n=1)
AWGENKS 0.29% (n=1)
NWGANEG 0.29% (n=1)
TWGENDS 0.29% (n=1)
SWGANES 0.29% (n=1)
NWGGNET 0.29% (n=1)
TWGEHET 0.29% (n=1)
TWGVNET 0.29% (n=1)
NWGDNDT 0.29% (n=1)
NFGENES 0.29% (n=1)
NWGGNES 0.29% (n=1)
SWGENQS 0.29% (n=1)
TWGANKS 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Subtype 6a:

TWGENET 79.34% (n=96)
TWGDNET 4.96% (n=6)
NWGENET 4.13% (n=5)
NWGDNET 2.48% (n=3)
TWGENES 0.83% (n=1)
TWGENVT 0.83% (n=1)
TWGENWT 0.83% (n=1)
TWGQNET 0.83% (n=1)
SWGDNET 0.83% (n=1)
NWGENVT 0.83% (n=1)
SWGENET 0.83% (n=1)
HWGENET 0.83% (n=1)
NWGENDT 0.83% (n=1)
TWGKNET 0.83% (n=1)
TWGANET 0.83% (n=1)
---------------------------------------------------------------------------------------
Region 528-534 (antibodies: [H77.31] ), HCV Genotype 7:

TWGENES 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 414-418 (antibodies: [H77.39] ), HCV Genotype 1:

INTNG 62.90% (n=14460)
VNTNG 24.04% (n=5527)
INSNG 4.70% (n=1080)
VNSNG 1.71% (n=394)
IKTNG 0.86% (n=198)
VNANG 0.86% (n=197)
MNTNG 0.57% (n=132)
ISTNG 0.53% (n=121)
TNTNG 0.52% (n=119)
MNSNG 0.33% (n=75)
INANG 0.27% (n=63)
VSTNG 0.25% (n=58)
VNENG 0.23% (n=54)
INTNN 0.19% (n=44)
IHTNG 0.19% (n=43)
IKSNG 0.13% (n=29)
INTSG 0.12% (n=27)
VNASG 0.12% (n=27)
VKTNG 0.11% (n=25)
ANTNG 0.10% (n=23)
VNTSG 0.09% (n=21)
INTDG 0.07% (n=16)
IDTNG 0.06% (n=14)
INTRG 0.05% (n=12)
INTND 0.04% (n=10)
INSSG 0.04% (n=10)
IYSNG 0.04% (n=10)
INPNG 0.04% (n=9)
INSDG 0.04% (n=9)
VNRNG 0.04% (n=9)
INRNG 0.04% (n=9)
INTNS 0.03% (n=8)
VNTDG 0.03% (n=8)
VYTNG 0.03% (n=8)
VNNNG 0.03% (n=8)
VNING 0.03% (n=6)
LNTNG 0.03% (n=6)
VHTNG 0.03% (n=6)
VDTNG 0.02% (n=5)
VNSSG 0.02% (n=5)
VNTNS 0.02% (n=4)
VNKNG 0.02% (n=4)
INNNG 0.02% (n=4)
IRTNG 0.02% (n=4)
INKNG 0.02% (n=4)
METNG 0.02% (n=4)
INTEG 0.01% (n=3)
IYTNG 0.01% (n=3)
VTTNG 0.01% (n=3)
VHANG 0.01% (n=3)
INTTG 0.01% (n=3)
TNSNG 0.01% (n=3)
INSN- 0.01% (n=3)
INTHG 0.01% (n=2)
VNTKG 0.01% (n=2)
VNADG 0.01% (n=2)
IHKNG 0.01% (n=2)
INING 0.01% (n=2)
VATNG 0.01% (n=2)
INTNR 0.01% (n=2)
INT-- 0.01% (n=2)
VNTND 0.01% (n=2)
MHTNG 0.01% (n=2)
I---- 0.01% (n=2)
TKSNG 0.00% (n=1)
MKTND 0.00% (n=1)
IQTNG 0.00% (n=1)
IKTDG 0.00% (n=1)
ISSNG 0.00% (n=1)
INFNG 0.00% (n=1)
VSENG 0.00% (n=1)
VNEND 0.00% (n=1)
INTGG 0.00% (n=1)
VYSNG 0.00% (n=1)
VDTSG 0.00% (n=1)
MYTNG 0.00% (n=1)
VNSHG 0.00% (n=1)
VNKDG 0.00% (n=1)
INASG 0.00% (n=1)
VKAND 0.00% (n=1)
VNVND 0.00% (n=1)
VNTNR 0.00% (n=1)
ANTSG 0.00% (n=1)
TSTNG 0.00% (n=1)
IGTNG 0.00% (n=1)
INTIG 0.00% (n=1)
INSIG 0.00% (n=1)
INTKG 0.00% (n=1)
INSND 0.00% (n=1)
MSTNG 0.00% (n=1)
INTNV 0.00% (n=1)
VKTEG 0.00% (n=1)
CNTNA 0.00% (n=1)
YNTNG 0.00% (n=1)
VN--- 0.00% (n=1)
VH--- 0.00% (n=1)
VHSNG 0.00% (n=1)
VRANG 0.00% (n=1)
MKTNG 0.00% (n=1)
V---- 0.00% (n=1)
MNTSG 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 1a:

INTNG 63.81% (n=8715)
VNTNG 18.03% (n=2463)
INSNG 7.13% (n=974)
VNSNG 1.87% (n=256)
VNANG 1.43% (n=195)
IKTNG 1.38% (n=189)
TNTNG 0.86% (n=118)
MNTNG 0.78% (n=107)
ISTNG 0.64% (n=87)
MNSNG 0.55% (n=75)
INANG 0.41% (n=56)
VNENG 0.40% (n=54)
VSTNG 0.34% (n=46)
INTNN 0.32% (n=44)
IKSNG 0.21% (n=28)
ANTNG 0.15% (n=20)
INTSG 0.14% (n=19)
INTRG 0.09% (n=12)
INTDG 0.08% (n=11)
IDTNG 0.07% (n=10)
INSSG 0.07% (n=10)
IYSNG 0.07% (n=10)
INSDG 0.07% (n=9)
INRNG 0.07% (n=9)
VNRNG 0.06% (n=8)
INPNG 0.05% (n=7)
INTND 0.05% (n=7)
VNTSG 0.05% (n=7)
VYTNG 0.04% (n=6)
VDTNG 0.04% (n=5)
VNTDG 0.04% (n=5)
VNNNG 0.04% (n=5)
INTNS 0.03% (n=4)
VNSSG 0.03% (n=4)
VNKNG 0.03% (n=4)
INNNG 0.03% (n=4)
IHTNG 0.03% (n=4)
INKNG 0.03% (n=4)
VNING 0.02% (n=3)
INTEG 0.02% (n=3)
INTTG 0.02% (n=3)
TNSNG 0.02% (n=3)
INSN- 0.02% (n=3)
VKTNG 0.02% (n=3)
IRTNG 0.02% (n=3)
INTHG 0.01% (n=2)
VNASG 0.01% (n=2)
LNTNG 0.01% (n=2)
VNADG 0.01% (n=2)
IHKNG 0.01% (n=2)
VHTNG 0.01% (n=2)
VATNG 0.01% (n=2)
VNTNS 0.01% (n=1)
TKSNG 0.01% (n=1)
MKTND 0.01% (n=1)
IQTNG 0.01% (n=1)
IKTDG 0.01% (n=1)
ISSNG 0.01% (n=1)
INFNG 0.01% (n=1)
IYTNG 0.01% (n=1)
VSENG 0.01% (n=1)
VNEND 0.01% (n=1)
VNTKG 0.01% (n=1)
VTTNG 0.01% (n=1)
INTGG 0.01% (n=1)
VYSNG 0.01% (n=1)
VDTSG 0.01% (n=1)
MYTNG 0.01% (n=1)
VHANG 0.01% (n=1)
VNSHG 0.01% (n=1)
VNKDG 0.01% (n=1)
INASG 0.01% (n=1)
VKAND 0.01% (n=1)
VNVND 0.01% (n=1)
VNTNR 0.01% (n=1)
ANTSG 0.01% (n=1)
TSTNG 0.01% (n=1)
IGTNG 0.01% (n=1)
INTIG 0.01% (n=1)
INSIG 0.01% (n=1)
INTKG 0.01% (n=1)
INSND 0.01% (n=1)
INING 0.01% (n=1)
MSTNG 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 1b:

INTNG 61.61% (n=5719)
VNTNG 32.94% (n=3058)
VNSNG 1.45% (n=135)
INSNG 1.09% (n=101)
IHTNG 0.40% (n=37)
ISTNG 0.32% (n=30)
MNTNG 0.27% (n=25)
VNASG 0.27% (n=25)
VKTNG 0.24% (n=22)
VNTSG 0.15% (n=14)
VSTNG 0.13% (n=12)
IKTNG 0.10% (n=9)
INTSG 0.09% (n=8)
INANG 0.08% (n=7)
INTDG 0.05% (n=5)
LNTNG 0.04% (n=4)
VHTNG 0.04% (n=4)
INTNS 0.04% (n=4)
METNG 0.04% (n=4)
IDTNG 0.04% (n=4)
VNTNS 0.03% (n=3)
VNNNG 0.03% (n=3)
VNING 0.03% (n=3)
VNTDG 0.03% (n=3)
ANTNG 0.03% (n=3)
INTND 0.03% (n=3)
IYTNG 0.02% (n=2)
INTNR 0.02% (n=2)
INPNG 0.02% (n=2)
INT-- 0.02% (n=2)
VNTND 0.02% (n=2)
VYTNG 0.02% (n=2)
VTTNG 0.02% (n=2)
VHANG 0.02% (n=2)
MHTNG 0.02% (n=2)
VNANG 0.02% (n=2)
INTNV 0.01% (n=1)
VKTEG 0.01% (n=1)
CNTNA 0.01% (n=1)
YNTNG 0.01% (n=1)
VN--- 0.01% (n=1)
VH--- 0.01% (n=1)
VNRNG 0.01% (n=1)
VHSNG 0.01% (n=1)
IRTNG 0.01% (n=1)
VRANG 0.01% (n=1)
VNSSG 0.01% (n=1)
TNTNG 0.01% (n=1)
MKTNG 0.01% (n=1)
IKSNG 0.01% (n=1)
VNTKG 0.01% (n=1)
INING 0.01% (n=1)
V---- 0.01% (n=1)
I---- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 2:

INTNG 45.31% (n=614)
INSNG 21.40% (n=290)
IHTNG 8.34% (n=113)
IHSNG 6.35% (n=86)
IHNNG 5.90% (n=80)
ISTNG 3.39% (n=46)
VNTNG 2.73% (n=37)
IKTNG 1.11% (n=15)
VNSNG 0.59% (n=8)
IYTNG 0.52% (n=7)
INANG 0.30% (n=4)
IN--- 0.30% (n=4)
INNNG 0.22% (n=3)
VNANG 0.22% (n=3)
IRNNG 0.22% (n=3)
I---- 0.22% (n=3)
INSSG 0.15% (n=2)
IDTNG 0.15% (n=2)
VKTNG 0.15% (n=2)
VHTNG 0.07% (n=1)
TNSNG 0.07% (n=1)
IYSNG 0.07% (n=1)
VNDNG 0.07% (n=1)
IDTKG 0.07% (n=1)
VSANG 0.07% (n=1)
INTSG 0.07% (n=1)
VNTSG 0.07% (n=1)
IKSNG 0.07% (n=1)
MNTSG 0.07% (n=1)
NHSNG 0.07% (n=1)
INKNG 0.07% (n=1)
ISSNG 0.07% (n=1)
IKNNG 0.07% (n=1)
VNNNG 0.07% (n=1)
NHTNG 0.07% (n=1)
INTNV 0.07% (n=1)
INTNS 0.07% (n=1)
VSTNG 0.07% (n=1)
INTTG 0.07% (n=1)
INTDG 0.07% (n=1)
IPMAA 0.07% (n=1)
IKENG 0.07% (n=1)
MNTNG 0.07% (n=1)
IYNNG 0.07% (n=1)
THTNG 0.07% (n=1)
IRTNG 0.07% (n=1)
INDNG 0.07% (n=1)
INSDG 0.07% (n=1)
IRSNG 0.07% (n=1)
V---- 0.07% (n=1)
INPNG 0.07% (n=1)
MKTNG 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 2a:

INTNG 50.69% (n=146)
INSNG 39.58% (n=114)
VNTNG 3.13% (n=9)
INNNG 0.69% (n=2)
INSSG 0.69% (n=2)
VNSNG 0.69% (n=2)
TNSNG 0.35% (n=1)
IKTNG 0.35% (n=1)
IYSNG 0.35% (n=1)
VNDNG 0.35% (n=1)
IDTKG 0.35% (n=1)
IDTNG 0.35% (n=1)
VSANG 0.35% (n=1)
VNANG 0.35% (n=1)
ISTNG 0.35% (n=1)
INTSG 0.35% (n=1)
VNTSG 0.35% (n=1)
IKSNG 0.35% (n=1)
MNTSG 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 2b:

INTNG 72.89% (n=336)
ISTNG 9.54% (n=44)
VNTNG 4.56% (n=21)
IKTNG 2.82% (n=13)
IHTNG 2.82% (n=13)
INSNG 2.17% (n=10)
VNSNG 1.08% (n=5)
INANG 0.65% (n=3)
NHSNG 0.22% (n=1)
INKNG 0.22% (n=1)
INNNG 0.22% (n=1)
ISSNG 0.22% (n=1)
IKNNG 0.22% (n=1)
VNNNG 0.22% (n=1)
VKTNG 0.22% (n=1)
NHTNG 0.22% (n=1)
INTNV 0.22% (n=1)
INTNS 0.22% (n=1)
VSTNG 0.22% (n=1)
INTTG 0.22% (n=1)
INTDG 0.22% (n=1)
IYTNG 0.22% (n=1)
IKENG 0.22% (n=1)
MNTNG 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 2c:

INSNG 34.36% (n=156)
IHTNG 21.59% (n=98)
IHSNG 18.50% (n=84)
IHNNG 17.62% (n=80)
INTNG 3.96% (n=18)
IYTNG 0.88% (n=4)
IRNNG 0.66% (n=3)
VNTNG 0.44% (n=2)
IN--- 0.22% (n=1)
IYNNG 0.22% (n=1)
THTNG 0.22% (n=1)
VKTNG 0.22% (n=1)
VNANG 0.22% (n=1)
IRTNG 0.22% (n=1)
ISTNG 0.22% (n=1)
INDNG 0.22% (n=1)
INSDG 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 3:

VNTNG 44.62% (n=1751)
INTNG 25.79% (n=1012)
VNSNG 12.00% (n=471)
VRTNG 8.03% (n=315)
IYTNG 2.62% (n=103)
INSNG 2.42% (n=95)
IETQG 0.61% (n=24)
VNANG 0.48% (n=19)
-NTNG 0.36% (n=14)
VYTNG 0.28% (n=11)
IETNG 0.23% (n=9)
VHTNG 0.20% (n=8)
VN--- 0.18% (n=7)
VSTNG 0.13% (n=5)
V---- 0.13% (n=5)
VKTNG 0.13% (n=5)
INANG 0.10% (n=4)
IHTNG 0.10% (n=4)
IN--- 0.10% (n=4)
VNSSG 0.08% (n=3)
VDTNG 0.08% (n=3)
VKSNG 0.08% (n=3)
VNTSG 0.08% (n=3)
VETNG 0.08% (n=3)
VHSNG 0.08% (n=3)
VSSNG 0.08% (n=3)
VNTND 0.05% (n=2)
IKTNG 0.05% (n=2)
IDTNG 0.05% (n=2)
INTHG 0.05% (n=2)
VNDSG 0.05% (n=2)
MNTNG 0.05% (n=2)
VHNNG 0.03% (n=1)
ISSNG 0.03% (n=1)
INTND 0.03% (n=1)
VNING 0.03% (n=1)
INTYG 0.03% (n=1)
VNTYG 0.03% (n=1)
ICTNA 0.03% (n=1)
TNTNG 0.03% (n=1)
VETKG 0.03% (n=1)
MKTGD 0.03% (n=1)
ISTNG 0.03% (n=1)
IQTNG 0.03% (n=1)
IKTNN 0.03% (n=1)
INSSG 0.03% (n=1)
INDNG 0.03% (n=1)
VNKNG 0.03% (n=1)
INTDG 0.03% (n=1)
VNNNG 0.03% (n=1)
VNTDG 0.03% (n=1)
VESNG 0.03% (n=1)
MNSNG 0.03% (n=1)
MESNG 0.03% (n=1)
TNSNG 0.03% (n=1)
VDSNG 0.03% (n=1)
VYSNG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 3a:

VNTNG 50.76% (n=1666)
INTNG 30.56% (n=1003)
VRTNG 9.60% (n=315)
IYTNG 3.11% (n=102)
VNSNG 0.98% (n=32)
IETQG 0.73% (n=24)
VNANG 0.58% (n=19)
INSNG 0.58% (n=19)
-NTNG 0.43% (n=14)
VYTNG 0.30% (n=10)
VHTNG 0.24% (n=8)
IETNG 0.24% (n=8)
VSTNG 0.15% (n=5)
VKTNG 0.15% (n=5)
INANG 0.12% (n=4)
IHTNG 0.12% (n=4)
VDTNG 0.09% (n=3)
VNTSG 0.09% (n=3)
VETNG 0.09% (n=3)
VNTND 0.06% (n=2)
IKTNG 0.06% (n=2)
VKSNG 0.06% (n=2)
IDTNG 0.06% (n=2)
INTHG 0.06% (n=2)
V---- 0.06% (n=2)
VNDSG 0.06% (n=2)
VHNNG 0.03% (n=1)
VNSSG 0.03% (n=1)
ISSNG 0.03% (n=1)
INTND 0.03% (n=1)
VNING 0.03% (n=1)
INTYG 0.03% (n=1)
VNTYG 0.03% (n=1)
ICTNA 0.03% (n=1)
TNTNG 0.03% (n=1)
VETKG 0.03% (n=1)
MKTGD 0.03% (n=1)
ISTNG 0.03% (n=1)
IQTNG 0.03% (n=1)
IKTNN 0.03% (n=1)
INSSG 0.03% (n=1)
INDNG 0.03% (n=1)
VNKNG 0.03% (n=1)
INTDG 0.03% (n=1)
VNNNG 0.03% (n=1)
VNTDG 0.03% (n=1)
MNTNG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 3b:

VNSNG 84.03% (n=342)
VNTNG 11.55% (n=47)
VN--- 0.98% (n=4)
VHSNG 0.74% (n=3)
VSSNG 0.49% (n=2)
VNSSG 0.49% (n=2)
VESNG 0.25% (n=1)
IETNG 0.25% (n=1)
VYTNG 0.25% (n=1)
MNTNG 0.25% (n=1)
MNSNG 0.25% (n=1)
MESNG 0.25% (n=1)
TNSNG 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 4:

INTNG 78.23% (n=600)
INSNG 8.87% (n=68)
VNKNG 3.78% (n=29)
IHTNG 2.22% (n=17)
VNTNG 1.69% (n=13)
VNSNG 1.43% (n=11)
ISTNG 1.43% (n=11)
IDTNG 0.65% (n=5)
IYTNG 0.39% (n=3)
INTGG 0.39% (n=3)
TNTNG 0.39% (n=3)
VKTNG 0.26% (n=2)
INS-- 0.13% (n=1)
INTNE 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 4a:

INTNG 40.63% (n=65)
INSNG 38.13% (n=61)
VNKNG 18.13% (n=29)
VNSNG 1.88% (n=3)
INS-- 0.63% (n=1)
VNTNG 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 4d:

INTNG 92.25% (n=500)
IHTNG 2.58% (n=14)
ISTNG 2.03% (n=11)
IDTNG 0.74% (n=4)
INTGG 0.55% (n=3)
TNTNG 0.55% (n=3)
IYTNG 0.37% (n=2)
VKTNG 0.37% (n=2)
INTNE 0.18% (n=1)
VNTNG 0.18% (n=1)
INSNG 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 5:

INTNG 68.66% (n=92)
VNTNG 7.46% (n=10)
INSNG 4.48% (n=6)
IHSNG 2.99% (n=4)
ISTNG 2.24% (n=3)
INNQG 1.49% (n=2)
IRTNG 1.49% (n=2)
VNSNG 1.49% (n=2)
IHTNG 1.49% (n=2)
INTSG 0.75% (n=1)
MKTNG 0.75% (n=1)
VHTNG 0.75% (n=1)
MKTGE 0.75% (n=1)
VKTNG 0.75% (n=1)
HNTNG 0.75% (n=1)
MNSNG 0.75% (n=1)
VRSNG 0.75% (n=1)
IKTNG 0.75% (n=1)
METNG 0.75% (n=1)
IQNGS 0.75% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 6:

INTNG 54.41% (n=327)
VNTNG 16.31% (n=98)
INSNG 8.82% (n=53)
VNSNG 8.32% (n=50)
IN--- 3.33% (n=20)
MNTNG 2.16% (n=13)
VN--- 1.50% (n=9)
IHTNG 0.67% (n=4)
VHTNG 0.50% (n=3)
VKTNG 0.50% (n=3)
IKTNG 0.50% (n=3)
IYTNG 0.50% (n=3)
IKNGS 0.17% (n=1)
IKSNG 0.17% (n=1)
INTKG 0.17% (n=1)
VRTNG 0.17% (n=1)
ICTNG 0.17% (n=1)
VNNNG 0.17% (n=1)
VNTSG 0.17% (n=1)
VHANG 0.17% (n=1)
IYSNG 0.17% (n=1)
VNKNG 0.17% (n=1)
IK--- 0.17% (n=1)
VKING 0.17% (n=1)
INTDG 0.17% (n=1)
IETNG 0.17% (n=1)
ISTNG 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Subtype 6a:

INTNG 67.38% (n=221)
VNTNG 20.73% (n=68)
INSNG 4.57% (n=15)
IN--- 1.22% (n=4)
VNSNG 0.91% (n=3)
VHTNG 0.61% (n=2)
VKTNG 0.61% (n=2)
IKNGS 0.30% (n=1)
IKSNG 0.30% (n=1)
INTKG 0.30% (n=1)
VRTNG 0.30% (n=1)
ICTNG 0.30% (n=1)
IHTNG 0.30% (n=1)
VNNNG 0.30% (n=1)
VNTSG 0.30% (n=1)
VHANG 0.30% (n=1)
IYSNG 0.30% (n=1)
IKTNG 0.30% (n=1)
VNKNG 0.30% (n=1)
IYTNG 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 414-418 (antibodies: [H77.39] ), HCV Genotype 7:

INTNG 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 424-429 (antibodies: [HC-1] ), HCV Genotype 1:

RTALNC 76.56% (n=17596)
STALNC 21.32% (n=4900)
RTSLNC 0.53% (n=121)
RTALSC 0.39% (n=90)
RAALNC 0.14% (n=32)
STSLNC 0.11% (n=25)
RTALNR 0.09% (n=21)
RTALDC 0.07% (n=16)
RTAPNC 0.06% (n=13)
GTALNC 0.05% (n=11)
RTVLNC 0.04% (n=10)
RTASNC 0.04% (n=9)
STALNR 0.03% (n=7)
HTALNC 0.03% (n=7)
RTTLNC 0.03% (n=6)
RTALNY 0.03% (n=6)
RMALNC 0.03% (n=6)
RTALTC 0.02% (n=5)
RSALNC 0.02% (n=5)
CTALNC 0.02% (n=5)
STALSC 0.02% (n=5)
SAALNC 0.02% (n=4)
KTALNC 0.02% (n=4)
TTALNC 0.02% (n=4)
RTGLNC 0.01% (n=3)
RTAVNC 0.01% (n=3)
STALKC 0.01% (n=2)
PTALNC 0.01% (n=2)
SMALNC 0.01% (n=2)
RTALNW 0.01% (n=2)
RTARNC 0.01% (n=2)
QTALNC 0.01% (n=2)
NTALNC 0.01% (n=2)
STAPNC 0.01% (n=2)
RTALNG 0.01% (n=2)
RAALSC 0.01% (n=2)
RTALHC 0.01% (n=2)
LTALNC 0.01% (n=2)
RTALNF 0.01% (n=2)
RIALNC 0.01% (n=2)
RTAMNC 0.01% (n=2)
RTALKC 0.01% (n=2)
STALRC 0.01% (n=2)
STAFNC 0.00% (n=1)
STALIC 0.00% (n=1)
SSALNC 0.00% (n=1)
STAPPT 0.00% (n=1)
STALDC 0.00% (n=1)
RRALNC 0.00% (n=1)
STTLNC 0.00% (n=1)
STALTC 0.00% (n=1)
RKALNC 0.00% (n=1)
STALNS 0.00% (n=1)
STASNC 0.00% (n=1)
-TALNC 0.00% (n=1)
STVPNC 0.00% (n=1)
RTALIC 0.00% (n=1)
RTALN- 0.00% (n=1)
TTSLNC 0.00% (n=1)
RTAMSR 0.00% (n=1)
RTVLSC 0.00% (n=1)
HTALSC 0.00% (n=1)
RTALSR 0.00% (n=1)
RTAMSC 0.00% (n=1)
RTALGC 0.00% (n=1)
STVLNC 0.00% (n=1)
SIALNC 0.00% (n=1)
RTALAC 0.00% (n=1)
TGPPEL 0.00% (n=1)
RNALNC 0.00% (n=1)
RTPLNC 0.00% (n=1)
RTALYC 0.00% (n=1)
ETALNC 0.00% (n=1)
RTAFNC 0.00% (n=1)
RPALNC 0.00% (n=1)
WTALNC 0.00% (n=1)
RTAHNC 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 1a:

RTALNC 64.27% (n=8783)
STALNC 34.17% (n=4669)
RTALSC 0.41% (n=56)
RAALNC 0.15% (n=20)
RTASNC 0.07% (n=9)
STALNR 0.05% (n=7)
HTALNC 0.05% (n=7)
RMALNC 0.04% (n=6)
RTALTC 0.04% (n=5)
CTALNC 0.04% (n=5)
RTALDC 0.04% (n=5)
STALSC 0.04% (n=5)
SAALNC 0.03% (n=4)
RTALNR 0.03% (n=4)
RSALNC 0.03% (n=4)
TTALNC 0.03% (n=4)
RTAPNC 0.03% (n=4)
RTALNY 0.02% (n=3)
GTALNC 0.02% (n=3)
RTSLNC 0.02% (n=3)
RTVLNC 0.02% (n=3)
STALKC 0.01% (n=2)
RTGLNC 0.01% (n=2)
PTALNC 0.01% (n=2)
RTTLNC 0.01% (n=2)
SMALNC 0.01% (n=2)
KTALNC 0.01% (n=2)
RTARNC 0.01% (n=2)
QTALNC 0.01% (n=2)
NTALNC 0.01% (n=2)
RTALNG 0.01% (n=2)
RAALSC 0.01% (n=2)
RTALHC 0.01% (n=2)
LTALNC 0.01% (n=2)
RTALNF 0.01% (n=2)
STAFNC 0.01% (n=1)
STALIC 0.01% (n=1)
SSALNC 0.01% (n=1)
STAPPT 0.01% (n=1)
RTALNW 0.01% (n=1)
STALDC 0.01% (n=1)
RRALNC 0.01% (n=1)
STTLNC 0.01% (n=1)
STALTC 0.01% (n=1)
RKALNC 0.01% (n=1)
STALNS 0.01% (n=1)
STASNC 0.01% (n=1)
-TALNC 0.01% (n=1)
STVPNC 0.01% (n=1)
STAPNC 0.01% (n=1)
RTALIC 0.01% (n=1)
RTALN- 0.01% (n=1)
TTSLNC 0.01% (n=1)
RTAMSR 0.01% (n=1)
RTVLSC 0.01% (n=1)
HTALSC 0.01% (n=1)
RTALSR 0.01% (n=1)
RTAMSC 0.01% (n=1)
RTALGC 0.01% (n=1)
STVLNC 0.01% (n=1)
SIALNC 0.01% (n=1)
RIALNC 0.01% (n=1)
RTALAC 0.01% (n=1)
RTAVNC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 1b:

RTALNC 94.65% (n=8773)
STALNC 2.46% (n=228)
RTSLNC 1.25% (n=116)
RTALSC 0.35% (n=32)
STSLNC 0.27% (n=25)
RTALNR 0.18% (n=17)
RAALNC 0.13% (n=12)
RTALDC 0.12% (n=11)
RTAPNC 0.10% (n=9)
GTALNC 0.09% (n=8)
RTVLNC 0.08% (n=7)
RTTLNC 0.04% (n=4)
RTALNY 0.03% (n=3)
RTAMNC 0.02% (n=2)
RTALKC 0.02% (n=2)
STALRC 0.02% (n=2)
RTAVNC 0.02% (n=2)
KTALNC 0.02% (n=2)
RTALNW 0.01% (n=1)
RSALNC 0.01% (n=1)
TGPPEL 0.01% (n=1)
RNALNC 0.01% (n=1)
RTPLNC 0.01% (n=1)
RIALNC 0.01% (n=1)
RTGLNC 0.01% (n=1)
RTALYC 0.01% (n=1)
STAPNC 0.01% (n=1)
ETALNC 0.01% (n=1)
RTAFNC 0.01% (n=1)
RPALNC 0.01% (n=1)
WTALNC 0.01% (n=1)
RTAHNC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 2:

RTALNC 98.82% (n=1339)
STALNC 0.22% (n=3)
RTALKC 0.15% (n=2)
RIALNC 0.15% (n=2)
RTALDC 0.15% (n=2)
RTAPNC 0.07% (n=1)
RHPLTA 0.07% (n=1)
RTGLNC 0.07% (n=1)
RTALNY 0.07% (n=1)
RAALDC 0.07% (n=1)
RTTLNC 0.07% (n=1)
WTALNC 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 2a:

RTALNC 97.97% (n=289)
STALNC 1.02% (n=3)
RIALNC 0.34% (n=1)
RTAPNC 0.34% (n=1)
RHPLTA 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 2b:

RTALNC 98.70% (n=455)
RTALKC 0.22% (n=1)
RTALDC 0.22% (n=1)
RTGLNC 0.22% (n=1)
RTALNY 0.22% (n=1)
RAALDC 0.22% (n=1)
RTTLNC 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 2c:

RTALNC 99.34% (n=451)
RTALDC 0.22% (n=1)
WTALNC 0.22% (n=1)
RIALNC 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 3:

STALNC 54.76% (n=2141)
RTALNC 39.82% (n=1557)
STALSC 3.63% (n=142)
RTSLNC 0.36% (n=14)
RT---- 0.33% (n=13)
RAALNC 0.13% (n=5)
STAPNC 0.10% (n=4)
TTALNC 0.10% (n=4)
RTSLNR 0.08% (n=3)
STSLNC 0.05% (n=2)
STVLNC 0.05% (n=2)
RTAPNC 0.05% (n=2)
RTARNC 0.05% (n=2)
GTALNC 0.05% (n=2)
RTALDC 0.05% (n=2)
STVLHC 0.05% (n=2)
RTVLNC 0.03% (n=1)
GAALNC 0.03% (n=1)
CTALNC 0.03% (n=1)
RTAPTC 0.03% (n=1)
WTAGNG 0.03% (n=1)
RTALSC 0.03% (n=1)
SAALNC 0.03% (n=1)
ST---- 0.03% (n=1)
QTALNC 0.03% (n=1)
STALNY 0.03% (n=1)
STARNC 0.03% (n=1)
STALTC 0.03% (n=1)
RTALNR 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 3a:

STALNC 57.56% (n=1888)
RTALNC 40.49% (n=1328)
RTSLNC 0.43% (n=14)
RT---- 0.40% (n=13)
RAALNC 0.15% (n=5)
STAPNC 0.12% (n=4)
RTSLNR 0.09% (n=3)
STSLNC 0.06% (n=2)
STVLNC 0.06% (n=2)
RTAPNC 0.06% (n=2)
RTARNC 0.06% (n=2)
GTALNC 0.06% (n=2)
RTALDC 0.06% (n=2)
STVLHC 0.06% (n=2)
STALSC 0.06% (n=2)
RTVLNC 0.03% (n=1)
GAALNC 0.03% (n=1)
CTALNC 0.03% (n=1)
RTAPTC 0.03% (n=1)
WTAGNG 0.03% (n=1)
RTALSC 0.03% (n=1)
SAALNC 0.03% (n=1)
ST---- 0.03% (n=1)
QTALNC 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 3b:

STALNC 61.98% (n=251)
STALSC 34.57% (n=140)
RTALNC 1.73% (n=7)
TTALNC 0.99% (n=4)
STALNY 0.25% (n=1)
STARNC 0.25% (n=1)
STALTC 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 4:

RTALNC 97.90% (n=747)
RTSLNC 1.31% (n=10)
STALNC 0.39% (n=3)
GTALNC 0.13% (n=1)
RTALNS 0.13% (n=1)
RIALNC 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 4a:

RTALNC 98.15% (n=159)
GTALNC 0.62% (n=1)
RTSLNC 0.62% (n=1)
RTALNS 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 4d:

RTALNC 99.45% (n=539)
STALNC 0.37% (n=2)
RIALNC 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 5:

RTALNC 78.26% (n=36)
S----- 13.04% (n=6)
STALNC 6.52% (n=3)
RTAL-- 2.17% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 6:

RTALNC 98.81% (n=579)
STALNC 0.68% (n=4)
RTALSC 0.51% (n=3)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Subtype 6a:

RTALNC 99.70% (n=333)
STALNC 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 424-429 (antibodies: [HC-1] ), HCV Genotype 7:

RTALNC 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 435-437 (antibodies: [HC-1] ), HCV Genotype 1:

TGW 57.03% (n=13111)
TGF 39.66% (n=9116)
AGW 2.24% (n=514)
PGF 0.23% (n=52)
SGW 0.17% (n=39)
SGF 0.14% (n=32)
TGL 0.06% (n=14)
AGF 0.06% (n=14)
TG* 0.05% (n=11)
TGS 0.04% (n=9)
TGR 0.03% (n=8)
TAW 0.03% (n=7)
TDW 0.03% (n=6)
PGW 0.02% (n=5)
TAG 0.02% (n=5)
IGW 0.02% (n=5)
IGF 0.02% (n=5)
TGG 0.02% (n=4)
NGF 0.02% (n=4)
TSW 0.01% (n=3)
ADW 0.01% (n=3)
TRF 0.01% (n=3)
TEF 0.01% (n=3)
TGC 0.01% (n=2)
VGW 0.01% (n=2)
TGV 0.01% (n=2)
TRW 0.00% (n=1)
AGY 0.00% (n=1)
TDF 0.00% (n=1)
TG- 0.00% (n=1)
ASW 0.00% (n=1)
LGS 0.00% (n=1)
TGI 0.00% (n=1)
TVF 0.00% (n=1)
PGS 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 1a:

TGW 91.65% (n=12530)
TGF 3.94% (n=539)
AGW 3.61% (n=493)
SGW 0.29% (n=39)
TG* 0.08% (n=11)
TGR 0.06% (n=8)
TAW 0.05% (n=7)
TDW 0.04% (n=6)
PGW 0.04% (n=5)
TAG 0.04% (n=5)
IGW 0.04% (n=5)
TGG 0.03% (n=4)
TSW 0.02% (n=3)
TGL 0.02% (n=3)
ADW 0.02% (n=3)
TGC 0.01% (n=2)
AGF 0.01% (n=2)
VGW 0.01% (n=2)
TRW 0.01% (n=1)
AGY 0.01% (n=1)
TDF 0.01% (n=1)
TG- 0.01% (n=1)
ASW 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 1b:

TGF 92.21% (n=8547)
TGW 6.08% (n=564)
PGF 0.56% (n=52)
SGF 0.35% (n=32)
AGW 0.23% (n=21)
AGF 0.13% (n=12)
TGL 0.12% (n=11)
TGS 0.10% (n=9)
IGF 0.05% (n=5)
NGF 0.04% (n=4)
TRF 0.03% (n=3)
TEF 0.03% (n=3)
TGV 0.02% (n=2)
LGS 0.01% (n=1)
TGI 0.01% (n=1)
TVF 0.01% (n=1)
PGS 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 2:

TGF 93.95% (n=1274)
TGW 4.06% (n=55)
AGF 0.66% (n=9)
SGF 0.29% (n=4)
TGS 0.29% (n=4)
TGL 0.22% (n=3)
SGC 0.15% (n=2)
MGF 0.15% (n=2)
IGF 0.07% (n=1)
IGW 0.07% (n=1)
TGI 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 2a:

TGF 96.61% (n=285)
AGF 2.03% (n=6)
SGF 1.02% (n=3)
IGF 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 2b:

TGF 86.80% (n=401)
TGW 11.47% (n=53)
SGC 0.43% (n=2)
MGF 0.43% (n=2)
AGF 0.43% (n=2)
IGW 0.22% (n=1)
TGL 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 2c:

TGF 98.02% (n=445)
TGS 0.88% (n=4)
TGW 0.44% (n=2)
SGF 0.22% (n=1)
TGL 0.22% (n=1)
TGI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 3:

TGF 99.23% (n=3868)
AGF 0.31% (n=12)
TGS 0.18% (n=7)
HRF 0.10% (n=4)
TGL 0.08% (n=3)
TEF 0.05% (n=2)
TG- 0.03% (n=1)
PGF 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 3a:

TGF 99.17% (n=3241)
AGF 0.34% (n=11)
TGS 0.21% (n=7)
HRF 0.12% (n=4)
TGL 0.09% (n=3)
TEF 0.06% (n=2)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 3b:

TGF 99.26% (n=402)
AGF 0.25% (n=1)
TG- 0.25% (n=1)
PGF 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 4:

TGF 98.95% (n=754)
TGW 0.79% (n=6)
TGL 0.13% (n=1)
AGW 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 4a:

TGF 100.00% (n=161)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 4d:

TGF 99.82% (n=540)
TGL 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 5:

TGF 100.00% (n=39)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 6:

TGF 99.15% (n=582)
TGW 0.51% (n=3)
TEF 0.17% (n=1)
SGF 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Subtype 6a:

TGF 99.70% (n=334)
TEF 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 435-437 (antibodies: [HC-1] ), HCV Genotype 7:

TGF 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 528-536 (antibodies: [HC-1] ), HCV Genotype 1:

NWGENDTDV 18.36% (n=1875)
SWGENETDV 12.12% (n=1238)
NWGENETDV 6.91% (n=706)
RWGENETDV 5.38% (n=550)
SWGENDTDV 5.37% (n=549)
NWGSNDTDV 5.02% (n=513)
NWGANETDV 4.61% (n=471)
NWGDNDTDV 4.18% (n=427)
SWGGNETDV 4.09% (n=418)
TWGENETDV 3.92% (n=400)
RWGANDTDV 3.74% (n=382)
SWGANDTDV 3.12% (n=319)
NWGANDTDV 2.57% (n=262)
NWGSNETDV 2.30% (n=235)
NWGENATDV 1.18% (n=121)
NWGDNETDV 0.98% (n=100)
GWGANDTDV 0.90% (n=92)
TWGGNVTDV 0.78% (n=80)
NWGCNDTDV 0.61% (n=62)
NWGGNDTDV 0.61% (n=62)
NWGGNETDV 0.56% (n=57)
SWGANETDV 0.53% (n=54)
NWGSNDTDI 0.40% (n=41)
NWGENNTDV 0.34% (n=35)
SWGGNDTDV 0.28% (n=29)
NWGANDTDI 0.28% (n=29)
TWGANDTDV 0.26% (n=27)
NWGAKETDV 0.26% (n=27)
NWGGKDTDV 0.26% (n=27)
NWGAREEDV 0.25% (n=26)
NWGANVTDV 0.24% (n=25)
TWGENDTDV 0.24% (n=25)
NWGENVTDV 0.24% (n=25)
RWGANETDV 0.21% (n=21)
TWGSNDTDV 0.20% (n=20)
DWGSNDTDV 0.20% (n=20)
GWGSNDTDV 0.20% (n=20)
TWGENKTDV 0.20% (n=20)
NWGENQTDV 0.20% (n=20)
SWGENKTDV 0.19% (n=19)
SWGEKETDV 0.18% (n=18)
KWGANETDV 0.18% (n=18)
SWGSNETDV 0.17% (n=17)
NWGADETDV 0.17% (n=17)
SWGANDTDF 0.16% (n=16)
KWGENETDV 0.14% (n=14)
SWGKNETDV 0.14% (n=14)
TWGANETDV 0.13% (n=13)
-------DV 0.12% (n=12)
NWGENKTDV 0.12% (n=12)
NWGANDTDF 0.11% (n=11)
GWGDNDTDV 0.10% (n=10)
SWGENVTDV 0.10% (n=10)
SWGSNDTDV 0.10% (n=10)
GWGENDTDV 0.10% (n=10)
NWGTNETDV 0.10% (n=10)
NWGANEMDV 0.10% (n=10)
NWGEGGTDV 0.10% (n=10)
NWGGNKTDV 0.10% (n=10)
SWGGNVTDV 0.10% (n=10)
--GENETDV 0.09% (n=9)
SWGANNTDV 0.08% (n=8)
TWGGNDTDF 0.08% (n=8)
NWGANKTDV 0.08% (n=8)
TWGGNETDV 0.08% (n=8)
NWGQNDTDV 0.07% (n=7)
NWGNNDTDV 0.06% (n=6)
SWGEKDTDV 0.06% (n=6)
SWGVNDTDV 0.06% (n=6)
NWGAHETDV 0.06% (n=6)
NWGTREEDV 0.06% (n=6)
NWGVNETDV 0.06% (n=6)
NWGGNRTDV 0.06% (n=6)
NWGNNETDV 0.06% (n=6)
AWGGNETDV 0.06% (n=6)
SWGENGTDV 0.05% (n=5)
RWGENDTDV 0.05% (n=5)
NWGENETDI 0.05% (n=5)
NWGENESDV 0.05% (n=5)
DWGENETDV 0.05% (n=5)
TWGSNNTDV 0.05% (n=5)
SWGENETGV 0.05% (n=5)
SWGTNDTDV 0.04% (n=4)
NWGVNETDI 0.04% (n=4)
TWGGSVKDV 0.04% (n=4)
NWGQNETDV 0.04% (n=4)
NWGCNETDV 0.04% (n=4)
SWGVNETDV 0.04% (n=4)
NWGTNDTDV 0.04% (n=4)
NWGSDDKDV 0.04% (n=4)
NWGVNKTDV 0.04% (n=4)
NWGTQEEDV 0.04% (n=4)
NWGTREGDV 0.04% (n=4)
SWGE----- 0.04% (n=4)
GWGENETDV 0.04% (n=4)
SWGENETNV 0.03% (n=3)
NWGGDDTDV 0.03% (n=3)
SWGATDADV 0.03% (n=3)
TWGEKDTDV 0.03% (n=3)
NWGSNSTDV 0.03% (n=3)
SWGDNETDV 0.03% (n=3)
NWGENDMDV 0.03% (n=3)
NWGSNNTDV 0.03% (n=3)
DWGENDTDV 0.03% (n=3)
KWGANDTDV 0.03% (n=3)
DWGSNDVDV 0.03% (n=3)
NWGGNVTDV 0.03% (n=3)
DWGENETDA 0.03% (n=3)
TWGENVTDV 0.03% (n=3)
SWGGNKTDV 0.03% (n=3)
QWGENETDV 0.03% (n=3)
TWGENVSDV 0.03% (n=3)
TWGESETDV 0.03% (n=3)
NWGSNRTDV 0.02% (n=2)
NWGANDTYF 0.02% (n=2)
NWGENDTDF 0.02% (n=2)
NWGENDADV 0.02% (n=2)
GWGGNDTDV 0.02% (n=2)
NWGENDKDV 0.02% (n=2)
TFGENETDV 0.02% (n=2)
NWGEDDSDV 0.02% (n=2)
SWGSNDSDV 0.02% (n=2)
NWGINDTDV 0.02% (n=2)
DWGANDTDV 0.02% (n=2)
SWGADEADV 0.02% (n=2)
NWGENDSDV 0.02% (n=2)
NWGRNDTDV 0.02% (n=2)
TWGEKETDV 0.02% (n=2)
SWGENEADV 0.02% (n=2)
NWGDSDTDV 0.02% (n=2)
NWGASDTDV 0.02% (n=2)
NWGEDDTDV 0.02% (n=2)
QLGYQYHGR 0.02% (n=2)
RWGESEADV 0.02% (n=2)
SWGANDADV 0.02% (n=2)
SWGGTDTDV 0.02% (n=2)
NWGGNDTDF 0.02% (n=2)
NWGAGETDV 0.02% (n=2)
NWGGNATDV 0.02% (n=2)
NWGENHTDV 0.02% (n=2)
NWGENTTDV 0.02% (n=2)
NWGGNETDI 0.02% (n=2)
NWSENETDV 0.02% (n=2)
NWGEEDTDV 0.02% (n=2)
DWGAREEDV 0.02% (n=2)
NWGIREEDV 0.02% (n=2)
TWGNSSTDV 0.02% (n=2)
SWGSDTKDV 0.02% (n=2)
NWGCNVTDV 0.02% (n=2)
SWGDNDTDV 0.02% (n=2)
AWGANETDV 0.02% (n=2)
SWGENETDM 0.02% (n=2)
RWGDNETDV 0.02% (n=2)
TWGENETDM 0.02% (n=2)
TWGVNETDV 0.02% (n=2)
NWGENEADV 0.02% (n=2)
GWGANETDV 0.02% (n=2)
TWGENATDV 0.02% (n=2)
TWGENEADV 0.02% (n=2)
TWGDNETDV 0.02% (n=2)
RWGENKTDV 0.02% (n=2)
TWGENGTDV 0.02% (n=2)
SWGENATDV 0.02% (n=2)
SWGENETDA 0.02% (n=2)
SWGENQTDV 0.02% (n=2)
TWGGNKSDV 0.02% (n=2)
--GENEIDV 0.02% (n=2)
--GESETDV 0.02% (n=2)
TSGANDTDF 0.02% (n=2)
NSGANDTDF 0.02% (n=2)
TWGSNDTDF 0.01% (n=1)
TWGSNDTDA 0.01% (n=1)
SWGSNKTDV 0.01% (n=1)
NWGENDVDV 0.01% (n=1)
NWGSNDTVV 0.01% (n=1)
NWCANETGV 0.01% (n=1)
SWGGNNADV 0.01% (n=1)
SWGANEADV 0.01% (n=1)
NWGANDMDV 0.01% (n=1)
NWGANNTDV 0.01% (n=1)
NWGANETDI 0.01% (n=1)
NWGTNDTNV 0.01% (n=1)
NWGENDTGV 0.01% (n=1)
SWGADDTDV 0.01% (n=1)
NWGINETDV 0.01% (n=1)
SWGVTDTDV 0.01% (n=1)
NWGDNGADV 0.01% (n=1)
N*GDNDTDV 0.01% (n=1)
SWVENDTDV 0.01% (n=1)
NWGSDTTDV 0.01% (n=1)
TCGENDTDV 0.01% (n=1)
SWGEHDTDV 0.01% (n=1)
TWGSNVSDV 0.01% (n=1)
TWGSNHSDV 0.01% (n=1)
NWGNTSEDV 0.01% (n=1)
SWGANVTDV 0.01% (n=1)
SWGENDKDV 0.01% (n=1)
SWGSNVTDV 0.01% (n=1)
RWGSNDTDV 0.01% (n=1)
DWGGNVTDV 0.01% (n=1)
NWGSNDSDV 0.01% (n=1)
SWGERDRDV 0.01% (n=1)
DWGRNDTDV 0.01% (n=1)
NWGANESDV 0.01% (n=1)
NFGANQTDV 0.01% (n=1)
NWGESDMDV 0.01% (n=1)
NWGSSDKDV 0.01% (n=1)
NWGRNDTDF 0.01% (n=1)
TWGESDKDV 0.01% (n=1)
NWGANEADV 0.01% (n=1)
SWGSDDTDV 0.01% (n=1)
NWGTNATDV 0.01% (n=1)
NWGSNYTDV 0.01% (n=1)
DWGSNVTDV 0.01% (n=1)
DWGSNETDV 0.01% (n=1)
SWGGKVTDV 0.01% (n=1)
NFGTNETDV 0.01% (n=1)
NWGDSDEDV 0.01% (n=1)
NWGENDTDG 0.01% (n=1)
NWGVNDTDF 0.01% (n=1)
DWGENESDV 0.01% (n=1)
TWGERDTDV 0.01% (n=1)
NWGANDSDV 0.01% (n=1)
NWGGNETGV 0.01% (n=1)
NWGSNVTDV 0.01% (n=1)
NWGSNDTGI 0.01% (n=1)
NWGENDTDA 0.01% (n=1)
SWGEYDTDV 0.01% (n=1)
S*GENDTDV 0.01% (n=1)
SWGENDTGI 0.01% (n=1)
GRGENDTDV 0.01% (n=1)
SRGENDTDV 0.01% (n=1)
NWGENGTDV 0.01% (n=1)
NWGDNQTDV 0.01% (n=1)
NWGANETEV 0.01% (n=1)
NRGANDTDV 0.01% (n=1)
DWGSSDVDV 0.01% (n=1)
SWGANDTAV 0.01% (n=1)
SWGANGTDV 0.01% (n=1)
SWGATDTDV 0.01% (n=1)
SWGVNDTGV 0.01% (n=1)
SRGANDTDV 0.01% (n=1)
SWGANDTGV 0.01% (n=1)
SWGANDTDA 0.01% (n=1)
SWGVNDKDV 0.01% (n=1)
NWGAKKTDV 0.01% (n=1)
NWGTNVTDV 0.01% (n=1)
NWGADKTDV 0.01% (n=1)
NWGANEKDV 0.01% (n=1)
NWGAKQTDV 0.01% (n=1)
NWGARETDV 0.01% (n=1)
NWGASETDV 0.01% (n=1)
NWGATETDV 0.01% (n=1)
NWGTNETDI 0.01% (n=1)
NWGTNKTDV 0.01% (n=1)
NWGDNEADV 0.01% (n=1)
SWGANDTDI 0.01% (n=1)
NWGVNDTDI 0.01% (n=1)
SWGENDSDV 0.01% (n=1)
NWGCND--- 0.01% (n=1)
RWGKNETDV 0.01% (n=1)
YWGENDTDV 0.01% (n=1)
DWGVNDTDV 0.01% (n=1)
SWGSNATDV 0.01% (n=1)
SWGESEADV 0.01% (n=1)
RWGTNDTDV 0.01% (n=1)
NWGANITDV 0.01% (n=1)
TWGDNDTDV 0.01% (n=1)
SWGSDNTDV 0.01% (n=1)
NWGSNITDV 0.01% (n=1)
NWGETDKDV 0.01% (n=1)
RWGVNETDV 0.01% (n=1)
NWGANMTDV 0.01% (n=1)
TWGGNDTDV 0.01% (n=1)
SWGENEKDV 0.01% (n=1)
NWVSNDTDV 0.01% (n=1)
SWGSNNTDV 0.01% (n=1)
NWGEQDTDV 0.01% (n=1)
NWGENETDA 0.01% (n=1)
RWGENEKDV 0.01% (n=1)
TWGENESDV 0.01% (n=1)
TWGSSDADV 0.01% (n=1)
NWGGNDADV 0.01% (n=1)
NWGGGDTDV 0.01% (n=1)
NWGRKDTDV 0.01% (n=1)
NWGMNDTDV 0.01% (n=1)
DWGANETDV 0.01% (n=1)
NWGVNDTDV 0.01% (n=1)
NWGKNDTDV 0.01% (n=1)
VRGENGTDV 0.01% (n=1)
NWGVNESDV 0.01% (n=1)
SWRENETDV 0.01% (n=1)
TWGENETNV 0.01% (n=1)
RWGEKETDV 0.01% (n=1)
RWGEIETDV 0.01% (n=1)
SGRGIETDV 0.01% (n=1)
MWGEYETDV 0.01% (n=1)
SWGGNETDM 0.01% (n=1)
SWGGIKPDV 0.01% (n=1)
SWGGNRTDV 0.01% (n=1)
SWGENETCV 0.01% (n=1)
TWGGNKTDV 0.01% (n=1)
NWGENGSDV 0.01% (n=1)
NWGGNASDV 0.01% (n=1)
DWGGNETDV 0.01% (n=1)
RWGGNETDV 0.01% (n=1)
RWGANESDV 0.01% (n=1)
TWEENETDV 0.01% (n=1)
SWGGNTSDV 0.01% (n=1)
SWGGNKSDV 0.01% (n=1)
--------V 0.01% (n=1)
NWGENKSDV 0.01% (n=1)
TWGTNESDV 0.01% (n=1)
RWGENGTDV 0.01% (n=1)
ILGENETDV 0.01% (n=1)
TWGGNASDV 0.01% (n=1)
SWGGNATDV 0.01% (n=1)
SWGENKSDV 0.01% (n=1)
RWGENESDV 0.01% (n=1)
NWGANQTDV 0.01% (n=1)
HWGENKTDV 0.01% (n=1)
RWGENSSDV 0.01% (n=1)
SWGANKTDV 0.01% (n=1)
SWGESETDV 0.01% (n=1)
TWGENQTDV 0.01% (n=1)
TWGTNETDV 0.01% (n=1)
SWGEDETDV 0.01% (n=1)
SRGENEADV 0.01% (n=1)
QWGENKTDV 0.01% (n=1)
GWGGNETDV 0.01% (n=1)
TWGENETGV 0.01% (n=1)
SWGRNETDV 0.01% (n=1)
SWGKNETDM 0.01% (n=1)
SWGENESDV 0.01% (n=1)
TWGRNETDV 0.01% (n=1)
RRGGNETDV 0.01% (n=1)
AWGENETDV 0.01% (n=1)
QWGENESDV 0.01% (n=1)
--GENESDV 0.01% (n=1)
RWGENETDA 0.01% (n=1)
TWGENETDI 0.01% (n=1)
TWGANDSDV 0.01% (n=1)
NWGANVSDV 0.01% (n=1)
TWGEHESDV 0.01% (n=1)
EWGEGASDV 0.01% (n=1)
TSGANETDF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 1a:

NWGENDTDV 25.79% (n=1875)
SWGENDTDV 7.50% (n=545)
NWGSNDTDV 7.06% (n=513)
NWGENETDV 6.19% (n=450)
NWGANETDV 6.16% (n=448)
NWGDNDTDV 5.83% (n=424)
RWGANDTDV 5.25% (n=382)
SWGANDTDV 4.39% (n=319)
NWGANDTDV 3.60% (n=262)
NWGSNETDV 3.23% (n=235)
RWGENETDV 2.79% (n=203)
SWGENETDV 2.67% (n=194)
NWGENATDV 1.61% (n=117)
GWGANDTDV 1.27% (n=92)
NWGDNETDV 1.02% (n=74)
NWGCNDTDV 0.85% (n=62)
NWGGNDTDV 0.85% (n=62)
NWGSNDTDI 0.56% (n=41)
SWGANETDV 0.52% (n=38)
NWGENNTDV 0.48% (n=35)
SWGGNDTDV 0.40% (n=29)
NWGANDTDI 0.40% (n=29)
TWGANDTDV 0.37% (n=27)
NWGGNETDV 0.37% (n=27)
NWGAKETDV 0.37% (n=27)
NWGGKDTDV 0.37% (n=27)
NWGAREEDV 0.36% (n=26)
NWGANVTDV 0.34% (n=25)
TWGENETDV 0.33% (n=24)
TWGENDTDV 0.32% (n=23)
NWGENVTDV 0.30% (n=22)
TWGSNDTDV 0.28% (n=20)
DWGSNDTDV 0.28% (n=20)
GWGSNDTDV 0.28% (n=20)
KWGANETDV 0.25% (n=18)
SWGSNETDV 0.23% (n=17)
SWGEKETDV 0.23% (n=17)
NWGADETDV 0.23% (n=17)
SWGANDTDF 0.22% (n=16)
RWGANETDV 0.21% (n=15)
-------DV 0.17% (n=12)
NWGANDTDF 0.15% (n=11)
GWGDNDTDV 0.14% (n=10)
SWGSNDTDV 0.14% (n=10)
GWGENDTDV 0.14% (n=10)
NWGTNETDV 0.14% (n=10)
NWGANEMDV 0.14% (n=10)
NWGEGGTDV 0.14% (n=10)
NWGGNKTDV 0.14% (n=10)
SWGANNTDV 0.11% (n=8)
TWGGNDTDF 0.11% (n=8)
NWGANKTDV 0.11% (n=8)
NWGENKTDV 0.11% (n=8)
NWGQNDTDV 0.10% (n=7)
NWGNNDTDV 0.08% (n=6)
SWGEKDTDV 0.08% (n=6)
SWGVNDTDV 0.08% (n=6)
NWGAHETDV 0.08% (n=6)
NWGTREEDV 0.08% (n=6)
RWGENDTDV 0.07% (n=5)
NWGENESDV 0.07% (n=5)
TWGSNNTDV 0.07% (n=5)
SWGTNDTDV 0.06% (n=4)
NWGVNETDI 0.06% (n=4)
TWGGSVKDV 0.06% (n=4)
NWGQNETDV 0.06% (n=4)
NWGCNETDV 0.06% (n=4)
SWGENVTDV 0.06% (n=4)
NWGTNDTDV 0.06% (n=4)
NWGSDDKDV 0.06% (n=4)
NWGVNKTDV 0.06% (n=4)
NWGTQEEDV 0.06% (n=4)
NWGTREGDV 0.06% (n=4)
NWGGDDTDV 0.04% (n=3)
SWGATDADV 0.04% (n=3)
NWGENETDI 0.04% (n=3)
TWGEKDTDV 0.04% (n=3)
NWGSNSTDV 0.04% (n=3)
NWGENDMDV 0.04% (n=3)
NWGSNNTDV 0.04% (n=3)
DWGENDTDV 0.04% (n=3)
KWGANDTDV 0.04% (n=3)
DWGSNDVDV 0.04% (n=3)
DWGENETDA 0.04% (n=3)
NWGSNRTDV 0.03% (n=2)
NWGANDTYF 0.03% (n=2)
NWGENDTDF 0.03% (n=2)
NWGENDADV 0.03% (n=2)
GWGGNDTDV 0.03% (n=2)
NWGENDKDV 0.03% (n=2)
TFGENETDV 0.03% (n=2)
NWGEDDSDV 0.03% (n=2)
SWGSNDSDV 0.03% (n=2)
NWGINDTDV 0.03% (n=2)
DWGANDTDV 0.03% (n=2)
SWGADEADV 0.03% (n=2)
NWGENDSDV 0.03% (n=2)
NWGRNDTDV 0.03% (n=2)
NWGDSDTDV 0.03% (n=2)
NWGASDTDV 0.03% (n=2)
NWGEDDTDV 0.03% (n=2)
QLGYQYHGR 0.03% (n=2)
RWGESEADV 0.03% (n=2)
SWGANDADV 0.03% (n=2)
SWGGTDTDV 0.03% (n=2)
NWGGNDTDF 0.03% (n=2)
NWGAGETDV 0.03% (n=2)
NWGENHTDV 0.03% (n=2)
NWGENTTDV 0.03% (n=2)
NWGGNETDI 0.03% (n=2)
NWSENETDV 0.03% (n=2)
NWGEEDTDV 0.03% (n=2)
DWGAREEDV 0.03% (n=2)
NWGIREEDV 0.03% (n=2)
TWGNSSTDV 0.03% (n=2)
SWGSDTKDV 0.03% (n=2)
NWGCNVTDV 0.03% (n=2)
TWGANETDV 0.03% (n=2)
SWGDNDTDV 0.03% (n=2)
SWGENGTDV 0.01% (n=1)
SWGENETNV 0.01% (n=1)
TWGSNDTDF 0.01% (n=1)
TWGSNDTDA 0.01% (n=1)
SWGSNKTDV 0.01% (n=1)
NWGENDVDV 0.01% (n=1)
NWGSNDTVV 0.01% (n=1)
NWCANETGV 0.01% (n=1)
SWGGNNADV 0.01% (n=1)
SWGANEADV 0.01% (n=1)
NWGANDMDV 0.01% (n=1)
NWGANNTDV 0.01% (n=1)
NWGANETDI 0.01% (n=1)
NWGTNDTNV 0.01% (n=1)
NWGENDTGV 0.01% (n=1)
SWGADDTDV 0.01% (n=1)
NWGINETDV 0.01% (n=1)
SWGVTDTDV 0.01% (n=1)
NWGDNGADV 0.01% (n=1)
N*GDNDTDV 0.01% (n=1)
SWVENDTDV 0.01% (n=1)
NWGSDTTDV 0.01% (n=1)
TCGENDTDV 0.01% (n=1)
SWGEHDTDV 0.01% (n=1)
TWGSNVSDV 0.01% (n=1)
TWGSNHSDV 0.01% (n=1)
SWGDNETDV 0.01% (n=1)
NWGNTSEDV 0.01% (n=1)
SWGVNETDV 0.01% (n=1)
SWGANVTDV 0.01% (n=1)
SWGENDKDV 0.01% (n=1)
SWGSNVTDV 0.01% (n=1)
RWGSNDTDV 0.01% (n=1)
DWGGNVTDV 0.01% (n=1)
NWGSNDSDV 0.01% (n=1)
SWGERDRDV 0.01% (n=1)
DWGRNDTDV 0.01% (n=1)
NWGANESDV 0.01% (n=1)
NFGANQTDV 0.01% (n=1)
NWGESDMDV 0.01% (n=1)
NWGSSDKDV 0.01% (n=1)
NWGRNDTDF 0.01% (n=1)
TWGESDKDV 0.01% (n=1)
NWGANEADV 0.01% (n=1)
SWGSDDTDV 0.01% (n=1)
NWGTNATDV 0.01% (n=1)
NWGSNYTDV 0.01% (n=1)
TWGEKETDV 0.01% (n=1)
DWGSNVTDV 0.01% (n=1)
DWGSNETDV 0.01% (n=1)
SWGGKVTDV 0.01% (n=1)
SWGENEADV 0.01% (n=1)
SWGGNETDV 0.01% (n=1)
NFGTNETDV 0.01% (n=1)
NWGDSDEDV 0.01% (n=1)
NWGENDTDG 0.01% (n=1)
NWGVNDTDF 0.01% (n=1)
DWGENESDV 0.01% (n=1)
TWGERDTDV 0.01% (n=1)
NWGANDSDV 0.01% (n=1)
NWGGNETGV 0.01% (n=1)
NWGSNVTDV 0.01% (n=1)
NWGSNDTGI 0.01% (n=1)
NWGENDTDA 0.01% (n=1)
SWGEYDTDV 0.01% (n=1)
S*GENDTDV 0.01% (n=1)
SWGENDTGI 0.01% (n=1)
GRGENDTDV 0.01% (n=1)
SRGENDTDV 0.01% (n=1)
NWGENGTDV 0.01% (n=1)
NWGDNQTDV 0.01% (n=1)
NWGANETEV 0.01% (n=1)
NRGANDTDV 0.01% (n=1)
DWGSSDVDV 0.01% (n=1)
SWGANDTAV 0.01% (n=1)
SWGANGTDV 0.01% (n=1)
SWGATDTDV 0.01% (n=1)
SWGVNDTGV 0.01% (n=1)
SRGANDTDV 0.01% (n=1)
SWGANDTGV 0.01% (n=1)
SWGANDTDA 0.01% (n=1)
SWGVNDKDV 0.01% (n=1)
NWGAKKTDV 0.01% (n=1)
NWGTNVTDV 0.01% (n=1)
NWGADKTDV 0.01% (n=1)
NWGANEKDV 0.01% (n=1)
NWGAKQTDV 0.01% (n=1)
NWGARETDV 0.01% (n=1)
NWGASETDV 0.01% (n=1)
NWGATETDV 0.01% (n=1)
NWGTNETDI 0.01% (n=1)
NWGTNKTDV 0.01% (n=1)
NWGDNEADV 0.01% (n=1)
SWGANDTDI 0.01% (n=1)
NWGVNDTDI 0.01% (n=1)
NWGGNATDV 0.01% (n=1)
SWGENDSDV 0.01% (n=1)
NWGGNVTDV 0.01% (n=1)
RWGKNETDV 0.01% (n=1)
YWGENDTDV 0.01% (n=1)
DWGVNDTDV 0.01% (n=1)
SWGSNATDV 0.01% (n=1)
SWGESEADV 0.01% (n=1)
RWGTNDTDV 0.01% (n=1)
NWGANITDV 0.01% (n=1)
TWGDNDTDV 0.01% (n=1)
SWGSDNTDV 0.01% (n=1)
NWGSNITDV 0.01% (n=1)
AWGANETDV 0.01% (n=1)
NWGETDKDV 0.01% (n=1)
RWGVNETDV 0.01% (n=1)
NWGANMTDV 0.01% (n=1)
TWGGNDTDV 0.01% (n=1)
NWGVNETDV 0.01% (n=1)
SWGENEKDV 0.01% (n=1)
NWVSNDTDV 0.01% (n=1)
SWGSNNTDV 0.01% (n=1)
NWGEQDTDV 0.01% (n=1)
DWGENETDV 0.01% (n=1)
NWGENETDA 0.01% (n=1)
RWGENEKDV 0.01% (n=1)
TWGENESDV 0.01% (n=1)
TWGSSDADV 0.01% (n=1)
NWGGNDADV 0.01% (n=1)
NWGGGDTDV 0.01% (n=1)
NWGRKDTDV 0.01% (n=1)
NWGMNDTDV 0.01% (n=1)
DWGANETDV 0.01% (n=1)
NWGVNDTDV 0.01% (n=1)
NWGKNDTDV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 1b:

SWGENETDV 35.75% (n=1040)
SWGGNETDV 14.33% (n=417)
TWGENETDV 12.62% (n=367)
RWGENETDV 11.89% (n=346)
NWGENETDV 8.66% (n=252)
TWGGNVTDV 2.75% (n=80)
NWGGNETDV 1.03% (n=30)
NWGDNETDV 0.79% (n=23)
NWGANETDV 0.79% (n=23)
TWGENKTDV 0.69% (n=20)
NWGENQTDV 0.69% (n=20)
SWGENKTDV 0.65% (n=19)
SWGANETDV 0.55% (n=16)
KWGENETDV 0.48% (n=14)
SWGKNETDV 0.48% (n=14)
TWGANETDV 0.38% (n=11)
SWGGNVTDV 0.34% (n=10)
--GENETDV 0.31% (n=9)
TWGGNETDV 0.28% (n=8)
SWGENVTDV 0.21% (n=6)
NWGGNRTDV 0.21% (n=6)
NWGNNETDV 0.21% (n=6)
AWGGNETDV 0.21% (n=6)
RWGANETDV 0.17% (n=5)
NWGVNETDV 0.17% (n=5)
SWGENETGV 0.17% (n=5)
SWGENDTDV 0.14% (n=4)
SWGENGTDV 0.14% (n=4)
NWGENKTDV 0.14% (n=4)
SWGE----- 0.14% (n=4)
DWGENETDV 0.14% (n=4)
NWGENATDV 0.14% (n=4)
GWGENETDV 0.14% (n=4)
SWGVNETDV 0.10% (n=3)
NWGDNDTDV 0.10% (n=3)
TWGENVTDV 0.10% (n=3)
SWGGNKTDV 0.10% (n=3)
QWGENETDV 0.10% (n=3)
NWGENVTDV 0.10% (n=3)
TWGENVSDV 0.10% (n=3)
TWGESETDV 0.10% (n=3)
SWGENETDM 0.07% (n=2)
NWGENETDI 0.07% (n=2)
SWGENETNV 0.07% (n=2)
RWGDNETDV 0.07% (n=2)
TWGENETDM 0.07% (n=2)
TWGVNETDV 0.07% (n=2)
NWGGNVTDV 0.07% (n=2)
NWGENEADV 0.07% (n=2)
GWGANETDV 0.07% (n=2)
TWGENATDV 0.07% (n=2)
TWGENEADV 0.07% (n=2)
SWGDNETDV 0.07% (n=2)
TWGDNETDV 0.07% (n=2)
RWGENKTDV 0.07% (n=2)
TWGENGTDV 0.07% (n=2)
SWGENATDV 0.07% (n=2)
SWGENETDA 0.07% (n=2)
SWGENQTDV 0.07% (n=2)
TWGGNKSDV 0.07% (n=2)
--GENEIDV 0.07% (n=2)
--GESETDV 0.07% (n=2)
VRGENGTDV 0.03% (n=1)
NWGVNESDV 0.03% (n=1)
SWRENETDV 0.03% (n=1)
TWGENETNV 0.03% (n=1)
RWGEKETDV 0.03% (n=1)
RWGEIETDV 0.03% (n=1)
SGRGIETDV 0.03% (n=1)
MWGEYETDV 0.03% (n=1)
SWGGNETDM 0.03% (n=1)
SWGGIKPDV 0.03% (n=1)
SWGGNRTDV 0.03% (n=1)
SWGENETCV 0.03% (n=1)
TWGGNKTDV 0.03% (n=1)
TWGEKETDV 0.03% (n=1)
NWGENGSDV 0.03% (n=1)
NWGGNASDV 0.03% (n=1)
DWGGNETDV 0.03% (n=1)
RWGGNETDV 0.03% (n=1)
RWGANESDV 0.03% (n=1)
TWEENETDV 0.03% (n=1)
SWGGNTSDV 0.03% (n=1)
SWGGNKSDV 0.03% (n=1)
--------V 0.03% (n=1)
NWGENKSDV 0.03% (n=1)
AWGANETDV 0.03% (n=1)
TWGTNESDV 0.03% (n=1)
SWGENEADV 0.03% (n=1)
RWGENGTDV 0.03% (n=1)
ILGENETDV 0.03% (n=1)
TWGGNASDV 0.03% (n=1)
SWGGNATDV 0.03% (n=1)
SWGENKSDV 0.03% (n=1)
RWGENESDV 0.03% (n=1)
NWGANQTDV 0.03% (n=1)
HWGENKTDV 0.03% (n=1)
TWGENDTDV 0.03% (n=1)
RWGENSSDV 0.03% (n=1)
SWGANKTDV 0.03% (n=1)
SWGESETDV 0.03% (n=1)
TWGENQTDV 0.03% (n=1)
TWGTNETDV 0.03% (n=1)
SWGEDETDV 0.03% (n=1)
SRGENEADV 0.03% (n=1)
QWGENKTDV 0.03% (n=1)
GWGGNETDV 0.03% (n=1)
TWGENETGV 0.03% (n=1)
SWGRNETDV 0.03% (n=1)
SWGKNETDM 0.03% (n=1)
SWGENESDV 0.03% (n=1)
TWGRNETDV 0.03% (n=1)
RRGGNETDV 0.03% (n=1)
NWGGNATDV 0.03% (n=1)
SWGEKETDV 0.03% (n=1)
AWGENETDV 0.03% (n=1)
QWGENESDV 0.03% (n=1)
--GENESDV 0.03% (n=1)
RWGENETDA 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 2:

SWGENETDV 35.61% (n=188)
TWGENETDV 28.41% (n=150)
NWGDNETDV 13.45% (n=71)
NWGENETDV 7.58% (n=40)
GWGENETDV 2.27% (n=12)
RWGENETDV 1.33% (n=7)
TWGENDTDV 1.33% (n=7)
SWGANETDV 0.95% (n=5)
TGEGNETDV 0.57% (n=3)
TWGENETDF 0.57% (n=3)
TWGENESDV 0.57% (n=3)
TWGDNETDV 0.57% (n=3)
TWGANETDV 0.57% (n=3)
SWGENQTDV 0.38% (n=2)
SWGVNETDV 0.38% (n=2)
KWGENETDV 0.38% (n=2)
TWGENDTNV 0.19% (n=1)
TWGGNETDV 0.19% (n=1)
MWEGNETDV 0.19% (n=1)
MGEGNETDV 0.19% (n=1)
TWGANETDF 0.19% (n=1)
TWGVNETDV 0.19% (n=1)
RWGERETDV 0.19% (n=1)
PWRRNDTDV 0.19% (n=1)
AWGENETDV 0.19% (n=1)
MWGENETDV 0.19% (n=1)
NWGGNDTDV 0.19% (n=1)
NWGDNGTDV 0.19% (n=1)
SWGENESDV 0.19% (n=1)
SWGENDTDV 0.19% (n=1)
NWGENDTDV 0.19% (n=1)
DWGQNETDV 0.19% (n=1)
TWGANDTDV 0.19% (n=1)
TWGENKTDV 0.19% (n=1)
SWGENETDL 0.19% (n=1)
TWGENDTDF 0.19% (n=1)
SWGDNETDV 0.19% (n=1)
NWGESEKDV 0.19% (n=1)
TWGGNDTDV 0.19% (n=1)
TWEENETDV 0.19% (n=1)
TWGGNVKDV 0.19% (n=1)
SWGGGDKDV 0.19% (n=1)
NWGANETDV 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 2a:

TWGENETDV 80.26% (n=61)
TGEGNETDV 3.95% (n=3)
TWGENETDF 2.63% (n=2)
TWGENESDV 2.63% (n=2)
TWGENDTNV 1.32% (n=1)
RWGENETDV 1.32% (n=1)
TWGGNETDV 1.32% (n=1)
SWGENETDV 1.32% (n=1)
MWEGNETDV 1.32% (n=1)
MGEGNETDV 1.32% (n=1)
TWGANETDF 1.32% (n=1)
TWGENDTDV 1.32% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 2b:

SWGENETDV 49.71% (n=174)
NWGDNETDV 20.29% (n=71)
TWGENETDV 11.71% (n=41)
NWGENETDV 6.00% (n=21)
RWGENETDV 1.71% (n=6)
GWGENETDV 1.71% (n=6)
SWGANETDV 1.43% (n=5)
TWGENDTDV 1.14% (n=4)
SWGENQTDV 0.57% (n=2)
TWGDNETDV 0.57% (n=2)
TWGVNETDV 0.29% (n=1)
RWGERETDV 0.29% (n=1)
PWRRNDTDV 0.29% (n=1)
AWGENETDV 0.29% (n=1)
TWGANETDV 0.29% (n=1)
MWGENETDV 0.29% (n=1)
NWGGNDTDV 0.29% (n=1)
NWGDNGTDV 0.29% (n=1)
SWGENESDV 0.29% (n=1)
SWGENDTDV 0.29% (n=1)
NWGENDTDV 0.29% (n=1)
DWGQNETDV 0.29% (n=1)
TWGANDTDV 0.29% (n=1)
SWGVNETDV 0.29% (n=1)
TWGENKTDV 0.29% (n=1)
SWGENETDL 0.29% (n=1)
TWGENDTDF 0.29% (n=1)
SWGDNETDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 2c:

TWGENETDV 45.16% (n=28)
NWGENETDV 24.19% (n=15)
SWGENETDV 11.29% (n=7)
GWGENETDV 9.68% (n=6)
TWGANETDV 3.23% (n=2)
NWGESEKDV 1.61% (n=1)
TWGGNDTDV 1.61% (n=1)
TWEENETDV 1.61% (n=1)
TWGGNVKDV 1.61% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 3:

TWGANETDV 17.56% (n=484)
TWGENETDV 13.43% (n=370)
NWGENETDV 11.18% (n=308)
NWGANETDV 6.79% (n=187)
TWGENKTDV 6.79% (n=187)
NFGENETDV 4.72% (n=130)
TWGENESDV 3.48% (n=96)
NWGENESDV 3.30% (n=91)
NFGANETDV 3.12% (n=86)
NWGANESDV 2.32% (n=64)
TWGANKTDV 1.56% (n=43)
NWGENKSDV 1.42% (n=39)
SWGENETDV 1.42% (n=39)
TWGENDTDV 1.23% (n=34)
DWGENETDV 1.20% (n=33)
NWGANETDA 0.98% (n=27)
NWGANVTDV 0.94% (n=26)
NFGANESDV 0.94% (n=26)
TFGENETDV 0.80% (n=22)
TWGGNETDV 0.62% (n=17)
AWGENETDV 0.62% (n=17)
NWGENKTDV 0.62% (n=17)
SFGENETDV 0.62% (n=17)
TWGANESDV 0.54% (n=15)
SWGANETDV 0.51% (n=14)
TWGTNETDV 0.47% (n=13)
SWGANESDV 0.47% (n=13)
NFGENKTDV 0.40% (n=11)
TWGENATDV 0.40% (n=11)
TWGGNKTDV 0.36% (n=10)
NWGGNETDV 0.33% (n=9)
NWGGNKTDV 0.33% (n=9)
TWGANDTDV 0.25% (n=7)
YWGENKTDV 0.22% (n=6)
TWGENVTDV 0.18% (n=5)
NWGANKTDV 0.15% (n=4)
GWGANESDV 0.15% (n=4)
NWGENATDV 0.15% (n=4)
RWGENETDV 0.15% (n=4)
NWGVNETDV 0.15% (n=4)
NFGDNETDV 0.15% (n=4)
TFGANETDV 0.15% (n=4)
SFGENESDV 0.15% (n=4)
TWGGNATDV 0.11% (n=3)
TWGENEADV 0.11% (n=3)
TWGENETDM 0.11% (n=3)
TWGEKETDV 0.11% (n=3)
KWGENETDV 0.11% (n=3)
SWGAKESDV 0.11% (n=3)
TWGENQTDV 0.11% (n=3)
GWGENETDV 0.11% (n=3)
TWGANKSDV 0.11% (n=3)
NFGGNESDV 0.11% (n=3)
NFGENESDV 0.11% (n=3)
NFGENDTDV 0.11% (n=3)
TWGENEKDV 0.07% (n=2)
NWGGDETDV 0.07% (n=2)
TWGGNESDV 0.07% (n=2)
YWGENETDV 0.07% (n=2)
FWGANESDV 0.07% (n=2)
SWGANKSDV 0.07% (n=2)
TWGGNVTDV 0.07% (n=2)
TRGENETDV 0.07% (n=2)
RLGENETDV 0.07% (n=2)
NWGANEADV 0.07% (n=2)
TWGVNETDV 0.07% (n=2)
TWGDNESDV 0.07% (n=2)
NWGENVTDV 0.07% (n=2)
SWGENESDV 0.07% (n=2)
TFGANESDV 0.07% (n=2)
NWGGNDTDV 0.07% (n=2)
TWGETEKDV 0.07% (n=2)
NWGENDTDV 0.07% (n=2)
NWGTNETDV 0.07% (n=2)
RWGENQSDV 0.07% (n=2)
NWGGNATDV 0.07% (n=2)
TWGANVTDV 0.07% (n=2)
TWGDNKTDV 0.07% (n=2)
TWGTNVTDV 0.07% (n=2)
TWGMNETDV 0.07% (n=2)
TWGENKTDM 0.07% (n=2)
EWGENETDV 0.07% (n=2)
NWGENQTDV 0.07% (n=2)
TWGANQTDV 0.07% (n=2)
QWGENETDV 0.07% (n=2)
SWGENKTDV 0.07% (n=2)
NWGDNETDV 0.07% (n=2)
AWGANETDV 0.07% (n=2)
NWGANVSDV 0.07% (n=2)
SFGANETDV 0.07% (n=2)
NFGVNETDV 0.07% (n=2)
NFGGNETDV 0.07% (n=2)
TFGEKETDV 0.07% (n=2)
RFGENETDV 0.07% (n=2)
TWGENASDV 0.04% (n=1)
SFGTNETDV 0.04% (n=1)
TWGENVRDV 0.04% (n=1)
TWDANETDV 0.04% (n=1)
NWGANETDM 0.04% (n=1)
NWGADETDV 0.04% (n=1)
GWGGNKSDV 0.04% (n=1)
SFGENETDC 0.04% (n=1)
TWGANTSDV 0.04% (n=1)
NWGADVTDV 0.04% (n=1)
NWSANVTDV 0.04% (n=1)
TWGEDGTDV 0.04% (n=1)
DWGENEADV 0.04% (n=1)
DWSENETDV 0.04% (n=1)
YWGENKTDM 0.04% (n=1)
CWGENKSDV 0.04% (n=1)
SWGASESDV 0.04% (n=1)
TWGENETDA 0.04% (n=1)
TWGENETGV 0.04% (n=1)
NWGESESDV 0.04% (n=1)
PWGANKTEG 0.04% (n=1)
NGGGDETDV 0.04% (n=1)
SWGENEKDV 0.04% (n=1)
TWGENETDG 0.04% (n=1)
TWGANETDM 0.04% (n=1)
TWSENETDV 0.04% (n=1)
SWSENETDV 0.04% (n=1)
TLSENETDV 0.04% (n=1)
TLGENETDV 0.04% (n=1)
RLGENETNV 0.04% (n=1)
TKSSNETEV 0.04% (n=1)
TWGANETEV 0.04% (n=1)
CSNDNESDV 0.04% (n=1)
NRGANETDV 0.04% (n=1)
NWGANGTDV 0.04% (n=1)
DWGENESDV 0.04% (n=1)
NWGSNDTDV 0.04% (n=1)
DWGANKSDV 0.04% (n=1)
NWGMNETDV 0.04% (n=1)
SWGEKETDV 0.04% (n=1)
NWGENEADV 0.04% (n=1)
NWGDNKTDV 0.04% (n=1)
SWGAEESDV 0.04% (n=1)
NWGRNESDV 0.04% (n=1)
TWGGNDTDL 0.04% (n=1)
GWGENESDV 0.04% (n=1)
NWGQWL*AL 0.04% (n=1)
QW-E-L*AL 0.04% (n=1)
NWGANESDG 0.04% (n=1)
TGGANESDV 0.04% (n=1)
TWGANKADV 0.04% (n=1)
AWGANKTDV 0.04% (n=1)
TWGTNATDV 0.04% (n=1)
DWGANESDV 0.04% (n=1)
DWGGKETDV 0.04% (n=1)
DWGANASDV 0.04% (n=1)
NWGANDSDV 0.04% (n=1)
TWGENTTDV 0.04% (n=1)
NWGANDADV 0.04% (n=1)
KWGEGEKDV 0.04% (n=1)
NWGENATDM 0.04% (n=1)
SWGENQTDV 0.04% (n=1)
NFGANKTDV 0.04% (n=1)
SWGANQTDV 0.04% (n=1)
TWGEDKSDV 0.04% (n=1)
KWGENKTDV 0.04% (n=1)
EWGENQTDV 0.04% (n=1)
TWGEQERDV 0.04% (n=1)
TWGENKSDV 0.04% (n=1)
NWGANATDV 0.04% (n=1)
NWGQNDSDV 0.04% (n=1)
TYGTNKTDV 0.04% (n=1)
TWGANNTDV 0.04% (n=1)
TWGGNQTDV 0.04% (n=1)
TFGGNKTDV 0.04% (n=1)
TWGANKTDM 0.04% (n=1)
NFGENQTDV 0.04% (n=1)
KWGANETDV 0.04% (n=1)
TWGANATDV 0.04% (n=1)
NWGQNQTDV 0.04% (n=1)
TWGENDADV 0.04% (n=1)
NWGANETDT 0.04% (n=1)
RWGANETDV 0.04% (n=1)
NWGENETDL 0.04% (n=1)
DWGANETDV 0.04% (n=1)
SWGVNETDV 0.04% (n=1)
NWGENDTDM 0.04% (n=1)
TFGENQTDV 0.04% (n=1)
NWGENATDW 0.04% (n=1)
QWGANKTDV 0.04% (n=1)
NWGENKTDK 0.04% (n=1)
TWGGNKTDM 0.04% (n=1)
QWGANETDV 0.04% (n=1)
TWGANTTDV 0.04% (n=1)
RFGANESDV 0.04% (n=1)
TWGESATDV 0.04% (n=1)
NWGASPADV 0.04% (n=1)
SWGGNKTDV 0.04% (n=1)
TWGENKTDF 0.04% (n=1)
TWGANETDR 0.04% (n=1)
RFGVNESDV 0.04% (n=1)
NFGENEADV 0.04% (n=1)
NFGENETDM 0.04% (n=1)
KFGENESDV 0.04% (n=1)
TFGENESDV 0.04% (n=1)
KFGENETDV 0.04% (n=1)
NFGEDETDV 0.04% (n=1)
NFGGNQTDV 0.04% (n=1)
NFGENKADK 0.04% (n=1)
NFGENEKDV 0.04% (n=1)
AFGENETDV 0.04% (n=1)
NFGENTTDV 0.04% (n=1)
SFGANKTDV 0.04% (n=1)
SFGEKETDV 0.04% (n=1)
DFGENETDV 0.04% (n=1)
AFGANETDV 0.04% (n=1)
GFGENETDV 0.04% (n=1)
TFGGNESDV 0.04% (n=1)
NFGENKMDV 0.04% (n=1)
SFGANESDV 0.04% (n=1)
GFGANESDV 0.04% (n=1)
NFGSNDTDV 0.04% (n=1)
TFGGNDTDV 0.04% (n=1)
TFGGNDSDV 0.04% (n=1)
SFGDNVTDV 0.04% (n=1)
TFGENDTDV 0.04% (n=1)
TFGENVTDV 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 3a:

TWGANETDV 19.94% (n=470)
TWGENETDV 15.66% (n=369)
NWGENETDV 13.07% (n=308)
NWGANETDV 7.93% (n=187)
TWGENKTDV 7.93% (n=187)
TWGENESDV 4.03% (n=95)
NWGENESDV 3.82% (n=90)
NWGANESDV 2.72% (n=64)
NWGENKSDV 1.65% (n=39)
SWGENETDV 1.61% (n=38)
TWGENDTDV 1.44% (n=34)
DWGENETDV 1.40% (n=33)
NWGANETDA 1.15% (n=27)
NWGANVTDV 1.10% (n=26)
TWGGNETDV 0.72% (n=17)
TWGANKTDV 0.72% (n=17)
AWGENETDV 0.72% (n=17)
NWGENKTDV 0.72% (n=17)
SWGANETDV 0.59% (n=14)
TWGTNETDV 0.55% (n=13)
SWGANESDV 0.55% (n=13)
TWGANESDV 0.55% (n=13)
TWGENATDV 0.47% (n=11)
TWGGNKTDV 0.42% (n=10)
NWGGNETDV 0.38% (n=9)
NWGGNKTDV 0.38% (n=9)
TWGANDTDV 0.30% (n=7)
YWGENKTDV 0.25% (n=6)
TWGENVTDV 0.21% (n=5)
NWGANKTDV 0.17% (n=4)
GWGANESDV 0.17% (n=4)
NWGENATDV 0.17% (n=4)
RWGENETDV 0.17% (n=4)
TWGGNATDV 0.13% (n=3)
TWGENEADV 0.13% (n=3)
TWGENETDM 0.13% (n=3)
TWGEKETDV 0.13% (n=3)
KWGENETDV 0.13% (n=3)
SWGAKESDV 0.13% (n=3)
TWGENQTDV 0.13% (n=3)
GWGENETDV 0.13% (n=3)
NWGVNETDV 0.13% (n=3)
TWGANKSDV 0.13% (n=3)
TWGENEKDV 0.08% (n=2)
NWGGDETDV 0.08% (n=2)
TWGGNESDV 0.08% (n=2)
YWGENETDV 0.08% (n=2)
FWGANESDV 0.08% (n=2)
SWGANKSDV 0.08% (n=2)
TWGGNVTDV 0.08% (n=2)
TRGENETDV 0.08% (n=2)
RLGENETDV 0.08% (n=2)
NWGANEADV 0.08% (n=2)
TWGVNETDV 0.08% (n=2)
TWGDNESDV 0.08% (n=2)
NWGENVTDV 0.08% (n=2)
SWGENESDV 0.08% (n=2)
NWGGNDTDV 0.08% (n=2)
TWGETEKDV 0.08% (n=2)
NWGENDTDV 0.08% (n=2)
NWGTNETDV 0.08% (n=2)
RWGENQSDV 0.08% (n=2)
NWGGNATDV 0.08% (n=2)
TWGANVTDV 0.08% (n=2)
TWGDNKTDV 0.08% (n=2)
TWGTNVTDV 0.08% (n=2)
TWGMNETDV 0.08% (n=2)
TWGENKTDM 0.08% (n=2)
EWGENETDV 0.08% (n=2)
NWGENQTDV 0.08% (n=2)
TWGANQTDV 0.08% (n=2)
QWGENETDV 0.08% (n=2)
SWGENKTDV 0.08% (n=2)
NWGDNETDV 0.08% (n=2)
AWGANETDV 0.08% (n=2)
NWGANVSDV 0.08% (n=2)
TWGENASDV 0.04% (n=1)
SFGTNETDV 0.04% (n=1)
TWGENVRDV 0.04% (n=1)
TWDANETDV 0.04% (n=1)
NWGANETDM 0.04% (n=1)
NWGADETDV 0.04% (n=1)
GWGGNKSDV 0.04% (n=1)
SFGENETDC 0.04% (n=1)
TWGANTSDV 0.04% (n=1)
NWGADVTDV 0.04% (n=1)
NWSANVTDV 0.04% (n=1)
TWGEDGTDV 0.04% (n=1)
DWGENEADV 0.04% (n=1)
DWSENETDV 0.04% (n=1)
YWGENKTDM 0.04% (n=1)
CWGENKSDV 0.04% (n=1)
NFGENKTDV 0.04% (n=1)
SWGASESDV 0.04% (n=1)
TWGENETDA 0.04% (n=1)
TWGENETGV 0.04% (n=1)
NWGESESDV 0.04% (n=1)
PWGANKTEG 0.04% (n=1)
NGGGDETDV 0.04% (n=1)
SWGENEKDV 0.04% (n=1)
TWGENETDG 0.04% (n=1)
TWGANETDM 0.04% (n=1)
TWSENETDV 0.04% (n=1)
SWSENETDV 0.04% (n=1)
TLSENETDV 0.04% (n=1)
TLGENETDV 0.04% (n=1)
RLGENETNV 0.04% (n=1)
TKSSNETEV 0.04% (n=1)
TWGANETEV 0.04% (n=1)
CSNDNESDV 0.04% (n=1)
NRGANETDV 0.04% (n=1)
NWGANGTDV 0.04% (n=1)
DWGENESDV 0.04% (n=1)
NWGSNDTDV 0.04% (n=1)
DWGANKSDV 0.04% (n=1)
TFGANESDV 0.04% (n=1)
NWGMNETDV 0.04% (n=1)
SWGEKETDV 0.04% (n=1)
NWGENEADV 0.04% (n=1)
NWGDNKTDV 0.04% (n=1)
SWGAEESDV 0.04% (n=1)
NWGRNESDV 0.04% (n=1)
TWGGNDTDL 0.04% (n=1)
GWGENESDV 0.04% (n=1)
NWGQWL*AL 0.04% (n=1)
QW-E-L*AL 0.04% (n=1)
NWGANESDG 0.04% (n=1)
TGGANESDV 0.04% (n=1)
TWGTNATDV 0.04% (n=1)
DWGANESDV 0.04% (n=1)
DWGGKETDV 0.04% (n=1)
DWGANASDV 0.04% (n=1)
NWGANDSDV 0.04% (n=1)
TWGENTTDV 0.04% (n=1)
NWGANDADV 0.04% (n=1)
KWGEGEKDV 0.04% (n=1)
NWGENATDM 0.04% (n=1)
SWGENQTDV 0.04% (n=1)
NFGANKTDV 0.04% (n=1)
SWGANQTDV 0.04% (n=1)
TWGEDKSDV 0.04% (n=1)
KWGENKTDV 0.04% (n=1)
EWGENQTDV 0.04% (n=1)
TWGEQERDV 0.04% (n=1)
TWGENKSDV 0.04% (n=1)
NWGANATDV 0.04% (n=1)
NWGQNDSDV 0.04% (n=1)
TYGTNKTDV 0.04% (n=1)
TWGANNTDV 0.04% (n=1)
TWGGNQTDV 0.04% (n=1)
TFGGNKTDV 0.04% (n=1)
TWGANKTDM 0.04% (n=1)
NFGENQTDV 0.04% (n=1)
KWGANETDV 0.04% (n=1)
TWGANATDV 0.04% (n=1)
NWGQNQTDV 0.04% (n=1)
TWGENDADV 0.04% (n=1)
NWGANETDT 0.04% (n=1)
RWGANETDV 0.04% (n=1)
NWGENETDL 0.04% (n=1)
DWGANETDV 0.04% (n=1)
SWGVNETDV 0.04% (n=1)
NWGENDTDM 0.04% (n=1)
TFGENQTDV 0.04% (n=1)
NWGENATDW 0.04% (n=1)
QWGANKTDV 0.04% (n=1)
NWGENKTDK 0.04% (n=1)
TWGGNKTDM 0.04% (n=1)
QWGANETDV 0.04% (n=1)
TWGANTTDV 0.04% (n=1)
RFGANESDV 0.04% (n=1)
TWGESATDV 0.04% (n=1)
NWGASPADV 0.04% (n=1)
SWGGNKTDV 0.04% (n=1)
TWGENKTDF 0.04% (n=1)
TWGANETDR 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 3b:

NFGENETDV 38.35% (n=130)
NFGANETDV 25.37% (n=86)
NFGANESDV 7.67% (n=26)
TFGENETDV 5.01% (n=17)
SFGENETDV 5.01% (n=17)
NFGENKTDV 2.95% (n=10)
NFGDNETDV 1.18% (n=4)
TFGANETDV 1.18% (n=4)
SFGENESDV 1.18% (n=4)
NFGGNESDV 0.88% (n=3)
NFGENESDV 0.88% (n=3)
NFGENDTDV 0.88% (n=3)
SFGANETDV 0.59% (n=2)
NFGVNETDV 0.59% (n=2)
NFGGNETDV 0.59% (n=2)
TFGEKETDV 0.59% (n=2)
RFGVNESDV 0.29% (n=1)
NFGENEADV 0.29% (n=1)
NFGENETDM 0.29% (n=1)
KFGENESDV 0.29% (n=1)
TFGENESDV 0.29% (n=1)
TFGANESDV 0.29% (n=1)
KFGENETDV 0.29% (n=1)
NFGEDETDV 0.29% (n=1)
NFGGNQTDV 0.29% (n=1)
NFGENKADK 0.29% (n=1)
NFGENEKDV 0.29% (n=1)
AFGENETDV 0.29% (n=1)
NFGENTTDV 0.29% (n=1)
SFGANKTDV 0.29% (n=1)
SFGEKETDV 0.29% (n=1)
DFGENETDV 0.29% (n=1)
AFGANETDV 0.29% (n=1)
GFGENETDV 0.29% (n=1)
RFGENETDV 0.29% (n=1)
TFGGNESDV 0.29% (n=1)
NFGENKMDV 0.29% (n=1)
SFGANESDV 0.29% (n=1)
GFGANESDV 0.29% (n=1)
NFGSNDTDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 4:

TWGENESDV 47.21% (n=110)
TWGENETDV 16.31% (n=38)
TWGENDTDV 8.58% (n=20)
NWGENETDV 7.73% (n=18)
NWGENESDV 1.72% (n=4)
SWGENETDV 1.72% (n=4)
TWGGNETDV 1.29% (n=3)
NWGANETDV 1.29% (n=3)
TWGENVSDV 0.86% (n=2)
TWGANETDV 0.86% (n=2)
NWGENVTDV 0.86% (n=2)
GWGGNETDV 0.86% (n=2)
NWGVNETDV 0.86% (n=2)
NWGENKTDV 0.86% (n=2)
TWGANESDA 0.43% (n=1)
NWGGNETDV 0.43% (n=1)
TWGENASDV 0.43% (n=1)
TLGGNETDV 0.43% (n=1)
TWGDNESDV 0.43% (n=1)
TWGENKTDV 0.43% (n=1)
SWGANETDV 0.43% (n=1)
NWGDNETDV 0.43% (n=1)
SWGDNETDV 0.43% (n=1)
AWGENETDV 0.43% (n=1)
GWGTGKDDV 0.43% (n=1)
SFGGNDTDV 0.43% (n=1)
NWGENATDV 0.43% (n=1)
YWGGNDTDV 0.43% (n=1)
TWGANGTDV 0.43% (n=1)
DWGVNETNV 0.43% (n=1)
DWGGNETDV 0.43% (n=1)
TWGQNKTDV 0.43% (n=1)
NWGENDTDV 0.43% (n=1)
RWGENETDV 0.43% (n=1)
TWGENESDI 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 4a:

TWGENESDV 68.13% (n=109)
TWGENDTDV 12.50% (n=20)
TWGENETDV 10.00% (n=16)
NWGENESDV 2.50% (n=4)
NWGENETDV 2.50% (n=4)
TWGENVSDV 1.25% (n=2)
TWGANESDA 0.63% (n=1)
NWGGNETDV 0.63% (n=1)
TWGENASDV 0.63% (n=1)
TLGGNETDV 0.63% (n=1)
TWGDNESDV 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 4d:

TWGENETDV 84.62% (n=11)
TWGGNETDV 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 5:

NWGSNETDI 28.95% (n=11)
NWGSNETDV 13.16% (n=5)
NWGENETDI 10.53% (n=4)
TWGENETDV 7.89% (n=3)
NWGENETDV 7.89% (n=3)
SWGENETDI 2.63% (n=1)
TWGENETDI 2.63% (n=1)
NWGSNDTDI 2.63% (n=1)
NWGENDTDI 2.63% (n=1)
DWGSNESDV 2.63% (n=1)
SWGDNETDV 2.63% (n=1)
SWGANETDV 2.63% (n=1)
TWGTNETDI 2.63% (n=1)
SWGSNDTDI 2.63% (n=1)
NWGVNETDV 2.63% (n=1)
NWGENDTDV 2.63% (n=1)
NWGSNVTDF 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 6:

TWGENETDV 37.17% (n=126)
TWGENESDV 11.21% (n=38)
NWGENETDV 4.72% (n=16)
NWGENVSDV 3.83% (n=13)
TWGANESDV 2.65% (n=9)
NWGENESDV 2.36% (n=8)
TWGDNETDV 1.77% (n=6)
NWGDNETDV 1.77% (n=6)
TWGENVSDV 1.77% (n=6)
NWGENMSDV 1.77% (n=6)
NWGENASDV 1.77% (n=6)
SWGENESDV 1.47% (n=5)
NWGANVSDV 1.47% (n=5)
SWGENETDV 1.18% (n=4)
TWGANETDV 1.18% (n=4)
TWGGNESDV 1.18% (n=4)
NWGENATDV 0.88% (n=3)
NWGGNVSDV 0.88% (n=3)
NWGANESDV 0.88% (n=3)
TWGTNETDV 0.88% (n=3)
NWGANASDV 0.88% (n=3)
TWGDNESDV 0.88% (n=3)
TWGENVTDV 0.59% (n=2)
SWGVNESDV 0.59% (n=2)
AWGANETDV 0.59% (n=2)
AWGENETDV 0.59% (n=2)
NWGDNESDV 0.59% (n=2)
NWGDNVSDV 0.59% (n=2)
TWGANATDV 0.59% (n=2)
TWGENWTDV 0.29% (n=1)
TWGQNETDV 0.29% (n=1)
SWGDNETDV 0.29% (n=1)
NWGENVTDV 0.29% (n=1)
HWGENETDV 0.29% (n=1)
NWGENDTDV 0.29% (n=1)
TWGKNETDV 0.29% (n=1)
TFGENETDV 0.29% (n=1)
SFGDNETDV 0.29% (n=1)
SFGDNESDV 0.29% (n=1)
EWGENASDV 0.29% (n=1)
NWGVNESDV 0.29% (n=1)
QWGENQSDV 0.29% (n=1)
TWGENITDV 0.29% (n=1)
GWGGNDSDV 0.29% (n=1)
DWGENVTDV 0.29% (n=1)
SWGGNETDV 0.29% (n=1)
TWGDNVSDV 0.29% (n=1)
NWGNNMSDV 0.29% (n=1)
NWGANETDV 0.29% (n=1)
NWGDNVTDV 0.29% (n=1)
NWGDNMSDV 0.29% (n=1)
SWGENVSDV 0.29% (n=1)
TWGENASDV 0.29% (n=1)
NWGVNVSDV 0.29% (n=1)
PWGGNDSDV 0.29% (n=1)
GWGENETDV 0.29% (n=1)
RWGENETDV 0.29% (n=1)
TWGDNKTDV 0.29% (n=1)
TWGENMTDV 0.29% (n=1)
TWGANKTDV 0.29% (n=1)
TLGENESDV 0.29% (n=1)
AWGENKSDV 0.29% (n=1)
NWGANEGDV 0.29% (n=1)
TWGENDSDV 0.29% (n=1)
SWGANESDV 0.29% (n=1)
NWGGNETDV 0.29% (n=1)
TWGENETDI 0.29% (n=1)
TWGEHETDV 0.29% (n=1)
TWGVNETDV 0.29% (n=1)
NWGDNDTDV 0.29% (n=1)
NFGENESDV 0.29% (n=1)
NWGGNESDV 0.29% (n=1)
SWGENQSDV 0.29% (n=1)
TWGANKSDV 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Subtype 6a:

TWGENETDV 79.34% (n=96)
TWGDNETDV 4.96% (n=6)
NWGENETDV 4.13% (n=5)
NWGDNETDV 2.48% (n=3)
TWGENESDV 0.83% (n=1)
TWGENVTDV 0.83% (n=1)
TWGENWTDV 0.83% (n=1)
TWGQNETDV 0.83% (n=1)
SWGDNETDV 0.83% (n=1)
NWGENVTDV 0.83% (n=1)
SWGENETDV 0.83% (n=1)
HWGENETDV 0.83% (n=1)
NWGENDTDV 0.83% (n=1)
TWGKNETDV 0.83% (n=1)
TWGANETDV 0.83% (n=1)
---------------------------------------------------------------------------------------
Region 528-536 (antibodies: [HC-1] ), HCV Genotype 7:

TWGENESDV 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 424-432 (antibodies: [HC-11] ), HCV Genotype 1:

RTALNCNDS 53.03% (n=12182)
RTALNCNAS 14.83% (n=3406)
STALNCNDS 14.81% (n=3401)
RTALNCNES 5.60% (n=1286)
STALNCNAS 4.59% (n=1054)
RTALNCNDT 1.21% (n=278)
STALNCNES 0.81% (n=187)
STALNCNTS 0.69% (n=159)
RTSLNCNDS 0.51% (n=117)
RTALNCKDS 0.44% (n=101)
RTALNCEDS 0.44% (n=100)
STALNCNDT 0.27% (n=61)
RTALSCNAS 0.19% (n=44)
RTALSCNDS 0.18% (n=42)
RTALNCDDS 0.14% (n=33)
RTALNCNTS 0.13% (n=29)
STSLNCNDS 0.11% (n=25)
RAALNCNDS 0.10% (n=23)
RTALNCNSS 0.10% (n=23)
RTALNCNDA 0.10% (n=23)
RTALNRNDS 0.08% (n=19)
RTALNCNVS 0.08% (n=18)
RTALNCSDS 0.07% (n=15)
RTALNCNDP 0.06% (n=14)
RTALNCNGS 0.06% (n=13)
STALNCNGS 0.05% (n=12)
RTALDCNDS 0.05% (n=12)
RTAPNCNDS 0.05% (n=12)
GTALNCNDS 0.05% (n=11)
RAALNCNAS 0.03% (n=8)
RTVLNCNDS 0.03% (n=8)
RTASNCNAS 0.03% (n=7)
RTALNCNNS 0.03% (n=7)
RTALNCDAS 0.03% (n=7)
RTALNCNAN 0.03% (n=6)
RTTLNCNDS 0.02% (n=5)
RTALNCDES 0.02% (n=5)
RTALNCSAS 0.02% (n=5)
RTALNCFDS 0.02% (n=5)
KTALNCNDS 0.02% (n=4)
RMALNCNDS 0.02% (n=4)
HTALNCNAS 0.02% (n=4)
RTALNCNAG 0.02% (n=4)
STALNCDAS 0.02% (n=4)
RTALNCNDG 0.02% (n=4)
CTALNCNAS 0.02% (n=4)
RTALNYNDS 0.02% (n=4)
STALNRNES 0.01% (n=3)
HTALNCNDS 0.01% (n=3)
RSALNCNDS 0.01% (n=3)
STALNRNDS 0.01% (n=3)
RTALNCNEG 0.01% (n=3)
STALNCNSS 0.01% (n=3)
STALNCSDS 0.01% (n=2)
RTALTCNAS 0.01% (n=2)
RTGLNCNAS 0.01% (n=2)
RTALNCKAS 0.01% (n=2)
PTALNCNAS 0.01% (n=2)
SAALNCNDS 0.01% (n=2)
RTALNYNAS 0.01% (n=2)
SMALNCNDS 0.01% (n=2)
RMALNCNAS 0.01% (n=2)
STALNCNDN 0.01% (n=2)
RTASNCNDS 0.01% (n=2)
STALNCNDG 0.01% (n=2)
STALNCNNS 0.01% (n=2)
STALNCDDS 0.01% (n=2)
QTALNCNAS 0.01% (n=2)
RTALNCNEN 0.01% (n=2)
RTALDCNAS 0.01% (n=2)
TTALNCNDS 0.01% (n=2)
RTALSCDAS 0.01% (n=2)
STAPNCNDS 0.01% (n=2)
RTALNGNDS 0.01% (n=2)
RTALTCNGS 0.01% (n=2)
RAALSCNAS 0.01% (n=2)
RTALHCNAS 0.01% (n=2)
LTALNCNDS 0.01% (n=2)
RTVLNCNES 0.01% (n=2)
RTALNFNAS 0.01% (n=2)
STALNCYDS 0.01% (n=2)
TTALNCNAS 0.01% (n=2)
RTALSCNES 0.01% (n=2)
RTALKCNDS 0.01% (n=2)
STALRCNDT 0.01% (n=2)
RTAVNCNDS 0.01% (n=2)
STALKCNGS 0.00% (n=1)
STAFNCNDS 0.00% (n=1)
RTTLNCNAS 0.00% (n=1)
SAALNCNES 0.00% (n=1)
STALICNES 0.00% (n=1)
SSALNCNDS 0.00% (n=1)
STALKCNDS 0.00% (n=1)
STALNCNDP 0.00% (n=1)
RTALNCNDN 0.00% (n=1)
STAPPTAMI 0.00% (n=1)
RTALNWNDR 0.00% (n=1)
RAALNCNTS 0.00% (n=1)
STALDCNDS 0.00% (n=1)
RRALNCNAS 0.00% (n=1)
STTLNCNDS 0.00% (n=1)
CTALNCNDS 0.00% (n=1)
STALTCNDS 0.00% (n=1)
RKALNCNDS 0.00% (n=1)
STALNSNDS 0.00% (n=1)
STASNCNDS 0.00% (n=1)
RTARNCNES 0.00% (n=1)
RTALTCNDS 0.00% (n=1)
NTALNCNES 0.00% (n=1)
------QSG 0.00% (n=1)
RTALNCEAS 0.00% (n=1)
RTSLNCDDS 0.00% (n=1)
RTALNCSDT 0.00% (n=1)
RTSLNCNAS 0.00% (n=1)
STALNCHDS 0.00% (n=1)
-TALNCNDS 0.00% (n=1)
STALNCNET 0.00% (n=1)
RSALNCNAS 0.00% (n=1)
RTALNCNAC 0.00% (n=1)
STALSCDDS 0.00% (n=1)
STVPNCNDS 0.00% (n=1)
NTALNCNDS 0.00% (n=1)
RTALICNDS 0.00% (n=1)
RTALNCQDS 0.00% (n=1)
RTARNCNAS 0.00% (n=1)
RTALDCNES 0.00% (n=1)
STALSCNAS 0.00% (n=1)
RTALN---- 0.00% (n=1)
TTSLNCNDS 0.00% (n=1)
RTALNCNDI 0.00% (n=1)
RTAMSRNAS 0.00% (n=1)
RTVLSCNAS 0.00% (n=1)
HTALSCNAS 0.00% (n=1)
RTALSRNAS 0.00% (n=1)
RTAMSCNAS 0.00% (n=1)
RTALGCNAS 0.00% (n=1)
RTALNRNAS 0.00% (n=1)
STALSCNDS 0.00% (n=1)
STVLNCNDS 0.00% (n=1)
RTALNCN-S 0.00% (n=1)
SIALNCNTS 0.00% (n=1)
STALNCNTG 0.00% (n=1)
STALNCSTS 0.00% (n=1)
SAALNCNTS 0.00% (n=1)
STALNRNTS 0.00% (n=1)
RIALNCNAS 0.00% (n=1)
RTALACNDS 0.00% (n=1)
STALSCKDS 0.00% (n=1)
STALSCNES 0.00% (n=1)
RTAVNCNAS 0.00% (n=1)
RTALDCKAS 0.00% (n=1)
RTALNWDDS 0.00% (n=1)
RSALNCNDA 0.00% (n=1)
RTALNRNDA 0.00% (n=1)
TGPPELHDS 0.00% (n=1)
RNALNCNDS 0.00% (n=1)
RTALNCYDS 0.00% (n=1)
RTPLNCNDS 0.00% (n=1)
RTALNCTDS 0.00% (n=1)
RTAMNCNDS 0.00% (n=1)
RTALNCNDF 0.00% (n=1)
RIALNCNDS 0.00% (n=1)
RTGLNCNDS 0.00% (n=1)
RTAPNCNDT 0.00% (n=1)
RTALYCNDS 0.00% (n=1)
RTALNCHDA 0.00% (n=1)
RTALNCNGT 0.00% (n=1)
RTAMNCKDS 0.00% (n=1)
ETALNCNDS 0.00% (n=1)
RTSLNCNES 0.00% (n=1)
RTSLNCNDT 0.00% (n=1)
RTALNCYDT 0.00% (n=1)
RTAFNCNDS 0.00% (n=1)
RPALNCNDS 0.00% (n=1)
WTALNCNDS 0.00% (n=1)
RTAHNCNDS 0.00% (n=1)
RTALNCKDT 0.00% (n=1)
RTALNCN-- 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 1a:

RTALNCNDS 32.05% (n=4379)
RTALNCNAS 24.90% (n=3402)
STALNCNDS 23.28% (n=3180)
STALNCNAS 7.71% (n=1053)
RTALNCNES 5.75% (n=786)
STALNCNES 1.36% (n=186)
STALNCNTS 1.16% (n=159)
STALNCNDT 0.39% (n=53)
RTALNCKDS 0.34% (n=46)
RTALSCNAS 0.32% (n=44)
RTALNCEDS 0.23% (n=32)
RTALNCNTS 0.21% (n=29)
RTALNCNSS 0.17% (n=23)
STALNCNGS 0.09% (n=12)
RAALNCNDS 0.08% (n=11)
RTALSCNDS 0.07% (n=9)
RTALNCNVS 0.07% (n=9)
RTALNCDDS 0.06% (n=8)
RAALNCNAS 0.06% (n=8)
RTALNCSDS 0.06% (n=8)
RTASNCNAS 0.05% (n=7)
RTALNCDAS 0.05% (n=7)
RTALNCNAN 0.04% (n=6)
RTALNCNGS 0.04% (n=5)
RTALNCSAS 0.04% (n=5)
RTALNCNDT 0.04% (n=5)
RMALNCNDS 0.03% (n=4)
HTALNCNAS 0.03% (n=4)
RTALNCNAG 0.03% (n=4)
STALNCDAS 0.03% (n=4)
RTALNCNNS 0.03% (n=4)
RTAPNCNDS 0.03% (n=4)
RTALNCNDG 0.03% (n=4)
CTALNCNAS 0.03% (n=4)
STALNRNES 0.02% (n=3)
HTALNCNDS 0.02% (n=3)
RTALNRNDS 0.02% (n=3)
RSALNCNDS 0.02% (n=3)
STALNRNDS 0.02% (n=3)
GTALNCNDS 0.02% (n=3)
RTALNCDES 0.02% (n=3)
RTALNCNEG 0.02% (n=3)
STALNCNSS 0.02% (n=3)
STALNCSDS 0.01% (n=2)
RTALTCNAS 0.01% (n=2)
RTGLNCNAS 0.01% (n=2)
RTALNCKAS 0.01% (n=2)
PTALNCNAS 0.01% (n=2)
SAALNCNDS 0.01% (n=2)
RTALNYNAS 0.01% (n=2)
SMALNCNDS 0.01% (n=2)
RMALNCNAS 0.01% (n=2)
KTALNCNDS 0.01% (n=2)
STALNCNDN 0.01% (n=2)
RTALDCNDS 0.01% (n=2)
RTASNCNDS 0.01% (n=2)
STALNCNDG 0.01% (n=2)
STALNCNNS 0.01% (n=2)
STALNCDDS 0.01% (n=2)
QTALNCNAS 0.01% (n=2)
RTALNCNEN 0.01% (n=2)
RTALDCNAS 0.01% (n=2)
TTALNCNDS 0.01% (n=2)
RTALSCDAS 0.01% (n=2)
RTVLNCNDS 0.01% (n=2)
RTALNGNDS 0.01% (n=2)
RTALTCNGS 0.01% (n=2)
RAALSCNAS 0.01% (n=2)
RTALHCNAS 0.01% (n=2)
LTALNCNDS 0.01% (n=2)
RTALNFNAS 0.01% (n=2)
STALNCYDS 0.01% (n=2)
TTALNCNAS 0.01% (n=2)
STALKCNGS 0.01% (n=1)
STAFNCNDS 0.01% (n=1)
RTTLNCNAS 0.01% (n=1)
SAALNCNES 0.01% (n=1)
STALICNES 0.01% (n=1)
SSALNCNDS 0.01% (n=1)
STALKCNDS 0.01% (n=1)
STALNCNDP 0.01% (n=1)
RTALNCNDN 0.01% (n=1)
STAPPTAMI 0.01% (n=1)
RTTLNCNDS 0.01% (n=1)
RTALNWNDR 0.01% (n=1)
RAALNCNTS 0.01% (n=1)
STALDCNDS 0.01% (n=1)
RRALNCNAS 0.01% (n=1)
STTLNCNDS 0.01% (n=1)
CTALNCNDS 0.01% (n=1)
STALTCNDS 0.01% (n=1)
RKALNCNDS 0.01% (n=1)
STALNSNDS 0.01% (n=1)
STASNCNDS 0.01% (n=1)
RTARNCNES 0.01% (n=1)
RTALTCNDS 0.01% (n=1)
RTALNCNDA 0.01% (n=1)
NTALNCNES 0.01% (n=1)
------QSG 0.01% (n=1)
RTALNCEAS 0.01% (n=1)
RTSLNCDDS 0.01% (n=1)
RTALNCSDT 0.01% (n=1)
RTSLNCNAS 0.01% (n=1)
STALNCHDS 0.01% (n=1)
-TALNCNDS 0.01% (n=1)
STALNCNET 0.01% (n=1)
RSALNCNAS 0.01% (n=1)
RTALNCNAC 0.01% (n=1)
STALSCDDS 0.01% (n=1)
STVPNCNDS 0.01% (n=1)
STAPNCNDS 0.01% (n=1)
NTALNCNDS 0.01% (n=1)
RTALICNDS 0.01% (n=1)
RTALNCQDS 0.01% (n=1)
RTARNCNAS 0.01% (n=1)
RTALDCNES 0.01% (n=1)
STALSCNAS 0.01% (n=1)
RTALN---- 0.01% (n=1)
TTSLNCNDS 0.01% (n=1)
RTALNCNDI 0.01% (n=1)
RTAMSRNAS 0.01% (n=1)
RTVLSCNAS 0.01% (n=1)
HTALSCNAS 0.01% (n=1)
RTALSRNAS 0.01% (n=1)
RTAMSCNAS 0.01% (n=1)
RTALGCNAS 0.01% (n=1)
RTALNRNAS 0.01% (n=1)
STALSCNDS 0.01% (n=1)
RTVLNCNES 0.01% (n=1)
RTSLNCNDS 0.01% (n=1)
RTALNYNDS 0.01% (n=1)
STVLNCNDS 0.01% (n=1)
RTALNCN-S 0.01% (n=1)
SIALNCNTS 0.01% (n=1)
STALNCNTG 0.01% (n=1)
STALNCSTS 0.01% (n=1)
SAALNCNTS 0.01% (n=1)
STALNRNTS 0.01% (n=1)
RIALNCNAS 0.01% (n=1)
RTALSCNES 0.01% (n=1)
RTALACNDS 0.01% (n=1)
STALSCKDS 0.01% (n=1)
STALSCNES 0.01% (n=1)
RTAVNCNAS 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 1b:

RTALNCNDS 83.97% (n=7777)
RTALNCNES 5.34% (n=495)
RTALNCNDT 2.93% (n=271)
STALNCNDS 2.36% (n=219)
RTSLNCNDS 1.23% (n=114)
RTALNCEDS 0.73% (n=68)
RTALNCKDS 0.59% (n=55)
RTALSCNDS 0.33% (n=31)
RTALNCDDS 0.27% (n=25)
STSLNCNDS 0.27% (n=25)
RTALNCNDA 0.24% (n=22)
RTALNRNDS 0.17% (n=16)
RTALNCNDP 0.15% (n=14)
RAALNCNDS 0.13% (n=12)
RTALDCNDS 0.11% (n=10)
RTALNCNVS 0.10% (n=9)
RTALNCNGS 0.09% (n=8)
RTAPNCNDS 0.09% (n=8)
GTALNCNDS 0.09% (n=8)
STALNCNDT 0.09% (n=8)
RTALNCSDS 0.08% (n=7)
RTVLNCNDS 0.06% (n=6)
RTTLNCNDS 0.04% (n=4)
RTALNCNNS 0.03% (n=3)
RTALNYNDS 0.03% (n=3)
RTALNCNAS 0.02% (n=2)
RTALKCNDS 0.02% (n=2)
STALRCNDT 0.02% (n=2)
RTAVNCNDS 0.02% (n=2)
RTALNCDES 0.02% (n=2)
KTALNCNDS 0.02% (n=2)
RTALDCKAS 0.01% (n=1)
RTALNWDDS 0.01% (n=1)
RSALNCNDA 0.01% (n=1)
RTALNRNDA 0.01% (n=1)
TGPPELHDS 0.01% (n=1)
RNALNCNDS 0.01% (n=1)
RTALNCYDS 0.01% (n=1)
RTPLNCNDS 0.01% (n=1)
RTALNCTDS 0.01% (n=1)
RTAMNCNDS 0.01% (n=1)
RTALNCNDF 0.01% (n=1)
RIALNCNDS 0.01% (n=1)
RTGLNCNDS 0.01% (n=1)
RTALSCNES 0.01% (n=1)
RTAPNCNDT 0.01% (n=1)
STALNCNES 0.01% (n=1)
RTVLNCNES 0.01% (n=1)
RTALYCNDS 0.01% (n=1)
RTALNCHDA 0.01% (n=1)
RTALNCNGT 0.01% (n=1)
RTAMNCKDS 0.01% (n=1)
STAPNCNDS 0.01% (n=1)
ETALNCNDS 0.01% (n=1)
RTSLNCNES 0.01% (n=1)
RTSLNCNDT 0.01% (n=1)
RTALNCYDT 0.01% (n=1)
RTAFNCNDS 0.01% (n=1)
RPALNCNDS 0.01% (n=1)
WTALNCNDS 0.01% (n=1)
RTAHNCNDS 0.01% (n=1)
RTALNCKDT 0.01% (n=1)
RTALNCN-- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 2:

RTALNCNDS 92.37% (n=1247)
RTALNCNES 2.15% (n=29)
RTALNCNAS 1.63% (n=22)
RTALNCNDT 0.74% (n=10)
RTALNCSDS 0.59% (n=8)
RTALNCDDS 0.30% (n=4)
STALNCNDS 0.22% (n=3)
RTALKCNDS 0.15% (n=2)
RIALNCNDS 0.15% (n=2)
RTALNCNDR 0.15% (n=2)
RTALNCNNS 0.07% (n=1)
RTAPNCNDS 0.07% (n=1)
RTALNCKDS 0.07% (n=1)
RTALNCHDS 0.07% (n=1)
RTALNCNDP 0.07% (n=1)
RTALNCAKL 0.07% (n=1)
RTALNCEKL 0.07% (n=1)
RTALNCEDS 0.07% (n=1)
RHPLTAMTP 0.07% (n=1)
RTALDCNES 0.07% (n=1)
RTGLNCNES 0.07% (n=1)
RTALNYNES 0.07% (n=1)
RTALNCNSS 0.07% (n=1)
RAALDCNDS 0.07% (n=1)
RTALNCNDN 0.07% (n=1)
RTALNCMTS 0.07% (n=1)
RTTLNCNDS 0.07% (n=1)
RTALNCNDG 0.07% (n=1)
RTALDCNDS 0.07% (n=1)
WTALNCNDS 0.07% (n=1)
RTALNCHDN 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 2a:

RTALNCNDS 90.69% (n=263)
RTALNCSDS 2.41% (n=7)
RTALNCDDS 1.38% (n=4)
STALNCNDS 1.03% (n=3)
RTALNCNES 0.69% (n=2)
RTALNCNDT 0.69% (n=2)
RIALNCNDS 0.34% (n=1)
RTAPNCNDS 0.34% (n=1)
RTALNCKDS 0.34% (n=1)
RTALNCHDS 0.34% (n=1)
RTALNCNDP 0.34% (n=1)
RTALNCAKL 0.34% (n=1)
RTALNCEKL 0.34% (n=1)
RTALNCEDS 0.34% (n=1)
RHPLTAMTP 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 2b:

RTALNCNDS 87.42% (n=403)
RTALNCNES 5.42% (n=25)
RTALNCNAS 4.34% (n=20)
RTALNCNDT 0.87% (n=4)
RTALKCNDS 0.22% (n=1)
RTALDCNES 0.22% (n=1)
RTGLNCNES 0.22% (n=1)
RTALNYNES 0.22% (n=1)
RTALNCNSS 0.22% (n=1)
RAALDCNDS 0.22% (n=1)
RTALNCNDN 0.22% (n=1)
RTALNCMTS 0.22% (n=1)
RTTLNCNDS 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 2c:

RTALNCNDS 96.92% (n=440)
RTALNCNDT 0.44% (n=2)
RTALNCNES 0.44% (n=2)
RTALNCNAS 0.44% (n=2)
RTALNCNDR 0.44% (n=2)
RTALNCSDS 0.22% (n=1)
RTALNCNDG 0.22% (n=1)
RTALDCNDS 0.22% (n=1)
WTALNCNDS 0.22% (n=1)
RIALNCNDS 0.22% (n=1)
RTALNCHDN 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 3:

STALNCNES 28.49% (n=1113)
STALNCNDS 23.84% (n=931)
RTALNCNDS 17.54% (n=685)
RTALNCNES 11.55% (n=451)
RTALNCNDT 7.04% (n=275)
STALSCNDS 3.51% (n=137)
RTALNCDES 2.36% (n=92)
STALNCDES 1.23% (n=48)
RTALNCDDS 0.84% (n=33)
STALNCNDT 0.44% (n=17)
RTSLNCNDS 0.33% (n=13)
RT------- 0.33% (n=13)
STALNCDDS 0.26% (n=10)
RTALNCNAS 0.18% (n=7)
STALNCNDP 0.15% (n=6)
STALNCKDS 0.10% (n=4)
TTALNCNDT 0.10% (n=4)
RTSLNRNDS 0.08% (n=3)
RTALNCNTS 0.08% (n=3)
STALSCNDT 0.08% (n=3)
STAPNCNES 0.05% (n=2)
STVLNCNES 0.05% (n=2)
STALNCNNS 0.05% (n=2)
RTAPNCNES 0.05% (n=2)
RTARNCNES 0.05% (n=2)
RAALNCNDS 0.05% (n=2)
RTALDCDDS 0.05% (n=2)
STVLHCNES 0.05% (n=2)
STAPNCNDS 0.05% (n=2)
STALNCNTS 0.05% (n=2)
STALNCNAS 0.05% (n=2)
STSLNCNES 0.03% (n=1)
RTVLNCNDS 0.03% (n=1)
GAALNCNES 0.03% (n=1)
STALNCYES 0.03% (n=1)
CTALNCDES 0.03% (n=1)
RAALNCNES 0.03% (n=1)
STALNCSDS 0.03% (n=1)
STALNCNEA 0.03% (n=1)
RTAPTCNES 0.03% (n=1)
WTAGNGNES 0.03% (n=1)
RTALNCNEY 0.03% (n=1)
GTALNCNES 0.03% (n=1)
RTALNCNGS 0.03% (n=1)
RTALNCNDP 0.03% (n=1)
RTALSCNDS 0.03% (n=1)
RAALNCDDS 0.03% (n=1)
SAALNCNES 0.03% (n=1)
STALNCSES 0.03% (n=1)
RTALNCGES 0.03% (n=1)
RAALNCDES 0.03% (n=1)
GTALNCDES 0.03% (n=1)
STSLNCNDS 0.03% (n=1)
------NES 0.03% (n=1)
ST------- 0.03% (n=1)
RTALNCDET 0.03% (n=1)
RTALNCEDA 0.03% (n=1)
QTALNCNDS 0.03% (n=1)
RTSLNCNES 0.03% (n=1)
RTALNCKDS 0.03% (n=1)
STALNYNDS 0.03% (n=1)
STALNCNDA 0.03% (n=1)
STARNCNDS 0.03% (n=1)
STALTCNES 0.03% (n=1)
STALSCHDS 0.03% (n=1)
RTALNRNDS 0.03% (n=1)
RTALNCDDA 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 3a:

STALNCNES 33.28% (n=1091)
STALNCNDS 22.00% (n=721)
RTALNCNDS 14.92% (n=489)
RTALNCNES 12.84% (n=421)
RTALNCNDT 8.33% (n=273)
RTALNCDES 2.81% (n=92)
STALNCDES 1.46% (n=48)
RTALNCDDS 1.01% (n=33)
RTSLNCNDS 0.40% (n=13)
RT------- 0.40% (n=13)
STALNCDDS 0.24% (n=8)
RTALNCNAS 0.21% (n=7)
STALNCNDP 0.18% (n=6)
RTSLNRNDS 0.09% (n=3)
STALNCNDT 0.09% (n=3)
RTALNCNTS 0.09% (n=3)
STAPNCNES 0.06% (n=2)
STVLNCNES 0.06% (n=2)
STALNCNNS 0.06% (n=2)
RTAPNCNES 0.06% (n=2)
RTARNCNES 0.06% (n=2)
RAALNCNDS 0.06% (n=2)
RTALDCDDS 0.06% (n=2)
STVLHCNES 0.06% (n=2)
STAPNCNDS 0.06% (n=2)
STALNCNTS 0.06% (n=2)
STALSCNDS 0.06% (n=2)
STALNCNAS 0.06% (n=2)
STSLNCNES 0.03% (n=1)
RTVLNCNDS 0.03% (n=1)
GAALNCNES 0.03% (n=1)
STALNCYES 0.03% (n=1)
CTALNCDES 0.03% (n=1)
RAALNCNES 0.03% (n=1)
STALNCSDS 0.03% (n=1)
STALNCNEA 0.03% (n=1)
RTAPTCNES 0.03% (n=1)
WTAGNGNES 0.03% (n=1)
RTALNCNEY 0.03% (n=1)
GTALNCNES 0.03% (n=1)
RTALNCNGS 0.03% (n=1)
RTALNCNDP 0.03% (n=1)
RTALSCNDS 0.03% (n=1)
RAALNCDDS 0.03% (n=1)
SAALNCNES 0.03% (n=1)
STALNCSES 0.03% (n=1)
RTALNCGES 0.03% (n=1)
RAALNCDES 0.03% (n=1)
GTALNCDES 0.03% (n=1)
STSLNCNDS 0.03% (n=1)
STALNCKDS 0.03% (n=1)
------NES 0.03% (n=1)
ST------- 0.03% (n=1)
RTALNCDET 0.03% (n=1)
RTALNCEDA 0.03% (n=1)
QTALNCNDS 0.03% (n=1)
RTSLNCNES 0.03% (n=1)
RTALNCKDS 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 3b:

STALNCNDS 51.86% (n=209)
STALSCNDS 33.50% (n=135)
STALNCNES 5.46% (n=22)
STALNCNDT 3.47% (n=14)
RTALNCNDS 1.49% (n=6)
TTALNCNDT 0.99% (n=4)
STALSCNDT 0.74% (n=3)
STALNCKDS 0.50% (n=2)
STALNCDDS 0.50% (n=2)
STALNYNDS 0.25% (n=1)
RTALNCNES 0.25% (n=1)
STALNCNDA 0.25% (n=1)
STARNCNDS 0.25% (n=1)
STALTCNES 0.25% (n=1)
STALSCHDS 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 4:

RTALNCNDS 89.78% (n=685)
RTALNCDDS 6.95% (n=53)
RTSLNCNDS 1.31% (n=10)
RTALNCKDS 0.92% (n=7)
STALNCNDS 0.39% (n=3)
RTALNCNES 0.26% (n=2)
GTALNCNDS 0.13% (n=1)
RTALNSNDR 0.13% (n=1)
RIALNCNDS 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 4a:

RTALNCNDS 96.91% (n=157)
GTALNCNDS 0.62% (n=1)
RTSLNCNDS 0.62% (n=1)
RTALNSNDR 0.62% (n=1)
RTALNCKDS 0.62% (n=1)
RTALNCNES 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 4d:

RTALNCNDS 88.93% (n=482)
RTALNCDDS 9.41% (n=51)
RTALNCKDS 1.11% (n=6)
STALNCNDS 0.37% (n=2)
RIALNCNDS 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 5:

RTALNCNDS 71.74% (n=33)
S-------- 13.04% (n=6)
STALNCNDS 4.35% (n=2)
RTAL----- 2.17% (n=1)
RTALNCNES 2.17% (n=1)
RTALNCHDS 2.17% (n=1)
STALNCNDT 2.17% (n=1)
RTALNCQDS 2.17% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 6:

RTALNCNDS 92.23% (n=534)
RTALNCNDT 2.94% (n=17)
RTALNCNES 1.55% (n=9)
RTALNCIDS 0.69% (n=4)
STALNCNDS 0.69% (n=4)
RTALNCDDS 0.69% (n=4)
RTALSCNDS 0.52% (n=3)
RTALNCNAS 0.17% (n=1)
RTALNCDES 0.17% (n=1)
RTALNCEDS 0.17% (n=1)
RTALNCKDS 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Subtype 6a:

RTALNCNDS 97.27% (n=321)
RTALNCNDT 1.82% (n=6)
RTALNCIDS 0.30% (n=1)
STALNCNDS 0.30% (n=1)
RTALNCNAS 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 424-432 (antibodies: [HC-11] ), HCV Genotype 7:

RTALNCNDS 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 1:

GFLAALFYT 14.44% (n=3305)
GWLAGLFYH 7.69% (n=1760)
GWIAGLFYY 6.99% (n=1600)
GWVAGLFYY 6.86% (n=1571)
GFLAALFYA 4.37% (n=1000)
GWVAGLLYY 3.78% (n=866)
GWVAGLFYH 3.62% (n=829)
GWLAGLFYY 3.08% (n=704)
GWIAGLLYY 3.05% (n=699)
GFIAALFYA 2.97% (n=679)
GWIAGLFYH 2.95% (n=675)
GFLAALFYV 2.39% (n=548)
GWLAALFYT 2.26% (n=517)
GFIAALFYT 2.03% (n=465)
GWIAGLFYR 1.97% (n=451)
GFIAALFYR 1.87% (n=428)
GWIAGLLYH 1.66% (n=381)
GFIAALFYV 1.59% (n=363)
GWVAGLFYR 1.55% (n=355)
GFFAALFYA 1.45% (n=332)
GWIAGLFYS 1.43% (n=327)
GWIAGLIYY 1.29% (n=295)
GFISALFYV 1.15% (n=263)
GWIAGLIYH 1.10% (n=251)
GWLAGLLYY 0.90% (n=207)
GWLAGLFYR 0.76% (n=174)
GFLAALFYK 0.74% (n=170)
GWLAGLFYQ 0.70% (n=160)
GWVAGLLYH 0.59% (n=136)
GFIAGLFYY 0.59% (n=134)
GFIAALIYA 0.52% (n=118)
GFIAGLFYH 0.50% (n=114)
GWVAALFYS 0.45% (n=103)
GWVAGLIYY 0.43% (n=98)
GFLASLFYV 0.37% (n=85)
GWLAGLIYY 0.34% (n=77)
GWLAGLLYH 0.31% (n=72)
GFIAGLFHY 0.31% (n=72)
GFLAGLLYA 0.30% (n=69)
GWLAGLVYY 0.30% (n=68)
GWMAGLFYH 0.29% (n=67)
GWLAGLFYS 0.28% (n=64)
GWIAALFYH 0.27% (n=61)
GFIAALLYA 0.25% (n=58)
GFITALFYR 0.25% (n=58)
GWIAGLIYQ 0.24% (n=54)
GWLAALFYR 0.24% (n=54)
GFIAALFYS 0.23% (n=53)
GFIAGLLYA 0.22% (n=51)
GFVAALFYA 0.19% (n=44)
GWITGLFYY 0.18% (n=42)
GFLAALFYS 0.18% (n=42)
GWIAGLLYR 0.18% (n=41)
GWVAGLFYP 0.15% (n=34)
GWIAGLFYT 0.14% (n=32)
GFVAGLFYY 0.14% (n=32)
GWVAGLIYR 0.14% (n=31)
GFIAALIYR 0.14% (n=31)
GFIAGLLYR 0.13% (n=30)
GWLTGLFYV 0.13% (n=29)
GWIAGLFYV 0.11% (n=26)
GFIAALFYK 0.11% (n=25)
GFFAALFYT 0.11% (n=25)
GWIAGLMYY 0.10% (n=24)
GWIAGLFYF 0.10% (n=23)
GFFTALFYA 0.10% (n=23)
GWVAGLFYS 0.10% (n=22)
GWVAGLIYH 0.10% (n=22)
GFFAALFYV 0.10% (n=22)
GWMAGLFYY 0.09% (n=21)
GWIAGLLYS 0.08% (n=19)
GFVAALIYK 0.08% (n=19)
GFFAALFYY 0.08% (n=18)
GWLASLFYS 0.07% (n=17)
GFLAALFYH 0.07% (n=17)
GFIAGLLYY 0.07% (n=16)
GWIAGLIYR 0.07% (n=16)
GFIAALVYA 0.07% (n=16)
GFLAALFYR 0.07% (n=16)
GFLAGLFYH 0.07% (n=15)
GWLAALFYS 0.07% (n=15)
GFLAALIYA 0.07% (n=15)
GWLAALFYA 0.07% (n=15)
GFLSALFYV 0.07% (n=15)
GWLAGLIYF 0.06% (n=14)
GFLTALFYK 0.06% (n=14)
GWLAGLFYF 0.06% (n=13)
GWIAGLLYT 0.06% (n=13)
GFIAALLYY 0.06% (n=13)
GWIAGLFHY 0.05% (n=12)
GWLAGLLYP 0.05% (n=12)
GFIAALFYH 0.05% (n=12)
GWVAGLFYF 0.05% (n=11)
GWIAGLFYA 0.05% (n=11)
GWIAGLIYF 0.05% (n=11)
GFFSALFYV 0.05% (n=11)
GFIAALLYS 0.05% (n=11)
GWLAGLLYR 0.04% (n=10)
GWLAGLIYH 0.04% (n=10)
GWLAGLLYF 0.04% (n=10)
GFLAALSYT 0.04% (n=10)
GFLASLFYA 0.04% (n=10)
GWLAGLMYS 0.04% (n=9)
GFLASLFYT 0.04% (n=9)
GWVTGLFYY 0.03% (n=8)
GWVAALFYY 0.03% (n=8)
GFLAGLFYY 0.03% (n=8)
GWVAALFYA 0.03% (n=8)
GFLAALFYY 0.03% (n=8)
GFIAALLYR 0.03% (n=8)
GFIAALFYY 0.03% (n=8)
GWLAGLMYV 0.03% (n=7)
GWIAGLFYP 0.03% (n=7)
GWLAGLFYV 0.03% (n=7)
GWLAGLFYA 0.03% (n=7)
GWLTGLFHV 0.03% (n=7)
GLLAALFYT 0.03% (n=7)
GFFAALVYA 0.03% (n=7)
GFLAALLYT 0.03% (n=7)
GFISALFYR 0.03% (n=7)
GWLAGLMYI 0.03% (n=6)
GWLAGLFYL 0.03% (n=6)
GWIAGLLYP 0.03% (n=6)
GWLVGLFYY 0.03% (n=6)
GWLAALFYH 0.03% (n=6)
GWLAGLFHH 0.03% (n=6)
GWLAGLFHY 0.03% (n=6)
GWLASLFYT 0.03% (n=6)
GWIAGLLYF 0.03% (n=6)
GFVAALFYT 0.03% (n=6)
GFIAGLFYR 0.02% (n=5)
GWLAGLFYN 0.02% (n=5)
GWLAGLLYV 0.02% (n=5)
AWIAGLLYR 0.02% (n=5)
AGIAGLLYR 0.02% (n=5)
GWVAGLFYL 0.02% (n=5)
GWVAALLYS 0.02% (n=5)
GWIAALFYQ 0.02% (n=5)
GWIAALFYR 0.02% (n=5)
GFISALFYA 0.02% (n=5)
GFLAAPFYT 0.02% (n=5)
GFIASLFYA 0.02% (n=5)
GWLVGLFYH 0.02% (n=4)
GWLAGLFYP 0.02% (n=4)
GFVAGLLYY 0.02% (n=4)
GWLAGLIYQ 0.02% (n=4)
GFIAGLLYH 0.02% (n=4)
GWLAGLFYT 0.02% (n=4)
GFVAALFYR 0.02% (n=4)
GWIVGLFYY 0.02% (n=4)
GWMAGLFYS 0.02% (n=4)
GW------- 0.02% (n=4)
GFLTALFYT 0.02% (n=4)
GFLAVLFYT 0.02% (n=4)
GFFAALIYA 0.02% (n=4)
GSLAALFYT 0.02% (n=4)
GFLAALFHT 0.02% (n=4)
GFFAALFYI 0.02% (n=4)
GFIAALVYR 0.02% (n=4)
GFIAGLFYT 0.02% (n=4)
GFVAALFYS 0.02% (n=4)
GWIAGLFNY 0.01% (n=3)
GWLAGLMYT 0.01% (n=3)
GWLAGLMYF 0.01% (n=3)
GFITSLFYR 0.01% (n=3)
GGVAGLFYY 0.01% (n=3)
GWLAGLIYS 0.01% (n=3)
DWLAGLFYY 0.01% (n=3)
GWLAALFYY 0.01% (n=3)
GWIAGLMYH 0.01% (n=3)
GWLAGLMYH 0.01% (n=3)
GFTAGLFYH 0.01% (n=3)
GWLAGLFNY 0.01% (n=3)
GWLAGLFSY 0.01% (n=3)
GWAAGLFYY 0.01% (n=3)
GWIAGLVYY 0.01% (n=3)
GWLTGLFYY 0.01% (n=3)
GWIAGLLYA 0.01% (n=3)
GWMAGLLYY 0.01% (n=3)
GWIAGLIYA 0.01% (n=3)
G*VAGLFYR 0.01% (n=3)
GWFVGLFYY 0.01% (n=3)
GWMAGLFYR 0.01% (n=3)
GWLTGLFYI 0.01% (n=3)
GWIAGLLYL 0.01% (n=3)
GWIAGLFYL 0.01% (n=3)
GFISALFYT 0.01% (n=3)
GFLAALFNT 0.01% (n=3)
GFLTALFYR 0.01% (n=3)
GFIATLFYT 0.01% (n=3)
EFLAALFYT 0.01% (n=3)
GFIAALMYA 0.01% (n=3)
GFIASLFYV 0.01% (n=3)
GFVAALFYK 0.01% (n=3)
GFIAALLYV 0.01% (n=3)
GWVAALFYH 0.01% (n=2)
GRVAGLFYY 0.01% (n=2)
G*LAGLFYH 0.01% (n=2)
GWLAGLIYA 0.01% (n=2)
GFIAGLFHH 0.01% (n=2)
GWGAGLFYY 0.01% (n=2)
GWLAGLSYH 0.01% (n=2)
GWLAGLF*Y 0.01% (n=2)
GWLAGPFYH 0.01% (n=2)
GWVAGLFHY 0.01% (n=2)
GFMAGLLYH 0.01% (n=2)
GRIAGLFYH 0.01% (n=2)
GWIAGLLYV 0.01% (n=2)
GWLAGLLYS 0.01% (n=2)
AWLAGLLYR 0.01% (n=2)
GWIAGLVYH 0.01% (n=2)
GWLAGLLHY 0.01% (n=2)
GFLAGLFSY 0.01% (n=2)
GWVAGLFYQ 0.01% (n=2)
GFIAGLMYY 0.01% (n=2)
GWLAGPFSY 0.01% (n=2)
GWVAGLLYA 0.01% (n=2)
GWVAGLLYS 0.01% (n=2)
GWVAGLFYV 0.01% (n=2)
GWIAGLVYR 0.01% (n=2)
GWLAGLLYA 0.01% (n=2)
GWIAGLIYL 0.01% (n=2)
GWLAGLFYI 0.01% (n=2)
GWVARLFYY 0.01% (n=2)
GFIAGLIYY 0.01% (n=2)
GWVAGLLYL 0.01% (n=2)
GWVAGLLYF 0.01% (n=2)
GFVAGLIYY 0.01% (n=2)
GFMAGLFYY 0.01% (n=2)
GFIAGLFCY 0.01% (n=2)
GWVAGLLYR 0.01% (n=2)
DWLAGLFYH 0.01% (n=2)
GWIAGLFYC 0.01% (n=2)
GWVAGLFYT 0.01% (n=2)
GFLAGLFYQ 0.01% (n=2)
GFLAALFYF 0.01% (n=2)
GFLAALFYE 0.01% (n=2)
GFLAALLYA 0.01% (n=2)
GFIAALVYS 0.01% (n=2)
GFITALIYS 0.01% (n=2)
GFIDALVYA 0.01% (n=2)
GFLAALLYS 0.01% (n=2)
GFLAALFYQ 0.01% (n=2)
GFITALFYA 0.01% (n=2)
GFFSALFYA 0.01% (n=2)
GVLAALFYT 0.01% (n=2)
GFIAALLYH 0.01% (n=2)
GFVASLFYA 0.01% (n=2)
GWVAALFYT 0.01% (n=2)
GFVAALFYY 0.01% (n=2)
GFIAGLFYA 0.01% (n=2)
GFITALFYT 0.01% (n=2)
RFPAALFYA 0.01% (n=2)
GFIAALVYH 0.01% (n=2)
GFIASLFYT 0.01% (n=2)
GFIAALFCR 0.01% (n=2)
GSIAALFYT 0.01% (n=2)
GFIAALLYT 0.01% (n=2)
GLIAALFYR 0.01% (n=2)
GSLAALFYA 0.01% (n=2)
GFIAALFYI 0.01% (n=2)
GFLAGLFYA 0.01% (n=2)
GFLAALFAR 0.01% (n=2)
GRVAGLFYH 0.00% (n=1)
GWIAGLPYH 0.00% (n=1)
G*IAGLFYH 0.00% (n=1)
GWVAGLFCY 0.00% (n=1)
GWLAGLMYA 0.00% (n=1)
GRVAGLLYY 0.00% (n=1)
GWVAGPFYY 0.00% (n=1)
GWLARLLYY 0.00% (n=1)
GFITRPFYR 0.00% (n=1)
GWLAGPFYP 0.00% (n=1)
GWLAGLLCP 0.00% (n=1)
GWLAGFSYH 0.00% (n=1)
GWVAGLSYH 0.00% (n=1)
GWLAGLVYH 0.00% (n=1)
GWLAGLLYN 0.00% (n=1)
GWIAGLFCS 0.00% (n=1)
SWVAGLFYH 0.00% (n=1)
GWIAGPSYS 0.00% (n=1)
GWDSRAFLF 0.00% (n=1)
RWIGRLFYS 0.00% (n=1)
GWVAGLIYC 0.00% (n=1)
GRVAGLIYR 0.00% (n=1)
GWVAGLIHR 0.00% (n=1)
GWLGSRASS 0.00% (n=1)
GWEAGLFYY 0.00% (n=1)
DWVAGLFYY 0.00% (n=1)
GWIAGLLPQ 0.00% (n=1)
GWVAGLHYY 0.00% (n=1)
GWVAGFLYY 0.00% (n=1)
DWVAGLLYY 0.00% (n=1)
GWLAGLVYS 0.00% (n=1)
GCLAGLFYY 0.00% (n=1)
GWTAGLFYH 0.00% (n=1)
GWLAGHFYH 0.00% (n=1)
GWLAGPLYY 0.00% (n=1)
GWTAGLLYY 0.00% (n=1)
GWMAGLIYH 0.00% (n=1)
GWIAGLNYY 0.00% (n=1)
GWIGGLFYY 0.00% (n=1)
GWVAAPFYY 0.00% (n=1)
GWVAGLFHR 0.00% (n=1)
GWVTGLFYH 0.00% (n=1)
GWKAGLIYY 0.00% (n=1)
GWIAGLTYY 0.00% (n=1)
GFIAGPFYH 0.00% (n=1)
GFITGLLYR 0.00% (n=1)
SWLAGLIYY 0.00% (n=1)
GWLTGLFSY 0.00% (n=1)
GWLAGLIYL 0.00% (n=1)
GLVAGLLYY 0.00% (n=1)
G*VAGLFYY 0.00% (n=1)
GWVAGLFYA 0.00% (n=1)
GWLAGLFYK 0.00% (n=1)
GFIASLFYH 0.00% (n=1)
GFLAGLLYR 0.00% (n=1)
GWIAGLIHH 0.00% (n=1)
GFIAGLIYL 0.00% (n=1)
GFLAGLIYH 0.00% (n=1)
GWIAGLIYT 0.00% (n=1)
GFVAGLFYA 0.00% (n=1)
GYPADQH*R 0.00% (n=1)
GWIAGLFSH 0.00% (n=1)
GFIAGLLYI 0.00% (n=1)
GWVASLFYR 0.00% (n=1)
GWIRGLFYR 0.00% (n=1)
GWLAGLFNH 0.00% (n=1)
GFVAGLFYH 0.00% (n=1)
GWIAGLVYV 0.00% (n=1)
GCIAGLFYY 0.00% (n=1)
GWLVGLLYY 0.00% (n=1)
GWTAGLFYY 0.00% (n=1)
-----LFYH 0.00% (n=1)
GWLAWLFYH 0.00% (n=1)
GWLARLFYR 0.00% (n=1)
GWVAGLFCR 0.00% (n=1)
GWVAELFYS 0.00% (n=1)
GRLVGLFYY 0.00% (n=1)
GWAAGLFYH 0.00% (n=1)
GFLAGLFYR 0.00% (n=1)
GWIAGLLYQ 0.00% (n=1)
GFIAGPFYY 0.00% (n=1)
DFIAGLFYY 0.00% (n=1)
GLTAGLFYY 0.00% (n=1)
GFIAGLFYC 0.00% (n=1)
GFTAGLFYY 0.00% (n=1)
GFIAGLFYD 0.00% (n=1)
GLIAGLFYY 0.00% (n=1)
GWITGLIYH 0.00% (n=1)
G*VAALFYS 0.00% (n=1)
G*IAGLIYY 0.00% (n=1)
GWIAGPIYY 0.00% (n=1)
SWLAGLFYY 0.00% (n=1)
GWLAELFYY 0.00% (n=1)
DWVAGLLYH 0.00% (n=1)
GWVAGLHYH 0.00% (n=1)
GWVVGLLYH 0.00% (n=1)
G*VAGLLYH 0.00% (n=1)
GWKAGLLYY 0.00% (n=1)
GWIAGPLYY 0.00% (n=1)
GWVAGPFYR 0.00% (n=1)
GWWRGLFYH 0.00% (n=1)
GWVPGLFYH 0.00% (n=1)
GWVAGLFCH 0.00% (n=1)
G*IAGLLYH 0.00% (n=1)
GWLSGAPLS 0.00% (n=1)
GFLTGLFYH 0.00% (n=1)
GWIA----- 0.00% (n=1)
G-------- 0.00% (n=1)
SWLAGLFYA 0.00% (n=1)
GWVAGLFSY 0.00% (n=1)
GWVAGFFYH 0.00% (n=1)
GWLAGLSTT 0.00% (n=1)
GFLAALIYR 0.00% (n=1)
GWIAGLIYS 0.00% (n=1)
GWLAGLVYL 0.00% (n=1)
DWLAGLLYY 0.00% (n=1)
GWLAGLLYC 0.00% (n=1)
GWVTGLLYY 0.00% (n=1)
GWLAGLLNY 0.00% (n=1)
GWLAGFLYY 0.00% (n=1)
GWLAGLPYY 0.00% (n=1)
GWLAWLLYY 0.00% (n=1)
GGLAGLFYH 0.00% (n=1)
GWAAGLLYY 0.00% (n=1)
GFIAGLIYR 0.00% (n=1)
GWVAGLFNY 0.00% (n=1)
GWISGLFYS 0.00% (n=1)
GWVAGLFFY 0.00% (n=1)
GWLASLFYR 0.00% (n=1)
GWIAGLFCH 0.00% (n=1)
GWIAGPFYH 0.00% (n=1)
GWAAGLVYY 0.00% (n=1)
GWLARLFYH 0.00% (n=1)
GWVAGLIYL 0.00% (n=1)
GWIAGLFYQ 0.00% (n=1)
GWIAGLSYH 0.00% (n=1)
GFLATLFYV 0.00% (n=1)
GFIATLFYA 0.00% (n=1)
GFLGALFYT 0.00% (n=1)
GFLAALFFT 0.00% (n=1)
GFLATLFYT 0.00% (n=1)
GLLAALFYV 0.00% (n=1)
GFLAALIYT 0.00% (n=1)
GFLPALFYT 0.00% (n=1)
GFITSLFYT 0.00% (n=1)
GFIAALIYY 0.00% (n=1)
GFLAELFYT 0.00% (n=1)
GFLAAL--- 0.00% (n=1)
GFLAGVFYH 0.00% (n=1)
GFLAARFYT 0.00% (n=1)
RFLAALFYK 0.00% (n=1)
GSLAALFYK 0.00% (n=1)
GFLAALFYM 0.00% (n=1)
GWLAALIYK 0.00% (n=1)
GFIASLFYI 0.00% (n=1)
GFIAALFHA 0.00% (n=1)
GFLAALLYK 0.00% (n=1)
GFLAALFFV 0.00% (n=1)
GFIAALIYN 0.00% (n=1)
GFLSALFYA 0.00% (n=1)
GFIAGLIYK 0.00% (n=1)
GWLAALFYK 0.00% (n=1)
GFIKALFYA 0.00% (n=1)
GSLASLFYV 0.00% (n=1)
GFIAALMYV 0.00% (n=1)
GFLVALFYS 0.00% (n=1)
GFLSALFYT 0.00% (n=1)
GFIAELFYT 0.00% (n=1)
GFITALFYS 0.00% (n=1)
GILAALFYT 0.00% (n=1)
GFFVALFYA 0.00% (n=1)
VFFAALFYA 0.00% (n=1)
GFTAALFYT 0.00% (n=1)
GFIAALSYR 0.00% (n=1)
GFIAALSYA 0.00% (n=1)
GFFTVLFYA 0.00% (n=1)
GFLAALFYI 0.00% (n=1)
GFFAALFYF 0.00% (n=1)
GFIASLFYR 0.00% (n=1)
GFMAALFYY 0.00% (n=1)
GFMAALFYV 0.00% (n=1)
GFLTALFYA 0.00% (n=1)
GFIAALIYK 0.00% (n=1)
GFIAALFYG 0.00% (n=1)
GFIAELFYA 0.00% (n=1)
GFLAALVYT 0.00% (n=1)
GFLVALFYT 0.00% (n=1)
GFFAALFYH 0.00% (n=1)
GFLATLFYA 0.00% (n=1)
GLLAALFYA 0.00% (n=1)
GFLVALFYA 0.00% (n=1)
GFLTALFYQ 0.00% (n=1)
GFITSLFYY 0.00% (n=1)
GFMAALFYA 0.00% (n=1)
GFLASLFYI 0.00% (n=1)
GWLASLFYA 0.00% (n=1)
GFFVALFYS 0.00% (n=1)
GFIAALVYV 0.00% (n=1)
GFIATLFYR 0.00% (n=1)
GFIAAPFYV 0.00% (n=1)
GFIAVLFYV 0.00% (n=1)
GSIAALFYR 0.00% (n=1)
GFPAALFYT 0.00% (n=1)
GFLAALFCT 0.00% (n=1)
GFVSALFYV 0.00% (n=1)
GFTSALFYV 0.00% (n=1)
GFISALSYV 0.00% (n=1)
GFISALFHV 0.00% (n=1)
GFISALFCV 0.00% (n=1)
GFVAALFYI 0.00% (n=1)
GFVAALFYV 0.00% (n=1)
GFPAALFYV 0.00% (n=1)
GWLASLFYY 0.00% (n=1)
GWIASLFYY 0.00% (n=1)
GFLVSLFYT 0.00% (n=1)
GFLAGLFYT 0.00% (n=1)
GFLAALFAK 0.00% (n=1)
GFLAALFLR 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 1a:

GWLAGLFYH 12.92% (n=1760)
GWIAGLFYY 11.75% (n=1600)
GWVAGLFYY 11.51% (n=1568)
GWVAGLLYY 6.36% (n=866)
GWVAGLFYH 6.09% (n=829)
GWLAGLFYY 5.17% (n=704)
GWIAGLLYY 5.13% (n=699)
GWIAGLFYH 4.96% (n=675)
GWIAGLFYR 3.31% (n=451)
GWIAGLLYH 2.80% (n=381)
GWVAGLFYR 2.61% (n=355)
GWIAGLFYS 2.40% (n=327)
GWIAGLIYY 2.17% (n=295)
GWIAGLIYH 1.84% (n=251)
GWLAGLLYY 1.51% (n=206)
GWLAGLFYR 1.28% (n=174)
GWLAGLFYQ 1.17% (n=160)
GWVAGLLYH 1.00% (n=136)
GFIAGLFYY 0.98% (n=134)
GFIAGLFYH 0.84% (n=114)
GWVAGLIYY 0.72% (n=98)
GWVAALFYS 0.71% (n=97)
GWLAGLIYY 0.57% (n=77)
GWLAGLLYH 0.53% (n=72)
GFIAGLFHY 0.53% (n=72)
GWLAGLVYY 0.50% (n=68)
GWMAGLFYH 0.49% (n=67)
GFLAGLLYA 0.48% (n=65)
GWLAGLFYS 0.46% (n=63)
GWIAGLIYQ 0.40% (n=54)
GWLAALFYR 0.40% (n=54)
GWIAALFYH 0.36% (n=49)
GWITGLFYY 0.31% (n=42)
GWIAGLLYR 0.30% (n=41)
GWVAGLFYP 0.25% (n=34)
GWIAGLFYT 0.23% (n=32)
GFVAGLFYY 0.23% (n=32)
GWVAGLIYR 0.23% (n=31)
GFIAGLLYR 0.22% (n=30)
GWLTGLFYV 0.21% (n=29)
GWIAGLFYV 0.19% (n=26)
GWIAGLMYY 0.18% (n=24)
GWIAGLFYF 0.17% (n=23)
GWVAGLFYS 0.16% (n=22)
GWVAGLIYH 0.16% (n=22)
GWMAGLFYY 0.15% (n=21)
GWIAGLLYS 0.14% (n=19)
GWIAGLIYR 0.12% (n=16)
GFIAGLLYY 0.11% (n=15)
GFLAGLFYH 0.11% (n=15)
GWLAGLIYF 0.10% (n=14)
GWLAGLFYF 0.10% (n=13)
GWIAGLLYT 0.10% (n=13)
GWIAGLFHY 0.09% (n=12)
GWLAGLLYP 0.09% (n=12)
GWLAALFYS 0.09% (n=12)
GWVAGLFYF 0.08% (n=11)
GWIAGLFYA 0.08% (n=11)
GWIAGLIYF 0.08% (n=11)
GWLAGLLYR 0.07% (n=10)
GWLAGLIYH 0.07% (n=10)
GWLAGLLYF 0.07% (n=10)
GWLAGLMYS 0.07% (n=9)
GWVTGLFYY 0.06% (n=8)
GWVAALFYY 0.06% (n=8)
GWLAGLMYV 0.05% (n=7)
GWIAGLFYP 0.05% (n=7)
GWLAGLFYV 0.05% (n=7)
GWLAGLFYA 0.05% (n=7)
GWVAALFYA 0.05% (n=7)
GWLTGLFHV 0.05% (n=7)
GWLAGLMYI 0.04% (n=6)
GWLAGLFYL 0.04% (n=6)
GWIAGLLYP 0.04% (n=6)
GWLVGLFYY 0.04% (n=6)
GWLAGLFHH 0.04% (n=6)
GWLAGLFHY 0.04% (n=6)
GFLAGLFYY 0.04% (n=6)
GWIAGLLYF 0.04% (n=6)
GFIAGLFYR 0.04% (n=5)
GWLAGLFYN 0.04% (n=5)
GWLAGLLYV 0.04% (n=5)
AWIAGLLYR 0.04% (n=5)
AGIAGLLYR 0.04% (n=5)
GWIAALFYQ 0.04% (n=5)
GWIAALFYR 0.04% (n=5)
GWLVGLFYH 0.03% (n=4)
GWLAGLFYP 0.03% (n=4)
GFVAGLLYY 0.03% (n=4)
GWLAGLIYQ 0.03% (n=4)
GFIAGLLYH 0.03% (n=4)
GWVAGLFYL 0.03% (n=4)
GWLAGLFYT 0.03% (n=4)
GWIVGLFYY 0.03% (n=4)
GWMAGLFYS 0.03% (n=4)
GW------- 0.03% (n=4)
GWIAGLFNY 0.02% (n=3)
GWLAGLMYT 0.02% (n=3)
GWLAGLMYF 0.02% (n=3)
GGVAGLFYY 0.02% (n=3)
GWLAGLIYS 0.02% (n=3)
DWLAGLFYY 0.02% (n=3)
GWIAGLMYH 0.02% (n=3)
GWLAGLMYH 0.02% (n=3)
GFTAGLFYH 0.02% (n=3)
GWLAGLFNY 0.02% (n=3)
GWLAGLFSY 0.02% (n=3)
GWAAGLFYY 0.02% (n=3)
GWIAGLVYY 0.02% (n=3)
GWLTGLFYY 0.02% (n=3)
GWIAGLLYA 0.02% (n=3)
GWMAGLLYY 0.02% (n=3)
GWIAGLIYA 0.02% (n=3)
G*VAGLFYR 0.02% (n=3)
GWFVGLFYY 0.02% (n=3)
GWMAGLFYR 0.02% (n=3)
GWLTGLFYI 0.02% (n=3)
GWIAGLLYL 0.02% (n=3)
GWIAGLFYL 0.02% (n=3)
GRVAGLFYY 0.01% (n=2)
G*LAGLFYH 0.01% (n=2)
GWLAGLIYA 0.01% (n=2)
GFIAGLFHH 0.01% (n=2)
GFITSLFYR 0.01% (n=2)
GWGAGLFYY 0.01% (n=2)
GWLAGLSYH 0.01% (n=2)
GWLAGLF*Y 0.01% (n=2)
GWLAGPFYH 0.01% (n=2)
GWVAGLFHY 0.01% (n=2)
GFMAGLLYH 0.01% (n=2)
GWLAALFYY 0.01% (n=2)
GRIAGLFYH 0.01% (n=2)
GWIAGLLYV 0.01% (n=2)
GWLAGLLYS 0.01% (n=2)
AWLAGLLYR 0.01% (n=2)
GWIAGLVYH 0.01% (n=2)
GWLAGLLHY 0.01% (n=2)
GFLAGLFSY 0.01% (n=2)
GWVAGLFYQ 0.01% (n=2)
GFIAGLMYY 0.01% (n=2)
GWLAGPFSY 0.01% (n=2)
GWVAGLLYA 0.01% (n=2)
GWVAGLLYS 0.01% (n=2)
GWVAGLFYV 0.01% (n=2)
GWIAGLVYR 0.01% (n=2)
GWLAGLLYA 0.01% (n=2)
GWIAGLIYL 0.01% (n=2)
GFIAGLLYA 0.01% (n=2)
GWLAGLFYI 0.01% (n=2)
GWVARLFYY 0.01% (n=2)
GFIAGLIYY 0.01% (n=2)
GWVAGLLYL 0.01% (n=2)
GWLASLFYT 0.01% (n=2)
GWVAGLLYF 0.01% (n=2)
GFVAGLIYY 0.01% (n=2)
GFMAGLFYY 0.01% (n=2)
GFIAGLFCY 0.01% (n=2)
GWVAALLYS 0.01% (n=2)
GWVAGLLYR 0.01% (n=2)
DWLAGLFYH 0.01% (n=2)
GWIAGLFYC 0.01% (n=2)
GWVAALFYH 0.01% (n=1)
GRVAGLFYH 0.01% (n=1)
GWIAGLPYH 0.01% (n=1)
G*IAGLFYH 0.01% (n=1)
GWVAGLFCY 0.01% (n=1)
GWLAGLMYA 0.01% (n=1)
GRVAGLLYY 0.01% (n=1)
GWVAGPFYY 0.01% (n=1)
GWLARLLYY 0.01% (n=1)
GFITRPFYR 0.01% (n=1)
GWLAGPFYP 0.01% (n=1)
GWLAGLLCP 0.01% (n=1)
GWLAGFSYH 0.01% (n=1)
GWVAGLSYH 0.01% (n=1)
GWLAGLVYH 0.01% (n=1)
GWLAGLLYN 0.01% (n=1)
GWIAGLFCS 0.01% (n=1)
SWVAGLFYH 0.01% (n=1)
GWIAGPSYS 0.01% (n=1)
GWDSRAFLF 0.01% (n=1)
RWIGRLFYS 0.01% (n=1)
GWVAGLIYC 0.01% (n=1)
GRVAGLIYR 0.01% (n=1)
GWVAGLIHR 0.01% (n=1)
GWLGSRASS 0.01% (n=1)
GWEAGLFYY 0.01% (n=1)
DWVAGLFYY 0.01% (n=1)
GWIAGLLPQ 0.01% (n=1)
GWVAGLHYY 0.01% (n=1)
GWVAGFLYY 0.01% (n=1)
DWVAGLLYY 0.01% (n=1)
GWLAGLVYS 0.01% (n=1)
GCLAGLFYY 0.01% (n=1)
GWTAGLFYH 0.01% (n=1)
GWLAGHFYH 0.01% (n=1)
GWLAGPLYY 0.01% (n=1)
GWTAGLLYY 0.01% (n=1)
GWMAGLIYH 0.01% (n=1)
GWIAGLNYY 0.01% (n=1)
GWIGGLFYY 0.01% (n=1)
GWVAAPFYY 0.01% (n=1)
GWVAGLFHR 0.01% (n=1)
GWVTGLFYH 0.01% (n=1)
GWKAGLIYY 0.01% (n=1)
GWIAGLTYY 0.01% (n=1)
GFIAGPFYH 0.01% (n=1)
GFITGLLYR 0.01% (n=1)
SWLAGLIYY 0.01% (n=1)
GWLAALFYH 0.01% (n=1)
GWLTGLFSY 0.01% (n=1)
GWLAGLIYL 0.01% (n=1)
GLVAGLLYY 0.01% (n=1)
G*VAGLFYY 0.01% (n=1)
GWVAGLFYA 0.01% (n=1)
GWLAGLFYK 0.01% (n=1)
GFIASLFYH 0.01% (n=1)
GFLAGLLYR 0.01% (n=1)
GWIAGLIHH 0.01% (n=1)
GFIAGLIYL 0.01% (n=1)
GFLAGLIYH 0.01% (n=1)
GWIAGLIYT 0.01% (n=1)
GFVAGLFYA 0.01% (n=1)
GYPADQH*R 0.01% (n=1)
GWIAGLFSH 0.01% (n=1)
GFIAGLLYI 0.01% (n=1)
GWVASLFYR 0.01% (n=1)
GFVAALFYR 0.01% (n=1)
GWIRGLFYR 0.01% (n=1)
GWLAGLFNH 0.01% (n=1)
GFVAGLFYH 0.01% (n=1)
GWIAGLVYV 0.01% (n=1)
GCIAGLFYY 0.01% (n=1)
GWLVGLLYY 0.01% (n=1)
GWTAGLFYY 0.01% (n=1)
-----LFYH 0.01% (n=1)
GWLAWLFYH 0.01% (n=1)
GWLARLFYR 0.01% (n=1)
GWVAGLFCR 0.01% (n=1)
GWVAELFYS 0.01% (n=1)
GRLVGLFYY 0.01% (n=1)
GWAAGLFYH 0.01% (n=1)
GFLAGLFYR 0.01% (n=1)
GWIAGLLYQ 0.01% (n=1)
GFIAGPFYY 0.01% (n=1)
DFIAGLFYY 0.01% (n=1)
GLTAGLFYY 0.01% (n=1)
GFIAGLFYC 0.01% (n=1)
GFTAGLFYY 0.01% (n=1)
GFIAGLFYD 0.01% (n=1)
GLIAGLFYY 0.01% (n=1)
GWITGLIYH 0.01% (n=1)
G*VAALFYS 0.01% (n=1)
G*IAGLIYY 0.01% (n=1)
GWIAGPIYY 0.01% (n=1)
SWLAGLFYY 0.01% (n=1)
GWLAELFYY 0.01% (n=1)
DWVAGLLYH 0.01% (n=1)
GWVAGLHYH 0.01% (n=1)
GWVVGLLYH 0.01% (n=1)
G*VAGLLYH 0.01% (n=1)
GWKAGLLYY 0.01% (n=1)
GWIAGPLYY 0.01% (n=1)
GWVAGPFYR 0.01% (n=1)
GWWRGLFYH 0.01% (n=1)
GWVPGLFYH 0.01% (n=1)
GWVAGLFCH 0.01% (n=1)
G*IAGLLYH 0.01% (n=1)
GWLSGAPLS 0.01% (n=1)
GFLTGLFYH 0.01% (n=1)
GWIA----- 0.01% (n=1)
G-------- 0.01% (n=1)
SWLAGLFYA 0.01% (n=1)
GWVAGLFSY 0.01% (n=1)
GWVAGFFYH 0.01% (n=1)
GWLAGLSTT 0.01% (n=1)
GFLAALIYR 0.01% (n=1)
GWIAGLIYS 0.01% (n=1)
GWLAGLVYL 0.01% (n=1)
GWVAGLFYT 0.01% (n=1)
DWLAGLLYY 0.01% (n=1)
GWLAGLLYC 0.01% (n=1)
GWVTGLLYY 0.01% (n=1)
GWLAGLLNY 0.01% (n=1)
GWLAGFLYY 0.01% (n=1)
GWLAGLPYY 0.01% (n=1)
GWLAWLLYY 0.01% (n=1)
GGLAGLFYH 0.01% (n=1)
GWAAGLLYY 0.01% (n=1)
GFIAGLIYR 0.01% (n=1)
GFLAGLFYQ 0.01% (n=1)
GWVAGLFNY 0.01% (n=1)
GWISGLFYS 0.01% (n=1)
GWVAGLFFY 0.01% (n=1)
GWLASLFYR 0.01% (n=1)
GWIAGLFCH 0.01% (n=1)
GWIAGPFYH 0.01% (n=1)
GWAAGLVYY 0.01% (n=1)
GWLARLFYH 0.01% (n=1)
GWVAGLIYL 0.01% (n=1)
GWIAGLFYQ 0.01% (n=1)
GWIAGLSYH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 1b:

GFLAALFYT 35.82% (n=3304)
GFLAALFYA 10.83% (n=999)
GFIAALFYA 7.35% (n=678)
GFLAALFYV 5.94% (n=548)
GWLAALFYT 5.58% (n=515)
GFIAALFYT 5.01% (n=462)
GFIAALFYR 4.64% (n=428)
GFIAALFYV 3.94% (n=363)
GFFAALFYA 3.60% (n=332)
GFISALFYV 2.85% (n=263)
GFLAALFYK 1.83% (n=169)
GFIAALIYA 1.27% (n=117)
GFLASLFYV 0.91% (n=84)
GFIAALLYA 0.63% (n=58)
GFITALFYR 0.63% (n=58)
GFIAALFYS 0.57% (n=53)
GFIAGLLYA 0.53% (n=49)
GFVAALFYA 0.48% (n=44)
GFLAALFYS 0.44% (n=41)
GFIAALIYR 0.34% (n=31)
GFIAALFYK 0.27% (n=25)
GFFAALFYT 0.27% (n=25)
GFFTALFYA 0.25% (n=23)
GFFAALFYV 0.24% (n=22)
GFVAALIYK 0.21% (n=19)
GFFAALFYY 0.20% (n=18)
GWLASLFYS 0.18% (n=17)
GFLAALFYH 0.18% (n=17)
GFIAALVYA 0.17% (n=16)
GFLAALFYR 0.17% (n=16)
GFLAALIYA 0.16% (n=15)
GWLAALFYA 0.16% (n=15)
GFLSALFYV 0.16% (n=15)
GFLTALFYK 0.15% (n=14)
GFIAALLYY 0.14% (n=13)
GFIAALFYH 0.13% (n=12)
GWIAALFYH 0.13% (n=12)
GFFSALFYV 0.12% (n=11)
GFIAALLYS 0.12% (n=11)
GFLAALSYT 0.11% (n=10)
GFLASLFYA 0.11% (n=10)
GFIAALLYR 0.09% (n=8)
GFIAALFYY 0.09% (n=8)
GFLASLFYT 0.09% (n=8)
GFLAALFYY 0.08% (n=7)
GLLAALFYT 0.08% (n=7)
GFFAALVYA 0.08% (n=7)
GFLAALLYT 0.08% (n=7)
GFISALFYR 0.08% (n=7)
GFVAALFYT 0.07% (n=6)
GFISALFYA 0.05% (n=5)
GFLAAPFYT 0.05% (n=5)
GFIASLFYA 0.05% (n=5)
GWLAALFYH 0.05% (n=5)
GFLTALFYT 0.04% (n=4)
GFLAVLFYT 0.04% (n=4)
GFFAALIYA 0.04% (n=4)
GSLAALFYT 0.04% (n=4)
GFLAALFHT 0.04% (n=4)
GWVAALFYS 0.04% (n=4)
GFFAALFYI 0.04% (n=4)
GFIAGLFYT 0.04% (n=4)
GFVAALFYS 0.04% (n=4)
GFISALFYT 0.03% (n=3)
GFLAALFNT 0.03% (n=3)
GFLTALFYR 0.03% (n=3)
GFIATLFYT 0.03% (n=3)
EFLAALFYT 0.03% (n=3)
GFIAALVYR 0.03% (n=3)
GFIAALMYA 0.03% (n=3)
GFIASLFYV 0.03% (n=3)
GWVAALLYS 0.03% (n=3)
GFVAALFYR 0.03% (n=3)
GFVAALFYK 0.03% (n=3)
GFLAALFYF 0.02% (n=2)
GFLAALFYE 0.02% (n=2)
GFLAALLYA 0.02% (n=2)
GFIAALVYS 0.02% (n=2)
GFITALIYS 0.02% (n=2)
GFIDALVYA 0.02% (n=2)
GFLAALLYS 0.02% (n=2)
GFLAALFYQ 0.02% (n=2)
GFITALFYA 0.02% (n=2)
GFFSALFYA 0.02% (n=2)
GVLAALFYT 0.02% (n=2)
GFIAALLYH 0.02% (n=2)
GFVASLFYA 0.02% (n=2)
GWVAALFYT 0.02% (n=2)
GFVAALFYY 0.02% (n=2)
GFITALFYT 0.02% (n=2)
GWLAALFYS 0.02% (n=2)
RFPAALFYA 0.02% (n=2)
GFIAALVYH 0.02% (n=2)
GFIASLFYT 0.02% (n=2)
GWLASLFYT 0.02% (n=2)
GFIAALFCR 0.02% (n=2)
GSIAALFYT 0.02% (n=2)
GFIAALLYT 0.02% (n=2)
GLIAALFYR 0.02% (n=2)
GSLAALFYA 0.02% (n=2)
GFIAALLYV 0.02% (n=2)
GFIAALFYI 0.02% (n=2)
GFLAGLLYA 0.01% (n=1)
GFLATLFYV 0.01% (n=1)
GFIATLFYA 0.01% (n=1)
GFLGALFYT 0.01% (n=1)
GFLAALFFT 0.01% (n=1)
GFLATLFYT 0.01% (n=1)
GLLAALFYV 0.01% (n=1)
GFLAALIYT 0.01% (n=1)
GFLPALFYT 0.01% (n=1)
GFITSLFYT 0.01% (n=1)
GFIAALIYY 0.01% (n=1)
GFLAELFYT 0.01% (n=1)
GFLAAL--- 0.01% (n=1)
GFLAGVFYH 0.01% (n=1)
GFLAARFYT 0.01% (n=1)
RFLAALFYK 0.01% (n=1)
GSLAALFYK 0.01% (n=1)
GFLAALFYM 0.01% (n=1)
GWLAALIYK 0.01% (n=1)
GFIASLFYI 0.01% (n=1)
GFLAGLFYQ 0.01% (n=1)
GFIAALFHA 0.01% (n=1)
GFLAALLYK 0.01% (n=1)
GFLAALFFV 0.01% (n=1)
GFIAALIYN 0.01% (n=1)
GFLSALFYA 0.01% (n=1)
GFIAGLIYK 0.01% (n=1)
GFITSLFYR 0.01% (n=1)
GWLAALFYK 0.01% (n=1)
GFIKALFYA 0.01% (n=1)
GSLASLFYV 0.01% (n=1)
GFIAALMYV 0.01% (n=1)
GFIAGLFYA 0.01% (n=1)
GFLVALFYS 0.01% (n=1)
GFLSALFYT 0.01% (n=1)
GFIAELFYT 0.01% (n=1)
GFITALFYS 0.01% (n=1)
GILAALFYT 0.01% (n=1)
GFFVALFYA 0.01% (n=1)
VFFAALFYA 0.01% (n=1)
GFTAALFYT 0.01% (n=1)
GFIAALSYR 0.01% (n=1)
GFIAALSYA 0.01% (n=1)
GFFTVLFYA 0.01% (n=1)
GFLAALFYI 0.01% (n=1)
GFFAALFYF 0.01% (n=1)
GWVAALFYH 0.01% (n=1)
GFIASLFYR 0.01% (n=1)
GFMAALFYY 0.01% (n=1)
GFMAALFYV 0.01% (n=1)
GFLTALFYA 0.01% (n=1)
GFIAALIYK 0.01% (n=1)
GFIAALFYG 0.01% (n=1)
GFIAELFYA 0.01% (n=1)
GFLAALVYT 0.01% (n=1)
GFLVALFYT 0.01% (n=1)
GFFAALFYH 0.01% (n=1)
GFLATLFYA 0.01% (n=1)
GLLAALFYA 0.01% (n=1)
GFLVALFYA 0.01% (n=1)
GFLTALFYQ 0.01% (n=1)
GWVAALFYA 0.01% (n=1)
GFITSLFYY 0.01% (n=1)
GFMAALFYA 0.01% (n=1)
GFLASLFYI 0.01% (n=1)
GWLASLFYA 0.01% (n=1)
GFFVALFYS 0.01% (n=1)
GFIAALVYV 0.01% (n=1)
GFIATLFYR 0.01% (n=1)
GFIAAPFYV 0.01% (n=1)
GFIAVLFYV 0.01% (n=1)
GSIAALFYR 0.01% (n=1)
GFPAALFYT 0.01% (n=1)
GFLAALFCT 0.01% (n=1)
GFVSALFYV 0.01% (n=1)
GFTSALFYV 0.01% (n=1)
GFISALSYV 0.01% (n=1)
GFISALFHV 0.01% (n=1)
GFISALFCV 0.01% (n=1)
GFVAALFYI 0.01% (n=1)
GFVAALFYV 0.01% (n=1)
GFPAALFYV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 2:

GFIAALFYT 21.67% (n=288)
GFIASLFYT 19.19% (n=255)
GFLASLFYT 16.25% (n=216)
GFIAALFYH 10.99% (n=146)
GFIASLFYV 4.97% (n=66)
GFIASLFYA 3.09% (n=41)
GFLAALFYT 2.41% (n=32)
GFVASLFYT 2.26% (n=30)
GWLASLFYT 2.18% (n=29)
GFLASLFYV 1.88% (n=25)
GWLASLFYI 0.98% (n=13)
GFIAALFYA 0.83% (n=11)
GFLASLFYA 0.68% (n=9)
GFLAALFYV 0.60% (n=8)
GFITSLFYA 0.60% (n=8)
GFVAALFYT 0.53% (n=7)
GFLVSLFYT 0.45% (n=6)
GFMASLFYT 0.38% (n=5)
GFVASLFYA 0.38% (n=5)
GWIHSLFYT 0.38% (n=5)
GFLAALFYA 0.30% (n=4)
GFFASLFYT 0.30% (n=4)
GWIASLFYT 0.30% (n=4)
GFIAALFYV 0.30% (n=4)
GSIAALFYH 0.30% (n=4)
GFIAALFYR 0.23% (n=3)
GFITALFYA 0.23% (n=3)
GFIASLFYI 0.23% (n=3)
GFFAALFYA 0.23% (n=3)
GFMASLFYA 0.23% (n=3)
GFISSLFYT 0.23% (n=3)
GFLASLFHT 0.15% (n=2)
GFIASLFYY 0.15% (n=2)
GFLASLFYI 0.15% (n=2)
GFFASLFYA 0.15% (n=2)
GFLAALFYS 0.15% (n=2)
GFITSLFYT 0.15% (n=2)
GFIATLFFT 0.15% (n=2)
GFMAALFYA 0.15% (n=2)
GFVAALFYA 0.15% (n=2)
GCLSSLFYT 0.15% (n=2)
GFISSLFYA 0.15% (n=2)
GFIAALFYS 0.15% (n=2)
GFIAALLYH 0.15% (n=2)
GFLAALFHT 0.08% (n=1)
GFFTALFYI 0.08% (n=1)
GFISALIYR 0.08% (n=1)
GFIVSLFYA 0.08% (n=1)
GFLGSLFYT 0.08% (n=1)
GFMAALFYT 0.08% (n=1)
GFIASLFYG 0.08% (n=1)
GFISSLFYV 0.08% (n=1)
GFLASPFYT 0.08% (n=1)
GFLTSLFYT 0.08% (n=1)
GFLSSLFYT 0.08% (n=1)
GFVCQLFYT 0.08% (n=1)
GFVTQLFYT 0.08% (n=1)
GFIAALFFT 0.08% (n=1)
GFVAALFYV 0.08% (n=1)
GFIAALLYN 0.08% (n=1)
GFIAALVYR 0.08% (n=1)
GFLAALFRY 0.08% (n=1)
GFIRALFYS 0.08% (n=1)
GFIASLFYF 0.08% (n=1)
GFIHSLFYA 0.08% (n=1)
GFIASLFYS 0.08% (n=1)
GFIASLFYH 0.08% (n=1)
GFIAALVYA 0.08% (n=1)
GFLASLFYY 0.08% (n=1)
GFLASLFYS 0.08% (n=1)
GFIASLF-T 0.08% (n=1)
GFFAALFYV 0.08% (n=1)
GWLAPLFYN 0.08% (n=1)
GWLASLVYI 0.08% (n=1)
GWLASLLYT 0.08% (n=1)
GLIASLFYV 0.08% (n=1)
GFIAPLFYV 0.08% (n=1)
GFITSLFYR 0.08% (n=1)
GFITALFYS 0.08% (n=1)
GFIVSLFYV 0.08% (n=1)
GFFAALLYT 0.08% (n=1)
GFVAALLYV 0.08% (n=1)
GFLSALFYA 0.08% (n=1)
GFIAALFCT 0.08% (n=1)
GFFAALFYS 0.08% (n=1)
GFFSALFYA 0.08% (n=1)
GFIAGLIYT 0.08% (n=1)
GFLTALFYA 0.08% (n=1)
GFFAALFYT 0.08% (n=1)
GWLASLFYA 0.08% (n=1)
GWVAALFYV 0.08% (n=1)
GFIAALFHH 0.08% (n=1)
GFIAVLFYH 0.08% (n=1)
GLIAALFYH 0.08% (n=1)
GFIAALFYY 0.08% (n=1)
GIIAALFYH 0.08% (n=1)
GFIASLFHY 0.08% (n=1)
GFISALFYV 0.08% (n=1)
GFIAALFYQ 0.08% (n=1)
GFPASLFYT 0.08% (n=1)
GLLASLFYT 0.08% (n=1)
GFLAPLFYT 0.08% (n=1)
GFLASLSYT 0.08% (n=1)
GFLTSLFYR 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 2a:

GFLASLFYT 38.15% (n=103)
GFVASLFYT 11.11% (n=30)
GFIASLFYT 10.74% (n=29)
GFLAALFYT 5.56% (n=15)
GFIAALFYT 5.19% (n=14)
GFIASLFYA 2.96% (n=8)
GFLASLFYA 2.22% (n=6)
GFLASLFYV 1.85% (n=5)
GFVASLFYA 1.85% (n=5)
GFIASLFYV 1.48% (n=4)
GFVAALFYT 1.48% (n=4)
GFLAALFYV 1.11% (n=3)
GFMASLFYT 1.11% (n=3)
GFLAALFYA 0.74% (n=2)
GFLASLFHT 0.74% (n=2)
GFITALFYA 0.74% (n=2)
GFFASLFYA 0.74% (n=2)
GFFASLFYT 0.74% (n=2)
GFIATLFFT 0.74% (n=2)
GFLVSLFYT 0.74% (n=2)
GFFTALFYI 0.37% (n=1)
GFISALIYR 0.37% (n=1)
GFIVSLFYA 0.37% (n=1)
GFLGSLFYT 0.37% (n=1)
GFIASLFYY 0.37% (n=1)
GFMAALFYT 0.37% (n=1)
GFIASLFYG 0.37% (n=1)
GFLASLFYI 0.37% (n=1)
GFISSLFYV 0.37% (n=1)
GFLASPFYT 0.37% (n=1)
GFLTSLFYT 0.37% (n=1)
GFLAALFYS 0.37% (n=1)
GFLSSLFYT 0.37% (n=1)
GFVCQLFYT 0.37% (n=1)
GFVTQLFYT 0.37% (n=1)
GFITSLFYT 0.37% (n=1)
GFIAALFFT 0.37% (n=1)
GFVAALFYV 0.37% (n=1)
GFIAALFYH 0.37% (n=1)
GFMAALFYA 0.37% (n=1)
GFVAALFYA 0.37% (n=1)
GFIAALLYN 0.37% (n=1)
GFIAALVYR 0.37% (n=1)
GFIAALFYA 0.37% (n=1)
GFLAALFRY 0.37% (n=1)
GFIRALFYS 0.37% (n=1)
GFIASLFYF 0.37% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 2b:

GFIASLFYT 47.62% (n=220)
GFIASLFYV 12.34% (n=57)
GFIASLFYA 6.49% (n=30)
GWLASLFYT 6.28% (n=29)
GFLASLFYT 4.33% (n=20)
GFLASLFYV 3.68% (n=17)
GWLASLFYI 2.81% (n=13)
GFIAALFYT 1.95% (n=9)
GFITSLFYA 1.73% (n=8)
GWIHSLFYT 1.08% (n=5)
GWIASLFYT 0.87% (n=4)
GFIASLFYI 0.65% (n=3)
GFLASLFYA 0.65% (n=3)
GFMASLFYA 0.65% (n=3)
GFISSLFYT 0.65% (n=3)
GFIAALFYA 0.43% (n=2)
GCLSSLFYT 0.43% (n=2)
GFMASLFYT 0.43% (n=2)
GFIAALFYR 0.43% (n=2)
GFISSLFYA 0.43% (n=2)
GFMAALFYA 0.22% (n=1)
GFIHSLFYA 0.22% (n=1)
GFIASLFYS 0.22% (n=1)
GFIASLFYH 0.22% (n=1)
GFLASLFYI 0.22% (n=1)
GFFAALFYA 0.22% (n=1)
GFIAALVYA 0.22% (n=1)
GFITALFYA 0.22% (n=1)
GFLASLFYY 0.22% (n=1)
GFITSLFYT 0.22% (n=1)
GFLASLFYS 0.22% (n=1)
GFIASLF-T 0.22% (n=1)
GFFAALFYV 0.22% (n=1)
GWLAPLFYN 0.22% (n=1)
GWLASLVYI 0.22% (n=1)
GWLASLLYT 0.22% (n=1)
GLIASLFYV 0.22% (n=1)
GFIAPLFYV 0.22% (n=1)
GFITSLFYR 0.22% (n=1)
GFITALFYS 0.22% (n=1)
GFLAALFYS 0.22% (n=1)
GFFASLFYT 0.22% (n=1)
GFIASLFYY 0.22% (n=1)
GFIVSLFYV 0.22% (n=1)
GFFAALLYT 0.22% (n=1)
GFVAALFYT 0.22% (n=1)
GFVAALLYV 0.22% (n=1)
GFLSALFYA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 2c:

GFIAALFYT 57.30% (n=259)
GFIAALFYH 32.08% (n=145)
GFLAALFYT 2.88% (n=13)
GFIAALFYA 0.88% (n=4)
GSIAALFYH 0.88% (n=4)
GFIAALFYV 0.66% (n=3)
GFLAALFYV 0.44% (n=2)
GFFAALFYA 0.44% (n=2)
GFLASLFYV 0.44% (n=2)
GFIASLFYT 0.22% (n=1)
GFIAALFCT 0.22% (n=1)
GFFAALFYS 0.22% (n=1)
GFVAALFYA 0.22% (n=1)
GFIAALFYS 0.22% (n=1)
GFFSALFYA 0.22% (n=1)
GFIAGLIYT 0.22% (n=1)
GFLTALFYA 0.22% (n=1)
GFFAALFYT 0.22% (n=1)
GWLASLFYA 0.22% (n=1)
GWVAALFYV 0.22% (n=1)
GFIASLFYA 0.22% (n=1)
GFIAALFHH 0.22% (n=1)
GFIAVLFYH 0.22% (n=1)
GFIAALLYH 0.22% (n=1)
GLIAALFYH 0.22% (n=1)
GFIAALFYY 0.22% (n=1)
GIIAALFYH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 3:

GFIAGLFYY 44.73% (n=1732)
GFIAGLIYY 16.17% (n=626)
GFIAGLFYH 8.19% (n=317)
GFLAGLFYY 7.77% (n=301)
GFLAALFYT 4.49% (n=174)
GFIAGLLYY 3.07% (n=119)
GFIAGLMYY 2.22% (n=86)
GFIAGLFYF 2.20% (n=85)
GFIAGLFSY 1.63% (n=63)
GFIAGLIYH 1.21% (n=47)
GFIAGLFHY 1.08% (n=42)
GFLAGLFYV 1.06% (n=41)
GFIAGLIYF 0.67% (n=26)
GFVAGLFYY 0.65% (n=25)
GFLVGLFYY 0.57% (n=22)
GFLAGLFYH 0.52% (n=20)
GFIAGLVYY 0.41% (n=16)
GFIAGLFNY 0.26% (n=10)
GFLAGLFYF 0.21% (n=8)
GFIAGLIYR 0.21% (n=8)
GFIAGLFHF 0.18% (n=7)
GFIAGLFYR 0.15% (n=6)
GFFAGLFYH 0.10% (n=4)
GFLAGLLYH 0.10% (n=4)
GFMAGLFYY 0.10% (n=4)
GFIAGLLYH 0.10% (n=4)
GFVAGLIYY 0.10% (n=4)
GLIAGLFYY 0.08% (n=3)
RFLAGLFYY 0.08% (n=3)
GFIAGLMYF 0.08% (n=3)
GFIAGLLYF 0.08% (n=3)
GFLAGLIYY 0.08% (n=3)
GFIAGLMYH 0.08% (n=3)
GFIAGLFYL 0.05% (n=2)
GSIAGLFYY 0.05% (n=2)
GFLAGLLYY 0.05% (n=2)
GFIAGLLYR 0.05% (n=2)
GFIAGLFRF 0.03% (n=1)
GFIARLFYY 0.03% (n=1)
GFIAGMFYY 0.03% (n=1)
GFIAGLFCY 0.03% (n=1)
GFIAGLSYY 0.03% (n=1)
GFIVGLFYY 0.03% (n=1)
GFIAELIYY 0.03% (n=1)
EFIAGLMYY 0.03% (n=1)
GSIAGLMYY 0.03% (n=1)
GSIAGLLYY 0.03% (n=1)
GFMAGLFNY 0.03% (n=1)
RFLAGLIYY 0.03% (n=1)
GSIAGLIYY 0.03% (n=1)
GFIAGSFYY 0.03% (n=1)
GFITGLMYY 0.03% (n=1)
GFIAELFYY 0.03% (n=1)
EFLAGLFYY 0.03% (n=1)
GFIAGFDYY 0.03% (n=1)
GFTAGLFYY 0.03% (n=1)
GFLAGLMYY 0.03% (n=1)
GFIAGCFYY 0.03% (n=1)
GFVAGLFHY 0.03% (n=1)
GFIAGLVYH 0.03% (n=1)
GS*LGCFII 0.03% (n=1)
GSLAGLIYY 0.03% (n=1)
GFIAGLFYW 0.03% (n=1)
GFFAGLFYY 0.03% (n=1)
GFVAGLLYY 0.03% (n=1)
GFLAGLIYH 0.03% (n=1)
GFIAGLFFY 0.03% (n=1)
GFMAGLFYF 0.03% (n=1)
GFLAGLFHY 0.03% (n=1)
GFLAGLVYY 0.03% (n=1)
GFLAGLFYR 0.03% (n=1)
GFLVGLFYH 0.03% (n=1)
GFMAGLFHY 0.03% (n=1)
GFIAGLFYV 0.03% (n=1)
GFMAGLLYY 0.03% (n=1)
GFLAGLFSY 0.03% (n=1)
GFIARLMYY 0.03% (n=1)
G-IAGLLYY 0.03% (n=1)
GFIAGLFYK 0.03% (n=1)
GFITGLFYY 0.03% (n=1)
GFIAGLFYS 0.03% (n=1)
GFIAALFYR 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 3a:

GFIAGLFYY 49.54% (n=1610)
GFIAGLIYY 13.02% (n=423)
GFIAGLFYH 9.63% (n=313)
GFLAGLFYY 9.17% (n=298)
GFIAGLLYY 3.02% (n=98)
GFIAGLFYF 2.58% (n=84)
GFIAGLFSY 1.88% (n=61)
GFIAGLMYY 1.38% (n=45)
GFIAGLFHY 1.26% (n=41)
GFLAGLFYV 1.26% (n=41)
GFIAGLIYH 0.74% (n=24)
GFLVGLFYY 0.68% (n=22)
GFIAGLIYF 0.65% (n=21)
GFLAGLFYH 0.62% (n=20)
GFVAGLFYY 0.58% (n=19)
GFIAGLVYY 0.34% (n=11)
GFIAGLFNY 0.28% (n=9)
GFLAGLFYF 0.25% (n=8)
GFIAGLIYR 0.25% (n=8)
GFIAGLFHF 0.22% (n=7)
GFIAGLFYR 0.18% (n=6)
GFFAGLFYH 0.12% (n=4)
GFLAGLLYH 0.12% (n=4)
GFMAGLFYY 0.12% (n=4)
GFIAGLLYH 0.12% (n=4)
GFVAGLIYY 0.12% (n=4)
GLIAGLFYY 0.09% (n=3)
RFLAGLFYY 0.09% (n=3)
GFIAGLMYF 0.09% (n=3)
GFIAGLLYF 0.09% (n=3)
GFLAGLIYY 0.09% (n=3)
GFIAGLFYL 0.06% (n=2)
GSIAGLFYY 0.06% (n=2)
GFLAGLLYY 0.06% (n=2)
GFIAGLFRF 0.03% (n=1)
GFIARLFYY 0.03% (n=1)
GFIAGMFYY 0.03% (n=1)
GFIAGLFCY 0.03% (n=1)
GFIAGLSYY 0.03% (n=1)
GFIVGLFYY 0.03% (n=1)
GFIAELIYY 0.03% (n=1)
EFIAGLMYY 0.03% (n=1)
GSIAGLMYY 0.03% (n=1)
GSIAGLLYY 0.03% (n=1)
GFMAGLFNY 0.03% (n=1)
RFLAGLIYY 0.03% (n=1)
GSIAGLIYY 0.03% (n=1)
GFIAGSFYY 0.03% (n=1)
GFITGLMYY 0.03% (n=1)
GFIAELFYY 0.03% (n=1)
EFLAGLFYY 0.03% (n=1)
GFIAGFDYY 0.03% (n=1)
GFTAGLFYY 0.03% (n=1)
GFLAGLMYY 0.03% (n=1)
GFIAGCFYY 0.03% (n=1)
GFVAGLFHY 0.03% (n=1)
GFIAGLVYH 0.03% (n=1)
GS*LGCFII 0.03% (n=1)
GSLAGLIYY 0.03% (n=1)
GFIAGLLYR 0.03% (n=1)
GFIAGLFYW 0.03% (n=1)
GFFAGLFYY 0.03% (n=1)
GFVAGLLYY 0.03% (n=1)
GFLAGLIYH 0.03% (n=1)
GFIAGLFFY 0.03% (n=1)
GFMAGLFYF 0.03% (n=1)
GFLAGLFHY 0.03% (n=1)
GFLAGLVYY 0.03% (n=1)
GFLAGLFYR 0.03% (n=1)
GFLVGLFYH 0.03% (n=1)
GFMAGLFHY 0.03% (n=1)
GFIAGLFYV 0.03% (n=1)
GFMAGLLYY 0.03% (n=1)
GFLAGLFSY 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 3b:

GFIAGLIYY 50.63% (n=201)
GFIAGLFYY 21.41% (n=85)
GFIAGLMYY 9.82% (n=39)
GFIAGLIYH 5.54% (n=22)
GFIAGLLYY 4.79% (n=19)
GFIAGLVYY 1.26% (n=5)
GFVAGLFYY 1.26% (n=5)
GFIAGLIYF 1.26% (n=5)
GFIAGLFYH 0.50% (n=2)
GFIAGLFSY 0.50% (n=2)
GFIAGLMYH 0.50% (n=2)
GFLAGLFYY 0.50% (n=2)
GFIARLMYY 0.25% (n=1)
GFIAGLFNY 0.25% (n=1)
GFIAGLFYF 0.25% (n=1)
G-IAGLLYY 0.25% (n=1)
GFIAGLFYK 0.25% (n=1)
GFIAGLFHY 0.25% (n=1)
GFITGLFYY 0.25% (n=1)
GFIAGLLYR 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 4:

GFIASLFYT 36.40% (n=277)
GFLASLFYT 29.83% (n=227)
GFIAGLFYA 6.18% (n=47)
GFLASLFYA 5.12% (n=39)
GFLAGLFYH 3.55% (n=27)
GFIAGLLYA 2.10% (n=16)
GFIASLFYA 1.71% (n=13)
GFIASLFYR 1.05% (n=8)
GFLASLFYI 0.92% (n=7)
GFIASLFYH 0.92% (n=7)
GFLAGLFYA 0.79% (n=6)
GFLANLFYI 0.79% (n=6)
GFLANLFYT 0.79% (n=6)
GFIAGLLYY 0.79% (n=6)
GFLAALFYH 0.66% (n=5)
GFIAGLFYY 0.53% (n=4)
GFLAGLFYY 0.39% (n=3)
GFLASLFYF 0.39% (n=3)
GFLASLFYV 0.26% (n=2)
GFLAGLFYR 0.26% (n=2)
GFIAALFYT 0.26% (n=2)
GFIVSLFYR 0.26% (n=2)
GFFASLFYI 0.26% (n=2)
GFIAALFYA 0.26% (n=2)
GFIAGLFYR 0.26% (n=2)
GFLAGLFYS 0.26% (n=2)
GFLAALFYV 0.26% (n=2)
GWLASLFYA 0.26% (n=2)
GFLAALFYT 0.13% (n=1)
GFFASLFYT 0.13% (n=1)
GFLTGLFYV 0.13% (n=1)
GFLASLFYY 0.13% (n=1)
GLIASLFYA 0.13% (n=1)
GFITGLFYA 0.13% (n=1)
GFIASLLYY 0.13% (n=1)
GFLAGLFYF 0.13% (n=1)
GFIAGLFYF 0.13% (n=1)
GFFASLFYA 0.13% (n=1)
GFLAGLLYT 0.13% (n=1)
GFIAGLFYT 0.13% (n=1)
GFIAGLFRY 0.13% (n=1)
GFIASLFYS 0.13% (n=1)
GFIASLFYI 0.13% (n=1)
GFIAGLIYR 0.13% (n=1)
GFMVGLFYR 0.13% (n=1)
GFLAGLLYA 0.13% (n=1)
GFIAGLMYY 0.13% (n=1)
GFLAGLFYT 0.13% (n=1)
GFLAGLFYV 0.13% (n=1)
GFFAALFYT 0.13% (n=1)
GFVASLFYA 0.13% (n=1)
GFIAGLIYS 0.13% (n=1)
GFLAGLIYY 0.13% (n=1)
GWAAALFYT 0.13% (n=1)
GWVASLFYT 0.13% (n=1)
GWFAALFYA 0.13% (n=1)
GWLASLFYT 0.13% (n=1)
GWLAGLFYT 0.13% (n=1)
GFIAGLIYH 0.13% (n=1)
GFIAGLFYS 0.13% (n=1)
GFIAGLFYH 0.13% (n=1)
GFVAGLFYH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 4a:

GFLASLFYT 51.88% (n=83)
GFLASLFYA 22.50% (n=36)
GFLAGLFYH 15.63% (n=25)
GFLAALFYH 3.13% (n=5)
GFLAGLFYA 1.88% (n=3)
GFLAALFYT 0.63% (n=1)
GFLASLFYV 0.63% (n=1)
GFFASLFYT 0.63% (n=1)
GFLAGLFYR 0.63% (n=1)
GFLANLFYI 0.63% (n=1)
GFLTGLFYV 0.63% (n=1)
GFIAGLFYA 0.63% (n=1)
GFIAGLLYA 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 4d:

GFIASLFYT 50.55% (n=274)
GFLASLFYT 26.01% (n=141)
GFIAGLFYA 7.38% (n=40)
GFIASLFYA 2.21% (n=12)
GFIAGLLYA 2.03% (n=11)
GFLASLFYI 1.29% (n=7)
GFIASLFYR 1.29% (n=7)
GFLANLFYT 1.11% (n=6)
GFIASLFYH 1.11% (n=6)
GFLANLFYI 0.92% (n=5)
GFLASLFYA 0.55% (n=3)
GFIAGLFYY 0.55% (n=3)
GFLASLFYF 0.55% (n=3)
GFIAALFYT 0.37% (n=2)
GFIVSLFYR 0.37% (n=2)
GFIAGLLYY 0.37% (n=2)
GFFASLFYI 0.37% (n=2)
GFIAALFYA 0.37% (n=2)
GFLASLFYY 0.18% (n=1)
GLIASLFYA 0.18% (n=1)
GFITGLFYA 0.18% (n=1)
GFIASLLYY 0.18% (n=1)
GFLAGLFYY 0.18% (n=1)
GFLAGLFYF 0.18% (n=1)
GFIAGLFYF 0.18% (n=1)
GFFASLFYA 0.18% (n=1)
GFLAGLLYT 0.18% (n=1)
GFIAGLFYT 0.18% (n=1)
GFIAGLFRY 0.18% (n=1)
GFIASLFYS 0.18% (n=1)
GFLASLFYV 0.18% (n=1)
GFIASLFYI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 5:

GFIAGLMYV 12.82% (n=5)
GFIAGLMYA 10.26% (n=4)
GFVAGLLYY 7.69% (n=3)
GFIAGLIYA 7.69% (n=3)
GFIAGLLYA 7.69% (n=3)
GFIAGLFYA 5.13% (n=2)
GFIAGLMYF 5.13% (n=2)
GFIAGLMYY 5.13% (n=2)
GFIAGLFYY 5.13% (n=2)
GFIAGLVYY 2.56% (n=1)
GFLAGLLYV 2.56% (n=1)
GFIAGLFYV 2.56% (n=1)
GFIAGLIYY 2.56% (n=1)
GFIAGLLYY 2.56% (n=1)
GFIAGLIYF 2.56% (n=1)
GFLAGLFYA 2.56% (n=1)
GFLAGLFYF 2.56% (n=1)
GFIAGLIYH 2.56% (n=1)
GFFAGLFYV 2.56% (n=1)
GFIAGLLYF 2.56% (n=1)
GFIAGLIYI 2.56% (n=1)
GFIAGLMYI 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 6:

GFIASLFYT 19.89% (n=104)
GFIAGLFYY 8.03% (n=42)
GFIASLFYA 7.65% (n=40)
GFIASLFYI 7.65% (n=40)
GFIASLFYV 3.44% (n=18)
GFLAGLFYH 3.44% (n=18)
GFIAGLFYH 3.25% (n=17)
GFIAALFYT 2.87% (n=15)
GFVASLFYA 2.10% (n=11)
GFLASLFYT 1.91% (n=10)
GFIAALFYA 1.72% (n=9)
GFVAALFYA 1.72% (n=9)
GFIAGLLYY 1.34% (n=7)
GFVASLFYT 1.15% (n=6)
GFIAGLFYT 1.15% (n=6)
GFIAGLLYH 0.96% (n=5)
GFLAGLFYY 0.96% (n=5)
GFIAALFYR 0.76% (n=4)
GFIAGLLYA 0.76% (n=4)
GFMAALFYT 0.76% (n=4)
GFIASLFYF 0.76% (n=4)
GFIAGLFYR 0.76% (n=4)
GFIAGLFYA 0.76% (n=4)
GFMASLFYT 0.57% (n=3)
GFMAALFYA 0.57% (n=3)
GFIAGLFYS 0.57% (n=3)
GFLSALFYR 0.57% (n=3)
GFIAGLFSY 0.57% (n=3)
GFVAGLFYY 0.57% (n=3)
GFLAGLLYY 0.57% (n=3)
GFLAGLIYH 0.57% (n=3)
GFLASLFYV 0.38% (n=2)
GFITSLFYA 0.38% (n=2)
GFMASLFYI 0.38% (n=2)
GFVASLFYV 0.38% (n=2)
GFIAALFYV 0.38% (n=2)
GFIASLLYI 0.38% (n=2)
GFIASLFYR 0.38% (n=2)
GFVASLFYR 0.38% (n=2)
GFVASLFYI 0.38% (n=2)
GFLAGLFYT 0.38% (n=2)
GFFAALFYV 0.38% (n=2)
GFLAALFYR 0.38% (n=2)
GFIAGLIYY 0.38% (n=2)
GFIAGLMYV 0.38% (n=2)
GFIAGLMYH 0.38% (n=2)
GFIAGLLYS 0.38% (n=2)
GFLAGLLYH 0.38% (n=2)
GFIAGLIYH 0.38% (n=2)
GFLAGLFYR 0.38% (n=2)
GFLASLFYA 0.38% (n=2)
GFIAGLFYL 0.38% (n=2)
GFVASLFYH 0.19% (n=1)
GFIASLIYA 0.19% (n=1)
GFVAALFYS 0.19% (n=1)
GFIASLIYV 0.19% (n=1)
GFIAALFYI 0.19% (n=1)
GFIASLFYN 0.19% (n=1)
GFIAALFYS 0.19% (n=1)
GFIVSLFYT 0.19% (n=1)
GFIASLFYS 0.19% (n=1)
GFITALFYN 0.19% (n=1)
GFVSALFYT 0.19% (n=1)
GFLAALFYV 0.19% (n=1)
GFITSLFYT 0.19% (n=1)
GFIASLMYA 0.19% (n=1)
GFFASLFYT 0.19% (n=1)
EFIASLFYA 0.19% (n=1)
GFLTSLFYA 0.19% (n=1)
GFVAALIYK 0.19% (n=1)
GFRASLFYT 0.19% (n=1)
GFIAALIYA 0.19% (n=1)
GFIAGLLYR 0.19% (n=1)
GFMAALFYL 0.19% (n=1)
GFFAALFYA 0.19% (n=1)
GFITALFYT 0.19% (n=1)
GFMASLFYV 0.19% (n=1)
GFISALFYA 0.19% (n=1)
GFIASLFYY 0.19% (n=1)
GFLVSLFYS 0.19% (n=1)
GFLANLFYV 0.19% (n=1)
GFLANLFYA 0.19% (n=1)
GFIAGLFAR 0.19% (n=1)
GFFVPLFYK 0.19% (n=1)
GFLAPLFYR 0.19% (n=1)
GFLAPLFYK 0.19% (n=1)
GFIAGLIYR 0.19% (n=1)
GFIAGLVYR 0.19% (n=1)
GFIAGLIYA 0.19% (n=1)
GFMAALFYQ 0.19% (n=1)
GFLAGLIYK 0.19% (n=1)
GFIASLFYQ 0.19% (n=1)
GFIAGLIYL 0.19% (n=1)
GFIAGLFYQ 0.19% (n=1)
GFFTALFYK 0.19% (n=1)
GWLASLFYS 0.19% (n=1)
GWLASLFYN 0.19% (n=1)
GFIAALFYH 0.19% (n=1)
GFLTGLLYY 0.19% (n=1)
GFVTALFYS 0.19% (n=1)
GFLAALFYH 0.19% (n=1)
GFIAGLFYV 0.19% (n=1)
GFITGLFYL 0.19% (n=1)
GFLAGLFNH 0.19% (n=1)
GFLTGLFYV 0.19% (n=1)
GFLAGLFYK 0.19% (n=1)
GFIAGLIYS 0.19% (n=1)
GFLAGLFAH 0.19% (n=1)
GFIAGLFAV 0.19% (n=1)
GFIAGLFYM 0.19% (n=1)
GFFTSLFYA 0.19% (n=1)
GFISALFYR 0.19% (n=1)
GFLTSLFYY 0.19% (n=1)
GFLSALFTK 0.19% (n=1)
GFIAALLYR 0.19% (n=1)
GFFASLFYI 0.19% (n=1)
GFLAGLFYA 0.19% (n=1)
GFLAGLFYV 0.19% (n=1)
GFITALFYQ 0.19% (n=1)
GWLAGLLYA 0.19% (n=1)
GFIAGLIYV 0.19% (n=1)
GFITALFYA 0.19% (n=1)
GFLAGLFYS 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Subtype 6a:

GFIASLFYT 35.05% (n=102)
GFIASLFYI 13.75% (n=40)
GFIASLFYA 12.37% (n=36)
GFIASLFYV 5.50% (n=16)
GFVASLFYA 3.78% (n=11)
GFIAALFYT 3.44% (n=10)
GFLASLFYT 2.75% (n=8)
GFVAALFYA 2.75% (n=8)
GFIAALFYA 2.41% (n=7)
GFVASLFYT 2.06% (n=6)
GFMAALFYA 1.03% (n=3)
GFMASLFYT 0.69% (n=2)
GFIAALFYR 0.69% (n=2)
GFITSLFYA 0.69% (n=2)
GFMASLFYI 0.69% (n=2)
GFVASLFYV 0.69% (n=2)
GFIASLLYI 0.69% (n=2)
GFVASLFYR 0.69% (n=2)
GFVASLFYI 0.69% (n=2)
GFIASLFYF 0.69% (n=2)
GFLASLFYV 0.34% (n=1)
GFVASLFYH 0.34% (n=1)
GFIASLIYA 0.34% (n=1)
GFVAALFYS 0.34% (n=1)
GFIAALFYV 0.34% (n=1)
GFIAGLLYA 0.34% (n=1)
GFIASLIYV 0.34% (n=1)
GFIAALFYI 0.34% (n=1)
GFIASLFYN 0.34% (n=1)
GFIAALFYS 0.34% (n=1)
GFIVSLFYT 0.34% (n=1)
GFIASLFYS 0.34% (n=1)
GFITALFYN 0.34% (n=1)
GFIAGLFYS 0.34% (n=1)
GFIASLFYR 0.34% (n=1)
GFVSALFYT 0.34% (n=1)
GFMAALFYT 0.34% (n=1)
GFLAALFYV 0.34% (n=1)
GFITSLFYT 0.34% (n=1)
GFIASLMYA 0.34% (n=1)
GFFASLFYT 0.34% (n=1)
EFIASLFYA 0.34% (n=1)
GFLTSLFYA 0.34% (n=1)
GFVAALIYK 0.34% (n=1)
GFRASLFYT 0.34% (n=1)
GFIAALIYA 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 436-444 (antibodies: [HC-11, HC84.21, HC84.22] ), HCV Genotype 7:

GFIAALFYT 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 1:

AKQNIQLINTNGSWH 14.35% (n=3352)
ARQNIQLINTNGSWH 4.89% (n=1142)
PSQKIQLINTNGSWH 4.08% (n=954)
ASQKIQLINTNGSWH 4.00% (n=934)
ASQNIQLINTNGSWH 3.66% (n=856)
PSQKIQLVNTNGSWH 3.15% (n=736)
AQQNIQLINTNGSWH 2.62% (n=611)
PKQNIQLINTNGSWH 2.60% (n=607)
PKQNIQLVNTNGSWH 1.91% (n=447)
AKQNVQLINTNGSWH 1.70% (n=398)
AQQDIQLVNTNGSWH 1.63% (n=382)
AKQNIQLVNTNGSWH 1.48% (n=346)
AMQNIQLVNTNGSWH 1.43% (n=333)
AQQNVQLINTNGSWH 1.31% (n=306)
AKQNIQLINSNGSWH 1.31% (n=305)
PAQKLQLINTNGSWH 1.11% (n=259)
PSQNIQLINTNGSWH 1.06% (n=248)
SRQNVQLINTNGSWH 1.06% (n=248)
AKQDIQLINTNGSWH 1.01% (n=237)
PQQKIQLINTNGSWH 0.98% (n=230)
PQQKIQLVNTNGSWH 0.95% (n=222)
ASQRIQLINTNGSWH 0.88% (n=205)
AKQNVQLVNTNGSWH 0.83% (n=194)
PS------------- 0.80% (n=188)
PKQNVHLINTNGSWH 0.78% (n=183)
ARQNVQLINTNGSWH 0.77% (n=180)
PSQNIQLVNTNGSWH 0.77% (n=179)
AQQKIQLVNANGSWH 0.72% (n=168)
SSQNIQLVNTNGSWH 0.70% (n=164)
SSQKIQLINTNGSWH 0.69% (n=162)
ASQKIQLVNTNGSWH 0.67% (n=156)
PQQNIQLINTNGSWH 0.65% (n=152)
PSQKLQLVNTNGSWH 0.65% (n=151)
SRQNIQLINTNGSWH 0.63% (n=147)
ASQNIQLVNTNGSWH 0.62% (n=145)
PKQNIHLIKTNGSWH 0.62% (n=145)
PRQKLQLINTNGSWH 0.60% (n=140)
PAQKIQLVNTNGSWH 0.56% (n=131)
SRQHIQLINTNGSWH 0.54% (n=127)
AKQDVQLINTNGSWH 0.53% (n=124)
PKQNVQLINTNGSWH 0.48% (n=112)
PA------------- 0.47% (n=110)
PKQDVQLVNTNGSWH 0.46% (n=108)
AKQNIQLVNSNGSWH 0.45% (n=106)
SSQRIQLVNTNGSWH 0.41% (n=95)
ASQKLQLINTNGSWH 0.39% (n=91)
AKQDIQLINSNGSWH 0.37% (n=86)
PSQNIKLTNTNGSWH 0.35% (n=82)
PSQKVQLINTNGSWH 0.34% (n=80)
PKQDIQLINTNGSWH 0.34% (n=79)
SAQKIQLINTNGSWH 0.34% (n=79)
PSQNLQLVNTNGSWH 0.33% (n=77)
PAQNIQLVNTNGSWH 0.33% (n=76)
PKQNIQLINSNGSWH 0.32% (n=75)
AKQNIQLMNTNGSWH 0.32% (n=75)
ARQNIQLVNTNGSWH 0.32% (n=74)
AKQNVQLINSNGSWH 0.32% (n=74)
AKQNIQLMNSNGSWH 0.32% (n=74)
SYQKVQLVNTNGSWH 0.31% (n=72)
SSQRIQLINTNGSWH 0.30% (n=71)
PRQNIQLINTNGSWH 0.30% (n=70)
PSQRIQLVNTNGSWH 0.29% (n=68)
ASQRIQLVNTNGSWH 0.28% (n=66)
PSQKIQLISTNGSWH 0.27% (n=64)
SKQNIQLINTNGSWH 0.27% (n=64)
PTQKIQLVNTNGSWH 0.26% (n=61)
SKQNLQLINTNGSWH 0.25% (n=59)
SKQNIQLINSNGSWH 0.25% (n=58)
PHQKIQLVNTNGSWH 0.25% (n=58)
ASQQIQLINTNGSWH 0.25% (n=58)
SQQHIQLINTNGSWH 0.24% (n=57)
AKQSIQLVNTNGSWH 0.24% (n=56)
AKQKIQLINTNGSWH 0.24% (n=55)
PSQNIQLINSNGSWH 0.23% (n=53)
PSQEIQLVNENGSWH 0.22% (n=51)
AKQRIQLINTNGSWH 0.21% (n=50)
PTQKIQLINTNGSWH 0.21% (n=50)
PSQKIQLVNSNGSWH 0.21% (n=50)
PKQKIQLINTNGSWH 0.21% (n=49)
SSQKVQLVNTNGSWH 0.21% (n=49)
PAQTIQLVNTNGSWH 0.21% (n=49)
SSQKIQLVNTNGSWH 0.21% (n=48)
ARQKLQLINTNGSWH 0.20% (n=46)
PSQDIQLINTNGSWH 0.20% (n=46)
AQQKIQLINTNGSWH 0.19% (n=44)
PKQNIQLINTNNSWH 0.19% (n=44)
PRQKIQLINTNGSWH 0.18% (n=43)
ASQNIRLINTNGSWH 0.18% (n=42)
PRQNIQLINSNGSWH 0.18% (n=41)
AQQNIQLVNTNGSWH 0.18% (n=41)
ANQNIQLINTNGSWH 0.18% (n=41)
PKQKIQLVNTNGSWH 0.18% (n=41)
PSQTIQLVNTNGSWH 0.18% (n=41)
SNQKIQLINTNGSWH 0.17% (n=40)
ARQNIQLVNSNGSWH 0.17% (n=39)
PGQKIQLVNTNGSWH 0.17% (n=39)
PT------------- 0.17% (n=39)
ASQKLQLVNTNGSWH 0.16% (n=38)
AKQDIQLVNSNGSWH 0.16% (n=37)
PSQRIQLINTNGSWH 0.15% (n=35)
PKQNIQLIKTNGSWH 0.15% (n=34)
ASQNVQLINTNGSWH 0.14% (n=33)
ARQNIQLINSNGSWH 0.14% (n=33)
PKQDIQLVNTNGSWH 0.14% (n=32)
PKQDIKLINTNGSWH 0.14% (n=32)
SSQNIQLINTNGSWH 0.13% (n=31)
SA------------- 0.13% (n=31)
AKQNIQLVSTNGSWH 0.13% (n=30)
ANQNIQLINSNGSWH 0.13% (n=30)
SAQKIQLVNTNGSWH 0.13% (n=30)
SS------------- 0.13% (n=30)
AQQSIQLVNTNGSWH 0.12% (n=29)
AQQKIQLVNTNGSWH 0.12% (n=27)
ASQNVQLINSNGSWH 0.12% (n=27)
PKQDVQLINTNGSWH 0.12% (n=27)
SRQNIQLVNTNGSWH 0.12% (n=27)
P-------------- 0.11% (n=26)
AQQKIQLINSNGSWH 0.11% (n=25)
ASQKIQLVNASGSWH 0.11% (n=25)
PRQNIQLVNTNGSWH 0.10% (n=24)
SKQNVQLINTNGSWH 0.10% (n=24)
PSQKIQLINSNGSWH 0.10% (n=24)
AQQNIQLINANGSWH 0.10% (n=24)
SAQNIQLINTNGSWH 0.10% (n=24)
SNQKIQLVNTNGSWH 0.10% (n=24)
PQQNIQLVNTNGSWH 0.10% (n=23)
AKQDIQLVNTNGSWH 0.10% (n=23)
PSQNLQLINSNGSWH 0.09% (n=22)
SRQKIQLINTNGSWH 0.09% (n=22)
ARQNVQLVNTNGSWH 0.09% (n=21)
ANQNVQLINTNGSWH 0.09% (n=20)
PSQNIQLVNSNGSWH 0.09% (n=20)
AKQNIRLIKSNGSWH 0.08% (n=19)
SQQKIQLINTNGSWH 0.08% (n=19)
AQQDIQLINTNGSWH 0.08% (n=18)
ASQNIQLISTNGSWH 0.08% (n=18)
SHQKVQLVKTNGSWH 0.08% (n=18)
PAQQIQLVNTNGSWH 0.08% (n=18)
PAQQIQLINTNGSWH 0.08% (n=18)
AS------------- 0.08% (n=18)
PSQDIRLINTNGSWH 0.07% (n=17)
ARQKIQLINSNGSWH 0.07% (n=17)
PAQKIQLINTNGSWH 0.07% (n=17)
PTQNIQLINTNGSWH 0.07% (n=17)
ASQRIQLVNSNGSWH 0.07% (n=17)
AKQNIQLVNTNGSW- 0.07% (n=16)
AQQNVRLINTNGSWH 0.07% (n=16)
ASQNIQLINSNGSWH 0.06% (n=15)
AKQNIRLINTNGSWH 0.06% (n=15)
SKQDIQLINTNGSWH 0.06% (n=15)
ASQKVQLINTNGSWH 0.06% (n=15)
SKQDVQLVNTNGSWH 0.06% (n=15)
PAQNLQLINTNGSWH 0.06% (n=15)
ARQKIQLINTNGSWH 0.06% (n=14)
PSQKIQLVNANGSWH 0.06% (n=14)
PKQDVRLINTNGSWH 0.06% (n=14)
AKQKIQLINSNGSWH 0.06% (n=14)
AKQNLQLINTNGSWH 0.06% (n=14)
AKQNLQLVNTNGSWH 0.06% (n=14)
PSQTIRLANTNGSWH 0.06% (n=14)
PAQEIQLINTNGSWH 0.06% (n=14)
SSQRIQLVNSNGSWH 0.06% (n=14)
PSQNVQLINTNGSWH 0.06% (n=13)
SKQDVQLINTNGSWH 0.06% (n=13)
PNQKIQLINTNGSWH 0.06% (n=13)
AKQDIKLINSNGSWH 0.06% (n=13)
ARQAIQLINSNGSWH 0.06% (n=13)
PSQNLQLINTNGSWH 0.06% (n=13)
PAQNIQLINTNGSWH 0.06% (n=13)
PSQKLQLINTNGSWH 0.06% (n=13)
PSQKIRLINTNGSWH 0.05% (n=12)
SQQNVQLINTNGSWH 0.05% (n=12)
ARQDIQLINTNGSWH 0.05% (n=12)
AKQGVQLVNTNGSWH 0.05% (n=12)
AKQNIQLINTRGSWH 0.05% (n=12)
ASQRVQLINTNGSWH 0.05% (n=12)
PAQRIQLVNTNGSWH 0.05% (n=12)
PQQKVQLINTNGSW- 0.05% (n=12)
PSQNIRLTNTNGSWH 0.05% (n=11)
PTQRIQLINTNGSWH 0.05% (n=11)
ASQKIELIHTNGSWH 0.05% (n=11)
ARQNLQLVNTNGSWH 0.05% (n=11)
SAQRIQLVNTNGSWH 0.05% (n=11)
PQQKLQLVNTNGSWH 0.05% (n=11)
SRQNLQLVNTNGSWH 0.05% (n=11)
SSQKLQLINSNGSWH 0.05% (n=11)
PAQEVQLINTNGSWH 0.05% (n=11)
AKQDIRLINTNGSWH 0.04% (n=10)
SKQNIQLVNTNGSWH 0.04% (n=10)
PKQNIQLTNTNGSWH 0.04% (n=10)
PKQNIQLVNSNGSWH 0.04% (n=10)
ANQDIQLINTNGSWH 0.04% (n=10)
ASQNIQLMNTNGSWH 0.04% (n=10)
PSQSIQLVNTNGSWH 0.04% (n=10)
ARQNIQLMNTNGSWH 0.04% (n=9)
PKQNLQLINSDGSWH 0.04% (n=9)
PRQNVQLINTNGSWH 0.04% (n=9)
PTQNIQLVNTNGSWH 0.04% (n=9)
PSQQIQLINTNGSWH 0.04% (n=9)
AKQKIQLVNTNGSWH 0.04% (n=9)
SRQNIQLINRNGSWH 0.04% (n=9)
PGQKIQLINTNGSWH 0.04% (n=9)
SKQKLQLINTNGSWH 0.04% (n=9)
PAQEIHLINTNGSWH 0.04% (n=9)
ASQKIQLIHTNGSWH 0.04% (n=9)
PSQKLQLVNSNGSWH 0.04% (n=9)
AQQNVQLVNTNGSWH 0.03% (n=8)
PKQDIRLINTNGSWH 0.03% (n=8)
SQQHIQLVNSNGSWH 0.03% (n=8)
AKQNIQLISTNGSWH 0.03% (n=8)
PKQKVQLINTNGSWH 0.03% (n=8)
AMQDIQLVNTNGSWH 0.03% (n=8)
AQQNIQLISTNGSWH 0.03% (n=8)
ARQNIQLVNRNGSWH 0.03% (n=8)
PLQKIQLINTNGSWH 0.03% (n=8)
PTQHIQLVNTNGSWH 0.03% (n=8)
AKQNIQLIKSNGSWH 0.03% (n=7)
PSQNIRLINTNGSWH 0.03% (n=7)
PQQNVQLINTNGSWH 0.03% (n=7)
PSQNIQLMNTNGSWH 0.03% (n=7)
ARQKIQLVNTNGSWH 0.03% (n=7)
PKQNVQLINSNGSWH 0.03% (n=7)
PRQDVQLINTNGSWH 0.03% (n=7)
PTQRIQLVNTNGSWH 0.03% (n=7)
ASQKIELINTNGSWH 0.03% (n=7)
SKQKIQLINTNGSWH 0.03% (n=7)
GQQDIRLINTNGSWH 0.03% (n=7)
ASQKLQLINTSGSWH 0.03% (n=6)
ARQNIQLINANGSWH 0.03% (n=6)
PSQNIRLVNSNGSWH 0.03% (n=6)
AKQDIKLINTNGSWH 0.03% (n=6)
AQQKVQLINTNGSWH 0.03% (n=6)
AKQDIQLIYSNGSWH 0.03% (n=6)
SKQNLQ--------- 0.03% (n=6)
ARQDIQLINSNGSWH 0.03% (n=6)
PSQKVQLVNTNGSWH 0.03% (n=6)
ASQNIQLINTNGSRH 0.03% (n=6)
PAQSINLVNTNGSWH 0.03% (n=6)
ASQKIQLINSNGSWH 0.03% (n=6)
PSQKIELVNTNGSWH 0.03% (n=6)
PSQKIHLVNTNGSWH 0.03% (n=6)
SAQNIQLVNTNGSWH 0.03% (n=6)
SQQKVQLINTNGSWH 0.03% (n=6)
PNQKIQLVNTNGSWH 0.03% (n=6)
-SQKIQLINTNGSWH 0.03% (n=6)
PSQELQLVSTNGSWH 0.03% (n=6)
PQQNIQLINSNGSWH 0.02% (n=5)
PKQNIRLINTNGSWH 0.02% (n=5)
PKQNIQLVSTNGSWH 0.02% (n=5)
PNQNIQLINTNGSWH 0.02% (n=5)
AQQNVQLINSNGSWH 0.02% (n=5)
PSQNIRLINSNGSWH 0.02% (n=5)
SQQNIQLVNSNGSWH 0.02% (n=5)
AKQDIKLINTNGSCH 0.02% (n=5)
PKQNLQLVNTNGSWH 0.02% (n=5)
PSQKIQLVNTSGSWH 0.02% (n=5)
PKQNIQLVYTNGSWH 0.02% (n=5)
PKQNIHLINTNGSWH 0.02% (n=5)
ASHNIQLINTNGSWH 0.02% (n=5)
SQQNIQLINTNGSWH 0.02% (n=5)
SRQNIQLINSNGSWH 0.02% (n=5)
PMQNVQLINTNGSWH 0.02% (n=5)
PSQSIRLTNTNGSWH 0.02% (n=5)
PKQNIQLINANGSWH 0.02% (n=5)
PQQKIQLINSNGSWH 0.02% (n=5)
ANQKIQLINTNGSWH 0.02% (n=5)
PKQN----------- 0.02% (n=5)
AKQN----------- 0.02% (n=5)
AKQNVRLINTNGSWH 0.02% (n=5)
PAQRIQLINTNGSWH 0.02% (n=5)
PTQKLQLVNTNGSWH 0.02% (n=5)
AHQKIQLINTNGSWH 0.02% (n=5)
PGQNVQLVNTNGSWH 0.02% (n=5)
SSQKLQLMNTNGSWH 0.02% (n=5)
SHQKIQLVNTNGSWH 0.02% (n=5)
PAQKVQLINTNGSWH 0.02% (n=5)
AKQNIQPINTNGSWH 0.02% (n=4)
AKQSIQLINTNGSWH 0.02% (n=4)
AQHNVQLINTNGSWH 0.02% (n=4)
PSQKLYLINTNGSWH 0.02% (n=4)
ARQNVQLINSNGSWH 0.02% (n=4)
AMQNIQLVSTNGSWH 0.02% (n=4)
AKQNIQLINANGSWH 0.02% (n=4)
ARQNIQLIDTNGSWH 0.02% (n=4)
AQQNIQLMNTNGSWH 0.02% (n=4)
ARQNIQLINTDGSWH 0.02% (n=4)
SNQNIQLINSNGSWH 0.02% (n=4)
AKQNIQLINTNGSRH 0.02% (n=4)
PKQNVQLVNTNGSWH 0.02% (n=4)
PKQNIQLVNANGSWH 0.02% (n=4)
AQQRIQLVNTNGSWH 0.02% (n=4)
AKQNVQLVNSNGSWH 0.02% (n=4)
PKQNIQLINSSGSWH 0.02% (n=4)
AKQDVQLINSNGSWH 0.02% (n=4)
SNQNIQLVNSNGSWH 0.02% (n=4)
AMRNIQLVNTNGSWH 0.02% (n=4)
AKQNIQLINSSGSWH 0.02% (n=4)
AQQNIQLINSNGSWH 0.02% (n=4)
SMQNIQLINTNGSWH 0.02% (n=4)
PNQRIQLINTNGSWH 0.02% (n=4)
ARQNVRLINTNGSWH 0.02% (n=4)
PQQEVQLINANGSWH 0.02% (n=4)
APQNIQLINTNGSWH 0.02% (n=4)
PSQKIQLINTNGSWL 0.02% (n=4)
PAQSIKLVNTSGSWH 0.02% (n=4)
PSQEIQLIHTNGSWH 0.02% (n=4)
PSQHIQLVNTNGSWH 0.02% (n=4)
ASQKIQLINTNGSW- 0.02% (n=4)
ASQRIQLISTNGSWH 0.02% (n=4)
PQQKIQLVNSNGSWH 0.02% (n=4)
PFQKIQLINTNGSWH 0.02% (n=4)
PKQKLQLVNTNGSWH 0.02% (n=4)
AQQKLQLVNTNGSWH 0.02% (n=4)
PQQRIQLVNTNGSWH 0.02% (n=4)
ASQNIQLMETNGSWH 0.02% (n=4)
PSQKLQLVSTNGSWH 0.02% (n=4)
PSQQLQLVNTNGSWH 0.02% (n=4)
ASQKIQLISTNGSWH 0.02% (n=4)
PAQKPQLINTNGSWH 0.02% (n=4)
PSQRIQLISTNGSWH 0.01% (n=3)
AKQDVQLVNSNGSWH 0.01% (n=3)
TKQNIQLVNTNGSWH 0.01% (n=3)
AKRNVQLVNTNGSWH 0.01% (n=3)
AKRNIQLINTNGSWH 0.01% (n=3)
AKQDVQLINTEGSWH 0.01% (n=3)
AKQNIQLINTNSSWH 0.01% (n=3)
AQQNLQLINTNGSWH 0.01% (n=3)
PRQNIQLVNSNGSWH 0.01% (n=3)
ARQNIQLVSTNGSWH 0.01% (n=3)
ARQSIQLINTNGSWH 0.01% (n=3)
ASQNVQLIKTNGSWH 0.01% (n=3)
AKQNIQLINTNDSWH 0.01% (n=3)
AKQHIQLINTNGSWH 0.01% (n=3)
AKQNIQLTNTNGSWH 0.01% (n=3)
AKQDVQLVNTNGSWH 0.01% (n=3)
AKQKVQLIKTNGSWH 0.01% (n=3)
PKQDIKLINTNGSCH 0.01% (n=3)
PRQDIQLINTNGSWH 0.01% (n=3)
ANQNVQLVNSNGSWH 0.01% (n=3)
AKQNIQLIYSNGSWH 0.01% (n=3)
ARQKVQLINTNGSWH 0.01% (n=3)
PKQNLQLINTNGSWH 0.01% (n=3)
PKQNVQLVNSNGSWH 0.01% (n=3)
PQQNIQLVNSNGSWH 0.01% (n=3)
AEQNVQLINTNGSWH 0.01% (n=3)
SKQNIQ--------- 0.01% (n=3)
ARQNIRLINTNGSWH 0.01% (n=3)
PSQDIRLANTNGSWH 0.01% (n=3)
AKQNIQLANTNGSWH 0.01% (n=3)
PKQNIHLVKTNGSWH 0.01% (n=3)
PKQNIQLIRTNGSWH 0.01% (n=3)
PSQKIQLINTSGSWH 0.01% (n=3)
SQQNIQLINANGSWH 0.01% (n=3)
PKQNIQLVNTNGSWY 0.01% (n=3)
SRQKIQLVNTNGSWH 0.01% (n=3)
AKQKVQLINTNGSWH 0.01% (n=3)
PSQKIQLLNTNGSWH 0.01% (n=3)
ASQDIQLINTNGSWH 0.01% (n=3)
PAQNIQLVNTSGSWH 0.01% (n=3)
PTQPINLVNTNGSWH 0.01% (n=3)
PSQEIQLINTNGSWH 0.01% (n=3)
PAQRLQLINTNGSWH 0.01% (n=3)
SHQKIQLINTNGSWH 0.01% (n=3)
SQQKIQLVNTNGSWH 0.01% (n=3)
AHQKVQLVKTNGSWH 0.01% (n=3)
SQQKIQLIKTNGSWH 0.01% (n=3)
PQQKVQLINTNGSWH 0.01% (n=3)
PAQKIQ--------- 0.01% (n=3)
ASQKIRLINTNGSWH 0.01% (n=3)
ASQKIELVNTNGSWH 0.01% (n=3)
AHQNIQLINTNGSWH 0.01% (n=3)
AKQNIQLVNINGSWH 0.01% (n=2)
AKQNVQLVDTNGSWH 0.01% (n=2)
AQQNVQLIDTNGSWH 0.01% (n=2)
AQQNVQLINTNGSGH 0.01% (n=2)
AQQNVQLINTNGTWH 0.01% (n=2)
ARQNVKLINTNGSWH 0.01% (n=2)
AKQNVQPINTNGSWH 0.01% (n=2)
PSQKLHLINTNGSWH 0.01% (n=2)
ASQNIQLVNSSGSWH 0.01% (n=2)
ASQNIQLVNSNGSWH 0.01% (n=2)
PNQNVQLINTNGSWH 0.01% (n=2)
ANQNVQLVNTNGSWH 0.01% (n=2)
PKQNIQLVNTNGNWH 0.01% (n=2)
AKQNIQLINTDGSWH 0.01% (n=2)
AKQDIQLINTNGNWH 0.01% (n=2)
AEQNIQLINTNGSWH 0.01% (n=2)
AQQNIQLINTDGSWH 0.01% (n=2)
AKQGIQLINTNGSWH 0.01% (n=2)
PSQSIQLINTNGSWH 0.01% (n=2)
AQQNIQLVNANGSWH 0.01% (n=2)
AQQKVQLINSNGSWH 0.01% (n=2)
PKQNLQLINSNGSWH 0.01% (n=2)
AKQNIQLINPNGSWH 0.01% (n=2)
AQQKIQLINANGSWH 0.01% (n=2)
SRQDIQLINSNGSWH 0.01% (n=2)
AKQNIQLINTNGS*H 0.01% (n=2)
ARQEIRLINTNGSWH 0.01% (n=2)
AMQNIQLINTNGSWH 0.01% (n=2)
PRQNVQLINSNGSWH 0.01% (n=2)
PSQEIQLVNKNGSWH 0.01% (n=2)
AKQNTQLINTNGSWH 0.01% (n=2)
AKQNIQLIDTNGSWH 0.01% (n=2)
ARQNIQMINTNGSWH 0.01% (n=2)
AQQNIQLVDTNGSWH 0.01% (n=2)
AKQSIQLINSNGSWH 0.01% (n=2)
ARQDVQLINTNGSWH 0.01% (n=2)
AKQNIQLINTSGSWH 0.01% (n=2)
AKQDLQLINTNGSWH 0.01% (n=2)
AQQNIQLINTSGSWH 0.01% (n=2)
AQQNIRLINTNGSWH 0.01% (n=2)
PKQHIQLVNANGSWH 0.01% (n=2)
AKQDVRLINTNGSWH 0.01% (n=2)
SRQNLQLINTNGSWH 0.01% (n=2)
ARQNIQLINTSGSWH 0.01% (n=2)
PQQKIQLVNTDGSWH 0.01% (n=2)
ALQNVQLINTNGSWH 0.01% (n=2)
AKQNIQLINTNGGWH 0.01% (n=2)
SKQNIELINSNGSWH 0.01% (n=2)
PNQNIQLINSNGSWH 0.01% (n=2)
PSQKIQLVNNNGSWH 0.01% (n=2)
AKQDIKLMNTNGSWH 0.01% (n=2)
TMQNIQLVNTNGSWH 0.01% (n=2)
AAQNVQLINTNGSWH 0.01% (n=2)
SRQSIQLINTNGSWH 0.01% (n=2)
SRQNIQLINTTGSSH 0.01% (n=2)
ARQAIQLINSNGSRH 0.01% (n=2)
PKQNIQLINPNGSWH 0.01% (n=2)
PQQNIQLVNTDGSWH 0.01% (n=2)
AGQNIQLINTNGSWH 0.01% (n=2)
AKQSVQLINTNGSWH 0.01% (n=2)
AKQNVQLINTNGSRH 0.01% (n=2)
AMQNIQLVNTNGSRH 0.01% (n=2)
AMQNIQLVNTNGS*H 0.01% (n=2)
PNQKVQLINTNGSWH 0.01% (n=2)
PSQNVQ--------- 0.01% (n=2)
RKQDIQLINSNGSWH 0.01% (n=2)
ARQNIQLINTNGSRH 0.01% (n=2)
PKQDIQLINTNGSWR 0.01% (n=2)
PQQKIQLINTNGSRH 0.01% (n=2)
ARQNVQLLNTNGSWH 0.01% (n=2)
ARQNVQLINTNGSWR 0.01% (n=2)
PQQKIQLISTNGSWH 0.01% (n=2)
SRQYVQLINTNGSWH 0.01% (n=2)
AQQKIQLVNADGSWH 0.01% (n=2)
SQQHVQLINTNGSWH 0.01% (n=2)
AKQNIQVINTNGSWH 0.01% (n=2)
ARQHVQLVNTNGSWH 0.01% (n=2)
PRQNLQLVSTNGSWH 0.01% (n=2)
HNQKIQLINSNGSWH 0.01% (n=2)
PKQDIQLIHKNGSWH 0.01% (n=2)
AKQNIHLINTNGSWH 0.01% (n=2)
AQQK----------- 0.01% (n=2)
ASQNVQLVNTNGSWH 0.01% (n=2)
PQQDIRLVNTNGSWH 0.01% (n=2)
PKQKVQLVNTNGSWH 0.01% (n=2)
PRQKVQLVNTNGSWH 0.01% (n=2)
PQQKVQLINANGSWH 0.01% (n=2)
PKQNIQLVNTNGSRH 0.01% (n=2)
AKQNVQLINTNGS*H 0.01% (n=2)
PSQQIQLINSNGSWH 0.01% (n=2)
AKQNIQLVATNGSWH 0.01% (n=2)
PKQNIQLINKNGSWH 0.01% (n=2)
PKQDIQLINKNGSWH 0.01% (n=2)
AMQNVQLINTNGSWH 0.01% (n=2)
AQQKIQLVNSNGSWH 0.01% (n=2)
PQQRIQLINTNGSWH 0.01% (n=2)
SAQKLQLINTNGSWH 0.01% (n=2)
PSQKIQLMNTNGSWH 0.01% (n=2)
PAHKIQLVNTNGSWH 0.01% (n=2)
ASQEIQLIYTNGSWH 0.01% (n=2)
PAQKIQLVNSNGSWH 0.01% (n=2)
ASQRIQLINSNGSWH 0.01% (n=2)
PSHKIQLVNTNGSWH 0.01% (n=2)
ASQSIQLINTNGSWH 0.01% (n=2)
ASHNIHLINTNGSWH 0.01% (n=2)
ASQNIQLINTNRSWH 0.01% (n=2)
ASQNIQLINTSGSWH 0.01% (n=2)
ASQNTQLINTNGSWH 0.01% (n=2)
VSQKIQLINTNGSWH 0.01% (n=2)
PAQPIKLVNTSGSWH 0.01% (n=2)
PAHRIQLVNTNGSWH 0.01% (n=2)
PAQKVQLVNTNGSWH 0.01% (n=2)
SSQKIQLVNSNGSWH 0.01% (n=2)
PAQKIELVNTNGSWH 0.01% (n=2)
ASQEIQLIHTNGSWH 0.01% (n=2)
PSQKIQLIHTNGSWH 0.01% (n=2)
PTQHIQLINTNGSWH 0.01% (n=2)
AQQRIQLINTNGSWH 0.01% (n=2)
PTQNLQLINTNGSWH 0.01% (n=2)
PSQPLQLIHTNGSWH 0.01% (n=2)
SSQNIQLVNINGSWH 0.01% (n=2)
ASQRIQLVNTNGSW- 0.01% (n=2)
ASQRVQLVNTNGSWH 0.01% (n=2)
PRQKIQLVNTNGSWH 0.01% (n=2)
SNQNIQLINTNGSWH 0.01% (n=2)
PAQNIQLVNSNGSWH 0.01% (n=2)
AAQNIQLVNTNGSWH 0.01% (n=2)
ASQKVQLVNTNGSWH 0.01% (n=2)
PTQKIQLVNSNGSWH 0.01% (n=2)
PQQKIQLVHANGSWH 0.01% (n=2)
SAQRVQLVNTNGSWH 0.01% (n=2)
PQQNVQLINSNGSWH 0.01% (n=2)
SSQNVQLINTNGSWH 0.01% (n=2)
TSQKIQLINTNGSWH 0.01% (n=2)
ASQKIQLMNTNGSWH 0.01% (n=2)
ASQKIQLMHTNGSWH 0.01% (n=2)
AKQKIQLMNTNGSWH 0.01% (n=2)
ASQEIQLINTNGSWH 0.01% (n=2)
PSQNIHLVNTNGSWH 0.01% (n=2)
SSQKLQLINTNGSWH 0.01% (n=2)
PAQNLQLVNTNGSWH 0.01% (n=2)
PSQKIQ--------- 0.01% (n=2)
ASRKIQLINTNGSWH 0.01% (n=2)
ASQKIQLINANGSWH 0.01% (n=2)
PRQNLQLVNTNGSWH 0.01% (n=2)
PPQNIQLINTNGSWH 0.01% (n=2)
SKQKIQLVNTNGSWH 0.01% (n=2)
SRQKVQLINTNGSWH 0.01% (n=2)
SPQKIQLINTNGSWH 0.01% (n=2)
-AQKIQLVNTNGSWH 0.01% (n=2)
PSQELQLVNTNGSWH 0.01% (n=2)
PQQKIQLINTSGSWH 0.01% (n=2)
PAQKLQLIDTNGSWH 0.01% (n=2)
PAQKLQLIKTNGSWH 0.01% (n=2)
PAQKLQLINTNGSWY 0.01% (n=2)
PAQKLQLINTNSSWH 0.01% (n=2)
SAQKIQLINTDGSWH 0.01% (n=2)
SKQTIQLINTNGSWH 0.01% (n=2)
PAQKIELINTNGSWH 0.01% (n=2)
PVQHLQLINTNGSWH 0.01% (n=2)
AKQNIQLVNTNGSWQ 0.00% (n=1)
AKQNIQLVNTNGSWR 0.00% (n=1)
AEQNVQLVNTNGSWH 0.00% (n=1)
AKLNVQLVNTNGSWH 0.00% (n=1)
AKQNIQLVNTNGSWL 0.00% (n=1)
PSQNAQLINTNGSWH 0.00% (n=1)
AKQDVQLINTHGSWH 0.00% (n=1)
AKQDIQLINTNGSWD 0.00% (n=1)
PKENIQLVNTNGSWH 0.00% (n=1)
PKQNIQLVNTNSSWH 0.00% (n=1)
PKRNIQLVNTNGSWH 0.00% (n=1)
AGQNVQLINTNGSWH 0.00% (n=1)
PKQNV*LINTNGSWH 0.00% (n=1)
PSQDTRLINTNGSWH 0.00% (n=1)
PSQNIYLINTNGSWH 0.00% (n=1)
PSQDIRLINPNGSWH 0.00% (n=1)
VKQNIQLVNSNGSWH 0.00% (n=1)
PKQSVQLINTNGSWH 0.00% (n=1)
PKQNVQLTNTNGSWH 0.00% (n=1)
AKQNIQLTKSNGSWH 0.00% (n=1)
AKQNIQLIKSNGSRH 0.00% (n=1)
ARQNIQPINSNGSWH 0.00% (n=1)
ARQNTQLVNSNGSWH 0.00% (n=1)
AKRDIQLINTNGSWH 0.00% (n=1)
VKQNIQLINTNGSWH 0.00% (n=1)
AKRNIQLINSNGSWH 0.00% (n=1)
PSQDVRLINTNGSWH 0.00% (n=1)
PQQHIQLVNANGSWH 0.00% (n=1)
PSQNIQLVNSNGNWH 0.00% (n=1)
PKQDIKLMKTNDSWH 0.00% (n=1)
ARQEIQLINTNGSWH 0.00% (n=1)
AQQKIQLVNTNGSRH 0.00% (n=1)
AQQKIQLVDTNGSWH 0.00% (n=1)
PKQNVQLINTNDSWH 0.00% (n=1)
PEQNVQLINTNGSWH 0.00% (n=1)
PSQNIQLVNINGSWH 0.00% (n=1)
PSQNIQLVNTNGS*H 0.00% (n=1)
PGQNIQLVNTNGSWH 0.00% (n=1)
ASQNVQLIQTNGSWH 0.00% (n=1)
ASQNVQLINTSGSWH 0.00% (n=1)
ASQNVQLIKTDGSWH 0.00% (n=1)
AKQNIQLINTNGSWD 0.00% (n=1)
SKQNIQLINTNG-WH 0.00% (n=1)
ASQNAQLINSNGSWH 0.00% (n=1)
ASQNVQLISSNGSWH 0.00% (n=1)
ASQNVQLINFNGSWH 0.00% (n=1)
ASQNVQLVNSNGSWH 0.00% (n=1)
PSRVIQLINTNGSWH 0.00% (n=1)
AQQNIQLINTNSSWH 0.00% (n=1)
PKQNVQLINTSGSWH 0.00% (n=1)
PKLNVQLINTNGSWH 0.00% (n=1)
LKQNVQLINTNGSWH 0.00% (n=1)
AQHNIQLINTNGSWH 0.00% (n=1)
AKQDIHLINTNGSWH 0.00% (n=1)
AQQNVQLTNTNGSWH 0.00% (n=1)
PSQNIQLINTDGSWH 0.00% (n=1)
PSQNTQLINTNGSWH 0.00% (n=1)
PKQNVQLIYTNGSWH 0.00% (n=1)
PRQKIQLINSNGSWH 0.00% (n=1)
PKQDIRLINSNGSWH 0.00% (n=1)
PRQNIQLINSNGSWY 0.00% (n=1)
GKQNIQLINTNGSWH 0.00% (n=1)
AKQKVQLMNTNGSWH 0.00% (n=1)
AQQNIQLIDTNGSWH 0.00% (n=1)
AQQKVQLMNTNGSWH 0.00% (n=1)
AKQKVQLINANGSWH 0.00% (n=1)
AKQKVQLINSNGSWH 0.00% (n=1)
AQQSIQLINTNGSWH 0.00% (n=1)
ASQNIQLINSNGRWH 0.00% (n=1)
ARQNIQLISTNGSWH 0.00% (n=1)
ARQNIQVINTNGSWH 0.00% (n=1)
PKQNIRLVNSNGSWH 0.00% (n=1)
PKQQVQLINSNGSWH 0.00% (n=1)
AKQDIKLINTNGSGH 0.00% (n=1)
PKQDIKLINTNGSGH 0.00% (n=1)
PKQGIKLINTNGSWH 0.00% (n=1)
AKQDIKLINTNGSCA 0.00% (n=1)
ARQDIQLVNSNGSWH 0.00% (n=1)
PKQNIQLINTNGSW- 0.00% (n=1)
PQQNIQLINTNGSW- 0.00% (n=1)
SSQNLQLINSNGSWH 0.00% (n=1)
PSQDLQLINSNGSWH 0.00% (n=1)
PKQNIQPINSNGSWH 0.00% (n=1)
AKQKIQLINSNGGWH 0.00% (n=1)
ARQKIQLINSNGSWR 0.00% (n=1)
PSQEIQLVSENGSWH 0.00% (n=1)
LSQEIQLVNENGSWH 0.00% (n=1)
PSQEIQQVNENGSWH 0.00% (n=1)
PSQEIQLVNENDSWH 0.00% (n=1)
PSQDIQLVNKNGSWH 0.00% (n=1)
AKQNIQLINTNGRWH 0.00% (n=1)
AKQNIQLINTNGSWR 0.00% (n=1)
ARQSIQMVNTNGSWH 0.00% (n=1)
PSQNLQLVNTDGSWH 0.00% (n=1)
PKQNIQLVNTKGSWH 0.00% (n=1)
ANQNIQLVNTNGSWH 0.00% (n=1)
ASQNIQPVNTNGSWH 0.00% (n=1)
ASQNIQLVTTNGSWH 0.00% (n=1)
ASQNIQLANTNGSWH 0.00% (n=1)
ASQSIQLVNTNGSWH 0.00% (n=1)
ASQNIQLVNTNGSWR 0.00% (n=1)
AKQNIQLVNTSGSWH 0.00% (n=1)
AQQNTQLVNTNGSWH 0.00% (n=1)
AQQNVQLVNSNGSWH 0.00% (n=1)
AMQNIQLMNTNGSWH 0.00% (n=1)
ARQNIQLINNNGSWH 0.00% (n=1)
ARQPIGLINTNGSWH 0.00% (n=1)
PQQKIHLINTNGSWH 0.00% (n=1)
PKQDVQLINSNGSWH 0.00% (n=1)
PRQTIRLINSNGSWH 0.00% (n=1)
PQQNIQLINTSGSWH 0.00% (n=1)
AQQNIQLINTGGSWH 0.00% (n=1)
AQQNIQLIYSNGSWH 0.00% (n=1)
AKQNIQLVYSNGSWH 0.00% (n=1)
PKQNIQLVYTNGSWR 0.00% (n=1)
LKQDIQLVNSNGSWH 0.00% (n=1)
AQQTVQLINTNGSWH 0.00% (n=1)
AN*DIQLINTNGSWH 0.00% (n=1)
ANQDIQLISTNGSWH 0.00% (n=1)
ARRNVQLINTNGSWH 0.00% (n=1)
AKQDVQLINANGSWH 0.00% (n=1)
AKQDVQLINTNGGWH 0.00% (n=1)
PKQDIQLINTNDSWH 0.00% (n=1)
AQQKIQLMNTNGSWH 0.00% (n=1)
AKQNVQLVNANGSWH 0.00% (n=1)
AKQNVQLMNTNGSWH 0.00% (n=1)
AKQHVQLINTNGSWH 0.00% (n=1)
AQQKIQLVNASGSWH 0.00% (n=1)
PNQNIQLVNNNGSWH 0.00% (n=1)
AQQNIKLINTNGSWH 0.00% (n=1)
PTQNIQLINSNGSWH 0.00% (n=1)
PSQKIELVDTSGSWH 0.00% (n=1)
ARQNIQLMYTNGSWH 0.00% (n=1)
AKQNIQLVHANGSWH 0.00% (n=1)
ARQNIQLVNSHGSWD 0.00% (n=1)
SQQNVQLINTDGSWH 0.00% (n=1)
PSQHIQLINTNGSWH 0.00% (n=1)
SKQDIQLVNTNGSWH 0.00% (n=1)
AKQNIQLVNTNGRWH 0.00% (n=1)
AQQDVQLINTNGSWH 0.00% (n=1)
PRQSIKLINTNGSWH 0.00% (n=1)
PRQNIQLINTSGSWH 0.00% (n=1)
PKQDIQLVNTSGSWH 0.00% (n=1)
AQQNVQLMNTNGSWH 0.00% (n=1)
PSQNIQLVNTSGSWH 0.00% (n=1)
AMQDIQLINTNGSWH 0.00% (n=1)
PKQNIHLVNSNGSWH 0.00% (n=1)
AKQNIQLVNANGSWH 0.00% (n=1)
PKQKLQLINSNGSWH 0.00% (n=1)
AKQQINLINTNGSWH 0.00% (n=1)
PKQNIQLVNNNGSWH 0.00% (n=1)
PKQNIQLINNNGSWH 0.00% (n=1)
PKQDIQLINSSGSWH 0.00% (n=1)
AQQKIQLVNKNGSWH 0.00% (n=1)
ANQDIHLINSNGSWH 0.00% (n=1)
AQQKIQLIHTNGSWH 0.00% (n=1)
HHQNIQLVNKDGSWH 0.00% (n=1)
AKQNIQLIHTNGSWH 0.00% (n=1)
PKQNIQLINTNGTWH 0.00% (n=1)
PRQSIQLINTNGSWH 0.00% (n=1)
PQQNIQLIKSNGSWH 0.00% (n=1)
AKQNIQLVNSSGSWH 0.00% (n=1)
AQQNVQLISTNGSWH 0.00% (n=1)
PSQHIQLINSNGSWH 0.00% (n=1)
AKQNIELINTNGSWH 0.00% (n=1)
PKQNLRLVNSNGSWH 0.00% (n=1)
AKQDINLVNTNGSWH 0.00% (n=1)
PKQDLQLINTNGSWH 0.00% (n=1)
ARQDVRLINTNGSWH 0.00% (n=1)
AQQRVQLINSNGSWH 0.00% (n=1)
ANQKVQLINTNGSWH 0.00% (n=1)
PKQDIRLIHTNGSWH 0.00% (n=1)
AQQNIQLVSTNGSWH 0.00% (n=1)
AQQNIQLVNSNGSWH 0.00% (n=1)
PRQEIQLVNTNGSWH 0.00% (n=1)
ARQNIQLINASGSWH 0.00% (n=1)
AMQNIRLINTNGSWH 0.00% (n=1)
AQQKIQLVKANDSWH 0.00% (n=1)
ARQNIQLVNNNGSWH 0.00% (n=1)
PRQKIELVNVNDSWH 0.00% (n=1)
PQQQIQLVNSNGSWH 0.00% (n=1)
PRQDVRLINTNGSWH 0.00% (n=1)
SKQNIRLINTNGSWH 0.00% (n=1)
PKQNIQLTNSNGSWH 0.00% (n=1)
AKQNIQLINTNGSWQ 0.00% (n=1)
PQQDIQLVNTNGSRH 0.00% (n=1)
PQQSIQLVNTNGSWH 0.00% (n=1)
PQQNIQPVNTNGSWH 0.00% (n=1)
PQQDIQLVNTNGSWH 0.00% (n=1)
AEQDIQLINTNGSWH 0.00% (n=1)
AKQDIQLTNTNGSWH 0.00% (n=1)
ARQNIQLINTNGSWR 0.00% (n=1)
PRQNLQLINTNGSWH 0.00% (n=1)
PKQKAQLINTNGSWH 0.00% (n=1)
ARQNVQLINANGSWH 0.00% (n=1)
AKQNVQLISTNGSWH 0.00% (n=1)
AKQNVQLINTNGGWH 0.00% (n=1)
AKQNVQLINTNDSWH 0.00% (n=1)
AKQNVQLINANGSWH 0.00% (n=1)
AKQNVQLINTNGSWR 0.00% (n=1)
AKHNDQPINTHGSWH 0.00% (n=1)
ARQNLQLVNTNRSWH 0.00% (n=1)
AMQNIQLVNTNGSWY 0.00% (n=1)
AMQNIQLVNTNGNWH 0.00% (n=1)
AKQNIQLVNTNGNWH 0.00% (n=1)
AMQNVQLVNTNGSWH 0.00% (n=1)
AMQSIQLVNTNGSWH 0.00% (n=1)
VMQNIQLVNTNGSWH 0.00% (n=1)
TEQDIQLVNTNGSWH 0.00% (n=1)
PKQDVQLVNTNGSWR 0.00% (n=1)
PKQDVQLVNTNGSRH 0.00% (n=1)
PRQNIQLINSNGNWH 0.00% (n=1)
PRLNIQLINSNGNWH 0.00% (n=1)
ANQRVQLVNSNGSWH 0.00% (n=1)
ANQKVQLVNTNGSWH 0.00% (n=1)
PRQNIQLINSSGSWH 0.00% (n=1)
AKQNI*LINTNGSWH 0.00% (n=1)
PSQQIQ--------- 0.00% (n=1)
PSQDVQ--------- 0.00% (n=1)
AKQDIQ--------- 0.00% (n=1)
PSQNIQ--------- 0.00% (n=1)
SKQDVQFINSNGSWH 0.00% (n=1)
SRQDVQLINSNGSWH 0.00% (n=1)
ARQNVQLINSN---- 0.00% (n=1)
PRQKVQLINSN---- 0.00% (n=1)
PKQNVQLINSN---- 0.00% (n=1)
AKQNIQFINTNGSWH 0.00% (n=1)
AKQNIQLINTTGSWH 0.00% (n=1)
ARQNIQLINTNGSWY 0.00% (n=1)
VRQNIQLINTNGSWH 0.00% (n=1)
PKQNIQLINTNGS*H 0.00% (n=1)
PSQTIRLANTSGSWH 0.00% (n=1)
PGQNIKLTNTNGSWH 0.00% (n=1)
PSQNIKLTSTNGSWH 0.00% (n=1)
PSQSIRLANTNGSWH 0.00% (n=1)
PRQNIKLTNTNGSWH 0.00% (n=1)
PSQTIRLTNTNGSWH 0.00% (n=1)
PPQKIQLISTNGSWH 0.00% (n=1)
PSQKIQLIGTNGSWH 0.00% (n=1)
PSQKIELINPNGGWH 0.00% (n=1)
PSQKIELINTNGSWH 0.00% (n=1)
PKQNIQMINTNGSWH 0.00% (n=1)
TKQNIQLINTNGSWH 0.00% (n=1)
VKQNIQLINTNDSWH 0.00% (n=1)
AQQKIQLINTNGCWH 0.00% (n=1)
AQQKIQLINTNGSWY 0.00% (n=1)
AQQKIQLTNTNGSWH 0.00% (n=1)
AQQKIQLINTIGSWH 0.00% (n=1)
AQQKI*LINTNGSWH 0.00% (n=1)
AQRKIQLINTNGSWH 0.00% (n=1)
AQQKIQLINTNGSWR 0.00% (n=1)
AQQKIQLINTNGS*H 0.00% (n=1)
SKQNIQLINSIGSWH 0.00% (n=1)
SKQNVQLINSNGSWH 0.00% (n=1)
SKQNIQLINPNGSWH 0.00% (n=1)
SK*NIQLINSNGSWH 0.00% (n=1)
SKQNIQLTNSNGSWH 0.00% (n=1)
SRQNIQLINTNGS*H 0.00% (n=1)
SR*NIQLINTNGSWH 0.00% (n=1)
SRQNIQLISTNGSWH 0.00% (n=1)
SRQNIQLVNANGSWH 0.00% (n=1)
AKHNIQLVNTNGSWH 0.00% (n=1)
AMQNIQLVNTDGSWH 0.00% (n=1)
AKQYIQLINTNGSWH 0.00% (n=1)
PQQKIQLIKTNGSWH 0.00% (n=1)
PQQNIHLIKTNGSWH 0.00% (n=1)
PKQNIHLIKTNGGWH 0.00% (n=1)
PKQNIQLIKTNGRWH 0.00% (n=1)
AQQNVQLINTNGSWL 0.00% (n=1)
PKQNVHLISTNGSWH 0.00% (n=1)
SQQDIQLINSNGSWH 0.00% (n=1)
ANQGIRLINTNGSWH 0.00% (n=1)
SRQNIQLVSTNGSWH 0.00% (n=1)
PKQNIQLVNSSGSWH 0.00% (n=1)
PKQDIHLVNTNGSWH 0.00% (n=1)
ARQQIRLINTNGSWH 0.00% (n=1)
ASQKLQLVNSNGSWH 0.00% (n=1)
AKQSIQLINNNGSWH 0.00% (n=1)
PKQNIQLVHTNGSWH 0.00% (n=1)
PSQNLHLINTNGSWH 0.00% (n=1)
PKQNIQLVNENGSWH 0.00% (n=1)
AKQKIQLVNANGSWH 0.00% (n=1)
PQQNIRLINTNGSWH 0.00% (n=1)
AKQNIQLTNSNGSWH 0.00% (n=1)
SRQNVQLINSNGSWH 0.00% (n=1)
SRQNVQLMNTNGNWH 0.00% (n=1)
AQQNIQLVHTNGSWH 0.00% (n=1)
AQQNIRLVNTNGSWH 0.00% (n=1)
PRQN----------- 0.00% (n=1)
PTQN----------- 0.00% (n=1)
SQQN----------- 0.00% (n=1)
ARQN----------- 0.00% (n=1)
AQQE----------- 0.00% (n=1)
SRQN----------- 0.00% (n=1)
PKQH----------- 0.00% (n=1)
AQQEIQLINSNGSWH 0.00% (n=1)
AKQDIQLVNTSGSWH 0.00% (n=1)
PRQNIRLVNTNGSWH 0.00% (n=1)
AQQNVQLINTNGSRH 0.00% (n=1)
PRQDIQLVNTNGSWH 0.00% (n=1)
ARQNIQLINTKGSWH 0.00% (n=1)
AQQKLQLINTSGSWH 0.00% (n=1)
AQQEIQLINTNGSWH 0.00% (n=1)
PKQDIRLVNTNGSWH 0.00% (n=1)
ARQNIQLVNASGSWH 0.00% (n=1)
AKQDIQLINSNGSGH 0.00% (n=1)
PKQNIQLIDTNGSWH 0.00% (n=1)
AQQDIQLINSNGSWH 0.00% (n=1)
ARQNIRLINSNGSWH 0.00% (n=1)
PKQDIQLINSNGSWH 0.00% (n=1)
PRQNVQLVNTNGSWH 0.00% (n=1)
PNQSVQLINTNGSWH 0.00% (n=1)
PQQNVQLINANGSWH 0.00% (n=1)
PQQRVQLINTNGSWH 0.00% (n=1)
AKQNIQPINSNGSWH 0.00% (n=1)
ANQNIQLVNSNGSWH 0.00% (n=1)
AKQNTQLINSNGSWH 0.00% (n=1)
AKQNIQLINSNDSWH 0.00% (n=1)
AEQNIQLINSNGSWH 0.00% (n=1)
AKQNVQLININGSWH 0.00% (n=1)
AKQNV*LINTNGSRH 0.00% (n=1)
AKQNVQLINTNGSWY 0.00% (n=1)
AKQNVQLINTNGCWH 0.00% (n=1)
AKQNVQPVNTNGSWH 0.00% (n=1)
AKQNVQLVNTNGSWR 0.00% (n=1)
TKQNVQLVNTNGSWH 0.00% (n=1)
AKQNVHLINSNGSWH 0.00% (n=1)
AKQNLQLMNSNGSWH 0.00% (n=1)
PAQNIRLINSNGSWH 0.00% (n=1)
ARQNIQLVNANGSWH 0.00% (n=1)
SQQNVQLINSNGSWH 0.00% (n=1)
AKQNVQLINNNGSWH 0.00% (n=1)
PQQNLQLINSNGSWH 0.00% (n=1)
PKQNIHLVNNNGSWH 0.00% (n=1)
ALQNIQLINSNGSWH 0.00% (n=1)
AQQKVQLVNTNGSWH 0.00% (n=1)
AHQNIQLVNTNGSWH 0.00% (n=1)
PRQDIQLINSNGSWH 0.00% (n=1)
PRQKVQLINTNGSWH 0.00% (n=1)
AKQNIQLMSTNGSWH 0.00% (n=1)
PKQNIQLIHTNGSWH 0.00% (n=1)
PKQDIQLINTDGSWH 0.00% (n=1)
PSQDVQLINTNGSWH 0.00% (n=1)
PRQKI---------- 0.00% (n=1)
PHQKLQLINTNGSWH 0.00% (n=1)
ASQKIQLINTNVSWH 0.00% (n=1)
PTQKLQLINTNGSWH 0.00% (n=1)
PKQQIQLVNTNGSWH 0.00% (n=1)
SAQEIQLVNTNGSWH 0.00% (n=1)
PSQKIQLVNTNSSWH 0.00% (n=1)
PKQKVQLMNTNGSWH 0.00% (n=1)
AKQEVQLINTNGSWH 0.00% (n=1)
PSQKNQLMNTNGSWH 0.00% (n=1)
PAQKIQLIKTNGSWH 0.00% (n=1)
AAQKIQLIKTNGSWH 0.00% (n=1)
PSQNIQLVKTEGNWH 0.00% (n=1)
PSQKIQLVNTNGGWH 0.00% (n=1)
SSQKVQLVHTNGSWH 0.00% (n=1)
SSQKDQLVNTNGSWH 0.00% (n=1)
ASQNIQLINTDGSWH 0.00% (n=1)
VSEDIPACNTNAAWG 0.00% (n=1)
PAQSIKLVNTSGSWY 0.00% (n=1)
PAQSVNLVNTNGSWH 0.00% (n=1)
PTSENPAYNTNGSWH 0.00% (n=1)
ASQKIQLVKTNGSWH 0.00% (n=1)
ASQKIQLINPNGSWH 0.00% (n=1)
SAQKLELVNTNGSWH 0.00% (n=1)
ASQKIQLVN------ 0.00% (n=1)
PAQKIQIINT----- 0.00% (n=1)
ASQNIQLVH------ 0.00% (n=1)
PSQKIQL-------- 0.00% (n=1)
ASQKIQLINT----- 0.00% (n=1)
ASQNLQLIKTNGSWH 0.00% (n=1)
PAQRIQLVNSNGSWH 0.00% (n=1)
ASQKIELINTNGNWH 0.00% (n=1)
PSQEIQLIHTNGSWD 0.00% (n=1)
PSQEIHLIHTNGSWH 0.00% (n=1)
GSQKIELIHTNGSWH 0.00% (n=1)
ASQKIELIHTNGRWH 0.00% (n=1)
ASQNIQLINTNGGWH 0.00% (n=1)
ASQNIQLLNTNGSWH 0.00% (n=1)
ASQNIHLINTNGSWH 0.00% (n=1)
ASQNIQLINTNGRWH 0.00% (n=1)
ASQNIQLINPNGSWH 0.00% (n=1)
SQENIQLINTNGSWH 0.00% (n=1)
RCQTIQLINTNGSW- 0.00% (n=1)
ARQNIQIINTNGSWH 0.00% (n=1)
ASQGIQLINTNGSWH 0.00% (n=1)
ASQRIQLINANGSWH 0.00% (n=1)
ASQRVQLINTNGSCH 0.00% (n=1)
APQRIQLVNTNGSWH 0.00% (n=1)
SSQNIQLVNTNGSRH 0.00% (n=1)
PSQKVQLISTNGSWH 0.00% (n=1)
PAQKLQLVNTNGSWH 0.00% (n=1)
PSQNIQLVNRNGSWH 0.00% (n=1)
PQ*KIQLVNSNGSWH 0.00% (n=1)
SRRKIQLINTNGSWH 0.00% (n=1)
PSQRIQLVNTNDSWH 0.00% (n=1)
PSRRIQLVNTNGSWH 0.00% (n=1)
PSQRIQLVNTSGSWH 0.00% (n=1)
SSQKIQLVNTNDSWH 0.00% (n=1)
SSQNVQLINSNGSWH 0.00% (n=1)
AKQKIQLVNSNGSWH 0.00% (n=1)
SHQKIQLINSNGSWH 0.00% (n=1)
SSQKIQLVHSNGSWH 0.00% (n=1)
SAQKIQLINSNGSWH 0.00% (n=1)
ACQNIQLINTNGSWH 0.00% (n=1)
SHQNVQLINTNGSWH 0.00% (n=1)
PAQNIRLVNTNGSWH 0.00% (n=1)
ASQGIQLVNTNGSWH 0.00% (n=1)
AQQKIQLIRTNGSWH 0.00% (n=1)
PTQNLQLVNTNGSWH 0.00% (n=1)
PAQSLQLVNTNGSWH 0.00% (n=1)
PAQKIHLINTNGSWH 0.00% (n=1)
PHQNIQLINTNGSWH 0.00% (n=1)
PVQKIQLINTNGSWH 0.00% (n=1)
PLQQIQLINTNGSWH 0.00% (n=1)
SAQKVQLINTNGSWH 0.00% (n=1)
SAQRIQLVNSNGSWH 0.00% (n=1)
PSQSIHLVYTNGSWH 0.00% (n=1)
SYQKVQLINTNGSWH 0.00% (n=1)
SHQKVQLINTNGSWH 0.00% (n=1)
PTQKIQLINSNGSWH 0.00% (n=1)
PKQSIQLVNTNGSWH 0.00% (n=1)
ANQNIQLINTDGSWH 0.00% (n=1)
PSQPIQLVNTNGSWH 0.00% (n=1)
PAQTIQLVTTNGSWH 0.00% (n=1)
PQQKIQLVRANGSWH 0.00% (n=1)
PSQKLQLVNINGSWH 0.00% (n=1)
PGQKVQLINTNGSWH 0.00% (n=1)
ASQNIQPINTNGSWH 0.00% (n=1)
SRQSIQLVNTNGSWH 0.00% (n=1)
SKQTLQLINTNGSWH 0.00% (n=1)
SSQKVQLINTNGSWH 0.00% (n=1)
PGQNVQLINTNGSWH 0.00% (n=1)
SNQNVQLINTNGSWH 0.00% (n=1)
ASRNIQLINTNGSWH 0.00% (n=1)
PSQEIQLVNTNGSWH 0.00% (n=1)
ASQKIQLINTNGSWY 0.00% (n=1)
PPQKIQLINTNGSWH 0.00% (n=1)
PSQNTQLVNTNGSWH 0.00% (n=1)
PAQQVQLVNTNGSWH 0.00% (n=1)
PAQQIQLVNTNGSRH 0.00% (n=1)
SQQKIQLINTSGSWH 0.00% (n=1)
SQQRIQLINTNGSWH 0.00% (n=1)
SQQKIQLINTNSSWH 0.00% (n=1)
ARQSIQLVNTNGSWH 0.00% (n=1)
ARQSIQLVNTDGSWH 0.00% (n=1)
SAQRIQLINTNGSWH 0.00% (n=1)
AHQKLQLINTNGSWH 0.00% (n=1)
GQQNIQLINTNGSWH 0.00% (n=1)
GKQDIRLINTNGSWH 0.00% (n=1)
ARQNLQLINTNGSWH 0.00% (n=1)
ASQHIQLINTNGSWH 0.00% (n=1)
ATQNIQLINTNGSWH 0.00% (n=1)
PSQMIQLVNTNGSWH 0.00% (n=1)
PSRKIQLINTNGSWH 0.00% (n=1)
PTQNVQLINTNGSWH 0.00% (n=1)
SSQKLQLVNSNGSWH 0.00% (n=1)
AQQKLQLMNTNGSWH 0.00% (n=1)
PTQNIQLVNTSGSWH 0.00% (n=1)
ANQKIQLVNTNGSWH 0.00% (n=1)
PKQEIRLVNTNGSWH 0.00% (n=1)
PNQQIQLVNTNGSWH 0.00% (n=1)
PIQKIQLVNTNGSWH 0.00% (n=1)
PGQEIKLVNTNGSWH 0.00% (n=1)
PVQKIQLVNTNGSWH 0.00% (n=1)
AKQNIQLVYTNGSWH 0.00% (n=1)
PTQTIQLVNTNGSWH 0.00% (n=1)
ATQNIQLVNTNGSWH 0.00% (n=1)
SAQEIKLVNTNGSWH 0.00% (n=1)
SQQKLQLVNTNGSWH 0.00% (n=1)
AKQRIQLVNTNGSWH 0.00% (n=1)
PTQELRLVNTNGSWH 0.00% (n=1)
PSQGIQLVNSNGSWH 0.00% (n=1)
PAQKIQLVNSSGSWH 0.00% (n=1)
AAQTIQ--------- 0.00% (n=1)
PRQNILLVNTNGSWH 0.00% (n=1)
SSQRIQLINSNGSWH 0.00% (n=1)
VS------------- 0.00% (n=1)
ASQRIQLINTNDSWH 0.00% (n=1)
ATQKIQLINTNGSWH 0.00% (n=1)
PTQKVQLVNTNGSWH 0.00% (n=1)
PAQKIQLVHTNGSWH 0.00% (n=1)
PSQSIQLINSNGSWH 0.00% (n=1)
PAQKLHLVNTNGSWH 0.00% (n=1)
ASQKLQLVNTNGGWH 0.00% (n=1)
PSQKFQLVNTNGSWH 0.00% (n=1)
ASQNIQLTNTNGSWH 0.00% (n=1)
ASQNIRIINTNGSWH 0.00% (n=1)
ASQNIQLMKTNGSWH 0.00% (n=1)
PSQKIQLINTNGSWY 0.00% (n=1)
PSQNIQLVNSNGSWR 0.00% (n=1)
PSQCIQLINTNGSWH 0.00% (n=1)
PSQNIQLINTNGGWH 0.00% (n=1)
PSRKIQLVNSNGSWH 0.00% (n=1)
AFQNIHLINTNGSWH 0.00% (n=1)
PSQTLQLVNTNGSWH 0.00% (n=1)
LYQRIQLVNTNGSWH 0.00% (n=1)
AAQKIQLINTNGSWH 0.00% (n=1)
PSQNIQLIKSNGSWH 0.00% (n=1)
ARQKIQLVNSNGSWH 0.00% (n=1)
PDQKIQLVNTNGSWH 0.00% (n=1)
PTQKIQLISTNGSWH 0.00% (n=1)
SHQSIQLVNTNGSWH 0.00% (n=1)
SSQNIQLVHTNGSWH 0.00% (n=1)
ASQKIQLVNSNGSWH 0.00% (n=1)
SAQKIQLVNSNGSWH 0.00% (n=1)
ASQRLQLVNTNGSWH 0.00% (n=1)
SAQKIQLIKTNGSWH 0.00% (n=1)
PGQNIQLINTNGSWH 0.00% (n=1)
SAQNIRLINTNGSWH 0.00% (n=1)
SAQNVQLINTNGSWH 0.00% (n=1)
PQQK----------- 0.00% (n=1)
PQQ------------ 0.00% (n=1)
AQQR----------- 0.00% (n=1)
PSQTIQLINTNGSWH 0.00% (n=1)
SYQKIQLINTNGSWH 0.00% (n=1)
SSQRVQLINTNGSWH 0.00% (n=1)
SSQRIQLVNTNGSRH 0.00% (n=1)
SSQRVQLVNTNGSWH 0.00% (n=1)
SSQRIQLINTNGSWR 0.00% (n=1)
SSQRIQLVSTNGSWH 0.00% (n=1)
-KQKIQLVNTNGSWH 0.00% (n=1)
-SQKIQLVNNNGSWH 0.00% (n=1)
-SQKIQLVNTNGSWH 0.00% (n=1)
PSQEVQLINTNGSWH 0.00% (n=1)
PSQELQLINTNGSWH 0.00% (n=1)
PQQKIQLVNTNSSWH 0.00% (n=1)
PQQKIQLVTTNGSWH 0.00% (n=1)
PQQKIQLVNTNGS*H 0.00% (n=1)
PQQKIQLIDTNGSWH 0.00% (n=1)
SRQHIQLINTNGSRH 0.00% (n=1)
SRQHTQLINTNGSWH 0.00% (n=1)
LRQHIQLINTNGSWH 0.00% (n=1)
SRQHIQLINTNGSWR 0.00% (n=1)
PSRKLQLVNTNGSWH 0.00% (n=1)
PSQKLQLVNTNGNWH 0.00% (n=1)
SSQELQLVSTNGSWH 0.00% (n=1)
PSQKLQLANTNGSWH 0.00% (n=1)
PSQKPQLVNTNGSWH 0.00% (n=1)
SSQEIQLINTNGSWH 0.00% (n=1)
PSQELKLVNTNGSWR 0.00% (n=1)
PSQKLQLMNTNGSWH 0.00% (n=1)
PSQKLQPVNTNGSWH 0.00% (n=1)
PSQKLQLVNANGSWH 0.00% (n=1)
PSQKLQLVNTNSSWH 0.00% (n=1)
PSQKLQLVNTKGSWH 0.00% (n=1)
SPQNTQLINTNGSWH 0.00% (n=1)
SSQKIQPINTNGSWH 0.00% (n=1)
PQQKIQLMNTNGSWH 0.00% (n=1)
PQQKIQLINANGSWH 0.00% (n=1)
P*QKIQLINTNGSWH 0.00% (n=1)
ASHKIQLINTNGSWH 0.00% (n=1)
ASQKIQLIDTNGSWH 0.00% (n=1)
ASQKIQLINTNGSRH 0.00% (n=1)
ASQKIQLINTSGSWH 0.00% (n=1)
ASQKIQLVNTNGSWR 0.00% (n=1)
ASQKIQLINTNSSWH 0.00% (n=1)
ASQKTQLINTNGSWH 0.00% (n=1)
ASQKIQLININGSWH 0.00% (n=1)
PAQNLQLINTNGSWR 0.00% (n=1)
PAQKLPLINTNGSWH 0.00% (n=1)
PAQKLQLINANGSWH 0.00% (n=1)
PAQKLQLINTDGSWH 0.00% (n=1)
PAQKLQLINTNGTWH 0.00% (n=1)
PAQKLLLINTNGSWH 0.00% (n=1)
PAQKLQLIHTNGSWH 0.00% (n=1)
PAQKLQLINSNGGWH 0.00% (n=1)
LAQKLQLINTNGSWH 0.00% (n=1)
PAQKLQLINTSGSWH 0.00% (n=1)
PAQKLQLINTNDSWH 0.00% (n=1)
PAQKLQLISTNGSWH 0.00% (n=1)
PALKLQLINTNGSWH 0.00% (n=1)
ASQKIQLINTNGSWR 0.00% (n=1)
ASQKIQHINTNGSWH 0.00% (n=1)
ASQKIQPINTNGSWH 0.00% (n=1)
PRQNIQLINANGSWH 0.00% (n=1)
PSQNIQLINTNGSWR 0.00% (n=1)
SAQKIQLINTNGSWR 0.00% (n=1)
PSQKIQLINTNDSWH 0.00% (n=1)
PSQKIQLINTNGSRH 0.00% (n=1)
ASQKLQLINANGSWH 0.00% (n=1)
ASQ*LQLINTNGSWH 0.00% (n=1)
ASQKLQLINTNGSWR 0.00% (n=1)
PNQKVQLVNTNGSWH 0.00% (n=1)
SHQNIQLINTNGSWH 0.00% (n=1)
PQQTIQLVNTNGSWH 0.00% (n=1)
DGQKIQLVNTNGSWH 0.00% (n=1)
PSQKIQLVNTNGSWN 0.00% (n=1)
RSQKI---------- 0.00% (n=1)
QEQKIQLIHTNGSWH 0.00% (n=1)
PSQKIQLINTNGS-- 0.00% (n=1)
PSQTIQLVNTNGS-- 0.00% (n=1)
PSQKIQLVNSNGSRH 0.00% (n=1)
PKQNIQIINTNGSWH 0.00% (n=1)
PTQKIQLVNNNGIWH 0.00% (n=1)
ASQKIQLV------- 0.00% (n=1)
ATQNIQLI------- 0.00% (n=1)
ASQNIQLIHTNGSWH 0.00% (n=1)
SRQNLQLI------- 0.00% (n=1)
SRQSLQLINTNGSWH 0.00% (n=1)
SKQSLQLINTNGSWH 0.00% (n=1)
PQQRLQLVNSNGSWH 0.00% (n=1)
PHQKIQLMNTSGSWH 0.00% (n=1)
ASQDVQLINTNGSWH 0.00% (n=1)
AQQQLQLINTNGSWH 0.00% (n=1)
AQQRLQLVNTNGSWH 0.00% (n=1)
AQQSLQLINTNGSWH 0.00% (n=1)
PKQKLQLINTNGSWH 0.00% (n=1)
PQQKLELVNTNGSWH 0.00% (n=1)
AQQQLQLVNSNGSWH 0.00% (n=1)
AQQRLQLVNSNGSWH 0.00% (n=1)
PTQKLQLIHTNGSWH 0.00% (n=1)
SQQNIQLVNTNGSWH 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 1a:

AKQNIQLINTNGSWH 24.03% (n=3277)
ARQNIQLINTNGSWH 6.35% (n=866)
PKQNIQLINTNGSWH 4.25% (n=580)
PKQNIQLVNTNGSWH 2.98% (n=407)
AQQNIQLINTNGSWH 2.98% (n=407)
AKQNVQLINTNGSWH 2.91% (n=397)
AQQDIQLVNTNGSWH 2.80% (n=382)
AKQNIQLVNTNGSWH 2.49% (n=339)
AMQNIQLVNTNGSWH 2.44% (n=333)
AQQNVQLINTNGSWH 2.24% (n=306)
AKQNIQLINSNGSWH 2.10% (n=287)
AKQDIQLINTNGSWH 1.73% (n=236)
SRQNVQLINTNGSWH 1.73% (n=236)
AKQNVQLVNTNGSWH 1.42% (n=194)
PKQNVHLINTNGSWH 1.34% (n=183)
ARQNVQLINTNGSWH 1.28% (n=175)
AQQKIQLVNANGSWH 1.23% (n=168)
PQQNIQLINTNGSWH 1.07% (n=146)
PKQNIHLIKTNGSWH 1.06% (n=145)
PRQKLQLINTNGSWH 1.03% (n=140)
AKQDVQLINTNGSWH 0.91% (n=124)
PKQNVQLINTNGSWH 0.82% (n=112)
PSQNIQLINTNGSWH 0.82% (n=112)
PKQDVQLVNTNGSWH 0.79% (n=108)
AKQNIQLVNSNGSWH 0.78% (n=106)
PSQKIQLINTNGSWH 0.75% (n=102)
ASQNIQLVNTNGSWH 0.63% (n=86)
AKQDIQLINSNGSWH 0.63% (n=86)
PSQNIKLTNTNGSWH 0.60% (n=82)
PKQDIQLINTNGSWH 0.58% (n=79)
PKQNIQLINSNGSWH 0.55% (n=75)
AKQNIQLMNTNGSWH 0.55% (n=75)
AKQNVQLINSNGSWH 0.54% (n=74)
AKQNIQLMNSNGSWH 0.54% (n=74)
PQQKIQLINTNGSWH 0.48% (n=65)
PSQKIQLISTNGSWH 0.46% (n=63)
PRQNIQLINTNGSWH 0.43% (n=59)
SRQNIQLINTNGSWH 0.43% (n=58)
SKQNIQLINSNGSWH 0.43% (n=58)
AKQSIQLVNTNGSWH 0.41% (n=56)
SQQHIQLINTNGSWH 0.41% (n=56)
PSQNIQLVNTNGSWH 0.39% (n=53)
PSQEIQLVNENGSWH 0.37% (n=51)
ARQKLQLINTNGSWH 0.34% (n=46)
PKQNIQLINTNNSWH 0.32% (n=44)
PSQDIQLINTNGSWH 0.32% (n=43)
AQQKIQLINTNGSWH 0.31% (n=42)
PKQKIQLINTNGSWH 0.31% (n=42)
SKQNIQLINTNGSWH 0.30% (n=41)
ARQNIQLVNTNGSWH 0.29% (n=40)
PRQNIQLINSNGSWH 0.29% (n=40)
ARQNIQLVNSNGSWH 0.28% (n=38)
AKQDIQLVNSNGSWH 0.27% (n=37)
AQQNIQLVNTNGSWH 0.27% (n=37)
PKQNIQLIKTNGSWH 0.25% (n=34)
PSQKIQLVNTNGSWH 0.24% (n=33)
PKQDIKLINTNGSWH 0.23% (n=32)
PKQDIQLVNTNGSWH 0.23% (n=31)
ASQNVQLINTNGSWH 0.22% (n=30)
AKQNIQLVSTNGSWH 0.22% (n=30)
PRQKIQLINTNGSWH 0.22% (n=30)
ANQNIQLINSNGSWH 0.22% (n=30)
ARQNIQLINSNGSWH 0.21% (n=29)
AQQSIQLVNTNGSWH 0.21% (n=29)
ANQNIQLINTNGSWH 0.21% (n=28)
ASQNVQLINSNGSWH 0.20% (n=27)
PKQDVQLINTNGSWH 0.20% (n=27)
AQQKIQLINSNGSWH 0.18% (n=25)
PSQNLQLVNTNGSWH 0.18% (n=25)
AQQNIQLINANGSWH 0.18% (n=24)
PRQNIQLVNTNGSWH 0.17% (n=23)
SKQNVQLINTNGSWH 0.17% (n=23)
AKQDIQLVNTNGSWH 0.17% (n=23)
PSQNLQLINSNGSWH 0.16% (n=22)
AQQKIQLVNTNGSWH 0.15% (n=21)
ARQNVQLVNTNGSWH 0.15% (n=21)
ANQNVQLINTNGSWH 0.15% (n=20)
PQQNIQLVNTNGSWH 0.15% (n=20)
PSQKIQLINSNGSWH 0.15% (n=20)
AKQNIRLIKSNGSWH 0.14% (n=19)
AKQKIQLINTNGSWH 0.13% (n=18)
AQQDIQLINTNGSWH 0.13% (n=18)
PSQDIRLINTNGSWH 0.12% (n=17)
ARQKIQLINSNGSWH 0.12% (n=17)
AKQNIQLVNTNGSW- 0.12% (n=16)
AQQNVRLINTNGSWH 0.12% (n=16)
AKQNIRLINTNGSWH 0.11% (n=15)
SKQDIQLINTNGSWH 0.11% (n=15)
PQQKIQLVNTNGSWH 0.11% (n=15)
SKQDVQLVNTNGSWH 0.11% (n=15)
PKQDVRLINTNGSWH 0.10% (n=14)
AKQKIQLINSNGSWH 0.10% (n=14)
AKQNLQLINTNGSWH 0.10% (n=14)
PSQTIRLANTNGSWH 0.10% (n=14)
SKQDVQLINTNGSWH 0.10% (n=13)
PSQKIQLVNANGSWH 0.10% (n=13)
AKQDIKLINSNGSWH 0.10% (n=13)
PSQNIQLINSNGSWH 0.10% (n=13)
ARQAIQLINSNGSWH 0.10% (n=13)
PSQNVQLINTNGSWH 0.09% (n=12)
ASQNIQLINSNGSWH 0.09% (n=12)
ARQDIQLINTNGSWH 0.09% (n=12)
AKQGVQLVNTNGSWH 0.09% (n=12)
AKQNIQLINTRGSWH 0.09% (n=12)
ASQNIQLINTNGSWH 0.08% (n=11)
PNQKIQLINTNGSWH 0.08% (n=11)
SQQNVQLINTNGSWH 0.08% (n=11)
PSQNIRLTNTNGSWH 0.08% (n=11)
ARQKIQLINTNGSWH 0.07% (n=10)
PKQNIQLTNTNGSWH 0.07% (n=10)
PKQNIQLVNSNGSWH 0.07% (n=10)
ANQDIQLINTNGSWH 0.07% (n=10)
ARQNIQLMNTNGSWH 0.07% (n=9)
PKQNLQLINSDGSWH 0.07% (n=9)
PRQNVQLINTNGSWH 0.07% (n=9)
PSQNLQLINTNGSWH 0.07% (n=9)
SRQNIQLINRNGSWH 0.07% (n=9)
AQQNVQLVNTNGSWH 0.06% (n=8)
SQQHIQLVNSNGSWH 0.06% (n=8)
PKQKVQLINTNGSWH 0.06% (n=8)
AMQDIQLVNTNGSWH 0.06% (n=8)
AQQNIQLISTNGSWH 0.06% (n=8)
ARQNIQLVNRNGSWH 0.06% (n=8)
AKQDIRLINTNGSWH 0.05% (n=7)
AKQNIQLIKSNGSWH 0.05% (n=7)
PSQNIRLINTNGSWH 0.05% (n=7)
PRQDVQLINTNGSWH 0.05% (n=7)
AKQKIQLVNTNGSWH 0.05% (n=7)
PKQDIRLINTNGSWH 0.04% (n=6)
ASQKLQLINTSGSWH 0.04% (n=6)
ARQNIQLINANGSWH 0.04% (n=6)
PSQNIRLVNSNGSWH 0.04% (n=6)
AKQDIKLINTNGSWH 0.04% (n=6)
AKQDIQLIYSNGSWH 0.04% (n=6)
AKQNIQLISTNGSWH 0.04% (n=6)
PSQNIQLMNTNGSWH 0.04% (n=6)
ARQKIQLVNTNGSWH 0.04% (n=6)
SKQNLQ--------- 0.04% (n=6)
SKQNLQLINTNGSWH 0.04% (n=6)
ARQDIQLINSNGSWH 0.04% (n=6)
PKQNIRLINTNGSWH 0.04% (n=5)
PKQNIQLVSTNGSWH 0.04% (n=5)
AQQNVQLINSNGSWH 0.04% (n=5)
PSQNIRLINSNGSWH 0.04% (n=5)
SQQNIQLVNSNGSWH 0.04% (n=5)
AKQDIKLINTNGSCH 0.04% (n=5)
PKQNLQLVNTNGSWH 0.04% (n=5)
PQQNVQLINTNGSWH 0.04% (n=5)
PKQNIQLVYTNGSWH 0.04% (n=5)
SRQNIQLINSNGSWH 0.04% (n=5)
PMQNVQLINTNGSWH 0.04% (n=5)
PSQSIRLTNTNGSWH 0.04% (n=5)
PKQNIQLINANGSWH 0.04% (n=5)
PQQKIQLINSNGSWH 0.04% (n=5)
PKQN----------- 0.04% (n=5)
AKQN----------- 0.04% (n=5)
AKQNVRLINTNGSWH 0.04% (n=5)
AKQNIQPINTNGSWH 0.03% (n=4)
AKQSIQLINTNGSWH 0.03% (n=4)
AQHNVQLINTNGSWH 0.03% (n=4)
PSQKLYLINTNGSWH 0.03% (n=4)
ARQNVQLINSNGSWH 0.03% (n=4)
AMQNIQLVSTNGSWH 0.03% (n=4)
AKQNIQLINANGSWH 0.03% (n=4)
ARQNIQLIDTNGSWH 0.03% (n=4)
PQQNIQLINSNGSWH 0.03% (n=4)
AQQNIQLMNTNGSWH 0.03% (n=4)
ARQNIQLINTDGSWH 0.03% (n=4)
SNQNIQLINSNGSWH 0.03% (n=4)
AKQNIQLINTNGSRH 0.03% (n=4)
PKQNVQLVNTNGSWH 0.03% (n=4)
PKQNIQLVNANGSWH 0.03% (n=4)
AKQNVQLVNSNGSWH 0.03% (n=4)
PKQNIQLINSSGSWH 0.03% (n=4)
AKQRIQLINTNGSWH 0.03% (n=4)
AKQDVQLINSNGSWH 0.03% (n=4)
SRQNIQLVNTNGSWH 0.03% (n=4)
PKQNVQLINSNGSWH 0.03% (n=4)
SNQNIQLVNSNGSWH 0.03% (n=4)
AMRNIQLVNTNGSWH 0.03% (n=4)
AKQNIQLINSSGSWH 0.03% (n=4)
AQQNIQLINSNGSWH 0.03% (n=4)
ANQKIQLINTNGSWH 0.03% (n=4)
SMQNIQLINTNGSWH 0.03% (n=4)
ARQNVRLINTNGSWH 0.03% (n=4)
PQQEVQLINANGSWH 0.03% (n=4)
AKQDVQLVNSNGSWH 0.02% (n=3)
TKQNIQLVNTNGSWH 0.02% (n=3)
SKQNIQLVNTNGSWH 0.02% (n=3)
AKRNVQLVNTNGSWH 0.02% (n=3)
AKRNIQLINTNGSWH 0.02% (n=3)
AKQDVQLINTEGSWH 0.02% (n=3)
AKQNIQLINTNSSWH 0.02% (n=3)
PRQNIQLVNSNGSWH 0.02% (n=3)
ARQNIQLVSTNGSWH 0.02% (n=3)
ARQSIQLINTNGSWH 0.02% (n=3)
ASQNVQLIKTNGSWH 0.02% (n=3)
AKQNIQLINTNDSWH 0.02% (n=3)
AKQHIQLINTNGSWH 0.02% (n=3)
PNQNIQLINTNGSWH 0.02% (n=3)
AKQNIQLTNTNGSWH 0.02% (n=3)
AKQDVQLVNTNGSWH 0.02% (n=3)
AKQKVQLIKTNGSWH 0.02% (n=3)
PKQDIKLINTNGSCH 0.02% (n=3)
PRQDIQLINTNGSWH 0.02% (n=3)
ANQNVQLVNSNGSWH 0.02% (n=3)
PSQKIQLVNTSGSWH 0.02% (n=3)
AKQNIQLIYSNGSWH 0.02% (n=3)
PKQNLQLINTNGSWH 0.02% (n=3)
PKQNIHLINTNGSWH 0.02% (n=3)
PKQNVQLVNSNGSWH 0.02% (n=3)
SQQNIQLINTNGSWH 0.02% (n=3)
PQQNIQLVNSNGSWH 0.02% (n=3)
AEQNVQLINTNGSWH 0.02% (n=3)
AKQNLQLVNTNGSWH 0.02% (n=3)
SKQNIQ--------- 0.02% (n=3)
ARQNIRLINTNGSWH 0.02% (n=3)
PSQDIRLANTNGSWH 0.02% (n=3)
PKQNIHLVKTNGSWH 0.02% (n=3)
PKQNIQLIRTNGSWH 0.02% (n=3)
ASQNIQLMNTNGSWH 0.02% (n=3)
SQQNIQLINANGSWH 0.02% (n=3)
PKQNIQLVNTNGSWY 0.02% (n=3)
AKQNIQLVNINGSWH 0.01% (n=2)
AKQNVQLVDTNGSWH 0.01% (n=2)
AQQNVQLIDTNGSWH 0.01% (n=2)
AQQNVQLINTNGSGH 0.01% (n=2)
AQQNVQLINTNGTWH 0.01% (n=2)
AQQNLQLINTNGSWH 0.01% (n=2)
ARQNVKLINTNGSWH 0.01% (n=2)
AKQNVQPINTNGSWH 0.01% (n=2)
ASQNIQLVNSSGSWH 0.01% (n=2)
ASQNIQLVNSNGSWH 0.01% (n=2)
PNQNVQLINTNGSWH 0.01% (n=2)
ANQNVQLVNTNGSWH 0.01% (n=2)
PSQNIQLVNSNGSWH 0.01% (n=2)
PKQNIQLVNTNGNWH 0.01% (n=2)
AKQNIQLINTDGSWH 0.01% (n=2)
AKQDIQLINTNGNWH 0.01% (n=2)
AEQNIQLINTNGSWH 0.01% (n=2)
AQQNIQLINTDGSWH 0.01% (n=2)
AKQGIQLINTNGSWH 0.01% (n=2)
AQQNIQLVNANGSWH 0.01% (n=2)
AQQKVQLINSNGSWH 0.01% (n=2)
PKQNLQLINSNGSWH 0.01% (n=2)
AKQNIQLINPNGSWH 0.01% (n=2)
AQQKIQLINANGSWH 0.01% (n=2)
SRQDIQLINSNGSWH 0.01% (n=2)
AKQNIQLINTNGS*H 0.01% (n=2)
ARQEIRLINTNGSWH 0.01% (n=2)
AMQNIQLINTNGSWH 0.01% (n=2)
PRQNVQLINSNGSWH 0.01% (n=2)
PSQEIQLVNKNGSWH 0.01% (n=2)
AKQNTQLINTNGSWH 0.01% (n=2)
AKQNIQLIDTNGSWH 0.01% (n=2)
ARQNIQMINTNGSWH 0.01% (n=2)
AQQNIQLVDTNGSWH 0.01% (n=2)
AKQSIQLINSNGSWH 0.01% (n=2)
ARQDVQLINTNGSWH 0.01% (n=2)
AKQNIQLINTSGSWH 0.01% (n=2)
AQQKVQLINTNGSWH 0.01% (n=2)
AKQDLQLINTNGSWH 0.01% (n=2)
SNQKIQLINTNGSWH 0.01% (n=2)
AQQNIQLINTSGSWH 0.01% (n=2)
AQQNIRLINTNGSWH 0.01% (n=2)
PKQHIQLVNANGSWH 0.01% (n=2)
AKQDVRLINTNGSWH 0.01% (n=2)
ARQNIQLINTSGSWH 0.01% (n=2)
ALQNVQLINTNGSWH 0.01% (n=2)
AKQNIQLINTNGGWH 0.01% (n=2)
SKQNIELINSNGSWH 0.01% (n=2)
AKQDIKLMNTNGSWH 0.01% (n=2)
TMQNIQLVNTNGSWH 0.01% (n=2)
SRQSIQLINTNGSWH 0.01% (n=2)
SRQNIQLINTTGSSH 0.01% (n=2)
ARQAIQLINSNGSRH 0.01% (n=2)
PKQNIQLINPNGSWH 0.01% (n=2)
PQQNIQLVNTDGSWH 0.01% (n=2)
AGQNIQLINTNGSWH 0.01% (n=2)
AKQSVQLINTNGSWH 0.01% (n=2)
AKQNVQLINTNGSRH 0.01% (n=2)
AMQNIQLVNTNGSRH 0.01% (n=2)
AMQNIQLVNTNGS*H 0.01% (n=2)
PSQKVQLINTNGSWH 0.01% (n=2)
PNQKVQLINTNGSWH 0.01% (n=2)
PSQNVQ--------- 0.01% (n=2)
RKQDIQLINSNGSWH 0.01% (n=2)
ARQNIQLINTNGSRH 0.01% (n=2)
PKQDIQLINTNGSWR 0.01% (n=2)
ARQNVQLLNTNGSWH 0.01% (n=2)
ARQNVQLINTNGSWR 0.01% (n=2)
PSQKIQLINTSGSWH 0.01% (n=2)
PQQKIQLISTNGSWH 0.01% (n=2)
SRQYVQLINTNGSWH 0.01% (n=2)
AQQKIQLVNADGSWH 0.01% (n=2)
SQQHVQLINTNGSWH 0.01% (n=2)
AKQNIQVINTNGSWH 0.01% (n=2)
ARQHVQLVNTNGSWH 0.01% (n=2)
PSQQIQLINTNGSWH 0.01% (n=2)
PKQKIQLVNTNGSWH 0.01% (n=2)
PRQNLQLVSTNGSWH 0.01% (n=2)
HNQKIQLINSNGSWH 0.01% (n=2)
PKQDIQLIHKNGSWH 0.01% (n=2)
AKQNIHLINTNGSWH 0.01% (n=2)
PNQRIQLINTNGSWH 0.01% (n=2)
PQQDIRLVNTNGSWH 0.01% (n=2)
PKQKVQLVNTNGSWH 0.01% (n=2)
PRQKVQLVNTNGSWH 0.01% (n=2)
PQQKVQLINANGSWH 0.01% (n=2)
PKQNIQLVNTNGSRH 0.01% (n=2)
AKQNVQLINTNGS*H 0.01% (n=2)
AKQNIQLVATNGSWH 0.01% (n=2)
PKQNIQLINKNGSWH 0.01% (n=2)
PKQDIQLINKNGSWH 0.01% (n=2)
AMQNVQLINTNGSWH 0.01% (n=2)
AKQNIQLVNTNGSWQ 0.01% (n=1)
AKQNIQLVNTNGSWR 0.01% (n=1)
AEQNVQLVNTNGSWH 0.01% (n=1)
AKLNVQLVNTNGSWH 0.01% (n=1)
AKQNIQLVNTNGSWL 0.01% (n=1)
PSQNAQLINTNGSWH 0.01% (n=1)
AKQDVQLINTHGSWH 0.01% (n=1)
AKQDIQLINTNGSWD 0.01% (n=1)
PKENIQLVNTNGSWH 0.01% (n=1)
PKQNIQLVNTNSSWH 0.01% (n=1)
PKRNIQLVNTNGSWH 0.01% (n=1)
AGQNVQLINTNGSWH 0.01% (n=1)
PKQNV*LINTNGSWH 0.01% (n=1)
PSQKLHLINTNGSWH 0.01% (n=1)
PSQDTRLINTNGSWH 0.01% (n=1)
PSQNIYLINTNGSWH 0.01% (n=1)
PSQDIRLINPNGSWH 0.01% (n=1)
VKQNIQLVNSNGSWH 0.01% (n=1)
PKQSVQLINTNGSWH 0.01% (n=1)
PKQNVQLTNTNGSWH 0.01% (n=1)
AKQNIQLTKSNGSWH 0.01% (n=1)
AKQNIQLIKSNGSRH 0.01% (n=1)
ARQNIQPINSNGSWH 0.01% (n=1)
ARQNTQLVNSNGSWH 0.01% (n=1)
AKRDIQLINTNGSWH 0.01% (n=1)
VKQNIQLINTNGSWH 0.01% (n=1)
AKRNIQLINSNGSWH 0.01% (n=1)
PSQDVRLINTNGSWH 0.01% (n=1)
PQQHIQLVNANGSWH 0.01% (n=1)
PSQNIQLVNSNGNWH 0.01% (n=1)
PKQDIKLMKTNDSWH 0.01% (n=1)
ARQEIQLINTNGSWH 0.01% (n=1)
AQQKIQLVNTNGSRH 0.01% (n=1)
AQQKIQLVDTNGSWH 0.01% (n=1)
PKQNVQLINTNDSWH 0.01% (n=1)
PEQNVQLINTNGSWH 0.01% (n=1)
PSQNIQLVNINGSWH 0.01% (n=1)
PSQNIQLVNTNGS*H 0.01% (n=1)
PGQNIQLVNTNGSWH 0.01% (n=1)
ASQNVQLIQTNGSWH 0.01% (n=1)
ASQNVQLINTSGSWH 0.01% (n=1)
ASQNVQLIKTDGSWH 0.01% (n=1)
AKQNIQLINTNGSWD 0.01% (n=1)
SKQNIQLINTNG-WH 0.01% (n=1)
ASQNAQLINSNGSWH 0.01% (n=1)
ASQNVQLISSNGSWH 0.01% (n=1)
ASQNVQLINFNGSWH 0.01% (n=1)
ASQNVQLVNSNGSWH 0.01% (n=1)
PSRVIQLINTNGSWH 0.01% (n=1)
AQQNIQLINTNSSWH 0.01% (n=1)
PKQNVQLINTSGSWH 0.01% (n=1)
PKLNVQLINTNGSWH 0.01% (n=1)
LKQNVQLINTNGSWH 0.01% (n=1)
AQHNIQLINTNGSWH 0.01% (n=1)
AKQDIHLINTNGSWH 0.01% (n=1)
AQQNVQLTNTNGSWH 0.01% (n=1)
PSQKIRLINTNGSWH 0.01% (n=1)
PSQNIQLINTDGSWH 0.01% (n=1)
PSQNTQLINTNGSWH 0.01% (n=1)
PSQSIQLINTNGSWH 0.01% (n=1)
PKQNVQLIYTNGSWH 0.01% (n=1)
PRQKIQLINSNGSWH 0.01% (n=1)
PKQDIRLINSNGSWH 0.01% (n=1)
PRQNIQLINSNGSWY 0.01% (n=1)
GKQNIQLINTNGSWH 0.01% (n=1)
AKQKVQLMNTNGSWH 0.01% (n=1)
AQQNIQLIDTNGSWH 0.01% (n=1)
AQQKVQLMNTNGSWH 0.01% (n=1)
AKQKVQLINANGSWH 0.01% (n=1)
AKQKVQLINSNGSWH 0.01% (n=1)
AQQSIQLINTNGSWH 0.01% (n=1)
ASQNIQLINSNGRWH 0.01% (n=1)
ARQNIQLISTNGSWH 0.01% (n=1)
ARQNIQVINTNGSWH 0.01% (n=1)
PKQNIRLVNSNGSWH 0.01% (n=1)
PKQQVQLINSNGSWH 0.01% (n=1)
AKQDIKLINTNGSGH 0.01% (n=1)
PKQDIKLINTNGSGH 0.01% (n=1)
PKQGIKLINTNGSWH 0.01% (n=1)
AKQDIKLINTNGSCA 0.01% (n=1)
ARQDIQLVNSNGSWH 0.01% (n=1)
PKQNIQLINTNGSW- 0.01% (n=1)
PQQNIQLINTNGSW- 0.01% (n=1)
SSQNLQLINSNGSWH 0.01% (n=1)
PSQDLQLINSNGSWH 0.01% (n=1)
PKQNIQPINSNGSWH 0.01% (n=1)
AKQKIQLINSNGGWH 0.01% (n=1)
ARQKIQLINSNGSWR 0.01% (n=1)
PSQEIQLVSENGSWH 0.01% (n=1)
LSQEIQLVNENGSWH 0.01% (n=1)
PSQEIQQVNENGSWH 0.01% (n=1)
PSQEIQLVNENDSWH 0.01% (n=1)
PSQDIQLVNKNGSWH 0.01% (n=1)
AKQNIQLINTNGRWH 0.01% (n=1)
AKQNIQLINTNGSWR 0.01% (n=1)
ARQSIQMVNTNGSWH 0.01% (n=1)
PSQNLQLVNTDGSWH 0.01% (n=1)
PKQNIQLVNTKGSWH 0.01% (n=1)
ANQNIQLVNTNGSWH 0.01% (n=1)
ASQNIQPVNTNGSWH 0.01% (n=1)
ASQNIQLVTTNGSWH 0.01% (n=1)
ASQNIQLANTNGSWH 0.01% (n=1)
AQQRIQLVNTNGSWH 0.01% (n=1)
ASQSIQLVNTNGSWH 0.01% (n=1)
ASQNIQLVNTNGSWR 0.01% (n=1)
ASQKIQLVNTNGSWH 0.01% (n=1)
AKQNIQLVNTSGSWH 0.01% (n=1)
AQQNTQLVNTNGSWH 0.01% (n=1)
AQQNVQLVNSNGSWH 0.01% (n=1)
AMQNIQLMNTNGSWH 0.01% (n=1)
ARQNIQLINNNGSWH 0.01% (n=1)
ARQPIGLINTNGSWH 0.01% (n=1)
PQQKIHLINTNGSWH 0.01% (n=1)
PKQDVQLINSNGSWH 0.01% (n=1)
PRQTIRLINSNGSWH 0.01% (n=1)
PQQNIQLINTSGSWH 0.01% (n=1)
AQQNIQLINTGGSWH 0.01% (n=1)
AQQNIQLIYSNGSWH 0.01% (n=1)
AKQNIQLVYSNGSWH 0.01% (n=1)
PKQNIQLVYTNGSWR 0.01% (n=1)
LKQDIQLVNSNGSWH 0.01% (n=1)
AQQTVQLINTNGSWH 0.01% (n=1)
AN*DIQLINTNGSWH 0.01% (n=1)
ANQDIQLISTNGSWH 0.01% (n=1)
ARRNVQLINTNGSWH 0.01% (n=1)
AKQDVQLINANGSWH 0.01% (n=1)
AKQDVQLINTNGGWH 0.01% (n=1)
PKQDIQLINTNDSWH 0.01% (n=1)
AQQKIQLMNTNGSWH 0.01% (n=1)
AKQNVQLVNANGSWH 0.01% (n=1)
AKQNVQLMNTNGSWH 0.01% (n=1)
ARQKVQLINTNGSWH 0.01% (n=1)
AKQHVQLINTNGSWH 0.01% (n=1)
AQQKIQLVNASGSWH 0.01% (n=1)
PNQNIQLVNNNGSWH 0.01% (n=1)
AQQNIKLINTNGSWH 0.01% (n=1)
PTQNIQLINSNGSWH 0.01% (n=1)
PSQKIELVDTSGSWH 0.01% (n=1)
ARQNIQLMYTNGSWH 0.01% (n=1)
AKQNIQLVHANGSWH 0.01% (n=1)
ARQNIQLVNSHGSWD 0.01% (n=1)
SQQNVQLINTDGSWH 0.01% (n=1)
PSQHIQLINTNGSWH 0.01% (n=1)
SKQDIQLVNTNGSWH 0.01% (n=1)
AKQNIQLVNTNGRWH 0.01% (n=1)
ASQKIQLINTNGSWH 0.01% (n=1)
AQQDVQLINTNGSWH 0.01% (n=1)
PRQSIKLINTNGSWH 0.01% (n=1)
PRQNIQLINTSGSWH 0.01% (n=1)
PKQDIQLVNTSGSWH 0.01% (n=1)
AQQNVQLMNTNGSWH 0.01% (n=1)
PSQNIQLVNTSGSWH 0.01% (n=1)
AMQDIQLINTNGSWH 0.01% (n=1)
PKQNIHLVNSNGSWH 0.01% (n=1)
AKQNIQLVNANGSWH 0.01% (n=1)
PKQKLQLINSNGSWH 0.01% (n=1)
AKQQINLINTNGSWH 0.01% (n=1)
PKQNIQLVNNNGSWH 0.01% (n=1)
PKQNIQLINNNGSWH 0.01% (n=1)
SRQNLQLINTNGSWH 0.01% (n=1)
PKQDIQLINSSGSWH 0.01% (n=1)
AQQKIQLVNKNGSWH 0.01% (n=1)
PQQKIQLVNTDGSWH 0.01% (n=1)
ANQDIHLINSNGSWH 0.01% (n=1)
AQQKIQLIHTNGSWH 0.01% (n=1)
HHQNIQLVNKDGSWH 0.01% (n=1)
AKQNIQLIHTNGSWH 0.01% (n=1)
PKQNIQLINTNGTWH 0.01% (n=1)
PRQSIQLINTNGSWH 0.01% (n=1)
PQQNIQLIKSNGSWH 0.01% (n=1)
AKQNIQLVNSSGSWH 0.01% (n=1)
AQQNVQLISTNGSWH 0.01% (n=1)
PSQHIQLINSNGSWH 0.01% (n=1)
AKQNIELINTNGSWH 0.01% (n=1)
PKQNLRLVNSNGSWH 0.01% (n=1)
AKQDINLVNTNGSWH 0.01% (n=1)
PNQNIQLINSNGSWH 0.01% (n=1)
PKQDLQLINTNGSWH 0.01% (n=1)
ARQDVRLINTNGSWH 0.01% (n=1)
ASHNIQLINTNGSWH 0.01% (n=1)
AQQRVQLINSNGSWH 0.01% (n=1)
PSQKLQLVNTNGSWH 0.01% (n=1)
ANQKVQLINTNGSWH 0.01% (n=1)
PKQDIRLIHTNGSWH 0.01% (n=1)
AQQNIQLVSTNGSWH 0.01% (n=1)
ASQKVQLINTNGSWH 0.01% (n=1)
AQQNIQLVNSNGSWH 0.01% (n=1)
PRQEIQLVNTNGSWH 0.01% (n=1)
PSQKIQLVNNNGSWH 0.01% (n=1)
ARQNIQLINASGSWH 0.01% (n=1)
AMQNIRLINTNGSWH 0.01% (n=1)
AQQKIQLVKANDSWH 0.01% (n=1)
ARQNIQLVNNNGSWH 0.01% (n=1)
PRQKIELVNVNDSWH 0.01% (n=1)
PQQQIQLVNSNGSWH 0.01% (n=1)
SSQNIQLINTNGSWH 0.01% (n=1)
PRQDVRLINTNGSWH 0.01% (n=1)
AAQNVQLINTNGSWH 0.01% (n=1)
SKQNIRLINTNGSWH 0.01% (n=1)
PKQNIQLTNSNGSWH 0.01% (n=1)
AKQNIQLINTNGSWQ 0.01% (n=1)
PQQDIQLVNTNGSRH 0.01% (n=1)
PQQSIQLVNTNGSWH 0.01% (n=1)
PQQNIQPVNTNGSWH 0.01% (n=1)
PQQDIQLVNTNGSWH 0.01% (n=1)
AEQDIQLINTNGSWH 0.01% (n=1)
AKQDIQLTNTNGSWH 0.01% (n=1)
ARQNIQLINTNGSWR 0.01% (n=1)
PRQNLQLINTNGSWH 0.01% (n=1)
PKQKAQLINTNGSWH 0.01% (n=1)
ARQNVQLINANGSWH 0.01% (n=1)
AKQNVQLISTNGSWH 0.01% (n=1)
AKQNVQLINTNGGWH 0.01% (n=1)
AKQNVQLINTNDSWH 0.01% (n=1)
AKQNVQLINANGSWH 0.01% (n=1)
AKQNVQLINTNGSWR 0.01% (n=1)
AKHNDQPINTHGSWH 0.01% (n=1)
ARQNLQLVNTNRSWH 0.01% (n=1)
AMQNIQLVNTNGSWY 0.01% (n=1)
AMQNIQLVNTNGNWH 0.01% (n=1)
AKQNIQLVNTNGNWH 0.01% (n=1)
PTQNIQLVNTNGSWH 0.01% (n=1)
AMQNVQLVNTNGSWH 0.01% (n=1)
AMQSIQLVNTNGSWH 0.01% (n=1)
VMQNIQLVNTNGSWH 0.01% (n=1)
TEQDIQLVNTNGSWH 0.01% (n=1)
PKQDVQLVNTNGSWR 0.01% (n=1)
PKQDVQLVNTNGSRH 0.01% (n=1)
PRQNIQLINSNGNWH 0.01% (n=1)
PRLNIQLINSNGNWH 0.01% (n=1)
ANQRVQLVNSNGSWH 0.01% (n=1)
ANQKVQLVNTNGSWH 0.01% (n=1)
PRQNIQLINSSGSWH 0.01% (n=1)
AKQNI*LINTNGSWH 0.01% (n=1)
PSQQIQ--------- 0.01% (n=1)
PSQDVQ--------- 0.01% (n=1)
AKQDIQ--------- 0.01% (n=1)
PSQNIQ--------- 0.01% (n=1)
PGQKIQLVNTNGSWH 0.01% (n=1)
SKQDVQFINSNGSWH 0.01% (n=1)
SRQDVQLINSNGSWH 0.01% (n=1)
ARQNVQLINSN---- 0.01% (n=1)
PRQKVQLINSN---- 0.01% (n=1)
PKQNVQLINSN---- 0.01% (n=1)
AKQNIQFINTNGSWH 0.01% (n=1)
AKQNIQLINTTGSWH 0.01% (n=1)
ARQNIQLINTNGSWY 0.01% (n=1)
VRQNIQLINTNGSWH 0.01% (n=1)
PQQKIQLINTNGSRH 0.01% (n=1)
PKQNIQLINTNGS*H 0.01% (n=1)
PSQTIRLANTSGSWH 0.01% (n=1)
PGQNIKLTNTNGSWH 0.01% (n=1)
PSQNIKLTSTNGSWH 0.01% (n=1)
PSQSIRLANTNGSWH 0.01% (n=1)
PRQNIKLTNTNGSWH 0.01% (n=1)
PSQTIRLTNTNGSWH 0.01% (n=1)
PSQRIQLISTNGSWH 0.01% (n=1)
PPQKIQLISTNGSWH 0.01% (n=1)
PSQKIQLIGTNGSWH 0.01% (n=1)
PSQKIELINPNGGWH 0.01% (n=1)
PSQKIELINTNGSWH 0.01% (n=1)
AKQNIQLANTNGSWH 0.01% (n=1)
PKQNIQMINTNGSWH 0.01% (n=1)
TKQNIQLINTNGSWH 0.01% (n=1)
VKQNIQLINTNDSWH 0.01% (n=1)
AQQKIQLINTNGCWH 0.01% (n=1)
AQQKIQLINTNGSWY 0.01% (n=1)
AQQKIQLTNTNGSWH 0.01% (n=1)
AQQKIQLINTIGSWH 0.01% (n=1)
AQQKI*LINTNGSWH 0.01% (n=1)
AQRKIQLINTNGSWH 0.01% (n=1)
AQQKIQLINTNGSWR 0.01% (n=1)
AQQKIQLINTNGS*H 0.01% (n=1)
SKQNIQLINSIGSWH 0.01% (n=1)
SKQNVQLINSNGSWH 0.01% (n=1)
SKQNIQLINPNGSWH 0.01% (n=1)
SK*NIQLINSNGSWH 0.01% (n=1)
SKQNIQLTNSNGSWH 0.01% (n=1)
SRQNIQLINTNGS*H 0.01% (n=1)
SR*NIQLINTNGSWH 0.01% (n=1)
SRQNIQLISTNGSWH 0.01% (n=1)
SRQNIQLVNANGSWH 0.01% (n=1)
AKHNIQLVNTNGSWH 0.01% (n=1)
AMQNIQLVNTDGSWH 0.01% (n=1)
AKQYIQLINTNGSWH 0.01% (n=1)
PQQKIQLIKTNGSWH 0.01% (n=1)
PQQNIHLIKTNGSWH 0.01% (n=1)
PKQNIHLIKTNGGWH 0.01% (n=1)
PKQNIQLIKTNGRWH 0.01% (n=1)
AQQNVQLINTNGSWL 0.01% (n=1)
PKQNVHLISTNGSWH 0.01% (n=1)
SQQDIQLINSNGSWH 0.01% (n=1)
ANQGIRLINTNGSWH 0.01% (n=1)
SRQNIQLVSTNGSWH 0.01% (n=1)
PKQNIQLVNSSGSWH 0.01% (n=1)
PKQDIHLVNTNGSWH 0.01% (n=1)
ARQQIRLINTNGSWH 0.01% (n=1)
ASQKLQLVNSNGSWH 0.01% (n=1)
AKQSIQLINNNGSWH 0.01% (n=1)
PKQNIQLVHTNGSWH 0.01% (n=1)
PSQNLHLINTNGSWH 0.01% (n=1)
PKQNIQLVNENGSWH 0.01% (n=1)
AKQKIQLVNANGSWH 0.01% (n=1)
PQQNIRLINTNGSWH 0.01% (n=1)
AKQNIQLTNSNGSWH 0.01% (n=1)
SRQNVQLINSNGSWH 0.01% (n=1)
SRQNVQLMNTNGNWH 0.01% (n=1)
AQQNIQLVHTNGSWH 0.01% (n=1)
AQQNIRLVNTNGSWH 0.01% (n=1)
PRQN----------- 0.01% (n=1)
AQQK----------- 0.01% (n=1)
PTQN----------- 0.01% (n=1)
SQQN----------- 0.01% (n=1)
ARQN----------- 0.01% (n=1)
AQQE----------- 0.01% (n=1)
SRQN----------- 0.01% (n=1)
PKQH----------- 0.01% (n=1)
AQQEIQLINSNGSWH 0.01% (n=1)
AKQDIQLVNTSGSWH 0.01% (n=1)
ASQNVQLVNTNGSWH 0.01% (n=1)
PRQNIRLVNTNGSWH 0.01% (n=1)
AQQNVQLINTNGSRH 0.01% (n=1)
PRQDIQLVNTNGSWH 0.01% (n=1)
ARQNIQLINTKGSWH 0.01% (n=1)
AQQKLQLINTSGSWH 0.01% (n=1)
AQQEIQLINTNGSWH 0.01% (n=1)
PKQDIRLVNTNGSWH 0.01% (n=1)
ARQNIQLVNASGSWH 0.01% (n=1)
AKQDIQLINSNGSGH 0.01% (n=1)
PKQNIQLIDTNGSWH 0.01% (n=1)
AQQDIQLINSNGSWH 0.01% (n=1)
ARQNIRLINSNGSWH 0.01% (n=1)
PKQDIQLINSNGSWH 0.01% (n=1)
PRQNVQLVNTNGSWH 0.01% (n=1)
PNQSVQLINTNGSWH 0.01% (n=1)
PQQNVQLINANGSWH 0.01% (n=1)
PQQRVQLINTNGSWH 0.01% (n=1)
AKQNIQPINSNGSWH 0.01% (n=1)
ANQNIQLVNSNGSWH 0.01% (n=1)
AKQNTQLINSNGSWH 0.01% (n=1)
AKQNIQLINSNDSWH 0.01% (n=1)
AEQNIQLINSNGSWH 0.01% (n=1)
AKQNVQLININGSWH 0.01% (n=1)
AKQNV*LINTNGSRH 0.01% (n=1)
AKQNVQLINTNGSWY 0.01% (n=1)
AKQNVQLINTNGCWH 0.01% (n=1)
AKQNVQPVNTNGSWH 0.01% (n=1)
AKQNVQLVNTNGSWR 0.01% (n=1)
TKQNVQLVNTNGSWH 0.01% (n=1)
AKQNVHLINSNGSWH 0.01% (n=1)
AKQNLQLMNSNGSWH 0.01% (n=1)
PAQNIRLINSNGSWH 0.01% (n=1)
ARQNIQLVNANGSWH 0.01% (n=1)
PSQQIQLINSNGSWH 0.01% (n=1)
SQQNVQLINSNGSWH 0.01% (n=1)
AKQNVQLINNNGSWH 0.01% (n=1)
PQQNLQLINSNGSWH 0.01% (n=1)
PKQNIHLVNNNGSWH 0.01% (n=1)
ALQNIQLINSNGSWH 0.01% (n=1)
AQQKVQLVNTNGSWH 0.01% (n=1)
AHQNIQLVNTNGSWH 0.01% (n=1)
PRQDIQLINSNGSWH 0.01% (n=1)
PRQKVQLINTNGSWH 0.01% (n=1)
SQQKIQLINTNGSWH 0.01% (n=1)
AKQNIQLMSTNGSWH 0.01% (n=1)
AQQKIQLVNSNGSWH 0.01% (n=1)
PKQNIQLIHTNGSWH 0.01% (n=1)
PKQDIQLINTDGSWH 0.01% (n=1)
PQQRIQLINTNGSWH 0.01% (n=1)
PSQDVQLINTNGSWH 0.01% (n=1)
PRQKI---------- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 1b:

ASQKIQLINTNGSWH 9.64% (n=933)
PSQKIQLINTNGSWH 8.79% (n=851)
ASQNIQLINTNGSWH 8.72% (n=844)
PSQKIQLVNTNGSWH 7.26% (n=703)
ARQNIQLINTNGSWH 2.83% (n=274)
PAQKLQLINTNGSWH 2.68% (n=259)
PQQKIQLVNTNGSWH 2.14% (n=207)
ASQRIQLINTNGSWH 2.12% (n=205)
AQQNIQLINTNGSWH 2.10% (n=203)
PS------------- 1.94% (n=188)
PQQKIQLINTNGSWH 1.70% (n=165)
SSQNIQLVNTNGSWH 1.69% (n=164)
SSQKIQLINTNGSWH 1.67% (n=162)
ASQKIQLVNTNGSWH 1.60% (n=155)
PSQKLQLVNTNGSWH 1.55% (n=150)
PSQNIQLINTNGSWH 1.41% (n=136)
PAQKIQLVNTNGSWH 1.35% (n=131)
SRQHIQLINTNGSWH 1.31% (n=127)
PSQNIQLVNTNGSWH 1.30% (n=126)
PA------------- 1.14% (n=110)
SSQRIQLVNTNGSWH 0.98% (n=95)
ASQKLQLINTNGSWH 0.94% (n=91)
SRQNIQLINTNGSWH 0.92% (n=89)
SAQKIQLINTNGSWH 0.82% (n=79)
PSQKVQLINTNGSWH 0.81% (n=78)
PAQNIQLVNTNGSWH 0.79% (n=76)
SYQKVQLVNTNGSWH 0.74% (n=72)
AKQNIQLINTNGSWH 0.73% (n=71)
SSQRIQLINTNGSWH 0.73% (n=71)
PSQRIQLVNTNGSWH 0.70% (n=68)
ASQRIQLVNTNGSWH 0.68% (n=66)
PTQKIQLVNTNGSWH 0.63% (n=61)
ASQNIQLVNTNGSWH 0.61% (n=59)
PHQKIQLVNTNGSWH 0.60% (n=58)
ASQQIQLINTNGSWH 0.60% (n=58)
SKQNLQLINTNGSWH 0.55% (n=53)
PSQNLQLVNTNGSWH 0.54% (n=52)
PTQKIQLINTNGSWH 0.52% (n=50)
PSQKIQLVNSNGSWH 0.52% (n=50)
SSQKVQLVNTNGSWH 0.51% (n=49)
PAQTIQLVNTNGSWH 0.51% (n=49)
SSQKIQLVNTNGSWH 0.50% (n=48)
AKQRIQLINTNGSWH 0.48% (n=46)
ASQNIRLINTNGSWH 0.43% (n=42)
PSQTIQLVNTNGSWH 0.42% (n=41)
PKQNIQLVNTNGSWH 0.41% (n=40)
PKQKIQLVNTNGSWH 0.40% (n=39)
PSQNIQLINSNGSWH 0.40% (n=39)
PT------------- 0.40% (n=39)
ASQKLQLVNTNGSWH 0.39% (n=38)
PGQKIQLVNTNGSWH 0.39% (n=38)
SNQKIQLINTNGSWH 0.39% (n=38)
AKQKIQLINTNGSWH 0.36% (n=35)
PSQRIQLINTNGSWH 0.35% (n=34)
ARQNIQLVNTNGSWH 0.34% (n=33)
SA------------- 0.32% (n=31)
SSQNIQLINTNGSWH 0.31% (n=30)
SAQKIQLVNTNGSWH 0.31% (n=30)
SS------------- 0.31% (n=30)
P-------------- 0.27% (n=26)
ASQKIQLVNASGSWH 0.26% (n=25)
PKQNIQLINTNGSWH 0.26% (n=25)
SAQNIQLINTNGSWH 0.25% (n=24)
SNQKIQLVNTNGSWH 0.25% (n=24)
SRQNIQLVNTNGSWH 0.24% (n=23)
SRQKIQLINTNGSWH 0.23% (n=22)
SKQNIQLINTNGSWH 0.23% (n=22)
ASQNIQLISTNGSWH 0.19% (n=18)
SQQKIQLINTNGSWH 0.19% (n=18)
PSQNIQLVNSNGSWH 0.19% (n=18)
SHQKVQLVKTNGSWH 0.19% (n=18)
PAQQIQLVNTNGSWH 0.19% (n=18)
AKQNIQLINSNGSWH 0.19% (n=18)
PAQQIQLINTNGSWH 0.19% (n=18)
AS------------- 0.19% (n=18)
PAQKIQLINTNGSWH 0.18% (n=17)
PTQNIQLINTNGSWH 0.18% (n=17)
ASQRIQLVNSNGSWH 0.18% (n=17)
PAQNLQLINTNGSWH 0.15% (n=15)
ASQKVQLINTNGSWH 0.14% (n=14)
PAQEIQLINTNGSWH 0.14% (n=14)
SSQRIQLVNSNGSWH 0.14% (n=14)
PAQNIQLINTNGSWH 0.13% (n=13)
PSQKLQLINTNGSWH 0.13% (n=13)
PRQKIQLINTNGSWH 0.13% (n=13)
ANQNIQLINTNGSWH 0.13% (n=13)
ASQRVQLINTNGSWH 0.12% (n=12)
PAQRIQLVNTNGSWH 0.12% (n=12)
PQQKVQLINTNGSW- 0.12% (n=12)
SRQNVQLINTNGSWH 0.12% (n=12)
PTQRIQLINTNGSWH 0.11% (n=11)
ASQKIELIHTNGSWH 0.11% (n=11)
PRQNIQLINTNGSWH 0.11% (n=11)
ARQNLQLVNTNGSWH 0.11% (n=11)
SAQRIQLVNTNGSWH 0.11% (n=11)
AKQNLQLVNTNGSWH 0.11% (n=11)
PQQKLQLVNTNGSWH 0.11% (n=11)
SRQNLQLVNTNGSWH 0.11% (n=11)
SSQKLQLINSNGSWH 0.11% (n=11)
PSQKIRLINTNGSWH 0.11% (n=11)
PAQEVQLINTNGSWH 0.11% (n=11)
PSQSIQLVNTNGSWH 0.10% (n=10)
PGQKIQLINTNGSWH 0.09% (n=9)
SKQKLQLINTNGSWH 0.09% (n=9)
PAQEIHLINTNGSWH 0.09% (n=9)
ASQKIQLIHTNGSWH 0.09% (n=9)
PSQKLQLVNSNGSWH 0.09% (n=9)
PTQNIQLVNTNGSWH 0.08% (n=8)
PLQKIQLINTNGSWH 0.08% (n=8)
PTQHIQLVNTNGSWH 0.08% (n=8)
PTQRIQLVNTNGSWH 0.07% (n=7)
ASQKIELINTNGSWH 0.07% (n=7)
PKQKIQLINTNGSWH 0.07% (n=7)
SKQNIQLVNTNGSWH 0.07% (n=7)
PSQQIQLINTNGSWH 0.07% (n=7)
SKQKIQLINTNGSWH 0.07% (n=7)
AKQNIQLVNTNGSWH 0.07% (n=7)
GQQDIRLINTNGSWH 0.07% (n=7)
ASQNIQLMNTNGSWH 0.07% (n=7)
AQQKIQLVNTNGSWH 0.06% (n=6)
ASQNIQLINTNGSRH 0.06% (n=6)
PAQSINLVNTNGSWH 0.06% (n=6)
ASQKIQLINSNGSWH 0.06% (n=6)
PQQNIQLINTNGSWH 0.06% (n=6)
PSQKIELVNTNGSWH 0.06% (n=6)
PSQKIHLVNTNGSWH 0.06% (n=6)
SAQNIQLVNTNGSWH 0.06% (n=6)
SQQKVQLINTNGSWH 0.06% (n=6)
PNQKIQLVNTNGSWH 0.06% (n=6)
-SQKIQLINTNGSWH 0.06% (n=6)
PSQELQLVSTNGSWH 0.06% (n=6)
PSQKVQLVNTNGSWH 0.05% (n=5)
PAQRIQLINTNGSWH 0.05% (n=5)
PTQKLQLVNTNGSWH 0.05% (n=5)
AHQKIQLINTNGSWH 0.05% (n=5)
PGQNVQLVNTNGSWH 0.05% (n=5)
ARQNVQLINTNGSWH 0.05% (n=5)
SSQKLQLMNTNGSWH 0.05% (n=5)
SHQKIQLVNTNGSWH 0.05% (n=5)
PAQKVQLINTNGSWH 0.05% (n=5)
PSQKIQLINSNGSWH 0.04% (n=4)
AQQKVQLINTNGSWH 0.04% (n=4)
APQNIQLINTNGSWH 0.04% (n=4)
PSQKIQLINTNGSWL 0.04% (n=4)
ASHNIQLINTNGSWH 0.04% (n=4)
PAQSIKLVNTSGSWH 0.04% (n=4)
AQQNIQLVNTNGSWH 0.04% (n=4)
PSQEIQLIHTNGSWH 0.04% (n=4)
PSQHIQLVNTNGSWH 0.04% (n=4)
ASQKIQLINTNGSW- 0.04% (n=4)
ASQRIQLISTNGSWH 0.04% (n=4)
ARQKIQLINTNGSWH 0.04% (n=4)
PQQKIQLVNSNGSWH 0.04% (n=4)
PSQNLQLINTNGSWH 0.04% (n=4)
PFQKIQLINTNGSWH 0.04% (n=4)
ARQNIQLINSNGSWH 0.04% (n=4)
PKQKLQLVNTNGSWH 0.04% (n=4)
AQQKLQLVNTNGSWH 0.04% (n=4)
PQQRIQLVNTNGSWH 0.04% (n=4)
ASQNIQLMETNGSWH 0.04% (n=4)
PSQKLQLVSTNGSWH 0.04% (n=4)
PSQQLQLVNTNGSWH 0.04% (n=4)
ASQKIQLISTNGSWH 0.04% (n=4)
PAQKPQLINTNGSWH 0.04% (n=4)
SRQKIQLVNTNGSWH 0.03% (n=3)
AKQKVQLINTNGSWH 0.03% (n=3)
PSQKIQLLNTNGSWH 0.03% (n=3)
ASQDIQLINTNGSWH 0.03% (n=3)
PAQNIQLVNTSGSWH 0.03% (n=3)
PTQPINLVNTNGSWH 0.03% (n=3)
PSQEIQLINTNGSWH 0.03% (n=3)
PAQRLQLINTNGSWH 0.03% (n=3)
SHQKIQLINTNGSWH 0.03% (n=3)
SQQKIQLVNTNGSWH 0.03% (n=3)
ASQNVQLINTNGSWH 0.03% (n=3)
AHQKVQLVKTNGSWH 0.03% (n=3)
SQQKIQLIKTNGSWH 0.03% (n=3)
PQQKVQLINTNGSWH 0.03% (n=3)
PKQNVQLINSNGSWH 0.03% (n=3)
AKQDIRLINTNGSWH 0.03% (n=3)
PAQKIQ--------- 0.03% (n=3)
PQQNIQLVNTNGSWH 0.03% (n=3)
ASQKIRLINTNGSWH 0.03% (n=3)
PSQDIQLINTNGSWH 0.03% (n=3)
ASQKIELVNTNGSWH 0.03% (n=3)
AHQNIQLINTNGSWH 0.03% (n=3)
PNQKIQLINTNGSWH 0.02% (n=2)
SAQKLQLINTNGSWH 0.02% (n=2)
PSQKIQLMNTNGSWH 0.02% (n=2)
ARQKVQLINTNGSWH 0.02% (n=2)
PAHKIQLVNTNGSWH 0.02% (n=2)
ASQEIQLIYTNGSWH 0.02% (n=2)
PAQKIQLVNSNGSWH 0.02% (n=2)
ASQRIQLINSNGSWH 0.02% (n=2)
PSQKIQLVNTSGSWH 0.02% (n=2)
PSHKIQLVNTNGSWH 0.02% (n=2)
ASQSIQLINTNGSWH 0.02% (n=2)
ASHNIHLINTNGSWH 0.02% (n=2)
ASQNIQLINTNRSWH 0.02% (n=2)
ASQNIQLINTSGSWH 0.02% (n=2)
ASQNTQLINTNGSWH 0.02% (n=2)
VSQKIQLINTNGSWH 0.02% (n=2)
PAQPIKLVNTSGSWH 0.02% (n=2)
PAHRIQLVNTNGSWH 0.02% (n=2)
PNQRIQLINTNGSWH 0.02% (n=2)
PAQKVQLVNTNGSWH 0.02% (n=2)
SSQKIQLVNSNGSWH 0.02% (n=2)
PAQKIELVNTNGSWH 0.02% (n=2)
ASQEIQLIHTNGSWH 0.02% (n=2)
PSQKIQLIHTNGSWH 0.02% (n=2)
AQQRIQLVNTNGSWH 0.02% (n=2)
PTQHIQLINTNGSWH 0.02% (n=2)
AQQRIQLINTNGSWH 0.02% (n=2)
PTQNLQLINTNGSWH 0.02% (n=2)
PSQPLQLIHTNGSWH 0.02% (n=2)
SSQNIQLVNINGSWH 0.02% (n=2)
ASQRIQLVNTNGSW- 0.02% (n=2)
ASQRVQLVNTNGSWH 0.02% (n=2)
PRQKIQLVNTNGSWH 0.02% (n=2)
SNQNIQLINTNGSWH 0.02% (n=2)
PAQNIQLVNSNGSWH 0.02% (n=2)
AAQNIQLVNTNGSWH 0.02% (n=2)
ASQKVQLVNTNGSWH 0.02% (n=2)
PTQKIQLVNSNGSWH 0.02% (n=2)
ASQNIQLINSNGSWH 0.02% (n=2)
AKQNIQLANTNGSWH 0.02% (n=2)
PQQKIQLVHANGSWH 0.02% (n=2)
SAQRVQLVNTNGSWH 0.02% (n=2)
PQQNVQLINTNGSWH 0.02% (n=2)
PQQNVQLINSNGSWH 0.02% (n=2)
SSQNVQLINTNGSWH 0.02% (n=2)
TSQKIQLINTNGSWH 0.02% (n=2)
ASQKIQLMNTNGSWH 0.02% (n=2)
ASQKIQLMHTNGSWH 0.02% (n=2)
AKQKIQLMNTNGSWH 0.02% (n=2)
PKQDIRLINTNGSWH 0.02% (n=2)
ASQEIQLINTNGSWH 0.02% (n=2)
PSQNIHLVNTNGSWH 0.02% (n=2)
AKQKIQLVNTNGSWH 0.02% (n=2)
SSQKLQLINTNGSWH 0.02% (n=2)
PAQNLQLVNTNGSWH 0.02% (n=2)
PSQKIQ--------- 0.02% (n=2)
ASRKIQLINTNGSWH 0.02% (n=2)
ASQKIQLINANGSWH 0.02% (n=2)
PKQNIHLINTNGSWH 0.02% (n=2)
PRQNLQLVNTNGSWH 0.02% (n=2)
PNQNIQLINTNGSWH 0.02% (n=2)
PPQNIQLINTNGSWH 0.02% (n=2)
AQQKIQLINTNGSWH 0.02% (n=2)
SKQKIQLVNTNGSWH 0.02% (n=2)
SRQKVQLINTNGSWH 0.02% (n=2)
SPQKIQLINTNGSWH 0.02% (n=2)
-AQKIQLVNTNGSWH 0.02% (n=2)
PSQELQLVNTNGSWH 0.02% (n=2)
PQQKIQLINTSGSWH 0.02% (n=2)
PAQKLQLIDTNGSWH 0.02% (n=2)
PAQKLQLIKTNGSWH 0.02% (n=2)
PAQKLQLINTNGSWY 0.02% (n=2)
PAQKLQLINTNSSWH 0.02% (n=2)
SAQKIQLINTDGSWH 0.02% (n=2)
SKQTIQLINTNGSWH 0.02% (n=2)
PAQKIELINTNGSWH 0.02% (n=2)
PVQHLQLINTNGSWH 0.02% (n=2)
PHQKLQLINTNGSWH 0.01% (n=1)
ASQKIQLINTNVSWH 0.01% (n=1)
PSQNVQLINTNGSWH 0.01% (n=1)
PTQKLQLINTNGSWH 0.01% (n=1)
PKQQIQLVNTNGSWH 0.01% (n=1)
SAQEIQLVNTNGSWH 0.01% (n=1)
PSQKIQLVNTNSSWH 0.01% (n=1)
PKQKVQLMNTNGSWH 0.01% (n=1)
AKQEVQLINTNGSWH 0.01% (n=1)
PSQKNQLMNTNGSWH 0.01% (n=1)
PAQKIQLIKTNGSWH 0.01% (n=1)
ANQKIQLINTNGSWH 0.01% (n=1)
AAQKIQLIKTNGSWH 0.01% (n=1)
ARQNIQLVNSNGSWH 0.01% (n=1)
PSQNIQLVKTEGNWH 0.01% (n=1)
PSQKIQLVNTNGGWH 0.01% (n=1)
SSQKVQLVHTNGSWH 0.01% (n=1)
SSQKDQLVNTNGSWH 0.01% (n=1)
ASQNIQLINTDGSWH 0.01% (n=1)
VSEDIPACNTNAAWG 0.01% (n=1)
PAQSIKLVNTSGSWY 0.01% (n=1)
PAQSVNLVNTNGSWH 0.01% (n=1)
PTSENPAYNTNGSWH 0.01% (n=1)
ASQKIQLVKTNGSWH 0.01% (n=1)
ASQKIQLINPNGSWH 0.01% (n=1)
SAQKLELVNTNGSWH 0.01% (n=1)
ASQKIQLVN------ 0.01% (n=1)
PAQKIQIINT----- 0.01% (n=1)
ASQNIQLVH------ 0.01% (n=1)
PSQKIQL-------- 0.01% (n=1)
ASQKIQLINT----- 0.01% (n=1)
SKQNVQLINTNGSWH 0.01% (n=1)
ASQNLQLIKTNGSWH 0.01% (n=1)
PSQKIQLVNNNGSWH 0.01% (n=1)
PAQRIQLVNSNGSWH 0.01% (n=1)
ASQKIELINTNGNWH 0.01% (n=1)
PSQEIQLIHTNGSWD 0.01% (n=1)
PSQEIHLIHTNGSWH 0.01% (n=1)
GSQKIELIHTNGSWH 0.01% (n=1)
ASQKIELIHTNGRWH 0.01% (n=1)
ASQNIQLINTNGGWH 0.01% (n=1)
ASQNIQLLNTNGSWH 0.01% (n=1)
ASQNIHLINTNGSWH 0.01% (n=1)
ASQNIQLINTNGRWH 0.01% (n=1)
ASQNIQLINPNGSWH 0.01% (n=1)
SQENIQLINTNGSWH 0.01% (n=1)
RCQTIQLINTNGSW- 0.01% (n=1)
ARQNIQIINTNGSWH 0.01% (n=1)
ASQGIQLINTNGSWH 0.01% (n=1)
ASQRIQLINANGSWH 0.01% (n=1)
ASQRVQLINTNGSCH 0.01% (n=1)
APQRIQLVNTNGSWH 0.01% (n=1)
SSQNIQLVNTNGSRH 0.01% (n=1)
PSQKVQLISTNGSWH 0.01% (n=1)
PSQKIQLINTSGSWH 0.01% (n=1)
PAQKLQLVNTNGSWH 0.01% (n=1)
PQQKIQLVNTDGSWH 0.01% (n=1)
PSQNIQLVNRNGSWH 0.01% (n=1)
PQ*KIQLVNSNGSWH 0.01% (n=1)
SRRKIQLINTNGSWH 0.01% (n=1)
PSQRIQLVNTNDSWH 0.01% (n=1)
PSRRIQLVNTNGSWH 0.01% (n=1)
PSQRIQLVNTSGSWH 0.01% (n=1)
SSQKIQLVNTNDSWH 0.01% (n=1)
SSQNVQLINSNGSWH 0.01% (n=1)
AKQKIQLVNSNGSWH 0.01% (n=1)
SHQKIQLINSNGSWH 0.01% (n=1)
SSQKIQLVHSNGSWH 0.01% (n=1)
SAQKIQLINSNGSWH 0.01% (n=1)
ACQNIQLINTNGSWH 0.01% (n=1)
SHQNVQLINTNGSWH 0.01% (n=1)
PAQNIRLVNTNGSWH 0.01% (n=1)
ASQGIQLVNTNGSWH 0.01% (n=1)
AQQKIQLIRTNGSWH 0.01% (n=1)
PTQNLQLVNTNGSWH 0.01% (n=1)
PAQSLQLVNTNGSWH 0.01% (n=1)
PAQKIHLINTNGSWH 0.01% (n=1)
PHQNIQLINTNGSWH 0.01% (n=1)
PVQKIQLINTNGSWH 0.01% (n=1)
PLQQIQLINTNGSWH 0.01% (n=1)
SAQKVQLINTNGSWH 0.01% (n=1)
PSQKLHLINTNGSWH 0.01% (n=1)
SAQRIQLVNSNGSWH 0.01% (n=1)
PSQSIHLVYTNGSWH 0.01% (n=1)
SYQKVQLINTNGSWH 0.01% (n=1)
SHQKVQLINTNGSWH 0.01% (n=1)
PTQKIQLINSNGSWH 0.01% (n=1)
PKQSIQLVNTNGSWH 0.01% (n=1)
ANQNIQLINTDGSWH 0.01% (n=1)
PSQPIQLVNTNGSWH 0.01% (n=1)
PAQTIQLVTTNGSWH 0.01% (n=1)
PQQKIQLVRANGSWH 0.01% (n=1)
PSQKLQLVNINGSWH 0.01% (n=1)
PGQKVQLINTNGSWH 0.01% (n=1)
ASQNIQPINTNGSWH 0.01% (n=1)
PKQDIQLVNTNGSWH 0.01% (n=1)
SRQSIQLVNTNGSWH 0.01% (n=1)
SKQTLQLINTNGSWH 0.01% (n=1)
SSQKVQLINTNGSWH 0.01% (n=1)
PGQNVQLINTNGSWH 0.01% (n=1)
SNQNVQLINTNGSWH 0.01% (n=1)
ASRNIQLINTNGSWH 0.01% (n=1)
PSQEIQLVNTNGSWH 0.01% (n=1)
ASQKIQLINTNGSWY 0.01% (n=1)
PPQKIQLINTNGSWH 0.01% (n=1)
PSQNTQLVNTNGSWH 0.01% (n=1)
PAQQVQLVNTNGSWH 0.01% (n=1)
PAQQIQLVNTNGSRH 0.01% (n=1)
SQQKIQLINTSGSWH 0.01% (n=1)
SQQRIQLINTNGSWH 0.01% (n=1)
SQQKIQLINTNSSWH 0.01% (n=1)
ARQSIQLVNTNGSWH 0.01% (n=1)
ARQSIQLVNTDGSWH 0.01% (n=1)
SAQRIQLINTNGSWH 0.01% (n=1)
AHQKLQLINTNGSWH 0.01% (n=1)
GQQNIQLINTNGSWH 0.01% (n=1)
GKQDIRLINTNGSWH 0.01% (n=1)
SRQNLQLINTNGSWH 0.01% (n=1)
PSQQIQLINSNGSWH 0.01% (n=1)
AKQNIQLISTNGSWH 0.01% (n=1)
ARQNLQLINTNGSWH 0.01% (n=1)
ASQHIQLINTNGSWH 0.01% (n=1)
ATQNIQLINTNGSWH 0.01% (n=1)
PSQMIQLVNTNGSWH 0.01% (n=1)
PSRKIQLINTNGSWH 0.01% (n=1)
PTQNVQLINTNGSWH 0.01% (n=1)
SSQKLQLVNSNGSWH 0.01% (n=1)
AQQKLQLMNTNGSWH 0.01% (n=1)
PTQNIQLVNTSGSWH 0.01% (n=1)
ANQKIQLVNTNGSWH 0.01% (n=1)
PKQEIRLVNTNGSWH 0.01% (n=1)
PNQQIQLVNTNGSWH 0.01% (n=1)
PIQKIQLVNTNGSWH 0.01% (n=1)
PGQEIKLVNTNGSWH 0.01% (n=1)
PVQKIQLVNTNGSWH 0.01% (n=1)
AKQNIQLVYTNGSWH 0.01% (n=1)
PTQTIQLVNTNGSWH 0.01% (n=1)
AQQKIQLVNSNGSWH 0.01% (n=1)
ATQNIQLVNTNGSWH 0.01% (n=1)
SAQEIKLVNTNGSWH 0.01% (n=1)
SQQKLQLVNTNGSWH 0.01% (n=1)
AKQRIQLVNTNGSWH 0.01% (n=1)
PTQELRLVNTNGSWH 0.01% (n=1)
PSQSIQLINTNGSWH 0.01% (n=1)
PSQGIQLVNSNGSWH 0.01% (n=1)
PAQKIQLVNSSGSWH 0.01% (n=1)
AAQTIQ--------- 0.01% (n=1)
PRQNILLVNTNGSWH 0.01% (n=1)
SSQRIQLINSNGSWH 0.01% (n=1)
VS------------- 0.01% (n=1)
ASQRIQLINTNDSWH 0.01% (n=1)
ATQKIQLINTNGSWH 0.01% (n=1)
PTQKVQLVNTNGSWH 0.01% (n=1)
PAQKIQLVHTNGSWH 0.01% (n=1)
PSQSIQLINSNGSWH 0.01% (n=1)
PAQKLHLVNTNGSWH 0.01% (n=1)
ASQKLQLVNTNGGWH 0.01% (n=1)
PSQKFQLVNTNGSWH 0.01% (n=1)
ASQNIQLTNTNGSWH 0.01% (n=1)
ASQNIRIINTNGSWH 0.01% (n=1)
ASQNIQLMKTNGSWH 0.01% (n=1)
PSQKIQLINTNGSWY 0.01% (n=1)
PRQNIQLVNTNGSWH 0.01% (n=1)
PSQNIQLVNSNGSWR 0.01% (n=1)
PSQCIQLINTNGSWH 0.01% (n=1)
PSQNIQLINTNGGWH 0.01% (n=1)
PSRKIQLVNSNGSWH 0.01% (n=1)
AFQNIHLINTNGSWH 0.01% (n=1)
PSQTLQLVNTNGSWH 0.01% (n=1)
LYQRIQLVNTNGSWH 0.01% (n=1)
AAQKIQLINTNGSWH 0.01% (n=1)
PSQNIQLIKSNGSWH 0.01% (n=1)
ARQKIQLVNSNGSWH 0.01% (n=1)
PDQKIQLVNTNGSWH 0.01% (n=1)
ASQNVQLVNTNGSWH 0.01% (n=1)
PTQKIQLISTNGSWH 0.01% (n=1)
SHQSIQLVNTNGSWH 0.01% (n=1)
SSQNIQLVHTNGSWH 0.01% (n=1)
ASQKIQLVNSNGSWH 0.01% (n=1)
SAQKIQLVNSNGSWH 0.01% (n=1)
ASQRLQLVNTNGSWH 0.01% (n=1)
SQQNVQLINTNGSWH 0.01% (n=1)
SQQNIQLINTNGSWH 0.01% (n=1)
SAQKIQLIKTNGSWH 0.01% (n=1)
PGQNIQLINTNGSWH 0.01% (n=1)
AAQNVQLINTNGSWH 0.01% (n=1)
SAQNIRLINTNGSWH 0.01% (n=1)
SAQNVQLINTNGSWH 0.01% (n=1)
AKQDIQLINTNGSWH 0.01% (n=1)
AQQK----------- 0.01% (n=1)
PQQK----------- 0.01% (n=1)
PQQ------------ 0.01% (n=1)
AQQR----------- 0.01% (n=1)
PSQTIQLINTNGSWH 0.01% (n=1)
SYQKIQLINTNGSWH 0.01% (n=1)
SSQRVQLINTNGSWH 0.01% (n=1)
SSQRIQLVNTNGSRH 0.01% (n=1)
SSQRVQLVNTNGSWH 0.01% (n=1)
SSQRIQLINTNGSWR 0.01% (n=1)
SSQRIQLVSTNGSWH 0.01% (n=1)
-KQKIQLVNTNGSWH 0.01% (n=1)
-SQKIQLVNNNGSWH 0.01% (n=1)
-SQKIQLVNTNGSWH 0.01% (n=1)
PSQEVQLINTNGSWH 0.01% (n=1)
PSQELQLINTNGSWH 0.01% (n=1)
PQQKIQLVNTNSSWH 0.01% (n=1)
PQQKIQLVTTNGSWH 0.01% (n=1)
PQQKIQLVNTNGS*H 0.01% (n=1)
PQQKIQLIDTNGSWH 0.01% (n=1)
SRQHIQLINTNGSRH 0.01% (n=1)
SRQHTQLINTNGSWH 0.01% (n=1)
LRQHIQLINTNGSWH 0.01% (n=1)
SRQHIQLINTNGSWR 0.01% (n=1)
PSRKLQLVNTNGSWH 0.01% (n=1)
PSQKLQLVNTNGNWH 0.01% (n=1)
SSQELQLVSTNGSWH 0.01% (n=1)
PSQKLQLANTNGSWH 0.01% (n=1)
PSQKPQLVNTNGSWH 0.01% (n=1)
SSQEIQLINTNGSWH 0.01% (n=1)
PSQELKLVNTNGSWR 0.01% (n=1)
PSQKLQLMNTNGSWH 0.01% (n=1)
PSQKLQPVNTNGSWH 0.01% (n=1)
PSQKLQLVNANGSWH 0.01% (n=1)
PSQKLQLVNTNSSWH 0.01% (n=1)
PSQKLQLVNTKGSWH 0.01% (n=1)
SPQNTQLINTNGSWH 0.01% (n=1)
SSQKIQPINTNGSWH 0.01% (n=1)
PQQKIQLINTNGSRH 0.01% (n=1)
PQQKIQLMNTNGSWH 0.01% (n=1)
PQQKIQLINANGSWH 0.01% (n=1)
P*QKIQLINTNGSWH 0.01% (n=1)
PQQRIQLINTNGSWH 0.01% (n=1)
ASHKIQLINTNGSWH 0.01% (n=1)
ASQKIQLIDTNGSWH 0.01% (n=1)
ASQKIQLINTNGSRH 0.01% (n=1)
ASQKIQLINTSGSWH 0.01% (n=1)
ASQKIQLVNTNGSWR 0.01% (n=1)
ASQKIQLINTNSSWH 0.01% (n=1)
ASQKTQLINTNGSWH 0.01% (n=1)
ASQKIQLININGSWH 0.01% (n=1)
PAQNLQLINTNGSWR 0.01% (n=1)
PAQKLPLINTNGSWH 0.01% (n=1)
PAQKLQLINANGSWH 0.01% (n=1)
PAQKLQLINTDGSWH 0.01% (n=1)
PAQKLQLINTNGTWH 0.01% (n=1)
PAQKLLLINTNGSWH 0.01% (n=1)
PAQKLQLIHTNGSWH 0.01% (n=1)
PAQKLQLINSNGGWH 0.01% (n=1)
LAQKLQLINTNGSWH 0.01% (n=1)
PAQKLQLINTSGSWH 0.01% (n=1)
PAQKLQLINTNDSWH 0.01% (n=1)
PAQKLQLISTNGSWH 0.01% (n=1)
PALKLQLINTNGSWH 0.01% (n=1)
ASQKIQLINTNGSWR 0.01% (n=1)
ASQKIQHINTNGSWH 0.01% (n=1)
ASQKIQPINTNGSWH 0.01% (n=1)
PRQNIQLINANGSWH 0.01% (n=1)
PSQNIQLMNTNGSWH 0.01% (n=1)
PSQNIQLINTNGSWR 0.01% (n=1)
SAQKIQLINTNGSWR 0.01% (n=1)
PSQKIQLINTNDSWH 0.01% (n=1)
PSQKIQLINTNGSRH 0.01% (n=1)
ASQKLQLINANGSWH 0.01% (n=1)
ASQ*LQLINTNGSWH 0.01% (n=1)
ASQKLQLINTNGSWR 0.01% (n=1)
PNQKVQLVNTNGSWH 0.01% (n=1)
ARQKIQLVNTNGSWH 0.01% (n=1)
SHQNIQLINTNGSWH 0.01% (n=1)
PQQTIQLVNTNGSWH 0.01% (n=1)
DGQKIQLVNTNGSWH 0.01% (n=1)
PSQKIQLVNANGSWH 0.01% (n=1)
PSQKIQLVNTNGSWN 0.01% (n=1)
RSQKI---------- 0.01% (n=1)
QEQKIQLIHTNGSWH 0.01% (n=1)
PSQKIQLINTNGS-- 0.01% (n=1)
PSQTIQLVNTNGS-- 0.01% (n=1)
PSQKIQLVNSNGSRH 0.01% (n=1)
PKQNIQIINTNGSWH 0.01% (n=1)
PTQKIQLVNNNGIWH 0.01% (n=1)
ASQKIQLV------- 0.01% (n=1)
ATQNIQLI------- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 2:

SRQNIQLINSNGSWH 11.31% (n=149)
PSQKIQLINTNGSWH 6.15% (n=81)
AKQHIQLIHNNGSWH 5.39% (n=71)
AKQHIQLIHSNGSWH 5.39% (n=71)
AKQNIQLINSNGSWH 5.16% (n=68)
AKQNIQLINTNGSWH 3.19% (n=42)
AQQEISLINTNGSWH 2.88% (n=38)
AKQHIQLIHTNGSWH 2.81% (n=37)
PSQKLSLISTNGSWH 2.35% (n=31)
ARQNIQLINTNGSWH 2.05% (n=27)
PQQKINLINTNGSWH 1.82% (n=24)
PQQKLSLINTNGSWH 1.52% (n=20)
ARQHIQLIHTNGSWH 1.52% (n=20)
PQQNIQLINTNGSWH 1.44% (n=19)
PSQKLNLINTNGSWH 1.21% (n=16)
PSQKLSLINTNGSWH 1.21% (n=16)
SQQKLSLINTNGSWH 1.14% (n=15)
ARQNIQLINSNGSWH 1.06% (n=14)
PQQQITLINTNGSWH 0.99% (n=13)
PSQKLNLISTNGSWH 0.99% (n=13)
PKQNIQLINTNGSWH 0.91% (n=12)
AQQKINLINTNGSWH 0.91% (n=12)
AKQRIQLIHTNGSWH 0.91% (n=12)
SRQNIQLINTNGSWH 0.83% (n=11)
ARQHIQLIHSNGSWH 0.83% (n=11)
PSQKLNLIHTNGSWH 0.76% (n=10)
AQQRISLINTNGSWH 0.76% (n=10)
PKQNINLIKTNGSWH 0.68% (n=9)
AQQQISLINTNGSWH 0.68% (n=9)
PKQTLSLINTNGSWH 0.61% (n=8)
AQQNIQLINTNGSWH 0.53% (n=7)
ARQHIQLIHNNGSWH 0.53% (n=7)
PQQKIQLINTNGSWH 0.46% (n=6)
HKQNVQLINTNGSWH 0.46% (n=6)
PKQKIDLINTNGSWH 0.46% (n=6)
PSQRINLINTNGSWH 0.46% (n=6)
PQQRLQLINTNGSWH 0.46% (n=6)
PRQKIQLVNTNGSWH 0.38% (n=5)
SQQNIQLINTNGSWH 0.38% (n=5)
PKQNIQLINSNGSWH 0.38% (n=5)
AQQKLSLINTNGSWH 0.38% (n=5)
SQQRLSLINTNGSWH 0.38% (n=5)
ARQKISLINTNGSWH 0.38% (n=5)
PRQTLSLVNTNGSWH 0.38% (n=5)
SKQNIQLINTNGSWH 0.30% (n=4)
ARQKIQLINTNGSWH 0.30% (n=4)
SKQNIQLINSNGSWH 0.30% (n=4)
ASQNIQLINTNGSWH 0.30% (n=4)
PRQKIDLINTNGSWH 0.30% (n=4)
PKQRIDLINTNGSWH 0.30% (n=4)
PQQNLNLINTNGSWH 0.30% (n=4)
PSQKISLINTNGSWH 0.30% (n=4)
AQQKISLINTNGSWH 0.30% (n=4)
PSQRIQLINTNGSWH 0.30% (n=4)
AKQNIQLIHTNGSWH 0.23% (n=3)
SQQRLQLINTNGSWH 0.23% (n=3)
SQQNIQLINSNGSWH 0.23% (n=3)
PRQNIQLINTNGSWH 0.23% (n=3)
AQQNIQLINSNGSWH 0.23% (n=3)
PRQNIQLINSNGSWH 0.23% (n=3)
AKQNIYLINTNGSWH 0.23% (n=3)
PSQKINLINTNGSWH 0.23% (n=3)
PQQKIKLINTNGSWH 0.23% (n=3)
PQQKLTLVNTNGSWH 0.23% (n=3)
PSQRLSLINTNGSWH 0.23% (n=3)
AKQHIQLIRNNGSWH 0.23% (n=3)
SRQNIQLIHTNGSWH 0.23% (n=3)
SRQDIQLINSNGSWH 0.23% (n=3)
SKQHIQLINTNGSWH 0.15% (n=2)
ARQNLQLINSNGSWH 0.15% (n=2)
PQQQIQLINTNGSWH 0.15% (n=2)
ARQKLQLINSNGSWH 0.15% (n=2)
AKQNLQLINSNGSWH 0.15% (n=2)
PQQNIQLINSNGSWH 0.15% (n=2)
SKQNLQLINTNGSWH 0.15% (n=2)
AKQNIQLINSSGSWH 0.15% (n=2)
SRQNIQLVNSNGSWH 0.15% (n=2)
AQQKIQLINTNGSWH 0.15% (n=2)
ARQNIQLVNTNGSWH 0.15% (n=2)
PQQKLQLINTNGSWH 0.15% (n=2)
AKQSIQLINTNGSWH 0.15% (n=2)
PQQNLHLINTNGSWH 0.15% (n=2)
AKQNLQLINTNGSWH 0.15% (n=2)
PRQRIHLINTNGSWH 0.15% (n=2)
AKQNINLIKTNGSWH 0.15% (n=2)
PQQNIHLINTNGSWH 0.15% (n=2)
PQQQLHLINTNGSWH 0.15% (n=2)
PQQKLHLVNSNGSWH 0.15% (n=2)
AKQNLYLINTNGSWH 0.15% (n=2)
PKQQITLINTNGSWH 0.15% (n=2)
PKQKINLINTNGSWH 0.15% (n=2)
AQQQLSLINTNGSWH 0.15% (n=2)
PQQKLNLVNTNGSWH 0.15% (n=2)
PRQKLSLINTNGSWH 0.15% (n=2)
ARQRIQLIHNNGSWH 0.15% (n=2)
SKQNIQLIHTNGSWH 0.15% (n=2)
PSQRIQLIHTNGSWH 0.15% (n=2)
PKQHIQLIHTNGSWH 0.15% (n=2)
PQQKIQLIHTNGSWH 0.15% (n=2)
AQQRIQLIHTNGSWH 0.15% (n=2)
ASQNIQLIYTNGSWH 0.15% (n=2)
PQQKLQLVNTNGSWH 0.15% (n=2)
AKQTLQLINSNGSWH 0.08% (n=1)
AQQHVQLIHSNGSWH 0.08% (n=1)
AKQNIQLVHTNGSWH 0.08% (n=1)
ARQKIQLINSNGSWH 0.08% (n=1)
PIQHIQLVNTNGSWH 0.08% (n=1)
ARQQVQLINSNGSWH 0.08% (n=1)
PQQKIQLINNNGSWH 0.08% (n=1)
AHQNIQLVNTNGSWH 0.08% (n=1)
AKQIIQLINSNGSWH 0.08% (n=1)
AKQNIQLTNSNGSWH 0.08% (n=1)
AKQNTQLINSNGSWH 0.08% (n=1)
PTQNIQLINTNGSWH 0.08% (n=1)
AKQDIQLINTNGSWH 0.08% (n=1)
PRQNLQLINSNGSWH 0.08% (n=1)
PTQNLQLINTNGSWH 0.08% (n=1)
ARQNIQLIKTNGSWH 0.08% (n=1)
AKQKIQLINSNGSWH 0.08% (n=1)
AKQNIQLIYSNGSWH 0.08% (n=1)
PQQNIQLVNTNGSWH 0.08% (n=1)
SKQNIQLVNDNGSWH 0.08% (n=1)
ARQHIQLINSNGSWH 0.08% (n=1)
PSQNIQLINTNGSWH 0.08% (n=1)
AKQNIQLIDTKGSWH 0.08% (n=1)
PQQNIQLIDTNGSWH 0.08% (n=1)
PQQRIQLINTNGSWH 0.08% (n=1)
PQQRIQLVSANGSWH 0.08% (n=1)
SNQNIQLINSNGSWH 0.08% (n=1)
PQQTIQLVNANGSWH 0.08% (n=1)
PMQNIQLINTNGSWH 0.08% (n=1)
AKQNIQLVNTNGSWH 0.08% (n=1)
AKQNIQLISTNGSWH 0.08% (n=1)
AKQNIQLINTSGSWH 0.08% (n=1)
AKQDIQLINSNGSWH 0.08% (n=1)
ARQNLQLINTNGSWH 0.08% (n=1)
AQQNIQLVNTSGSWH 0.08% (n=1)
SRQNVQLINSNGSWH 0.08% (n=1)
AQQNIQLIKSNGSWH 0.08% (n=1)
SRQSIQLINTNGSWH 0.08% (n=1)
PSQNLRLMNTSGSWH 0.08% (n=1)
AQQNVQLINTNGSWH 0.08% (n=1)
PQQKLILVNSNGSWH 0.08% (n=1)
AQQEIRLINTNGSWH 0.08% (n=1)
PQQNVHLINTNGSWH 0.08% (n=1)
PKQNIHLINSNGSWH 0.08% (n=1)
SKQNIQLINANGSWH 0.08% (n=1)
AKQNIHLVNTNGSWH 0.08% (n=1)
PQQKNHLNHSNGSWH 0.08% (n=1)
PSQRLQLINTNGSWH 0.08% (n=1)
PRQNLQLINTNGSWH 0.08% (n=1)
PSQSIQLVNTNGSWH 0.08% (n=1)
PQQNIYLINKNGSWH 0.08% (n=1)
PQQKLNLIKTNGSWH 0.08% (n=1)
AQQRLSLVNTNGSWH 0.08% (n=1)
SQQNIQLINNNGSWH 0.08% (n=1)
PQQKISLINSNGSWH 0.08% (n=1)
AKQNLHLINTNGSWH 0.08% (n=1)
PQQKIQLINANGSWH 0.08% (n=1)
AQQPISLINTNGSWH 0.08% (n=1)
PKQNLQLISSNGSWH 0.08% (n=1)
PSQKLSLVNTNGSWH 0.08% (n=1)
SKQNIYLINTNGSWH 0.08% (n=1)
PHHSINLINSNGNWH 0.08% (n=1)
SQQNIHLIKNNGSWH 0.08% (n=1)
PQQKLQLINSNGSWH 0.08% (n=1)
PKQNIHLINTNGSWH 0.08% (n=1)
AKQNIMLINTNGSWH 0.08% (n=1)
PKQNLQLVNTNGSWH 0.08% (n=1)
PQQQLRLINTNGSWH 0.08% (n=1)
AKQKLSLINTNGSWH 0.08% (n=1)
PRQQLQLVNNNGSWH 0.08% (n=1)
AQQKIHLVKTNGSWH 0.08% (n=1)
ARQKIMLINTNGSWH 0.08% (n=1)
ASQKISLINTNGSWH 0.08% (n=1)
SRQDISLINTNGSWH 0.08% (n=1)
PQQQITLNHTNGSWH 0.08% (n=1)
PKKQITLINTNGSWH 0.08% (n=1)
PKQRIDLINANGSWH 0.08% (n=1)
PQQKINLINTNGSLH 0.08% (n=1)
PQQKINLINTNVNWH 0.08% (n=1)
PEQQITLINTNGS*H 0.08% (n=1)
P*QQITLINTNGSWH 0.08% (n=1)
PQQQITLINTNSSWH 0.08% (n=1)
AKQQLSLINTNGSWH 0.08% (n=1)
PQQKLSLVNTNGSRH 0.08% (n=1)
SKQKLSLINTNGSWH 0.08% (n=1)
PRQTLSLVSTNGSWH 0.08% (n=1)
SQQKLSLINTTGSWH 0.08% (n=1)
SQQKLSLINTNGSLH 0.08% (n=1)
PRQTVSLVNTNGSWH 0.08% (n=1)
PRQTL*LVNTNGSWH 0.08% (n=1)
PKQKLTLVNTNGNLH 0.08% (n=1)
SQQQLSLINTNGSLD 0.08% (n=1)
PKQNLNLINTNGSWH 0.08% (n=1)
PTRQINLINTNGSWH 0.08% (n=1)
PSQKFNLINTNGSWH 0.08% (n=1)
AQQRISLINTDGSWH 0.08% (n=1)
PKQKINLIKTNGSWH 0.08% (n=1)
AKQKIQLINTNGSWH 0.08% (n=1)
PAQKLSLINTNGSWH 0.08% (n=1)
PQQRLSLINTNGSWH 0.08% (n=1)
PQQRINLVNTNGSWH 0.08% (n=1)
PQQKIALINTNGSWH 0.08% (n=1)
SRQKLSLINTNGSWH 0.08% (n=1)
PSQTINLIHTNGSWH 0.08% (n=1)
PSQTLSLIHTNGSWH 0.08% (n=1)
PSQTINLIYTNGSWH 0.08% (n=1)
ARQQLMLINSNGSWH 0.08% (n=1)
PQQKISLINTNGSWH 0.08% (n=1)
AQQPLSLINTNGSWH 0.08% (n=1)
SKQKISLINTNGSWH 0.08% (n=1)
PKQNLALINTNGSWH 0.08% (n=1)
SRQRLSLINTNGSWH 0.08% (n=1)
VRKSVWLIPMAAGW- 0.08% (n=1)
PQQKISLIKENGSWH 0.08% (n=1)
PQQNLQLINTNGSWH 0.08% (n=1)
PSQKLALINTNGSWH 0.08% (n=1)
SKQNVHLINTNGSWH 0.08% (n=1)
PNQRISLINTNGSWH 0.08% (n=1)
ARQQISLINTNGSWH 0.08% (n=1)
AQQRLSLINTNGSWH 0.08% (n=1)
GKQDIMLINTNGSWH 0.08% (n=1)
PSQHISLMNTNGSWH 0.08% (n=1)
PSQQLSLINTNGSWH 0.08% (n=1)
PKQTISLINTNGSWH 0.08% (n=1)
PQQPLSLINTNGSWH 0.08% (n=1)
PHQRLSLINTNGSWH 0.08% (n=1)
PQQRIHLVNSNGSWH 0.08% (n=1)
PQQRIQLVNSNGSWH 0.08% (n=1)
PKQKLSLINTNGSWH 0.08% (n=1)
PQQTISLIHTNGSWH 0.08% (n=1)
ARQRISLINTNGSWH 0.08% (n=1)
PSQRIQLIHSNGSWH 0.08% (n=1)
SSQNIQLINTNGSWH 0.08% (n=1)
PQQNIQLIN------ 0.08% (n=1)
SQQRVQLIHTNGSWH 0.08% (n=1)
AKQHIQLIYNNGSWH 0.08% (n=1)
ARQHIQLTHTNGSWH 0.08% (n=1)
PKQRIQLVNTNGSWH 0.08% (n=1)
LQQRIQLIHTNGSWH 0.08% (n=1)
PQQRIQLIHTNGSWH 0.08% (n=1)
PQQKIQLVKTNGSWH 0.08% (n=1)
PQQTIQLIHTNGSWH 0.08% (n=1)
PRQHIQLIYTNGSWH 0.08% (n=1)
PNQKLQLIHTNGSWH 0.08% (n=1)
ARQSIQLIHTNGSWH 0.08% (n=1)
PKQRIQLVNANGSWH 0.08% (n=1)
SQQKIQLIHTNGSWH 0.08% (n=1)
PNQNIQLIHTNGSWH 0.08% (n=1)
SQQRIQLIRTNGSWH 0.08% (n=1)
PQQRIQLINSNGSWH 0.08% (n=1)
PKQRIQLINTNGSWH 0.08% (n=1)
PNQRIQLISTNGSWH 0.08% (n=1)
SNQKIQLIHTNGSWH 0.08% (n=1)
SRQHIQLIHTNGSWH 0.08% (n=1)
AKQAIQLIYTNGSWH 0.08% (n=1)
ARQHIQLINTNGSWH 0.08% (n=1)
PNQRLELVNTNGSWH 0.08% (n=1)
ARQRIQLINTNGSWH 0.08% (n=1)
PQQRLQLIYTNGSWH 0.08% (n=1)
SQQQIQLINTNGSWH 0.08% (n=1)
PKQRIQLIHTNGSWH 0.08% (n=1)
AQQHIQLIHTNGSWH 0.08% (n=1)
ARQKIQLINDNGTWH 0.08% (n=1)
PKQNIQLIHTNGSWH 0.08% (n=1)
PRQTIQLINTNGSWH 0.08% (n=1)
PQQRIQLIHSNGSWH 0.08% (n=1)
SQQNVQLINTNGSWH 0.08% (n=1)
SRQNI*LINSNGSWH 0.08% (n=1)
SRQNIRLINSNGSWH 0.08% (n=1)
SRQNTQLINSNGSWH 0.08% (n=1)
SRQNIHLINSNGSWH 0.08% (n=1)
SRQNIQLINSDGSWH 0.08% (n=1)
AQQKIQLIHTNGSWH 0.08% (n=1)
ARQKIQLIHTNGSWH 0.08% (n=1)
PSQRIQLIYTNGSWH 0.08% (n=1)
SQQHIQLIRSNGSWH 0.08% (n=1)
PKQNIQLI------- 0.08% (n=1)
PKQNIQLIN------ 0.08% (n=1)
SQQNIQLIN------ 0.08% (n=1)
ARQNIQLIN------ 0.08% (n=1)
PSQNLQLIKTNGSWH 0.08% (n=1)
PRQNIQLI------- 0.08% (n=1)
AKQNVQLI------- 0.08% (n=1)
SQQHLRLV------- 0.08% (n=1)
PRQNVQLINTNGSWH 0.08% (n=1)
SSQNVQLINTNGSWH 0.08% (n=1)
PQQRLQLIDTNGSWH 0.08% (n=1)
AQQNIQLIHSNGSWH 0.08% (n=1)
SQQNIQLVNTNGSWH 0.08% (n=1)
PQQHLQLVNTNGSWH 0.08% (n=1)
ARQKIQLVNANGSWH 0.08% (n=1)
PSQKTQLINTNGSWH 0.08% (n=1)
PSRKIQLINTNGSWH 0.08% (n=1)
PSQKIQLINPNGSWH 0.08% (n=1)
PSQKIQLINANGSWH 0.08% (n=1)
PSQNIMLMKTNGSWH 0.08% (n=1)
SRQHIQLINTNGSWH 0.08% (n=1)
ASQSLQLINTNGSWH 0.08% (n=1)
SQQNLQLINTNGSWH 0.08% (n=1)
PQQRLSLVNSNGSWH 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 2a:

AKQNIQLINSNGSWH 25.30% (n=64)
AKQNIQLINTNGSWH 11.86% (n=30)
ARQNIQLINTNGSWH 9.49% (n=24)
PQQNIQLINTNGSWH 5.93% (n=15)
ARQNIQLINSNGSWH 5.14% (n=13)
PKQNIQLINTNGSWH 2.77% (n=7)
HKQNVQLINTNGSWH 2.37% (n=6)
SRQNIQLINTNGSWH 2.37% (n=6)
PRQKIQLVNTNGSWH 1.98% (n=5)
AQQNIQLINTNGSWH 1.58% (n=4)
PKQNIQLINSNGSWH 1.58% (n=4)
SQQNIQLINSNGSWH 1.19% (n=3)
SQQNIQLINTNGSWH 1.19% (n=3)
SKQNIQLINTNGSWH 1.19% (n=3)
SKQNIQLINSNGSWH 1.19% (n=3)
PQQKIQLINTNGSWH 1.19% (n=3)
ASQNIQLINTNGSWH 1.19% (n=3)
AQQNIQLINSNGSWH 0.79% (n=2)
ARQKLQLINSNGSWH 0.79% (n=2)
AKQNLQLINSNGSWH 0.79% (n=2)
ARQKIQLINTNGSWH 0.79% (n=2)
SKQNLQLINTNGSWH 0.79% (n=2)
AKQNIQLINSSGSWH 0.79% (n=2)
SRQNIQLVNSNGSWH 0.79% (n=2)
PRQNIQLINSNGSWH 0.79% (n=2)
PQQKIQLINNNGSWH 0.40% (n=1)
AHQNIQLVNTNGSWH 0.40% (n=1)
AKQIIQLINSNGSWH 0.40% (n=1)
AKQNIQLTNSNGSWH 0.40% (n=1)
AKQNTQLINSNGSWH 0.40% (n=1)
PQQQIQLINTNGSWH 0.40% (n=1)
PRQNIQLINTNGSWH 0.40% (n=1)
PQQNIQLINSNGSWH 0.40% (n=1)
PTQNIQLINTNGSWH 0.40% (n=1)
AKQDIQLINTNGSWH 0.40% (n=1)
PRQNLQLINSNGSWH 0.40% (n=1)
PTQNLQLINTNGSWH 0.40% (n=1)
ARQNIQLIKTNGSWH 0.40% (n=1)
AKQKIQLINSNGSWH 0.40% (n=1)
AKQNIQLIYSNGSWH 0.40% (n=1)
PQQNIQLVNTNGSWH 0.40% (n=1)
SKQNIQLVNDNGSWH 0.40% (n=1)
AQQKIQLINTNGSWH 0.40% (n=1)
ARQHIQLINSNGSWH 0.40% (n=1)
PSQNIQLINTNGSWH 0.40% (n=1)
AKQNIQLIDTKGSWH 0.40% (n=1)
PQQNIQLIDTNGSWH 0.40% (n=1)
PQQRIQLINTNGSWH 0.40% (n=1)
PQQRIQLVSANGSWH 0.40% (n=1)
ARQNIQLVNTNGSWH 0.40% (n=1)
PQQKLQLINTNGSWH 0.40% (n=1)
SRQNIQLINSNGSWH 0.40% (n=1)
SNQNIQLINSNGSWH 0.40% (n=1)
PQQTIQLVNANGSWH 0.40% (n=1)
PMQNIQLINTNGSWH 0.40% (n=1)
AKQNIQLVNTNGSWH 0.40% (n=1)
AKQNIQLISTNGSWH 0.40% (n=1)
AKQNIQLINTSGSWH 0.40% (n=1)
AKQDIQLINSNGSWH 0.40% (n=1)
AKQSIQLINTNGSWH 0.40% (n=1)
ARQNLQLINTNGSWH 0.40% (n=1)
AQQNIQLVNTSGSWH 0.40% (n=1)
SRQNVQLINSNGSWH 0.40% (n=1)
AQQNIQLIKSNGSWH 0.40% (n=1)
SRQSIQLINTNGSWH 0.40% (n=1)
PSQNLRLMNTSGSWH 0.40% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 2b:

AQQEISLINTNGSWH 8.26% (n=38)
PSQKLSLISTNGSWH 6.74% (n=31)
PQQKINLINTNGSWH 5.22% (n=24)
PQQKLSLINTNGSWH 4.35% (n=20)
PSQKLNLINTNGSWH 3.48% (n=16)
PSQKLSLINTNGSWH 3.48% (n=16)
SQQKLSLINTNGSWH 3.26% (n=15)
PQQQITLINTNGSWH 2.83% (n=13)
PSQKLNLISTNGSWH 2.83% (n=13)
AQQKINLINTNGSWH 2.61% (n=12)
PSQKLNLIHTNGSWH 2.17% (n=10)
AQQRISLINTNGSWH 2.17% (n=10)
PKQNINLIKTNGSWH 1.96% (n=9)
AQQQISLINTNGSWH 1.96% (n=9)
AKQNIQLINTNGSWH 1.74% (n=8)
PKQTLSLINTNGSWH 1.74% (n=8)
PKQKIDLINTNGSWH 1.30% (n=6)
PSQRINLINTNGSWH 1.30% (n=6)
SRQNIQLINTNGSWH 1.09% (n=5)
AQQKLSLINTNGSWH 1.09% (n=5)
SQQRLSLINTNGSWH 1.09% (n=5)
ARQKISLINTNGSWH 1.09% (n=5)
PRQTLSLVNTNGSWH 1.09% (n=5)
PKQNIQLINTNGSWH 0.87% (n=4)
PRQKIDLINTNGSWH 0.87% (n=4)
PKQRIDLINTNGSWH 0.87% (n=4)
PQQNLNLINTNGSWH 0.87% (n=4)
PSQKISLINTNGSWH 0.87% (n=4)
AQQKISLINTNGSWH 0.87% (n=4)
AKQNIYLINTNGSWH 0.65% (n=3)
AQQNIQLINTNGSWH 0.65% (n=3)
PSQKINLINTNGSWH 0.65% (n=3)
PQQKIKLINTNGSWH 0.65% (n=3)
PQQKLTLVNTNGSWH 0.65% (n=3)
PSQRLSLINTNGSWH 0.65% (n=3)
PRQNIQLINTNGSWH 0.43% (n=2)
ARQKIQLINTNGSWH 0.43% (n=2)
AKQNIQLINSNGSWH 0.43% (n=2)
PRQRIHLINTNGSWH 0.43% (n=2)
AKQNINLIKTNGSWH 0.43% (n=2)
PQQNIHLINTNGSWH 0.43% (n=2)
PQQQLHLINTNGSWH 0.43% (n=2)
PQQKLHLVNSNGSWH 0.43% (n=2)
AKQNLYLINTNGSWH 0.43% (n=2)
PKQQITLINTNGSWH 0.43% (n=2)
PKQKINLINTNGSWH 0.43% (n=2)
AQQQLSLINTNGSWH 0.43% (n=2)
PQQKLNLVNTNGSWH 0.43% (n=2)
PRQKLSLINTNGSWH 0.43% (n=2)
AQQNVQLINTNGSWH 0.22% (n=1)
SKQNIQLINSNGSWH 0.22% (n=1)
PQQKLILVNSNGSWH 0.22% (n=1)
AQQEIRLINTNGSWH 0.22% (n=1)
PQQNVHLINTNGSWH 0.22% (n=1)
PKQNIQLINSNGSWH 0.22% (n=1)
PKQNIHLINSNGSWH 0.22% (n=1)
SKQNIQLINANGSWH 0.22% (n=1)
AKQNIHLVNTNGSWH 0.22% (n=1)
PQQKNHLNHSNGSWH 0.22% (n=1)
AKQSIQLINTNGSWH 0.22% (n=1)
PSQRLQLINTNGSWH 0.22% (n=1)
PQQNLHLINTNGSWH 0.22% (n=1)
PRQNLQLINTNGSWH 0.22% (n=1)
ASQNIQLINTNGSWH 0.22% (n=1)
PQQNIQLINTNGSWH 0.22% (n=1)
PSQSIQLVNTNGSWH 0.22% (n=1)
PQQNIYLINKNGSWH 0.22% (n=1)
AKQNLQLINTNGSWH 0.22% (n=1)
PQQKLNLIKTNGSWH 0.22% (n=1)
ARQNIQLVNTNGSWH 0.22% (n=1)
AQQRLSLVNTNGSWH 0.22% (n=1)
SQQNIQLINNNGSWH 0.22% (n=1)
AKQNLHLINTNGSWH 0.22% (n=1)
PQQKIQLINANGSWH 0.22% (n=1)
AQQPISLINTNGSWH 0.22% (n=1)
PKQNLQLISSNGSWH 0.22% (n=1)
PSQKLSLVNTNGSWH 0.22% (n=1)
SKQNIYLINTNGSWH 0.22% (n=1)
PHHSINLINSNGNWH 0.22% (n=1)
SQQNIHLIKNNGSWH 0.22% (n=1)
PQQKLQLINSNGSWH 0.22% (n=1)
PKQNIHLINTNGSWH 0.22% (n=1)
AKQNIMLINTNGSWH 0.22% (n=1)
PKQNLQLVNTNGSWH 0.22% (n=1)
PQQNIQLINSNGSWH 0.22% (n=1)
PQQQLRLINTNGSWH 0.22% (n=1)
AKQKLSLINTNGSWH 0.22% (n=1)
PRQQLQLVNNNGSWH 0.22% (n=1)
AQQKIHLVKTNGSWH 0.22% (n=1)
ARQKIMLINTNGSWH 0.22% (n=1)
ASQKISLINTNGSWH 0.22% (n=1)
SRQDISLINTNGSWH 0.22% (n=1)
PQQQITLNHTNGSWH 0.22% (n=1)
PKKQITLINTNGSWH 0.22% (n=1)
PKQRIDLINANGSWH 0.22% (n=1)
PQQKINLINTNGSLH 0.22% (n=1)
PQQKINLINTNVNWH 0.22% (n=1)
PEQQITLINTNGS*H 0.22% (n=1)
P*QQITLINTNGSWH 0.22% (n=1)
PQQQITLINTNSSWH 0.22% (n=1)
AKQQLSLINTNGSWH 0.22% (n=1)
PQQKLSLVNTNGSRH 0.22% (n=1)
SKQKLSLINTNGSWH 0.22% (n=1)
PRQTLSLVSTNGSWH 0.22% (n=1)
SQQKLSLINTTGSWH 0.22% (n=1)
SQQKLSLINTNGSLH 0.22% (n=1)
PRQTVSLVNTNGSWH 0.22% (n=1)
PRQTL*LVNTNGSWH 0.22% (n=1)
PKQKLTLVNTNGNLH 0.22% (n=1)
SQQQLSLINTNGSLD 0.22% (n=1)
PKQNLNLINTNGSWH 0.22% (n=1)
PTRQINLINTNGSWH 0.22% (n=1)
PSQKFNLINTNGSWH 0.22% (n=1)
AQQRISLINTDGSWH 0.22% (n=1)
PKQKINLIKTNGSWH 0.22% (n=1)
AKQKIQLINTNGSWH 0.22% (n=1)
ARQNLQLINSNGSWH 0.22% (n=1)
PAQKLSLINTNGSWH 0.22% (n=1)
PQQRLSLINTNGSWH 0.22% (n=1)
PQQRINLVNTNGSWH 0.22% (n=1)
PQQKIALINTNGSWH 0.22% (n=1)
SRQKLSLINTNGSWH 0.22% (n=1)
PSQTINLIHTNGSWH 0.22% (n=1)
PSQTLSLIHTNGSWH 0.22% (n=1)
PSQTINLIYTNGSWH 0.22% (n=1)
ARQQLMLINSNGSWH 0.22% (n=1)
PQQKISLINTNGSWH 0.22% (n=1)
AQQPLSLINTNGSWH 0.22% (n=1)
SKQKISLINTNGSWH 0.22% (n=1)
PKQNLALINTNGSWH 0.22% (n=1)
SRQRLSLINTNGSWH 0.22% (n=1)
-------------W- 0.22% (n=1)
PQQKISLIKENGSWH 0.22% (n=1)
PQQNLQLINTNGSWH 0.22% (n=1)
PSQKLALINTNGSWH 0.22% (n=1)
SKQNVHLINTNGSWH 0.22% (n=1)
PNQRISLINTNGSWH 0.22% (n=1)
ARQQISLINTNGSWH 0.22% (n=1)
AQQRLSLINTNGSWH 0.22% (n=1)
GKQDIMLINTNGSWH 0.22% (n=1)
PSQHISLMNTNGSWH 0.22% (n=1)
PSQQLSLINTNGSWH 0.22% (n=1)
PKQTISLINTNGSWH 0.22% (n=1)
PQQPLSLINTNGSWH 0.22% (n=1)
PHQRLSLINTNGSWH 0.22% (n=1)
PQQRIHLVNSNGSWH 0.22% (n=1)
PQQRIQLVNSNGSWH 0.22% (n=1)
PKQKLSLINTNGSWH 0.22% (n=1)
PQQTISLIHTNGSWH 0.22% (n=1)
ARQRISLINTNGSWH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 2c:

SRQNIQLINSNGSWH 32.38% (n=147)
AKQHIQLIHNNGSWH 15.64% (n=71)
AKQHIQLIHSNGSWH 15.64% (n=71)
AKQHIQLIHTNGSWH 8.15% (n=37)
ARQHIQLIHTNGSWH 4.41% (n=20)
AKQRIQLIHTNGSWH 2.64% (n=12)
ARQHIQLIHSNGSWH 2.42% (n=11)
ARQHIQLIHNNGSWH 1.54% (n=7)
PQQRLQLINTNGSWH 1.32% (n=6)
AKQHIQLIRNNGSWH 0.66% (n=3)
SRQNIQLIHTNGSWH 0.66% (n=3)
SRQDIQLINSNGSWH 0.66% (n=3)
AKQNIQLIHTNGSWH 0.44% (n=2)
ARQRIQLIHNNGSWH 0.44% (n=2)
PSQRIQLIHTNGSWH 0.44% (n=2)
PKQHIQLIHTNGSWH 0.44% (n=2)
PQQKIQLIHTNGSWH 0.44% (n=2)
AQQRIQLIHTNGSWH 0.44% (n=2)
PSQRIQLIHSNGSWH 0.22% (n=1)
PQQQIQLINTNGSWH 0.22% (n=1)
SSQNIQLINTNGSWH 0.22% (n=1)
PQQNIQLIN------ 0.22% (n=1)
SQQRVQLIHTNGSWH 0.22% (n=1)
AKQHIQLIYNNGSWH 0.22% (n=1)
ARQHIQLTHTNGSWH 0.22% (n=1)
SKQNIQLIHTNGSWH 0.22% (n=1)
PKQRIQLVNTNGSWH 0.22% (n=1)
LQQRIQLIHTNGSWH 0.22% (n=1)
PQQRIQLIHTNGSWH 0.22% (n=1)
PQQKIQLVKTNGSWH 0.22% (n=1)
ARQNIQLINTNGSWH 0.22% (n=1)
PQQKIQLINTNGSWH 0.22% (n=1)
SKQHIQLINTNGSWH 0.22% (n=1)
PQQTIQLIHTNGSWH 0.22% (n=1)
PRQHIQLIYTNGSWH 0.22% (n=1)
PNQKLQLIHTNGSWH 0.22% (n=1)
ARQSIQLIHTNGSWH 0.22% (n=1)
PKQRIQLVNANGSWH 0.22% (n=1)
SQQKIQLIHTNGSWH 0.22% (n=1)
PNQNIQLIHTNGSWH 0.22% (n=1)
SQQRIQLIRTNGSWH 0.22% (n=1)
PQQRIQLINSNGSWH 0.22% (n=1)
PKQRIQLINTNGSWH 0.22% (n=1)
PNQRIQLISTNGSWH 0.22% (n=1)
SNQKIQLIHTNGSWH 0.22% (n=1)
SRQHIQLIHTNGSWH 0.22% (n=1)
AKQAIQLIYTNGSWH 0.22% (n=1)
ARQHIQLINTNGSWH 0.22% (n=1)
PRQNIQLINSNGSWH 0.22% (n=1)
PNQRLELVNTNGSWH 0.22% (n=1)
ARQRIQLINTNGSWH 0.22% (n=1)
PQQRLQLIYTNGSWH 0.22% (n=1)
SQQQIQLINTNGSWH 0.22% (n=1)
PKQRIQLIHTNGSWH 0.22% (n=1)
PKQNIQLINTNGSWH 0.22% (n=1)
AQQHIQLIHTNGSWH 0.22% (n=1)
ARQKIQLINDNGTWH 0.22% (n=1)
PKQNIQLIHTNGSWH 0.22% (n=1)
PRQTIQLINTNGSWH 0.22% (n=1)
PQQRIQLIHSNGSWH 0.22% (n=1)
SQQNVQLINTNGSWH 0.22% (n=1)
SRQNI*LINSNGSWH 0.22% (n=1)
SRQNIRLINSNGSWH 0.22% (n=1)
SRQNTQLINSNGSWH 0.22% (n=1)
SRQNIHLINSNGSWH 0.22% (n=1)
SRQNIQLINSDGSWH 0.22% (n=1)
AQQKIQLIHTNGSWH 0.22% (n=1)
ARQKIQLIHTNGSWH 0.22% (n=1)
PSQRIQLIYTNGSWH 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 3:

AQQKLQLVNTNGSWH 9.10% (n=357)
PQQKLQLVRTNGSWH 8.03% (n=315)
ASQKLELINTNGSWH 6.86% (n=269)
PRQNLQLINTNGSWH 6.50% (n=255)
AKQKLQLVNTNGSWH 6.02% (n=236)
ARQNLQLVNTNGSWH 5.56% (n=218)
AKQNLQLVNTNGSWH 4.72% (n=185)
ANQKLQLVNTNGSWH 3.72% (n=146)
AQQKIQLVNSNGSWH 2.40% (n=94)
PRQNLHLVNSNGSWH 1.94% (n=76)
PKQNLQLVNTNGSWH 1.91% (n=75)
SRQNIQLINSNGSWH 1.89% (n=74)
AQQRLQLVNTNGSWH 1.38% (n=54)
AKQNLQLINTNGSWH 1.30% (n=51)
ARQNLQLIYTNGSWH 1.25% (n=49)
PRQNLQLVNTNGSWH 1.15% (n=45)
PKQNLHLVNSNGSWH 1.10% (n=43)
PKQNLQLINTNGSWH 1.02% (n=40)
ARQKLQLINTNGSWH 0.99% (n=39)
PSQNLHLVNSNGSWH 0.99% (n=39)
ARQNLQLINTNGSWH 0.92% (n=36)
ANQRLELINTNGSWH 0.89% (n=35)
AQQNLQLVNTNGSWH 0.87% (n=34)
ASQNLELINTNGSWH 0.82% (n=32)
AKQKLQLVNTNGSWY 0.82% (n=32)
SRQNLQLVNTNGSWH 0.82% (n=32)
AQQKLQLINTNGSWH 0.74% (n=29)
ANQKLELINTNGSWH 0.74% (n=29)
PSQNLHLVNTNGSWH 0.74% (n=29)
ARQNLHLVNSNGSWH 0.71% (n=28)
PQQKLQLINTNGSWH 0.66% (n=26)
ASQKLQLVNTNGSWH 0.66% (n=26)
ASQNLQLIYTNGSWH 0.64% (n=25)
ASQNLQLIETQGSWH 0.61% (n=24)
PSQNLQLVNSNGSWH 0.56% (n=22)
ARQKLQLVNTNGSWH 0.54% (n=21)
PQQKLQLVNTNGSWH 0.51% (n=20)
AQQKLELVNTNGSWH 0.48% (n=19)
ASQNLQLINTNGSWH 0.43% (n=17)
ASQKLQLINTNGSWH 0.41% (n=16)
PSQSLHLVNSNGSWH 0.38% (n=15)
PSQNLQLVNTNGSWH 0.36% (n=14)
AQQKLHLVNTNGSWH 0.36% (n=14)
ARQSLQLIYTNGSWH 0.36% (n=14)
--------NTNGSWH 0.36% (n=14)
PKQNLQLVNSNGSWH 0.36% (n=14)
PSQKLHLVNSNGSWH 0.31% (n=12)
ANQNLQLIYTNGSWH 0.28% (n=11)
PSQKLQLVNTNGSWH 0.25% (n=10)
ASQNLQLVNTNGSWH 0.23% (n=9)
PNQDLQLINTNGSWH 0.23% (n=9)
PNQNLQLINTNGSWH 0.23% (n=9)
AKQNLQLVNSNGSWH 0.23% (n=9)
PQQNLHLVNSNGSWH 0.23% (n=9)
PNQKLQLVNTNGSWH 0.20% (n=8)
PKQKLQLVNANGSWH 0.20% (n=8)
SKQNLQLVNTNGSWH 0.20% (n=8)
AQQNLQLINTNGSWH 0.20% (n=8)
PQQNLQLVNSNGSWH 0.20% (n=8)
PRQSLHLVNSNGSWH 0.20% (n=8)
AKQKLQLINTNGSWH 0.18% (n=7)
AKQNLQLINSNGSWH 0.18% (n=7)
AQQKLQLVHTNGSWH 0.18% (n=7)
PQQNLQLVNTNGSWH 0.18% (n=7)
PSQKLQLVNSNGSWH 0.18% (n=7)
AKQKLQLVYTNGSWH 0.15% (n=6)
SKQNLQLINTNGSWH 0.15% (n=6)
PKQKLQLINTNGSWH 0.15% (n=6)
SRQNLQLINTNGSWH 0.15% (n=6)
PRQNLQLVNSNGSWH 0.15% (n=6)
SNQKLQLVNTNGSWH 0.13% (n=5)
AQQNLQLVNSNGSWH 0.13% (n=5)
ARQNLQLINSNGSWH 0.13% (n=5)
ANQNLQLVNTNGSWH 0.13% (n=5)
PNQNLQLVNTNGSWH 0.13% (n=5)
AQQK----------- 0.13% (n=5)
PKQDLQLVNTNGSWH 0.10% (n=4)
PQQKLQLVNSNGSWH 0.10% (n=4)
ARQNLQLVNTNGSW- 0.10% (n=4)
PSQNLQLINTNGSWH 0.10% (n=4)
ASQNLQLIETNGSWH 0.10% (n=4)
PQQK----------- 0.10% (n=4)
PKQN----------- 0.10% (n=4)
PKQKLQLVNTNGSWH 0.10% (n=4)
PSQKLQLINTNGSWH 0.10% (n=4)
PQQNLQLINTNGSWH 0.10% (n=4)
ARQNLQLVNSNGSWH 0.10% (n=4)
PKQNLHLVNTNGSWH 0.10% (n=4)
ASQKLELVNTNGSWH 0.10% (n=4)
SKQNLQLVNSNGSWH 0.10% (n=4)
SRQNLQLVNSNGSWH 0.10% (n=4)
ARQRLQLVNTNGSWH 0.08% (n=3)
AQQKLQLVNSNGSWH 0.08% (n=3)
AQQKLQLVSTNGSWH 0.08% (n=3)
PRQNLQLV------- 0.08% (n=3)
PQQKLALINTNGSWH 0.08% (n=3)
PSQTLQLVNTNGSWH 0.08% (n=3)
AKQN----------- 0.08% (n=3)
ASQRLELINTNGSWH 0.08% (n=3)
PKQKIQLINTNGSWH 0.08% (n=3)
ARQKLELVNTNGSWH 0.08% (n=3)
SQQKLQLINTNGSWH 0.08% (n=3)
SNQNLQLVNTNGSWH 0.08% (n=3)
PRQNLHLVNTNGSWH 0.08% (n=3)
PKQKLQLVNSNGSWH 0.08% (n=3)
ANQKLQLINTNGSWH 0.05% (n=2)
PSQSLQLVNTNGSWH 0.05% (n=2)
PNQKLALVNTNGSWH 0.05% (n=2)
ARQNLQLINANGSWH 0.05% (n=2)
ASQKLELINTNGPWH 0.05% (n=2)
ARQNLELINTNGSWH 0.05% (n=2)
AKQNLELINTNGSWH 0.05% (n=2)
TKQKLQLVNTNGSWH 0.05% (n=2)
AKQDLQLVNTNGSWH 0.05% (n=2)
AKQNLQLVNANGSWH 0.05% (n=2)
AQQKLQLVNTNDSWH 0.05% (n=2)
PSQRLQLVNTNGSWH 0.05% (n=2)
AGQKLQLVNTNGSWH 0.05% (n=2)
ARQNLQPVNTNGSWH 0.05% (n=2)
AQRRLQLVNTNGSWH 0.05% (n=2)
ANQRLQLVNTNGSWH 0.05% (n=2)
PQQN----------- 0.05% (n=2)
PRQKLELVNTNGSWH 0.05% (n=2)
PQQRLQLINTNGSWH 0.05% (n=2)
AQQNLQLINSNGSWH 0.05% (n=2)
AKQQLQLVNTNGSWH 0.05% (n=2)
AKQSLQLINTNGSWH 0.05% (n=2)
ARQKLQLVNSNGSWH 0.05% (n=2)
PKQRLQLVNTNGSWH 0.05% (n=2)
PSQNLRLVNTNGSWH 0.05% (n=2)
AKQDLQLINTNGSWH 0.05% (n=2)
PRQKLQLVNSNGSWH 0.05% (n=2)
PSQNLQLINANGSWH 0.05% (n=2)
PKQQLQLINTNGSWH 0.05% (n=2)
AQQNLQLVYTNGSWH 0.05% (n=2)
PRQNLELVNTNGSWH 0.05% (n=2)
AKQNLQLVKTNGSWH 0.05% (n=2)
PRQHLQLVNTNGSWH 0.05% (n=2)
ARQNLQLVNDSGSWH 0.05% (n=2)
ANQKLELVNTNGSWH 0.05% (n=2)
PTQNLQLINTNGSWH 0.05% (n=2)
PKQNLELINTNGSWH 0.05% (n=2)
PSQRLQLVNSNGSWH 0.05% (n=2)
PKQNLQLVHSNGSWH 0.05% (n=2)
PKQNLQLVN------ 0.05% (n=2)
PKQDLRLVNSNGSWH 0.05% (n=2)
PNQNLHLVNSNGSWH 0.05% (n=2)
PKQNLHLVSSNGSWH 0.05% (n=2)
PKQDLHLVNSNGSWH 0.05% (n=2)
PSQDLQLVNANGSWH 0.03% (n=1)
PRQKLQLVHNNGSWH 0.03% (n=1)
ARQNLELVNTNGSWH 0.03% (n=1)
SNQKLQLINTNGSWH 0.03% (n=1)
AQQELQLVNSNGSWH 0.03% (n=1)
AKQNQQLINSNGSWH 0.03% (n=1)
PRQQLQLVNSSGSWH 0.03% (n=1)
ARQNLQLISSNGSWH 0.03% (n=1)
PRQQLQLVNSNGSWH 0.03% (n=1)
ASQKLELINTNDSWH 0.03% (n=1)
ARQKLELINTNGSWH 0.03% (n=1)
AKQKLQLVSTNGSWH 0.03% (n=1)
AKRNLQLVNTNGSWH 0.03% (n=1)
AKQNLQLVDTNGSWH 0.03% (n=1)
AKQNLQLVNTNGPWH 0.03% (n=1)
ARQNLQLVNINGSWH 0.03% (n=1)
AQQKPQLVNTNGPWH 0.03% (n=1)
PQQKLQLINTYGSGH 0.03% (n=1)
PQQKLQLVNTYGSLH 0.03% (n=1)
RHQRLELINTNGSWH 0.03% (n=1)
RLQRLELICTNASWH 0.03% (n=1)
SRQGHELIKTNGSWH 0.03% (n=1)
AKQKLQLVKSNGSWH 0.03% (n=1)
AQQKLQLVNTNGPWH 0.03% (n=1)
ASQDLQLINTNGSWH 0.03% (n=1)
ASQNLQLTNTNGSWH 0.03% (n=1)
PKQNLQLINTNGSRH 0.03% (n=1)
SRQSLQLVNTNGSWH 0.03% (n=1)
ANQNVQLVETKGSWH 0.03% (n=1)
ARQNPQLVNTNGSWH 0.03% (n=1)
ARQSLQLINTNGSWH 0.03% (n=1)
ARQNLRLIYTNGSWH 0.03% (n=1)
AKQELQLVNTNGSWH 0.03% (n=1)
PKQNLQLIDTNGSWH 0.03% (n=1)
PEQRLELINTHGSWH 0.03% (n=1)
AKQTLQLINTNGSWH 0.03% (n=1)
AKQRLQLVNTNGSWH 0.03% (n=1)
AKQWLQLVNTNGSWH 0.03% (n=1)
PHQKLALINTNGSWH 0.03% (n=1)
ASQSLQLIETNGSWH 0.03% (n=1)
AQQKLQLIDTNGSWH 0.03% (n=1)
AHQKLQLVNTNGSWH 0.03% (n=1)
RQQNLQLVNTNGSWH 0.03% (n=1)
AQRRLRLVNTNGSWH 0.03% (n=1)
SKQNVQLINTNGSWH 0.03% (n=1)
AQQNLQLVKTNGSWH 0.03% (n=1)
ASQKLLLVNTNGSWH 0.03% (n=1)
----LELINTHGSWH 0.03% (n=1)
AQPELQLINTNGSWH 0.03% (n=1)
ASQN----------- 0.03% (n=1)
ANQRLQLVNANGSWH 0.03% (n=1)
FPTK----------- 0.03% (n=1)
PKQRLELVNTNGSWH 0.03% (n=1)
PR------------- 0.03% (n=1)
ARQN----------- 0.03% (n=1)
SRQE----------- 0.03% (n=1)
PQH------------ 0.03% (n=1)
AHQK----------- 0.03% (n=1)
PRQ------------ 0.03% (n=1)
PSQK----------- 0.03% (n=1)
VQQN----------- 0.03% (n=1)
PKPK----------- 0.03% (n=1)
SKQN----------- 0.03% (n=1)
PQQR----------- 0.03% (n=1)
AQQN----------- 0.03% (n=1)
PKQNLQLVNANGSWH 0.03% (n=1)
VRQKLQLVNTNGSWH 0.03% (n=1)
PSQNLELINTNGSWH 0.03% (n=1)
AKQNIQLVNTNGSWH 0.03% (n=1)
PRQNLQLVNTSGSWH 0.03% (n=1)
AQQKLQLVNANGSWH 0.03% (n=1)
PQQKLQLVNANGSWH 0.03% (n=1)
AQQKLELINTNGSWH 0.03% (n=1)
AKQELQLINTNGSWH 0.03% (n=1)
SRQKLELVNTNGSWH 0.03% (n=1)
SKQNVQLMKTGDSWH 0.03% (n=1)
SRQELRLVNTNGSWH 0.03% (n=1)
AQQKLQLVDTNGSWH 0.03% (n=1)
PIQKLELVNTNGSWH 0.03% (n=1)
AQQHLQLVNTNGSWH 0.03% (n=1)
SKQKLQLVNTNGSWH 0.03% (n=1)
AKQDLQLVNANGSWH 0.03% (n=1)
PKQSLYLINTNGSWH 0.03% (n=1)
ASQNLQLVNTSGSWH 0.03% (n=1)
AQQKLQLIHTNGSWH 0.03% (n=1)
ARQHLQLVNTNGSWH 0.03% (n=1)
PSQNLQLIETNGSWH 0.03% (n=1)
PKQKLELVNTNGSWH 0.03% (n=1)
SRQDLRLVNTNGSWH 0.03% (n=1)
PKQNLKLVNTNGSWH 0.03% (n=1)
PKQNLQLVSTNGSWH 0.03% (n=1)
PMQRLQLVNTNGSWH 0.03% (n=1)
AQQKLELVYTNGSWH 0.03% (n=1)
ANQKLQLVNSNGSWH 0.03% (n=1)
ARQKLQLVNANGSWH 0.03% (n=1)
SRQNLQLIYTNGSWH 0.03% (n=1)
PKQHLQLINTNGSWH 0.03% (n=1)
ARQPLQLVNSNGSWH 0.03% (n=1)
ARQKLELIKTNGSWH 0.03% (n=1)
PSQSLKLINTNGSWH 0.03% (n=1)
PQQKLQLVDTNGSWH 0.03% (n=1)
ASQSLQLVNTNGSWH 0.03% (n=1)
PKQNLQLVHTNGSWH 0.03% (n=1)
ASQQLQLINTNGSWH 0.03% (n=1)
AQQSLQLVNTNGSWH 0.03% (n=1)
AKQSLQLINSNGSWH 0.03% (n=1)
ANQKLQLIHTNGSWH 0.03% (n=1)
PSQELQLVNTNGSWH 0.03% (n=1)
ASQKLQLINSNGSWH 0.03% (n=1)
SKQNLQLISTNGSWH 0.03% (n=1)
AKQKLELVNTNGSWH 0.03% (n=1)
SSQNLQLIQTNGSWH 0.03% (n=1)
SQQKLELVNTNGSWH 0.03% (n=1)
PSQKLELVNTNGSWH 0.03% (n=1)
ARQHLQLIKTNNSWH 0.03% (n=1)
PQQQLQLINTNGSWH 0.03% (n=1)
SKQNLQLINSSGSWH 0.03% (n=1)
PHQNLQLVNTNGSWH 0.03% (n=1)
PQQKLELVNTNGSWH 0.03% (n=1)
AKQQLQLVETNGSWH 0.03% (n=1)
PKQNLELVNTNGSWH 0.03% (n=1)
PRQNLQLIHTNGSWH 0.03% (n=1)
PQQKLELIHTNGSWH 0.03% (n=1)
ARQNIQLVNTNGSWH 0.03% (n=1)
SKQNLQLIYTNGSWH 0.03% (n=1)
AKQNLELVNTNGSWH 0.03% (n=1)
PRQKIQLVNTNGSWH 0.03% (n=1)
AKQRLELVNTNGSWH 0.03% (n=1)
PNQKLQLVNANGSWH 0.03% (n=1)
SQQRLQLVNSNGSWH 0.03% (n=1)
ANQPLQLINTNGSWH 0.03% (n=1)
PQQNLQLINDNGSWH 0.03% (n=1)
PKQNLQLINSNGSWH 0.03% (n=1)
PSQRLHLVNTNGSWH 0.03% (n=1)
SSQNLQLIYTNGSWH 0.03% (n=1)
AKQKLNLINTNGSWH 0.03% (n=1)
PNQKLHLVNTNGSWH 0.03% (n=1)
SRQNLQLVNKNGSWH 0.03% (n=1)
SRQNLQLVKSNGSWH 0.03% (n=1)
AHQNLQLINTNGSWH 0.03% (n=1)
AKQNLQLVNTSGSWH 0.03% (n=1)
PQQNLRLVNTNGSWH 0.03% (n=1)
ASQKIELINTNGSWH 0.03% (n=1)
PRQNLELINTNGSWH 0.03% (n=1)
AKQVLQLVNTNGSWH 0.03% (n=1)
SSQKLQLINTNGSWH 0.03% (n=1)
PKQNIQLINTNGSWH 0.03% (n=1)
AQQDLQLINTNGSWH 0.03% (n=1)
ARQKLELINTDGSWH 0.03% (n=1)
SQQNLQLINTNGSWH 0.03% (n=1)
SKQDLQLINTNGSWH 0.03% (n=1)
SQQNLQLVNNNGSWH 0.03% (n=1)
PQQNLELINTNGSWH 0.03% (n=1)
AQQKLELIETNGSWH 0.03% (n=1)
PQQNLQLINSNGSWH 0.03% (n=1)
PQQKLELVNANGSWH 0.03% (n=1)
PRQKLQLVNTNGSWH 0.03% (n=1)
PGQKLQLVYTNGSWH 0.03% (n=1)
AQQNLQLVNTDGSWH 0.03% (n=1)
PNQKLQLVNSNGSWH 0.03% (n=1)
PKQELRLVNTNGSWH 0.03% (n=1)
ANQQLQLINTNGSWH 0.03% (n=1)
ARQNLQLVETNGSWH 0.03% (n=1)
AQQKLQLVETNGSWH 0.03% (n=1)
AKQNLQLIETNGSWH 0.03% (n=1)
AAQNLKLINTNGSWH 0.03% (n=1)
PSQKLELMNTNGSWH 0.03% (n=1)
PAQNLQLVNTNGSWH 0.03% (n=1)
ARQPLQLVKTNGSWH 0.03% (n=1)
PSQSLQLVNSNGSWH 0.03% (n=1)
ANQKL---------- 0.03% (n=1)
PQQKLQLVKTNGSWH 0.03% (n=1)
PSQKLQLVNSNGS-- 0.03% (n=1)
SQQNLQLVN------ 0.03% (n=1)
PSQNLQLVN------ 0.03% (n=1)
PQQKLHLVNTNGSWH 0.03% (n=1)
PKQSLHLVNSNGSWH 0.03% (n=1)
SQQNLQLVNSNGSWH 0.03% (n=1)
PVQKLHLVNSNGSWH 0.03% (n=1)
PSQQLHLVESNGSWH 0.03% (n=1)
PKQSLQLVNSNGSWH 0.03% (n=1)
PSQELQLVNSNGSWH 0.03% (n=1)
AKQNLHLIETNGSWH 0.03% (n=1)
SKQNLHLVNSNGSWH 0.03% (n=1)
PAQNLKLVNTNGSWH 0.03% (n=1)
PNQNLDLVYTNGSWH 0.03% (n=1)
PTQNLNLVNTNGSWH 0.03% (n=1)
PKQKLNLVNSNGSWH 0.03% (n=1)
PSQDLQLVNSNGSWH 0.03% (n=1)
PRQNLRLVNSNGSWH 0.03% (n=1)
SRQNLNLVNSNGSWH 0.03% (n=1)
PKQDLQLVNSNGSWH 0.03% (n=1)
PKQNLNLVNSNGSWH 0.03% (n=1)
AKQALHLVNTNGSWH 0.03% (n=1)
PSQDLHLVNSNGSWH 0.03% (n=1)
PQQKLNLVNSNGSWH 0.03% (n=1)
PRQNLHLVNSNGSRH 0.03% (n=1)
PKQSLSLVNTNGSWH 0.03% (n=1)
PSQNLQLMNTNGSWH 0.03% (n=1)
PKQQLHLVNSNGSWH 0.03% (n=1)
PSQNLQLVHSNGSWH 0.03% (n=1)
PAQKLHLVNSNGSWH 0.03% (n=1)
PQQNLHLVNSSGSWH 0.03% (n=1)
PQQKLHLVNSNGSWH 0.03% (n=1)
PRQDLHLVNSNGSWH 0.03% (n=1)
PSQNLNLVNSNGSWH 0.03% (n=1)
PSQNLQLMNSNGSWH 0.03% (n=1)
PSQGLHLVNSNGSWH 0.03% (n=1)
PKQNLQLMESNGSWH 0.03% (n=1)
PTQHLNLVNSNGSWH 0.03% (n=1)
SRQNLQLTNSNGSWH 0.03% (n=1)
PKQTIQLV------- 0.03% (n=1)
PSQNLQLIN------ 0.03% (n=1)
AAQRIQLIN------ 0.03% (n=1)
AAQRIQLINTNGSWH 0.03% (n=1)
ARQQLQLV------- 0.03% (n=1)
PAQKLQLVNTNGSWH 0.03% (n=1)
PRQTLQLINTNGSWH 0.03% (n=1)
PAQQIQLVNSNGSWH 0.03% (n=1)
AQQKIQLVDSNGSWH 0.03% (n=1)
AQQKIQLVSSNGSWH 0.03% (n=1)
AQQKIQLVYSNGSWH 0.03% (n=1)
AQQKIQLVNSNGFWH 0.03% (n=1)
AQQKIQLINSNGSWH 0.03% (n=1)
AQQNIQLINSNGSWH 0.03% (n=1)
ARQQLQLVNTNGSWH 0.03% (n=1)
PKQNIQLIN------ 0.03% (n=1)
AKQPLHLVN------ 0.03% (n=1)
ARQNLQLVN------ 0.03% (n=1)
SNQNLQLVN------ 0.03% (n=1)
PKQHIQLIN------ 0.03% (n=1)
AKQPLHLVNTNGSWH 0.03% (n=1)
SRQNLHLVNTNGSWH 0.03% (n=1)
SKQNLHLINTNGSWH 0.03% (n=1)
PQQKLELVKSNGSWH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 3a:

AQQKLQLVNTNGSWH 10.02% (n=330)
PQQKLQLVRTNGSWH 9.56% (n=315)
ASQKLELINTNGSWH 8.17% (n=269)
PRQNLQLINTNGSWH 7.74% (n=255)
AKQKLQLVNTNGSWH 7.16% (n=236)
ARQNLQLVNTNGSWH 6.56% (n=216)
AKQNLQLVNTNGSWH 5.62% (n=185)
ANQKLQLVNTNGSWH 4.43% (n=146)
PKQNLQLVNTNGSWH 2.16% (n=71)
AQQRLQLVNTNGSWH 1.64% (n=54)
AKQNLQLINTNGSWH 1.55% (n=51)
ARQNLQLIYTNGSWH 1.49% (n=49)
PRQNLQLVNTNGSWH 1.34% (n=44)
PKQNLQLINTNGSWH 1.21% (n=40)
ARQKLQLINTNGSWH 1.18% (n=39)
ARQNLQLINTNGSWH 1.06% (n=35)
ANQRLELINTNGSWH 1.06% (n=35)
AQQNLQLVNTNGSWH 1.03% (n=34)
ASQNLELINTNGSWH 0.97% (n=32)
AKQKLQLVNTNGSWY 0.97% (n=32)
SRQNLQLVNTNGSWH 0.97% (n=32)
AQQKLQLINTNGSWH 0.88% (n=29)
ANQKLELINTNGSWH 0.88% (n=29)
PQQKLQLINTNGSWH 0.79% (n=26)
ASQKLQLVNTNGSWH 0.79% (n=26)
ASQNLQLIYTNGSWH 0.76% (n=25)
ASQNLQLIETQGSWH 0.73% (n=24)
ARQKLQLVNTNGSWH 0.64% (n=21)
PQQKLQLVNTNGSWH 0.61% (n=20)
AQQKLELVNTNGSWH 0.58% (n=19)
ASQNLQLINTNGSWH 0.52% (n=17)
ASQKLQLINTNGSWH 0.49% (n=16)
PSQNLQLVNTNGSWH 0.43% (n=14)
AQQKLHLVNTNGSWH 0.43% (n=14)
ARQSLQLIYTNGSWH 0.43% (n=14)
--------NTNGSWH 0.43% (n=14)
ANQNLQLIYTNGSWH 0.33% (n=11)
PSQKLQLVNTNGSWH 0.30% (n=10)
ASQNLQLVNTNGSWH 0.27% (n=9)
PNQDLQLINTNGSWH 0.27% (n=9)
PNQNLQLINTNGSWH 0.27% (n=9)
PNQKLQLVNTNGSWH 0.24% (n=8)
PKQKLQLVNANGSWH 0.24% (n=8)
AQQNLQLINTNGSWH 0.24% (n=8)
AKQKLQLINTNGSWH 0.21% (n=7)
AKQNLQLINSNGSWH 0.21% (n=7)
AQQKLQLVHTNGSWH 0.21% (n=7)
AKQKLQLVYTNGSWH 0.18% (n=6)
SKQNLQLVNTNGSWH 0.18% (n=6)
PKQKLQLINTNGSWH 0.18% (n=6)
SNQKLQLVNTNGSWH 0.15% (n=5)
AQQNLQLVNSNGSWH 0.15% (n=5)
ARQNLQLINSNGSWH 0.15% (n=5)
ANQNLQLVNTNGSWH 0.15% (n=5)
AQQK----------- 0.15% (n=5)
SRQNLQLINTNGSWH 0.15% (n=5)
AKQNLQLVNSNGSWH 0.15% (n=5)
PKQDLQLVNTNGSWH 0.12% (n=4)
ARQNLQLVNTNGSW- 0.12% (n=4)
PSQNLQLINTNGSWH 0.12% (n=4)
ASQNLQLIETNGSWH 0.12% (n=4)
PNQNLQLVNTNGSWH 0.12% (n=4)
PQQK----------- 0.12% (n=4)
SKQNLQLINTNGSWH 0.12% (n=4)
PKQN----------- 0.12% (n=4)
PKQKLQLVNTNGSWH 0.12% (n=4)
PSQKLQLINTNGSWH 0.12% (n=4)
PQQNLQLINTNGSWH 0.12% (n=4)
ASQKLELVNTNGSWH 0.12% (n=4)
ARQRLQLVNTNGSWH 0.09% (n=3)
AQQKLQLVNSNGSWH 0.09% (n=3)
AQQKLQLVSTNGSWH 0.09% (n=3)
PQQKLALINTNGSWH 0.09% (n=3)
AKQN----------- 0.09% (n=3)
ASQRLELINTNGSWH 0.09% (n=3)
PKQKIQLINTNGSWH 0.09% (n=3)
ARQKLELVNTNGSWH 0.09% (n=3)
SQQKLQLINTNGSWH 0.09% (n=3)
PQQNLQLVNTNGSWH 0.09% (n=3)
SNQNLQLVNTNGSWH 0.09% (n=3)
ANQKLQLINTNGSWH 0.06% (n=2)
PSQSLQLVNTNGSWH 0.06% (n=2)
PQQKLQLVNSNGSWH 0.06% (n=2)
PNQKLALVNTNGSWH 0.06% (n=2)
ARQNLQLINANGSWH 0.06% (n=2)
ASQKLELINTNGPWH 0.06% (n=2)
ARQNLELINTNGSWH 0.06% (n=2)
AKQNLELINTNGSWH 0.06% (n=2)
TKQKLQLVNTNGSWH 0.06% (n=2)
AKQDLQLVNTNGSWH 0.06% (n=2)
AKQNLQLVNANGSWH 0.06% (n=2)
AQQKLQLVNTNDSWH 0.06% (n=2)
PSQRLQLVNTNGSWH 0.06% (n=2)
AGQKLQLVNTNGSWH 0.06% (n=2)
ARQNLQPVNTNGSWH 0.06% (n=2)
PRQNLQLV------- 0.06% (n=2)
AQRRLQLVNTNGSWH 0.06% (n=2)
ANQRLQLVNTNGSWH 0.06% (n=2)
PSQTLQLVNTNGSWH 0.06% (n=2)
PQQN----------- 0.06% (n=2)
PRQKLELVNTNGSWH 0.06% (n=2)
PQQRLQLINTNGSWH 0.06% (n=2)
AQQNLQLINSNGSWH 0.06% (n=2)
AKQQLQLVNTNGSWH 0.06% (n=2)
AKQSLQLINTNGSWH 0.06% (n=2)
ARQKLQLVNSNGSWH 0.06% (n=2)
PKQRLQLVNTNGSWH 0.06% (n=2)
AKQDLQLINTNGSWH 0.06% (n=2)
PSQNLQLINANGSWH 0.06% (n=2)
ARQNLQLVNSNGSWH 0.06% (n=2)
PKQQLQLINTNGSWH 0.06% (n=2)
AQQNLQLVYTNGSWH 0.06% (n=2)
PRQNLELVNTNGSWH 0.06% (n=2)
AKQNLQLVKTNGSWH 0.06% (n=2)
PRQHLQLVNTNGSWH 0.06% (n=2)
ARQNLQLVNDSGSWH 0.06% (n=2)
ANQKLELVNTNGSWH 0.06% (n=2)
PSQNLHLVNTNGSWH 0.06% (n=2)
PKQNLELINTNGSWH 0.06% (n=2)
PSQRLQLVNSNGSWH 0.06% (n=2)
PSQDLQLVNANGSWH 0.03% (n=1)
PRQKLQLVHNNGSWH 0.03% (n=1)
ARQNLELVNTNGSWH 0.03% (n=1)
SNQKLQLINTNGSWH 0.03% (n=1)
AQQELQLVNSNGSWH 0.03% (n=1)
AKQNQQLINSNGSWH 0.03% (n=1)
PRQQLQLVNSSGSWH 0.03% (n=1)
ARQNLQLISSNGSWH 0.03% (n=1)
PRQQLQLVNSNGSWH 0.03% (n=1)
ASQKLELINTNDSWH 0.03% (n=1)
ARQKLELINTNGSWH 0.03% (n=1)
AKQKLQLVSTNGSWH 0.03% (n=1)
AKRNLQLVNTNGSWH 0.03% (n=1)
AKQNLQLVDTNGSWH 0.03% (n=1)
AKQNLQLVNTNGPWH 0.03% (n=1)
ARQNLQLVNINGSWH 0.03% (n=1)
AQQKPQLVNTNGPWH 0.03% (n=1)
PQQKLQLINTYGSGH 0.03% (n=1)
PQQKLQLVNTYGSLH 0.03% (n=1)
RHQRLELINTNGSWH 0.03% (n=1)
RLQRLELICTNASWH 0.03% (n=1)
SRQGHELIKTNGSWH 0.03% (n=1)
AKQKLQLVKSNGSWH 0.03% (n=1)
AQQKLQLVNTNGPWH 0.03% (n=1)
ASQDLQLINTNGSWH 0.03% (n=1)
ASQNLQLTNTNGSWH 0.03% (n=1)
PKQNLQLINTNGSRH 0.03% (n=1)
SRQSLQLVNTNGSWH 0.03% (n=1)
ANQNVQLVETKGSWH 0.03% (n=1)
ARQNPQLVNTNGSWH 0.03% (n=1)
ARQSLQLINTNGSWH 0.03% (n=1)
ARQNLRLIYTNGSWH 0.03% (n=1)
AKQELQLVNTNGSWH 0.03% (n=1)
PKQNLQLIDTNGSWH 0.03% (n=1)
PEQRLELINTHGSWH 0.03% (n=1)
AKQTLQLINTNGSWH 0.03% (n=1)
AKQRLQLVNTNGSWH 0.03% (n=1)
AKQWLQLVNTNGSWH 0.03% (n=1)
PHQKLALINTNGSWH 0.03% (n=1)
ASQSLQLIETNGSWH 0.03% (n=1)
AQQKLQLIDTNGSWH 0.03% (n=1)
AHQKLQLVNTNGSWH 0.03% (n=1)
RQQNLQLVNTNGSWH 0.03% (n=1)
AQRRLRLVNTNGSWH 0.03% (n=1)
SKQNVQLINTNGSWH 0.03% (n=1)
AQQNLQLVKTNGSWH 0.03% (n=1)
ASQKLLLVNTNGSWH 0.03% (n=1)
----LELINTHGSWH 0.03% (n=1)
AQPELQLINTNGSWH 0.03% (n=1)
ASQN----------- 0.03% (n=1)
ANQRLQLVNANGSWH 0.03% (n=1)
FPTK----------- 0.03% (n=1)
PKQRLELVNTNGSWH 0.03% (n=1)
PR------------- 0.03% (n=1)
ARQN----------- 0.03% (n=1)
SRQE----------- 0.03% (n=1)
PQH------------ 0.03% (n=1)
AHQK----------- 0.03% (n=1)
PRQ------------ 0.03% (n=1)
PSQK----------- 0.03% (n=1)
VQQN----------- 0.03% (n=1)
PKPK----------- 0.03% (n=1)
SKQN----------- 0.03% (n=1)
PQQR----------- 0.03% (n=1)
AQQN----------- 0.03% (n=1)
PKQNLQLVNANGSWH 0.03% (n=1)
VRQKLQLVNTNGSWH 0.03% (n=1)
PSQNLELINTNGSWH 0.03% (n=1)
AKQNIQLVNTNGSWH 0.03% (n=1)
PRQNLQLVNTSGSWH 0.03% (n=1)
AQQKLQLVNANGSWH 0.03% (n=1)
PQQKLQLVNANGSWH 0.03% (n=1)
AQQKLELINTNGSWH 0.03% (n=1)
AKQELQLINTNGSWH 0.03% (n=1)
SRQKLELVNTNGSWH 0.03% (n=1)
SKQNVQLMKTGDSWH 0.03% (n=1)
SRQELRLVNTNGSWH 0.03% (n=1)
AQQKLQLVDTNGSWH 0.03% (n=1)
PIQKLELVNTNGSWH 0.03% (n=1)
AQQHLQLVNTNGSWH 0.03% (n=1)
SKQKLQLVNTNGSWH 0.03% (n=1)
AKQDLQLVNANGSWH 0.03% (n=1)
PKQSLYLINTNGSWH 0.03% (n=1)
ASQNLQLVNTSGSWH 0.03% (n=1)
AQQKLQLIHTNGSWH 0.03% (n=1)
PSQNLQLVNSNGSWH 0.03% (n=1)
ARQHLQLVNTNGSWH 0.03% (n=1)
PSQNLQLIETNGSWH 0.03% (n=1)
PSQNLRLVNTNGSWH 0.03% (n=1)
PKQKLELVNTNGSWH 0.03% (n=1)
SRQDLRLVNTNGSWH 0.03% (n=1)
PKQNLKLVNTNGSWH 0.03% (n=1)
PKQNLQLVSTNGSWH 0.03% (n=1)
PMQRLQLVNTNGSWH 0.03% (n=1)
AQQKLELVYTNGSWH 0.03% (n=1)
ANQKLQLVNSNGSWH 0.03% (n=1)
ARQKLQLVNANGSWH 0.03% (n=1)
SRQNLQLIYTNGSWH 0.03% (n=1)
PKQHLQLINTNGSWH 0.03% (n=1)
ARQPLQLVNSNGSWH 0.03% (n=1)
ARQKLELIKTNGSWH 0.03% (n=1)
PSQSLKLINTNGSWH 0.03% (n=1)
PQQKLQLVDTNGSWH 0.03% (n=1)
ASQSLQLVNTNGSWH 0.03% (n=1)
PRQKLQLVNSNGSWH 0.03% (n=1)
PKQNLQLVHTNGSWH 0.03% (n=1)
ASQQLQLINTNGSWH 0.03% (n=1)
AQQSLQLVNTNGSWH 0.03% (n=1)
AKQSLQLINSNGSWH 0.03% (n=1)
ANQKLQLIHTNGSWH 0.03% (n=1)
PSQELQLVNTNGSWH 0.03% (n=1)
ASQKLQLINSNGSWH 0.03% (n=1)
SKQNLQLISTNGSWH 0.03% (n=1)
AKQKLELVNTNGSWH 0.03% (n=1)
SSQNLQLIQTNGSWH 0.03% (n=1)
SQQKLELVNTNGSWH 0.03% (n=1)
PSQKLELVNTNGSWH 0.03% (n=1)
ARQHLQLIKTNNSWH 0.03% (n=1)
PQQQLQLINTNGSWH 0.03% (n=1)
SKQNLQLINSSGSWH 0.03% (n=1)
PHQNLQLVNTNGSWH 0.03% (n=1)
PQQKLELVNTNGSWH 0.03% (n=1)
AKQQLQLVETNGSWH 0.03% (n=1)
PKQNLHLVNTNGSWH 0.03% (n=1)
PKQNLELVNTNGSWH 0.03% (n=1)
PRQNLQLIHTNGSWH 0.03% (n=1)
PQQKLELIHTNGSWH 0.03% (n=1)
ARQNIQLVNTNGSWH 0.03% (n=1)
SKQNLQLIYTNGSWH 0.03% (n=1)
AKQNLELVNTNGSWH 0.03% (n=1)
PRQKIQLVNTNGSWH 0.03% (n=1)
AKQRLELVNTNGSWH 0.03% (n=1)
PNQKLQLVNANGSWH 0.03% (n=1)
SQQRLQLVNSNGSWH 0.03% (n=1)
ANQPLQLINTNGSWH 0.03% (n=1)
PQQNLQLINDNGSWH 0.03% (n=1)
PKQNLQLINSNGSWH 0.03% (n=1)
PTQNLQLINTNGSWH 0.03% (n=1)
PSQRLHLVNTNGSWH 0.03% (n=1)
AKQKLNLINTNGSWH 0.03% (n=1)
PNQKLHLVNTNGSWH 0.03% (n=1)
SRQNLQLVNKNGSWH 0.03% (n=1)
SRQNLQLVKSNGSWH 0.03% (n=1)
AHQNLQLINTNGSWH 0.03% (n=1)
AKQNLQLVNTSGSWH 0.03% (n=1)
PQQNLRLVNTNGSWH 0.03% (n=1)
ASQKIELINTNGSWH 0.03% (n=1)
PRQNLELINTNGSWH 0.03% (n=1)
AKQVLQLVNTNGSWH 0.03% (n=1)
PRQNLHLVNTNGSWH 0.03% (n=1)
PKQKLQLVNSNGSWH 0.03% (n=1)
SSQKLQLINTNGSWH 0.03% (n=1)
PKQNIQLINTNGSWH 0.03% (n=1)
AQQDLQLINTNGSWH 0.03% (n=1)
ARQKLELINTDGSWH 0.03% (n=1)
SQQNLQLINTNGSWH 0.03% (n=1)
SKQDLQLINTNGSWH 0.03% (n=1)
SQQNLQLVNNNGSWH 0.03% (n=1)
PQQNLELINTNGSWH 0.03% (n=1)
PSQKLQLVNSNGSWH 0.03% (n=1)
AQQKLELIETNGSWH 0.03% (n=1)
PQQNLQLINSNGSWH 0.03% (n=1)
PQQKLELVNANGSWH 0.03% (n=1)
PRQKLQLVNTNGSWH 0.03% (n=1)
PGQKLQLVYTNGSWH 0.03% (n=1)
AQQNLQLVNTDGSWH 0.03% (n=1)
PNQKLQLVNSNGSWH 0.03% (n=1)
PKQELRLVNTNGSWH 0.03% (n=1)
ANQQLQLINTNGSWH 0.03% (n=1)
ARQNLQLVETNGSWH 0.03% (n=1)
AQQKLQLVETNGSWH 0.03% (n=1)
AKQNLQLIETNGSWH 0.03% (n=1)
AAQNLKLINTNGSWH 0.03% (n=1)
PSQKLELMNTNGSWH 0.03% (n=1)
PAQNLQLVNTNGSWH 0.03% (n=1)
ARQPLQLVKTNGSWH 0.03% (n=1)
PSQSLQLVNSNGSWH 0.03% (n=1)
ANQKL---------- 0.03% (n=1)
PQQKLQLVKTNGSWH 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 3b:

PRQNLHLVNSNGSWH 19.24% (n=76)
PKQNLHLVNSNGSWH 10.89% (n=43)
PSQNLHLVNSNGSWH 9.87% (n=39)
ARQNLHLVNSNGSWH 7.09% (n=28)
PSQNLHLVNTNGSWH 6.84% (n=27)
PSQNLQLVNSNGSWH 5.32% (n=21)
PSQSLHLVNSNGSWH 3.80% (n=15)
PKQNLQLVNSNGSWH 3.54% (n=14)
PSQKLHLVNSNGSWH 3.04% (n=12)
PQQNLHLVNSNGSWH 2.28% (n=9)
PQQNLQLVNSNGSWH 2.03% (n=8)
PRQSLHLVNSNGSWH 2.03% (n=8)
PSQKLQLVNSNGSWH 1.52% (n=6)
PRQNLQLVNSNGSWH 1.52% (n=6)
SKQNLQLVNSNGSWH 1.01% (n=4)
SRQNLQLVNSNGSWH 1.01% (n=4)
PKQNLHLVNTNGSWH 0.76% (n=3)
AKQNLQLVNSNGSWH 0.76% (n=3)
PKQNLQLVNTNGSWH 0.76% (n=3)
PKQNLQLVHSNGSWH 0.51% (n=2)
PKQNLQLVN------ 0.51% (n=2)
PRQNLHLVNTNGSWH 0.51% (n=2)
PKQDLRLVNSNGSWH 0.51% (n=2)
ARQNLQLVNSNGSWH 0.51% (n=2)
PQQNLQLVNTNGSWH 0.51% (n=2)
PNQNLHLVNSNGSWH 0.51% (n=2)
PKQNLHLVSSNGSWH 0.51% (n=2)
PKQKLQLVNSNGSWH 0.51% (n=2)
PKQDLHLVNSNGSWH 0.51% (n=2)
PQQKLQLVNSNGSWH 0.51% (n=2)
PSQKLQLVNSNGS-- 0.25% (n=1)
SQQNLQLVN------ 0.25% (n=1)
PSQNLQLVN------ 0.25% (n=1)
PQQKLHLVNTNGSWH 0.25% (n=1)
PKQSLHLVNSNGSWH 0.25% (n=1)
SQQNLQLVNSNGSWH 0.25% (n=1)
PVQKLHLVNSNGSWH 0.25% (n=1)
PSQQLHLVESNGSWH 0.25% (n=1)
SKQNLQLVNTNGSWH 0.25% (n=1)
PKQSLQLVNSNGSWH 0.25% (n=1)
PNQNLQLVNTNGSWH 0.25% (n=1)
PSQELQLVNSNGSWH 0.25% (n=1)
AKQNLHLIETNGSWH 0.25% (n=1)
PRQNLQLVNTNGSWH 0.25% (n=1)
SKQNLHLVNSNGSWH 0.25% (n=1)
PAQNLKLVNTNGSWH 0.25% (n=1)
PNQNLDLVYTNGSWH 0.25% (n=1)
PTQNLNLVNTNGSWH 0.25% (n=1)
PKQKLNLVNSNGSWH 0.25% (n=1)
PSQDLQLVNSNGSWH 0.25% (n=1)
PRQNLRLVNSNGSWH 0.25% (n=1)
SRQNLNLVNSNGSWH 0.25% (n=1)
PKQDLQLVNSNGSWH 0.25% (n=1)
PKQNLNLVNSNGSWH 0.25% (n=1)
AKQALHLVNTNGSWH 0.25% (n=1)
PSQNLRLVNTNGSWH 0.25% (n=1)
PSQDLHLVNSNGSWH 0.25% (n=1)
PQQKLNLVNSNGSWH 0.25% (n=1)
PRQNLHLVNSNGSRH 0.25% (n=1)
PKQSLSLVNTNGSWH 0.25% (n=1)
PSQNLQLMNTNGSWH 0.25% (n=1)
PKQQLHLVNSNGSWH 0.25% (n=1)
PSQNLQLVHSNGSWH 0.25% (n=1)
PAQKLHLVNSNGSWH 0.25% (n=1)
PQQNLHLVNSSGSWH 0.25% (n=1)
PQQKLHLVNSNGSWH 0.25% (n=1)
PRQDLHLVNSNGSWH 0.25% (n=1)
PSQNLNLVNSNGSWH 0.25% (n=1)
PSQNLQLMNSNGSWH 0.25% (n=1)
PSQGLHLVNSNGSWH 0.25% (n=1)
PKQNLQLMESNGSWH 0.25% (n=1)
PTQHLNLVNSNGSWH 0.25% (n=1)
SRQNLQLTNSNGSWH 0.25% (n=1)
PRQKLQLVNSNGSWH 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 4:

SQQNVQLINTNGSWH 34.16% (n=261)
SRQNVQLINTNGSWH 8.51% (n=65)
PSQNLGLINTNGSWH 8.12% (n=62)
SQQNLQLINTNGSWH 7.33% (n=56)
SKQNLQLINTNGSWH 6.94% (n=53)
SQQNIQLINTNGSWH 3.80% (n=29)
AQQRIQLVNKNGSWH 3.53% (n=27)
PSQKLHLINSNGSWH 2.49% (n=19)
PKQNLHLINSNGSWH 2.23% (n=17)
SKQNIQLINTNGSWH 2.09% (n=16)
SQQNIQLIHTNGSWH 1.83% (n=14)
SRQNIQLISTNGSWH 1.31% (n=10)
SRQNIQLINTNGSWH 1.05% (n=8)
ARQNLQLINSNGSWH 0.65% (n=5)
AKQNIQLINTNGSWH 0.65% (n=5)
SKQNLQLINSNGSWH 0.52% (n=4)
SQQNVQLIDTNGSWH 0.52% (n=4)
PKQNLQLINTNGSWH 0.52% (n=4)
SQQNLQLINSNGSWH 0.39% (n=3)
AKQNLQLINSNGSWH 0.39% (n=3)
ARQNLQLINTNGSWH 0.39% (n=3)
AQQNLQLINSNGSWH 0.39% (n=3)
PQQKLQLINTNGSWH 0.39% (n=3)
SRQNLQLINTNGSWH 0.39% (n=3)
SRQNIQLTNTNGSWH 0.39% (n=3)
AQQNLQLVNSNGSWH 0.26% (n=2)
AKQNVQLINSNGSWH 0.26% (n=2)
SKQNIQLINSNGSWH 0.26% (n=2)
PKQNIQLINTNGSWH 0.26% (n=2)
PRQNIQLINTNGSWH 0.26% (n=2)
SQQNIQLIYTNGSWH 0.26% (n=2)
SRQNIQLINTGGSWH 0.26% (n=2)
SQQNVQLINSNGSWH 0.13% (n=1)
AKQNLQLINS----- 0.13% (n=1)
AKQNLQLVNSNGSWH 0.13% (n=1)
ASQKLQLVNTNGSWH 0.13% (n=1)
PQQNLQLINSNGSWH 0.13% (n=1)
AQQTLQLVNKNGSWH 0.13% (n=1)
SRQNVQLINSNGSWH 0.13% (n=1)
SAQNLQLINSNGSWH 0.13% (n=1)
AQQRMQLVNKNGSWH 0.13% (n=1)
SRQDVQLINSNGSWH 0.13% (n=1)
PRQNVQLINSNGSWH 0.13% (n=1)
PRQNLQLINSNGSWH 0.13% (n=1)
PKQRIQLVNTNGSWH 0.13% (n=1)
SQQNVQLINTNESWH 0.13% (n=1)
SQQNVQLVNTNGSWH 0.13% (n=1)
GQQHIQLINTNGSWH 0.13% (n=1)
SHQKIQLINTNGSWH 0.13% (n=1)
PSQKLQLINTNGSWH 0.13% (n=1)
SKQNVQLINTNGSWH 0.13% (n=1)
PQQNIQLINTNGSWH 0.13% (n=1)
PRQNIQLINTGGSWH 0.13% (n=1)
PQQEMRLVKTNGSWH 0.13% (n=1)
PQQEIRLVKTNGSWH 0.13% (n=1)
AKQNVQLINTNGSWH 0.13% (n=1)
SRQNIHLINTNGSWH 0.13% (n=1)
SKQNIQLISTNGSWH 0.13% (n=1)
SKQDLQLINTNGSWH 0.13% (n=1)
ASQNLQLINTNGSWH 0.13% (n=1)
PQQRIQLVNSNGSWH 0.13% (n=1)
PTQKIQLVNSNGSWH 0.13% (n=1)
SRQNIMLINTNGSWH 0.13% (n=1)
SMQNIMLINTNGSWH 0.13% (n=1)
PQQKIQLVNTNGSWH 0.13% (n=1)
ARQDLKLINTNGSWH 0.13% (n=1)
PQQQLRLINTNGSWH 0.13% (n=1)
ARQNLQLVNTNGSWH 0.13% (n=1)
PKQNLQLVNTNGSWH 0.13% (n=1)
AKQNLQLIHTNGSWH 0.13% (n=1)
ARQNLQLVNSNGSWH 0.13% (n=1)
ASQNLQLVNTNGSWH 0.13% (n=1)
ARQKIQLVNTNGSWH 0.13% (n=1)
SQQKIQLINTNGSWH 0.13% (n=1)
PKQNIQLVNSNGSWH 0.13% (n=1)
PQQNLQLVNTNGSWH 0.13% (n=1)
SRQNLQLINSNGSWH 0.13% (n=1)
AQQRLQLINTNGSWH 0.13% (n=1)
PKQNLQLINTNGRWH 0.13% (n=1)
PEQNLQLINTNGSWH 0.13% (n=1)
PKQNLQLVNSNGSWH 0.13% (n=1)
PRQHLSLINSNGSWH 0.13% (n=1)
PRQALQLIHTNGSWH 0.13% (n=1)
PQQRLQLINTNGSWH 0.13% (n=1)
PNQQLQLVNSNGSWH 0.13% (n=1)
PQQRVQLINTNGSWH 0.13% (n=1)
PQQKLQLINSNGSWH 0.13% (n=1)
PSQNLHLVNSNGSWH 0.13% (n=1)
PRQDLQLINTNGSWH 0.13% (n=1)
AKQNLQLVNTNGSWH 0.13% (n=1)
PKQNLRLINTNGSWH 0.13% (n=1)
AKQNLRLINTNGSWH 0.13% (n=1)
AKQNLQLINTNGSWH 0.13% (n=1)
AKQPLQLINTNGSWH 0.13% (n=1)
GRQDIRLINTNGSWH 0.13% (n=1)
PRQKLQLIHTNGSWH 0.13% (n=1)
PKQDIKLVNSNGSWH 0.13% (n=1)
AKQSLQLIDTNGSWH 0.13% (n=1)
PRQNLQLINTNGSWH 0.13% (n=1)
AKQNIQLVNTNGSWH 0.13% (n=1)
PQQNLRLVNTNGSWH 0.13% (n=1)
AKQDVQLINTNGSWH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 4a:

PSQNLGLINTNGSWH 38.75% (n=62)
AQQRIQLVNKNGSWH 16.88% (n=27)
PSQKLHLINSNGSWH 11.88% (n=19)
PKQNLHLINSNGSWH 10.63% (n=17)
SKQNLQLINSNGSWH 2.50% (n=4)
ARQNLQLINSNGSWH 2.50% (n=4)
SQQNLQLINSNGSWH 1.88% (n=3)
AKQNLQLINSNGSWH 1.25% (n=2)
AQQNLQLINSNGSWH 1.25% (n=2)
PQQKLQLINTNGSWH 1.25% (n=2)
AQQNLQLVNSNGSWH 1.25% (n=2)
AKQNVQLINSNGSWH 1.25% (n=2)
SQQNVQLINSNGSWH 0.63% (n=1)
AKQNLQLINS----- 0.63% (n=1)
AKQNLQLVNSNGSWH 0.63% (n=1)
ASQKLQLVNTNGSWH 0.63% (n=1)
PQQNLQLINSNGSWH 0.63% (n=1)
ARQNLQLINTNGSWH 0.63% (n=1)
AQQTLQLVNKNGSWH 0.63% (n=1)
SRQNVQLINSNGSWH 0.63% (n=1)
SAQNLQLINSNGSWH 0.63% (n=1)
AQQRMQLVNKNGSWH 0.63% (n=1)
SRQDVQLINSNGSWH 0.63% (n=1)
PRQNVQLINSNGSWH 0.63% (n=1)
PRQNLQLINSNGSWH 0.63% (n=1)
SKQNIQLINSNGSWH 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 4d:

SQQNVQLINTNGSWH 48.15% (n=261)
SRQNVQLINTNGSWH 11.99% (n=65)
SQQNLQLINTNGSWH 10.33% (n=56)
SKQNLQLINTNGSWH 9.59% (n=52)
SQQNIQLINTNGSWH 5.35% (n=29)
SKQNIQLINTNGSWH 2.95% (n=16)
SQQNIQLIHTNGSWH 2.58% (n=14)
SRQNIQLISTNGSWH 1.85% (n=10)
SRQNIQLINTNGSWH 1.11% (n=6)
SQQNVQLIDTNGSWH 0.74% (n=4)
AKQNIQLINTNGSWH 0.55% (n=3)
SRQNIQLTNTNGSWH 0.55% (n=3)
PRQNIQLINTNGSWH 0.37% (n=2)
SQQNIQLIYTNGSWH 0.37% (n=2)
SRQNIQLINTGGSWH 0.37% (n=2)
SQQNVQLINTNESWH 0.18% (n=1)
SQQNVQLVNTNGSWH 0.18% (n=1)
GQQHIQLINTNGSWH 0.18% (n=1)
SHQKIQLINTNGSWH 0.18% (n=1)
PSQKLQLINTNGSWH 0.18% (n=1)
SRQNLQLINTNGSWH 0.18% (n=1)
PKQNIQLINTNGSWH 0.18% (n=1)
SKQNVQLINTNGSWH 0.18% (n=1)
PQQNIQLINTNGSWH 0.18% (n=1)
PRQNIQLINTGGSWH 0.18% (n=1)
PQQEMRLVKTNGSWH 0.18% (n=1)
PQQEIRLVKTNGSWH 0.18% (n=1)
SKQNIQLINSNGSWH 0.18% (n=1)
AKQNVQLINTNGSWH 0.18% (n=1)
SRQNIHLINTNGSWH 0.18% (n=1)
SKQNIQLISTNGSWH 0.18% (n=1)
SKQDLQLINTNGSWH 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 5:

PQQNLQLINTNGSWH 6.04% (n=9)
AKQNLQLINTNGSWH 5.37% (n=8)
AKQDLQLINTNGSWH 4.03% (n=6)
PSQNLQLINTNGSWH 4.03% (n=6)
ARQNLQLINTNGSWH 4.03% (n=6)
PQQKLQLINTNGSWH 3.36% (n=5)
SQQNLQLINTNGSWH 3.36% (n=5)
ANQPLQLIHSNGSWH 2.68% (n=4)
SRQNLQLINTNGSWH 2.68% (n=4)
PKQNLQLINTNGSWH 2.68% (n=4)
PKQNLQ--------- 2.01% (n=3)
AQQKLQLINTNGSWH 2.01% (n=3)
PRQNLQLINTNGSWH 2.01% (n=3)
PSQRLQLINTNGSWH 2.01% (n=3)
PQQNL---------- 1.34% (n=2)
PSQNLQ--------- 1.34% (n=2)
SKQNLQLINTNGSWH 1.34% (n=2)
PRQKLQLINTNGSWH 1.34% (n=2)
ARQPLQLVNTNGSWH 1.34% (n=2)
AQQNLQLINTNGSWH 1.34% (n=2)
ARQNLQLVNTNGSWH 1.34% (n=2)
PAQNLQLINTNGSWH 1.34% (n=2)
PQRQLQFVNTNGSWH 1.34% (n=2)
AKQNIQLINSNGSWH 0.67% (n=1)
PKQNIQ--------- 0.67% (n=1)
SAQNVQ--------- 0.67% (n=1)
PSQN----------- 0.67% (n=1)
PKQDL---------- 0.67% (n=1)
PKQHLQ--------- 0.67% (n=1)
AKQN----------- 0.67% (n=1)
PKQNLQL-------- 0.67% (n=1)
ARQNLQLISTNGSWH 0.67% (n=1)
ARQQLQLINSNGSWH 0.67% (n=1)
PSQNLQLINTSGSWH 0.67% (n=1)
PRQQLQLINTNGSWH 0.67% (n=1)
ARQNLQLINNQGSWH 0.67% (n=1)
PQQHLQLINTNGSWH 0.67% (n=1)
SQQNLQLINNQGSWH 0.67% (n=1)
PSQSLQLMKTNGSWH 0.67% (n=1)
SQQKLQLINTNGSWH 0.67% (n=1)
ARQKLQLISTNGSWH 0.67% (n=1)
PSQNLQIINTNGSWH 0.67% (n=1)
AQQ------------ 0.67% (n=1)
SHQHLQLINTNGSCH 0.67% (n=1)
PQQQLQLINTNGSWH 0.67% (n=1)
PKQRLQLINTNGSWH 0.67% (n=1)
AKQDLQLIRTNGSWH 0.67% (n=1)
PQQKLQLINSNGSWH 0.67% (n=1)
PQQKLQLISTNGSWH 0.67% (n=1)
AKAELQLINTNGSWH 0.67% (n=1)
AKQKLQLINTNGSWH 0.67% (n=1)
AHQKLELINTNGSWH 0.67% (n=1)
PSQKLQLINTNGSWH 0.67% (n=1)
PQQKLQLVHTNGSWH 0.67% (n=1)
PQQNLQLIRTNGSWH 0.67% (n=1)
AKQDLRLMKTGESWH 0.67% (n=1)
SKQPLQLVKTNGA-- 0.67% (n=1)
AKQNLQLVNSNGSWH 0.67% (n=1)
SQAESAAHNTNGSWH 0.67% (n=1)
PNQNLQLINTNGSWH 0.67% (n=1)
PYQNLQLINTNGSWH 0.67% (n=1)
PTQELQLINTNGSWH 0.67% (n=1)
PAQQLQLVNTNGSWH 0.67% (n=1)
PSQKLQLMNSNGSWH 0.67% (n=1)
PQQKLQLINTNGSWY 0.67% (n=1)
SKQNLQLVRSNGSWH 0.67% (n=1)
PKQKLQLIKTNGSWH 0.67% (n=1)
PKQDLQLINTNGSWH 0.67% (n=1)
ASQNLQLINTNGSWH 0.67% (n=1)
PIQNLQLMETNGSWH 0.67% (n=1)
PAQRLQLINTNGSWH 0.67% (n=1)
PSQNLQLIHTNGSWH 0.67% (n=1)
PKQKLQLINTNGSWH 0.67% (n=1)
PQQKLQLVNTNGSWH 0.67% (n=1)
ANQNLQLINSNGSWH 0.67% (n=1)
PKQNIQLIHTNGSWH 0.67% (n=1)
SKQNLQLVNSNGSWH 0.67% (n=1)
PSQKLQLVNTNGSWH 0.67% (n=1)
SHQKLQLINTNGSWH 0.67% (n=1)
AHQNLQLINTNGSWH 0.67% (n=1)
AKQNIQLINTNGSWH 0.67% (n=1)
PKQNLQLIQNGSSWH 0.67% (n=1)
PRQNLQLVNTNGSWH 0.67% (n=1)
PRQNLQLINSNGSWH 0.67% (n=1)
ARQNLQLINSNGSWH 0.67% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 6:

AKQNLQLINTNGSWH 15.80% (n=85)
ARQNLQLINTNGSWH 10.59% (n=57)
PKQNLQLVNTNGSWH 4.09% (n=22)
AKQNLQLVNTNGSWH 3.16% (n=17)
PKQNLQLINTNGSWH 3.16% (n=17)
ARQNLQLVNTNGSWH 2.42% (n=13)
SRQNLQLINTNGSWH 2.23% (n=12)
AKQNIQLINTNGSWH 2.04% (n=11)
SKQNLQLINTNGSWH 2.04% (n=11)
SQQNIQLVNSNGSWH 1.49% (n=8)
PKQNIQLVNSNGSWH 1.49% (n=8)
ARQNIQLINTNGSWH 1.30% (n=7)
PKQNIQLINTNGSWH 1.30% (n=7)
PQQKLQLINTNGSWH 1.12% (n=6)
ARQNIQLVNSNGSWH 1.12% (n=6)
ARQKLQLINTNGSWH 0.93% (n=5)
AQQNIQLINTNGSWH 0.93% (n=5)
SKQNIQLVNSNGSWH 0.93% (n=5)
SRQNIQLVNSNGSWH 0.93% (n=5)
PRQNLQLVNTNGSWH 0.74% (n=4)
PQQKLQLVNTNGSWH 0.74% (n=4)
PQQNLQLINTNGSWH 0.74% (n=4)
PRQNLQLINTNGSWH 0.74% (n=4)
PKQNLQLINSNGSWH 0.74% (n=4)
SKQNIQLMNTNGSWH 0.74% (n=4)
SRQNIQLINSNGSWH 0.74% (n=4)
ARQNIQLINSNGSWH 0.74% (n=4)
PRQNLQLIN------ 0.56% (n=3)
ARQNLQLIN------ 0.56% (n=3)
AKQNLQLINSNGSWH 0.56% (n=3)
AQQNLQLINTNGSWH 0.56% (n=3)
PKQSLQLVNTNGSWH 0.56% (n=3)
PSQKLQLINTNGSWH 0.56% (n=3)
ARQNLQLINSNGSWH 0.56% (n=3)
PQQNLQLVNTNGSWH 0.56% (n=3)
SKQNIQLINTNGSWH 0.56% (n=3)
AKQNIQLIYTNGSWH 0.56% (n=3)
PNQKIQLINTNGSWH 0.56% (n=3)
SKQNLQLVNSNGSWH 0.56% (n=3)
SQQNLQLINSNGSWH 0.56% (n=3)
SKQNLQLINSNGSWH 0.56% (n=3)
AKQNIQLMNTNGSWH 0.56% (n=3)
AKQNIQLINSNGSWH 0.56% (n=3)
SQQNLQLINTNGSWH 0.56% (n=3)
PQQNLQLIN------ 0.37% (n=2)
PSQNLQLINTNGSWH 0.37% (n=2)
PKQNLHLVNTNGSWH 0.37% (n=2)
PKQNLQLVNSNGSWH 0.37% (n=2)
SRQNLQLINSNGSWH 0.37% (n=2)
SQQNLQLVN------ 0.37% (n=2)
SQQKLQLVNTNGSWH 0.37% (n=2)
SRQNLQLVNSNGSWH 0.37% (n=2)
PQQRLQLIN------ 0.37% (n=2)
AQQNIQLIN------ 0.37% (n=2)
GKQNIQLINSNGSWH 0.37% (n=2)
SQQNIQLVNTNGSWH 0.37% (n=2)
SKQNIQLVNTNGSWH 0.37% (n=2)
SRQNIQLINTNGSWH 0.37% (n=2)
SAQKLQLINTNGSWH 0.37% (n=2)
SAQNLQLINTNGSWH 0.37% (n=2)
SRQNLQLVNTNGSWH 0.37% (n=2)
ASQNLQLIKNGSSWH 0.19% (n=1)
AKQNLQLIN------ 0.19% (n=1)
AKQNLQLIKSNGSWH 0.19% (n=1)
ARQSIQLINTKGSWH 0.19% (n=1)
PKQKLQLVHTNGSWH 0.19% (n=1)
PKQTLQLINTNGSWH 0.19% (n=1)
PKQGLQLVNTNGSWH 0.19% (n=1)
PRQNLQLVHTNGSWH 0.19% (n=1)
PQQKLHLVNTNGSWH 0.19% (n=1)
PSQKLHLVNTNGSWH 0.19% (n=1)
PQQNVQLINTNGSWH 0.19% (n=1)
ASQKLQLINTNGSWH 0.19% (n=1)
PKQKLQLINSNGSWH 0.19% (n=1)
ARQNIQLVNTNGSWH 0.19% (n=1)
AKQNLQLVRTNGSWH 0.19% (n=1)
AKQDLQLINTNGSWH 0.19% (n=1)
AKQNLQLICTNGSWH 0.19% (n=1)
ARQNLHLINTNGSWH 0.19% (n=1)
AKQKLQLINTNGSWH 0.19% (n=1)
ASQNLQLINTNGSWH 0.19% (n=1)
AMQNLQLVNTNGSWH 0.19% (n=1)
SKQNLQLVNTNGSWH 0.19% (n=1)
PKQTLQLIHTNGSWH 0.19% (n=1)
PRQKLQLINTNGSWH 0.19% (n=1)
PSQTIQLINSNGSWH 0.19% (n=1)
PKQKLQLVNNNGSWH 0.19% (n=1)
PKQNLHLVNTSGSWH 0.19% (n=1)
PKQNLQLVHANGSWH 0.19% (n=1)
ASQNLQLIYSNGSWH 0.19% (n=1)
PQQNLQLIKTNGSWH 0.19% (n=1)
PSQNLQLVNKNGSWH 0.19% (n=1)
ANQNLQLINTNGRWH 0.19% (n=1)
AKQNLQLINTNGSRH 0.19% (n=1)
SRQNIQFINTNGSWH 0.19% (n=1)
SKQNIQLVKTNGSWH 0.19% (n=1)
PSQRLQLINSNGSWH 0.19% (n=1)
PNQNIQLINTNGSWH 0.19% (n=1)
PRQNLQLVNSNGSWH 0.19% (n=1)
AKQNVQLINTNGSWH 0.19% (n=1)
ARQTLQLINTNGSWH 0.19% (n=1)
PSQNIQLINSNGSWH 0.19% (n=1)
AQQKLQLINTNGSWH 0.19% (n=1)
PNQKIQLIN------ 0.19% (n=1)
ASQKLQLVN------ 0.19% (n=1)
ASQKLQLVNTNGSWH 0.19% (n=1)
AKQNIHLINTNGSWH 0.19% (n=1)
AKQNIHLIN------ 0.19% (n=1)
PQQNLQLVN------ 0.19% (n=1)
AKQNLQLVN------ 0.19% (n=1)
PSQRLQLVNTNGSWH 0.19% (n=1)
SKQHLQLVNTNGSWH 0.19% (n=1)
PQQSLQLVNTNGSWH 0.19% (n=1)
SQQNLQLVNTNGSWH 0.19% (n=1)
PQQYLQLIN------ 0.19% (n=1)
AKQRLQLIN------ 0.19% (n=1)
PKQRLQLIN------ 0.19% (n=1)
AKQHLQLINSNGSWH 0.19% (n=1)
AHQRLQLINSNGSWH 0.19% (n=1)
PQQHLQLINSNGSWH 0.19% (n=1)
PQQRLQLINSNGSWH 0.19% (n=1)
PQQHIQLVN------ 0.19% (n=1)
PKQNIQLVN------ 0.19% (n=1)
PTQNLQLVNSNGSWH 0.19% (n=1)
PTQNLQLVN------ 0.19% (n=1)
SRQNLQLIN------ 0.19% (n=1)
PSQDLQLINTNGSWH 0.19% (n=1)
PQQNLQLINSNGSWH 0.19% (n=1)
PQQKLHLINTNGSWH 0.19% (n=1)
SKQNVQLIKTNGSWH 0.19% (n=1)
SKQNVQLIK------ 0.19% (n=1)
AQQNIQLVN------ 0.19% (n=1)
ASQNIQLINTNGSWH 0.19% (n=1)
PKQSIQLMNTNGSWH 0.19% (n=1)
SSQNIQLVNSNGSWH 0.19% (n=1)
PRQKIQLVNSNGSWH 0.19% (n=1)
ARQNIQLIHTNGSWH 0.19% (n=1)
AQQNIQLIHTNGSWH 0.19% (n=1)
AAQNIQLINTNGSWH 0.19% (n=1)
AKQNIQLIHTNGSWH 0.19% (n=1)
PRQDIQLVNTNGSWH 0.19% (n=1)
ARQNIQLVHTNGSWH 0.19% (n=1)
ARQNLQLVNSNGSWH 0.19% (n=1)
PRQSIQLVNTNGSWH 0.19% (n=1)
PKQNIQLVNTNGSWH 0.19% (n=1)
AQQSIQLINTNGSWH 0.19% (n=1)
SRQNIQLMNTNGSWH 0.19% (n=1)
PKQNIQLMNTNGSWH 0.19% (n=1)
SRQKIQLINTNGSWH 0.19% (n=1)
PSQNLHLINTNGSWH 0.19% (n=1)
AKQDLQLINSNGSWH 0.19% (n=1)
AKQRIQLINSNGSWH 0.19% (n=1)
SQQNIQLVKINGSWH 0.19% (n=1)
PQQNIQLINSNGSWH 0.19% (n=1)
SQQNIQLMNTNGSWH 0.19% (n=1)
SQQHLQLVNTNGSWH 0.19% (n=1)
ARQNIQLMNTNGSWH 0.19% (n=1)
ASQHLQLINTNGSWH 0.19% (n=1)
SKQNLQLIKTNGSWH 0.19% (n=1)
PKQKIQLINTNGSWH 0.19% (n=1)
SKQNVQLINTNGSWH 0.19% (n=1)
PSQHIQLINTNGSWH 0.19% (n=1)
PSQQLQLINTNGSWH 0.19% (n=1)
PRQNIQLINTNGSWH 0.19% (n=1)
AQQNLQLINSNGSWH 0.19% (n=1)
ASQNLQLVNSNGSWH 0.19% (n=1)
PSQTIQLINTNGSWH 0.19% (n=1)
PSQKLQLVNTNGSWH 0.19% (n=1)
SRQNIQLIN------ 0.19% (n=1)
PQQHLMLINTNGSWH 0.19% (n=1)
AKQNIQLVNSNGSWH 0.19% (n=1)
PSQKLQLINTDGSWH 0.19% (n=1)
PKQNLQLIETNGSWH 0.19% (n=1)
PKQRIQLISTNGSWH 0.19% (n=1)
AQQKLMLINTNGSWH 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Subtype 6a:

AKQNLQLINTNGSWH 27.24% (n=79)
ARQNLQLINTNGSWH 17.24% (n=50)
PKQNLQLVNTNGSWH 6.90% (n=20)
AKQNLQLVNTNGSWH 5.86% (n=17)
PKQNLQLINTNGSWH 5.52% (n=16)
ARQNLQLVNTNGSWH 3.10% (n=9)
ARQKLQLINTNGSWH 1.72% (n=5)
AKQNIQLINTNGSWH 1.72% (n=5)
PRQNLQLVNTNGSWH 1.38% (n=4)
PRQNLQLINTNGSWH 1.38% (n=4)
AQQNLQLINTNGSWH 1.03% (n=3)
PKQSLQLVNTNGSWH 1.03% (n=3)
SKQNLQLINTNGSWH 1.03% (n=3)
PQQKLQLVNTNGSWH 1.03% (n=3)
PQQNLQLINTNGSWH 1.03% (n=3)
ARQNLQLINSNGSWH 1.03% (n=3)
AKQNLQLINSNGSWH 0.69% (n=2)
PSQNLQLINTNGSWH 0.69% (n=2)
PQQKLQLINTNGSWH 0.69% (n=2)
PSQKLQLINTNGSWH 0.69% (n=2)
PKQNLQLINSNGSWH 0.69% (n=2)
PKQNLQLVNSNGSWH 0.69% (n=2)
ASQNLQLIKNGSSWH 0.34% (n=1)
AKQNLQLIN------ 0.34% (n=1)
PRQNLQLIN------ 0.34% (n=1)
ARQNLQLIN------ 0.34% (n=1)
PQQNLQLIN------ 0.34% (n=1)
AKQNLQLIKSNGSWH 0.34% (n=1)
ARQSIQLINTKGSWH 0.34% (n=1)
PKQKLQLVHTNGSWH 0.34% (n=1)
PKQTLQLINTNGSWH 0.34% (n=1)
PKQGLQLVNTNGSWH 0.34% (n=1)
PRQNLQLVHTNGSWH 0.34% (n=1)
PKQNLHLVNTNGSWH 0.34% (n=1)
PQQKLHLVNTNGSWH 0.34% (n=1)
PSQKLHLVNTNGSWH 0.34% (n=1)
PQQNVQLINTNGSWH 0.34% (n=1)
ASQKLQLINTNGSWH 0.34% (n=1)
PKQKLQLINSNGSWH 0.34% (n=1)
ARQNIQLVNTNGSWH 0.34% (n=1)
AKQNLQLVRTNGSWH 0.34% (n=1)
AKQDLQLINTNGSWH 0.34% (n=1)
AKQNLQLICTNGSWH 0.34% (n=1)
ARQNLHLINTNGSWH 0.34% (n=1)
AKQKLQLINTNGSWH 0.34% (n=1)
ASQNLQLINTNGSWH 0.34% (n=1)
PQQNLQLVNTNGSWH 0.34% (n=1)
AMQNLQLVNTNGSWH 0.34% (n=1)
SKQNLQLVNTNGSWH 0.34% (n=1)
PKQTLQLIHTNGSWH 0.34% (n=1)
SKQNIQLINTNGSWH 0.34% (n=1)
PRQKLQLINTNGSWH 0.34% (n=1)
PSQTIQLINSNGSWH 0.34% (n=1)
PKQKLQLVNNNGSWH 0.34% (n=1)
PKQNLHLVNTSGSWH 0.34% (n=1)
PKQNLQLVHANGSWH 0.34% (n=1)
ASQNLQLIYSNGSWH 0.34% (n=1)
PQQNLQLIKTNGSWH 0.34% (n=1)
PSQNLQLVNKNGSWH 0.34% (n=1)
ANQNLQLINTNGRWH 0.34% (n=1)
AKQNLQLINTNGSRH 0.34% (n=1)
SRQNIQFINTNGSWH 0.34% (n=1)
AQQNIQLINTNGSWH 0.34% (n=1)
SKQNIQLVKTNGSWH 0.34% (n=1)
AKQNIQLIYTNGSWH 0.34% (n=1)
PSQRLQLINSNGSWH 0.34% (n=1)
PNQNIQLINTNGSWH 0.34% (n=1)
ARQNIQLINTNGSWH 0.34% (n=1)
PRQNLQLVNSNGSWH 0.34% (n=1)
AKQNVQLINTNGSWH 0.34% (n=1)
ARQTLQLINTNGSWH 0.34% (n=1)
PSQNIQLINSNGSWH 0.34% (n=1)
AQQKLQLINTNGSWH 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 407-421 (antibodies: [HC33.29, HC33.8] ), HCV Genotype 7:

PSQRLQLINTNGSWH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 1:

AKQNIQLI 15.95% (n=3729)
ARQNIQLI 5.13% (n=1199)
PSQKIQLI 4.52% (n=1057)
ASQKIQLI 4.15% (n=970)
ASQNIQLI 3.87% (n=905)
PSQKIQLV 3.47% (n=811)
PKQNIQLI 3.35% (n=784)
AQQNIQLI 2.80% (n=655)
AKQNIQLV 2.19% (n=513)
PKQNIQLV 2.08% (n=486)
AKQNVQLI 2.07% (n=485)
AQQDIQLV 1.63% (n=382)
AMQNIQLV 1.47% (n=344)
AKQDIQLI 1.42% (n=333)
AQQNVQLI 1.37% (n=320)
PSQNIQLI 1.30% (n=305)
PAQKLQLI 1.18% (n=275)
SRQNVQLI 1.07% (n=249)
PQQKIQLI 1.04% (n=244)
PQQKIQLV 1.00% (n=234)
ASQRIQLI 0.91% (n=213)
PSQNIQLV 0.89% (n=207)
AQQKIQLV 0.88% (n=205)
AKQNVQLV 0.86% (n=202)
ARQNVQLI 0.80% (n=188)
PS------ 0.80% (n=188)
ASQKIQLV 0.80% (n=186)
PKQNVHLI 0.79% (n=184)
PSQKLQLV 0.72% (n=169)
SSQNIQLV 0.72% (n=168)
SRQNIQLI 0.71% (n=165)
SSQKIQLI 0.69% (n=162)
PQQNIQLI 0.68% (n=160)
ASQNIQLV 0.65% (n=152)
PKQNIHLI 0.65% (n=151)
AKQNIQLM 0.64% (n=150)
PRQKLQLI 0.60% (n=140)
PAQKIQLV 0.58% (n=135)
AKQDVQLI 0.57% (n=134)
SRQHIQLI 0.55% (n=129)
ARQNIQLV 0.55% (n=128)
SKQNIQLI 0.53% (n=125)
PKQNVQLI 0.53% (n=123)
PRQNIQLI 0.50% (n=116)
SSQRIQLV 0.47% (n=111)
PKQDVQLV 0.47% (n=110)
PA------ 0.47% (n=110)
ASQKLQLI 0.42% (n=99)
PKQDIQLI 0.38% (n=89)
ASQRIQLV 0.36% (n=85)
SAQKIQLI 0.36% (n=84)
PSQNIKLT 0.36% (n=83)
PSQKVQLI 0.35% (n=81)
PAQNIQLV 0.35% (n=81)
AQQKIQLI 0.33% (n=78)
PSQNLQLV 0.33% (n=78)
SSQRIQLI 0.31% (n=73)
ANQNIQLI 0.31% (n=72)
SYQKVQLV 0.31% (n=72)
AKQKIQLI 0.30% (n=70)
PSQRIQLV 0.30% (n=70)
ASQNVQLI 0.29% (n=68)
PTQKIQLV 0.28% (n=65)
AKQDIQLV 0.26% (n=61)
SKQNLQLI 0.25% (n=59)
PHQKIQLV 0.25% (n=58)
ASQQIQLI 0.25% (n=58)
SQQHIQLI 0.24% (n=57)
PSQEIQLV 0.24% (n=56)
AKQSIQLV 0.24% (n=56)
SSQKIQLV 0.23% (n=53)
PTQKIQLI 0.22% (n=52)
AKQRIQLI 0.21% (n=50)
SSQKVQLV 0.21% (n=50)
PAQTIQLV 0.21% (n=50)
PKQKIQLI 0.21% (n=49)
AQQNIQLV 0.21% (n=48)
ARQKLQLI 0.20% (n=46)
PSQDIQLI 0.20% (n=46)
PRQKIQLI 0.19% (n=44)
PSQTIQLV 0.18% (n=42)
ASQNIRLI 0.18% (n=42)
PKQKIQLV 0.18% (n=41)
SNQKIQLI 0.17% (n=40)
ASQKLQLV 0.17% (n=40)
PGQKIQLV 0.17% (n=39)
PT------ 0.17% (n=39)
PSQRIQLI 0.16% (n=38)
PKQDIKLI 0.15% (n=36)
PSQNLQLI 0.15% (n=35)
AKQNIRLI 0.15% (n=34)
PKQDIQLV 0.14% (n=33)
ARQKIQLI 0.14% (n=32)
SSQNIQLI 0.13% (n=31)
SAQKIQLV 0.13% (n=31)
SA------ 0.13% (n=31)
SS------ 0.13% (n=30)
SRQNIQLV 0.12% (n=29)
AQQSIQLV 0.12% (n=29)
PKQDVQLI 0.12% (n=28)
PQQNIQLV 0.12% (n=28)
PRQNIQLV 0.12% (n=27)
AKQDIKLI 0.11% (n=26)
P------- 0.11% (n=26)
SKQNVQLI 0.11% (n=25)
SQQKIQLI 0.10% (n=24)
SAQNIQLI 0.10% (n=24)
SNQKIQLV 0.10% (n=24)
SRQKIQLI 0.09% (n=22)
ARQNVQLV 0.09% (n=21)
ANQNVQLI 0.09% (n=20)
ASQKIELI 0.09% (n=20)
AQQDIQLI 0.08% (n=19)
PAQQIQLV 0.08% (n=19)
PSQDIRLI 0.08% (n=18)
ARQDIQLI 0.08% (n=18)
PTQNIQLI 0.08% (n=18)
PAQKIQLI 0.08% (n=18)
SHQKVQLV 0.08% (n=18)
PAQQIQLI 0.08% (n=18)
AS------ 0.08% (n=18)
PQQKVQLI 0.07% (n=17)
AQQNVRLI 0.07% (n=16)
PAQNLQLI 0.07% (n=16)
SKQDIQLI 0.06% (n=15)
ASQKVQLI 0.06% (n=15)
ARQAIQLI 0.06% (n=15)
SKQDVQLV 0.06% (n=15)
PSQTIRLA 0.06% (n=15)
ASQNIQLM 0.06% (n=15)
PKQNLQLI 0.06% (n=14)
PKQDVRLI 0.06% (n=14)
SQQNVQLI 0.06% (n=14)
AKQNLQLI 0.06% (n=14)
AKQNLQLV 0.06% (n=14)
PAQEIQLI 0.06% (n=14)
PSQNVQLI 0.06% (n=13)
SKQDVQLI 0.06% (n=13)
PNQKIQLI 0.06% (n=13)
PAQNIQLI 0.06% (n=13)
PSQKLQLI 0.06% (n=13)
ASQRVQLI 0.06% (n=13)
PAQRIQLV 0.06% (n=13)
SSQKLQLI 0.06% (n=13)
PSQKIRLI 0.05% (n=12)
PSQNIRLI 0.05% (n=12)
AKQGVQLV 0.05% (n=12)
ARQNLQLV 0.05% (n=12)
SAQRIQLV 0.05% (n=12)
PKQNIQLT 0.05% (n=11)
PRQNVQLI 0.05% (n=11)
ANQDIQLI 0.05% (n=11)
PSQNIRLT 0.05% (n=11)
PSQQIQLI 0.05% (n=11)
AKQKIQLV 0.05% (n=11)
PTQRIQLI 0.05% (n=11)
PQQKLQLV 0.05% (n=11)
SRQNLQLV 0.05% (n=11)
PAQEVQLI 0.05% (n=11)
AKQDIRLI 0.04% (n=10)
SKQNIQLV 0.04% (n=10)
PKQDIRLI 0.04% (n=10)
ARQNIQLM 0.04% (n=10)
PQQNVQLI 0.04% (n=10)
PTQNIQLV 0.04% (n=10)
PSQSIQLV 0.04% (n=10)
AQQNVQLV 0.04% (n=9)
PGQKIQLI 0.04% (n=9)
SKQKLQLI 0.04% (n=9)
PAQEIHLI 0.04% (n=9)
AQQKVQLI 0.03% (n=8)
SQQHIQLV 0.03% (n=8)
AKQKVQLI 0.03% (n=8)
SQQNIQLI 0.03% (n=8)
ARQKIQLV 0.03% (n=8)
PKQKVQLI 0.03% (n=8)
AMQDIQLV 0.03% (n=8)
PSQEIQLI 0.03% (n=8)
PLQKIQLI 0.03% (n=8)
PTQHIQLV 0.03% (n=8)
PSQELQLV 0.03% (n=8)
AKQSIQLI 0.03% (n=7)
PNQNIQLI 0.03% (n=7)
PKQNVQLV 0.03% (n=7)
PSQNIQLM 0.03% (n=7)
PSQKIELV 0.03% (n=7)
PRQDVQLI 0.03% (n=7)
PTQRIQLV 0.03% (n=7)
SKQKIQLI 0.03% (n=7)
GQQDIRLI 0.03% (n=7)
AKQDVQLV 0.03% (n=6)
SQQNIQLV 0.03% (n=6)
PSQNIRLV 0.03% (n=6)
SNQNIQLI 0.03% (n=6)
SKQNLQ-- 0.03% (n=6)
PSQKVQLV 0.03% (n=6)
ASQEIQLI 0.03% (n=6)
PAQSINLV 0.03% (n=6)
PSQKIHLV 0.03% (n=6)
SAQNIQLV 0.03% (n=6)
SQQKVQLI 0.03% (n=6)
PNQKIQLV 0.03% (n=6)
-SQKIQLI 0.03% (n=6)
AKQNIQPI 0.02% (n=5)
AKQNIQLT 0.02% (n=5)
PKQNIRLI 0.02% (n=5)
ANQNVQLV 0.02% (n=5)
PKQNLQLV 0.02% (n=5)
PKQNIHLV 0.02% (n=5)
ASHNIQLI 0.02% (n=5)
PMQNVQLI 0.02% (n=5)
PSQSIRLT 0.02% (n=5)
ANQKIQLI 0.02% (n=5)
PKQN---- 0.02% (n=5)
AKQN---- 0.02% (n=5)
AKQNVRLI 0.02% (n=5)
PAQSIKLV 0.02% (n=5)
PAQRIQLI 0.02% (n=5)
PTQKLQLV 0.02% (n=5)
AHQKIQLI 0.02% (n=5)
PGQNVQLV 0.02% (n=5)
SSQKLQLM 0.02% (n=5)
SHQKIQLV 0.02% (n=5)
PAQKVQLI 0.02% (n=5)
AKRNIQLI 0.02% (n=4)
AQHNVQLI 0.02% (n=4)
PSQKLYLI 0.02% (n=4)
AQQNIQLM 0.02% (n=4)
PRQDIQLI 0.02% (n=4)
AQQRIQLV 0.02% (n=4)
SNQNIQLV 0.02% (n=4)
AMRNIQLV 0.02% (n=4)
ARQNIRLI 0.02% (n=4)
PRQNLQLV 0.02% (n=4)
SMQNIQLI 0.02% (n=4)
PNQRIQLI 0.02% (n=4)
ARQNVRLI 0.02% (n=4)
PQQEVQLI 0.02% (n=4)
APQNIQLI 0.02% (n=4)
PSQHIQLV 0.02% (n=4)
SHQKIQLI 0.02% (n=4)
ASQKIQLM 0.02% (n=4)
PFQKIQLI 0.02% (n=4)
PKQKLQLV 0.02% (n=4)
AQQKLQLV 0.02% (n=4)
PQQRIQLV 0.02% (n=4)
PSQQLQLV 0.02% (n=4)
PAQKPQLI 0.02% (n=4)
TKQNIQLV 0.01% (n=3)
AKRNVQLV 0.01% (n=3)
AQQNLQLI 0.01% (n=3)
ARQSIQLI 0.01% (n=3)
AKQHIQLI 0.01% (n=3)
ASQNVQLV 0.01% (n=3)
AEQNIQLI 0.01% (n=3)
PSQSIQLI 0.01% (n=3)
AKQNTQLI 0.01% (n=3)
ARQKVQLI 0.01% (n=3)
SRQNLQLI 0.01% (n=3)
AEQNVQLI 0.01% (n=3)
SKQNIQ-- 0.01% (n=3)
PSQDIRLA 0.01% (n=3)
AKQNIQLA 0.01% (n=3)
SRQKIQLV 0.01% (n=3)
PSQKIQLL 0.01% (n=3)
ASQDIQLI 0.01% (n=3)
PTQPINLV 0.01% (n=3)
PAQRLQLI 0.01% (n=3)
SSQNVQLI 0.01% (n=3)
SQQKIQLV 0.01% (n=3)
AHQKVQLV 0.01% (n=3)
PAQKIQ-- 0.01% (n=3)
ASQKIRLI 0.01% (n=3)
ASQKIELV 0.01% (n=3)
AHQNIQLI 0.01% (n=3)
ARQNVKLI 0.01% (n=2)
AKQNVQPI 0.01% (n=2)
PSQKLHLI 0.01% (n=2)
VKQNIQLI 0.01% (n=2)
PNQNVQLI 0.01% (n=2)
AKQGIQLI 0.01% (n=2)
SRQDIQLI 0.01% (n=2)
ARQEIRLI 0.01% (n=2)
AMQNIQLI 0.01% (n=2)
ARQNIQMI 0.01% (n=2)
ANQNIQLV 0.01% (n=2)
ARQDVQLI 0.01% (n=2)
AKQDLQLI 0.01% (n=2)
PSQHIQLI 0.01% (n=2)
AQQNIRLI 0.01% (n=2)
PKQHIQLV 0.01% (n=2)
PKQKLQLI 0.01% (n=2)
AKQDVRLI 0.01% (n=2)
ALQNVQLI 0.01% (n=2)
SKQNIELI 0.01% (n=2)
AKQDIKLM 0.01% (n=2)
TMQNIQLV 0.01% (n=2)
AAQNVQLI 0.01% (n=2)
SRQSIQLI 0.01% (n=2)
PQQDIQLV 0.01% (n=2)
AGQNIQLI 0.01% (n=2)
AKQSVQLI 0.01% (n=2)
PNQKVQLI 0.01% (n=2)
PSQNVQ-- 0.01% (n=2)
PRQKVQLI 0.01% (n=2)
RKQDIQLI 0.01% (n=2)
PPQKIQLI 0.01% (n=2)
PSQKIELI 0.01% (n=2)
ARQNVQLL 0.01% (n=2)
SRQYVQLI 0.01% (n=2)
SQQHVQLI 0.01% (n=2)
AKQNIQVI 0.01% (n=2)
ARQHVQLV 0.01% (n=2)
HNQKIQLI 0.01% (n=2)
AKQNIHLI 0.01% (n=2)
AQQK---- 0.01% (n=2)
AQQEIQLI 0.01% (n=2)
PQQDIRLV 0.01% (n=2)
PKQKVQLV 0.01% (n=2)
PRQKVQLV 0.01% (n=2)
AMQNVQLI 0.01% (n=2)
PQQRIQLI 0.01% (n=2)
PTQKLQLI 0.01% (n=2)
SAQKLQLI 0.01% (n=2)
PSQKIQLM 0.01% (n=2)
PAHKIQLV 0.01% (n=2)
AAQKIQLI 0.01% (n=2)
PSHKIQLV 0.01% (n=2)
ASQSIQLI 0.01% (n=2)
ASHNIHLI 0.01% (n=2)
ASQNTQLI 0.01% (n=2)
VSQKIQLI 0.01% (n=2)
PAQPIKLV 0.01% (n=2)
PAHRIQLV 0.01% (n=2)
PAQKVQLV 0.01% (n=2)
PAQKIELV 0.01% (n=2)
PTQHIQLI 0.01% (n=2)
AQQRIQLI 0.01% (n=2)
PTQNLQLI 0.01% (n=2)
PSQPLQLI 0.01% (n=2)
ASQRVQLV 0.01% (n=2)
PRQKIQLV 0.01% (n=2)
AAQNIQLV 0.01% (n=2)
ASQKVQLV 0.01% (n=2)
SAQRVQLV 0.01% (n=2)
TSQKIQLI 0.01% (n=2)
ARQSIQLV 0.01% (n=2)
AKQKIQLM 0.01% (n=2)
PSQNIHLV 0.01% (n=2)
ATQNIQLI 0.01% (n=2)
PAQNLQLV 0.01% (n=2)
PSQKIQ-- 0.01% (n=2)
ASRKIQLI 0.01% (n=2)
PPQNIQLI 0.01% (n=2)
SKQKIQLV 0.01% (n=2)
SRQKVQLI 0.01% (n=2)
SPQKIQLI 0.01% (n=2)
-AQKIQLV 0.01% (n=2)
-SQKIQLV 0.01% (n=2)
SKQTIQLI 0.01% (n=2)
PAQKIELI 0.01% (n=2)
PVQHLQLI 0.01% (n=2)
AQQRLQLV 0.01% (n=2)
AEQNVQLV 0.00% (n=1)
AKLNVQLV 0.00% (n=1)
PSQNAQLI 0.00% (n=1)
PKENIQLV 0.00% (n=1)
PKRNIQLV 0.00% (n=1)
AGQNVQLI 0.00% (n=1)
PKQNV*LI 0.00% (n=1)
PSQDTRLI 0.00% (n=1)
PSQNIYLI 0.00% (n=1)
VKQNIQLV 0.00% (n=1)
PKQSVQLI 0.00% (n=1)
PKQNVQLT 0.00% (n=1)
ARQNIQPI 0.00% (n=1)
ARQNTQLV 0.00% (n=1)
AKRDIQLI 0.00% (n=1)
PSQDVRLI 0.00% (n=1)
PQQHIQLV 0.00% (n=1)
PKQDIKLM 0.00% (n=1)
ARQEIQLI 0.00% (n=1)
PEQNVQLI 0.00% (n=1)
PGQNIQLV 0.00% (n=1)
ASQNAQLI 0.00% (n=1)
PSRVIQLI 0.00% (n=1)
PKLNVQLI 0.00% (n=1)
LKQNVQLI 0.00% (n=1)
AQHNIQLI 0.00% (n=1)
AKQDIHLI 0.00% (n=1)
AQQNVQLT 0.00% (n=1)
PSQNTQLI 0.00% (n=1)
GKQNIQLI 0.00% (n=1)
AKQKVQLM 0.00% (n=1)
AQQKVQLM 0.00% (n=1)
AQQSIQLI 0.00% (n=1)
ARQNIQVI 0.00% (n=1)
PKQNIRLV 0.00% (n=1)
PKQQVQLI 0.00% (n=1)
PKQGIKLI 0.00% (n=1)
ARQDIQLV 0.00% (n=1)
SSQNLQLI 0.00% (n=1)
PSQDLQLI 0.00% (n=1)
PKQNIQPI 0.00% (n=1)
LSQEIQLV 0.00% (n=1)
PSQEIQQV 0.00% (n=1)
PSQDIQLV 0.00% (n=1)
ARQSIQMV 0.00% (n=1)
ASQNIQPV 0.00% (n=1)
ASQNIQLA 0.00% (n=1)
ASQSIQLV 0.00% (n=1)
AQQNTQLV 0.00% (n=1)
AMQNIQLM 0.00% (n=1)
ARQPIGLI 0.00% (n=1)
PQQKIHLI 0.00% (n=1)
PRQTIRLI 0.00% (n=1)
LKQDIQLV 0.00% (n=1)
AQQTVQLI 0.00% (n=1)
AN*DIQLI 0.00% (n=1)
ARRNVQLI 0.00% (n=1)
AQQKIQLM 0.00% (n=1)
AKQNVQLM 0.00% (n=1)
AKQHVQLI 0.00% (n=1)
PNQNIQLV 0.00% (n=1)
AQQNIKLI 0.00% (n=1)
SKQDIQLV 0.00% (n=1)
AQQDVQLI 0.00% (n=1)
PRQSIKLI 0.00% (n=1)
AQQNVQLM 0.00% (n=1)
AMQDIQLI 0.00% (n=1)
AKQQINLI 0.00% (n=1)
ANQDIHLI 0.00% (n=1)
HHQNIQLV 0.00% (n=1)
PRQSIQLI 0.00% (n=1)
AKQNIELI 0.00% (n=1)
PKQNLRLV 0.00% (n=1)
AKQDINLV 0.00% (n=1)
PKQDLQLI 0.00% (n=1)
ARQDVRLI 0.00% (n=1)
AQQRVQLI 0.00% (n=1)
ANQKVQLI 0.00% (n=1)
PRQEIQLV 0.00% (n=1)
AMQNIRLI 0.00% (n=1)
PRQKIELV 0.00% (n=1)
PQQQIQLV 0.00% (n=1)
PRQDVRLI 0.00% (n=1)
SKQNIRLI 0.00% (n=1)
PQQSIQLV 0.00% (n=1)
PQQNIQPV 0.00% (n=1)
AEQDIQLI 0.00% (n=1)
AKQDIQLT 0.00% (n=1)
PRQNLQLI 0.00% (n=1)
PKQKAQLI 0.00% (n=1)
AKHNDQPI 0.00% (n=1)
AMQNVQLV 0.00% (n=1)
AMQSIQLV 0.00% (n=1)
VMQNIQLV 0.00% (n=1)
TEQDIQLV 0.00% (n=1)
PRLNIQLI 0.00% (n=1)
ANQRVQLV 0.00% (n=1)
ANQKVQLV 0.00% (n=1)
AKQNI*LI 0.00% (n=1)
PSQQIQ-- 0.00% (n=1)
PSQDVQ-- 0.00% (n=1)
AKQDIQ-- 0.00% (n=1)
PSQNIQ-- 0.00% (n=1)
SKQDVQFI 0.00% (n=1)
SRQDVQLI 0.00% (n=1)
AKQNIQFI 0.00% (n=1)
VRQNIQLI 0.00% (n=1)
PGQNIKLT 0.00% (n=1)
PSQSIRLA 0.00% (n=1)
PRQNIKLT 0.00% (n=1)
PSQTIRLT 0.00% (n=1)
PKQNIQMI 0.00% (n=1)
TKQNIQLI 0.00% (n=1)
AQQKIQLT 0.00% (n=1)
AQQKI*LI 0.00% (n=1)
AQRKIQLI 0.00% (n=1)
SK*NIQLI 0.00% (n=1)
SKQNIQLT 0.00% (n=1)
SR*NIQLI 0.00% (n=1)
AKHNIQLV 0.00% (n=1)
AKQYIQLI 0.00% (n=1)
PQQNIHLI 0.00% (n=1)
SQQDIQLI 0.00% (n=1)
ANQGIRLI 0.00% (n=1)
PKQDIHLV 0.00% (n=1)
ARQQIRLI 0.00% (n=1)
PSQNLHLI 0.00% (n=1)
PQQNIRLI 0.00% (n=1)
SRQNVQLM 0.00% (n=1)
AQQNIRLV 0.00% (n=1)
PRQN---- 0.00% (n=1)
PTQN---- 0.00% (n=1)
SQQN---- 0.00% (n=1)
ARQN---- 0.00% (n=1)
AQQE---- 0.00% (n=1)
SRQN---- 0.00% (n=1)
PKQH---- 0.00% (n=1)
PRQNIRLV 0.00% (n=1)
PRQDIQLV 0.00% (n=1)
AQQKLQLI 0.00% (n=1)
PKQDIRLV 0.00% (n=1)
PRQNVQLV 0.00% (n=1)
PNQSVQLI 0.00% (n=1)
PQQRVQLI 0.00% (n=1)
AKQNV*LI 0.00% (n=1)
AKQNVQPV 0.00% (n=1)
TKQNVQLV 0.00% (n=1)
AKQNVHLI 0.00% (n=1)
AKQNLQLM 0.00% (n=1)
PAQNIRLI 0.00% (n=1)
PQQNLQLI 0.00% (n=1)
ALQNIQLI 0.00% (n=1)
AQQKVQLV 0.00% (n=1)
AHQNIQLV 0.00% (n=1)
PSQDVQLI 0.00% (n=1)
PRQKI--- 0.00% (n=1)
PHQKLQLI 0.00% (n=1)
PKQQIQLV 0.00% (n=1)
SAQEIQLV 0.00% (n=1)
PKQKVQLM 0.00% (n=1)
AKQEVQLI 0.00% (n=1)
PSQKNQLM 0.00% (n=1)
SSQKDQLV 0.00% (n=1)
VSEDIPAC 0.00% (n=1)
PAQSVNLV 0.00% (n=1)
PTSENPAY 0.00% (n=1)
SAQKLELV 0.00% (n=1)
PAQKIQII 0.00% (n=1)
PSQKIQL- 0.00% (n=1)
ASQNLQLI 0.00% (n=1)
PSQEIHLI 0.00% (n=1)
GSQKIELI 0.00% (n=1)
ASQNIQLL 0.00% (n=1)
ASQNIHLI 0.00% (n=1)
SQENIQLI 0.00% (n=1)
RCQTIQLI 0.00% (n=1)
ARQNIQII 0.00% (n=1)
ASQGIQLI 0.00% (n=1)
APQRIQLV 0.00% (n=1)
PAQKLQLV 0.00% (n=1)
PQ*KIQLV 0.00% (n=1)
SRRKIQLI 0.00% (n=1)
PSRRIQLV 0.00% (n=1)
ACQNIQLI 0.00% (n=1)
SHQNVQLI 0.00% (n=1)
PAQNIRLV 0.00% (n=1)
ASQGIQLV 0.00% (n=1)
PTQNLQLV 0.00% (n=1)
PAQSLQLV 0.00% (n=1)
PAQKIHLI 0.00% (n=1)
PHQNIQLI 0.00% (n=1)
PVQKIQLI 0.00% (n=1)
PLQQIQLI 0.00% (n=1)
SAQKVQLI 0.00% (n=1)
PSQSIHLV 0.00% (n=1)
SYQKVQLI 0.00% (n=1)
SHQKVQLI 0.00% (n=1)
PKQSIQLV 0.00% (n=1)
PSQPIQLV 0.00% (n=1)
PGQKVQLI 0.00% (n=1)
ASQNIQPI 0.00% (n=1)
SRQSIQLV 0.00% (n=1)
SKQTLQLI 0.00% (n=1)
SSQKVQLI 0.00% (n=1)
PGQNVQLI 0.00% (n=1)
SNQNVQLI 0.00% (n=1)
ASRNIQLI 0.00% (n=1)
PSQNTQLV 0.00% (n=1)
PAQQVQLV 0.00% (n=1)
SQQRIQLI 0.00% (n=1)
SAQRIQLI 0.00% (n=1)
AHQKLQLI 0.00% (n=1)
GQQNIQLI 0.00% (n=1)
GKQDIRLI 0.00% (n=1)
ARQNLQLI 0.00% (n=1)
ASQHIQLI 0.00% (n=1)
PSQMIQLV 0.00% (n=1)
PSRKIQLI 0.00% (n=1)
PTQNVQLI 0.00% (n=1)
SSQKLQLV 0.00% (n=1)
AQQKLQLM 0.00% (n=1)
ANQKIQLV 0.00% (n=1)
PKQEIRLV 0.00% (n=1)
PNQQIQLV 0.00% (n=1)
PIQKIQLV 0.00% (n=1)
PGQEIKLV 0.00% (n=1)
PVQKIQLV 0.00% (n=1)
PTQTIQLV 0.00% (n=1)
ATQNIQLV 0.00% (n=1)
SAQEIKLV 0.00% (n=1)
SQQKLQLV 0.00% (n=1)
AKQRIQLV 0.00% (n=1)
PTQELRLV 0.00% (n=1)
PSQGIQLV 0.00% (n=1)
AAQTIQ-- 0.00% (n=1)
PRQNILLV 0.00% (n=1)
VS------ 0.00% (n=1)
ATQKIQLI 0.00% (n=1)
PTQKVQLV 0.00% (n=1)
PAQKLHLV 0.00% (n=1)
PSQKFQLV 0.00% (n=1)
ASQNIQLT 0.00% (n=1)
ASQNIRII 0.00% (n=1)
PSQCIQLI 0.00% (n=1)
PSRKIQLV 0.00% (n=1)
AFQNIHLI 0.00% (n=1)
PSQTLQLV 0.00% (n=1)
LYQRIQLV 0.00% (n=1)
PDQKIQLV 0.00% (n=1)
SHQSIQLV 0.00% (n=1)
ASQRLQLV 0.00% (n=1)
PGQNIQLI 0.00% (n=1)
SAQNIRLI 0.00% (n=1)
SAQNVQLI 0.00% (n=1)
PQQK---- 0.00% (n=1)
PQQ----- 0.00% (n=1)
AQQR---- 0.00% (n=1)
PSQTIQLI 0.00% (n=1)
SYQKIQLI 0.00% (n=1)
SSQRVQLI 0.00% (n=1)
SSQRVQLV 0.00% (n=1)
-KQKIQLV 0.00% (n=1)
PSQEVQLI 0.00% (n=1)
PSQELQLI 0.00% (n=1)
SRQHTQLI 0.00% (n=1)
LRQHIQLI 0.00% (n=1)
PSRKLQLV 0.00% (n=1)
SSQELQLV 0.00% (n=1)
PSQKLQLA 0.00% (n=1)
PSQKPQLV 0.00% (n=1)
SSQEIQLI 0.00% (n=1)
PSQELKLV 0.00% (n=1)
PSQKLQLM 0.00% (n=1)
PSQKLQPV 0.00% (n=1)
SPQNTQLI 0.00% (n=1)
SSQKIQPI 0.00% (n=1)
PQQKIQLM 0.00% (n=1)
P*QKIQLI 0.00% (n=1)
ASHKIQLI 0.00% (n=1)
ASQKTQLI 0.00% (n=1)
PAQKLPLI 0.00% (n=1)
PAQKLLLI 0.00% (n=1)
LAQKLQLI 0.00% (n=1)
PALKLQLI 0.00% (n=1)
ASQKIQHI 0.00% (n=1)
ASQKIQPI 0.00% (n=1)
ASQ*LQLI 0.00% (n=1)
PNQKVQLV 0.00% (n=1)
SHQNIQLI 0.00% (n=1)
PQQTIQLV 0.00% (n=1)
DGQKIQLV 0.00% (n=1)
RSQKI--- 0.00% (n=1)
QEQKIQLI 0.00% (n=1)
PKQNIQII 0.00% (n=1)
SRQSLQLI 0.00% (n=1)
SKQSLQLI 0.00% (n=1)
PQQRLQLV 0.00% (n=1)
PHQKIQLM 0.00% (n=1)
ASQDVQLI 0.00% (n=1)
AQQQLQLI 0.00% (n=1)
AQQSLQLI 0.00% (n=1)
PQQKLELV 0.00% (n=1)
AQQQLQLV 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 1a:

AKQNIQLI 26.63% (n=3634)
ARQNIQLI 6.74% (n=919)
PKQNIQLI 5.55% (n=757)
AKQNIQLV 3.70% (n=505)
AKQNVQLI 3.55% (n=484)
AQQNIQLI 3.31% (n=451)
PKQNIQLV 3.27% (n=446)
AQQDIQLV 2.80% (n=382)
AMQNIQLV 2.52% (n=344)
AKQDIQLI 2.43% (n=332)
AQQNVQLI 2.35% (n=320)
SRQNVQLI 1.74% (n=237)
AKQNVQLV 1.48% (n=202)
AQQKIQLV 1.44% (n=197)
PSQKIQLI 1.38% (n=188)
PKQNVHLI 1.35% (n=184)
ARQNVQLI 1.34% (n=183)
PQQNIQLI 1.12% (n=153)
AKQNIQLM 1.10% (n=150)
PKQNIHLI 1.09% (n=149)
PRQKLQLI 1.03% (n=140)
AKQDVQLI 0.98% (n=134)
PSQNIQLI 0.92% (n=126)
PKQNVQLI 0.88% (n=120)
PKQDVQLV 0.81% (n=110)
PRQNIQLI 0.75% (n=103)
SKQNIQLI 0.75% (n=102)
ARQNIQLV 0.68% (n=93)
ASQNIQLV 0.67% (n=92)
PKQDIQLI 0.65% (n=89)
PSQNIKLT 0.61% (n=83)
SRQNIQLI 0.56% (n=76)
AQQKIQLI 0.55% (n=75)
PQQKIQLI 0.54% (n=74)
ASQNVQLI 0.48% (n=65)
AKQDIQLV 0.45% (n=61)
PSQNIQLV 0.43% (n=59)
ANQNIQLI 0.43% (n=58)
AKQSIQLV 0.41% (n=56)
SQQHIQLI 0.41% (n=56)
PSQEIQLV 0.40% (n=55)
PSQKIQLV 0.37% (n=50)
ARQKLQLI 0.34% (n=46)
AQQNIQLV 0.32% (n=44)
PSQDIQLI 0.32% (n=43)
PKQKIQLI 0.31% (n=42)
PKQDIKLI 0.26% (n=36)
AKQNIRLI 0.25% (n=34)
AKQKIQLI 0.24% (n=33)
PKQDIQLV 0.23% (n=32)
PRQKIQLI 0.23% (n=31)
PSQNLQLI 0.23% (n=31)
AQQSIQLV 0.21% (n=29)
ARQKIQLI 0.21% (n=28)
PKQDVQLI 0.21% (n=28)
PRQNIQLV 0.19% (n=26)
AKQDIKLI 0.19% (n=26)
PSQNLQLV 0.19% (n=26)
PQQNIQLV 0.18% (n=25)
ASQNIQLI 0.18% (n=24)
SKQNVQLI 0.18% (n=24)
ARQNVQLV 0.15% (n=21)
ANQNVQLI 0.15% (n=20)
AQQDIQLI 0.14% (n=19)
PSQDIRLI 0.13% (n=18)
ARQDIQLI 0.13% (n=18)
PQQKIQLV 0.12% (n=16)
AQQNVRLI 0.12% (n=16)
SKQDIQLI 0.11% (n=15)
ARQAIQLI 0.11% (n=15)
SKQDVQLV 0.11% (n=15)
PSQTIRLA 0.11% (n=15)
PKQNLQLI 0.10% (n=14)
PKQDVRLI 0.10% (n=14)
AKQNLQLI 0.10% (n=14)
SKQDVQLI 0.10% (n=13)
SQQNVQLI 0.10% (n=13)
PSQNVQLI 0.09% (n=12)
PSQNIRLI 0.09% (n=12)
AKQGVQLV 0.09% (n=12)
PKQNIQLT 0.08% (n=11)
PNQKIQLI 0.08% (n=11)
PRQNVQLI 0.08% (n=11)
ANQDIQLI 0.08% (n=11)
PSQNIRLT 0.08% (n=11)
ARQNIQLM 0.07% (n=10)
AQQNVQLV 0.07% (n=9)
PKQDIRLI 0.06% (n=8)
SQQHIQLV 0.06% (n=8)
PKQKVQLI 0.06% (n=8)
AMQDIQLV 0.06% (n=8)
AKQKIQLV 0.06% (n=8)
AKQDIRLI 0.05% (n=7)
AKQSIQLI 0.05% (n=7)
PKQNVQLV 0.05% (n=7)
PRQDVQLI 0.05% (n=7)
AKQDVQLV 0.04% (n=6)
ASQKLQLI 0.04% (n=6)
PSQNIRLV 0.04% (n=6)
PQQNVQLI 0.04% (n=6)
PSQNIQLM 0.04% (n=6)
SRQNIQLV 0.04% (n=6)
SQQNIQLI 0.04% (n=6)
ARQKIQLV 0.04% (n=6)
SKQNLQ-- 0.04% (n=6)
SKQNLQLI 0.04% (n=6)
AKQNIQPI 0.04% (n=5)
AKQNIQLT 0.04% (n=5)
PKQNIRLI 0.04% (n=5)
ANQNVQLV 0.04% (n=5)
SQQNIQLV 0.04% (n=5)
AKQKVQLI 0.04% (n=5)
PKQNLQLV 0.04% (n=5)
PKQNIHLV 0.04% (n=5)
PMQNVQLI 0.04% (n=5)
PSQSIRLT 0.04% (n=5)
PKQN---- 0.04% (n=5)
AKQN---- 0.04% (n=5)
AKQNVRLI 0.04% (n=5)
AKRNIQLI 0.03% (n=4)
AQHNVQLI 0.03% (n=4)
PSQKLYLI 0.03% (n=4)
PNQNIQLI 0.03% (n=4)
AQQKVQLI 0.03% (n=4)
AQQNIQLM 0.03% (n=4)
SNQNIQLI 0.03% (n=4)
PRQDIQLI 0.03% (n=4)
AKQRIQLI 0.03% (n=4)
SNQNIQLV 0.03% (n=4)
AMRNIQLV 0.03% (n=4)
ARQNIRLI 0.03% (n=4)
ANQKIQLI 0.03% (n=4)
SMQNIQLI 0.03% (n=4)
ARQNVRLI 0.03% (n=4)
PQQEVQLI 0.03% (n=4)
TKQNIQLV 0.02% (n=3)
SKQNIQLV 0.02% (n=3)
AKRNVQLV 0.02% (n=3)
ARQSIQLI 0.02% (n=3)
AKQHIQLI 0.02% (n=3)
AEQNIQLI 0.02% (n=3)
AKQNTQLI 0.02% (n=3)
AEQNVQLI 0.02% (n=3)
AKQNLQLV 0.02% (n=3)
SKQNIQ-- 0.02% (n=3)
PSQDIRLA 0.02% (n=3)
ASQNIQLM 0.02% (n=3)
PSQQIQLI 0.02% (n=3)
AQQNLQLI 0.01% (n=2)
ARQNVKLI 0.01% (n=2)
AKQNVQPI 0.01% (n=2)
VKQNIQLI 0.01% (n=2)
PNQNVQLI 0.01% (n=2)
ASQNVQLV 0.01% (n=2)
AKQGIQLI 0.01% (n=2)
SRQDIQLI 0.01% (n=2)
ARQEIRLI 0.01% (n=2)
AMQNIQLI 0.01% (n=2)
ARQNIQMI 0.01% (n=2)
ANQNIQLV 0.01% (n=2)
ARQDVQLI 0.01% (n=2)
AKQDLQLI 0.01% (n=2)
SNQKIQLI 0.01% (n=2)
PSQHIQLI 0.01% (n=2)
AQQNIRLI 0.01% (n=2)
PKQHIQLV 0.01% (n=2)
AKQDVRLI 0.01% (n=2)
ALQNVQLI 0.01% (n=2)
SKQNIELI 0.01% (n=2)
AKQDIKLM 0.01% (n=2)
TMQNIQLV 0.01% (n=2)
SRQSIQLI 0.01% (n=2)
PQQDIQLV 0.01% (n=2)
AGQNIQLI 0.01% (n=2)
AKQSVQLI 0.01% (n=2)
PSQKVQLI 0.01% (n=2)
PNQKVQLI 0.01% (n=2)
PSQNVQ-- 0.01% (n=2)
PRQKVQLI 0.01% (n=2)
RKQDIQLI 0.01% (n=2)
PSQKIELI 0.01% (n=2)
ARQNVQLL 0.01% (n=2)
SRQYVQLI 0.01% (n=2)
SQQHVQLI 0.01% (n=2)
AKQNIQVI 0.01% (n=2)
ARQHVQLV 0.01% (n=2)
PKQKIQLV 0.01% (n=2)
PRQNLQLV 0.01% (n=2)
HNQKIQLI 0.01% (n=2)
AKQNIHLI 0.01% (n=2)
AQQEIQLI 0.01% (n=2)
PNQRIQLI 0.01% (n=2)
PQQDIRLV 0.01% (n=2)
PKQKVQLV 0.01% (n=2)
PRQKVQLV 0.01% (n=2)
PQQKVQLI 0.01% (n=2)
AMQNVQLI 0.01% (n=2)
AEQNVQLV 0.01% (n=1)
AKLNVQLV 0.01% (n=1)
PSQNAQLI 0.01% (n=1)
PKENIQLV 0.01% (n=1)
PKRNIQLV 0.01% (n=1)
AGQNVQLI 0.01% (n=1)
PKQNV*LI 0.01% (n=1)
PSQKLHLI 0.01% (n=1)
PSQDTRLI 0.01% (n=1)
PSQNIYLI 0.01% (n=1)
VKQNIQLV 0.01% (n=1)
PKQSVQLI 0.01% (n=1)
PKQNVQLT 0.01% (n=1)
ARQNIQPI 0.01% (n=1)
ARQNTQLV 0.01% (n=1)
AKRDIQLI 0.01% (n=1)
PSQDVRLI 0.01% (n=1)
PQQHIQLV 0.01% (n=1)
PKQDIKLM 0.01% (n=1)
ARQEIQLI 0.01% (n=1)
PEQNVQLI 0.01% (n=1)
PGQNIQLV 0.01% (n=1)
ASQNAQLI 0.01% (n=1)
PSRVIQLI 0.01% (n=1)
PKLNVQLI 0.01% (n=1)
LKQNVQLI 0.01% (n=1)
AQHNIQLI 0.01% (n=1)
AKQDIHLI 0.01% (n=1)
AQQNVQLT 0.01% (n=1)
PSQKIRLI 0.01% (n=1)
PSQNTQLI 0.01% (n=1)
PSQSIQLI 0.01% (n=1)
GKQNIQLI 0.01% (n=1)
AKQKVQLM 0.01% (n=1)
AQQKVQLM 0.01% (n=1)
AQQSIQLI 0.01% (n=1)
ARQNIQVI 0.01% (n=1)
PKQNIRLV 0.01% (n=1)
PKQQVQLI 0.01% (n=1)
PKQGIKLI 0.01% (n=1)
ARQDIQLV 0.01% (n=1)
SSQNLQLI 0.01% (n=1)
PSQDLQLI 0.01% (n=1)
PKQNIQPI 0.01% (n=1)
LSQEIQLV 0.01% (n=1)
PSQEIQQV 0.01% (n=1)
PSQDIQLV 0.01% (n=1)
ARQSIQMV 0.01% (n=1)
ASQNIQPV 0.01% (n=1)
ASQNIQLA 0.01% (n=1)
AQQRIQLV 0.01% (n=1)
ASQSIQLV 0.01% (n=1)
ASQKIQLV 0.01% (n=1)
AQQNTQLV 0.01% (n=1)
AMQNIQLM 0.01% (n=1)
ARQPIGLI 0.01% (n=1)
PQQKIHLI 0.01% (n=1)
PRQTIRLI 0.01% (n=1)
LKQDIQLV 0.01% (n=1)
AQQTVQLI 0.01% (n=1)
AN*DIQLI 0.01% (n=1)
ARRNVQLI 0.01% (n=1)
AQQKIQLM 0.01% (n=1)
AKQNVQLM 0.01% (n=1)
ARQKVQLI 0.01% (n=1)
AKQHVQLI 0.01% (n=1)
PNQNIQLV 0.01% (n=1)
AQQNIKLI 0.01% (n=1)
PTQNIQLI 0.01% (n=1)
PSQKIELV 0.01% (n=1)
SKQDIQLV 0.01% (n=1)
ASQKIQLI 0.01% (n=1)
AQQDVQLI 0.01% (n=1)
PRQSIKLI 0.01% (n=1)
AQQNVQLM 0.01% (n=1)
AMQDIQLI 0.01% (n=1)
PKQKLQLI 0.01% (n=1)
AKQQINLI 0.01% (n=1)
SRQNLQLI 0.01% (n=1)
ANQDIHLI 0.01% (n=1)
HHQNIQLV 0.01% (n=1)
PRQSIQLI 0.01% (n=1)
AKQNIELI 0.01% (n=1)
PKQNLRLV 0.01% (n=1)
AKQDINLV 0.01% (n=1)
PKQDLQLI 0.01% (n=1)
ARQDVRLI 0.01% (n=1)
ASHNIQLI 0.01% (n=1)
AQQRVQLI 0.01% (n=1)
PSQKLQLV 0.01% (n=1)
ANQKVQLI 0.01% (n=1)
ASQKVQLI 0.01% (n=1)
PRQEIQLV 0.01% (n=1)
AMQNIRLI 0.01% (n=1)
PRQKIELV 0.01% (n=1)
PQQQIQLV 0.01% (n=1)
SSQNIQLI 0.01% (n=1)
PRQDVRLI 0.01% (n=1)
AAQNVQLI 0.01% (n=1)
SKQNIRLI 0.01% (n=1)
PQQSIQLV 0.01% (n=1)
PQQNIQPV 0.01% (n=1)
AEQDIQLI 0.01% (n=1)
AKQDIQLT 0.01% (n=1)
PRQNLQLI 0.01% (n=1)
PKQKAQLI 0.01% (n=1)
AKHNDQPI 0.01% (n=1)
ARQNLQLV 0.01% (n=1)
PTQNIQLV 0.01% (n=1)
AMQNVQLV 0.01% (n=1)
AMQSIQLV 0.01% (n=1)
VMQNIQLV 0.01% (n=1)
TEQDIQLV 0.01% (n=1)
PRLNIQLI 0.01% (n=1)
ANQRVQLV 0.01% (n=1)
ANQKVQLV 0.01% (n=1)
AKQNI*LI 0.01% (n=1)
PSQQIQ-- 0.01% (n=1)
PSQDVQ-- 0.01% (n=1)
AKQDIQ-- 0.01% (n=1)
PSQNIQ-- 0.01% (n=1)
PGQKIQLV 0.01% (n=1)
SKQDVQFI 0.01% (n=1)
SRQDVQLI 0.01% (n=1)
AKQNIQFI 0.01% (n=1)
VRQNIQLI 0.01% (n=1)
PGQNIKLT 0.01% (n=1)
PSQSIRLA 0.01% (n=1)
PRQNIKLT 0.01% (n=1)
PSQTIRLT 0.01% (n=1)
PSQRIQLI 0.01% (n=1)
PPQKIQLI 0.01% (n=1)
AKQNIQLA 0.01% (n=1)
PKQNIQMI 0.01% (n=1)
TKQNIQLI 0.01% (n=1)
AQQKIQLT 0.01% (n=1)
AQQKI*LI 0.01% (n=1)
AQRKIQLI 0.01% (n=1)
SK*NIQLI 0.01% (n=1)
SKQNIQLT 0.01% (n=1)
SR*NIQLI 0.01% (n=1)
AKHNIQLV 0.01% (n=1)
AKQYIQLI 0.01% (n=1)
PQQNIHLI 0.01% (n=1)
SQQDIQLI 0.01% (n=1)
ANQGIRLI 0.01% (n=1)
PKQDIHLV 0.01% (n=1)
ARQQIRLI 0.01% (n=1)
ASQKLQLV 0.01% (n=1)
PSQNLHLI 0.01% (n=1)
PQQNIRLI 0.01% (n=1)
SRQNVQLM 0.01% (n=1)
AQQNIRLV 0.01% (n=1)
PRQN---- 0.01% (n=1)
AQQK---- 0.01% (n=1)
PTQN---- 0.01% (n=1)
SQQN---- 0.01% (n=1)
ARQN---- 0.01% (n=1)
AQQE---- 0.01% (n=1)
SRQN---- 0.01% (n=1)
PKQH---- 0.01% (n=1)
PRQNIRLV 0.01% (n=1)
PRQDIQLV 0.01% (n=1)
AQQKLQLI 0.01% (n=1)
PKQDIRLV 0.01% (n=1)
PRQNVQLV 0.01% (n=1)
PNQSVQLI 0.01% (n=1)
PQQRVQLI 0.01% (n=1)
AKQNV*LI 0.01% (n=1)
AKQNVQPV 0.01% (n=1)
TKQNVQLV 0.01% (n=1)
AKQNVHLI 0.01% (n=1)
AKQNLQLM 0.01% (n=1)
PAQNIRLI 0.01% (n=1)
PQQNLQLI 0.01% (n=1)
ALQNIQLI 0.01% (n=1)
AQQKVQLV 0.01% (n=1)
AHQNIQLV 0.01% (n=1)
SQQKIQLI 0.01% (n=1)
PQQRIQLI 0.01% (n=1)
PSQDVQLI 0.01% (n=1)
PRQKI--- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 1b:

ASQKIQLI 10.01% (n=969)
ASQNIQLI 9.07% (n=878)
PSQKIQLI 8.95% (n=867)
PSQKIQLV 7.86% (n=761)
ARQNIQLI 2.87% (n=278)
PAQKLQLI 2.84% (n=275)
PQQKIQLV 2.25% (n=218)
ASQRIQLI 2.20% (n=213)
AQQNIQLI 2.10% (n=203)
PS------ 1.94% (n=188)
ASQKIQLV 1.91% (n=185)
PSQNIQLI 1.84% (n=178)
PQQKIQLI 1.76% (n=170)
PSQKLQLV 1.73% (n=168)
SSQNIQLV 1.73% (n=168)
SSQKIQLI 1.67% (n=162)
PSQNIQLV 1.53% (n=148)
PAQKIQLV 1.39% (n=135)
SRQHIQLI 1.33% (n=129)
SSQRIQLV 1.15% (n=111)
PA------ 1.14% (n=110)
ASQKLQLI 0.96% (n=93)
AKQNIQLI 0.93% (n=90)
SRQNIQLI 0.92% (n=89)
ASQRIQLV 0.88% (n=85)
SAQKIQLI 0.87% (n=84)
PAQNIQLV 0.84% (n=81)
PSQKVQLI 0.82% (n=79)
SSQRIQLI 0.75% (n=73)
SYQKVQLV 0.74% (n=72)
PSQRIQLV 0.72% (n=70)
PTQKIQLV 0.67% (n=65)
ASQNIQLV 0.62% (n=60)
PHQKIQLV 0.60% (n=58)
ASQQIQLI 0.60% (n=58)
SSQKIQLV 0.55% (n=53)
SKQNLQLI 0.55% (n=53)
PTQKIQLI 0.54% (n=52)
PSQNLQLV 0.54% (n=52)
SSQKVQLV 0.52% (n=50)
PAQTIQLV 0.52% (n=50)
AKQRIQLI 0.47% (n=46)
PSQTIQLV 0.43% (n=42)
ASQNIRLI 0.43% (n=42)
PKQNIQLV 0.41% (n=40)
ASQKLQLV 0.40% (n=39)
PKQKIQLV 0.40% (n=39)
PT------ 0.40% (n=39)
PGQKIQLV 0.39% (n=38)
SNQKIQLI 0.39% (n=38)
AKQKIQLI 0.36% (n=35)
PSQRIQLI 0.35% (n=34)
ARQNIQLV 0.35% (n=34)
SAQKIQLV 0.32% (n=31)
SA------ 0.32% (n=31)
SSQNIQLI 0.31% (n=30)
SS------ 0.31% (n=30)
P------- 0.27% (n=26)
PKQNIQLI 0.26% (n=25)
SAQNIQLI 0.25% (n=24)
SNQKIQLV 0.25% (n=24)
SQQKIQLI 0.24% (n=23)
SRQNIQLV 0.24% (n=23)
SRQKIQLI 0.23% (n=22)
SKQNIQLI 0.23% (n=22)
ASQKIELI 0.21% (n=20)
PAQQIQLV 0.20% (n=19)
PAQKIQLI 0.19% (n=18)
SHQKVQLV 0.19% (n=18)
PAQQIQLI 0.19% (n=18)
AS------ 0.19% (n=18)
PTQNIQLI 0.18% (n=17)
PAQNLQLI 0.17% (n=16)
PQQKVQLI 0.15% (n=15)
ASQKVQLI 0.14% (n=14)
PAQEIQLI 0.14% (n=14)
ANQNIQLI 0.14% (n=14)
PAQNIQLI 0.13% (n=13)
PSQKLQLI 0.13% (n=13)
ASQRVQLI 0.13% (n=13)
PAQRIQLV 0.13% (n=13)
PRQKIQLI 0.13% (n=13)
SSQKLQLI 0.13% (n=13)
PRQNIQLI 0.12% (n=12)
SAQRIQLV 0.12% (n=12)
SRQNVQLI 0.12% (n=12)
ASQNIQLM 0.12% (n=12)
PTQRIQLI 0.11% (n=11)
ARQNLQLV 0.11% (n=11)
AKQNLQLV 0.11% (n=11)
PQQKLQLV 0.11% (n=11)
SRQNLQLV 0.11% (n=11)
PSQKIRLI 0.11% (n=11)
PAQEVQLI 0.11% (n=11)
PSQSIQLV 0.10% (n=10)
PTQNIQLV 0.09% (n=9)
PGQKIQLI 0.09% (n=9)
SKQKLQLI 0.09% (n=9)
PAQEIHLI 0.09% (n=9)
AQQKIQLV 0.08% (n=8)
PSQEIQLI 0.08% (n=8)
PSQQIQLI 0.08% (n=8)
AKQNIQLV 0.08% (n=8)
PLQKIQLI 0.08% (n=8)
PTQHIQLV 0.08% (n=8)
PSQELQLV 0.08% (n=8)
PTQRIQLV 0.07% (n=7)
PKQKIQLI 0.07% (n=7)
SKQNIQLV 0.07% (n=7)
SKQKIQLI 0.07% (n=7)
GQQDIRLI 0.07% (n=7)
ASQEIQLI 0.06% (n=6)
PAQSINLV 0.06% (n=6)
PQQNIQLI 0.06% (n=6)
PSQKIELV 0.06% (n=6)
PSQKIHLV 0.06% (n=6)
SAQNIQLV 0.06% (n=6)
SQQKVQLI 0.06% (n=6)
PNQKIQLV 0.06% (n=6)
-SQKIQLI 0.06% (n=6)
PSQKVQLV 0.05% (n=5)
PAQSIKLV 0.05% (n=5)
PAQRIQLI 0.05% (n=5)
PTQKLQLV 0.05% (n=5)
AHQKIQLI 0.05% (n=5)
PGQNVQLV 0.05% (n=5)
ARQNVQLI 0.05% (n=5)
SSQKLQLM 0.05% (n=5)
SHQKIQLV 0.05% (n=5)
PAQKVQLI 0.05% (n=5)
AQQKVQLI 0.04% (n=4)
APQNIQLI 0.04% (n=4)
ASHNIQLI 0.04% (n=4)
AQQNIQLV 0.04% (n=4)
PSQHIQLV 0.04% (n=4)
ARQKIQLI 0.04% (n=4)
SHQKIQLI 0.04% (n=4)
PSQNLQLI 0.04% (n=4)
PQQNVQLI 0.04% (n=4)
ASQKIQLM 0.04% (n=4)
PFQKIQLI 0.04% (n=4)
PKQKLQLV 0.04% (n=4)
AQQKLQLV 0.04% (n=4)
PQQRIQLV 0.04% (n=4)
PSQQLQLV 0.04% (n=4)
PAQKPQLI 0.04% (n=4)
SRQKIQLV 0.03% (n=3)
AKQKVQLI 0.03% (n=3)
PSQKIQLL 0.03% (n=3)
ASQDIQLI 0.03% (n=3)
PTQPINLV 0.03% (n=3)
PAQRLQLI 0.03% (n=3)
SSQNVQLI 0.03% (n=3)
AKQKIQLV 0.03% (n=3)
AQQKIQLI 0.03% (n=3)
SQQKIQLV 0.03% (n=3)
ASQNVQLI 0.03% (n=3)
AHQKVQLV 0.03% (n=3)
PKQNVQLI 0.03% (n=3)
AKQDIRLI 0.03% (n=3)
PAQKIQ-- 0.03% (n=3)
PQQNIQLV 0.03% (n=3)
ASQKIRLI 0.03% (n=3)
PSQDIQLI 0.03% (n=3)
ASQKIELV 0.03% (n=3)
AHQNIQLI 0.03% (n=3)
PNQKIQLI 0.02% (n=2)
SAQKLQLI 0.02% (n=2)
PSQKIQLM 0.02% (n=2)
ARQKVQLI 0.02% (n=2)
PAHKIQLV 0.02% (n=2)
AAQKIQLI 0.02% (n=2)
PSHKIQLV 0.02% (n=2)
ASQSIQLI 0.02% (n=2)
ASHNIHLI 0.02% (n=2)
ASQNTQLI 0.02% (n=2)
VSQKIQLI 0.02% (n=2)
PAQPIKLV 0.02% (n=2)
PAHRIQLV 0.02% (n=2)
PNQRIQLI 0.02% (n=2)
PAQKVQLV 0.02% (n=2)
PAQKIELV 0.02% (n=2)
AQQRIQLV 0.02% (n=2)
PTQHIQLI 0.02% (n=2)
AQQRIQLI 0.02% (n=2)
PTQNLQLI 0.02% (n=2)
PSQPLQLI 0.02% (n=2)
ASQRVQLV 0.02% (n=2)
PRQKIQLV 0.02% (n=2)
SNQNIQLI 0.02% (n=2)
AAQNIQLV 0.02% (n=2)
ASQKVQLV 0.02% (n=2)
AKQNIQLA 0.02% (n=2)
SAQRVQLV 0.02% (n=2)
TSQKIQLI 0.02% (n=2)
ARQSIQLV 0.02% (n=2)
AKQKIQLM 0.02% (n=2)
PKQDIRLI 0.02% (n=2)
PSQNIHLV 0.02% (n=2)
ATQNIQLI 0.02% (n=2)
PAQNLQLV 0.02% (n=2)
PSQSIQLI 0.02% (n=2)
PSQKIQ-- 0.02% (n=2)
ASRKIQLI 0.02% (n=2)
PKQNIHLI 0.02% (n=2)
PRQNLQLV 0.02% (n=2)
PNQNIQLI 0.02% (n=2)
PPQNIQLI 0.02% (n=2)
ARQKIQLV 0.02% (n=2)
SKQKIQLV 0.02% (n=2)
SRQKVQLI 0.02% (n=2)
SPQKIQLI 0.02% (n=2)
-AQKIQLV 0.02% (n=2)
-SQKIQLV 0.02% (n=2)
SKQTIQLI 0.02% (n=2)
PAQKIELI 0.02% (n=2)
PVQHLQLI 0.02% (n=2)
PHQKLQLI 0.01% (n=1)
PSQNVQLI 0.01% (n=1)
PTQKLQLI 0.01% (n=1)
PKQQIQLV 0.01% (n=1)
SAQEIQLV 0.01% (n=1)
PKQKVQLM 0.01% (n=1)
AKQEVQLI 0.01% (n=1)
PSQKNQLM 0.01% (n=1)
ANQKIQLI 0.01% (n=1)
SSQKDQLV 0.01% (n=1)
VSEDIPAC 0.01% (n=1)
PAQSVNLV 0.01% (n=1)
PTSENPAY 0.01% (n=1)
SAQKLELV 0.01% (n=1)
PAQKIQII 0.01% (n=1)
PSQKIQL- 0.01% (n=1)
SKQNVQLI 0.01% (n=1)
ASQNLQLI 0.01% (n=1)
PSQEIHLI 0.01% (n=1)
GSQKIELI 0.01% (n=1)
ASQNIQLL 0.01% (n=1)
ASQNIHLI 0.01% (n=1)
SQENIQLI 0.01% (n=1)
RCQTIQLI 0.01% (n=1)
ARQNIQII 0.01% (n=1)
ASQGIQLI 0.01% (n=1)
APQRIQLV 0.01% (n=1)
PAQKLQLV 0.01% (n=1)
PQ*KIQLV 0.01% (n=1)
SRRKIQLI 0.01% (n=1)
PSRRIQLV 0.01% (n=1)
ACQNIQLI 0.01% (n=1)
SHQNVQLI 0.01% (n=1)
PAQNIRLV 0.01% (n=1)
ASQGIQLV 0.01% (n=1)
PTQNLQLV 0.01% (n=1)
PAQSLQLV 0.01% (n=1)
PAQKIHLI 0.01% (n=1)
PHQNIQLI 0.01% (n=1)
PVQKIQLI 0.01% (n=1)
PLQQIQLI 0.01% (n=1)
SAQKVQLI 0.01% (n=1)
PSQKLHLI 0.01% (n=1)
PSQSIHLV 0.01% (n=1)
SYQKVQLI 0.01% (n=1)
SHQKVQLI 0.01% (n=1)
PKQSIQLV 0.01% (n=1)
PSQPIQLV 0.01% (n=1)
PGQKVQLI 0.01% (n=1)
ASQNIQPI 0.01% (n=1)
PKQDIQLV 0.01% (n=1)
SRQSIQLV 0.01% (n=1)
SKQTLQLI 0.01% (n=1)
SSQKVQLI 0.01% (n=1)
PGQNVQLI 0.01% (n=1)
SNQNVQLI 0.01% (n=1)
ASRNIQLI 0.01% (n=1)
PSQEIQLV 0.01% (n=1)
PPQKIQLI 0.01% (n=1)
PSQNTQLV 0.01% (n=1)
PAQQVQLV 0.01% (n=1)
SQQRIQLI 0.01% (n=1)
SAQRIQLI 0.01% (n=1)
AHQKLQLI 0.01% (n=1)
GQQNIQLI 0.01% (n=1)
GKQDIRLI 0.01% (n=1)
SRQNLQLI 0.01% (n=1)
ARQNLQLI 0.01% (n=1)
ASQHIQLI 0.01% (n=1)
PSQMIQLV 0.01% (n=1)
PSRKIQLI 0.01% (n=1)
PTQNVQLI 0.01% (n=1)
SSQKLQLV 0.01% (n=1)
AQQKLQLM 0.01% (n=1)
ANQKIQLV 0.01% (n=1)
PKQEIRLV 0.01% (n=1)
PNQQIQLV 0.01% (n=1)
PIQKIQLV 0.01% (n=1)
PGQEIKLV 0.01% (n=1)
PVQKIQLV 0.01% (n=1)
PTQTIQLV 0.01% (n=1)
ATQNIQLV 0.01% (n=1)
SAQEIKLV 0.01% (n=1)
SQQKLQLV 0.01% (n=1)
AKQRIQLV 0.01% (n=1)
PTQELRLV 0.01% (n=1)
PSQGIQLV 0.01% (n=1)
AAQTIQ-- 0.01% (n=1)
PRQNILLV 0.01% (n=1)
VS------ 0.01% (n=1)
ATQKIQLI 0.01% (n=1)
PTQKVQLV 0.01% (n=1)
PAQKLHLV 0.01% (n=1)
PSQKFQLV 0.01% (n=1)
ASQNIQLT 0.01% (n=1)
ASQNIRII 0.01% (n=1)
PRQNIQLV 0.01% (n=1)
PSQCIQLI 0.01% (n=1)
PSRKIQLV 0.01% (n=1)
AFQNIHLI 0.01% (n=1)
PSQTLQLV 0.01% (n=1)
LYQRIQLV 0.01% (n=1)
PDQKIQLV 0.01% (n=1)
ASQNVQLV 0.01% (n=1)
SHQSIQLV 0.01% (n=1)
ASQRLQLV 0.01% (n=1)
SQQNVQLI 0.01% (n=1)
SQQNIQLI 0.01% (n=1)
PGQNIQLI 0.01% (n=1)
AAQNVQLI 0.01% (n=1)
SAQNIRLI 0.01% (n=1)
SAQNVQLI 0.01% (n=1)
AKQDIQLI 0.01% (n=1)
AQQK---- 0.01% (n=1)
PQQK---- 0.01% (n=1)
PQQ----- 0.01% (n=1)
AQQR---- 0.01% (n=1)
PSQTIQLI 0.01% (n=1)
SYQKIQLI 0.01% (n=1)
SSQRVQLI 0.01% (n=1)
SSQRVQLV 0.01% (n=1)
-KQKIQLV 0.01% (n=1)
PSQEVQLI 0.01% (n=1)
PSQELQLI 0.01% (n=1)
SRQHTQLI 0.01% (n=1)
LRQHIQLI 0.01% (n=1)
PSRKLQLV 0.01% (n=1)
SSQELQLV 0.01% (n=1)
PSQKLQLA 0.01% (n=1)
PSQKPQLV 0.01% (n=1)
SSQEIQLI 0.01% (n=1)
PSQELKLV 0.01% (n=1)
PSQKLQLM 0.01% (n=1)
PSQKLQPV 0.01% (n=1)
SPQNTQLI 0.01% (n=1)
SSQKIQPI 0.01% (n=1)
PQQKIQLM 0.01% (n=1)
P*QKIQLI 0.01% (n=1)
PQQRIQLI 0.01% (n=1)
ASHKIQLI 0.01% (n=1)
ASQKTQLI 0.01% (n=1)
PAQKLPLI 0.01% (n=1)
PAQKLLLI 0.01% (n=1)
LAQKLQLI 0.01% (n=1)
PALKLQLI 0.01% (n=1)
ASQKIQHI 0.01% (n=1)
ASQKIQPI 0.01% (n=1)
PSQNIQLM 0.01% (n=1)
ASQ*LQLI 0.01% (n=1)
PNQKVQLV 0.01% (n=1)
SHQNIQLI 0.01% (n=1)
PQQTIQLV 0.01% (n=1)
DGQKIQLV 0.01% (n=1)
RSQKI--- 0.01% (n=1)
QEQKIQLI 0.01% (n=1)
PKQNIQII 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 2:

AKQHIQLI 13.85% (n=183)
SRQNIQLI 12.41% (n=164)
AKQNIQLI 9.08% (n=120)
PSQKIQLI 6.28% (n=83)
PSQKLSLI 3.56% (n=47)
ARQNIQLI 3.26% (n=43)
ARQHIQLI 3.03% (n=40)
PSQKLNLI 2.95% (n=39)
AQQEISLI 2.88% (n=38)
PQQKINLI 1.97% (n=26)
PQQNIQLI 1.82% (n=24)
PKQNIQLI 1.51% (n=20)
PQQKLSLI 1.51% (n=20)
SQQKLSLI 1.29% (n=17)
PQQQITLI 1.06% (n=14)
AQQNIQLI 0.91% (n=12)
AQQKINLI 0.91% (n=12)
AKQRIQLI 0.91% (n=12)
SKQNIQLI 0.83% (n=11)
AQQRISLI 0.83% (n=11)
PQQKIQLI 0.76% (n=10)
SQQNIQLI 0.76% (n=10)
PKQNINLI 0.68% (n=9)
AQQQISLI 0.68% (n=9)
PKQTLSLI 0.61% (n=8)
PSQRIQLI 0.61% (n=8)
PQQRLQLI 0.61% (n=8)
ARQKIQLI 0.53% (n=7)
PRQNIQLI 0.53% (n=7)
ASQNIQLI 0.45% (n=6)
HKQNVQLI 0.45% (n=6)
PKQKIDLI 0.45% (n=6)
PRQTLSLV 0.45% (n=6)
PSQRINLI 0.45% (n=6)
PRQKIQLV 0.38% (n=5)
AQQKLSLI 0.38% (n=5)
SQQRLSLI 0.38% (n=5)
ARQKISLI 0.38% (n=5)
PKQRIDLI 0.38% (n=5)
AKQNLQLI 0.30% (n=4)
PQQRIQLI 0.30% (n=4)
PRQKIDLI 0.30% (n=4)
PQQNLNLI 0.30% (n=4)
PSQKISLI 0.30% (n=4)
AQQKISLI 0.30% (n=4)
SQQRLQLI 0.23% (n=3)
ARQNLQLI 0.23% (n=3)
AQQKIQLI 0.23% (n=3)
PQQKLQLI 0.23% (n=3)
AKQNIYLI 0.23% (n=3)
PQQKISLI 0.23% (n=3)
PSQKINLI 0.23% (n=3)
PKQKINLI 0.23% (n=3)
PQQKIKLI 0.23% (n=3)
PQQKLTLV 0.23% (n=3)
PSQRLSLI 0.23% (n=3)
ARQRIQLI 0.23% (n=3)
SRQDIQLI 0.23% (n=3)
SKQHIQLI 0.15% (n=2)
AKQNIQLV 0.15% (n=2)
PQQQIQLI 0.15% (n=2)
ARQKLQLI 0.15% (n=2)
AKQDIQLI 0.15% (n=2)
PRQNLQLI 0.15% (n=2)
SKQNLQLI 0.15% (n=2)
AKQKIQLI 0.15% (n=2)
SRQNIQLV 0.15% (n=2)
PQQRIQLV 0.15% (n=2)
ARQNIQLV 0.15% (n=2)
AKQSIQLI 0.15% (n=2)
PKQNIHLI 0.15% (n=2)
PQQNLHLI 0.15% (n=2)
PRQRIHLI 0.15% (n=2)
AKQNINLI 0.15% (n=2)
PQQNIHLI 0.15% (n=2)
PQQQLHLI 0.15% (n=2)
PQQKLHLV 0.15% (n=2)
AKQNLYLI 0.15% (n=2)
PKQQITLI 0.15% (n=2)
AQQQLSLI 0.15% (n=2)
PQQKLNLV 0.15% (n=2)
PSQTINLI 0.15% (n=2)
PRQKLSLI 0.15% (n=2)
PKQRIQLV 0.15% (n=2)
PKQHIQLI 0.15% (n=2)
PKQRIQLI 0.15% (n=2)
SRQHIQLI 0.15% (n=2)
AQQRIQLI 0.15% (n=2)
PQQKLQLV 0.15% (n=2)
AKQTLQLI 0.08% (n=1)
AQQHVQLI 0.08% (n=1)
PIQHIQLV 0.08% (n=1)
ARQQVQLI 0.08% (n=1)
AHQNIQLV 0.08% (n=1)
AKQIIQLI 0.08% (n=1)
AKQNIQLT 0.08% (n=1)
AKQNTQLI 0.08% (n=1)
PTQNIQLI 0.08% (n=1)
PTQNLQLI 0.08% (n=1)
PQQNIQLV 0.08% (n=1)
SKQNIQLV 0.08% (n=1)
PSQNIQLI 0.08% (n=1)
SNQNIQLI 0.08% (n=1)
PQQTIQLV 0.08% (n=1)
PMQNIQLI 0.08% (n=1)
AQQNIQLV 0.08% (n=1)
SRQNVQLI 0.08% (n=1)
SRQSIQLI 0.08% (n=1)
PSQNLRLM 0.08% (n=1)
AQQNVQLI 0.08% (n=1)
PQQKLILV 0.08% (n=1)
AQQEIRLI 0.08% (n=1)
PQQNVHLI 0.08% (n=1)
AKQNIHLV 0.08% (n=1)
PQQKNHLN 0.08% (n=1)
PSQRLQLI 0.08% (n=1)
PSQSIQLV 0.08% (n=1)
PQQNIYLI 0.08% (n=1)
PQQKLNLI 0.08% (n=1)
AQQRLSLV 0.08% (n=1)
AKQNLHLI 0.08% (n=1)
AQQPISLI 0.08% (n=1)
PKQNLQLI 0.08% (n=1)
PSQKLSLV 0.08% (n=1)
SKQNIYLI 0.08% (n=1)
PHHSINLI 0.08% (n=1)
SQQNIHLI 0.08% (n=1)
AKQNIMLI 0.08% (n=1)
PKQNLQLV 0.08% (n=1)
PQQQLRLI 0.08% (n=1)
AKQKLSLI 0.08% (n=1)
PRQQLQLV 0.08% (n=1)
AQQKIHLV 0.08% (n=1)
ARQKIMLI 0.08% (n=1)
ASQKISLI 0.08% (n=1)
SRQDISLI 0.08% (n=1)
PQQQITLN 0.08% (n=1)
PKKQITLI 0.08% (n=1)
PEQQITLI 0.08% (n=1)
P*QQITLI 0.08% (n=1)
AKQQLSLI 0.08% (n=1)
PQQKLSLV 0.08% (n=1)
SKQKLSLI 0.08% (n=1)
PRQTVSLV 0.08% (n=1)
PRQTL*LV 0.08% (n=1)
PKQKLTLV 0.08% (n=1)
SQQQLSLI 0.08% (n=1)
PKQNLNLI 0.08% (n=1)
PTRQINLI 0.08% (n=1)
PSQKFNLI 0.08% (n=1)
PAQKLSLI 0.08% (n=1)
PQQRLSLI 0.08% (n=1)
PQQRINLV 0.08% (n=1)
PQQKIALI 0.08% (n=1)
SRQKLSLI 0.08% (n=1)
PSQTLSLI 0.08% (n=1)
ARQQLMLI 0.08% (n=1)
AQQPLSLI 0.08% (n=1)
SKQKISLI 0.08% (n=1)
PKQNLALI 0.08% (n=1)
SRQRLSLI 0.08% (n=1)
VRKSVWLI 0.08% (n=1)
PQQNLQLI 0.08% (n=1)
PSQKLALI 0.08% (n=1)
SKQNVHLI 0.08% (n=1)
PNQRISLI 0.08% (n=1)
ARQQISLI 0.08% (n=1)
AQQRLSLI 0.08% (n=1)
GKQDIMLI 0.08% (n=1)
PSQHISLM 0.08% (n=1)
PSQQLSLI 0.08% (n=1)
PKQTISLI 0.08% (n=1)
PQQPLSLI 0.08% (n=1)
PHQRLSLI 0.08% (n=1)
PQQRIHLV 0.08% (n=1)
PKQKLSLI 0.08% (n=1)
PQQTISLI 0.08% (n=1)
ARQRISLI 0.08% (n=1)
SSQNIQLI 0.08% (n=1)
SQQRVQLI 0.08% (n=1)
ARQHIQLT 0.08% (n=1)
LQQRIQLI 0.08% (n=1)
PQQKIQLV 0.08% (n=1)
PQQTIQLI 0.08% (n=1)
PRQHIQLI 0.08% (n=1)
PNQKLQLI 0.08% (n=1)
ARQSIQLI 0.08% (n=1)
SQQKIQLI 0.08% (n=1)
PNQNIQLI 0.08% (n=1)
SQQRIQLI 0.08% (n=1)
PNQRIQLI 0.08% (n=1)
SNQKIQLI 0.08% (n=1)
AKQAIQLI 0.08% (n=1)
PNQRLELV 0.08% (n=1)
SQQQIQLI 0.08% (n=1)
AQQHIQLI 0.08% (n=1)
PRQTIQLI 0.08% (n=1)
SQQNVQLI 0.08% (n=1)
SRQNI*LI 0.08% (n=1)
SRQNIRLI 0.08% (n=1)
SRQNTQLI 0.08% (n=1)
SRQNIHLI 0.08% (n=1)
SQQHIQLI 0.08% (n=1)
PSQNLQLI 0.08% (n=1)
AKQNVQLI 0.08% (n=1)
PSQNIQLV 0.08% (n=1)
SQQHLRLV 0.08% (n=1)
PRQNVQLI 0.08% (n=1)
SSQNVQLI 0.08% (n=1)
SQQNIQLV 0.08% (n=1)
PQQHLQLV 0.08% (n=1)
ARQKIQLV 0.08% (n=1)
PSQKTQLI 0.08% (n=1)
PSRKIQLI 0.08% (n=1)
PSQNIMLM 0.08% (n=1)
ASQSLQLI 0.08% (n=1)
SQQNLQLI 0.08% (n=1)
PQQRLSLV 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 2a:

AKQNIQLI 39.61% (n=101)
ARQNIQLI 14.90% (n=38)
PQQNIQLI 7.06% (n=18)
PKQNIQLI 4.31% (n=11)
AQQNIQLI 2.75% (n=7)
SRQNIQLI 2.75% (n=7)
SQQNIQLI 2.35% (n=6)
SKQNIQLI 2.35% (n=6)
HKQNVQLI 2.35% (n=6)
PRQKIQLV 1.96% (n=5)
PQQKIQLI 1.57% (n=4)
PRQNIQLI 1.18% (n=3)
ASQNIQLI 1.18% (n=3)
ARQKLQLI 0.78% (n=2)
AKQNLQLI 0.78% (n=2)
AKQDIQLI 0.78% (n=2)
ARQKIQLI 0.78% (n=2)
SKQNLQLI 0.78% (n=2)
SRQNIQLV 0.78% (n=2)
AHQNIQLV 0.39% (n=1)
AKQIIQLI 0.39% (n=1)
AKQNIQLT 0.39% (n=1)
AKQNTQLI 0.39% (n=1)
PQQQIQLI 0.39% (n=1)
PTQNIQLI 0.39% (n=1)
PRQNLQLI 0.39% (n=1)
PTQNLQLI 0.39% (n=1)
AKQKIQLI 0.39% (n=1)
PQQNIQLV 0.39% (n=1)
SKQNIQLV 0.39% (n=1)
AQQKIQLI 0.39% (n=1)
ARQHIQLI 0.39% (n=1)
PSQNIQLI 0.39% (n=1)
PQQRIQLI 0.39% (n=1)
PQQRIQLV 0.39% (n=1)
ARQNIQLV 0.39% (n=1)
PQQKLQLI 0.39% (n=1)
SNQNIQLI 0.39% (n=1)
PQQTIQLV 0.39% (n=1)
PMQNIQLI 0.39% (n=1)
AKQNIQLV 0.39% (n=1)
AKQSIQLI 0.39% (n=1)
ARQNLQLI 0.39% (n=1)
AQQNIQLV 0.39% (n=1)
SRQNVQLI 0.39% (n=1)
SRQSIQLI 0.39% (n=1)
PSQNLRLM 0.39% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 2b:

PSQKLSLI 10.24% (n=47)
PSQKLNLI 8.50% (n=39)
AQQEISLI 8.28% (n=38)
PQQKINLI 5.66% (n=26)
PQQKLSLI 4.36% (n=20)
SQQKLSLI 3.70% (n=17)
PQQQITLI 3.05% (n=14)
AQQKINLI 2.61% (n=12)
AQQRISLI 2.40% (n=11)
AKQNIQLI 2.18% (n=10)
PKQNINLI 1.96% (n=9)
AQQQISLI 1.96% (n=9)
PKQTLSLI 1.74% (n=8)
PKQKIDLI 1.31% (n=6)
PRQTLSLV 1.31% (n=6)
PSQRINLI 1.31% (n=6)
PKQNIQLI 1.09% (n=5)
SRQNIQLI 1.09% (n=5)
AQQKLSLI 1.09% (n=5)
SQQRLSLI 1.09% (n=5)
ARQKISLI 1.09% (n=5)
PKQRIDLI 1.09% (n=5)
PRQKIDLI 0.87% (n=4)
PQQNLNLI 0.87% (n=4)
PSQKISLI 0.87% (n=4)
AQQKISLI 0.87% (n=4)
AKQNIYLI 0.65% (n=3)
AQQNIQLI 0.65% (n=3)
PSQKINLI 0.65% (n=3)
PKQKINLI 0.65% (n=3)
PQQKIKLI 0.65% (n=3)
PQQKLTLV 0.65% (n=3)
PSQRLSLI 0.65% (n=3)
SKQNIQLI 0.44% (n=2)
PKQNIHLI 0.44% (n=2)
PRQNIQLI 0.44% (n=2)
PQQNIQLI 0.44% (n=2)
ARQKIQLI 0.44% (n=2)
PRQRIHLI 0.44% (n=2)
AKQNINLI 0.44% (n=2)
PQQNIHLI 0.44% (n=2)
PQQQLHLI 0.44% (n=2)
PQQKLHLV 0.44% (n=2)
AKQNLYLI 0.44% (n=2)
PKQQITLI 0.44% (n=2)
AQQQLSLI 0.44% (n=2)
PQQKLNLV 0.44% (n=2)
PSQTINLI 0.44% (n=2)
PRQKLSLI 0.44% (n=2)
PQQKISLI 0.44% (n=2)
AQQNVQLI 0.22% (n=1)
PQQKLILV 0.22% (n=1)
AQQEIRLI 0.22% (n=1)
PQQNVHLI 0.22% (n=1)
AKQNIHLV 0.22% (n=1)
PQQKNHLN 0.22% (n=1)
AKQSIQLI 0.22% (n=1)
PSQRLQLI 0.22% (n=1)
PQQNLHLI 0.22% (n=1)
PRQNLQLI 0.22% (n=1)
ASQNIQLI 0.22% (n=1)
PSQSIQLV 0.22% (n=1)
PQQNIYLI 0.22% (n=1)
AKQNLQLI 0.22% (n=1)
PQQKLNLI 0.22% (n=1)
ARQNIQLV 0.22% (n=1)
AQQRLSLV 0.22% (n=1)
SQQNIQLI 0.22% (n=1)
AKQNLHLI 0.22% (n=1)
PQQKIQLI 0.22% (n=1)
AQQPISLI 0.22% (n=1)
PKQNLQLI 0.22% (n=1)
PSQKLSLV 0.22% (n=1)
SKQNIYLI 0.22% (n=1)
PHHSINLI 0.22% (n=1)
SQQNIHLI 0.22% (n=1)
PQQKLQLI 0.22% (n=1)
AKQNIMLI 0.22% (n=1)
PKQNLQLV 0.22% (n=1)
PQQQLRLI 0.22% (n=1)
AKQKLSLI 0.22% (n=1)
PRQQLQLV 0.22% (n=1)
AQQKIHLV 0.22% (n=1)
ARQKIMLI 0.22% (n=1)
ASQKISLI 0.22% (n=1)
SRQDISLI 0.22% (n=1)
PQQQITLN 0.22% (n=1)
PKKQITLI 0.22% (n=1)
PEQQITLI 0.22% (n=1)
P*QQITLI 0.22% (n=1)
AKQQLSLI 0.22% (n=1)
PQQKLSLV 0.22% (n=1)
SKQKLSLI 0.22% (n=1)
PRQTVSLV 0.22% (n=1)
PRQTL*LV 0.22% (n=1)
PKQKLTLV 0.22% (n=1)
SQQQLSLI 0.22% (n=1)
PKQNLNLI 0.22% (n=1)
PTRQINLI 0.22% (n=1)
PSQKFNLI 0.22% (n=1)
AKQKIQLI 0.22% (n=1)
ARQNLQLI 0.22% (n=1)
PAQKLSLI 0.22% (n=1)
PQQRLSLI 0.22% (n=1)
PQQRINLV 0.22% (n=1)
PQQKIALI 0.22% (n=1)
SRQKLSLI 0.22% (n=1)
PSQTLSLI 0.22% (n=1)
ARQQLMLI 0.22% (n=1)
AQQPLSLI 0.22% (n=1)
SKQKISLI 0.22% (n=1)
PKQNLALI 0.22% (n=1)
SRQRLSLI 0.22% (n=1)
PQQNLQLI 0.22% (n=1)
PSQKLALI 0.22% (n=1)
SKQNVHLI 0.22% (n=1)
PNQRISLI 0.22% (n=1)
ARQQISLI 0.22% (n=1)
AQQRLSLI 0.22% (n=1)
GKQDIMLI 0.22% (n=1)
PSQHISLM 0.22% (n=1)
PSQQLSLI 0.22% (n=1)
PKQTISLI 0.22% (n=1)
PQQPLSLI 0.22% (n=1)
PHQRLSLI 0.22% (n=1)
PQQRIHLV 0.22% (n=1)
PQQRIQLV 0.22% (n=1)
PKQKLSLI 0.22% (n=1)
PQQTISLI 0.22% (n=1)
ARQRISLI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 2c:

AKQHIQLI 40.31% (n=183)
SRQNIQLI 33.26% (n=151)
ARQHIQLI 8.59% (n=39)
AKQRIQLI 2.64% (n=12)
PQQRLQLI 1.54% (n=7)
PSQRIQLI 0.88% (n=4)
ARQRIQLI 0.66% (n=3)
PQQRIQLI 0.66% (n=3)
PQQKIQLI 0.66% (n=3)
SRQDIQLI 0.66% (n=3)
AKQNIQLI 0.44% (n=2)
PKQRIQLV 0.44% (n=2)
PKQHIQLI 0.44% (n=2)
PKQRIQLI 0.44% (n=2)
AQQRIQLI 0.44% (n=2)
PKQNIQLI 0.44% (n=2)
ARQKIQLI 0.44% (n=2)
PQQQIQLI 0.22% (n=1)
SSQNIQLI 0.22% (n=1)
PQQNIQLI 0.22% (n=1)
SQQRVQLI 0.22% (n=1)
ARQHIQLT 0.22% (n=1)
SKQNIQLI 0.22% (n=1)
LQQRIQLI 0.22% (n=1)
PQQKIQLV 0.22% (n=1)
ARQNIQLI 0.22% (n=1)
SKQHIQLI 0.22% (n=1)
PQQTIQLI 0.22% (n=1)
PRQHIQLI 0.22% (n=1)
PNQKLQLI 0.22% (n=1)
ARQSIQLI 0.22% (n=1)
SQQKIQLI 0.22% (n=1)
PNQNIQLI 0.22% (n=1)
SQQRIQLI 0.22% (n=1)
PNQRIQLI 0.22% (n=1)
SNQKIQLI 0.22% (n=1)
SRQHIQLI 0.22% (n=1)
AKQAIQLI 0.22% (n=1)
PRQNIQLI 0.22% (n=1)
PNQRLELV 0.22% (n=1)
SQQQIQLI 0.22% (n=1)
AQQHIQLI 0.22% (n=1)
PRQTIQLI 0.22% (n=1)
SQQNVQLI 0.22% (n=1)
SRQNI*LI 0.22% (n=1)
SRQNIRLI 0.22% (n=1)
SRQNTQLI 0.22% (n=1)
SRQNIHLI 0.22% (n=1)
AQQKIQLI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 3:

AQQKLQLV 9.62% (n=376)
PQQKLQLV 8.77% (n=343)
AKQKLQLV 7.06% (n=276)
ASQKLELI 6.96% (n=272)
PRQNLQLI 6.55% (n=256)
ARQNLQLV 5.91% (n=231)
AKQNLQLV 5.14% (n=201)
ANQKLQLV 3.76% (n=147)
AQQKIQLV 2.51% (n=98)
PKQNLQLV 2.46% (n=96)
ARQNLQLI 2.38% (n=93)
PRQNLHLV 2.05% (n=80)
SRQNIQLI 1.89% (n=74)
ASQNLQLI 1.79% (n=70)
PSQNLHLV 1.74% (n=68)
AKQNLQLI 1.51% (n=59)
PRQNLQLV 1.41% (n=55)
AQQRLQLV 1.38% (n=54)
PKQNLHLV 1.25% (n=49)
PKQNLQLI 1.10% (n=43)
AQQNLQLV 1.10% (n=43)
ARQKLQLI 1.00% (n=39)
PSQNLQLV 0.97% (n=38)
SRQNLQLV 0.97% (n=38)
ANQRLELI 0.90% (n=35)
ASQNLELI 0.82% (n=32)
AQQKLQLI 0.79% (n=31)
ANQKLELI 0.74% (n=29)
ARQNLHLV 0.72% (n=28)
PQQKLQLI 0.69% (n=27)
ASQKLQLV 0.67% (n=26)
ARQKLQLV 0.61% (n=24)
AQQKLELV 0.51% (n=20)
PSQKLQLV 0.46% (n=18)
ASQKLQLI 0.43% (n=17)
ARQSLQLI 0.38% (n=15)
PKQKLQLV 0.38% (n=15)
PQQNLQLV 0.38% (n=15)
PSQSLHLV 0.38% (n=15)
AQQKLHLV 0.36% (n=14)
SKQNLQLV 0.31% (n=12)
PSQKLHLV 0.31% (n=12)
ANQNLQLI 0.28% (n=11)
PNQKLQLV 0.26% (n=10)
ASQNLQLV 0.26% (n=10)
AQQNLQLI 0.26% (n=10)
PQQNLHLV 0.26% (n=10)
PNQDLQLI 0.23% (n=9)
PNQNLQLI 0.23% (n=9)
SKQNLQLI 0.23% (n=9)
PSQNLQLI 0.20% (n=8)
PRQSLHLV 0.20% (n=8)
AKQKLQLI 0.18% (n=7)
SRQNLQLI 0.18% (n=7)
PKQKLQLI 0.15% (n=6)
PQQNLQLI 0.15% (n=6)
PKQDLQLV 0.13% (n=5)
SNQKLQLV 0.13% (n=5)
ANQNLQLV 0.13% (n=5)
PNQNLQLV 0.13% (n=5)
AQQK---- 0.13% (n=5)
PRQKLQLV 0.10% (n=4)
PSQRLQLV 0.10% (n=4)
PQQK---- 0.10% (n=4)
PKQN---- 0.10% (n=4)
PSQKLQLI 0.10% (n=4)
ASQKLELV 0.10% (n=4)
SNQNLQLV 0.10% (n=4)
ANQKLQLI 0.08% (n=3)
PSQSLQLV 0.08% (n=3)
ARQRLQLV 0.08% (n=3)
ARQKLELI 0.08% (n=3)
AKQDLQLV 0.08% (n=3)
PQQKLALI 0.08% (n=3)
ANQRLQLV 0.08% (n=3)
PSQTLQLV 0.08% (n=3)
AKQN---- 0.08% (n=3)
ASQRLELI 0.08% (n=3)
PKQKIQLI 0.08% (n=3)
ARQKLELV 0.08% (n=3)
AKQQLQLV 0.08% (n=3)
SQQKLQLI 0.08% (n=3)
AKQSLQLI 0.08% (n=3)
PQQKLELV 0.08% (n=3)
SQQNLQLV 0.08% (n=3)
PSQDLQLV 0.05% (n=2)
PNQKLALV 0.05% (n=2)
PRQQLQLV 0.05% (n=2)
ARQNLELI 0.05% (n=2)
AKQNLELI 0.05% (n=2)
TKQKLQLV 0.05% (n=2)
AGQKLQLV 0.05% (n=2)
ARQNLQPV 0.05% (n=2)
AQRRLQLV 0.05% (n=2)
PQQN---- 0.05% (n=2)
PRQKLELV 0.05% (n=2)
PQQRLQLI 0.05% (n=2)
AQQKLELI 0.05% (n=2)
PKQRLQLV 0.05% (n=2)
PSQNLRLV 0.05% (n=2)
AKQDLQLI 0.05% (n=2)
ARQPLQLV 0.05% (n=2)
PSQELQLV 0.05% (n=2)
SSQNLQLI 0.05% (n=2)
PKQQLQLI 0.05% (n=2)
PRQNLELV 0.05% (n=2)
PRQHLQLV 0.05% (n=2)
ANQKLELV 0.05% (n=2)
PTQNLQLI 0.05% (n=2)
PKQNLELI 0.05% (n=2)
PKQNIQLI 0.05% (n=2)
PQQKLHLV 0.05% (n=2)
PKQDLRLV 0.05% (n=2)
PNQNLHLV 0.05% (n=2)
PKQDLHLV 0.05% (n=2)
PSQNLQLM 0.05% (n=2)
AAQRIQLI 0.05% (n=2)
ARQQLQLV 0.05% (n=2)
AKQPLHLV 0.05% (n=2)
ARQNLELV 0.03% (n=1)
SNQKLQLI 0.03% (n=1)
AQQELQLV 0.03% (n=1)
AKQNQQLI 0.03% (n=1)
AKRNLQLV 0.03% (n=1)
AQQKPQLV 0.03% (n=1)
RHQRLELI 0.03% (n=1)
RLQRLELI 0.03% (n=1)
SRQGHELI 0.03% (n=1)
ASQDLQLI 0.03% (n=1)
ASQNLQLT 0.03% (n=1)
SRQSLQLV 0.03% (n=1)
ANQNVQLV 0.03% (n=1)
ARQNPQLV 0.03% (n=1)
ARQNLRLI 0.03% (n=1)
AKQELQLV 0.03% (n=1)
PEQRLELI 0.03% (n=1)
AKQTLQLI 0.03% (n=1)
AKQRLQLV 0.03% (n=1)
AKQWLQLV 0.03% (n=1)
PHQKLALI 0.03% (n=1)
ASQSLQLI 0.03% (n=1)
AHQKLQLV 0.03% (n=1)
RQQNLQLV 0.03% (n=1)
AQRRLRLV 0.03% (n=1)
SKQNVQLI 0.03% (n=1)
ASQKLLLV 0.03% (n=1)
----LELI 0.03% (n=1)
AQPELQLI 0.03% (n=1)
ASQN---- 0.03% (n=1)
FPTK---- 0.03% (n=1)
PKQRLELV 0.03% (n=1)
PR------ 0.03% (n=1)
ARQN---- 0.03% (n=1)
SRQE---- 0.03% (n=1)
PQH----- 0.03% (n=1)
AHQK---- 0.03% (n=1)
PRQ----- 0.03% (n=1)
PSQK---- 0.03% (n=1)
VQQN---- 0.03% (n=1)
PKPK---- 0.03% (n=1)
SKQN---- 0.03% (n=1)
PQQR---- 0.03% (n=1)
AQQN---- 0.03% (n=1)
VRQKLQLV 0.03% (n=1)
PSQNLELI 0.03% (n=1)
AKQNIQLV 0.03% (n=1)
AKQELQLI 0.03% (n=1)
SRQKLELV 0.03% (n=1)
SKQNVQLM 0.03% (n=1)
SRQELRLV 0.03% (n=1)
PIQKLELV 0.03% (n=1)
AQQHLQLV 0.03% (n=1)
SKQKLQLV 0.03% (n=1)
PKQSLYLI 0.03% (n=1)
ARQHLQLV 0.03% (n=1)
PKQKLELV 0.03% (n=1)
SRQDLRLV 0.03% (n=1)
PKQNLKLV 0.03% (n=1)
PMQRLQLV 0.03% (n=1)
PKQHLQLI 0.03% (n=1)
PSQSLKLI 0.03% (n=1)
ASQSLQLV 0.03% (n=1)
ASQQLQLI 0.03% (n=1)
AQQSLQLV 0.03% (n=1)
AKQKLELV 0.03% (n=1)
SQQKLELV 0.03% (n=1)
PSQKLELV 0.03% (n=1)
ARQHLQLI 0.03% (n=1)
PQQQLQLI 0.03% (n=1)
PHQNLQLV 0.03% (n=1)
PKQNLELV 0.03% (n=1)
PQQKLELI 0.03% (n=1)
ARQNIQLV 0.03% (n=1)
AKQNLELV 0.03% (n=1)
PRQKIQLV 0.03% (n=1)
AKQRLELV 0.03% (n=1)
SQQRLQLV 0.03% (n=1)
ANQPLQLI 0.03% (n=1)
PSQRLHLV 0.03% (n=1)
AKQKLNLI 0.03% (n=1)
PNQKLHLV 0.03% (n=1)
AHQNLQLI 0.03% (n=1)
PQQNLRLV 0.03% (n=1)
ASQKIELI 0.03% (n=1)
PRQNLELI 0.03% (n=1)
AKQVLQLV 0.03% (n=1)
SSQKLQLI 0.03% (n=1)
AQQDLQLI 0.03% (n=1)
SQQNLQLI 0.03% (n=1)
SKQDLQLI 0.03% (n=1)
PQQNLELI 0.03% (n=1)
PGQKLQLV 0.03% (n=1)
PKQELRLV 0.03% (n=1)
ANQQLQLI 0.03% (n=1)
AAQNLKLI 0.03% (n=1)
PSQKLELM 0.03% (n=1)
PAQNLQLV 0.03% (n=1)
ANQKL--- 0.03% (n=1)
PKQSLHLV 0.03% (n=1)
PVQKLHLV 0.03% (n=1)
PSQQLHLV 0.03% (n=1)
PKQSLQLV 0.03% (n=1)
AKQNLHLI 0.03% (n=1)
SKQNLHLV 0.03% (n=1)
PAQNLKLV 0.03% (n=1)
PNQNLDLV 0.03% (n=1)
PTQNLNLV 0.03% (n=1)
PKQKLNLV 0.03% (n=1)
PRQNLRLV 0.03% (n=1)
SRQNLNLV 0.03% (n=1)
PKQNLNLV 0.03% (n=1)
AKQALHLV 0.03% (n=1)
PSQDLHLV 0.03% (n=1)
PQQKLNLV 0.03% (n=1)
PKQSLSLV 0.03% (n=1)
PKQQLHLV 0.03% (n=1)
PAQKLHLV 0.03% (n=1)
PRQDLHLV 0.03% (n=1)
PSQNLNLV 0.03% (n=1)
PSQGLHLV 0.03% (n=1)
PKQNLQLM 0.03% (n=1)
PTQHLNLV 0.03% (n=1)
SRQNLQLT 0.03% (n=1)
PKQTIQLV 0.03% (n=1)
PAQKLQLV 0.03% (n=1)
PRQTLQLI 0.03% (n=1)
PAQQIQLV 0.03% (n=1)
AQQKIQLI 0.03% (n=1)
AQQNIQLI 0.03% (n=1)
PKQHIQLI 0.03% (n=1)
SRQNLHLV 0.03% (n=1)
SKQNLHLI 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 3a:

AQQKLQLV 10.64% (n=349)
PQQKLQLV 10.40% (n=341)
AKQKLQLV 8.41% (n=276)
ASQKLELI 8.29% (n=272)
PRQNLQLI 7.80% (n=256)
ARQNLQLV 6.89% (n=226)
AKQNLQLV 6.01% (n=197)
ANQKLQLV 4.48% (n=147)
ARQNLQLI 2.80% (n=92)
PKQNLQLV 2.26% (n=74)
ASQNLQLI 2.13% (n=70)
AKQNLQLI 1.80% (n=59)
AQQRLQLV 1.65% (n=54)
PRQNLQLV 1.43% (n=47)
PKQNLQLI 1.31% (n=43)
AQQNLQLV 1.31% (n=43)
ARQKLQLI 1.19% (n=39)
ANQRLELI 1.07% (n=35)
SRQNLQLV 1.04% (n=34)
ASQNLELI 0.98% (n=32)
AQQKLQLI 0.95% (n=31)
ANQKLELI 0.88% (n=29)
PQQKLQLI 0.82% (n=27)
ASQKLQLV 0.79% (n=26)
ARQKLQLV 0.73% (n=24)
AQQKLELV 0.61% (n=20)
ASQKLQLI 0.52% (n=17)
PSQNLQLV 0.46% (n=15)
ARQSLQLI 0.46% (n=15)
AQQKLHLV 0.43% (n=14)
PKQKLQLV 0.40% (n=13)
ANQNLQLI 0.34% (n=11)
PSQKLQLV 0.34% (n=11)
PNQKLQLV 0.30% (n=10)
ASQNLQLV 0.30% (n=10)
AQQNLQLI 0.30% (n=10)
PNQDLQLI 0.27% (n=9)
PNQNLQLI 0.27% (n=9)
AKQKLQLI 0.21% (n=7)
PSQNLQLI 0.21% (n=7)
SKQNLQLI 0.21% (n=7)
SKQNLQLV 0.18% (n=6)
PKQKLQLI 0.18% (n=6)
SRQNLQLI 0.18% (n=6)
PQQNLQLI 0.18% (n=6)
SNQKLQLV 0.15% (n=5)
ANQNLQLV 0.15% (n=5)
AQQK---- 0.15% (n=5)
PKQDLQLV 0.12% (n=4)
PSQRLQLV 0.12% (n=4)
PNQNLQLV 0.12% (n=4)
PQQK---- 0.12% (n=4)
PKQN---- 0.12% (n=4)
PSQKLQLI 0.12% (n=4)
ASQKLELV 0.12% (n=4)
ANQKLQLI 0.09% (n=3)
PSQSLQLV 0.09% (n=3)
PRQKLQLV 0.09% (n=3)
ARQRLQLV 0.09% (n=3)
ARQKLELI 0.09% (n=3)
AKQDLQLV 0.09% (n=3)
PQQKLALI 0.09% (n=3)
ANQRLQLV 0.09% (n=3)
AKQN---- 0.09% (n=3)
ASQRLELI 0.09% (n=3)
PKQKIQLI 0.09% (n=3)
ARQKLELV 0.09% (n=3)
AKQQLQLV 0.09% (n=3)
SQQKLQLI 0.09% (n=3)
AKQSLQLI 0.09% (n=3)
PQQNLQLV 0.09% (n=3)
SNQNLQLV 0.09% (n=3)
PNQKLALV 0.06% (n=2)
PRQQLQLV 0.06% (n=2)
ARQNLELI 0.06% (n=2)
AKQNLELI 0.06% (n=2)
TKQKLQLV 0.06% (n=2)
AGQKLQLV 0.06% (n=2)
ARQNLQPV 0.06% (n=2)
AQRRLQLV 0.06% (n=2)
PSQTLQLV 0.06% (n=2)
PQQN---- 0.06% (n=2)
PRQKLELV 0.06% (n=2)
PQQRLQLI 0.06% (n=2)
AQQKLELI 0.06% (n=2)
PKQRLQLV 0.06% (n=2)
AKQDLQLI 0.06% (n=2)
ARQPLQLV 0.06% (n=2)
PKQQLQLI 0.06% (n=2)
PQQKLELV 0.06% (n=2)
PRQNLELV 0.06% (n=2)
PRQHLQLV 0.06% (n=2)
ANQKLELV 0.06% (n=2)
PSQNLHLV 0.06% (n=2)
PKQNLELI 0.06% (n=2)
PSQDLQLV 0.03% (n=1)
ARQNLELV 0.03% (n=1)
SNQKLQLI 0.03% (n=1)
AQQELQLV 0.03% (n=1)
AKQNQQLI 0.03% (n=1)
AKRNLQLV 0.03% (n=1)
AQQKPQLV 0.03% (n=1)
RHQRLELI 0.03% (n=1)
RLQRLELI 0.03% (n=1)
SRQGHELI 0.03% (n=1)
ASQDLQLI 0.03% (n=1)
ASQNLQLT 0.03% (n=1)
SRQSLQLV 0.03% (n=1)
ANQNVQLV 0.03% (n=1)
ARQNPQLV 0.03% (n=1)
ARQNLRLI 0.03% (n=1)
AKQELQLV 0.03% (n=1)
PEQRLELI 0.03% (n=1)
AKQTLQLI 0.03% (n=1)
AKQRLQLV 0.03% (n=1)
AKQWLQLV 0.03% (n=1)
PHQKLALI 0.03% (n=1)
ASQSLQLI 0.03% (n=1)
AHQKLQLV 0.03% (n=1)
RQQNLQLV 0.03% (n=1)
AQRRLRLV 0.03% (n=1)
SKQNVQLI 0.03% (n=1)
ASQKLLLV 0.03% (n=1)
----LELI 0.03% (n=1)
AQPELQLI 0.03% (n=1)
ASQN---- 0.03% (n=1)
FPTK---- 0.03% (n=1)
PKQRLELV 0.03% (n=1)
PR------ 0.03% (n=1)
ARQN---- 0.03% (n=1)
SRQE---- 0.03% (n=1)
PQH----- 0.03% (n=1)
AHQK---- 0.03% (n=1)
PRQ----- 0.03% (n=1)
PSQK---- 0.03% (n=1)
VQQN---- 0.03% (n=1)
PKPK---- 0.03% (n=1)
SKQN---- 0.03% (n=1)
PQQR---- 0.03% (n=1)
AQQN---- 0.03% (n=1)
VRQKLQLV 0.03% (n=1)
PSQNLELI 0.03% (n=1)
AKQNIQLV 0.03% (n=1)
AKQELQLI 0.03% (n=1)
SRQKLELV 0.03% (n=1)
SKQNVQLM 0.03% (n=1)
SRQELRLV 0.03% (n=1)
PIQKLELV 0.03% (n=1)
AQQHLQLV 0.03% (n=1)
SKQKLQLV 0.03% (n=1)
PKQSLYLI 0.03% (n=1)
ARQHLQLV 0.03% (n=1)
PSQNLRLV 0.03% (n=1)
PKQKLELV 0.03% (n=1)
SRQDLRLV 0.03% (n=1)
PKQNLKLV 0.03% (n=1)
PMQRLQLV 0.03% (n=1)
PKQHLQLI 0.03% (n=1)
PSQSLKLI 0.03% (n=1)
ASQSLQLV 0.03% (n=1)
ASQQLQLI 0.03% (n=1)
AQQSLQLV 0.03% (n=1)
PSQELQLV 0.03% (n=1)
AKQKLELV 0.03% (n=1)
SSQNLQLI 0.03% (n=1)
SQQKLELV 0.03% (n=1)
PSQKLELV 0.03% (n=1)
ARQHLQLI 0.03% (n=1)
PQQQLQLI 0.03% (n=1)
PHQNLQLV 0.03% (n=1)
PKQNLHLV 0.03% (n=1)
PKQNLELV 0.03% (n=1)
PQQKLELI 0.03% (n=1)
ARQNIQLV 0.03% (n=1)
AKQNLELV 0.03% (n=1)
PRQKIQLV 0.03% (n=1)
AKQRLELV 0.03% (n=1)
SQQRLQLV 0.03% (n=1)
ANQPLQLI 0.03% (n=1)
PTQNLQLI 0.03% (n=1)
PSQRLHLV 0.03% (n=1)
AKQKLNLI 0.03% (n=1)
PNQKLHLV 0.03% (n=1)
AHQNLQLI 0.03% (n=1)
PQQNLRLV 0.03% (n=1)
ASQKIELI 0.03% (n=1)
PRQNLELI 0.03% (n=1)
AKQVLQLV 0.03% (n=1)
PRQNLHLV 0.03% (n=1)
SSQKLQLI 0.03% (n=1)
PKQNIQLI 0.03% (n=1)
AQQDLQLI 0.03% (n=1)
SQQNLQLI 0.03% (n=1)
SKQDLQLI 0.03% (n=1)
SQQNLQLV 0.03% (n=1)
PQQNLELI 0.03% (n=1)
PGQKLQLV 0.03% (n=1)
PKQELRLV 0.03% (n=1)
ANQQLQLI 0.03% (n=1)
AAQNLKLI 0.03% (n=1)
PSQKLELM 0.03% (n=1)
PAQNLQLV 0.03% (n=1)
ANQKL--- 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 3b:

PRQNLHLV 20.00% (n=79)
PSQNLHLV 16.71% (n=66)
PKQNLHLV 12.15% (n=48)
ARQNLHLV 7.09% (n=28)
PSQNLQLV 5.82% (n=23)
PKQNLQLV 5.32% (n=21)
PSQSLHLV 3.80% (n=15)
PSQKLHLV 3.04% (n=12)
PQQNLQLV 2.53% (n=10)
PQQNLHLV 2.53% (n=10)
PRQSLHLV 2.03% (n=8)
PSQKLQLV 1.77% (n=7)
PRQNLQLV 1.77% (n=7)
SKQNLQLV 1.27% (n=5)
SRQNLQLV 1.01% (n=4)
AKQNLQLV 0.76% (n=3)
SQQNLQLV 0.51% (n=2)
PQQKLHLV 0.51% (n=2)
PKQDLRLV 0.51% (n=2)
ARQNLQLV 0.51% (n=2)
PNQNLHLV 0.51% (n=2)
PKQKLQLV 0.51% (n=2)
PKQDLHLV 0.51% (n=2)
PQQKLQLV 0.51% (n=2)
PSQNLQLM 0.51% (n=2)
PKQSLHLV 0.25% (n=1)
PVQKLHLV 0.25% (n=1)
PSQQLHLV 0.25% (n=1)
PKQSLQLV 0.25% (n=1)
PNQNLQLV 0.25% (n=1)
PSQELQLV 0.25% (n=1)
AKQNLHLI 0.25% (n=1)
SKQNLHLV 0.25% (n=1)
PAQNLKLV 0.25% (n=1)
PNQNLDLV 0.25% (n=1)
PTQNLNLV 0.25% (n=1)
PKQKLNLV 0.25% (n=1)
PSQDLQLV 0.25% (n=1)
PRQNLRLV 0.25% (n=1)
SRQNLNLV 0.25% (n=1)
PKQDLQLV 0.25% (n=1)
PKQNLNLV 0.25% (n=1)
AKQALHLV 0.25% (n=1)
PSQNLRLV 0.25% (n=1)
PSQDLHLV 0.25% (n=1)
PQQKLNLV 0.25% (n=1)
PKQSLSLV 0.25% (n=1)
PKQQLHLV 0.25% (n=1)
PAQKLHLV 0.25% (n=1)
PRQDLHLV 0.25% (n=1)
PSQNLNLV 0.25% (n=1)
PSQGLHLV 0.25% (n=1)
PKQNLQLM 0.25% (n=1)
PTQHLNLV 0.25% (n=1)
SRQNLQLT 0.25% (n=1)
PRQKLQLV 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 4:

SQQNVQLI 34.90% (n=267)
SRQNVQLI 8.63% (n=66)
PSQNLGLI 8.10% (n=62)
SQQNLQLI 7.71% (n=59)
SKQNLQLI 7.45% (n=57)
SQQNIQLI 5.88% (n=45)
AQQRIQLV 3.53% (n=27)
SRQNIQLI 2.61% (n=20)
PSQKLHLI 2.48% (n=19)
SKQNIQLI 2.48% (n=19)
PKQNLHLI 2.22% (n=17)
ARQNLQLI 1.05% (n=8)
AKQNLQLI 0.78% (n=6)
AKQNIQLI 0.65% (n=5)
PKQNLQLI 0.65% (n=5)
PQQKLQLI 0.52% (n=4)
SRQNLQLI 0.52% (n=4)
AQQNLQLI 0.39% (n=3)
AKQNVQLI 0.39% (n=3)
PRQNIQLI 0.39% (n=3)
SRQNIQLT 0.39% (n=3)
AKQNLQLV 0.26% (n=2)
AQQNLQLV 0.26% (n=2)
PRQNLQLI 0.26% (n=2)
PKQNIQLI 0.26% (n=2)
ARQNLQLV 0.26% (n=2)
PKQNLQLV 0.26% (n=2)
ASQKLQLV 0.13% (n=1)
PQQNLQLI 0.13% (n=1)
AQQTLQLV 0.13% (n=1)
SAQNLQLI 0.13% (n=1)
AQQRMQLV 0.13% (n=1)
SRQDVQLI 0.13% (n=1)
PRQNVQLI 0.13% (n=1)
PKQRIQLV 0.13% (n=1)
SQQNVQLV 0.13% (n=1)
GQQHIQLI 0.13% (n=1)
SHQKIQLI 0.13% (n=1)
PSQKLQLI 0.13% (n=1)
SKQNVQLI 0.13% (n=1)
PQQNIQLI 0.13% (n=1)
PQQEMRLV 0.13% (n=1)
PQQEIRLV 0.13% (n=1)
SRQNIHLI 0.13% (n=1)
SKQDLQLI 0.13% (n=1)
ASQNLQLI 0.13% (n=1)
PQQRIQLV 0.13% (n=1)
PTQKIQLV 0.13% (n=1)
SRQNIMLI 0.13% (n=1)
SMQNIMLI 0.13% (n=1)
PQQKIQLV 0.13% (n=1)
ARQDLKLI 0.13% (n=1)
PQQQLRLI 0.13% (n=1)
ASQNLQLV 0.13% (n=1)
ARQKIQLV 0.13% (n=1)
SQQKIQLI 0.13% (n=1)
PKQNIQLV 0.13% (n=1)
PQQNLQLV 0.13% (n=1)
AQQRLQLI 0.13% (n=1)
PEQNLQLI 0.13% (n=1)
AQQNIRLI 0.13% (n=1)
PRQHLSLI 0.13% (n=1)
PRQALQLI 0.13% (n=1)
PQQRLQLI 0.13% (n=1)
PNQQLQLV 0.13% (n=1)
PQQRVQLI 0.13% (n=1)
PSQNLHLV 0.13% (n=1)
PRQDLQLI 0.13% (n=1)
PKQNLRLI 0.13% (n=1)
AKQNLRLI 0.13% (n=1)
AKQPLQLI 0.13% (n=1)
GRQDIRLI 0.13% (n=1)
PRQKLQLI 0.13% (n=1)
PKQDIKLV 0.13% (n=1)
AKQSLQLI 0.13% (n=1)
AKQNIQLV 0.13% (n=1)
PQQNLRLV 0.13% (n=1)
AKQDVQLI 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 4a:

PSQNLGLI 38.75% (n=62)
AQQRIQLV 16.88% (n=27)
PSQKLHLI 11.88% (n=19)
PKQNLHLI 10.63% (n=17)
ARQNLQLI 3.13% (n=5)
SKQNLQLI 2.50% (n=4)
AKQNLQLI 1.88% (n=3)
SQQNLQLI 1.88% (n=3)
AQQNLQLI 1.25% (n=2)
PQQKLQLI 1.25% (n=2)
AQQNLQLV 1.25% (n=2)
AKQNVQLI 1.25% (n=2)
SQQNVQLI 0.63% (n=1)
AKQNLQLV 0.63% (n=1)
ASQKLQLV 0.63% (n=1)
PQQNLQLI 0.63% (n=1)
AQQTLQLV 0.63% (n=1)
SRQNVQLI 0.63% (n=1)
SAQNLQLI 0.63% (n=1)
AQQRMQLV 0.63% (n=1)
SRQDVQLI 0.63% (n=1)
PRQNVQLI 0.63% (n=1)
PRQNLQLI 0.63% (n=1)
SKQNIQLI 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 4d:

SQQNVQLI 49.08% (n=266)
SRQNVQLI 11.99% (n=65)
SQQNLQLI 10.33% (n=56)
SKQNLQLI 9.59% (n=52)
SQQNIQLI 8.30% (n=45)
SKQNIQLI 3.32% (n=18)
SRQNIQLI 3.32% (n=18)
AKQNIQLI 0.55% (n=3)
PRQNIQLI 0.55% (n=3)
SRQNIQLT 0.55% (n=3)
SQQNVQLV 0.18% (n=1)
GQQHIQLI 0.18% (n=1)
SHQKIQLI 0.18% (n=1)
PSQKLQLI 0.18% (n=1)
SRQNLQLI 0.18% (n=1)
PKQNIQLI 0.18% (n=1)
SKQNVQLI 0.18% (n=1)
PQQNIQLI 0.18% (n=1)
PQQEMRLV 0.18% (n=1)
PQQEIRLV 0.18% (n=1)
AKQNVQLI 0.18% (n=1)
SRQNIHLI 0.18% (n=1)
SKQDLQLI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 5:

PQQNLQLI 6.71% (n=10)
ARQNLQLI 6.04% (n=9)
PQQKLQLI 5.37% (n=8)
AKQNLQLI 5.37% (n=8)
PSQNLQLI 5.37% (n=8)
AKQDLQLI 4.70% (n=7)
SQQNLQLI 4.03% (n=6)
PKQNLQLI 3.36% (n=5)
PRQNLQLI 2.68% (n=4)
ANQPLQLI 2.68% (n=4)
SRQNLQLI 2.68% (n=4)
PKQNLQ-- 2.01% (n=3)
AQQKLQLI 2.01% (n=3)
PSQRLQLI 2.01% (n=3)
AKQNIQLI 1.34% (n=2)
PQQNL--- 1.34% (n=2)
PSQNLQ-- 1.34% (n=2)
SKQNLQLI 1.34% (n=2)
PRQKLQLI 1.34% (n=2)
ARQPLQLV 1.34% (n=2)
AQQNLQLI 1.34% (n=2)
PQQKLQLV 1.34% (n=2)
ARQNLQLV 1.34% (n=2)
SKQNLQLV 1.34% (n=2)
PKQKLQLI 1.34% (n=2)
PAQNLQLI 1.34% (n=2)
PQRQLQFV 1.34% (n=2)
PKQNIQ-- 0.67% (n=1)
SAQNVQ-- 0.67% (n=1)
PSQN---- 0.67% (n=1)
PKQDL--- 0.67% (n=1)
PKQHLQ-- 0.67% (n=1)
AKQN---- 0.67% (n=1)
PKQNLQL- 0.67% (n=1)
ARQQLQLI 0.67% (n=1)
PRQQLQLI 0.67% (n=1)
PQQHLQLI 0.67% (n=1)
PSQSLQLM 0.67% (n=1)
SQQKLQLI 0.67% (n=1)
ARQKLQLI 0.67% (n=1)
PSQNLQII 0.67% (n=1)
AQQ----- 0.67% (n=1)
SHQHLQLI 0.67% (n=1)
PQQQLQLI 0.67% (n=1)
PKQRLQLI 0.67% (n=1)
AKAELQLI 0.67% (n=1)
AKQKLQLI 0.67% (n=1)
AHQKLELI 0.67% (n=1)
PSQKLQLI 0.67% (n=1)
AKQDLRLM 0.67% (n=1)
SKQPLQLV 0.67% (n=1)
AKQNLQLV 0.67% (n=1)
SQAESAAH 0.67% (n=1)
PNQNLQLI 0.67% (n=1)
PYQNLQLI 0.67% (n=1)
PTQELQLI 0.67% (n=1)
PAQQLQLV 0.67% (n=1)
PSQKLQLM 0.67% (n=1)
PKQDLQLI 0.67% (n=1)
ASQNLQLI 0.67% (n=1)
PIQNLQLM 0.67% (n=1)
PAQRLQLI 0.67% (n=1)
ANQNLQLI 0.67% (n=1)
PKQNIQLI 0.67% (n=1)
PSQKLQLV 0.67% (n=1)
SHQKLQLI 0.67% (n=1)
AHQNLQLI 0.67% (n=1)
PRQNLQLV 0.67% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 6:

AKQNLQLI 17.04% (n=92)
ARQNLQLI 11.67% (n=63)
PKQNLQLV 4.63% (n=25)
PKQNLQLI 4.07% (n=22)
AKQNLQLV 3.52% (n=19)
AKQNIQLI 3.33% (n=18)
SKQNLQLI 2.78% (n=15)
SRQNLQLI 2.78% (n=15)
ARQNLQLV 2.59% (n=14)
ARQNIQLI 2.22% (n=12)
SQQNIQLV 2.04% (n=11)
PKQNIQLV 1.85% (n=10)
PQQNLQLI 1.48% (n=8)
ARQNIQLV 1.48% (n=8)
AQQNIQLI 1.48% (n=8)
SKQNIQLV 1.48% (n=8)
PRQNLQLI 1.30% (n=7)
PKQNIQLI 1.30% (n=7)
SRQNIQLI 1.30% (n=7)
PRQNLQLV 1.11% (n=6)
PQQKLQLI 1.11% (n=6)
SQQNLQLI 1.11% (n=6)
ARQKLQLI 0.93% (n=5)
SRQNIQLV 0.93% (n=5)
AQQNLQLI 0.74% (n=4)
PQQKLQLV 0.74% (n=4)
PSQKLQLI 0.74% (n=4)
PQQNLQLV 0.74% (n=4)
SKQNLQLV 0.74% (n=4)
PNQKIQLI 0.74% (n=4)
SRQNLQLV 0.74% (n=4)
SKQNIQLM 0.74% (n=4)
ASQNLQLI 0.56% (n=3)
PKQSLQLV 0.56% (n=3)
PKQNLHLV 0.56% (n=3)
SKQNIQLI 0.56% (n=3)
SQQNLQLV 0.56% (n=3)
PQQRLQLI 0.56% (n=3)
SKQNVQLI 0.56% (n=3)
AKQNIQLM 0.56% (n=3)
PSQNLQLI 0.37% (n=2)
PKQKLQLV 0.37% (n=2)
PKQTLQLI 0.37% (n=2)
AKQDLQLI 0.37% (n=2)
PSQTIQLI 0.37% (n=2)
ASQKLQLV 0.37% (n=2)
AKQNIHLI 0.37% (n=2)
SQQKLQLV 0.37% (n=2)
PTQNLQLV 0.37% (n=2)
GKQNIQLI 0.37% (n=2)
SAQKLQLI 0.37% (n=2)
SAQNLQLI 0.37% (n=2)
ARQSIQLI 0.19% (n=1)
PKQGLQLV 0.19% (n=1)
PQQKLHLV 0.19% (n=1)
AKQNLQLM 0.19% (n=1)
PSQKLHLV 0.19% (n=1)
PQQNVQLI 0.19% (n=1)
ASQKLQLI 0.19% (n=1)
PKQKLQLI 0.19% (n=1)
ARQNLHLI 0.19% (n=1)
AKQKLQLI 0.19% (n=1)
AMQNLQLV 0.19% (n=1)
PRQKLQLI 0.19% (n=1)
PSQNLQLV 0.19% (n=1)
ANQNLQLI 0.19% (n=1)
SRQNIQFI 0.19% (n=1)
SQQNVQLI 0.19% (n=1)
PSQRLQLI 0.19% (n=1)
PNQNIQLI 0.19% (n=1)
AKQNVQLI 0.19% (n=1)
ARQTLQLI 0.19% (n=1)
PSQNIQLI 0.19% (n=1)
AQQKLQLI 0.19% (n=1)
PSQRLQLV 0.19% (n=1)
SKQHLQLV 0.19% (n=1)
PQQSLQLV 0.19% (n=1)
PQQYLQLI 0.19% (n=1)
AKQRLQLI 0.19% (n=1)
PKQRLQLI 0.19% (n=1)
AKQHLQLI 0.19% (n=1)
AHQRLQLI 0.19% (n=1)
PQQHLQLI 0.19% (n=1)
PQQHIQLV 0.19% (n=1)
PSQDLQLI 0.19% (n=1)
PQQKLHLI 0.19% (n=1)
AQQNIQLV 0.19% (n=1)
ASQNIQLI 0.19% (n=1)
PKQSIQLM 0.19% (n=1)
SSQNIQLV 0.19% (n=1)
PRQKIQLV 0.19% (n=1)
AAQNIQLI 0.19% (n=1)
PRQDIQLV 0.19% (n=1)
PRQSIQLV 0.19% (n=1)
AQQSIQLI 0.19% (n=1)
SRQNIQLM 0.19% (n=1)
PKQNIQLM 0.19% (n=1)
SRQKIQLI 0.19% (n=1)
PSQNLHLI 0.19% (n=1)
AKQRIQLI 0.19% (n=1)
PQQNIQLI 0.19% (n=1)
SQQNIQLM 0.19% (n=1)
SQQHLQLV 0.19% (n=1)
ARQNIQLM 0.19% (n=1)
ASQHLQLI 0.19% (n=1)
PKQKIQLI 0.19% (n=1)
PSQHIQLI 0.19% (n=1)
PSQQLQLI 0.19% (n=1)
PRQNIQLI 0.19% (n=1)
ASQNLQLV 0.19% (n=1)
PSQKLQLV 0.19% (n=1)
PQQHLMLI 0.19% (n=1)
AKQNIQLV 0.19% (n=1)
PKQRIQLI 0.19% (n=1)
AQQKLMLI 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Subtype 6a:

AKQNLQLI 29.11% (n=85)
ARQNLQLI 18.49% (n=54)
PKQNLQLV 7.88% (n=23)
AKQNLQLV 6.16% (n=18)
PKQNLQLI 6.16% (n=18)
ARQNLQLV 3.08% (n=9)
PRQNLQLV 2.05% (n=6)
AKQNIQLI 2.05% (n=6)
PRQNLQLI 1.71% (n=5)
PQQNLQLI 1.71% (n=5)
ARQKLQLI 1.71% (n=5)
ASQNLQLI 1.03% (n=3)
AQQNLQLI 1.03% (n=3)
PKQSLQLV 1.03% (n=3)
SKQNLQLI 1.03% (n=3)
PQQKLQLV 1.03% (n=3)
PSQNLQLI 0.68% (n=2)
PKQKLQLV 0.68% (n=2)
PKQTLQLI 0.68% (n=2)
PQQKLQLI 0.68% (n=2)
PKQNLHLV 0.68% (n=2)
PSQKLQLI 0.68% (n=2)
ARQSIQLI 0.34% (n=1)
PKQGLQLV 0.34% (n=1)
PQQKLHLV 0.34% (n=1)
AKQNLQLM 0.34% (n=1)
PSQKLHLV 0.34% (n=1)
PQQNVQLI 0.34% (n=1)
ASQKLQLI 0.34% (n=1)
PKQKLQLI 0.34% (n=1)
ARQNIQLV 0.34% (n=1)
AKQDLQLI 0.34% (n=1)
ARQNLHLI 0.34% (n=1)
AKQKLQLI 0.34% (n=1)
PQQNLQLV 0.34% (n=1)
AMQNLQLV 0.34% (n=1)
SKQNLQLV 0.34% (n=1)
SKQNIQLI 0.34% (n=1)
PRQKLQLI 0.34% (n=1)
PSQTIQLI 0.34% (n=1)
PSQNLQLV 0.34% (n=1)
ANQNLQLI 0.34% (n=1)
SRQNIQFI 0.34% (n=1)
AQQNIQLI 0.34% (n=1)
SKQNIQLV 0.34% (n=1)
SQQNVQLI 0.34% (n=1)
PSQRLQLI 0.34% (n=1)
PNQNIQLI 0.34% (n=1)
ARQNIQLI 0.34% (n=1)
AKQNVQLI 0.34% (n=1)
ARQTLQLI 0.34% (n=1)
PSQNIQLI 0.34% (n=1)
AQQKLQLI 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 407-414 (antibodies: [HC33.4] ), HCV Genotype 7:

PSQRLQLI 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 1:

GLFY 41.40% (n=9501)
ALFY 38.87% (n=8922)
GLLY 11.84% (n=2718)
GLIY 3.99% (n=915)
ALIY 0.85% (n=196)
SLFY 0.69% (n=159)
ALLY 0.50% (n=114)
GLFH 0.47% (n=108)
GLVY 0.35% (n=80)
GLMY 0.27% (n=61)
ALVY 0.15% (n=35)
ALSY 0.06% (n=13)
GLFN 0.03% (n=8)
GPFY 0.03% (n=8)
GLFS 0.03% (n=8)
TLFY 0.03% (n=8)
GLFC 0.03% (n=7)
APFY 0.03% (n=7)
VLFY 0.03% (n=6)
ALFH 0.03% (n=6)
RLFY 0.02% (n=5)
ELFY 0.02% (n=5)
GLSY 0.02% (n=4)
ALMY 0.02% (n=4)
ALFC 0.02% (n=4)
ALFN 0.01% (n=3)
ALFA 0.01% (n=3)
GLPY 0.01% (n=2)
GLF* 0.01% (n=2)
GLIH 0.01% (n=2)
GLHY 0.01% (n=2)
GFLY 0.01% (n=2)
GPLY 0.01% (n=2)
GLLH 0.01% (n=2)
GPFS 0.01% (n=2)
ALFF 0.01% (n=2)
RLLY 0.00% (n=1)
RPFY 0.00% (n=1)
GLLC 0.00% (n=1)
GFSY 0.00% (n=1)
GPSY 0.00% (n=1)
RAFL 0.00% (n=1)
SRAS 0.00% (n=1)
GLLP 0.00% (n=1)
GHFY 0.00% (n=1)
GLNY 0.00% (n=1)
GLTY 0.00% (n=1)
DQH* 0.00% (n=1)
-LFY 0.00% (n=1)
WLFY 0.00% (n=1)
GPIY 0.00% (n=1)
GAPL 0.00% (n=1)
GFFY 0.00% (n=1)
GLST 0.00% (n=1)
GLLN 0.00% (n=1)
WLLY 0.00% (n=1)
GLFF 0.00% (n=1)
AL-- 0.00% (n=1)
GVFY 0.00% (n=1)
ARFY 0.00% (n=1)
ALFL 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 1a:

GLFY 69.52% (n=9483)
GLLY 19.51% (n=2662)
GLIY 6.70% (n=914)
ALFY 1.78% (n=243)
GLFH 0.79% (n=108)
GLVY 0.59% (n=80)
GLMY 0.45% (n=61)
GLFN 0.06% (n=8)
GPFY 0.06% (n=8)
GLFS 0.06% (n=8)
GLFC 0.05% (n=7)
SLFY 0.05% (n=7)
RLFY 0.04% (n=5)
GLSY 0.03% (n=4)
GLPY 0.01% (n=2)
GLF* 0.01% (n=2)
GLIH 0.01% (n=2)
GLHY 0.01% (n=2)
GFLY 0.01% (n=2)
GPLY 0.01% (n=2)
GLLH 0.01% (n=2)
GPFS 0.01% (n=2)
ELFY 0.01% (n=2)
ALLY 0.01% (n=2)
RLLY 0.01% (n=1)
RPFY 0.01% (n=1)
GLLC 0.01% (n=1)
GFSY 0.01% (n=1)
GPSY 0.01% (n=1)
RAFL 0.01% (n=1)
SRAS 0.01% (n=1)
GLLP 0.01% (n=1)
GHFY 0.01% (n=1)
GLNY 0.01% (n=1)
APFY 0.01% (n=1)
GLTY 0.01% (n=1)
DQH* 0.01% (n=1)
-LFY 0.01% (n=1)
WLFY 0.01% (n=1)
GPIY 0.01% (n=1)
GAPL 0.01% (n=1)
GFFY 0.01% (n=1)
GLST 0.01% (n=1)
ALIY 0.01% (n=1)
GLLN 0.01% (n=1)
WLLY 0.01% (n=1)
GLFF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 1b:

ALFY 93.52% (n=8664)
ALIY 2.09% (n=194)
SLFY 1.57% (n=145)
ALLY 1.20% (n=111)
GLLY 0.55% (n=51)
ALVY 0.37% (n=34)
ALSY 0.14% (n=13)
TLFY 0.09% (n=8)
APFY 0.06% (n=6)
VLFY 0.06% (n=6)
ALFH 0.06% (n=6)
GLFY 0.06% (n=6)
ALMY 0.04% (n=4)
ALFC 0.04% (n=4)
ALFN 0.03% (n=3)
ELFY 0.03% (n=3)
ALFF 0.02% (n=2)
AL-- 0.01% (n=1)
GVFY 0.01% (n=1)
ARFY 0.01% (n=1)
GLIY 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 2:

SLFY 57.62% (n=779)
ALFY 40.16% (n=543)
ALLY 0.37% (n=5)
SLFH 0.22% (n=3)
PLFY 0.22% (n=3)
ALFH 0.15% (n=2)
QLFY 0.15% (n=2)
TLFF 0.15% (n=2)
ALVY 0.15% (n=2)
ALIY 0.07% (n=1)
SPFY 0.07% (n=1)
ALFF 0.07% (n=1)
ALFR 0.07% (n=1)
SLF- 0.07% (n=1)
SLVY 0.07% (n=1)
SLLY 0.07% (n=1)
ALFC 0.07% (n=1)
GLIY 0.07% (n=1)
VLFY 0.07% (n=1)
SLSY 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 2a:

SLFY 77.66% (n=226)
ALFY 18.21% (n=53)
SLFH 0.69% (n=2)
QLFY 0.69% (n=2)
TLFF 0.69% (n=2)
ALIY 0.34% (n=1)
SPFY 0.34% (n=1)
ALFF 0.34% (n=1)
ALLY 0.34% (n=1)
ALVY 0.34% (n=1)
ALFR 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 2b:

SLFY 93.72% (n=433)
ALFY 4.55% (n=21)
PLFY 0.43% (n=2)
ALLY 0.43% (n=2)
ALVY 0.22% (n=1)
SLF- 0.22% (n=1)
SLVY 0.22% (n=1)
SLLY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 2c:

ALFY 97.58% (n=443)
SLFY 1.32% (n=6)
ALFC 0.22% (n=1)
GLIY 0.22% (n=1)
ALFH 0.22% (n=1)
VLFY 0.22% (n=1)
ALLY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 3:

GLFY 66.80% (n=2592)
GLIY 18.58% (n=721)
ALFY 4.51% (n=175)
GLLY 3.56% (n=138)
GLMY 2.47% (n=96)
GLFS 1.65% (n=64)
GLFH 1.34% (n=52)
GLVY 0.46% (n=18)
GLFN 0.28% (n=11)
GLFR 0.03% (n=1)
RLFY 0.03% (n=1)
GMFY 0.03% (n=1)
GLFC 0.03% (n=1)
GLSY 0.03% (n=1)
ELIY 0.03% (n=1)
GSFY 0.03% (n=1)
ELFY 0.03% (n=1)
GFDY 0.03% (n=1)
GCFY 0.03% (n=1)
GCFI 0.03% (n=1)
GLFF 0.03% (n=1)
RLMY 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 3a:

GLFY 75.32% (n=2450)
GLIY 15.00% (n=488)
GLLY 3.54% (n=115)
GLFS 1.91% (n=62)
GLMY 1.60% (n=52)
GLFH 1.57% (n=51)
GLVY 0.40% (n=13)
GLFN 0.31% (n=10)
GLFR 0.03% (n=1)
RLFY 0.03% (n=1)
GMFY 0.03% (n=1)
GLFC 0.03% (n=1)
GLSY 0.03% (n=1)
ELIY 0.03% (n=1)
GSFY 0.03% (n=1)
ELFY 0.03% (n=1)
GFDY 0.03% (n=1)
GCFY 0.03% (n=1)
GCFI 0.03% (n=1)
GLFF 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 3b:

GLIY 57.21% (n=230)
GLFY 24.88% (n=100)
GLMY 10.20% (n=41)
GLLY 5.22% (n=21)
GLVY 1.24% (n=5)
GLFS 0.50% (n=2)
RLMY 0.25% (n=1)
GLFN 0.25% (n=1)
GLFH 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 4:

SLFY 78.56% (n=601)
GLFY 13.86% (n=106)
GLLY 3.14% (n=24)
ALFY 1.96% (n=15)
NLFY 1.57% (n=12)
GLIY 0.52% (n=4)
SLLY 0.13% (n=1)
GLFR 0.13% (n=1)
GLMY 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 4a:

SLFY 75.93% (n=123)
GLFY 19.14% (n=31)
ALFY 3.70% (n=6)
NLFY 0.62% (n=1)
GLLY 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 4d:

SLFY 85.42% (n=463)
GLFY 8.86% (n=48)
GLLY 2.58% (n=14)
NLFY 2.03% (n=11)
ALFY 0.74% (n=4)
SLLY 0.18% (n=1)
GLFR 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 5:

GLMY 35.90% (n=14)
GLLY 23.08% (n=9)
GLFY 20.51% (n=8)
GLIY 17.95% (n=7)
GLVY 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 6:

SLFY 54.23% (n=308)
GLFY 21.13% (n=120)
ALFY 12.68% (n=72)
GLLY 5.11% (n=29)
GLIY 2.29% (n=13)
GLMY 0.70% (n=4)
GLFA 0.53% (n=3)
GLFS 0.53% (n=3)
PLFY 0.53% (n=3)
SLIY 0.35% (n=2)
SLLY 0.35% (n=2)
ALIY 0.35% (n=2)
NLFY 0.35% (n=2)
SLMY 0.18% (n=1)
GLVY 0.18% (n=1)
GLFN 0.18% (n=1)
ALFT 0.18% (n=1)
ALLY 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Subtype 6a:

SLFY 85.11% (n=280)
ALFY 11.85% (n=39)
SLIY 0.61% (n=2)
GLLY 0.61% (n=2)
SLLY 0.61% (n=2)
ALIY 0.61% (n=2)
GLFY 0.30% (n=1)
SLMY 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 440-443 (antibodies: [HC84.1, HC84.25, HC84.26] ), HCV Genotype 7:

ALFY 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 1:

ALFYT 19.02% (n=4357)
GLFYY 18.21% (n=4170)
GLFYH 15.23% (n=3488)
ALFYA 9.28% (n=2125)
GLLYY 7.88% (n=1804)
ALFYV 5.37% (n=1229)
GLFYR 4.34% (n=994)
GLLYH 2.62% (n=600)
ALFYR 2.53% (n=579)
GLIYY 2.08% (n=477)
GLFYS 1.82% (n=418)
GLIYH 1.25% (n=287)
ALFYS 0.96% (n=221)
ALFYK 0.94% (n=215)
GLFYQ 0.72% (n=165)
ALIYA 0.60% (n=137)
GLLYA 0.56% (n=128)
ALFYH 0.43% (n=99)
GLLYR 0.42% (n=97)
GLFHY 0.40% (n=92)
SLFYV 0.39% (n=89)
GLVYY 0.31% (n=72)
GLFYV 0.28% (n=64)
ALLYA 0.26% (n=60)
GLIYQ 0.25% (n=58)
GLIYR 0.21% (n=49)
ALFYY 0.21% (n=48)
GLFYF 0.21% (n=47)
GLFYP 0.20% (n=45)
GLFYT 0.19% (n=43)
ALIYR 0.14% (n=32)
GLMYY 0.11% (n=26)
GLFYA 0.11% (n=25)
GLIYF 0.11% (n=25)
ALVYA 0.11% (n=25)
GLLYS 0.10% (n=23)
ALIYK 0.09% (n=21)
SLFYT 0.08% (n=19)
SLFYA 0.08% (n=19)
GLLYP 0.08% (n=18)
GLLYF 0.08% (n=18)
ALLYS 0.08% (n=18)
SLFYS 0.07% (n=17)
GLFYL 0.06% (n=14)
GLLYT 0.06% (n=13)
ALLYY 0.06% (n=13)
ALSYT 0.04% (n=10)
GLMYS 0.04% (n=9)
ALLYT 0.04% (n=9)
GLFHH 0.03% (n=8)
ALFYQ 0.03% (n=8)
ALLYR 0.03% (n=8)
ALFYI 0.03% (n=8)
GLFNY 0.03% (n=7)
GLMYV 0.03% (n=7)
GLLYV 0.03% (n=7)
GLFSY 0.03% (n=7)
GLFHV 0.03% (n=7)
GLMYI 0.03% (n=6)
SLFYR 0.03% (n=6)
GLMYH 0.03% (n=6)
GLIYA 0.02% (n=5)
GLFYN 0.02% (n=5)
GLIYL 0.02% (n=5)
GLFYI 0.02% (n=5)
GLLYL 0.02% (n=5)
APFYT 0.02% (n=5)
GLSYH 0.02% (n=4)
GPFYH 0.02% (n=4)
GLIYS 0.02% (n=4)
TLFYT 0.02% (n=4)
VLFYT 0.02% (n=4)
ALFHT 0.02% (n=4)
ALVYR 0.02% (n=4)
GLFCY 0.01% (n=3)
GLMYT 0.01% (n=3)
GLMYF 0.01% (n=3)
GLVYH 0.01% (n=3)
GLFYC 0.01% (n=3)
ALFYF 0.01% (n=3)
ALFNT 0.01% (n=3)
ALMYA 0.01% (n=3)
SLFYY 0.01% (n=3)
ALLYV 0.01% (n=3)
GPFYY 0.01% (n=2)
GLF*Y 0.01% (n=2)
GFLYY 0.01% (n=2)
GPLYY 0.01% (n=2)
GLLHY 0.01% (n=2)
GPFSY 0.01% (n=2)
GLVYR 0.01% (n=2)
RLFYY 0.01% (n=2)
GLFCH 0.01% (n=2)
TLFYA 0.01% (n=2)
ALFYE 0.01% (n=2)
ALVYS 0.01% (n=2)
ALIYS 0.01% (n=2)
ELFYT 0.01% (n=2)
ALLYH 0.01% (n=2)
SLFYI 0.01% (n=2)
ALVYH 0.01% (n=2)
ALFCR 0.01% (n=2)
ALFAR 0.01% (n=2)
GLPYH 0.00% (n=1)
GLMYA 0.00% (n=1)
RLLYY 0.00% (n=1)
RPFYR 0.00% (n=1)
GPFYP 0.00% (n=1)
GLLCP 0.00% (n=1)
GFSYH 0.00% (n=1)
GLLYN 0.00% (n=1)
GLFCS 0.00% (n=1)
GPSYS 0.00% (n=1)
RAFLF 0.00% (n=1)
RLFYS 0.00% (n=1)
GLIYC 0.00% (n=1)
GLIHR 0.00% (n=1)
SRASS 0.00% (n=1)
GLLPQ 0.00% (n=1)
GLHYY 0.00% (n=1)
GLVYS 0.00% (n=1)
GHFYH 0.00% (n=1)
GLNYY 0.00% (n=1)
APFYY 0.00% (n=1)
GLFHR 0.00% (n=1)
GLTYY 0.00% (n=1)
GLFYK 0.00% (n=1)
SLFYH 0.00% (n=1)
GLIHH 0.00% (n=1)
GLIYT 0.00% (n=1)
DQH*R 0.00% (n=1)
GLFSH 0.00% (n=1)
GLLYI 0.00% (n=1)
GLFNH 0.00% (n=1)
GLVYV 0.00% (n=1)
-LFYH 0.00% (n=1)
WLFYH 0.00% (n=1)
RLFYR 0.00% (n=1)
GLFCR 0.00% (n=1)
ELFYS 0.00% (n=1)
GLLYQ 0.00% (n=1)
GLFYD 0.00% (n=1)
GPIYY 0.00% (n=1)
ELFYY 0.00% (n=1)
GLHYH 0.00% (n=1)
GPFYR 0.00% (n=1)
GAPLS 0.00% (n=1)
GFFYH 0.00% (n=1)
GLSTT 0.00% (n=1)
GLVYL 0.00% (n=1)
GLLYC 0.00% (n=1)
GLLNY 0.00% (n=1)
GLPYY 0.00% (n=1)
WLLYY 0.00% (n=1)
GLFFY 0.00% (n=1)
RLFYH 0.00% (n=1)
TLFYV 0.00% (n=1)
ALFFT 0.00% (n=1)
ALIYT 0.00% (n=1)
ALIYY 0.00% (n=1)
AL--- 0.00% (n=1)
GVFYH 0.00% (n=1)
ARFYT 0.00% (n=1)
ALFYM 0.00% (n=1)
ALFHA 0.00% (n=1)
ALLYK 0.00% (n=1)
ALFFV 0.00% (n=1)
ALIYN 0.00% (n=1)
GLIYK 0.00% (n=1)
ALMYV 0.00% (n=1)
ALSYR 0.00% (n=1)
ALSYA 0.00% (n=1)
VLFYA 0.00% (n=1)
ALFYG 0.00% (n=1)
ELFYA 0.00% (n=1)
ALVYT 0.00% (n=1)
ALVYV 0.00% (n=1)
TLFYR 0.00% (n=1)
APFYV 0.00% (n=1)
VLFYV 0.00% (n=1)
ALFCT 0.00% (n=1)
ALSYV 0.00% (n=1)
ALFHV 0.00% (n=1)
ALFCV 0.00% (n=1)
ALFAK 0.00% (n=1)
ALFLR 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 1a:

GLFYY 30.57% (n=4165)
GLFYH 25.60% (n=3488)
GLLYY 13.23% (n=1802)
GLFYR 7.30% (n=994)
GLLYH 4.40% (n=600)
GLIYY 3.50% (n=477)
GLFYS 3.06% (n=417)
GLIYH 2.11% (n=287)
GLFYQ 1.20% (n=164)
ALFYS 0.81% (n=110)
GLLYR 0.71% (n=97)
GLFHY 0.68% (n=92)
GLLYA 0.54% (n=74)
GLVYY 0.53% (n=72)
GLFYV 0.47% (n=64)
ALFYR 0.44% (n=60)
GLIYQ 0.43% (n=58)
ALFYH 0.37% (n=51)
GLIYR 0.36% (n=49)
GLFYF 0.34% (n=47)
GLFYP 0.33% (n=45)
GLFYT 0.27% (n=37)
GLMYY 0.19% (n=26)
GLIYF 0.18% (n=25)
GLLYS 0.17% (n=23)
GLFYA 0.15% (n=21)
GLLYP 0.13% (n=18)
GLLYF 0.13% (n=18)
GLFYL 0.10% (n=13)
GLLYT 0.10% (n=13)
ALFYY 0.07% (n=10)
GLMYS 0.07% (n=9)
GLFHH 0.06% (n=8)
GLFNY 0.05% (n=7)
GLMYV 0.05% (n=7)
GLLYV 0.05% (n=7)
GLFSY 0.05% (n=7)
ALFYA 0.05% (n=7)
GLFHV 0.05% (n=7)
GLMYI 0.04% (n=6)
GLMYH 0.04% (n=6)
GLIYA 0.04% (n=5)
GLFYN 0.04% (n=5)
GLIYL 0.04% (n=5)
GLFYI 0.04% (n=5)
GLLYL 0.04% (n=5)
ALFYQ 0.04% (n=5)
SLFYR 0.03% (n=4)
GLSYH 0.03% (n=4)
GPFYH 0.03% (n=4)
GLIYS 0.03% (n=4)
GLFCY 0.02% (n=3)
GLMYT 0.02% (n=3)
GLMYF 0.02% (n=3)
GLVYH 0.02% (n=3)
GLFYC 0.02% (n=3)
GPFYY 0.01% (n=2)
GLF*Y 0.01% (n=2)
GFLYY 0.01% (n=2)
GPLYY 0.01% (n=2)
GLLHY 0.01% (n=2)
GPFSY 0.01% (n=2)
GLVYR 0.01% (n=2)
RLFYY 0.01% (n=2)
SLFYT 0.01% (n=2)
ALLYS 0.01% (n=2)
GLFCH 0.01% (n=2)
GLPYH 0.01% (n=1)
GLMYA 0.01% (n=1)
RLLYY 0.01% (n=1)
RPFYR 0.01% (n=1)
GPFYP 0.01% (n=1)
GLLCP 0.01% (n=1)
GFSYH 0.01% (n=1)
GLLYN 0.01% (n=1)
GLFCS 0.01% (n=1)
GPSYS 0.01% (n=1)
RAFLF 0.01% (n=1)
RLFYS 0.01% (n=1)
GLIYC 0.01% (n=1)
GLIHR 0.01% (n=1)
SRASS 0.01% (n=1)
GLLPQ 0.01% (n=1)
GLHYY 0.01% (n=1)
GLVYS 0.01% (n=1)
GHFYH 0.01% (n=1)
GLNYY 0.01% (n=1)
APFYY 0.01% (n=1)
GLFHR 0.01% (n=1)
GLTYY 0.01% (n=1)
GLFYK 0.01% (n=1)
SLFYH 0.01% (n=1)
GLIHH 0.01% (n=1)
GLIYT 0.01% (n=1)
DQH*R 0.01% (n=1)
GLFSH 0.01% (n=1)
GLLYI 0.01% (n=1)
GLFNH 0.01% (n=1)
GLVYV 0.01% (n=1)
-LFYH 0.01% (n=1)
WLFYH 0.01% (n=1)
RLFYR 0.01% (n=1)
GLFCR 0.01% (n=1)
ELFYS 0.01% (n=1)
GLLYQ 0.01% (n=1)
GLFYD 0.01% (n=1)
GPIYY 0.01% (n=1)
ELFYY 0.01% (n=1)
GLHYH 0.01% (n=1)
GPFYR 0.01% (n=1)
GAPLS 0.01% (n=1)
GFFYH 0.01% (n=1)
GLSTT 0.01% (n=1)
ALIYR 0.01% (n=1)
GLVYL 0.01% (n=1)
GLLYC 0.01% (n=1)
GLLNY 0.01% (n=1)
GLPYY 0.01% (n=1)
WLLYY 0.01% (n=1)
GLFFY 0.01% (n=1)
RLFYH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 1b:

ALFYT 47.12% (n=4351)
ALFYA 22.92% (n=2116)
ALFYV 13.31% (n=1229)
ALFYR 5.62% (n=519)
ALFYK 2.32% (n=214)
ALIYA 1.47% (n=136)
ALFYS 1.16% (n=107)
SLFYV 0.95% (n=88)
ALLYA 0.65% (n=60)
GLLYA 0.55% (n=51)
ALFYH 0.52% (n=48)
ALFYY 0.39% (n=36)
ALIYR 0.34% (n=31)
ALVYA 0.27% (n=25)
ALIYK 0.23% (n=21)
SLFYA 0.21% (n=19)
SLFYS 0.18% (n=17)
ALLYS 0.17% (n=16)
SLFYT 0.14% (n=13)
ALLYY 0.14% (n=13)
ALSYT 0.11% (n=10)
ALLYT 0.10% (n=9)
ALLYR 0.09% (n=8)
ALFYI 0.09% (n=8)
APFYT 0.05% (n=5)
TLFYT 0.04% (n=4)
VLFYT 0.04% (n=4)
ALFHT 0.04% (n=4)
GLFYT 0.04% (n=4)
ALFYF 0.03% (n=3)
ALFNT 0.03% (n=3)
ALFYQ 0.03% (n=3)
ALVYR 0.03% (n=3)
ALMYA 0.03% (n=3)
TLFYA 0.02% (n=2)
ALFYE 0.02% (n=2)
ALVYS 0.02% (n=2)
ALIYS 0.02% (n=2)
ELFYT 0.02% (n=2)
ALLYH 0.02% (n=2)
SLFYI 0.02% (n=2)
SLFYR 0.02% (n=2)
ALVYH 0.02% (n=2)
ALFCR 0.02% (n=2)
ALLYV 0.02% (n=2)
TLFYV 0.01% (n=1)
ALFFT 0.01% (n=1)
ALIYT 0.01% (n=1)
ALIYY 0.01% (n=1)
AL--- 0.01% (n=1)
GVFYH 0.01% (n=1)
ARFYT 0.01% (n=1)
ALFYM 0.01% (n=1)
GLFYQ 0.01% (n=1)
ALFHA 0.01% (n=1)
ALLYK 0.01% (n=1)
ALFFV 0.01% (n=1)
ALIYN 0.01% (n=1)
GLIYK 0.01% (n=1)
ALMYV 0.01% (n=1)
GLFYA 0.01% (n=1)
ALSYR 0.01% (n=1)
ALSYA 0.01% (n=1)
VLFYA 0.01% (n=1)
ALFYG 0.01% (n=1)
ELFYA 0.01% (n=1)
ALVYT 0.01% (n=1)
SLFYY 0.01% (n=1)
ALVYV 0.01% (n=1)
TLFYR 0.01% (n=1)
APFYV 0.01% (n=1)
VLFYV 0.01% (n=1)
ALFCT 0.01% (n=1)
ALSYV 0.01% (n=1)
ALFHV 0.01% (n=1)
ALFCV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 2:

SLFYT 42.73% (n=573)
ALFYT 24.68% (n=331)
ALFYH 11.33% (n=152)
SLFYV 7.08% (n=95)
SLFYA 5.59% (n=75)
ALFYA 2.09% (n=28)
SLFYI 1.34% (n=18)
ALFYV 1.19% (n=16)
ALFYS 0.52% (n=7)
ALFYR 0.22% (n=3)
SLFYY 0.22% (n=3)
SLFHT 0.15% (n=2)
QLFYT 0.15% (n=2)
TLFFT 0.15% (n=2)
SLFYS 0.15% (n=2)
SLFYR 0.15% (n=2)
ALLYH 0.15% (n=2)
ALFHT 0.07% (n=1)
ALFYI 0.07% (n=1)
ALIYR 0.07% (n=1)
SLFYG 0.07% (n=1)
SPFYT 0.07% (n=1)
ALFFT 0.07% (n=1)
ALLYN 0.07% (n=1)
ALVYR 0.07% (n=1)
ALFRY 0.07% (n=1)
SLFYF 0.07% (n=1)
SLFYH 0.07% (n=1)
ALVYA 0.07% (n=1)
SLF-T 0.07% (n=1)
PLFYN 0.07% (n=1)
SLVYI 0.07% (n=1)
SLLYT 0.07% (n=1)
PLFYV 0.07% (n=1)
ALLYT 0.07% (n=1)
ALLYV 0.07% (n=1)
ALFCT 0.07% (n=1)
GLIYT 0.07% (n=1)
ALFHH 0.07% (n=1)
VLFYH 0.07% (n=1)
ALFYY 0.07% (n=1)
SLFHY 0.07% (n=1)
ALFYQ 0.07% (n=1)
PLFYT 0.07% (n=1)
SLSYT 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 2a:

SLFYT 64.29% (n=180)
ALFYT 12.50% (n=35)
SLFYA 8.57% (n=24)
SLFYV 3.57% (n=10)
ALFYA 2.50% (n=7)
ALFYV 1.43% (n=4)
SLFHT 0.71% (n=2)
ALFYS 0.71% (n=2)
QLFYT 0.71% (n=2)
TLFFT 0.71% (n=2)
ALFYI 0.36% (n=1)
ALIYR 0.36% (n=1)
SLFYY 0.36% (n=1)
SLFYG 0.36% (n=1)
SLFYI 0.36% (n=1)
SPFYT 0.36% (n=1)
ALFFT 0.36% (n=1)
ALFYH 0.36% (n=1)
ALLYN 0.36% (n=1)
ALVYR 0.36% (n=1)
ALFRY 0.36% (n=1)
SLFYF 0.36% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 2b:

SLFYT 62.12% (n=287)
SLFYV 16.45% (n=76)
SLFYA 10.17% (n=47)
SLFYI 3.68% (n=17)
ALFYT 2.16% (n=10)
ALFYA 1.30% (n=6)
SLFYS 0.43% (n=2)
SLFYY 0.43% (n=2)
ALFYR 0.43% (n=2)
ALFYS 0.43% (n=2)
SLFYH 0.22% (n=1)
ALVYA 0.22% (n=1)
SLF-T 0.22% (n=1)
ALFYV 0.22% (n=1)
PLFYN 0.22% (n=1)
SLVYI 0.22% (n=1)
SLLYT 0.22% (n=1)
PLFYV 0.22% (n=1)
SLFYR 0.22% (n=1)
ALLYT 0.22% (n=1)
ALLYV 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 2c:

ALFYT 60.35% (n=274)
ALFYH 33.26% (n=151)
ALFYA 1.98% (n=9)
ALFYV 1.32% (n=6)
SLFYV 0.66% (n=3)
ALFYS 0.44% (n=2)
SLFYA 0.44% (n=2)
SLFYT 0.22% (n=1)
ALFCT 0.22% (n=1)
GLIYT 0.22% (n=1)
ALFHH 0.22% (n=1)
VLFYH 0.22% (n=1)
ALLYH 0.22% (n=1)
ALFYY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 3:

GLFYY 54.16% (n=2101)
GLIYY 16.45% (n=638)
GLFYH 8.84% (n=343)
ALFYT 4.49% (n=174)
GLLYY 3.22% (n=125)
GLFYF 2.42% (n=94)
GLMYY 2.32% (n=90)
GLFSY 1.65% (n=64)
GLIYH 1.24% (n=48)
GLFHY 1.16% (n=45)
GLFYV 1.08% (n=42)
GLIYF 0.67% (n=26)
GLVYY 0.44% (n=17)
GLFNY 0.28% (n=11)
GLLYH 0.21% (n=8)
GLIYR 0.21% (n=8)
GLFHF 0.18% (n=7)
GLFYR 0.18% (n=7)
GLMYF 0.08% (n=3)
GLLYF 0.08% (n=3)
GLMYH 0.08% (n=3)
GLFYL 0.05% (n=2)
GLLYR 0.05% (n=2)
GLFRF 0.03% (n=1)
RLFYY 0.03% (n=1)
GMFYY 0.03% (n=1)
GLFCY 0.03% (n=1)
GLSYY 0.03% (n=1)
ELIYY 0.03% (n=1)
GSFYY 0.03% (n=1)
ELFYY 0.03% (n=1)
GFDYY 0.03% (n=1)
GCFYY 0.03% (n=1)
GLVYH 0.03% (n=1)
GCFII 0.03% (n=1)
GLFYW 0.03% (n=1)
GLFFY 0.03% (n=1)
RLMYY 0.03% (n=1)
GLFYK 0.03% (n=1)
GLFYS 0.03% (n=1)
ALFYR 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 3a:

GLFYY 60.49% (n=1967)
GLIYY 13.31% (n=433)
GLFYH 10.39% (n=338)
GLLYY 3.17% (n=103)
GLFYF 2.86% (n=93)
GLFSY 1.91% (n=62)
GLMYY 1.51% (n=49)
GLFHY 1.35% (n=44)
GLFYV 1.29% (n=42)
GLIYH 0.77% (n=25)
GLIYF 0.65% (n=21)
GLVYY 0.37% (n=12)
GLFNY 0.31% (n=10)
GLLYH 0.25% (n=8)
GLIYR 0.25% (n=8)
GLFHF 0.22% (n=7)
GLFYR 0.22% (n=7)
GLMYF 0.09% (n=3)
GLLYF 0.09% (n=3)
GLFYL 0.06% (n=2)
GLFRF 0.03% (n=1)
RLFYY 0.03% (n=1)
GMFYY 0.03% (n=1)
GLFCY 0.03% (n=1)
GLSYY 0.03% (n=1)
ELIYY 0.03% (n=1)
GSFYY 0.03% (n=1)
ELFYY 0.03% (n=1)
GFDYY 0.03% (n=1)
GCFYY 0.03% (n=1)
GLVYH 0.03% (n=1)
GCFII 0.03% (n=1)
GLLYR 0.03% (n=1)
GLFYW 0.03% (n=1)
GLFFY 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 3b:

GLIYY 50.50% (n=203)
GLFYY 23.63% (n=95)
GLMYY 9.70% (n=39)
GLIYH 5.47% (n=22)
GLLYY 4.98% (n=20)
GLVYY 1.24% (n=5)
GLIYF 1.24% (n=5)
GLFYH 0.75% (n=3)
GLFSY 0.50% (n=2)
GLMYH 0.50% (n=2)
RLMYY 0.25% (n=1)
GLFNY 0.25% (n=1)
GLFYF 0.25% (n=1)
GLFYK 0.25% (n=1)
GLFHY 0.25% (n=1)
GLLYR 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 4:

SLFYT 66.54% (n=507)
SLFYA 7.48% (n=57)
GLFYA 7.22% (n=55)
GLFYH 3.81% (n=29)
GLLYA 2.23% (n=17)
SLFYI 1.31% (n=10)
SLFYR 1.31% (n=10)
SLFYH 0.92% (n=7)
GLFYY 0.92% (n=7)
NLFYI 0.79% (n=6)
NLFYT 0.79% (n=6)
GLLYY 0.79% (n=6)
ALFYT 0.66% (n=5)
GLFYR 0.66% (n=5)
ALFYH 0.66% (n=5)
SLFYF 0.39% (n=3)
ALFYA 0.39% (n=3)
GLFYT 0.39% (n=3)
GLFYS 0.39% (n=3)
SLFYV 0.26% (n=2)
GLFYV 0.26% (n=2)
GLFYF 0.26% (n=2)
ALFYV 0.26% (n=2)
SLFYY 0.13% (n=1)
SLLYY 0.13% (n=1)
GLLYT 0.13% (n=1)
GLFRY 0.13% (n=1)
SLFYS 0.13% (n=1)
GLIYR 0.13% (n=1)
GLMYY 0.13% (n=1)
GLIYS 0.13% (n=1)
GLIYY 0.13% (n=1)
GLIYH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 4a:

SLFYT 52.50% (n=84)
SLFYA 22.50% (n=36)
GLFYH 15.63% (n=25)
ALFYH 3.13% (n=5)
GLFYA 2.50% (n=4)
ALFYT 0.63% (n=1)
SLFYV 0.63% (n=1)
GLFYR 0.63% (n=1)
NLFYI 0.63% (n=1)
GLFYV 0.63% (n=1)
GLLYA 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 4d:

SLFYT 76.57% (n=415)
GLFYA 7.56% (n=41)
SLFYA 3.14% (n=17)
GLLYA 2.03% (n=11)
SLFYI 1.85% (n=10)
SLFYR 1.66% (n=9)
NLFYT 1.11% (n=6)
SLFYH 1.11% (n=6)
NLFYI 0.92% (n=5)
GLFYY 0.74% (n=4)
SLFYF 0.55% (n=3)
ALFYT 0.37% (n=2)
GLFYF 0.37% (n=2)
GLLYY 0.37% (n=2)
ALFYA 0.37% (n=2)
SLFYY 0.18% (n=1)
SLLYY 0.18% (n=1)
GLLYT 0.18% (n=1)
GLFYT 0.18% (n=1)
GLFRY 0.18% (n=1)
SLFYS 0.18% (n=1)
SLFYV 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 5:

GLMYV 12.82% (n=5)
GLLYY 10.26% (n=4)
GLMYA 10.26% (n=4)
GLFYA 7.69% (n=3)
GLIYA 7.69% (n=3)
GLLYA 7.69% (n=3)
GLMYF 5.13% (n=2)
GLFYV 5.13% (n=2)
GLMYY 5.13% (n=2)
GLFYY 5.13% (n=2)
GLVYY 2.56% (n=1)
GLLYV 2.56% (n=1)
GLIYY 2.56% (n=1)
GLIYF 2.56% (n=1)
GLFYF 2.56% (n=1)
GLIYH 2.56% (n=1)
GLLYF 2.56% (n=1)
GLIYI 2.56% (n=1)
GLMYI 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 6:

SLFYT 24.48% (n=130)
SLFYA 11.11% (n=59)
GLFYY 9.60% (n=51)
SLFYI 8.47% (n=45)
GLFYH 6.59% (n=35)
ALFYA 4.71% (n=25)
SLFYV 4.71% (n=25)
ALFYT 3.95% (n=21)
GLLYY 2.07% (n=11)
ALFYR 1.88% (n=10)
GLFYT 1.51% (n=8)
GLLYH 1.32% (n=7)
GLFYR 1.13% (n=6)
ALFYV 0.94% (n=5)
GLLYA 0.94% (n=5)
GLFYA 0.94% (n=5)
GLIYH 0.94% (n=5)
GLFYS 0.75% (n=4)
SLFYR 0.75% (n=4)
SLFYF 0.75% (n=4)
ALFYS 0.56% (n=3)
SLFYS 0.56% (n=3)
GLFSY 0.56% (n=3)
GLFYV 0.56% (n=3)
GLFYL 0.56% (n=3)
SLFYN 0.38% (n=2)
SLLYI 0.38% (n=2)
SLFYY 0.38% (n=2)
GLIYY 0.38% (n=2)
PLFYK 0.38% (n=2)
GLMYV 0.38% (n=2)
ALFYQ 0.38% (n=2)
GLMYH 0.38% (n=2)
GLLYS 0.38% (n=2)
ALFYH 0.38% (n=2)
SLFYH 0.19% (n=1)
SLIYA 0.19% (n=1)
SLIYV 0.19% (n=1)
ALFYI 0.19% (n=1)
ALFYN 0.19% (n=1)
SLMYA 0.19% (n=1)
ALIYK 0.19% (n=1)
ALIYA 0.19% (n=1)
GLLYR 0.19% (n=1)
ALFYL 0.19% (n=1)
NLFYV 0.19% (n=1)
NLFYA 0.19% (n=1)
GLFAR 0.19% (n=1)
PLFYR 0.19% (n=1)
GLIYR 0.19% (n=1)
GLVYR 0.19% (n=1)
GLIYA 0.19% (n=1)
GLIYK 0.19% (n=1)
SLFYQ 0.19% (n=1)
GLIYL 0.19% (n=1)
GLFYQ 0.19% (n=1)
ALFYK 0.19% (n=1)
GLFNH 0.19% (n=1)
GLFYK 0.19% (n=1)
GLIYS 0.19% (n=1)
GLFAH 0.19% (n=1)
GLFAV 0.19% (n=1)
GLFYM 0.19% (n=1)
ALFTK 0.19% (n=1)
ALLYR 0.19% (n=1)
GLIYV 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Subtype 6a:

SLFYT 42.09% (n=125)
SLFYA 17.51% (n=52)
SLFYI 14.81% (n=44)
SLFYV 6.73% (n=20)
ALFYA 6.40% (n=19)
ALFYT 4.04% (n=12)
SLFYR 1.01% (n=3)
ALFYR 0.67% (n=2)
ALFYS 0.67% (n=2)
ALFYV 0.67% (n=2)
SLLYI 0.67% (n=2)
SLFYF 0.67% (n=2)
SLFYH 0.34% (n=1)
SLIYA 0.34% (n=1)
GLLYA 0.34% (n=1)
SLIYV 0.34% (n=1)
ALFYI 0.34% (n=1)
SLFYN 0.34% (n=1)
SLFYS 0.34% (n=1)
ALFYN 0.34% (n=1)
GLFYS 0.34% (n=1)
SLMYA 0.34% (n=1)
ALIYK 0.34% (n=1)
ALIYA 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 440-444 (antibodies: [HC84.20] ), HCV Genotype 7:

ALFYT 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 1:

PYRLWH 87.01% (n=7344)
SYRLWH 4.89% (n=413)
AYRLWH 2.87% (n=242)
PYRL-- 2.16% (n=182)
PHRLWH 1.07% (n=90)
GYRLWH 0.53% (n=45)
QYRL-- 0.26% (n=22)
PYRPWH 0.17% (n=14)
PYRLW- 0.17% (n=14)
QYRLWH 0.13% (n=11)
PYRLWR 0.11% (n=9)
PYGLWH 0.07% (n=6)
PYRLWY 0.07% (n=6)
PYRLRH 0.06% (n=5)
EYRLWH 0.04% (n=3)
DYRLWH 0.04% (n=3)
PCRLWH 0.04% (n=3)
TYRLWH 0.02% (n=2)
PYKLWH 0.02% (n=2)
HYRLWH 0.02% (n=2)
PYRL*H 0.02% (n=2)
HRQLWH 0.02% (n=2)
LYRLWH 0.02% (n=2)
PSRLWH 0.02% (n=2)
PYRI-- 0.01% (n=1)
PYR--- 0.01% (n=1)
SYRLW- 0.01% (n=1)
SYGLWH 0.01% (n=1)
PYRIWH 0.01% (n=1)
SYRLGH 0.01% (n=1)
P----- 0.01% (n=1)
PYRPW- 0.01% (n=1)
PYRRWH 0.01% (n=1)
SYRFWH 0.01% (n=1)
HYSLTG 0.01% (n=1)
SYRPWH 0.01% (n=1)
P*-LWH 0.01% (n=1)
PYRLLH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 1a:

PYRLWH 84.58% (n=5524)
SYRLWH 5.91% (n=386)
AYRLWH 3.67% (n=240)
PYRL-- 2.16% (n=141)
PHRLWH 1.35% (n=88)
GYRLWH 0.69% (n=45)
QYRL-- 0.34% (n=22)
PYRLW- 0.21% (n=14)
QYRLWH 0.17% (n=11)
PYRPWH 0.15% (n=10)
PYRLWR 0.11% (n=7)
PYRLRH 0.08% (n=5)
PYGLWH 0.06% (n=4)
DYRLWH 0.05% (n=3)
PCRLWH 0.05% (n=3)
PYRLWY 0.05% (n=3)
TYRLWH 0.03% (n=2)
PYKLWH 0.03% (n=2)
HYRLWH 0.03% (n=2)
PYRL*H 0.03% (n=2)
----WH 0.03% (n=2)
LYRLWH 0.03% (n=2)
PYRI-- 0.02% (n=1)
PYR--- 0.02% (n=1)
SYRLW- 0.02% (n=1)
SYGLWH 0.02% (n=1)
PYRIWH 0.02% (n=1)
EYRLWH 0.02% (n=1)
SYRLGH 0.02% (n=1)
P----- 0.02% (n=1)
PYRPW- 0.02% (n=1)
PYRRWH 0.02% (n=1)
SYRFWH 0.02% (n=1)
HYSLTG 0.02% (n=1)
SYRPWH 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 1b:

PYRLWH 95.37% (n=1791)
PYRL-- 2.18% (n=41)
SYRLWH 1.44% (n=27)
PYRPWH 0.21% (n=4)
PYRLWY 0.16% (n=3)
AYRLWH 0.11% (n=2)
PYGLWH 0.11% (n=2)
PHRLWH 0.11% (n=2)
PSRLWH 0.11% (n=2)
PYRLWR 0.11% (n=2)
P*-LWH 0.05% (n=1)
PYRLLH 0.05% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 2:

PYRLWH 98.32% (n=469)
AYRLWH 0.84% (n=4)
PYRLGI 0.21% (n=1)
SYRLWH 0.21% (n=1)
HHLYGL 0.21% (n=1)
PYGLWH 0.21% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 2a:

PYRLWH 98.48% (n=65)
PYRLGI 1.52% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 2b:

PYRLWH 98.86% (n=347)
SYRLWH 0.28% (n=1)
HHLYGL 0.28% (n=1)
PYGLWH 0.28% (n=1)
AYRLWH 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 2c:

PYRLWH 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 3:

PYRLWH 99.32% (n=2489)
PYRLWR 0.08% (n=2)
SIPALA 0.08% (n=2)
SYRLWH 0.08% (n=2)
PYRLWL 0.04% (n=1)
PYRLRH 0.04% (n=1)
LYRLWH 0.04% (n=1)
PYRLWY 0.04% (n=1)
PSR--- 0.04% (n=1)
PYPLWH 0.04% (n=1)
PYRLCH 0.04% (n=1)
PYRVWH 0.04% (n=1)
PYRL*H 0.04% (n=1)
PYWLWH 0.04% (n=1)
AYRLWH 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 3a:

PYRLWH 99.31% (n=2311)
PYRLWR 0.09% (n=2)
SIPALA 0.09% (n=2)
SYRLWH 0.09% (n=2)
PYRLWL 0.04% (n=1)
PYRLRH 0.04% (n=1)
LYRLWH 0.04% (n=1)
PYRLWY 0.04% (n=1)
PSR--- 0.04% (n=1)
PYPLWH 0.04% (n=1)
PYRLCH 0.04% (n=1)
PYRVWH 0.04% (n=1)
PYRL*H 0.04% (n=1)
PYWLWH 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 3b:

PYRLWH 100.00% (n=160)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 4:

PYRLWH 96.12% (n=198)
AYRLWH 2.43% (n=5)
SIPAVA 0.49% (n=1)
SYRLWH 0.49% (n=1)
QYRLWH 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 4a:

PYRLWH 97.73% (n=129)
AYRLWH 0.76% (n=1)
SIPAVA 0.76% (n=1)
SYRLWH 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 4d:

PYRLWH 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 5:

PYRLWH 94.59% (n=35)
PYRMWH 2.70% (n=1)
SYRLWH 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 6:

PYRLWH 95.00% (n=209)
SYRLWH 2.73% (n=6)
AYRLWH 1.82% (n=4)
TYRLWH 0.45% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Subtype 6a:

PYRLWH 97.00% (n=97)
AYRLWH 2.00% (n=2)
SYRLWH 1.00% (n=1)
---------------------------------------------------------------------------------------
Region 612-617 (antibodies: [HC84.20] ), HCV Genotype 7:

PYRLWH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 1:

LNC 99.05% (n=22772)
LSC 0.43% (n=100)
LNR 0.12% (n=28)
LDC 0.07% (n=17)
PNC 0.07% (n=16)
SNC 0.04% (n=10)
LTC 0.03% (n=6)
LNY 0.03% (n=6)
LKC 0.02% (n=4)
VNC 0.01% (n=3)
FNC 0.01% (n=2)
LIC 0.01% (n=2)
LNW 0.01% (n=2)
RNC 0.01% (n=2)
LNG 0.01% (n=2)
LHC 0.01% (n=2)
LNF 0.01% (n=2)
MNC 0.01% (n=2)
LRC 0.01% (n=2)
PPT 0.00% (n=1)
LNS 0.00% (n=1)
LN- 0.00% (n=1)
MSR 0.00% (n=1)
LSR 0.00% (n=1)
MSC 0.00% (n=1)
LGC 0.00% (n=1)
LAC 0.00% (n=1)
PEL 0.00% (n=1)
LYC 0.00% (n=1)
HNC 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 1a:

LNC 99.04% (n=13542)
LSC 0.48% (n=66)
LNR 0.08% (n=11)
SNC 0.07% (n=10)
LTC 0.04% (n=6)
LDC 0.04% (n=6)
PNC 0.04% (n=6)
LNY 0.02% (n=3)
LKC 0.01% (n=2)
LIC 0.01% (n=2)
RNC 0.01% (n=2)
LNG 0.01% (n=2)
LHC 0.01% (n=2)
LNF 0.01% (n=2)
FNC 0.01% (n=1)
PPT 0.01% (n=1)
LNW 0.01% (n=1)
LNS 0.01% (n=1)
LN- 0.01% (n=1)
MSR 0.01% (n=1)
LSR 0.01% (n=1)
MSC 0.01% (n=1)
LGC 0.01% (n=1)
LAC 0.01% (n=1)
VNC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 1b:

LNC 99.07% (n=9185)
LSC 0.35% (n=32)
LNR 0.18% (n=17)
LDC 0.12% (n=11)
PNC 0.11% (n=10)
LNY 0.03% (n=3)
MNC 0.02% (n=2)
LKC 0.02% (n=2)
LRC 0.02% (n=2)
VNC 0.02% (n=2)
LNW 0.01% (n=1)
PEL 0.01% (n=1)
LYC 0.01% (n=1)
FNC 0.01% (n=1)
HNC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 2:

LNC 99.41% (n=1349)
LDC 0.22% (n=3)
LKC 0.15% (n=2)
PNC 0.07% (n=1)
LTA 0.07% (n=1)
LNY 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 2a:

LNC 99.32% (n=294)
PNC 0.34% (n=1)
LTA 0.34% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 2b:

LNC 99.13% (n=458)
LDC 0.43% (n=2)
LKC 0.22% (n=1)
LNY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 2c:

LNC 99.78% (n=453)
LDC 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 3:

LNC 95.79% (n=3735)
LSC 3.67% (n=143)
PNC 0.15% (n=6)
LNR 0.10% (n=4)
RNC 0.08% (n=3)
LDC 0.05% (n=2)
LHC 0.05% (n=2)
PTC 0.03% (n=1)
GNG 0.03% (n=1)
LNY 0.03% (n=1)
LTC 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 3a:

LNC 99.39% (n=3249)
PNC 0.18% (n=6)
LSC 0.09% (n=3)
LNR 0.09% (n=3)
RNC 0.06% (n=2)
LDC 0.06% (n=2)
LHC 0.06% (n=2)
PTC 0.03% (n=1)
GNG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 3b:

LNC 64.69% (n=262)
LSC 34.57% (n=140)
LNY 0.25% (n=1)
RNC 0.25% (n=1)
LTC 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 4:

LNC 99.74% (n=762)
LNS 0.13% (n=1)
LSC 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 4a:

LNC 99.38% (n=161)
LNS 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 4d:

LNC 100.00% (n=542)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 5:

LNC 97.50% (n=39)
L-- 2.50% (n=1)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 6:

LNC 99.49% (n=583)
LSC 0.51% (n=3)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Subtype 6a:

LNC 100.00% (n=334)
---------------------------------------------------------------------------------------
Region 427-429 (antibodies: [HC84.21, HC84.22] ), HCV Genotype 7:

LNC 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 1:

LWH 96.87% (n=8175)
L-- 2.42% (n=204)
LW- 0.18% (n=15)
PWH 0.18% (n=15)
LWR 0.11% (n=9)
LWY 0.07% (n=6)
LRH 0.06% (n=5)
L*H 0.02% (n=2)
I-- 0.01% (n=1)
IWH 0.01% (n=1)
LGH 0.01% (n=1)
PW- 0.01% (n=1)
RWH 0.01% (n=1)
FWH 0.01% (n=1)
LTG 0.01% (n=1)
LLH 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 1a:

LWH 96.71% (n=6315)
L-- 2.50% (n=163)
LW- 0.23% (n=15)
PWH 0.17% (n=11)
LWR 0.11% (n=7)
LRH 0.08% (n=5)
LWY 0.05% (n=3)
L*H 0.03% (n=2)
-WH 0.03% (n=2)
I-- 0.02% (n=1)
IWH 0.02% (n=1)
LGH 0.02% (n=1)
PW- 0.02% (n=1)
RWH 0.02% (n=1)
FWH 0.02% (n=1)
LTG 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 1b:

LWH 97.28% (n=1827)
L-- 2.18% (n=41)
PWH 0.21% (n=4)
LWY 0.16% (n=3)
LWR 0.11% (n=2)
LLH 0.05% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 2:

LWH 99.58% (n=475)
LGI 0.21% (n=1)
YGL 0.21% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 2a:

LWH 98.48% (n=65)
LGI 1.52% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 2b:

LWH 99.72% (n=350)
YGL 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 2c:

LWH 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 3:

LWH 99.60% (n=2495)
LWR 0.08% (n=2)
ALA 0.08% (n=2)
LWL 0.04% (n=1)
LRH 0.04% (n=1)
LWY 0.04% (n=1)
LCH 0.04% (n=1)
VWH 0.04% (n=1)
L*H 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 3a:

LWH 99.57% (n=2316)
LWR 0.09% (n=2)
ALA 0.09% (n=2)
LWL 0.04% (n=1)
LRH 0.04% (n=1)
LWY 0.04% (n=1)
LCH 0.04% (n=1)
VWH 0.04% (n=1)
L*H 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 3b:

LWH 100.00% (n=160)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 4:

LWH 99.51% (n=205)
AVA 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 4a:

LWH 99.24% (n=131)
AVA 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 4d:

LWH 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 5:

LWH 97.30% (n=36)
MWH 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 6:

LWH 100.00% (n=223)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Subtype 6a:

LWH 100.00% (n=102)
---------------------------------------------------------------------------------------
Region 615-617 (antibodies: [HC84.22, HC84.25, HC84.26, HC84.27] ), HCV Genotype 7:

LWH 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 1:

LFYT 19.34% (n=4430)
LFYY 18.44% (n=4224)
LFYH 15.68% (n=3591)
LFYA 9.49% (n=2173)
LLYY 7.94% (n=1819)
LFYR 6.91% (n=1582)
LFYV 6.04% (n=1384)
LFYS 2.88% (n=659)
LLYH 2.63% (n=602)
LIYY 2.09% (n=478)
LIYH 1.25% (n=287)
LFYK 0.94% (n=216)
LLYA 0.82% (n=188)
LFYQ 0.76% (n=173)
LIYA 0.62% (n=142)
LLYR 0.46% (n=105)
LFHY 0.40% (n=92)
LIYR 0.35% (n=81)
LVYY 0.31% (n=72)
LIYQ 0.25% (n=58)
LFYF 0.22% (n=50)
LFYP 0.20% (n=45)
LLYS 0.18% (n=41)
LMYY 0.11% (n=26)
LIYF 0.11% (n=25)
LVYA 0.11% (n=25)
LLYT 0.10% (n=22)
LIYK 0.10% (n=22)
LLYP 0.08% (n=18)
LLYF 0.08% (n=18)
LFYI 0.07% (n=15)
LFYL 0.06% (n=14)
LLYV 0.04% (n=10)
LSYT 0.04% (n=10)
LMYS 0.04% (n=9)
LMYV 0.03% (n=8)
LFHH 0.03% (n=8)
LFHV 0.03% (n=8)
LFNY 0.03% (n=7)
LFSY 0.03% (n=7)
LMYI 0.03% (n=6)
LIYS 0.03% (n=6)
LMYH 0.03% (n=6)
LVYR 0.03% (n=6)
LFYN 0.02% (n=5)
LVYH 0.02% (n=5)
LIYL 0.02% (n=5)
LLYL 0.02% (n=5)
PFYT 0.02% (n=5)
LMYA 0.02% (n=4)
LSYH 0.02% (n=4)
PFYH 0.02% (n=4)
LFHT 0.02% (n=4)
LFCY 0.01% (n=3)
LMYT 0.01% (n=3)
LMYF 0.01% (n=3)
PFYY 0.01% (n=3)
LVYS 0.01% (n=3)
LFCR 0.01% (n=3)
LFYC 0.01% (n=3)
LFNT 0.01% (n=3)
PFYR 0.01% (n=2)
LF*Y 0.01% (n=2)
FLYY 0.01% (n=2)
PLYY 0.01% (n=2)
LLHY 0.01% (n=2)
PFSY 0.01% (n=2)
LIYT 0.01% (n=2)
LVYV 0.01% (n=2)
LFCH 0.01% (n=2)
LFYE 0.01% (n=2)
LFAR 0.01% (n=2)
LPYH 0.00% (n=1)
PFYP 0.00% (n=1)
LLCP 0.00% (n=1)
FSYH 0.00% (n=1)
LLYN 0.00% (n=1)
LFCS 0.00% (n=1)
PSYS 0.00% (n=1)
AFLF 0.00% (n=1)
LIYC 0.00% (n=1)
LIHR 0.00% (n=1)
RASS 0.00% (n=1)
LLPQ 0.00% (n=1)
LHYY 0.00% (n=1)
HFYH 0.00% (n=1)
LNYY 0.00% (n=1)
LFHR 0.00% (n=1)
LTYY 0.00% (n=1)
LIHH 0.00% (n=1)
QH*R 0.00% (n=1)
LFSH 0.00% (n=1)
LLYI 0.00% (n=1)
LFNH 0.00% (n=1)
LLYQ 0.00% (n=1)
LFYD 0.00% (n=1)
PIYY 0.00% (n=1)
LHYH 0.00% (n=1)
APLS 0.00% (n=1)
FFYH 0.00% (n=1)
LSTT 0.00% (n=1)
LVYL 0.00% (n=1)
LLYC 0.00% (n=1)
LLNY 0.00% (n=1)
LPYY 0.00% (n=1)
LFFY 0.00% (n=1)
LFFT 0.00% (n=1)
L--- 0.00% (n=1)
VFYH 0.00% (n=1)
RFYT 0.00% (n=1)
LFYM 0.00% (n=1)
LFHA 0.00% (n=1)
LLYK 0.00% (n=1)
LFFV 0.00% (n=1)
LIYN 0.00% (n=1)
LSYR 0.00% (n=1)
LSYA 0.00% (n=1)
LFYG 0.00% (n=1)
LVYT 0.00% (n=1)
LFNI 0.00% (n=1)
PFYV 0.00% (n=1)
LFCT 0.00% (n=1)
LSYV 0.00% (n=1)
LFCV 0.00% (n=1)
LFAK 0.00% (n=1)
LFLR 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 1a:

LFYY 30.66% (n=4178)
LFYH 26.00% (n=3543)
LLYY 13.24% (n=1804)
LFYR 7.77% (n=1059)
LLYH 4.40% (n=600)
LFYS 3.88% (n=529)
LIYY 3.50% (n=477)
LIYH 2.11% (n=287)
LFYQ 1.24% (n=169)
LLYR 0.71% (n=97)
LFHY 0.68% (n=92)
LLYA 0.54% (n=74)
LVYY 0.53% (n=72)
LFYV 0.47% (n=64)
LIYQ 0.43% (n=58)
LIYR 0.37% (n=50)
LFYF 0.34% (n=47)
LFYP 0.33% (n=45)
LFYT 0.29% (n=39)
LFYA 0.21% (n=28)
LMYY 0.19% (n=26)
LLYS 0.18% (n=25)
LIYF 0.18% (n=25)
LLYP 0.13% (n=18)
LLYF 0.13% (n=18)
LFYL 0.10% (n=13)
LLYT 0.10% (n=13)
LMYS 0.07% (n=9)
LFHH 0.06% (n=8)
LFNY 0.05% (n=7)
LMYV 0.05% (n=7)
LLYV 0.05% (n=7)
LFSY 0.05% (n=7)
LFHV 0.05% (n=7)
LMYI 0.04% (n=6)
LMYH 0.04% (n=6)
LIYA 0.04% (n=5)
LFYN 0.04% (n=5)
LIYL 0.04% (n=5)
LFYI 0.04% (n=5)
LLYL 0.04% (n=5)
LSYH 0.03% (n=4)
PFYH 0.03% (n=4)
LIYS 0.03% (n=4)
LFCY 0.02% (n=3)
LMYT 0.02% (n=3)
LMYF 0.02% (n=3)
PFYY 0.02% (n=3)
LVYH 0.02% (n=3)
LFYC 0.02% (n=3)
PFYR 0.01% (n=2)
LF*Y 0.01% (n=2)
FLYY 0.01% (n=2)
PLYY 0.01% (n=2)
LLHY 0.01% (n=2)
PFSY 0.01% (n=2)
LVYR 0.01% (n=2)
LFCH 0.01% (n=2)
LPYH 0.01% (n=1)
LMYA 0.01% (n=1)
PFYP 0.01% (n=1)
LLCP 0.01% (n=1)
FSYH 0.01% (n=1)
LLYN 0.01% (n=1)
LFCS 0.01% (n=1)
PSYS 0.01% (n=1)
AFLF 0.01% (n=1)
LIYC 0.01% (n=1)
LIHR 0.01% (n=1)
RASS 0.01% (n=1)
LLPQ 0.01% (n=1)
LHYY 0.01% (n=1)
LVYS 0.01% (n=1)
HFYH 0.01% (n=1)
LNYY 0.01% (n=1)
LFHR 0.01% (n=1)
LTYY 0.01% (n=1)
LFYK 0.01% (n=1)
LIHH 0.01% (n=1)
LIYT 0.01% (n=1)
QH*R 0.01% (n=1)
LFSH 0.01% (n=1)
LLYI 0.01% (n=1)
LFNH 0.01% (n=1)
LVYV 0.01% (n=1)
LFCR 0.01% (n=1)
LLYQ 0.01% (n=1)
LFYD 0.01% (n=1)
PIYY 0.01% (n=1)
LHYH 0.01% (n=1)
APLS 0.01% (n=1)
FFYH 0.01% (n=1)
LSTT 0.01% (n=1)
LVYL 0.01% (n=1)
LLYC 0.01% (n=1)
LLNY 0.01% (n=1)
LPYY 0.01% (n=1)
LFFY 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 1b:

LFYT 47.40% (n=4379)
LFYA 23.17% (n=2140)
LFYV 14.28% (n=1319)
LFYR 5.66% (n=523)
LFYK 2.32% (n=214)
LIYA 1.47% (n=136)
LFYS 1.35% (n=125)
LLYA 1.20% (n=111)
LFYH 0.52% (n=48)
LFYY 0.40% (n=37)
LIYR 0.34% (n=31)
LVYA 0.27% (n=25)
LIYK 0.24% (n=22)
LLYS 0.17% (n=16)
LLYY 0.14% (n=13)
LSYT 0.11% (n=10)
LFYI 0.11% (n=10)
LLYT 0.10% (n=9)
LLYR 0.09% (n=8)
PFYT 0.05% (n=5)
LFYQ 0.04% (n=4)
LFHT 0.04% (n=4)
LFYF 0.03% (n=3)
LFNT 0.03% (n=3)
LVYR 0.03% (n=3)
LMYA 0.03% (n=3)
LFYE 0.02% (n=2)
LVYS 0.02% (n=2)
LIYS 0.02% (n=2)
LLYH 0.02% (n=2)
LVYH 0.02% (n=2)
LFCR 0.02% (n=2)
LLYV 0.02% (n=2)
LFFT 0.01% (n=1)
LIYT 0.01% (n=1)
LIYY 0.01% (n=1)
L--- 0.01% (n=1)
VFYH 0.01% (n=1)
RFYT 0.01% (n=1)
LFYM 0.01% (n=1)
LFHA 0.01% (n=1)
LLYK 0.01% (n=1)
LFFV 0.01% (n=1)
LIYN 0.01% (n=1)
LMYV 0.01% (n=1)
LSYR 0.01% (n=1)
LSYA 0.01% (n=1)
LFYG 0.01% (n=1)
LVYT 0.01% (n=1)
LFNI 0.01% (n=1)
LVYV 0.01% (n=1)
PFYV 0.01% (n=1)
LFCT 0.01% (n=1)
LSYV 0.01% (n=1)
LFHV 0.01% (n=1)
LFCV 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 2:

LFYT 67.59% (n=907)
LFYH 11.48% (n=154)
LFYV 8.35% (n=112)
LFYA 7.68% (n=103)
LFYI 1.42% (n=19)
LFYS 0.67% (n=9)
LFYR 0.37% (n=5)
LFYY 0.30% (n=4)
LFFT 0.30% (n=4)
LFHT 0.22% (n=3)
LLYT 0.15% (n=2)
LLYH 0.15% (n=2)
LIYR 0.07% (n=1)
LFYG 0.07% (n=1)
PFYT 0.07% (n=1)
LLYN 0.07% (n=1)
LVYR 0.07% (n=1)
LFRY 0.07% (n=1)
LFYF 0.07% (n=1)
LVYA 0.07% (n=1)
LF-T 0.07% (n=1)
LFYN 0.07% (n=1)
LVYI 0.07% (n=1)
LLYV 0.07% (n=1)
LFCT 0.07% (n=1)
LIYT 0.07% (n=1)
LFHH 0.07% (n=1)
LFHY 0.07% (n=1)
LFYQ 0.07% (n=1)
LSYT 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 2a:

LFYT 77.22% (n=217)
LFYA 11.03% (n=31)
LFYV 4.98% (n=14)
LFFT 1.42% (n=4)
LFYI 0.71% (n=2)
LFHT 0.71% (n=2)
LFYS 0.71% (n=2)
LIYR 0.36% (n=1)
LFYY 0.36% (n=1)
LFYG 0.36% (n=1)
PFYT 0.36% (n=1)
LFYH 0.36% (n=1)
LLYN 0.36% (n=1)
LVYR 0.36% (n=1)
LFRY 0.36% (n=1)
LFYF 0.36% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 2b:

LFYT 64.29% (n=297)
LFYV 16.88% (n=78)
LFYA 11.47% (n=53)
LFYI 3.68% (n=17)
LFYS 0.87% (n=4)
LFYR 0.65% (n=3)
LFYY 0.43% (n=2)
LLYT 0.43% (n=2)
LFYH 0.22% (n=1)
LVYA 0.22% (n=1)
LF-T 0.22% (n=1)
LFYN 0.22% (n=1)
LVYI 0.22% (n=1)
LLYV 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 2c:

LFYT 60.57% (n=275)
LFYH 33.48% (n=152)
LFYA 2.42% (n=11)
LFYV 1.98% (n=9)
LFYS 0.44% (n=2)
LFCT 0.22% (n=1)
LIYT 0.22% (n=1)
LFHH 0.22% (n=1)
LLYH 0.22% (n=1)
LFYY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 3:

LFYY 54.22% (n=2103)
LIYY 16.47% (n=639)
LFYH 8.84% (n=343)
LFYT 4.49% (n=174)
LLYY 3.22% (n=125)
LFYF 2.42% (n=94)
LMYY 2.35% (n=91)
LFSY 1.65% (n=64)
LIYH 1.24% (n=48)
LFHY 1.16% (n=45)
LFYV 1.08% (n=42)
LIYF 0.67% (n=26)
LVYY 0.44% (n=17)
LFNY 0.28% (n=11)
LLYH 0.21% (n=8)
LIYR 0.21% (n=8)
LFYR 0.21% (n=8)
LFHF 0.18% (n=7)
LMYF 0.08% (n=3)
LLYF 0.08% (n=3)
LMYH 0.08% (n=3)
LFYL 0.05% (n=2)
LLYR 0.05% (n=2)
LFRF 0.03% (n=1)
MFYY 0.03% (n=1)
LFCY 0.03% (n=1)
LSYY 0.03% (n=1)
SFYY 0.03% (n=1)
FDYY 0.03% (n=1)
CFYY 0.03% (n=1)
LVYH 0.03% (n=1)
CFII 0.03% (n=1)
LFYW 0.03% (n=1)
LFFY 0.03% (n=1)
LFYK 0.03% (n=1)
LFYS 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 3a:

LFYY 60.55% (n=1969)
LIYY 13.35% (n=434)
LFYH 10.39% (n=338)
LLYY 3.17% (n=103)
LFYF 2.86% (n=93)
LFSY 1.91% (n=62)
LMYY 1.51% (n=49)
LFHY 1.35% (n=44)
LFYV 1.29% (n=42)
LIYH 0.77% (n=25)
LIYF 0.65% (n=21)
LVYY 0.37% (n=12)
LFNY 0.31% (n=10)
LLYH 0.25% (n=8)
LIYR 0.25% (n=8)
LFHF 0.22% (n=7)
LFYR 0.22% (n=7)
LMYF 0.09% (n=3)
LLYF 0.09% (n=3)
LFYL 0.06% (n=2)
LFRF 0.03% (n=1)
MFYY 0.03% (n=1)
LFCY 0.03% (n=1)
LSYY 0.03% (n=1)
SFYY 0.03% (n=1)
FDYY 0.03% (n=1)
CFYY 0.03% (n=1)
LVYH 0.03% (n=1)
CFII 0.03% (n=1)
LLYR 0.03% (n=1)
LFYW 0.03% (n=1)
LFFY 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 3b:

LIYY 50.50% (n=203)
LFYY 23.63% (n=95)
LMYY 9.95% (n=40)
LIYH 5.47% (n=22)
LLYY 4.98% (n=20)
LVYY 1.24% (n=5)
LIYF 1.24% (n=5)
LFYH 0.75% (n=3)
LFSY 0.50% (n=2)
LMYH 0.50% (n=2)
LFNY 0.25% (n=1)
LFYF 0.25% (n=1)
LFYK 0.25% (n=1)
LFHY 0.25% (n=1)
LLYR 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 4:

LFYT 68.37% (n=521)
LFYA 15.09% (n=115)
LFYH 5.38% (n=41)
LLYA 2.23% (n=17)
LFYI 2.10% (n=16)
LFYR 1.97% (n=15)
LFYY 1.05% (n=8)
LLYY 0.92% (n=7)
LFYV 0.79% (n=6)
LFYF 0.66% (n=5)
LFYS 0.52% (n=4)
LLYT 0.13% (n=1)
LFRY 0.13% (n=1)
LIYR 0.13% (n=1)
LMYY 0.13% (n=1)
LIYS 0.13% (n=1)
LIYY 0.13% (n=1)
LIYH 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 4a:

LFYT 53.13% (n=85)
LFYA 25.00% (n=40)
LFYH 18.75% (n=30)
LFYV 1.25% (n=2)
LFYR 0.63% (n=1)
LFYI 0.63% (n=1)
LLYA 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 4d:

LFYT 78.23% (n=424)
LFYA 11.07% (n=60)
LFYI 2.77% (n=15)
LLYA 2.03% (n=11)
LFYR 1.66% (n=9)
LFYH 1.11% (n=6)
LFYY 0.92% (n=5)
LFYF 0.92% (n=5)
LLYY 0.55% (n=3)
LLYT 0.18% (n=1)
LFRY 0.18% (n=1)
LFYS 0.18% (n=1)
LFYV 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 5:

LMYV 12.82% (n=5)
LLYY 10.26% (n=4)
LMYA 10.26% (n=4)
LFYA 7.69% (n=3)
LIYA 7.69% (n=3)
LLYA 7.69% (n=3)
LMYF 5.13% (n=2)
LFYV 5.13% (n=2)
LMYY 5.13% (n=2)
LFYY 5.13% (n=2)
LVYY 2.56% (n=1)
LLYV 2.56% (n=1)
LIYY 2.56% (n=1)
LIYF 2.56% (n=1)
LFYF 2.56% (n=1)
LIYH 2.56% (n=1)
LLYF 2.56% (n=1)
LIYI 2.56% (n=1)
LMYI 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 6:

LFYT 29.78% (n=159)
LFYA 17.04% (n=91)
LFYY 10.11% (n=54)
LFYI 8.61% (n=46)
LFYH 7.12% (n=38)
LFYV 6.37% (n=34)
LFYR 3.93% (n=21)
LLYY 2.06% (n=11)
LFYS 1.87% (n=10)
LLYH 1.31% (n=7)
LLYA 0.94% (n=5)
LFYF 0.94% (n=5)
LIYH 0.94% (n=5)
LFYL 0.75% (n=4)
LFYK 0.75% (n=4)
LFYQ 0.75% (n=4)
LIYA 0.56% (n=3)
LFYN 0.56% (n=3)
LFSY 0.56% (n=3)
LIYV 0.37% (n=2)
LLYI 0.37% (n=2)
LIYK 0.37% (n=2)
LLYR 0.37% (n=2)
LIYY 0.37% (n=2)
LMYV 0.37% (n=2)
LMYH 0.37% (n=2)
LLYS 0.37% (n=2)
LMYA 0.19% (n=1)
LFAR 0.19% (n=1)
LIYR 0.19% (n=1)
LVYR 0.19% (n=1)
LIYL 0.19% (n=1)
LFNH 0.19% (n=1)
LIYS 0.19% (n=1)
LFAH 0.19% (n=1)
LFAV 0.19% (n=1)
LFYM 0.19% (n=1)
LFTK 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Subtype 6a:

LFYT 45.82% (n=137)
LFYA 24.08% (n=72)
LFYI 15.05% (n=45)
LFYV 7.36% (n=22)
LFYR 1.67% (n=5)
LFYS 1.34% (n=4)
LFYF 1.00% (n=3)
LIYA 0.67% (n=2)
LFYN 0.67% (n=2)
LLYI 0.67% (n=2)
LFYH 0.33% (n=1)
LLYA 0.33% (n=1)
LIYV 0.33% (n=1)
LMYA 0.33% (n=1)
LIYK 0.33% (n=1)
---------------------------------------------------------------------------------------
Region 441-444 (antibodies: [HC84.24] ), HCV Genotype 7:

LFYT 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 1:

ALFYTHKF 9.57% (n=2186)
GLFYYHKF 8.28% (n=1890)
GLFYHHKF 5.82% (n=1328)
GLLYYHKF 5.63% (n=1285)
GLFYYNKF 5.24% (n=1197)
ALFYTHRF 4.73% (n=1079)
ALFYAHKF 3.85% (n=879)
GLFYRYKF 3.11% (n=711)
ALFYTNKF 2.24% (n=512)
ALFYVNKF 1.98% (n=452)
ALFYAHRF 1.84% (n=419)
GLFYHHRF 1.83% (n=418)
GLFYHNRF 1.78% (n=407)
GLFYYHRF 1.48% (n=339)
GLFYSNKF 1.32% (n=302)
ALFYVRSF 1.31% (n=299)
GLFYHNKF 1.24% (n=284)
GLLYHHKF 1.20% (n=274)
GLLYYHRF 1.10% (n=250)
GLFYHHGF 1.03% (n=236)
GLFYYNRF 0.96% (n=220)
GLIYHHKF 0.89% (n=203)
GLIYYNKF 0.87% (n=199)
GLFYHYKF 0.80% (n=183)
ALFYANKF 0.77% (n=175)
ALFYRHGF 0.74% (n=169)
ALFYARKF 0.73% (n=166)
GLFYHQKF 0.71% (n=163)
GLIYYHKF 0.70% (n=160)
GLLYHNKF 0.69% (n=158)
GLLYYNKF 0.60% (n=136)
GLFYHRSF 0.56% (n=127)
ALFYKHKF 0.55% (n=126)
GLLYAHKF 0.53% (n=121)
ALFYTRKF 0.52% (n=119)
GLFYRNNF 0.52% (n=118)
ALFYVHRF 0.50% (n=115)
ALFYRHKF 0.46% (n=106)
GLFYQHKF 0.42% (n=95)
GLFYRYNF 0.40% (n=92)
ALFYANRF 0.36% (n=83)
ALIYAHRF 0.35% (n=81)
SLFYVNKF 0.35% (n=79)
ALFYTRNF 0.34% (n=78)
ALFYARKL 0.33% (n=76)
GLFYHRNF 0.33% (n=75)
ALFYVHKF 0.32% (n=74)
GLFYYYKF 0.32% (n=72)
GLFYHYNF 0.31% (n=71)
GLFHYHKF 0.30% (n=68)
ALFYRHGI 0.29% (n=66)
GLFYQHNF 0.28% (n=65)
ALFYTSKF 0.28% (n=65)
GLFYYSKF 0.27% (n=62)
ALFYSSKF 0.27% (n=61)
GLLYHHRF 0.26% (n=59)
ALFYHHKF 0.24% (n=55)
ALFYSHRF 0.24% (n=55)
ALFYTRRF 0.24% (n=55)
GLFYVHKF 0.24% (n=54)
GLFYYHQF 0.23% (n=53)
ALFYAHKI 0.23% (n=53)
ALFYRLNI 0.23% (n=53)
ALFYVREF 0.23% (n=53)
GLFYYHNF 0.23% (n=52)
ALFYTHSF 0.23% (n=52)
GLVYYNKF 0.22% (n=50)
GLFYHRKF 0.21% (n=49)
GLIYRHKF 0.21% (n=47)
ALLYANKF 0.21% (n=47)
GLFYYNQF 0.20% (n=46)
ALFYTRSF 0.20% (n=45)
GLFYPHRF 0.19% (n=44)
GLIYHHRF 0.18% (n=42)
GLFYYRKF 0.18% (n=41)
ALFYARRF 0.18% (n=41)
GLLYRNRF 0.18% (n=40)
GLFYYQKF 0.17% (n=39)
ALFYRKNF 0.17% (n=38)
GLIYYTRF 0.16% (n=36)
GLIYQHRF 0.15% (n=35)
ALFYARNF 0.15% (n=35)
ALFYSHKF 0.15% (n=35)
GLFYSHKF 0.14% (n=33)
GLLYRHKF 0.14% (n=33)
GLFYYDKF 0.14% (n=33)
ALFYVRKF 0.14% (n=33)
GLLYYSKF 0.14% (n=32)
ALFYRNKF 0.14% (n=32)
GLFYHHNF 0.14% (n=31)
GLFYSHNF 0.14% (n=31)
ALFYSNKF 0.13% (n=30)
GLLYHQKF 0.13% (n=29)
ALIYAHKF 0.13% (n=29)
GLIYHNKF 0.12% (n=28)
GLFYTHRF 0.12% (n=28)
GLLYYHSF 0.12% (n=27)
GLFYSHRF 0.11% (n=26)
ALFYKYKF 0.11% (n=26)
GLLYYNRF 0.11% (n=25)
ALFYKHRF 0.11% (n=25)
ALIYANKF 0.11% (n=25)
ALFYAKKI 0.11% (n=24)
ALFYTHKL 0.11% (n=24)
ALFYTQRF 0.10% (n=23)
ALFYVRNF 0.10% (n=23)
ALFYTTKF 0.10% (n=23)
ALIYRHKF 0.10% (n=23)
GLFYFHKF 0.10% (n=22)
GLFYFNKF 0.10% (n=22)
GLFYHHQF 0.10% (n=22)
ALFYRHRF 0.10% (n=22)
GLMYYNKF 0.09% (n=21)
ALFYAKKF 0.09% (n=21)
ALFYVQKF 0.09% (n=21)
GLFYRHKF 0.09% (n=20)
ALFYAKSF 0.09% (n=20)
ALFYVHSF 0.09% (n=20)
GLFYYNNF 0.08% (n=19)
GLLYHHKI 0.08% (n=19)
ALFYVKKF 0.08% (n=19)
ALFYVRNL 0.08% (n=19)
ALFYAHKL 0.08% (n=19)
GLLYPHRF 0.08% (n=18)
ALIYKHRF 0.08% (n=18)
GLFYHYTF 0.07% (n=17)
SLFYSHRF 0.07% (n=17)
ALFYHRRF 0.07% (n=17)
GLFHYNKF 0.07% (n=16)
GLFYYHSF 0.07% (n=16)
GLLYSHKF 0.07% (n=16)
ALFYRNNF 0.07% (n=16)
ALVYAHKF 0.07% (n=16)
GLFYAHKF 0.07% (n=15)
GLFYYTKF 0.07% (n=15)
ALFYTYRF 0.07% (n=15)
ALFYARKI 0.07% (n=15)
GLIYQHKF 0.06% (n=14)
GLFYHRRF 0.06% (n=14)
ALFYSNRF 0.06% (n=14)
GLVYYSKF 0.06% (n=14)
ALFYASKF 0.06% (n=14)
ALFYRRSF 0.06% (n=14)
ALFYVRSL 0.06% (n=14)
ALLYSHKF 0.06% (n=14)
GLLYHRKF 0.06% (n=13)
GLIYYHRF 0.06% (n=13)
GLLYHNRF 0.06% (n=13)
GLIYYTKF 0.06% (n=13)
GLIYFRKF 0.06% (n=13)
ALFYVNRF 0.06% (n=13)
ALLYYHKF 0.06% (n=13)
ALFYVSKF 0.06% (n=13)
GLLYRNKF 0.05% (n=12)
GLLYYNNF 0.05% (n=12)
GLIYYNRF 0.05% (n=12)
GLLYTHKF 0.05% (n=12)
GLLYHRNF 0.05% (n=12)
GLIYFNKF 0.05% (n=12)
GLIYYNQF 0.05% (n=11)
GLIYYHQF 0.05% (n=11)
SLFYTHKF 0.05% (n=11)
GLIYYQKF 0.05% (n=11)
ALFYVRRF 0.05% (n=11)
ALFYVREL 0.05% (n=11)
GLFYHKRF 0.04% (n=10)
GLFYRYRF 0.04% (n=10)
GLFYYRSF 0.04% (n=10)
GLFYVNKF 0.04% (n=10)
GLLYHNKI 0.04% (n=10)
SLFYAHKF 0.04% (n=10)
GLMYSHKF 0.04% (n=9)
GLLYYDKF 0.04% (n=9)
ALFYSRKF 0.04% (n=9)
GLFYRHRF 0.04% (n=8)
GLLYFQKF 0.04% (n=8)
ALFYYKKF 0.04% (n=8)
ALVYAHRF 0.04% (n=8)
ALSYTHKF 0.04% (n=8)
ALFYYNKF 0.04% (n=8)
ALLYAHKF 0.04% (n=8)
ALFYHRKF 0.04% (n=8)
ALFYAHRL 0.04% (n=8)
GLFNYHKF 0.03% (n=7)
GLMYVHKF 0.03% (n=7)
GLFYHYQF 0.03% (n=7)
GLFYYDRF 0.03% (n=7)
GLIYQYRF 0.03% (n=7)
ALFYYDKF 0.03% (n=7)
ALFYHNKF 0.03% (n=7)
GLLYRYKF 0.03% (n=7)
GLFYTHKF 0.03% (n=7)
GLFHVHKF 0.03% (n=7)
GLLYFHKF 0.03% (n=7)
ALFYARSF 0.03% (n=7)
ALFYRHQV 0.03% (n=7)
ALLYRHRV 0.03% (n=7)
ALFYTSRF 0.03% (n=7)
ALFYKRSF 0.03% (n=7)
ALFYKNQF 0.03% (n=7)
ALFYHYRF 0.03% (n=7)
GLMYIHKF 0.03% (n=6)
GLFYLNKF 0.03% (n=6)
GLMYHHKF 0.03% (n=6)
GLFYYSRF 0.03% (n=6)
GLFYSNRF 0.03% (n=6)
GLIYYRKF 0.03% (n=6)
GLFYRHNF 0.03% (n=6)
ALFYQHKF 0.03% (n=6)
ALFYAHSF 0.03% (n=6)
SLFYTHRF 0.03% (n=6)
ALFYYTKF 0.03% (n=6)
ALFYYKSF 0.03% (n=6)
ALLYTHKF 0.03% (n=6)
ALFYRHQF 0.03% (n=6)
ALFYKNRF 0.03% (n=6)
ALFYAYKF 0.03% (n=6)
ALFYTRPF 0.03% (n=6)
ALFYVDKF 0.03% (n=6)
GLFYHYRF 0.02% (n=5)
GLFYHNTF 0.02% (n=5)
GLFYYNTF 0.02% (n=5)
------KF 0.02% (n=5)
SLFYAHRF 0.02% (n=5)
ALFYYRKF 0.02% (n=5)
ALFYRHNF 0.02% (n=5)
ALFYAREF 0.02% (n=5)
GLFYTYKF 0.02% (n=4)
GLFYHNNF 0.02% (n=4)
GLFYYHGF 0.02% (n=4)
GLLYSNKF 0.02% (n=4)
GLFYYRRF 0.02% (n=4)
GLIYHYKF 0.02% (n=4)
GLLYYRKF 0.02% (n=4)
GLFSYHKF 0.02% (n=4)
GLFHYHRF 0.02% (n=4)
GLVYYHKF 0.02% (n=4)
GLFYRYQF 0.02% (n=4)
GLVYYNRF 0.02% (n=4)
GLFYLHKF 0.02% (n=4)
SLFYVHKF 0.02% (n=4)
ALFYTHRL 0.02% (n=4)
APFYTHKF 0.02% (n=4)
VLFYTHKF 0.02% (n=4)
ALFYRYKF 0.02% (n=4)
ALFYRNRF 0.02% (n=4)
ALFYVKRF 0.02% (n=4)
ALFYSRSF 0.02% (n=4)
ALFYAHQF 0.02% (n=4)
ALFYTHKY 0.02% (n=4)
ALFYRSKF 0.02% (n=4)
GLFYSRRF 0.01% (n=3)
GLFYHHKL 0.01% (n=3)
GLIYHYRF 0.01% (n=3)
GLMYTHKF 0.01% (n=3)
GLFHHYKF 0.01% (n=3)
GLFHYYKF 0.01% (n=3)
GLFYNHKF 0.01% (n=3)
GLFYHNKL 0.01% (n=3)
GLVYHHKF 0.01% (n=3)
GPFYHHKF 0.01% (n=3)
GLIYSHKF 0.01% (n=3)
GLLYVHKF 0.01% (n=3)
GLFYRNRF 0.01% (n=3)
GLLYVNKF 0.01% (n=3)
GLFYHHSF 0.01% (n=3)
GLMYYHKF 0.01% (n=3)
GLLYFNKF 0.01% (n=3)
GLFYRSNF 0.01% (n=3)
GLFYTNKF 0.01% (n=3)
GLFYRNKF 0.01% (n=3)
GLLYLHKF 0.01% (n=3)
GLFHHHKF 0.01% (n=3)
GLFYRFKF 0.01% (n=3)
GLIYARKF 0.01% (n=3)
GLFYSYRF 0.01% (n=3)
GLFYHSNF 0.01% (n=3)
GLFYIHKF 0.01% (n=3)
ALFYAQKF 0.01% (n=3)
ALFYTHEF 0.01% (n=3)
ALFYTHNF 0.01% (n=3)
ALIYRHRV 0.01% (n=3)
ALFYRHRV 0.01% (n=3)
TLFYTHRF 0.01% (n=3)
ALFYRNQF 0.01% (n=3)
ALFYVNEF 0.01% (n=3)
ALFYYHKF 0.01% (n=3)
ALFYIHKF 0.01% (n=3)
ALFYVRQF 0.01% (n=3)
SLFYVHSF 0.01% (n=3)
ALMYAHRF 0.01% (n=3)
ALFYANKL 0.01% (n=3)
ALFYSHQF 0.01% (n=3)
ALFYTYKF 0.01% (n=3)
ALFYHHRF 0.01% (n=3)
ALFYTKSF 0.01% (n=3)
ALFYATKF 0.01% (n=3)
ALFYRHGS 0.01% (n=3)
ALLYVNKF 0.01% (n=3)
ALFYARNI 0.01% (n=3)
SLFYVHRF 0.01% (n=2)
GLFYHLKF 0.01% (n=2)
GLIYAHKF 0.01% (n=2)
GLMYFHKF 0.01% (n=2)
SLFYRHHF 0.01% (n=2)
GLLYHYKF 0.01% (n=2)
GLFYLHRF 0.01% (n=2)
GLSYHNKF 0.01% (n=2)
GLSYHHKF 0.01% (n=2)
GLF*YNKF 0.01% (n=2)
GLFYSRNF 0.01% (n=2)
GLFYSQKF 0.01% (n=2)
GFLYYHKF 0.01% (n=2)
GLFYYNKI 0.01% (n=2)
GLLHYNKF 0.01% (n=2)
GLLYYHNF 0.01% (n=2)
GLFYYYRF 0.01% (n=2)
GLFYQYKF 0.01% (n=2)
GLIYLNKF 0.01% (n=2)
GPFSYHKF 0.01% (n=2)
GLLYANKF 0.01% (n=2)
GLIYLHKF 0.01% (n=2)
GLFYSYKF 0.01% (n=2)
GLLYRNNF 0.01% (n=2)
GLFYYNSF 0.01% (n=2)
GLLYANRF 0.01% (n=2)
GLFYYGKF 0.01% (n=2)
GLFYRTKF 0.01% (n=2)
ALFYRHSF 0.01% (n=2)
GLFYHRQF 0.01% (n=2)
GLFYANKF 0.01% (n=2)
GLFYAYKF 0.01% (n=2)
GLFYRYEF 0.01% (n=2)
GLLYYNRL 0.01% (n=2)
GLFYYCKF 0.01% (n=2)
ALLYSSKF 0.01% (n=2)
GLIYHHEF 0.01% (n=2)
GLFYYDEF 0.01% (n=2)
GLLYLNKF 0.01% (n=2)
GLLYHHKV 0.01% (n=2)
GLMYYSSF 0.01% (n=2)
GLFYSNKL 0.01% (n=2)
GLFYRYKS 0.01% (n=2)
GLFYCYKF 0.01% (n=2)
GLIYHNRF 0.01% (n=2)
GLFYRSRF 0.01% (n=2)
GLFYYRNF 0.01% (n=2)
ALIYRNKF 0.01% (n=2)
GLLYYHKL 0.01% (n=2)
GLFYANRF 0.01% (n=2)
ALFYARSL 0.01% (n=2)
TLFYAHKF 0.01% (n=2)
ALFYAHEF 0.01% (n=2)
ALLYANRF 0.01% (n=2)
ALVYSHKF 0.01% (n=2)
ALIYSHRF 0.01% (n=2)
ALLYSHRF 0.01% (n=2)
ALFNTHRS 0.01% (n=2)
ALLYAHRF 0.01% (n=2)
ALFYATSF 0.01% (n=2)
ALFYVQRF 0.01% (n=2)
ALLYHNKF 0.01% (n=2)
ALLYTHRF 0.01% (n=2)
ALFHTRKF 0.01% (n=2)
ALFYANSF 0.01% (n=2)
ALFYVNKL 0.01% (n=2)
ALFYVSRF 0.01% (n=2)
ALFYVRHF 0.01% (n=2)
ALFYVRNI 0.01% (n=2)
ALFYTHGF 0.01% (n=2)
ALFYRRNF 0.01% (n=2)
ALFYKHSF 0.01% (n=2)
ALFYTNRF 0.01% (n=2)
ALFYRRKF 0.01% (n=2)
ALFYRRKL 0.01% (n=2)
ALFYIRSF 0.01% (n=2)
ALFYTTRF 0.01% (n=2)
ALFYTRRI 0.01% (n=2)
ALFYARHF 0.01% (n=2)
ALFYKSRF 0.01% (n=2)
ALFYRQRF 0.01% (n=2)
ALFYRQKF 0.01% (n=2)
ALFYRYQF 0.01% (n=2)
ALVYRYKF 0.01% (n=2)
ALFYARTF 0.01% (n=2)
ALFYARRY 0.01% (n=2)
ALVYHHKF 0.01% (n=2)
ALFYVSHF 0.01% (n=2)
ALFCRHGF 0.01% (n=2)
ALFYTREF 0.01% (n=2)
ALFYVKRL 0.01% (n=2)
ALFYIRKF 0.01% (n=2)
ALFYKYRF 0.01% (n=2)
SLFYYHKF 0.01% (n=2)
ALFARPKV 0.01% (n=2)
GLLYHHSF 0.00% (n=1)
GLPYHHRF 0.00% (n=1)
GLFCYHKF 0.00% (n=1)
GLFYHHRY 0.00% (n=1)
GLFYYHKL 0.00% (n=1)
GLMYFNKF 0.00% (n=1)
GLMYAHKF 0.00% (n=1)
GPFYYNKF 0.00% (n=1)
GLFYHTKF 0.00% (n=1)
GLFYHTQF 0.00% (n=1)
RLLYYNRF 0.00% (n=1)
RPFYRHHF 0.00% (n=1)
GPFYPHRF 0.00% (n=1)
GLLCPHRF 0.00% (n=1)
GLFYYH*F 0.00% (n=1)
GFSYHHKF 0.00% (n=1)
GLLYNNKF 0.00% (n=1)
GLFCSHRF 0.00% (n=1)
GLFYSHNS 0.00% (n=1)
GLFYSHSF 0.00% (n=1)
GPSYSHRF 0.00% (n=1)
GLFYFHRF 0.00% (n=1)
GLFYFQKF 0.00% (n=1)
RAFLFPQI 0.00% (n=1)
RLFYSHKF 0.00% (n=1)
GLIYCHKF 0.00% (n=1)
GLIHRHKF 0.00% (n=1)
SRASSITT 0.00% (n=1)
GLLPQHRL 0.00% (n=1)
GLHYYHKF 0.00% (n=1)
GLFYYHTF 0.00% (n=1)
GLFYSNKS 0.00% (n=1)
GLVYSHKF 0.00% (n=1)
GLFYYHSL 0.00% (n=1)
GLFYYHQS 0.00% (n=1)
ALFYYNSF 0.00% (n=1)
GLFYYRGF 0.00% (n=1)
GLIYYRGF 0.00% (n=1)
GLFYYNKL 0.00% (n=1)
GHFYHHKF 0.00% (n=1)
GPLYYNKF 0.00% (n=1)
GLFYYNGF 0.00% (n=1)
GLNYYNQF 0.00% (n=1)
GLLYHHGF 0.00% (n=1)
GLLYHHRV 0.00% (n=1)
GLLYYHTF 0.00% (n=1)
APFYYDKF 0.00% (n=1)
GLFHRYKF 0.00% (n=1)
GLFYYLRF 0.00% (n=1)
GLTYYNRF 0.00% (n=1)
GLFHHHRF 0.00% (n=1)
GPFYHHRF 0.00% (n=1)
GLFSYYKF 0.00% (n=1)
GLFSYRHV 0.00% (n=1)
GLIYQYNF 0.00% (n=1)
GLLYTHRF 0.00% (n=1)
GLLYSHRF 0.00% (n=1)
GLFYKYNF 0.00% (n=1)
GLVYRHKF 0.00% (n=1)
SLFYHHKF 0.00% (n=1)
GLLYHNQF 0.00% (n=1)
GLFYFKNF 0.00% (n=1)
GLFYYYQF 0.00% (n=1)
GLLYSNNF 0.00% (n=1)
GLIHHHKF 0.00% (n=1)
GLFYHQRF 0.00% (n=1)
GLIYHQQI 0.00% (n=1)
GLFYRSKF 0.00% (n=1)
GLFYAHNF 0.00% (n=1)
GLIYTYKF 0.00% (n=1)
GLLYAGRF 0.00% (n=1)
GLIYYYRF 0.00% (n=1)
GLFYAHRF 0.00% (n=1)
GLFYSGRF 0.00% (n=1)
GLFYTHNF 0.00% (n=1)
GLFYLNRF 0.00% (n=1)
GLLYVNRF 0.00% (n=1)
GLLYYRRF 0.00% (n=1)
GLLYYNKY 0.00% (n=1)
DQH*RQLV 0.00% (n=1)
GLFYISRF 0.00% (n=1)
RLFYYHRF 0.00% (n=1)
ALFYYHRS 0.00% (n=1)
GLFYINKF 0.00% (n=1)
GLLYRYRF 0.00% (n=1)
GLIYQWKF 0.00% (n=1)
GLFSHYNF 0.00% (n=1)
GLLYSYKF 0.00% (n=1)
GLLYINSF 0.00% (n=1)
SLFYRYRF 0.00% (n=1)
GLIYRFSF 0.00% (n=1)
GLFYSNQF 0.00% (n=1)
GLFYRISF 0.00% (n=1)
GLFNHYKF 0.00% (n=1)
GLVYVNRF 0.00% (n=1)
GLFYPYKF 0.00% (n=1)
GLLYYNQF 0.00% (n=1)
GLLYYNRS 0.00% (n=1)
GLLYYDRF 0.00% (n=1)
RLFYYHKF 0.00% (n=1)
-LFYHHKF 0.00% (n=1)
GLFYHHKV 0.00% (n=1)
GLFYRFRF 0.00% (n=1)
WLFYHYKF 0.00% (n=1)
GLFYRYTF 0.00% (n=1)
RLFYRYTF 0.00% (n=1)
GLFCRYKF 0.00% (n=1)
ELFYSYKF 0.00% (n=1)
------RF 0.00% (n=1)
GLFYYNEF 0.00% (n=1)
ALFYYHKL 0.00% (n=1)
GLLYQHKF 0.00% (n=1)
GLLYRYNF 0.00% (n=1)
GLFYYNRS 0.00% (n=1)
GPFYYNRF 0.00% (n=1)
GLFCYNRF 0.00% (n=1)
GLFYYNRI 0.00% (n=1)
GLFCYNRI 0.00% (n=1)
GLFYCNRF 0.00% (n=1)
GLFHYNRF 0.00% (n=1)
GLFYDNRF 0.00% (n=1)
GLFYHYYF 0.00% (n=1)
GLIYYHVF 0.00% (n=1)
GLIYYHEF 0.00% (n=1)
GPIYYHKF 0.00% (n=1)
ELFYYDKF 0.00% (n=1)
GLFYYDKS 0.00% (n=1)
GLHYHHKF 0.00% (n=1)
GPLYYHKF 0.00% (n=1)
GPFYRYKF 0.00% (n=1)
GLFYHYGF 0.00% (n=1)
GLFHHHGF 0.00% (n=1)
GLFCHHRF 0.00% (n=1)
GAPLSHKI 0.00% (n=1)
GLFYHNSF 0.00% (n=1)
GLFYNKRF 0.00% (n=1)
GLFYLDRF 0.00% (n=1)
GLIYHDKF 0.00% (n=1)
GLFYHNQF 0.00% (n=1)
GLLYYRNF 0.00% (n=1)
GLIYHRKF 0.00% (n=1)
GLFYYYNF 0.00% (n=1)
GLLYHHNF 0.00% (n=1)
GLLYRRNF 0.00% (n=1)
GLFYASKF 0.00% (n=1)
GLFSYRKF 0.00% (n=1)
GFFYHHKF 0.00% (n=1)
GLSTTTSF 0.00% (n=1)
GLFYQHKY 0.00% (n=1)
GLFYHSKF 0.00% (n=1)
GLIYSNKF 0.00% (n=1)
GLVYLNKF 0.00% (n=1)
GLLYCHKF 0.00% (n=1)
GLLNYHKF 0.00% (n=1)
GLPYYHKF 0.00% (n=1)
WLLYYHKF 0.00% (n=1)
GLFYHQKL 0.00% (n=1)
GLIYRFNF 0.00% (n=1)
GLFYQYRF 0.00% (n=1)
GLLYYYKF 0.00% (n=1)
GLFFYHKF 0.00% (n=1)
SLFYRHRF 0.00% (n=1)
GLVYRYQF 0.00% (n=1)
GLLYYSRF 0.00% (n=1)
GLIYYSRF 0.00% (n=1)
GLFCHHKF 0.00% (n=1)
ALFYHNRF 0.00% (n=1)
RLFYHRNF 0.00% (n=1)
GLFYNYRF 0.00% (n=1)
GLIYLYKF 0.00% (n=1)
GLFYSYNF 0.00% (n=1)
ALFYAHNL 0.00% (n=1)
GLLYAKKF 0.00% (n=1)
TLFYVHKF 0.00% (n=1)
ALFYAHMF 0.00% (n=1)
ALFYFRRF 0.00% (n=1)
ALFYFNRF 0.00% (n=1)
ALFYTRGF 0.00% (n=1)
ALFYAGNF 0.00% (n=1)
ALFYEKNF 0.00% (n=1)
ALFYERNF 0.00% (n=1)
ALFYTGNF 0.00% (n=1)
ALFYVKNF 0.00% (n=1)
ALFFTHRF 0.00% (n=1)
TLFYTTKF 0.00% (n=1)
ALFYASRF 0.00% (n=1)
ALFYQNKF 0.00% (n=1)
ALIYTHRF 0.00% (n=1)
ALIYYNKF 0.00% (n=1)
ALFYTKQF 0.00% (n=1)
ALFNTHSF 0.00% (n=1)
ALFYAHRC 0.00% (n=1)
SLFYAQKF 0.00% (n=1)
ALFYTNKS 0.00% (n=1)
ELFYTNKF 0.00% (n=1)
AL------ 0.00% (n=1)
GVFYHNKF 0.00% (n=1)
ALFYKKNF 0.00% (n=1)
ALFYKKNI 0.00% (n=1)
ARFYTHKF 0.00% (n=1)
ALFYMHRF 0.00% (n=1)
ALFYTHRS 0.00% (n=1)
ALLYTRKF 0.00% (n=1)
ALFHTHRF 0.00% (n=1)
ALLYARRF 0.00% (n=1)
ALFYRNEV 0.00% (n=1)
ALFYTKRF 0.00% (n=1)
ALIYKHKL 0.00% (n=1)
ALIYRHKV 0.00% (n=1)
ALFYSARF 0.00% (n=1)
SLFYINRF 0.00% (n=1)
ALFYRHNI 0.00% (n=1)
ALFYTNSF 0.00% (n=1)
ALFYSKKF 0.00% (n=1)
GLFYQGKF 0.00% (n=1)
ALFHAHKI 0.00% (n=1)
ALVYRNKF 0.00% (n=1)
ALLYKNKF 0.00% (n=1)
ALFFVNKF 0.00% (n=1)
ALIYNHRF 0.00% (n=1)
ALFYTKKF 0.00% (n=1)
GLIYKYKF 0.00% (n=1)
SLFYRYKF 0.00% (n=1)
ALFYKNNF 0.00% (n=1)
ALFYAGKF 0.00% (n=1)
ALFYAKNL 0.00% (n=1)
ALFYTSSF 0.00% (n=1)
ALFYARTV 0.00% (n=1)
ALMYVHRF 0.00% (n=1)
ALFYANRL 0.00% (n=1)
ALFYRHKL 0.00% (n=1)
ALFYKTQF 0.00% (n=1)
ALFYKKQF 0.00% (n=1)
ELFYTHRF 0.00% (n=1)
ALFYRYRF 0.00% (n=1)
GLLYAHRF 0.00% (n=1)
ALSYRNKF 0.00% (n=1)
ALSYAHKF 0.00% (n=1)
ALFYSRSL 0.00% (n=1)
VLFYAKKI 0.00% (n=1)
SLFYAHSF 0.00% (n=1)
ALFYFRKF 0.00% (n=1)
ALFYKRKF 0.00% (n=1)
SLFYTYKF 0.00% (n=1)
ALIYRYKF 0.00% (n=1)
SLFYRHKF 0.00% (n=1)
ALFYRHHF 0.00% (n=1)
ALIYKNKF 0.00% (n=1)
ALFYKNHF 0.00% (n=1)
ALFYGHKF 0.00% (n=1)
ALFYVKGF 0.00% (n=1)
ALFYRHWF 0.00% (n=1)
ALFHTHKF 0.00% (n=1)
ALFYAQRF 0.00% (n=1)
ELFYAHKF 0.00% (n=1)
ALVYTHKF 0.00% (n=1)
ALFYHRTF 0.00% (n=1)
SLFYYKKF 0.00% (n=1)
ALFYSRRF 0.00% (n=1)
SLFYIYKF 0.00% (n=1)
ALFYTHAF 0.00% (n=1)
ALFYVNSF 0.00% (n=1)
ALFYINKF 0.00% (n=1)
ALFYQHRF 0.00% (n=1)
ALFYTNNF 0.00% (n=1)
ALFYRSRF 0.00% (n=1)
ALIYKSKF 0.00% (n=1)
ALFYRYKL 0.00% (n=1)
ALFYSVKI 0.00% (n=1)
ALIYRSKF 0.00% (n=1)
ALVYANKF 0.00% (n=1)
ALFYKNKF 0.00% (n=1)
SLFYATRF 0.00% (n=1)
ALFYSKEF 0.00% (n=1)
ALVYVNKF 0.00% (n=1)
ALFYTTSF 0.00% (n=1)
SLFYVHKL 0.00% (n=1)
TLFYRHGF 0.00% (n=1)
ALFYKHGF 0.00% (n=1)
APFYVNKF 0.00% (n=1)
VLFYVNKF 0.00% (n=1)
ALLYRHKF 0.00% (n=1)
ALFCTHKF 0.00% (n=1)
ALFYVCSF 0.00% (n=1)
ALFYVHGF 0.00% (n=1)
ALSYVRSF 0.00% (n=1)
ALFHVRSF 0.00% (n=1)
ALFCVRSF 0.00% (n=1)
ALSYTSKF 0.00% (n=1)
ALFYRDKF 0.00% (n=1)
APFYTSKF 0.00% (n=1)
ALFYADKF 0.00% (n=1)
ALFYVNTF 0.00% (n=1)
ALSYTYRF 0.00% (n=1)
ALIYAHKI 0.00% (n=1)
ALFYYHNF 0.00% (n=1)
SLFYTQRF 0.00% (n=1)
GLFYAHRI 0.00% (n=1)
ALVYRHRF 0.00% (n=1)
ALIYARKF 0.00% (n=1)
ALFAKPKV 0.00% (n=1)
GLLYYHKV 0.00% (n=1)
ALFLRSRV 0.00% (n=1)
ALFYKPKV 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 1a:

GLFYYHKF 13.87% (n=1887)
GLFYHHKF 9.76% (n=1328)
GLLYYHKF 9.44% (n=1284)
GLFYYNKF 8.79% (n=1196)
GLFYRYKF 5.23% (n=711)
GLFYHHRF 3.07% (n=418)
GLFYHNRF 2.99% (n=407)
GLFYYHRF 2.49% (n=339)
GLFYSNKF 2.21% (n=301)
GLFYHNKF 2.09% (n=284)
GLLYHHKF 2.01% (n=274)
GLLYYHRF 1.84% (n=250)
GLFYHHGF 1.74% (n=236)
GLFYYNRF 1.62% (n=220)
GLIYHHKF 1.49% (n=203)
GLIYYNKF 1.46% (n=199)
GLFYHYKF 1.35% (n=183)
GLFYHQKF 1.20% (n=163)
GLIYYHKF 1.18% (n=160)
GLLYHNKF 1.16% (n=158)
GLLYYNKF 1.00% (n=136)
GLFYHRSF 0.93% (n=127)
GLFYRNNF 0.87% (n=118)
GLFYQHKF 0.70% (n=95)
GLFYRYNF 0.68% (n=92)
GLFYHRNF 0.55% (n=75)
GLFYYYKF 0.53% (n=72)
GLFYHYNF 0.52% (n=71)
GLLYAHKF 0.51% (n=69)
GLFHYHKF 0.50% (n=68)
GLFYQHNF 0.48% (n=65)
GLFYYSKF 0.46% (n=62)
ALFYSSKF 0.45% (n=61)
GLLYHHRF 0.43% (n=59)
GLFYVHKF 0.40% (n=54)
GLFYYHQF 0.39% (n=53)
GLFYYHNF 0.38% (n=52)
GLVYYNKF 0.37% (n=50)
ALFYHHKF 0.36% (n=49)
GLFYHRKF 0.36% (n=49)
GLIYRHKF 0.35% (n=47)
GLFYYNQF 0.34% (n=46)
GLFYPHRF 0.32% (n=44)
GLIYHHRF 0.31% (n=42)
GLFYYRKF 0.30% (n=41)
GLLYRNRF 0.29% (n=40)
GLFYYQKF 0.29% (n=39)
ALFYRKNF 0.28% (n=38)
GLIYYTRF 0.26% (n=36)
GLIYQHRF 0.26% (n=35)
GLFYSHKF 0.24% (n=33)
GLLYRHKF 0.24% (n=33)
GLFYYDKF 0.24% (n=33)
GLLYYSKF 0.24% (n=32)
GLFYHHNF 0.23% (n=31)
GLFYSHNF 0.23% (n=31)
GLLYHQKF 0.21% (n=29)
ALFYSNKF 0.21% (n=29)
GLIYHNKF 0.21% (n=28)
GLLYYHSF 0.20% (n=27)
GLFYSHRF 0.19% (n=26)
GLLYYNRF 0.18% (n=25)
GLFYTHRF 0.17% (n=23)
GLFYFHKF 0.16% (n=22)
GLFYFNKF 0.16% (n=22)
GLFYHHQF 0.16% (n=22)
GLMYYNKF 0.15% (n=21)
GLFYRHKF 0.15% (n=20)
GLLYHHKI 0.14% (n=19)
GLLYPHRF 0.13% (n=18)
GLFYYNNF 0.13% (n=18)
GLFYHYTF 0.12% (n=17)
GLFHYNKF 0.12% (n=16)
GLFYYHSF 0.12% (n=16)
GLLYSHKF 0.12% (n=16)
ALFYRNNF 0.12% (n=16)
GLFYYTKF 0.11% (n=15)
GLIYQHKF 0.10% (n=14)
GLFYHRRF 0.10% (n=14)
GLFYAHKF 0.10% (n=14)
GLVYYSKF 0.10% (n=14)
GLLYHRKF 0.10% (n=13)
GLIYYHRF 0.10% (n=13)
GLLYHNRF 0.10% (n=13)
GLIYYTKF 0.10% (n=13)
ALFYSNRF 0.10% (n=13)
GLIYFRKF 0.10% (n=13)
GLLYRNKF 0.09% (n=12)
GLLYYNNF 0.09% (n=12)
GLIYYNRF 0.09% (n=12)
GLLYTHKF 0.09% (n=12)
GLLYHRNF 0.09% (n=12)
GLIYFNKF 0.09% (n=12)
GLIYYNQF 0.08% (n=11)
GLIYYHQF 0.08% (n=11)
GLIYYQKF 0.08% (n=11)
GLFYHKRF 0.07% (n=10)
GLFYRYRF 0.07% (n=10)
GLFYYRSF 0.07% (n=10)
GLFYVNKF 0.07% (n=10)
GLLYHNKI 0.07% (n=10)
GLMYSHKF 0.07% (n=9)
GLLYYDKF 0.07% (n=9)
GLFYRHRF 0.06% (n=8)
GLLYFQKF 0.06% (n=8)
GLFNYHKF 0.05% (n=7)
GLMYVHKF 0.05% (n=7)
GLFYHYQF 0.05% (n=7)
GLFYYDRF 0.05% (n=7)
GLIYQYRF 0.05% (n=7)
ALFYYDKF 0.05% (n=7)
GLLYRYKF 0.05% (n=7)
GLFYTHKF 0.05% (n=7)
ALFYANRF 0.05% (n=7)
ALFYSRKF 0.05% (n=7)
GLFHVHKF 0.05% (n=7)
GLLYFHKF 0.05% (n=7)
GLMYIHKF 0.04% (n=6)
GLFYLNKF 0.04% (n=6)
GLMYHHKF 0.04% (n=6)
GLFYYSRF 0.04% (n=6)
GLFYSNRF 0.04% (n=6)
GLIYYRKF 0.04% (n=6)
GLFYRHNF 0.04% (n=6)
GLFYHYRF 0.04% (n=5)
GLFYHNTF 0.04% (n=5)
GLFYYNTF 0.04% (n=5)
------KF 0.04% (n=5)
ALFYQHKF 0.04% (n=5)
ALFYRHKF 0.04% (n=5)
GLFYTYKF 0.03% (n=4)
GLFYHNNF 0.03% (n=4)
GLFYYHGF 0.03% (n=4)
GLLYSNKF 0.03% (n=4)
GLFYYRRF 0.03% (n=4)
GLIYHYKF 0.03% (n=4)
GLLYYRKF 0.03% (n=4)
GLFSYHKF 0.03% (n=4)
GLFHYHRF 0.03% (n=4)
GLVYYHKF 0.03% (n=4)
GLFYRYQF 0.03% (n=4)
GLVYYNRF 0.03% (n=4)
GLFYSRRF 0.02% (n=3)
GLFYHHKL 0.02% (n=3)
GLIYHYRF 0.02% (n=3)
GLMYTHKF 0.02% (n=3)
GLFHHYKF 0.02% (n=3)
GLFHYYKF 0.02% (n=3)
GLFYNHKF 0.02% (n=3)
GLFYHNKL 0.02% (n=3)
GLVYHHKF 0.02% (n=3)
GPFYHHKF 0.02% (n=3)
GLIYSHKF 0.02% (n=3)
GLLYVHKF 0.02% (n=3)
GLFYRNRF 0.02% (n=3)
GLLYVNKF 0.02% (n=3)
GLFYHHSF 0.02% (n=3)
GLMYYHKF 0.02% (n=3)
GLLYFNKF 0.02% (n=3)
GLFYRSNF 0.02% (n=3)
GLFYRNKF 0.02% (n=3)
GLLYLHKF 0.02% (n=3)
GLFHHHKF 0.02% (n=3)
GLFYRFKF 0.02% (n=3)
GLIYARKF 0.02% (n=3)
GLFYSYRF 0.02% (n=3)
GLFYHSNF 0.02% (n=3)
GLFYIHKF 0.02% (n=3)
GLFYLHKF 0.02% (n=3)
GLFYHLKF 0.01% (n=2)
GLIYAHKF 0.01% (n=2)
GLMYFHKF 0.01% (n=2)
SLFYRHHF 0.01% (n=2)
GLLYHYKF 0.01% (n=2)
GLFYLHRF 0.01% (n=2)
GLSYHNKF 0.01% (n=2)
GLSYHHKF 0.01% (n=2)
GLF*YNKF 0.01% (n=2)
GLFYSRNF 0.01% (n=2)
GLFYSQKF 0.01% (n=2)
GFLYYHKF 0.01% (n=2)
GLFYYNKI 0.01% (n=2)
GLLHYNKF 0.01% (n=2)
GLLYYHNF 0.01% (n=2)
GLFYYYRF 0.01% (n=2)
GLFYQYKF 0.01% (n=2)
GLIYLNKF 0.01% (n=2)
GPFSYHKF 0.01% (n=2)
GLLYANKF 0.01% (n=2)
GLIYLHKF 0.01% (n=2)
GLFYSYKF 0.01% (n=2)
GLLYRNNF 0.01% (n=2)
GLFYYNSF 0.01% (n=2)
GLLYANRF 0.01% (n=2)
GLFYTNKF 0.01% (n=2)
GLFYYGKF 0.01% (n=2)
GLFYRTKF 0.01% (n=2)
GLFYHRQF 0.01% (n=2)
GLFYANKF 0.01% (n=2)
GLFYRYEF 0.01% (n=2)
SLFYTHKF 0.01% (n=2)
GLLYYNRL 0.01% (n=2)
GLFYYCKF 0.01% (n=2)
ALLYSSKF 0.01% (n=2)
GLIYHHEF 0.01% (n=2)
GLFYYDEF 0.01% (n=2)
GLLYLNKF 0.01% (n=2)
GLLYHHKV 0.01% (n=2)
GLMYYSSF 0.01% (n=2)
GLFYSNKL 0.01% (n=2)
GLFYRYKS 0.01% (n=2)
GLFYCYKF 0.01% (n=2)
GLIYHNRF 0.01% (n=2)
GLFYRSRF 0.01% (n=2)
GLFYYRNF 0.01% (n=2)
GLLYYHKL 0.01% (n=2)
GLLYHHSF 0.01% (n=1)
GLPYHHRF 0.01% (n=1)
GLFCYHKF 0.01% (n=1)
GLFYHHRY 0.01% (n=1)
GLFYYHKL 0.01% (n=1)
GLMYFNKF 0.01% (n=1)
GLMYAHKF 0.01% (n=1)
GPFYYNKF 0.01% (n=1)
GLFYHTKF 0.01% (n=1)
GLFYHTQF 0.01% (n=1)
RLLYYNRF 0.01% (n=1)
RPFYRHHF 0.01% (n=1)
GPFYPHRF 0.01% (n=1)
GLLCPHRF 0.01% (n=1)
GLFYYH*F 0.01% (n=1)
GFSYHHKF 0.01% (n=1)
GLLYNNKF 0.01% (n=1)
GLFCSHRF 0.01% (n=1)
GLFYSHNS 0.01% (n=1)
GLFYSHSF 0.01% (n=1)
GPSYSHRF 0.01% (n=1)
GLFYFHRF 0.01% (n=1)
GLFYFQKF 0.01% (n=1)
RAFLFPQI 0.01% (n=1)
RLFYSHKF 0.01% (n=1)
GLIYCHKF 0.01% (n=1)
GLIHRHKF 0.01% (n=1)
SRASSITT 0.01% (n=1)
GLLPQHRL 0.01% (n=1)
GLHYYHKF 0.01% (n=1)
GLFYYHTF 0.01% (n=1)
GLFYSNKS 0.01% (n=1)
GLVYSHKF 0.01% (n=1)
GLFYYHSL 0.01% (n=1)
GLFYYHQS 0.01% (n=1)
ALFYYNSF 0.01% (n=1)
GLFYYRGF 0.01% (n=1)
GLIYYRGF 0.01% (n=1)
GLFYYNKL 0.01% (n=1)
GHFYHHKF 0.01% (n=1)
GPLYYNKF 0.01% (n=1)
GLFYYNGF 0.01% (n=1)
GLNYYNQF 0.01% (n=1)
GLLYHHGF 0.01% (n=1)
GLLYHHRV 0.01% (n=1)
GLLYYHTF 0.01% (n=1)
APFYYDKF 0.01% (n=1)
GLFHRYKF 0.01% (n=1)
GLFYYLRF 0.01% (n=1)
GLTYYNRF 0.01% (n=1)
GLFHHHRF 0.01% (n=1)
GPFYHHRF 0.01% (n=1)
ALFYHNKF 0.01% (n=1)
GLFSYYKF 0.01% (n=1)
GLFSYRHV 0.01% (n=1)
GLIYQYNF 0.01% (n=1)
GLLYTHRF 0.01% (n=1)
GLLYSHRF 0.01% (n=1)
GLFYKYNF 0.01% (n=1)
GLVYRHKF 0.01% (n=1)
SLFYHHKF 0.01% (n=1)
GLLYHNQF 0.01% (n=1)
GLFYFKNF 0.01% (n=1)
GLFYYYQF 0.01% (n=1)
GLLYSNNF 0.01% (n=1)
GLIHHHKF 0.01% (n=1)
GLFYHQRF 0.01% (n=1)
GLIYHQQI 0.01% (n=1)
GLFYRSKF 0.01% (n=1)
GLFYAHNF 0.01% (n=1)
GLIYTYKF 0.01% (n=1)
GLLYAGRF 0.01% (n=1)
GLIYYYRF 0.01% (n=1)
GLFYAHRF 0.01% (n=1)
GLFYSGRF 0.01% (n=1)
GLFYTHNF 0.01% (n=1)
GLFYLNRF 0.01% (n=1)
GLLYVNRF 0.01% (n=1)
GLLYYRRF 0.01% (n=1)
GLLYYNKY 0.01% (n=1)
DQH*RQLV 0.01% (n=1)
GLFYISRF 0.01% (n=1)
RLFYYHRF 0.01% (n=1)
ALFYYHRS 0.01% (n=1)
GLFYINKF 0.01% (n=1)
GLLYRYRF 0.01% (n=1)
GLIYQWKF 0.01% (n=1)
GLFSHYNF 0.01% (n=1)
GLLYSYKF 0.01% (n=1)
GLLYINSF 0.01% (n=1)
SLFYRYRF 0.01% (n=1)
ALFYRHSF 0.01% (n=1)
GLIYRFSF 0.01% (n=1)
GLFYSNQF 0.01% (n=1)
GLFYRISF 0.01% (n=1)
GLFYAYKF 0.01% (n=1)
GLFNHYKF 0.01% (n=1)
GLVYVNRF 0.01% (n=1)
GLFYPYKF 0.01% (n=1)
GLLYYNQF 0.01% (n=1)
GLLYYNRS 0.01% (n=1)
GLLYYDRF 0.01% (n=1)
RLFYYHKF 0.01% (n=1)
-LFYHHKF 0.01% (n=1)
GLFYHHKV 0.01% (n=1)
GLFYRFRF 0.01% (n=1)
WLFYHYKF 0.01% (n=1)
GLFYRYTF 0.01% (n=1)
RLFYRYTF 0.01% (n=1)
GLFCRYKF 0.01% (n=1)
ELFYSYKF 0.01% (n=1)
------RF 0.01% (n=1)
GLFYYNEF 0.01% (n=1)
ALFYYHKL 0.01% (n=1)
GLLYQHKF 0.01% (n=1)
GLLYRYNF 0.01% (n=1)
GLFYYNRS 0.01% (n=1)
GPFYYNRF 0.01% (n=1)
GLFCYNRF 0.01% (n=1)
GLFYYNRI 0.01% (n=1)
GLFCYNRI 0.01% (n=1)
GLFYCNRF 0.01% (n=1)
GLFHYNRF 0.01% (n=1)
GLFYDNRF 0.01% (n=1)
GLFYHYYF 0.01% (n=1)
GLIYYHVF 0.01% (n=1)
GLIYYHEF 0.01% (n=1)
GPIYYHKF 0.01% (n=1)
ELFYYDKF 0.01% (n=1)
GLFYYDKS 0.01% (n=1)
GLHYHHKF 0.01% (n=1)
GPLYYHKF 0.01% (n=1)
GPFYRYKF 0.01% (n=1)
GLFYHYGF 0.01% (n=1)
GLFHHHGF 0.01% (n=1)
GLFCHHRF 0.01% (n=1)
GAPLSHKI 0.01% (n=1)
GLFYHNSF 0.01% (n=1)
GLFYNKRF 0.01% (n=1)
GLFYLDRF 0.01% (n=1)
GLIYHDKF 0.01% (n=1)
GLFYHNQF 0.01% (n=1)
GLLYYRNF 0.01% (n=1)
GLIYHRKF 0.01% (n=1)
GLFYYYNF 0.01% (n=1)
GLLYHHNF 0.01% (n=1)
GLLYRRNF 0.01% (n=1)
GLFYASKF 0.01% (n=1)
GLFSYRKF 0.01% (n=1)
GFFYHHKF 0.01% (n=1)
GLSTTTSF 0.01% (n=1)
GLFYQHKY 0.01% (n=1)
ALIYRNKF 0.01% (n=1)
GLFYHSKF 0.01% (n=1)
GLIYSNKF 0.01% (n=1)
GLVYLNKF 0.01% (n=1)
GLLYCHKF 0.01% (n=1)
GLLNYHKF 0.01% (n=1)
GLPYYHKF 0.01% (n=1)
WLLYYHKF 0.01% (n=1)
GLFYHQKL 0.01% (n=1)
GLIYRFNF 0.01% (n=1)
GLFYQYRF 0.01% (n=1)
GLLYYYKF 0.01% (n=1)
GLFFYHKF 0.01% (n=1)
GLFYANRF 0.01% (n=1)
SLFYRHRF 0.01% (n=1)
GLVYRYQF 0.01% (n=1)
GLLYYSRF 0.01% (n=1)
GLIYYSRF 0.01% (n=1)
GLFCHHKF 0.01% (n=1)
ALFYHNRF 0.01% (n=1)
RLFYHRNF 0.01% (n=1)
GLFYNYRF 0.01% (n=1)
GLIYLYKF 0.01% (n=1)
GLFYSYNF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 1b:

ALFYTHKF 23.78% (n=2184)
ALFYTHRF 11.74% (n=1078)
ALFYAHKF 9.57% (n=879)
ALFYTNKF 5.57% (n=512)
ALFYVNKF 4.92% (n=452)
ALFYAHRF 4.55% (n=418)
ALFYVRSF 3.26% (n=299)
ALFYANKF 1.91% (n=175)
ALFYRHGF 1.84% (n=169)
ALFYARKF 1.81% (n=166)
ALFYKHKF 1.37% (n=126)
ALFYTRKF 1.30% (n=119)
ALFYVHRF 1.25% (n=115)
ALFYRHKF 1.10% (n=101)
ALIYAHRF 0.88% (n=81)
SLFYVNKF 0.86% (n=79)
ALFYTRNF 0.85% (n=78)
ALFYARKL 0.83% (n=76)
ALFYANRF 0.82% (n=75)
ALFYVHKF 0.81% (n=74)
ALFYRHGI 0.72% (n=66)
ALFYTSKF 0.71% (n=65)
ALFYSHRF 0.60% (n=55)
ALFYTRRF 0.59% (n=54)
ALFYAHKI 0.58% (n=53)
ALFYRLNI 0.58% (n=53)
ALFYVREF 0.58% (n=53)
ALFYTHSF 0.57% (n=52)
GLLYAHKF 0.53% (n=49)
ALLYANKF 0.51% (n=47)
ALFYTRSF 0.48% (n=44)
ALFYARRF 0.45% (n=41)
ALFYARNF 0.38% (n=35)
ALFYVRKF 0.36% (n=33)
ALFYSHKF 0.35% (n=32)
ALFYRNKF 0.35% (n=32)
ALIYAHKF 0.32% (n=29)
ALFYKYKF 0.28% (n=26)
ALFYKHRF 0.27% (n=25)
ALIYANKF 0.27% (n=25)
ALFYAKKI 0.26% (n=24)
ALFYTHKL 0.26% (n=24)
ALFYTQRF 0.25% (n=23)
ALFYVRNF 0.25% (n=23)
ALFYTTKF 0.25% (n=23)
ALIYRHKF 0.25% (n=23)
ALFYRHRF 0.24% (n=22)
ALFYAKKF 0.23% (n=21)
ALFYVQKF 0.23% (n=21)
ALFYAKSF 0.22% (n=20)
ALFYVHSF 0.22% (n=20)
ALFYVKKF 0.21% (n=19)
ALFYVRNL 0.21% (n=19)
ALFYAHKL 0.21% (n=19)
ALIYKHRF 0.20% (n=18)
SLFYSHRF 0.19% (n=17)
ALFYHRRF 0.19% (n=17)
ALVYAHKF 0.17% (n=16)
ALFYTYRF 0.16% (n=15)
ALFYARKI 0.16% (n=15)
ALFYASKF 0.15% (n=14)
ALFYRRSF 0.15% (n=14)
ALFYVRSL 0.15% (n=14)
ALLYSHKF 0.15% (n=14)
ALFYVNRF 0.14% (n=13)
ALLYYHKF 0.14% (n=13)
ALFYVSKF 0.14% (n=13)
ALFYVRRF 0.12% (n=11)
ALFYVREL 0.12% (n=11)
SLFYAHKF 0.11% (n=10)
ALFYYKKF 0.09% (n=8)
ALVYAHRF 0.09% (n=8)
ALSYTHKF 0.09% (n=8)
ALFYYNKF 0.09% (n=8)
ALLYAHKF 0.09% (n=8)
ALFYHRKF 0.09% (n=8)
ALFYAHRL 0.09% (n=8)
ALFYARSF 0.08% (n=7)
ALFYRHQV 0.08% (n=7)
ALLYRHRV 0.08% (n=7)
ALFYTSRF 0.08% (n=7)
ALFYKRSF 0.08% (n=7)
ALFYKNQF 0.08% (n=7)
ALFYHYRF 0.08% (n=7)
ALFYAHSF 0.07% (n=6)
ALFYHHKF 0.07% (n=6)
SLFYTHRF 0.07% (n=6)
ALFYYTKF 0.07% (n=6)
ALFYYKSF 0.07% (n=6)
ALLYTHKF 0.07% (n=6)
ALFYRHQF 0.07% (n=6)
ALFYKNRF 0.07% (n=6)
ALFYAYKF 0.07% (n=6)
ALFYTRPF 0.07% (n=6)
ALFYHNKF 0.07% (n=6)
SLFYTHKF 0.07% (n=6)
ALFYVDKF 0.07% (n=6)
SLFYAHRF 0.05% (n=5)
ALFYYRKF 0.05% (n=5)
ALFYRHNF 0.05% (n=5)
ALFYAREF 0.05% (n=5)
SLFYVHKF 0.04% (n=4)
ALFYTHRL 0.04% (n=4)
APFYTHKF 0.04% (n=4)
VLFYTHKF 0.04% (n=4)
ALFYRYKF 0.04% (n=4)
ALFYRNRF 0.04% (n=4)
GLFYTHRF 0.04% (n=4)
ALFYVKRF 0.04% (n=4)
ALFYAHQF 0.04% (n=4)
ALFYTHKY 0.04% (n=4)
ALFYRSKF 0.04% (n=4)
ALFYAQKF 0.03% (n=3)
ALFYTHEF 0.03% (n=3)
ALFYTHNF 0.03% (n=3)
ALIYRHRV 0.03% (n=3)
ALFYRHRV 0.03% (n=3)
TLFYTHRF 0.03% (n=3)
ALFYRNQF 0.03% (n=3)
ALFYVNEF 0.03% (n=3)
ALFYIHKF 0.03% (n=3)
ALFYVRQF 0.03% (n=3)
SLFYVHSF 0.03% (n=3)
ALMYAHRF 0.03% (n=3)
ALFYANKL 0.03% (n=3)
ALFYSHQF 0.03% (n=3)
ALFYSRSF 0.03% (n=3)
ALFYTYKF 0.03% (n=3)
ALFYHHRF 0.03% (n=3)
ALFYTKSF 0.03% (n=3)
ALFYATKF 0.03% (n=3)
ALFYRHGS 0.03% (n=3)
ALFYARNI 0.03% (n=3)
ALFYARSL 0.02% (n=2)
TLFYAHKF 0.02% (n=2)
ALFYAHEF 0.02% (n=2)
ALLYANRF 0.02% (n=2)
ALVYSHKF 0.02% (n=2)
ALIYSHRF 0.02% (n=2)
ALLYSHRF 0.02% (n=2)
ALFNTHRS 0.02% (n=2)
ALLYAHRF 0.02% (n=2)
ALFYATSF 0.02% (n=2)
ALFYVQRF 0.02% (n=2)
ALLYHNKF 0.02% (n=2)
ALLYTHRF 0.02% (n=2)
ALFHTRKF 0.02% (n=2)
ALFYANSF 0.02% (n=2)
ALFYYHKF 0.02% (n=2)
ALFYVNKL 0.02% (n=2)
ALFYVSRF 0.02% (n=2)
ALFYVRHF 0.02% (n=2)
ALFYVRNI 0.02% (n=2)
ALFYTHGF 0.02% (n=2)
ALFYRRNF 0.02% (n=2)
ALFYKHSF 0.02% (n=2)
ALFYTNRF 0.02% (n=2)
ALFYRRKF 0.02% (n=2)
ALFYRRKL 0.02% (n=2)
ALFYIRSF 0.02% (n=2)
ALFYTTRF 0.02% (n=2)
ALFYTRRI 0.02% (n=2)
ALFYARHF 0.02% (n=2)
ALFYKSRF 0.02% (n=2)
ALFYRQRF 0.02% (n=2)
ALFYSRKF 0.02% (n=2)
ALFYRQKF 0.02% (n=2)
ALFYRYQF 0.02% (n=2)
ALVYRYKF 0.02% (n=2)
ALFYARTF 0.02% (n=2)
ALFYARRY 0.02% (n=2)
ALVYHHKF 0.02% (n=2)
ALFYVSHF 0.02% (n=2)
ALFCRHGF 0.02% (n=2)
ALFYTREF 0.02% (n=2)
ALFYVKRL 0.02% (n=2)
ALLYVNKF 0.02% (n=2)
ALFYIRKF 0.02% (n=2)
ALFYKYRF 0.02% (n=2)
ALFYAHNL 0.01% (n=1)
GLLYAKKF 0.01% (n=1)
TLFYVHKF 0.01% (n=1)
ALFYAHMF 0.01% (n=1)
ALFYFRRF 0.01% (n=1)
ALFYFNRF 0.01% (n=1)
ALFYTRGF 0.01% (n=1)
ALFYAGNF 0.01% (n=1)
ALFYEKNF 0.01% (n=1)
ALFYERNF 0.01% (n=1)
ALFYTGNF 0.01% (n=1)
ALFYVKNF 0.01% (n=1)
ALFFTHRF 0.01% (n=1)
TLFYTTKF 0.01% (n=1)
ALFYASRF 0.01% (n=1)
ALFYQNKF 0.01% (n=1)
ALIYTHRF 0.01% (n=1)
ALIYYNKF 0.01% (n=1)
ALFYTKQF 0.01% (n=1)
ALFNTHSF 0.01% (n=1)
ALFYAHRC 0.01% (n=1)
SLFYAQKF 0.01% (n=1)
ALFYTNKS 0.01% (n=1)
ELFYTNKF 0.01% (n=1)
AL------ 0.01% (n=1)
GVFYHNKF 0.01% (n=1)
ALFYKKNF 0.01% (n=1)
ALFYKKNI 0.01% (n=1)
ARFYTHKF 0.01% (n=1)
ALFYMHRF 0.01% (n=1)
ALFYTHRS 0.01% (n=1)
ALLYTRKF 0.01% (n=1)
ALFHTHRF 0.01% (n=1)
ALLYARRF 0.01% (n=1)
ALFYRNEV 0.01% (n=1)
ALFYTKRF 0.01% (n=1)
ALIYKHKL 0.01% (n=1)
ALIYRHKV 0.01% (n=1)
ALFYSARF 0.01% (n=1)
SLFYINRF 0.01% (n=1)
ALFYRHNI 0.01% (n=1)
ALFYTNSF 0.01% (n=1)
ALFYSKKF 0.01% (n=1)
GLFYQGKF 0.01% (n=1)
ALFHAHKI 0.01% (n=1)
ALVYRNKF 0.01% (n=1)
ALLYKNKF 0.01% (n=1)
ALFFVNKF 0.01% (n=1)
ALIYNHRF 0.01% (n=1)
ALFYTKKF 0.01% (n=1)
GLIYKYKF 0.01% (n=1)
SLFYRYKF 0.01% (n=1)
ALFYKNNF 0.01% (n=1)
ALFYAGKF 0.01% (n=1)
ALFYAKNL 0.01% (n=1)
ALFYTSSF 0.01% (n=1)
ALFYARTV 0.01% (n=1)
ALMYVHRF 0.01% (n=1)
ALFYRHSF 0.01% (n=1)
ALFYANRL 0.01% (n=1)
GLFYAHKF 0.01% (n=1)
ALFYRHKL 0.01% (n=1)
ALFYKTQF 0.01% (n=1)
ALFYKKQF 0.01% (n=1)
ELFYTHRF 0.01% (n=1)
ALFYRYRF 0.01% (n=1)
GLLYAHRF 0.01% (n=1)
ALSYRNKF 0.01% (n=1)
ALSYAHKF 0.01% (n=1)
ALFYSRSL 0.01% (n=1)
VLFYAKKI 0.01% (n=1)
SLFYVHRF 0.01% (n=1)
SLFYAHSF 0.01% (n=1)
ALFYFRKF 0.01% (n=1)
ALFYKRKF 0.01% (n=1)
SLFYTYKF 0.01% (n=1)
ALIYRYKF 0.01% (n=1)
SLFYRHKF 0.01% (n=1)
ALFYRHHF 0.01% (n=1)
ALIYKNKF 0.01% (n=1)
ALFYKNHF 0.01% (n=1)
ALFYGHKF 0.01% (n=1)
ALFYVKGF 0.01% (n=1)
ALIYRNKF 0.01% (n=1)
ALFYRHWF 0.01% (n=1)
ALFHTHKF 0.01% (n=1)
ALFYAQRF 0.01% (n=1)
ELFYAHKF 0.01% (n=1)
ALVYTHKF 0.01% (n=1)
ALFYHRTF 0.01% (n=1)
ALFYQHKF 0.01% (n=1)
SLFYYKKF 0.01% (n=1)
ALFYSRRF 0.01% (n=1)
SLFYIYKF 0.01% (n=1)
ALFYTHAF 0.01% (n=1)
ALFYVNSF 0.01% (n=1)
ALFYSNRF 0.01% (n=1)
ALFYSNKF 0.01% (n=1)
ALFYINKF 0.01% (n=1)
ALFYQHRF 0.01% (n=1)
ALFYTNNF 0.01% (n=1)
ALFYRSRF 0.01% (n=1)
ALIYKSKF 0.01% (n=1)
ALFYRYKL 0.01% (n=1)
ALFYSVKI 0.01% (n=1)
ALIYRSKF 0.01% (n=1)
ALVYANKF 0.01% (n=1)
ALFYKNKF 0.01% (n=1)
SLFYATRF 0.01% (n=1)
ALFYSKEF 0.01% (n=1)
ALVYVNKF 0.01% (n=1)
ALFYTTSF 0.01% (n=1)
SLFYVHKL 0.01% (n=1)
TLFYRHGF 0.01% (n=1)
ALFYKHGF 0.01% (n=1)
APFYVNKF 0.01% (n=1)
VLFYVNKF 0.01% (n=1)
ALLYRHKF 0.01% (n=1)
ALFCTHKF 0.01% (n=1)
ALFYVCSF 0.01% (n=1)
ALFYVHGF 0.01% (n=1)
ALSYVRSF 0.01% (n=1)
ALFHVRSF 0.01% (n=1)
ALFCVRSF 0.01% (n=1)
ALSYTSKF 0.01% (n=1)
ALFYRDKF 0.01% (n=1)
APFYTSKF 0.01% (n=1)
ALFYADKF 0.01% (n=1)
ALFYVNTF 0.01% (n=1)
ALSYTYRF 0.01% (n=1)
ALIYAHKI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 2:

ALFYTTSF 18.11% (n=240)
ALFYHYRF 10.94% (n=145)
SLFYTHRF 9.06% (n=120)
SLFYTKNF 8.23% (n=109)
SLFYTHSF 6.79% (n=90)
SLFYTSKF 5.51% (n=73)
SLFYTHKF 3.25% (n=43)
SLFYVNRF 1.89% (n=25)
SLFYVRNF 1.74% (n=23)
SLFYTKSF 1.43% (n=19)
ALFYTHSF 1.13% (n=15)
ALFYTHRF 1.06% (n=14)
SLFYAHRF 0.98% (n=13)
SLFYTKKF 0.98% (n=13)
SLFYTRSF 0.91% (n=12)
SLFYTTKF 0.91% (n=12)
SLFYITKF 0.91% (n=12)
SLFYVNNF 0.91% (n=12)
SLFYTNRF 0.83% (n=11)
ALFYTNRF 0.75% (n=10)
SLFYTYRF 0.75% (n=10)
ALFYTRSF 0.68% (n=9)
SLFYANNF 0.68% (n=9)
SLFYTRRF 0.60% (n=8)
SLFYAHKF 0.60% (n=8)
SLFYTNNF 0.60% (n=8)
SLFYANRF 0.53% (n=7)
SLFYTRNF 0.53% (n=7)
SLFYVRSF 0.53% (n=7)
SLFYANKF 0.45% (n=6)
ALFYTKSF 0.45% (n=6)
ALFYANRF 0.38% (n=5)
ALFYVRSF 0.38% (n=5)
ALFYANKF 0.38% (n=5)
ALFYAHKF 0.38% (n=5)
SLFYTNKF 0.38% (n=5)
SLFYAKRF 0.38% (n=5)
ALFYHHRF 0.38% (n=5)
ALFYTKNI 0.38% (n=5)
ALFYTHKF 0.30% (n=4)
SLFYVHSF 0.30% (n=4)
SLFYVKNF 0.30% (n=4)
SLFYVRHF 0.30% (n=4)
SLFYARRF 0.23% (n=3)
ALFYTSRF 0.23% (n=3)
SLFYAKSF 0.23% (n=3)
SLFYVRQF 0.23% (n=3)
ALFYARSF 0.23% (n=3)
ALFYRHKF 0.15% (n=2)
SLFYARNF 0.15% (n=2)
SLFYTKHF 0.15% (n=2)
SLFYAYRF 0.15% (n=2)
ALFYTRRF 0.15% (n=2)
ALFYTTKF 0.15% (n=2)
SLFYTQRF 0.15% (n=2)
QLFYTHSF 0.15% (n=2)
TLFFTSRF 0.15% (n=2)
ALFYVRNF 0.15% (n=2)
ALFYAHRF 0.15% (n=2)
SLFYAHSF 0.15% (n=2)
SLFYTRQF 0.15% (n=2)
SLFYTRKF 0.15% (n=2)
SLFYVKSF 0.15% (n=2)
SLFYAYKF 0.15% (n=2)
SLFYTKTF 0.15% (n=2)
SLFYVNNI 0.15% (n=2)
SLFYVQHF 0.15% (n=2)
SLFYTNSF 0.15% (n=2)
SLFYTKSL 0.15% (n=2)
SLFYTRHF 0.15% (n=2)
ALFYTSSF 0.15% (n=2)
SLFYTTSF 0.15% (n=2)
SLFYTNKI 0.08% (n=1)
ALFHTQTF 0.08% (n=1)
ALFYIHKF 0.08% (n=1)
SLFYAKNF 0.08% (n=1)
ALFYVHRF 0.08% (n=1)
ALIYRNRF 0.08% (n=1)
SLFYTHRC 0.08% (n=1)
SLFHTHRF 0.08% (n=1)
SLFYTHQF 0.08% (n=1)
SLFHTHKF 0.08% (n=1)
SLFYYNNF 0.08% (n=1)
ALFYTKNF 0.08% (n=1)
SLFYTHAF 0.08% (n=1)
SLFYGQRF 0.08% (n=1)
SLFYIRNF 0.08% (n=1)
ALFYARHF 0.08% (n=1)
SPFYTYRF 0.08% (n=1)
SLFYAFRF 0.08% (n=1)
ALFYSNRF 0.08% (n=1)
ALFFTSRF 0.08% (n=1)
ALFYTSHF 0.08% (n=1)
SLFYVRRF 0.08% (n=1)
ALFYTYRF 0.08% (n=1)
ALFYHKAI 0.08% (n=1)
ALLYNHRF 0.08% (n=1)
ALVYRNRF 0.08% (n=1)
ALFYTRNF 0.08% (n=1)
SLFYTHNF 0.08% (n=1)
SLFYARQF 0.08% (n=1)
ALFRYNRF 0.08% (n=1)
SLFYTSHF 0.08% (n=1)
ALFYSNKF 0.08% (n=1)
ALFYVKRF 0.08% (n=1)
ALFYTRHF 0.08% (n=1)
SLFYFHRF 0.08% (n=1)
SLFYARTF 0.08% (n=1)
SLFYSRNF 0.08% (n=1)
SLFYIHKF 0.08% (n=1)
SLFYVNKF 0.08% (n=1)
SLFYHNKF 0.08% (n=1)
SLFYINRF 0.08% (n=1)
ALVYANRF 0.08% (n=1)
SLFYVKKL 0.08% (n=1)
SLFYAGKF 0.08% (n=1)
ALFYTTKI 0.08% (n=1)
SLFYVNSF 0.08% (n=1)
SLFYANTL 0.08% (n=1)
ALFYAKKF 0.08% (n=1)
SLFYYGKF 0.08% (n=1)
SLFYTSRF 0.08% (n=1)
SLFYSHKF 0.08% (n=1)
SLFYAKKF 0.08% (n=1)
SLF-TPIV 0.08% (n=1)
SLFYTYKF 0.08% (n=1)
SLFYANSF 0.08% (n=1)
ALFYVRRF 0.08% (n=1)
PLFYNHKF 0.08% (n=1)
SLFYIPKF 0.08% (n=1)
SLVYITKF 0.08% (n=1)
SLLYTKNF 0.08% (n=1)
PLFYVNRF 0.08% (n=1)
SLFYIKNF 0.08% (n=1)
SLFYITRF 0.08% (n=1)
SLFYRHDI 0.08% (n=1)
ALFYSKHF 0.08% (n=1)
SLFYYNRF 0.08% (n=1)
ALFYTNNF 0.08% (n=1)
ALFYTKRF 0.08% (n=1)
SLFYANQF 0.08% (n=1)
ALLYTNKF 0.08% (n=1)
SLFYTSSF 0.08% (n=1)
ALFYRQNF 0.08% (n=1)
ALLYVKSF 0.08% (n=1)
SLFYVKHF 0.08% (n=1)
ALFCTTSF 0.08% (n=1)
ALFYSASF 0.08% (n=1)
ALFYTTSL 0.08% (n=1)
ALFYATSF 0.08% (n=1)
ALFYVRTL 0.08% (n=1)
ALFYSRSF 0.08% (n=1)
ALFYTDSL 0.08% (n=1)
ALFYTHAF 0.08% (n=1)
ALFYTTHF 0.08% (n=1)
GLIYTTSF 0.08% (n=1)
ALFYTNSF 0.08% (n=1)
SLFYAHRV 0.08% (n=1)
ALFYATGF 0.08% (n=1)
ALFYAHSF 0.08% (n=1)
ALFYVKSF 0.08% (n=1)
SLFYATSF 0.08% (n=1)
ALFYHYRS 0.08% (n=1)
ALFHHYRF 0.08% (n=1)
VLFYHYRF 0.08% (n=1)
ALLYHYRF 0.08% (n=1)
ALFYYYRF 0.08% (n=1)
ALFYTKHI 0.08% (n=1)
SLFHYGKF 0.08% (n=1)
ALLYHGKF 0.08% (n=1)
ALFYSHKF 0.08% (n=1)
ALFYVNKF 0.08% (n=1)
ALFYVNSF 0.08% (n=1)
ALFYARKF 0.08% (n=1)
ALFYTRSL 0.08% (n=1)
ALFYQRRF 0.08% (n=1)
PLFYTHRF 0.08% (n=1)
SLSYTHSF 0.08% (n=1)
SLFYRVKF 0.08% (n=1)
SLFYVQRF 0.08% (n=1)
ALFYVDKF 0.08% (n=1)
SLFYVHRF 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 2a:

SLFYTHRF 39.70% (n=106)
SLFYTHKF 8.24% (n=22)
SLFYTHSF 5.24% (n=14)
ALFYTNRF 3.75% (n=10)
SLFYTYRF 3.37% (n=9)
SLFYAHRF 3.37% (n=9)
SLFYTNRF 2.62% (n=7)
ALFYTHRF 2.62% (n=7)
SLFYTRRF 1.87% (n=5)
SLFYVHSF 1.12% (n=3)
SLFYANRF 1.12% (n=3)
SLFYVNRF 1.12% (n=3)
ALFYTSRF 1.12% (n=3)
ALFYANRF 0.75% (n=2)
SLFYAYRF 0.75% (n=2)
ALFYTRRF 0.75% (n=2)
ALFYTRSF 0.75% (n=2)
QLFYTHSF 0.75% (n=2)
SLFYARRF 0.75% (n=2)
TLFFTSRF 0.75% (n=2)
SLFYTRNF 0.75% (n=2)
SLFYVRSF 0.75% (n=2)
ALFYIHKF 0.37% (n=1)
SLFYAKNF 0.37% (n=1)
ALFYVHRF 0.37% (n=1)
ALIYRNRF 0.37% (n=1)
SLFYARNF 0.37% (n=1)
SLFYTHRC 0.37% (n=1)
SLFHTHRF 0.37% (n=1)
SLFYTHQF 0.37% (n=1)
SLFHTHKF 0.37% (n=1)
SLFYYNNF 0.37% (n=1)
ALFYTKNF 0.37% (n=1)
SLFYTHAF 0.37% (n=1)
SLFYVRNF 0.37% (n=1)
SLFYTKHF 0.37% (n=1)
SLFYGQRF 0.37% (n=1)
SLFYIRNF 0.37% (n=1)
ALFYARHF 0.37% (n=1)
ALFYTTKF 0.37% (n=1)
SPFYTYRF 0.37% (n=1)
ALFYTHSF 0.37% (n=1)
SLFYTQRF 0.37% (n=1)
SLFYAFRF 0.37% (n=1)
ALFYSNRF 0.37% (n=1)
ALFFTSRF 0.37% (n=1)
SLFYTRSF 0.37% (n=1)
ALFYTSHF 0.37% (n=1)
ALFYVRNF 0.37% (n=1)
ALFYVRSF 0.37% (n=1)
SLFYVRRF 0.37% (n=1)
ALFYTYRF 0.37% (n=1)
ALFYHKAI 0.37% (n=1)
ALFYAHRF 0.37% (n=1)
ALLYNHRF 0.37% (n=1)
SLFYAHSF 0.37% (n=1)
ALVYRNRF 0.37% (n=1)
ALFYTRNF 0.37% (n=1)
SLFYTHNF 0.37% (n=1)
SLFYAHKF 0.37% (n=1)
ALFYTHKF 0.37% (n=1)
ALFYANKF 0.37% (n=1)
SLFYARQF 0.37% (n=1)
SLFYTRQF 0.37% (n=1)
ALFRYNRF 0.37% (n=1)
SLFYTSHF 0.37% (n=1)
ALFYSNKF 0.37% (n=1)
ALFYVKRF 0.37% (n=1)
ALFYTRHF 0.37% (n=1)
SLFYFHRF 0.37% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 2b:

SLFYTKNF 23.64% (n=109)
SLFYTSKF 15.84% (n=73)
SLFYVNRF 4.77% (n=22)
SLFYVRNF 4.34% (n=20)
SLFYTKSF 4.12% (n=19)
SLFYTHKF 2.82% (n=13)
SLFYTKKF 2.82% (n=13)
SLFYTTKF 2.60% (n=12)
SLFYITKF 2.60% (n=12)
SLFYVNNF 2.60% (n=12)
SLFYANNF 1.95% (n=9)
SLFYTHRF 1.74% (n=8)
SLFYTNNF 1.74% (n=8)
SLFYANKF 1.30% (n=6)
SLFYAHKF 1.30% (n=6)
SLFYAKRF 1.08% (n=5)
SLFYAHRF 0.87% (n=4)
SLFYVKNF 0.87% (n=4)
SLFYTRNF 0.87% (n=4)
SLFYTNKF 0.87% (n=4)
SLFYTNRF 0.87% (n=4)
SLFYANRF 0.87% (n=4)
SLFYTHSF 0.65% (n=3)
ALFYAHKF 0.65% (n=3)
SLFYAKSF 0.65% (n=3)
SLFYVRHF 0.65% (n=3)
SLFYVRQF 0.65% (n=3)
ALFYANKF 0.43% (n=2)
SLFYTRKF 0.43% (n=2)
SLFYVKSF 0.43% (n=2)
ALFYTHSF 0.43% (n=2)
SLFYTKTF 0.43% (n=2)
SLFYVNNI 0.43% (n=2)
SLFYVQHF 0.43% (n=2)
SLFYTNSF 0.43% (n=2)
SLFYTKSL 0.43% (n=2)
SLFYTRHF 0.43% (n=2)
SLFYVRSF 0.43% (n=2)
SLFYARTF 0.22% (n=1)
SLFYSRNF 0.22% (n=1)
SLFYIHKF 0.22% (n=1)
SLFYVNKF 0.22% (n=1)
SLFYHNKF 0.22% (n=1)
SLFYINRF 0.22% (n=1)
SLFYARRF 0.22% (n=1)
ALFYTRSF 0.22% (n=1)
SLFYAYKF 0.22% (n=1)
ALVYANRF 0.22% (n=1)
SLFYVKKL 0.22% (n=1)
SLFYAGKF 0.22% (n=1)
ALFYTTKI 0.22% (n=1)
SLFYANTL 0.22% (n=1)
ALFYAKKF 0.22% (n=1)
SLFYYGKF 0.22% (n=1)
SLFYTSRF 0.22% (n=1)
SLFYSHKF 0.22% (n=1)
SLFYAKKF 0.22% (n=1)
SLF-TPIV 0.22% (n=1)
SLFYAHSF 0.22% (n=1)
SLFYTYKF 0.22% (n=1)
ALFYTHRF 0.22% (n=1)
SLFYTKHF 0.22% (n=1)
SLFYTRRF 0.22% (n=1)
SLFYANSF 0.22% (n=1)
ALFYVRRF 0.22% (n=1)
PLFYNHKF 0.22% (n=1)
SLFYIPKF 0.22% (n=1)
SLVYITKF 0.22% (n=1)
SLLYTKNF 0.22% (n=1)
PLFYVNRF 0.22% (n=1)
ALFYRHKF 0.22% (n=1)
SLFYIKNF 0.22% (n=1)
SLFYTRQF 0.22% (n=1)
SLFYITRF 0.22% (n=1)
SLFYRHDI 0.22% (n=1)
ALFYSKHF 0.22% (n=1)
SLFYYNRF 0.22% (n=1)
ALFYTTSF 0.22% (n=1)
ALFYTNNF 0.22% (n=1)
ALFYTKRF 0.22% (n=1)
SLFYANQF 0.22% (n=1)
ALLYTNKF 0.22% (n=1)
SLFYTSSF 0.22% (n=1)
ALFYRQNF 0.22% (n=1)
ALFYTHKF 0.22% (n=1)
ALLYVKSF 0.22% (n=1)
SLFYARNF 0.22% (n=1)
ALFYTTKF 0.22% (n=1)
SLFYVHSF 0.22% (n=1)
SLFYVKHF 0.22% (n=1)
SLFYTRSF 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 2c:

ALFYTTSF 52.76% (n=239)
ALFYHYRF 32.01% (n=145)
ALFYTHSF 1.99% (n=9)
ALFYTKSF 1.32% (n=6)
ALFYHHRF 1.10% (n=5)
ALFYTKNI 1.10% (n=5)
ALFYVRSF 0.88% (n=4)
ALFYTRSF 0.88% (n=4)
ALFYARSF 0.66% (n=3)
ALFYTSSF 0.44% (n=2)
ALFYANRF 0.44% (n=2)
SLFYVRSF 0.44% (n=2)
SLFYTHKF 0.22% (n=1)
ALFYTHKF 0.22% (n=1)
ALFCTTSF 0.22% (n=1)
ALFYSASF 0.22% (n=1)
ALFYTTSL 0.22% (n=1)
ALFYAHRF 0.22% (n=1)
ALFYATSF 0.22% (n=1)
ALFYVRTL 0.22% (n=1)
ALFYSRSF 0.22% (n=1)
ALFYTDSL 0.22% (n=1)
ALFYTHAF 0.22% (n=1)
ALFYTTHF 0.22% (n=1)
GLIYTTSF 0.22% (n=1)
ALFYTNSF 0.22% (n=1)
ALFYTHRF 0.22% (n=1)
SLFYAHRV 0.22% (n=1)
ALFYATGF 0.22% (n=1)
ALFYAHSF 0.22% (n=1)
ALFYVKSF 0.22% (n=1)
SLFYVRHF 0.22% (n=1)
SLFYATSF 0.22% (n=1)
ALFYHYRS 0.22% (n=1)
ALFHHYRF 0.22% (n=1)
VLFYHYRF 0.22% (n=1)
ALLYHYRF 0.22% (n=1)
ALFYYYRF 0.22% (n=1)
ALFYTKHI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 3:

GLFYYHKF 43.29% (n=1674)
GLIYYHKF 15.49% (n=599)
GLFYYHRF 6.85% (n=265)
GLFYHHRF 6.85% (n=265)
GLLYYHKF 3.05% (n=118)
GLFYFHKF 2.09% (n=81)
GLMYYHKF 2.09% (n=81)
ALFYTHSF 1.91% (n=74)
ALFYTHRF 1.71% (n=66)
GLFYYNKF 1.53% (n=59)
GLFSYHKF 1.50% (n=58)
GLFYHHKF 1.19% (n=46)
GLFYVYKF 1.06% (n=41)
GLIYHHKF 0.98% (n=38)
GLFHYHKF 0.88% (n=34)
ALFYTHKF 0.85% (n=33)
GLFYYNNF 0.67% (n=26)
GLIYFHKF 0.62% (n=24)
GLFYHYKF 0.49% (n=19)
GLIYYHRF 0.36% (n=14)
GLVYYHKF 0.34% (n=13)
GLFYYNRF 0.31% (n=12)
GLIYYNKF 0.28% (n=11)
GLFYFHRF 0.28% (n=11)
GLFHYHRF 0.26% (n=10)
GLFYYHSF 0.21% (n=8)
GLFYYHEF 0.18% (n=7)
GLIYHHRF 0.18% (n=7)
GLFYYHKL 0.16% (n=6)
GLFHFHRF 0.16% (n=6)
GLFNYHKF 0.13% (n=5)
GLLYHHKF 0.13% (n=5)
GLIYRYRF 0.13% (n=5)
GLFSYHRF 0.10% (n=4)
GLMYYHSF 0.10% (n=4)
GLLYYHRF 0.10% (n=4)
GLFYHNKF 0.10% (n=4)
GLVYYHRF 0.10% (n=4)
GLFYYHNF 0.10% (n=4)
GLIYYRKF 0.10% (n=4)
GLFYYYKF 0.10% (n=4)
GLIYYHSF 0.08% (n=3)
GLFYYHQF 0.08% (n=3)
GLMYFHRF 0.08% (n=3)
GLLYFHRF 0.08% (n=3)
GLFNYYKF 0.08% (n=3)
GLFYYRKF 0.08% (n=3)
GLIYYNRF 0.05% (n=2)
GLFYYRNL 0.05% (n=2)
GLFYYRNF 0.05% (n=2)
GLFYYRHF 0.05% (n=2)
GLFNYHRF 0.05% (n=2)
GLFYYRSF 0.05% (n=2)
GLFYRYKF 0.05% (n=2)
GLIYRHKF 0.05% (n=2)
GLFYRYQF 0.05% (n=2)
GLFYYQKF 0.05% (n=2)
GLFYHYRF 0.05% (n=2)
GLLYHQKF 0.05% (n=2)
GLFYYHKI 0.05% (n=2)
GLFSYHKV 0.05% (n=2)
GLMYHHKF 0.05% (n=2)
GLFYYHKV 0.05% (n=2)
GLMYYHRF 0.05% (n=2)
GLFYLHKF 0.03% (n=1)
GLFRFHKF 0.03% (n=1)
GLFYHYQF 0.03% (n=1)
RLFYYHKF 0.03% (n=1)
GLLYYNKF 0.03% (n=1)
GMFYYHMF 0.03% (n=1)
GLFCYHKF 0.03% (n=1)
GLSYYHKF 0.03% (n=1)
GLLYYRKF 0.03% (n=1)
ELIYYHKF 0.03% (n=1)
GLFNYHAF 0.03% (n=1)
GLFYYKNF 0.03% (n=1)
GSFYYHRF 0.03% (n=1)
GLFYYSKF 0.03% (n=1)
GLFYYDKF 0.03% (n=1)
GLFYYHMF 0.03% (n=1)
ELFYYHKF 0.03% (n=1)
GFDYYHKV 0.03% (n=1)
GLIYFRKF 0.03% (n=1)
GCFYYHKF 0.03% (n=1)
GLFHYNKF 0.03% (n=1)
GLVYHYKF 0.03% (n=1)
GLIYYRRF 0.03% (n=1)
GLFYFHQF 0.03% (n=1)
GCFIIISS 0.03% (n=1)
GLLYRYRF 0.03% (n=1)
GLFYWHQF 0.03% (n=1)
GLFYHYNF 0.03% (n=1)
GLIYYYKF 0.03% (n=1)
GLFHFHKF 0.03% (n=1)
GLFYHRRF 0.03% (n=1)
GLFYLHRF 0.03% (n=1)
GLFYRQVV 0.03% (n=1)
GLIYHNRF 0.03% (n=1)
GLFFYHKF 0.03% (n=1)
GLFYYKKF 0.03% (n=1)
GLFYRHRF 0.03% (n=1)
GLFYHHRI 0.03% (n=1)
GLIYFHRF 0.03% (n=1)
GLIYHNKF 0.03% (n=1)
GLIYRHRF 0.03% (n=1)
GLFYYRRF 0.03% (n=1)
GLLYHYKF 0.03% (n=1)
GLIYHHQF 0.03% (n=1)
GLFYHHNF 0.03% (n=1)
GLFYVHKF 0.03% (n=1)
GLFYRYRF 0.03% (n=1)
GLFYYTKF 0.03% (n=1)
GLFYHQKF 0.03% (n=1)
GLFYHNQF 0.03% (n=1)
RLMYYHKF 0.03% (n=1)
GLMYYRKF 0.03% (n=1)
GLFYKHKF 0.03% (n=1)
GLIYYHKY 0.03% (n=1)
GLLYRYQF 0.03% (n=1)
GLFYSYKF 0.03% (n=1)
GLLYYHKI 0.03% (n=1)
ALFYTHKL 0.03% (n=1)
GLMYYNRF 0.03% (n=1)
GLMYHNRF 0.03% (n=1)
GLMYYNKF 0.03% (n=1)
ALFYRNNV 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 3a:

GLFYYHKF 48.20% (n=1564)
GLIYYHKF 12.54% (n=407)
GLFYHHRF 8.17% (n=265)
GLFYYHRF 7.83% (n=254)
GLLYYHKF 3.05% (n=99)
GLFYFHKF 2.50% (n=81)
GLFSYHKF 1.76% (n=57)
GLFYYNKF 1.69% (n=55)
GLMYYHKF 1.39% (n=45)
GLFYHHKF 1.33% (n=43)
GLFYVYKF 1.26% (n=41)
GLFHYHKF 1.02% (n=33)
GLFYYNNF 0.80% (n=26)
GLIYHHKF 0.62% (n=20)
GLFYHYKF 0.59% (n=19)
GLIYFHKF 0.59% (n=19)
GLFYYNRF 0.37% (n=12)
GLFYFHRF 0.31% (n=10)
GLFHYHRF 0.31% (n=10)
GLVYYHKF 0.28% (n=9)
GLIYYNKF 0.25% (n=8)
GLIYYHRF 0.22% (n=7)
GLFYYHEF 0.22% (n=7)
GLFYYHSF 0.22% (n=7)
GLFYYHKL 0.18% (n=6)
GLFHFHRF 0.18% (n=6)
GLFNYHKF 0.15% (n=5)
GLLYHHKF 0.15% (n=5)
GLIYRYRF 0.15% (n=5)
GLFSYHRF 0.12% (n=4)
GLMYYHSF 0.12% (n=4)
GLFYYHNF 0.12% (n=4)
GLIYYRKF 0.12% (n=4)
GLIYYHSF 0.09% (n=3)
GLVYYHRF 0.09% (n=3)
GLFYYHQF 0.09% (n=3)
GLMYFHRF 0.09% (n=3)
GLLYFHRF 0.09% (n=3)
GLFYYRKF 0.09% (n=3)
GLFYYYKF 0.09% (n=3)
GLIYYNRF 0.06% (n=2)
GLLYYHRF 0.06% (n=2)
GLFYHNKF 0.06% (n=2)
GLFYYRNL 0.06% (n=2)
GLIYHHRF 0.06% (n=2)
GLFNYYKF 0.06% (n=2)
GLFYYRNF 0.06% (n=2)
GLFYYRHF 0.06% (n=2)
GLFNYHRF 0.06% (n=2)
GLFYYRSF 0.06% (n=2)
GLFYRYKF 0.06% (n=2)
GLIYRHKF 0.06% (n=2)
GLFYRYQF 0.06% (n=2)
GLFYHYRF 0.06% (n=2)
GLLYHQKF 0.06% (n=2)
GLFYLHKF 0.03% (n=1)
GLFRFHKF 0.03% (n=1)
GLFYHYQF 0.03% (n=1)
RLFYYHKF 0.03% (n=1)
GLLYYNKF 0.03% (n=1)
GMFYYHMF 0.03% (n=1)
GLFCYHKF 0.03% (n=1)
GLSYYHKF 0.03% (n=1)
GLLYYRKF 0.03% (n=1)
ELIYYHKF 0.03% (n=1)
GLFNYHAF 0.03% (n=1)
GLFYYKNF 0.03% (n=1)
GSFYYHRF 0.03% (n=1)
GLFYYSKF 0.03% (n=1)
GLFYYDKF 0.03% (n=1)
GLFYYHMF 0.03% (n=1)
ELFYYHKF 0.03% (n=1)
GFDYYHKV 0.03% (n=1)
GLIYFRKF 0.03% (n=1)
GCFYYHKF 0.03% (n=1)
GLFHYNKF 0.03% (n=1)
GLVYHYKF 0.03% (n=1)
GLIYYRRF 0.03% (n=1)
GLFYFHQF 0.03% (n=1)
GCFIIISS 0.03% (n=1)
GLLYRYRF 0.03% (n=1)
GLFYWHQF 0.03% (n=1)
GLFYHYNF 0.03% (n=1)
GLIYYYKF 0.03% (n=1)
GLFHFHKF 0.03% (n=1)
GLFYHRRF 0.03% (n=1)
GLFYLHRF 0.03% (n=1)
GLFYRQVV 0.03% (n=1)
GLIYHNRF 0.03% (n=1)
GLFFYHKF 0.03% (n=1)
GLFYYKKF 0.03% (n=1)
GLFYRHRF 0.03% (n=1)
GLFYHHRI 0.03% (n=1)
GLIYFHRF 0.03% (n=1)
GLIYHNKF 0.03% (n=1)
GLIYRHRF 0.03% (n=1)
GLFYYRRF 0.03% (n=1)
GLFYYQKF 0.03% (n=1)
GLLYHYKF 0.03% (n=1)
GLIYHHQF 0.03% (n=1)
GLFYHHNF 0.03% (n=1)
GLFYYHKI 0.03% (n=1)
GLFYVHKF 0.03% (n=1)
GLFYRYRF 0.03% (n=1)
GLFYYTKF 0.03% (n=1)
GLFYHQKF 0.03% (n=1)
GLFSYHKV 0.03% (n=1)
GLFYHNQF 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 3b:

GLIYYHKF 48.36% (n=192)
GLFYYHKF 19.40% (n=77)
GLMYYHKF 9.07% (n=36)
GLLYYHKF 4.53% (n=18)
GLIYHHKF 4.53% (n=18)
GLFYYHRF 2.52% (n=10)
GLIYYHRF 1.76% (n=7)
GLIYFHKF 1.26% (n=5)
GLVYYHKF 1.01% (n=4)
GLIYHHRF 1.01% (n=4)
GLFYHHKF 0.76% (n=3)
GLLYYHRF 0.50% (n=2)
GLMYHHKF 0.50% (n=2)
GLFYYHKV 0.50% (n=2)
GLMYYHRF 0.50% (n=2)
GLIYYNKF 0.25% (n=1)
RLMYYHKF 0.25% (n=1)
GLFNYYKF 0.25% (n=1)
GLMYYRKF 0.25% (n=1)
GLFSYHKF 0.25% (n=1)
GLVYYHRF 0.25% (n=1)
GLFYYYKF 0.25% (n=1)
GLFYFHRF 0.25% (n=1)
GLFYYHSF 0.25% (n=1)
GLFSYHKV 0.25% (n=1)
GLFYYQKF 0.25% (n=1)
GLFYKHKF 0.25% (n=1)
GLFHYHKF 0.25% (n=1)
GLIYYHKY 0.25% (n=1)
GLLYRYQF 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 4:

SLFYTHKF 51.25% (n=390)
SLFYTRKF 8.15% (n=62)
GLFYAHKF 6.70% (n=51)
SLFYTHRF 5.91% (n=45)
SLFYAHKF 5.39% (n=41)
GLFYHYKF 3.15% (n=24)
GLLYAHKF 2.10% (n=16)
SLFYAHRF 1.45% (n=11)
SLFYIQKF 0.92% (n=7)
ALFYHYKF 0.66% (n=5)
SLFYTHSF 0.53% (n=4)
GLFYYHKF 0.53% (n=4)
SLFYRNNF 0.39% (n=3)
GLLYYHKF 0.39% (n=3)
NLFYTHKF 0.39% (n=3)
GLFYRHKF 0.39% (n=3)
SLFYTNRF 0.26% (n=2)
GLFYHYSF 0.26% (n=2)
NLFYIHKF 0.26% (n=2)
SLFYIRRF 0.26% (n=2)
SLFYARNF 0.26% (n=2)
SLFYRNSF 0.26% (n=2)
SLFYRHRF 0.26% (n=2)
SLFYRHSF 0.26% (n=2)
SLFYHHRF 0.26% (n=2)
GLFYFHKF 0.26% (n=2)
SLFYHRKF 0.26% (n=2)
SLFYHRRF 0.26% (n=2)
SLFYFRKF 0.26% (n=2)
ALFYANNF 0.26% (n=2)
NLFYTHRF 0.26% (n=2)
GLFYSHKF 0.26% (n=2)
GLLYYNKF 0.26% (n=2)
ALFYTNRF 0.13% (n=1)
SLFYVNKF 0.13% (n=1)
SLFYTNKF 0.13% (n=1)
GLFYRYKF 0.13% (n=1)
SLFYTRRF 0.13% (n=1)
NLFYIRQF 0.13% (n=1)
GLFYVSRF 0.13% (n=1)
GLFYAYKF 0.13% (n=1)
GLLYAYKF 0.13% (n=1)
GLFYAHSF 0.13% (n=1)
SLFYYRRF 0.13% (n=1)
ALFYTHKF 0.13% (n=1)
NLFYTYRF 0.13% (n=1)
NLFYINKF 0.13% (n=1)
SLFYTYKF 0.13% (n=1)
NLFYIHRF 0.13% (n=1)
NLFYIYKF 0.13% (n=1)
SLLYYRKF 0.13% (n=1)
SLFYIHKF 0.13% (n=1)
SLFYFHKF 0.13% (n=1)
ALFYTKNF 0.13% (n=1)
GLLYTHRF 0.13% (n=1)
GLFYTHRF 0.13% (n=1)
GLFRYHKF 0.13% (n=1)
SLFYSHKF 0.13% (n=1)
SLFYVRKF 0.13% (n=1)
GLIYRNKF 0.13% (n=1)
SLFYRNKF 0.13% (n=1)
GLFYRSKF 0.13% (n=1)
GLFYHHKF 0.13% (n=1)
GLMYYNKF 0.13% (n=1)
GLLYYKQF 0.13% (n=1)
GLFYTHKF 0.13% (n=1)
GLFYVHKF 0.13% (n=1)
ALFYTHAF 0.13% (n=1)
ALFYVNKF 0.13% (n=1)
SLFYARSF 0.13% (n=1)
ALFYVNRL 0.13% (n=1)
GLFYYHRF 0.13% (n=1)
GLFYAHRF 0.13% (n=1)
GLIYSHKF 0.13% (n=1)
GLFYYNKF 0.13% (n=1)
GLIYYHKF 0.13% (n=1)
ALFYTHSF 0.13% (n=1)
ALFYARKF 0.13% (n=1)
GLFYTYKF 0.13% (n=1)
GLIYHWKF 0.13% (n=1)
SLFYHSKF 0.13% (n=1)
GLFYSHRF 0.13% (n=1)
GLFYHRRF 0.13% (n=1)
SLFYAHKV 0.13% (n=1)
SLFYTHTF 0.13% (n=1)
SLFYASNF 0.13% (n=1)
GLFYHHRF 0.13% (n=1)
GLFYATRF 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 4a:

SLFYTRKF 38.75% (n=62)
SLFYAHKF 16.25% (n=26)
GLFYHYKF 14.38% (n=23)
SLFYTHKF 6.88% (n=11)
SLFYAHRF 6.25% (n=10)
SLFYTHRF 3.75% (n=6)
ALFYHYKF 3.13% (n=5)
SLFYTNRF 1.25% (n=2)
GLFYAHKF 1.25% (n=2)
GLFYHYSF 1.25% (n=2)
ALFYTNRF 0.63% (n=1)
SLFYVNKF 0.63% (n=1)
SLFYTHSF 0.63% (n=1)
SLFYTNKF 0.63% (n=1)
GLFYRYKF 0.63% (n=1)
SLFYTRRF 0.63% (n=1)
NLFYIRQF 0.63% (n=1)
GLFYVSRF 0.63% (n=1)
GLFYAYKF 0.63% (n=1)
GLLYAYKF 0.63% (n=1)
GLFYAHSF 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 4d:

SLFYTHKF 69.56% (n=377)
GLFYAHKF 7.56% (n=41)
SLFYTHRF 6.64% (n=36)
SLFYAHKF 2.58% (n=14)
GLLYAHKF 2.03% (n=11)
SLFYIQKF 1.29% (n=7)
GLFYYHKF 0.74% (n=4)
SLFYRNNF 0.55% (n=3)
NLFYTHKF 0.55% (n=3)
NLFYIHKF 0.37% (n=2)
SLFYIRRF 0.37% (n=2)
SLFYARNF 0.37% (n=2)
SLFYRNSF 0.37% (n=2)
SLFYRHRF 0.37% (n=2)
SLFYRHSF 0.37% (n=2)
SLFYHHRF 0.37% (n=2)
GLFYFHKF 0.37% (n=2)
SLFYHRKF 0.37% (n=2)
GLLYYHKF 0.37% (n=2)
SLFYHRRF 0.37% (n=2)
SLFYFRKF 0.37% (n=2)
ALFYANNF 0.37% (n=2)
NLFYTHRF 0.37% (n=2)
SLFYYRRF 0.18% (n=1)
ALFYTHKF 0.18% (n=1)
SLFYAHRF 0.18% (n=1)
NLFYTYRF 0.18% (n=1)
NLFYINKF 0.18% (n=1)
SLFYTYKF 0.18% (n=1)
NLFYIHRF 0.18% (n=1)
NLFYIYKF 0.18% (n=1)
SLFYTHSF 0.18% (n=1)
SLLYYRKF 0.18% (n=1)
SLFYIHKF 0.18% (n=1)
SLFYFHKF 0.18% (n=1)
ALFYTKNF 0.18% (n=1)
GLLYTHRF 0.18% (n=1)
GLFYTHRF 0.18% (n=1)
GLFRYHKF 0.18% (n=1)
SLFYSHKF 0.18% (n=1)
SLFYVRKF 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 5:

GLLYYHKF 10.53% (n=4)
GLMYAHKF 10.53% (n=4)
GLLYAHKF 7.89% (n=3)
GLIYAHKF 5.26% (n=2)
GLMYVHKF 5.26% (n=2)
GLFYANKF 2.63% (n=1)
GLMYFHKF 2.63% (n=1)
GLVYYNKF 2.63% (n=1)
GLLYVHRF 2.63% (n=1)
GLFYVNKF 2.63% (n=1)
GLIYAYKF 2.63% (n=1)
GLMYYQRF 2.63% (n=1)
GLMYYRKF 2.63% (n=1)
GLMYVTKF 2.63% (n=1)
GLFYYNSF 2.63% (n=1)
GLMYVNKF 2.63% (n=1)
GLIYYNKF 2.63% (n=1)
GLFYAHKI 2.63% (n=1)
GLIYFHKF 2.63% (n=1)
GLFYAHRF 2.63% (n=1)
GLFYFRKF 2.63% (n=1)
GLIYHHRF 2.63% (n=1)
GLMYVYKF 2.63% (n=1)
GLLYFNKF 2.63% (n=1)
GLIYIRKF 2.63% (n=1)
GLMYFRNF 2.63% (n=1)
GLMYIRNF 2.63% (n=1)
GLFYYHKF 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 6:

SLFYTHKF 13.25% (n=66)
SLFYTHRF 5.82% (n=29)
SLFYIHKI 4.62% (n=23)
SLFYAHKF 4.22% (n=21)
GLFYYHKF 3.41% (n=17)
GLFYHHKF 2.81% (n=14)
SLFYAHRF 1.81% (n=9)
SLFYAYKF 1.41% (n=7)
SLFYIHKF 1.41% (n=7)
GLFYYNKF 1.41% (n=7)
ALFYAHKF 1.20% (n=6)
SLFYVNKF 1.20% (n=6)
GLFYYRNF 1.20% (n=6)
SLFYTHKL 1.00% (n=5)
SLFYINKF 1.00% (n=5)
GLFYHHRF 1.00% (n=5)
GLLYHHKF 1.00% (n=5)
SLFYVRKF 0.80% (n=4)
ALFYARRF 0.80% (n=4)
SLFYARKF 0.80% (n=4)
SLFYVHKF 0.80% (n=4)
SLFYTHKI 0.80% (n=4)
SLFYFNKF 0.80% (n=4)
GLFYTHRF 0.80% (n=4)
GLFYYHNF 0.80% (n=4)
GLFYYNRF 0.80% (n=4)
GLFYHYKF 0.80% (n=4)
GLIYHHKF 0.80% (n=4)
SLFYAHKL 0.60% (n=3)
SLFYVSKF 0.60% (n=3)
ALFYTHKF 0.60% (n=3)
ALFYARKF 0.60% (n=3)
SLFYTRNF 0.60% (n=3)
ALFYTHRF 0.60% (n=3)
SLFYANRF 0.60% (n=3)
ALFYRSNF 0.60% (n=3)
GLFYYHRF 0.60% (n=3)
GLFYHNKF 0.60% (n=3)
ALFYTNRF 0.60% (n=3)
GLFYLHKF 0.60% (n=3)
GLLYYHKF 0.60% (n=3)
SLFYTRSF 0.40% (n=2)
ALFYTNKF 0.40% (n=2)
SLFYIHRF 0.40% (n=2)
ALFYAYKF 0.40% (n=2)
ALFYRNKF 0.40% (n=2)
ALFYANKF 0.40% (n=2)
ALFYTRNF 0.40% (n=2)
SLFYTYKF 0.40% (n=2)
SLFYIQKF 0.40% (n=2)
SLFYARNI 0.40% (n=2)
ALFYSHKF 0.40% (n=2)
SLLYIHKI 0.40% (n=2)
SLFYANKF 0.40% (n=2)
ALFYTYRF 0.40% (n=2)
GLLYYNRF 0.40% (n=2)
GLMYVNKF 0.40% (n=2)
GLLYAHKF 0.40% (n=2)
GLFYYNNF 0.40% (n=2)
GLFSYHRF 0.40% (n=2)
GLFYRYRF 0.40% (n=2)
GLFYHYRF 0.40% (n=2)
GLFYTHSF 0.40% (n=2)
GLFYHQRF 0.40% (n=2)
SLFYHNRF 0.20% (n=1)
SLFYAHTF 0.20% (n=1)
SLFYTHRL 0.20% (n=1)
SLFYIRKF 0.20% (n=1)
SLFYARKL 0.20% (n=1)
ALFYTTRF 0.20% (n=1)
SLFYVNKL 0.20% (n=1)
SLFYVNRF 0.20% (n=1)
SLIYAHKF 0.20% (n=1)
ALFYSNKF 0.20% (n=1)
ALFYVSKF 0.20% (n=1)
ALFYASKF 0.20% (n=1)
GLLYANRF 0.20% (n=1)
SLFYVRNL 0.20% (n=1)
SLIYVNKF 0.20% (n=1)
SLFYTNRF 0.20% (n=1)
ALFYIHKI 0.20% (n=1)
SLFYNHKI 0.20% (n=1)
SLFYVHKI 0.20% (n=1)
SLFYTRKI 0.20% (n=1)
SLFYIHKV 0.20% (n=1)
ALFYTNNF 0.20% (n=1)
SLFYIQKI 0.20% (n=1)
ALFYARNF 0.20% (n=1)
SLFYSHKF 0.20% (n=1)
ALFYTRKF 0.20% (n=1)
SLFYTHSF 0.20% (n=1)
ALFYNRPV 0.20% (n=1)
SLFYARSV 0.20% (n=1)
SLFYVRSF 0.20% (n=1)
ALFYANRV 0.20% (n=1)
GLFYSNKF 0.20% (n=1)
ALFYAHRF 0.20% (n=1)
SLFYRQRF 0.20% (n=1)
SLFYTNKF 0.20% (n=1)
ALFYANKI 0.20% (n=1)
SLFYRHKF 0.20% (n=1)
SLFYITKF 0.20% (n=1)
ALFYVHKF 0.20% (n=1)
SLMYAHKF 0.20% (n=1)
SLFYANNF 0.20% (n=1)
ALIYKNKF 0.20% (n=1)
SLFYTRRF 0.20% (n=1)
SLFYVQRF 0.20% (n=1)
SLFYRSKF 0.20% (n=1)
GLFYTKNY 0.20% (n=1)
GLLYRHRF 0.20% (n=1)
ALFYLHKF 0.20% (n=1)
ALFYAHSF 0.20% (n=1)
ALFYTRSV 0.20% (n=1)
ALFYANRF 0.20% (n=1)
ALFYVDKF 0.20% (n=1)
SLFYYNKF 0.20% (n=1)
ALFYRRGV 0.20% (n=1)
SLFYTQKI 0.20% (n=1)
NLFYVHKI 0.20% (n=1)
NLFYAHKI 0.20% (n=1)
SLFYRNKF 0.20% (n=1)
GLFARYKF 0.20% (n=1)
GLFSYHKF 0.20% (n=1)
GLLYHHQF 0.20% (n=1)
GLIYYHKF 0.20% (n=1)
PLFYKQNI 0.20% (n=1)
PLFYRWKT 0.20% (n=1)
PLFYKWNI 0.20% (n=1)
GLLYYSRF 0.20% (n=1)
GLLYAHRF 0.20% (n=1)
GLIYRNKF 0.20% (n=1)
GLVYRYQF 0.20% (n=1)
GLIYAHKF 0.20% (n=1)
ALFYQHKF 0.20% (n=1)
GLFYHNRF 0.20% (n=1)
GLLYYHRF 0.20% (n=1)
GLIYKHKF 0.20% (n=1)
SLFYQREF 0.20% (n=1)
GLMYHRKF 0.20% (n=1)
GLFYHYNF 0.20% (n=1)
GLIYLHKF 0.20% (n=1)
GLMYHHKF 0.20% (n=1)
GLFYRHKF 0.20% (n=1)
GLFYYNIF 0.20% (n=1)
GLFYYNSF 0.20% (n=1)
GLFYSRNF 0.20% (n=1)
ALFYRHKF 0.20% (n=1)
GLFYQHKF 0.20% (n=1)
GLFYSHKF 0.20% (n=1)
GLFYHHMF 0.20% (n=1)
GLFYRYKF 0.20% (n=1)
GLFYHHSF 0.20% (n=1)
GLFYRHNF 0.20% (n=1)
GLIYYRNF 0.20% (n=1)
ALFYKHHF 0.20% (n=1)
SLFYSRRF 0.20% (n=1)
SLFYNNKF 0.20% (n=1)
GLFYARRF 0.20% (n=1)
ALFYVNRF 0.20% (n=1)
GLFYAHSF 0.20% (n=1)
GLLYASKF 0.20% (n=1)
GLLYSRNF 0.20% (n=1)
ALFYHNKF 0.20% (n=1)
GLLYYHKI 0.20% (n=1)
GLLYHRKF 0.20% (n=1)
GLLYYKHF 0.20% (n=1)
ALFYVHHF 0.20% (n=1)
ALFYHHKF 0.20% (n=1)
GLIYHYKF 0.20% (n=1)
GLFYVRKF 0.20% (n=1)
GLFYYYKF 0.20% (n=1)
GLFNHHKF 0.20% (n=1)
GLFYVSGF 0.20% (n=1)
GLFYKYRF 0.20% (n=1)
GLIYSHKF 0.20% (n=1)
GLFAHHRF 0.20% (n=1)
GLFAVRGF 0.20% (n=1)
GLLYSYKF 0.20% (n=1)
ALFYRRKF 0.20% (n=1)
GLFYTNRF 0.20% (n=1)
GLFYAHQF 0.20% (n=1)
ALFYRNHF 0.20% (n=1)
SLFYYHKF 0.20% (n=1)
GLFYYRRF 0.20% (n=1)
ALFTKRSL 0.20% (n=1)
ALLYRNKF 0.20% (n=1)
GLFYAWKF 0.20% (n=1)
GLLYYRRF 0.20% (n=1)
GLFYVNKF 0.20% (n=1)
ALFYQKGL 0.20% (n=1)
GLFYRQNF 0.20% (n=1)
GLIYVHKF 0.20% (n=1)
ALFYADKF 0.20% (n=1)
GLFYSFKF 0.20% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Subtype 6a:

SLFYTHKF 23.64% (n=65)
SLFYTHRF 10.18% (n=28)
SLFYIHKI 8.36% (n=23)
SLFYAHKF 7.27% (n=20)
SLFYAHRF 2.91% (n=8)
SLFYIHKF 2.55% (n=7)
SLFYAYKF 2.18% (n=6)
SLFYTHKL 1.82% (n=5)
SLFYVRKF 1.45% (n=4)
ALFYARRF 1.45% (n=4)
SLFYINKF 1.45% (n=4)
SLFYVHKF 1.45% (n=4)
SLFYTHKI 1.45% (n=4)
ALFYAHKF 1.09% (n=3)
SLFYARKF 1.09% (n=3)
SLFYAHKL 1.09% (n=3)
ALFYARKF 1.09% (n=3)
SLFYTRNF 1.09% (n=3)
SLFYTRSF 0.73% (n=2)
SLFYVNKF 0.73% (n=2)
SLFYIHRF 0.73% (n=2)
ALFYAYKF 0.73% (n=2)
ALFYRNKF 0.73% (n=2)
SLFYVSKF 0.73% (n=2)
ALFYANKF 0.73% (n=2)
ALFYTHKF 0.73% (n=2)
ALFYTRNF 0.73% (n=2)
SLFYIQKF 0.73% (n=2)
SLFYARNI 0.73% (n=2)
SLLYIHKI 0.73% (n=2)
ALFYTHRF 0.73% (n=2)
SLFYFNKF 0.73% (n=2)
SLFYHNRF 0.36% (n=1)
SLFYAHTF 0.36% (n=1)
SLFYTHRL 0.36% (n=1)
SLFYIRKF 0.36% (n=1)
ALFYTNKF 0.36% (n=1)
SLFYARKL 0.36% (n=1)
ALFYTTRF 0.36% (n=1)
SLFYVNKL 0.36% (n=1)
SLFYVNRF 0.36% (n=1)
SLIYAHKF 0.36% (n=1)
ALFYSNKF 0.36% (n=1)
ALFYVSKF 0.36% (n=1)
ALFYASKF 0.36% (n=1)
GLLYANRF 0.36% (n=1)
SLFYVRNL 0.36% (n=1)
SLFYTYKF 0.36% (n=1)
SLIYVNKF 0.36% (n=1)
SLFYTNRF 0.36% (n=1)
ALFYIHKI 0.36% (n=1)
SLFYNHKI 0.36% (n=1)
SLFYVHKI 0.36% (n=1)
ALFYSHKF 0.36% (n=1)
SLFYTRKI 0.36% (n=1)
SLFYIHKV 0.36% (n=1)
ALFYTNNF 0.36% (n=1)
SLFYIQKI 0.36% (n=1)
ALFYARNF 0.36% (n=1)
SLFYSHKF 0.36% (n=1)
ALFYTRKF 0.36% (n=1)
SLFYTHSF 0.36% (n=1)
ALFYNRPV 0.36% (n=1)
SLFYARSV 0.36% (n=1)
SLFYVRSF 0.36% (n=1)
ALFYANRV 0.36% (n=1)
GLFYSNKF 0.36% (n=1)
ALFYAHRF 0.36% (n=1)
SLFYRQRF 0.36% (n=1)
SLFYTNKF 0.36% (n=1)
ALFYANKI 0.36% (n=1)
SLFYRHKF 0.36% (n=1)
SLFYITKF 0.36% (n=1)
ALFYVHKF 0.36% (n=1)
SLMYAHKF 0.36% (n=1)
SLFYANNF 0.36% (n=1)
SLFYANRF 0.36% (n=1)
SLFYANKF 0.36% (n=1)
ALIYKNKF 0.36% (n=1)
SLFYTRRF 0.36% (n=1)
SLFYVQRF 0.36% (n=1)
SLFYRSKF 0.36% (n=1)
---------------------------------------------------------------------------------------
Region 440-447 (antibodies: [HC84.27] ), HCV Genotype 7:

ALFYTHRF 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 1:

QLINTNGSWHIN 57.01% (n=13111)
QLVNTNGSWHIN 23.04% (n=5298)
QLINSNGSWHIN 4.46% (n=1025)
QLINTNGSWHLN 2.31% (n=531)
QLVNSNGSWHIN 1.61% (n=370)
HLINTNGSWHIN 0.91% (n=209)
QLVNANGSWHIN 0.86% (n=197)
QLINTNGSWHVN 0.82% (n=189)
RLINTNGSWHIN 0.80% (n=183)
HLIKTNGSWHIN 0.63% (n=144)
QLMNTNGSWHIN 0.56% (n=129)
QLISTNGSWHIN 0.51% (n=117)
QLVNTNGSWHVN 0.44% (n=102)
KLTNTNGSWHIN 0.36% (n=83)
QLMNSNGSWHIN 0.33% (n=75)
QLINANGSWHIN 0.27% (n=61)
QLVSTNGSWHIN 0.24% (n=55)
QLVNENGSWHIN 0.22% (n=51)
QLIKTNGSWHIN 0.22% (n=50)
QLINTNNSWHIN 0.19% (n=44)
KLINTNGSWHIN 0.18% (n=42)
QLVNASGSWHIN 0.12% (n=27)
QLIHTNGSWHIN 0.12% (n=27)
QLINTSGSWHIN 0.11% (n=26)
QLVKTNGSWHIN 0.10% (n=22)
Q----------- 0.09% (n=21)
QLINTNGSW--- 0.08% (n=19)
QLTNTNGSWHIN 0.08% (n=18)
RLIKSNGSWHIN 0.08% (n=18)
QLVNTNGSW--- 0.08% (n=18)
RLANTNGSWHIN 0.08% (n=18)
QLINTDGSWHIN 0.07% (n=16)
QLINTNGSRHIN 0.07% (n=16)
RLTNTNGSWHIN 0.07% (n=16)
QLIDTNGSWHIN 0.06% (n=14)
KLINSNGSWHIN 0.06% (n=13)
QLVNTSGSWHIN 0.06% (n=13)
ELVNTNGSWHIN 0.06% (n=13)
QLVNSNGSWHVN 0.05% (n=12)
QLINTRGSWHIN 0.05% (n=12)
ELIHTNGSWHIN 0.05% (n=12)
RLINSNGSWHIN 0.05% (n=11)
QLINTNGSWRIN 0.05% (n=11)
ELINTNGSWHIN 0.05% (n=11)
QLINTNGSWHTN 0.04% (n=10)
QLVNTNGSRHIN 0.04% (n=10)
QLINTNGSWHID 0.04% (n=10)
QLINSSGSWHIN 0.04% (n=10)
QLIYSNGSWHIN 0.04% (n=10)
NLVNTNGSWHIN 0.04% (n=10)
HLVNTNGSWHIN 0.04% (n=10)
QLIKSNGSWHIN 0.04% (n=9)
QLINTNDSWHIN 0.04% (n=9)
QLINSDGSWHIN 0.04% (n=9)
QLVNRNGSWHIN 0.04% (n=9)
QLINRNGSWHIN 0.04% (n=9)
QPINTNGSWHIN 0.03% (n=8)
QLINTNSSWHIN 0.03% (n=8)
QLVNTNGSWHTN 0.03% (n=8)
RLVNSNGSWHIN 0.03% (n=8)
KLINTNGSCHIN 0.03% (n=8)
QLVNTDGSWHIN 0.03% (n=8)
RLVNTNGSWHIN 0.03% (n=8)
QLINTNGS*HIN 0.03% (n=7)
QLINTNGSWYIN 0.03% (n=7)
QLVNINGSWHIN 0.03% (n=6)
QLINPNGSWHIN 0.03% (n=6)
QLVYTNGSWHIN 0.03% (n=6)
QLVNNNGSWHIN 0.03% (n=6)
KLVNTSGSWHIN 0.03% (n=6)
QLVNTNGSWRIN 0.02% (n=5)
QLVNTNGSWHIS 0.02% (n=5)
QLVDTNGSWHIN 0.02% (n=5)
YLINTNGSWHIN 0.02% (n=5)
QLVNSSGSWHIN 0.02% (n=5)
QLVNTNGNWHIN 0.02% (n=5)
QLANTNGSWHIN 0.02% (n=5)
QLINTNGGWHIN 0.02% (n=5)
QLINTNGSWHIS 0.02% (n=5)
QLINTNGSWLIN 0.02% (n=5)
QLVNTNSSWHIN 0.02% (n=4)
QLINTNGTWHIN 0.02% (n=4)
QLVNTNGS*HIN 0.02% (n=4)
QLINSNGSWHVN 0.02% (n=4)
QLVNKNGSWHIN 0.02% (n=4)
QPVNTNGSWHIN 0.02% (n=4)
QLINNNGSWHIN 0.02% (n=4)
QLVNTNGSWYIN 0.02% (n=4)
QLIRTNGSWHIN 0.02% (n=4)
QLVHTNGSWHIN 0.02% (n=4)
QLINKNGSWHIN 0.02% (n=4)
QLMETNGSWHIN 0.02% (n=4)
QLINTEGSWHIN 0.01% (n=3)
*LINTNGSWHIN 0.01% (n=3)
QPINSNGSWHIN 0.01% (n=3)
QLIYTNGSWHIN 0.01% (n=3)
QVINTNGSWHIN 0.01% (n=3)
QLVTTNGSWHIN 0.01% (n=3)
QLINTNGSWHFN 0.01% (n=3)
QLVHANGSWHIN 0.01% (n=3)
QLTNSNGSWHIN 0.01% (n=3)
QLINTNGSRHLN 0.01% (n=3)
QLINSN------ 0.01% (n=3)
HLVKTNGSWHIN 0.01% (n=3)
QLLNTNGSWHIN 0.01% (n=3)
QLLNTNGSWHVN 0.01% (n=3)
QLINTNGSWDIN 0.01% (n=2)
QLINTNGSGHIN 0.01% (n=2)
QLVSTNGSWHIS 0.01% (n=2)
QLINSNGSWHIS 0.01% (n=2)
QLINTNGNWHIN 0.01% (n=2)
QLINTNGSWHIH 0.01% (n=2)
KLINTNGSGHIN 0.01% (n=2)
QLINSNGGWHIN 0.01% (n=2)
QLINTNGRWHIN 0.01% (n=2)
QMINTNGSWHIN 0.01% (n=2)
QLVNTNGSWHLN 0.01% (n=2)
QLVNTKGSWHIN 0.01% (n=2)
HLINSNGSWHIN 0.01% (n=2)
ELINSNGSWHIN 0.01% (n=2)
KLMNTNGSWHIN 0.01% (n=2)
QLINTTGSSHIN 0.01% (n=2)
QLINSNGSRHIN 0.01% (n=2)
QLINTNGSWHPN 0.01% (n=2)
QLINANGSWHLN 0.01% (n=2)
QLISTNGSWHLN 0.01% (n=2)
QLINSNGNWHIN 0.01% (n=2)
QLINTNGSWRVN 0.01% (n=2)
QLINTNGCWHIN 0.01% (n=2)
RLINTNGSWHLN 0.01% (n=2)
HLIKTNGSWHVN 0.01% (n=2)
QLVNADGSWHIN 0.01% (n=2)
QLIHKNGSWHIN 0.01% (n=2)
QLINSNGSWHID 0.01% (n=2)
QLININGSWHIN 0.01% (n=2)
QLVATNGSWHIN 0.01% (n=2)
QLINSNGSWHLN 0.01% (n=2)
QLINTNRSWHIN 0.01% (n=2)
QIINTNGSWHIN 0.01% (n=2)
QLVNTNDSWHIN 0.01% (n=2)
QLMHTNGSWHIN 0.01% (n=2)
KLVNTNGSWHIN 0.01% (n=2)
QLI--------- 0.01% (n=2)
QLVNTNGSWQLN 0.00% (n=1)
QLVNTNGSWLIN 0.00% (n=1)
QLINTNGSWHAN 0.00% (n=1)
QLINTHGSWHIN 0.00% (n=1)
RLINPNGSWHIN 0.00% (n=1)
QLTKSNGSWHIN 0.00% (n=1)
RLIKSNGSWHSN 0.00% (n=1)
QLIKSNGSRHIN 0.00% (n=1)
QLVNSNGNWHIN 0.00% (n=1)
KLMKTNDSWHIN 0.00% (n=1)
QLIQTNGSWHIN 0.00% (n=1)
QLIKTDGSWHIN 0.00% (n=1)
QLINTNG-WHIN 0.00% (n=1)
QLISSNGSWHIN 0.00% (n=1)
QLINFNGSWHIN 0.00% (n=1)
QLINTSGSWHTN 0.00% (n=1)
QLINSNGSWYIN 0.00% (n=1)
QLINSNGRWHIN 0.00% (n=1)
KLINTNGSCAIN 0.00% (n=1)
KLINTNGSWHVN 0.00% (n=1)
QLINSNGSWHTN 0.00% (n=1)
QLINSNGSWRIN 0.00% (n=1)
QLVSENGSWHIN 0.00% (n=1)
QLVNENGSWHVN 0.00% (n=1)
QQVNENGSWHIN 0.00% (n=1)
QLVNENDSWHIN 0.00% (n=1)
QLVNENGSWHTN 0.00% (n=1)
QMVNTNGSWHIN 0.00% (n=1)
GLINTNGSWHIN 0.00% (n=1)
QLINTGGSWHIN 0.00% (n=1)
QLVYSNGSWHIN 0.00% (n=1)
QLVYTNGSWRIN 0.00% (n=1)
ELVDTSGSWHIN 0.00% (n=1)
QLMYTNGSWHIN 0.00% (n=1)
QLVNSHGSWDIN 0.00% (n=1)
QLVNTNGRWHIN 0.00% (n=1)
HLVNSNGSWHIN 0.00% (n=1)
NLINTNGSWHIN 0.00% (n=1)
QLVNKDGSWHIN 0.00% (n=1)
RLIHTNGSWHIN 0.00% (n=1)
QLINASGSWHIN 0.00% (n=1)
QLVKANDSWHIN 0.00% (n=1)
ELVNVNDSWHIN 0.00% (n=1)
QLINTNGSWQIN 0.00% (n=1)
QPINTNGSWHLN 0.00% (n=1)
QLINTNGGWHLN 0.00% (n=1)
QLINTNDSWHLN 0.00% (n=1)
QLINTNGSWRLN 0.00% (n=1)
QPINTHGSWHIN 0.00% (n=1)
QLVNTNRSWHIN 0.00% (n=1)
QLVNTNGSWHSN 0.00% (n=1)
QLVNTNGSWHID 0.00% (n=1)
QFINSNGSWHIN 0.00% (n=1)
QFINTNGSWHIN 0.00% (n=1)
QLINTTGSWHIN 0.00% (n=1)
QLINTNGSRHVN 0.00% (n=1)
RLANTSGSWHIN 0.00% (n=1)
KLTNTNGSWHVN 0.00% (n=1)
KLTSTNGSWHIN 0.00% (n=1)
RLTNTNGSWHTN 0.00% (n=1)
QLISTNGSWHID 0.00% (n=1)
QLIGTNGSWHVN 0.00% (n=1)
ELINPNGGWHIN 0.00% (n=1)
QMINTNGSWHLN 0.00% (n=1)
QLINTIGSWHIN 0.00% (n=1)
QLINSIGSWHIN 0.00% (n=1)
HLIKTNGGWHIN 0.00% (n=1)
QLIKTNGRWHIN 0.00% (n=1)
HLISTNGSWHIN 0.00% (n=1)
QLMNTNGNWHIN 0.00% (n=1)
QLINTKGSWHIN 0.00% (n=1)
QLVSTNGSWHVN 0.00% (n=1)
QLINSNGSGHIN 0.00% (n=1)
QLINSNDSWHIN 0.00% (n=1)
QLVNTNGSWHNN 0.00% (n=1)
*LINTNGSRHIN 0.00% (n=1)
HLVNNNGSWHIN 0.00% (n=1)
QLMSTNGSWHIN 0.00% (n=1)
QLINTNVSWHIN 0.00% (n=1)
QLVKTEGNWHIN 0.00% (n=1)
QLVNTSGSWHVN 0.00% (n=1)
QLVNTNGGWHVN 0.00% (n=1)
PACNTNAAWGTS 0.00% (n=1)
KLVNTSGSWYIN 0.00% (n=1)
NLVNTNGSWHTN 0.00% (n=1)
PAYNTNGSWHIN 0.00% (n=1)
QLVN-------- 0.00% (n=1)
QIINT------- 0.00% (n=1)
QLVH-------- 0.00% (n=1)
QL---------- 0.00% (n=1)
QLINT------- 0.00% (n=1)
ELINTNGNWHIN 0.00% (n=1)
QLIHTNGSWDIN 0.00% (n=1)
HLIHTNGSWHIN 0.00% (n=1)
ELIHTNGRWHIN 0.00% (n=1)
QLINPNGSWHFN 0.00% (n=1)
QLINTNGSCHIN 0.00% (n=1)
QLVHSNGSWHIN 0.00% (n=1)
HLVYTNGSWHIN 0.00% (n=1)
QLVRANGSWHIN 0.00% (n=1)
QLINTNGSWHIT 0.00% (n=1)
LLVNTNGSWHIN 0.00% (n=1)
QLVHTNGSWHVN 0.00% (n=1)
QLVNTNGGWHIN 0.00% (n=1)
RIINTNGSWHIN 0.00% (n=1)
QLMKTNGSWHIN 0.00% (n=1)
QLVNSNGSWRIN 0.00% (n=1)
KLVNTNGSWRIN 0.00% (n=1)
QLINTNGSWHNN 0.00% (n=1)
PLINTNGSWHIN 0.00% (n=1)
LLINTNGSWHIN 0.00% (n=1)
QHINTNGSWHIN 0.00% (n=1)
QLINTNGSWRIS 0.00% (n=1)
QLVNTNGSWNIN 0.00% (n=1)
QLINTNGS---- 0.00% (n=1)
QLVNTNGS---- 0.00% (n=1)
QLVNSNGSRHIN 0.00% (n=1)
QLVNNNGIWHIN 0.00% (n=1)
QLV--------- 0.00% (n=1)
QLMNTSGSWHIN 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 1a:

QLINTNGSWHIN 55.47% (n=7582)
QLVNTNGSWHIN 17.42% (n=2381)
QLINSNGSWHIN 6.74% (n=921)
QLINTNGSWHLN 3.86% (n=528)
QLVNSNGSWHIN 1.74% (n=238)
QLVNANGSWHIN 1.43% (n=195)
HLINTNGSWHIN 1.40% (n=192)
QLINTNGSWHVN 1.09% (n=149)
HLIKTNGSWHIN 1.05% (n=144)
RLINTNGSWHIN 0.83% (n=113)
QLMNTNGSWHIN 0.76% (n=104)
QLISTNGSWHIN 0.61% (n=83)
KLTNTNGSWHIN 0.61% (n=83)
QLMNSNGSWHIN 0.55% (n=75)
QLINANGSWHIN 0.40% (n=54)
QLVNENGSWHIN 0.37% (n=51)
QLVSTNGSWHIN 0.32% (n=44)
QLINTNNSWHIN 0.32% (n=44)
KLINTNGSWHIN 0.31% (n=42)
QLIKTNGSWHIN 0.30% (n=41)
RLIKSNGSWHIN 0.13% (n=18)
QLINTSGSWHIN 0.13% (n=18)
QLVNTNGSWHVN 0.13% (n=18)
RLANTNGSWHIN 0.13% (n=18)
QLTNTNGSWHIN 0.12% (n=17)
QLVNTNGSW--- 0.12% (n=16)
RLTNTNGSWHIN 0.12% (n=16)
Q----------- 0.11% (n=15)
KLINSNGSWHIN 0.10% (n=13)
QLINTRGSWHIN 0.09% (n=12)
QLINTDGSWHIN 0.08% (n=11)
RLINSNGSWHIN 0.08% (n=11)
QLIDTNGSWHIN 0.07% (n=10)
QLINSSGSWHIN 0.07% (n=10)
QLIYSNGSWHIN 0.07% (n=10)
QLINSDGSWHIN 0.07% (n=9)
QLINRNGSWHIN 0.07% (n=9)
QLIKSNGSWHIN 0.06% (n=8)
RLVNSNGSWHIN 0.06% (n=8)
KLINTNGSCHIN 0.06% (n=8)
QLVNSNGSWHVN 0.06% (n=8)
QLVNRNGSWHIN 0.06% (n=8)
QLINTNGSWHTN 0.05% (n=7)
QLVNTNGSRHIN 0.05% (n=7)
QLINTNGS*HIN 0.05% (n=7)
QLVNTSGSWHIN 0.05% (n=7)
QLINTNDSWHIN 0.04% (n=6)
QLINTNGSRHIN 0.04% (n=6)
QLVDTNGSWHIN 0.04% (n=5)
QPINTNGSWHIN 0.04% (n=5)
YLINTNGSWHIN 0.04% (n=5)
QLVNTNGSWHTN 0.04% (n=5)
QLINPNGSWHIN 0.04% (n=5)
QLINTNGSWRIN 0.04% (n=5)
QLVNTDGSWHIN 0.04% (n=5)
QLVYTNGSWHIN 0.04% (n=5)
RLVNTNGSWHIN 0.04% (n=5)
QLVNTNGSWRIN 0.03% (n=4)
QLINTNSSWHIN 0.03% (n=4)
QLVNSSGSWHIN 0.03% (n=4)
QLVNTNGNWHIN 0.03% (n=4)
QLINTNGSWHID 0.03% (n=4)
QLINSNGSWHVN 0.03% (n=4)
QLVNKNGSWHIN 0.03% (n=4)
QLINNNGSWHIN 0.03% (n=4)
QLVNNNGSWHIN 0.03% (n=4)
QLVNTNGSWYIN 0.03% (n=4)
QLINKNGSWHIN 0.03% (n=4)
QLVNINGSWHIN 0.02% (n=3)
QLINTEGSWHIN 0.02% (n=3)
QLINTNGTWHIN 0.02% (n=3)
*LINTNGSWHIN 0.02% (n=3)
QPINSNGSWHIN 0.02% (n=3)
QLVNTNGS*HIN 0.02% (n=3)
QVINTNGSWHIN 0.02% (n=3)
QPVNTNGSWHIN 0.02% (n=3)
QLINTNGGWHIN 0.02% (n=3)
QLIHTNGSWHIN 0.02% (n=3)
QLTNSNGSWHIN 0.02% (n=3)
QLINTNGSRHLN 0.02% (n=3)
QLINSN------ 0.02% (n=3)
QLINTNGSWYIN 0.02% (n=3)
HLVKTNGSWHIN 0.02% (n=3)
QLIRTNGSWHIN 0.02% (n=3)
QLVNTNGSWHIS 0.01% (n=2)
QLINTNGSWDIN 0.01% (n=2)
QLINTNGSGHIN 0.01% (n=2)
QLINSNGSWHIS 0.01% (n=2)
QLINTNGNWHIN 0.01% (n=2)
KLINTNGSGHIN 0.01% (n=2)
QLINTNGSW--- 0.01% (n=2)
QMINTNGSWHIN 0.01% (n=2)
QLANTNGSWHIN 0.01% (n=2)
QLVNASGSWHIN 0.01% (n=2)
HLINSNGSWHIN 0.01% (n=2)
ELINTNGSWHIN 0.01% (n=2)
ELINSNGSWHIN 0.01% (n=2)
KLMNTNGSWHIN 0.01% (n=2)
QLINTTGSSHIN 0.01% (n=2)
QLINSNGSRHIN 0.01% (n=2)
QLINTNGSWHPN 0.01% (n=2)
QLINANGSWHLN 0.01% (n=2)
QLISTNGSWHLN 0.01% (n=2)
QLINSNGNWHIN 0.01% (n=2)
QLINTNGSWRVN 0.01% (n=2)
QLINTNGCWHIN 0.01% (n=2)
RLINTNGSWHLN 0.01% (n=2)
HLIKTNGSWHVN 0.01% (n=2)
QLLNTNGSWHIN 0.01% (n=2)
QLVNADGSWHIN 0.01% (n=2)
QLIHKNGSWHIN 0.01% (n=2)
QLVHTNGSWHIN 0.01% (n=2)
QLINSNGSWHID 0.01% (n=2)
QLVATNGSWHIN 0.01% (n=2)
QLINSNGSWHLN 0.01% (n=2)
QLVNTNGSWQLN 0.01% (n=1)
QLVNTNGSWLIN 0.01% (n=1)
QLINTNGSWHAN 0.01% (n=1)
QLINTHGSWHIN 0.01% (n=1)
QLVNTNSSWHIN 0.01% (n=1)
RLINPNGSWHIN 0.01% (n=1)
QLTKSNGSWHIN 0.01% (n=1)
RLIKSNGSWHSN 0.01% (n=1)
QLIKSNGSRHIN 0.01% (n=1)
QLVNSNGNWHIN 0.01% (n=1)
KLMKTNDSWHIN 0.01% (n=1)
QLVSTNGSWHIS 0.01% (n=1)
QLIQTNGSWHIN 0.01% (n=1)
QLIKTDGSWHIN 0.01% (n=1)
QLINTNG-WHIN 0.01% (n=1)
QLISSNGSWHIN 0.01% (n=1)
QLINFNGSWHIN 0.01% (n=1)
QLINTSGSWHTN 0.01% (n=1)
QLIYTNGSWHIN 0.01% (n=1)
QLINTNGSWHIH 0.01% (n=1)
QLINSNGSWYIN 0.01% (n=1)
QLINSNGRWHIN 0.01% (n=1)
KLINTNGSCAIN 0.01% (n=1)
KLINTNGSWHVN 0.01% (n=1)
QLINSNGSWHTN 0.01% (n=1)
QLINSNGGWHIN 0.01% (n=1)
QLINSNGSWRIN 0.01% (n=1)
QLVSENGSWHIN 0.01% (n=1)
QLVNENGSWHVN 0.01% (n=1)
QQVNENGSWHIN 0.01% (n=1)
QLVNENDSWHIN 0.01% (n=1)
QLVNENGSWHTN 0.01% (n=1)
QLINTNGRWHIN 0.01% (n=1)
QMVNTNGSWHIN 0.01% (n=1)
QLVNTNGSWHLN 0.01% (n=1)
QLVNTKGSWHIN 0.01% (n=1)
QLVTTNGSWHIN 0.01% (n=1)
GLINTNGSWHIN 0.01% (n=1)
QLINTGGSWHIN 0.01% (n=1)
QLVYSNGSWHIN 0.01% (n=1)
QLVYTNGSWRIN 0.01% (n=1)
QLINTNGSWHFN 0.01% (n=1)
ELVDTSGSWHIN 0.01% (n=1)
QLMYTNGSWHIN 0.01% (n=1)
QLVHANGSWHIN 0.01% (n=1)
QLVNSHGSWDIN 0.01% (n=1)
QLVNTNGRWHIN 0.01% (n=1)
HLVNSNGSWHIN 0.01% (n=1)
NLINTNGSWHIN 0.01% (n=1)
QLVNKDGSWHIN 0.01% (n=1)
NLVNTNGSWHIN 0.01% (n=1)
RLIHTNGSWHIN 0.01% (n=1)
QLINASGSWHIN 0.01% (n=1)
QLVKANDSWHIN 0.01% (n=1)
ELVNVNDSWHIN 0.01% (n=1)
QLINTNGSWQIN 0.01% (n=1)
QPINTNGSWHLN 0.01% (n=1)
QLINTNGGWHLN 0.01% (n=1)
QLINTNDSWHLN 0.01% (n=1)
QLINTNGSWRLN 0.01% (n=1)
QPINTHGSWHIN 0.01% (n=1)
QLVNTNRSWHIN 0.01% (n=1)
QLVNTNGSWHSN 0.01% (n=1)
QLVNTNGSWHID 0.01% (n=1)
QFINSNGSWHIN 0.01% (n=1)
QLINTNGSWHIS 0.01% (n=1)
QFINTNGSWHIN 0.01% (n=1)
QLINTTGSWHIN 0.01% (n=1)
QLINTNGSRHVN 0.01% (n=1)
RLANTSGSWHIN 0.01% (n=1)
KLTNTNGSWHVN 0.01% (n=1)
KLTSTNGSWHIN 0.01% (n=1)
RLTNTNGSWHTN 0.01% (n=1)
QLISTNGSWHID 0.01% (n=1)
QLIGTNGSWHVN 0.01% (n=1)
ELINPNGGWHIN 0.01% (n=1)
QMINTNGSWHLN 0.01% (n=1)
QLINTIGSWHIN 0.01% (n=1)
QLINSIGSWHIN 0.01% (n=1)
HLIKTNGGWHIN 0.01% (n=1)
QLIKTNGRWHIN 0.01% (n=1)
QLINTNGSWLIN 0.01% (n=1)
HLISTNGSWHIN 0.01% (n=1)
HLVNTNGSWHIN 0.01% (n=1)
QLMNTNGNWHIN 0.01% (n=1)
QLINTKGSWHIN 0.01% (n=1)
QLVSTNGSWHVN 0.01% (n=1)
QLINSNGSGHIN 0.01% (n=1)
QLINSNDSWHIN 0.01% (n=1)
QLVNTNGSWHNN 0.01% (n=1)
QLININGSWHIN 0.01% (n=1)
*LINTNGSRHIN 0.01% (n=1)
HLVNNNGSWHIN 0.01% (n=1)
QLMSTNGSWHIN 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 1b:

QLINTNGSWHIN 59.31% (n=5506)
QLVNTNGSWHIN 31.39% (n=2914)
QLVNSNGSWHIN 1.39% (n=129)
QLINSNGSWHIN 1.07% (n=99)
QLVNTNGSWHVN 0.89% (n=83)
RLINTNGSWHIN 0.75% (n=70)
QLINTNGSWHVN 0.42% (n=39)
QLISTNGSWHIN 0.32% (n=30)
QLMNTNGSWHIN 0.27% (n=25)
QLVNASGSWHIN 0.27% (n=25)
QLVKTNGSWHIN 0.24% (n=22)
QLIHTNGSWHIN 0.24% (n=22)
HLINTNGSWHIN 0.18% (n=17)
QLINTNGSW--- 0.18% (n=17)
ELVNTNGSWHIN 0.13% (n=12)
ELIHTNGSWHIN 0.13% (n=12)
QLVSTNGSWHIN 0.12% (n=11)
QLINTNGSRHIN 0.11% (n=10)
QLIKTNGSWHIN 0.10% (n=9)
NLVNTNGSWHIN 0.10% (n=9)
ELINTNGSWHIN 0.10% (n=9)
HLVNTNGSWHIN 0.10% (n=9)
QLINTSGSWHIN 0.09% (n=8)
QLINANGSWHIN 0.08% (n=7)
KLVNTSGSWHIN 0.06% (n=6)
QLVNTSGSWHIN 0.06% (n=6)
QLINTNGSWHID 0.06% (n=6)
Q----------- 0.06% (n=6)
QLINTNGSWRIN 0.06% (n=6)
QLINTDGSWHIN 0.05% (n=5)
QLINTNGSWLIN 0.04% (n=4)
QLVNSNGSWHVN 0.04% (n=4)
QLINTNGSWHIS 0.04% (n=4)
QLINTNGSWYIN 0.04% (n=4)
QLINTNSSWHIN 0.04% (n=4)
QLMETNGSWHIN 0.04% (n=4)
QLIDTNGSWHIN 0.04% (n=4)
QLVNTNSSWHIN 0.03% (n=3)
QLLNTNGSWHVN 0.03% (n=3)
QLVNINGSWHIN 0.03% (n=3)
QLVNTNGSWHIS 0.03% (n=3)
QLVNTNGSRHIN 0.03% (n=3)
QLVNTDGSWHIN 0.03% (n=3)
RLVNTNGSWHIN 0.03% (n=3)
QLANTNGSWHIN 0.03% (n=3)
QPINTNGSWHIN 0.03% (n=3)
QLVNTNGSWHTN 0.03% (n=3)
QLINTNGSWHTN 0.03% (n=3)
QLINTNDSWHIN 0.03% (n=3)
QLIYTNGSWHIN 0.02% (n=2)
QLVHTNGSWHIN 0.02% (n=2)
QLINTNRSWHIN 0.02% (n=2)
QLINTNGSWHFN 0.02% (n=2)
QLVNNNGSWHIN 0.02% (n=2)
QLINTNGGWHIN 0.02% (n=2)
QLVNTNGSW--- 0.02% (n=2)
QIINTNGSWHIN 0.02% (n=2)
QLVNTNDSWHIN 0.02% (n=2)
QLVTTNGSWHIN 0.02% (n=2)
QLVHANGSWHIN 0.02% (n=2)
QLMHTNGSWHIN 0.02% (n=2)
KLVNTNGSWHIN 0.02% (n=2)
QLVNANGSWHIN 0.02% (n=2)
QLINTNVSWHIN 0.01% (n=1)
QLVKTEGNWHIN 0.01% (n=1)
QLVNTSGSWHVN 0.01% (n=1)
QLVNTNGGWHVN 0.01% (n=1)
PACNTNAAWGTS 0.01% (n=1)
KLVNTSGSWYIN 0.01% (n=1)
NLVNTNGSWHTN 0.01% (n=1)
PAYNTNGSWHIN 0.01% (n=1)
QLINPNGSWHIN 0.01% (n=1)
QLVN-------- 0.01% (n=1)
QIINT------- 0.01% (n=1)
QLVH-------- 0.01% (n=1)
QL---------- 0.01% (n=1)
QLINT------- 0.01% (n=1)
ELINTNGNWHIN 0.01% (n=1)
QLIHTNGSWDIN 0.01% (n=1)
HLIHTNGSWHIN 0.01% (n=1)
ELIHTNGRWHIN 0.01% (n=1)
QLLNTNGSWHIN 0.01% (n=1)
QLINTNGRWHIN 0.01% (n=1)
QLINPNGSWHFN 0.01% (n=1)
QLINTNGSCHIN 0.01% (n=1)
QLVNRNGSWHIN 0.01% (n=1)
QLVHSNGSWHIN 0.01% (n=1)
QLIRTNGSWHIN 0.01% (n=1)
HLVYTNGSWHIN 0.01% (n=1)
QLVRANGSWHIN 0.01% (n=1)
QLINTNGSWHIT 0.01% (n=1)
QLVYTNGSWHIN 0.01% (n=1)
QLVNSSGSWHIN 0.01% (n=1)
LLVNTNGSWHIN 0.01% (n=1)
QLVHTNGSWHVN 0.01% (n=1)
QLVNTNGGWHIN 0.01% (n=1)
QLTNTNGSWHIN 0.01% (n=1)
RIINTNGSWHIN 0.01% (n=1)
QLMKTNGSWHIN 0.01% (n=1)
QLVNSNGSWRIN 0.01% (n=1)
QLIKSNGSWHIN 0.01% (n=1)
QLVNTNGS*HIN 0.01% (n=1)
QLVNTNGNWHIN 0.01% (n=1)
QLVSTNGSWHIS 0.01% (n=1)
KLVNTNGSWRIN 0.01% (n=1)
QPVNTNGSWHIN 0.01% (n=1)
QLVNTKGSWHIN 0.01% (n=1)
QLVNTNGSWRIN 0.01% (n=1)
QLININGSWHIN 0.01% (n=1)
QLINTNGSWHNN 0.01% (n=1)
PLINTNGSWHIN 0.01% (n=1)
QLINTNGTWHIN 0.01% (n=1)
LLINTNGSWHIN 0.01% (n=1)
QLINSNGGWHIN 0.01% (n=1)
QHINTNGSWHIN 0.01% (n=1)
QLINTNGSWRIS 0.01% (n=1)
QLINTNGSWHIH 0.01% (n=1)
QLINTNGSWHLN 0.01% (n=1)
QLVNTNGSWNIN 0.01% (n=1)
QLINTNGS---- 0.01% (n=1)
QLVNTNGS---- 0.01% (n=1)
QLVNSNGSRHIN 0.01% (n=1)
QLVNNNGIWHIN 0.01% (n=1)
QLV--------- 0.01% (n=1)
QLI--------- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 2:

QLINTNGSWHIN 21.60% (n=292)
QLINSNGSWHIN 20.49% (n=277)
SLINTNGSWHIN 12.50% (n=169)
QLIHTNGSWHIN 6.73% (n=91)
QLIHSNGSWHIN 6.36% (n=86)
QLIHNNGSWHIN 5.92% (n=80)
NLINTNGSWHIN 5.18% (n=70)
SLISTNGSWHIN 2.29% (n=31)
TLINTNGSWHIN 1.26% (n=17)
QLVNTNGSWHIN 1.18% (n=16)
QLINTNGSWHVN 1.04% (n=14)
DLINTNGSWHIN 1.04% (n=14)
NLIKTNGSWHIN 0.96% (n=13)
NLISTNGSWHIN 0.96% (n=13)
HLINTNGSWHIN 0.89% (n=12)
NLIHTNGSWHIN 0.81% (n=11)
QLIHTNGSWHVN 0.67% (n=9)
SLVNTNGSWHIN 0.59% (n=8)
YLINTNGSWHIN 0.44% (n=6)
QLINSNGSWHVN 0.37% (n=5)
QLIYTNGSWHIN 0.37% (n=5)
QLIN-------- 0.30% (n=4)
QLINNNGSWHIN 0.22% (n=3)
QLVNANGSWHIN 0.22% (n=3)
QLINANGSWHIN 0.22% (n=3)
MLINTNGSWHIN 0.22% (n=3)
HLVNSNGSWHIN 0.22% (n=3)
KLINTNGSWHIN 0.22% (n=3)
NLVNTNGSWHIN 0.22% (n=3)
TLVNTNGSWHIN 0.22% (n=3)
QLIRNNGSWHIN 0.22% (n=3)
QLI--------- 0.22% (n=3)
QLVNTNGSWHVN 0.15% (n=2)
QLIKTNGSWHIN 0.15% (n=2)
QLINSSGSWHIN 0.15% (n=2)
QLVNSNGSWHIN 0.15% (n=2)
QLIDTNGSWHIN 0.15% (n=2)
QLISTNGSWHIN 0.15% (n=2)
RLINTNGSWHIN 0.15% (n=2)
HLINSNGSWHIN 0.15% (n=2)
ALINTNGSWHIN 0.15% (n=2)
SLIHTNGSWHIN 0.15% (n=2)
QLVHTNGSWHIN 0.07% (n=1)
QLINSNGSWHTN 0.07% (n=1)
QLTNSNGSWHIN 0.07% (n=1)
QLINTNGSWHLN 0.07% (n=1)
QLIYSNGSWHIN 0.07% (n=1)
QLVNDNGSWHIN 0.07% (n=1)
QLIDTKGSWHIN 0.07% (n=1)
QLVSANGSWHIN 0.07% (n=1)
QLINTSGSWHIN 0.07% (n=1)
QLVNTSGSWHIN 0.07% (n=1)
QLIKSNGSWHIN 0.07% (n=1)
QLVNSNGSWHVN 0.07% (n=1)
RLMNTSGSWHIN 0.07% (n=1)
ILVNSNGSWHIN 0.07% (n=1)
HLVNTNGSWHIN 0.07% (n=1)
HLNHSNGSWHIN 0.07% (n=1)
YLINKNGSWHIN 0.07% (n=1)
SLINSNGSWHIN 0.07% (n=1)
QLISSNGSWHIN 0.07% (n=1)
NLINSNGNWHIN 0.07% (n=1)
HLIKNNGSWHIN 0.07% (n=1)
QLVNNNGSWHIN 0.07% (n=1)
HLVKTNGSWHIN 0.07% (n=1)
TLNHTNGSWHIN 0.07% (n=1)
DLINANGSWHIN 0.07% (n=1)
NLINTNGSWHID 0.07% (n=1)
NLINTNGSLHIN 0.07% (n=1)
NLINTNVNWHID 0.07% (n=1)
TLINTNGS*HIN 0.07% (n=1)
TLINTNSSWHIN 0.07% (n=1)
SLVNTNGSRHIN 0.07% (n=1)
SLVSTNGSWHIN 0.07% (n=1)
SLINTTGSWHVN 0.07% (n=1)
SLINTNGSLHIN 0.07% (n=1)
*LVNTNGSWHIN 0.07% (n=1)
TLVNTNGNLHIN 0.07% (n=1)
SLINTNGSLDIN 0.07% (n=1)
SLINTDGSWHIN 0.07% (n=1)
NLIYTNGSWHIN 0.07% (n=1)
MLINSNGSWHIN 0.07% (n=1)
WLIPMAAGW-IN 0.07% (n=1)
SLIKENGSWHIN 0.07% (n=1)
ALINTNGSWHVN 0.07% (n=1)
SLMNTNGSWHIN 0.07% (n=1)
QLIYNNGSWHIN 0.07% (n=1)
QLTHTNGSWHIN 0.07% (n=1)
QLVKTNGSWHIN 0.07% (n=1)
QLIRTNGSWHVN 0.07% (n=1)
ELVNTNGSWHIN 0.07% (n=1)
QLIYTNGSWHVN 0.07% (n=1)
QLINDNGTWHIN 0.07% (n=1)
*LINSNGSWHIN 0.07% (n=1)
RLINSNGSWHIN 0.07% (n=1)
QLINSDGSWHIN 0.07% (n=1)
QLIRSNGSWHIN 0.07% (n=1)
RLV--------- 0.07% (n=1)
QLINPNGSWHIN 0.07% (n=1)
MLMKTNGSWHIN 0.07% (n=1)
SLVNSNGSWHIN 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 2a:

QLINTNGSWHIN 46.32% (n=132)
QLINSNGSWHIN 38.25% (n=109)
QLINTNGSWHVN 3.51% (n=10)
QLVNTNGSWHIN 2.81% (n=8)
QLINSNGSWHVN 1.40% (n=4)
QLINNNGSWHIN 0.70% (n=2)
QLINSSGSWHIN 0.70% (n=2)
QLVNTNGSWHVN 0.35% (n=1)
QLINSNGSWHTN 0.35% (n=1)
QLTNSNGSWHIN 0.35% (n=1)
QLINTNGSWHLN 0.35% (n=1)
QLIKTNGSWHIN 0.35% (n=1)
QLIYSNGSWHIN 0.35% (n=1)
QLVNSNGSWHIN 0.35% (n=1)
QLVNDNGSWHIN 0.35% (n=1)
QLIDTKGSWHIN 0.35% (n=1)
QLIDTNGSWHIN 0.35% (n=1)
QLVSANGSWHIN 0.35% (n=1)
QLVNANGSWHIN 0.35% (n=1)
QLISTNGSWHIN 0.35% (n=1)
QLINTSGSWHIN 0.35% (n=1)
QLVNTSGSWHIN 0.35% (n=1)
QLIKSNGSWHIN 0.35% (n=1)
QLVNSNGSWHVN 0.35% (n=1)
RLMNTSGSWHIN 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 2b:

SLINTNGSWHIN 36.58% (n=169)
NLINTNGSWHIN 15.15% (n=70)
QLINTNGSWHIN 7.14% (n=33)
SLISTNGSWHIN 6.71% (n=31)
TLINTNGSWHIN 3.68% (n=17)
DLINTNGSWHIN 3.03% (n=14)
NLIKTNGSWHIN 2.81% (n=13)
NLISTNGSWHIN 2.81% (n=13)
HLINTNGSWHIN 2.38% (n=11)
NLIHTNGSWHIN 2.38% (n=11)
SLVNTNGSWHIN 1.73% (n=8)
QLINSNGSWHIN 1.52% (n=7)
YLINTNGSWHIN 1.30% (n=6)
QLVNTNGSWHIN 0.65% (n=3)
MLINTNGSWHIN 0.65% (n=3)
HLVNSNGSWHIN 0.65% (n=3)
KLINTNGSWHIN 0.65% (n=3)
NLVNTNGSWHIN 0.65% (n=3)
TLVNTNGSWHIN 0.65% (n=3)
RLINTNGSWHIN 0.43% (n=2)
QLINANGSWHIN 0.43% (n=2)
ALINTNGSWHIN 0.43% (n=2)
SLIHTNGSWHIN 0.43% (n=2)
ILVNSNGSWHIN 0.22% (n=1)
HLINSNGSWHIN 0.22% (n=1)
HLVNTNGSWHIN 0.22% (n=1)
HLNHSNGSWHIN 0.22% (n=1)
YLINKNGSWHIN 0.22% (n=1)
QLINNNGSWHIN 0.22% (n=1)
QLISSNGSWHIN 0.22% (n=1)
NLINSNGNWHIN 0.22% (n=1)
HLIKNNGSWHIN 0.22% (n=1)
QLVNNNGSWHIN 0.22% (n=1)
HLVKTNGSWHIN 0.22% (n=1)
TLNHTNGSWHIN 0.22% (n=1)
DLINANGSWHIN 0.22% (n=1)
NLINTNGSWHID 0.22% (n=1)
NLINTNGSLHIN 0.22% (n=1)
NLINTNVNWHID 0.22% (n=1)
TLINTNGS*HIN 0.22% (n=1)
TLINTNSSWHIN 0.22% (n=1)
SLVNTNGSRHIN 0.22% (n=1)
SLVSTNGSWHIN 0.22% (n=1)
SLINTTGSWHVN 0.22% (n=1)
SLINTNGSLHIN 0.22% (n=1)
*LVNTNGSWHIN 0.22% (n=1)
TLVNTNGNLHIN 0.22% (n=1)
SLINTNGSLDIN 0.22% (n=1)
SLINTDGSWHIN 0.22% (n=1)
NLIYTNGSWHIN 0.22% (n=1)
MLINSNGSWHIN 0.22% (n=1)
--------W-IN 0.22% (n=1)
SLIKENGSWHIN 0.22% (n=1)
ALINTNGSWHVN 0.22% (n=1)
SLMNTNGSWHIN 0.22% (n=1)
QLVNSNGSWHIN 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 2c:

QLINSNGSWHIN 33.48% (n=152)
QLIHTNGSWHIN 19.60% (n=89)
QLIHSNGSWHIN 18.50% (n=84)
QLIHNNGSWHIN 17.62% (n=80)
QLINTNGSWHIN 3.52% (n=16)
QLIHTNGSWHVN 1.98% (n=9)
QLIRNNGSWHIN 0.66% (n=3)
QLIYTNGSWHIN 0.66% (n=3)
QLINTNGSWHVN 0.44% (n=2)
QLIN-------- 0.22% (n=1)
QLIYNNGSWHIN 0.22% (n=1)
QLTHTNGSWHIN 0.22% (n=1)
QLVNTNGSWHIN 0.22% (n=1)
QLVKTNGSWHIN 0.22% (n=1)
QLVNANGSWHIN 0.22% (n=1)
QLIRTNGSWHVN 0.22% (n=1)
QLINSNGSWHVN 0.22% (n=1)
QLISTNGSWHIN 0.22% (n=1)
ELVNTNGSWHIN 0.22% (n=1)
QLIYTNGSWHVN 0.22% (n=1)
QLINDNGTWHIN 0.22% (n=1)
*LINSNGSWHIN 0.22% (n=1)
RLINSNGSWHIN 0.22% (n=1)
HLINSNGSWHIN 0.22% (n=1)
QLINSDGSWHIN 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 3:

QLVNTNGSWHIN 40.56% (n=1590)
QLINTNGSWHIN 15.71% (n=616)
ELINTNGSWHIN 9.72% (n=381)
QLVRTNGSWHIN 8.04% (n=315)
HLVNSNGSWHIN 6.33% (n=248)
QLVNSNGSWHIN 5.28% (n=207)
QLIYTNGSWHVN 2.50% (n=98)
QLINSNGSWHIN 2.42% (n=95)
HLVNTNGSWHIN 1.43% (n=56)
ELVNTNGSWHIN 1.12% (n=44)
QLVNTNGSWYIN 0.82% (n=32)
QLIETQGSWHIN 0.61% (n=24)
QLVNANGSWHIN 0.46% (n=18)
---NTNGSWHIN 0.36% (n=14)
QLVYTNGSWHIN 0.23% (n=9)
QLVHTNGSWHIN 0.20% (n=8)
QLIETNGSWHIN 0.18% (n=7)
RLVNTNGSWHIN 0.18% (n=7)
QLVN-------- 0.15% (n=6)
NLVNSNGSWHIN 0.15% (n=6)
QLVSTNGSWHIN 0.13% (n=5)
QLV--------- 0.13% (n=5)
QLVKTNGSWHIN 0.13% (n=5)
QLINANGSWHIN 0.10% (n=4)
QLVNTNGSW--- 0.10% (n=4)
ALINTNGSWHIN 0.10% (n=4)
QLIN-------- 0.10% (n=4)
QLVDTNGSWHIN 0.08% (n=3)
QLVNTNGPWHIN 0.08% (n=3)
QLVNTSGSWHIN 0.08% (n=3)
QLIHTNGSWHIN 0.08% (n=3)
QLIYTNGSWHIN 0.08% (n=3)
QLVETNGSWHIN 0.08% (n=3)
QLVHSNGSWHIN 0.08% (n=3)
RLVNSNGSWHIN 0.08% (n=3)
ALVNTNGSWHIN 0.05% (n=2)
QLVNSSGSWHIN 0.05% (n=2)
ELINTNGPWHIN 0.05% (n=2)
QLVNTNDSWHIN 0.05% (n=2)
ELIKTNGSWHIN 0.05% (n=2)
QLVKSNGSWHIN 0.05% (n=2)
QLVNTNGSWHVN 0.05% (n=2)
QPVNTNGSWHIN 0.05% (n=2)
QLINTNGSWHVN 0.05% (n=2)
ELINTHGSWHIN 0.05% (n=2)
KLVNTNGSWHIN 0.05% (n=2)
KLINTNGSWHIN 0.05% (n=2)
QLVNDSGSWHIN 0.05% (n=2)
HLVSSNGSWHIN 0.05% (n=2)
QLVHNNGSWHIN 0.03% (n=1)
QLISSNGSWHIN 0.03% (n=1)
QLVNTNGSWHTN 0.03% (n=1)
ELINTNDSWHIN 0.03% (n=1)
QLVNTNGSWHIS 0.03% (n=1)
QLVNINGSWHIN 0.03% (n=1)
QLINTYGSGHIN 0.03% (n=1)
QLVNTYGSLHIS 0.03% (n=1)
ELICTNASWHIN 0.03% (n=1)
QLTNTNGSWHIN 0.03% (n=1)
QLINTNGSRHIN 0.03% (n=1)
QLVETKGSWHIN 0.03% (n=1)
RLIYTNGSWHVN 0.03% (n=1)
QLIYTNGSWHVS 0.03% (n=1)
QLIDTNGSWHIS 0.03% (n=1)
QLINTNGSWHTN 0.03% (n=1)
QLIDTNGSWHIN 0.03% (n=1)
LLVNTNGSWHIN 0.03% (n=1)
QLMKTGDSWHIN 0.03% (n=1)
YLINTNGSWHIN 0.03% (n=1)
ELVYTNGSWHIN 0.03% (n=1)
QLISTNGSWHIN 0.03% (n=1)
QLIQTNGSWHIN 0.03% (n=1)
QLIKTNNSWHIN 0.03% (n=1)
QLINSSGSWHIN 0.03% (n=1)
ELIHTNGSWHIN 0.03% (n=1)
QLINDNGSWHIN 0.03% (n=1)
NLINTNGSWHIN 0.03% (n=1)
QLVNKNGSWHIN 0.03% (n=1)
ELINTDGSWHIN 0.03% (n=1)
QLVNNNGSWHIN 0.03% (n=1)
ELIETNGSWHIN 0.03% (n=1)
ELVNANGSWHIN 0.03% (n=1)
QLVNTDGSWHIN 0.03% (n=1)
ELMNTNGSWHIN 0.03% (n=1)
QLVNSNGS---- 0.03% (n=1)
HLVESNGSWHIN 0.03% (n=1)
HLIETNGSWHIN 0.03% (n=1)
DLVYTNGSWHIN 0.03% (n=1)
NLVNTNGSWHIN 0.03% (n=1)
HLVNSNGSRHIN 0.03% (n=1)
SLVNTNGSWHIN 0.03% (n=1)
QLMNTNGSWHIN 0.03% (n=1)
HLVNSSGSWHIN 0.03% (n=1)
QLMNSNGSWHIN 0.03% (n=1)
QLMESNGSWHIN 0.03% (n=1)
QLTNSNGSWHIN 0.03% (n=1)
QLVNTNGSWHLN 0.03% (n=1)
QLVNSNGSWHVN 0.03% (n=1)
QLVDSNGSWHIN 0.03% (n=1)
QLVSSNGSWHIN 0.03% (n=1)
QLVYSNGSWHIN 0.03% (n=1)
QLVNSNGFWHIN 0.03% (n=1)
HLVN-------- 0.03% (n=1)
HLINTNGSWHIN 0.03% (n=1)
ELVKSNGSWHIN 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 3a:

QLVNTNGSWHIN 47.17% (n=1548)
QLINTNGSWHIN 18.56% (n=609)
ELINTNGSWHIN 11.61% (n=381)
QLVRTNGSWHIN 9.60% (n=315)
QLIYTNGSWHVN 2.99% (n=98)
ELVNTNGSWHIN 1.34% (n=44)
QLVNSNGSWHIN 0.98% (n=32)
QLVNTNGSWYIN 0.98% (n=32)
QLIETQGSWHIN 0.73% (n=24)
HLVNTNGSWHIN 0.61% (n=20)
QLINSNGSWHIN 0.58% (n=19)
QLVNANGSWHIN 0.55% (n=18)
---NTNGSWHIN 0.43% (n=14)
QLVYTNGSWHIN 0.27% (n=9)
QLVHTNGSWHIN 0.24% (n=8)
QLIETNGSWHIN 0.21% (n=7)
RLVNTNGSWHIN 0.18% (n=6)
QLVSTNGSWHIN 0.15% (n=5)
QLVKTNGSWHIN 0.15% (n=5)
QLINANGSWHIN 0.12% (n=4)
QLVNTNGSW--- 0.12% (n=4)
ALINTNGSWHIN 0.12% (n=4)
QLVDTNGSWHIN 0.09% (n=3)
QLVNTNGPWHIN 0.09% (n=3)
QLVNTSGSWHIN 0.09% (n=3)
QLIHTNGSWHIN 0.09% (n=3)
QLVETNGSWHIN 0.09% (n=3)
ALVNTNGSWHIN 0.06% (n=2)
ELINTNGPWHIN 0.06% (n=2)
QLVNTNDSWHIN 0.06% (n=2)
ELIKTNGSWHIN 0.06% (n=2)
QLVKSNGSWHIN 0.06% (n=2)
QPVNTNGSWHIN 0.06% (n=2)
ELINTHGSWHIN 0.06% (n=2)
QLV--------- 0.06% (n=2)
QLIYTNGSWHIN 0.06% (n=2)
KLINTNGSWHIN 0.06% (n=2)
QLVNDSGSWHIN 0.06% (n=2)
QLVHNNGSWHIN 0.03% (n=1)
QLVNSSGSWHIN 0.03% (n=1)
QLISSNGSWHIN 0.03% (n=1)
QLVNTNGSWHTN 0.03% (n=1)
ELINTNDSWHIN 0.03% (n=1)
QLVNTNGSWHIS 0.03% (n=1)
QLVNINGSWHIN 0.03% (n=1)
QLINTYGSGHIN 0.03% (n=1)
QLVNTYGSLHIS 0.03% (n=1)
ELICTNASWHIN 0.03% (n=1)
QLTNTNGSWHIN 0.03% (n=1)
QLVNTNGSWHVN 0.03% (n=1)
QLINTNGSRHIN 0.03% (n=1)
QLVETKGSWHIN 0.03% (n=1)
RLIYTNGSWHVN 0.03% (n=1)
QLIYTNGSWHVS 0.03% (n=1)
QLIDTNGSWHIS 0.03% (n=1)
QLINTNGSWHVN 0.03% (n=1)
QLINTNGSWHTN 0.03% (n=1)
QLIDTNGSWHIN 0.03% (n=1)
LLVNTNGSWHIN 0.03% (n=1)
QLMKTGDSWHIN 0.03% (n=1)
YLINTNGSWHIN 0.03% (n=1)
KLVNTNGSWHIN 0.03% (n=1)
ELVYTNGSWHIN 0.03% (n=1)
QLISTNGSWHIN 0.03% (n=1)
QLIQTNGSWHIN 0.03% (n=1)
QLIKTNNSWHIN 0.03% (n=1)
QLINSSGSWHIN 0.03% (n=1)
ELIHTNGSWHIN 0.03% (n=1)
QLINDNGSWHIN 0.03% (n=1)
NLINTNGSWHIN 0.03% (n=1)
QLVNKNGSWHIN 0.03% (n=1)
ELINTDGSWHIN 0.03% (n=1)
QLVNNNGSWHIN 0.03% (n=1)
ELIETNGSWHIN 0.03% (n=1)
ELVNANGSWHIN 0.03% (n=1)
QLVNTDGSWHIN 0.03% (n=1)
ELMNTNGSWHIN 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 3b:

HLVNSNGSWHIN 61.54% (n=248)
QLVNSNGSWHIN 19.85% (n=80)
HLVNTNGSWHIN 8.44% (n=34)
QLVNTNGSWHIN 1.99% (n=8)
NLVNSNGSWHIN 1.49% (n=6)
QLVN-------- 0.99% (n=4)
QLVHSNGSWHIN 0.74% (n=3)
RLVNSNGSWHIN 0.74% (n=3)
HLVSSNGSWHIN 0.50% (n=2)
QLVNSNGS---- 0.25% (n=1)
HLVESNGSWHIN 0.25% (n=1)
HLIETNGSWHIN 0.25% (n=1)
KLVNTNGSWHIN 0.25% (n=1)
DLVYTNGSWHIN 0.25% (n=1)
NLVNTNGSWHIN 0.25% (n=1)
QLVNSSGSWHIN 0.25% (n=1)
RLVNTNGSWHIN 0.25% (n=1)
HLVNSNGSRHIN 0.25% (n=1)
SLVNTNGSWHIN 0.25% (n=1)
QLMNTNGSWHIN 0.25% (n=1)
HLVNSSGSWHIN 0.25% (n=1)
QLMNSNGSWHIN 0.25% (n=1)
QLMESNGSWHIN 0.25% (n=1)
QLTNSNGSWHIN 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 4:

QLINTNGSWHIN 67.93% (n=521)
GLINTNGSWHIN 8.08% (n=62)
HLINSNGSWHIN 4.69% (n=36)
QLINSNGSWHIN 3.78% (n=29)
QLVNKNGSWHIN 3.78% (n=29)
QLIHTNGSWHIN 2.22% (n=17)
QLVNTNGSWHIN 1.43% (n=11)
QLISTNGSWHIN 1.43% (n=11)
QLVNSNGSWHIN 1.17% (n=9)
QLIDTNGSWHIN 0.65% (n=5)
QLINTNGSWHVN 0.52% (n=4)
QLINTNGSWHL- 0.52% (n=4)
QLINTGGSWHIN 0.39% (n=3)
QLTNTNGSWHIN 0.39% (n=3)
RLINTNGSWHIN 0.39% (n=3)
QLINSNGSWHVN 0.26% (n=2)
QLIYTNGSWHIN 0.26% (n=2)
RLVKTNGSWHIN 0.26% (n=2)
QLINS------- 0.13% (n=1)
QLINTNESWHIN 0.13% (n=1)
HLINTNGSWHIN 0.13% (n=1)
MLINTNGSWHVN 0.13% (n=1)
MLINTNGSWHIN 0.13% (n=1)
KLINTNGSWHIN 0.13% (n=1)
QLINTNGRWHL- 0.13% (n=1)
SLINSNGSWHIN 0.13% (n=1)
QLIYTNGSWHVN 0.13% (n=1)
HLVNSNGSWHIN 0.13% (n=1)
RLINTNGSWHVN 0.13% (n=1)
KLVNSNGSWHIN 0.13% (n=1)
QLVNTNGSWHVN 0.13% (n=1)
RLVNTNGSWHIN 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 4a:

GLINTNGSWHIN 38.75% (n=62)
HLINSNGSWHIN 22.50% (n=36)
QLVNKNGSWHIN 18.13% (n=29)
QLINSNGSWHIN 14.38% (n=23)
QLVNSNGSWHIN 1.88% (n=3)
QLINTNGSWHIN 1.88% (n=3)
QLINSNGSWHVN 1.25% (n=2)
QLINS------- 0.63% (n=1)
QLVNTNGSWHIN 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 4d:

QLINTNGSWHIN 92.07% (n=499)
QLIHTNGSWHIN 2.58% (n=14)
QLISTNGSWHIN 2.03% (n=11)
QLIDTNGSWHIN 0.74% (n=4)
QLINTGGSWHIN 0.55% (n=3)
QLTNTNGSWHIN 0.55% (n=3)
QLIYTNGSWHIN 0.37% (n=2)
RLVKTNGSWHIN 0.37% (n=2)
QLINTNESWHIN 0.18% (n=1)
QLVNTNGSWHIN 0.18% (n=1)
QLINSNGSWHIN 0.18% (n=1)
HLINTNGSWHIN 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 5:

QLINTNGSWHIN 60.14% (n=86)
Q----------- 5.59% (n=8)
QLVNTNGSWHIN 5.59% (n=8)
QLINSNGSWHIN 3.50% (n=5)
QLIHSNGSWHIN 2.80% (n=4)
QLISTNGSWHIN 2.10% (n=3)
QLINNQGSWHIN 1.40% (n=2)
QLIRTNGSWHIN 1.40% (n=2)
QLVNSNGSWHIN 1.40% (n=2)
QLIHTNGSWHIN 1.40% (n=2)
QFVNTNGSWHIN 1.40% (n=2)
QL---------- 0.70% (n=1)
QLINSNGSWHI- 0.70% (n=1)
QLINTSGSWHIN 0.70% (n=1)
QLINTNGSWH-- 0.70% (n=1)
QLMKTNGSWHIN 0.70% (n=1)
QIINTNGSWHIN 0.70% (n=1)
QLINTNGSCHI- 0.70% (n=1)
ELINTNGSWHIN 0.70% (n=1)
QLVHTNGSWHIN 0.70% (n=1)
RLMKTGESWHIN 0.70% (n=1)
QLVKTNGA---- 0.70% (n=1)
AAHNTNGSWHIN 0.70% (n=1)
QLMNSNGSWHIN 0.70% (n=1)
QLINTNGSWYI- 0.70% (n=1)
QLVRSNGSWHIN 0.70% (n=1)
QLIKTNGSWHIN 0.70% (n=1)
QLINTNGSWHI- 0.70% (n=1)
QLMETNGSWHIN 0.70% (n=1)
QLIQNGSSWHIN 0.70% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 6:

QLINTNGSWHIN 50.25% (n=299)
QLVNTNGSWHIN 14.45% (n=86)
QLINSNGSWHIN 6.55% (n=39)
QLVNSNGSWHIN 5.04% (n=30)
QLVNSNGSWHVN 3.36% (n=20)
QLIN-------- 3.19% (n=19)
QLINTNGSWHVN 2.35% (n=14)
QLINSNGSWHVN 2.02% (n=12)
QLVN-------- 1.51% (n=9)
QLMNTNGSWHVN 1.18% (n=7)
QLMNTNGSWHIN 1.01% (n=6)
QLVNTNGSWHVN 1.01% (n=6)
HLVNTNGSWHIN 0.67% (n=4)
QLIHTNGSWHIN 0.67% (n=4)
QLVKTNGSWHIN 0.50% (n=3)
HLINTNGSWHIN 0.50% (n=3)
QLVHTNGSWHIN 0.34% (n=2)
ELINTNGSWHIN 0.34% (n=2)
QLIKTNGSWHIN 0.34% (n=2)
QLIYTNGSWHVN 0.34% (n=2)
QLIKNGSSWHIN 0.17% (n=1)
QLIKSNGSWHIN 0.17% (n=1)
QLINTKGSWHIN 0.17% (n=1)
QLVRTNGSWHIN 0.17% (n=1)
QLICTNGSWHIN 0.17% (n=1)
QLVNNNGSWHIN 0.17% (n=1)
HLVNTSGSWHIN 0.17% (n=1)
QLVHANGSWHIN 0.17% (n=1)
QLIYSNGSWHIN 0.17% (n=1)
QLVNKNGSWHIN 0.17% (n=1)
QLINTNGRWHIN 0.17% (n=1)
QLINTNGSRHIN 0.17% (n=1)
QFINTNGSWHIN 0.17% (n=1)
QLIYTNGSWHIN 0.17% (n=1)
HLIN-------- 0.17% (n=1)
QLINTNGSWHLN 0.17% (n=1)
QLIK-------- 0.17% (n=1)
QLVHTNGSWHLN 0.17% (n=1)
HLINTNGSWHLN 0.17% (n=1)
QLVKINGSWHVN 0.17% (n=1)
QLIKTNGSWHVN 0.17% (n=1)
MLINTNGSWHIN 0.17% (n=1)
QLINTDGSWHIN 0.17% (n=1)
QLIETNGSWHIN 0.17% (n=1)
QLISTNGSWHVN 0.17% (n=1)
MLINTNGSWHVN 0.17% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Subtype 6a:

QLINTNGSWHIN 65.64% (n=214)
QLVNTNGSWHIN 19.63% (n=64)
QLINSNGSWHIN 4.60% (n=15)
QLIN-------- 1.23% (n=4)
HLVNTNGSWHIN 0.92% (n=3)
QLVNSNGSWHIN 0.92% (n=3)
QLVHTNGSWHIN 0.61% (n=2)
ELINTNGSWHIN 0.61% (n=2)
QLVKTNGSWHIN 0.61% (n=2)
QLIKNGSSWHIN 0.31% (n=1)
QLIKSNGSWHIN 0.31% (n=1)
QLINTKGSWHIN 0.31% (n=1)
QLVRTNGSWHIN 0.31% (n=1)
QLICTNGSWHIN 0.31% (n=1)
HLINTNGSWHIN 0.31% (n=1)
QLIHTNGSWHIN 0.31% (n=1)
QLVNNNGSWHIN 0.31% (n=1)
HLVNTSGSWHIN 0.31% (n=1)
QLVHANGSWHIN 0.31% (n=1)
QLIYSNGSWHIN 0.31% (n=1)
QLIKTNGSWHIN 0.31% (n=1)
QLVNKNGSWHIN 0.31% (n=1)
QLINTNGRWHIN 0.31% (n=1)
QLINTNGSRHIN 0.31% (n=1)
QFINTNGSWHIN 0.31% (n=1)
QLIYTNGSWHIN 0.31% (n=1)
---------------------------------------------------------------------------------------
Region 412-423 (antibodies: [Hu5B3.v3] ), HCV Genotype 7:

QLINTNGSWHIN 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 523-530 (antibodies: [J6.27] ), HCV Genotype 1:

GAPTYNWG 33.04% (n=3376)
GVPTYSWG 13.26% (n=1355)
GAPTYSWG 12.48% (n=1275)
GVPTYNWG 10.90% (n=1114)
GVPTYRWG 4.99% (n=510)
GAPTYRWG 4.49% (n=459)
GVPTYTWG 3.76% (n=384)
GAPAYNWG 3.31% (n=338)
GAPTFNWG 3.16% (n=323)
GAPTYTWG 2.23% (n=228)
GEPTYNWG 1.50% (n=153)
GIPTYSWG 1.15% (n=117)
GAPTYGWG 1.00% (n=102)
GQPTYNWG 0.37% (n=38)
GVPTYGWG 0.25% (n=26)
GAPTYDWG 0.24% (n=25)
GAPTYKWG 0.23% (n=23)
GVPTYDWG 0.20% (n=20)
GHPTYNWG 0.20% (n=20)
GTPTYSWG 0.19% (n=19)
GAPTHTWG 0.17% (n=17)
GTPTYNWG 0.16% (n=16)
GAPTFSWG 0.16% (n=16)
GMPTYNWG 0.14% (n=14)
-------G 0.14% (n=14)
GVPTYKWG 0.12% (n=12)
GDPTYGWG 0.10% (n=10)
GLPTYNWG 0.10% (n=10)
GAPTHNWG 0.08% (n=8)
GVPT---- 0.08% (n=8)
GVPTYAWG 0.07% (n=7)
GTPTYTWG 0.06% (n=6)
GMPTYSWG 0.06% (n=6)
GVPTFTWG 0.06% (n=6)
GVPTFSWG 0.06% (n=6)
GAPTHSWG 0.05% (n=5)
GVATYSWG 0.04% (n=4)
EAPTYNWG 0.04% (n=4)
GTPTFTWG 0.04% (n=4)
GALTYNWG 0.04% (n=4)
----YSWG 0.04% (n=4)
GASTYNWG 0.04% (n=4)
DVPTYSWG 0.03% (n=3)
GAPTFTWG 0.03% (n=3)
GAPSYNWG 0.03% (n=3)
GAATYSWG 0.03% (n=3)
GAPTCSWG 0.03% (n=3)
GAPTYSRG 0.03% (n=3)
GIPTYTWG 0.03% (n=3)
GTPTFSWG 0.03% (n=3)
GVPTYQWG 0.03% (n=3)
GDPTFGWG 0.02% (n=2)
GAPTFTFG 0.02% (n=2)
GSPTYRWG 0.02% (n=2)
GVPTFNWG 0.02% (n=2)
GVPTHSWG 0.02% (n=2)
GSPTYSWG 0.02% (n=2)
GVPTYNFG 0.02% (n=2)
GLAYFQLG 0.02% (n=2)
GVPTHNWG 0.02% (n=2)
GEPTYRWG 0.02% (n=2)
GAPTNNWG 0.02% (n=2)
GAPTYNWS 0.02% (n=2)
GTPTHNWG 0.02% (n=2)
SVPT---- 0.02% (n=2)
GAPTYQWG 0.02% (n=2)
GNPTYTWG 0.02% (n=2)
GDPTYNWG 0.02% (n=2)
GAPTYAWG 0.02% (n=2)
GNPTYRWG 0.02% (n=2)
GLPTYTWG 0.02% (n=2)
GNPTFNSG 0.02% (n=2)
GVSTYSWG 0.01% (n=1)
GAPTCNWG 0.01% (n=1)
GVPTYNWC 0.01% (n=1)
GAPT-NWG 0.01% (n=1)
GAPTHDWG 0.01% (n=1)
CAPTYNWG 0.01% (n=1)
GDPTYSWG 0.01% (n=1)
DVPTYNWG 0.01% (n=1)
GVPTYN*G 0.01% (n=1)
GAPTYSWV 0.01% (n=1)
GVPTYTCG 0.01% (n=1)
NTPTFTWG 0.01% (n=1)
GQATYSWG 0.01% (n=1)
RKPTYSWG 0.01% (n=1)
GAPSYTWG 0.01% (n=1)
GTPTYDWG 0.01% (n=1)
GAPIYSWG 0.01% (n=1)
GVPTLNWG 0.01% (n=1)
GVPIYGWG 0.01% (n=1)
GAPTYS*G 0.01% (n=1)
GGPTYSWG 0.01% (n=1)
GAPTYGRG 0.01% (n=1)
GALTYNRG 0.01% (n=1)
GAPAYSWG 0.01% (n=1)
GEPTYYWG 0.01% (n=1)
GSPTYNWG 0.01% (n=1)
SAPTYNWG 0.01% (n=1)
SAPTYSWG 0.01% (n=1)
GVPTYNWV 0.01% (n=1)
GGPTYNWG 0.01% (n=1)
GVPAYNWG 0.01% (n=1)
GAPTSVRG 0.01% (n=1)
GVRTYNWG 0.01% (n=1)
GNPTYSWG 0.01% (n=1)
GVRT---- 0.01% (n=1)
GARKYSWG 0.01% (n=1)
GASTYSWG 0.01% (n=1)
GTPTYRWG 0.01% (n=1)
GAPTYSWR 0.01% (n=1)
GPPTYSWG 0.01% (n=1)
GVSTYTWG 0.01% (n=1)
GVPTYSGR 0.01% (n=1)
GVPTYMWG 0.01% (n=1)
SVPTYRWG 0.01% (n=1)
GNPTYNWG 0.01% (n=1)
GVPTCTWG 0.01% (n=1)
GVPTYTWE 0.01% (n=1)
GTATFNWG 0.01% (n=1)
GVPSYRWG 0.01% (n=1)
SRRSYILG 0.01% (n=1)
GAPTYHWG 0.01% (n=1)
GDPTYTWG 0.01% (n=1)
GVPTHTWG 0.01% (n=1)
GAPTYRRG 0.01% (n=1)
GNPTFTSG 0.01% (n=1)
GVPTYEWG 0.01% (n=1)
GMPTYTSG 0.01% (n=1)
GAPTFTSG 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 1a:

GAPTYNWG 44.06% (n=3202)
GAPTYSWG 12.84% (n=933)
GVPTYNWG 12.66% (n=920)
GAPTYRWG 5.67% (n=412)
GAPAYNWG 4.65% (n=338)
GAPTFNWG 4.42% (n=321)
GVPTYRWG 2.70% (n=196)
GEPTYNWG 2.11% (n=153)
GVPTYSWG 2.05% (n=149)
GIPTYSWG 1.60% (n=116)
GAPTYGWG 1.39% (n=101)
GAPTYTWG 0.77% (n=56)
GVPTYTWG 0.59% (n=43)
GQPTYNWG 0.52% (n=38)
GAPTYDWG 0.34% (n=25)
GAPTYKWG 0.29% (n=21)
GVPTYGWG 0.28% (n=20)
GTPTYSWG 0.23% (n=17)
GAPTHTWG 0.22% (n=16)
GVPTYDWG 0.21% (n=15)
GMPTYNWG 0.19% (n=14)
GTPTYNWG 0.15% (n=11)
GDPTYGWG 0.14% (n=10)
GLPTYNWG 0.11% (n=8)
GAPTFSWG 0.11% (n=8)
GAPTHNWG 0.11% (n=8)
GMPTYSWG 0.08% (n=6)
GAPTHSWG 0.07% (n=5)
GVPTFTWG 0.07% (n=5)
GVATYSWG 0.06% (n=4)
EAPTYNWG 0.06% (n=4)
GTPTFTWG 0.06% (n=4)
GALTYNWG 0.06% (n=4)
----YSWG 0.06% (n=4)
GASTYNWG 0.06% (n=4)
GAPSYNWG 0.04% (n=3)
GAATYSWG 0.04% (n=3)
GAPTCSWG 0.04% (n=3)
GHPTYNWG 0.04% (n=3)
GDPTFGWG 0.03% (n=2)
GAPTFTFG 0.03% (n=2)
GSPTYRWG 0.03% (n=2)
GVPTFNWG 0.03% (n=2)
GVPTHSWG 0.03% (n=2)
GSPTYSWG 0.03% (n=2)
GVPTYNFG 0.03% (n=2)
GAPTYSRG 0.03% (n=2)
GLAYFQLG 0.03% (n=2)
GEPTYRWG 0.03% (n=2)
GAPTNNWG 0.03% (n=2)
GAPTYNWS 0.03% (n=2)
GTPTHNWG 0.03% (n=2)
DVPTYSWG 0.01% (n=1)
GVSTYSWG 0.01% (n=1)
GAPTCNWG 0.01% (n=1)
GVPTYNWC 0.01% (n=1)
GAPT-NWG 0.01% (n=1)
GAPTHDWG 0.01% (n=1)
GAPTFTWG 0.01% (n=1)
CAPTYNWG 0.01% (n=1)
GDPTYSWG 0.01% (n=1)
DVPTYNWG 0.01% (n=1)
GVPTYN*G 0.01% (n=1)
GAPTYSWV 0.01% (n=1)
GVPTYTCG 0.01% (n=1)
GTPTYTWG 0.01% (n=1)
NTPTFTWG 0.01% (n=1)
GQATYSWG 0.01% (n=1)
RKPTYSWG 0.01% (n=1)
GAPSYTWG 0.01% (n=1)
GTPTYDWG 0.01% (n=1)
GAPIYSWG 0.01% (n=1)
GVPTLNWG 0.01% (n=1)
GVPIYGWG 0.01% (n=1)
GAPTYS*G 0.01% (n=1)
GGPTYSWG 0.01% (n=1)
GAPTYGRG 0.01% (n=1)
GALTYNRG 0.01% (n=1)
GVPTHNWG 0.01% (n=1)
GAPAYSWG 0.01% (n=1)
GEPTYYWG 0.01% (n=1)
GSPTYNWG 0.01% (n=1)
GIPTYTWG 0.01% (n=1)
SAPTYNWG 0.01% (n=1)
GVPTYAWG 0.01% (n=1)
SAPTYSWG 0.01% (n=1)
GVPTYNWV 0.01% (n=1)
GTPTFSWG 0.01% (n=1)
GGPTYNWG 0.01% (n=1)
GVPAYNWG 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 1b:

GVPTYSWG 41.23% (n=1202)
GAPTYSWG 11.73% (n=342)
GVPTYTWG 11.39% (n=332)
GVPTYRWG 10.74% (n=313)
GVPTYNWG 6.59% (n=192)
GAPTYTWG 5.80% (n=169)
GAPTYNWG 5.76% (n=168)
GAPTYRWG 1.61% (n=47)
GHPTYNWG 0.58% (n=17)
-------G 0.48% (n=14)
GVPTYKWG 0.41% (n=12)
GVPT---- 0.27% (n=8)
GAPTFSWG 0.27% (n=8)
GVPTYGWG 0.21% (n=6)
GVPTYAWG 0.21% (n=6)
GVPTFSWG 0.21% (n=6)
GVPTYDWG 0.17% (n=5)
GTPTYTWG 0.17% (n=5)
GTPTYNWG 0.17% (n=5)
GVPTYQWG 0.10% (n=3)
GAPTYKWG 0.07% (n=2)
SVPT---- 0.07% (n=2)
GTPTYSWG 0.07% (n=2)
GAPTYQWG 0.07% (n=2)
GNPTYTWG 0.07% (n=2)
GDPTYNWG 0.07% (n=2)
GAPTFTWG 0.07% (n=2)
GAPTYAWG 0.07% (n=2)
GIPTYTWG 0.07% (n=2)
DVPTYSWG 0.07% (n=2)
GTPTFSWG 0.07% (n=2)
GAPTFNWG 0.07% (n=2)
GAPTSVRG 0.03% (n=1)
GVRTYNWG 0.03% (n=1)
GNPTYSWG 0.03% (n=1)
GVRT---- 0.03% (n=1)
GARKYSWG 0.03% (n=1)
GASTYSWG 0.03% (n=1)
GTPTYRWG 0.03% (n=1)
GAPTYSWR 0.03% (n=1)
GPPTYSWG 0.03% (n=1)
GVSTYTWG 0.03% (n=1)
GVPTYSGR 0.03% (n=1)
GVPTYMWG 0.03% (n=1)
SVPTYRWG 0.03% (n=1)
GVPTFTWG 0.03% (n=1)
GVPTHNWG 0.03% (n=1)
GNPTYNWG 0.03% (n=1)
GVPTCTWG 0.03% (n=1)
GVPTYTWE 0.03% (n=1)
GTATFNWG 0.03% (n=1)
GVPSYRWG 0.03% (n=1)
SRRSYILG 0.03% (n=1)
GLPTYNWG 0.03% (n=1)
GIPTYSWG 0.03% (n=1)
GAPTYHWG 0.03% (n=1)
GNPTYRWG 0.03% (n=1)
GDPTYTWG 0.03% (n=1)
GAPTYGWG 0.03% (n=1)
GAPTYSRG 0.03% (n=1)
GVPTHTWG 0.03% (n=1)
GAPTHTWG 0.03% (n=1)
GAPTYRRG 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 2:

GVPTYTWG 26.33% (n=139)
GVPTYSWG 23.11% (n=122)
GVPTYNWG 19.70% (n=104)
GAPTYSWG 14.58% (n=77)
GAPTYTWG 4.92% (n=26)
GAPTYNWG 1.89% (n=10)
GAPTYGWG 1.14% (n=6)
GVPTYGWG 1.14% (n=6)
GAPTYRWG 0.95% (n=5)
GVPTYRWG 0.57% (n=3)
GAPPRTGE 0.57% (n=3)
GVPT---- 0.38% (n=2)
GLPTYTWG 0.38% (n=2)
GTPTYTWG 0.38% (n=2)
GVPTYKWG 0.38% (n=2)
EAPTYTWG 0.19% (n=1)
GAPTRMWE 0.19% (n=1)
GAPTRMGE 0.19% (n=1)
GAPPHTGE 0.19% (n=1)
GAPTCPWR 0.19% (n=1)
GVPTHTWG 0.19% (n=1)
GIPTYSWG 0.19% (n=1)
GVPTYAWG 0.19% (n=1)
GIPTYTWG 0.19% (n=1)
GAPTYMWG 0.19% (n=1)
GLPTYSWG 0.19% (n=1)
GVPTYDWG 0.19% (n=1)
GVATYTWG 0.19% (n=1)
GMPTYTWG 0.19% (n=1)
GMPTYNWG 0.19% (n=1)
GVPTYTWE 0.19% (n=1)
GQPTYTWG 0.19% (n=1)
GVPAYTWG 0.19% (n=1)
RVPTYSWG 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 2a:

GVPTYTWG 71.79% (n=56)
GAPTYTWG 14.10% (n=11)
GAPPRTGE 3.85% (n=3)
GVPT---- 2.56% (n=2)
EAPTYTWG 1.28% (n=1)
GVPTYRWG 1.28% (n=1)
GVPTYSWG 1.28% (n=1)
GAPTRMWE 1.28% (n=1)
GAPTRMGE 1.28% (n=1)
GAPPHTGE 1.28% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 2b:

GVPTYSWG 30.57% (n=107)
GVPTYNWG 26.00% (n=91)
GAPTYSWG 22.00% (n=77)
GVPTYTWG 12.00% (n=42)
GAPTYGWG 1.71% (n=6)
GAPTYRWG 1.43% (n=5)
GAPTYNWG 1.14% (n=4)
GAPTYTWG 0.57% (n=2)
GVPTYRWG 0.57% (n=2)
GLPTYTWG 0.57% (n=2)
GTPTYTWG 0.57% (n=2)
GAPTCPWR 0.29% (n=1)
GVPTHTWG 0.29% (n=1)
GIPTYSWG 0.29% (n=1)
GVPTYAWG 0.29% (n=1)
GIPTYTWG 0.29% (n=1)
GAPTYMWG 0.29% (n=1)
GLPTYSWG 0.29% (n=1)
GVPTYDWG 0.29% (n=1)
GVATYTWG 0.29% (n=1)
GMPTYTWG 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 2c:

GVPTYTWG 40.00% (n=24)
GVPTYNWG 15.00% (n=9)
GVPTYSWG 11.67% (n=7)
GAPTYTWG 10.00% (n=6)
GVPTYGWG 10.00% (n=6)
GAPTYNWG 8.33% (n=5)
GMPTYNWG 1.67% (n=1)
GVPTYTWE 1.67% (n=1)
GQPTYTWG 1.67% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 3:

GAPTYTWG 25.03% (n=693)
GVPTYNWG 19.28% (n=534)
GVPTYTWG 19.18% (n=531)
GLPTYNFG 8.16% (n=226)
GAPTYNWG 7.40% (n=205)
GAPTYSWG 1.77% (n=49)
GSPTYNFG 1.55% (n=43)
GTPTYTWG 1.34% (n=37)
GVPTYSWG 1.01% (n=28)
GIPTYNWG 0.98% (n=27)
GAPTFTWG 0.94% (n=26)
GAPTFNWG 0.94% (n=26)
GTPTYDWG 0.90% (n=25)
GEPTYTWG 0.83% (n=23)
GLPTYSFG 0.76% (n=21)
GLPTYTFG 0.72% (n=20)
GVPTYAWG 0.54% (n=15)
---TYTWG 0.47% (n=13)
GVPTYTFG 0.40% (n=11)
GNPTYTWG 0.29% (n=8)
GVPTYYWG 0.29% (n=8)
GTPTYNWG 0.25% (n=7)
GAPTYNFG 0.25% (n=7)
GVPTYNFG 0.22% (n=6)
GVPTFTWG 0.22% (n=6)
GSPTYTWG 0.22% (n=6)
GAPTYDWG 0.22% (n=6)
GVPTYDWG 0.22% (n=6)
GAPTYGWG 0.18% (n=5)
GMPTYTWG 0.18% (n=5)
GAPTYAWG 0.18% (n=5)
GAPTYRWG 0.18% (n=5)
GAPTYTFG 0.18% (n=5)
GVPTYSFG 0.14% (n=4)
GTPTYSWG 0.14% (n=4)
GAPTYKWG 0.14% (n=4)
GSPTYTFG 0.14% (n=4)
GASTYNWG 0.11% (n=3)
GLPTYNWG 0.11% (n=3)
GEPTYNWG 0.11% (n=3)
GMPTYNWG 0.11% (n=3)
GVPTFNWG 0.11% (n=3)
GDPTYNWG 0.11% (n=3)
GLPTYRFG 0.11% (n=3)
GSPTYSFG 0.11% (n=3)
GIPTHNWG 0.07% (n=2)
GAPTYFWG 0.07% (n=2)
GRPTYNWG 0.07% (n=2)
GVPTYTRG 0.07% (n=2)
GAPTYRLG 0.07% (n=2)
GVPIYTWG 0.07% (n=2)
GNPTFNWG 0.07% (n=2)
GSPTYNWG 0.07% (n=2)
GVPTYRWG 0.07% (n=2)
GTPTFTWG 0.07% (n=2)
---TYNWG 0.07% (n=2)
GDPTYTWG 0.07% (n=2)
GVPTYGWG 0.07% (n=2)
GVPTYKWG 0.07% (n=2)
GAPTYQWG 0.07% (n=2)
GTPTFNWG 0.07% (n=2)
GVPTYKFG 0.07% (n=2)
GVPTYTWD 0.04% (n=1)
GGPTYNWG 0.04% (n=1)
GGSTYNWG 0.04% (n=1)
GVPTFGWG 0.04% (n=1)
GVPRYNWG 0.04% (n=1)
GIPTYSFG 0.04% (n=1)
GAPTYNWS 0.04% (n=1)
GTPTYDWS 0.04% (n=1)
G-PTYDWG 0.04% (n=1)
GTSTYDWG 0.04% (n=1)
GAPTCTWG 0.04% (n=1)
GVPTYCWG 0.04% (n=1)
GVPTYPWG 0.04% (n=1)
GAPTYTWS 0.04% (n=1)
GAPTYSWS 0.04% (n=1)
GVPTYTLS 0.04% (n=1)
GVPTYTLG 0.04% (n=1)
GVPTYRLG 0.04% (n=1)
GTPTYTKS 0.04% (n=1)
GAPTYCSN 0.04% (n=1)
GQPTYNWG 0.04% (n=1)
GVPTYNRG 0.04% (n=1)
GKPTYTWG 0.04% (n=1)
GVATYNWG 0.04% (n=1)
GAPTYYWG 0.04% (n=1)
GASTYQW- 0.04% (n=1)
GAPTYTGG 0.04% (n=1)
GAPTYEWG 0.04% (n=1)
GVQTLNWG 0.04% (n=1)
GVPRYTWG 0.04% (n=1)
GEATFNWG 0.04% (n=1)
GVPTYEWG 0.04% (n=1)
GKPTYGWG 0.04% (n=1)
GALTYNWG 0.04% (n=1)
GDPTYTYG 0.04% (n=1)
GSPTYQWG 0.04% (n=1)
GLPTYTWG 0.04% (n=1)
GRPTYTWG 0.04% (n=1)
GNPTFTWG 0.04% (n=1)
GVATYTWG 0.04% (n=1)
GNPTYNWG 0.04% (n=1)
GIPTYTWG 0.04% (n=1)
GNPTFDWG 0.04% (n=1)
GNPTYEWG 0.04% (n=1)
GVPTFQWG 0.04% (n=1)
GNPTYSWG 0.04% (n=1)
GLPTYSWG 0.04% (n=1)
GHPTYNWG 0.04% (n=1)
GLPTYDFG 0.04% (n=1)
GLPTYAFG 0.04% (n=1)
GAPTYGFG 0.04% (n=1)
GIPTYNFG 0.04% (n=1)
GLPTCNFG 0.04% (n=1)
GLPTYGFG 0.04% (n=1)
GTPTYTFG 0.04% (n=1)
GAPTYRFG 0.04% (n=1)
GYPTFTWG 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 3a:

GAPTYTWG 28.08% (n=664)
GVPTYNWG 22.54% (n=533)
GVPTYTWG 22.41% (n=530)
GAPTYNWG 8.63% (n=204)
GAPTYSWG 2.07% (n=49)
GTPTYTWG 1.56% (n=37)
GVPTYSWG 1.14% (n=27)
GIPTYNWG 1.14% (n=27)
GAPTFTWG 1.10% (n=26)
GAPTFNWG 1.10% (n=26)
GTPTYDWG 1.06% (n=25)
GEPTYTWG 0.97% (n=23)
GVPTYAWG 0.63% (n=15)
GNPTYTWG 0.34% (n=8)
GVPTYYWG 0.34% (n=8)
GTPTYNWG 0.30% (n=7)
GVPTFTWG 0.25% (n=6)
GAPTYDWG 0.25% (n=6)
GVPTYDWG 0.25% (n=6)
GAPTYGWG 0.21% (n=5)
GMPTYTWG 0.21% (n=5)
GSPTYTWG 0.21% (n=5)
GAPTYRWG 0.21% (n=5)
GTPTYSWG 0.17% (n=4)
GAPTYAWG 0.17% (n=4)
GAPTYKWG 0.17% (n=4)
GASTYNWG 0.13% (n=3)
GLPTYNWG 0.13% (n=3)
GEPTYNWG 0.13% (n=3)
GVPTYTFG 0.13% (n=3)
GMPTYNWG 0.13% (n=3)
GVPTFNWG 0.13% (n=3)
GDPTYNWG 0.13% (n=3)
GIPTHNWG 0.08% (n=2)
GVPTYNFG 0.08% (n=2)
GAPTYFWG 0.08% (n=2)
GRPTYNWG 0.08% (n=2)
GVPTYTRG 0.08% (n=2)
GAPTYRLG 0.08% (n=2)
GVPIYTWG 0.08% (n=2)
GNPTFNWG 0.08% (n=2)
GSPTYNWG 0.08% (n=2)
GVPTYRWG 0.08% (n=2)
GTPTFTWG 0.08% (n=2)
---TYNWG 0.08% (n=2)
GDPTYTWG 0.08% (n=2)
GVPTYGWG 0.08% (n=2)
GVPTYKWG 0.08% (n=2)
GAPTYQWG 0.08% (n=2)
GTPTFNWG 0.08% (n=2)
GVPTYSFG 0.04% (n=1)
GVPTYTWD 0.04% (n=1)
GGPTYNWG 0.04% (n=1)
GGSTYNWG 0.04% (n=1)
GVPTFGWG 0.04% (n=1)
GVPRYNWG 0.04% (n=1)
GIPTYSFG 0.04% (n=1)
GAPTYNWS 0.04% (n=1)
GTPTYDWS 0.04% (n=1)
G-PTYDWG 0.04% (n=1)
GTSTYDWG 0.04% (n=1)
GAPTCTWG 0.04% (n=1)
GVPTYCWG 0.04% (n=1)
GVPTYPWG 0.04% (n=1)
GAPTYTWS 0.04% (n=1)
GAPTYSWS 0.04% (n=1)
GVPTYTLS 0.04% (n=1)
GVPTYTLG 0.04% (n=1)
GVPTYRLG 0.04% (n=1)
GTPTYTKS 0.04% (n=1)
GAPTYCSN 0.04% (n=1)
GQPTYNWG 0.04% (n=1)
GVPTYNRG 0.04% (n=1)
GKPTYTWG 0.04% (n=1)
GVATYNWG 0.04% (n=1)
GAPTYYWG 0.04% (n=1)
-----QW- 0.04% (n=1)
GAPTYTGG 0.04% (n=1)
GAPTYEWG 0.04% (n=1)
GVQTLNWG 0.04% (n=1)
GVPRYTWG 0.04% (n=1)
GEATFNWG 0.04% (n=1)
GVPTYEWG 0.04% (n=1)
GKPTYGWG 0.04% (n=1)
GALTYNWG 0.04% (n=1)
GDPTYTYG 0.04% (n=1)
GSPTYQWG 0.04% (n=1)
GLPTYTWG 0.04% (n=1)
GRPTYTWG 0.04% (n=1)
GAPTYNFG 0.04% (n=1)
GNPTFTWG 0.04% (n=1)
GVATYTWG 0.04% (n=1)
GNPTYNWG 0.04% (n=1)
GIPTYTWG 0.04% (n=1)
GNPTFDWG 0.04% (n=1)
GNPTYEWG 0.04% (n=1)
GVPTFQWG 0.04% (n=1)
GNPTYSWG 0.04% (n=1)
GLPTYRFG 0.04% (n=1)
GLPTYSWG 0.04% (n=1)
GHPTYNWG 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 3b:

GLPTYNFG 65.70% (n=226)
GSPTYNFG 12.50% (n=43)
GLPTYSFG 6.10% (n=21)
GLPTYTFG 5.81% (n=20)
GAPTYNFG 1.74% (n=6)
GVPTYNFG 1.16% (n=4)
GSPTYTFG 1.16% (n=4)
GSPTYSFG 0.87% (n=3)
GVPTYTFG 0.87% (n=3)
GLPTYRFG 0.58% (n=2)
GVPTYKFG 0.58% (n=2)
GVPTYSFG 0.58% (n=2)
GAPTYTFG 0.58% (n=2)
GLPTYDFG 0.29% (n=1)
GLPTYAFG 0.29% (n=1)
GAPTYGFG 0.29% (n=1)
GIPTYNFG 0.29% (n=1)
GLPTCNFG 0.29% (n=1)
GLPTYGFG 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 4:

GVPTYTWG 66.95% (n=156)
GVPTYNWG 9.01% (n=21)
GAPTYTWG 6.87% (n=16)
GVPTHTWG 1.72% (n=4)
GAPTYSWG 1.72% (n=4)
GAPTYNWG 1.29% (n=3)
GDPTYNWG 1.29% (n=3)
GLPTYNWG 0.86% (n=2)
GSPTYNWG 0.86% (n=2)
GIPTYTWG 0.86% (n=2)
GVPTYDWG 0.86% (n=2)
GLPTYTWG 0.86% (n=2)
GVPTYTLG 0.43% (n=1)
GVPTYSWG 0.43% (n=1)
GAPTYAWG 0.43% (n=1)
GIPTYNWG 0.43% (n=1)
GDPTYGWG 0.43% (n=1)
GNPTYSFG 0.43% (n=1)
GNPTYYWG 0.43% (n=1)
GNPTYGWG 0.43% (n=1)
GYPTHNWG 0.43% (n=1)
GNPTYTWG 0.43% (n=1)
GLPTYGWG 0.43% (n=1)
GHPTYSWG 0.43% (n=1)
GDPTYTWG 0.43% (n=1)
GTPTYNWG 0.43% (n=1)
GHPTYNWG 0.43% (n=1)
GLPTYRWG 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 4a:

GVPTYTWG 90.57% (n=144)
GVPTYNWG 4.40% (n=7)
GVPTHTWG 2.52% (n=4)
GAPTYNWG 0.63% (n=1)
GVPTYTLG 0.63% (n=1)
GAPTYTWG 0.63% (n=1)
GLPTYNWG 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 4d:

GAPTYTWG 76.92% (n=10)
GVPTYTWG 23.08% (n=3)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 5:

GYPTYNWG 50.00% (n=19)
GYPTYSWG 7.89% (n=3)
GNPTYNWG 5.26% (n=2)
GVPSYNWG 5.26% (n=2)
GCPTYNWG 5.26% (n=2)
GLPTYTWG 2.63% (n=1)
GNPTYSWG 2.63% (n=1)
GLPTYNWG 2.63% (n=1)
GHPTYTWG 2.63% (n=1)
GYPTYTWG 2.63% (n=1)
GVPTYTWG 2.63% (n=1)
GFPTYNWG 2.63% (n=1)
GNPTYDWG 2.63% (n=1)
GCPTYTWG 2.63% (n=1)
GHPTYNWG 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 6:

GNPTYTWG 32.48% (n=114)
GLPTYTWG 17.09% (n=60)
GLPTYNWG 17.09% (n=60)
GFPTYTWG 4.84% (n=17)
GNPTYNWG 3.42% (n=12)
GAPTYTWG 2.85% (n=10)
GLPTYSWG 2.56% (n=9)
GVPTYTWG 1.99% (n=7)
GIPTYTWG 1.14% (n=4)
GNPTYSWG 1.14% (n=4)
GFPTYNWG 1.14% (n=4)
GLPTYAWG 1.14% (n=4)
GTPTYTWG 0.85% (n=3)
GIPTYNWG 0.85% (n=3)
GHPTYNWG 0.57% (n=2)
GSPTYTWG 0.57% (n=2)
GKPTYTWG 0.57% (n=2)
GFPTYSWG 0.57% (n=2)
GLPTYGWG 0.57% (n=2)
GHPTYTWG 0.57% (n=2)
GVPTYNWG 0.57% (n=2)
GRPTYNWG 0.57% (n=2)
GDPTYTWG 0.57% (n=2)
GNPTYHWG 0.28% (n=1)
GAPTYTFG 0.28% (n=1)
GVPTYSFG 0.28% (n=1)
GAPTYSFG 0.28% (n=1)
GLPTYEWG 0.28% (n=1)
GLPTYQWG 0.28% (n=1)
GLPTFTWG 0.28% (n=1)
GLPTYDWG 0.28% (n=1)
GHPTFNWG 0.28% (n=1)
GLPKYNWG 0.28% (n=1)
GVPTYPWG 0.28% (n=1)
GSPTYRWG 0.28% (n=1)
GSPTYNWG 0.28% (n=1)
GLPTYTLG 0.28% (n=1)
GFATYNWG 0.28% (n=1)
GSATYTWG 0.28% (n=1)
GAPTFTWG 0.28% (n=1)
GAPTYNFG 0.28% (n=1)
GVPTYSWG 0.28% (n=1)
GNPTYAWG 0.28% (n=1)
GAPTYNWG 0.28% (n=1)
GTPTFTWG 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Subtype 6a:

GNPTYTWG 82.64% (n=100)
GNPTYNWG 5.79% (n=7)
GIPTYTWG 2.48% (n=3)
GNPTYSWG 1.65% (n=2)
GTPTYTWG 1.65% (n=2)
GHPTYNWG 0.83% (n=1)
GSPTYTWG 0.83% (n=1)
GKPTYTWG 0.83% (n=1)
GNPTYHWG 0.83% (n=1)
GVPTYTWG 0.83% (n=1)
GFPTYNWG 0.83% (n=1)
GAPTYTWG 0.83% (n=1)
---------------------------------------------------------------------------------------
Region 523-530 (antibodies: [J6.27] ), HCV Genotype 7:

GVPTYTWG 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 402-407 (antibodies: [J6.36] ), HCV Genotype 1:

LFSPGA 8.12% (n=1893)
LFTPGA 4.45% (n=1038)
LFSSGA 3.50% (n=816)
LFNPGA 2.80% (n=654)
LFTSGA 2.17% (n=506)
LFTPGP 2.11% (n=493)
FFSPGP 1.80% (n=419)
FFQPGA 1.79% (n=417)
FFSPGA 1.76% (n=411)
LLTPGA 1.63% (n=381)
LLSPGA 1.59% (n=370)
FLSIGP 1.48% (n=344)
FLSPGP 1.46% (n=341)
IFSPGA 1.45% (n=339)
LFSPGP 1.31% (n=306)
LFMSGA 1.15% (n=268)
LFSPGS 1.13% (n=263)
LFRPGA 1.12% (n=261)
LFNSGA 1.10% (n=256)
LFSAGS 1.10% (n=256)
LFTRGA 1.02% (n=238)
LFAPGA 0.97% (n=227)
LFAAGS 0.97% (n=227)
IFSPGP 0.93% (n=217)
LFSFGA 0.91% (n=213)
LFTSGP 0.84% (n=196)
LFTQGA 0.81% (n=190)
LFLQGP 0.78% (n=183)
LFSQGA 0.76% (n=177)
LFTLGP 0.69% (n=162)
FFDRGP 0.69% (n=162)
LFSSGP 0.66% (n=154)
LFQPGA 0.65% (n=152)
LLSRGP 0.65% (n=152)
FFTPGA 0.65% (n=151)
LFAPGP 0.65% (n=151)
IFTSGA 0.64% (n=150)
LFTRGP 0.63% (n=148)
LFQLGP 0.61% (n=142)
WFRQGP 0.60% (n=140)
LLTRGP 0.53% (n=123)
LLSPGP 0.53% (n=123)
LFTTGP 0.51% (n=120)
LFTPGS 0.49% (n=115)
FFDPGP 0.48% (n=111)
LFSRGA 0.47% (n=110)
IFAPGA 0.47% (n=109)
LFTLGA 0.46% (n=108)
LLTPGP 0.46% (n=108)
LLAPGA 0.45% (n=105)
IFTPGA 0.45% (n=105)
FLTPGA 0.45% (n=104)
LFAPGS 0.45% (n=104)
LFTTGA 0.42% (n=99)
FFSSGP 0.42% (n=98)
LFTQGP 0.41% (n=96)
FFTPGP 0.41% (n=95)
FFSLGP 0.41% (n=95)
LFSLGA 0.39% (n=91)
FFTSGP 0.39% (n=90)
LLSLGA 0.38% (n=89)
LFRPGP 0.38% (n=88)
LFSTGS 0.38% (n=88)
FFTLGP 0.36% (n=84)
LFSLGS 0.36% (n=83)
IFSLGA 0.35% (n=81)
FLTQGA 0.35% (n=81)
LFTVGP 0.35% (n=81)
MFSFGA 0.35% (n=81)
LFTFGA 0.34% (n=80)
FFAPGP 0.33% (n=78)
FLSLGP 0.33% (n=78)
MFAPGA 0.33% (n=77)
LFSQGP 0.33% (n=76)
LFSSGS 0.33% (n=76)
FFSQGA 0.32% (n=75)
FFSSGA 0.32% (n=75)
LFSRGS 0.30% (n=70)
FFNPGA 0.30% (n=69)
LFSTGP 0.30% (n=69)
IFSVGA 0.30% (n=69)
MFMNGP 0.29% (n=68)
LFSVGP 0.28% (n=65)
LFNTGP 0.28% (n=65)
LLTSGA 0.27% (n=64)
LFMRGP 0.27% (n=64)
FLSPGA 0.27% (n=63)
FFHLGP 0.27% (n=63)
LFQSGA 0.27% (n=62)
FFTQGP 0.26% (n=60)
MFTSGA 0.26% (n=60)
FFTAGP 0.26% (n=60)
FFSPGS 0.26% (n=60)
LFAVGP 0.25% (n=59)
LFSVGS 0.24% (n=57)
VFSPGA 0.24% (n=57)
LLTRGA 0.24% (n=56)
LFNPGP 0.23% (n=53)
LFSAGA 0.23% (n=53)
IFAPGP 0.23% (n=53)
IFNPGA 0.22% (n=52)
IFSVGS 0.22% (n=52)
LFSLGP 0.22% (n=51)
LFASGP 0.21% (n=49)
FFAPGA 0.21% (n=49)
LFQLGS 0.21% (n=48)
LLSTGA 0.20% (n=47)
LFAQGP 0.20% (n=46)
LFTLGS 0.20% (n=46)
LFNLGP 0.19% (n=45)
FLTQGP 0.19% (n=45)
IFSSGP 0.19% (n=45)
LFALGP 0.19% (n=45)
LFDRGA 0.19% (n=44)
FLAPGA 0.18% (n=43)
LFMTGA 0.18% (n=43)
FFSAGA 0.18% (n=42)
IFTSGP 0.18% (n=41)
FFSAGS 0.17% (n=40)
LLAPGP 0.17% (n=39)
FLSSGA 0.17% (n=39)
FFSVGA 0.17% (n=39)
LFNRGP 0.17% (n=39)
LFRVGP 0.17% (n=39)
IFSSGS 0.17% (n=39)
LFNLGS 0.16% (n=38)
WFERGA 0.16% (n=38)
FFTRGP 0.16% (n=37)
MFALGP 0.16% (n=37)
LFSTGA 0.15% (n=36)
LFSRGP 0.15% (n=36)
LFDTGA 0.15% (n=35)
LFNPGS 0.15% (n=35)
LFTVGA 0.15% (n=34)
FFKAGP 0.15% (n=34)
LLTSGP 0.14% (n=33)
MFHRGP 0.14% (n=33)
LFTFGP 0.14% (n=33)
LFTKGA 0.14% (n=32)
IFTRGP 0.14% (n=32)
IFTPGP 0.14% (n=32)
LFTAGS 0.14% (n=32)
LFHSGA 0.13% (n=31)
LFTAGP 0.13% (n=31)
FLSSGP 0.13% (n=31)
LFMPGA 0.13% (n=31)
LFAAGP 0.13% (n=31)
WFDPGP 0.13% (n=31)
FLNPGA 0.13% (n=30)
FFTQGA 0.12% (n=29)
LFDFGP 0.12% (n=29)
FLTRGP 0.12% (n=28)
IFSLGP 0.12% (n=28)
LFRSGA 0.12% (n=28)
LLKPGA 0.12% (n=27)
FLTAGP 0.12% (n=27)
LLTQGA 0.11% (n=26)
LFSIGP 0.11% (n=26)
IFNPGS 0.11% (n=26)
LFRSGP 0.11% (n=26)
LFSFGP 0.11% (n=26)
IFQPGA 0.11% (n=26)
LFLPGA 0.11% (n=26)
FFSRGP 0.11% (n=25)
FFQQGA 0.11% (n=25)
FLTLGA 0.11% (n=25)
LLSSGA 0.10% (n=24)
IFSSGA 0.10% (n=24)
VFAPGA 0.10% (n=24)
LFEPGA 0.10% (n=23)
LFNQGA 0.10% (n=23)
LFNSGP 0.10% (n=23)
LFQRGA 0.10% (n=23)
FFSRGA 0.10% (n=23)
LFDPGA 0.09% (n=22)
LFDLGP 0.09% (n=22)
IFASGP 0.09% (n=22)
FFNPGP 0.09% (n=20)
LFYRGA 0.09% (n=20)
LFRQGS 0.09% (n=20)
FLSFGP 0.09% (n=20)
FFTSGA 0.08% (n=19)
LFQPGS 0.08% (n=19)
LFDRGP 0.08% (n=19)
LFTQGS 0.08% (n=19)
FFDPGA 0.08% (n=18)
LFHPGP 0.08% (n=18)
IFSRGP 0.08% (n=18)
LFTSGS 0.08% (n=18)
LFHFGA 0.08% (n=18)
LFKPGA 0.07% (n=17)
FFTAGA 0.07% (n=17)
IFSPGS 0.07% (n=17)
FLSVGS 0.07% (n=17)
FLDRGP 0.07% (n=16)
LLQRGA 0.07% (n=16)
FFSQGP 0.07% (n=16)
LLRQGA 0.07% (n=16)
FFMQGP 0.07% (n=16)
IFSKGA 0.07% (n=16)
LFNLGA 0.07% (n=16)
FFASGP 0.07% (n=16)
LFQQGS 0.07% (n=16)
FLTSGP 0.06% (n=15)
LFNTGS 0.06% (n=15)
FFNAGP 0.06% (n=15)
LFQPGP 0.06% (n=15)
LFKLGP 0.06% (n=14)
FFKQGA 0.06% (n=14)
IFSAGP 0.06% (n=14)
LFTAGA 0.06% (n=14)
LFTRGS 0.06% (n=14)
FFALGP 0.06% (n=14)
FFDLGP 0.06% (n=14)
IFSQGP 0.06% (n=14)
LFKVGP 0.06% (n=14)
LFSVGA 0.06% (n=13)
MFSSGA 0.06% (n=13)
LFNMGP 0.06% (n=13)
LFQQGA 0.06% (n=13)
LLQPGA 0.06% (n=13)
IFSQGA 0.06% (n=13)
LFNVGP 0.06% (n=13)
LFISGP 0.06% (n=13)
MFTLGP 0.06% (n=13)
LFTPG- 0.06% (n=13)
IFNSGA 0.05% (n=12)
FLTRGA 0.05% (n=12)
FFRSGP 0.05% (n=12)
FFQLGA 0.05% (n=12)
LFSAGP 0.05% (n=12)
LLTTGA 0.05% (n=11)
LFSQGS 0.05% (n=11)
IFSAGA 0.05% (n=11)
FFNPGS 0.04% (n=10)
IFEPGA 0.04% (n=10)
ILQRGA 0.04% (n=10)
LLSQGA 0.04% (n=10)
IFNPGP 0.04% (n=10)
FFTRGA 0.04% (n=10)
FFSVGP 0.04% (n=10)
IFSMGA 0.04% (n=10)
LFRSGS 0.04% (n=10)
FFNVGP 0.04% (n=10)
LFTFGS 0.04% (n=10)
FLSRGP 0.04% (n=9)
FLQPGA 0.04% (n=9)
LLTPGS 0.04% (n=9)
LSAPGS 0.04% (n=9)
LFVLGP 0.04% (n=9)
FLTLGP 0.04% (n=9)
MFSSGP 0.04% (n=9)
LFKQGA 0.04% (n=9)
LFRVGA 0.04% (n=9)
IFSRGA 0.04% (n=9)
LFRQGP 0.04% (n=9)
FLARGP 0.04% (n=9)
FFRPGP 0.04% (n=9)
FFRAGP 0.04% (n=9)
LFNVGA 0.04% (n=9)
LFSRGG 0.04% (n=9)
IFRSGP 0.04% (n=9)
ILSPGA 0.03% (n=8)
LFRLGP 0.03% (n=8)
LLTLGP 0.03% (n=8)
LFELGP 0.03% (n=8)
LFSFGS 0.03% (n=8)
LLTTGP 0.03% (n=8)
MFSPGA 0.03% (n=7)
LFNQGP 0.03% (n=7)
FFRPGA 0.03% (n=7)
MFSVGP 0.03% (n=7)
IFALGP 0.03% (n=7)
MFTIGA 0.03% (n=7)
FFQTGP 0.03% (n=7)
LFVSGP 0.03% (n=7)
FFSRGS 0.03% (n=7)
LLSRGA 0.03% (n=6)
LFRLGA 0.03% (n=6)
LFNRGA 0.03% (n=6)
FLQRGP 0.03% (n=6)
FFTLGA 0.03% (n=6)
FFRQGP 0.03% (n=6)
LFRTGP 0.03% (n=6)
FFDMGA 0.03% (n=6)
FFQVGA 0.03% (n=6)
FFSLGA 0.03% (n=6)
LFRRGA 0.03% (n=6)
FFSFGA 0.03% (n=6)
LFASGS 0.03% (n=6)
FFSAGP 0.03% (n=6)
IFQSGA 0.02% (n=5)
MFSLGA 0.02% (n=5)
FFPPGP 0.02% (n=5)
PFNPGA 0.02% (n=5)
LFKLGA 0.02% (n=5)
LFRQGA 0.02% (n=5)
LFRTGA 0.02% (n=5)
LLNPGS 0.02% (n=5)
FFSTGP 0.02% (n=5)
FFNLGP 0.02% (n=5)
LLKRGA 0.02% (n=5)
LISPGA 0.02% (n=5)
MFSPGP 0.02% (n=5)
FFQRGA 0.02% (n=5)
LFDLGA 0.02% (n=5)
LLSPGS 0.02% (n=5)
FFNQGP 0.02% (n=5)
FFSQGS 0.02% (n=5)
FLSQGP 0.02% (n=5)
LFDMGP 0.02% (n=5)
FFTVGP 0.02% (n=5)
IFSTGP 0.02% (n=5)
LFLRGS 0.02% (n=5)
LFNFGS 0.02% (n=5)
LFRFGA 0.02% (n=5)
LFNFGP 0.02% (n=5)
VFSLGA 0.02% (n=5)
LFSPGT 0.02% (n=4)
LFSPGV 0.02% (n=4)
MFTPGA 0.02% (n=4)
FFRLGP 0.02% (n=4)
FFKLGP 0.02% (n=4)
LFDWGP 0.02% (n=4)
LFQRGS 0.02% (n=4)
LFVRGP 0.02% (n=4)
LLQQGA 0.02% (n=4)
LFGPGP 0.02% (n=4)
LLTVGP 0.02% (n=4)
LFRIGA 0.02% (n=4)
LFTKGP 0.02% (n=4)
LFNAGP 0.02% (n=4)
LFAVGS 0.02% (n=4)
MFRVGP 0.02% (n=4)
LFKVGA 0.02% (n=4)
FLSPGS 0.02% (n=4)
IFNVGA 0.02% (n=4)
LFDTGP 0.02% (n=4)
IFTQGP 0.02% (n=4)
FLAPGP 0.02% (n=4)
LFIPGP 0.02% (n=4)
LFTHGP 0.02% (n=4)
LFKPGP 0.02% (n=4)
FFSVGS 0.02% (n=4)
IFTLGP 0.02% (n=4)
-FTPGP 0.02% (n=4)
IFTAGA 0.02% (n=4)
LFHPGA 0.02% (n=4)
LFSYGA 0.02% (n=4)
VFSSGP 0.02% (n=4)
FPSPGP 0.02% (n=4)
LFKFGA 0.01% (n=3)
LFAIGP 0.01% (n=3)
LFARGP 0.01% (n=3)
LFNQGS 0.01% (n=3)
LFMPGP 0.01% (n=3)
LFSMGA 0.01% (n=3)
LFKPGS 0.01% (n=3)
ILTPGA 0.01% (n=3)
FFEPGS 0.01% (n=3)
LLTQGP 0.01% (n=3)
FLSTGP 0.01% (n=3)
LFSYGP 0.01% (n=3)
WLSQGP 0.01% (n=3)
VFTQGA 0.01% (n=3)
LFPPGA 0.01% (n=3)
FFDTGP 0.01% (n=3)
LLTTGS 0.01% (n=3)
LFEPGP 0.01% (n=3)
LFHLGP 0.01% (n=3)
LLNPGA 0.01% (n=3)
LLAVGP 0.01% (n=3)
LLRQGP 0.01% (n=3)
LFNRGS 0.01% (n=3)
FWSPGA 0.01% (n=3)
LFTPGT 0.01% (n=3)
LFKTGA 0.01% (n=3)
PFTPGA 0.01% (n=3)
VFTPGA 0.01% (n=3)
LLTAGS 0.01% (n=3)
LFKAGS 0.01% (n=3)
MFASGP 0.01% (n=3)
LLARGP 0.01% (n=3)
FFEPGP 0.01% (n=3)
WFSPGS 0.01% (n=3)
LFNFGA 0.01% (n=3)
FFIQGP 0.01% (n=3)
LFRHGP 0.01% (n=3)
LFPPGS 0.01% (n=3)
LFSPG- 0.01% (n=3)
VFSSGA 0.01% (n=3)
LLASGA 0.01% (n=2)
FLSVGP 0.01% (n=2)
IFDPGA 0.01% (n=2)
LFDQGA 0.01% (n=2)
LFKTGP 0.01% (n=2)
IFNAGP 0.01% (n=2)
IFKQGA 0.01% (n=2)
LLTIGP 0.01% (n=2)
LFSEGA 0.01% (n=2)
FSSPGA 0.01% (n=2)
FLDRGA 0.01% (n=2)
MLQPGA 0.01% (n=2)
LFRPGS 0.01% (n=2)
TFSPGA 0.01% (n=2)
LFNAGA 0.01% (n=2)
LFVPGA 0.01% (n=2)
IFTTGA 0.01% (n=2)
MFSTGS 0.01% (n=2)
LFSIGA 0.01% (n=2)
LFIPGA 0.01% (n=2)
MFSLGP 0.01% (n=2)
FLMPGA 0.01% (n=2)
FLAPGS 0.01% (n=2)
MFSTGA 0.01% (n=2)
IFNLGP 0.01% (n=2)
FLTPGP 0.01% (n=2)
LLSFGP 0.01% (n=2)
LFRMGP 0.01% (n=2)
FLNRGP 0.01% (n=2)
IFSTGA 0.01% (n=2)
LFDSGP 0.01% (n=2)
LFQTGA 0.01% (n=2)
MFSQGP 0.01% (n=2)
IFRPGP 0.01% (n=2)
LLSVGP 0.01% (n=2)
LLTLGA 0.01% (n=2)
FFRRGA 0.01% (n=2)
LFVQGP 0.01% (n=2)
LFKRGP 0.01% (n=2)
LFTTGS 0.01% (n=2)
LFAVGA 0.01% (n=2)
PLTPGA 0.01% (n=2)
LFTIGP 0.01% (n=2)
LFTQDP 0.01% (n=2)
LPAPGA 0.01% (n=2)
IFDLGP 0.01% (n=2)
FLSKGP 0.01% (n=2)
FFSSGR 0.01% (n=2)
FFTVGA 0.01% (n=2)
LFDRDA 0.01% (n=2)
LFKSGA 0.01% (n=2)
FFTKGA 0.01% (n=2)
FFNMGP 0.01% (n=2)
FFDMGP 0.01% (n=2)
MFHQGP 0.01% (n=2)
LFDTGS 0.01% (n=2)
LFRAGP 0.01% (n=2)
LFDVGP 0.01% (n=2)
LLSAGP 0.01% (n=2)
FFTTGP 0.01% (n=2)
FLDPGS 0.01% (n=2)
LLSLGP 0.01% (n=2)
PFTPGP 0.01% (n=2)
LFNTGA 0.01% (n=2)
FFTRGS 0.01% (n=2)
FFTPGS 0.01% (n=2)
IFDRGA 0.01% (n=2)
LFHTGP 0.01% (n=2)
FFLSGP 0.01% (n=2)
LFASGA 0.01% (n=2)
FLTKGP 0.01% (n=2)
WLSPGA 0.01% (n=2)
IFTPGS 0.01% (n=2)
LSTSGA 0.01% (n=2)
PFTSGA 0.01% (n=2)
LFTSWA 0.01% (n=2)
FFGPGA 0.01% (n=2)
IFSPGV 0.01% (n=2)
LLAAGP 0.01% (n=2)
FFAVGP 0.01% (n=2)
MFSDGP 0.01% (n=2)
MFTSGP 0.01% (n=2)
LFKRGS 0.01% (n=2)
MFSRGP 0.01% (n=2)
MFSTGP 0.01% (n=2)
LFQKGS 0.01% (n=2)
LFQFGA 0.01% (n=2)
LFDRGS 0.01% (n=2)
FFATGP 0.01% (n=2)
WFAPGS 0.01% (n=2)
LFDHGP 0.01% (n=2)
MLAPGP 0.01% (n=2)
LLSSGP 0.01% (n=2)
----GP 0.01% (n=2)
IFQSGP 0.01% (n=2)
LFTLG- 0.01% (n=2)
LFQAGS 0.01% (n=2)
FFSHGP 0.01% (n=2)
FFSLGS 0.01% (n=2)
FFAAGS 0.01% (n=2)
LFALGS 0.01% (n=2)
LFRIGP 0.01% (n=2)
LFKIGP 0.01% (n=2)
-FSSGP 0.01% (n=2)
VFSPGS 0.01% (n=2)
LFRLGS 0.01% (n=2)
LFPAGS 0.01% (n=2)
PFSAGS 0.01% (n=2)
WFHQGP 0.01% (n=2)
PFSLGS 0.01% (n=2)
FFDPEP 0.01% (n=2)
IFSFGA 0.01% (n=2)
LFAQGS 0.01% (n=2)
LFPAGA 0.00% (n=1)
LFDVGA 0.00% (n=1)
FFSPCP 0.00% (n=1)
FSSPGP 0.00% (n=1)
FFSKGP 0.00% (n=1)
TFTSGA 0.00% (n=1)
PFNQGA 0.00% (n=1)
PFAPGA 0.00% (n=1)
LFGQGA 0.00% (n=1)
LLSPGV 0.00% (n=1)
LFNIGP 0.00% (n=1)
MFALGA 0.00% (n=1)
LLDRGP 0.00% (n=1)
ILAPGA 0.00% (n=1)
LFESGP 0.00% (n=1)
SFNPGA 0.00% (n=1)
FSNPGA 0.00% (n=1)
LFSQAP 0.00% (n=1)
LIEPGA 0.00% (n=1)
FFEPGA 0.00% (n=1)
LFNQGL 0.00% (n=1)
PFHSGA 0.00% (n=1)
LFQPSS 0.00% (n=1)
SFAPGP 0.00% (n=1)
FLSMGP 0.00% (n=1)
IWTPGP 0.00% (n=1)
FFSPGG 0.00% (n=1)
LFAAGA 0.00% (n=1)
PFTAGA 0.00% (n=1)
LFQQDA 0.00% (n=1)
LFRAGA 0.00% (n=1)
VFSQGA 0.00% (n=1)
LLNQGA 0.00% (n=1)
LFRPDP 0.00% (n=1)
LSRPGP 0.00% (n=1)
LLRPGP 0.00% (n=1)
LYTLGA 0.00% (n=1)
PFTLGA 0.00% (n=1)
LFRPGL 0.00% (n=1)
FPTLGP 0.00% (n=1)
LLLPGA 0.00% (n=1)
LIMPGA 0.00% (n=1)
IFQTGA 0.00% (n=1)
FFNLGS 0.00% (n=1)
LFRQGL 0.00% (n=1)
LF-NGP 0.00% (n=1)
FPTPGA 0.00% (n=1)
FLRPGA 0.00% (n=1)
VFSNGP 0.00% (n=1)
IFKPGA 0.00% (n=1)
FFSIGA 0.00% (n=1)
VFDSGP 0.00% (n=1)
LFEIGP 0.00% (n=1)
LFRKGA 0.00% (n=1)
LFRRGP 0.00% (n=1)
LFGPGA 0.00% (n=1)
LLQSGP 0.00% (n=1)
FFKPGP 0.00% (n=1)
FFLPGP 0.00% (n=1)
LLSVGA 0.00% (n=1)
FFDVGP 0.00% (n=1)
LFNVGS 0.00% (n=1)
LLQAGP 0.00% (n=1)
FLSVGA 0.00% (n=1)
LLSMGP 0.00% (n=1)
FFARGS 0.00% (n=1)
FFRVGP 0.00% (n=1)
MLTRGP 0.00% (n=1)
LFYPGP 0.00% (n=1)
LFTPGH 0.00% (n=1)
LITPGS 0.00% (n=1)
MFQRGS 0.00% (n=1)
FFTTGA 0.00% (n=1)
FLSQGA 0.00% (n=1)
FFKTGA 0.00% (n=1)
LLTQGS 0.00% (n=1)
ILNPGA 0.00% (n=1)
MFTTGS 0.00% (n=1)
LLSTGS 0.00% (n=1)
LLTTDA 0.00% (n=1)
FFRLGA 0.00% (n=1)
IFNTGP 0.00% (n=1)
FFVQGP 0.00% (n=1)
LFKSGP 0.00% (n=1)
MFNSGS 0.00% (n=1)
LFKRGA 0.00% (n=1)
L----- 0.00% (n=1)
LFHTGA 0.00% (n=1)
LFSMGP 0.00% (n=1)
FLAHGP 0.00% (n=1)
FLQPGP 0.00% (n=1)
LFAQGA 0.00% (n=1)
LLQVGP 0.00% (n=1)
FLALGP 0.00% (n=1)
LFHAGA 0.00% (n=1)
FFNTGP 0.00% (n=1)
IFNQGA 0.00% (n=1)
FFVAGP 0.00% (n=1)
IFQPGS 0.00% (n=1)
FFKPGA 0.00% (n=1)
FLMQGP 0.00% (n=1)
MFGVGP 0.00% (n=1)
LFKIGA 0.00% (n=1)
FFLPGA 0.00% (n=1)
FFSPGT 0.00% (n=1)
FFDAGP 0.00% (n=1)
LFGTGP 0.00% (n=1)
LLRVGP 0.00% (n=1)
FLTPGS 0.00% (n=1)
FLPPGS 0.00% (n=1)
LLTLGS 0.00% (n=1)
VFTPGS 0.00% (n=1)
IFTRGA 0.00% (n=1)
LVSPGA 0.00% (n=1)
LFPSGA 0.00% (n=1)
FFHRGP 0.00% (n=1)
MFMDGP 0.00% (n=1)
IFSEGA 0.00% (n=1)
LLSQGP 0.00% (n=1)
-FNPGA 0.00% (n=1)
LF*PGA 0.00% (n=1)
PFDTGA 0.00% (n=1)
FLSIGA 0.00% (n=1)
MFSAGP 0.00% (n=1)
HVPPGA 0.00% (n=1)
LFNPGH 0.00% (n=1)
LFIRGA 0.00% (n=1)
FFSTGA 0.00% (n=1)
LFARGA 0.00% (n=1)
LFTVGS 0.00% (n=1)
IFRMGA 0.00% (n=1)
LFHPGH 0.00% (n=1)
LFQSGS 0.00% (n=1)
LFHSGS 0.00% (n=1)
FFASGA 0.00% (n=1)
HFTPGS 0.00% (n=1)
LFHQGA 0.00% (n=1)
LFHVGP 0.00% (n=1)
LFETGP 0.00% (n=1)
MFTRGA 0.00% (n=1)
LFTTSA 0.00% (n=1)
LLTVGA 0.00% (n=1)
FL---- 0.00% (n=1)
IFNIGP 0.00% (n=1)
ISSVGP 0.00% (n=1)
VFSAGA 0.00% (n=1)
FFDSGP 0.00% (n=1)
WFTRGA 0.00% (n=1)
LFS--- 0.00% (n=1)
MFQLGP 0.00% (n=1)
WFNQGA 0.00% (n=1)
LWSSGA 0.00% (n=1)
LFLQGA 0.00% (n=1)
FLRQGP 0.00% (n=1)
FFHQGP 0.00% (n=1)
FFNEGP 0.00% (n=1)
LFAFGA 0.00% (n=1)
LSTPGA 0.00% (n=1)
FFDQGP 0.00% (n=1)
FFYRGP 0.00% (n=1)
FSDRGP 0.00% (n=1)
LFTPSA 0.00% (n=1)
LPSPGA 0.00% (n=1)
LLGPGA 0.00% (n=1)
LLSPGT 0.00% (n=1)
LFEVGP 0.00% (n=1)
LFDQGP 0.00% (n=1)
LLRPGA 0.00% (n=1)
LFDSGA 0.00% (n=1)
ILSTGP 0.00% (n=1)
FFIRGP 0.00% (n=1)
FFTLSP 0.00% (n=1)
IFSPDA 0.00% (n=1)
LFSKGA 0.00% (n=1)
FFNKGA 0.00% (n=1)
IFEPGS 0.00% (n=1)
WWSPGA 0.00% (n=1)
LFQVGA 0.00% (n=1)
LFISGA 0.00% (n=1)
MFAFGP 0.00% (n=1)
LFTCGP 0.00% (n=1)
IFAAGP 0.00% (n=1)
IFMPGP 0.00% (n=1)
LFQSEP 0.00% (n=1)
FLTVGP 0.00% (n=1)
MFSFGS 0.00% (n=1)
LFNAGS 0.00% (n=1)
FSQLGV 0.00% (n=1)
LFYSGP 0.00% (n=1)
LLTFGP 0.00% (n=1)
SFSPGA 0.00% (n=1)
WLARGP 0.00% (n=1)
IFDLGS 0.00% (n=1)
MFTRGS 0.00% (n=1)
ILTRGP 0.00% (n=1)
LFDFGA 0.00% (n=1)
FFAPGS 0.00% (n=1)
LFTCGA 0.00% (n=1)
FFSCGP 0.00% (n=1)
FFSSRA 0.00% (n=1)
IFSPGG 0.00% (n=1)
LFSTGR 0.00% (n=1)
FFPPGS 0.00% (n=1)
LFIAGP 0.00% (n=1)
LFTMGS 0.00% (n=1)
LFKFGP 0.00% (n=1)
MFKLGS 0.00% (n=1)
LLSTGP 0.00% (n=1)
LLVSGP 0.00% (n=1)
LFGSGP 0.00% (n=1)
LFRFGS 0.00% (n=1)
ILTAGP 0.00% (n=1)
FFSMGS 0.00% (n=1)
IFQLGP 0.00% (n=1)
LFSMGS 0.00% (n=1)
LFYRGP 0.00% (n=1)
ILSSGP 0.00% (n=1)
FFKQGP 0.00% (n=1)
GLTSGP 0.00% (n=1)
ILSPGP 0.00% (n=1)
FLRAGP 0.00% (n=1)
VFSAGP 0.00% (n=1)
FFSHGA 0.00% (n=1)
FFARGP 0.00% (n=1)
LIRVGP 0.00% (n=1)
MFNFGP 0.00% (n=1)
MFSFGP 0.00% (n=1)
IFDSGP 0.00% (n=1)
LFQLGA 0.00% (n=1)
IFCSGP 0.00% (n=1)
MFSSGS 0.00% (n=1)
PFSSGP 0.00% (n=1)
LFTLEP 0.00% (n=1)
IFSFGS 0.00% (n=1)
FFLRGP 0.00% (n=1)
IFDPGP 0.00% (n=1)
FFKVGP 0.00% (n=1)
LFHSGP 0.00% (n=1)
MFNPGP 0.00% (n=1)
LLNPGP 0.00% (n=1)
LFAFGP 0.00% (n=1)
LLAHGP 0.00% (n=1)
LFSLG- 0.00% (n=1)
LFATGS 0.00% (n=1)
LFSHGP 0.00% (n=1)
LCIPGP 0.00% (n=1)
SFHVG- 0.00% (n=1)
LFTSGV 0.00% (n=1)
FLHLG- 0.00% (n=1)
FFSFGP 0.00% (n=1)
LFPLG- 0.00% (n=1)
-LRVGP 0.00% (n=1)
-LSPGP 0.00% (n=1)
-FSFGA 0.00% (n=1)
FFTFGA 0.00% (n=1)
SFTSGP 0.00% (n=1)
LFATGP 0.00% (n=1)
LFTPGL 0.00% (n=1)
IFDRGP 0.00% (n=1)
LFSYGS 0.00% (n=1)
FLARWA 0.00% (n=1)
LFVTGP 0.00% (n=1)
VLSPGA 0.00% (n=1)
WFSPGA 0.00% (n=1)
MFSVGS 0.00% (n=1)
IFAAGS 0.00% (n=1)
LFTCGS 0.00% (n=1)
LFRVGS 0.00% (n=1)
LFHLGA 0.00% (n=1)
IFSRGS 0.00% (n=1)
LSTSRP 0.00% (n=1)
LLSAGS 0.00% (n=1)
LFKAGP 0.00% (n=1)
WFRQEP 0.00% (n=1)
PFSPGS 0.00% (n=1)
TFSVGS 0.00% (n=1)
LFSPGL 0.00% (n=1)
IFSPEP 0.00% (n=1)
IFSPRP 0.00% (n=1)
PFAPGP 0.00% (n=1)
FFGPGP 0.00% (n=1)
FFYPGP 0.00% (n=1)
SFSVGA 0.00% (n=1)
MFPFGA 0.00% (n=1)
IFSVGP 0.00% (n=1)
MFSVGA 0.00% (n=1)
IFPVGA 0.00% (n=1)
FLSPWP 0.00% (n=1)
FRSPGP 0.00% (n=1)
FLSPGL 0.00% (n=1)
LSSSGA 0.00% (n=1)
LFSSGT 0.00% (n=1)
IFVPGP 0.00% (n=1)
LYTPGS 0.00% (n=1)
PFTPGS 0.00% (n=1)
LFSIGR 0.00% (n=1)
LFMPGQ 0.00% (n=1)
LLTHGP 0.00% (n=1)
LYTRGP 0.00% (n=1)
LLDIGP 0.00% (n=1)
FFYPGA 0.00% (n=1)
LFTMGP 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 1a:

LFSPGA 10.36% (n=1410)
LFTPGA 4.67% (n=636)
LFNPGA 4.66% (n=634)
FFQPGA 3.06% (n=417)
LLTPGA 2.72% (n=370)
LLSPGA 2.64% (n=360)
FFSPGA 2.26% (n=307)
IFSPGA 2.00% (n=272)
LFMSGA 1.97% (n=268)
LFNSGA 1.87% (n=254)
LFRPGA 1.86% (n=253)
LFSSGA 1.79% (n=244)
LFAAGS 1.67% (n=227)
LFTRGA 1.65% (n=225)
LFTSGA 1.59% (n=217)
FFSPGP 1.47% (n=200)
LFTQGA 1.38% (n=188)
LFLQGP 1.34% (n=183)
LFSQGA 1.25% (n=170)
FFDRGP 1.18% (n=161)
LFSPGP 1.18% (n=160)
LLSRGP 1.12% (n=152)
LFQPGA 1.06% (n=144)
LFAPGA 1.06% (n=144)
LFQLGP 1.04% (n=141)
LFTPGP 0.99% (n=135)
FFTPGA 0.90% (n=122)
LLAPGA 0.76% (n=104)
FLTPGA 0.74% (n=101)
LFTLGA 0.72% (n=98)
LFTTGA 0.72% (n=98)
LLSLGA 0.65% (n=89)
LFRPGP 0.65% (n=88)
FLTQGA 0.60% (n=81)
LFTSGP 0.56% (n=76)
MFAPGA 0.56% (n=76)
IFAPGA 0.55% (n=75)
FFSQGA 0.55% (n=75)
IFSPGP 0.54% (n=74)
LFSRGA 0.53% (n=72)
LFSSGP 0.53% (n=72)
FFNPGA 0.50% (n=68)
LFTQGP 0.49% (n=67)
MFMNGP 0.48% (n=65)
LFNTGP 0.47% (n=64)
LFMRGP 0.47% (n=64)
LLTRGP 0.46% (n=63)
FFHLGP 0.46% (n=63)
LLTSGA 0.46% (n=62)
LFSRGS 0.43% (n=59)
LLTRGA 0.41% (n=56)
FLSPGA 0.40% (n=54)
LFAPGS 0.40% (n=54)
IFNPGA 0.38% (n=52)
LFTRGP 0.38% (n=52)
FLSLGP 0.38% (n=52)
FFSSGA 0.38% (n=52)
FFAPGP 0.37% (n=51)
LFTTGP 0.37% (n=50)
LFSTGP 0.36% (n=49)
LFQLGS 0.35% (n=48)
LLSPGP 0.35% (n=47)
LLSTGA 0.35% (n=47)
LFAQGP 0.34% (n=46)
LLTPGP 0.34% (n=46)
FLTQGP 0.33% (n=45)
LFNPGP 0.33% (n=45)
FLSPGP 0.33% (n=45)
LFMTGA 0.32% (n=43)
LFDRGA 0.32% (n=43)
FLAPGA 0.29% (n=40)
FFSAGA 0.29% (n=40)
LFALGP 0.29% (n=40)
FLSSGA 0.29% (n=39)
WFERGA 0.28% (n=38)
FFTLGP 0.27% (n=37)
LFDTGA 0.26% (n=35)
LFQSGA 0.26% (n=35)
FFKAGP 0.25% (n=34)
LFTLGP 0.24% (n=33)
FFTQGP 0.24% (n=33)
MFHRGP 0.24% (n=33)
LFTPGS 0.24% (n=32)
LFTKGA 0.24% (n=32)
LFSQGP 0.24% (n=32)
LFHSGA 0.23% (n=31)
IFTRGP 0.23% (n=31)
LFSRGP 0.22% (n=30)
LFMPGA 0.22% (n=30)
FLNPGA 0.22% (n=30)
LFSAGA 0.21% (n=29)
LLAPGP 0.21% (n=29)
FFTQGA 0.21% (n=28)
FFTRGP 0.20% (n=27)
LLKPGA 0.20% (n=27)
IFSLGP 0.20% (n=27)
LFRSGA 0.20% (n=27)
LFSPGS 0.19% (n=26)
LLTQGA 0.19% (n=26)
FFAPGA 0.19% (n=26)
IFQPGA 0.19% (n=26)
FFQQGA 0.18% (n=25)
FFTPGP 0.18% (n=25)
FLTLGA 0.18% (n=25)
LFLPGA 0.18% (n=25)
LFSTGA 0.18% (n=24)
LFAPGP 0.18% (n=24)
LLSSGA 0.18% (n=24)
LFEPGA 0.17% (n=23)
LFNQGA 0.17% (n=23)
LFQRGA 0.17% (n=23)
LFRSGP 0.15% (n=21)
FFSRGA 0.15% (n=20)
LFYRGA 0.15% (n=20)
LFDRGP 0.14% (n=19)
LFNSGP 0.14% (n=19)
LFNLGP 0.13% (n=18)
FFDPGA 0.12% (n=17)
LFNPGS 0.12% (n=17)
LFHPGP 0.12% (n=17)
FFNPGP 0.12% (n=17)
IFSRGP 0.12% (n=17)
IFAPGP 0.12% (n=17)
FLTRGP 0.12% (n=16)
IFTPGA 0.12% (n=16)
FLDRGP 0.12% (n=16)
LLQRGA 0.12% (n=16)
FFSQGP 0.12% (n=16)
LFDLGP 0.12% (n=16)
LFQPGS 0.12% (n=16)
LLRQGA 0.12% (n=16)
FFTAGA 0.12% (n=16)
FFMQGP 0.12% (n=16)
IFSKGA 0.12% (n=16)
LFTFGA 0.11% (n=15)
LFNTGS 0.11% (n=15)
FFNAGP 0.11% (n=15)
LFSLGA 0.10% (n=14)
FFKQGA 0.10% (n=14)
FFDLGP 0.10% (n=14)
LFQPGP 0.10% (n=14)
LFNMGP 0.10% (n=13)
LFQQGA 0.10% (n=13)
LLQPGA 0.10% (n=13)
IFSQGP 0.10% (n=13)
LFKPGA 0.09% (n=12)
FLTRGA 0.09% (n=12)
IFSQGA 0.09% (n=12)
FFRSGP 0.08% (n=11)
LLTTGA 0.08% (n=11)
LFDPGA 0.08% (n=11)
FFSRGP 0.07% (n=10)
IFEPGA 0.07% (n=10)
ILQRGA 0.07% (n=10)
LFSQGS 0.07% (n=10)
LFTVGA 0.07% (n=10)
LLSQGA 0.07% (n=10)
IFNPGP 0.07% (n=10)
FFTRGA 0.07% (n=10)
IFSPGS 0.07% (n=10)
LFNVGP 0.07% (n=10)
FFTAGP 0.07% (n=10)
IFSMGA 0.07% (n=10)
LFSVGP 0.07% (n=9)
FLQPGA 0.07% (n=9)
LLTPGS 0.07% (n=9)
LSAPGS 0.07% (n=9)
LFVLGP 0.07% (n=9)
IFSRGA 0.07% (n=9)
LFRQGP 0.07% (n=9)
FFRPGP 0.07% (n=9)
LFSVGA 0.06% (n=8)
FFNPGS 0.06% (n=8)
LFELGP 0.06% (n=8)
FLTLGP 0.06% (n=8)
LFKQGA 0.06% (n=8)
LFRVGA 0.06% (n=8)
IFSSGP 0.06% (n=8)
LLTTGP 0.06% (n=8)
LFNRGP 0.06% (n=8)
FLSRGP 0.05% (n=7)
LLTSGP 0.05% (n=7)
LFNQGP 0.05% (n=7)
FFRPGA 0.05% (n=7)
LFTAGA 0.05% (n=7)
LFTVGP 0.05% (n=7)
IFTSGP 0.05% (n=7)
MFTIGA 0.05% (n=7)
FFQTGP 0.05% (n=7)
LLSRGA 0.04% (n=6)
ILSPGA 0.04% (n=6)
LFRLGA 0.04% (n=6)
MFSPGA 0.04% (n=6)
LFNRGA 0.04% (n=6)
LFASGP 0.04% (n=6)
FLQRGP 0.04% (n=6)
FLSSGP 0.04% (n=6)
FFRQGP 0.04% (n=6)
LFRTGP 0.04% (n=6)
FFDMGA 0.04% (n=6)
FFQVGA 0.04% (n=6)
IFQSGA 0.04% (n=5)
MFSLGA 0.04% (n=5)
FFSSGP 0.04% (n=5)
PFNPGA 0.04% (n=5)
LFKLGA 0.04% (n=5)
LFRQGA 0.04% (n=5)
LFRTGA 0.04% (n=5)
LLNPGS 0.04% (n=5)
FFTSGA 0.04% (n=5)
LFTAGP 0.04% (n=5)
LLKRGA 0.04% (n=5)
LISPGA 0.04% (n=5)
FFTLGA 0.04% (n=5)
FFQRGA 0.04% (n=5)
LFTRGS 0.04% (n=5)
FFALGP 0.04% (n=5)
FLSQGP 0.04% (n=5)
LFDMGP 0.04% (n=5)
LFSPGT 0.03% (n=4)
LFKLGP 0.03% (n=4)
LFSPGV 0.03% (n=4)
MFSSGA 0.03% (n=4)
FFRLGP 0.03% (n=4)
FFKLGP 0.03% (n=4)
LFDWGP 0.03% (n=4)
LLQQGA 0.03% (n=4)
LFGPGP 0.03% (n=4)
LFRIGA 0.03% (n=4)
LFSLGP 0.03% (n=4)
MFSPGP 0.03% (n=4)
LFTSGS 0.03% (n=4)
FFNQGP 0.03% (n=4)
FFSQGS 0.03% (n=4)
MFRVGP 0.03% (n=4)
LFKVGA 0.03% (n=4)
IFNVGA 0.03% (n=4)
LFDTGP 0.03% (n=4)
MFTPGA 0.02% (n=3)
LFKFGA 0.02% (n=3)
LFAIGP 0.02% (n=3)
LFSIGP 0.02% (n=3)
LLTLGP 0.02% (n=3)
LFNQGS 0.02% (n=3)
IFSLGA 0.02% (n=3)
LFSAGP 0.02% (n=3)
LLTVGP 0.02% (n=3)
LFSMGA 0.02% (n=3)
ILTPGA 0.02% (n=3)
LLSPGS 0.02% (n=3)
FFEPGS 0.02% (n=3)
IFSSGA 0.02% (n=3)
VFTQGA 0.02% (n=3)
LFPPGA 0.02% (n=3)
FFDTGP 0.02% (n=3)
LLTTGS 0.02% (n=3)
FLSPGS 0.02% (n=3)
LFEPGP 0.02% (n=3)
LFHLGP 0.02% (n=3)
FFTSGP 0.02% (n=3)
LLNPGA 0.02% (n=3)
FLAPGP 0.02% (n=3)
LLRQGP 0.02% (n=3)
FWSPGA 0.02% (n=3)
LFIPGP 0.02% (n=3)
LFKTGA 0.02% (n=3)
FFSVGS 0.02% (n=3)
LLASGA 0.01% (n=2)
IFNSGA 0.01% (n=2)
FLSVGP 0.01% (n=2)
IFNPGS 0.01% (n=2)
IFDPGA 0.01% (n=2)
LFDQGA 0.01% (n=2)
LFKTGP 0.01% (n=2)
IFSAGP 0.01% (n=2)
IFNAGP 0.01% (n=2)
IFKQGA 0.01% (n=2)
FFNLGP 0.01% (n=2)
LFQRGS 0.01% (n=2)
LLTIGP 0.01% (n=2)
LFSEGA 0.01% (n=2)
FSSPGA 0.01% (n=2)
FFDPGP 0.01% (n=2)
LFVRGP 0.01% (n=2)
FLDRGA 0.01% (n=2)
MLQPGA 0.01% (n=2)
LFRPGS 0.01% (n=2)
TFSPGA 0.01% (n=2)
LFNAGA 0.01% (n=2)
LFSVGS 0.01% (n=2)
IFTTGA 0.01% (n=2)
MFSTGS 0.01% (n=2)
LFSIGA 0.01% (n=2)
LFIPGA 0.01% (n=2)
MFSLGP 0.01% (n=2)
FLMPGA 0.01% (n=2)
FLAPGS 0.01% (n=2)
LFKPGS 0.01% (n=2)
MFTSGA 0.01% (n=2)
LFDLGA 0.01% (n=2)
LFTKGP 0.01% (n=2)
FLTPGP 0.01% (n=2)
LLSFGP 0.01% (n=2)
LFRMGP 0.01% (n=2)
FLNRGP 0.01% (n=2)
IFSTGA 0.01% (n=2)
LFDSGP 0.01% (n=2)
LFQTGA 0.01% (n=2)
MFSQGP 0.01% (n=2)
LLTQGP 0.01% (n=2)
MFSVGP 0.01% (n=2)
LFNLGS 0.01% (n=2)
LLSVGP 0.01% (n=2)
LLTLGA 0.01% (n=2)
FFRRGA 0.01% (n=2)
LFKRGP 0.01% (n=2)
LFTTGS 0.01% (n=2)
LFNAGP 0.01% (n=2)
LFAVGA 0.01% (n=2)
PLTPGA 0.01% (n=2)
LFTQDP 0.01% (n=2)
LPAPGA 0.01% (n=2)
IFDLGP 0.01% (n=2)
FLSKGP 0.01% (n=2)
FFSSGR 0.01% (n=2)
FFSPGS 0.01% (n=2)
IFALGP 0.01% (n=2)
FFTVGA 0.01% (n=2)
FFSVGA 0.01% (n=2)
LFDRDA 0.01% (n=2)
LFTQGS 0.01% (n=2)
LFKSGA 0.01% (n=2)
LFNLGA 0.01% (n=2)
FFTKGA 0.01% (n=2)
FFNMGP 0.01% (n=2)
FFDMGP 0.01% (n=2)
MFHQGP 0.01% (n=2)
LFDTGS 0.01% (n=2)
FFRAGP 0.01% (n=2)
LFRAGP 0.01% (n=2)
LFDVGP 0.01% (n=2)
IFTQGP 0.01% (n=2)
LFSAGS 0.01% (n=2)
FLDPGS 0.01% (n=2)
LFNRGS 0.01% (n=2)
LFTPGT 0.01% (n=2)
IFDRGA 0.01% (n=2)
PFTPGA 0.01% (n=2)
LFHTGP 0.01% (n=2)
FFLSGP 0.01% (n=2)
FLTKGP 0.01% (n=2)
WLSPGA 0.01% (n=2)
LFRRGA 0.01% (n=2)
LFPAGA 0.01% (n=1)
LFDVGA 0.01% (n=1)
FFSPCP 0.01% (n=1)
FSSPGP 0.01% (n=1)
FFPPGP 0.01% (n=1)
FFSKGP 0.01% (n=1)
TFTSGA 0.01% (n=1)
PFNQGA 0.01% (n=1)
PFAPGA 0.01% (n=1)
LFGQGA 0.01% (n=1)
LLSPGV 0.01% (n=1)
LFARGP 0.01% (n=1)
FFSTGP 0.01% (n=1)
LFNIGP 0.01% (n=1)
MFALGA 0.01% (n=1)
LLDRGP 0.01% (n=1)
ILAPGA 0.01% (n=1)
LFRLGP 0.01% (n=1)
LFESGP 0.01% (n=1)
SFNPGA 0.01% (n=1)
FSNPGA 0.01% (n=1)
LFSQAP 0.01% (n=1)
LIEPGA 0.01% (n=1)
FFEPGA 0.01% (n=1)
LFNQGL 0.01% (n=1)
FFQLGA 0.01% (n=1)
PFHSGA 0.01% (n=1)
LFQPSS 0.01% (n=1)
SFAPGP 0.01% (n=1)
FLSMGP 0.01% (n=1)
IWTPGP 0.01% (n=1)
FFSPGG 0.01% (n=1)
LFAAGA 0.01% (n=1)
PFTAGA 0.01% (n=1)
LFQQDA 0.01% (n=1)
LFRAGA 0.01% (n=1)
VFSQGA 0.01% (n=1)
LLNQGA 0.01% (n=1)
LFRPDP 0.01% (n=1)
LSRPGP 0.01% (n=1)
LLRPGP 0.01% (n=1)
LYTLGA 0.01% (n=1)
PFTLGA 0.01% (n=1)
LFRPGL 0.01% (n=1)
LFMPGP 0.01% (n=1)
FPTLGP 0.01% (n=1)
LLLPGA 0.01% (n=1)
LIMPGA 0.01% (n=1)
MFSSGP 0.01% (n=1)
LFVPGA 0.01% (n=1)
IFQTGA 0.01% (n=1)
IFSVGA 0.01% (n=1)
FFNLGS 0.01% (n=1)
LFRQGL 0.01% (n=1)
IFASGP 0.01% (n=1)
LF-NGP 0.01% (n=1)
FPTPGA 0.01% (n=1)
FLRPGA 0.01% (n=1)
VFSNGP 0.01% (n=1)
IFKPGA 0.01% (n=1)
MFSTGA 0.01% (n=1)
FFSIGA 0.01% (n=1)
VFDSGP 0.01% (n=1)
LFEIGP 0.01% (n=1)
LFRKGA 0.01% (n=1)
LFRRGP 0.01% (n=1)
LFGPGA 0.01% (n=1)
IFNLGP 0.01% (n=1)
LFSFGP 0.01% (n=1)
LLQSGP 0.01% (n=1)
FFKPGP 0.01% (n=1)
FFLPGP 0.01% (n=1)
LLSVGA 0.01% (n=1)
FFDVGP 0.01% (n=1)
LFNVGS 0.01% (n=1)
LLQAGP 0.01% (n=1)
FLSVGA 0.01% (n=1)
LLSMGP 0.01% (n=1)
FFARGS 0.01% (n=1)
FFRVGP 0.01% (n=1)
MLTRGP 0.01% (n=1)
LFYPGP 0.01% (n=1)
LFSLGS 0.01% (n=1)
FFSVGP 0.01% (n=1)
LFTPGH 0.01% (n=1)
LITPGS 0.01% (n=1)
MFQRGS 0.01% (n=1)
FFTTGA 0.01% (n=1)
IFRPGP 0.01% (n=1)
FLSQGA 0.01% (n=1)
FFKTGA 0.01% (n=1)
LLTQGS 0.01% (n=1)
ILNPGA 0.01% (n=1)
MFTTGS 0.01% (n=1)
LLSTGS 0.01% (n=1)
LLTTDA 0.01% (n=1)
FFRLGA 0.01% (n=1)
IFNTGP 0.01% (n=1)
FLSTGP 0.01% (n=1)
FFVQGP 0.01% (n=1)
LFKSGP 0.01% (n=1)
MFNSGS 0.01% (n=1)
LFSFGS 0.01% (n=1)
LFKRGA 0.01% (n=1)
L----- 0.01% (n=1)
LFHTGA 0.01% (n=1)
LFSMGP 0.01% (n=1)
FLAHGP 0.01% (n=1)
FLQPGP 0.01% (n=1)
LFVQGP 0.01% (n=1)
LFAQGA 0.01% (n=1)
FLARGP 0.01% (n=1)
LLQVGP 0.01% (n=1)
FLALGP 0.01% (n=1)
LFHAGA 0.01% (n=1)
FFNTGP 0.01% (n=1)
LFSYGP 0.01% (n=1)
FLTSGP 0.01% (n=1)
IFNQGA 0.01% (n=1)
FFVAGP 0.01% (n=1)
VFSPGA 0.01% (n=1)
IFQPGS 0.01% (n=1)
LFAVGS 0.01% (n=1)
WLSQGP 0.01% (n=1)
FFKPGA 0.01% (n=1)
FLMQGP 0.01% (n=1)
LFTIGP 0.01% (n=1)
LFAVGP 0.01% (n=1)
MFGVGP 0.01% (n=1)
LFKIGA 0.01% (n=1)
FFLPGA 0.01% (n=1)
FFSPGT 0.01% (n=1)
FFDAGP 0.01% (n=1)
LFGTGP 0.01% (n=1)
LLRVGP 0.01% (n=1)
FLTPGS 0.01% (n=1)
FLPPGS 0.01% (n=1)
LLTLGS 0.01% (n=1)
VFTPGS 0.01% (n=1)
IFTRGA 0.01% (n=1)
LVSPGA 0.01% (n=1)
LFPSGA 0.01% (n=1)
FFHRGP 0.01% (n=1)
MFMDGP 0.01% (n=1)
IFTPGP 0.01% (n=1)
IFSEGA 0.01% (n=1)
LLSQGP 0.01% (n=1)
-FNPGA 0.01% (n=1)
LF*PGA 0.01% (n=1)
PFDTGA 0.01% (n=1)
FLSIGA 0.01% (n=1)
MFSAGP 0.01% (n=1)
LLSAGP 0.01% (n=1)
HVPPGA 0.01% (n=1)
LFNPGH 0.01% (n=1)
LFIRGA 0.01% (n=1)
FFSTGA 0.01% (n=1)
FFTTGP 0.01% (n=1)
LFARGA 0.01% (n=1)
LFTVGS 0.01% (n=1)
IFRMGA 0.01% (n=1)
LFHPGH 0.01% (n=1)
LLAVGP 0.01% (n=1)
LFQSGS 0.01% (n=1)
FFSLGP 0.01% (n=1)
LFHSGS 0.01% (n=1)
LLSLGP 0.01% (n=1)
FFASGA 0.01% (n=1)
PFTPGP 0.01% (n=1)
LFHQGA 0.01% (n=1)
LFRSGS 0.01% (n=1)
LFHVGP 0.01% (n=1)
LFNTGA 0.01% (n=1)
LFETGP 0.01% (n=1)
MFTRGA 0.01% (n=1)
LFTTSA 0.01% (n=1)
LLTVGA 0.01% (n=1)
FL---- 0.01% (n=1)
IFNIGP 0.01% (n=1)
ISSVGP 0.01% (n=1)
VFSAGA 0.01% (n=1)
FFDSGP 0.01% (n=1)
WFTRGA 0.01% (n=1)
LFS--- 0.01% (n=1)
MFQLGP 0.01% (n=1)
WFNQGA 0.01% (n=1)
LWSSGA 0.01% (n=1)
LFLQGA 0.01% (n=1)
FFTRGS 0.01% (n=1)
FFTPGS 0.01% (n=1)
LFTHGP 0.01% (n=1)
FLRQGP 0.01% (n=1)
FFHQGP 0.01% (n=1)
FFNEGP 0.01% (n=1)
LFKPGP 0.01% (n=1)
LFAFGA 0.01% (n=1)
LSTPGA 0.01% (n=1)
FFDQGP 0.01% (n=1)
FFYRGP 0.01% (n=1)
FSDRGP 0.01% (n=1)
LFTPSA 0.01% (n=1)
LPSPGA 0.01% (n=1)
LLGPGA 0.01% (n=1)
LLSPGT 0.01% (n=1)
LFEVGP 0.01% (n=1)
FFSLGA 0.01% (n=1)
LFTFGP 0.01% (n=1)
LFASGA 0.01% (n=1)
LFDQGP 0.01% (n=1)
LLRPGA 0.01% (n=1)
LFDSGA 0.01% (n=1)
ILSTGP 0.01% (n=1)
FFTVGP 0.01% (n=1)
FFIRGP 0.01% (n=1)
FFTLSP 0.01% (n=1)
IFSPDA 0.01% (n=1)
LFSKGA 0.01% (n=1)
FFNKGA 0.01% (n=1)
IFEPGS 0.01% (n=1)
WWSPGA 0.01% (n=1)
IFTPGS 0.01% (n=1)
LFQVGA 0.01% (n=1)
LFISGA 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 1b:

LFSSGA 5.92% (n=572)
LFSPGA 4.92% (n=475)
LFTPGA 4.13% (n=399)
LFTPGP 3.68% (n=355)
FLSIGP 3.56% (n=344)
FLSPGP 3.06% (n=296)
LFTSGA 2.99% (n=289)
LFSAGS 2.63% (n=254)
LFSPGS 2.43% (n=235)
FFSPGP 2.27% (n=219)
LFSFGA 2.21% (n=213)
IFTSGA 1.55% (n=150)
LFSPGP 1.51% (n=146)
IFSPGP 1.48% (n=143)
WFRQGP 1.45% (n=140)
LFTLGP 1.34% (n=129)
LFAPGP 1.31% (n=127)
LFTSGP 1.24% (n=120)
FFDPGP 1.13% (n=109)
FFSPGA 1.08% (n=104)
LFTRGP 0.98% (n=95)
FFSLGP 0.96% (n=93)
FFSSGP 0.96% (n=93)
IFTPGA 0.92% (n=89)
LFSTGS 0.91% (n=88)
FFTSGP 0.90% (n=87)
LFAPGA 0.86% (n=83)
LFTPGS 0.86% (n=83)
LFSSGP 0.85% (n=82)
LFSLGS 0.85% (n=82)
MFSFGA 0.84% (n=81)
IFSLGA 0.81% (n=78)
LFSLGA 0.80% (n=77)
LFSSGS 0.79% (n=76)
LLSPGP 0.79% (n=76)
LFTVGP 0.77% (n=74)
LFTTGP 0.72% (n=70)
FFTPGP 0.71% (n=69)
IFSVGA 0.70% (n=68)
IFSPGA 0.69% (n=67)
LFTFGA 0.67% (n=65)
LLTPGP 0.64% (n=62)
LLTRGP 0.61% (n=59)
LFAVGP 0.60% (n=58)
MFTSGA 0.60% (n=58)
FFSPGS 0.60% (n=58)
VFSPGA 0.58% (n=56)
LFSVGP 0.58% (n=56)
LFSVGS 0.57% (n=55)
IFSVGS 0.54% (n=52)
LFAPGS 0.52% (n=50)
FFTAGP 0.52% (n=50)
FFTLGP 0.49% (n=47)
LFSLGP 0.48% (n=46)
LFTLGS 0.48% (n=46)
LFSQGP 0.46% (n=44)
LFASGP 0.45% (n=43)
FFSAGS 0.41% (n=40)
LFRVGP 0.40% (n=39)
IFSSGS 0.40% (n=39)
LFSRGA 0.39% (n=38)
MFALGP 0.38% (n=37)
IFSSGP 0.38% (n=37)
FFSVGA 0.38% (n=37)
IFAPGP 0.37% (n=36)
LFNLGS 0.37% (n=36)
IFTSGP 0.35% (n=34)
LFTFGP 0.33% (n=32)
LFTAGS 0.33% (n=32)
IFAPGA 0.33% (n=32)
LFAAGP 0.32% (n=31)
IFTPGP 0.32% (n=31)
LFNRGP 0.32% (n=31)
WFDPGP 0.32% (n=31)
FFTPGA 0.30% (n=29)
LFTQGP 0.30% (n=29)
LFDFGP 0.30% (n=29)
FFAPGP 0.28% (n=27)
FFTQGP 0.28% (n=27)
LFQSGA 0.28% (n=27)
FLTAGP 0.28% (n=27)
LFTAGP 0.27% (n=26)
LLTSGP 0.27% (n=26)
LFNLGP 0.27% (n=26)
FLSLGP 0.27% (n=26)
FLSSGP 0.26% (n=25)
LFSFGP 0.26% (n=25)
LFSAGA 0.25% (n=24)
LFTVGA 0.25% (n=24)
IFNPGS 0.25% (n=24)
VFAPGA 0.25% (n=24)
FFSSGA 0.24% (n=23)
LFSIGP 0.24% (n=23)
FFAPGA 0.23% (n=22)
IFASGP 0.22% (n=21)
IFSSGA 0.22% (n=21)
LFRQGS 0.21% (n=20)
FLSFGP 0.21% (n=20)
LFNPGA 0.20% (n=19)
LFSTGP 0.20% (n=19)
LFNPGS 0.19% (n=18)
LFHFGA 0.19% (n=18)
FLSVGS 0.18% (n=17)
LFTQGS 0.18% (n=17)
FFASGP 0.17% (n=16)
LFQQGS 0.17% (n=16)
FFSRGP 0.16% (n=15)
FFTSGA 0.14% (n=14)
FLTSGP 0.14% (n=14)
LFNLGA 0.14% (n=14)
LFTSGS 0.14% (n=14)
LFKVGP 0.14% (n=14)
LFTRGA 0.13% (n=13)
LFISGP 0.13% (n=13)
MFTLGP 0.13% (n=13)
LFTPG- 0.13% (n=13)
LFSTGA 0.12% (n=12)
FLTRGP 0.12% (n=12)
IFSAGP 0.12% (n=12)
LLTPGA 0.11% (n=11)
IFSAGA 0.11% (n=11)
FFQLGA 0.11% (n=11)
LFDPGA 0.11% (n=11)
LFSRGS 0.10% (n=10)
LLAPGP 0.10% (n=10)
IFNSGA 0.10% (n=10)
LFKLGP 0.10% (n=10)
LLSPGA 0.10% (n=10)
FFNVGP 0.10% (n=10)
LFTFGS 0.10% (n=10)
LFSAGP 0.09% (n=9)
FFSVGP 0.09% (n=9)
LFTLGA 0.09% (n=9)
LFRSGS 0.09% (n=9)
FFTRGP 0.09% (n=9)
FFALGP 0.09% (n=9)
LFNVGA 0.09% (n=9)
LFSRGG 0.09% (n=9)
IFRSGP 0.09% (n=9)
MFSSGA 0.09% (n=9)
LFRPGA 0.08% (n=8)
FLSPGA 0.08% (n=8)
MFSSGP 0.08% (n=8)
FLARGP 0.08% (n=8)
LFVSGP 0.07% (n=7)
LFTRGS 0.07% (n=7)
LFRLGP 0.07% (n=7)
LFTAGA 0.07% (n=7)
LFQPGA 0.07% (n=7)
IFSPGS 0.07% (n=7)
LFSFGS 0.07% (n=7)
LFNPGP 0.07% (n=7)
FFRAGP 0.07% (n=7)
FFSRGS 0.07% (n=7)
LFSRGP 0.06% (n=6)
FFSFGA 0.06% (n=6)
LFDLGP 0.06% (n=6)
LFSQGA 0.06% (n=6)
LFASGS 0.06% (n=6)
FFSAGP 0.06% (n=6)
LFSVGA 0.05% (n=5)
LFALGP 0.05% (n=5)
LLTLGP 0.05% (n=5)
MFSVGP 0.05% (n=5)
LFRSGP 0.05% (n=5)
IFALGP 0.05% (n=5)
IFSTGP 0.05% (n=5)
LFLRGS 0.05% (n=5)
LFNFGS 0.05% (n=5)
LFKPGA 0.05% (n=5)
LFRFGA 0.05% (n=5)
LFNFGP 0.05% (n=5)
VFSLGA 0.05% (n=5)
IFTLGP 0.04% (n=4)
FFSTGP 0.04% (n=4)
FFTVGP 0.04% (n=4)
FFPPGP 0.04% (n=4)
-FTPGP 0.04% (n=4)
IFTAGA 0.04% (n=4)
LFNSGP 0.04% (n=4)
FFSLGA 0.04% (n=4)
LFHPGA 0.04% (n=4)
LFSYGA 0.04% (n=4)
LFRRGA 0.04% (n=4)
VFSSGP 0.04% (n=4)
FPSPGP 0.04% (n=4)
LFNVGP 0.03% (n=3)
LFKPGP 0.03% (n=3)
LFDLGA 0.03% (n=3)
VFTPGA 0.03% (n=3)
LLTAGS 0.03% (n=3)
LFTHGP 0.03% (n=3)
LFAVGS 0.03% (n=3)
LFKAGS 0.03% (n=3)
MFASGP 0.03% (n=3)
FFNPGP 0.03% (n=3)
FFNLGP 0.03% (n=3)
LLARGP 0.03% (n=3)
FFEPGP 0.03% (n=3)
FLTPGA 0.03% (n=3)
WFSPGS 0.03% (n=3)
FFSRGA 0.03% (n=3)
LFQPGS 0.03% (n=3)
LFNFGA 0.03% (n=3)
FFIQGP 0.03% (n=3)
LFRHGP 0.03% (n=3)
LFPPGS 0.03% (n=3)
LFSPG- 0.03% (n=3)
VFSSGA 0.03% (n=3)
FLSTGP 0.02% (n=2)
LFVRGP 0.02% (n=2)
LFTQGA 0.02% (n=2)
LLAVGP 0.02% (n=2)
LSTSGA 0.02% (n=2)
PFTSGA 0.02% (n=2)
LLTSGA 0.02% (n=2)
LFTSWA 0.02% (n=2)
FFGPGA 0.02% (n=2)
IFSPGV 0.02% (n=2)
FLAPGA 0.02% (n=2)
LLAAGP 0.02% (n=2)
FFSAGA 0.02% (n=2)
FFAVGP 0.02% (n=2)
WLSQGP 0.02% (n=2)
MFSDGP 0.02% (n=2)
MFTSGP 0.02% (n=2)
LFKRGS 0.02% (n=2)
MFSRGP 0.02% (n=2)
LFARGP 0.02% (n=2)
MFSTGP 0.02% (n=2)
LFMPGP 0.02% (n=2)
LLSPGS 0.02% (n=2)
ILSPGA 0.02% (n=2)
LFQRGS 0.02% (n=2)
LFQKGS 0.02% (n=2)
LFQFGA 0.02% (n=2)
LFDRGS 0.02% (n=2)
LFNSGA 0.02% (n=2)
FFATGP 0.02% (n=2)
WFAPGS 0.02% (n=2)
LFDHGP 0.02% (n=2)
LFSYGP 0.02% (n=2)
MLAPGP 0.02% (n=2)
LLSSGP 0.02% (n=2)
FFNPGS 0.02% (n=2)
----GP 0.02% (n=2)
IFQSGP 0.02% (n=2)
LFTKGP 0.02% (n=2)
LFTLG- 0.02% (n=2)
LFQAGS 0.02% (n=2)
FFSHGP 0.02% (n=2)
FFSLGS 0.02% (n=2)
FFAAGS 0.02% (n=2)
LFALGS 0.02% (n=2)
LFRIGP 0.02% (n=2)
LFKIGP 0.02% (n=2)
-FSSGP 0.02% (n=2)
LFNAGP 0.02% (n=2)
VFSPGS 0.02% (n=2)
LFRLGS 0.02% (n=2)
LFPAGS 0.02% (n=2)
PFSAGS 0.02% (n=2)
FLSRGP 0.02% (n=2)
WFHQGP 0.02% (n=2)
PFSLGS 0.02% (n=2)
FFDPEP 0.02% (n=2)
IFSFGA 0.02% (n=2)
IFTQGP 0.02% (n=2)
LFAQGS 0.02% (n=2)
MFAFGP 0.01% (n=1)
LFTCGP 0.01% (n=1)
FFTLGA 0.01% (n=1)
IFAAGP 0.01% (n=1)
IFMPGP 0.01% (n=1)
FFNQGP 0.01% (n=1)
FFTQGA 0.01% (n=1)
LFQSEP 0.01% (n=1)
FLTVGP 0.01% (n=1)
MFSFGS 0.01% (n=1)
LFRVGA 0.01% (n=1)
LFNAGS 0.01% (n=1)
FSQLGV 0.01% (n=1)
LFYSGP 0.01% (n=1)
LLTFGP 0.01% (n=1)
SFSPGA 0.01% (n=1)
WLARGP 0.01% (n=1)
IFDLGS 0.01% (n=1)
IFTRGP 0.01% (n=1)
IFNLGP 0.01% (n=1)
MFTRGS 0.01% (n=1)
ILTRGP 0.01% (n=1)
LFDFGA 0.01% (n=1)
FFAPGS 0.01% (n=1)
LFTCGA 0.01% (n=1)
FFSCGP 0.01% (n=1)
FFDRGP 0.01% (n=1)
FFSSRA 0.01% (n=1)
IFSPGG 0.01% (n=1)
LFLPGA 0.01% (n=1)
LFSTGR 0.01% (n=1)
PFTPGA 0.01% (n=1)
FFPPGS 0.01% (n=1)
LFRSGA 0.01% (n=1)
FLSPGS 0.01% (n=1)
LFIAGP 0.01% (n=1)
LFTMGS 0.01% (n=1)
LFKFGP 0.01% (n=1)
MFKLGS 0.01% (n=1)
LLSTGP 0.01% (n=1)
LLVSGP 0.01% (n=1)
LFGSGP 0.01% (n=1)
LFRFGS 0.01% (n=1)
ILTAGP 0.01% (n=1)
FFSMGS 0.01% (n=1)
LFNTGP 0.01% (n=1)
IFQLGP 0.01% (n=1)
LFSMGS 0.01% (n=1)
LFKQGA 0.01% (n=1)
LFMPGA 0.01% (n=1)
LFYRGP 0.01% (n=1)
ILSSGP 0.01% (n=1)
FFKQGP 0.01% (n=1)
GLTSGP 0.01% (n=1)
ILSPGP 0.01% (n=1)
FLRAGP 0.01% (n=1)
VFSAGP 0.01% (n=1)
MFSPGA 0.01% (n=1)
FFSHGA 0.01% (n=1)
FFARGP 0.01% (n=1)
LIRVGP 0.01% (n=1)
MFNFGP 0.01% (n=1)
MFSFGP 0.01% (n=1)
IFSQGP 0.01% (n=1)
IFDSGP 0.01% (n=1)
MFTPGA 0.01% (n=1)
IFRPGP 0.01% (n=1)
LFQLGA 0.01% (n=1)
LFQPGP 0.01% (n=1)
FFTRGS 0.01% (n=1)
FFNPGA 0.01% (n=1)
LFTPGT 0.01% (n=1)
IFCSGP 0.01% (n=1)
MFSSGS 0.01% (n=1)
PFSSGP 0.01% (n=1)
LFSQGS 0.01% (n=1)
LFTLEP 0.01% (n=1)
IFSFGS 0.01% (n=1)
IFTPGS 0.01% (n=1)
LFVPGA 0.01% (n=1)
FFDPGA 0.01% (n=1)
LFDRGA 0.01% (n=1)
FFLRGP 0.01% (n=1)
IFDPGP 0.01% (n=1)
FFKVGP 0.01% (n=1)
LFHSGP 0.01% (n=1)
LLTVGP 0.01% (n=1)
MFSPGP 0.01% (n=1)
FFSQGS 0.01% (n=1)
LLSAGP 0.01% (n=1)
MFNPGP 0.01% (n=1)
IFSQGA 0.01% (n=1)
LLTQGP 0.01% (n=1)
LLNPGP 0.01% (n=1)
FFRSGP 0.01% (n=1)
LFIPGP 0.01% (n=1)
LFHPGP 0.01% (n=1)
LFAFGP 0.01% (n=1)
LFQLGP 0.01% (n=1)
LFVQGP 0.01% (n=1)
FFTTGP 0.01% (n=1)
LLAHGP 0.01% (n=1)
LFSLG- 0.01% (n=1)
LFATGS 0.01% (n=1)
LFSHGP 0.01% (n=1)
LCIPGP 0.01% (n=1)
PFTPGP 0.01% (n=1)
IFSRGP 0.01% (n=1)
SFHVG- 0.01% (n=1)
LFTSGV 0.01% (n=1)
FLHLG- 0.01% (n=1)
FFSFGP 0.01% (n=1)
LFPLG- 0.01% (n=1)
FLTLGP 0.01% (n=1)
FLAPGP 0.01% (n=1)
-LRVGP 0.01% (n=1)
-LSPGP 0.01% (n=1)
-FSFGA 0.01% (n=1)
FFTFGA 0.01% (n=1)
LFASGA 0.01% (n=1)
SFTSGP 0.01% (n=1)
LFATGP 0.01% (n=1)
MFAPGA 0.01% (n=1)
LFTPGL 0.01% (n=1)
IFDRGP 0.01% (n=1)
IFSLGP 0.01% (n=1)
LFSYGS 0.01% (n=1)
FLARWA 0.01% (n=1)
LFTIGP 0.01% (n=1)
LFVTGP 0.01% (n=1)
VLSPGA 0.01% (n=1)
FFTAGA 0.01% (n=1)
WFSPGA 0.01% (n=1)
MFSVGS 0.01% (n=1)
LLSLGP 0.01% (n=1)
IFAAGS 0.01% (n=1)
LFTCGS 0.01% (n=1)
MFSTGA 0.01% (n=1)
LFRVGS 0.01% (n=1)
LFKPGS 0.01% (n=1)
LFHLGA 0.01% (n=1)
IFSRGS 0.01% (n=1)
LFNTGA 0.01% (n=1)
LSTSRP 0.01% (n=1)
LLSAGS 0.01% (n=1)
LFKAGP 0.01% (n=1)
WFRQEP 0.01% (n=1)
PFSPGS 0.01% (n=1)
TFSVGS 0.01% (n=1)
LFSPGL 0.01% (n=1)
IFSPEP 0.01% (n=1)
IFSPRP 0.01% (n=1)
PFAPGP 0.01% (n=1)
FFGPGP 0.01% (n=1)
FFYPGP 0.01% (n=1)
SFSVGA 0.01% (n=1)
MFPFGA 0.01% (n=1)
IFSVGP 0.01% (n=1)
MFSVGA 0.01% (n=1)
IFPVGA 0.01% (n=1)
FLSPWP 0.01% (n=1)
FRSPGP 0.01% (n=1)
FLSPGL 0.01% (n=1)
LSSSGA 0.01% (n=1)
LFSSGT 0.01% (n=1)
IFVPGP 0.01% (n=1)
LYTPGS 0.01% (n=1)
PFTPGS 0.01% (n=1)
FFSVGS 0.01% (n=1)
LFNRGS 0.01% (n=1)
LFSIGR 0.01% (n=1)
LFMPGQ 0.01% (n=1)
LLAPGA 0.01% (n=1)
LLTHGP 0.01% (n=1)
LYTRGP 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 2:

FTSRGS 10.52% (n=136)
IFSQGA 6.88% (n=89)
LFSSGA 6.03% (n=78)
IFSPGP 5.10% (n=66)
IFSPGA 3.94% (n=51)
LFSPGA 3.09% (n=40)
LFNPGP 2.94% (n=38)
LFTPGA 2.71% (n=35)
MFSPGP 2.32% (n=30)
IFSRGA 2.17% (n=28)
FFSQGA 2.17% (n=28)
LFTPGP 1.86% (n=24)
LFSPGP 1.78% (n=23)
LFSLGP 1.70% (n=22)
LFTSGP 1.55% (n=20)
LFTQGP 1.55% (n=20)
IFSKGA 1.47% (n=19)
LFSSGS 1.39% (n=18)
IFAPGP 1.39% (n=18)
FFTPGA 1.31% (n=17)
LTSRGS 1.31% (n=17)
IFTPGA 1.01% (n=13)
FFSPGP 0.93% (n=12)
LFTTGA 0.93% (n=12)
FFTRGP 0.93% (n=12)
LFSQGA 0.93% (n=12)
LFTSGA 0.85% (n=11)
VFSHGP 0.77% (n=10)
IFTSGA 0.70% (n=9)
IFNPGP 0.70% (n=9)
LFSPGS 0.62% (n=8)
LFTFGP 0.62% (n=8)
LFAPGP 0.62% (n=8)
LLSPGA 0.54% (n=7)
LFTLGP 0.54% (n=7)
LFAPGA 0.46% (n=6)
LFNPGA 0.46% (n=6)
FFSPGA 0.39% (n=5)
LFDMGP 0.39% (n=5)
LFSAGA 0.39% (n=5)
MFTPGA 0.39% (n=5)
LFTQGA 0.31% (n=4)
LFSAGS 0.31% (n=4)
LFTPGS 0.31% (n=4)
LFSTGS 0.31% (n=4)
LFTVGP 0.31% (n=4)
LLSLGP 0.31% (n=4)
LFDLGP 0.31% (n=4)
LLSPGP 0.31% (n=4)
FFAPGA 0.23% (n=3)
LFTRGP 0.23% (n=3)
LLSPGS 0.23% (n=3)
FFTPGP 0.23% (n=3)
IFAPGA 0.23% (n=3)
WFSPGP 0.23% (n=3)
VFSSGP 0.23% (n=3)
LFSTGA 0.23% (n=3)
IFSSGP 0.23% (n=3)
LFTTGP 0.23% (n=3)
LFTQGS 0.23% (n=3)
LFNAGP 0.23% (n=3)
LFDPGP 0.23% (n=3)
LFARGP 0.23% (n=3)
LFKSGP 0.23% (n=3)
FFKSGP 0.23% (n=3)
LFSAGP 0.23% (n=3)
LFNLGP 0.23% (n=3)
LFILGP 0.23% (n=3)
LFTRGS 0.23% (n=3)
LFVRGP 0.15% (n=2)
LFSLGS 0.15% (n=2)
LFTVGA 0.15% (n=2)
IFTSGP 0.15% (n=2)
LFTAGA 0.15% (n=2)
FLSPGP 0.15% (n=2)
IFQPGA 0.15% (n=2)
LFMPGA 0.15% (n=2)
MFSPGA 0.15% (n=2)
VFSPGA 0.15% (n=2)
MFALGH 0.15% (n=2)
LFSPGH 0.15% (n=2)
IFSPGS 0.15% (n=2)
VFAPGP 0.15% (n=2)
LFRPGA 0.15% (n=2)
LFSTGP 0.15% (n=2)
IFSSGA 0.15% (n=2)
LFSVGS 0.15% (n=2)
LFSFGA 0.15% (n=2)
LFSDGA 0.15% (n=2)
LFTAGP 0.15% (n=2)
LFNFGP 0.15% (n=2)
LFNLGS 0.15% (n=2)
LFDAGP 0.15% (n=2)
LFSIGP 0.15% (n=2)
LFASGP 0.15% (n=2)
LFPSGP 0.15% (n=2)
LFSLGA 0.15% (n=2)
FLSRGP 0.15% (n=2)
LFTFGS 0.15% (n=2)
FFSTGP 0.15% (n=2)
LFSSGP 0.15% (n=2)
LFSVGP 0.15% (n=2)
LFTLGA 0.15% (n=2)
LFSRGA 0.15% (n=2)
LFQPGS 0.15% (n=2)
LFRLGS 0.15% (n=2)
LFNPGS 0.08% (n=1)
IFTQGA 0.08% (n=1)
AFSPGA 0.08% (n=1)
VFTAGA 0.08% (n=1)
-FSLGS 0.08% (n=1)
LFTRGA 0.08% (n=1)
LFYRGA 0.08% (n=1)
MFTYGA 0.08% (n=1)
LFTLGS 0.08% (n=1)
MFSIGA 0.08% (n=1)
LLTPGA 0.08% (n=1)
MFSSGA 0.08% (n=1)
IFNSGP 0.08% (n=1)
LLSRGP 0.08% (n=1)
MFSLGA 0.08% (n=1)
MFSSGS 0.08% (n=1)
LFRSGP 0.08% (n=1)
MFRPGA 0.08% (n=1)
LFTFGA 0.08% (n=1)
FFNPGA 0.08% (n=1)
MFTSGA 0.08% (n=1)
FFTSGA 0.08% (n=1)
IFNSGA 0.08% (n=1)
FFDVGA 0.08% (n=1)
LFAPGH 0.08% (n=1)
LLSLGH 0.08% (n=1)
LFDVGS 0.08% (n=1)
MFTLGP 0.08% (n=1)
LFKLGS 0.08% (n=1)
IFTAGS 0.08% (n=1)
LFSFGS 0.08% (n=1)
MFTPGP 0.08% (n=1)
MFTLGA 0.08% (n=1)
LFQPGA 0.08% (n=1)
IFNPGA 0.08% (n=1)
LFKTGA 0.08% (n=1)
MLAPGA 0.08% (n=1)
IFMPGA 0.08% (n=1)
WFSPGA 0.08% (n=1)
MFRAGP 0.08% (n=1)
MFSPGS 0.08% (n=1)
LLRSGS 0.08% (n=1)
FFMRGA 0.08% (n=1)
FFSHGA 0.08% (n=1)
LFSHGA 0.08% (n=1)
LFNVGP 0.08% (n=1)
LFTSGS 0.08% (n=1)
VFTLGS 0.08% (n=1)
WFTQGP 0.08% (n=1)
LFKLGA 0.08% (n=1)
LFVPGP 0.08% (n=1)
IFSSGS 0.08% (n=1)
LFHTGA 0.08% (n=1)
FLTLGP 0.08% (n=1)
LFTYGA 0.08% (n=1)
LLTPGP 0.08% (n=1)
MFSSGP 0.08% (n=1)
LFAIGP 0.08% (n=1)
LFDLGA 0.08% (n=1)
IFHSGP 0.08% (n=1)
LFTTGS 0.08% (n=1)
MFTRGP 0.08% (n=1)
LFTNGS 0.08% (n=1)
IFTPGP 0.08% (n=1)
MFRSGS 0.08% (n=1)
LFNSGA 0.08% (n=1)
LSNAGP 0.08% (n=1)
LFSIGA 0.08% (n=1)
IFSAGA 0.08% (n=1)
IFTVGP 0.08% (n=1)
IFSVGP 0.08% (n=1)
LFPPGP 0.08% (n=1)
LFKSCP 0.08% (n=1)
LLSLCP 0.08% (n=1)
LFSWGA 0.08% (n=1)
LSVLGS 0.08% (n=1)
IFPPGP 0.08% (n=1)
LLTSGP 0.08% (n=1)
FFKTGP 0.08% (n=1)
LSTPGP 0.08% (n=1)
LFGSGA 0.08% (n=1)
LFVHGP 0.08% (n=1)
LSSLGP 0.08% (n=1)
LFRYGP 0.08% (n=1)
LFNSGP 0.08% (n=1)
LFAHGP 0.08% (n=1)
LFATGA 0.08% (n=1)
LLSLGS 0.08% (n=1)
YFLVPV 0.08% (n=1)
FFSLGA 0.08% (n=1)
LFDSGP 0.08% (n=1)
IFQPGS 0.08% (n=1)
LLSQGP 0.08% (n=1)
LFHFGA 0.08% (n=1)
IFSPGG 0.08% (n=1)
WFNPGP 0.08% (n=1)
FFQLGP 0.08% (n=1)
FFDRGP 0.08% (n=1)
IFSHGP 0.08% (n=1)
IISPGA 0.08% (n=1)
FFNSGP 0.08% (n=1)
LLAPGP 0.08% (n=1)
MFSLGS 0.08% (n=1)
FFSKGA 0.08% (n=1)
LMTPGS 0.08% (n=1)
LFDFGP 0.08% (n=1)
LFSSGL 0.08% (n=1)
MFSRGP 0.08% (n=1)
LFQSGP 0.08% (n=1)
LFQTGA 0.08% (n=1)
FFSQGP 0.08% (n=1)
LFDKGP 0.08% (n=1)
FFQPGP 0.08% (n=1)
LFLTGP 0.08% (n=1)
LFHRGS 0.08% (n=1)
LFRQGS 0.08% (n=1)
FFTQGP 0.08% (n=1)
LLTRGP 0.08% (n=1)
FFNQGP 0.08% (n=1)
LFSFGP 0.08% (n=1)
LFSQGP 0.08% (n=1)
PTSRGS 0.08% (n=1)
FTYRGS 0.08% (n=1)
LFQQGS 0.08% (n=1)
FFASGP 0.08% (n=1)
LFKAGA 0.08% (n=1)
FFDLGP 0.08% (n=1)
LLASGP 0.08% (n=1)
LFRMGA 0.08% (n=1)
MFTNGP 0.08% (n=1)
LFSVGA 0.08% (n=1)
VFSPGP 0.08% (n=1)
FFAPGP 0.08% (n=1)
-FSPGP 0.08% (n=1)
FLSQGP 0.08% (n=1)
IFSTGP 0.08% (n=1)
LFSQGS 0.08% (n=1)
MFSVGA 0.08% (n=1)
FLSPGS 0.08% (n=1)
IFSLGA 0.08% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 2a:

LFTPGA 11.59% (n=27)
FFTPGA 7.30% (n=17)
IFTPGA 5.15% (n=12)
VFSHGP 4.29% (n=10)
IFTSGA 3.86% (n=9)
LFSPGA 3.86% (n=9)
LFTSGA 3.43% (n=8)
IFSPGA 3.43% (n=8)
LFTSGP 2.58% (n=6)
LFDMGP 2.15% (n=5)
LLSPGA 1.72% (n=4)
LFTTGA 1.72% (n=4)
MFTPGA 1.72% (n=4)
LFTQGA 1.29% (n=3)
LFSPGP 1.29% (n=3)
LFSSGA 1.29% (n=3)
LFSPGS 1.29% (n=3)
FFSPGA 0.86% (n=2)
LFTVGA 0.86% (n=2)
IFTSGP 0.86% (n=2)
LFSAGA 0.86% (n=2)
LLSPGS 0.86% (n=2)
LFTAGA 0.86% (n=2)
MFSPGA 0.86% (n=2)
FFSPGP 0.86% (n=2)
VFSPGA 0.86% (n=2)
LFTFGP 0.86% (n=2)
MFALGH 0.86% (n=2)
LFSPGH 0.86% (n=2)
IFSPGP 0.86% (n=2)
LFAPGA 0.86% (n=2)
LFSTGA 0.86% (n=2)
AFSPGA 0.43% (n=1)
LFVRGP 0.43% (n=1)
VFTAGA 0.43% (n=1)
LFSLGS 0.43% (n=1)
-FSLGS 0.43% (n=1)
LFTRGA 0.43% (n=1)
FFAPGA 0.43% (n=1)
LFYRGA 0.43% (n=1)
MFTYGA 0.43% (n=1)
LFTRGP 0.43% (n=1)
LFTLGS 0.43% (n=1)
LFTQGP 0.43% (n=1)
MFSIGA 0.43% (n=1)
LLTPGA 0.43% (n=1)
MFSSGA 0.43% (n=1)
IFNSGP 0.43% (n=1)
FLSPGP 0.43% (n=1)
LLSRGP 0.43% (n=1)
MFSLGA 0.43% (n=1)
MFSSGS 0.43% (n=1)
LFRSGP 0.43% (n=1)
IFQPGA 0.43% (n=1)
LFMPGA 0.43% (n=1)
MFRPGA 0.43% (n=1)
LFTFGA 0.43% (n=1)
LFSAGS 0.43% (n=1)
FFNPGA 0.43% (n=1)
MFTSGA 0.43% (n=1)
LFTPGS 0.43% (n=1)
FFTSGA 0.43% (n=1)
IFNSGA 0.43% (n=1)
FFDVGA 0.43% (n=1)
LFAPGH 0.43% (n=1)
LLSLGH 0.43% (n=1)
LFNPGA 0.43% (n=1)
IFSPGS 0.43% (n=1)
FFTPGP 0.43% (n=1)
LFDVGS 0.43% (n=1)
IFAPGA 0.43% (n=1)
MFTLGP 0.43% (n=1)
WFSPGP 0.43% (n=1)
LFKLGS 0.43% (n=1)
IFTAGS 0.43% (n=1)
LFNPGP 0.43% (n=1)
LFSFGS 0.43% (n=1)
VFAPGP 0.43% (n=1)
MFTPGP 0.43% (n=1)
LFRPGA 0.43% (n=1)
MFTLGA 0.43% (n=1)
LFQPGA 0.43% (n=1)
IFNPGA 0.43% (n=1)
LFKTGA 0.43% (n=1)
MLAPGA 0.43% (n=1)
IFMPGA 0.43% (n=1)
VFSSGP 0.43% (n=1)
WFSPGA 0.43% (n=1)
LFSTGP 0.43% (n=1)
MFRAGP 0.43% (n=1)
MFSPGS 0.43% (n=1)
LLRSGS 0.43% (n=1)
FFMRGA 0.43% (n=1)
FFSHGA 0.43% (n=1)
LFSHGA 0.43% (n=1)
LFNVGP 0.43% (n=1)
IFSSGA 0.43% (n=1)
LFTSGS 0.43% (n=1)
VFTLGS 0.43% (n=1)
WFTQGP 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 2b:

LFSSGA 16.45% (n=75)
LFNPGP 8.11% (n=37)
IFSPGP 6.58% (n=30)
LFSLGP 4.82% (n=22)
LFTPGP 4.17% (n=19)
LFSSGS 3.73% (n=17)
LFSPGP 3.73% (n=17)
LFTQGP 3.51% (n=16)
FFTRGP 2.41% (n=11)
IFNPGP 1.97% (n=9)
LFTSGP 1.75% (n=8)
LFTLGP 1.54% (n=7)
LFAPGP 1.54% (n=7)
LFTTGA 1.32% (n=6)
IFSPGA 1.32% (n=6)
LFSPGA 1.32% (n=6)
LFTFGP 1.10% (n=5)
FFSPGP 1.10% (n=5)
LFTPGA 0.88% (n=4)
LFTVGP 0.88% (n=4)
LLSLGP 0.88% (n=4)
LFDLGP 0.88% (n=4)
IFSSGP 0.66% (n=3)
LFTTGP 0.66% (n=3)
LFSTGS 0.66% (n=3)
LFSAGA 0.66% (n=3)
LFNAGP 0.66% (n=3)
LFKSGP 0.66% (n=3)
FFKSGP 0.66% (n=3)
LFSAGP 0.66% (n=3)
LLSPGP 0.66% (n=3)
LFILGP 0.66% (n=3)
LFSFGA 0.44% (n=2)
LFSDGA 0.44% (n=2)
LFNPGA 0.44% (n=2)
LFAPGA 0.44% (n=2)
LFTAGP 0.44% (n=2)
LFNFGP 0.44% (n=2)
LFTRGP 0.44% (n=2)
LFNLGS 0.44% (n=2)
LFSAGS 0.44% (n=2)
LFDAGP 0.44% (n=2)
LFDPGP 0.44% (n=2)
LFSIGP 0.44% (n=2)
LFARGP 0.44% (n=2)
LFPSGP 0.44% (n=2)
LFSLGA 0.44% (n=2)
LFTSGA 0.44% (n=2)
LFNLGP 0.44% (n=2)
FFSTGP 0.44% (n=2)
LFKLGA 0.22% (n=1)
LFVPGP 0.22% (n=1)
IFSSGS 0.22% (n=1)
LFSVGS 0.22% (n=1)
LFHTGA 0.22% (n=1)
FLTLGP 0.22% (n=1)
FFSPGA 0.22% (n=1)
IFSSGA 0.22% (n=1)
LFTYGA 0.22% (n=1)
LLTPGP 0.22% (n=1)
MFSSGP 0.22% (n=1)
IFTPGA 0.22% (n=1)
LFSTGA 0.22% (n=1)
LFAIGP 0.22% (n=1)
LFDLGA 0.22% (n=1)
LFTPGS 0.22% (n=1)
IFHSGP 0.22% (n=1)
LFTTGS 0.22% (n=1)
MFTRGP 0.22% (n=1)
LFTNGS 0.22% (n=1)
LFTQGS 0.22% (n=1)
MFTPGA 0.22% (n=1)
IFTPGP 0.22% (n=1)
MFRSGS 0.22% (n=1)
LFNSGA 0.22% (n=1)
LFSLGS 0.22% (n=1)
LSNAGP 0.22% (n=1)
LFSIGA 0.22% (n=1)
IFSAGA 0.22% (n=1)
IFTVGP 0.22% (n=1)
IFSVGP 0.22% (n=1)
IFSPGS 0.22% (n=1)
LFPPGP 0.22% (n=1)
LFASGP 0.22% (n=1)
LFKSCP 0.22% (n=1)
LLSLCP 0.22% (n=1)
LFSWGA 0.22% (n=1)
LSVLGS 0.22% (n=1)
IFPPGP 0.22% (n=1)
LLTSGP 0.22% (n=1)
FFKTGP 0.22% (n=1)
FLSRGP 0.22% (n=1)
LSTPGP 0.22% (n=1)
LFGSGA 0.22% (n=1)
LFVHGP 0.22% (n=1)
LSSLGP 0.22% (n=1)
LFRYGP 0.22% (n=1)
LFNSGP 0.22% (n=1)
LFTFGS 0.22% (n=1)
LFAHGP 0.22% (n=1)
LFMPGA 0.22% (n=1)
LLSPGS 0.22% (n=1)
LFATGA 0.22% (n=1)
LLSLGS 0.22% (n=1)
YFL--- 0.22% (n=1)
FFSLGA 0.22% (n=1)
WFSPGP 0.22% (n=1)
LFDSGP 0.22% (n=1)
LFSPGS 0.22% (n=1)
IFQPGS 0.22% (n=1)
LLSQGP 0.22% (n=1)
LFSSGP 0.22% (n=1)
LFHFGA 0.22% (n=1)
IFSPGG 0.22% (n=1)
WFNPGP 0.22% (n=1)
FFTPGP 0.22% (n=1)
LFSVGP 0.22% (n=1)
FFQLGP 0.22% (n=1)
FFDRGP 0.22% (n=1)
IFSHGP 0.22% (n=1)
LFTLGA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 2c:

FTSRGS 30.09% (n=136)
IFSQGA 19.69% (n=89)
IFSPGA 7.96% (n=36)
FFSQGA 6.19% (n=28)
IFSRGA 5.97% (n=27)
LFSPGA 4.42% (n=20)
IFSKGA 4.20% (n=19)
LTSRGS 3.76% (n=17)
LFSQGA 2.65% (n=12)
LFTSGP 1.33% (n=6)
LFTPGP 0.66% (n=3)
LFTQGP 0.66% (n=3)
IFAPGA 0.44% (n=2)
LFSRGA 0.44% (n=2)
LFRLGS 0.44% (n=2)
LFTQGS 0.44% (n=2)
IISPGA 0.22% (n=1)
FFNSGP 0.22% (n=1)
LFNLGP 0.22% (n=1)
LFSSGS 0.22% (n=1)
LLAPGP 0.22% (n=1)
MFSLGS 0.22% (n=1)
FFSKGA 0.22% (n=1)
FFSPGA 0.22% (n=1)
LMTPGS 0.22% (n=1)
LFDFGP 0.22% (n=1)
LFSSGL 0.22% (n=1)
FLSPGP 0.22% (n=1)
MFSRGP 0.22% (n=1)
LFQSGP 0.22% (n=1)
LFTTGA 0.22% (n=1)
LFRPGA 0.22% (n=1)
LFQPGS 0.22% (n=1)
FFTPGP 0.22% (n=1)
LFARGP 0.22% (n=1)
LFQTGA 0.22% (n=1)
IFSPGP 0.22% (n=1)
FFSQGP 0.22% (n=1)
LFSVGS 0.22% (n=1)
LFDKGP 0.22% (n=1)
FFQPGP 0.22% (n=1)
LFASGP 0.22% (n=1)
LFLTGP 0.22% (n=1)
LFTRGS 0.22% (n=1)
LFNPGA 0.22% (n=1)
LFSPGP 0.22% (n=1)
LFSVGP 0.22% (n=1)
LLSPGA 0.22% (n=1)
LFHRGS 0.22% (n=1)
LFDPGP 0.22% (n=1)
LFRQGS 0.22% (n=1)
FFTQGP 0.22% (n=1)
LLTRGP 0.22% (n=1)
FFNQGP 0.22% (n=1)
IFQPGA 0.22% (n=1)
LFTLGA 0.22% (n=1)
LFSFGP 0.22% (n=1)
LFSQGP 0.22% (n=1)
PTSRGS 0.22% (n=1)
FTYRGS 0.22% (n=1)
LFTSGA 0.22% (n=1)
FFAPGA 0.22% (n=1)
LLSPGP 0.22% (n=1)
LFTQGA 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 3:

LFSVGA 13.14% (n=510)
LLSLGP 8.17% (n=317)
FLSVGP 6.73% (n=261)
LFSAGA 5.46% (n=212)
LFSPGA 4.41% (n=171)
LFSMGA 4.36% (n=169)
LFSRGA 2.96% (n=115)
LFSTGA 2.35% (n=91)
LFRVGA 2.16% (n=84)
LFTLGP 2.16% (n=84)
LFTVGA 2.14% (n=83)
LFSLGA 2.09% (n=81)
LLSPGS 1.93% (n=75)
WFSPGA 1.75% (n=68)
IFSPGA 1.34% (n=52)
LFTRGP 1.34% (n=52)
LFRPGA 1.29% (n=50)
LFNPGP 1.21% (n=47)
LFSPGP 1.16% (n=45)
FFQPGA 1.11% (n=43)
LFTPGA 1.03% (n=40)
FFSPGA 1.01% (n=39)
FFSRGA 1.01% (n=39)
LFAPGA 0.95% (n=37)
LFNVGA 0.90% (n=35)
LFTSGP 0.90% (n=35)
LFSPGS 0.85% (n=33)
LFARGP 0.82% (n=32)
LFQPGA 0.80% (n=31)
LFTQGA 0.77% (n=30)
MFQQGA 0.62% (n=24)
LFSQGA 0.59% (n=23)
LFSSGP 0.59% (n=23)
LFTQGP 0.54% (n=21)
LFTSGA 0.52% (n=20)
IFSQGA 0.52% (n=20)
LFRMGA 0.44% (n=17)
LFSSGA 0.39% (n=15)
LFSTGP 0.36% (n=14)
LFSAGP 0.36% (n=14)
LFTPGP 0.34% (n=13)
LFNTGP 0.31% (n=12)
LFDLGA 0.31% (n=12)
FFDLGA 0.31% (n=12)
IFAPGA 0.31% (n=12)
FFTSGP 0.31% (n=12)
LFSQGP 0.28% (n=11)
LFAPGP 0.28% (n=11)
LFSLGP 0.28% (n=11)
LFNLGA 0.26% (n=10)
LFNPGA 0.26% (n=10)
LFTAGP 0.26% (n=10)
LFTVGP 0.23% (n=9)
LFSIGA 0.23% (n=9)
LLSFGP 0.23% (n=9)
LFSLGS 0.23% (n=9)
LFTRGA 0.23% (n=9)
LFDIGP 0.21% (n=8)
LFNSGP 0.21% (n=8)
LFSFGP 0.21% (n=8)
FFSQGA 0.21% (n=8)
LFSWGP 0.21% (n=8)
FFTRGP 0.21% (n=8)
LFQSGA 0.18% (n=7)
LFSVGS 0.18% (n=7)
FFSLGA 0.15% (n=6)
LFDVGA 0.15% (n=6)
LFRLGA 0.15% (n=6)
IFSSGA 0.15% (n=6)
FFSVGA 0.15% (n=6)
LFSVGP 0.15% (n=6)
FLTSGP 0.15% (n=6)
LFSRGP 0.15% (n=6)
LFNLGP 0.15% (n=6)
LFSMGP 0.13% (n=5)
LFNTGA 0.13% (n=5)
LFLPGA 0.13% (n=5)
LFVRGP 0.13% (n=5)
MFSAGP 0.13% (n=5)
FFSPGP 0.13% (n=5)
LFNRGP 0.13% (n=5)
MFAPGA 0.13% (n=5)
IFSVGA 0.13% (n=5)
IFSPGP 0.13% (n=5)
LFNQGA 0.13% (n=5)
LFNRGA 0.10% (n=4)
FFQLGA 0.10% (n=4)
LFTTGP 0.10% (n=4)
MFSTGP 0.10% (n=4)
LFNSGA 0.10% (n=4)
LLTRGP 0.10% (n=4)
LFTAGA 0.10% (n=4)
LLTLGP 0.10% (n=4)
LFSQGS 0.10% (n=4)
LFTPGS 0.10% (n=4)
FFSMGA 0.10% (n=4)
LLSRGP 0.10% (n=4)
LFSMGS 0.08% (n=3)
LFRQGA 0.08% (n=3)
FFSVGP 0.08% (n=3)
FLSFGP 0.08% (n=3)
LFSFGA 0.08% (n=3)
LLTPGA 0.08% (n=3)
LFNPGS 0.08% (n=3)
FFSLGP 0.08% (n=3)
IFSTGP 0.08% (n=3)
LFNQGP 0.08% (n=3)
LFTLGA 0.08% (n=3)
LFRTGA 0.08% (n=3)
FFSAGP 0.08% (n=3)
LFQRGP 0.08% (n=3)
LFDRGA 0.08% (n=3)
LFTQGS 0.08% (n=3)
LFNAGA 0.08% (n=3)
FFTLGP 0.08% (n=3)
MFSPGP 0.08% (n=3)
MFSPGA 0.08% (n=3)
LFQQGA 0.08% (n=3)
LFTMGP 0.08% (n=3)
LFSRGS 0.08% (n=3)
LFSIGP 0.08% (n=3)
LFRKGP 0.08% (n=3)
LFQAGP 0.05% (n=2)
LFQRGA 0.05% (n=2)
LFQLGP 0.05% (n=2)
FFARGP 0.05% (n=2)
PFSVGA 0.05% (n=2)
PFSMGA 0.05% (n=2)
LFRVGT 0.05% (n=2)
LFPTGA 0.05% (n=2)
LLSPGA 0.05% (n=2)
LLNPGA 0.05% (n=2)
FFQRGA 0.05% (n=2)
LFDIGA 0.05% (n=2)
LFDRGP 0.05% (n=2)
LLSAGP 0.05% (n=2)
IFSQGP 0.05% (n=2)
LFTMGA 0.05% (n=2)
LFTIGA 0.05% (n=2)
LFRQGS 0.05% (n=2)
LFNAGP 0.05% (n=2)
LFAPGS 0.05% (n=2)
LFDSGP 0.05% (n=2)
LFKLGP 0.05% (n=2)
LFQMGA 0.05% (n=2)
LFKMGA 0.05% (n=2)
LFDMGP 0.05% (n=2)
LFNMGP 0.05% (n=2)
LFQVGA 0.05% (n=2)
LFAVGA 0.05% (n=2)
MFSLGP 0.05% (n=2)
FLTRGP 0.05% (n=2)
LFAAGP 0.05% (n=2)
WFNVGP 0.05% (n=2)
FFTQGA 0.05% (n=2)
LFTLGS 0.05% (n=2)
LFNVGP 0.05% (n=2)
LFRQGP 0.05% (n=2)
LFRTGP 0.05% (n=2)
LLSPGP 0.05% (n=2)
FLSRGP 0.05% (n=2)
WFTQGP 0.05% (n=2)
LFTTGA 0.05% (n=2)
LFALGP 0.05% (n=2)
LFARGS 0.05% (n=2)
LFVQGP 0.05% (n=2)
LFATGP 0.05% (n=2)
MFSMGP 0.05% (n=2)
LFTKGP 0.05% (n=2)
LFDTGP 0.03% (n=1)
LLRAGP 0.03% (n=1)
FFNRGA 0.03% (n=1)
LFATGA 0.03% (n=1)
FFSIGS 0.03% (n=1)
LFNMGA 0.03% (n=1)
LFNGGA 0.03% (n=1)
LFRAGA 0.03% (n=1)
LFRSGA 0.03% (n=1)
LSQPGA 0.03% (n=1)
FFRPGA 0.03% (n=1)
FFLLGA 0.03% (n=1)
LFQLGA 0.03% (n=1)
FFNLGA 0.03% (n=1)
LIHIGR 0.03% (n=1)
LIHLGR 0.03% (n=1)
VTNPES 0.03% (n=1)
LFWVGP 0.03% (n=1)
LLSAGA 0.03% (n=1)
LFKVGA 0.03% (n=1)
LCTLGP 0.03% (n=1)
LFGPGS 0.03% (n=1)
FFSAGA 0.03% (n=1)
LFASGA 0.03% (n=1)
LIVRGP 0.03% (n=1)
LFDSGA 0.03% (n=1)
LSSPGA 0.03% (n=1)
LSTRGP 0.03% (n=1)
PFHIGR 0.03% (n=1)
LFNAGS 0.03% (n=1)
HISAGA 0.03% (n=1)
FFTVGA 0.03% (n=1)
IFNLGA 0.03% (n=1)
FFDVGF 0.03% (n=1)
LFSIGS 0.03% (n=1)
FFNAGP 0.03% (n=1)
LVSIAP 0.03% (n=1)
IFSPGV 0.03% (n=1)
LLNRGP 0.03% (n=1)
VYTV-- 0.03% (n=1)
LFQTGA 0.03% (n=1)
WFSVGP 0.03% (n=1)
LFQVGV 0.03% (n=1)
LFDPGP 0.03% (n=1)
WFSVGA 0.03% (n=1)
WFSMGP 0.03% (n=1)
WFNVGA 0.03% (n=1)
LFFKGA 0.03% (n=1)
IFSVGP 0.03% (n=1)
WFAQGP 0.03% (n=1)
LFRRGA 0.03% (n=1)
PFSRGA 0.03% (n=1)
LFPRGA 0.03% (n=1)
FFDTGP 0.03% (n=1)
LFKPGA 0.03% (n=1)
LFNVGS 0.03% (n=1)
LLNVGA 0.03% (n=1)
LFSHGP 0.03% (n=1)
MFSRGA 0.03% (n=1)
VFSPGP 0.03% (n=1)
LFDHGP 0.03% (n=1)
WFDRGP 0.03% (n=1)
LLAIGP 0.03% (n=1)
LFQPGP 0.03% (n=1)
LTSLGP 0.03% (n=1)
LLRRGS 0.03% (n=1)
LFNIGA 0.03% (n=1)
LFRSGP 0.03% (n=1)
LFDMGA 0.03% (n=1)
IFSAGA 0.03% (n=1)
MFSVGA 0.03% (n=1)
LFNRGS 0.03% (n=1)
LLSMGP 0.03% (n=1)
LFHAGP 0.03% (n=1)
WFSPGP 0.03% (n=1)
FFTQGP 0.03% (n=1)
LFEAGP 0.03% (n=1)
LFNLGS 0.03% (n=1)
IFSAGS 0.03% (n=1)
FFTIGA 0.03% (n=1)
LLDFGP 0.03% (n=1)
LFTRGS 0.03% (n=1)
LFETGP 0.03% (n=1)
VFNAGP 0.03% (n=1)
IFSLGA 0.03% (n=1)
FFTIGP 0.03% (n=1)
LFNSGS 0.03% (n=1)
WFDLGP 0.03% (n=1)
WLQSGP 0.03% (n=1)
FFSRGP 0.03% (n=1)
MFSAGA 0.03% (n=1)
MFSTGA 0.03% (n=1)
LFSAGS 0.03% (n=1)
WFSAGA 0.03% (n=1)
IFNVGP 0.03% (n=1)
LFLPGP 0.03% (n=1)
LFNKGP 0.03% (n=1)
LFRWGP 0.03% (n=1)
LFDVGS 0.03% (n=1)
LFESGP 0.03% (n=1)
LFHRGA 0.03% (n=1)
IFSSGP 0.03% (n=1)
LFVTGP 0.03% (n=1)
LFKMGP 0.03% (n=1)
IFSLGP 0.03% (n=1)
FFAPGP 0.03% (n=1)
LFNQGS 0.03% (n=1)
LFDRGS 0.03% (n=1)
LLSTGP 0.03% (n=1)
MFTPGP 0.03% (n=1)
LLQVGP 0.03% (n=1)
LMSKGP 0.03% (n=1)
LFDPGS 0.03% (n=1)
FFSLGS 0.03% (n=1)
FFSIGA 0.03% (n=1)
VFALGP 0.03% (n=1)
LLTRGA 0.03% (n=1)
LFQAGA 0.03% (n=1)
WFSPGS 0.03% (n=1)
LFAQGP 0.03% (n=1)
FFQQGA 0.03% (n=1)
LFYPGA 0.03% (n=1)
LFDPGA 0.03% (n=1)
WLSAGP 0.03% (n=1)
IFMPGP 0.03% (n=1)
LLAPGA 0.03% (n=1)
LFDTGA 0.03% (n=1)
FFDVGA 0.03% (n=1)
LFDVGP 0.03% (n=1)
LFAMGP 0.03% (n=1)
KLFSGS 0.03% (n=1)
LFTSGS 0.03% (n=1)
LFTFGP 0.03% (n=1)
LFRPGP 0.03% (n=1)
MFTMGP 0.03% (n=1)
LFHQGA 0.03% (n=1)
IFSPGS 0.03% (n=1)
LLTSGP 0.03% (n=1)
FFDRGP 0.03% (n=1)
LFQQGP 0.03% (n=1)
LFAVGP 0.03% (n=1)
LLASGP 0.03% (n=1)
WFTSGP 0.03% (n=1)
FFTPGP 0.03% (n=1)
WFTRGP 0.03% (n=1)
LFTIGP 0.03% (n=1)
LFISGP 0.03% (n=1)
MFTQGP 0.03% (n=1)
LFTWGP 0.03% (n=1)
LFYSGP 0.03% (n=1)
FFSSGP 0.03% (n=1)
VFTPGP 0.03% (n=1)
LLRPGA 0.03% (n=1)
FFNPGA 0.03% (n=1)
LFQLGS 0.03% (n=1)
IFNPGA 0.03% (n=1)
LFTTGS 0.03% (n=1)
LFCTGP 0.03% (n=1)
VLNPGS 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 3a:

LFSVGA 15.62% (n=510)
LLSLGP 9.71% (n=317)
FLSVGP 7.99% (n=261)
LFSAGA 6.49% (n=212)
LFSMGA 5.17% (n=169)
LFSPGA 4.16% (n=136)
LFSRGA 2.76% (n=90)
LFSTGA 2.73% (n=89)
LFRVGA 2.57% (n=84)
LFTVGA 2.54% (n=83)
LFSLGA 2.48% (n=81)
IFSPGA 1.53% (n=50)
LFRPGA 1.53% (n=50)
FFQPGA 1.32% (n=43)
FFSPGA 1.19% (n=39)
FFSRGA 1.19% (n=39)
LFNPGP 1.16% (n=38)
LFNVGA 1.07% (n=35)
LFTPGA 1.01% (n=33)
LFTLGP 1.01% (n=33)
LFQPGA 0.95% (n=31)
LFTQGA 0.89% (n=29)
LFSPGS 0.83% (n=27)
LFSPGP 0.73% (n=24)
MFQQGA 0.73% (n=24)
LFSQGA 0.70% (n=23)
LFTSGA 0.61% (n=20)
IFSQGA 0.61% (n=20)
LFTSGP 0.55% (n=18)
LFRMGA 0.52% (n=17)
LFSSGP 0.46% (n=15)
LFSSGA 0.43% (n=14)
LFDLGA 0.37% (n=12)
FFDLGA 0.37% (n=12)
IFAPGA 0.37% (n=12)
FFTSGP 0.37% (n=12)
LFNLGA 0.31% (n=10)
LFAPGA 0.31% (n=10)
LFSAGP 0.31% (n=10)
LFNPGA 0.31% (n=10)
LFSTGP 0.28% (n=9)
LFSIGA 0.28% (n=9)
LLSFGP 0.28% (n=9)
LFTRGA 0.28% (n=9)
LFDIGP 0.24% (n=8)
FFSQGA 0.24% (n=8)
LFNTGP 0.21% (n=7)
LFQSGA 0.21% (n=7)
LFSFGP 0.21% (n=7)
LFSVGS 0.21% (n=7)
FFSLGA 0.18% (n=6)
LFDVGA 0.18% (n=6)
LFRLGA 0.18% (n=6)
LFSLGS 0.18% (n=6)
IFSSGA 0.18% (n=6)
FFSVGA 0.18% (n=6)
LFAPGP 0.18% (n=6)
FLTSGP 0.18% (n=6)
LFNTGA 0.15% (n=5)
LFLPGA 0.15% (n=5)
FFSPGP 0.15% (n=5)
LFTPGP 0.15% (n=5)
MFAPGA 0.15% (n=5)
LFTAGP 0.15% (n=5)
IFSVGA 0.15% (n=5)
LFNQGA 0.15% (n=5)
LFSLGP 0.15% (n=5)
LFTVGP 0.12% (n=4)
LFNRGA 0.12% (n=4)
FFQLGA 0.12% (n=4)
LFTRGP 0.12% (n=4)
LFNSGP 0.12% (n=4)
MFSAGP 0.12% (n=4)
MFSTGP 0.12% (n=4)
LFNSGA 0.12% (n=4)
LFTAGA 0.12% (n=4)
LFTQGP 0.12% (n=4)
LFSQGS 0.12% (n=4)
FFSMGA 0.12% (n=4)
LLSRGP 0.12% (n=4)
LFSMGS 0.09% (n=3)
LFRQGA 0.09% (n=3)
FFSVGP 0.09% (n=3)
FLSFGP 0.09% (n=3)
LFSFGA 0.09% (n=3)
LLTPGA 0.09% (n=3)
LFNPGS 0.09% (n=3)
FFSLGP 0.09% (n=3)
LFNQGP 0.09% (n=3)
LFTLGA 0.09% (n=3)
LFRTGA 0.09% (n=3)
FFSAGP 0.09% (n=3)
LFQRGP 0.09% (n=3)
LFNRGP 0.09% (n=3)
LFDRGA 0.09% (n=3)
LFTQGS 0.09% (n=3)
LFNAGA 0.09% (n=3)
FFTLGP 0.09% (n=3)
LLTLGP 0.09% (n=3)
LFSRGP 0.09% (n=3)
IFSPGP 0.09% (n=3)
MFSPGP 0.09% (n=3)
MFSPGA 0.09% (n=3)
LFQQGA 0.09% (n=3)
LFSRGS 0.09% (n=3)
LFQAGP 0.06% (n=2)
LFSMGP 0.06% (n=2)
WFSPGA 0.06% (n=2)
LFQRGA 0.06% (n=2)
LFQLGP 0.06% (n=2)
FFARGP 0.06% (n=2)
PFSVGA 0.06% (n=2)
PFSMGA 0.06% (n=2)
LFRVGT 0.06% (n=2)
LFPTGA 0.06% (n=2)
LFVRGP 0.06% (n=2)
LFTTGP 0.06% (n=2)
LLSPGA 0.06% (n=2)
LLNPGA 0.06% (n=2)
FFQRGA 0.06% (n=2)
IFSTGP 0.06% (n=2)
LFDIGA 0.06% (n=2)
LFDRGP 0.06% (n=2)
LLSAGP 0.06% (n=2)
LFTMGA 0.06% (n=2)
LFTIGA 0.06% (n=2)
LFRQGS 0.06% (n=2)
LLTRGP 0.06% (n=2)
LFNAGP 0.06% (n=2)
LFSVGP 0.06% (n=2)
LFKLGP 0.06% (n=2)
LFQMGA 0.06% (n=2)
LFKMGA 0.06% (n=2)
LFDMGP 0.06% (n=2)
LFNMGP 0.06% (n=2)
LFQVGA 0.06% (n=2)
LFAVGA 0.06% (n=2)
MFSLGP 0.06% (n=2)
FLTRGP 0.06% (n=2)
LFTMGP 0.06% (n=2)
WFNVGP 0.06% (n=2)
FFTQGA 0.06% (n=2)
LFRQGP 0.06% (n=2)
LLSPGP 0.06% (n=2)
FLSRGP 0.06% (n=2)
LFSIGP 0.06% (n=2)
LFARGS 0.06% (n=2)
LFDTGP 0.03% (n=1)
LLRAGP 0.03% (n=1)
FFNRGA 0.03% (n=1)
LFATGA 0.03% (n=1)
FFSIGS 0.03% (n=1)
LFNMGA 0.03% (n=1)
LFNGGA 0.03% (n=1)
LFRAGA 0.03% (n=1)
LFRSGA 0.03% (n=1)
LSQPGA 0.03% (n=1)
FFRPGA 0.03% (n=1)
FFLLGA 0.03% (n=1)
LFQLGA 0.03% (n=1)
FFNLGA 0.03% (n=1)
LIHIGR 0.03% (n=1)
LIHLGR 0.03% (n=1)
VTNPES 0.03% (n=1)
LFWVGP 0.03% (n=1)
LLSAGA 0.03% (n=1)
LFKVGA 0.03% (n=1)
LCTLGP 0.03% (n=1)
LFGPGS 0.03% (n=1)
FFSAGA 0.03% (n=1)
LFASGA 0.03% (n=1)
LIVRGP 0.03% (n=1)
LFDSGA 0.03% (n=1)
LFSQGP 0.03% (n=1)
LSSPGA 0.03% (n=1)
IFSQGP 0.03% (n=1)
LSTRGP 0.03% (n=1)
PFHIGR 0.03% (n=1)
LFNAGS 0.03% (n=1)
HISAGA 0.03% (n=1)
FFTVGA 0.03% (n=1)
IFNLGA 0.03% (n=1)
FFDVGF 0.03% (n=1)
LFSIGS 0.03% (n=1)
FFNAGP 0.03% (n=1)
LVSIAP 0.03% (n=1)
IFSPGV 0.03% (n=1)
LLNRGP 0.03% (n=1)
VYTV-- 0.03% (n=1)
LFAPGS 0.03% (n=1)
LFDSGP 0.03% (n=1)
LFQTGA 0.03% (n=1)
WFSVGP 0.03% (n=1)
LFQVGV 0.03% (n=1)
LFDPGP 0.03% (n=1)
WFSVGA 0.03% (n=1)
WFSMGP 0.03% (n=1)
WFNVGA 0.03% (n=1)
LFFKGA 0.03% (n=1)
IFSVGP 0.03% (n=1)
WFAQGP 0.03% (n=1)
LFTPGS 0.03% (n=1)
LFRRGA 0.03% (n=1)
FFDTGP 0.03% (n=1)
LFKPGA 0.03% (n=1)
LFNVGS 0.03% (n=1)
LLNVGA 0.03% (n=1)
LFSHGP 0.03% (n=1)
MFSRGA 0.03% (n=1)
VFSPGP 0.03% (n=1)
LFDHGP 0.03% (n=1)
WFDRGP 0.03% (n=1)
LLAIGP 0.03% (n=1)
LFQPGP 0.03% (n=1)
LTSLGP 0.03% (n=1)
LLRRGS 0.03% (n=1)
LFAAGP 0.03% (n=1)
LFNIGA 0.03% (n=1)
LFRSGP 0.03% (n=1)
LFDMGA 0.03% (n=1)
LFTLGS 0.03% (n=1)
IFSAGA 0.03% (n=1)
LFNVGP 0.03% (n=1)
MFSVGA 0.03% (n=1)
LFNRGS 0.03% (n=1)
LLSMGP 0.03% (n=1)
LFHAGP 0.03% (n=1)
WFSPGP 0.03% (n=1)
LFRTGP 0.03% (n=1)
FFTQGP 0.03% (n=1)
LFEAGP 0.03% (n=1)
LFNLGS 0.03% (n=1)
IFSAGS 0.03% (n=1)
FFTIGA 0.03% (n=1)
LLDFGP 0.03% (n=1)
LFTRGS 0.03% (n=1)
LFETGP 0.03% (n=1)
WFTQGP 0.03% (n=1)
LFSWGP 0.03% (n=1)
VFNAGP 0.03% (n=1)
IFSLGA 0.03% (n=1)
FFTIGP 0.03% (n=1)
LFTTGA 0.03% (n=1)
LFNSGS 0.03% (n=1)
WFDLGP 0.03% (n=1)
WLQSGP 0.03% (n=1)
FFSRGP 0.03% (n=1)
MFSAGA 0.03% (n=1)
MFSTGA 0.03% (n=1)
LFSAGS 0.03% (n=1)
WFSAGA 0.03% (n=1)
IFNVGP 0.03% (n=1)
LFLPGP 0.03% (n=1)
LFNKGP 0.03% (n=1)
LFRWGP 0.03% (n=1)
LFALGP 0.03% (n=1)
LFESGP 0.03% (n=1)
LFHRGA 0.03% (n=1)
LLSPGS 0.03% (n=1)
IFSSGP 0.03% (n=1)
LFVTGP 0.03% (n=1)
LFKMGP 0.03% (n=1)
IFSLGP 0.03% (n=1)
FFAPGP 0.03% (n=1)
LFNQGS 0.03% (n=1)
LFDRGS 0.03% (n=1)
LLSTGP 0.03% (n=1)
MFTPGP 0.03% (n=1)
LLQVGP 0.03% (n=1)
LMSKGP 0.03% (n=1)
LFDPGS 0.03% (n=1)
FFSLGS 0.03% (n=1)
FFSIGA 0.03% (n=1)
VFALGP 0.03% (n=1)
LLTRGA 0.03% (n=1)
LFQAGA 0.03% (n=1)
WFSPGS 0.03% (n=1)
LFAQGP 0.03% (n=1)
FFQQGA 0.03% (n=1)
LFYPGA 0.03% (n=1)
LFDPGA 0.03% (n=1)
WLSAGP 0.03% (n=1)
IFMPGP 0.03% (n=1)
LLAPGA 0.03% (n=1)
LFDTGA 0.03% (n=1)
FFDVGA 0.03% (n=1)
LFDVGP 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 3b:

LFTLGP 13.39% (n=51)
LFTRGP 12.34% (n=47)
LFARGP 8.40% (n=32)
LFAPGA 7.09% (n=27)
LFSPGP 5.51% (n=21)
LFTSGP 4.46% (n=17)
LFTQGP 4.46% (n=17)
LFSQGP 2.62% (n=10)
LFNPGP 2.36% (n=9)
FFTRGP 2.10% (n=8)
LFTPGP 1.84% (n=7)
LFSSGP 1.84% (n=7)
LFSWGP 1.84% (n=7)
LFNLGP 1.57% (n=6)
LFAPGP 1.31% (n=5)
LFSLGP 1.31% (n=5)
LFTAGP 1.31% (n=5)
LFTVGP 1.31% (n=5)
LFSTGP 1.31% (n=5)
LFSAGP 1.05% (n=4)
LFTPGA 1.05% (n=4)
LFNTGP 1.05% (n=4)
LFSVGP 0.79% (n=3)
LFSMGP 0.79% (n=3)
LFTPGS 0.79% (n=3)
LFSPGS 0.79% (n=3)
LFSRGP 0.79% (n=3)
LFNSGP 0.79% (n=3)
LFVRGP 0.79% (n=3)
LFSLGS 0.79% (n=3)
LFRKGP 0.79% (n=3)
LLTRGP 0.52% (n=2)
LFNRGP 0.52% (n=2)
LFVQGP 0.52% (n=2)
LFSPGA 0.52% (n=2)
LFATGP 0.52% (n=2)
MFSMGP 0.52% (n=2)
LFTKGP 0.52% (n=2)
IFSPGP 0.52% (n=2)
LFAMGP 0.26% (n=1)
IFSTGP 0.26% (n=1)
MFSAGP 0.26% (n=1)
KLFSGS 0.26% (n=1)
LFTSGS 0.26% (n=1)
LFTLGS 0.26% (n=1)
LFTFGP 0.26% (n=1)
LFSIGP 0.26% (n=1)
LFRPGP 0.26% (n=1)
MFTMGP 0.26% (n=1)
LFHQGA 0.26% (n=1)
IFSPGS 0.26% (n=1)
LLTSGP 0.26% (n=1)
LFNVGP 0.26% (n=1)
LFRTGP 0.26% (n=1)
FFDRGP 0.26% (n=1)
LFTQGA 0.26% (n=1)
LFQQGP 0.26% (n=1)
LLTLGP 0.26% (n=1)
LFALGP 0.26% (n=1)
LFTMGP 0.26% (n=1)
LFAVGP 0.26% (n=1)
LLASGP 0.26% (n=1)
LFTTGP 0.26% (n=1)
WFTSGP 0.26% (n=1)
LFAAGP 0.26% (n=1)
FFTPGP 0.26% (n=1)
WFTQGP 0.26% (n=1)
WFTRGP 0.26% (n=1)
LFTIGP 0.26% (n=1)
LFSFGP 0.26% (n=1)
LFISGP 0.26% (n=1)
MFTQGP 0.26% (n=1)
LFTWGP 0.26% (n=1)
LFYSGP 0.26% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 4:

LFQRGS 20.71% (n=158)
LFQPGS 8.91% (n=68)
LFTSGP 8.52% (n=65)
LFKPGS 7.08% (n=54)
LFRQGS 6.55% (n=50)
LFHRGS 4.85% (n=37)
LFTPGA 4.19% (n=32)
LFKRGS 3.80% (n=29)
LLSPGP 2.49% (n=19)
LFTPGS 2.49% (n=19)
LLTPGP 2.36% (n=18)
LFHQGS 2.10% (n=16)
MFSQGS 1.57% (n=12)
LFSPGS 1.31% (n=10)
LFSSGS 1.18% (n=9)
LFSPGA 1.18% (n=9)
LFNPGS 1.05% (n=8)
LFTSGS 1.05% (n=8)
LFSQGS 0.92% (n=7)
LFTQGS 0.79% (n=6)
LFTRGS 0.79% (n=6)
LFNQGS 0.66% (n=5)
LLLSGP 0.66% (n=5)
MFSRGS 0.52% (n=4)
IFTPGA 0.39% (n=3)
IFTPGP 0.39% (n=3)
LLTPGS 0.39% (n=3)
MFSPGS 0.39% (n=3)
FFAPGA 0.26% (n=2)
MFTPGA 0.26% (n=2)
LFTPGP 0.26% (n=2)
LFNPGA 0.26% (n=2)
LFQQGS 0.26% (n=2)
FFTPGS 0.26% (n=2)
IFSQGS 0.26% (n=2)
MFSLGS 0.26% (n=2)
IFSPGP 0.26% (n=2)
LFNSGS 0.26% (n=2)
LFSRGS 0.26% (n=2)
LFTLGP 0.26% (n=2)
LFSLGS 0.26% (n=2)
LFNLGS 0.26% (n=2)
WFTRGP 0.26% (n=2)
IFNPGS 0.26% (n=2)
FFSPGA 0.26% (n=2)
LFQSGS 0.26% (n=2)
LFSPGP 0.26% (n=2)
LFKPGA 0.26% (n=2)
LFRLGS 0.13% (n=1)
LFTYGS 0.13% (n=1)
MFAPGA 0.13% (n=1)
LFTTGP 0.13% (n=1)
LFTAGA 0.13% (n=1)
LFQHGS 0.13% (n=1)
LFGPGP 0.13% (n=1)
LFTAGS 0.13% (n=1)
LFAPGS 0.13% (n=1)
FLTPGP 0.13% (n=1)
LFSAGP 0.13% (n=1)
LLSPGA 0.13% (n=1)
FFNKGS 0.13% (n=1)
LFRRGS 0.13% (n=1)
LFTMGG 0.13% (n=1)
LLNLGP 0.13% (n=1)
LFTQGP 0.13% (n=1)
LLRPGS 0.13% (n=1)
LFRPGA 0.13% (n=1)
LLRSGS 0.13% (n=1)
LFLPGA 0.13% (n=1)
LFIPGA 0.13% (n=1)
MFSPGP 0.13% (n=1)
MFKPGS 0.13% (n=1)
LFTTGS 0.13% (n=1)
IFNLGS 0.13% (n=1)
WLTRGP 0.13% (n=1)
LFTLGS 0.13% (n=1)
IFSRGS 0.13% (n=1)
LFKSGS 0.13% (n=1)
LFKTGS 0.13% (n=1)
MFSVGS 0.13% (n=1)
LFNAGS 0.13% (n=1)
LFTTGA 0.13% (n=1)
LLDRGA 0.13% (n=1)
LFAVGP 0.13% (n=1)
FFKPGP 0.13% (n=1)
LFTFGA 0.13% (n=1)
LFTYGP 0.13% (n=1)
LFSSGA 0.13% (n=1)
LFSQGP 0.13% (n=1)
LFRTGS 0.13% (n=1)
LFRLGA 0.13% (n=1)
LFAPGA 0.13% (n=1)
FFSPGP 0.13% (n=1)
MFASGP 0.13% (n=1)
VFSPGA 0.13% (n=1)
LFAPGP 0.13% (n=1)
LLTRGP 0.13% (n=1)
LFTSGA 0.13% (n=1)
LFTRGP 0.13% (n=1)
IFTSGA 0.13% (n=1)
LLSPGG 0.13% (n=1)
LFSTGP 0.13% (n=1)
IFSPGA 0.13% (n=1)
LFSLGP 0.13% (n=1)
IFSRGP 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 4a:

LFTSGP 38.99% (n=62)
LFTPGA 16.98% (n=27)
LLTPGP 11.32% (n=18)
LLSPGP 10.69% (n=17)
LFSSGS 3.77% (n=6)
LFSPGA 3.77% (n=6)
LFNPGA 1.26% (n=2)
IFTPGA 1.26% (n=2)
LFRLGS 0.63% (n=1)
FFAPGA 0.63% (n=1)
LFTYGS 0.63% (n=1)
MFAPGA 0.63% (n=1)
LFTTGP 0.63% (n=1)
LFTAGA 0.63% (n=1)
LFQHGS 0.63% (n=1)
LFGPGP 0.63% (n=1)
LFTAGS 0.63% (n=1)
LFSPGS 0.63% (n=1)
LFAPGS 0.63% (n=1)
MFTPGA 0.63% (n=1)
LFTPGP 0.63% (n=1)
FLTPGP 0.63% (n=1)
LFQRGS 0.63% (n=1)
LFSAGP 0.63% (n=1)
LLSPGA 0.63% (n=1)
IFTPGP 0.63% (n=1)
FFNKGS 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 4d:

LFQRGS 29.02% (n=157)
LFQPGS 12.57% (n=68)
LFKPGS 9.98% (n=54)
LFRQGS 9.24% (n=50)
LFHRGS 6.84% (n=37)
LFKRGS 5.36% (n=29)
LFTPGS 3.14% (n=17)
LFHQGS 2.96% (n=16)
MFSQGS 2.22% (n=12)
LFNPGS 1.48% (n=8)
LFTSGS 1.48% (n=8)
LFSQGS 1.29% (n=7)
LFSPGS 1.11% (n=6)
LFTQGS 1.11% (n=6)
LFTRGS 1.11% (n=6)
LFNQGS 0.92% (n=5)
MFSRGS 0.74% (n=4)
LLTPGS 0.55% (n=3)
MFSPGS 0.55% (n=3)
LFQQGS 0.37% (n=2)
FFTPGS 0.37% (n=2)
IFSQGS 0.37% (n=2)
MFSLGS 0.37% (n=2)
LFNSGS 0.37% (n=2)
LFSRGS 0.37% (n=2)
LFSLGS 0.37% (n=2)
LFNLGS 0.37% (n=2)
WFTRGP 0.37% (n=2)
LFSSGS 0.37% (n=2)
LFQSGS 0.37% (n=2)
LFRRGS 0.18% (n=1)
LFTMGG 0.18% (n=1)
LLNLGP 0.18% (n=1)
LFTQGP 0.18% (n=1)
LLRPGS 0.18% (n=1)
LFRPGA 0.18% (n=1)
LLRSGS 0.18% (n=1)
LFLPGA 0.18% (n=1)
LFIPGA 0.18% (n=1)
MFSPGP 0.18% (n=1)
IFSPGP 0.18% (n=1)
MFKPGS 0.18% (n=1)
LFTTGS 0.18% (n=1)
LFTLGP 0.18% (n=1)
IFNLGS 0.18% (n=1)
WLTRGP 0.18% (n=1)
LFTLGS 0.18% (n=1)
IFSRGS 0.18% (n=1)
IFNPGS 0.18% (n=1)
FFSPGA 0.18% (n=1)
LFKSGS 0.18% (n=1)
LFKTGS 0.18% (n=1)
MFSVGS 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 5:

LFTPGA 10.14% (n=15)
LFSPGA 6.76% (n=10)
LFTPGP 4.73% (n=7)
LFNPGP 3.38% (n=5)
LFSPGS 3.38% (n=5)
LFSPGP 3.38% (n=5)
LFTSGP 2.70% (n=4)
LFAPGS 2.70% (n=4)
IFSLGP 2.03% (n=3)
IFSPGP 2.03% (n=3)
LFSFGA 2.03% (n=3)
FFNPGP 2.03% (n=3)
LFTPGS 1.35% (n=2)
LFSTGP 1.35% (n=2)
LFAPGA 1.35% (n=2)
LFSAGP 1.35% (n=2)
LFSSGP 1.35% (n=2)
LFTLGP 1.35% (n=2)
LFTLGA 1.35% (n=2)
FFSPGP 1.35% (n=2)
MFTLGP 0.68% (n=1)
LFAYGP 0.68% (n=1)
LFSP-- 0.68% (n=1)
LFTAGP 0.68% (n=1)
LFNAGP 0.68% (n=1)
FLSPGP 0.68% (n=1)
LLAPGP 0.68% (n=1)
LFSIGA 0.68% (n=1)
LFDLGP 0.68% (n=1)
LFFPGA 0.68% (n=1)
FFTTGP 0.68% (n=1)
FFTVGP 0.68% (n=1)
FFAPGS 0.68% (n=1)
ILSPGA 0.68% (n=1)
IFHLGP 0.68% (n=1)
LFAIGS 0.68% (n=1)
LLAPGS 0.68% (n=1)
LFNLGA 0.68% (n=1)
LFD-SS 0.68% (n=1)
FFTRGP 0.68% (n=1)
LFTTGA 0.68% (n=1)
FFTPGP 0.68% (n=1)
FFSRGP 0.68% (n=1)
LFKPGA 0.68% (n=1)
LFNPGS 0.68% (n=1)
FLTLGP 0.68% (n=1)
LFSSGS 0.68% (n=1)
LFRPRA 0.68% (n=1)
IFSSGA 0.68% (n=1)
FFNLGP 0.68% (n=1)
LFRPGA 0.68% (n=1)
LFSSGA 0.68% (n=1)
LFNTGA 0.68% (n=1)
FLTRGP 0.68% (n=1)
LFTRGA 0.68% (n=1)
LFAPGP 0.68% (n=1)
YFPP-S 0.68% (n=1)
LFS--- 0.68% (n=1)
LFQTGA 0.68% (n=1)
LFVSGP 0.68% (n=1)
LFSIGP 0.68% (n=1)
FLRPRP 0.68% (n=1)
LLSPGA 0.68% (n=1)
LLTPGP 0.68% (n=1)
LFDIGP 0.68% (n=1)
FFDFGP 0.68% (n=1)
LFASGP 0.68% (n=1)
LFSTGS 0.68% (n=1)
FFTMGP 0.68% (n=1)
LFTRGP 0.68% (n=1)
LFHPGP 0.68% (n=1)
LFSRGP 0.68% (n=1)
LFNYGP 0.68% (n=1)
LFKRGA 0.68% (n=1)
FFSSGP 0.68% (n=1)
LFNTGP 0.68% (n=1)
FFSAGP 0.68% (n=1)
LFTVGP 0.68% (n=1)
LFQRGS 0.68% (n=1)
LFSRGA 0.68% (n=1)
LFTSGA 0.68% (n=1)
IFTPGP 0.68% (n=1)
WLAPGP 0.68% (n=1)
WFAPGA 0.68% (n=1)
FITRGA 0.68% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 6:

LFTPGA 6.52% (n=33)
LFSPGA 5.14% (n=26)
LFTPGS 3.36% (n=17)
IFSPGA 2.17% (n=11)
LFTSGA 2.17% (n=11)
MFSPGA 2.17% (n=11)
LFAPGA 1.98% (n=10)
IFTPGA 1.98% (n=10)
LFTPGP 1.98% (n=10)
LFSSGA 1.98% (n=10)
MFAPGA 1.98% (n=10)
LFSSGP 1.78% (n=9)
LFTSGP 1.58% (n=8)
LFTTGP 1.58% (n=8)
LFSPGP 1.58% (n=8)
LFSPGS 1.58% (n=8)
LFSTGA 1.38% (n=7)
LFTTGA 1.38% (n=7)
LFTRGS 1.19% (n=6)
MFSSGA 0.99% (n=5)
FFSPGA 0.99% (n=5)
LLTPGA 0.99% (n=5)
LFSTGP 0.99% (n=5)
LFSSGS 0.99% (n=5)
LFTLGP 0.99% (n=5)
LFSLGA 0.99% (n=5)
LFQSGS 0.99% (n=5)
FFTPGA 0.79% (n=4)
LFNPGA 0.79% (n=4)
IFTPGP 0.79% (n=4)
IFAPGA 0.79% (n=4)
LFSLGP 0.79% (n=4)
MFASGA 0.79% (n=4)
LFAPGS 0.79% (n=4)
IFSSGP 0.79% (n=4)
LFSQGS 0.79% (n=4)
LLTPGS 0.79% (n=4)
LLSPGS 0.79% (n=4)
IFSPGP 0.59% (n=3)
LLSPGP 0.59% (n=3)
FFSPGP 0.59% (n=3)
LFNTGP 0.59% (n=3)
LFSFGP 0.59% (n=3)
FLSFGP 0.59% (n=3)
LLSPGA 0.59% (n=3)
LFQTGA 0.59% (n=3)
MFTPGA 0.59% (n=3)
LFTSGS 0.59% (n=3)
LFTAGS 0.59% (n=3)
FFSPGS 0.59% (n=3)
LFSTGS 0.59% (n=3)
LFNPGS 0.59% (n=3)
LFSVGS 0.59% (n=3)
LFTFGP 0.40% (n=2)
LFQPGA 0.40% (n=2)
LFSIGA 0.40% (n=2)
LFTYGS 0.40% (n=2)
IFAPGP 0.40% (n=2)
LFSAGP 0.40% (n=2)
LLAPGP 0.40% (n=2)
VFAPGA 0.40% (n=2)
MFTSGA 0.40% (n=2)
LFNPGP 0.40% (n=2)
LFSAGA 0.40% (n=2)
WFSQGS 0.40% (n=2)
FLSPGP 0.40% (n=2)
LFSVGA 0.40% (n=2)
LFSTGG 0.40% (n=2)
WFTPGS 0.40% (n=2)
LFTLGA 0.40% (n=2)
LFAPGP 0.40% (n=2)
LFKPGS 0.40% (n=2)
LFNQGS 0.40% (n=2)
FLSSGP 0.40% (n=2)
FFSAGP 0.40% (n=2)
FLSPGA 0.40% (n=2)
IFSLGA 0.20% (n=1)
ILPSGA 0.20% (n=1)
LFNLGA 0.20% (n=1)
FFTTGA 0.20% (n=1)
FLAPGP 0.20% (n=1)
IFHPGP 0.20% (n=1)
WFSAGA 0.20% (n=1)
LFVPGP 0.20% (n=1)
LFTIGA 0.20% (n=1)
MFATGP 0.20% (n=1)
FFNPGP 0.20% (n=1)
FFTPGP 0.20% (n=1)
LFNTGA 0.20% (n=1)
VFSLGP 0.20% (n=1)
LFASGP 0.20% (n=1)
FFTAGP 0.20% (n=1)
LFSYGA 0.20% (n=1)
FFAPGP 0.20% (n=1)
LLSYGA 0.20% (n=1)
LFLSGA 0.20% (n=1)
FFTTGP 0.20% (n=1)
LLAPGA 0.20% (n=1)
FFFPGP 0.20% (n=1)
FFSSGA 0.20% (n=1)
AFAPGP 0.20% (n=1)
VFATGA 0.20% (n=1)
MFSFGA 0.20% (n=1)
WLSSGP 0.20% (n=1)
LFSFGS 0.20% (n=1)
MLSPGA 0.20% (n=1)
LFGSGP 0.20% (n=1)
MFTTGA 0.20% (n=1)
MFSSGP 0.20% (n=1)
MFNPGA 0.20% (n=1)
FLTPGA 0.20% (n=1)
IFTTGA 0.20% (n=1)
FFASGP 0.20% (n=1)
FFSLGP 0.20% (n=1)
IFSLGP 0.20% (n=1)
IFYPGP 0.20% (n=1)
FFTQGP 0.20% (n=1)
LFHSGP 0.20% (n=1)
LFNSGP 0.20% (n=1)
IFSTGA 0.20% (n=1)
LFNLGS 0.20% (n=1)
LFNFGA 0.20% (n=1)
FFKTGA 0.20% (n=1)
LFSQGP 0.20% (n=1)
LFKPGA 0.20% (n=1)
LFYPGA 0.20% (n=1)
LLARGP 0.20% (n=1)
FFSSGP 0.20% (n=1)
LFRSGA 0.20% (n=1)
LFASGA 0.20% (n=1)
LFSLGS 0.20% (n=1)
LFHSGS 0.20% (n=1)
LFKSGS 0.20% (n=1)
MFNPGS 0.20% (n=1)
LFHRGS 0.20% (n=1)
LFTQGP 0.20% (n=1)
LFALGP 0.20% (n=1)
LFSQGA 0.20% (n=1)
IFSHGP 0.20% (n=1)
WFGVGP 0.20% (n=1)
LFSAGS 0.20% (n=1)
FLLPGP 0.20% (n=1)
LFTRGP 0.20% (n=1)
LFAIGP 0.20% (n=1)
MFSQGA 0.20% (n=1)
IFNPGP 0.20% (n=1)
MFMPGA 0.20% (n=1)
WLTPGS 0.20% (n=1)
LLSTGP 0.20% (n=1)
LFEPGA 0.20% (n=1)
VFSPGA 0.20% (n=1)
IFHPGA 0.20% (n=1)
LFHPGS 0.20% (n=1)
LFAHGP 0.20% (n=1)
VFSPGS 0.20% (n=1)
LLSSGA 0.20% (n=1)
IFTSGP 0.20% (n=1)
LFSFGA 0.20% (n=1)
LFNSGA 0.20% (n=1)
LFNRGA 0.20% (n=1)
LFTQGA 0.20% (n=1)
LFDSGP 0.20% (n=1)
LFNLGP 0.20% (n=1)
LFTRGA 0.20% (n=1)
LFTIGP 0.20% (n=1)
LFKAGS 0.20% (n=1)
LFRPGS 0.20% (n=1)
LFEPGS 0.20% (n=1)
LFSMGS 0.20% (n=1)
LFESGP 0.20% (n=1)
FFAPGA 0.20% (n=1)
LLTLGS 0.20% (n=1)
IFAPGS 0.20% (n=1)
LFTLGS 0.20% (n=1)
LFNVGS 0.20% (n=1)
LFQLGA 0.20% (n=1)
LFDLGP 0.20% (n=1)
IFAQGP 0.20% (n=1)
IFDQGP 0.20% (n=1)
LFNVGA 0.20% (n=1)
MFTSGP 0.20% (n=1)
LFTAGP 0.20% (n=1)
IFSPGS 0.20% (n=1)
LFMPGA 0.20% (n=1)
LFQAGP 0.20% (n=1)
LFSHGP 0.20% (n=1)
IFLPGA 0.20% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Subtype 6a:

LFTPGA 9.62% (n=25)
LFSPGA 5.38% (n=14)
MFSPGA 4.23% (n=11)
LFTSGA 3.85% (n=10)
MFAPGA 3.85% (n=10)
LFAPGA 3.08% (n=8)
LFTSGP 3.08% (n=8)
IFSPGA 2.69% (n=7)
LFSTGA 2.31% (n=6)
LFTPGP 2.31% (n=6)
LFSSGA 2.31% (n=6)
LFTTGA 2.31% (n=6)
LFSSGP 2.31% (n=6)
MFSSGA 1.92% (n=5)
FFSPGA 1.92% (n=5)
LFTTGP 1.92% (n=5)
FFTPGA 1.54% (n=4)
IFAPGA 1.54% (n=4)
MFASGA 1.54% (n=4)
IFTPGA 1.15% (n=3)
LLTPGA 1.15% (n=3)
FFSPGP 1.15% (n=3)
LFSFGP 1.15% (n=3)
FLSFGP 1.15% (n=3)
MFTPGA 1.15% (n=3)
LFTFGP 0.77% (n=2)
LFNPGA 0.77% (n=2)
IFTPGP 0.77% (n=2)
LFSIGA 0.77% (n=2)
LFTYGS 0.77% (n=2)
IFAPGP 0.77% (n=2)
LFNTGP 0.77% (n=2)
LFSLGP 0.77% (n=2)
LLSPGA 0.77% (n=2)
LLAPGP 0.77% (n=2)
VFAPGA 0.77% (n=2)
MFTSGA 0.77% (n=2)
LFAPGS 0.77% (n=2)
LFSLGA 0.77% (n=2)
IFSLGA 0.38% (n=1)
ILPSGA 0.38% (n=1)
LFQPGA 0.38% (n=1)
IFSPGP 0.38% (n=1)
LFNLGA 0.38% (n=1)
FFTTGA 0.38% (n=1)
FLAPGP 0.38% (n=1)
IFHPGP 0.38% (n=1)
WFSAGA 0.38% (n=1)
LFVPGP 0.38% (n=1)
LFTIGA 0.38% (n=1)
MFATGP 0.38% (n=1)
LLSPGP 0.38% (n=1)
FFNPGP 0.38% (n=1)
LFSTGP 0.38% (n=1)
FFTPGP 0.38% (n=1)
LFNTGA 0.38% (n=1)
LFSAGP 0.38% (n=1)
VFSLGP 0.38% (n=1)
LFASGP 0.38% (n=1)
FFTAGP 0.38% (n=1)
LFSYGA 0.38% (n=1)
FFAPGP 0.38% (n=1)
LLSYGA 0.38% (n=1)
LFQTGA 0.38% (n=1)
LFLSGA 0.38% (n=1)
FFTTGP 0.38% (n=1)
LLAPGA 0.38% (n=1)
FFFPGP 0.38% (n=1)
FFSSGA 0.38% (n=1)
AFAPGP 0.38% (n=1)
VFATGA 0.38% (n=1)
MFSFGA 0.38% (n=1)
WLSSGP 0.38% (n=1)
LFSFGS 0.38% (n=1)
MLSPGA 0.38% (n=1)
LFGSGP 0.38% (n=1)
MFTTGA 0.38% (n=1)
MFSSGP 0.38% (n=1)
MFNPGA 0.38% (n=1)
FLTPGA 0.38% (n=1)
LFSSGS 0.38% (n=1)
IFTTGA 0.38% (n=1)
FFASGP 0.38% (n=1)
FFSLGP 0.38% (n=1)
IFSLGP 0.38% (n=1)
IFYPGP 0.38% (n=1)
LFSPGP 0.38% (n=1)
FFTQGP 0.38% (n=1)
LFHSGP 0.38% (n=1)
LFNSGP 0.38% (n=1)
IFSTGA 0.38% (n=1)
LFNLGS 0.38% (n=1)
LFTSGS 0.38% (n=1)
LFNFGA 0.38% (n=1)
FFKTGA 0.38% (n=1)
LFSQGP 0.38% (n=1)
LFTLGP 0.38% (n=1)
LFKPGA 0.38% (n=1)
LFYPGA 0.38% (n=1)
LLARGP 0.38% (n=1)
LFNPGP 0.38% (n=1)
FFSSGP 0.38% (n=1)
LFRSGA 0.38% (n=1)
---------------------------------------------------------------------------------------
Region 402-407 (antibodies: [J6.36] ), HCV Genotype 7:

LLNPGP 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 1:

GFLAALFY 22.37% (n=5129)
GWIAGLFY 13.79% (n=3162)
GWLAGLFY 12.72% (n=2916)
GWVAGLFY 12.37% (n=2837)
GFIAALFY 8.89% (n=2039)
GWIAGLLY 5.12% (n=1175)
GWVAGLLY 4.41% (n=1012)
GWIAGLIY 2.77% (n=635)
GWLAALFY 2.67% (n=613)
GFFAALFY 1.76% (n=403)
GWLAGLLY 1.40% (n=322)
GFISALFY 1.21% (n=278)
GFIAGLFY 1.14% (n=261)
GWVAGLIY 0.67% (n=153)
GFIAALIY 0.66% (n=152)
GWVAALFY 0.54% (n=123)
GWLAGLIY 0.49% (n=112)
GFLASLFY 0.47% (n=107)
GFIAGLLY 0.44% (n=102)
GFIAALLY 0.42% (n=97)
GWMAGLFY 0.41% (n=95)
GFIAGLFH 0.32% (n=74)
GWLAGLVY 0.31% (n=71)
GWIAALFY 0.31% (n=71)
GFLAGLLY 0.31% (n=70)
GFVAALFY 0.28% (n=65)
GFITALFY 0.27% (n=63)
GWITGLFY 0.18% (n=42)
GWLTGLFY 0.15% (n=35)
GFVAGLFY 0.15% (n=34)
GWLAGLMY 0.14% (n=32)
GFLAGLFY 0.13% (n=29)
GWIAGLMY 0.12% (n=27)
GWLASLFY 0.11% (n=26)
GFIAALVY 0.11% (n=25)
GFLTALFY 0.10% (n=23)
GFFTALFY 0.10% (n=23)
GFVAALIY 0.09% (n=20)
GFLAALIY 0.07% (n=17)
GFLSALFY 0.07% (n=17)
GFIASLFY 0.06% (n=13)
GFFSALFY 0.06% (n=13)
GWIAGLFH 0.05% (n=12)
GWLAGLFH 0.05% (n=12)
GFLAALLY 0.05% (n=12)
GWLVGLFY 0.04% (n=10)
GFLAALSY 0.04% (n=10)
GWVTGLFY 0.04% (n=9)
GLLAALFY 0.04% (n=9)
GWIAGLVY 0.03% (n=8)
GWLTGLFH 0.03% (n=7)
GFFAALVY 0.03% (n=7)
GSLAALFY 0.03% (n=7)
GFITSLFY 0.02% (n=5)
DWLAGLFY 0.02% (n=5)
AWIAGLLY 0.02% (n=5)
AGIAGLLY 0.02% (n=5)
GFIAGLIY 0.02% (n=5)
GWVAALLY 0.02% (n=5)
GFIATLFY 0.02% (n=5)
GFLAAPFY 0.02% (n=5)
GFVAGLLY 0.02% (n=4)
GFTAGLFY 0.02% (n=4)
GWLAGLFN 0.02% (n=4)
GWAAGLFY 0.02% (n=4)
G*VAGLFY 0.02% (n=4)
GWIVGLFY 0.02% (n=4)
GW------ 0.02% (n=4)
GFLAVLFY 0.02% (n=4)
GFFAALIY 0.02% (n=4)
GFLAALFH 0.02% (n=4)
GFIAALMY 0.02% (n=4)
GRVAGLFY 0.01% (n=3)
GWVAGLFC 0.01% (n=3)
GWIAGLFN 0.01% (n=3)
GWLAGPFY 0.01% (n=3)
GGVAGLFY 0.01% (n=3)
GWVAGLFH 0.01% (n=3)
GWLAGLFS 0.01% (n=3)
GWMAGLLY 0.01% (n=3)
GWFVGLFY 0.01% (n=3)
GFLATLFY 0.01% (n=3)
GFLAALFN 0.01% (n=3)
EFLAALFY 0.01% (n=3)
GFLVALFY 0.01% (n=3)
GFMAALFY 0.01% (n=3)
GSIAALFY 0.01% (n=3)
GFLAALFA 0.01% (n=3)
G*LAGLFY 0.01% (n=2)
GWVAGPFY 0.01% (n=2)
GWGAGLFY 0.01% (n=2)
GWLAGLSY 0.01% (n=2)
GWLAGLF* 0.01% (n=2)
GWIAGLFC 0.01% (n=2)
GFMAGLLY 0.01% (n=2)
GWVAGLHY 0.01% (n=2)
DWVAGLLY 0.01% (n=2)
GWTAGLFY 0.01% (n=2)
GRIAGLFY 0.01% (n=2)
AWLAGLLY 0.01% (n=2)
GWLAGLLH 0.01% (n=2)
GFIAGPFY 0.01% (n=2)
GFLAGLFS 0.01% (n=2)
GFIAGLMY 0.01% (n=2)
GWLAGPFS 0.01% (n=2)
GWVARLFY 0.01% (n=2)
GWLARLFY 0.01% (n=2)
GFVAGLIY 0.01% (n=2)
GFMAGLFY 0.01% (n=2)
GFIAGLFC 0.01% (n=2)
SWLAGLFY 0.01% (n=2)
GFLAALFF 0.01% (n=2)
GFITALIY 0.01% (n=2)
GFIDALVY 0.01% (n=2)
GVLAALFY 0.01% (n=2)
GFVASLFY 0.01% (n=2)
GFIAELFY 0.01% (n=2)
GFFVALFY 0.01% (n=2)
GFIAALSY 0.01% (n=2)
RFPAALFY 0.01% (n=2)
GFIAALFC 0.01% (n=2)
GLIAALFY 0.01% (n=2)
GFPAALFY 0.01% (n=2)
GWIAGLPY 0.00% (n=1)
G*IAGLFY 0.00% (n=1)
GRVAGLLY 0.00% (n=1)
GWLARLLY 0.00% (n=1)
GFITRPFY 0.00% (n=1)
GWLAGLLC 0.00% (n=1)
GWLAGFSY 0.00% (n=1)
GWVAGLSY 0.00% (n=1)
SWVAGLFY 0.00% (n=1)
GWIAGPSY 0.00% (n=1)
GWDSRAFL 0.00% (n=1)
RWIGRLFY 0.00% (n=1)
GRVAGLIY 0.00% (n=1)
GWVAGLIH 0.00% (n=1)
GWLGSRAS 0.00% (n=1)
GWEAGLFY 0.00% (n=1)
DWVAGLFY 0.00% (n=1)
GWIAGLLP 0.00% (n=1)
GWVAGFLY 0.00% (n=1)
GCLAGLFY 0.00% (n=1)
GWLAGHFY 0.00% (n=1)
GWLAGPLY 0.00% (n=1)
GWTAGLLY 0.00% (n=1)
GWMAGLIY 0.00% (n=1)
GWIAGLNY 0.00% (n=1)
GWIGGLFY 0.00% (n=1)
GWVAAPFY 0.00% (n=1)
GWKAGLIY 0.00% (n=1)
GWIAGLTY 0.00% (n=1)
GFITGLLY 0.00% (n=1)
SWLAGLIY 0.00% (n=1)
GWLTGLFS 0.00% (n=1)
GLVAGLLY 0.00% (n=1)
GWIAGLIH 0.00% (n=1)
GFLAGLIY 0.00% (n=1)
GYPADQH* 0.00% (n=1)
GWIAGLFS 0.00% (n=1)
GWVASLFY 0.00% (n=1)
GWIRGLFY 0.00% (n=1)
GCIAGLFY 0.00% (n=1)
GWLVGLLY 0.00% (n=1)
-----LFY 0.00% (n=1)
GWLAWLFY 0.00% (n=1)
GWVAELFY 0.00% (n=1)
GRLVGLFY 0.00% (n=1)
DFIAGLFY 0.00% (n=1)
GLTAGLFY 0.00% (n=1)
GLIAGLFY 0.00% (n=1)
GWITGLIY 0.00% (n=1)
G*VAALFY 0.00% (n=1)
G*IAGLIY 0.00% (n=1)
GWIAGPIY 0.00% (n=1)
GWLAELFY 0.00% (n=1)
GWVVGLLY 0.00% (n=1)
G*VAGLLY 0.00% (n=1)
GWKAGLLY 0.00% (n=1)
GWIAGPLY 0.00% (n=1)
GWWRGLFY 0.00% (n=1)
GWVPGLFY 0.00% (n=1)
G*IAGLLY 0.00% (n=1)
GWLSGAPL 0.00% (n=1)
GFLTGLFY 0.00% (n=1)
GWIA---- 0.00% (n=1)
G------- 0.00% (n=1)
GWVAGLFS 0.00% (n=1)
GWVAGFFY 0.00% (n=1)
GWLAGLST 0.00% (n=1)
DWLAGLLY 0.00% (n=1)
GWVTGLLY 0.00% (n=1)
GWLAGLLN 0.00% (n=1)
GWLAGFLY 0.00% (n=1)
GWLAGLPY 0.00% (n=1)
GWLAWLLY 0.00% (n=1)
GGLAGLFY 0.00% (n=1)
GWAAGLLY 0.00% (n=1)
GWVAGLFN 0.00% (n=1)
GWISGLFY 0.00% (n=1)
GWVAGLFF 0.00% (n=1)
GWIAGPFY 0.00% (n=1)
GWAAGLVY 0.00% (n=1)
GWIAGLSY 0.00% (n=1)
GFLGALFY 0.00% (n=1)
GFLPALFY 0.00% (n=1)
GFLAELFY 0.00% (n=1)
GFLAAL-- 0.00% (n=1)
GFLAGVFY 0.00% (n=1)
GFLAARFY 0.00% (n=1)
RFLAALFY 0.00% (n=1)
GWLAALIY 0.00% (n=1)
GFIAALFH 0.00% (n=1)
GFIKALFY 0.00% (n=1)
GSLASLFY 0.00% (n=1)
GILAALFY 0.00% (n=1)
VFFAALFY 0.00% (n=1)
GFTAALFY 0.00% (n=1)
GFFTVLFY 0.00% (n=1)
GFLAALVY 0.00% (n=1)
GFFASLFY 0.00% (n=1)
GFIAAPFY 0.00% (n=1)
GFIAVLFY 0.00% (n=1)
GFLAALFC 0.00% (n=1)
GFVSALFY 0.00% (n=1)
GFTSALFY 0.00% (n=1)
GFISALSY 0.00% (n=1)
GFISALFH 0.00% (n=1)
GFISALFC 0.00% (n=1)
GWIASLFY 0.00% (n=1)
GFLVSLFY 0.00% (n=1)
GFLAALFL 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 1a:

GWIAGLFY 23.19% (n=3162)
GWLAGLFY 21.38% (n=2915)
GWVAGLFY 20.77% (n=2832)
GWIAGLLY 8.62% (n=1175)
GWVAGLLY 7.42% (n=1012)
GWIAGLIY 4.66% (n=635)
GWLAGLLY 2.35% (n=321)
GFIAGLFY 1.87% (n=255)
GWVAGLIY 1.12% (n=153)
GWVAALFY 0.83% (n=113)
GWLAGLIY 0.82% (n=112)
GWMAGLFY 0.70% (n=95)
GFIAGLFH 0.54% (n=74)
GWLAGLVY 0.52% (n=71)
GWLAALFY 0.51% (n=69)
GFLAGLLY 0.48% (n=66)
GWIAALFY 0.43% (n=59)
GFIAGLLY 0.38% (n=52)
GWITGLFY 0.31% (n=42)
GWLTGLFY 0.26% (n=35)
GFVAGLFY 0.25% (n=34)
GWLAGLMY 0.23% (n=32)
GWIAGLMY 0.20% (n=27)
GFLAGLFY 0.17% (n=23)
GWIAGLFH 0.09% (n=12)
GWLAGLFH 0.09% (n=12)
GWLVGLFY 0.07% (n=10)
GWVTGLFY 0.07% (n=9)
GWIAGLVY 0.06% (n=8)
GWLTGLFH 0.05% (n=7)
DWLAGLFY 0.04% (n=5)
AWIAGLLY 0.04% (n=5)
AGIAGLLY 0.04% (n=5)
GFVAGLLY 0.03% (n=4)
GFTAGLFY 0.03% (n=4)
GWLAGLFN 0.03% (n=4)
GWAAGLFY 0.03% (n=4)
G*VAGLFY 0.03% (n=4)
GFIAGLIY 0.03% (n=4)
GWIVGLFY 0.03% (n=4)
GW------ 0.03% (n=4)
GRVAGLFY 0.02% (n=3)
GWVAGLFC 0.02% (n=3)
GWIAGLFN 0.02% (n=3)
GWLAGPFY 0.02% (n=3)
GGVAGLFY 0.02% (n=3)
GWVAGLFH 0.02% (n=3)
GWLAGLFS 0.02% (n=3)
GWLASLFY 0.02% (n=3)
GWMAGLLY 0.02% (n=3)
GWFVGLFY 0.02% (n=3)
G*LAGLFY 0.01% (n=2)
GWVAGPFY 0.01% (n=2)
GFITSLFY 0.01% (n=2)
GWGAGLFY 0.01% (n=2)
GWLAGLSY 0.01% (n=2)
GWLAGLF* 0.01% (n=2)
GWIAGLFC 0.01% (n=2)
GFMAGLLY 0.01% (n=2)
GWVAGLHY 0.01% (n=2)
DWVAGLLY 0.01% (n=2)
GWTAGLFY 0.01% (n=2)
GRIAGLFY 0.01% (n=2)
AWLAGLLY 0.01% (n=2)
GWLAGLLH 0.01% (n=2)
GFIAGPFY 0.01% (n=2)
GFLAGLFS 0.01% (n=2)
GFIAGLMY 0.01% (n=2)
GWLAGPFS 0.01% (n=2)
GWVARLFY 0.01% (n=2)
GWLARLFY 0.01% (n=2)
GFVAGLIY 0.01% (n=2)
GFMAGLFY 0.01% (n=2)
GFIAGLFC 0.01% (n=2)
GWVAALLY 0.01% (n=2)
SWLAGLFY 0.01% (n=2)
GWIAGLPY 0.01% (n=1)
G*IAGLFY 0.01% (n=1)
GRVAGLLY 0.01% (n=1)
GWLARLLY 0.01% (n=1)
GFITRPFY 0.01% (n=1)
GWLAGLLC 0.01% (n=1)
GWLAGFSY 0.01% (n=1)
GWVAGLSY 0.01% (n=1)
SWVAGLFY 0.01% (n=1)
GWIAGPSY 0.01% (n=1)
GWDSRAFL 0.01% (n=1)
RWIGRLFY 0.01% (n=1)
GRVAGLIY 0.01% (n=1)
GWVAGLIH 0.01% (n=1)
GWLGSRAS 0.01% (n=1)
GWEAGLFY 0.01% (n=1)
DWVAGLFY 0.01% (n=1)
GWIAGLLP 0.01% (n=1)
GWVAGFLY 0.01% (n=1)
GCLAGLFY 0.01% (n=1)
GWLAGHFY 0.01% (n=1)
GWLAGPLY 0.01% (n=1)
GWTAGLLY 0.01% (n=1)
GWMAGLIY 0.01% (n=1)
GWIAGLNY 0.01% (n=1)
GWIGGLFY 0.01% (n=1)
GWVAAPFY 0.01% (n=1)
GWKAGLIY 0.01% (n=1)
GWIAGLTY 0.01% (n=1)
GFITGLLY 0.01% (n=1)
SWLAGLIY 0.01% (n=1)
GWLTGLFS 0.01% (n=1)
GLVAGLLY 0.01% (n=1)
GFIASLFY 0.01% (n=1)
GWIAGLIH 0.01% (n=1)
GFLAGLIY 0.01% (n=1)
GYPADQH* 0.01% (n=1)
GWIAGLFS 0.01% (n=1)
GWVASLFY 0.01% (n=1)
GFVAALFY 0.01% (n=1)
GWIRGLFY 0.01% (n=1)
GCIAGLFY 0.01% (n=1)
GWLVGLLY 0.01% (n=1)
-----LFY 0.01% (n=1)
GWLAWLFY 0.01% (n=1)
GWVAELFY 0.01% (n=1)
GRLVGLFY 0.01% (n=1)
DFIAGLFY 0.01% (n=1)
GLTAGLFY 0.01% (n=1)
GLIAGLFY 0.01% (n=1)
GWITGLIY 0.01% (n=1)
G*VAALFY 0.01% (n=1)
G*IAGLIY 0.01% (n=1)
GWIAGPIY 0.01% (n=1)
GWLAELFY 0.01% (n=1)
GWVVGLLY 0.01% (n=1)
G*VAGLLY 0.01% (n=1)
GWKAGLLY 0.01% (n=1)
GWIAGPLY 0.01% (n=1)
GWWRGLFY 0.01% (n=1)
GWVPGLFY 0.01% (n=1)
G*IAGLLY 0.01% (n=1)
GWLSGAPL 0.01% (n=1)
GFLTGLFY 0.01% (n=1)
GWIA---- 0.01% (n=1)
G------- 0.01% (n=1)
GWVAGLFS 0.01% (n=1)
GWVAGFFY 0.01% (n=1)
GWLAGLST 0.01% (n=1)
GFLAALIY 0.01% (n=1)
DWLAGLLY 0.01% (n=1)
GWVTGLLY 0.01% (n=1)
GWLAGLLN 0.01% (n=1)
GWLAGFLY 0.01% (n=1)
GWLAGLPY 0.01% (n=1)
GWLAWLLY 0.01% (n=1)
GGLAGLFY 0.01% (n=1)
GWAAGLLY 0.01% (n=1)
GWVAGLFN 0.01% (n=1)
GWISGLFY 0.01% (n=1)
GWVAGLFF 0.01% (n=1)
GWIAGPFY 0.01% (n=1)
GWAAGLVY 0.01% (n=1)
GWIAGLSY 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 1b:

GFLAALFY 55.41% (n=5124)
GFIAALFY 22.00% (n=2035)
GWLAALFY 5.84% (n=540)
GFFAALFY 4.36% (n=403)
GFISALFY 3.01% (n=278)
GFIAALIY 1.63% (n=151)
GFLASLFY 1.14% (n=105)
GFIAALLY 1.04% (n=96)
GFVAALFY 0.69% (n=64)
GFITALFY 0.68% (n=63)
GFIAGLLY 0.53% (n=49)
GFIAALVY 0.26% (n=24)
GFLTALFY 0.25% (n=23)
GFFTALFY 0.25% (n=23)
GFVAALIY 0.22% (n=20)
GWLASLFY 0.22% (n=20)
GFLSALFY 0.18% (n=17)
GFLAALIY 0.17% (n=16)
GFFSALFY 0.14% (n=13)
GFLAALLY 0.13% (n=12)
GFIASLFY 0.13% (n=12)
GWIAALFY 0.13% (n=12)
GFLAALSY 0.11% (n=10)
GLLAALFY 0.10% (n=9)
GWVAALFY 0.09% (n=8)
GFFAALVY 0.08% (n=7)
GSLAALFY 0.08% (n=7)
GFIATLFY 0.05% (n=5)
GFLAAPFY 0.05% (n=5)
GFIAGLFY 0.05% (n=5)
GFLAVLFY 0.04% (n=4)
GFFAALIY 0.04% (n=4)
GFLAALFH 0.04% (n=4)
GFIAALMY 0.04% (n=4)
GFLATLFY 0.03% (n=3)
GFLAALFN 0.03% (n=3)
GFITSLFY 0.03% (n=3)
EFLAALFY 0.03% (n=3)
GFLVALFY 0.03% (n=3)
GWVAALLY 0.03% (n=3)
GFMAALFY 0.03% (n=3)
GSIAALFY 0.03% (n=3)
GFLAALFF 0.02% (n=2)
GFITALIY 0.02% (n=2)
GFIDALVY 0.02% (n=2)
GVLAALFY 0.02% (n=2)
GFVASLFY 0.02% (n=2)
GFIAELFY 0.02% (n=2)
GFFVALFY 0.02% (n=2)
GFIAALSY 0.02% (n=2)
RFPAALFY 0.02% (n=2)
GFIAALFC 0.02% (n=2)
GLIAALFY 0.02% (n=2)
GFPAALFY 0.02% (n=2)
GFLAGLLY 0.01% (n=1)
GFLGALFY 0.01% (n=1)
GFLPALFY 0.01% (n=1)
GFLAELFY 0.01% (n=1)
GFLAAL-- 0.01% (n=1)
GFLAGVFY 0.01% (n=1)
GFLAARFY 0.01% (n=1)
RFLAALFY 0.01% (n=1)
GWLAALIY 0.01% (n=1)
GFLAGLFY 0.01% (n=1)
GFIAALFH 0.01% (n=1)
GFIAGLIY 0.01% (n=1)
GFIKALFY 0.01% (n=1)
GSLASLFY 0.01% (n=1)
GILAALFY 0.01% (n=1)
VFFAALFY 0.01% (n=1)
GFTAALFY 0.01% (n=1)
GFFTVLFY 0.01% (n=1)
GFLAALVY 0.01% (n=1)
GFFASLFY 0.01% (n=1)
GFIAAPFY 0.01% (n=1)
GFIAVLFY 0.01% (n=1)
GFLAALFC 0.01% (n=1)
GFVSALFY 0.01% (n=1)
GFTSALFY 0.01% (n=1)
GFISALSY 0.01% (n=1)
GFISALFH 0.01% (n=1)
GFISALFC 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 2:

GFIAALFY 34.11% (n=456)
GFIASLFY 27.82% (n=372)
GFLASLFY 19.37% (n=259)
GFLAALFY 3.52% (n=47)
GWLASLFY 3.22% (n=43)
GFVASLFY 2.69% (n=36)
GFITSLFY 0.82% (n=11)
GFVAALFY 0.75% (n=10)
GFMASLFY 0.60% (n=8)
GFISSLFY 0.45% (n=6)
GFFASLFY 0.45% (n=6)
GFLVSLFY 0.45% (n=6)
GFFAALFY 0.45% (n=6)
GWIHSLFY 0.37% (n=5)
GFITALFY 0.30% (n=4)
GWIASLFY 0.30% (n=4)
GSIAALFY 0.30% (n=4)
GFMAALFY 0.22% (n=3)
GFIAALLY 0.22% (n=3)
GFIVSLFY 0.15% (n=2)
GFLASLFH 0.15% (n=2)
GFLTSLFY 0.15% (n=2)
GFIATLFF 0.15% (n=2)
GFIAALVY 0.15% (n=2)
GCLSSLFY 0.15% (n=2)
GFLAALFH 0.07% (n=1)
GFFTALFY 0.07% (n=1)
GFISALIY 0.07% (n=1)
GFLGSLFY 0.07% (n=1)
GFLASPFY 0.07% (n=1)
GFLSSLFY 0.07% (n=1)
GFVCQLFY 0.07% (n=1)
GFVTQLFY 0.07% (n=1)
GFIAALFF 0.07% (n=1)
GFLAALFR 0.07% (n=1)
GFIRALFY 0.07% (n=1)
GFIHSLFY 0.07% (n=1)
GFIASLF- 0.07% (n=1)
GWLAPLFY 0.07% (n=1)
GWLASLVY 0.07% (n=1)
GWLASLLY 0.07% (n=1)
GLIASLFY 0.07% (n=1)
GFIAPLFY 0.07% (n=1)
GFFAALLY 0.07% (n=1)
GFVAALLY 0.07% (n=1)
GFLSALFY 0.07% (n=1)
GFIAALFC 0.07% (n=1)
GFFSALFY 0.07% (n=1)
GFIAGLIY 0.07% (n=1)
GFLTALFY 0.07% (n=1)
GWVAALFY 0.07% (n=1)
GFIAALFH 0.07% (n=1)
GFIAVLFY 0.07% (n=1)
GLIAALFY 0.07% (n=1)
GIIAALFY 0.07% (n=1)
GFIASLFH 0.07% (n=1)
GFISALFY 0.07% (n=1)
GFPASLFY 0.07% (n=1)
GLLASLFY 0.07% (n=1)
GFLAPLFY 0.07% (n=1)
GFLASLSY 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 2a:

GFLASLFY 43.17% (n=120)
GFIASLFY 16.19% (n=45)
GFVASLFY 12.95% (n=36)
GFLAALFY 7.91% (n=22)
GFIAALFY 5.76% (n=16)
GFVAALFY 2.16% (n=6)
GFFASLFY 1.44% (n=4)
GFMASLFY 1.08% (n=3)
GFLASLFH 0.72% (n=2)
GFMAALFY 0.72% (n=2)
GFITALFY 0.72% (n=2)
GFIATLFF 0.72% (n=2)
GFLVSLFY 0.72% (n=2)
GFFTALFY 0.36% (n=1)
GFISALIY 0.36% (n=1)
GFIVSLFY 0.36% (n=1)
GFLGSLFY 0.36% (n=1)
GFISSLFY 0.36% (n=1)
GFLASPFY 0.36% (n=1)
GFLTSLFY 0.36% (n=1)
GFLSSLFY 0.36% (n=1)
GFVCQLFY 0.36% (n=1)
GFVTQLFY 0.36% (n=1)
GFITSLFY 0.36% (n=1)
GFIAALFF 0.36% (n=1)
GFIAALLY 0.36% (n=1)
GFIAALVY 0.36% (n=1)
GFLAALFR 0.36% (n=1)
GFIRALFY 0.36% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 2b:

GFIASLFY 67.75% (n=313)
GFLASLFY 9.31% (n=43)
GWLASLFY 9.09% (n=42)
GFIAALFY 2.81% (n=13)
GFITSLFY 2.16% (n=10)
GFMASLFY 1.08% (n=5)
GFISSLFY 1.08% (n=5)
GWIHSLFY 1.08% (n=5)
GWIASLFY 0.87% (n=4)
GCLSSLFY 0.43% (n=2)
GFFAALFY 0.43% (n=2)
GFITALFY 0.43% (n=2)
GFMAALFY 0.22% (n=1)
GFIHSLFY 0.22% (n=1)
GFIAALVY 0.22% (n=1)
GFIASLF- 0.22% (n=1)
GWLAPLFY 0.22% (n=1)
GWLASLVY 0.22% (n=1)
GWLASLLY 0.22% (n=1)
GLIASLFY 0.22% (n=1)
GFIAPLFY 0.22% (n=1)
GFLAALFY 0.22% (n=1)
GFFASLFY 0.22% (n=1)
GFIVSLFY 0.22% (n=1)
GFFAALLY 0.22% (n=1)
GFVAALFY 0.22% (n=1)
GFVAALLY 0.22% (n=1)
GFLSALFY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 2c:

GFIAALFY 91.37% (n=413)
GFLAALFY 3.32% (n=15)
GFFAALFY 0.88% (n=4)
GSIAALFY 0.88% (n=4)
GFIASLFY 0.44% (n=2)
GFLASLFY 0.44% (n=2)
GFIAALFC 0.22% (n=1)
GFVAALFY 0.22% (n=1)
GFFSALFY 0.22% (n=1)
GFIAGLIY 0.22% (n=1)
GFLTALFY 0.22% (n=1)
GWLASLFY 0.22% (n=1)
GWVAALFY 0.22% (n=1)
GFIAALFH 0.22% (n=1)
GFIAVLFY 0.22% (n=1)
GFIAALLY 0.22% (n=1)
GLIAALFY 0.22% (n=1)
GIIAALFY 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 3:

GFIAGLFY 55.42% (n=2146)
GFIAGLIY 18.26% (n=707)
GFLAGLFY 9.58% (n=371)
GFLAALFY 4.49% (n=174)
GFIAGLLY 3.31% (n=128)
GFIAGLMY 2.38% (n=92)
GFIAGLFS 1.63% (n=63)
GFIAGLFH 1.27% (n=49)
GFVAGLFY 0.65% (n=25)
GFLVGLFY 0.59% (n=23)
GFIAGLVY 0.44% (n=17)
GFIAGLFN 0.26% (n=10)
GFLAGLLY 0.15% (n=6)
GFFAGLFY 0.13% (n=5)
GFMAGLFY 0.13% (n=5)
GFVAGLIY 0.10% (n=4)
GFLAGLIY 0.10% (n=4)
GLIAGLFY 0.08% (n=3)
RFLAGLFY 0.08% (n=3)
GSIAGLFY 0.05% (n=2)
GFIAGLFR 0.03% (n=1)
GFIARLFY 0.03% (n=1)
GFIAGMFY 0.03% (n=1)
GFIAGLFC 0.03% (n=1)
GFIAGLSY 0.03% (n=1)
GFIVGLFY 0.03% (n=1)
GFIAELIY 0.03% (n=1)
EFIAGLMY 0.03% (n=1)
GSIAGLMY 0.03% (n=1)
GSIAGLLY 0.03% (n=1)
GFMAGLFN 0.03% (n=1)
RFLAGLIY 0.03% (n=1)
GSIAGLIY 0.03% (n=1)
GFIAGSFY 0.03% (n=1)
GFITGLMY 0.03% (n=1)
GFIAELFY 0.03% (n=1)
EFLAGLFY 0.03% (n=1)
GFIAGFDY 0.03% (n=1)
GFTAGLFY 0.03% (n=1)
GFLAGLMY 0.03% (n=1)
GFIAGCFY 0.03% (n=1)
GFVAGLFH 0.03% (n=1)
GS*LGCFI 0.03% (n=1)
GSLAGLIY 0.03% (n=1)
GFVAGLLY 0.03% (n=1)
GFIAGLFF 0.03% (n=1)
GFLAGLFH 0.03% (n=1)
GFLAGLVY 0.03% (n=1)
GFMAGLFH 0.03% (n=1)
GFMAGLLY 0.03% (n=1)
GFLAGLFS 0.03% (n=1)
GFIARLMY 0.03% (n=1)
G-IAGLLY 0.03% (n=1)
GFITGLFY 0.03% (n=1)
GFIAALFY 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 3a:

GFIAGLFY 62.06% (n=2017)
GFIAGLIY 14.65% (n=476)
GFLAGLFY 11.32% (n=368)
GFIAGLLY 3.26% (n=106)
GFIAGLFS 1.88% (n=61)
GFIAGLFH 1.48% (n=48)
GFIAGLMY 1.48% (n=48)
GFLVGLFY 0.71% (n=23)
GFVAGLFY 0.58% (n=19)
GFIAGLVY 0.37% (n=12)
GFIAGLFN 0.28% (n=9)
GFLAGLLY 0.18% (n=6)
GFFAGLFY 0.15% (n=5)
GFMAGLFY 0.15% (n=5)
GFVAGLIY 0.12% (n=4)
GFLAGLIY 0.12% (n=4)
GLIAGLFY 0.09% (n=3)
RFLAGLFY 0.09% (n=3)
GSIAGLFY 0.06% (n=2)
GFIAGLFR 0.03% (n=1)
GFIARLFY 0.03% (n=1)
GFIAGMFY 0.03% (n=1)
GFIAGLFC 0.03% (n=1)
GFIAGLSY 0.03% (n=1)
GFIVGLFY 0.03% (n=1)
GFIAELIY 0.03% (n=1)
EFIAGLMY 0.03% (n=1)
GSIAGLMY 0.03% (n=1)
GSIAGLLY 0.03% (n=1)
GFMAGLFN 0.03% (n=1)
RFLAGLIY 0.03% (n=1)
GSIAGLIY 0.03% (n=1)
GFIAGSFY 0.03% (n=1)
GFITGLMY 0.03% (n=1)
GFIAELFY 0.03% (n=1)
EFLAGLFY 0.03% (n=1)
GFIAGFDY 0.03% (n=1)
GFTAGLFY 0.03% (n=1)
GFLAGLMY 0.03% (n=1)
GFIAGCFY 0.03% (n=1)
GFVAGLFH 0.03% (n=1)
GS*LGCFI 0.03% (n=1)
GSLAGLIY 0.03% (n=1)
GFVAGLLY 0.03% (n=1)
GFIAGLFF 0.03% (n=1)
GFLAGLFH 0.03% (n=1)
GFLAGLVY 0.03% (n=1)
GFMAGLFH 0.03% (n=1)
GFMAGLLY 0.03% (n=1)
GFLAGLFS 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 3b:

GFIAGLIY 57.43% (n=228)
GFIAGLFY 22.42% (n=89)
GFIAGLMY 10.33% (n=41)
GFIAGLLY 5.04% (n=20)
GFIAGLVY 1.26% (n=5)
GFVAGLFY 1.26% (n=5)
GFIAGLFS 0.50% (n=2)
GFLAGLFY 0.50% (n=2)
GFIARLMY 0.25% (n=1)
GFIAGLFN 0.25% (n=1)
G-IAGLLY 0.25% (n=1)
GFIAGLFH 0.25% (n=1)
GFITGLFY 0.25% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 4:

GFIASLFY 40.18% (n=307)
GFLASLFY 36.91% (n=282)
GFIAGLFY 7.46% (n=57)
GFLAGLFY 5.63% (n=43)
GFIAGLLY 2.88% (n=22)
GFLANLFY 1.57% (n=12)
GFLAALFY 1.05% (n=8)
GFFASLFY 0.52% (n=4)
GFIAALFY 0.52% (n=4)
GFIAGLIY 0.39% (n=3)
GWLASLFY 0.39% (n=3)
GFIVSLFY 0.26% (n=2)
GFLAGLLY 0.26% (n=2)
GFLTGLFY 0.13% (n=1)
GLIASLFY 0.13% (n=1)
GFITGLFY 0.13% (n=1)
GFIASLLY 0.13% (n=1)
GFIAGLFR 0.13% (n=1)
GFMVGLFY 0.13% (n=1)
GFIAGLMY 0.13% (n=1)
GFFAALFY 0.13% (n=1)
GFVASLFY 0.13% (n=1)
GFLAGLIY 0.13% (n=1)
GWAAALFY 0.13% (n=1)
GWVASLFY 0.13% (n=1)
GWFAALFY 0.13% (n=1)
GWLAGLFY 0.13% (n=1)
GFVAGLFY 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 4a:

GFLASLFY 75.31% (n=122)
GFLAGLFY 17.90% (n=29)
GFLAALFY 3.70% (n=6)
GFFASLFY 0.62% (n=1)
GFLANLFY 0.62% (n=1)
GFLTGLFY 0.62% (n=1)
GFIAGLFY 0.62% (n=1)
GFIAGLLY 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 4d:

GFIASLFY 55.54% (n=301)
GFLASLFY 28.78% (n=156)
GFIAGLFY 8.30% (n=45)
GFIAGLLY 2.40% (n=13)
GFLANLFY 2.03% (n=11)
GFIAALFY 0.74% (n=4)
GFFASLFY 0.55% (n=3)
GFIVSLFY 0.37% (n=2)
GFLAGLFY 0.37% (n=2)
GLIASLFY 0.18% (n=1)
GFITGLFY 0.18% (n=1)
GFIASLLY 0.18% (n=1)
GFLAGLLY 0.18% (n=1)
GFIAGLFR 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 5:

GFIAGLMY 35.90% (n=14)
GFIAGLIY 17.95% (n=7)
GFIAGLFY 12.82% (n=5)
GFIAGLLY 12.82% (n=5)
GFVAGLLY 7.69% (n=3)
GFLAGLFY 5.13% (n=2)
GFIAGLVY 2.56% (n=1)
GFLAGLLY 2.56% (n=1)
GFFAGLFY 2.56% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 6:

GFIASLFY 42.70% (n=237)
GFIAGLFY 14.77% (n=82)
GFIAALFY 5.95% (n=33)
GFLAGLFY 5.77% (n=32)
GFVASLFY 4.32% (n=24)
GFIAGLLY 3.96% (n=22)
GFLASLFY 2.70% (n=15)
GFVAALFY 1.80% (n=10)
GFMAALFY 1.62% (n=9)
GFIAGLIY 1.62% (n=9)
GFMASLFY 1.26% (n=7)
GFLAGLLY 0.90% (n=5)
GFITALFY 0.72% (n=4)
GFLAALFY 0.72% (n=4)
GFIAGLMY 0.72% (n=4)
GFLAGLIY 0.72% (n=4)
GFITSLFY 0.54% (n=3)
GFLSALFY 0.54% (n=3)
GFFAALFY 0.54% (n=3)
GFIAGLFS 0.54% (n=3)
GFVAGLFY 0.54% (n=3)
GFIASLIY 0.36% (n=2)
GFIASLLY 0.36% (n=2)
GFFASLFY 0.36% (n=2)
GFLTSLFY 0.36% (n=2)
GFISALFY 0.36% (n=2)
GFLANLFY 0.36% (n=2)
GFIAGLFA 0.36% (n=2)
GFLAPLFY 0.36% (n=2)
GWLASLFY 0.36% (n=2)
GFIVSLFY 0.18% (n=1)
GFVSALFY 0.18% (n=1)
GFIASLMY 0.18% (n=1)
EFIASLFY 0.18% (n=1)
GFVAALIY 0.18% (n=1)
GFRASLFY 0.18% (n=1)
GFIAALIY 0.18% (n=1)
GFLVSLFY 0.18% (n=1)
GFFVPLFY 0.18% (n=1)
GFIAGLVY 0.18% (n=1)
GFFTALFY 0.18% (n=1)
GFLTGLLY 0.18% (n=1)
GFVTALFY 0.18% (n=1)
GFITGLFY 0.18% (n=1)
GFLAGLFN 0.18% (n=1)
GFLTGLFY 0.18% (n=1)
GFLAGLFA 0.18% (n=1)
GFFTSLFY 0.18% (n=1)
GFLSALFT 0.18% (n=1)
GFIAALLY 0.18% (n=1)
GWLAGLLY 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Subtype 6a:

GFIASLFY 70.44% (n=224)
GFVASLFY 7.55% (n=24)
GFIAALFY 6.92% (n=22)
GFLASLFY 2.83% (n=9)
GFVAALFY 2.83% (n=9)
GFMASLFY 1.57% (n=5)
GFMAALFY 1.26% (n=4)
GFITSLFY 0.94% (n=3)
GFIASLIY 0.63% (n=2)
GFIAGLLY 0.63% (n=2)
GFIASLLY 0.63% (n=2)
GFIVSLFY 0.31% (n=1)
GFITALFY 0.31% (n=1)
GFIAGLFY 0.31% (n=1)
GFVSALFY 0.31% (n=1)
GFLAALFY 0.31% (n=1)
GFIASLMY 0.31% (n=1)
GFFASLFY 0.31% (n=1)
EFIASLFY 0.31% (n=1)
GFLTSLFY 0.31% (n=1)
GFVAALIY 0.31% (n=1)
GFRASLFY 0.31% (n=1)
GFIAALIY 0.31% (n=1)
---------------------------------------------------------------------------------------
Region 436-443 (antibodies: [mAb#8] ), HCV Genotype 7:

GFIAALFY 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 415-422 (antibodies: [Mab24] ), HCV Genotype 1:

NTNGSWHI 83.66% (n=19251)
NSNGSWHI 6.63% (n=1526)
NTNGSWHL 2.33% (n=537)
NTNGSWHV 1.29% (n=296)
NANGSWHI 1.12% (n=258)
KTNGSWHI 0.96% (n=220)
STNGSWHI 0.77% (n=178)
NENGSWHI 0.23% (n=52)
HTNGSWHI 0.21% (n=48)
NTSGSWHI 0.20% (n=47)
NTNNSWHI 0.19% (n=44)
NTNGSW-- 0.16% (n=37)
KSNGSWHI 0.12% (n=28)
NASGSWHI 0.12% (n=28)
NTNGSRHI 0.12% (n=27)
NRNGSWHI 0.11% (n=26)
NTDGSWHI 0.10% (n=24)
NTNGSWHT 0.09% (n=20)
DTNGSWHI 0.08% (n=19)
NTNGSWRI 0.08% (n=18)
NSNGSWHV 0.07% (n=16)
NSSGSWHI 0.07% (n=15)
NTNSSWHI 0.05% (n=12)
NTRGSWHI 0.05% (n=12)
NTNDSWHI 0.05% (n=11)
NTNGS*HI 0.05% (n=11)
YTNGSWHI 0.05% (n=11)
NNNGSWHI 0.05% (n=11)
YSNGSWHI 0.05% (n=11)
NTNGSWYI 0.05% (n=11)
NTNGNWHI 0.04% (n=9)
NSDGSWHI 0.04% (n=9)
NTNGSCHI 0.04% (n=9)
NINGSWHI 0.03% (n=8)
NKNGSWHI 0.03% (n=8)
NPNGSWHI 0.03% (n=7)
NTNGSWLI 0.03% (n=6)
NTNGGWHI 0.03% (n=6)
NTNGSGHI 0.02% (n=4)
NTNGTWHI 0.02% (n=4)
RTNGSWHI 0.02% (n=4)
ETNGSWHI 0.02% (n=4)
NTEGSWHI 0.01% (n=3)
NSNGNWHI 0.01% (n=3)
NTNGRWHI 0.01% (n=3)
NTKGSWHI 0.01% (n=3)
TTNGSWHI 0.01% (n=3)
NTNGSWHF 0.01% (n=3)
HANGSWHI 0.01% (n=3)
NSNGSRHI 0.01% (n=3)
NTNGSRHL 0.01% (n=3)
NTNRSWHI 0.01% (n=3)
NSN----- 0.01% (n=3)
NTHGSWHI 0.01% (n=2)
NTNGSWDI 0.01% (n=2)
NSNGGWHI 0.01% (n=2)
NSNGSWRI 0.01% (n=2)
NTTGSSHI 0.01% (n=2)
NTNGSWHP 0.01% (n=2)
NANGSWHL 0.01% (n=2)
STNGSWHL 0.01% (n=2)
NTNGSWRV 0.01% (n=2)
NTNGCWHI 0.01% (n=2)
KTNGSWHV 0.01% (n=2)
NADGSWHI 0.01% (n=2)
HKNGSWHI 0.01% (n=2)
NTNGSWHN 0.01% (n=2)
ATNGSWHI 0.01% (n=2)
NSNGSWHL 0.01% (n=2)
NT------ 0.01% (n=2)
NTNGS--- 0.01% (n=2)
NTNGSWQL 0.00% (n=1)
NTNGSWHA 0.00% (n=1)
KSNGSWHS 0.00% (n=1)
KSNGSRHI 0.00% (n=1)
KTNDSWHI 0.00% (n=1)
QTNGSWHI 0.00% (n=1)
KTDGSWHI 0.00% (n=1)
NTNG-WHI 0.00% (n=1)
SSNGSWHI 0.00% (n=1)
NFNGSWHI 0.00% (n=1)
NTSGSWHT 0.00% (n=1)
NSNGSWYI 0.00% (n=1)
NSNGRWHI 0.00% (n=1)
NTNGSCAI 0.00% (n=1)
NSNGSWHT 0.00% (n=1)
SENGSWHI 0.00% (n=1)
NENGSWHV 0.00% (n=1)
NENDSWHI 0.00% (n=1)
NENGSWHT 0.00% (n=1)
NTGGSWHI 0.00% (n=1)
YTNGSWRI 0.00% (n=1)
DTSGSWHI 0.00% (n=1)
NSHGSWDI 0.00% (n=1)
NKDGSWHI 0.00% (n=1)
KANDSWHI 0.00% (n=1)
NVNDSWHI 0.00% (n=1)
NTNGSWQI 0.00% (n=1)
NTNGGWHL 0.00% (n=1)
NTNDSWHL 0.00% (n=1)
NTNGSWRL 0.00% (n=1)
NTNGSWHS 0.00% (n=1)
NTTGSWHI 0.00% (n=1)
NTNGSRHV 0.00% (n=1)
GTNGSWHV 0.00% (n=1)
NPNGGWHI 0.00% (n=1)
NTIGSWHI 0.00% (n=1)
NSIGSWHI 0.00% (n=1)
KTNGGWHI 0.00% (n=1)
KTNGRWHI 0.00% (n=1)
STNGSWHV 0.00% (n=1)
NSNGSGHI 0.00% (n=1)
NSNDSWHI 0.00% (n=1)
KENGSWHI 0.00% (n=1)
NTNVSWHI 0.00% (n=1)
KTEGNWHI 0.00% (n=1)
NTSGSWHV 0.00% (n=1)
NTNGGWHV 0.00% (n=1)
NTNAAWGT 0.00% (n=1)
NTSGSWYI 0.00% (n=1)
N------- 0.00% (n=1)
H------- 0.00% (n=1)
HTNGSWDI 0.00% (n=1)
HTNGRWHI 0.00% (n=1)
NPNGSWHF 0.00% (n=1)
HSNGSWHI 0.00% (n=1)
RANGSWHI 0.00% (n=1)
HTNGSWHV 0.00% (n=1)
NTNGSWNI 0.00% (n=1)
NNNGIWHI 0.00% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 1a:

NTNGSWHI 77.54% (n=10608)
NSNGSWHI 9.43% (n=1290)
NTNGSWHL 3.90% (n=533)
NANGSWHI 1.82% (n=249)
KTNGSWHI 1.37% (n=188)
NTNGSWHV 1.24% (n=169)
STNGSWHI 0.96% (n=132)
NENGSWHI 0.38% (n=52)
NTNNSWHI 0.32% (n=44)
KSNGSWHI 0.20% (n=27)
NTSGSWHI 0.19% (n=26)
NRNGSWHI 0.18% (n=25)
NTNGSW-- 0.13% (n=18)
NTDGSWHI 0.12% (n=16)
DTNGSWHI 0.11% (n=15)
NSSGSWHI 0.10% (n=14)
NTNGSRHI 0.10% (n=14)
NTNGSWHT 0.10% (n=13)
NSNGSWHV 0.09% (n=12)
NTRGSWHI 0.09% (n=12)
YSNGSWHI 0.08% (n=11)
NTNGS*HI 0.07% (n=10)
NTNGSWRI 0.07% (n=9)
NSDGSWHI 0.07% (n=9)
NNNGSWHI 0.07% (n=9)
NTNGSCHI 0.06% (n=8)
NKNGSWHI 0.06% (n=8)
NTNGNWHI 0.05% (n=7)
YTNGSWHI 0.05% (n=7)
NTNGSWYI 0.05% (n=7)
NPNGSWHI 0.04% (n=6)
NTNDSWHI 0.04% (n=6)
HTNGSWHI 0.04% (n=6)
NTNSSWHI 0.04% (n=5)
NINGSWHI 0.03% (n=4)
NTNGSGHI 0.03% (n=4)
NTEGSWHI 0.02% (n=3)
NTNGTWHI 0.02% (n=3)
NSNGNWHI 0.02% (n=3)
NTNGGWHI 0.02% (n=3)
NASGSWHI 0.02% (n=3)
NTNGSRHL 0.02% (n=3)
NSN----- 0.02% (n=3)
RTNGSWHI 0.02% (n=3)
NTNGSWLI 0.01% (n=2)
NTHGSWHI 0.01% (n=2)
NTNGSWDI 0.01% (n=2)
NTNGRWHI 0.01% (n=2)
NTKGSWHI 0.01% (n=2)
NTTGSSHI 0.01% (n=2)
NSNGSRHI 0.01% (n=2)
NTNGSWHP 0.01% (n=2)
NANGSWHL 0.01% (n=2)
STNGSWHL 0.01% (n=2)
NTNGSWRV 0.01% (n=2)
NTNGCWHI 0.01% (n=2)
KTNGSWHV 0.01% (n=2)
NADGSWHI 0.01% (n=2)
HKNGSWHI 0.01% (n=2)
ATNGSWHI 0.01% (n=2)
NSNGSWHL 0.01% (n=2)
NTNGSWQL 0.01% (n=1)
NTNGSWHA 0.01% (n=1)
KSNGSWHS 0.01% (n=1)
KSNGSRHI 0.01% (n=1)
KTNDSWHI 0.01% (n=1)
QTNGSWHI 0.01% (n=1)
KTDGSWHI 0.01% (n=1)
NTNG-WHI 0.01% (n=1)
SSNGSWHI 0.01% (n=1)
NFNGSWHI 0.01% (n=1)
NTSGSWHT 0.01% (n=1)
NSNGSWYI 0.01% (n=1)
NSNGRWHI 0.01% (n=1)
NTNGSCAI 0.01% (n=1)
NSNGSWHT 0.01% (n=1)
NSNGGWHI 0.01% (n=1)
NSNGSWRI 0.01% (n=1)
SENGSWHI 0.01% (n=1)
NENGSWHV 0.01% (n=1)
NENDSWHI 0.01% (n=1)
NENGSWHT 0.01% (n=1)
TTNGSWHI 0.01% (n=1)
NTGGSWHI 0.01% (n=1)
YTNGSWRI 0.01% (n=1)
NTNGSWHF 0.01% (n=1)
DTSGSWHI 0.01% (n=1)
HANGSWHI 0.01% (n=1)
NSHGSWDI 0.01% (n=1)
NKDGSWHI 0.01% (n=1)
KANDSWHI 0.01% (n=1)
NVNDSWHI 0.01% (n=1)
NTNGSWQI 0.01% (n=1)
NTNGGWHL 0.01% (n=1)
NTNDSWHL 0.01% (n=1)
NTNGSWRL 0.01% (n=1)
NTNRSWHI 0.01% (n=1)
NTNGSWHS 0.01% (n=1)
NTTGSWHI 0.01% (n=1)
NTNGSRHV 0.01% (n=1)
GTNGSWHV 0.01% (n=1)
NPNGGWHI 0.01% (n=1)
NTIGSWHI 0.01% (n=1)
NSIGSWHI 0.01% (n=1)
KTNGGWHI 0.01% (n=1)
KTNGRWHI 0.01% (n=1)
STNGSWHV 0.01% (n=1)
NSNGSGHI 0.01% (n=1)
NSNDSWHI 0.01% (n=1)
NTNGSWHN 0.01% (n=1)
KENGSWHI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 1b:

NTNGSWHI 92.81% (n=8616)
NSNGSWHI 2.46% (n=228)
NTNGSWHV 1.35% (n=125)
STNGSWHI 0.45% (n=42)
HTNGSWHI 0.43% (n=40)
KTNGSWHI 0.34% (n=32)
NASGSWHI 0.27% (n=25)
NTSGSWHI 0.22% (n=20)
NTNGSW-- 0.20% (n=19)
NTNGSRHI 0.14% (n=13)
NANGSWHI 0.10% (n=9)
NTNGSWRI 0.10% (n=9)
NTDGSWHI 0.09% (n=8)
NTNSSWHI 0.08% (n=7)
NTNGSWHT 0.08% (n=7)
NTNDSWHI 0.05% (n=5)
YTNGSWHI 0.04% (n=4)
NTNGSWLI 0.04% (n=4)
NSNGSWHV 0.04% (n=4)
NINGSWHI 0.04% (n=4)
NTNGSWYI 0.04% (n=4)
ETNGSWHI 0.04% (n=4)
DTNGSWHI 0.04% (n=4)
NTNGGWHI 0.03% (n=3)
NTNRSWHI 0.02% (n=2)
NTNGSWHF 0.02% (n=2)
NT------ 0.02% (n=2)
NNNGSWHI 0.02% (n=2)
NTNGNWHI 0.02% (n=2)
TTNGSWHI 0.02% (n=2)
HANGSWHI 0.02% (n=2)
NTNGS--- 0.02% (n=2)
NTNVSWHI 0.01% (n=1)
KTEGNWHI 0.01% (n=1)
NTSGSWHV 0.01% (n=1)
NTNGGWHV 0.01% (n=1)
NTNAAWGT 0.01% (n=1)
NTSGSWYI 0.01% (n=1)
NPNGSWHI 0.01% (n=1)
N------- 0.01% (n=1)
H------- 0.01% (n=1)
HTNGSWDI 0.01% (n=1)
HTNGRWHI 0.01% (n=1)
NTNGRWHI 0.01% (n=1)
NPNGSWHF 0.01% (n=1)
NTNGSCHI 0.01% (n=1)
NRNGSWHI 0.01% (n=1)
HSNGSWHI 0.01% (n=1)
RTNGSWHI 0.01% (n=1)
RANGSWHI 0.01% (n=1)
NSSGSWHI 0.01% (n=1)
HTNGSWHV 0.01% (n=1)
NSNGSWRI 0.01% (n=1)
KSNGSWHI 0.01% (n=1)
NTNGS*HI 0.01% (n=1)
NTKGSWHI 0.01% (n=1)
NTNGSWHN 0.01% (n=1)
NTNGTWHI 0.01% (n=1)
NSNGGWHI 0.01% (n=1)
NTNGSWHL 0.01% (n=1)
NTNGSWNI 0.01% (n=1)
NSNGSRHI 0.01% (n=1)
NNNGIWHI 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 2:

NTNGSWHI 46.30% (n=625)
NSNGSWHI 21.63% (n=292)
HTNGSWHI 7.93% (n=107)
HSNGSWHI 6.44% (n=87)
HNNGSWHI 5.93% (n=80)
STNGSWHI 3.48% (n=47)
KTNGSWHI 1.33% (n=18)
NTNGSWHV 1.26% (n=17)
HTNGSWHV 0.67% (n=9)
YTNGSWHI 0.52% (n=7)
NANGSWHI 0.52% (n=7)
NSNGSWHV 0.44% (n=6)
NNNGSWHI 0.30% (n=4)
N------- 0.30% (n=4)
NTSGSWHI 0.22% (n=3)
RNNGSWHI 0.22% (n=3)
NSSGSWHI 0.15% (n=2)
DTNGSWHI 0.15% (n=2)
NTNGSLHI 0.15% (n=2)
NSNGSWHT 0.07% (n=1)
NTNGSWHL 0.07% (n=1)
YSNGSWHI 0.07% (n=1)
NDNGSWHI 0.07% (n=1)
DTKGSWHI 0.07% (n=1)
SANGSWHI 0.07% (n=1)
KSNGSWHI 0.07% (n=1)
NKNGSWHI 0.07% (n=1)
SSNGSWHI 0.07% (n=1)
NSNGNWHI 0.07% (n=1)
KNNGSWHI 0.07% (n=1)
NTNVNWHI 0.07% (n=1)
NTNGS*HI 0.07% (n=1)
NTNSSWHI 0.07% (n=1)
NTNGSRHI 0.07% (n=1)
NTTGSWHV 0.07% (n=1)
NTNGNLHI 0.07% (n=1)
NTNGSLDI 0.07% (n=1)
NTDGSWHI 0.07% (n=1)
PMAAGW-I 0.07% (n=1)
KENGSWHI 0.07% (n=1)
YNNGSWHI 0.07% (n=1)
RTNGSWHV 0.07% (n=1)
YTNGSWHV 0.07% (n=1)
NDNGTWHI 0.07% (n=1)
NSDGSWHI 0.07% (n=1)
RSNGSWHI 0.07% (n=1)
NPNGSWHI 0.07% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 2a:

NTNGSWHI 48.78% (n=140)
NSNGSWHI 39.02% (n=112)
NTNGSWHV 3.83% (n=11)
NSNGSWHV 1.74% (n=5)
NTSGSWHI 1.05% (n=3)
NNNGSWHI 0.70% (n=2)
NSSGSWHI 0.70% (n=2)
NSNGSWHT 0.35% (n=1)
NTNGSWHL 0.35% (n=1)
KTNGSWHI 0.35% (n=1)
YSNGSWHI 0.35% (n=1)
NDNGSWHI 0.35% (n=1)
DTKGSWHI 0.35% (n=1)
DTNGSWHI 0.35% (n=1)
YTNGSWHI 0.35% (n=1)
SANGSWHI 0.35% (n=1)
NANGSWHI 0.35% (n=1)
STNGSWHI 0.35% (n=1)
KSNGSWHI 0.35% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 2b:

NTNGSWHI 75.97% (n=351)
STNGSWHI 9.74% (n=45)
NSNGSWHI 3.03% (n=14)
KTNGSWHI 3.03% (n=14)
HTNGSWHI 3.03% (n=14)
NANGSWHI 0.65% (n=3)
NNNGSWHI 0.43% (n=2)
NTNGSLHI 0.43% (n=2)
HSNGSWHI 0.22% (n=1)
NKNGSWHI 0.22% (n=1)
SSNGSWHI 0.22% (n=1)
NSNGNWHI 0.22% (n=1)
KNNGSWHI 0.22% (n=1)
NTNVNWHI 0.22% (n=1)
NTNGS*HI 0.22% (n=1)
NTNSSWHI 0.22% (n=1)
NTNGSRHI 0.22% (n=1)
NTTGSWHV 0.22% (n=1)
NTNGNLHI 0.22% (n=1)
NTNGSLDI 0.22% (n=1)
NTDGSWHI 0.22% (n=1)
YTNGSWHI 0.22% (n=1)
-----W-I 0.22% (n=1)
KENGSWHI 0.22% (n=1)
NTNGSWHV 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 2c:

NSNGSWHI 34.14% (n=155)
HTNGSWHI 19.82% (n=90)
HSNGSWHI 18.50% (n=84)
HNNGSWHI 17.62% (n=80)
NTNGSWHI 3.96% (n=18)
HTNGSWHV 1.98% (n=9)
RNNGSWHI 0.66% (n=3)
YTNGSWHI 0.66% (n=3)
NTNGSWHV 0.44% (n=2)
N------- 0.22% (n=1)
YNNGSWHI 0.22% (n=1)
KTNGSWHI 0.22% (n=1)
NANGSWHI 0.22% (n=1)
RTNGSWHV 0.22% (n=1)
NSNGSWHV 0.22% (n=1)
STNGSWHI 0.22% (n=1)
YTNGSWHV 0.22% (n=1)
NDNGTWHI 0.22% (n=1)
NSDGSWHI 0.22% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 3:

NTNGSWHI 69.70% (n=2735)
NSNGSWHI 14.40% (n=565)
RTNGSWHI 8.03% (n=315)
YTNGSWHV 2.55% (n=100)
NTNGSWYI 0.82% (n=32)
ETQGSWHI 0.61% (n=24)
NANGSWHI 0.59% (n=23)
YTNGSWHI 0.36% (n=14)
HTNGSWHI 0.31% (n=12)
ETNGSWHI 0.31% (n=12)
N------- 0.28% (n=11)
KTNGSWHI 0.18% (n=7)
STNGSWHI 0.15% (n=6)
NTNGPWHI 0.13% (n=5)
DTNGSWHI 0.13% (n=5)
NSSGSWHI 0.10% (n=4)
SSNGSWHI 0.10% (n=4)
NTNGSW-- 0.10% (n=4)
NTNGSWHV 0.10% (n=4)
NTNDSWHI 0.08% (n=3)
KSNGSWHI 0.08% (n=3)
NTSGSWHI 0.08% (n=3)
HSNGSWHI 0.08% (n=3)
NTNGSWHT 0.05% (n=2)
NTHGSWHI 0.05% (n=2)
NDSGSWHI 0.05% (n=2)
NTDGSWHI 0.05% (n=2)
ESNGSWHI 0.05% (n=2)
HNNGSWHI 0.03% (n=1)
NINGSWHI 0.03% (n=1)
NTYGSGHI 0.03% (n=1)
NTYGSLHI 0.03% (n=1)
CTNASWHI 0.03% (n=1)
NTNGSRHI 0.03% (n=1)
ETKGSWHI 0.03% (n=1)
KTGDSWHI 0.03% (n=1)
QTNGSWHI 0.03% (n=1)
KTNNSWHI 0.03% (n=1)
NDNGSWHI 0.03% (n=1)
NKNGSWHI 0.03% (n=1)
NNNGSWHI 0.03% (n=1)
NSNGS--- 0.03% (n=1)
NSNGSRHI 0.03% (n=1)
NTNGSWHL 0.03% (n=1)
NSNGSWHV 0.03% (n=1)
DSNGSWHI 0.03% (n=1)
YSNGSWHI 0.03% (n=1)
NSNGFWHI 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 3a:

NTNGSWHI 80.48% (n=2642)
RTNGSWHI 9.59% (n=315)
YTNGSWHV 3.05% (n=100)
NSNGSWHI 1.55% (n=51)
NTNGSWYI 0.97% (n=32)
ETQGSWHI 0.73% (n=24)
NANGSWHI 0.70% (n=23)
YTNGSWHI 0.37% (n=12)
HTNGSWHI 0.37% (n=12)
ETNGSWHI 0.34% (n=11)
KTNGSWHI 0.21% (n=7)
STNGSWHI 0.18% (n=6)
NTNGPWHI 0.15% (n=5)
DTNGSWHI 0.15% (n=5)
NTNGSW-- 0.12% (n=4)
NTNDSWHI 0.09% (n=3)
NTSGSWHI 0.09% (n=3)
NSSGSWHI 0.06% (n=2)
NTNGSWHT 0.06% (n=2)
KSNGSWHI 0.06% (n=2)
NTNGSWHV 0.06% (n=2)
NTHGSWHI 0.06% (n=2)
NDSGSWHI 0.06% (n=2)
NTDGSWHI 0.06% (n=2)
HNNGSWHI 0.03% (n=1)
SSNGSWHI 0.03% (n=1)
NINGSWHI 0.03% (n=1)
NTYGSGHI 0.03% (n=1)
NTYGSLHI 0.03% (n=1)
CTNASWHI 0.03% (n=1)
NTNGSRHI 0.03% (n=1)
ETKGSWHI 0.03% (n=1)
KTGDSWHI 0.03% (n=1)
QTNGSWHI 0.03% (n=1)
KTNNSWHI 0.03% (n=1)
NDNGSWHI 0.03% (n=1)
NKNGSWHI 0.03% (n=1)
NNNGSWHI 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 3b:

NSNGSWHI 83.86% (n=343)
NTNGSWHI 11.98% (n=49)
N------- 0.98% (n=4)
HSNGSWHI 0.73% (n=3)
ESNGSWHI 0.49% (n=2)
SSNGSWHI 0.49% (n=2)
NSSGSWHI 0.49% (n=2)
NSNGS--- 0.24% (n=1)
ETNGSWHI 0.24% (n=1)
YTNGSWHI 0.24% (n=1)
NSNGSRHI 0.24% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 4:

NTNGSWHI 78.67% (n=605)
NSNGSWHI 10.14% (n=78)
NKNGSWHI 3.77% (n=29)
HTNGSWHI 2.21% (n=17)
STNGSWHI 1.43% (n=11)
NTNGSWHV 0.91% (n=7)
DTNGSWHI 0.65% (n=5)
NTNGSWHL 0.52% (n=4)
NTGGSWHI 0.39% (n=3)
NSNGSWHV 0.26% (n=2)
YTNGSWHI 0.26% (n=2)
KTNGSWHI 0.26% (n=2)
NS------ 0.13% (n=1)
NTNESWHI 0.13% (n=1)
NTNGRWHL 0.13% (n=1)
YTNGSWHV 0.13% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 4a:

NTNGSWHI 41.36% (n=67)
NSNGSWHI 38.89% (n=63)
NKNGSWHI 17.90% (n=29)
NSNGSWHV 1.23% (n=2)
NS------ 0.62% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 4d:

NTNGSWHI 92.99% (n=504)
HTNGSWHI 2.58% (n=14)
STNGSWHI 2.03% (n=11)
DTNGSWHI 0.74% (n=4)
NTGGSWHI 0.55% (n=3)
YTNGSWHI 0.37% (n=2)
KTNGSWHI 0.37% (n=2)
NTNESWHI 0.18% (n=1)
NSNGSWHI 0.18% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 5:

NTNGSWHI 74.63% (n=100)
NSNGSWHI 6.72% (n=9)
HSNGSWHI 2.99% (n=4)
STNGSWHI 2.24% (n=3)
HTNGSWHI 2.24% (n=3)
NNQGSWHI 1.49% (n=2)
KTNGSWHI 1.49% (n=2)
RTNGSWHI 1.49% (n=2)
NTSGSWHI 0.75% (n=1)
NTNGSWH- 0.75% (n=1)
NTNGSCHI 0.75% (n=1)
KTGESWHI 0.75% (n=1)
KTNGA--- 0.75% (n=1)
NTNGSWYI 0.75% (n=1)
RSNGSWHI 0.75% (n=1)
ETNGSWHI 0.75% (n=1)
QNGSSWHI 0.75% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 6:

NTNGSWHI 67.82% (n=413)
NSNGSWHI 11.66% (n=71)
NSNGSWHV 5.25% (n=32)
N------- 4.76% (n=29)
NTNGSWHV 4.60% (n=28)
HTNGSWHI 0.99% (n=6)
KTNGSWHI 0.82% (n=5)
NTSGSWHI 0.33% (n=2)
NTNGSWHL 0.33% (n=2)
YTNGSWHV 0.33% (n=2)
KNGSSWHI 0.16% (n=1)
KSNGSWHI 0.16% (n=1)
NTKGSWHI 0.16% (n=1)
RTNGSWHI 0.16% (n=1)
CTNGSWHI 0.16% (n=1)
NNNGSWHI 0.16% (n=1)
HANGSWHI 0.16% (n=1)
YSNGSWHI 0.16% (n=1)
NKNGSWHI 0.16% (n=1)
NTNGRWHI 0.16% (n=1)
NTNGSRHI 0.16% (n=1)
YTNGSWHI 0.16% (n=1)
K------- 0.16% (n=1)
HTNGSWHL 0.16% (n=1)
KINGSWHV 0.16% (n=1)
KTNGSWHV 0.16% (n=1)
NTDGSWHI 0.16% (n=1)
ETNGSWHI 0.16% (n=1)
STNGSWHV 0.16% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Subtype 6a:

NTNGSWHI 87.20% (n=293)
NSNGSWHI 5.65% (n=19)
N------- 1.19% (n=4)
HTNGSWHI 0.89% (n=3)
KTNGSWHI 0.89% (n=3)
NTSGSWHI 0.60% (n=2)
KNGSSWHI 0.30% (n=1)
KSNGSWHI 0.30% (n=1)
NTKGSWHI 0.30% (n=1)
RTNGSWHI 0.30% (n=1)
CTNGSWHI 0.30% (n=1)
NNNGSWHI 0.30% (n=1)
HANGSWHI 0.30% (n=1)
YSNGSWHI 0.30% (n=1)
NKNGSWHI 0.30% (n=1)
NTNGRWHI 0.30% (n=1)
NTNGSRHI 0.30% (n=1)
YTNGSWHI 0.30% (n=1)
---------------------------------------------------------------------------------------
Region 415-422 (antibodies: [Mab24] ), HCV Genotype 7:

NTNGSWHI 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 522-526 (antibodies: [MAb44] ), HCV Genotype 1:

SGAPT 31.22% (n=3184)
SGVPT 12.75% (n=1300)
AGAPT 11.15% (n=1137)
FGVPT 8.51% (n=868)
LGAPT 8.20% (n=836)
LGVPT 7.53% (n=768)
FGAPT 5.08% (n=518)
AGAPA 3.29% (n=335)
AGVPT 2.63% (n=268)
SGEPT 1.52% (n=155)
RGVPT 1.17% (n=119)
AGIPT 1.13% (n=115)
RGAPT 0.86% (n=88)
MGAPT 0.49% (n=50)
TGVPT 0.49% (n=50)
YGVPT 0.45% (n=46)
LGQPT 0.36% (n=37)
HGVPT 0.23% (n=23)
HGAPT 0.22% (n=22)
SGTPT 0.20% (n=20)
LGHPT 0.19% (n=19)
TGAPT 0.16% (n=16)
AGTPT 0.16% (n=16)
LGDPT 0.14% (n=14)
SGMPT 0.13% (n=13)
YGAPT 0.10% (n=10)
VGVPT 0.09% (n=9)
LGTPT 0.08% (n=8)
VGAPT 0.08% (n=8)
FGTPT 0.08% (n=8)
KGAPT 0.06% (n=6)
RGMPT 0.06% (n=6)
WGVPT 0.05% (n=5)
QGAPT 0.05% (n=5)
LGLPT 0.05% (n=5)
LGVAT 0.04% (n=4)
SEAPT 0.04% (n=4)
SGLPT 0.04% (n=4)
LGALT 0.04% (n=4)
SGAST 0.04% (n=4)
LDVPT 0.03% (n=3)
WGAPT 0.03% (n=3)
LGSPT 0.03% (n=3)
SGAAT 0.03% (n=3)
PGVPT 0.03% (n=3)
SGNPT 0.03% (n=3)
FGIPT 0.03% (n=3)
KGSPT 0.02% (n=2)
SGAPS 0.02% (n=2)
QGVPT 0.02% (n=2)
PGAPT 0.02% (n=2)
AGAPS 0.02% (n=2)
SGGPT 0.02% (n=2)
VGLAY 0.02% (n=2)
SGAPA 0.02% (n=2)
LGNPT 0.02% (n=2)
SSVPT 0.02% (n=2)
FGNPT 0.02% (n=2)
DGVPT 0.02% (n=2)
TGLPT 0.02% (n=2)
ADVPT 0.01% (n=1)
SGVST 0.01% (n=1)
SGQPT 0.01% (n=1)
SCAPT 0.01% (n=1)
KGEPT 0.01% (n=1)
EGAPT 0.01% (n=1)
LNTPT 0.01% (n=1)
MGVPT 0.01% (n=1)
SGQAT 0.01% (n=1)
LGMPT 0.01% (n=1)
GRKPT 0.01% (n=1)
SGAPI 0.01% (n=1)
LGVPI 0.01% (n=1)
TGALT 0.01% (n=1)
WGAPA 0.01% (n=1)
KGIPT 0.01% (n=1)
SGHPT 0.01% (n=1)
LSAPT 0.01% (n=1)
-GAPT 0.01% (n=1)
LGIPT 0.01% (n=1)
SSAPT 0.01% (n=1)
VGAPA 0.01% (n=1)
AGVPA 0.01% (n=1)
LGVRT 0.01% (n=1)
FGVRT 0.01% (n=1)
FSVPT 0.01% (n=1)
FGARK 0.01% (n=1)
FGAST 0.01% (n=1)
FGPPT 0.01% (n=1)
FGVST 0.01% (n=1)
F---- 0.01% (n=1)
SGDPT 0.01% (n=1)
CGVPT 0.01% (n=1)
FGTAT 0.01% (n=1)
FGVPS 0.01% (n=1)
SSRRS 0.01% (n=1)
HGDPT 0.01% (n=1)
QGLPT 0.01% (n=1)
RGNPT 0.01% (n=1)
EGVPT 0.01% (n=1)
KGVPT 0.01% (n=1)
KGNPT 0.01% (n=1)
TGMPT 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 1a:

SGAPT 41.11% (n=2985)
AGAPT 15.66% (n=1137)
LGAPT 11.28% (n=819)
LGVPT 7.07% (n=513)
SGVPT 5.69% (n=413)
AGAPA 4.61% (n=335)
AGVPT 3.50% (n=254)
SGEPT 2.13% (n=155)
AGIPT 1.58% (n=115)
RGVPT 1.43% (n=104)
RGAPT 1.18% (n=86)
MGAPT 0.69% (n=50)
TGVPT 0.65% (n=47)
LGQPT 0.51% (n=37)
FGVPT 0.22% (n=16)
AGTPT 0.22% (n=16)
TGAPT 0.18% (n=13)
SGMPT 0.18% (n=13)
SGTPT 0.18% (n=13)
LGDPT 0.18% (n=13)
LGTPT 0.11% (n=8)
VGAPT 0.11% (n=8)
FGAPT 0.08% (n=6)
KGAPT 0.08% (n=6)
RGMPT 0.08% (n=6)
WGVPT 0.07% (n=5)
QGAPT 0.07% (n=5)
VGVPT 0.07% (n=5)
LGVAT 0.06% (n=4)
SEAPT 0.06% (n=4)
SGLPT 0.06% (n=4)
LGLPT 0.06% (n=4)
LGALT 0.06% (n=4)
SGAST 0.06% (n=4)
WGAPT 0.04% (n=3)
LGSPT 0.04% (n=3)
SGAAT 0.04% (n=3)
KGSPT 0.03% (n=2)
SGAPS 0.03% (n=2)
QGVPT 0.03% (n=2)
PGAPT 0.03% (n=2)
AGAPS 0.03% (n=2)
SGGPT 0.03% (n=2)
VGLAY 0.03% (n=2)
SGAPA 0.03% (n=2)
LGHPT 0.03% (n=2)
ADVPT 0.01% (n=1)
SGVST 0.01% (n=1)
SGQPT 0.01% (n=1)
SCAPT 0.01% (n=1)
LDVPT 0.01% (n=1)
KGEPT 0.01% (n=1)
EGAPT 0.01% (n=1)
HGAPT 0.01% (n=1)
HGVPT 0.01% (n=1)
LNTPT 0.01% (n=1)
MGVPT 0.01% (n=1)
SGQAT 0.01% (n=1)
LGMPT 0.01% (n=1)
GRKPT 0.01% (n=1)
SGAPI 0.01% (n=1)
LGVPI 0.01% (n=1)
TGALT 0.01% (n=1)
WGAPA 0.01% (n=1)
KGIPT 0.01% (n=1)
SGHPT 0.01% (n=1)
LSAPT 0.01% (n=1)
-GAPT 0.01% (n=1)
LGIPT 0.01% (n=1)
SSAPT 0.01% (n=1)
YGAPT 0.01% (n=1)
VGAPA 0.01% (n=1)
AGVPA 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 1b:

SGVPT 30.58% (n=887)
FGVPT 29.37% (n=852)
FGAPT 17.65% (n=512)
LGVPT 8.72% (n=253)
SGAPT 6.69% (n=194)
YGVPT 1.55% (n=45)
HGVPT 0.76% (n=22)
HGAPT 0.72% (n=21)
LGHPT 0.59% (n=17)
LGAPT 0.48% (n=14)
RGVPT 0.41% (n=12)
YGAPT 0.31% (n=9)
FGTPT 0.28% (n=8)
SGTPT 0.24% (n=7)
AGVPT 0.24% (n=7)
VGVPT 0.14% (n=4)
PGVPT 0.10% (n=3)
FGIPT 0.10% (n=3)
LGNPT 0.07% (n=2)
TGAPT 0.07% (n=2)
SSVPT 0.07% (n=2)
FGNPT 0.07% (n=2)
LDVPT 0.07% (n=2)
DGVPT 0.07% (n=2)
LGVRT 0.03% (n=1)
FGVRT 0.03% (n=1)
FSVPT 0.03% (n=1)
FGARK 0.03% (n=1)
FGAST 0.03% (n=1)
FGPPT 0.03% (n=1)
FGVST 0.03% (n=1)
F---- 0.03% (n=1)
TGVPT 0.03% (n=1)
LGDPT 0.03% (n=1)
SGDPT 0.03% (n=1)
CGVPT 0.03% (n=1)
SGNPT 0.03% (n=1)
RGAPT 0.03% (n=1)
FGTAT 0.03% (n=1)
FGVPS 0.03% (n=1)
SSRRS 0.03% (n=1)
LGLPT 0.03% (n=1)
HGDPT 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 2:

QGVPT 29.11% (n=154)
RGVPT 22.87% (n=121)
QGAPT 17.58% (n=93)
LGVPT 9.83% (n=52)
AGVPT 4.35% (n=23)
TGVPT 2.27% (n=12)
LGAPT 1.89% (n=10)
AGAPT 1.70% (n=9)
FGVPT 1.51% (n=8)
SGVPT 0.76% (n=4)
RGAPT 0.76% (n=4)
PGAPP 0.76% (n=4)
EGVPT 0.57% (n=3)
QGLPT 0.57% (n=3)
YGVPT 0.57% (n=3)
FGAPT 0.57% (n=3)
PGAPT 0.38% (n=2)
YGAPT 0.38% (n=2)
QGIPT 0.38% (n=2)
HGVPT 0.38% (n=2)
TGAPT 0.38% (n=2)
SGAPT 0.38% (n=2)
LEAPT 0.19% (n=1)
QGTPT 0.19% (n=1)
QGVAT 0.19% (n=1)
LGTPT 0.19% (n=1)
QGMPT 0.19% (n=1)
TGMPT 0.19% (n=1)
TGQPT 0.19% (n=1)
VGVPT 0.19% (n=1)
NGAPT 0.19% (n=1)
QGVPA 0.19% (n=1)
ARVPT 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 2a:

RGVPT 37.18% (n=29)
LGVPT 37.18% (n=29)
LGAPT 10.26% (n=8)
PGAPP 5.13% (n=4)
RGAPT 2.56% (n=2)
PGAPT 2.56% (n=2)
LEAPT 1.28% (n=1)
SGVPT 1.28% (n=1)
YGAPT 1.28% (n=1)
FGVPT 1.28% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 2b:

QGVPT 43.02% (n=151)
QGAPT 26.50% (n=93)
RGVPT 22.51% (n=79)
LGVPT 1.99% (n=7)
EGVPT 0.85% (n=3)
QGLPT 0.85% (n=3)
RGAPT 0.57% (n=2)
QGIPT 0.57% (n=2)
HGVPT 0.57% (n=2)
YGVPT 0.57% (n=2)
QGTPT 0.28% (n=1)
SGVPT 0.28% (n=1)
LGAPT 0.28% (n=1)
QGVAT 0.28% (n=1)
LGTPT 0.28% (n=1)
FGVPT 0.28% (n=1)
QGMPT 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 2c:

AGVPT 38.33% (n=23)
TGVPT 20.00% (n=12)
AGAPT 11.67% (n=7)
LGVPT 10.00% (n=6)
FGVPT 5.00% (n=3)
TGAPT 3.33% (n=2)
RGVPT 3.33% (n=2)
TGMPT 1.67% (n=1)
FGAPT 1.67% (n=1)
TGQPT 1.67% (n=1)
SGVPT 1.67% (n=1)
NGAPT 1.67% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 3:

KGVPT 36.70% (n=1018)
KGAPT 21.74% (n=603)
RGAPT 15.07% (n=418)
KGLPT 9.63% (n=267)
RGVPT 4.40% (n=122)
KGSPT 1.69% (n=47)
EGTPT 1.41% (n=39)
KGTPT 0.97% (n=27)
KGEPT 0.90% (n=25)
RGIPT 0.76% (n=21)
QGVPT 0.54% (n=15)
----T 0.54% (n=15)
KGNPT 0.40% (n=11)
KGIPT 0.36% (n=10)
RGLPT 0.36% (n=10)
EGVPT 0.32% (n=9)
SGAPT 0.25% (n=7)
RGSPT 0.25% (n=7)
RGTPT 0.25% (n=7)
QGAPT 0.25% (n=7)
EGAPT 0.22% (n=6)
TGVPT 0.22% (n=6)
AGAPT 0.22% (n=6)
KGMPT 0.18% (n=5)
KGDPT 0.18% (n=5)
MGAPT 0.11% (n=3)
KGRPT 0.11% (n=3)
GGAPT 0.11% (n=3)
RGNPT 0.11% (n=3)
KGAST 0.07% (n=2)
QGTPT 0.07% (n=2)
VGAPT 0.07% (n=2)
KGVPI 0.07% (n=2)
RGAST 0.07% (n=2)
RGMPT 0.07% (n=2)
TGTPT 0.07% (n=2)
EGSPT 0.07% (n=2)
KGGPT 0.04% (n=1)
KGGST 0.04% (n=1)
EGVPR 0.04% (n=1)
EG-PT 0.04% (n=1)
EGTST 0.04% (n=1)
MGTPT 0.04% (n=1)
RGQPT 0.04% (n=1)
GGVPT 0.04% (n=1)
RGEPT 0.04% (n=1)
AGMPT 0.04% (n=1)
TGKPT 0.04% (n=1)
GGSPT 0.04% (n=1)
EGNPT 0.04% (n=1)
KGVAT 0.04% (n=1)
GGTPT 0.04% (n=1)
GGDPT 0.04% (n=1)
EGVQT 0.04% (n=1)
AGVPT 0.04% (n=1)
KGVPR 0.04% (n=1)
KGEAT 0.04% (n=1)
AGKPT 0.04% (n=1)
SGSPT 0.04% (n=1)
RGALT 0.04% (n=1)
QGVAT 0.04% (n=1)
EGIPT 0.04% (n=1)
TGAPT 0.04% (n=1)
DGTPT 0.04% (n=1)
KGHPT 0.04% (n=1)
TGLPT 0.04% (n=1)
EGLPT 0.04% (n=1)
LGSPT 0.04% (n=1)
LGVPT 0.04% (n=1)
LGYPT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 3a:

KGVPT 42.42% (n=1005)
KGAPT 23.85% (n=565)
RGAPT 17.43% (n=413)
RGVPT 4.90% (n=116)
EGTPT 1.65% (n=39)
KGTPT 1.14% (n=27)
KGEPT 1.06% (n=25)
RGIPT 0.89% (n=21)
QGVPT 0.59% (n=14)
KGNPT 0.46% (n=11)
EGVPT 0.38% (n=9)
KGIPT 0.38% (n=9)
QGAPT 0.30% (n=7)
EGAPT 0.25% (n=6)
TGVPT 0.25% (n=6)
AGAPT 0.25% (n=6)
SGAPT 0.25% (n=6)
RGTPT 0.25% (n=6)
KGMPT 0.21% (n=5)
KGLPT 0.21% (n=5)
KGDPT 0.21% (n=5)
KGSPT 0.17% (n=4)
MGAPT 0.13% (n=3)
KGRPT 0.13% (n=3)
GGAPT 0.13% (n=3)
RGNPT 0.13% (n=3)
KGAST 0.08% (n=2)
QGTPT 0.08% (n=2)
VGAPT 0.08% (n=2)
KGVPI 0.08% (n=2)
RGSPT 0.08% (n=2)
----T 0.08% (n=2)
RGMPT 0.08% (n=2)
TGTPT 0.08% (n=2)
KGGPT 0.04% (n=1)
KGGST 0.04% (n=1)
EGVPR 0.04% (n=1)
RGLPT 0.04% (n=1)
EG-PT 0.04% (n=1)
EGTST 0.04% (n=1)
MGTPT 0.04% (n=1)
RGQPT 0.04% (n=1)
GGVPT 0.04% (n=1)
RGEPT 0.04% (n=1)
AGMPT 0.04% (n=1)
TGKPT 0.04% (n=1)
GGSPT 0.04% (n=1)
EGNPT 0.04% (n=1)
KGVAT 0.04% (n=1)
RGAST 0.04% (n=1)
R---- 0.04% (n=1)
GGTPT 0.04% (n=1)
GGDPT 0.04% (n=1)
EGVQT 0.04% (n=1)
AGVPT 0.04% (n=1)
KGVPR 0.04% (n=1)
KGEAT 0.04% (n=1)
AGKPT 0.04% (n=1)
SGSPT 0.04% (n=1)
RGALT 0.04% (n=1)
QGVAT 0.04% (n=1)
EGIPT 0.04% (n=1)
TGAPT 0.04% (n=1)
DGTPT 0.04% (n=1)
KGHPT 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 3b:

KGLPT 76.16% (n=262)
KGSPT 12.50% (n=43)
KGVPT 2.62% (n=9)
RGLPT 2.62% (n=9)
KGAPT 2.33% (n=8)
RGSPT 1.45% (n=5)
RGVPT 0.87% (n=3)
RGAPT 0.29% (n=1)
EGSPT 0.29% (n=1)
TGLPT 0.29% (n=1)
EGLPT 0.29% (n=1)
KGIPT 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 4:

LGVPT 57.51% (n=134)
FGVPT 13.73% (n=32)
LGAPT 6.87% (n=16)
RGVPT 5.15% (n=12)
VGVPT 2.15% (n=5)
RGAPT 2.15% (n=5)
LGLPT 1.29% (n=3)
LGDPT 1.29% (n=3)
SGSPT 0.86% (n=2)
SGVPT 0.43% (n=1)
FGAPT 0.43% (n=1)
IGLPT 0.43% (n=1)
AGLPT 0.43% (n=1)
QGIPT 0.43% (n=1)
QGDPT 0.43% (n=1)
QGAPT 0.43% (n=1)
KGNPT 0.43% (n=1)
SGDPT 0.43% (n=1)
RGNPT 0.43% (n=1)
SGNPT 0.43% (n=1)
RGIPT 0.43% (n=1)
LGIPT 0.43% (n=1)
AGAPT 0.43% (n=1)
RGYPT 0.43% (n=1)
AGNPT 0.43% (n=1)
LGHPT 0.43% (n=1)
QGVPT 0.43% (n=1)
RGTPT 0.43% (n=1)
RGHPT 0.43% (n=1)
FGLPT 0.43% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 4a:

LGVPT 72.96% (n=116)
FGVPT 20.13% (n=32)
VGVPT 2.52% (n=4)
RGVPT 1.89% (n=3)
LGAPT 0.63% (n=1)
SGVPT 0.63% (n=1)
FGAPT 0.63% (n=1)
IGLPT 0.63% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 4d:

LGAPT 53.85% (n=7)
LGVPT 23.08% (n=3)
RGAPT 23.08% (n=3)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 5:

RGYPT 47.37% (n=18)
KGNPT 7.89% (n=3)
KGYPT 7.89% (n=3)
RGCPT 7.89% (n=3)
AGVPS 5.26% (n=2)
KGLPT 2.63% (n=1)
RGLPT 2.63% (n=1)
LGHPT 2.63% (n=1)
RGVPT 2.63% (n=1)
RGFPT 2.63% (n=1)
TGNPT 2.63% (n=1)
LGYPT 2.63% (n=1)
TGYPT 2.63% (n=1)
KGHPT 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 6:

KGLPT 32.10% (n=113)
RGNPT 29.26% (n=103)
RGLPT 5.11% (n=18)
LGNPT 4.83% (n=17)
KGFPT 3.41% (n=12)
RGAPT 2.84% (n=10)
RGFPT 2.84% (n=10)
RGVPT 2.27% (n=8)
KGNPT 1.99% (n=7)
TGLPT 1.42% (n=5)
RGIPT 1.14% (n=4)
KGVPT 1.14% (n=4)
RGHPT 0.85% (n=3)
KGAPT 0.85% (n=3)
KGIPT 0.85% (n=3)
RGSPT 0.85% (n=3)
QGNPT 0.57% (n=2)
PGNPT 0.57% (n=2)
RGKPT 0.57% (n=2)
LGAPT 0.57% (n=2)
RGTPT 0.57% (n=2)
VGLPT 0.57% (n=2)
KGHPT 0.57% (n=2)
RGRPT 0.57% (n=2)
RGDPT 0.57% (n=2)
LGSPT 0.28% (n=1)
QGFPT 0.28% (n=1)
AGLPT 0.28% (n=1)
GGLPT 0.28% (n=1)
KGLPK 0.28% (n=1)
KGTPT 0.28% (n=1)
MGNPT 0.28% (n=1)
DGFAT 0.28% (n=1)
KGSAT 0.28% (n=1)
QGAPT 0.28% (n=1)
GGTPT 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Subtype 6a:

RGNPT 78.05% (n=96)
LGNPT 8.94% (n=11)
RGIPT 2.44% (n=3)
QGNPT 1.63% (n=2)
PGNPT 1.63% (n=2)
RGTPT 1.63% (n=2)
RGHPT 0.81% (n=1)
LGSPT 0.81% (n=1)
RGKPT 0.81% (n=1)
RGVPT 0.81% (n=1)
QGFPT 0.81% (n=1)
LGAPT 0.81% (n=1)
RGAPT 0.81% (n=1)
---------------------------------------------------------------------------------------
Region 522-526 (antibodies: [MAb44] ), HCV Genotype 7:

RGVPT 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 539-541 (antibodies: [MAb44] ), HCV Genotype 1:

LNN 98.05% (n=10002)
LTN 0.97% (n=99)
LNS 0.40% (n=41)
LDN 0.12% (n=12)
PNN 0.08% (n=8)
LKN 0.06% (n=6)
FNN 0.05% (n=5)
LND 0.04% (n=4)
LSN 0.03% (n=3)
LKK 0.03% (n=3)
LNT 0.02% (n=2)
SNQ 0.02% (n=2)
LTD 0.02% (n=2)
LNY 0.01% (n=1)
INN 0.01% (n=1)
LDI 0.01% (n=1)
FKN 0.01% (n=1)
SNN 0.01% (n=1)
LIN 0.01% (n=1)
LN- 0.01% (n=1)
--N 0.01% (n=1)
LNG 0.01% (n=1)
LYN 0.01% (n=1)
PKK 0.01% (n=1)
QNN 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 1a:

LNN 97.95% (n=7136)
LTN 1.32% (n=96)
LNS 0.19% (n=14)
LDN 0.14% (n=10)
PNN 0.08% (n=6)
LND 0.05% (n=4)
FNN 0.03% (n=2)
SNQ 0.03% (n=2)
LTD 0.03% (n=2)
LNT 0.01% (n=1)
LNY 0.01% (n=1)
INN 0.01% (n=1)
LDI 0.01% (n=1)
FKN 0.01% (n=1)
SNN 0.01% (n=1)
LKN 0.01% (n=1)
LSN 0.01% (n=1)
LIN 0.01% (n=1)
LN- 0.01% (n=1)
--N 0.01% (n=1)
LNG 0.01% (n=1)
LYN 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 1b:

LNN 98.44% (n=2837)
LNS 0.80% (n=23)
LKN 0.17% (n=5)
FNN 0.10% (n=3)
LKK 0.10% (n=3)
LTN 0.10% (n=3)
LSN 0.07% (n=2)
LDN 0.07% (n=2)
PNN 0.07% (n=2)
PKK 0.03% (n=1)
QNN 0.03% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 2:

LNS 98.49% (n=522)
LNT 0.38% (n=2)
LKS 0.19% (n=1)
LGS 0.19% (n=1)
LNG 0.19% (n=1)
INS 0.19% (n=1)
LSS 0.19% (n=1)
LNN 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 2a:

LNS 94.81% (n=73)
LNT 2.60% (n=2)
LKS 1.30% (n=1)
LGS 1.30% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 2b:

LNS 99.15% (n=348)
LNG 0.28% (n=1)
INS 0.28% (n=1)
LSS 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 2c:

LNS 100.00% (n=62)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 3:

LES 37.46% (n=1041)
LKS 26.88% (n=747)
LRS 12.02% (n=334)
LTS 10.40% (n=289)
LNS 3.92% (n=109)
LDS 2.73% (n=76)
LGS 2.41% (n=67)
LQS 2.20% (n=61)
LSS 0.72% (n=20)
LAS 0.68% (n=19)
LPS 0.14% (n=4)
LHS 0.11% (n=3)
LNP 0.07% (n=2)
LRA 0.07% (n=2)
LE- 0.04% (n=1)
VLS 0.04% (n=1)
VNS 0.04% (n=1)
VQS 0.04% (n=1)
VES 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 3a:

LES 43.60% (n=1033)
LKS 29.93% (n=709)
LRS 14.01% (n=332)
LGS 2.79% (n=66)
LQS 2.57% (n=61)
LTS 2.41% (n=57)
LNS 2.07% (n=49)
LDS 1.31% (n=31)
LAS 0.63% (n=15)
LHS 0.13% (n=3)
LSS 0.13% (n=3)
LNP 0.08% (n=2)
LRA 0.08% (n=2)
LE- 0.04% (n=1)
VLS 0.04% (n=1)
VNS 0.04% (n=1)
VQS 0.04% (n=1)
LPS 0.04% (n=1)
VES 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 3b:

LTS 65.80% (n=229)
LNS 17.24% (n=60)
LKS 6.03% (n=21)
LDS 4.60% (n=16)
LSS 3.16% (n=11)
LAS 0.86% (n=3)
LPS 0.86% (n=3)
LES 0.57% (n=2)
LRS 0.57% (n=2)
LGS 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 4:

LNS 92.23% (n=190)
LNT 5.34% (n=11)
LNA 0.97% (n=2)
LGS 0.49% (n=1)
MNS 0.49% (n=1)
MNA 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 4a:

LNS 99.24% (n=131)
LNA 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 4d:

LNT 84.62% (n=11)
LNS 15.38% (n=2)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 5:

LNN 89.47% (n=34)
LNS 7.89% (n=3)
MNN 2.63% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 6:

LES 50.97% (n=183)
LQS 27.58% (n=99)
LAS 3.90% (n=14)
LGS 2.79% (n=10)
LTS 1.95% (n=7)
LRS 1.95% (n=7)
LQG 1.95% (n=7)
LDS 1.39% (n=5)
MSS 1.39% (n=5)
LSS 1.39% (n=5)
LKS 0.56% (n=2)
LHS 0.56% (n=2)
LYS 0.56% (n=2)
LNS 0.56% (n=2)
YDS 0.28% (n=1)
LRN 0.28% (n=1)
LQN 0.28% (n=1)
LMS 0.28% (n=1)
LQT 0.28% (n=1)
MTS 0.28% (n=1)
MES 0.28% (n=1)
MQS 0.28% (n=1)
LTG 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Subtype 6a:

LES 88.71% (n=110)
LGS 4.84% (n=6)
LDS 3.23% (n=4)
YDS 0.81% (n=1)
LQS 0.81% (n=1)
LAS 0.81% (n=1)
LKS 0.81% (n=1)
---------------------------------------------------------------------------------------
Region 539-541 (antibodies: [MAb44] ), HCV Genotype 7:

LNS 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 548-550 (antibodies: [MAb44] ), HCV Genotype 1:

NWF 99.19% (n=8811)
SWF 0.26% (n=23)
NWL 0.08% (n=7)
GWF 0.08% (n=7)
N-- 0.05% (n=4)
NW- 0.05% (n=4)
NWS 0.05% (n=4)
DWF 0.03% (n=3)
TWF 0.03% (n=3)
N*F 0.02% (n=2)
GW- 0.02% (n=2)
NRF 0.02% (n=2)
QIV 0.02% (n=2)
AWF 0.02% (n=2)
-W- 0.01% (n=1)
KWF 0.01% (n=1)
--F 0.01% (n=1)
TWL 0.01% (n=1)
NKF 0.01% (n=1)
PWF 0.01% (n=1)
FWF 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 1a:

NWF 99.37% (n=6469)
SWF 0.09% (n=6)
NWL 0.08% (n=5)
GWF 0.08% (n=5)
N-- 0.06% (n=4)
NW- 0.06% (n=4)
NWS 0.05% (n=3)
N*F 0.03% (n=2)
GW- 0.03% (n=2)
NRF 0.03% (n=2)
QIV 0.03% (n=2)
-W- 0.02% (n=1)
DWF 0.02% (n=1)
TWF 0.02% (n=1)
KWF 0.02% (n=1)
--F 0.02% (n=1)
TWL 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 1b:

NWF 98.85% (n=2315)
SWF 0.73% (n=17)
DWF 0.09% (n=2)
NWL 0.09% (n=2)
TWF 0.09% (n=2)
NKF 0.04% (n=1)
NWS 0.04% (n=1)
PWF 0.04% (n=1)
FWF 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 2:

AWF 66.60% (n=353)
SWF 27.74% (n=147)
PWF 2.83% (n=15)
GWF 1.51% (n=8)
RWF 0.38% (n=2)
LWF 0.19% (n=1)
ACF 0.19% (n=1)
DRF 0.19% (n=1)
FWF 0.19% (n=1)
SWV 0.19% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 2a:

SWF 89.61% (n=69)
PWF 3.90% (n=3)
AWF 2.60% (n=2)
RWF 2.60% (n=2)
LWF 1.30% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 2b:

AWF 74.36% (n=261)
SWF 21.65% (n=76)
PWF 2.85% (n=10)
ACF 0.28% (n=1)
DRF 0.28% (n=1)
FWF 0.28% (n=1)
SWV 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 2c:

AWF 95.16% (n=59)
GWF 4.84% (n=3)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 3:

RWF 71.51% (n=1988)
QWF 24.21% (n=673)
RWY 2.37% (n=66)
RWL 0.72% (n=20)
GWF 0.14% (n=4)
KWF 0.14% (n=4)
PWF 0.14% (n=4)
HWF 0.11% (n=3)
RWC 0.07% (n=2)
GGL 0.07% (n=2)
RW- 0.04% (n=1)
RGF 0.04% (n=1)
RSF 0.04% (n=1)
RCF 0.04% (n=1)
RCY 0.04% (n=1)
RLF 0.04% (n=1)
ASM 0.04% (n=1)
AEM 0.04% (n=1)
SWF 0.04% (n=1)
SVV 0.04% (n=1)
R-- 0.04% (n=1)
WWF 0.04% (n=1)
LWF 0.04% (n=1)
AWF 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 3a:

RWF 67.47% (n=1599)
QWF 28.06% (n=665)
RWY 2.78% (n=66)
RWL 0.84% (n=20)
KWF 0.17% (n=4)
RWC 0.08% (n=2)
GGL 0.08% (n=2)
RW- 0.04% (n=1)
RGF 0.04% (n=1)
GWF 0.04% (n=1)
RSF 0.04% (n=1)
RCF 0.04% (n=1)
RCY 0.04% (n=1)
RLF 0.04% (n=1)
HWF 0.04% (n=1)
ASM 0.04% (n=1)
AEM 0.04% (n=1)
SWF 0.04% (n=1)
SVV 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 3b:

RWF 96.55% (n=336)
QWF 1.44% (n=5)
PWF 0.57% (n=2)
GWF 0.57% (n=2)
HWF 0.29% (n=1)
R-- 0.29% (n=1)
WWF 0.29% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 4:

AWF 87.38% (n=180)
GWF 7.28% (n=15)
SWF 3.88% (n=8)
AWY 0.49% (n=1)
CWF 0.49% (n=1)
GWY 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 4a:

AWF 99.24% (n=131)
AWY 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 4d:

AWF 92.31% (n=12)
CWF 7.69% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 5:

NWF 94.59% (n=35)
NWY 2.70% (n=1)
SWF 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 6:

GWF 43.53% (n=158)
AWF 29.48% (n=107)
GWY 18.46% (n=67)
SWF 3.86% (n=14)
PWF 1.65% (n=6)
WWF 0.83% (n=3)
RWF 0.55% (n=2)
AWV 0.28% (n=1)
AWY 0.28% (n=1)
CWF 0.28% (n=1)
VWF 0.28% (n=1)
QWF 0.28% (n=1)
YWF 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Subtype 6a:

GWF 96.80% (n=121)
AWF 2.40% (n=3)
AWV 0.80% (n=1)
---------------------------------------------------------------------------------------
Region 548-550 (antibodies: [MAb44] ), HCV Genotype 7:

SWF 100.00% (n=2)
---------------------------------------------------------------------------------------

Region 612-614 (antibodies: [MAb44] ), HCV Genotype 1:

PYR 89.84% (n=7583)
SYR 4.94% (n=417)
AYR 2.87% (n=242)
PHR 1.07% (n=90)
GYR 0.53% (n=45)
QYR 0.39% (n=33)
PYG 0.07% (n=6)
EYR 0.04% (n=3)
DYR 0.04% (n=3)
PCR 0.04% (n=3)
TYR 0.02% (n=2)
PYK 0.02% (n=2)
HYR 0.02% (n=2)
HRQ 0.02% (n=2)
LYR 0.02% (n=2)
PSR 0.02% (n=2)
SYG 0.01% (n=1)
P-- 0.01% (n=1)
HYS 0.01% (n=1)
P*- 0.01% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 1a:

PYR 87.47% (n=5712)
SYR 5.97% (n=390)
AYR 3.68% (n=240)
PHR 1.35% (n=88)
GYR 0.69% (n=45)
QYR 0.51% (n=33)
PYG 0.06% (n=4)
DYR 0.05% (n=3)
PCR 0.05% (n=3)
TYR 0.03% (n=2)
PYK 0.03% (n=2)
HYR 0.03% (n=2)
LYR 0.03% (n=2)
SYG 0.02% (n=1)
EYR 0.02% (n=1)
P-- 0.02% (n=1)
HYS 0.02% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 1b:

PYR 98.08% (n=1842)
SYR 1.44% (n=27)
AYR 0.11% (n=2)
PYG 0.11% (n=2)
PHR 0.11% (n=2)
PSR 0.11% (n=2)
P*- 0.05% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 2:

PYR 98.53% (n=470)
AYR 0.84% (n=4)
SYR 0.21% (n=1)
HHL 0.21% (n=1)
PYG 0.21% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 2a:

PYR 100.00% (n=66)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 2b:

PYR 98.86% (n=347)
SYR 0.28% (n=1)
HHL 0.28% (n=1)
PYG 0.28% (n=1)
AYR 0.28% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 2c:

PYR 100.00% (n=20)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 3:

PYR 99.64% (n=2497)
SIP 0.08% (n=2)
SYR 0.08% (n=2)
LYR 0.04% (n=1)
PSR 0.04% (n=1)
PYP 0.04% (n=1)
PYW 0.04% (n=1)
AYR 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 3a:

PYR 99.66% (n=2319)
SIP 0.09% (n=2)
SYR 0.09% (n=2)
LYR 0.04% (n=1)
PSR 0.04% (n=1)
PYP 0.04% (n=1)
PYW 0.04% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 3b:

PYR 100.00% (n=160)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 4:

PYR 96.12% (n=198)
AYR 2.43% (n=5)
SIP 0.49% (n=1)
SYR 0.49% (n=1)
QYR 0.49% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 4a:

PYR 97.73% (n=129)
AYR 0.76% (n=1)
SIP 0.76% (n=1)
SYR 0.76% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 4d:

PYR 100.00% (n=13)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 5:

PYR 97.30% (n=36)
SYR 2.70% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 6:

PYR 95.00% (n=209)
SYR 2.73% (n=6)
AYR 1.82% (n=4)
TYR 0.45% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Subtype 6a:

PYR 97.00% (n=97)
AYR 2.00% (n=2)
SYR 1.00% (n=1)
---------------------------------------------------------------------------------------
Region 612-614 (antibodies: [MAb44] ), HCV Genotype 7:

PYR 100.00% (n=2)
---------------------------------------------------------------------------------------

